<SEC-DOCUMENT>0000917520-21-000018.txt : 20210223
<SEC-HEADER>0000917520-21-000018.hdr.sgml : 20210223
<ACCEPTANCE-DATETIME>20210223172240
ACCESSION NUMBER:		0000917520-21-000018
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210223
DATE AS OF CHANGE:		20210223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		21666889

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>iart-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb,d:0e66bbc7ee8049f2984ce8179f803ee5--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iart="http://integralife.com/20201231" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV80LTEtMS0xLTA_a44cff47-9258-4985-bd22-43bf8c0df7eb">false</ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV82LTEtMS0xLTA_d3a03359-9fda-4e79-a468-c8447c0d03fe">2020</ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV83LTEtMS0xLTA_298ba369-f1e8-42c5-a78f-1f03eaffb7bc">FY</ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV8xMC0xLTEtMS0w_8d27f640-8c2e-4527-ac9d-0f46b44954d6">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTAtMS0xLTQ4MTQ_60a2b1eb-e906-4b52-95c5-e75f107ed1c2">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="icd4d43ed9aaa4295bc161260fc7b793c_D20200101-20201231" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">P1M</ix:nonNumeric><ix:nonNumeric contextRef="i6977fff2340446e5b9fddb49366b8f03_I20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzEtMS0xLTEtMA_d4ec7142-cfe6-4eda-bc0f-3c82444d2879">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ifa620d0c12614afdb67624c661a4bb74_I20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzItMS0xLTEtMA_7d917124-4a1f-40f8-b4ac-bad98f6ad59d">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ib860ee74ea084f9ba7268bd39ee3150c_I20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzMtMS0xLTEtMA_a495badd-7248-49ef-82fd-71a70201b519">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i42d8dcf211fa42229071773bf3eec9bb_I20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzQtMS0xLTEtMA_1e871729-d456-45db-b303-e4ddedf87d8b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzUtMS0xLTEtMA_ae441da0-f957-4b29-8001-8f54328b3ab3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="idabf7271b67c4332a6789f4f602fb426_I20201231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzYtMS0xLTEtMA_34472128-7e9b-4f9c-88e0-a37b386d8ec5"></ix:nonNumeric><ix:nonNumeric contextRef="i4708887913eb44ee9d09a54ce6c2ef29_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTI_0bee5ce3-e334-433a-bccf-d7c4674263bf">P6Y</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMS0xLTEtMA_e38351f4-5b5d-425e-a077-34e94f0c666d">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMi0xLTEtMA_4e90cd51-3d1f-4d71-b49b-57f61a74be5f">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMy0xLTEtMA_e6c4b7be-5d0b-44b0-81ba-ab1afb430d4a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMS0xLTEtMA_a6fc0fb3-3635-45bb-932f-45c3435aa8b4">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMi0xLTEtMA_dc88d4cd-6509-4146-b975-09f787bb29fa">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMy0xLTEtMA_f77ec525-9514-4d9a-945c-5736ce249b76">&#8212;</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i18ce1819527143ad9240d8c63f2a1b8c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ifce09928a8cc4ee6b297ba253c589b14_I20210219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7fac4ecd14854b13af640b05c1490ec6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7a841c52734456191bb4acc617e9711_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b1715655e084da08f6d9ab45911c30b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5702024fe01646a99a5c8c9d326d73b8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06366190454d4344b400d993f2607508_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46bce481a126499b834dce55ac892b0a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib76545c6be754fe480f77ca7f4e7d426_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i025e2bc5ebd44e56b9b8bbabc7eaffbb_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i917e1a0f095e414696fff9407e57d2ab_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430afd434f8f4e0b920162b510d18135_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3389b103d9454724bfcbe626c43e56b1_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6003d7368ff432dba6f6c8d16fda86c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2f87c2a02444565be0fe283d70f915f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e538c5631943ab9dc9c1111151d639_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9bf134b357c4919a6ed50721d05bef5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd3b20ac1684e6890f3b832a8159d60_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if693bb2c04eb453dab7357baad063eab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3052346d0d1e442993b001a9e6866d9c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b4835211dd45938131096fbda835e5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884dd79183f04dbd8d842cc6dd3f195f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440a16199b1a46eab8f2b708f7afaf8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979d19139f0248f7be2e1547901b2e99_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d2265b32274b0abed4046b6e8c8fbf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe917d8b4db45fca1b875cfe91360b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3690ff275714417291e650f8a4240643_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74b0cb7135c471fb7477ac4e8075cf4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497e63eb02a0453ab237c03dcd73f5c8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db0a5177566492e8f23fe58e51f50f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b32ed643324b139a34db4854dda958_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df7e9b7d0f848bfb4d01ca0a5a26007_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f66841395594a8eb57dc2f4410517fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea2b70053244d36874db3dfcc9d258a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ad1ea87dcac4b829d2588d82938711d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic061214734524284b9c2541bfba9d676_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18fa80bc94ee43818c76548c1fd3568f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3ee32a6e3c2419ba466a1eb81b4f062_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8f8ec1a3743483194234c2451da620d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c49ccb94924cfa94f6a78e004703f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17b901b49949495faaa89878c46c3086_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b55ca139a647439102e704399dd5ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2b20b5fc6546aba122baf9aa9b536c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8231a181e67848db899ebd091030a9dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92fd388308054b95b72691d24cfafc71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe61dd55956c46e7be4abd99ed4d4eca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9629a17bb5ca4cecba3ac552967e78f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c6c62a5f0c34c8d9e968867f9fdbc20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3db348720f7447a190b76b7b33df0e2a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50891c775ac2413498b01c0f0be08a09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5b9cac723b4b70971c2953732ddfed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b51f4ea22f452dad1d082f51094afb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bcc60f2ada445349c7587d684b4d230_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f95eb36b67d4b5991bd8922a0d99122_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e95fa808684df59048d6ca1ca85347_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9426879a0034a178a96eb71152c9db4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d5fad11b772466095bd787febda3045_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1c7b54ac414cadbec5a89aae8c910f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2edb072a4ba4101a8dce01c004fa0a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900361f2b62f48298b6b5a2e45b6e3d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58a11695b3447a89cd0f3f1254e39ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999b358cac9a43668d1ccf8e82ea992b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab2eadc90de4c8bb070c20656a5fbed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iart:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="reporting_unit"><xbrli:measure>iart:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i83fed34960cd4b7783e4140052f46fee_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38390ecc6ebf4364b0eaad6d1de33927_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd4d43ed9aaa4295bc161260fc7b793c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9485be95a6c24efca36864f26dd854fa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>iart:Customer</xbrli:measure></xbrli:unit><xbrli:context id="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade82fb3205f44c5a097aba1eb4be42d_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07472adf71764b7291b105f7455877fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie811913eab234ddc8c4112b2e8a244a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2156cb0dcc194220a546b328fa630c07_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6977fff2340446e5b9fddb49366b8f03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa620d0c12614afdb67624c661a4bb74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib860ee74ea084f9ba7268bd39ee3150c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d8dcf211fa42229071773bf3eec9bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idabf7271b67c4332a6789f4f602fb426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1647e4d8490d449bbdd63555d13bff5f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fdf88a449ea464f8b834eda1ecc3784_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552e291806f3436eb7cc1d37dea5b0ca_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8aeedc7aea74a4ca21f9bb6fe08f272_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d87508b86884995a4852692cd256f3c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71eebee9e7bc45b89edecf002f3b63c3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ad1d30cc6b413e8157213aa0027a9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie71dda56b32044428763726b23029626_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96624b2de4ce4641be5e012372eafc14_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38654dd730af46f2b20f7e1f70f9cb97_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73807d89fa8f442f9bcd07bd546c66fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79bfb53150fc49a6be6633a165cc595d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53063f0ec44441beaf67e6134faf51ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id364004a8c804fdf9bb65e44092e258c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51536a40efdc4ab2ad8c26840f07e52e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab11d9606b8c493e897237f5afc49895_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d98108080747959bd511b7c066fcd3_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29ef932d028d41118f879bbe261bf689_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa338878261f40e2ba360dfc8fe15384_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e089d0cd7be41ef953212d6a49bfc21_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8459aff7b64dc6a0ccd87d609c74b1_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddac580fb69647188ee6543fba4be5ed_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id88f287fd2124c55ba6e236730478cee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i118da3e2985e4e5d8bd87b7884e68786_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieffdc4cad57b47f4b1fd3d56ceefa79c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="asset"><xbrli:measure>iart:asset</xbrli:measure></xbrli:unit><xbrli:context id="ic2e05e186ade4bdfa5df3778adab6e61_I20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfedde3073f4a829d00d679dffc6b6b_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c9ff50901a4a85ad2ef0c19c9c5530_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabdc38db0fd442a69aa920353ffe2441_D20190909-20190909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:DeferredTaxAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-09</xbrli:startDate><xbrli:endDate>2019-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa850870800416cb442b162e112d697_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a2549c743743298aa4d44d68f4239e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-04</xbrli:startDate><xbrli:endDate>2019-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54369f3ad8944d81a87891c2071ad9e0_I20190104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2460cb74a44d40809765b3973c5e5005_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c97a92749542e68b530970e7f0bae2_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2741743d8a14b23aa6c8c40f03c28fa_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i822435be5fe4477c9241a3f93cf99a87_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd6869fdd4b488e8e7e6aad20f49ad8_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaffaed4533cd4d7f923869baf4414f46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a2c2dd31e44bce86f8e4abfb0af083_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a539237847c4312a3c668310be66ce7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i298c0a2f362f453e873de725dc394c2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49f96e7c8d5e48878ac299da142f760c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4830065b1af74874a4c52fb3bafa551f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c96b9a4f97464e96a052e5709abec5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf265712ad124ba89a2f02239c34e380_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6e31801eea246ef887ebfaca154f1e0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56827768c653452f9319641e79b282e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83699ed312514c98a332a62de3af0841_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65fa74c6109b4c1681870661fed5fbc5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3103df919ce14fd6a69dd88d8c19042a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b21d0525850444caddaeaa48e4a223f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe1597bfefe488e9ef0166c6fc025d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e0a93f507a747b688ad749cb942864f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5c954d5edc4790bc0a3e952a5fa55e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f9c93552d04276a8fec11d2ad465b6_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97ea17415c04e59a282e2ba0da43d2c_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3493c77a931f4e3ab849649297db9345_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc2ed32dcfc40b0983a4a55b9ff5c6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ccafd7c32d435e937a09b89142d9c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:ThreeMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic68e8212dd194d45aa7eefc82e905835_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:ThreeMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcdababe54704b90bc657174386789e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b0554dce964957a691c822f1f3043e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib885eed1bf1b439dbc39829817261b39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a06f7aaf6154a9698fb47226200c829_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib208df2927f640368f449fd7a1bab824_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9903cb1395540e6935aa24e96754aa8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79dd3445c4749509e1d9ed68b515d6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1c6073cff140ba89c5d30979e23572_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50fd52cb301e4ea99eebffb661ac3237_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if978c4aaca6e44a4bbe6ada7c5392621_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68595196347b44cbac22b32806b9b6a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aaf1027151e43ceb191ea669249f7e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1969a1e3586d4414bbe07f86c1051136_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife3e874c024d4214a79490debf6accc5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife27494f1af045df91344528d6d7bcd9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a7efef2b48401aba4a5a87989794ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bb8b17ef654169a3a82f9faae899f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccb72845f5c4cabb5085a4a21a261ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb9c27423b0432ca325ac7ec1736f68_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c52c77498d84321911b79b005966e55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f7517e74e44d0094f93c18a90e6827_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c6f3f64c6944fab4ab95454984b3ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7848c2a813504ed493eda06395e04483_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic51105541e884bc88363f2c16b76284b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21c8a2fa5834558b130cf3274625a05_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99730906a9c94d02acef61305dbefc02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66609e8dad741d88f6e535da2241aee_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76071dabaf7a463f9b7a7648e7452343_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:context id="i5431ea3c598245fb8a0ff97ff620359f_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80156bc966174b7491215c549eab3021_I20201221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd2b8368f50349cf9cd91e15a4474d2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22b15ef56d7f41dea561d0d6c48e9900_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92168257e704b7ba6330782524c310d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d930dc104ea4e35be06d768b767f67a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide7cbf63723a4f00aabbbd3146cc357d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f663fff566d4cffa41b7ce376813595_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e053946dbfa4feb8860666b23d97916_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2afcc89a124c74a254bd7642ca84b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c0daaf7584842a682f9d005209fecb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddf34cd2c7ad4523bd4a9e5bdb8a433e_I20201002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2f97b5e5ef49c59e8f51a58cdce3c9_D20201002-20201002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-02</xbrli:startDate><xbrli:endDate>2020-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c4cb8967c4415791e71b38671c9b83_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36e756e95b544b0a0fb7875d3ba1806_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92773db83f15438fafd773f6fb0a4f69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c262926c3642dc99cf046a2be2277b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11ae94eb73344fe4baa3eb613e126fd6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b7b0af6afdc4c7cb5bb5d039bd634a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73bd05d1164d4fcab0652f994e052939_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57db2cc4d5949e0b6b05067d6981e47_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48478e34f29c4b82be39b744c2f0b79c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7e15c52a94e4723b18f36e548f5062b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="idf914a28f9c1424fb32fb39c3ed8a539_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf7eee990834d3a938377a8f728b7a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54146d4c72e64bd8ac7ba073c9652d05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34576a32def44b2f86955da60a86e5a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcbce85f34d34671b93acf1d523b3e35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idea77615dc3f4d0d97ccc1e74db31850_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2309435ccb874b0c9e92d1729715a5ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f2e3f206fd240638c356c5f147eb7cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d463a647b74dbbac5a09c81ac5bbf8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib76b40dac61b4789a4966e9e25feb6e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a46df5051a4c80a3e36d832eac8967_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ac6be413b64bc6bf1f3f04ce303568_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28578860967b41c294978d5e0297abf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd250c3fbece43cca3832888e0a8c8d4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if88e234e4f3a4e5c85212a69688f3faa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91abedb43abe4a5ea0f381a1428eaea3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf11bff9c64b4754a527c74b53924753_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14091819c033463cad6998b7b746e5fc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea2b1c6283949ceaa1fd9a23141822b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55642fef06114bbbaa0e9b54ee498dcc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2518cd8291254b57a41eaca854f8ee2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i983ae52a561a4268998a536714c2506d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d848444c85b4f3aa4d2887527d13238_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788742cc668e4a9e99a0ea702ad3d42e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a622203039f4ebc8dabf0964e1920eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8694924571d49acaf88ce860616d9a7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f485cf6d3cb439c9abb0271be10b04a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a498ed728646b99350fc4768d04511_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8596a5dc2a9407fb48a1259cc8b60a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f26f3f5ca842b9bcfeb28c25b7245d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc58818c04f441f891165122cbb127a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3d3833f9944c22a925b20ef544e53c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b73e364f8cb4e7097673c44db096076_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df7db3ed850456e8523c316fdcffbe8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f198bdda2744619e39ee6d06daf04a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd87cdab9fc241a1834dc1c837593ca0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0efb49fa37042d0a1c94e20bee2ffad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1cfb7d1b2ba444ab717d976ea2463a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf7770e24164a6cb82df37fedffd4dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f21d2308620492c8147ea5fb1a29c9d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dacd48e9fb84225a7df20fc991135c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e3ca927bf2472499ec316b98adc47c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60dcf124861c4dcd8c60d1b9a2d582cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a69f1e2f244056a1abc1ef23d1d66e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id965015cdd944376a9330f2a1a1b4e90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d6723512224dd2a550d187cc37550d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81895cd4fe274608b53fe6fac2745d58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43732e30fc6543ff8f68d243116e4edb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib70bb386c50747c78872c44b364b546c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f677197bca449f96127ace53983925_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac16087789404550974baece7b19f37c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd343399440746e3bd50a65789b34828_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07cfdd65748d4ca59460e1d27696d43c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c34edcc03241479e1fdf702a89833c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a6eb3108674eb19a2f94ab9501e524_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25f07babdbf146d2bdd61ee3648d7f8b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c32a29f20594ea08849b5c78a01c303_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b8d6aac1514b89b77c76b4631e8a4d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e783237cfd44078b28b484e0a4a54e9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21a72c6dbaf94f4986204acdd33b9437_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a4bc84478844f9292b2a97d07b3b406_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d9addf58ff4b909342306f36c7c6c5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf741411a24e4f0ea99ed3515168dfcd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib46eb1c774ef46438bc4de7a317c1c18_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c81a038dd442ef966fb0c16bf36274_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68056af4a5754484b976b39412544f18_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79dcb769cedf45fd8ca2b400d2d5b642_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9eec322417b4498975fcd6677b0b74e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6dbc8b92cd747a69077527fcede8db9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcdcf2f1832a490e8de4583c2ee8ada2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06f4af4cdf347728b3fd0fe3c5c26be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f1f16c648d4e59b8f700fb4215b8de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbbe4092d3414952b63ded2528617b83_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8651611aee6c43578f75fe1703fd12b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9fe9bfb03ab426eb4daedcb791f9292_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e04a4dac0194a64b97de520023edd3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic18c09773aab473bab4a6b8ff55ea00b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb7106a152b4473997f284c52bd417a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75c1907d0ffb4c6690f775d97d70d2c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6cf137b302d469180a56297d93fb47a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4933189a9bc343b1b84567e1726af5aa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie733e2047f5a4b2aa169696427558a08_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i034043822a11407680de78bc3d1ec452_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3ef2091813046c682a8769926db401b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03f54a56c22e4237a9643f89c03a66f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb0bc85723e14b2890301593c5ad7ebb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88bd7cfc94f24140a0e0f7f140778b39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c7ab6df120c48e7bbf814ae41c07bfa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f217e07c0494603be881cbbb3995d4e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7077633fc80146898fa719dfec3ebf6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5101596f43440d6ae335163c5bd50ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f050bd2ac1429b8c14a8f6b606813a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d02ef36bfd440290608745175b9676_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i368c48b7000e48679bf0f4f0b55eb9af_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iart:ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia08ed94918db4fc09d8f42783aacc8b6_I20201207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib238505ff51c45719c413427f70bcbd0_I20201206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46a618f65cc54536b6ac22edf2a4b181_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f222fedde3d473d8469d82836a431b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:CertainPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i303b890f4cb5458b9feafec5da48c4c6_I20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0150909d1797401a995dc4ea8c351908_D20200205-20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-05</xbrli:startDate><xbrli:endDate>2020-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11fc02008134b78802f99d57c698ae8_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5677f7e2a974dc7b6ffd0e7f9e6fb9c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie462e47008de43c29915a7628f16f658_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56f741b7288452bab43bdc3b9a4da17_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1bf91d6b7164e5fbd293ba20be27e48_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0c355852c74d3ea007543365176e1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901bb4e610764e9ca257b79fa0ec7ada_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c85dafb1abd4865944b64fe294a1bf0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibebf86aa0e7747829800552078a209b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>iart:plan</xbrli:measure></xbrli:unit><xbrli:context id="i1bdab55a19f54c7cb717d1ca9d9e5ff2_D20100501-20100531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-05-01</xbrli:startDate><xbrli:endDate>2010-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2367de66733d4c9e86c3fcfb6c69836c_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ae198d152944a9bff341fb3a413ddf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a61d7f582cc439487176679b8b9d6c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705ff9d8a2094da5af5170fc081b60f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093928b71e5f461b98a025cef7849d83_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed5ceec7dc240c6b98379fe92fa71b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4708887913eb44ee9d09a54ce6c2ef29_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic58808a8f364461da081a8acfb8e751a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie560a306d89242d79633b548637d6187_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbab38d90c9b47fdbbcf4d4bb7cbfd50_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1180226ca50f46c48ae3ef906f7f99d9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b3f1452538f40ecaabbbef187076889_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58d59da5a4945d88d46c8031ef25907_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic773caffde25407cabce511afbf4e3d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i424d9c8811b649708c4148b20d4b24a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id717c22f443f4448bfd741ee42b60e90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i493a7b5721d64329a45399d533ad986c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec97182214d345158f5fdc86adce0e84_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a88c7ddb0d4436f9142a1530eb72a9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id09d3023efe741e390f961699ce66f28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d34a9446c5345f1ba23501963098bb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e70f4e6a1b48118ea9ee130e1f63ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">iart:AustriaFranceAndGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>iart:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6445287799cf40d983f351dc75cf6a15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i328cafabba8048a388b6e3eaae3d3c02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87b5e7d299f74563945c1f633f7076ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc6918309ec745bfa72b3ffa07503e44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i318233f5e7da424d999484de82e6a8ca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1747a2e124d4e99bb909cc9389b61af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee52a1107e0348d3bebdc40d768c9567_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd913cb502474113a910bca29ccf36d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0506efb6e60a43dc9e261858a7124158_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99ba8984a21448d9a3835880d4febea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71e189e172134a198e45306e30524e45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0e6743ee86466485e0e297c82bd874_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d8ce88e979437bbf5ec18f685dd329_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ca63c7a2bb40df97707e469661c625_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iart:UpThroughTaxYear2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd9f45dbd07e4b1b8f8a22de6eb41518_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceSharesandRestrictedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i915fe0a79f884cefa4d9cbc4dde21cf6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600d3779342744ec92eb111d87aab117_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a845487839e48b7893f0fdea00c7b8d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d55f040424d496588091e3d160b684b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc5a0abf78444e0842fe3e1f0f3ca37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b3b046492264f83b1bdda8c4af96853_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec541285c404f83866591c6e23fb0e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2d80105ffa4482aed85b57eea1cada_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bdd1096ee664d10a6e61b228ea2a3df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538dfb31e082468593d9ba7bb909acfa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7690a3012a274b599aaf7c76ca6b957b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8333dd78848247469f7bf32fef58b0db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77408f824582469ea836cdd585f88b2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a4563e0592c40fe8a9fa8580f8985a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i199d883ab45d4d4c923d9ec6bdebfc34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia77d428b66b340ff9b3911c6b4f91b35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0220d6c969a24d77a0ae61fb694918c6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee18fbfc3a8b42098ed3d5d2cbcb6209_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib76aeec8929647b3b5f7a4e8e1a3555f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>iart:product</xbrli:measure></xbrli:unit><xbrli:context id="i7a492f361fc641fcb8a66e8610864f1b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a577c66303495c9c64b30f3697ad11_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca2760ceb9e4f12a8d64b4b643f2254_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaebb1da81e224630986e6e6ff2c7c7f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea59ee130b064410ba6588bc3f86922c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9f30770ba94367a94a9f76eda74407_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0339f7ff81b9436da44be79de840be6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d605ea1557460e8056284eeac6508e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0b754b8abd4e25ababaec4ec893e6c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74738422d75348bcba75c40c5f3ddfcb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb51ca4dfba44ab9a951fe9bc3434c2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44e1eb3bcc0f40f5950dfd270c3208b3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab9fed755274b8bab9f12726270620d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab753bf745234f46a5d7d0762901ed84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312af3201ee346458bf3076a77de0b3e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da3dc5527e64b279b398c99855b2504_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39dc2f2111394426b38f70b228c05252_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd720fd7705748f5b9f4dd5218b65a36_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f314852dfa54284ab10723c587b8b21_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c94f499c38242379f9bbbeea658eb17_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f21d5bd0b244efd8b12f153cded75a9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e91b9abbee04f569341599829c2c727_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc989d0ee9f45a6a3f3bd44a0972156_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f47f06a0f24932a7f6cda6d309f09f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56cc64b365d84a6ca6fc1c66b40c0afe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffdd35dd74547d58bb2c5c82ed5912f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec02ac258524a4f81b14306dd3256d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec796a8dea1494f959cf4013fc839af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i487980db30c14d9298651dad86a5d2cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d472c1a60c4976af5221d730388b12_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic11b11343fea42b7b40dc6964a49dc48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bfda1bfd48c4de2b4ae4d4bdf4a010d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1cbbb9e128841cf9fa63ba54ab3ffa8_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8aec2854c5740fcb5bf9baf57f0ef8a_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia880589c0d5d4323b971f4a8272c48aa_I20210219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanAndTwoThousandOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id717ba89e124459c8d3ed604888d7343_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c8d0b64387943148ed765fd23753bc5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd07fac1f2c4ee7b985bcbb9e9e40cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474dfc678b2e48f7b2fd713e31a2915a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i634cc8f5164246f487b40cd525f33427_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied10a71639c3481ba9aefa7b862c3fbf_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab29dbb0b9741c09878d1f0e26205c2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44ad85cfd93e4d96b0dd6c63182cff35_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI3_5792f7bb-424c-46f1-9c48-c6ab8b4775c9">10-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6M2E0ZmE3MDFlZTUxNGU3NTkxYmQ0MTdlZjA1NzZiODAvdGFibGVyYW5nZTozYTRmYTcwMWVlNTE0ZTc1OTFiZDQxN2VmMDU3NmI4MF8wLTAtMS0xLTA_5f197cfc-e615-4350-b7d9-9b4faf9e6b17">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended  <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18xMDk5NTExNjMxMDA3_4f87b79c-f1d3-4883-a7af-913a07e5895a"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18xMDk5NTExNjMxMDA3_e387a1eb-bdc9-4ecd-acba-80870238d35a">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6NzkxNGU4N2M1YWQ1NGU4NGEyMTBmZTk1YmZlYTBiMGYvdGFibGVyYW5nZTo3OTE0ZTg3YzVhZDU0ZTg0YTIxMGZlOTViZmVhMGIwZl8wLTAtMS0xLTA_4df9fde3-3729-472d-9613-a3792860c713">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NO. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIx_744259fe-9e71-41a0-a75c-7ac451933483">0-26224</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIy_e30ec496-8126-486e-adb2-eea0f5e8c6b9">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8wLTAtMS0xLTA_5967d9be-ba33-43a3-afc2-265ebc54a7ca">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8wLTQtMS0xLTA_4c09c422-0c09-40c9-9f19-ab5f86afc3e2">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(STATE OR OTHER JURISDICTION OF<br/>INCORPORATION OR ORGANIZATION)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. EMPLOYER<br/>IDENTIFICATION NO.)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8zLTAtMS0xLTA_05a1ee74-ec56-4696-93b5-9fac4a4e37d2">1100 Campus Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8zLTQtMS0xLTA_4d9a6043-a4e3-4755-9ae4-cdbe703065b2">08540</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl80LTAtMS0xLTA_f7768684-8f74-4638-af63-1ca0fbcf3b49">Princeton</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl80LTItMS0xLTA_d5c58022-866c-4145-ac7f-74285a8b9313">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ZIP CODE)</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIz_21da938f-d114-459f-95b2-60e17ded6fca">609</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE3_39b9d158-7ac7-4177-9c39-760b6ed4d075">275-0500</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:37.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTAtMS0xLTA_64801ed8-7eac-4684-8f3f-51b33167ddcc">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTEtMS0xLTA_a3db5686-9894-4d89-93c3-2f9bb12808b8">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTItMS0xLTA_51a7e9de-4ec4-49d7-b8ce-3ac92e99f264">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NONE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI0_db8eff97-9c95-42a1-b664-51a1d986e874">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE4_370690c3-2215-4653-a854-b45e74e2e139">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE5_1460a25c-3517-4908-aacd-1ba4f70a0e3e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI1_bb86f443-101c-4030-9471-9c42eda4849f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN18wLTAtMS0xLTA_9f92cb49-5aa1-4b15-a467-8368dc5b2780">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN18yLTMtMS0xLTA_ae6d013c-5eef-4472-a842-9e7d75fc1502">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN180LTEtMS0xLTA_37ae44af-0f7b-4087-93a9-91b60ec54656">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check if the registrant has elected not to use the extended transition period for complying with any new revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18zMjk4NTM0ODg2Njgx_4c3cec57-7f39-4b1a-b997-e90a420c539b">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18zMjk4NTM0ODg2Njky_47e1432d-4d38-42cf-9bbd-a7c8393fd067">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2020, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="i18ce1819527143ad9240d8c63f2a1b8c_I20200630" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yMzc1_706ea729-279a-4ca3-8c28-06440024feb6">3,370.2</ix:nonFraction> million based upon the closing sales price of the registrant&#8217;s common stock on The Nasdaq Global Select Market on such date. The number of shares of the registrant&#8217;s Common Stock, $0.01 par value, outstanding as of February&#160;19, 2021 was <ix:nonFraction unitRef="shares" contextRef="ifce09928a8cc4ee6b297ba253c589b14_I20210219" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yNTky_8a2e3d85-ace1-455b-a9dd-c34bf674b741">84,369,946</ix:nonFraction>.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI2_dd5a317c-cca1-4f6b-9ae4-dae815b346b6" escape="true">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;14, 2021 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:90.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_10">PART&#160;I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_13">Item 1.      Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_16">Item 1A.   Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_16">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_22">Item 1B.   Unresolved Staff Comment</a></span><span style="color:#1a3cbf;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_22">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_25">Item 2.      Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_25">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_28">Item 3.      Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_28">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_31">Item 4.      Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_31">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_34">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_37">Item 5.     Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_37">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_40">Item 6.     Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_40">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_43">Item 7.     Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_43">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_73">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_73">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_79">Item 8.     Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_79">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_82">Item 9.     Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_82">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_85">Item 9A.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_85">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_88">Item 9B.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_88">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">Item 10.   Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">Item 11.   Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matter</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">Item 13.   Certain Relationships, Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">Item 14.   Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_91">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_109">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_112">Item 15.    Exhibits and Financial Statements Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_112">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_115">Item 16.    Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_115">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_118">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_118">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company&#8221; and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries, unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, headquartered in Princeton, New Jersey, is a world leader in medical technology. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds, to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical devices, advanced wound care products, and orthopedic hardware through a combination of several global acquisitions and development of products internally to further meet the needs of its customers and impact patient care.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and sell our products in two reportable business segments: Codman Specialty Surgical and Orthopedics and Tissue Technologies. Our Codman Specialty Surgical products are comprised of specialty surgical implants and instrumentation for a broad range of specialties. This segment includes products and solutions for dural access and repair, instruments, advanced energy, cerebral spinal fluid ("CSF") management and neuro monitoring including market-leading product portfolios used in neurosurgery operating suites and critical care units. Codman Specialty Surgical products are sold through a combination of directly employed sales representatives, distributors and wholesalers, depending on the customer call point. Our Orthopedics and Tissue Technologies product portfolio consists of differentiated regenerative technology products for soft tissue repair and tissue regeneration products and surgical reconstruction. This business also includes private label sales of a broad set of our regenerative and wound care medicine technologies. Orthopedics and Tissue Technologies products are sold through directly employed sales representatives and distributors focused on their respective surgical specialties, and by strategic partners. In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately&#8239;$240&#8239;million in cash. This transaction enables us to increase our investments in our business which will strengthen our existing leadership positions in both areas, fund pipeline opportunities to drive future growth and expand our addressable markets. See Note 18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, New Jersey, Ohio, Massachusetts, Tennessee, Canada, France, Germany, Ireland, Switzerland, and Puerto Rico. We also source most of our handheld surgical instruments and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vision</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aspire to continue to be a worldwide leader in neurosurgery and reconstructive surgery, with a portfolio of leading businesses that delivers outstanding customer experiences through innovation, execution and teamwork to positively impact the lives of millions of patients and their families.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) building an execution-focused culture, 2) optimizing relevant scale, 3) improving agility and innovation, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned tuck-in acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. In December 2020, Integra entered into a merger agreement to acquire ACell, Inc., an innovative regenerative medicine company. This acquisition, which closed on January 20, 2021, expands our product offering of regenerative technology and is complementary to Integra&#8217;s existing tissue technologies portfolio. The acquisition also supports our long-term growth and profitability strategy with a financial profile similar to Integra&#8217;s tissue products. In 2020, we continued to invest in our two recent acquisitions from 2019, Arkis Biosciences, Inc. and Rebound Therapeutics Corporation, both of which are developing innovative technologies for neurosurgery. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Optimization and New Product Introductions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises and are focused on the potential for significant returns on investment. In February 2020, we launched the AmnioExcel&#174; Plus Placental Allograft Membrane, the next generation wound care offering to support soft tissue repair. Throughout 2020, we continued to reap the benefits of many of our 10 new product launches from 2019. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">existing products. We continue to identify ways of optimizing our portfolio including identifying low-growth, low-margin products and product franchises for discontinuation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately&#8239;$240&#8239;million in cash. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;With acquisitions, new product introductions and a broad portfolio of products, investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. Internationally, we have increased our commercial resources significantly in many markets and are making investments to support our sales organization and maximize our commercial opportunities. We now have a strong international sales channel that delivers our current portfolio as well as positions us for future expansion. In addition, we continue to build upon our leadership brands across our product franchises, enabling us to engage customers through enterprise-wide contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthen our relationships with all customers. We strive to consistently deliver outstanding customer service and continue to invest in technologies, systems and processes to improve the way our customers do business with us. Additionally, we utilize professional education programs to drive customer familiarity with our growing portfolio of medical technologies globally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS SEGMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra currently manufactures and sells our products and technologies in the following two global reportable business segments: Codman Specialty Surgical and Orthopedics and Tissue Technologies. We include financial information regarding our reportable business segments and certain geographic information under "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations", Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Codman Specialty Surgical</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Codman Specialty Surgical business offers global, neurosurgery market-leading technologies, brands and instrumentation. The product portfolio represents a continuum of care from pre-operative, to the neurosurgery operating room, to the neuro-critical care unit and post care for both adult and pediatric patients suffering from brain tumors, brain injury, cerebrospinal fluid pressure complications and other neurological conditions. We offer leading technologies in dural repair, ultrasonic tissue ablation, intracranial pressure ("ICP") monitoring, hydrocephalus management, and cranial stabilization systems, while providing a rich research and development pipeline for growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rounding out the portfolio is a catalog of surgical headlamps, surgical instrumentation, as well as after-market service. With thousands of surgical instrument products, including specialty surgical instruments, we call on the central sterile processing unit of hospitals and acute care surgical centers. Additionally, through a strong U.S. distribution model, we can serve the needs of hundreds of medical offices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orthopedics and Tissue Technologies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orthopedics and Tissue Technologies products serves some of the fastest growing markets in the medical technology industry. The broad range of regenerative tissue technologies primarily address the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made significant investments with our channel expansion in the U.S. and created dedicated sales channels to have more focus and specialization within our call points to drive sustainable growth. We have a specialized sales organization composed of directly employed sales representatives, as well as specialty distributors, organized based upon their call point. Our wound reconstruction sales representatives call on surgeons doing procedures in limb salvage, trauma, wound reconstruction and burns, and on physicians who treat chronic wounds in the outpatient wound care clinic setting. We also have a dedicated surgical reconstruction sales team focused on plastic and reconstructive surgery and hernia procedures with differentiated products. Finally, we have a distributor network focused on biologics.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., we have a combination of direct and indirect channels in our international markets to sell certain product lines.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business segment also includes private-label sales of a broad set of our regenerative and wound care technologies. Our customers are other medical technology companies that sell to end markets primarily in orthopedics, spine, surgical and wound care.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors for Codman Specialty Surgical are Medtronic, Inc., Stryker Corporation, Becton Dickinson and Company and Aesculap division of B. Braun Medical, Inc. In addition, we compete with many smaller specialized companies and larger companies that do not otherwise focus on the offerings of Codman Specialty Surgical technologies. We rely on the depth and breadth of our sales and marketing organization, our innovative technology, and our procurement and manufacturing operations to maintain our competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competition in Orthopedics and Tissue Technologies includes the DePuy/Synthes business of Johnson &amp; Johnson, Stryker Corporation, Smith &amp; Nephew plc, MiMedx Group, Inc., LifeCell Corporation, a subsidiary of Allergan PLC, and Zimmer Biomet Holdings, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our products also compete against medical practices that treat a condition without using a medical device or any particular product, such as medical practices that utilize autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products. Depending on the product line, we compete based on our products' features, strength of our sales force or distributors, sophistication of our technology and cost effectiveness of our solution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT STRATEGY </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities focus on identifying unmet surgical needs and addressing those needs with innovative solutions and products. We apply our core competency in regenerative technology to products for neurosurgical, orthopedic and wound applications, plastic surgery, and reconstructive surgery and we have extensive programs for our core platforms of orthopedic hardware and electromechanical technologies.  Additionally, we conduct products and clinical studies to generate efficacy and health economic evidence.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regenerative Technologies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra was the first Company to receive a United States Food and Drug Administration ("FDA") claim for regeneration of dermal tissue and is a world leader in regenerative technology. Because regenerative technology products represent a fast-growing, high-margin opportunity for us, we allocate a large portion of our research and development budget to these projects. Our regenerative technology development program applies our expertise in bioengineering to a range of biomaterials including natural collagen and human tissues as well as synthetics such as polymers. These unique product designs are used for neurosurgical and orthopedic surgical applications, as well as dermal regeneration, including the healing of chronic and acute wounds, tendon and nerve repair. Our regenerative technology platform includes our legacy Integra&#174; Dermal Regeneration Template (IDRT) products and complementary technologies that we have acquired over the last few years. Our collagen manufacturing capability, combined with our history of innovation, provides us with strong platform technologies for multiple indications. We also continued to benefit from our 2019 product launches, such as DuraGen&#174; in Japan which is the first and only non-autologous collagen xenograft approved for use as a dural substitute in Japan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2020, we launched AmnioExcel&#174; Plus Placental Allograft Membrane, a human placental tissue product for treatment of wounds. Additionally, the Company announced positive clinical and economic data on Integra&#174; Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons looks for ways to efficiently and effectively repair and close wounds during these challenging times, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orthopedic Reconstruction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We developed fixation and small joint reconstruction implants and instruments for upper and lower extremities to both provide next generation solutions and expand our product portfolio. This portfolio focuses on joint replacement products. Integra has a strong shoulder portfolio, which includes a total shoulder system and a reverse shoulder. We continue to work on advanced shoulder products and are developing next generation anatomical designs, bone preserving products and techniques, and a pyrocarbon shoulder hemiarthroplasty product to add to that portfolio. We have a strong differentiated asset that resides in our patented pyrocarbon products, and we continue to invest to bring new products to market with this technology, which has shown significantly less wear on bone than traditional metals. We also continued to benefit from the 2019 U.S. product launches, such as the Panta&#174; II TTC Arthrodesis Nail System. The Panta II system is our new fusion nail used in ankle fixation. We also launched a small post baseplate in our reverse shoulder system that accommodates smaller patients. In addition, we initiated the limited market release of enhancements to our Salto Talaris&#174; Total Ankle System.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Electromechanical Technologies and Instrumentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Because our electromechanical products and instruments address significant needs in surgical procedures and limit uncertainty for surgeons, we continue to invest in approvals for new indications and next generation improvements to our market-leading products. We have several active programs focused on life cycle management and innovation, for capital and disposable products in our portfolio. Our product development efforts are focused on core clinical applications in cerebral spinal fluid ("CSF") management, neuro-critical care ("NCC") monitoring, minimally invasive instruments and electrosurgery and ultrasonic medical technologies. In the Codman Specialty Surgical segment, our focus is also on the new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas&#8482; Plus Programmable Valve along with additional shunt configurations. Our lighting franchise is among the most </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dynamic in the industry. We continue to work with several instrument partners to bring new surgical instrument platforms to the market. This enables us to add new instruments with minimal expense and invest in ongoing development, such as our next generation of LED technology with our DUO LED Surgical Headlight System&#8482;. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop core clinical applications in our electromechanical technologies portfolio. In 2020, we updated our CUSA Clarity platform to incorporate a new ultrasonic handpiece, surgical tips and integrated electrosurgical capabilities. In addition, the CUSA&#174; Clarity Ultrasonic Surgical Aspirator System was cleared to treat malignant and benign tumors, but not limited to meningiomas and gliomas. It is the first and only ultrasonic tissue ablation system with this specific indication. The FDA clearance is based on a wealth of peer-reviewed clinical publications and 40 years of surgical cases involving resection of brain and spinal tumors. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Throughout the year, we continued to advance the early-stage technology platforms we acquired in 2019. Through the Arkis Biosciences acquisition, we added a platform technology, CerebroFlo&#174; external ventricular drainage (EVD) catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. We also acquired a company, Rebound Therapeutics, developers of a single-use medical device known as the AURORA Surgiscope&#174; System ("Aurora") that enables minimally invasive access with enhanced lighting and visualization to the neurosurgery suite.  Importantly, these new platforms provide us with the opportunity to expand into new, faster growth therapeutic areas, such as intracerebral hemorrhage and minimally invasive neurosurgery.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, raw materials essential to our businesses are readily available from multiple sources. For reasons of quality assurance, availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. Our practice is to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products, including but not limited to our dermal regeneration products, duraplasty products, wound care products, bone void fillers, nerve and tendon repair products, contain material derived from bovine tissue. We take great care to provide products that are safe and free of agents that can cause disease. In particular, the collagen used in the products that we manufacture is derived either from the deep flexor tendon of cattle less than 24 months old from New Zealand, a country that has never had a reported case of bovine spongiform encephalopathy (&#8220;BSE&#8221;) (otherwise known as mad cow disease), or from the U.S. or from fetal bovine dermis. The World Health Organization classifies different types of cattle tissue for relative risk of BSE transmission. Deep flexor tendon and fetal bovine skin are in the lowest-risk category for BSE transmission, and therefore considered to have a negligible risk of containing the agent that causes BSE.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek patent and trademark protection for our key technology, products and product improvements, both in the U.S. and in selected foreign countries. When determined appropriate, we have enforced and plan to continue to enforce and defend our patent and trademark rights. In general, however, we do not rely solely on our patent and trademark estate to provide us with any significant competitive advantages as it relates to our existing product lines. We also rely upon trade secrets and continuing technological innovations to develop and maintain our competitive position. In an effort to protect our trade secrets, we have a policy of requiring our employees, consultants and advisors to execute proprietary information and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements also provide that all confidential information developed or made known to the individual during the course of their relationship with us must be kept confidential, except in specified circumstances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AccuDrain&#174;, Algicell&#174;, AmnioExcel&#174;, AmnioMatrix&#174;, Aquasonic&#174;, Auragen&#174;, Bactiseal&#174;, BioBlock&#174;, BioDFactor&#174;, BioDFence&#174;, BioDOptix&#174;, BioDRestore&#8482;, Bioguard&#174;, BioMotion&#174;, Bold&#174;, Brainet&#174;, Budde&#174;, Buzz&#8482;, Capture&#8482;, CereLink&#8482;, CerebroFlo&#174; EVD Catheter with Endexo&#174; Technology, Certas&#174;, Codman&#174;, Codman Accu-Flo&#174;, Codman Bicol&#174;, Codman Certas&#174;, Codman Hakim&#174;, Codman Holter&#174;, Codman ICP Express&#174;, Codman Microsensor&#174;, Codman VersaTru&#174;, Codman VPV&#174;, Contour-Flex&#174;, Cranioplastic&#174;, CRW&#174;, CRW Precision&#8482;, Cterm&#8482;, CUSA&#174;, DigiFuse&#174;, DirectLink&#174;, DuraGen&#174;, DuraSeal&#174;, Endorelease&#8482;, First Choice&#174;, HeliCote&#174;, HeliPlug&#174;, HeliTape&#174;, HeliMend&#174;, Helistat&#174;, Helitene&#174;, Hermetic&#8482;, Hy-Tape&#174;, ICP Express&#174;, Integra&#174;, IntegraLink&#174;, IPP-ON&#174;, Isocool&#174;, Jarit&#174;, Katalyst&#8482;, Lead-Lok&#8482;, Licox&#174;, LimiTorr&#8482;, Luxtec&#174;, Mayfield&#174;, MediHoney&#174;, MemoFix&#174;, MicroFrance&#174;, Miltex&#174;, Mischler&#8482;, MoniTorr ICP&#8482;, Movement&#174;, Natus&#174;, NeuraGen&#174;, NeuraWrap&#8482;, Nicolet&#174;, NuGrip&#174;, Omnigraft&#174;, Omni-Tract&#174;, OSV II&#174;, Padgett&#174;, PriMatrix&#174;, Pureflow&#8482;, PyroSphere&#174;, Q-Snor&#8482;, Qwix&#174;, Redmond&#8482;, Revize&#8482;, Ruggles&#174;, SafeGuard&#174;, Signacreme&#174;, Spider&#8482;, Spin&#174;, Subtalar MBA&#174;, SurgiMend&#174;, TCC-EZ&#174;, TenoGlide&#174;, Ti6&#174;, Tibiaxys&#174;, TissueMend&#174;, TruArch&#174;, Ultra VS&#8482;, Uni-CP&#174;, Uni-Clip&#174;, VersaTru&#174;, Xtrasorb&#174;, zRIP&#8482;, and the Integra logo are some of the material trademarks of Integra LifeSciences Corporation and its subsidiaries. MAYFIELD&#174; is a registered trademark of SM USA, Inc., and is used by Integra under license.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEASONALITY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues during our fourth quarter tend to be stronger than other quarters because many hospitals increase their purchases of our products during the fourth quarter to coincide with the end of their budget cycles in the U.S. In general, our first quarter usually has lower revenues than the preceding fourth quarter, the second and third quarters have higher revenues than the first quarter, and the fourth quarter revenues are the highest in the year. The main exceptions to this pattern occur because of material acquisitions as well as impacts of the novel coronavirus ("COVID-19") in 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic on our business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization recognized the novel strain of coronavirus, COVID-19, as a pandemic.&#8239;This coronavirus outbreak has significantly impacted both the world and U.S. economies.&#8239;In response to this coronavirus outbreak, the governments of many cities, counties, states and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations and are advising or requiring individuals to limit or forego their time outside of their homes which has created significant uncertainties in the U.S. economy.&#8239;In certain geographic regions in which the Company operates, temporary closures of businesses have been ordered or suggested and numerous other businesses have temporarily closed voluntarily.&#8239;Further, individuals' ability to travel has been curtailed through mandated travel restrictions and may be further limited through additional voluntary or mandated closures of travel-related businesses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's focus during this global crisis remains on supporting patients, providing customers with life-saving products, and protecting the well-being of our employees. The rapid and evolving spread of the virus has resulted in an unprecedented challenge to the global healthcare industry, as medical resources are reallocated to fight COVID-19. During 2020, we were able to sustain ongoing operations by implementing contingency plans such as enabling its manufacturing and distribution sites around the world to continue operating at levels required to meet demand and to provide for the safety of our employees. During April of 2020, the Company implemented cost-savings measures, which included the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced executive management compensation through July 2020 and director compensation;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced cash compensation for all other employees through reduced commissions, reduction in hours through July 2020 and/or furloughs;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hiring freeze, elimination of overtime, reduction in certain employee benefit costs, cessation of third-party services and temporary contractor relationships; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant reduction in capital expenditures and discretionary spending including travel, events and marketing programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company restored employee wages and other spending in the third quarter of 2020, as revenues sequentially increased approximately 43.1% as compared to the second quarter of 2020. We also continue to implement programs and strategies to effectively manage the business during the pandemic, such as partnering with key opinion leaders to increase our customer engagement through educational webinars and to improve the clinical components of sales training. We remain confident that the underlying markets in which the Company competes remain attractive over the long term. We also remain focused on managing the business for the long-term, including preserving full time jobs needed to support the rebound in surgical procedure volumes. The Company's adaptability and resiliency in the face of this unprecedented crisis is made possible in part by prior investments in technology infrastructure and operations, as well as by our talented and committed global workforce. Throughout this period, we continue to prioritize and invest in critical R&amp;D and clinical programs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to additional risk factors as it relates to the COVID-19 pandemic can be found in Item 1A. Risk Factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION AND COMPLIANCE</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a manufacturer and marketer of medical devices, and therefore are subject to extensive regulation by the FDA, the Center for Medicare Services of the U.S.&#160;Department of Health and Human Services, other federal governmental agencies and, in some jurisdictions, by state and foreign governmental authorities. These regulations govern the introduction of new medical devices, the observance of certain standards with respect to the design, manufacture, testing, labeling, promotion and sales of the devices, the maintenance of certain records, the ability to track devices, the reporting of potential product defects, the import and export of devices, and other matters. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Food and Drug Administration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory process for obtaining product approvals and clearances can be onerous and costly. The FDA requires, as a condition to marketing a medical device in the U.S., that we secure a Premarket Notification clearance pursuant to Section&#160;510(k) of the Federal Food, Drug and Cosmetic Act (the &#8220;FD&amp;C Act&#8221;) or an approved premarket approval ("PMA") application (or supplemental PMA application). Obtaining these approvals and clearances can take up to several years and may involve preclinical studies and clinical trials. The FDA also may require a post-approval clinical study as a condition of approval. To perform clinical trials for significant risk devices in the U.S. on an unapproved product, we are required to obtain </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an Investigational Device Exemption ("IDE") from the FDA. The FDA may also require a filing for approval prior to marketing products that are modifications of existing products or new indications for existing products. Moreover, after clearance/approval is given, if the product is shown to be hazardous or defective, the FDA and foreign regulatory agencies have the power to withdraw the clearance or approval, as the case may be, or require us to change the device, its manufacturing process or its labeling, to supply additional proof of its safety and effectiveness or to recall, repair, replace or refund the cost of the medical device. Because we currently export medical devices manufactured in the U.S. that have not been approved by the FDA for distribution in the U.S., we are required to obtain approval/registration in the country to which we are exporting and maintain certain records relating to exports and make these available to the FDA for inspection, if required. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Cells, Tissues and Cellular and Tissue-Based Products </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, through the acquisition of Derma Sciences and BioD LLC ("BioD") is involved with the recovery, processing, storage, transportation and distribution of donated amniotic tissue. The FDA has specific regulations governing human cells, tissues and cellular and tissue-based products, or HCT/Ps. An HCT/P is a product containing, or consisting of, human cells or tissue intended for transplantation into a human patient. Examples of HCT/P include bone, ligament, skin and cornea. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some HCT/Ps fall within the definition of a biological product, medical device or drug regulated under the FD&amp;C Act. These biologic, device or drug HCT/Ps must comply both with the requirements exclusively applicable to HCT/Ps and, in addition, with requirements applicable to biologics, devices or drugs, including premarket clearance or approval from the FDA. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;361 of the Public Health Service Act (&#8220;Section 361&#8221;), authorizes the FDA to issue regulations to prevent the introduction, transmission or spread of communicable disease. HCT/Ps regulated as &#8220;361&#8221; HCT/Ps are subject to requirements relating to registering facilities and listing products with the FDA, screening and testing for tissue donor eligibility, and Good Tissue Practices when processing, storing, labeling, and distributing HCT/Ps, including required labeling information, stringent record keeping, and adverse event reporting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Association of Tissue Banks (&#8220;AATB&#8221;) has issued operating standards for tissue banking. Compliance with these standards is a requirement in order to become an AATB-accredited tissue establishment. In addition, some states have their own tissue banking regulations. We are licensed or have permits for tissue banking in California, Delaware, Illinois, Maryland, New York, Oregon, and Tennessee. In Tennessee, we are registered with the FDA Center for Biological Evaluations and Research.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">National Organ Transplant Act</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Procurement of certain human organs and tissue for transplantation is subject to the restrictions of the National Organ Transplant Act, which prohibits the transfer of certain human organs, including skin and related tissue for valuable consideration, but permits the reasonable payment associated with the removal, transportation, implantation, processing, preservation, quality control and storage of human tissue and skin. Our subsidiary, BioD LLC is a registered Tissue Bank and is involved with the recovery, storage and transportation of donated human amniotic tissue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2015, the FDA issued an Untitled Letter (the "Untitled Letter") alleging that BioD's morselized amniotic membrane tissue based products do not meet the criteria for regulation as HCT/Ps solely under Section 361 of the Public Health Services Act ("Section 361") and that, as a result, BioD would need a biologics license to lawfully market those morselized products. Since the issuance of the Untitled Letter, BioD and more recently the Company have been in discussions with the FDA to communicate their disagreement with the FDA&#8217;s assertion that certain products are more than minimally manipulated. The FDA has not changed its position that certain of the BioD acquired products are not eligible for marketing solely under Section 361. In July, 2020, the FDA issued the final guidance document related to human tissue titled, &#8220;Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use&#8221; (the &#8220;HCT/PFinal Guidance&#8221;). This Guidance document supersedes the November 2017 guidance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HCT/P Final Guidance maintains the FDA&#8217;s position that products such as the Company&#8217;s morselized amniotic membrane tissue-based products do not meet the criteria for regulation solely as HCT/Ps. In addition, the FDA articulated a risk-based approach to enforcement and, while some uses for amniotic membrane tissue-based products would have as much as thirty-six months of enforcement discretion, other high risk uses could be subject to immediate enforcement action. The revised final guidance extends the discretionary enforcement period to May 31, 2021. The Company does not believe the uses for its amniotic membrane tissue-based products fall into the high-risk category.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;23, 2021, the Company has not received any further notice of enforcement action from the FDA regarding its morselized amniotic tissue-based products. Nonetheless, we can make no assurances that the FDA will continue to exercise its enforcement discretion with respect to the Company&#8217;s morselized amniotic membrane tissue-based products, and any potential action of the FDA could have a financial impact regarding the sales of such products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from BioD morselized amniotic membrane-based products for the year ended December&#160;31, 2020 were less than 1.0% of consolidated revenues. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Device Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are required to register with the FDA as a medical device manufacturer. As such, our manufacturing sites are subject to periodic inspection by the FDA for compliance with the FDA's Quality System Regulations. These regulations require that we manufacture our products and maintain our documents in a prescribed manner with respect to design, manufacturing, testing and control activities. Further, we are required to comply with various FDA requirements and other legal requirements for labeling and promotion. If the FDA believes that a company is not in compliance with applicable regulations, it may issue a warning letter, institute proceedings to detain or seize products, issue a recall order, impose operating restrictions, enjoin future violations and assess civil penalties against that company, its officers or its employees and may recommend criminal prosecution to the U.S. Department of Justice. All Integra manufacturing facilities participate in the Medical Device Single Audit Program and are audited annually for compliance with the Quality System for US FDA, Canada, Australia, Brazil, and Japan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device regulations also are in effect in many of the countries in which we do business outside the U.S. These laws range from comprehensive medical device approval and Quality System requirements for some or all of our medical device products to simpler requests for product data or certifications. Under the European Union Medical Device Directive, medical devices must meet the Medical Device Directive standards and receive CE Mark Certification prior to marketing in the European Union (the &#8220;EU&#8221;). In addition, the EU enacted the EU Medical Device Regulation, which imposes stricter requirements on the marketing and sales of medical devices which includes but is not limited to quality systems, labeling and clinical data. CE Mark Certification requires a comprehensive quality system program, technical documentation, clinical evaluation and data on the product, which are then reviewed by a Notified Body. A Notified Body is an organization designated by the national governments of the EU member states to make independent judgments about whether a product complies with the requirements established by each CE&#160;marking directive. The Medical Device Directive, Medical Device Regulation, ISO 9000 series and ISO 13485 are recognized international quality standards that are designed to ensure that we develop and manufacture quality medical devices. Other countries are also instituting regulations regarding medical devices or interpreting and enforcing existing regulations more strictly. Compliance with these regulations requires extensive documentation and clinical reports for our products, revisions to labeling, and other requirements such as facility inspections to comply with the registration requirements. A recognized Notified Body audits our facilities annually to verify our compliance with the ISO 13485 Quality System standard. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain countries, as well as the EU, have issued regulations that govern products that contain materials derived from animal sources. Regulatory authorities are particularly concerned with materials infected with the agent that causes bovine spongiform encephalopathy (&#8220;BSE&#8221;), otherwise known as mad cow disease. These regulations affect our dermal regeneration products, duraplasty products, hernia repair products, biomaterial products for the spine, nerve and tendon repair products and certain other products, all of which contain material derived from bovine tissue. Although we take great care to provide that our products are safe and free of agents that can cause disease, products that contain materials derived from animals, including our products, may become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for prion transmission. Significant new regulations, a ban of our products, or a movement away from bovine-derived products because of an outbreak of BSE could have a material, adverse effect on our current business or our ability to expand our business. See &#8220;Item&#160;1A. Risk Factors&#160;- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain of our products contain materials derived from animal sources and may become subject to additional regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postmarket Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved for commercial distribution, numerous regulatory requirements apply. These include the FDA Quality System Regulations which cover the procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of medical devices; the FDA's general prohibition against promoting products for unapproved or 'off-label' uses; the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur; and the Reports of Corrections and Removals regulation, which require manufacturers to report recalls and field corrective actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a violation of the FD&amp;C Act. Postmarket requirements are also followed globally where our products are registered and approved. These foreign jurisdictions have similar requirements to the FDA which include reporting requirements such as adverse events, recalls, etc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other regulations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Bribery Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the U.S., we are subject to laws and regulations pertaining to healthcare fraud and abuse, including anti-kickback laws and physician self-referral laws that regulate the means by which companies in the health care industry may market their products to hospitals and health care professionals and may compete by discounting the prices of their products. Similar anti-bribery laws exist in many of the countries in which we sell our products outside the U.S., as well as the United States Foreign Corrupt Practices Act (which addresses the activities of U.S. companies in foreign markets). Our products also are subject to regulation regarding reimbursement, and U.S. healthcare laws apply when a customer submits a claim for a product that is reimbursed under a federally funded healthcare program. These global laws require that we exercise care in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">designing our sales and marketing practices, including involving interactions with healthcare professionals, and customer discount arrangements. See &#8220;Item&#160;1A. Risk Factors&#160;for further details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Import-export</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, and import-export. Among other things, these laws restrict, and in some cases can prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in our business dealings with entities in and from foreign countries. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hazardous materials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our research, development and manufacturing processes involve the controlled use of certain hazardous materials. We are subject to country-specific, federal, state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these materials and certain waste products. We believe that our environmental, health and safety procedures for handling and disposing of these materials comply with the standards prescribed by the controlling laws and regulations. However, risk of accidental releases or injury from these materials is possible. These risks are managed to minimize or eliminate associated business impacts. In the event of this type of accident, we could be held liable for damages and face a liability that could exceed our resources. We could be subject to a regulatory shutdown of a facility that could prevent the distribution and sale of products manufactured there for a significant period of time, and we could suffer a casualty loss that could require a shutdown of the facility in order to repair it, any of which could have a material, adverse effect on our business. Although we continuously strive to maintain full compliance with respect to all applicable global environmental, health and safety laws and regulations, we could incur substantial costs to fully comply with future laws and regulations, and our operations, business or assets may be negatively affected. Furthermore, global environmental, health and safety compliance is an ongoing process. Integra has compliance procedures in place for compliance with Employee Health &amp; Safety laws, driven by a centrally led organizational structure that ensures proper implementation, which is essential to our overall business objectives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above regulations, we are, and may be, subject to regulation under country-specific federal and state laws, including, but not limited to, requirements regarding record keeping, and the maintenance of personal information, including personal health information. As a public Company, we are subject to the securities laws and regulations, including the Sarbanes-Oxley Act of 2002. We also are subject to other present and could be subject to possible future, local, state, federal and foreign regulations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third-Party Reimbursement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers that purchase medical devices generally rely on third-party payors, including, in the U.S., the Medicare and Medicaid programs and private payors, such as indemnity insurers, employer group health insurance programs and managed care plans, to reimburse all or part of the cost of the products. As a result, demand for our products is and will continue to be dependent in part on the coverage and reimbursement policies of these payors. The manner in which reimbursement is sought and obtained varies based upon the type of payor involved and the setting in which the product is furnished and utilized. Reimbursement from Medicare, Medicaid and other third-party payors may be subject to periodic adjustments as a result of legislative, regulatory and policy changes, as well as budgetary pressures. Possible reductions in, or eliminations of, coverage or reimbursement by third-party payors, or denial of, or provision of uneconomical reimbursement for new products may affect our customers' revenue and ability to purchase our products. Any changes in the healthcare regulatory, payment or enforcement landscape relative to our customers' healthcare services have the potential to significantly affect our operations and revenue. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Privacy and Cybersecurity Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a business with a significant global footprint, compliance with evolving regulations and standards in data privacy and cybersecurity (relating to the confidentiality and security of our information technology systems, products such as medical devices, and other services provided by us) may result in increased costs, lower revenue, new complexities in compliance, new challenges for competition, and the threat of increased regulatory enforcement activity. Our business relies on the secure electronic transmission, storage and hosting of sensitive information, including personal information, financial information, intellectual property, and other sensitive information related to our customers and workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in the U.S., the collection, maintenance, protection, use, transmission, disclosure and disposal of certain personal information and the security of medical devices are regulated at the U.S. federal and state, and industry levels. U.S. federal and state laws protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information by health care providers. In addition, the FDA has issued guidance advising manufacturers to take cybersecurity risks into account in product design for connected medical devices and systems, to assure that appropriate safeguards are in place to reduce the risk of unauthorized access or modification to medical devices that contain software and reduce the risk of introducing threats into hospital systems that are connected to such devices. The FDA also issued guidance on post market management of cyber security in medical devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., we are impacted by the privacy and data security requirements at the international, national and regional level, and on an industry specific basis. Legal requirements in these countries relating to the collection, storage, handling and transfer of personal data and, potentially, intellectual property continue to evolve with increasingly strict enforcement regimes. In </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Europe, for example, we are subject to EU General Data Protection Regulation ("GDPR") which requires member states to impose minimum restrictions on the collection, use and transfer of personal data and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR also requires companies processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Item 1A. Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to requirements relating to information technology which could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations impact the ways in which we use and manage personal data, protected health information, and our information technology systems. They also impact our ability to move, store, and access data across geographic boundaries. Compliance with these requirements may require changes in business practices, complicate our operations, and add complexity and additional management and oversight needs. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMAN CAPITAL</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workforce Demographics</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#8239; December&#160;31, 2020, we had approximately  3,700 full-time and part-time employees and 700 contingent, subcontracted and outsourced partners. As of December&#160;31, 2020, 64% of our workforce was located in the United States, 25% in Europe, 4% in Latin America and Canada and 7% in Asia Pacific which includes Australia and New Zealand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="iart-20201231_g1.jpg" alt="iart-20201231_g1.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:498px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A diverse workforce and an inclusive culture and work environment is a business priority and a key to our long-term success.   Our commitment to diversity and inclusion ("D&amp;I") begins with our Board of Directors and CEO, and extends to all levels of the Company as we focus on attracting, retaining, and developing our global talent.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership Commitment and Accountability. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The executive leadership team members set the D&amp;I goals for the company and for the past three years it has been a company-wide goal to advance diversity and inclusion initiatives to build stronger teams.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership Councils, Employee Resource Groups and External Partnerships. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accountable to our diversity commitment through our leadership councils, employee resource groups, and external partnerships.   </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.15pt">Peter Arduini, President &amp; Chief Executive Officer has chaired our Women&#8217;s Leadership Council since its inception in 2017. The Women&#8217;s Leadership Council is an action and results-oriented advisory group comprised of fifteen of our senior women leaders. The specific charter of the Council is to work together to identify ways to continue to attract and retain female talent, advance the development of our women into leadership roles, increase the cultural awareness of the value of inclusion and diversity in our company, and create specific development forums for high performing women. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Our employee resources groups encourage a culture of awareness and inclusion, assist in the attraction and retention of diverse talent, and help colleagues develop leadership skills. Members of the executive leadership team serve as sponsors for each of Integra&#8217;s employee resources groups. Integra has four employee resources groups: </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Women of Integra Networks with 20+ chapters globally</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">African American Affinity Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Veteran Employee Resource Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Indian American Professional Network</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">We reinforce our commitment to diversity by partnering with other organizations focused on driving inclusion in the work place including the CEO Action for Diversity &amp; Inclusion, which is the largest CEO-driven business commitment to advance D&amp;I in the work place and the Healthcare Businesswomen&#8217;s Association, an association dedicated to furthering the advancement and impact of women in the business of healthcare.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Promoting an Inclusive Culture Through Learning Opportunities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> To help drive our culture of inclusion, our colleagues participate in programs focused on how to manage bias and value differences.<br/>   </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Members of our executive leadership, senior management team, and larger scope leaders participate in a half-day micro-inequities training. The content includes understanding unconscious bias and subtle behaviors that devalue, discourage and impair workplace performance, identifying these in day-to-day interactions, and exploring ways to mitigate these micro-inequities on an individual and organizational level.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2020, Integra colleagues globally participated in two programs to promote inclusion: a course that creates awareness of unconscious biases in the workplaces and tools to build-bias breaking skills and a course which examines what practicing inclusion in the workplace looks like.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Gender Diversity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We believe that our company is better and delivers strong operating results when we build diverse teams and leverage broad perspectives to meet the needs of our shareholders, customers, colleagues, and communities we serve. Integra's overall employee population is 47% female and 53% is male. We continue to strive to ensure that diversity in our leadership ranks is representative of our overall population. Through mentorship, sponsorship, recruitment efforts, and development programs we look to continue to grow our population of females in leadership roles at Integra. Currently, 33% of our executive leaders and 36% of senior leaders (non-executive vice presidents) are female.   </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="iart-20201231_g2.jpg" alt="iart-20201231_g2.jpg" style="height:399px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In partnership with Leadership Edge, a company founded by women leaders and dedicated to growing and mentoring women,  Integra sponsors the Excel Women&#8217;s Leadership Program.  The program is designed to accelerate the development and advancement of high potential, mid-career female leaders into senior leadership roles.   The program has assisted in further building our pipeline of women leaders with 60% of the program&#8217;s graduates being promoted into roles with increased responsibility.   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION ABOUT GEOGRAPHIC AREAS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information about our geographical areas is set forth in our financial statements Note&#160;17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our consolidated financial statements.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;). In accordance with the Exchange Act, we file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission (the "SEC"). Our financial information may be viewed, including the information contained in this report, and other reports we file with the SEC, on the Internet, without charge as soon as reasonably practicable after we file them with the SEC, in the &#8220;SEC Filings&#8221; page of the Investor Relations section of our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.integralife.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A copy may also be obtained for any of these reports, without charge, from our Investor Relations department, 1100 Campus Road, Princeton, NJ 08540. Alternatively, reports filed may be viewed or obtained through the SEC's website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made statements in this report, including statements under &#8220;Business&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; that constitute forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Exchange Act. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about us including, among other things: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, both nationally and in our international markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and estimates concerning future financial performance, financing plans and the impact of competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends in our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated demand for our products, particularly capital equipment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to produce regenerative-based products in sufficient quantities to meet sales demands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations concerning our ongoing restructuring, integration and manufacturing transfer and expansion activities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">existing and future regulations affecting our business, and enforcement of those regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional debt and equity financing to fund capital expenditures, working capital requirements and acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physicians' willingness to adopt our recently launched and planned products, third-party payors' willingness to provide or continue reimbursement for any of our products and our ability to secure regulatory approval for products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiatives launched by our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property, including trade secrets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, integrate operations post-acquisition and maintain relationships with customers of acquired entities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to remediate all matters identified in FDA observations and warning letters that we received or may receive; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risk factors described in the section entitled "Risk Factors" in this report.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements can be identified by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions in this report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_22"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNRESOLVED STAFF COMMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Annual Report on Form 10-K, we had no unresolved comments from the staff of the Securities and Exchange Commission that were received not less than 180 days before the end of our 2020 fiscal year. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_16"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO COVID-19</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the COVID-19 pandemic continue to significantly impact global economic conditions and have affected, and may continue to affect, our operations, supply chain, distribution, sales force, as well as the financial stability of hospitals and other customers, and have caused and could again cause a reduction in procedures, which could materially adversely affect our business, results of operations, financial condition, and stock price.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization (&#8220;WHO&#8221;) characterized the Novel Coronavirus Disease 2019 (&#8220;COVID-19&#8221;) as a pandemic. To date, and in continuing efforts to control the spread of COVID-19, and a highly contagious variant of COVID-19, governments around the world, including in the U.S., have and continue to implement various preventative measures including quarantines, &#8220;shelter in place&#8221; orders, &#8220;stay at home&#8221; orders, travel restrictions, business operation restrictions, school closures, and other similar types of measures. The impact of the pandemic, while still evolving, has caused and will likely continue to cause significant economic and financial uncertainty in the U.S. and around the world, generating concerns the effects will lead to a global recession or depression.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic and related mitigation efforts, similar to many other employers in the U.S., the Company has and continues to require many employees to work remotely. The Company has continued to operate certain manufacturing facilities to date in compliance with federal, state and local orders regarding COVID-19.  The health of the Company&#8217;s workforce is our top concern and the Company has procured equipment and implemented safety protocols in an effort to maintain the health and safety of our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While demand for our products has improved since mid-April 2020 when healthcare institutions were altering how they managed medical procedures in light of virus-related constraints, it is not possible to predict with precision whether and when demand for our products will return fully to levels that existed prior to the onset of the pandemic. The Company has implemented extensive business contingency plans across its global organization and network of business partners which helps limit some of the impact of the COVID-19 pandemic but does not completely prevent or avoid a negative impact on the business. The extent to which the COVID-19 pandemic will negatively affect the Company's operations and financial position will depend on future developments that remain uncertain and cannot be predicted with precision. For example, including, without limitation, the pandemic could cause: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued fluctuations in our operational results, revenues, and cash flows which may negatively impact our stock price; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Impact our operations and sales including but not limited to delays in orders, ability to market, sell, deliver and service our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in demand for our products and services due to the impact of COVID-19 on hospitals and customers such as continued or future postponement or cancellations of procedures, hospital postponement or cancellation of capital purchases, or elimination of services; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Local and/or global recessions, which may result in hospitals and customers reducing capital spending and could materially affect our business, including but not limited to our future access to capital, and negatively impact the value of our stock.; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued limitations on our operations due to restrictions associated with &#8220;shelter in place&#8221; orders and travel restrictions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Distraction of management time and focus; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased risk that insurance coverage will not provide protection for all of the COVID-19-related disruption;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption to manufacturing operations and distribution supply chains; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased challenges or restraints in obtaining necessary products or components from our suppliers and vendors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduction or interruption to our manufacturing processes which could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued and/or increased risks related to the health and safety of our employees (and retention issues), volatility of foreign currency exchange rates, and risk of cybersecurity attacks and breaches; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Possible liquidity constraints and credit impact;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays in obtaining regulatory clearances, approval to market products, quality inspections, or delays to clinical trial activity; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Delays in coverage decisions by private and public health insurers and foreign governmental health systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Delays in the completion of supportive clinical studies for payer coverage decisions or clinical and economic decision makers due to slowed study enrollments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays to acquisition plans, increased risks to the operations and financial condition of newly acquired businesses, and increased costs or delays to integration of newly acquired businesses;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of any reprioritization of capital allocations on our ability to achieve our strategic objectives over the medium and long-term; and,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Write downs or impairments of investments in third parties, goodwill or intangible assets from recently acquired businesses, accounts receivable, or other assets;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the situation surrounding the COVID-19 pandemic remains fluid, it is difficult to predict, with any certainty, the duration and extent of its impact which depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions including the distribution of a vaccine locally and globally, and the impact of these and other factors on our employees, customers, suppliers, service providers and business partners.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If COVID-19, or a variant strain, continues to spread and escalate domestically or internationally, or if governments impose additional measures intended to mitigate the spread and related effects of the pandemic, the risks described above could be elevated significantly. Should that occur, and the COVID-19 pandemic persist for a prolonged time, the above factors and others that are currently unknown could have a material adverse impact on our business, results of operations, financial conditions and prospects and could elevate known risks described in this Item 1A. Risk Factors. Information pertaining to the potential impact of the COVID-19 pandemic and associated economic disruptions, and the actual operational and financial impacts that we have experienced to date can be found in Management's Discussion and Analysis of Financial Position and Results of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATING TO OUR BUSINESS</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results, including components of operating results such as gross margin and cost of product sales, may fluctuate from time to time, and such fluctuations could affect our stock price. Our operating results have fluctuated in the past and can be expected to do so from time to time in the future. Some of the factors that may cause these fluctuations include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to COVID-19;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic conditions worldwide, which could affect the ability of hospitals and other customers to purchase our products and could result in a reduction in elective and non-reimbursed operative procedures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of acquisitions, our ability to integrate acquisitions, and our restructuring activities including portfolio rationalization, divestitures and product lifecycle management;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenditures for major initiatives, including acquired businesses and integrations thereof and restructuring;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of significant customer orders, which tend to increase in the fourth quarter coinciding with the end of budget cycles; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition for a wide range of customers across all our product lines in the markets our products are sold;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of our existing products, as well as products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">retention of current employees and recruiting of new employees in light of market competition for talent and relevant skills; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of regulatory approvals as well as changes in country-specific regulatory requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the exchange rates between the U.S. dollar and foreign currencies of countries in which we do business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the variable interest rates of our debt instruments which could impact debt service requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential backorders, lost sales and expenses incurred in connection with product recalls or field corrective actions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption of our operations and sales resulting from extreme weather conditions or natural disasters that damage our manufacturing, distribution, or infrastructure of those facilities, or the suppliers and service providers for those facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture and ship our products efficiently or in sufficient quantities to meet sales demands; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the cost or decreases in the supply of raw materials and services, including sterilization, energy, steel and honey;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of our research and development expenditures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reimbursement for our products by third-party payors such as Medicare, Medicaid, private and public health insurers and foreign governmental health systems;  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to maintain existing distribution rights to and from certain third parties;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to maintain business if or when we opt to convert such business from distributors to a direct sales model;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our commercial sales representatives to obtain sales targets in a reasonable time frame;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of changes to our sales organization, continued channel expansion, including increased specialization;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">peer-reviewed publications discussing the clinical effectiveness of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inspections of our manufacturing facilities for compliance with Quality System Regulations (Good Manufacturing Practices) which could result in Form 483 observations, warning letters, injunctions or other adverse findings from the FDA or from equivalent regulatory bodies, and corrective actions, procedural changes and other actions that we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine are necessary or appropriate to address the results of those inspections, any of which may affect production and our ability to supply our customers with our products;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulations or guidelines that impact the sales and marketing practices for products that we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increased regulatory scrutiny of certain of our products, including products which we manufacture for others, could result in removal from the market or involve field corrective actions that could affect the marketability of our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcement or defense of intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws, or their interpretations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of goodwill and intangible asset impairment charges if future operating results of the acquired businesses are significantly less than the results anticipated at the time of the acquisitions.  </span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The industry and market segments in which we operate are highly competitive, and we may be unable to compete effectively with other companies.</span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is intense competition among medical device companies. We compete with established medical technology companies in many of our product areas. Competition also comes from early-stage companies, universities, research institutions and other non-profit entities. In certain cases, our products compete primarily against medical practices that treat a condition without using a device or any particular product, such as the medical practices that use autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products, or that use other technologies that cost less than our products. Many of our competitors have access to greater financial, technical, research and development, marketing, manufacturing, sales, distribution, administrative, consulting and other resources than we do. Our competitors may be more effective at developing commercial products. They may be able to gain market share by offering lower-cost products or products that enjoy better reimbursement from third-party payors and foreign governmental health systems.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position depends on our ability to achieve market acceptance for our products, develop new products, implement production and marketing plans, secure regulatory approval for products under development, demonstrate clinical and economic effectiveness, obtain and maintain reimbursement coverage and funding under third-party payors and foreign governmental health systems, obtain patent protection and produce products consistently in sufficient quantities to meet demand. We may need to develop new applications for our products to remain competitive. Technological advances by one or more of our current or future competitors or their achievement of superior reimbursement from third-party payors and foreign governmental health systems could render our present or future products obsolete or uneconomical. Our future success will depend upon our ability to compete effectively against current technology as well as to respond effectively to technological advances, changes in customers' requirements or in payor or regulatory evidence requirements. Additionally, purchasing decisions of our customers may be based on clinical evidence or comparative effectiveness studies and, because of our vast array of products, we might not be able to fund the studies necessary to gain entry or maintain our position or provide the required information to compete effectively. Other companies may have more resources available to fund such studies. For example, competitors have launched and are developing products to compete with our dural repair products, regenerative skin, neuro critical care monitors and ultrasonic tissue ablation devices, among others. In the current environment of managed care, consolidation among health care providers, increased competition, and declining reimbursement rates, we have been increasingly required to compete on the basis of price. Competitive pressures could adversely affect our profitability. Given these factors, we cannot guarantee that we will be able to compete effectively or continue our level of success in the areas in which we compete.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the healthcare industry may require us to decrease the selling price for our products, may reduce the size of the market for our products, or may eliminate a market, any of which could have a negative impact on our financial performance.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trends toward managed care, healthcare cost containment and other changes in government and private sector initiatives in the U.S. and other countries in which we do business are placing increased emphasis on the delivery of more cost-effective medical therapies that could adversely affect the sale and/or the prices of our products. For example:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party payors of hospital services and hospital outpatient services, including Medicare, Medicaid, private and public health insurers and foreign governmental health systems, annually revise their payment methodologies, which can result in stricter standards for reimbursement of hospital charges for certain medical procedures or the elimination of reimbursement; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">several foreign countries have implemented reforms of their respective healthcare sectors in an effort to reduce healthcare spending, including restricting funding to only those medical technologies and procedures with proven effectiveness, and increasing patient co-payments. Governmental health systems have revised and continue to consider </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revisions of healthcare budgets, which could result in stricter standards for implementing certain medical procedures, increased scrutiny of medical devices, and downward pricing pressure;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare, Medicaid, private and public health insurer and foreign governmental cutbacks could create downward pricing pressure on our products;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the U.S., Medicare and Medicaid coverage as well as commercial payor coverage determinations could reduce or eliminate reimbursement or coverage for certain of our wound matrix, amniotic, surgical reconstruction and advanced wound dressing products as well as other products in most regions, negatively affecting our market for these products, and future determinations could reduce or eliminate reimbursement or coverage for these products in other regions and could reduce or eliminate reimbursement or coverage for other products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there has been a consolidation among healthcare facilities and purchasers of medical devices in the U.S., some of whom prefer to limit the number of suppliers from whom they purchase medical products, and these entities may decide to stop purchasing our products or demand discounts on our prices;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the U.S., we are party to contracts with group purchasing organizations, which negotiate pricing for many member hospitals, require us to discount our prices for certain of our products and limit our ability to raise prices for certain of our products, particularly surgical instruments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is economic pressure to contain healthcare costs in domestic and international markets, and, regardless of the consolidation discussed above, providers generally are exploring ways to cut costs by eliminating purchases or driving reductions in the prices that they pay for medical devices, or increasing clinical or economic evidence thresholds for product formularies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are proposed and existing laws, regulations and industry policies in domestic and international markets regulating the sales and marketing practices and the pricing and profitability of companies in the healthcare industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proposed laws or regulations may permit hospitals to provide financial incentives to doctors for reducing hospital costs, will award physician efficiency, and will encourage partnerships with healthcare service and goods providers to reduce prices; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                        </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there have been initiatives by third-party payors and foreign governmental health systems to challenge the prices charged for medical products that could affect our ability to sell products on a competitive basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any and all of the above factors could materially and adversely affect our levels of revenue and our profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current strategy involves growth through acquisitions, which requires us to incur substantial costs and potential liabilities for which we may never realize the anticipated benefits, and also requires us to successfully integrate acquired businesses into our business operations in order to avoid our business being materially and adversely affected.</span></div><div style="margin-top:2pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to internally generated growth, our current strategy involves growth through acquisitions. Between January 1, 2018 and December&#160;31, 2020, we have acquired 2 businesses at a total cost of approximately $70.7 million. In addition, in January 2021, we acquired ACell, Inc. for $300&#160;million, which added products to our complex wound management product portfolio and advanced growth of our Tissue Technologies segment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to continue to implement our growth strategy and it may ultimately be unsuccessful. A significant portion of our growth in revenues has resulted from, and is expected to continue to result from, the acquisition of businesses or products complementary to our own. We engage in evaluations of potential acquisitions and are in various stages of discussion regarding possible acquisitions, certain of which, if consummated, could be significant to us. Any new acquisition could result in material transaction expenses, increased interest and amortization expense, increased depreciation expense, increased operating expense, and possible in-process research and development charges for acquisitions that do not meet the definition of a &#8220;business,&#8221; any of which could have a material, adverse effect on our operating results. Certain businesses that we acquire may not have adequate financial, disclosure, regulatory, quality or other compliance controls at the time we acquire them and could require significant expenditures to address those controls or subject us to increased risk. As we grow by acquisition, we must manage and integrate the new businesses to bring them into our systems for financial, disclosure, compliance, regulatory and quality control, realize economies of scale, and control costs. If we cannot integrate acquired businesses and operations, manage the cost of providing our products or price our products appropriately, our profitability could suffer. In addition, acquisitions involve other risks, including diversion of management resources otherwise available for the running of our business and the development of our business as well as risks associated with entering markets in which our marketing teams and sales force has limited experience or where experienced distribution alliances are not available. Some acquisitions may include the need for ongoing product development to occur consistent with time sensitive milestones in order for the Company to achieve its commercial projections for the acquisition. Our future profitability will depend in part upon our ability to develop our resources to adapt to these new products or business areas and to identify and enter into or maintain satisfactory distribution networks. As a result of our acquisitions of other healthcare businesses, we may be subject to the risk of unanticipated business uncertainties, regulatory and other compliance matters or legal liabilities relating to those acquired businesses for which the sellers of the acquired businesses may not indemnify us, for which we may not be able to obtain insurance (or adequate insurance), or for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which the indemnification may not be sufficient to cover the ultimate liabilities. We may not be able to identify suitable acquisition candidates in the future, obtain acceptable financing or consummate any future acquisitions. Certain potential acquisitions are subject to antitrust and competition laws, which laws could impact our ability to pursue strategic acquisitions and could result in mandated divestitures. If we are unsuccessful in our acquisition strategy, we may be unable to meet our financial targets and our financial performance could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, the failure to integrate the business operations of recently acquired or future acquisitions successfully would have a material, adverse effect on our business, financial condition and results of operations. Integrating the operations of multiple new businesses with that of our own is a complex, costly and time-consuming process, which requires significant management attention and resources, including the coordination of information technologies, sales and marketing, research and development, operations, manufacturing and finance functions. The integration process could disrupt the businesses and, if implemented ineffectively, could preclude realization of the full benefits that we expect from these transactions. Our failure to meet the challenges involved in integrating the businesses in order to realize the anticipated benefits of the acquisitions could cause an interruption of, or a loss of momentum in, our activities and could materially and adversely affect our results of operations. Prior to each acquisition, the acquired business operated independently, with its own business, corporate culture, locations, employees and systems, any of which may prove incompatible with our Company. There may be substantial difficulties, costs and delays involved in any integration of other businesses with that of our own. For example, there could be adverse effects on existing business relationships with suppliers or customers, including failure to retain key customers and suppliers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we may fail to retain key employees of our Company and of the acquired businesses.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks may be heightened in cases where the majority of the former businesses&#8217; operations, employees and customers are located outside the U.S. Any one or all of these factors could increase operating costs or lower anticipated financial performance. Many of these factors are also outside of our control. In addition, dispositions of certain key products, technologies and other rights, including pursuant to conditions imposed on us to obtain regulatory approvals, may affect our business operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the operations of the businesses are integrated successfully, we may not realize the full benefits of the acquisition, including the synergies, cost savings or sales or growth opportunities that we expect. These benefits may not be achieved within the anticipated time frame, or at all. Additional unanticipated costs could be incurred in the integration of the businesses. All of these factors could cause a reduction to our earnings per share, decrease or delay the expected accretive effect of the transaction, and negatively impact the price of our ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future financial results could be adversely affected by impairments or other charges. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to test both goodwill and indefinite-lived intangible assets for impairment on an annual basis based upon a fair value approach, rather than amortizing them over time. We are also required to test goodwill and indefinite-lived intangible assets for impairment between annual tests if an event occurs such as a significant decline in revenues or cash flows for certain products, or the discount rates used in the calculations of discounted cash flows change significantly, or circumstances change that would more likely than not reduce our enterprise fair value below its book value. If such a decline, rate change or circumstance were to materialize, we may record an impairment of these intangible assets that could be material to the financial statements. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates&#8221; of this report. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The guidance on long-lived assets requires that we assess the impairment of our long-lived assets, including finite-lived intangible assets, whenever events or changes in circumstances indicate that the carrying value may not be recoverable as measured by the sum of the expected future undiscounted cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, Company decisions and other economic factors relating to our trade names may occur over time. For instance, we may discontinue certain products in the future as we continue to assess the profitability of our product lines. As a result, we may need to record impairment c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">harges or accelerate amortization on certain trade names or technology-related intangible assets in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of a medical device business is often volatile, and the assumptions underlying our estimates made in connection with our assessments under the guidance may change as a result of that volatility or other factors outside our control and may result in impairment charges. The amount of any such impairment charges could be significant and have a material, adverse effect on our reported financial results for the period in which the charge is taken and could have an adverse effect on the market price of our securities, including the notes and the common stock into which they may be converted.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lack of market acceptance for our products or market preference for technologies that compete with our products could reduce our revenues and profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market acceptance of our products depends on many factors, including our ability to convince prospective collaborators and customers that our technology is an attractive alternative to other technologies, to manufacture products in sufficient quantities and at acceptable costs, and to supply and service sufficient quantities of our products directly or through our distribution alliances. For example, the use of autograft tissue is a well-established means for repairing the dermis, and it competes for acceptance in the market with our collagen-based wound care products. In addition, unfavorable payment amounts or adverse coverage determinations of third-party payors, including Medicare, Medicaid, private and public health insurers, and foreign governmental health systems, regarding our products or third-party determinations that favor a competitor&#8217;s product over ours, could harm acceptance or continued use of our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For example, greater market acceptance of our wound graft products may ultimately depend on our ability to demonstrate that coverage and reimbursement are available and favorable, or because they are an attractive, cost-effective alternative to other treatment options. </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If there are negative events in the industry, whether real or perceived, there could be a negative impact on the industry as a whole. The industry is subject to rapid and continuous change arising from, among other things, consolidation, technological improvements, the pressure on governments, third-party payors and providers to reduce healthcare costs, and healthcare reform legislation and initiatives domestically and internationally. In addition, our future success depends, in part, on our ability to license and develop additional products. Even if we determine that a product candidate has medical benefits, the cost of commercializing, either through internal development or payments associated with licensing arrangements, could be too high to justify development and we could ultimately face competitors with more effective products and better reimbursement status that cost less and are ready for commercial introduction before our products. If we are unable to develop additional commercially viable products, our future prospects could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One or more of these factors could vary unpredictably, and such variations could have a material, adverse effect on our competitive position. We may not be able to adjust our contemplated plan of development to meet changing market demands.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It could be difficult to replace some of our suppliers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside vendors, some of whom are sole-source suppliers, provide key components and raw materials used in the manufacture of our products. Although we believe that alternative sources for many of these components and raw materials are available, any interruption in supply of a limited or sole-source component or raw material could harm our ability to manufacture our products until a new or alternative source of supply is identified and qualified. In addition, an uncorrected defect or supplier&#8217;s variation in a component or raw material, either unknown to us or incompatible with our manufacturing process, could harm our ability to manufacture products. We may not be able to find a sufficient alternative supplier in a reasonable time period, or on commercially reasonable terms, if at all, and our ability to produce and supply our products could be impaired. We believe that these factors are most likely to affect the following products that we manufacture:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our collagen-based products, such as the Integra Dermal Regeneration Template and wound matrix products, the DuraGen&#174; family of products, our Absorbable Collagen Sponges, PriMatrix and SurgiMend products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our products made from silicone, such as our neurosurgical shunts and drainage systems and hemodynamic shunts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which use many different specialty parts or chemicals from numerous suppliers, such as our intracranial monitors, shunts, catheters and headlights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which are amniotic tissue-based</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products which are porcine tissue-based;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products that use medical grade leptospermum honey, such as our Medihoney products; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our TCC-EZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> total contact cast system products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of amniotic tissue-based products depends upon, among other factors, the availability of tissue from human donors.  Access to donated amniotic tissue could also be adversely impacted by regulatory changes or evolving public perceptions of the donor process.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, many of our products require sterilization by third-party suppliers. To the extent these suppliers are unable to provide sterilization services, whether due to lack of capacity, regulatory requirements, environmental concerns such as those relating to ethylene oxide or otherwise, we may be unable to transition sterilization to other suppliers in a timely or cost effective manner, or at all, which could have an adverse impact on our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is our policy to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time, we remain at risk that we will not be able to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">qualify new components or materials quickly enough to prevent a disruption if one or more of our suppliers ceases production of important components or materials.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience difficulties, delays, performance impact or unexpected costs from consolidation of facilities.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consolidated several facilities in recent years and may further consolidate our operations in the future in order to improve our cost structure, achieve increased operating efficiencies, and improve our competitive standing or results of operations and/or to address unfavorable economic conditions. As part of these initiatives, we may also lose favorable tax incentives or not be able to renew leases on acceptable terms. We may further reduce staff, make changes to certain capital projects, close certain production operations and abandon leases for certain facilities that will not be used in our operations. In conjunction with any actions, we will continue to make significant investments and build the framework for our future growth. We may not realize, in full or in part, the anticipated benefits and savings from these efforts because of unforeseen difficulties, delays, implementation issues or unexpected costs. If we are unable to achieve or maintain all of the resulting savings or benefits to our business or other unforeseen events occur, our business and results of operations may be adversely affected.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have significant product liability exposure and our insurance may not cover all potential claims.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to product liability and other claims if our technologies or products are alleged to have caused harm. We may not be able to obtain insurance for the potential liability on acceptable terms with adequate coverage or at reasonable costs. Any potential product liability claims could exceed the amount of our insurance coverage or may be excluded from coverage under the terms of the policy. Our insurance may not be renewed at a cost and level of coverage comparable to that then in effect.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic and political instability around the world could adversely affect the ability of hospitals, other customers, suppliers and distributors to access funds or otherwise have available liquidity, which could reduce orders for our products or interrupt our production or distribution or result in a reduction in elective and non-reimbursed operative procedures.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic and political instability around the world could adversely affect the ability of hospitals and other customers to access funds to enable them to fund their operating and capital budgets. As a result, hospitals and other customers could reduce budgets or put all or part of their budgets on hold or close their operations, which could have a negative effect on our sales, particularly the sales of capital equipment such as our ultrasonic surgical aspirators, neuromonitors and stereotactic products, or result in a reduction in elective and non-reimbursed procedures. The occurrence of those economic conditions could make it more difficult for us to accurately forecast and plan our future business activities and depending on their severity, could have a material, adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our private-label product lines depend significantly on key relationships with third parties, which we could be unable to establish and maintain.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our private-label business depends in part on entering into and maintaining long-term supply agreements with third parties. The third parties with whom we have entered into agreements might terminate these agreements for a variety of reasons, including developing other sources for the products that we supply. Termination of our most important relationships could adversely affect our expectations for the growth of private-label products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR REGULATORY ENVIRONMENT </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The adoption of healthcare reform in the U.S. and initiatives sponsored by other governments may adversely affect our business, results of operations and/or financial condition.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations may be substantially affected by potential fundamental changes in the global political, economic and regulatory landscape of the healthcare industry. Government and private sector initiatives to limit the growth of healthcare costs are continuing in the U.S., and in many other countries in which we do business, causing the marketplace to put increased emphasis on the delivery of more cost-effective treatments. These initiatives include price regulation, competitive pricing, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements. The adoption of some or all of these initiatives could have a material, adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Patient Protection and Affordable Care Act (the &#8220;ACA&#8221;), signed into law in March 2010, includes several provisions that impact our businesses in the U.S. The ACA includes provisions that, among other things, reduce and/or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limit Medicare reimbursement, require all individuals to have health insurance (with limited exceptions), and require detailed disclosure of transfers of value made to healthcare professionals.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what impact ongoing uncertainty regarding federal and state health reform proposals, including the implementation or repeal of the ACA, instability of the insurance markets, changes in the U.S. administration and policy, an expansion in government&#8217;s role in and/or additional proposals and/or changes to the U.S. health care system or its legislation will have on our customer&#8217;s purchasing decisions and/or reimbursement which could have a material adverse effect on our business. We cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us. We continue to monitor the implementation of such legislation and, to the extent new market or industry trends or new governmental programs evolve, we will consider implementing or implement programs in response.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent domestic and foreign medical device regulations and oversight and any adverse action may adversely affect our ability to compete in the marketplace and our financial condition and business operations.</span></div><div style="text-align:justify;text-indent:9.35pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, development activities and manufacturing processes are subject to extensive and rigorous regulation by numerous government agencies, including the FDA and comparable foreign agencies, as discussed in &#8220;Part 1, Item 1. Business &#8211; Government Regulation.&#8221; To varying degrees, each of these agencies monitors and enforces our compliance with laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of our medical devices. We are also subject to regulations that may apply to certain of our products that are Drug/Device Combination products or are considered to be subject to pharmaceutical regulations outside the U.S. The process of obtaining marketing approval or clearance from the FDA and comparable foreign regulatory agencies for new products, or for enhancements or modifications to existing products could be costly, time consuming and burdensome, lead to failed clinical trials or weakened clinical evidence, involve modifications, repairs or replacements of our products and result in limitations on the indicated use of our products, which may negatively impact our ability to market our products and services, result in delays or prevent full commercial realization of future products or service. Furthermore, failure to obtain timely approvals or renewals may result in significant penalties and fines. Additional regulations govern the approval, initiation, conduct, monitoring, documentation and reporting of clinical studies to regulatory agencies in the countries or regions in which they are conducted. Failure to comply, could subject us to significant enforcement actions and sanctions, including halting the study, rejection of data generated in the study, seizure of investigational devices or data, sanctions against investigators, civil or criminal penalties, and other actions. In addition, without the data from one or more clinical studies, it may not be possible for us to secure the data necessary to support certain regulatory submissions, to secure reimbursement or demonstrate other requirements. We cannot assure you that access to clinical investigators, sites and subjects, documentation and data will be available on the terms and timeframes necessary.</span></div><div style="text-align:justify;text-indent:9.35pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to extensive complex regulatory requirements by domestic and foreign government agencies and any failure to comply with our ongoing responsibilities under their applicable laws and regulations could result in a material adverse impact on our business. Failure to comply with applicable regulations could result in future product recalls, injunctions preventing the shipment of products or other enforcement actions that could have a material adverse effect on our business. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the European Medical Device Regulation, which was adopted by the European Union (&#8220;EU&#8221;) as a common legal framework for all EU member states. The EU Parliament issued a delay in implementation by one year to May 26, 2021 due to the COVID-19 pandemic. The implementation for Class I products is scheduled for May 26, 2021 and the EUDAMED Database is May 26, 2022. Under this regulation, companies that wish to manufacture and distribute medical devices in EU member states must meet certain quality system, and safety requirements as well as ongoing product monitoring responsibilities. Companies must also obtain a &#8220;CE&#8221; marking (i.e., a mandatory conformity marking for certain products sold within the European Economic Area) for their products. Various penalties exist for non-compliance with the laws implementing the European Medical Device Regulations which if incurred, could have a material adverse impact on our business, results of operations and cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to laws and regulations that govern the means by which companies in the healthcare industry may market their products to healthcare professionals and may compete by discounting the prices of their products, including for example, the federal Anti-Kickback Statute, the federal False Claims Act, the federal Health Insurance Portability and Accountability Act of 1996, state law equivalents to these federal laws that are meant to protect against fraud and abuse and analogous laws in foreign countries. Violations of these laws are punishable by criminal and civil sanctions, including, but not limited to, in some instances civil and criminal penalties, damages, fines, exclusion from participation in federal and state healthcare programs, including Medicare and Medicaid. Although we exercise care in structuring our sales and marketing practices and customer discount arrangements to comply with those laws and regulations, we cannot assure that:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government officials charged with responsibility for enforcing those laws will not assert that our sales and marketing practices or customer discount arrangements are in violation of those laws or regulations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government regulators or courts will interpret those laws or regulations in a manner consistent with our interpretation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in place policies and procedures for compliance that we believe are at least as stringent as those set forth in the AdvaMed Code, and we regularly train our sales and marketing personnel on our policies regarding sales and marketing practices. Pursuant to the AdvaMed Code, we have certified our adoption of the AdvaMed Code. The sales and marketing practices of our industry have been the subject of increased scrutiny from federal and state government agencies, and we believe that this trend will continue. Various hospital organizations, medical societies and trade associations are establishing their own practices that may require detailed disclosures of relationships between healthcare professionals and medical device companies or ban or restrict certain marketing and sales practices such as gifts and business meals. Since these laws, regulations and ultimate enforcement continue to evolve, we cannot predict with certainty, what, if any, impact, changes to them may have on our business or our customers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the U.S. we are subject to privacy and data security regulations at the international, national and regional level, as well as on an industry specific basis. For example, in Europe, we are subject to the EU General Data Protection Regulation ("GDPR") which is related to the collection, processing, storage, transfer and use of personal data. In the U.S., we are subject to the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;) and other similar laws in the United States, at both the federal and state level. Noncompliance with GDPR could trigger fines of up to 4% of global annual revenues. Compliance with these requirements may require changes in business practices, complicate our operations, and add complexity and additional management and oversight needs. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data. Non-compliance may result in proceedings against us by governmental or other entities and/or significant fines which could negatively impact our reputation and adversely effect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Should we delay or fail to comply with one or more of the regulatory requirements we could have reduced sales, increased costs, delays to new product introductions, enhancements or our strategic plans, or harm to our reputation or competitiveness, which could have a material adverse effect on our business and financial results.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our products contain materials derived from animal sources and may become subject to additional regulation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products are derived from bovine or porcine tissue sources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may experience difficulties in processing and producing our bovine and porcine tissue products at scale, including problems related to yields, quality control and assurance, tissue availability, adequacy of control policies and procedures and availability of skilled personnel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to bovine, among other products, our dermal regeneration products, duraplasty products, wound care products, bone void fillers, nerve and tendon repair products and certain other products, contain material derived from bovine tissue. In 2020, approximately 39.3% of our revenues derived from products containing material derived from bovine tissue. Products that contain materials derived from animal sources, including food, pharmaceuticals and medical devices, are subject to scrutiny in the media and by regulatory authorities. Regulatory authorities are concerned about the potential for the transmission of disease from animals to humans via those materials. This public scrutiny has been particularly acute in Japan and Western Europe with respect to products derived from animal sources, because of concern that materials infected with the agent that causes bovine spongiform encephalopathy, otherwise known as BSE or mad cow disease, may, if ingested or implanted, cause a variant of the human Creutzfeldt-Jakob Disease, an ultimately fatal disease with no known cure. The World Organization for Animal Health ("OIE") recognizes the U.S. as having a negligible risk for BSE, which is the highest status available.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take care to provide that our products are safe and free of agents that can cause disease. In particular, we qualified a source of collagen from a country outside the U.S. that is considered BSE/TSE-free. The World Health Organization classifies different types of bovine tissue for relative risk of BSE transmission. Deep flexor tendon and bovine fetal skin, which are used in our products, are in the lowest-risk categories for BSE transmission and are therefore considered to have a negligible risk of containing the agent that causes BSE (an improperly folded protein known as a prion). Nevertheless, products that contain materials derived from animals, including our products, could become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for the transmission of prions. Significant new regulations, or a ban of our products, could have a material, adverse effect on our current business or our ability to expand our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain countries, such as Japan, China, Taiwan and Argentina, have issued regulations that require our collagen products be sourced from countries where no cases of BSE have occurred, and the EU has requested that our dural replacement products and other products that are used in neurological tissue be sourced from a country where no cases of BSE have occurred. Currently, we source bovine fetal hides from the U.S. and purchase tendon from the U.S. and New Zealand. New Zealand has </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">never had a case of BSE. We received approval in the U.S., the EU, Japan, Taiwan, China, Argentina as well as other countries for the use of New Zealand-sourced tendon in the manufacturing of our products. If we cannot continue to use or qualify a source of tendon from New Zealand or another country that has never had a case of BSE, we could be prohibited from selling our collagen products in certain countries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our products are derived from human tissue and are subject to additional regulations and requirements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and distribute products derived from human tissue. As discussed in detail above in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Cells, Tissues and Cellular and Tissue-Based Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," the FDA has specific regulations governing human cells, tissues and cellular and tissue-based products, or HCT/Ps. An HCT/P is a product containing or consisting of human cells or tissue intended for transplantation into a human patient.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2015, the FDA issued an Untitled Letter alleging that </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioD Logic LLC's ("BioD") </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">morselized amniotic membrane tissue based products do not meet the criteria for regulation as HCT/Ps solely under Section 361 and that, as a result, BioD would need a biologics license to lawfully market those morselized products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2017, the FDA issued the final guidance document related to human tissue titled, &#8220;Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use&#8221; (the &#8220;HCT/P Final Guidance&#8221;). The HCT/P Final Guidance maintains the FDA&#8217;s position that products such as the Company&#8217;s morselized amniotic membrane tissue-based products do not meet the criteria for regulation solely as HCT/Ps. In addition, the FDA articulated a risk-based approach to enforcement and, while some uses for amniotic membrane tissue-based products would enjoy as much as thirty-six months of enforcement discretion, other high risk uses could be subject to immediate enforcement action. The Company does not believe the uses for its amniotic membrane tissue-based products fall into the high risk-category. Nonetheless, we can make no assurances that the FDA will continue to exercise its enforcement discretion with respect to the Company&#8217;s amniotic membrane tissue-based products, and any potential action of the FDA could have a financial impact regarding the sales of such products. The Company has been considering and continues to consider regulatory approval pathways for its amniotic membrane tissue-based products. Revenues from BioD morselized amniotic material-based products for the year ended December 31, 2020 was less than 1% of consolidated revenues. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to current and potential future requirements relating to protection of the environment, such as hazardous materials regulations, which may impose significant compliance or other costs on us. </span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing, product development, research, and development operations and processes involve the controlled use of certain hazardous materials. In addition, we own and/or lease a number of facilities at which hazardous materials have been used in the past. Finally, we have acquired various companies that historically have used certain hazardous materials and that have owned and/or leased facilities at which hazardous materials have been used. For all of these reasons, we are subject to federal, state, foreign, and local laws and regulations governing the use, manufacture, storage, transportation, handling, treatment, remediation, and disposal of hazardous materials and certain waste products (&#8220;Environmental, Health, Safety and Transportation Laws&#8221;). Although we believe that our procedures for handling, transporting, and disposing of hazardous materials comply with the Environmental, Health, Safety and Transportation Laws, the Environmental Health, Safety and Transportation Laws may be amended in ways that increase our cost of compliance, perhaps materially.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the potential risk of accidental contamination or injury from these materials cannot be eliminated, and there is also a risk that such contamination previously has occurred in connection with one of our facilities or in connection with one of the companies we have purchased. In the event of such an accident or contamination, we could be held liable for any damages that result and any related liability could exceed the limits or fall outside the coverage of our insurance and could exceed our resources. We may not be able to maintain insurance on acceptable terms or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, climate change and sustainability efforts and potential climate change regulations could lead to business interruption, significantly increased costs and/or other adverse consequences to our business. If regulations are enacted in the United States, Europe, or any other jurisdictions in which we do business that, for example, limit or reduce allowable greenhouse gas emissions and other emissions, such restrictions could effect or interrupt our operations or the operations of our suppliers, potentially leading to higher costs, and therefore negatively impact our results of operations. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to requirements relating to information technology which could adversely affect our business.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain reliable information technology systems and prevent disruptions, outages, or data breaches, we may suffer regulatory consequences in addition to business consequences. Our worldwide operations means that we are subject to laws and regulations, including data protection and cyber security laws and regulations, in many jurisdictions. The variety of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and international privacy and cybersecurity laws and regulations impacting our operations are described in &#8220;Item 1. Business - Government Regulation - Other Factors - Data Privacy and Cybersecurity Laws and Regulations." We have programs to ensure compliance with such laws and regulations. However, there is no guarantee that we will avoid enforcement actions by governmental bodies. Enforcement actions may be costly and interrupt regular operations of our business. In addition, there has been a developing trend of civil lawsuits and class actions relating to breaches of consumer data held by large companies or incidents arising from other cyber-attacks. While Integra has not been named in any such suits, if a substantial breach or loss of data were to occur, we could become a target of such litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO TAX AND DEBT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have additional tax liabilities.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the U.S. and many foreign jurisdictions and are commonly audited by various tax authorities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Significant judgment is required in determining our worldwide provision for income taxes. Although we believe that our tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation could have a material, adverse effect on our financial statements in the period or periods for which that determination is made.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our leverage and debt service obligations could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage and debt service obligations could adversely affect our business. As of December&#160;31, 2020, our total consolidated external debt was approximately $1.1&#160;billion (See item 7 and Note 6 for a discussion of our consolidated external debt). We may also incur additional indebtedness in the future. Our substantial indebtedness could have material, adverse consequences, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult for us to satisfy our financial obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic, regulatory and industry conditions, and placing us at a disadvantage compared to our competitors that are less leveraged;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to compete and our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to borrow additional funds for working capital, capital expenditures, acquisitions and general corporate or other purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt service obligations will require us to use a portion of our operating cash flow to pay interest and principal on indebtedness instead of for other corporate purposes, including funding future expansion of our business, acquisitions, and ongoing capital expenditures, which could impede our growth. In addition, our ability to comply with, renegotiate or extend the Company&#8217;s debt obligations will depend on our operating and financial performance, which in turn is subject to prevailing economic conditions and financial, business and other factors beyond our control.  Any disruptions in our operations, the financial markets, or the overall economy, including as a result of COVID-19, may adversely affect the availability and cost of credit to us and/or our ability to comply with our existing obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the calculation and or complete replacement of LIBOR could have an impact on our business.  </span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s Financial Conduct Authority, which regulates LIBOR, announced in July 2017 that it will no longer persuade or require banks to submit rates for LIBOR after 2021. This announcement and global financial benchmark reforms generally have resulted in the future of certain interest rate benchmarks being more uncertain. LIBOR may be disrupted, materially change, or no longer be published in the future. We have multiple debt facilities which utilizes a variable rate equal to Eurodollar LIBOR rate as a component of our interest rate. The upcoming transition away from LIBOR as a common reference rate in the global financial market could have a material, adverse effect on our business. Management continues to monitor the status and discussions regarding LIBOR.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights may not provide meaningful commercial protection for our products, potentially enabling third parties to use our technology or very similar technology and could reduce our ability to compete in the market.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To compete effectively, we depend, in part, on our ability to maintain the proprietary nature of our technologies and manufacturing processes, which includes the ability to obtain, protect and enforce patents on our technology and to protect our trade secrets. We own or have licensed patents that cover aspects of some of our product lines. Our patents, however, may not provide us with any significant competitive advantage. Others may challenge our patents and, as a result, our patents could be narrowed, invalidated or rendered unenforceable. Competitors may develop products similar to ours that our patents do not cover. In addition, the approval or rejection of patent applications may take several years and our current and future patent applications may not result in the issuance of patents in the U.S. or foreign countries.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our competitive position depends, in part, upon unpatented trade secrets, which we may be unable to protect.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position also depends upon unpatented trade secrets, which are difficult to protect. We cannot assure that others will not independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets, that our trade secrets will not be disclosed or that we can effectively protect our rights to unpatented trade secrets.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to protect our trade secrets, we require our employees, consultants and advisors to execute confidentiality and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements provide that, except in specified circumstances, all confidential information developed or made known to the individual during the course of their relationships with us must be kept confidential. We cannot assure, however, that these agreements will provide meaningful protection for our trade secrets or other proprietary information in the event of the unauthorized use or disclosure of confidential information.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend partly on our ability to operate without infringing or misappropriating the proprietary rights of others.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be sued for infringing the intellectual property rights of others. In addition, we may find it necessary, if threatened, to initiate a lawsuit seeking a declaration from a court that we do not infringe the proprietary rights of others or that their rights are invalid or unenforceable. If we do not prevail in any litigation, in addition to any damages we might have to pay, we would be required to stop the infringing activity (which could include a cessation of selling the products in question) or obtain a license for the proprietary rights involved. Any required license may be unavailable to us on acceptable terms, if at all. In addition, some licenses may be nonexclusive and allow our competitors to access the same technology we license.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain a required license or are unable to design our products so as not to infringe on the proprietary rights of others, we may be unable to sell some of our products, and this potential inability could have a material, adverse effect on our revenues and profitability.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits relating to our intellectual property rights and promotional practices, which may be expensive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect or enforce our intellectual property rights, we may have to initiate or defend legal proceedings, such as infringement suits or opposition proceedings, against or by third parties. In addition, we may have to institute proceedings regarding our competitors&#8217; promotional practices or defend proceedings regarding our promotional practices. Legal proceedings are costly, and, even if we prevail, the cost of the legal proceedings could affect our profitability. In addition, litigation is time-consuming and could divert management's attention and resources away from our business. Moreover, in response to our claims against other parties, those parties could assert counterclaims against us.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO GLOBAL OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If any of our facilities or those of our suppliers were damaged and/or our manufacturing or business processes interrupted, we could experience lost revenues and our business could be seriously harmed.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damage to our manufacturing, distribution, development and/or research facilities because of fire, extreme weather conditions, natural disaster, power loss, communications failure, geopolitical disruption, unauthorized entry or other events, such as a flu or other health epidemic, such as COVID-19, could significantly disrupt our operations, the operations of suppliers and critical infrastructure and delay or prevent product manufacture and shipment during the time required to repair, rebuild or replace the damaged facilities. Certain of our manufacturing facilities are located in Puerto Rico, which in the past has experienced both severe earthquakes and other natural disasters. Climate change may increase both the frequency and severity of natural disasters and, consequently, risks to our operations and growth. Although we maintain property damage and business interruption </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance coverage on these facilities, our insurance might not cover all losses under such circumstances, and we may not be able to renew or obtain such insurance in the future on acceptable terms with adequate coverage or at reasonable costs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An experienced third-party hosts and maintains the enterprise business system used to support certain of our transaction processing for accounting and financial reporting, supply chain and manufacturing. Currently, we have developed a comprehensive disaster recovery plan for the Company&#8217;s infrastructure and we have tested this plan. In addition, we have implemented procedures to conduct annual disaster recovery testing for our enterprise business system. We also implemented a comprehensive backup and recovery process for our key applications. Our global production and distribution operations are dependent on the effective management of information flow between facilities. An interruption of the support provided by our enterprise business systems could have a material, adverse effect on the business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to a variety of risks relating to our international sales and operations.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate significant revenues outside the U.S. in multiple foreign currencies, and in U.S. dollar-denominated transactions conducted with customers who generate revenue in currencies other than the U.S. dollar. For those foreign customers who purchase our products in U.S. dollars, currency fluctuations between the U.S. dollar and the currencies in which those customers do business may have a negative impact on the demand for our products in foreign countries where the U.S. dollar has increased in value compared to the local currency.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have operations based outside the U.S. and we generate revenues and incur operating expenses in multiple foreign currencies, we experience currency exchange risk with respect to those foreign currency-denominated revenues and expenses. Our most significant currency exchange risk relates to transactions conducted in Australian dollars, British pounds, Canadian dollars, Chinese yuan, euros, Japanese yen, and Swiss francs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the consolidated effects of exchange rate fluctuations upon our future operating results because of the number of currencies involved, the variability of currency exposure and the potential volatility of currency exchange rates. Although we address currency risk management through regular operating and financing activities, and, on a limited basis, through the use of derivative financial instruments, those actions may not prove to be fully effective. For a description of our use of derivative financial instruments, see Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, import-export, laws regarding transactions in foreign countries, the U.S. Foreign Corrupt Practices Act and local anti-bribery and other laws regarding interactions with healthcare professionals, and product registration requirements. Among other things, these laws restrict, and in some cases prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in structuring our sales and marketing practices and effecting product registrations in foreign countries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s (&#8220;UK&#8221;) exit from the European Union on January 31, 2020, commonly referred to as Brexit, has caused, and may continue to cause uncertainty in the global political markets. It is possible that Brexit could, among other things, affect the legal and regulatory environments to which our business is subject, impose greater restrictions on imports and exports between the UK and the EU and other parties, and create economic and political uncertainty in the region.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, proposals are made to significantly change existing trade agreements and relationships between the U.S. and other countries. For instance, the U.S. and China have imposed tariffs on products imported into their respective countries. While we currently do not anticipate that these tariffs will have a material impact on our business, the list of items subject to these tariffs could change and it is possible that they could adversely impact our supply chain costs or our ability to sell certain of our products in China. More generally, additional tariffs or other trade barriers imposed by the U.S. or other countries could materially and adversely affect our operations and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyber-attacks or other disruptions to our information technology systems could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent on sophisticated information technology for our infrastructure and to support business decisions. Our information systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information, and changing customer </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patterns. Any significant breakdown, intrusion, interruption, corruption, or destruction of these systems, as well as any data breaches, could have a material, adverse effect on our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may attempt to breach our systems and may obtain data relating to patients, proprietary or sensitive information. If we fail to maintain or protect our information systems and data integrity effectively, we could lose existing customers, have difficulty attracting new customers, suffer backlash from negative public relations, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach, or suffer other adverse consequences.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have programs, processes (including ongoing improvements) and technologies in place to prevent, detect, contain, respond to and mitigate security related threats and potential incidents. Because the techniques used to obtain unauthorized access change frequently and can be difficult to detect, anticipating, identifying or preventing these intrusions or mitigating them if and when they occur, may be challenging. We are also dependent on third party vendors to supply and/or support certain aspects of our information technology systems which may contain defects in design or manufacture or other problems that could result in system disruption or unexpectedly compromise the information security of our own systems.  In addition, as we grow in part through new acquisitions we may face risks due to implementation, modification, or remediation of controls, procedures, and policies relating to data privacy and cybersecurity at the acquired business. We continue to consolidate and integrate the number of systems we operate, and to upgrade and expand our information system capabilities for stable and secure business operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_25"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">PROPERTIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we lease approximately 166,991 square feet of space in Princeton, NJ, where we house our principal headquarters, sales operations, and support functions. This lease expires in 2036.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in New Jersey, Ohio, Massachusetts, Tennessee, Canada, France, Germany, Ireland, Switzerland, California and Puerto Rico. Our instrument procurement operations are located in Germany. Our primary distribution centers are located in Nevada, Ohio, Kentucky, Australia, Belgium, Canada, Japan and France. In addition, we lease several smaller facilities to support additional administrative, assembly, and distribution operations. Third parties own and operate the facilities in Nevada, Kentucky, Japan and Belgium. We own facilities in Biot, France, Saint Aubin Le Monial, France, Rietheim-Weilheim, Germany and Ohio and we lease all of our other facilities. We also have repair centers in California, Massachusetts, Ohio, Australia, Japan and Germany. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing facilities are registered with the FDA. Our facilities are subject to FDA inspection to ensure compliance with Quality System regulations. For further information regarding the status of FDA inspections, see the "Government Regulation" and "Management's Discussion and Analysis of Financial Condition and Results of Operations - Update on Remediation Activities" sections in this Form 10-K.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_28"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in Note 16. Commitment and Contingencies in our 2020 Financial Statements.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_31"></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_34"></div><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_37"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information, Holders and Dividends </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on The NASDAQ Global Select Market under the symbol &#8220;IART.&#8221; The number of stockholders of record as of February&#160;19, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approximately 782, which includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stockholders whose shares were held in nominee name. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of unregistered securities during the years ended December&#160;31, 2020, 2019 or 2018. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Registered Securities </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, the Company commenced and closed on a public offering of common stock. The Company issued 6.0 million shares of common stock and received total proceeds, net of underwriting fees and offering expenses, of approximately $349.6 million. The net proceeds from the offering were used to reduce outstanding borrowings under the revolving credit portion of the Company's Senior Credit Facility.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225 million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225 million stock repurchase authorization, of which $125 million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2020. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of convertible notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the ASR, which represented approximately 80% of the expected total shares. Upon settlement of the ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our consolidated financial statements for further details. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_40"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">SELECTED FINANCIAL DATA</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth below should be read in conjunction with &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our consolidated financial statements and related notes included elsewhere in this report. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the impact of 2019 and 2018 acquisitions in Item 15 of this Form 10-K. </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Results:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">992,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,423,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,361,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">876,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net (1) (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Benefit from) provision for income taxes (4) (6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for diluted net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Position:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets (5) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,615,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,303,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,107,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,211,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,807,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under the term loan of the Senior Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under securitization facility (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings including the revolving portion of the Senior Credit Facility (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">933,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,198,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,210,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,781,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt (1) (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,514,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,375,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">962,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">839,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ended December 31, 2020, 2019, 2018, 2017, and 2016, we reported the borrowings outstanding under the revolving portion of our Senior Credit Facility as long-term debt, the 1.625% convertible senior notes due in 2016 ("2016 Convertible Notes"), and the 0.5% convertible senior notes due in 2025 ("2025 Convertible Notes"). We also reported the term loan as long-term debt with the exception of current principal payments due within 12 months, which are classified as short-term. At December 31, 2020, we have a total of $975 million outstanding under our Senior Credit Facility and $325.0 million available for future borrowings. </span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2020, the total amount outstanding under the Securitization Facility is classified as current on the consolidated balance sheet as the total amount is due on December 21, 2021. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2019, the total amount outstanding under the Securitization Facility was classified as long-term debt on the consolidated balance sheet. See Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for further details.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2018, we closed on a public offering of common stock. We issued&#160;6.0 million&#160;shares of common stock and received total proceeds, net of underwriting fees and offering expenses, of approximately&#160;$349.6 million.<br/></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;). The Company made an initial upfront payment of $67.1 million. The initial payment resulted in a $59.9 million IPR&amp;D expense. During the fourth quarter of 2019, the Company triggered a $5.0 milestone to be paid to former shareholders of Rebound. The Company recorded the $5.0 million as additional in-process research and development expense which was included in accrued liabilities at December 31, 2019 (see Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, of the consolidated financial statements).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On January 1, 2018, we adopted Topic 606 using the modified retrospective method. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. Total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2016, the Company elected to adopt Accounting Standard Update 2016-09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">, Improvements to Employee Share-Based Payment Accounting (Topic 718). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company elected to account for forfeitures as they occur. The impact in retained earnings as of December 31, 2015 from this provision was not significant. Amendments related to accounting for excess tax benefits have been adopted prospectively, resulting in recognition of excess tax benefits against income tax expenses rather than additional paid-in capital of $3.8 million for the year ended December 31, 2016.  </span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On January 1, 2019, the Company adopted the Lease Standard using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. As a result of the adoption of the New Lease Standard, the Company had an impact on our consolidated balance sheet due to the recognition of $76.4 million of lease liabilities with corresponding right-of-use assets ("ROU") of $67.3 million for operating leases. (see Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Leases and Related Party Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, of the consolidated financial statements).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2016, the Company adopted Accounting Standard Update 2015-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Presentation of Debt Issuance Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Company adopted this guidance effective January 1, 2016 on a retrospective basis. The Company reclassified a portion of the debt issuance costs from other assets to long-term debt as of December 31, 2015.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The benefit from income taxes in 2017 includes $43.4 million related to the re-measurement of our deferred taxes resulting from a reduction of the federal statutory rate from 35% to 21% from the Tax Cuts and Jobs Act (the "2017 Tax Act"), enacted in December 2017.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The benefit from income taxes in 2020 includes $59.2 million related to the Company completing an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. </span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_43"></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read together with the selected consolidated financial data and our financial statements and the related notes appearing elsewhere in this report. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparison of fiscal 2019 to 2018 has been omitted from this Form 10-K, but can be referenced in our Form 10-K for the fiscal year ended December 31, 2019&#8212;&#8220;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; filed on February 21, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made statements in this report which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters. These forward-looking statements include, but are not limited to, statements related to the Company's expectations regarding the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations. These</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: The Company's ability to obtain accurate procedure volume in the midst of the COVID-19 pandemic; the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; curtailed or delayed capital spending by the Company's customers; disruption to the Company's supply chain; closures of our facilities; delays in gathering clinical evidence; diversion of management and other resources to respond to the COVID-19 outbreak;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus or its variants disrupt local economies and causes economies in our key markets to enter prolonged recessions. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under the heading &#8220;Risk Factors.&#8221;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_46"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, headquartered in Princeton, New Jersey, is a world leader in medical technology. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds, to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products, advanced wound care, and orthopedic hardware through a combination of several global acquisitions and development of products internally to further meet the needs of its customers and impact patient care. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra now manufactures and sells our products in two reportable business segments: Codman Specialty Surgical and Orthopedics and Tissue Technologies. Our Codman Specialty Surgical products comprise of specialty surgical implants and instrumentation for a broad range of specialties. This segment includes products and solutions for dural access and repair, precision tools and instruments, advanced energy, cerebral spinal fluid ("CSF") management and neuro monitoring including market leading product portfolios used in neurosurgery operation suites and critical care units. Codman Specialty Surgical products are sold through a combination of directly employed sales representatives, distributors and wholesalers, depending on the customer call point. Our Orthopedics and Tissue Technologies product portfolios consist of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and surgical reconstruction. This business also includes private label sales of a broad set of our regenerative and wound care medicine technologies. Orthopedics and Tissue Technologies products are sold through directly employed sales representatives and distributors focused on their respective surgical specialties, and strategic partners. In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately&#8239;$240&#8239;million in cash. This transaction enables us to increase our investments in our business which will strengthen our existing leadership positions in both areas, fund pipeline opportunities to drive future growth and expand our addressable markets. See Note 18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Massachusetts, New Jersey, Ohio, Tennessee, Canada, France, Germany, Ireland, Puerto Rico a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd Switzerland. We also source most of our handheld surgical instruments, specialty metal and pyrocarbon implants, and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) building an execution-focused culture, 2) achieving relevant scale, 3) improving agility and innovation, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned tuck-in acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. In December 2020, Integra entered into a merger agreement to acquire ACell, Inc., an innovative regenerative medicine company. This acquisition, which closed on January 20, 2021, expands our product offering of regenerative technology and is complementary to Integra&#8217;s existing tissue technologies portfolio. The acquisition also supports our long-term growth and profitability strategy with a financial profile similar to Integra&#8217;s tissue products. In 2020, we continued to invest in our two most recent acquisitions from 2019, Arkis Biosciences, Inc. and Rebound Therapeutics Corporation, both of which are developing innovative technologies for neurosurgery. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Optimization and New Product Introductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential for significant returns on investment. In February 2020, we launched the AmnioExcel&#174; Plus Placental Allograft Membrane, the next generation wound care offering to support soft tissue repair. Throughout 2020, we continue to reap the benefits of many of our ten new products launches from 2019. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. We continue to identify ways of optimizing our portfolio including identifying low-growth, low-margin products and product franchises for discontinuation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately &#160;$240&#160;million in cash. This transaction enables us to increase our investments in our core Neurosurgery and Tissue Technology businesses which will strengthen our existing leadership positions in both areas, fund pipeline opportunities to drive future growth and expand our addressable markets. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;With acquisitions, new product introductions and a broader portfolio of products, investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. Internationally, we have increased our commercial resources significantly in many markets and are making investments to support our sales organization and maximize our commercial opportunities. We now have a strong international sales channel that will deliver our current portfolio as well as position us for expansion. In addition, we continue to build upon our leadership brands across our product franchises to enable us to engage customers through enterprise-wide contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthen our relationships with all customers. We strive to consistently deliver outstanding customer service and continue to invest in technologies, systems and processes to improve the way our customers do business with us. Additionally, we expect to build on the success of our professional education programs to drive continued customer familiarity with our growing portfolio of medical technologies globally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical and Product Development Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in collecting clinical evidence to support the Company's existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions. In each area, we continue to benefit from products launched over the past two years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Codman Specialty Surgical segment, the Company received FDA clearance in July 2020 to treat malignant and benign tumors, but not limited to meningiomas and gliomas, for its CUSA&#174; Clarity Ultrasonic Surgical Aspirator System, the first and only ultrasonic tissue ablation system with this specific indication. The FDA clearance is based on a wealth of peer-reviewed clinical publications and 40 years of surgical cases involving resection of brain and spinal tumors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company continued to reap the benefits of our product launches from the prior year from the Codman Specialty Surgical segment, including our new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas&#8482; Plus Programmable Valve along with additional shunt configurations. In Japan, we are experiencing strong growth as a result of the successful launch of DuraGen&#174; last year, which is the first and only collagen xenograft approved for use as a dural substitute in the country. We are focused on the development of core clinical applications in our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electromechanical technologies portfolio. Also, we updated our CUSA Clarity platform to incorporate a new ultrasonic handpiece, surgical tips and integrated electrosurgical capabilities. We continue to work with several instrument partners to bring new surgical instrument platforms to the market. This enables us to add new instruments with minimal expense and invest in ongoing development, such as our next generation of LED technology with our DUO LED Surgical Headlight System.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the year, we also continued to advance the early-stage technology platforms we acquired in 2019. Through the Arkis Biosciences acquisition, we added a platform technology, CerebroFlo&#174; external ventricular drainage (EVD) catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. We also acquired a company, Rebound Therapeutics, that specialized in single-use medical devices that enable minimally invasive access with enhanced lighting and visualization to the neurosurgery suite.  Importantly, these new platforms provide us with the opportunity to expand into new, faster growth therapeutic areas, such as intracerebral hemorrhage and minimally invasive neurosurgery.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Orthopedics and Tissue Technologies segment, in February 2020, we launched AmnioExcel&#174; Plus Placental Allograft Membrane, a human placental tissue product for treatment of wounds. We also launched a small post baseplate in our reverse shoulder system that accommodates smaller patients. In addition, we initiated the limited market release of enhancements to our Salto Talaris&#174; Total Ankle System.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company announced positive clinical and economic data on Integra&#174; Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons looks for ways to efficiently and effectively repair and close wounds during these challenging times, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this global crisis, the Company's focus remains on supporting patients, providing customers with life-saving products, and protecting the well-being of our employees. The rapid and evolving spread of the virus has resulted in an unprecedented challenge to the global healthcare industry, as medical resources were reallocated to fight COVID-19. During the first half of 2020, in response to the pandemic, we acted swiftly by implementing protocols to ensure continuity of our manufacturing and distribution sites around the world and to provide for the safety of our employees. We continued to invest in our key research, development and clinical programs but also implemented cost-savings measures, which included the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced executive management compensation through July 2020 and director compensation;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced cash compensation for all other employees through reduced commissions, reduction in hours through July 2020 and/or furloughs;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hiring freeze, elimination of overtime, reduction in certain employee benefit costs, cessation of third-party services and temporary contractor relationships; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant reduction in capital expenditures and discretionary spending including travel, events and marketing programs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the recovery began to take hold, we saw the benefit of our balanced pandemic response. In the second half of 2020, while continuing to methodically manage expenses, the Company restored employee wages, hired key positions and allocated additional funds toward growth and productivity projects. We remain confident that the underlying markets in which the Company competes remain attractive over the long term. We also remain focused on managing the business for the long-term, including preserving full time jobs needed to support the rebound in surgical procedure volumes. The Company's adaptability and resiliency in the face of this unprecedented crisis is made possible in part by prior investments in technology infrastructure and operations, as well as our talented and committed global workforce.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital markets and worldwide economies have also been significantly impacted by the COVID-19 pandemic, and it is possible that it could cause a local and/or global economic recession.&#160;Any such&#160;economic recession could have a material adverse effect on the Company's long-term business as hospitals curtail and reduce capital as well as&#160;overall spending. The COVID-19 pandemic and local actions, such as &#8220;shelter-in-place&#8221; orders and restrictions on&#160;travel and access to our customers or temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, could further significantly impact our sales and our ability to ship our products and supply our customers. Any of these events could negatively impact the number of surgical and medical intervention procedures performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to additional risk factors as it relates to the COVID-19 pandemic can be found in Item 1A. Risk Factors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Matters</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and distribute products derived from human tissue for which FDA has specific regulations governing human cells, tissues and cellular and tissue-based products, or HCT/Ps. An HCT/P is a product containing or consisting of human cells or tissue intended for transplantation into a human patient. Refer to Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details around these FDA regulations and their potential effect on the Company's portfolio of morselized amniotic material-based products as well as the impact on consolidated revenues.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2019, TEI Biosciences, Inc. a subsidiary of the Company received a Warning Letter (the &#8220;Warning Letter&#8221;), dated March 6, 2019, from the FDA. The warning letter relates to quality systems issues at our manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. The Company submitted its initial response to the FDA Warning Letter on March 28, 2019 and provides regular progress reports to the FDA as to its corrective actions and, since the conclusion of the inspection, has undertaken significant efforts to remediate the observations and continues to do so. The warning letter does not restrict the Company&#8217;s ability to manufacture or ship products or require the recall of any products. Nor does it restrict our ability to seek FDA 510(k) clearance of products. The letter states that requests for Certificates to Foreign Governments would not be granted. However, due to our progress reports, the FDA agreed to resume issuing Certificates to Foreign Governments to TEI due to substantial progress and the length of time it takes to resolve the Warning Letter. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix (EBM) products. The Company does not expect to incur material incremental expense for remediation activities. We cannot, however, give any assurances that the FDA will be satisfied with our response to the Warning Letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA&#8217;s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues of products manufactured in the TEI Boston facility for the year ended December&#160;31, 2020 were approximately 4.5% of consolidated revenues.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_49"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS &amp; DIVESTITURES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement (see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited. The Company received an aggregate purchase price of $240.0&#160;million from Smith and Nephew and concurrently paid $41.5&#160;million to CFO effectively terminating our licensing agreement (see Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy includes the acquisition of businesses, assets or products lines to increase the breadth of our offerings and the reach of our product portfolios and drive relevant scale to our customers. As a result of several acquisitions throughout 2019, our financial results for the year ended December&#160;31, 2020 may not be directly comparable to those of the corresponding prior-year periods. See Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 18- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for a further discussion.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell Inc. for an acquisition purchase price of $300 million. Under the terms of the definitive merger agreement, the Company paid the consideration for the merger as an upfront cash payment subject to a customary post-closing adjustment for certain working capital. The Company is also required to pay the former shareholders of ACell Inc. up to $100&#160;million based upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of December 31, 2020 was $15.1 million. The Company recorded $3.4 million in accrued expenses and other current liabilities and $11.7 million in other liabilities at December 31, 2020 in the consolidated balance sheets of the Company. Arkis was a privately-held company that marketed the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CerebroFlo&#174; external ventricular drainage (EVD) catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to clotting.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the Aurora which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of $67.1 million and committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones. The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company concluded that the acquired assets did not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million in-process research and development (IPR&amp;D) expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carryforward.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as IPR&amp;D expense in the consolidated statements of operations during the year ended December 31, 2019. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The milestone was paid during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Integrated Shoulder Collaboration, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales threshold of the short stem and stemless shoulder system, for an amount not to exceed $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. During the quarter ended March 31, 2019, the total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. In connection with the divestiture of the Extremity Orthopedics business, the Company paid $41.5&#160;million to the Consortium of Focused Orthopedists, LLC (&#8220;CFO&#8221;) concurrently pursuant to the terms of certain agreements between Integra and CFO relating to the development of shoulder arthroplasty products effectively terminating our licensing agreement with ISC. </span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_52"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIMIZATION AND INTEGRATION ACTIVITIES </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our ongoing acquisition strategy and significant growth in recent years, we have undertaken cost-saving initiatives to consolidate manufacturing operations, distribution facilities and transfer activities, implement a common ERP system, eliminate duplicative positions, realign various sales and marketing activities, and expand and upgrade production capacity for our regenerative technology products. These efforts are expected to continue and while we expect a positive impact from ongoing restructuring, integration, and manufacturing transfer and expansion activities, such results remain uncertain. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_55"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the year ended December&#160;31, 2020 was $133.9 million, or $1.57 per diluted share, compared to $50.2 million, or $0.58 per diluted share for the year ended December&#160;31, 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in net income for the year ended December 31, 2020 as compared to December 31, 2019 was primarily driven by two main components. The first was due to a net tax benefit in 2020 due to the impact of the intra-entity transfer of certain intellectual property which resulted in the recognition of a deferred tax benefit in the amount of $59.2 million. The second component of the increase in net income in 2020 compared to 2019 resulted from a $64.9&#160;million IPR&amp;D expense attributed to the Rebound transaction which occurred during the third quarter of 2019. Excluding these components, net income for the year ended December&#160;31, 2020 declined by $40.4 million compared to the prior year 2019. This decrease was attributable to the impact of the COVID-19 pandemic which resulted in lower revenues, and was partially offset by a decrease in the level of operating expenses due to cost-savings measures implemented by the Company during 2020. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company demonstrated recovery in both of our reporting segments in the second half of 2020 as compared to the first half of 2020. The revenue results </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the second half of 2020 along with expense management by the Company contributed to overall profitability and strong operating cash flows during a year in which the Company was severely affected by a global crisis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, total revenues were $1,371.9 million, representing a decline of 9.6% from prior year revenues due to COVID-19 related surgical procedure delays and capital spending deferrals. Given the variability throughout 2020, we have presented our results below including Revenue for the first and second half of 2020 as compared to the first and second half of 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:44.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First Half</span></td><td colspan="6" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second Half</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Special Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first half of 2020, total revenues declined $130.3&#160;million, representing a decline of 18%, compared to the first half of 2019 and reflected the impact of the COVID-19 pandemic on the Company from mid-March 2020 through June 30, 2020. The Company experienced the largest impact of COVID-19 during the second quarter of 2020 when revenues declined 32.6% compared to the same period in 2019. As a result of the speed and severity of the spread of COVID-19, the Company saw rapid and significant decline in surgical and medical intervention procedures as healthcare providers deferred non-urgent medical procedures in order to address the increasing demands caused by the COVID-19 pandemic. Despite the revenue decline experienced, the Company does not believe its underlying markets in neurosurgery and regenerative medicine have fundamentally changed, rather the revenue declines were driven by COVID-19 procedural delays. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second half of 2020, total revenues declined $15.3 million, representing a decline of 2% compared to the second half of 2019. In the second half of 2020, we experienced strong sequential revenue improvements across all franchises, representing an increase of 24% compared to the first of half of 2020. The Company's performance varied across regions and product lines based on the severity of the pandemic but in general, the Company saw broad based recovery across its portfolio when compared to the first half of 2020, as surgical procedures recovered and shelter in place restrictions were lifted. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Codman Specialty Surgical ("CSS") segment, revenues for the second half of 2020 increased 23.0% as compared to the first half of 2020. Both the Neurosurgery and Instruments portfolio showed significant sequential improvement compared to the first half of 2020. During the second half of 2020, CSS revenues declined 3.7% as compared to the second half of 2019. Sales in our neuro monitoring products increased high single digits and CSF management products increased mid single digits in the second half of 2020 compared to the second half of 2019. Despite showing low double digits sequential improvement as compared to the first half of 2020, sales in capital equipment products, declined low double digits in the second half of 2020 compared to the same period in the prior year as hospitals and healthcare institutions continued to allocate capital budgets to manage the increase in costs associated with the COVID pandemic. The Company continues to have a strong pipeline of new capital opportunities and believes the reallocation of capital budgets is only temporary. Sales from our Instruments portfolio decreased low double digits excluding discontinued products as compared to the second half of 2019, due to a decrease experienced in surgical procedures as a result of COVID-19.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Orthopedics and Tissue Technologies ("OTT") segment, revenues for the second half of 2020 increased 25.3% as compared to the first half of 2020. Sales in our Wound Reconstruction, Extremity Orthopedics and Private Label portfolios all showed sequential improvement in revenues as compared to the first half of 2020. During the second half of 2020, OTT revenues increased 1.3% as compared to the second half of 2019. Sales in our Private label portfolio increased high-single digits over the prior year. Sales of our Wound Reconstruction and Extremity Orthopedics portfolio remained flat as compared to the second half of 2019 led by growth in sales of Integra skin, nerve and Primatrix products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to closely monitor local, regional, and global COVID-19 surges as well as new variants of the virus for an impact on procedures during Q1 2021 and beyond. The reallocation of hospital resources to treat COVID-19 may continue to cause a financial strain on healthcare systems and reduce procedural volumes. Additionally, the Company does not expect all markets and product lines to improve at the same rate based on the level of recurrence of COVID-19 and its associated impact on the pace of procedure recovery and economic normalization.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Charges </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes includes the following special charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, divestiture and integration-related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural optimization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued product lines charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses related to debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 pandemic related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Charges relate to business interruptions and costs associated with the COVID-19 pandemic which impacted the Company's operations globally, partially offset by Coronavirus government relief programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) The Company included $64.9 million of IPR&amp;D expense within acquisition, divestiture and integration-related charges as a result of the Rebound transaction in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items reported above are reflected in the consolidated statements of operations as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,048&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Amortization and impairment charges related to technology based intangible assets is included in cost of goods sold.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Impairment charges related to non-technology based intangible assets such as customer relationships are included in Intangible asset amortization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, divestiture, integration and restructuring activities, and for which the amounts are non-cash in nature, or for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, against the business model objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues and Gross Margin </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and gross margin on product revenues were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin on total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, total revenues decreased by $145.7 million, or 9.6%, to $1,371.9 million from $1,517.6 million during the prior year. Domestic revenues decreased by $105.4 million, or 9.8%, to $972.0 million and were 70.9% of total revenues for the year ended December&#160;31, 2020. International revenues decreased by $40.3 million or 9.2% to $399.9 million, compared to $440.2 million during 2019. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net decrease of $145.7 million was a result of decline in both segments due to disruption from the COVID-19 pandemic, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$22.7 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to discontinued and divested products, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.7</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">favorable </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of foreign exchange.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Codman Specialty Surgical revenues were $894.8 million, a decrease of 10.2% from the prior year primarily due to disruption caused by the COVID-19 pandemic and impact of discontinued products. Orthopedics and Tissue Technologies revenues were $477.0 million, a decrease of 8.5% from the prior year primarily due to disruption caused by the COVID-19 pandemic.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our global reach, we generate revenues in multiple foreign currencies. Accordingly, we will experience currency exchange risk with respect to those foreign currency denominated revenues. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gross margin as a percentage of revenues was 62.0% in 2020 and 62.8% in 2019. The decrease in gross margin percentage from 2019 to 2020 was primarily due to the disruption caused by the COVID-19 pandemic, an increase related to the manufacturing transition of certain CSS products to our  Mansfield, MA facility, partially offset by favorable product mix.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_58"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of operating expenses as a percent of total revenues:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses, which consist of research and development, IPR&amp;D, selling, general and administrative, and amortization expenses, decreased by $159.5 million or 18.6% to $699.7 million in 2020, compared to $859.1 million in the prior year. Operating costs were managed lower in 2020 due to on-going cost reduction efforts to offset the impact of lower revenues driven by the COVID-19 pandemic. These cost reduction actions included temporary reduced compensation and work hours, hiring freezes, reduction in certain employee benefit costs, cessation of third party services and contractors, and reductions in discretionary spending, including travel, events and marketing programs for a period of time.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the year ended December&#160;31, 2020 largely remained flat year over year with only a slight decrease of $2.2 million compared to the prior year. The Company continues to invest in R&amp;D programs with spending in-line with prior year levels despite the challenges from the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-Process Research and Development</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D expense for the year ended December&#160;31, 2020 decreased $64.9 million from the same period last year as a result of IPR&amp;D expense attributed to the Rebound transaction which occurred during the third quarter of 2019. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2020 decreased by $93.1 million as compared to the prior year resulting from less acquisition, divestiture and integration related charges, lower commissions and selling costs resulting from lower revenue during the year and overall cost reduction actions resulting from cost-savings measures taken by the Company as a result of the impact of the COVID-19 pandemic.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset Amortization</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (excluding amounts reported in cost of product revenues for technology-based intangible assets) in 2020 was $27.8 million compared to $27.0 million in 2019.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may discontinue certain products in the future as we continue to assess the profitability of our product lines. As our profitability assessment evolves, we may make further decisions about our trade names and incur additional impairment charges or accelerated amortization. We expect total annual amortization expense (including amounts reported in cost of product revenues, but excluding any possible future amortization associated with acquired IPR&amp;D and recent acquisition of ACell Inc. completed on January 20, 2021) to be approximately $63.8 million in 2021, $61.4 million in 2022, $60.7 million in 2023, $60.2 million in 2024, $60.2 million in 2025 and $512.3 million thereafter. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Operating Income and Expenses</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of non-operating income and expenses:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,581)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income and expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,850)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,656)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the year ended December&#160;31, 2020 decreased by $1.5 million as compared to the same period last year primarily due to the termination of cross-currency swaps designated as net investment hedges in Q4 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December&#160;31, 2020 increased by $17.6 million as compared to the same period last year primarily due to an increase in non-cash interest expense due to the issuance of the Convertible Senior Notes and expenses associated with our Amended and Restated Senior Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the year ended December&#160;31, 2020 decreased by $5.1 million as compared to the same period last year primarily due to the unfavorable impact of foreign exchange and a $3.0 million gain from a legal settlement received during the prior year.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective inco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me tax rate was (43.2)% and 16.5% of income before income taxes in 2020 and 2019, respectively. See Note 13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our consolidated financial statements for a reconciliation of the United States federal statutory rate to our effective tax rate. Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain; the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow mo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">del based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Company recorded a $59.2&#160;million deferred tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> benefit in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. We estimate our worldwide effective income tax rate for 2021 to be approximately 20.0%.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had $9.9&#160;million of valuation allowance against the remaining $173.3&#160;million of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deferred tax assets recorded at December&#160;31, 2020. Our deferred tax asset valuation allowance remained substantially unchanged in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and increased by $2.9&#160;million in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This valuation allowance relates to deferred tax assets for which the Company does not believe it has satisfied the more likely than not threshold for realization. The increase in valuation allowance in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily resulted from certain assets from the Rebound and Arkis acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we had net operating loss carryforwards of $90.2&#160;million for federal income tax purposes, $36.7&#160;million for foreign income tax purposes and $41.6&#160;million for state income tax purposes to offset future taxable income. The federal net operating loss carryforwards decreased during 2020 due to the use of net operating losses. Of the total federal net operating loss carryforwards, $78.4&#160;million expire through 2037 and $11.8&#160;million have an indefinite carryforward period. Regarding the foreign net operating loss carryforwards, $0.3&#160;million expire through 2025, and the remaining $36.4 million have an indefinite carryforward period. The state net operating loss carryforwards expire in 2036.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested.&#160;Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;As such, the Company has determined the tax impact of repatriating these earnings would not be material as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_61"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers that generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for the Company's products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic revenues decreased by $105.4 million for the year ended December&#160;31, 2020 compared to the same period last year. European sales decreased by $24.8 million for the year ended December&#160;31, 2020 compared to the same period last year. Sales to customers in Asia Pacific decreased by only $0.2 million for the year ended December 31, 2020 compared to the same period last year driven by accelerated recovery in both the Japan and China markets in relation to otherwise negative COVID-19 impacts. The Rest of the World for the year ended December&#160;31, 2020 decreased by $15.3 million compared to the same period last year. The decrease in revenues globally was primarily due to adverse effects of the COVID-19 pandemic across all franchises.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_64"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and December&#160;31, 2019, working capital was $836.2&#160;million and $526.9&#160;million, respectively. Working capital consists of total current assets less total current liabilities as presented in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Marketable Securities</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents totaling approximately $470.2 million and $198.9 million&#160;at December&#160;31, 2020 and 2019, respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At December&#160;31, 2020, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our non-U.S. subsidiaries held approximately $234.0 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S. The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used (provided) by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,766)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate fluctuations on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by Operating Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the year ended December&#160;31, 2020 decreased compared to the same period in 2019. Net income after non-cash adjustments increased by approximately $0.8 million to $245.1&#160;million from $245.9&#160;million. The changes in assets and liabilities, net of business acquisitions, decreased cash flows from operating activities by $41.3 million in the year ended December&#160;31, 2020 compared to a decrease of $14.5 million for the same period in 2019. The decrease in 2020 is attributable to an increase in inventory to improve safety stock of select products. In addition, decreases were also dri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ven by reduced payables offset by decreases in accounts receivable due to lower revenues and continued collection efforts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we paid $38.9 million for capital expenditures, most of which were directed to our facilities located in Mansfield, MA; Boston, MA; Memphis, TN; and Princeton, NJ and $25.0&#160;million associated with achieving developmental milestones paid to the former shareholders of Rebound. During the year ended December&#160;31, 2019, we paid $69.5&#160;million for capital expenditures, most of which were directed to our new Mansfield, Massachusetts facility, Princeton, New Jersey facility and commercial expansion. Further we paid $95.5&#160;million for the Arkis and Rebound transactions, net of cash acquired.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by (Used in) Financing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of cash from financing activities for the year ended December&#160;31, 2020 were $515.3&#160;million in proceeds from the issuance of Convertible Senior Notes including the call and warrant transactions and $171.5&#160;million borrowing under our Senior Credit Facility and Securitization Facility. These were offset by repayments of $441.0&#160;million on the revolving portion of our Senior Credit Facility and Securitization Facility, $24.3&#160;million in debt issuance costs related to the Amended and Restated Senior Credit Agreement and the issuance of Convertible Senior Notes and $100.0&#160;million in purchases of treasury stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of cash from financing activities for the year ended December&#160;31, 2019 were $236.9&#160;million in borrowings under our Senior Credit Facility and Securitization Facility. These were offset by repayments of $246.1&#160;million on borrowings under our Senior Credit Facility and Securitization Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the current period&#8217;s consolidated financial statements for a discussion of our Amended and Restated Senior Credit Agreement, Convertible Senior Notes and Securitization Facility and Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our hedging activities. We are forecasting that for the next twelve months, sales and earnings will be sufficient to remain in compliance with our financial covenants under the terms of the February 2020 Amendment and July 2020 Amendment to the Senior Credit Facility. The Company entered into the July 2020 amendment to increase financial flexibility in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $125&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December&#160;31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as a part of our previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("ASR") to complete the remaining $100.0&#160;million of share repurchases. The Company received 1.3&#160;million shares through the ASR, which represented approximately 80% of the expected total shares. Upon settlement of the ASR in June 2020, the Company received an additional 0.6&#160;million shares, which was determined using the volume weighted average price of the Company's common stock during the term of the ASR.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures for the foreseeable future. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities. Further, as part of our actions to manage the impacts of the COVID-19 pandemic on our business, the Company significantly reduced capital expenditures in 2020 by approximately $30.6&#160;million as compared to the prior year. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off&#8211;balance sheet financing arrangements during the year-ended December&#160;31, 2020 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we were obligated to pay the following amounts under the following agreements: </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due by Calendar Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022-2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2025</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Facility (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Securities(4)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreements (3)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company may borrow and make payments against the revolving credit portion of its Senior Credit Facility and Securitization Facility from time to time and considers all of the outstanding amounts to be long term based on its current intent and ability to repay the borrowing outside of the next twelve-month period.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest is calculated on the term loan portion of the Senior Credit Facility based on current interest rates paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown under Employment Agreements do not include compensation resulting from a change in control.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its of 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. See Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, for the details on the 2025 Notes.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has excluded its contingent consideration obligation related to prior and current year acquisitions from the contractual obligations table above; this liability had a total estimated fair value of&#160;$15.4 million&#160;at&#160;December&#160;31, 2020. This liability has been excluded because the amount to be paid and the potential payment date is not fixed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the Company's Extremity Orthopedic business, the Company will pay $41.5&#160;million to Consortium of Focused Orthopedists,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> LLC (&#8220;CFO&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuant to the terms of certain agreements between Integra and CFO relating to the development of shoulder arthroplasty products. As a result, the Company has excluded its former option to acquire Integrated Shoulder Collaboration Inc., which becomes mandatory upon achievement of a certain sales threshold, for an amount not to exceed $80.0&#160;million, as the option is no longer available to the Company following the transaction with CFO. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details of the transaction.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has excluded its future pension contribution obligations from the table above. This has been excluded because the future amounts to be paid and the potential payment dates are not fixed.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has excluded the liability for uncertain tax benefits from the contractual obligations table above, including interest and penalties, totaling $0.9&#160;million at December&#160;31, 2020. This liability for uncertain tax benefits has been excluded because we cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_70"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND THE USE OF ESTIMATES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of financial conditions and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The COVID-19 pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following accounting policies, which form the basis for developing these estimates, are those that are most critical to the presentation of our consolidated financial statements and require the more difficult subjective and complex judgments:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowances for Doubtful Accounts Receivable and Sales Returns and Allowances </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to us, we record an allowance against amounts due to reduce the net recognized receivable to the amount that we reasonably expect to collect. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. If the financial condition of customers or the length of time that receivables are past due were to change, we may change the recorded amount of allowances for doubtful accounts in the future through charges or reductions to selling, general and administrative expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a provision for estimated sales returns and allowances on revenues in the same period as the related revenues are recorded. We base these estimates on historical sales returns and allowances and other known factors. If actual returns or allowances differ from our estimates and the related provisions for sales returns and allowances, we may change the provision in the future through an increase or decrease in revenues. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost (determined by the first-in, first-out method) or net realizable value. At each balance sheet date, we evaluate ending inventories for excess quantities, obsolescence or shelf-life expiration. Our evaluation includes an analysis of historical sales levels by product, projections of future demand by product, the risk of technological or competitive obsolescence for our products, general market conditions, a review of the shelf-life expiration dates for our products, and the feasibility of reworking or using </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which we do not have excess quantities in inventory. To the extent that we determine there are excess or obsolete quantities or quantities with a shelf life that is too near its expiration for us to reasonably expect that we can sell those products prior to their expiration, we adjust their carrying value to estimated net realizable value. If future demand or market conditions are lower than our projections, or if we are unable to rework excess or obsolete quantities into other products, we may record further adjustments to the carrying value of inventory through a charge to cost of product revenues in the period the revision is made. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. Net assets acquired are recorded at fair value at the date of the acquisition. Any purchase price in excess of these net assets is recorded as goodwill. The fair values of net assets acquired may be subject to revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recognized at the estimated fair value on the acquisition date for a business combination and recorded when probable for an asset acquisition. Subsequent changes to the fair value of contingent payments are recognized in earnings. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#8217;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Goodwill</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization, but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. Our assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. We review goodwill for impairment annually as of July 31 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Identifiable Intangible Assets</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, and sell medical devices globally. Our earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. We address these risks through a risk management program that includes the use of derivative financial instruments and operate the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. Our derivative instruments do not subject our earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. We have not entered into derivative transactions for speculative purposes and from time to time, we may enter into derivatives that are not designated as hedging instruments in order to protect the Company from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative instruments, using the framework prescribed by the authoritative guidance, by considering the estimated amount we would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and our creditworthiness for liabilities. In certain instances, we may utilize a discounted cash flow model to measure fair value. Generally, we use inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability, and inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we conduct operations on a global basis, our effective tax rate has and will depend upon the geographic distribution of our pre-tax earnings among locations with varying tax rates. Changes in the tax rates of the various jurisdictions in which we operate affect our profits. In addition, we maintain a reserve for uncertain tax benefits, changes to which could impact our effective tax rate in the period such changes are made. The effective tax rate can also be impacted by changes in valuation allowances of deferred tax assets, and tax law changes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes may change period-to-period based on specific events, such as the settlement of income tax audits and changes in tax laws, as well as general factors, including the geographic mix of income before taxes, state and local taxes and the effects of the Company's global income tax strategies. We maintain strategic management and operational activities in overseas subsidiaries. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our consolidated financial statements for disclosures related to foreign and domestic pretax income, foreign and domestic income tax expense (benefit) and the effect foreign taxes have on our overall effective tax rate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. The amount of the accrual for which an exposure exists is measured by determining the amount that has a greater than 50 percent likelihood of being realized upon ultimate settlement of the position. Components of the reserve are classified as a long-term liability in the consolidated balance sheets. We record interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have identified all reasonably identifiable exposures and that the reserve we have established for identifiable exposures is appropriate under the circumstances; however, it is possible that additional exposures exist and that exposures will be settled at amounts different from the amounts reserved. It is also possible that changes in facts and circumstances could cause us to either materially increase or reduce the carrying amount of our tax reserves. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their basis for income tax purposes, and the temporary differences created by the tax effects of capital loss, net operating loss and tax credit carryforwards. We record valuation allowances when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We could recognize no benefit from our deferred tax assets or we could recognize some or all of the future benefit depending on the amount and timing of taxable income we generate in the future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to indefinitely reinvest substantially all of our foreign earnings in our foreign subsidiaries unless there is a tax&#8211;free manner under which to remit the earnings. The current analysis indicates that we have sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. The 2017 Tax Act imposed a Toll Tax on a deemed repatriation of undistributed earnings of foreign subsidiaries. One time or unusual items that may impact our ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary, and changes in tax laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December 31, 2020.  The Company does not anticipate the need to repatriate earnings from foreign subsidiaries as a result of the impact of the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to claims and lawsuits in the ordinary course of our business, including claims by employees or former employees, and claims with respect to our products and involving commercial disputes. We accrue for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds, if applicable, and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. We consistently accrue legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost. Our financial statements do not reflect any material amounts related to possible unfavorable outcomes of claims and lawsuits to which we are currently a party because we currently believe that such claims and lawsuits are not expected, individually or in the aggregate, to result in a material, adverse effect on our financial condition. However, it is possible that these contingencies could materially affect our results of operations, financial position and cash flows in a particular period if we change our assessment of the likely outcome of these matters. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Benefits </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions. If the actual results and events for the pension plans differ from current assumptions, the benefit obligation may be over or under valued. We recognize the underfunded status of the defined benefit pension plans as an asset or a liability in the balance sheet, with changes in the funded status recorded through other comprehensive income in the year in which those changes occur. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2020, the discount rate was prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected return on plan assets represents the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rate of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts as of December&#160;31, 2020. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts are valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit cost and the actuarial present value of projected pension benefit obligations for the year ended December&#160;31, 2020 and 2019, respectively:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change of plus (minus) 25 basis points on expected rate of return on plan assets, with other assumptions held constant, would have an estimated $0.1 million favorable (unfavorable) impact on pension plan costs. As of December&#160;31, 2020, contributions expected to be paid to the plan in 2021 are $2.3 million. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the corridor approach in the valuation of defined benefit pension benefit plans. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the authoritative guidance for stock-based compensation. This guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards is based on the grant date fair value on using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards on a ratable basis over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in the provision for income taxes in the consolidated statement of operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Standards</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the consolidated financial statements for recently adopted accounting pronouncements.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_73"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange and Other Rate Risks</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros ("EUR"), British pounds ("GBP"), Swiss francs ("CHF"), Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity&#8217;s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations discussed herein have not been materially affected by inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis points movement in interest rates applicable to our cash and cash equivalents outstanding at December&#160;31, 2020 would increase interest income by approximately $4.7 million on an annual basis. No significant decrease in interest income would be expected as our cash balances are earning interest at rates of approximately one basis points. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our interest rate risk relates primarily to U.S. dollar LIBOR-indexed borrowings. We use interest rate swap derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected LIBOR-indexed floating-rate borrowings. The Company held the following interest rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.912%"><tr><td style="width:1.0%"></td><td style="width:19.713%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total interest rate derivatives designated as cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,875,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interest rate swaps were designated as cash flow hedges as of December 31, 2020. The total notional amounts related to the Company&#8217;s interest rate swaps were $1.9&#160;billion and with $975.0&#160;million effective as of December 31, 2020. Based on our outstanding borrowings at December&#160;31, 2020, a 100 basis points change in interest rates would have impacted interest expense on the unhedged portion of the debt by $1.1 million on an annualized basis.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_79"></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements and the financial statement schedule specified by this Item, together with the report thereon of PricewaterhouseCoopers LLP, are presented following Item 15 of this report. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on quarterly results of operations is set forth in our financial statements under Note 19, &#8220;Selected Quarterly Information &#8212; Unaudited,&#8221; to our consolidated financial statements. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_82"></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Exchange Act Rule 13a-15(b), we have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2020. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of December&#160;31, 2020 to provide such reasonable assurance. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) under the Securities Exchange Act of 1934, as amended. Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). We recognize that because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies and procedures may deteriorate. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To evaluate the effectiveness of our internal control over financial reporting, management used the criteria described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based upon this evaluation, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2020 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended December&#160;31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_88"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">OTHER INFORMATION</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_91"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION BY REFERENCE </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information called for by Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities relating to equity compensation plans, Item 10. Directors, Executive Officers and Corporate Governance, Item 11. Executive Compensation, Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters, Item 13. Certain Relationships and Related Transactions, and Director Independence and Item 14. Principal Accountant Fees and Services is incorporated herein by reference to the Company&#8217;s definitive proxy statement for its Annual Meeting of Stockholders sche</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duled to be held on May&#160;14, 2021, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich definitive proxy statement is expected to be filed with the Commission not later than 120 days after the end of the fiscal year to which this report relates. </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_94"></div><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_97"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_103"></div><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_106"></div><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_109"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_112"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">EXHIBITS AND FINANCIAL STATEMENT SCHEDULE</span></td></tr></table></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    (a) Documents filed as a part of this report. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The following financial statements and financial statement schedules are filed as a part of this report: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:92.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_124">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_124">F-1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">Consolidated Statements of Operations for the years ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">, 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127"> and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_127">F-3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">Consolidated Statements of Comprehensive Income for the years ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">19</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130"> and 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_130">F-4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133">Consolidated Balance Sheets as of December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133"> and 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133">01</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_133">F-5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">Consolidated Statements of Cash Flows for the years ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">, 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_139">F-6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">Consolidated Statements of Changes in Stockholders&#8217; Equity for the years ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">, 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142"> and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_142">F-7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_145">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_145">F-8</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2. Financial Statement Schedule</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">Schedule II &#8212; Valuation and Qualifying Accounts for the years ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">, 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244"> and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0e66bbc7ee8049f2984ce8179f803ee5_244">F-49</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules not listed above have been omitted, because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes thereto. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exhibits required to be filed by Item 601 of Regulation S-K.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312514012038/d647012dex101.htm">Stock Purchase Agreement, dated as of October 25, 2013, by and between Covidien Group S.A.R.L. and Integra LifeSciences Corporation (Incorporated by Reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 15, 2014)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000047/iart-20200930xexx21.htm">Put Option Agreement, dated September 29, 2020, between the Company and certain of its subsidiaries and Smith &amp; Nephew USD Limited, a subsidiary of Smith+Nephew (including the Purchase and Sale Agreement attached as Appendix 1 thereto)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000047/iart-20200930xexx21.htm"> (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312514383254/d802647dex21.htm">Stock and Asset Purchase Agreement by and among Medtronic, Inc., Medtronic Xomed Instrumentation, SAS, and Integra LifeSciences Corporation, dated as of September 12, 2014 (Incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on October 27, 2014)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515246787/d85302dex21.htm">Separation and Distribution Agreement between Integra LifeSciences Holdings Corporation and SeaSpine Holdings Corporation, dated as of June&#160;30, 2015 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on July 7, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515256459/d47708dex21.htm">Agreement and Plan of Merger by and among Integra LifeSciences Corporation, Patriot S1, Inc., TEI Biosciences Inc. and Dr. Yiannis Monovoukas, dated as of June 26, 2015 (Incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on July 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515256459/d47708dex22.htm">Agreement and Plan of Merger by and among Integra LifeSciences Corporation, Patriot S2, Inc., TEI Medical Inc. and Dr. Yiannis Monovoukas, dated as of June 26, 2015 (Incorporated by reference to Exhibit 2.2 to the Company's Current Report on Form 8-K filed on July 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517007393/d316863dex21.htm">Agreement and Plan of Merger by and among Integra LifeSciences Holdings Corporation, Integra Derma, Inc., and Derma Sciences, Inc. dated as of January 10, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on January 11, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517044517/d316120dex21.htm">Binding Offer Letter by and among Integra LifeSciences Holdings Corporation and DePuy Synthes, Inc., dated as of February 14, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on February 15, 2017</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312517170703/d395692dex21.htm">Asset Purchase Agreement accepted and countersigned by DePuy Synthes, dated May 11, 2017 (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on May 15, 2017)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000049/iart-20170930xexx21.htm">Asset Purchase Agreement, dated September 8, 2017, between the Company and certain of its subsidiaries and Natus Medical Incorporated (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on October 26, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex3-1aform10k031406.txt">Amended and Restated Certificate of Incorporation of the Company dated February 16, 1993 (Incorporated by reference to Exhibit 3.1(a) to the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-99-001063.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 22, 1998 (Incorporated by reference to Exhibit 3.1(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 1998)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv3w1wc.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 17, 1999 (Incorporated by reference to Exhibit 3.1(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000107/ex_3x1xfileddecember22x2016.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated December 21, 2016 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 22, 2016)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993312000849/exhibit1.htm">Amended and Restated Bylaws of the Company, effective as of May 17, 2012 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on April 13, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000042/ex3_1xsecondarbylawsxdec20.htm">Second Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of December 11, 2018 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-k filed on December 12, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012311059255/w83072k1exv4w1.htm">Purchase Agreement, dated June 9, 2011, by and between Integra LifeSciences Holdings Corporation and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Morgan Stanley &amp; Co. LLC, Deutsche Bank Securities Inc., RBC Capital Markets, LLC and Wells Fargo Securities, LLC (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on June 15, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012311059255/w83072k1exv4w2.htm">Indenture, dated June 15, 2011, by and between Integra LifeSciences Holdings Corporation and Wells Fargo Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on June 15, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">Indenture, dated as of February 7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee (Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm"> (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">Indenture, dated as of February 7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee (Incorporated by reference to Exhibit 4.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm"> to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 (b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000051/exhibit41.htm">First Supplemental Indenture, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee (Incorporated by reference to Exhibit 4.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000051/exhibit41.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000051/exhibit41.htm"> to the Company&#8217;s Current Report on Form 8-K filed on December 9, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex4-4form10k031406.txt">Security Agreement, dated as of December 22, 2005, among Integra LifeSciences Holdings Corporation and the additional grantors party thereto in favor of Bank of America, N.A., as administrative and collateral agent (Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex4-5form10k031406.txt">Pledge Agreement, dated as of December 22, 2005, among Integra LifeSciences Holdings Corporation and the additional grantors party thereto in favor of Bank of America, N.A., as administrative and collateral agent (Incorporated by reference to Exhibit 4.5 to the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex4-6form10k031406.txt">Subsidiary Guaranty Agreement, dated as of December 22, 2005, among the guarantors party thereto and individually as a &#8220;Guarantor&#8221;), in favor of Bank of America, N.A., as administrative and collateral agent (Incorporated by reference to Exhibit 4.6 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w1.htm">Indenture, dated June 11, 2007, among Integra LifeSciences Holdings Corporation, Integra LifeSciences Corporation and Wells Fargo Bank, N.A., as trustee (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on June 12, 2007)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w1.htm">Form of 2.75%&#160;Senior Convertible Note due 2010 (included in Exhibit 4.8) (Incorporated by reference to Exhibit B to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on June 12, 2007)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w3.htm">Indenture, dated June 11, 2007, among Integra LifeSciences Holdings Corporation, Integra LifeSciences Corporation and Wells Fargo Bank, N.A., as trustee (Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on June 12, 2007)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w3.htm">Form of 2.375%&#160;Senior Convertible Note due 2012 (included in Exhibit 4.10) (Incorporated by reference to Exhibit B to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on June 12, 2007)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w5.htm">Registration Rights Agreement, dated June 11, 2007, among Integra LifeSciences Holdings Corporation, Banc of America Securities LLC, J.P.&#160;Morgan Securities Inc. and Morgan Stanley &amp; Co., Incorporated, as representatives of the several initial purchasers (Incorporated by reference to Exhibit 4.5 to the Company&#8217;s Current Report on Form 8-K filed on June 12, 2007)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012307008582/y35988exv4w6.htm">Registration Rights Agreement, dated June&#160;11, 2007, among Integra LifeSciences Holdings Corporation, Banc of America Securities LLC, J.P.&#160;Morgan Securities Inc. and Morgan Stanley &amp; Co., Incorporated, as representatives of the several initial purchasers (Incorporated by reference to Exhibit 4.6 to the Company&#8217;s Current Report on Form 8-K filed on June&#160;12, 2007)</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312519155388/d752260dex44.htm">Integra LifeSciences Deferred Compensation Plan, effective as of May 16, 2019 (Incorporated by reference to Exhibit 4.13 to the Company's Current Form S-8 Registration Statement filed on May 23, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">Indenture, dated as of February&#160;7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee. (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx413.htm">Description of Securities+</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000112/ex10-1form8k110105.txt">Lease Modification #2 entered into as of October 28, 2005, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 2, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311000711/exhibit1.htm">Lease Modification #3 entered into as of March 2, 2011, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 3, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000017/exhibit101_leasemodificati.htm">Lease Modification #4 entered into as of April 20, 2017, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000088981200003496/0000889812-00-003496-0002.txt">Equipment Lease Agreement between Medicus Corporation and the Company, dated as of June 1, 2000 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2000)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231008008563/c78646exv10w1.htm">Form of Indemnification Agreement for Non-Employee Directors and Officers (effective prior to February 15, 2019) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 24, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000013/iart-20181231xexx103.htm">10.3 (c) Form of Indemnification Agreement for Non-Employee Director and Officers effective February 15, 2019. *</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">1996 Incentive Stock Option and Non-Qualified Stock Option Plan (as amended through December 27, 1997) (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on                                             February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000123/ex10-3form10q110905.txt">1998 Stock Option Plan (amended and restated as of July 26, 2005) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000123/ex10-4form10q110905.txt">1999 Stock Option Plan (amended and restated as of July 26, 2005) (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000099/ex4-1forms8081205.txt">Employee Stock Purchase Plan (as amended on May 17, 2004) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 (Registration No. 333-127488) filed on August 12, 2005)*</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000110/ex10-1form8k102705.txt">First Amendment to Employee Stock Purchase Plan, dated October 26, 2005 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 1, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310002081/exhibit1.htm">Second Amended and Restated 2003 Equity Incentive Plan effective May 19, 2010 (Incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed May 21, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex109.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective May 17, 2012 (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit104amendmenttosecon.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective January 1, 2013 (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000025/exhibit101-thirdamendedand.htm">Third Amended and Restated 2003 Equity Incentive Plan effective May 22, 2015 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 29, 2015)*</a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x1.htm">Fourth Amended and Restated 2003 Equity Incentive Plan, effective May 23, 2017 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000037/iart-20200630xexx101.htm">Amendment to the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1011.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. International plc. </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993312001435/exhibit1.htm">Letter Agreement dated June 7, 2012 between Stuart M. Essig and the Company (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 7, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Indemnity letter agreement dated December 27, 1997 from the Company to Stuart M. Essig (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit B of Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-10_2.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752004000031/0000917520-04-000031.txt">Registration Rights Provisions for Stuart M. Essig (Incorporated by reference to Exhibit B of Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312514211529/d732122dex101.htm">Second Amended and Restated 2005 Employment Agreement between the Company and John B. Henneman, III (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 23,                    2014)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310003662/exhibit1.htm">Consulting Agreement, dated October 12, 2010, between the Company and Inception Surgical (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 12, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1017.htm">Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association, New York Branch. </a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512081503/d261286dex1016c.htm">Severance Agreement between Judith O&#8217;Grady and the Company dated as of January 3, 2012 (Incorporated by reference to Exhibit 10.16(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000049/iart-20170930xexx101.htm">Third Amended and Restated Employment Agreement between the Company and Peter J. Arduini (Incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on October 26, 2017)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000037/iart-20200630xexx102.htm">Amendment to the Third Amendment to the Third Amended and Restated Employment Agreement between the Company and Peter J. Arduini (Incorporated by reference to the Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511351929/d273122dex102.htm">Form of Notice of Stock Option Grant with Eight-Year Term for Peter J. Arduini (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed December 23, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000019/iart-exx101arduinile.htm">Letter Agreement dated February 19, 2013 between Peter J. Arduini and Integra LifeSciences Holdings Corporation (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on                                                    February 25, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000149/ex10-3form10q110906.txt">Lease Contract, dated April 1, 2005, between the Puerto Rico Industrial Development Company and Integra CI, Inc. (executed on September 15, 2006) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311003262/exhibit1.htm">Amendment to Lease Contract dated as of November&#160;2, 2011, between Integra CI, Inc. and Puerto Rico Industrial Development Company (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November&#160;7, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512183626/d317931dex102.htm">Termination of Amendment to Lease Contract, dated as of April 2, 2012, between Integra CI, Inc. and Puerto Rico Industrial Development Company (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-98-000200.txt">Restricted&#160;Units&#160;Agreement&#160;dated&#160;December&#160;27,&#160;1997&#160;between&#160;the&#160;Company&#160;and&#160;Stuart&#160;M.&#160;Essig (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 1998)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_1.txt">Stock Option Grant and Agreement pursuant to 1999 Stock Option Plan dated December 22, 2000 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_2.txt">Stock Option Grant and Agreement pursuant to 2000 Equity Incentive Plan dated December 22, 2000 between the Company and Stuart M.&#160;Essig (Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091205701000619/a2034717zex-4_3.txt">Restricted Units Agreement dated December 22, 2000 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2001)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000137/ex10-1form8k110306.txt">Amendment 2006-1, dated as of October 30, 2006, to the Stuart M. Essig Restricted Units Agreement dated as of December 22, 2000 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 3, 2006)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w30.txt">Stock Option Grant and Agreement pursuant to 2003 Equity Incentive Plan dated July 27, 2004 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.30 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w31.txt">Contract Stock/Restricted Units Agreement pursuant to 2003 Equity Incentive Plan dated July 27, 2004 between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.31 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000137/ex10-2form8k110306.txt">Amendment 2006-1, dated as of October 30, 2006, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 27, 2004 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 3, 2006)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w25wc.htm">Amendment 2008-1, dated as of March 6, 2008, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 27, 2004 (Incorporated by reference to Exhibit 10.25(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex106.htm">Amendment 2011-1, dated as of May 17, 2011, to the Stuart M. Essig Contract Stock/Restricted Units Agreement dated as of July 24, 2004 (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311001582/exhibit2.htm">Contract Stock/Units Agreement dated as of May 17, 2011 between the Company and Stuart M.&#160;Essig (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 23, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex105.htm">Form of Amendment 2011-1 to Contract Stock/Restricted Units Agreements between the Company and Mr. Essig (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w32.txt">Form of Stock Option Grant and Agreement between the Company and Stuart M. Essig (Incorporated by reference to Exhibit 10.32 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w8.htm">Form of Contract Stock/Restricted Units Agreement for Stuart M. Essig (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012311017602/w80860exv10w28wxby.htm">New Form of Contract Stock/Restricted Units Agreement (for Annual Equity Awards) for Stuart M. Essig (Incorporated by reference to Exhibit 10.28(b) to the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex104.htm">Form of Amendment 2011-1 to Contract Stock/Restricted Units Agreement between the Company and Mr. Essig (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w9.htm">Form of Performance Stock Agreement for Stuart M. Essig (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993309001637/exhibit3.htm">Form of Restricted Stock Agreement for Stuart M. Essig for 2009 (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed April 13, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000019/iart-exx102performancestoc.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 25, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000075/exhibit10_1formofperforman.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 29, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000075/exhibit10_2formofperforman.htm">Form of Performance Stock Agreement for Peter J. Arduini (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Report on Form 8-K filed on February 29, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx101.htm">Form of Performance Stock Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018) *</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000019/iart-20180331xexx102.htm">Form of Performance Stock Agreement for Peter J. Arduini (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit103-performanceince.htm">Performance Incentive Compensation Plan effective January 1, 2013 (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000004/exhibit101.htm">First Amendment, dated as of February 15, 2017, to the Performance Incentive Compensation Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 17, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x2.htm">2018 Performance Incentive Compensation Plan, effective January 1, 2018 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312511203310/dex103.htm">New Form of Contract Stock/Restricted Units Agreement pursuant to 2003 Equity Incentive Plan (for 2011) Annual Equity Award for Stuart M. Essig) (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000090/ex10-1form8k72605.txt">Form of Notice of Grant of Stock Option and Stock Option Agreement (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on July 29, 2005)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w35.txt">Form of Non-Qualified Stock Option Agreement (Non-Directors) (Incorporated by reference to Exhibit 10.35 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w36.txt">Form of Incentive Stock Option Agreement (Incorporated by reference to Exhibit 10.36 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv10w37.txt">Form of Non-Qualified Stock Option Agreement (Directors) (Incorporated by reference to Exhibit&#160;10.37 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000022/iart-20150331xex101.htm">Form of Stock Option Agreement (Executive Officers) (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000022/iart-20150331xex102.htm">Form of Stock Option Agreement for Glenn Coleman (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000022/iart-20150331xex103.htm">Agreement and General Release by and between Robert Paltridge and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000013/iart-20181231xexx1043.htm">Agreement and General Release by and between Richard D. Gorelick and Integra LifeSciences Corporation</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">Form of Change in Control Severance Program (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000065/exhibit10-formcicfebruary2.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex104.htm">Form of Restricted Stock Agreement for Non-Employee Directors under the 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038b.htm">New Form of Restricted Stock Agreement for Non-Employee Directors under the 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.38(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009002762/c81593exv10w1.htm">Form of Restricted Stock Agreement for Executive Officers&#160;- Annual Vesting (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 25, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex105.htm">Form of Restricted Stock Agreement for Executive Officers - Annual Vesting (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038e.htm">New Form of Restricted Stock Agreement for Executive Officers - Annual Vesting (Incorporated by reference to Exhibit 10.38(e) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009006565/c84477exv10w8.htm">Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Quarter Report on Form 10-Q for the quarter ended March&#160;31, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex106.htm">Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s quarterly report on Form 10-Q for the quarter ended June 30, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000023/iart-20121231xexx1038h.htm">New Form of Restricted Stock Agreement for Executive Officers - Cliff Vesting (Incorporated by reference to Exhibit 10.38(h) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993309001637/exhibit6.htm">Form of Restricted Stock Agreement for Mr. Henneman for 2008 and 2009 (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on April 13, 2009)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231008008563/c78646exv10w4.htm">Form of Contract Stock/Restricted Units Agreement pursuant to 2003 Equity Incentive Plan for Mr. Henneman (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on                                                 December 24, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752008000034/ex10-1form8k6508.txt">Form of Option Agreement for John B.&#160;Henneman,&#160;III (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 6, 2008)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w37wb.htm">Form of Performance Stock Agreement for John B. Henneman,&#160;III (Incorporated by reference to Exhibit 10.37(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310003662/exhibit4.htm">Form of Contract Stock/Restricted Units Agreement (for Signing Grant) for Mr. Arduini (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on October 12, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310003662/exhibit5.htm">Form of Contract Stock/Restricted Units Agreement (for Annual Equity Awards) for Mr. Arduini (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on October 12, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310003662/exhibit6.htm">Form of Non-Qualified Stock Option Agreement for Mr. Arduini (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on October 12, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310003662/exhibit7.htm">Form of Restricted Stock Agreement for Mr. Henneman (Incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on October 12, 2010)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000917520/000119312512081503/d261286dex1039n.htm">Form of Restricted Stock Agreement (Annual Vesting) for Mr. Henneman (Incorporated by reference to Exhibit 10.39(n) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000104/exhibit_10x2xdecemberx5x20.htm">Davis Promotion Summary, effective December 1, 2016 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Coleman Promotion Summary, effective June 24, 2019(Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Anderson Offer Summary, effective June 24, 2019(Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000060/exhibit102-summaryofexecut.htm">Annual Executive Physical Medical Exam Arrangement (Incorporated by reference to the Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on July 29, 2013)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w43wc.htm">Amended and Restated Management Incentive Compensation Plan, as of January 1, 2008 (Incorporated by reference to Exhibit 10.43(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231008008623/c78732exv10w1.htm">Piggyback Registration Rights Agreement dated December 22, 2008 between Integra LifeSciences Holdings Corporation and George Heenan, Thomas Gilliam and Michael Evers, as trustees of The Bruce A. LeVahn 2008 Trust and Steven M. LeVahn (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 29, 2008)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012308009294/y65047exv10w10.htm">Lease Agreement between 109 Morgan Lane, LLC and Integra LifeSciences Corporation, dated May 15, 2008 (Incorporated by reference to Exhibit 10.10 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000136231009006565/c84477exv10w9.htm">First Amendment to Lease Agreement between 109 Morgan Lane, LLC and Integra LifeSciences Corporation, dated March 9, 2009 (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513279558/d559455dex101.htm">Lease Agreement dated as of July 1, 2013, between 109 Morgan Lane, LLC and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 1, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-1.htm">Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Association, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-2.htm">Purchase and Sale Agreement, dated as of December 21, 2018, by and among Integra LifeSciences Sales LLC, Integra LifeSciences Corporation and Integra Receivables LLC (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex101.htm">Sixth Amended and Restated Credit Agreement, dated as of February 3, 2020, among Integra LifeSciences Holdings Corporation, the lenders party thereto, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., TD Bank, N.A. and Truist Bank, as Co-Documentation Agents. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000030/amendmentno1sixtharca.htm">Amendment, dated July 14, 2020, to that Sixth Amended and Restated Credit Agreement, among Integra LifeSciences Holdings Corporation, a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A. as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., T.D. Bank, N.A. and Truist Bank, as Co-Documentation Agents (as amended, restated, modified and supplemented from time to time prior to the date hereof, the &#8220;Credit Agreement&#8221;) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on July 20, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex101.htm">Base Call Option Transaction Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex102.htm">Ratification Agreement, dated as of February&#160;3, 2020, between Integra LifeSciences Holdings Corporation, the Subsidiary Guarantors of Integra LifeSciences Holdings Corporation and Bank of America, N.A., as Administrative Agent (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex103.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. International plc. (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.64</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex104.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex105.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.66</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex106.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs&#160;&amp; Co. LLC. (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex107.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex108.htm">Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.69</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex109.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.70</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1010.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.10 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1011.htm">Additional Call Option Transaction Confirmation, dated as of February&#160;5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.11 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.72</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1012.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.12 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.73</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1013.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.13 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.74</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1014.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.14 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1015.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. plc. (Incorporated by reference to Exhibit 10.15 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.76</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1016.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.16 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1017.htm">Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association, New York Branch. (Incorporated by reference to Exhibit 10.17 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx21b.htm">Agreement and Plan of Merger by among Integra LifeSciences Holdings Corporation and ACell Inc. dated as of December 15, 2020+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx21.htm">Subsidiaries of the Company+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx23.htm">Consent of PricewaterhouseCoopers LLP+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx311.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx312.htm">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx321.htm">Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20201231xexx322.htm">Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512003597/d276820dex991.htm">Letter, dated December 21, 2011, from the United States Food and Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on January 5, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex991.htm">Food and Drug Administration Form FDA-483, dated July 30, 2012, relating to inspection of Plainsboro, NJ manufacturing facility (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512465243/d434963dex991.htm">Letter, dated November 1, 2012, from the United States Food and Drug Administration to Integra NeuroSciences Ltd. (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on November 13, 2012)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513065171/d487711dex991.htm">Letter, dated February&#160;13, 2013, from the United States Federal Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on February 19, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513381070/d606108dex991.htm">Letter, dated September 24, 2013, from the United States Federal Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on September 27, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312513459946/d637741dex991.htm">Food and Drug Administration Form FDA-483, dated November&#160;26, 2013, relating to the inspection of the A&#241;asco Facility (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on December 3, 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312515014048/d854281dex991.htm">Letter, dated January 14, 2015, from the United States Food and Drug Administration to Integra LifeSciences Corporation (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on January 20, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000033/iart-20150630xex991.htm">Letter, dated May 29, 2015, from the United States Food and Drug Administration to TEI Biosciences Inc. (Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000033/iart-20150630xex992.htm">Letter, dated June 30, 2015, from the United States Food and Drug Administration to Integra LifeSciences (Ireland) Limited &#160;(Incorporated by reference to Exhibit 99.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document+#</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates this document is filed as an exhibit herewith.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial information of Integra LifeSciences Holdings Corporation Annual Report on Form 10-K for the year ended December 31, 2020 filed on February 18, 2020 formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statement of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) Parenthetical Data to the Consolidated Balance Sheets, (v) the Consolidated Statements of Cash Flows, (vi) the Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vii) Notes to Consolidated Financial Statements, is furnished electronically herewith.</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Commission File Number for Reports on Form 10-K, Form 10-Q and Form 8-K is 0-26224.</span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_115"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FORM 10-K SUMMARY</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:50.146%"><tr><td style="width:1.0%"></td><td style="width:8.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.571%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter J. Arduini</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Arduini</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carrie L. Anderson</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer, and Treasurer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;23, 2021 </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant in the capacities indicated. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter J. Arduini</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Arduini</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carrie L. Anderson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Treasurer (Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rhonda Germany Ballintyn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhonda Germany Ballintyn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Lloyd W. Howell, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lloyd W. Howell, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_121"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra LifeSciences Holdings Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Integra LifeSciences Holdings Corporation and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2020 and 2019, and the related consolidated statements of operations, of comprehensive income, of changes in stockholders&#8217; equity and of cash flows for each of the three years in the period ended December 31, 2020, including the related notes and financial statement schedule listed in the index appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2013) issued by the COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accounting Principles</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019 and revenues from contracts with customers in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Excess or Obsolete Inventory Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 2 to the consolidated financial statements, the Company&#8217;s inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value, and the net inventory balance was $362.9 million as of December 31, 2020, $52.8 million of which is presented separately as Assets held for sale. At each balance sheet date, management evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation by management includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, management adjusts the carrying value to estimated net realizable value.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal considerations for our determination that performing procedures relating to excess or obsolete inventory adjustments is a critical audit matter are the significant judgment by management when developing the estimate for excess or obsolete inventory adjustments, which in turn led to a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating management&#8217;s analysis and significant assumptions related to projections of future demand and risk of technological or competitive obsolescence for products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of inventory, including controls over the estimate for excess or obsolete inventory adjustments and management&#8217;s projection of future demand and the risk of technological or competitive obsolescence for products.  These procedures also included, among others, testing management&#8217;s process for developing the estimate for excess or obsolete inventory adjustments, evaluating the appropriateness of the method, testing the completeness, accuracy, and relevance of underlying data used in the estimate; and evaluating the reasonableness of significant assumptions related to projections of future demand and risk of technological or competitive obsolescence for products. Evaluating the reasonableness of management&#8217;s assumption related to projections of future demand involved considering the product&#8217;s historical performance.  Evaluating the reasonableness of management&#8217;s assumption related to the risk of technological or competitive obsolescence for products involved considering the technological or competitive obsolescence experiences during the product life cycle of existing products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Valuation of Transferred Intellectual Property Rights That Give Rise to Deferred Tax Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 13 to the consolidated financial statements, in December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. Management determined the fair value using a discounted cash flow model based on management&#8217;s expectations of revenue growth rates, royalty rates, discount rates and useful lives of the intellectual </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">property. The Company recorded a $59.2 million deferred tax benefit in Switzerland related to the amortizable tax basis in the transferred intellectual property. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal considerations for our determination that performing procedures relating to the valuation of transferred intellectual property rights that give rise to deferred tax assets is a critical audit matter are  the significant judgment by management in developing the fair value of the intangible assets transferred, which is used as the basis for the recording of the deferred tax assets. This in turn led to significant auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s estimates and assumptions related to revenue growth rates, royalty rates, discount rates and useful lives. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of the intangible assets transferred. These procedures also included, among others, testing management&#8217;s process for developing the fair value of the intangible assets transferred; evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy, and relevance of underlying data used in the model; and evaluating the reasonableness of significant assumptions used by management related to revenue growth rates, royalty rates, discount rates and useful lives. Evaluating the reasonableness of management&#8217;s assumptions related to revenue growth rates and useful lives involved considering current and past performance of the products associated with the intellectual property rights and evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&#8217;s discounted cash flow model and the royalty rate and discount rate significant assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ PricewaterhouseCoopers LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Florham Park, New Jersey</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1989.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 3</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtMS0xLTEtMA_6e23a300-48e1-41fc-9ac0-ca11732c40e7">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtMy0xLTEtMA_f2f0f910-1b58-4cc0-8a1b-78e790197fb0">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtNS0xLTEtMA_6e18fb04-6de8-4bc3-b991-4da297c28510">1,472,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtMS0xLTEtMA_a08ab441-746d-40e3-ba7b-de20830fd3f2">520,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtMy0xLTEtMA_ab7a124b-b9d4-4b6e-9c1b-db71f2df799e">564,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtNS0xLTEtMA_115cd0dc-3533-4721-9459-aaa7a86dc3ad">571,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtMS0xLTEtMA_498dd407-1521-4a74-aaec-0047240ffa61">77,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtMy0xLTEtMA_81076463-05b1-4f6a-87ee-e0c504bece7b">79,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtNS0xLTEtMA_4f6e8245-84e4-49b8-b0ed-ffe9522f3d1c">78,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctMS0xLTEtMA_60cb5f6b-3991-4326-872d-dd9f317b75f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctMy0xLTEtMA_16daf3e8-135e-4e70-bd2e-07bce730fe52">64,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctNS0xLTEtMA_607f12cc-b13e-4ec8-b2a9-7d397f047b50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtMS0xLTEtMA_1b573a25-da10-43a8-9e51-3b68ed774f60">594,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtMy0xLTEtMA_8ccbb6a5-d0ae-4375-876a-d7602d59f4da">687,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtNS0xLTEtMA_f47303f1-eafe-4790-bcdf-73b30010f5a3">690,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktMS0xLTEtMA_1942ccd1-e55c-41d5-87e0-35eb5be363b7">27,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktMy0xLTEtMA_fb49ebb8-b1d7-4713-b784-785057202dd6">27,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktNS0xLTEtMA_af973649-9399-4d4f-bafe-cca18dea2af7">21,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTEtMS0xLTA_703c353b-7716-4b24-9fd9-7e59c1976338">1,220,498</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTMtMS0xLTA_bd30fa7e-5cab-4f39-a412-fc3f83d2ab6d">1,423,797</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTUtMS0xLTA_57c103b7-5bff-4c7c-a32b-a5570146acd1">1,361,443</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTEtMS0xLTA_43f19192-e989-46d3-aca5-3707a25c16c2">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTMtMS0xLTA_d2277fef-90c3-42fe-b293-00545a5b032e">93,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTUtMS0xLTA_08af56bd-c59d-4ea3-af13-5a169a7250a1">110,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTEtMS0xLTA_0a2e6e5c-adae-4651-b040-585c6fbb2fea">9,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTMtMS0xLTA_9055baad-37cd-41f1-af79-9861bccce8c7">10,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTUtMS0xLTA_46fc1565-3f12-45c1-8db9-41f6dc3681e9">2,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTEtMS0xLTA_b171c940-bae3-47a7-b1f3-ce51bf5e0755">71,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTMtMS0xLTA_61661f30-522b-4f11-8e72-159cd03c7cae">53,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTUtMS0xLTA_5608265b-7f2e-478b-9171-b5381158ae2d">64,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTEtMS0xLTA_22ff29f9-f10d-470a-b5ed-61ce6f921c8c">4,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTMtMS0xLTA_424e2183-feb5-4423-a654-076fd1541149">9,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTUtMS0xLTA_a5411999-fb34-4cab-885c-d2c1896204f9">8,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTEtMS0xLTA_a499f1ee-1269-47cd-aaf9-1c8065cccfe2">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTMtMS0xLTA_3014c59d-08db-4ef6-b6b7-f627568e7d5e">60,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTUtMS0xLTA_1d79285f-2829-46ed-ae8e-f7be0996a914">57,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTEtMS0xLTA_d96bbac1-890e-420f-9016-05e8d0ace25f">40,372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTMtMS0xLTA_698f0c03-ed7c-4e18-9007-feab2fa80b2e">9,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTUtMS0xLTA_f37c45b1-5cba-4c1b-a12c-8de397a6e9e9">3,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTEtMS0xLTIyNDY_3cf60f5f-b8b9-4229-af4b-b64ab3a2b670">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTMtMS0xLTIyNDY_298af82d-8013-49ff-b4e1-05f0d78a0da9">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTUtMS0xLTIyNDY_5dc979c8-5fee-44d2-9f08-b9b46812d91b">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTEtMS0xLTA_9cba329c-5ae7-4e97-9464-568fc7f50e3f">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTMtMS0xLTA_dab2b364-9955-4453-af87-f4499a5b4637">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTUtMS0xLTA_5bea97d4-9eef-4d51-80a4-c383966e0e7d">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTEtMS0xLTA_952a678d-192f-4a36-a588-97a4832cb3a4">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTMtMS0xLTA_4219b512-3c23-4338-9e3b-e76cadeb57e9">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTUtMS0xLTA_bad1a15a-12c9-4dc7-9d81-ec3d510ac65f">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding (See Note 14):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTEtMS0xLTA_6ebbd697-d8a8-438f-9215-6334dff432d2">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTMtMS0xLTA_492097b4-513b-4318-a8bf-4ce081c86231">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTUtMS0xLTA_8c4a1dcc-e59f-4850-bd48-c02b5003941b">82,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTEtMS0xLTA_6ec6da91-e794-4604-babf-ea5826106b67">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTMtMS0xLTA_a843ed34-5dfc-4382-91c1-1f64d05ae4d4">86,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTUtMS0xLTA_a5387611-9aa7-487c-a012-6b226f4bd058">83,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 4</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtMS0xLTEtMA_3a19097a-e9ab-4ee7-b841-1f617fef3de5">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtMy0xLTEtMA_298af82d-8013-49ff-b4e1-05f0d78a0da9">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtNS0xLTEtMA_5dc979c8-5fee-44d2-9f08-b9b46812d91b">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Change in foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtMS0xLTEtMA_7aea4bf4-9d4c-47c0-a7f9-cf058130ec41">53,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtMy0xLTEtMA_c1695be3-519f-4753-a777-1b0592b24fcd">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtNS0xLTEtMA_81a3fb1e-41be-4bc0-b7c5-e49a82d7964a">19,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unrealized derivative gain (loss) arising during period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtMS0xLTEtMA_e720e55e-65e4-419d-96f4-3cfd214b9243">96,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtMy0xLTEtMA_93771409-f66e-4480-9be6-84bc9f89d989">13,671</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtNS0xLTEtMA_19d05ab6-d3be-4869-82de-e2f949bd2d04">11,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reclassification adjustments for gain (loss)  included in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktMS0xLTEtMA_120e6cb0-f0e2-4d96-8bb9-f04a4c132347">24,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktMy0xLTEtMA_a241953c-12a1-4064-9f7c-623836e25de4">14,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktNS0xLTEtMA_862e1ac6-0977-49c2-b2a4-3ea1bc4c1dfa">13,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Unrealized loss on derivatives</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTEtMS0xLTA_1341f364-1620-4c51-a46c-c7bdaf15274f">72,395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTMtMS0xLTA_3b341f2a-12df-4f12-bd8b-95b40a2b1eec">28,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTUtMS0xLTA_327d6539-841a-439f-9ae5-41d2dd9413be">1,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Defined benefit pension plan - net gain (loss) arising during period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTEtMS0xLTA_58181765-af31-4662-8700-84acbb5f524c">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTMtMS0xLTA_b6fa6f05-8a9e-4d02-948c-5920a8041517">8,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTUtMS0xLTA_07210faf-10ad-4a4a-9cae-705681c58cc1">643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total other comprehensive loss, before tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTEtMS0xLTA_11036e91-28bd-470b-88b9-07ccae29a2fb">14,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTMtMS0xLTA_e37578b2-5aa9-4323-85b3-566b27049ed6">37,683</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTUtMS0xLTA_d748daaf-04ad-4950-a614-27a974a643aa">21,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense) related to items in other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTEtMS0xLTA_cc9705d8-f138-42cd-9010-fd2d9186d8f7">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTMtMS0xLTA_bd1ddee4-6531-44e4-9066-1d6887321421">6,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTUtMS0xLTA_1fb01380-7519-4708-a373-a1a7871eb32e">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTEtMS0xLTA_4e6388fc-0d72-4c89-92d2-1272f358cede">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTMtMS0xLTA_4eabb087-e4b5-441b-a7a5-d29a7f70f6d0">30,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTUtMS0xLTA_75851bcf-ebeb-4d5d-9c38-0bc24a2b2072">21,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTEtMS0xLTA_71a37ab3-1e0b-4fa7-8538-8259b6840e86">136,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTMtMS0xLTA_c68494c9-6227-4789-a4d4-74813e1a5cff">19,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTUtMS0xLTA_d694595a-63af-4940-acf7-bcb81d833c41">39,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 5</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzUtMS0xLTEtMA_95efdb9f-ca80-4a5b-9182-513a57e937b9">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzUtMy0xLTEtMA_f7e50d14-1afa-4a32-b91f-56d263986713">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMC0xLTEtMC90ZXh0cmVnaW9uOjE0N2Q0NzE2M2M2NDQ1YjJhOWJhMWM1ZWZlMmY2YjNhXzM4NDgyOTA2OTcyOTQ_de24deb6-ebd2-4177-a617-7212892b28aa">6,439</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMC0xLTEtMC90ZXh0cmVnaW9uOjE0N2Q0NzE2M2M2NDQ1YjJhOWJhMWM1ZWZlMmY2YjNhXzM4NDgyOTA2OTcyODc_ee3fce4f-1242-41ee-90e6-ed883f0b129b">4,303</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMS0xLTEtMA_bc9b7f53-3642-4541-aba8-5a3c0ab3a4a8">225,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMy0xLTEtMA_4f62c0c9-9d35-4b92-8947-4df20115db74">275,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzgtMS0xLTEtMA_27b2a151-a62a-4b7a-b1e4-a0559dbf2ba4">310,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzgtMy0xLTEtMA_f7e99319-4231-4e3b-839b-65c956ced617">316,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTEtMS0xLTM0OTQ_41b04db5-2ba3-433c-bb61-b061bcc204c4">162,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTMtMS0xLTM0OTQ_ca227ed2-5c11-4761-b039-a20eace54d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTEtMS0xLTA_f0a1cabb-5d21-4eeb-8753-39a328858de2">69,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTMtMS0xLTA_e70e5b48-06a7-420a-9538-435daac9f722">67,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEyLTEtMS0xLTA_16462f5f-28db-4a7b-9d51-76a7df6ade18">1,237,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEyLTMtMS0xLTA_03850edf-f3ec-42dd-9903-2f8fb6cdef55">858,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEzLTEtMS0xLTA_67bf677f-4c91-4d4b-b002-818dd2913cb4">287,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEzLTMtMS0xLTA_90e9bd9a-b6c2-485c-a543-5416c1e659ab">337,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE0LTEtMS0xLTA_61f77528-3ea9-47cf-a18a-205c327a8a7e">83,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE0LTMtMS0xLTI5Mg_d90544ac-2aa2-4b31-9e18-1115ece204e0">94,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE1LTEtMS0xLTA_9322414e-15ea-4669-98ed-3fde9ed4ca29">989,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE1LTMtMS0xLTA_0fb41df7-3375-4466-9313-292e499744eb">1,031,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE2LTEtMS0xLTA_380e4bcb-b1b8-4f20-a0eb-85f07a7576cd">932,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE2LTMtMS0xLTA_d9876959-45c6-4949-8e31-45f5cd7df1e2">954,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE3LTEtMS0xLTA_e25617fb-f435-462f-8f7b-a87ad76768ec">73,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE3LTMtMS0xLTA_3098ccac-cb90-4be8-b833-2e795a12388a">12,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE4LTEtMS0xLTA_af98c96d-2116-4320-be16-b5473f945c82">11,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE4LTMtMS0xLTA_e83852e1-0ad5-4c8d-a8cc-d9fe833e336a">14,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIwLTEtMS0xLTA_0a7f013a-8e77-406a-af18-4ace042383a0">3,615,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIwLTMtMS0xLTA_2e0a1db0-3c8a-4800-a60e-77feec720561">3,303,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under senior credit facility</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIzLTEtMS0xLTA_3f6b5815-f888-42a3-b2a9-04288edf2f7e">33,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIzLTMtMS0xLTA_36cbfe0e-e3f3-449c-b11c-8232bc4432e2">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under securitization facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:SecuredLongTermDebtSecuritizationProgramCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTEtMS0xLTg5MTY_c36eeba2-bb5a-4d8c-8746-60512e4e42a2">112,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="iart:SecuredLongTermDebtSecuritizationProgramCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTMtMS0xLTg5MDc_a21cb525-74d2-4ec2-816f-b4bf08f0e602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI0LTEtMS0xLTA_42ce1fdc-e6eb-4133-a871-2dde1076b6fb">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI0LTMtMS0xLTMwNg_675fb697-8303-4505-85f0-aaadbe11d582">12,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, trade</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTEtMS0xLTA_410bea87-03ed-4eaf-9a5b-a62530cb0fc9">54,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTMtMS0xLTA_553a8e23-4174-4bbb-8f75-4ff97e2fa85a">113,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI2LTEtMS0xLTA_19df6c87-8eb5-4923-9a94-d00a29f66e44">5,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI2LTMtMS0xLTA_a773a2d7-b3d7-4166-8186-bc6adcd39131">4,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI3LTEtMS0xLTA_65dc1875-dcb8-4aa9-a7aa-e0559c97200d">76,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI3LTMtMS0xLTA_743114d2-a27e-44de-99e2-3d6508f64d1e">79,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMwLTEtMS0xLTM1MDk_7f2cc82e-724d-4f76-a805-3423dce1f884">11,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMwLTMtMS0xLTM1MDk_3dd6f7c0-e2fa-4b4b-80fd-c71a57349dbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI5LTEtMS0xLTA_4113cbad-20f9-43f8-8013-6246122f26d6">94,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI5LTMtMS0xLTA_c879ad71-98f7-4164-b175-78277ee21c60">76,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMxLTEtMS0xLTA_5d0db366-c980-4595-82d9-401d3ee2ad18">401,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMxLTMtMS0xLTA_e049c86e-cc1d-4fa9-b1bf-e6a0ab902b00">331,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under senior credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMyLTEtMS0xLTA_1e0ae6f6-d914-47d6-a741-4063dd584a91">933,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMyLTMtMS0xLTA_6d892471-e2c6-41e8-b539-369cf7628350">1,198,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under securitization facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:zerodash" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMzLTEtMS0xLTA_f38f0dea-2586-469e-94f6-425af244f310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMzLTMtMS0xLTA_3ad579cd-30b3-43c9-8cca-f174ee82c0df">104,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTEtMS0xLTU5Njg_232d62b8-218c-4119-ad3d-a4f9aa079edc">474,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTMtMS0xLTU5NzI_34d59efb-734b-4619-995e-5487f72e6625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM0LTEtMS0xLTA_95504e7b-69e1-4f02-a663-a01ea44d3d1c">88,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM0LTMtMS0xLTMxNQ_39703b82-8afe-43b2-8657-b623b14ad207">97,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM1LTEtMS0xLTA_7e1b3932-2f6f-41fd-b943-2a3fde2276c8">16,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM1LTMtMS0xLTA_cd995a9b-cd71-4e77-a129-6bce9be01648">36,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTEtMS0xLTA_6547f88e-79ef-4a5b-9cfa-8cb1658311c2">186,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTMtMS0xLTA_51e488c8-f665-4f79-9161-0f1e3d48a612">118,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM4LTEtMS0xLTA_643b6313-25b5-4a9a-b19e-e659d3056998">2,100,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM4LTMtMS0xLTA_9041a5ef-3a91-4797-95af-c4fabcb7cbf5">1,886,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred Stock; <ix:nonFraction unitRef="usdPerShare" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzA1_2311f43d-649f-443d-9df5-37305fd6aa0a"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzA1_87f2c975-570e-48d9-b7a1-5da0b9c745e1">no</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3Mjk5_3e7158ab-d7a7-4858-bb68-ddf5b8a4d5f8"><ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3Mjk5_90e19347-4873-49ed-bc66-746a3f8bfd03">15,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzIw_0ab6e322-990a-4873-94bc-2b8d1c4c4bfc"><ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzIw_7784eee0-68ab-4070-b97b-582520c0f0f2">none</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTEtMS0xLTA_27f35ade-80a5-4a53-9ff8-e2afc4e46f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTMtMS0xLTA_2bf15f32-f27c-4b68-9a99-1c1aaba3452c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzQ3_3a577f46-a734-4e98-b3ae-6c1cdeecaca4"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzQ3_660f3e91-8ec1-41af-bc0a-66fbeee6fd81">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzU3_6ad36637-b680-474d-9e77-8adf7a93fa99"><ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzU3_aae4f977-ecf0-4199-a29a-1082ce111587">240,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3Mzc0_5ca2325c-2aa0-4695-8490-70064ff52091">89,251</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzY4_729f91c9-8144-4fc6-9422-31d4bcb83739">88,735</ix:nonFraction> issued at December&#160;31, 2020  and 2019, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTEtMS0xLTA_b7b77ef0-f969-414a-af9a-adc3632f47e5">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTMtMS0xLTA_63566050-3486-4616-a516-50e739f65ec2">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQzLTEtMS0xLTA_46acadeb-c7c2-4eb3-afc4-a5220a87d5fc">1,290,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQzLTMtMS0xLTA_b55a4c77-b3b0-488e-be0c-400a9ee13cda">1,213,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo2M2U3M2UwNjMwZjA0NzY1OGY0YzllMWE5MjA5NzE3ZF8zODQ4MjkwNjk3MzIw_8259c176-7ae7-4db9-89cb-42824a1fb2b6">4,914</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo2M2U3M2UwNjMwZjA0NzY1OGY0YzllMWE5MjA5NzE3ZF8zODQ4MjkwNjk3MzEz_63800b79-c3a4-468c-bd16-b89d995a41d2">2,865</ix:nonFraction> shares at December&#160;31, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTEtMS0xLTA_8d5c31d0-7176-4382-a51c-a079ac4a1a67">235,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTMtMS0xLTA_1def3fdc-19b3-480f-9880-fc386ecbef6d">119,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ1LTEtMS0xLTA_3ac007fd-e741-4d97-8456-b1dd146dfa25">74,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ1LTMtMS0xLTA_b250db75-8f20-4953-b72d-57268314f91d">76,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ2LTEtMS0xLTA_4c7e25a2-4d06-4873-9c28-c8cb0f9c4712">532,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ2LTMtMS0xLTA_524853ce-7589-4e3a-ba82-8e9c59004004">398,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ3LTEtMS0xLTA_82111e70-5297-4973-9ace-e14579942057">1,514,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ3LTMtMS0xLTA_9f5c95af-f47a-4797-a828-7470fd93b1d6">1,416,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ4LTEtMS0xLTA_2a8ef2eb-b88c-4b0a-bf1d-28f9f3cd4165">3,615,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ4LTMtMS0xLTA_fa564ddc-ada1-4c37-8df3-ad7be0284e53">3,303,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 6</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_139"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtMS0xLTEtMA_365fa077-ee55-49ca-8515-7451179b6394">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtMy0xLTEtMA_6a7fc0fd-910e-4bb5-91dd-9c951d42b777">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtNS0xLTEtMA_2ea053f3-63f4-4f63-b757-c0615bfc7d4d">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctMS0xLTEtMA_ddf6c939-a4f1-4984-9030-981dbb8d3e42">116,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctMy0xLTEtMA_33de4092-631c-4e43-9f56-861ce6660fd2">109,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctNS0xLTEtMA_4f9bb9e2-7762-47c2-9a11-053ee4ab2ef3">110,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Non-cash in-process research and development expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtMS0xLTEtMA_104cade0-debe-4e93-a6ca-8fb75d018e16">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtMy0xLTEtMA_8bfcba55-76f2-4051-bc87-22460fb32c28">64,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtNS0xLTEtMA_b97622b3-2bae-4eb3-8bd1-28b00c35faef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Non-cash impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTEtMS0xLTA_be2570b1-e43b-462d-88c4-a4baede7e6c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTMtMS0xLTA_130b4441-7c92-4951-b8f9-250ec4a7dc6a">5,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTUtMS0xLTA_2e505e51-f323-4ab9-be48-79b4babe1313">4,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTEtMS0xLTA_b7a83b07-d704-47fa-859b-7b2d6a273ba8">64,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTMtMS0xLTA_42352c84-0758-4d55-9b58-767464935be4">19,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTUtMS0xLTA_d6fd2292-8471-444b-aaa8-6c27b2a8ccd5">8,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTEtMS0xLTA_4525a4c8-3669-4262-a43e-e9d5eeb99c1a">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTMtMS0xLTA_1c767200-568f-4c71-b9d3-f16900611eae">21,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTUtMS0xLTA_735993e3-c4fe-4284-9fa9-be15175591d9">20,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and expenses associated with debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTEtMS0xLTA_36a26cdf-993c-4bc6-ad2f-edd5db9f9599">12,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTMtMS0xLTA_f65bb2d0-0f11-4bca-8e96-47864fc8860f">5,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTUtMS0xLTA_51020510-008d-4ec9-85b1-7fbd3641f56f">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTEtMS0xLTA_2f6d473d-76fe-46d8-8cc2-a700d62184a9">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTMtMS0xLTA_5c60bc87-1d70-44a7-a8b1-0c9db106b99f">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTUtMS0xLTA_3d4c0a6c-37bf-4d69-b5af-112ac69103e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Accretion of bond issuance discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTEtMS0xLTM1MjA_99d0f3e1-e6a8-4a31-9e07-4f18b8ed6322">15,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTMtMS0xLTM1MjA_ed41c464-6588-4304-b59c-053c2020a601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTUtMS0xLTM1MjA_da8f1ed5-1cc1-41a2-b21d-0381bd7d1357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment and construction in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTEtMS0xLTA_2736088c-b688-4a67-9611-ecdb07c9a1d5">7,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTMtMS0xLTA_31bc1939-960e-4ed4-9660-9a0b784aeaa5">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTUtMS0xLTA_a24f9f11-a1cb-49cb-a877-b6471751dacf">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration and others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTEtMS0xLTA_5e69ce73-5a2c-44e3-bf0a-1eda6d4e8098">951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTMtMS0xLTA_4ff6e3a9-5061-473a-8faa-c174983292e1">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTUtMS0xLTA_04a5b041-7765-4df9-ac6d-5cfc55bc1a3a">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTEtMS0xLTA_cdeee94a-8042-4912-948c-ebee8da6b801">52,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTMtMS0xLTA_30b4bdf4-a31f-4fdb-9966-ddd28563d063">9,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTUtMS0xLTA_0add5289-ba57-4322-b882-41ff007ad704">17,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTEtMS0xLTA_891062c0-082c-44df-b8f7-9cdc3aa24647">48,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTMtMS0xLTA_d5f289da-84a2-42ff-b981-751212b7efbe">43,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTUtMS0xLTA_d399a201-d5a7-4721-af34-b1bb9512b0af">8,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTEtMS0xLTA_68040b3c-8748-4493-b92b-4424f773c8f2">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTMtMS0xLTA_50f544b5-31af-496b-8f16-51665dfa46b0">13,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTUtMS0xLTA_e1bd6380-1097-45a9-b32d-94a9f86e336c">3,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTEtMS0xLTA_d9bb2fc0-1ac3-4e4c-bd0f-8bb77e33c4ed">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTMtMS0xLTA_5922362e-1eb6-4ceb-a43e-d44c79f4a8db">13,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTUtMS0xLTA_92fba39e-bc5c-42b8-b812-7e678f204301">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTEtMS0xLTA_69878665-641e-4507-9b12-314fc05eb12a">57,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTMtMS0xLTA_fe4d4db1-22ba-44ad-8895-a8e938b804a7">14,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTUtMS0xLTA_ab0ba3fa-c3cb-42c7-95d5-5607202eff7d">3,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTEtMS0xLTA_58301abd-8541-49d8-9ecc-1d7476e907e4">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTMtMS0xLTA_45b4beb9-680f-4eda-b38e-281122e6dfdd">607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTUtMS0xLTA_8c30de06-a619-4472-ac25-26f8fbe58831">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTEtMS0xLTA_082ecd8d-fb69-4e02-a20c-65de9d29f8b4">2,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTMtMS0xLTA_7f1a814d-c1e2-4ec2-a357-384d72f4afff">2,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTUtMS0xLTA_10c01fbc-9c2e-4daa-ad59-dee849be4753">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Net cash provided by operating activities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTEtMS0xLTA_7b214dcf-07c7-47b8-8ba5-9c47bf69b20b">203,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTMtMS0xLTA_e9feef92-1240-4571-9e60-df90aa18dca4">231,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTUtMS0xLTA_67b0dad8-be03-4692-a687-9927310579f4">199,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTEtMS0xLTM1Mzk_30d484df-24d4-4960-9fe5-d65efcfe378c">38,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTMtMS0xLTM1Mzk_202caf7e-f39e-4658-9368-48e57b1824c7">69,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTUtMS0xLTM1Mzk_b30a84ac-b47a-46ad-b5a2-0622ed8b08c9">77,741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Acquired in-process research and development and intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTEtMS0xLTM1NDg_1c422887-cc90-46ae-821c-ed9196c557bf">25,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTMtMS0xLTM1NDg_c9423f2c-70f4-494a-97c4-34df8627a785">64,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTUtMS0xLTM1NDg_9fb6e149-d221-4012-ba52-fa1172c7c579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTEtMS0xLTA_fb3a4982-94ad-4b5e-81cb-35461526d1dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTMtMS0xLTA_c032ed07-7d6f-408b-aae7-aa62ea5287d9">752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTUtMS0xLTA_861d808f-4cef-4462-86ef-34c90d7364b4">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cash used in business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsForProceedsFromBusinessAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTEtMS0xLTA_a1df2a68-563a-4f6d-b87f-f6a854b85484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:PaymentsForProceedsFromBusinessAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTMtMS0xLTA_76782f56-8c18-4653-8534-4570bad53b06">30,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="iart:PaymentsForProceedsFromBusinessAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTUtMS0xLTA_1932d73b-d541-459d-99d0-a35c6ba4c662">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from sales of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTEtMS0xLTA_3b5c1b1e-9dbe-440e-a0d3-f4ca999af6f6">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTMtMS0xLTA_8419e907-def2-4863-b421-82c9e7d92a18">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTUtMS0xLTA_3aa39733-6ecf-4529-a3e8-2f8516acc4c3">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net proceeds(payments) on swaps designated as net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTEtMS0xLTA_16396a50-fa5f-49e2-a486-4a9edc170076">7,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTMtMS0xLTA_b3900b18-3dcd-4978-a7d5-64c5c0f1da58">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTUtMS0xLTA_ea8c6dbf-8112-44c8-ba56-213c07963ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTEtMS0xLTA_1c0b1141-e75d-46bf-906c-c7494a46922c">68,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTMtMS0xLTA_0370c8c8-d4f0-44da-a108-0c95e152b958">162,668</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTUtMS0xLTA_da990f4d-b7c0-47e8-a904-0ec602b6c51c">49,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from borrowings of long-term indebtedness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTEtMS0xLTA_f137800f-3ce3-472c-aae3-6e0581b5f62a">171,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTMtMS0xLTA_02017051-216c-4347-97c3-53b10847815a">236,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTUtMS0xLTA_e884fead-6df7-4ce7-8699-afa9f03fb6ba">171,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Payments on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTEtMS0xLTA_03f9f349-b969-479e-a17e-004e94483ba9">441,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTMtMS0xLTA_19d2716c-5f6b-4ebf-af9e-c06775cb59bf">246,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTUtMS0xLTA_7359fa8d-c988-419d-ac64-5ae578511362">660,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Purchase of option hedge on convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTEtMS0xLTM2NTM_0d6e4b38-4f91-402b-981c-19d54c850f8b"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTEtMS0xLTM2NTM_83e16c8d-7617-41f2-8765-d864064b3ecf">104,248</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTMtMS0xLTM2NTM_cc273f1c-9e32-45da-8cd0-f3017baa7e49"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTMtMS0xLTM2NTM_d1bcce99-e785-4126-a63d-69668bc83818">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTUtMS0xLTM2NTM_b80e048b-5ae0-4c69-9764-da48bc7bfe7c"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTUtMS0xLTM2NTM_db6084c5-3311-4018-94e7-aa5526c47288">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from convertible notes issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTEtMS0xLTM2NTA_a43853c1-8c19-4ebd-8b7c-95af9aeaca30"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTEtMS0xLTM2NTA_f03d4e25-7222-411d-8245-27a07263b0d5">575,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTMtMS0xLTM2NTA_ddb71dca-0d27-47ef-8212-c910b86238ba"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTMtMS0xLTM2NTA_de55fc9a-4046-4fb8-929e-45151528b6ab">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTUtMS0xLTM2NTA_0c6ba471-bfe2-4d21-a6f6-c8e1a2c1dfba"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTUtMS0xLTM2NTA_4def7990-6ba0-4e91-901e-ecd7b79b97e5">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from sale of stock purchase warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTEtMS0xLTM2NTc_1e2db41d-18ec-4919-ab4a-628f879ec196">44,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTMtMS0xLTM2NTc_52072296-c293-4329-b7b7-79956232a222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTUtMS0xLTM2NTc_fabab5d5-ea09-4676-a64b-af7d2fc2c1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTEtMS0xLTM2NjA_bb7ac002-2305-48ab-bda8-72334515004a">24,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTMtMS0xLTM2NjA_81a21489-074b-416a-9d23-f94c7018ea7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTUtMS0xLTM2NjA_4efd1c49-22a5-4b8a-9063-fa4ab409fe1d">5,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTEtMS0xLTM2Njc_208a25b3-29d7-4c08-ae9d-60bf5a7920c4">100,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTMtMS0xLTM2Njc_0da58d3d-b866-4d55-b257-93c1d754f783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTUtMS0xLTM2Njc_e058d85a-f34a-4c40-9209-598c4742a787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from exercised stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTEtMS0xLTM2NzA_d0e720fa-907a-4917-a755-263869210b45">5,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTMtMS0xLTM2NzA_8daaded1-9267-4b1b-b7c6-41edfb654ebe">6,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTUtMS0xLTM2NzA_fb9e34f0-ea7f-496a-85c2-dc71fcaeeccb">9,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net cash paid for contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTEtMS0xLTA_0297ab81-fbb9-41d6-af48-159b36545dab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTMtMS0xLTA_670c1547-0807-403a-905e-fa8eb39ad350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTUtMS0xLTA_bb904fea-b350-48d6-b838-153c658e3f5f">38,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Proceeds from the issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTEtMS0xLTA_5ef688bd-12eb-40a8-8b44-451d7a3c6922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTMtMS0xLTA_af42c01d-bd6d-4b49-8e10-7ec4e53a1f22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTUtMS0xLTA_5be73991-14e7-435e-896f-4002616db98e">349,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cash taxes paid in net equity settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTEtMS0xLTA_ff4d34a5-55c2-4408-acfc-8703297424dd">5,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTMtMS0xLTA_956e0c8f-ad3c-4685-8142-09211e955755">6,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTUtMS0xLTA_652074d4-338b-463c-8e94-1ad3e5720864">7,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTEtMS0xLTA_5bd8c264-93a5-49d8-81b0-ef7149ce8772">121,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTMtMS0xLTA_256a9f3c-66c8-4c39-a17c-efb7a4ae1a9d">8,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTUtMS0xLTA_a71cf0fd-e9d0-49b3-b38c-4fc3571b8852">180,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTEtMS0xLTA_0ad91694-cbdf-45e8-81f4-25abc6802899">13,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTMtMS0xLTA_d1f18256-d3ab-4540-9da7-e5b0f98f3452">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTUtMS0xLTA_8359bf78-c311-486b-a21c-25c83ed40a88">5,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTEtMS0xLTA_a3371af9-ddca-4c4e-b3a0-9a42edf5929f">271,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTMtMS0xLTA_58cc2d94-e753-46bd-8b47-60a6b42098f8">60,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTUtMS0xLTA_2c433c06-e447-496c-8278-c9b16b159e3f">36,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTEtMS0xLTA_5562ccc3-a305-4cb0-b13b-b3ee34fb6eeb">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTMtMS0xLTA_5e125685-43e7-4942-9eef-7b9b239a8060">138,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTUtMS0xLTA_543c4e32-f741-424c-bf87-1eace5248599">174,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTEtMS0xLTA_a56f936a-f815-442f-8c1e-12535428ffa9">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTMtMS0xLTA_ba852d9f-0eea-4681-976d-dc74fc1bc514">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTUtMS0xLTA_18126690-f0b7-43b5-a9c3-0a2781e08800">138,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 7</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:29.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.856%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, January 1, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5702024fe01646a99a5c8c9d326d73b8_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEtMS0xLTgzOA_ed4c49a6-e8bd-4855-baf0-d1110f9abe22">81,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5702024fe01646a99a5c8c9d326d73b8_I20171231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTMtMS0xLTMxMDM_6e9a2306-8766-49b5-bff6-ac7f75446398">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06366190454d4344b400d993f2607508_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTUtMS0xLTMxMDM_5795fd62-9c6b-40dd-9917-ba595aecd7f8">2,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06366190454d4344b400d993f2607508_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTctMS0xLTMxMDM_841e9559-96ed-4f7d-b2b5-8d8b098164a3">121,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46bce481a126499b834dce55ac892b0a_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTktMS0xLTMxMDM_9c7c6c6b-6a7f-4e5b-8b6f-1b72b113ea54">821,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib76545c6be754fe480f77ca7f4e7d426_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTExLTEtMS0zMTAz_d4bafece-ccee-4720-acd8-d9f9b773263f">23,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025e2bc5ebd44e56b9b8bbabc7eaffbb_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEzLTEtMS0zMTAz_924eeb5d-cfe5-4474-99c9-6f4aa6b4c246">285,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTE1LTEtMS0zMTAz_bf4a9324-d486-4a85-add2-49041a5731ee">962,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of Update No. 2014-09</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917e1a0f095e414696fff9407e57d2ab_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEzLTEtMS0w_5559d6dd-58bb-4e3b-b173-f3b8164a68b8">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430afd434f8f4e0b920162b510d18135_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTE1LTEtMS0w_1c2bbdf5-d187-4e2c-aae1-e9c2b8b6c017">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of Update No. 2018-02</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231" decimals="-3" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQyLTEzLTEtMS0w_717290b9-297e-4dd1-bd0f-18d39d105945">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQyLTE1LTEtMS0w_5d76a4ab-6d6b-4f46-bf48-1425c23d6537">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQzLTEzLTEtMS0w_cd5804dc-db6e-4bd2-9fc3-a266c4a85f6f">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQzLTE1LTEtMS0w_aa6b45b1-b33f-42c7-be7d-960b336f39e9">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3389b103d9454724bfcbe626c43e56b1_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ0LTExLTEtMS0w_004dc687-9611-4305-96ab-2a09f81f44ae">21,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ0LTE1LTEtMS0w_52d7aa7d-f0e4-4702-a348-9c3cf85193a8">21,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ1LTktMS0xLTA_d4969dee-a5d6-4d48-a6c0-466d8b5c4be0">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ1LTE1LTEtMS0w_e9017574-ab4f-49a7-9c30-ff17cc4d5223">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTEtMS0xLTA_746f7f8f-5dd3-470b-961c-ab3452c043c5">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTMtMS0xLTA_9313933f-a4de-4421-8c7b-dec4a6f54e87">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTUtMS0xLTA_0e10eae5-6f3b-4d67-9912-3e4b618dc275">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTctMS0xLTA_ef032430-d5be-4f06-91b1-eefb88692885">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTktMS0xLTA_4aad5765-13e6-475d-b654-84cd276be803">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTE1LTEtMS0w_c20b3fa7-3cbf-4638-9ef2-7af7af312ccd">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTEtMS0xLTA_58b3ee98-7332-4483-b81d-b367451c899d">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTMtMS0xLTA_0fe6d063-8850-4eba-918c-69209e739ee4">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTktMS0xLTA_6f4f60ab-fb22-4c59-80b9-8ef7299becd8">349,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTE1LTEtMS0w_67a78fc9-f22d-4518-a647-eec6a879eb57">349,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTMtMS0xLTA_3b6a7740-5b44-4584-a4c1-c58e55fbb770">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTktMS0xLTA_c268803e-a23b-47ea-a432-2a7c692235a2">20,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTE1LTEtMS0w_edd12b4c-a778-499c-aa60-d4dcee272007">20,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December&#160;31, 2018</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6003d7368ff432dba6f6c8d16fda86c_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTEtMS0xLTA_7fed10ec-9002-417d-a022-2b3ed7ad207c">88,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6003d7368ff432dba6f6c8d16fda86c_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTMtMS0xLTA_43845e53-495e-483f-adef-7e349b06fa1e">880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id2f87c2a02444565be0fe283d70f915f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTUtMS0xLTA_98680687-f281-4bf8-882a-3900f9a11c7a">2,881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2f87c2a02444565be0fe283d70f915f_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTctMS0xLTA_7b89adfc-2d21-4dd5-bd48-91abebd11fb8">120,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e538c5631943ab9dc9c1111151d639_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTktMS0xLTA_77adaaf5-d570-46eb-b975-e0a209baf074">1,192,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9bf134b357c4919a6ed50721d05bef5_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTExLTEtMS0w_94ab765c-53ab-427c-944d-c90790eb41fb">45,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd3b20ac1684e6890f3b832a8159d60_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTEzLTEtMS0w_e6be55ad-0a04-4eff-821b-0f86ffd6629e">348,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTE1LTEtMS0w_1a885618-b725-4e61-ae5e-1a40b186fd33">1,375,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if693bb2c04eb453dab7357baad063eab_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUwLTEzLTEtMS0w_e84d07b9-19c0-4de9-b53c-f231e8131665">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUwLTE1LTEtMS0w_648d0965-f9e0-4ffb-8cd0-70625941ff72">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3052346d0d1e442993b001a9e6866d9c_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUxLTExLTEtMS0w_ca13c8fb-a19c-4c98-9b86-66b3e314f0cb">30,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUxLTE1LTEtMS0w_f5a9707d-dbab-4f3c-bfcc-a2f4ec159093">30,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTEtMS0xLTA_8ef14d45-02c4-4b5e-854e-6ca9b540ac36">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTktMS0xLTA_5df8a2a5-5f27-4ee1-92b6-ebc64960c5df">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTE1LTEtMS0w_83f3cc5f-6d0f-4eac-85bc-0a83ecb6b59a">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTEtMS0xLTA_5706559c-1e74-457d-aa71-b40b778f4489">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTMtMS0xLTA_24c92d27-dce6-47bd-8013-8d80cf7b4998">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTUtMS0xLTA_a8ca05a6-ed99-4f64-a76e-d0be9f2db40f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTctMS0xLTA_69628fdd-26c7-4b9b-a56f-29a6a639e17b">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTktMS0xLTA_86c90669-3572-46db-b9f7-bd767fbb4e51">961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTE1LTEtMS0w_5dd941d9-e8bb-4094-8cd5-e1b993062cb1">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU0LTktMS0xLTA_c16c658d-0a59-41b5-8d55-85bedb52de71">21,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU0LTE1LTEtMS0w_70e2d931-2c04-4d5f-9a97-ba274d373fb8">21,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i884dd79183f04dbd8d842cc6dd3f195f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTEtMS0xLTA_311e648b-913a-4242-acc7-dd02052a2749">88,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884dd79183f04dbd8d842cc6dd3f195f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTMtMS0xLTA_d488ee2b-1444-4f15-8982-bd01d9d0b74e">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i440a16199b1a46eab8f2b708f7afaf8c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTUtMS0xLTA_f826732f-7805-4799-9fd8-9be63909c9ec">2,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i440a16199b1a46eab8f2b708f7afaf8c_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTctMS0xLTA_ed11af48-cde4-4386-a8ce-1036c0ab5d12">119,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979d19139f0248f7be2e1547901b2e99_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTktMS0xLTA_6d2ace6b-7ada-4a2f-a7c1-cb2ac6f03d63">1,213,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9d2265b32274b0abed4046b6e8c8fbf_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTExLTEtMS0w_ded7fe47-d059-421f-880c-6e15497f8dc1">76,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe917d8b4db45fca1b875cfe91360b5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTEzLTEtMS0w_6840a322-fa3c-4b6b-afa5-99b9bdbd1119">398,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTE1LTEtMS0w_a9b56ead-2437-4d0a-a1e5-0ec4cba3253c">1,416,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3690ff275714417291e650f8a4240643_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU3LTEzLTEtMS0xMTE1_ce2aec9b-4fd6-41a3-a9df-9453add476ec">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU3LTE1LTEtMS03MDMw_3dce961e-a97f-41f9-bf6e-06e69115c69e">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74b0cb7135c471fb7477ac4e8075cf4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU4LTExLTEtMS0xMTE1_c79dcc05-9589-49a4-bf0d-6f09778ab39d">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU4LTE1LTEtMS03MDMw_8a78ed9b-57f3-4c48-beb4-0dad9d85a1fa">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTEtMS0xLTExMTU_378373fe-d2f9-4e8a-8073-ea2261097881">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTktMS0xLTExMTU_0038f6e7-a4cd-4cf4-888a-e62991407097">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTE1LTEtMS03MDMy_abd29fa3-cd7f-416a-ac36-e00d511a6868">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTEtMS0xLTExMTU_7a94d9f3-cf4d-41d4-9294-b043e7256874">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTMtMS0xLTExMTU_241f088f-0384-4ef4-9134-21d48d3f7af7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTUtMS0xLTExMTU_dc0b005c-8bdb-453e-a090-2435bd0d7ad7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTctMS0xLTExMTU_87f65a3d-82a9-4097-bdb4-81fa6e38cff3">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTktMS0xLTExMTU_5d69ea58-cdd3-4d39-9f3f-0cb9fad611d1">1,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTE1LTEtMS03MDM2_c5601b67-0bd2-43f5-b886-45f8f393405f">538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTMtMS0xLTExMTU_95a253b0-1f9b-4e27-a3f8-7bb3a870bac5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTktMS0xLTExMTU_b8c9bd9f-5689-4deb-a15e-0f2d77938a2f">19,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTE1LTEtMS03MDM5_e5675716-f451-4551-979a-596eac52e464">19,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase and equity component of the convertible note issuance, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYyLTktMS0xLTExMTU_01525c37-847f-4f70-a86e-4429a23e5e59">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYyLTE1LTEtMS03MDQy_56ac0589-fd2b-4b98-bb57-872c56e929ab">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTUtMS0xLTExMTU_79f2cf22-c942-4f30-adfe-b93e98599468">2,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTctMS0xLTExMTU_4baa57bc-9850-4bfb-9702-f62367d41696">115,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTktMS0xLTExMTU_9e598e61-cf63-427b-9b15-9064fabafbb1">15,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTE1LTEtMS03MDQ1_4fc7eab1-56f9-48b1-b292-2df97e859ba4">100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTAtMS0xLTQ4MTQ_60a2b1eb-e906-4b52-95c5-e75f107ed1c2">Adoption of Update No. 2016-13</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497e63eb02a0453ab237c03dcd73f5c8_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTEzLTEtMS0xMTE1_ec268b4e-7a76-4209-a079-9ed8c9d4a6a0">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db0a5177566492e8f23fe58e51f50f2_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTE1LTEtMS00ODEy_a1444cab-7aa4-4d31-ba90-96a62d54794a">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4b32ed643324b139a34db4854dda958_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTEtMS0xLTMxMzM_87c743eb-ab82-45b1-9615-57523d3ca110">89,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b32ed643324b139a34db4854dda958_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTMtMS0xLTMxMzM_f435730e-4e37-46ea-8a27-474e6d634f41">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTUtMS0xLTMxMzM_9a2ab862-3ec5-4f0d-8b99-fedbce6b4c48">4,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTctMS0xLTMxMzM_728c1199-44ba-4da9-9bf5-7fc73ed8de84">235,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df7e9b7d0f848bfb4d01ca0a5a26007_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTktMS0xLTMxMzM_a50fef0b-ffc4-46b1-a34a-49711105b4c7">1,290,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f66841395594a8eb57dc2f4410517fa_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTExLTEtMS0zMTMz_d2dbc2e8-b545-41fd-9090-a86879a3132d">74,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea2b70053244d36874db3dfcc9d258a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTEzLTEtMS0zMTMz_e7fef87a-9ad6-4969-a4d9-59806715f23c">532,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTE1LTEtMS0zMTMz_b7f3bb0b-0317-42f5-b33c-7b87d2c08796">1,514,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 8</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_148"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDgvZnJhZzo1MGM5N2IyNzIyYWY0ZjJiOTkwNDJmOWU0ZGE3ZGM5OS90ZXh0cmVnaW9uOjUwYzk3YjI3MjJhZjRmMmI5OTA0MmY5ZTRkYTdkYzk5XzU1OQ_45087ea8-113d-4f50-a915-d4e1ca5a22a7" continuedAt="i7a0f1bd87e83424a8c94665e5c5acb51" escape="true">BUSINESS</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a0f1bd87e83424a8c94665e5c5acb51">Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company, a worldwide leader in medical devices, is dedicated to limiting uncertainty for surgeons through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Its products are used primarily in neurosurgery,  reconstruction and general surgery. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</ix:continuation></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_151"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzE1_de234cc3-77ea-427d-bdf4-4f6a65c92f76" continuedAt="i72c0a083274440bbbaaff967c6b1bcd9" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i72c0a083274440bbbaaff967c6b1bcd9" continuedAt="ibace07cd1eb44e30a0331f5bcbb54ab6"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzU2_7bf75c87-c0ed-4b67-8bc6-97509f192970" continuedAt="i2582c86d4d124a4dad5d5d202162fe0d" escape="true">BASIS OF PRESENTATION </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2582c86d4d124a4dad5d5d202162fe0d">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</ix:continuation> </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDg0_6779724d-0a1b-4cb1-9ce5-63ff842d867a" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany accounts and transactions are eliminated in consolidation. See Note&#160;5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mjc3_2daeb533-d0db-42ec-b767-7cd1b400469c" continuedAt="ida19ca5f05a1487eba5050d22706527b" escape="true">USE OF ESTIMATES </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida19ca5f05a1487eba5050d22706527b">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</ix:continuation> The novel coronavirus (&#8220;COVID-19&#8221;) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzcz_4f1e4510-0e91-49ce-baf0-f8fa02b965df" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDI4_fb5369a3-6cc3-4d03-a012-049d23123680" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzc0_c1e704fe-e3a5-4c05-887e-3c570111eb51" continuedAt="i7547d84e46844fff8ffe109a3f425697" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7547d84e46844fff8ffe109a3f425697">The Company evaluates the collectability of accounts receivable based on a combination of factors.  The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibace07cd1eb44e30a0331f5bcbb54ab6" continuedAt="i4fd75f5e32cf46bda9ed3e49718459a7"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, were $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3NzQyMjc_feefacd4-2dc4-49f3-a622-c2a3bc370f7f">3.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM3ODU_b36fd92f-3ccc-412c-8b31-2c869500644b">2.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM3OTM_a37863e3-cd7c-4397-8229-3d33d9575e22">0.6</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzcw_923677d3-0c52-4875-9acc-6857911c079e" continuedAt="i8514dd975a384f289d8fa2a925c4cd08" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzg3_fcbb8d76-e0b7-47e4-9c30-17ddbe3f425c" continuedAt="i9e81bd5178ff482d8603f0f7b0fc9339" escape="true">Inventories consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><ix:continuation id="i9e81bd5178ff482d8603f0f7b0fc9339"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzMtMS0xLTEtMA_ae5e5bb3-5786-4c80-aebd-9f0d94932f84">180,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzMtMy0xLTEtMA_0b438f9a-7f62-4578-96f7-cf729d8c5efd">201,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzQtMS0xLTEtMA_9c1d2f96-1477-415f-8924-9b92a48969e3">53,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzQtMy0xLTEtMA_4d3a5765-5bb2-403a-b4bc-add0f6d2061f">48,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzUtMS0xLTEtMA_18fbe6fb-3bad-4ce3-9781-c3f21bc5d813">76,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzUtMy0xLTEtMA_3b75cf8d-8f5f-459b-9ceb-cdf7768e3fc4">65,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzYtMS0xLTEtMA_dcd5d87c-10e9-4d23-9902-65d5fc22791d">310,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzYtMy0xLTEtMA_469d8580-b8f6-4821-a59c-6e07cbd656cb">316,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3Njk1NDc_b6ba09a4-4c7a-4ef1-8c2f-075eacd24172">52.8</ix:nonFraction>&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8514dd975a384f289d8fa2a925c4cd08">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="iart:InventoryCapitalizedExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzU0OTU_11783260-3763-43dc-9421-e170f7452419"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="iart:InventoryCapitalizedExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzU0OTU_fc09db84-208f-4369-8372-6b97abe5e71a">No</ix:nonFraction></ix:nonFraction> such amounts were capitalized at December&#160;31, 2020 or 2019. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDY5_d433fdd2-b0a3-446b-9c75-60b390aa462e" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i4fd75f5e32cf46bda9ed3e49718459a7" continuedAt="i23011e747bcf4ac0b49e0d9ca8b1c5c2"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDMw_661d5895-54e1-4425-b736-cd6d63787e05" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic061214734524284b9c2541bfba9d676_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzMtMS0xLTEtMA_257f01d2-5830-4488-9e52-9be135addc3a">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fa80bc94ee43818c76548c1fd3568f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzMtMy0xLTEtMA_9175929c-7de3-485c-a2f6-7c416217ad01">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ee32a6e3c2419ba466a1eb81b4f062_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtMS0xLTEtMA_8bdf2d7e-5a11-411c-8a02-bad36b24e7b8">17,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f8ec1a3743483194234c2451da620d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtMy0xLTEtMA_f0f4c044-aa90-4e1e-a36e-b0af57f22611">16,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46c49ccb94924cfa94f6a78e004703f5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOmIxNDJjNWY2MDc3ZjQ0NTg5Nzg2ZDNiNjkwOGM2ZTMyXzM4NDgyOTA2OTcyMjA_19c35535-dbe9-4112-a0a2-005bacfae88a">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i17b901b49949495faaa89878c46c3086_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOmIxNDJjNWY2MDc3ZjQ0NTg5Nzg2ZDNiNjkwOGM2ZTMyXzM4NDgyOTA2OTcyMjQ_ce3e511d-b905-49ca-aff8-d965537e3f84">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b55ca139a647439102e704399dd5ae_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtMS0xLTEtMA_202c8c0d-2bea-4230-b856-928c6d7d3426">144,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2b20b5fc6546aba122baf9aa9b536c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtMy0xLTEtMA_ab51b9ae-b244-40f4-82a9-4fee24c70adb">114,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8231a181e67848db899ebd091030a9dd_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjMzU2NGMxZDJhZjRkOWFhMTI0OGVhYjNhZWJhODhjXzM4NDgyOTA2OTcyMjA_eb35ecd8-7cac-4b3b-8fce-33799d31efdb">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i92fd388308054b95b72691d24cfafc71_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjMzU2NGMxZDJhZjRkOWFhMTI0OGVhYjNhZWJhODhjXzM4NDgyOTA2OTcyMjQ_5466ddd1-4117-49a2-b675-90dca7960c9c">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe61dd55956c46e7be4abd99ed4d4eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtMS0xLTEtMA_297b4df5-0ed6-49a9-a328-90c50a3a16ed">166,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9629a17bb5ca4cecba3ac552967e78f7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtMy0xLTEtMA_ca281eff-797e-4d32-b358-c40e8750fe71">155,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6c62a5f0c34c8d9e968867f9fdbc20_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjI5MDgxYmMxNjJlMTQ1OWE5ZGI5Yzc5ZTNjYzQ0ZjU5XzM4NDgyOTA2OTcyMjA_9babca06-45f2-48c9-a589-0038a5f59549">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i3db348720f7447a190b76b7b33df0e2a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjI5MDgxYmMxNjJlMTQ1OWE5ZGI5Yzc5ZTNjYzQ0ZjU5XzM4NDgyOTA2OTcyMjQ_816b82ff-76ff-4b3a-ad4e-c6d117c3e19c">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50891c775ac2413498b01c0f0be08a09_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctMS0xLTEtMA_2773b5a4-5dc6-427c-b80f-7401ada87a97">1,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec5b9cac723b4b70971c2953732ddfed_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctMy0xLTEtMA_9dd100f4-c35f-4216-acd2-fa3c574f277c">33,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61b51f4ea22f452dad1d082f51094afb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjc0M2E0NTk1M2Q4OTRhN2E5ZjU3MjRmNmU5ZDA0NDJjXzM4NDgyOTA2OTcyMjA_0fc62416-01bc-429f-815b-9525436e6cb7">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i1bcc60f2ada445349c7587d684b4d230_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjc0M2E0NTk1M2Q4OTRhN2E5ZjU3MjRmNmU5ZDA0NDJjXzM4NDgyOTA2OTcyMjQ_ff3efb91-cdc9-4907-9357-8b579c4fc51e">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f95eb36b67d4b5991bd8922a0d99122_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtMS0xLTEtMA_ccc1cb6a-06de-4987-b74e-6402362a5b5a">143,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e95fa808684df59048d6ca1ca85347_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtMy0xLTEtMA_d3ba318d-688a-4162-8e09-0f033b1902ab">138,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia9426879a0034a178a96eb71152c9db4_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjc0MzdjYjc2YmU4YzQ1ZDFiNDM3YWEwZWFmNWE4OGI3XzM4NDgyOTA2OTcyMjA_1fb1baf2-df0a-4242-8d1b-3ba16c16775e">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i5d5fad11b772466095bd787febda3045_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjc0MzdjYjc2YmU4YzQ1ZDFiNDM3YWEwZWFmNWE4OGI3XzM4NDgyOTA2OTcyMjQ_4e412b74-2046-4a01-9293-587793e83c00">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1c7b54ac414cadbec5a89aae8c910f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktMS0xLTEtMA_e3d8b62a-b20b-49ff-8dde-0fb326e04460">20,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2edb072a4ba4101a8dce01c004fa0a5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktMy0xLTEtMA_1b819813-f625-4a7a-a0ac-7547ee335816">22,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i900361f2b62f48298b6b5a2e45b6e3d3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktNS0xLTEtMC90ZXh0cmVnaW9uOmE4YmRhZmE0YTM3OTRhYTlhYTg2NTg5YTBjMjY3NWFmXzM4NDgyOTA2OTcyMjA_9c5a178a-1ea9-4a0f-8ac0-4c150515e689">1</ix:nonNumeric>-<ix:nonNumeric contextRef="ie58a11695b3447a89cd0f3f1254e39ee_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktNS0xLTEtMC90ZXh0cmVnaW9uOmE4YmRhZmE0YTM3OTRhYTlhYTg2NTg5YTBjMjY3NWFmXzM4NDgyOTA2OTcyMjQ_9ea6740c-7d1b-4bdb-bbd9-b8ae175721dc">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999b358cac9a43668d1ccf8e82ea992b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEwLTEtMS0xLTA_72ec8e7c-193e-4304-abda-0f91b35c855c">73,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab2eadc90de4c8bb070c20656a5fbed_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEwLTMtMS0xLTA_6d529d39-d6c2-45b3-9472-3b9b20d88e8f">140,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzExLTEtMS0xLTA_39f51f14-aefe-4eb6-9197-23f95a79a5f0">570,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzExLTMtMS0xLTA_c003f9b4-1fcb-44a8-b3b3-079359953245">622,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEyLTEtMS0xLTA_907849a6-d51b-46c4-b0ba-42d62f4d4d65">282,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEyLTMtMS0xLTA_810a60e8-620a-45f8-9c4a-1492437c67e6">284,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEzLTEtMS0xLTA_21f52426-880c-48d6-8e19-84743987d93c">287,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEzLTMtMS0xLTA_3183589a-cf06-463a-a9ac-05fefbac85de">337,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3NzQyMjA_0e8973bb-6192-4f47-a019-478b3f477bb4">37.9</ix:nonFraction> million of  property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipment was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0Mjc_73227133-2cb3-4d9f-b51e-772a69ba875e">42.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0MzE_5aa87239-0675-4e44-901c-d198d6e25674">42.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0Mzk_e3ef5caa-b44e-438f-a87a-a9d8294e7f33">44.1</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $<ix:nonFraction unitRef="usd" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTAwNTY_d67775fb-ce51-4048-a0f5-7776b7533364">6.7</ix:nonFraction>&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:InterestCapitalizationPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDMy_467952ec-8312-4ace-8dae-b607f6bad878" continuedAt="i9b32271647ce431a942af16f8dc5d60d" escape="true">CAPITALIZED INTEREST</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9b32271647ce431a942af16f8dc5d60d">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</ix:continuation> For the years ended December&#160;31, 2020 and 2019, respectively, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalizedAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzcwNjc_90225a42-cb2e-44ea-9d76-6fef64e07b09">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalizedAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzcwNzQ_8adf286f-750c-4439-b132-94dd6f10b2ed">3.1</ix:nonFraction> million of interest expense into property, plant and equipment. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mjk1_660638e2-5549-4469-abd5-d804360027dd" continuedAt="i3ed084d5c05f40a4b296b01f7dccf30f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired Company are expensed as incurred. The operating results of the acquired business are reflected in the consolidated financial statements after the date of acquisition. Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. Contingent consideration is recognized at the estimated fair value on the acquisition date. Subsequent changes to the fair value of contingent payments are recognized in selling, general and administrative expense in consolidated statements of operations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#8217;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3ed084d5c05f40a4b296b01f7dccf30f">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</ix:continuation> Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><ix:continuation id="i23011e747bcf4ac0b49e0d9ca8b1c5c2" continuedAt="if425f76cd1984ce1a7d6a503044a42cf"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NTAz_d31e5f25-4a65-4dc4-bbd0-98128c266907" continuedAt="i826a3ac023f84b83b72f110af060758b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwMjM2_54425559-0a20-4e07-bd57-909a79251c82">two</ix:nonFraction> reportable segments with <ix:nonFraction unitRef="reporting_unit" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwMjY0_77d62e45-ebe6-40c6-9aba-151a24208255">three</ix:nonFraction> underlying reporting units. Refer to Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company acquires a business, the assets acquired, including IPR&amp;D, and liabilities assumed are recorded at their respective fair values as of the acquisition date. The Company's policy defines IPR&amp;D as the fair value of those projects for which the related products have not received regulatory approval and have no alternative future use. Determining the fair value of intangible assets, including IPR&amp;D, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i826a3ac023f84b83b72f110af060758b">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives.</ix:continuation> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDk2_46a84fb6-fd35-4e5e-bec5-f3bf544910b7" continuedAt="i3caf595b173640c7a715e89012d313f6" escape="true">LONG-LIVED ASSETS </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3caf595b173640c7a715e89012d313f6">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</ix:continuation> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="iart:FoundationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzAw_6c3dc0e8-6c1c-48e3-8b34-d3f3db05e6c7" continuedAt="i9ebefa59bbc94fe5be1d48e9634addea" escape="true">INTEGRA FOUNDATION </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9ebefa59bbc94fe5be1d48e9634addea">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</ix:continuation> The Company contributed $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTQ4_cc82e0c6-4028-42a8-8bf6-9c230d2a47fd">0.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTYw_b434e56f-d219-4640-8c06-bd87ead84fad">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTY3_d6f5ae24-ee7a-4917-8839-aac2aa7e3531">0.8</ix:nonFraction> million to the Integra Foundation during the years ended December&#160;31, 2020, 2019 and 2018, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="if425f76cd1984ce1a7d6a503044a42cf" continuedAt="ic1ef06df462042e69d620c25d9974ca5"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDkw_97ca2790-8119-4c26-9705-f36391370498" continuedAt="iab1a9b360a814f55a2853206feda282f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab1a9b360a814f55a2853206feda282f">The Company entered into a foreign currency forward contract that is not designated as a hedging instrument for accounting purposes. This contract is recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.</ix:continuation> Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzc3_fe349d97-87ea-45da-81a2-e65fd33419d8" continuedAt="i7fdf91d7159945c1b73096443772df50" escape="true">FOREIGN CURRENCY </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7fdf91d7159945c1b73096443772df50">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</ix:continuation> Foreign currency transaction losses of $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDgy_4f5f1dc9-c1d0-4895-acf6-a35e8de3d419">1.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDg2_03592272-f5be-4ba7-ae3b-c435a4fd1aab">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDkz_99a2f16f-6dbf-4ca8-9d39-2513df15dc73">1.7</ix:nonFraction> million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDUz_5338bf8c-f474-475d-beb1-892f54cd2287" continuedAt="i6739517b54e646afa559aa59caeb6aaa" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next  twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6739517b54e646afa559aa59caeb6aaa">The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.</ix:continuation> The Tax Cuts and Jobs Act (the &#8220;2017 Tax Act&#8221;), enacted in December 2017, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic1ef06df462042e69d620c25d9974ca5" continuedAt="iecf3ceca480e46b1b0e1573084a740be"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imposed a toll tax on a deemed repatriation of undistributed earnings of foreign subsidiaries. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzIy_6c8e407f-1268-4e32-b3b0-cd553e103628" continuedAt="i16362f5739464c1cafd3940afe305a0a" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i83fed34960cd4b7783e4140052f46fee_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyNjEw_3792437f-116e-4543-9559-a17b3d7b8a8c">1.9</ix:nonFraction> million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $<ix:nonFraction unitRef="usd" contextRef="i38390ecc6ebf4364b0eaad6d1de33927_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyOTgy_1b995972-b725-4ceb-973d-27c2bc86485b">7.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i38390ecc6ebf4364b0eaad6d1de33927_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyOTg5_efd882c7-090c-4d45-b43f-b8ee3e97cde3">5.2</ix:nonFraction> million, respectively, as of January 1, 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">one</span> to <ix:nonNumeric contextRef="i9485be95a6c24efca36864f26dd854fa_D20200101-20201231" format="ixt-sec:durwordsen" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTU2_f54cae76-26a4-4f18-93c5-d83a46a4e101">three months</ix:nonNumeric>. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i16362f5739464c1cafd3940afe305a0a" continuedAt="i47415d6db2464cdaaf03974a8430183f">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.</ix:continuation> Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDM2_41624739-6ec5-4d2b-9791-4fc89c5674c9" continuedAt="i1e6a5797cd9b4169b9ff76fb4986ec4a" escape="true">RESEARCH AND DEVELOPMENT </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1e6a5797cd9b4169b9ff76fb4986ec4a">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzY4_1ba06053-f2bc-44f8-8ae4-a31a5435f5d1" continuedAt="i34843607e5a24ae7bf3b6c6fb307eebb" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34843607e5a24ae7bf3b6c6fb307eebb">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</ix:continuation> </span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iecf3ceca480e46b1b0e1573084a740be" continuedAt="i45f4395d76e24eb681c0a3fdd1f90a7b"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company incurred restructuring costs of $<ix:nonFraction unitRef="usd" contextRef="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0NDU_9d08794d-f946-470a-a6b2-9fc08602f0d0">4.9</ix:nonFraction>&#160;million in cost of goods sold, $<ix:nonFraction unitRef="usd" contextRef="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0NzI_cd236007-e5cf-4bcc-b7d7-bbb70f41efc7">1.2</ix:nonFraction>&#160;million in selling, general and administrative and $<ix:nonFraction unitRef="usd" contextRef="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0OTk_526660d6-198d-471d-94ac-c9f315edd39a">0.3</ix:nonFraction>&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations. As of December&#160;31, 2020, the restructuring costs of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc1MjY_168932fe-b09a-4565-8649-7a98b1b991a1">6.4</ix:nonFraction>&#160;million were included in other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDEw_30209152-8419-4fbf-9cb9-e119dab82791" continuedAt="i6848a3a2e51a471f9f7ad5b7e2928a6b" escape="true">STOCK-BASED COMPENSATION </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6848a3a2e51a471f9f7ad5b7e2928a6b">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</ix:continuation> Refer to Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzIw_fa6fa6cd-7e98-4c6d-b62b-ab0634faeb97" continuedAt="i3b88b2512e1a433587156aec2920d244" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the &#8220;Plan&#8221;). Under the Plan, certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzczMjg_a652ee3c-3801-492f-8963-0c0a7c4c7e4a">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzczMzM_a314f10a-7ff3-45d6-85a1-1b9073f39aeb">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3b88b2512e1a433587156aec2920d244">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed  by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</ix:continuation> </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzkz_7bc8f9dd-1d59-4174-a5e5-2497615e9a89" continuedAt="i354ef303b4944bbf99e50296b523ebcc" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i354ef303b4944bbf99e50296b523ebcc">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</ix:continuation> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="customer" contextRef="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_89fb03b3-58b3-44ca-a4f1-f9541d226323"><ix:nonFraction unitRef="customer" contextRef="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_bc877e5e-578a-4f11-8ae5-ec4cd2a5ad9a"><ix:nonFraction unitRef="customer" contextRef="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_c50472e0-9a71-439d-ba22-88156907eb00">No</ix:nonFraction></ix:nonFraction></ix:nonFraction>ne of the Company's customers accounted for <ix:nonFraction unitRef="number" contextRef="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_08b2443a-be3a-4521-a06a-f1c5435b0618"><ix:nonFraction unitRef="number" contextRef="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_a9f7f076-d5c3-4765-8444-9fc37d374208"><ix:nonFraction unitRef="number" contextRef="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_ca81f5c8-5142-4044-b138-4a3fa84db0be">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% or more of the consolidated net sales during the years ended December&#160;31, 2020, 2019 and 2018.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDkx_e241d7ea-4991-4d28-b159-1a1fd60144e3" continuedAt="ic564d78ce8b642a2a604870d69de4ebf" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the New Lease Standard). The New Lease Standard requires that lessees recognize virtually all of its leases on the balance sheet by recording a right-of-use asset and lease liability (other than leases that meet the definition of a "short-term lease"). This update became effective for all annual periods and interim reporting periods beginning after December 15, 2018. The Company adopted the New Lease Standard as of January 1, 2019 using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. The Company elected the &#8216;package of practical expedients&#8217; which permits the Company not to reassess the prior conclusions about lease identification, lease classification and initial direct costs under the new standard. The Company also </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i45f4395d76e24eb681c0a3fdd1f90a7b" continuedAt="i6a10d5fb30714424808ab28a14700aac"><ix:continuation id="ic564d78ce8b642a2a604870d69de4ebf" continuedAt="i59ae2a81123440709afff7b6557c7bfa"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elected the use-of-hindsight practical expedient. As most of the leases do not provide an implicit rate, the Company used the collateralized incremental borrowing rate based on the information available at the lease implementation date in determining the present value of the lease payments. The adoption of the New Lease Standard had an initial impact on the consolidated balance sheet due to the recognition of $<ix:nonFraction unitRef="usd" contextRef="iade82fb3205f44c5a097aba1eb4be42d_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5NzQ1NDk_1d70d7c6-4e4c-42de-a767-4f3ad4415a98">76.4</ix:nonFraction>&#160;million of lease liabilities with corresponding right-of-use assets ("ROU") of $<ix:nonFraction unitRef="usd" contextRef="iade82fb3205f44c5a097aba1eb4be42d_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5NzQ1NjQ_528b7960-6d6c-4aec-a94e-91b3fda885d2">67.3</ix:nonFraction>&#160;million for operating leases. The difference between lease liabilities and right-of-use assets is primarily attributed to unamortized lease incentives which is amortized over the term of each respective lease. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Related Party Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. The ASU became effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance for the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill.  The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted.  The Company will adopt ASU No. 2019-12 effective January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively.  The Company does not expect this guidance to have a material impact on our results or financial position.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU became effective immediately and may be applied prospectively to contract modifications made and hedging </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6a10d5fb30714424808ab28a14700aac"><ix:continuation id="i59ae2a81123440709afff7b6557c7bfa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships entered into or evaluated on or before December 31, 2022.&#160;In January of 2021, the FASB also issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU No. 2020-04. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.&#160;The Company will adopt this standard on January 1, 2021 using the modified retrospective method. The estimated impact includes the convertible debt instrument being accounted for as a single liability measured at its amortized cost and elimination of the non-cash interest expense as the Company will not separately present the equity embedded conversion feature in such debt. The Company also expects to adopt the if-converted method for earnings per share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC&#8217;s regulations. The Company will adopt ASU 2020-10 as of the reporting period beginning January 1, 2021. The adoption of this update is not expected to have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have a significant effect on the Company's financial position, results of operations or cash flows.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MTYy_cfd0c658-dee5-48c6-824e-7a59ab6bb6a0">47.3</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MTcz_a8e99b72-b65c-4dfc-877f-ae4dbee4d00c">2.3</ix:nonFraction> million that was capitalized into construction in progress), $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MjI5_94f5baf2-1230-4b98-8f75-6f23b4340ae2">48.9</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MjQw_afd4a954-1412-4d9a-a313-dcc4f2515339">3.1</ix:nonFraction> million that was capitalized into construction in progress) and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1Mjk5_87280c90-0c77-4fde-9300-748ddf244976">58.3</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MzEw_bd60684f-6b6b-46ac-b89f-9567725ef645">2.3</ix:nonFraction> million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDYy_df970c03-b565-4b33-b320-6682f072547e">29.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDY2_c253b2a0-fc13-4e2c-8785-d94129bb2a16">16.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDcz_705d5a7b-d006-425f-8253-69b27725ef93">10.4</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING  AND FINANCING ACTIVITIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2020, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTEw_b1a4bd3d-7e17-4ad7-ac64-4950c40229ff">1.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTE1_cc0656f0-6d83-4633-96c9-7fccfd37256d">11.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTIz_62fd182a-534c-44a5-9110-d4da2f0024cc">5.4</ix:nonFraction> million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company achieved the first developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i07472adf71764b7291b105f7455877fb_I20191231" decimals="-5" format="ixt:numdotdecimal" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTE3NzM_e55de66c-9cb6-4a3e-89a7-887de959175a">5.0</ix:nonFraction>&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). In addition, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="ie811913eab234ddc8c4112b2e8a244a5_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTE4Njg_7faa3d4c-9074-4492-ae70-2e1c67df1065">5.0</ix:nonFraction>&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div></ix:continuation><div id="i0e66bbc7ee8049f2984ce8179f803ee5_157"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzMyOTg1MzQ4OTgyMDI_4f4c73fe-4fb6-4cf0-9706-ccd7859441b9" continuedAt="i88d54e5ea506462eae91a19270a8deb2" escape="true">ASSETS AND LIABILITIES HELD FOR SALE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i88d54e5ea506462eae91a19270a8deb2" continuedAt="ic50470d686ec4b9ebfa3b706fd1e9c82"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2020, the Company and certain of its subsidiaries entered into an agreement to sell its Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately $<ix:nonFraction unitRef="usd" contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzM4NDgyOTA3MTIwNjI_5b4dc0fa-d101-4141-a787-ba2a079bec10">240</ix:nonFraction>&#160;million in cash. The transaction includes the sale of the Company&#8217;s upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. In connection with the transaction, the Company will pay $<ix:nonFraction unitRef="usd" contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104" decimals="-5" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzM4NDgyOTA3MTIwNzY_7059f4ad-ffb7-4cdd-883e-c019ade622c1">41.5</ix:nonFraction>&#160;million to the Consortium of Focused Orthopedists,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> LLC (&#8220;CFO&#8221;) pursuant to the terms of certain agreements between Integra and CFO relating to the development of shoulder arthroplasty products.  On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited and received an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzMyOTg1MzQ4OTk4Mjg_4f90f366-b704-48cf-a1bd-bc962c492c69">240.0</ix:nonFraction>&#160;million. Refer to Note 18. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for details of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the assets and liabilities associated with the Extremity Orthopedics business to be accounted as held for-sale as the six criteria under ASC 260 were met during the third quarter of 2020. Upon designation of the assets and liabilities as held for sale, the Company recorded the assets at the lower of their carrying value or their estimated fair value, less </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic50470d686ec4b9ebfa3b706fd1e9c82"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated costs to sell. Goodwill was allocated to the assets and liabilities held for sale using the relative fair value method of the Extremity Orthopedics business to the Company's Orthopedics and Tissue Technologies reporting unit. The fair value of the business less costs to sell exceeded the related carrying value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Extremity Orthopedics business was treated as a single disposal group and presented separately in the consolidated balance sheet as assets and liabilities held for sale as of December&#160;31, 2020. These balances are presented as current assets and liabilities as they are expected to be sold within twelve months. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0Xzg3OTYwOTMwMzcwODM_bf81776c-3726-4228-8544-e30202385368" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities classified as a held for sale consisted of the following as of December&#160;31, 2020 (amounts in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzAtMS0xLTEtMzI5MQ_82fa667f-eb7a-4339-804b-3a406cd8863b">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEtMS0xLTEtMzI5MQ_35dbebf2-778a-4090-b99a-4a061bc5cd2b">3,186</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzItMS0xLTEtMzI5MQ_b2a720aa-de26-4815-84dd-2820e514fb4d">6,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzMtMS0xLTEtMzI5MQ_5af5e384-0036-487b-8991-73477d448a4d">13,332</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzQtMS0xLTEtMzI5MQ_b5fcba46-bd64-422a-a165-0b5376bdb0ef">37,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzUtMS0xLTEtMzI5MQ_eb504341-940c-4037-961b-d8ecfe1648f5">47,546</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzYtMS0xLTEtMzI5MQ_b11ae817-6428-48eb-aa67-1ea1e6d30ac8">52,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzctMS0xLTEtMzI5MQ_7d4a84ae-b3e6-4fe4-8122-cc6bca6dee3f">162,104</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzgtMS0xLTEtMzI5Nw_90be9fda-a042-47d6-adcb-35ec09c5572f">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzktMS0xLTEtMzI5Nw_e61ae7da-907c-400b-ba4f-5aea292e2bd7">539</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEwLTEtMS0xLTMyOTc_d846b4eb-53f5-4c13-91a4-4acb785f4ffb">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzExLTEtMS0xLTMyOTc_3c856ebf-bfdb-4fa4-a369-e6bb5d99d1e9">3,440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEyLTEtMS0xLTMyOTc_c88fed74-ee6f-4a34-bb45-876790dcd0e1">5,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEzLTEtMS0xLTMyOTc_8490707b-e036-4268-bab0-3d8da05c906a">11,751</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_163"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTQ_40e6d359-e059-4437-b9fa-8f95b5d1be83" continuedAt="i20a730ee2a6244c4820949c4c80c99ba" escape="true">REVENUES FROM CONTRACTS WITH CUSTOMERS</ix:nonNumeric></span></div><ix:continuation id="i20a730ee2a6244c4820949c4c80c99ba" continuedAt="i94da364f30f24b91a9bb7e06a2b6d3ff"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><ix:continuation id="i47415d6db2464cdaaf03974a8430183f" continuedAt="id07abf2711dc4bdab0ca4b9155b74b7b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:durwordsen" name="iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzE3NDc_b8d57d6d-befe-49ab-bee6-afff07ba3b24">ninety days</ix:nonNumeric>. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i94da364f30f24b91a9bb7e06a2b6d3ff" continuedAt="i78292cf1cb7b4f049b4164c98edf3bbc"><ix:continuation id="id07abf2711dc4bdab0ca4b9155b74b7b" continuedAt="i8fac070fd8f0402681dbdcd5a992605c"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div></ix:continuation><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTA_323ebd6c-7eaa-4347-bbf3-59042f4d7634" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzMtNS0xLTEtMA_4334161c-d4a1-41f8-bb1e-0fed95325bcc">8,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>     in beginning of the year contract asset </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzQtNS0xLTEtMA_da9dacfb-b5ea-43d1-8ecb-8b179bac2c0b">8,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzUtNS0xLTEtMA_ac0d09b4-9437-438a-ad5d-e51a9308283d">7,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzYtNS0xLTEtMA_c1a4f4d3-9379-4b94-81b5-11973b2ffa02">7,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzktNS0xLTEtMA_df5eb685-248a-4e97-afc2-3d518786fb83">11,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzEwLTUtMS0xLTA_47a21c8b-b2c4-40e4-a2f8-ae58f158628b">3,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzExLTUtMS0xLTA_2eb33697-dea8-43f4-a06d-142dd697a6be">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzEzLTUtMS0xLTA_7f0ff34e-21fa-497f-bc7f-c0b68c143c99">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzE0LTUtMS0xLTA_7eed5719-2f28-470d-8c50-dbb07ac53b1d">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the short-term portion of the contract liability of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMwMjI_6d765f32-f0e7-4d2d-b268-b0a6a912b486">5.3</ix:nonFraction> million and the long-term portion of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMwNjI_9b02b3c8-1e20-4b01-9878-ac179e1199c4">6.7</ix:nonFraction> million were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company is expected to recognize revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i6977fff2340446e5b9fddb49366b8f03_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyNjY_fd0faec0-2755-42b8-ba21-54db5a2b10b3">5.3</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="ifa620d0c12614afdb67624c661a4bb74_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyNzg_9952f71a-e5f1-4ea4-9973-137837cf31af">2.9</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ib860ee74ea084f9ba7268bd39ee3150c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyOTA_e4d6d9ba-3489-43f6-bf62-c040070f9008">1.5</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i42d8dcf211fa42229071773bf3eec9bb_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMDI_95ba4c23-bd78-4c66-8c19-b20a11370b75">0.8</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMTQ_4afc7642-327c-40ac-915e-05cdff14217a">0.6</ix:nonFraction> million in 2025, and $<ix:nonFraction unitRef="usd" contextRef="idabf7271b67c4332a6789f4f602fb426_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMzA_cb151f28-31b7-496b-8e77-233af29e4052">0.9</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:continuation id="i8fac070fd8f0402681dbdcd5a992605c" continuedAt="idf5307fc16c548e8b20322fb063b3556">Shipping and Handling Fees</ix:continuation></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idf5307fc16c548e8b20322fb063b3556">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</ix:continuation> </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ExtendedProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTM_6734de1a-fcf2-4869-a049-7c173b59e0ca" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:durwordsen" name="iart:RevenueProductWarrantyPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzQwNDQ_f56d2d0b-0ccb-4e35-be24-b109b0415b05">two years</ix:nonNumeric> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTk_5494042e-d730-4677-9ea1-a294a69d3b21" continuedAt="icf993319bea8444ea14a0f15532c6a0f" escape="true">Taxes Collected from Customers</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icf993319bea8444ea14a0f15532c6a0f">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NjA_bb413d1b-a5ad-41e0-9eed-35cf82684721" continuedAt="i8a9aaab77d7944a9a85422d935840b02" escape="true">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2020, 2019 and 2018 (amounts in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i78292cf1cb7b4f049b4164c98edf3bbc"><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><ix:continuation id="i8a9aaab77d7944a9a85422d935840b02"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1647e4d8490d449bbdd63555d13bff5f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNC0xLTEtMA_06ca3160-d7bc-4b91-9d2d-72e931d27297">716,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdf88a449ea464f8b834eda1ecc3784_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNS0xLTEtMA_47ce7f59-856a-4cfb-a2a2-3b76afc69134">767,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i552e291806f3436eb7cc1d37dea5b0ca_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNi0xLTEtMA_52f251ec-88e4-414e-a768-1fe37f6cd4c7">740,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8aeedc7aea74a4ca21f9bb6fe08f272_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNC0xLTEtMA_ae25f46a-9cd4-4796-bae4-2520b4387f11">178,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d87508b86884995a4852692cd256f3c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNS0xLTEtMA_d22afbe0-1c50-41e3-846a-cbe3c10674b6">228,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eebee9e7bc45b89edecf002f3b63c3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNi0xLTEtMA_54b66d0a-6e71-4af1-9786-ff62fc5074df">223,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNC0xLTEtMA_0c4c5926-4a86-4c46-bd19-7b8889128bf9">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNS0xLTEtMA_e09029f2-1f6d-413f-af2d-e7c714476dab">996,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNi0xLTEtMA_2445b91f-dbe1-4cff-a7ba-5efcbd8a3ba8">963,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ad1d30cc6b413e8157213aa0027a9d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNC0xLTEtMA_a486dcaf-6ca0-4c7d-abb9-12f48854bf60">293,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71dda56b32044428763726b23029626_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNS0xLTEtMA_4fdb30e4-dfe8-424e-8408-3f4be174ee4c">322,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96624b2de4ce4641be5e012372eafc14_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNi0xLTEtMA_6c949fd0-b39e-4759-82ba-4b9699d79d08">311,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38654dd730af46f2b20f7e1f70f9cb97_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNC0xLTEtMA_57b49eaa-60b0-4068-83d8-a165705c5296">78,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73807d89fa8f442f9bcd07bd546c66fd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNS0xLTEtMA_e085de6a-3d0a-4b95-b30e-2c06a449fc27">90,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bfb53150fc49a6be6633a165cc595d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNi0xLTEtMA_7710670b-7088-46ba-a0a3-eb9c5f18c720">90,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53063f0ec44441beaf67e6134faf51ad_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNC0xLTEtMA_a185b2c1-42a3-4c4c-b348-5139a4e4d003">105,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id364004a8c804fdf9bb65e44092e258c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNS0xLTEtMA_c779be7b-1796-4d45-9e5f-e6662ed336f9">108,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51536a40efdc4ab2ad8c26840f07e52e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNi0xLTEtMA_6e420fea-5556-40ad-9e90-6fb4224d1be3">106,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Orthopedics and Tissue Technologies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNC0xLTEtMA_16909e49-440d-41d0-aae2-c7d642501e93">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNS0xLTEtMA_c37058b9-cff8-4837-8f61-c9a51a6d3e33">521,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNi0xLTEtMA_cf7c3d4d-6ccc-4cf7-811c-eb62bac5e1cf">508,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTQtMS0xLTA_30a71820-ca31-41bf-8508-5e4a145a4775">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTUtMS0xLTA_a81a6a4a-da3e-4cf3-885c-b0c3a369f056">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTYtMS0xLTA_922a6674-3861-4075-9e2b-b8725958e95f">1,472,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div></ix:continuation><div id="i0e66bbc7ee8049f2984ce8179f803ee5_169"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjMzODE_4a9436c5-94a9-46fc-856f-e35dd23afc9a" continuedAt="i14c01739e72049708b806005ea8b3913" escape="true">ACQUISITIONS </ix:nonNumeric></span></div><ix:continuation id="i14c01739e72049708b806005ea8b3913" continuedAt="i7bed681514d64e0b9d72a8ff4c06ce20"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="iab11d9606b8c493e897237f5afc49895_D20190729-20190729" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzE3NQ_2b860ba9-f093-42f6-92da-135c1ec9f775">30.6</ix:nonFraction> million (the "Arkis Acquisition") plus contingent consideration of up to $<ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzI0Mw_14526504-a440-4b31-b52c-5f4dd8ddc674">25.5</ix:nonFraction> million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $<ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQxOQ_f12cd322-2acc-4811-ac64-aff5f44d7c9a">13.1</ix:nonFraction> million. Arkis was a privately-held company that marketed the CerebroFlo&#174; external ventricular drainage (EVD) catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzIyODgx_9e08b662-bd59-41aa-93bf-58cf6f4a4551" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzItMS0xLTEtMA_c4af76ed-1028-49b3-8173-8c49a699972b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzMtMS0xLTEtMA_5b40a499-01c7-4ad6-9bb9-832d4730f2da">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzQtMS0xLTEtMA_36384354-c9ca-40f3-93a2-462080dd27ef">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzUtMS0xLTEtMA_99c5effd-0ed1-425a-8808-38ba3cef6dea">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d98108080747959bd511b7c066fcd3_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzctMS0xLTEtMA_3eeca3c7-5649-40ec-a1f0-e4ee9c05edc2">20,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29ef932d028d41118f879bbe261bf689_D20190729-20190729" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzctMi0xLTEtMA_61529be1-52a4-4bcb-b546-4ba7e053ac35">15</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa338878261f40e2ba360dfc8fe15384_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzgtMS0xLTEtMA_575e9db6-8056-41da-b80d-7d40506b1fd3">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7e089d0cd7be41ef953212d6a49bfc21_D20190729-20190729" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzgtMi0xLTEtMA_2e837962-d7bb-4ab9-9c24-87a01df55e74">14</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzktMS0xLTEtMA_bcd048a7-4921-4304-99ac-2630f9598149">27,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEwLTEtMS0xLTA_f0edfa57-c03f-4494-95bd-fdc1b27154dc">52,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEyLTEtMS0xLTA_b38078f4-ae5f-46a7-b328-a2579280f46e">2,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEzLTEtMS0xLTA_9d6c9f62-b63a-426f-b312-6877930304b0">13,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzE0LTEtMS0xLTA_997f9983-5ed5-4b68-8b30-f0c59bc4ec39">5,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzE1LTEtMS0xLTA_2150be6f-8897-457d-9e6b-b74ec4c3729f">30,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7bed681514d64e0b9d72a8ff4c06ce20" continuedAt="iddd707b8e6614b75a78a6703cceaf115"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="INF" name="iart:AcquiredFinitelivedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzIxMTk_2ec28038-f6e1-4d6f-9629-7a56b82e4e6c">14.5</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $<ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ2MjI_60408f7a-4169-4079-b213-e10366a8ac37">25.5</ix:nonFraction> million based on the timing of certain development milestones of $<ix:nonFraction unitRef="usd" contextRef="idf8459aff7b64dc6a0ccd87d609c74b1_I20190729" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ2ODI_23e50338-e82d-42b7-95b2-92c6ed91de00">10</ix:nonFraction> million and commercial sales milestones of  $<ix:nonFraction unitRef="usd" contextRef="iddac580fb69647188ee6543fba4be5ed_I20190729" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ3MjE_e38d8aae-71fb-45a6-8c27-0bcb594b3805">15.5</ix:nonFraction> million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MzgxMzg_67d285c2-cc5f-437d-a739-85533d76f680">13.1</ix:nonFraction> million at the acquisition date. The estimated the fair value as of December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="id88f287fd2124c55ba6e236730478cee_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NDMx_6cb528ae-370e-413a-ab06-fd9b19e9f590">15.1</ix:nonFraction> million. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i118da3e2985e4e5d8bd87b7884e68786_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NTYx_645dd263-e4fd-48e1-ab23-54f0dac044ef">3.4</ix:nonFraction> million in accrued expenses and other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="ieffdc4cad57b47f4b1fd3d56ceefa79c_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NTcz_6d48dbb5-0ccc-49a3-a95a-6715b0c2ebdf">11.7</ix:nonFraction> million in other liabilities at December&#160;31, 2020 in the consolidated balance sheets of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the AURORA Surgiscope&#174; System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of  $<ix:nonFraction unitRef="usd" contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwMDQ_c4ab4eee-7db1-40fd-be2b-32418a8003fb">67.1</ix:nonFraction> million and are committed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909" decimals="INF" name="iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNDM_d716d8af-b279-4928-9e72-194e321eeab9">35.0</ix:nonFraction> million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in <ix:nonFraction unitRef="asset" contextRef="ic2e05e186ade4bdfa5df3778adab6e61_I20190909" decimals="INF" format="ixt-sec:numwordsen" name="iart:AssetAcquisitionNumberOfAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzYyMTM_14329d61-73dd-49e4-96cc-d75578587101">one</ix:nonFraction> single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $<ix:nonFraction unitRef="usd" contextRef="iccfedde3073f4a829d00d679dffc6b6b_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNTg_6851181f-24ee-4c4f-8352-dd5dbbc1ee48">59.9</ix:nonFraction> million IPR&amp;D expense. The balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNzM_49077b74-777a-48ff-9cd3-32898e5cb1c9">7.2</ix:nonFraction> million, which included $<ix:nonFraction unitRef="usd" contextRef="i45c9ff50901a4a85ad2ef0c19c9c5530_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwOTA_ba73e801-74d3-40aa-83cd-5439f4392016">2.1</ix:nonFraction> million of cash and cash equivalents and a net deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="iabdc38db0fd442a69aa920353ffe2441_D20190909-20190909" decimals="-5" name="iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxMDU_0866f765-e2d5-4aa8-bc58-9abce219e8f1">4.2</ix:nonFraction> million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i07472adf71764b7291b105f7455877fb_I20191231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxNjA_c7a3ec02-ab41-4715-96a4-6a8bb4dbcec1">5.0</ix:nonFraction> million obligation to be paid to former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i6fa850870800416cb442b162e112d697_D20191001-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxNzI_c8e6aa13-0715-4d0c-916b-c1b26ffd9fe4">5.0</ix:nonFraction> million as IPR&amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iddd707b8e6614b75a78a6703cceaf115"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i20a2549c743743298aa4d44d68f4239e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjQyMDM_6f53a850-2b73-4872-8419-045a1651ff07">20.0</ix:nonFraction>&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i20a2549c743743298aa4d44d68f4239e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjQyMTg_04a7b3e4-1f06-44e5-a75f-e4eab8e16d18">20.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Integrated Shoulder Collaboration, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $<ix:nonFraction unitRef="usd" contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2MjA_0e69765b-c3de-4ecd-8914-e824b71391e4">1.7</ix:nonFraction> million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date <ix:nonNumeric contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104" format="ixt-sec:durwordsen" name="iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzc4MTQ_73cc1645-478e-41ac-965b-72553d40d129">four years</ix:nonNumeric> subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed  $<ix:nonFraction unitRef="usd" contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104" decimals="INF" name="iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2MzQ_92828104-34f0-4a94-b550-316e312a9151">80.0</ix:nonFraction> million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily <ix:nonFraction unitRef="asset" contextRef="i54369f3ad8944d81a87891c2071ad9e0_I20190104" decimals="INF" format="ixt-sec:numwordsen" name="iart:AssetAcquisitionNumberOfAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzgxMjU_c8a6a0c3-3e8c-4906-a1bd-2369b40dd089">one</ix:nonFraction> asset. The total upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i2460cb74a44d40809765b3973c5e5005_D20190101-20190331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2NDg_ab9eb6d2-f915-4391-8e6a-3884ba88aed3">1.7</ix:nonFraction> million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $<ix:nonFraction unitRef="usd" contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104" decimals="-5" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzg3OTYwOTMwNjIyNjc_33147a39-15e7-4feb-89c8-c301e34908ad">41.5</ix:nonFraction>&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for details of the transaction.</span></div></ix:continuation><div id="i0e66bbc7ee8049f2984ce8179f803ee5_175"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MTY_6d6978d8-4f96-4e96-a2c7-227e16129c0e" continuedAt="i629853f4a7ac478180dc4a5fb280de14" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i629853f4a7ac478180dc4a5fb280de14" continuedAt="iec6a486800c04191aabbb99ce2785e6b"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzUwMA_5b159131-f960-465a-bd36-45ff2b2ab017">2.2</ix:nonFraction> billion available to it through the following facilities: (i) $<ix:nonFraction unitRef="usd" contextRef="ie5c97a92749542e68b530970e7f0bae2_I20200203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU1Ng_d45ea2e2-dec5-4ea7-95e9-04715b1e1f99">877.5</ix:nonFraction> million Term Loan facility, and (ii) a $<ix:nonFraction unitRef="usd" contextRef="id2741743d8a14b23aa6c8c40f03c28fa_I20200203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU4NQ_f96132f1-f7e3-4517-b071-0643a4d60698">1.3</ix:nonFraction> billion revolving credit facility, which includes a $<ix:nonFraction unitRef="usd" contextRef="i822435be5fe4477c9241a3f93cf99a87_I20200203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzYzMg_5bc3e5ae-b9ab-4cda-bd55-107cfd85c300">60.0</ix:nonFraction> million sublimit for the issuance of standby letters of credit and a $<ix:nonFraction unitRef="usd" contextRef="iffd6869fdd4b488e8e7e6aad20f49ad8_I20200203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzY5Ng_af22b96c-5cc6-4e28-aa47-8cd73aeb6b94">60.0</ix:nonFraction> million sublimit for swingline loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment does not increase the Company&#8217;s total indebtedness.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU0MTY_c3df3627-e2c6-4ccb-95e1-1788bef1d222" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 14, 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:75.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaffaed4533cd4d7f923869baf4414f46_I20201231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjE3MjhjODcxNTkxYTQwZTNhYTliNzAxNjFjZDkwOTQ2XzM4NDgyOTA2OTcyMzY_bd2204e0-25ad-48d1-b3a7-038379436a51">5.50</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8a2c2dd31e44bce86f8e4abfb0af083_I20201231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzQtMi0xLTEtMC90ZXh0cmVnaW9uOjRkOTgxMmZhZTI4NjQyYzZhZGRmNGJhZjg3MWRjNzU4XzM4NDgyOTA2OTcyMzY_a4daebb0-ffc7-4dc4-9cd7-d35eec8aea07">5.00</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a539237847c4312a3c668310be66ce7_I20201231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzUtMi0xLTEtMC90ZXh0cmVnaW9uOjQ0MTM0ZGUxMTViOTRjNDY4YTU5MDIyZjMzOGU5M2RlXzM4NDgyOTA2OTcyMzY_088a1d8b-1020-450a-8bab-c0f9ba67ba31">4.50</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i298c0a2f362f453e873de725dc394c2e_I20201231" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzYtMi0xLTEtMC90ZXh0cmVnaW9uOmM3ZTlhMmZlMDIwNjQxYWFiZTZmYjhhNTI3Y2RjMThiXzM4NDgyOTA2OTcyMzY_ea0b41f8-f263-4387-af1a-12ec7b319f2a">4.00</ix:nonFraction> to 1.00</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from <ix:nonFraction unitRef="number" contextRef="i49f96e7c8d5e48878ac299da142f760c_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzExODM_c53af0d2-0343-4378-a0f4-b4a3ca875569">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4830065b1af74874a4c52fb3bafa551f_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzExODk_cab6564c-b0d4-4886-883b-046cfd91f824">2.25</ix:nonFraction>%), or </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus <ix:nonFraction unitRef="number" contextRef="ib4c96b9a4f97464e96a052e5709abec5_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzEzMjU_b35b707c-eece-4070-ae81-9396942a7f91">0.50</ix:nonFraction>%</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus <ix:nonFraction unitRef="number" contextRef="ibf265712ad124ba89a2f02239c34e380_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE1MjA_489600e6-930c-4be9-bfd2-a268d95a1654">1.00</ix:nonFraction>% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA as defined by the July 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iec6a486800c04191aabbb99ce2785e6b" continuedAt="i15dd6e82ece24b2c831b46c63767e67b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from &#160;<ix:nonFraction unitRef="number" contextRef="id6e31801eea246ef887ebfaca154f1e0_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE5MzQ_f0dfaf91-316f-41b0-b89a-dd061397dceb">0.15</ix:nonFraction>%&#160;to&#160;<ix:nonFraction unitRef="number" contextRef="i56827768c653452f9319641e79b282e3_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE5NDA_c9332c9d-e013-41a6-9e88-e24fdaa3e237">0.30</ix:nonFraction>%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2020, the Company was in compliance with all such covenants and is expected to be in compliance over the next year. In connection with the February 2020 Amendment, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2NjU_6ba288c0-c2cf-410d-b759-1ae910344701">4.6</ix:nonFraction>&#160;million of financing costs in connection with modification of the Senior Credit Facility and wrote off $<ix:nonFraction unitRef="usd" contextRef="i83699ed312514c98a332a62de3af0841_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2Nzk_18965f97-bece-4710-b25b-e5b03b4f26eb">1.2</ix:nonFraction>&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment,  the Company expensed $<ix:nonFraction unitRef="usd" contextRef="i65fa74c6109b4c1681870661fed5fbc5_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2OTI_09abcc0d-1859-4543-b0c6-15e4cd3eaf4f">3.3</ix:nonFraction>&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i3103df919ce14fd6a69dd88d8c19042a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIxMDI_824ce291-d5b3-4900-a4b3-a39dc8bb063c">97.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIxMDk_1806172b-0928-472a-8a92-c30a8c890fa3">375.0</ix:nonFraction> million outstanding, respectively, under the revolving portion of the Senior Credit Facility at weighted average interest rates of <ix:nonFraction unitRef="number" contextRef="i3103df919ce14fd6a69dd88d8c19042a_I20201231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyMzY_a4106c47-1549-454d-80ed-56a3570fa802">1.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyNDM_052aa2c5-bb93-4661-af87-5638bbb27e48">3.2</ix:nonFraction>%, respectively. At December&#160;31, 2020 and 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyODU_242215db-5853-4159-a259-1c08b9a852c9"><ix:nonFraction unitRef="usd" contextRef="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyODU_dde9c67e-c769-43f3-bbbf-283f77fe91a8">877.5</ix:nonFraction></ix:nonFraction> million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at weighted average interest rates of <ix:nonFraction unitRef="number" contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzI0MTU_d034f992-3688-441f-be83-0841a8bf8d74">1.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzI0MjI_7ba0b2f5-12ab-4d4b-a06a-9feafd0c0f50">3.2</ix:nonFraction>%, respectively. At December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg5NDk_419304dc-2298-4f2d-895e-60ea4b5554f0">33.8</ix:nonFraction> million million of the Term Loan component of the Senior Credit Facility is classified as current on the consolidated balance sheet as the first mandatory repayment is due June 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit facility and Term Loan component at December&#160;31, 2020 were approximately $<ix:nonFraction unitRef="usd" contextRef="i7b21d0525850444caddaeaa48e4a223f_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDkxMDU_dd025116-6d35-425d-aa9a-13579852a82f">98.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabe1597bfefe488e9ef0166c6fc025d0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDkxMTM_10ed25af-cd70-4ad7-8554-648a7b25c1b6">883.6</ix:nonFraction> million, respectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2020 and 2019 totaled $<ix:nonFraction unitRef="usd" contextRef="i8e0a93f507a747b688ad749cb942864f_I20201231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDk4MTY_8aedb020-f18b-4f68-b6d0-103187b9122a">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5e5c954d5edc4790bc0a3e952a5fa55e_I20191231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDk4MzI_6afb22b6-089e-4d4b-9841-fc7d72675466">0.8</ix:nonFraction> million, respectively. There were <ix:nonFraction unitRef="usd" contextRef="i8e0a93f507a747b688ad749cb942864f_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MjM_348e3eb7-8025-40f2-a57a-ec7964bde347">no</ix:nonFraction> amounts drawn as of December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU0MDc_5252e9eb-5234-4e9c-962e-f5aa9a51845b" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Year-ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Repayment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzQtMS0xLTEtMA_59e54dea-e123-4b3c-a0cf-7ca073deab5d">33,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzUtMS0xLTEtMA_2f522f3b-5fa0-4367-bb56-2a7b525a5e39">45,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzYtMS0xLTEtMA_42d4a90e-b261-4598-ac4e-be0d183e416f">61,875</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzctMS0xLTEtMA_d893a6ba-a7ec-4387-8306-78ef77826e5d">67,500</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzgtMS0xLTEtMA_598fad83-49a7-4bb6-a4ad-ce0cdbf95796">669,375</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzktMS0xLTEtMA_adc29018-5880-42b5-a313-763c41713b2f">877,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNTM_facb2556-42e3-4355-804d-2033c22b0bf7">575.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNjk_fb2b92d6-e976-44bb-8e7e-42d1ee6d6249">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNzU_b70f898e-4016-43a9-96cf-d3dc9672064b">0.5</ix:nonFraction>% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $<ix:nonFraction unitRef="usd" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyODE_b1cc6ac4-f9af-4bf1-a49d-3868bf23bb3a">104.5</ix:nonFraction>&#160;million, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is <ix:nonFraction unitRef="number" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyOTc_3099cca2-b770-4525-b524-55f8c7702dec">4.2</ix:nonFraction>%. In connection with this offering, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzMDM_12e163b6-cf0a-4151-9841-8f7aeb0ededa">13.2</ix:nonFraction>&#160;million of financing fees. At December&#160;31, 2020, the carrying amount of the liability component was $<ix:nonFraction unitRef="usd" contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNDE_9aa43b24-a596-49f7-8121-1b5feb9a3a7f">485.9</ix:nonFraction>&#160;million, the remaining unamortized discount was $<ix:nonFraction unitRef="usd" contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNTc_0cf5e8e7-6d17-444d-a655-56759f6debc1">89.1</ix:nonFraction>&#160;million, and the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNzI_f181f51c-8a96-4fca-a7f9-a82acb3f6044">575.0</ix:nonFraction>&#160;million. The fair value of the 2025 Notes at December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0MDk_e5fbb5bb-a352-4680-8238-425ecafa1bdd">638.1</ix:nonFraction>&#160;million.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of <ix:nonFraction unitRef="number" contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0MjU_cd490924-fb6c-4ccc-b9bb-5d022103a1cd">13.5739</ix:nonFraction> shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NDI_e3651ee2-27ce-481b-9cbb-5a80773b7a9d">73.67</ix:nonFraction> per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least <ix:nonFraction unitRef="number" contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NTA_d40c90cc-8e1f-4012-9645-9a4f1c001b12">130</ix:nonFraction>% of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to <ix:nonFraction unitRef="number" contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumAverageConversionValueOfNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NjM_14a7858e-24e4-4176-a433-6e8fdb904dd9">98</ix:nonFraction>% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i15dd6e82ece24b2c831b46c63767e67b" continuedAt="id38632a1f0ac418080247469aa351360"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified corporate transactions occur. As of December&#160;31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $<ix:nonFraction unitRef="usd" contextRef="ia97ea17415c04e59a282e2ba0da43d2c_I20201209" decimals="INF" format="ixt:numdotdecimal" name="iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MTkyMDM_2666dbc4-5a60-4533-8686-eea9c3bb6ef1">1,000</ix:nonFraction>. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at <ix:nonFraction unitRef="number" contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0OTA_f0d88e7e-3958-4acb-a960-7b6b7314d9c5">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $<ix:nonFraction unitRef="usd" contextRef="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:PaymentsForOptionIndexToIssuersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0OTY_bb42dd5b-a45a-4265-bb14-b6eed6e04845">104.2</ix:nonFraction>&#160;million for the 2025 Notes. The Company received $<ix:nonFraction unitRef="usd" contextRef="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1MTI_f801929f-8907-4e28-9649-f71167f960e2">44.5</ix:nonFraction>&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i3493c77a931f4e3ab849649297db9345_D20200204-20200204" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1Mjc_ad4027c0-edde-403f-81b2-2d2a9d3c764e">73.67</ix:nonFraction>, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1MzU_faa377d9-64aa-436f-8a9a-c60aac0a48ff">113.34</ix:nonFraction> for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, the Company recognized cash interest related to the contractual interest coupon of $<ix:nonFraction unitRef="usd" contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1Nzk_0ebff5c1-8473-4ccd-86ba-d3690960c354">2.6</ix:nonFraction>&#160;million and amortization of the discount on the liability component of $<ix:nonFraction unitRef="usd" contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1OTM_6c85a651-f8f7-450e-8184-b25bfa6e1ab9">15.4</ix:nonFraction>&#160;million for a total interest charge of $<ix:nonFraction unitRef="usd" contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU2MDg_8f60c196-9204-4eb5-9491-d12e87367dee">18.0</ix:nonFraction>&#160;million on the 2025 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4MDI_51ad6c43-9dde-4d99-9cee-31b4b6db68e1">150.0</ix:nonFraction> million. The Securitization Facility Agreement ("Securitization Agreement") is for an initial <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:durwordsen" name="iart:DebtAccountsReceivableSecuritizationTerm" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MTc_41a846d1-1a18-47fc-b3c6-ade7bd550b67">three-year</ix:nonNumeric> term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2020, the Company was in compliance with the covenants and none of the termination events had occurred. The Company&#160;had $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:SecuredLongTermDebtSecuritizationProgramCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQzMDY_09d11ac8-de76-4826-85c9-18ad3523b167">112.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-5" format="ixt:numdotdecimal" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQzMTM_1a155a56-5a89-4493-8904-5e4882d8c8b0">104.5</ix:nonFraction> million of outstanding borrowings under its Securitization Facility at a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQ0MTU_2b80fd0f-0939-4184-9720-05cee1920a2e">1.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQ0MjI_8c2d858f-7012-4277-aa67-aa76483b6d47">2.8</ix:nonFraction>% as of December&#160;31, 2020 and 2019, respectively. At December&#160;31, 2020, the total amount outstanding under the Securitization Facility is classified as current on the consolidated balance sheet as the total amount is due on December 21, 2021.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id38632a1f0ac418080247469aa351360">The fair value of the outstanding borrowing of the Securitization facility at December&#160;31, 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="iecc2ed32dcfc40b0983a4a55b9ff5c6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:SecuritizationFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTg1MDc_07cf76b2-3e62-409b-a509-0394e5c54fdc">112.3</ix:nonFraction> million.</ix:continuation> </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_181"></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MDQxMDc_295f5adb-4185-42e3-bd31-83ff50d550d3" continuedAt="i11b8a5cf4df4433b987229fbab72fd26" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i11b8a5cf4df4433b987229fbab72fd26" continuedAt="i9d25d4e8789143469e988e66430fba78"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i9d25d4e8789143469e988e66430fba78" continuedAt="ic69b1cdad1ea41b49ec12db3a5067155"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MTE_fb42cee9-d01b-4997-ba91-7fdf6279fd17" continuedAt="i671428171cd74f85b036630bc11b2dbb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMS0xLTEtNDkwMw_938ec99c-85c5-41e1-92eb-2ff496c27274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68e8212dd194d45aa7eefc82e905835_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMi0xLTEtMA_d2383556-e9b1-4555-9a30-7f08c8637497">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMTAtMS0xLTA_6fbb8b00-29c8-4ad3-a014-5c55c7991526">1.834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTMtMS0xLTE5MDM_fda0b55a-7694-4579-9832-c2d4a6df4582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic68e8212dd194d45aa7eefc82e905835_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMTItMS0xLTA_75c8b83e-12fe-43fa-a22c-3e2c318bcc99">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcdababe54704b90bc657174386789e0_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMS0xLTEtNDkwMw_5750cb3d-237e-4b60-aadc-6accb58422a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMi0xLTEtMA_e032ddef-8ee0-4963-b66c-841424a78701">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idcdababe54704b90bc657174386789e0_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTAtMS0xLTA_ed04262b-3b5b-4219-b40d-96dcdea27914">1.652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcdababe54704b90bc657174386789e0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTMtMS0xLTE5MDM_4e92559d-9744-4e02-a4e9-6fd9eb8417c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTItMS0xLTA_f168921d-a0a5-49d5-99ef-7e0697464971">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMS0xLTEtNDkwMw_642ea148-2ec1-4e45-8013-2e6bb1f8997a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib885eed1bf1b439dbc39829817261b39_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMi0xLTEtMA_c34439e5-e719-43b9-a73a-6e1991567360">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTAtMS0xLTA_62acccba-2a7f-471a-afeb-19489d1b9578">1.971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTMtMS0xLTE5MDM_386ccb37-5caf-4707-b061-c7840a135653">929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib885eed1bf1b439dbc39829817261b39_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTItMS0xLTA_a209c979-486d-4ce2-a66b-ef5367d9b65d">581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMS0xLTEtNDkwMw_0c233132-3043-4b3f-bd82-7179aed18e73">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib208df2927f640368f449fd7a1bab824_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMi0xLTEtMA_154a4e14-cfd0-4fe9-8384-5e00ed5d270e">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTAtMS0xLTA_d8deb8bc-6f24-420c-aeb6-ff19c95526b9">2.201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTMtMS0xLTE5MDM_65b00885-eec0-4015-8853-5bd416942d09">6,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib208df2927f640368f449fd7a1bab824_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTItMS0xLTA_ad42c368-f722-4fa7-b846-765709dc9c60">2,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMS0xLTEtNDkwMw_4b1d1615-ab32-4564-94f8-508c6ca04d2d">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic79dd3445c4749509e1d9ed68b515d6a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMi0xLTEtMA_2f28267f-ebb4-4a07-9bd4-46e67f1508e2">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTAtMS0xLTA_65c27c42-331b-4f7c-8310-46cffecbf5a3">2.201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTMtMS0xLTE5MDM_582ef10c-99ea-4ad2-bed0-834ad6efc170">6,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic79dd3445c4749509e1d9ed68b515d6a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTItMS0xLTA_71f0ac30-077b-4df6-9f34-032b7b5ed726">2,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMS0xLTEtNDkwMw_2491df9f-c507-42f8-8c3f-3fb9c33ad208">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMi0xLTEtMA_15bbbac8-2567-41b9-8bfa-40bba412d3a5">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTAtMS0xLTA_9db13fcd-010c-4713-a2b6-13a2555602ea">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTMtMS0xLTE5MDM_c2e0ae09-6a27-4cff-bea9-26029e6d35bb">7,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTItMS0xLTA_fb723ff2-b6c6-436a-8d1e-cd001bce4754">3,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMS0xLTEtNDkwMw_668d8e9c-2c92-4717-ad86-409e8ef31f8f">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if978c4aaca6e44a4bbe6ada7c5392621_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMi0xLTEtMA_bd4fd4ce-3fc2-424e-927a-31382858c743">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTAtMS0xLTA_86a3b115-607f-414d-a618-19caa6c0313b">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTMtMS0xLTE5MDM_ecf752f1-100a-4da4-bc1c-95fe63f99b96">3,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if978c4aaca6e44a4bbe6ada7c5392621_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTItMS0xLTA_d8135be1-3742-4c19-90be-20af33683f6d">1,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEtMS0xLTQ5MDM_2be8c880-d1ec-4a9f-8b1e-d4b95f1aba71">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aaf1027151e43ceb191ea669249f7e4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMi0xLTEtMA_0e2ab300-660b-4d6e-baa8-444cb744342f">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTAtMS0xLTA_dd7a45c7-fd75-4fd5-a7e9-7cd2fa055eac">2.313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEzLTEtMS0xOTAz_16fd14c0-ce09-4b4e-9c26-5f1acb20db42">16,243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aaf1027151e43ceb191ea669249f7e4_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTItMS0xLTA_c10865ce-8882-426f-a195-c2278df12071">6,595</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEtMS0xLTQ5MDM_febbbba0-e2f3-4046-894f-768d4442b47e">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife3e874c024d4214a79490debf6accc5_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTItMS0xLTA_bdf2f74f-06ed-43cd-abee-bc991dad900f">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEwLTEtMS0w_553a0284-4237-406e-b613-787f86acfe8e">3.220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEzLTEtMS0xOTAz_5998c1ed-34bd-4825-994a-930cc15990a5">9,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife3e874c024d4214a79490debf6accc5_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEyLTEtMS0w_ba7e4d1e-84bb-4b37-88c1-6bcb52a7b39e">5,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEtMS0xLTQ5MDM_1c2cade7-b278-4dda-a666-85fc2805b0c6">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTItMS0xLTA_e16c63dc-b358-4902-af32-4d937585a27b">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEwLTEtMS0w_75741633-2542-48e3-a04d-b6895acfe32b">3.199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEzLTEtMS0xOTAz_c1686a76-3ce8-44dc-b30e-49092d76de55">9,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEyLTEtMS0w_ec7bfa71-558e-43d8-8d6d-67dc080d24c2">5,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEtMS0xLTQ5MDM_3ed333c1-db44-41c8-9b8e-661f8cab70d6">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTItMS0xLTA_7d8dd247-c025-46a2-a1e4-834c39411247">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEwLTEtMS0w_23ed0576-b42d-49ad-aabe-15e637096c36">3.209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEzLTEtMS0xOTAz_80f2dd27-e612-4c07-b50a-83e10f449783">9,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEyLTEtMS0w_52c17d12-ba8a-49fd-9d13-00cbda79dc4d">5,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEtMS0xLTQ5MDM_bd3a442b-eacd-4e07-874c-1f49a995c66a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bb8b17ef654169a3a82f9faae899f8_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTItMS0xLTA_d318e780-41f3-4ab3-a9e1-65ff626d6a4e">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEwLTEtMS0w_b2771c42-c350-47ab-b6cd-1ce080b216de">2.885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEzLTEtMS0xOTAz_d691abfd-6c88-4107-ab6e-4eae55858166">10,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66bb8b17ef654169a3a82f9faae899f8_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEyLTEtMS0w_38a88d12-5ad7-4de6-8c1f-ef8fe622e5ab">4,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEtMS0xLTQ5MDM_c1d0573a-4c3c-44e5-b058-bdd52a7a1053">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTItMS0xLTA_c415b015-8121-427b-963b-4ec29848a0c3">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEwLTEtMS0w_5e3920fe-5fef-409e-910b-cfc4645bb802">2.867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEzLTEtMS0xOTAz_999f236f-b1d3-4930-a644-c05532bfc019">10,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEyLTEtMS0w_74aabefc-8eef-4a40-b4c1-b031a7ec5cca">4,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEtMS0xLTYwMjY_d7ce6c1b-6819-4e54-934a-59ea7f529924">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb9c27423b0432ca325ac7ec1736f68_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTMtMS0xLTcxMDk_65460907-322b-43f4-b0c3-e43771efe537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTExLTEtMS02MDgz_33ad8908-7ea6-4eaf-858a-a87daec141b6">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEzLTEtMS02MDU4_cefd447f-1012-45eb-9c3d-8bffca7723f3">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb9c27423b0432ca325ac7ec1736f68_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTE1LTEtMS03MTEy_22124be6-0e02-4232-b694-c2e4d8ed0c08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTEtMS0xLTYwMjY_8f410105-b294-4670-885a-26b72bd91e09">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c52c77498d84321911b79b005966e55_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTMtMS0xLTcxMDk_e6143f71-41ce-44e1-887a-c48de2220057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTExLTEtMS02MDgz_32c16598-6b6d-4ee4-aeb1-c17d85556b5e">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTEzLTEtMS02MDU4_863c375a-cc18-4167-8bb6-ed7e5cc932e4">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c52c77498d84321911b79b005966e55_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTE1LTEtMS03MTEy_c2c38d4b-db31-4412-ab11-f031b08d46b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTEtMS0xLTYwMjY_bb1b3abb-b44e-4433-a41d-885093aa9f4f">225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f7517e74e44d0094f93c18a90e6827_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTMtMS0xLTcxMDk_61b7139f-28e8-4b6b-9e54-7b47b5d00c5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTExLTEtMS02MDgz_c1dae1de-0a19-4a8f-9050-ca735a23d5bb">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTEzLTEtMS02MDU4_76223587-b132-4421-b24d-99c5bd6fad9e">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f7517e74e44d0094f93c18a90e6827_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTE1LTEtMS03MTEy_9ddb296e-750e-4423-a174-f2dab65e65bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTEtMS0xLTYwMjY_9886f641-e976-40c7-96e2-3a59f1e66290">225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c6f3f64c6944fab4ab95454984b3ac_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTMtMS0xLTcxMDk_0565cdb3-b720-4d5f-ba53-4e2aaced96dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTExLTEtMS02MDgz_ec55ac0a-d563-47d1-b7db-4c3d428e448f">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTEzLTEtMS02MDU4_f1d7e30b-7fd0-4bf3-92e6-6a6715001cea">679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c6f3f64c6944fab4ab95454984b3ac_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTE1LTEtMS03MTEy_00830ba8-112b-49fb-ab35-e729ab6bae4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7848c2a813504ed493eda06395e04483_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTEtMS0xLTYwMjY_ff101b7e-5dcb-40e4-ab08-ae918bd09fe9">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTMtMS0xLTcxMDk_6941c7c3-9b84-4ad9-a431-f1d8d0589d4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7848c2a813504ed493eda06395e04483_I20201231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTExLTEtMS02MDgz_9d7e1b0e-5fdd-4f22-8e23-3752c819718a">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7848c2a813504ed493eda06395e04483_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTEzLTEtMS02MDU4_58f031ae-7353-438b-80c1-ba3912097d44">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTE1LTEtMS03MTEy_b9c55cf7-58dd-4ea5-a9df-3dcd4085f27b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total interest rate derivatives designated as cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51105541e884bc88363f2c16b76284b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEtMS0xLTQ5MDM_f69e3c93-0fb4-434c-b1bc-11e9532a1f71">1,875,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21c8a2fa5834558b130cf3274625a05_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTItMS0xLTA_08009db7-4d59-46ec-a3a8-0dbc74b0104c">1,325,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic51105541e884bc88363f2c16b76284b_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEzLTEtMS0xOTA3_0ceb5c6f-890c-4f80-bdc3-06f9596007b2">93,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id21c8a2fa5834558b130cf3274625a05_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEyLTEtMS0w_13366676-4c34-4121-ac46-56e538894172">45,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i99730906a9c94d02acef61305dbefc02_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1MDk_a42ccee6-7fef-4450-bbcc-21d6d5e66c2f">9.7</ix:nonFraction>&#160;million to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="id66609e8dad741d88f6e535da2241aee_D20201001-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1MjQ_d0e3b2fb-c281-4ea8-bbb4-e5d7eab47215">0.2</ix:nonFraction>&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations. The fair value of the foreign currency forward contracts was $<ix:nonFraction unitRef="usd" contextRef="i99730906a9c94d02acef61305dbefc02_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1Mzg_c304cec0-707e-405c-90dd-80079837677f">0.2</ix:nonFraction>&#160;million as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic69b1cdad1ea41b49ec12db3a5067155" continuedAt="ia3663039b64943578ab5c118761f1299"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i76071dabaf7a463f9b7a7648e7452343_I20171002" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM2Njg_a618d49f-ca45-4ca6-872d-697de776e70c">300.0</ix:nonFraction> million equivalent to <ix:nonFraction unitRef="chf" contextRef="i5431ea3c598245fb8a0ff97ff620359f_I20171002" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM2ODU_916f8455-7f18-46b2-90bf-d986814713b9">291.2</ix:nonFraction> million of Swiss francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i80156bc966174b7491215c549eab3021_I20201221" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzkzNDU4NDg4Njg0MDc_86226aa3-f2b1-43f4-b39b-33e7dd4f0aa9">471.6</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="chf" contextRef="i80156bc966174b7491215c549eab3021_I20201221" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3Mjg1MDI_731d933e-d3e4-4ea2-8922-ea2445535e27">420.1</ix:nonFraction> million of a CHF denominated intercompany loan into U.S. dollars. The CHF denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><ix:continuation id="i671428171cd74f85b036630bc11b2dbb" continuedAt="i9cba34e73f0b4c509cc1501451e942f1"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.897%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd2b8368f50349cf9cd91e15a4474d2e_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTYtMS0xLTA_824e7ae6-efd7-47be-84f3-fe0826ef627e">1.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="idd2b8368f50349cf9cd91e15a4474d2e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTktMS0xLTA_70fb3c6a-a23e-4123-95aa-cb73a84d834c">48,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22b15ef56d7f41dea561d0d6c48e9900_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTExLTItMS00OTEz_197ba609-ff98-4e89-9b62-b481ab536413">4,335</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib92168257e704b7ba6330782524c310d_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEzLTYtMS0xLTA_8d48027b-cb6a-461a-8799-945544b37a4a">4.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92168257e704b7ba6330782524c310d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEzLTktMS0xLTA_3a4f7868-202f-48c1-8747-26a94e7af858">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTYtMS0xLTA_a7ebcadc-b272-4eb4-85cf-804f4bd23c22">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTktMS0xLTA_575df18b-6a53-4d6c-b36c-5d55c4607f4f">145,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d930dc104ea4e35be06d768b767f67a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTExLTItMS00OTEz_9e46e20f-c11d-4950-9d15-01437f74cd91">11,262</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide7cbf63723a4f00aabbbd3146cc357d_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIyLTYtMS0xLTA_7b9f9ea6-2a89-47ab-a2c6-a86d0aa49019">4.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7cbf63723a4f00aabbbd3146cc357d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIyLTktMS0xLTA_a17d0bad-b2d5-4124-995d-f7b2282480a2">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f663fff566d4cffa41b7ce376813595_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTYtMS0xLTYxMzE_b7036ff2-a12a-40f3-b6e1-1437f57803d1">3.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i8f663fff566d4cffa41b7ce376813595_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTktMS0xLTYxMzc_9263d05a-7905-4b03-b9e1-c02452070a3f">420,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e053946dbfa4feb8860666b23d97916_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTExLTEtMS02MTQ1_0de53e7e-1aef-41fd-a2bb-e5e21dc37ef2">7,843</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa2afcc89a124c74a254bd7642ca84b5_I20201231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE5LTYtMS0xLTYxMzE_ef512740-2119-46c7-9a57-4bd5f730c06a">3.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2afcc89a124c74a254bd7642ca84b5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE5LTktMS0xLTYxMzc_6b1941ca-9662-4c25-95c4-f4f953f985da">471,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0daaf7584842a682f9d005209fecb7_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzI0LTExLTEtMS00OTEx_13c44eb8-aeeb-45e4-a23d-0a9db82f05e6">23,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="iddf34cd2c7ad4523bd4a9e5bdb8a433e_I20201002" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4OTU2MDQ2ODE5NTM_499cc75c-0deb-49b3-8115-b260a38b7135">33.3</ix:nonFraction>&#160;million. As a result of the settlement, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="ica2f97b5e5ef49c59e8f51a58cdce3c9_D20201002-20201002" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4OTU2MDQ2ODIwMjA_91eccb94-9c8c-43ef-990e-cbe4e524e8d5">0.3</ix:nonFraction>&#160;million in other income, net in the consolidated statement of operations.</span></div><ix:continuation id="i9cba34e73f0b4c509cc1501451e942f1" continuedAt="ibae8cc6ae8024b1994a5030aee07f2d3"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.897%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95c4cb8967c4415791e71b38671c9b83_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtNi0xLTEtODE4Nw_4a825071-dac3-4fb2-b538-80ad27ee4a97">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i95c4cb8967c4415791e71b38671c9b83_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtOS0xLTEtODE2NA_2c8fe3b4-0e35-48a6-b853-5066e801584b">32,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id36e756e95b544b0a0fb7875d3ba1806_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtMTEtMS0xLTgxNDg_e78d9571-5fe4-4671-9330-125f52a4c897">101</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92773db83f15438fafd773f6fb0a4f69_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzQtNi0xLTEtODE4Nw_929df526-5eb3-401a-8151-23c9266880f6">4.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92773db83f15438fafd773f6fb0a4f69_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzQtOS0xLTEtODE2NA_fa9632a7-57a7-4413-98ed-b770f1547369">33,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTYtMS0xLTgxOTI_dc4efdf6-3bf9-48cc-936c-aae81991443d">1.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTktMS0xLTgxNzc_779153ef-a534-41c6-8b6c-70edc11ab1d9">48,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07c262926c3642dc99cf046a2be2277b_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTExLTEtMS04MTU0_23983ccc-2d65-4836-b60d-28b5211f2401">119</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11ae94eb73344fe4baa3eb613e126fd6_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEzLTYtMS0xLTgxOTI_c65c15fe-f2d4-42d4-a4ec-f6d6c1ea4b25">4.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae94eb73344fe4baa3eb613e126fd6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEzLTktMS0xLTgxNzc_93cceb94-6223-4468-a475-c1285eb8bcb8">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTYtMS0xLTgxOTc_467d6356-23c3-4d17-aa46-2923a27eed4c">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTktMS0xLTgxODI_be95c9d4-b7b4-4f18-b9a3-6b874dab9a9b">145,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7b0af6afdc4c7cb5bb5d039bd634a4_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTExLTEtMS04MTU5_ee024f8b-3f5a-4f0b-956b-d0c967e0b73f">289</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73bd05d1164d4fcab0652f994e052939_I20191231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE2LTYtMS0xLTgxOTc_b3d88cda-81c6-485b-a195-b6fcc362ba6d">4.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73bd05d1164d4fcab0652f994e052939_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE2LTktMS0xLTgxODI_5fd3eb90-515f-4ffb-8166-5722f75d8ca1">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE4LTExLTEtMS04Mzgx_b5322313-5115-4a2c-b788-27cc8e165f64">509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia3663039b64943578ab5c118761f1299" continuedAt="idc972ceed2dd4194a93371ecf10be0fa"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMDA_adb5ae2a-47dd-4f2d-8dc1-fc3c74618bef">66.7</ix:nonFraction>&#160;million. The original maturity dates were October 2, 2020 however, as the intercompany loan settlement was consummated, the cross-currency swap was settled simultaneously. As a result of the settlements, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="ia57db2cc4d5949e0b6b05067d6981e47_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMTU_a91bb964-86e9-4f22-a1f8-c28e9b3224f8">0.4</ix:nonFraction>&#160;million in other income, net in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2020 and 2019, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss of $<ix:nonFraction unitRef="usd" contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzUzNTY_8c468750-4c7f-4b81-a996-6dea50b603f3">21.7</ix:nonFraction> million and loss of $<ix:nonFraction unitRef="usd" contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzUzNjg_8a242458-cbb9-4c5c-afc6-30e907cdf361">4.0</ix:nonFraction> million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation to offset the gains or losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded a loss of $<ix:nonFraction unitRef="usd" contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTQ1NDM_fcc2d2ef-e472-43bb-b314-2671cc12c8ed">17.1</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a gain of $<ix:nonFraction unitRef="usd" contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzU2MjY_13603da6-90c1-44dd-a635-a9e3f6546b28">9.3</ix:nonFraction> million, respectively, in AOCL related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company recor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ded gains of $<ix:nonFraction unitRef="usd" contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTQ1ODk_4c7c318c-1efa-4e20-af03-e02fdb4caba5">5.8</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzU3OTg_03704b98-d301-4084-8ecf-8e7739f4c759">7.0</ix:nonFraction> million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2020 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i48478e34f29c4b82be39b744c2f0b79c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzYwOTE_382a049c-c74e-4bb6-8a12-221e2b1ba0eb">3.3</ix:nonFraction> million. As of December&#160;31, 2020, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div><ix:continuation id="ibae8cc6ae8024b1994a5030aee07f2d3" continuedAt="i7851618563da4a95acb179d6a6c89ec9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7e15c52a94e4723b18f36e548f5062b_I20201231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtNi0xLTEtMA_71ce51b8-782a-47c2-9621-cbc468621a51">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia7e15c52a94e4723b18f36e548f5062b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtOS0xLTEtMA_6ee5cd88-ec45-4b89-9c88-bc8128578158">44,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf914a28f9c1424fb32fb39c3ed8a539_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtMTEtMi0xLTQ5MTc_cbbe832a-f26c-47ca-9e97-71cc3a5a5489">1,884</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzQtNi0xLTEtMA_71612f67-7e4d-495a-ba25-d8f8302a0f54">3.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzQtOS0xLTEtMA_c593c3e0-9c90-4b22-87b0-58033f4622f7">52,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1bf7eee990834d3a938377a8f728b7a0_I20201231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtNi0xLTEtMA_1ea31a55-8742-48ac-b62e-babc70b65fc8">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bf7eee990834d3a938377a8f728b7a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtOS0xLTEtMA_28a891c2-0ea3-431b-995f-25baf8986058">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54146d4c72e64bd8ac7ba073c9652d05_I20201231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtMTEtMi0xLTQ5MTc_040a2def-7620-479e-bac6-dc7d5174d296">450</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34576a32def44b2f86955da60a86e5a0_I20201231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzctNi0xLTEtMA_96478712-143a-4173-b491-19b82bede99a">2.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34576a32def44b2f86955da60a86e5a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzctOS0xLTEtMA_f0f215e7-0df8-4c68-85d4-10f130eb4065">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibcbce85f34d34671b93acf1d523b3e35_I20201231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktNi0xLTEtMA_157a0e8e-c902-4bc2-b232-898ab4f3be46">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibcbce85f34d34671b93acf1d523b3e35_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktOS0xLTEtMA_0546cc83-453c-4c23-bc41-03ac682b067c">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea77615dc3f4d0d97ccc1e74db31850_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktMTEtMi0xLTQ5MTc_547d1c43-c359-40c6-bff3-72c4600e01cd">92</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2309435ccb874b0c9e92d1729715a5ba_I20201231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzEwLTYtMS0xLTA_00fc8a71-61d2-490a-a256-e5278edebd2b">2.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2309435ccb874b0c9e92d1729715a5ba_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzEwLTktMS0xLTA_25623d47-18be-4c06-bc2f-d0fa6523728e">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f2e3f206fd240638c356c5f147eb7cb_I20201231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTYtMS0xLTYxNzA_ce9d78f4-2873-4225-a02b-7830a8966cce">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i3f2e3f206fd240638c356c5f147eb7cb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTktMS0xLTYyNzc_37505f84-9b71-4eb8-aef4-cf0e790c88ff">222,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7d463a647b74dbbac5a09c81ac5bbf8_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTExLTEtMS02MjY2_fb4f1db7-f4f9-4674-a06a-42782a2c09e9">3,794</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib76b40dac61b4789a4966e9e25feb6e5_I20201231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE5LTYtMS0xLTYxNzA_bdf89ada-7720-4b8f-92aa-1aa528576d7d">1.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76b40dac61b4789a4966e9e25feb6e5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE5LTktMS0xLTYyNzc_b7107096-a7ab-4bbb-9c9a-4a4b15d1cf3c">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTExLTEtMS0yMTA5_a59c7734-a77f-476e-9db7-8175db1c8d2e">6,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMjk_0c954a2d-7d7f-4244-8908-2ec5a8549a12">167.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="gbp" contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNDU_7c3b91d4-1766-4849-ad75-72827b3fae5a">128.3</ix:nonFraction>&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNjA_c8fecbbd-892a-4b61-bda6-da4071578201">7.8</ix:nonFraction>&#160;million in AOCL.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="idc972ceed2dd4194a93371ecf10be0fa" continuedAt="i437d623f3b174d54ab370e923dc362e8"><ix:continuation id="i7851618563da4a95acb179d6a6c89ec9"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82ac6be413b64bc6bf1f3f04ce303568_I20191231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtNi0xLTEtMjEwMDY_dcf6b9ff-47e5-420f-b18b-4d2a82cfdf86">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82ac6be413b64bc6bf1f3f04ce303568_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtOS0xLTEtODQwMg_2c25599d-bebb-453c-8179-97d7ff118d4b">44,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28578860967b41c294978d5e0297abf4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtMTEtMS0xLTg0MzE_8604ff52-b4c7-44c3-acbe-f1a8c92d585b">2,459</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd250c3fbece43cca3832888e0a8c8d4_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzQtNi0xLTEtMjEwMDY_0f3efdfa-f0f3-4d0f-8ac4-9934fa0b976f">3.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd250c3fbece43cca3832888e0a8c8d4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzQtOS0xLTEtODQwMg_fd5e87fe-7bb2-4677-ba18-f90867a30314">52,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if88e234e4f3a4e5c85212a69688f3faa_I20191231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtNi0xLTEtMjEwMTA_c7d47658-0f01-4a4e-9d58-9054c29a6138">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if88e234e4f3a4e5c85212a69688f3faa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtOS0xLTEtODQxMA_3c17036b-1f18-40be-81a2-acaf2cf64a2f">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91abedb43abe4a5ea0f381a1428eaea3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtMTEtMS0xLTg0MzQ_614a5479-a1cd-4151-8586-08e39afa4e36">3,087</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzctNi0xLTEtMjEwMDg_3eecf4b1-fee1-4528-abd4-de31f0a85f74">2.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzctOS0xLTEtODQxMA_3f48f5e6-68d6-46ba-a395-c9980bc6b81a">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf11bff9c64b4754a527c74b53924753_I20191231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktNi0xLTEtMjEwMTI_17feb1e7-41ae-460b-8562-7009a97df80c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf11bff9c64b4754a527c74b53924753_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktOS0xLTEtODQxNQ_46416957-b559-4edf-ab4b-24269aca80c5">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14091819c033463cad6998b7b746e5fc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktMTEtMS0xLTg0Mzc_f036d051-f7d5-4022-8140-35c3c9de188d">2,032</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea2b1c6283949ceaa1fd9a23141822b_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEwLTYtMS0xLTIxMDEy_267627f0-44a6-4e25-822b-c10f5ad091bd">2.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea2b1c6283949ceaa1fd9a23141822b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEwLTktMS0xLTg0MTU_1a7ef4d9-5747-4788-be7d-721eda8acb51">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTYtMS0xLTIxMDE0_88be7338-4114-4349-b048-ec136db61cd4">1.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTktMS0xLTg0MTg_11b3a003-e124-462c-a969-7dcd8def1632">128,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55642fef06114bbbaa0e9b54ee498dcc_I20191231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTExLTEtMS04NDQw_097a1d58-97a7-4d21-bcc8-ac97b8821d51">154</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEzLTYtMS0xLTIxMDE0_493c40a9-b410-4230-b09c-7cedf346558d">2.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEzLTktMS0xLTg0MTg_5e1c6682-6aaa-48e3-8759-8985951983ef">167,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2518cd8291254b57a41eaca854f8ee2b_I20191231" decimals="4" format="ixt:zerodash" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTYtMS0xLTIxMDE4_b9ca4030-6e67-40a4-bb97-aae64388df1d">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i2518cd8291254b57a41eaca854f8ee2b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTktMS0xLTg0MjI_2476815a-e258-4a65-8bcf-8f234e507db8">165,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983ae52a561a4268998a536714c2506d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTExLTEtMS04NDQz_69246346-7821-487e-b815-48184762b937">1,221</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d848444c85b4f3aa4d2887527d13238_I20191231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE2LTYtMS0xLTIxMDE2_61b67f46-b5a6-4e63-8bed-a25ceccd080f">1.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="i8d848444c85b4f3aa4d2887527d13238_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE2LTktMS0xLTg0MjI_83fcd3ff-128d-4bbd-a937-778d15af1bcc">128,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788742cc668e4a9e99a0ea702ad3d42e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE4LTExLTEtMS0xMjAxOQ_6038e26d-6ad7-41fa-9132-77ebeb74f9fb">8,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company settled a cross-currency swap designated as a net-investment hedge of with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i788742cc668e4a9e99a0ea702ad3d42e_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTgxMTM_ae4cdebb-afe2-48c8-92ef-a2220c6b03cb">30.0</ix:nonFraction>&#160;million. The original termination date was September 30, 2021. As a result of the settlement, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTgxMjg_4c0a3c7c-8326-4783-9980-7be92d81ca06">1.6</ix:nonFraction>&#160;million in AOCL.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2020 and 2019, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUyNzE_22385d12-138d-4d4e-a155-3aea91d39564">14.9</ix:nonFraction> million and a gain of $<ix:nonFraction unitRef="usd" contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUyNjQ_115f7238-f014-4c30-8ea9-f512ea65314f">20.5</ix:nonFraction> million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzMzU_0e630ca2-6fc1-4b47-a4fc-d22df2d35400">7.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzMjg_b6affe47-2e2a-47d4-a039-532a9c6e0e70">9.6</ix:nonFraction> million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2020 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzNDI_e855f121-68b6-4ba4-99fa-40bc5e44f99c">3.4</ix:nonFraction> million.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i437d623f3b174d54ab370e923dc362e8" continuedAt="i32f8a4818b7343859e79b53dbe994f83"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MDk_ccc0fc88-b361-49bd-b262-8c9795ce15ae" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a622203039f4ebc8dabf0964e1920eb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzYtMS0xLTEtMA_69c251e5-7275-44c7-b0f1-54a2d2e65476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8694924571d49acaf88ce860616d9a7_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzYtMy0xLTEtMA_8098de71-fbf1-4640-a3b7-fb719997fbbb">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f485cf6d3cb439c9abb0271be10b04a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzctMS0xLTEtMA_4ebbb445-4f99-446d-8081-bdefee250e53">7,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a498ed728646b99350fc4768d04511_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzctMy0xLTEtMA_9fbfc648-0c20-4348-be71-3154e0e2abbb">5,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8596a5dc2a9407fb48a1259cc8b60a2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzktMS0xLTEtMA_560ae77c-a009-42d0-b6f4-a515a2c184e2">5,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f26f3f5ca842b9bcfeb28c25b7245d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzktMy0xLTEtMA_bf39e01e-acb1-4ab5-8bf2-1f7abe1827e0">7,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc58818c04f441f891165122cbb127a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzEyLTEtMS0xLTA_43a9ec95-5d64-4d3f-977c-b865b0e3896e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3d3833f9944c22a925b20ef544e53c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzEyLTMtMS0xLTA_b01baf93-fd9c-460e-af61-c1442d6c2f0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b73e364f8cb4e7097673c44db096076_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE1LTEtMS0xLTA_c186cfb0-d99c-4a19-84dd-ad11c575d218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df7db3ed850456e8523c316fdcffbe8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE1LTMtMS0xLTA_e1bb8f9d-3354-4e33-a317-526539310094">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f198bdda2744619e39ee6d06daf04a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE2LTEtMS0xLTA_acb9cdc2-f918-4098-bf60-c143875e6ce9">12,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd87cdab9fc241a1834dc1c837593ca0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE2LTMtMS0xLTA_7358bacf-ddf8-40e9-a95e-ddcd9534c19d">16,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0efb49fa37042d0a1c94e20bee2ffad_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIxLTEtMS0xLTA_25742978-dd0a-4a03-8687-2490bbd1cfd6">22,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cfb7d1b2ba444ab717d976ea2463a8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIxLTMtMS0xLTA_2c133509-0291-47cf-9200-cd4180ef6e49">6,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf7770e24164a6cb82df37fedffd4dc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIyLTEtMS0xLTA_efa9ee4d-ffaf-4deb-b2d7-dfe1cadb7129">4,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f21d2308620492c8147ea5fb1a29c9d_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIyLTMtMS0xLTA_2143d1bb-c6be-4d4b-a864-629c1c8316c7">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dacd48e9fb84225a7df20fc991135c6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI0LTEtMS0xLTY3NDE_12b116cf-8e10-46e0-bbcb-8583ddfd59e8">1,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e3ca927bf2472499ec316b98adc47c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI0LTMtMS0xLTY3NDY_d26091cd-5ea4-4a9a-9118-b18d47f414d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60dcf124861c4dcd8c60d1b9a2d582cf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI1LTEtMS0xLTA_0af18620-04eb-42bc-9199-fca61e37ce2e">71,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a69f1e2f244056a1abc1ef23d1d66e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI1LTMtMS0xLTA_724d9cee-1a2b-449c-8a01-b746a363951e">38,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id965015cdd944376a9330f2a1a1b4e90_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI2LTEtMS0xLTA_4522cbcc-85a4-4240-bcd2-b3ebc745f68e">26,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d6723512224dd2a550d187cc37550d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI2LTMtMS0xLTA_35fa106f-fb9c-47b6-9c46-57fb58cd9a54">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81895cd4fe274608b53fe6fac2745d58_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI4LTEtMS0xLTA_0f9113ae-d12c-4e55-b4e8-d988c00f676d">9,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43732e30fc6543ff8f68d243116e4edb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI4LTMtMS0xLTA_5218bd07-50e8-4733-bc1e-ab27d87d9295">2,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative designated as hedges &#8212; Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f198bdda2744619e39ee6d06daf04a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI5LTEtMS0xLTA_b382d00a-16ee-4b1b-b912-f18148fb7115">136,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd87cdab9fc241a1834dc1c837593ca0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI5LTMtMS0xLTA_fbf86230-0feb-4ede-98b4-17a88f60c4d2">53,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt">At December 31, 2020 and 2019, the total notional amounts related to the Company&#8217;s interest rate swaps were $<ix:nonFraction unitRef="usd" contextRef="ib70bb386c50747c78872c44b364b546c_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNzQ_7f01ef8f-adbb-4fae-95d6-43f8105f01ca">1.9</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i31f677197bca449f96127ace53983925_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyODg_8c54a48a-7570-472a-94ee-c45e876b7cf5">1.3</ix:nonFraction>&#160;billion, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:31.5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i32f8a4818b7343859e79b53dbe994f83"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MTg_ab664587-75cd-4a97-bd2c-d4f980f35adf" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statements of operations during the years ended December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:26.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac16087789404550974baece7b19f37c_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtMS0xLTEtMA_e16a4a12-06cc-4619-b5bf-eecfff3e4fb0">45,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtMy0xLTEtMA_44e66347-9dd1-48ba-b5d9-eece24e105fb">64,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtNS0xLTEtMA_54018e76-ebbf-4af3-85b1-c56bbf1ea76c">16,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd343399440746e3bd50a65789b34828_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtNy0xLTEtMA_37bb0580-2014-4aa3-8c15-0f6e47a4c416">93,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cfdd65748d4ca59460e1d27696d43c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtMS0xLTEtMA_1ba4f50b-fc3f-4490-af72-8870636806ab">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtMy0xLTEtMA_67d210fe-ff53-4fbc-843b-d2fb7d26c1e6">17,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtNS0xLTEtMA_ec2d6184-645b-4654-af81-68efbbe49ac4">15,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1c34edcc03241479e1fdf702a89833c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtNy0xLTEtMA_d5f104bc-68ec-40ff-8b14-be9b1d20c8af">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a6eb3108674eb19a2f94ab9501e524_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctMS0xLTEtMA_bee72e39-173e-43c3-9a49-5975a6adb02c">10,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctMy0xLTEtMA_be41dd74-b863-4a49-9296-f0ed329ae45a">14,911</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctNS0xLTEtMA_3ef1e93d-9c03-4e0f-bb68-3a1c529faacf">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25f07babdbf146d2bdd61ee3648d7f8b_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctNy0xLTEtMA_3394f1f3-59f3-429d-8a83-f7e997dba421">12,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtMS0xLTEtMA_48d8a86f-c5d9-4709-a01f-b28370ba527d">34,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtMy0xLTEtMA_334ce07a-0325-4186-8f81-2d6ab0ecbefe">96,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtNS0xLTEtMA_f50c8616-8e07-4110-ae23-c4ff4b174ed8">24,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c32a29f20594ea08849b5c78a01c303_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtNy0xLTEtMA_4cb737ca-0969-4f72-8754-383f28e8d926">107,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b8d6aac1514b89b77c76b4631e8a4d_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTEtMS0xLTA_6d4bd751-dbfa-4ed5-bbd1-b1c1cd03f63f">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTMtMS0xLTA_2b0b6fef-52ac-4d0a-9bd9-186da6518f8e">43,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTUtMS0xLTA_8b95c76a-c9e1-4160-a1e3-76627c02d4dc">2,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac16087789404550974baece7b19f37c_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTctMS0xLTA_97f7b070-e80f-4e07-9b7a-7908e9fc3ecf">45,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e783237cfd44078b28b484e0a4a54e9_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTEtMS0xLTA_2342e2bb-b72d-4289-af47-049a02d519e9">6,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTMtMS0xLTA_e026a2ed-77fb-482b-a8b0-0245fbab6070">9,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTUtMS0xLTA_1e93f613-f8b8-456e-89ed-e98056e81ef2">2,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cfdd65748d4ca59460e1d27696d43c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTctMS0xLTA_d7f85491-25c0-414f-8928-7f9db38824fb">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21a72c6dbaf94f4986204acdd33b9437_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTEtMS0xLTA_646ff5fd-a202-4ead-889a-bbf37dcda406">632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTMtMS0xLTA_7902dde9-ecdb-4477-9afa-6c91d4f6fa97">20,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTUtMS0xLTA_931f5269-acb4-4dbd-ac85-6569888a5f8b">9,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a6eb3108674eb19a2f94ab9501e524_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTctMS0xLTA_ffb34260-00a2-4e92-87bb-e7c2b2c68e31">10,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a4bc84478844f9292b2a97d07b3b406_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTEtMS0xLTA_2245a7db-0faf-47f5-af41-658ad802daca">6,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTMtMS0xLTA_79aafd7d-fcd4-41b1-a399-030a73e7dd0e">13,671</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTUtMS0xLTA_3edcac70-0beb-4f8e-a469-2b7cdd6e8fb2">14,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTctMS0xLTA_177cddab-b05d-4ccc-b243-c10e9f2c087f">34,739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_184"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjk_cb09cb34-0a89-46b7-b88c-7784e92a4eb5" continuedAt="id59d57e8f4ae4faf82331298716ceeec" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS </ix:nonNumeric></span></div><ix:continuation id="id59d57e8f4ae4faf82331298716ceeec" continuedAt="ia28742e9515247a8bb640b0fef2c321c"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;<ix:nonFraction unitRef="reporting_unit" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzU0Ng_98fd4294-765f-424a-b933-d2ef9a3734bb">three</ix:nonFraction>&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of its <ix:nonFraction unitRef="reporting_unit" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3Xzc5Mw_98fd4294-765f-424a-b933-d2ef9a3734bb">three</ix:nonFraction> reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia28742e9515247a8bb640b0fef2c321c" continuedAt="i6ad0c4f6e5ae49ffbac802a5f7f77edc"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to perform a qualitative analysis for its three reporting units as of July 31, 2020. The Company determined, after performing qualitative analysis, that there was no evidence that it is more likely than not that the fair value of any identified reporting unit was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjY_44608630-7fc2-4210-a64f-dc9ac4803d07" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2020 and 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d9addf58ff4b909342306f36c7c6c5_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtMS0xLTEtMA_82b09dff-1150-42a7-bceb-4685a268996a">625,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf741411a24e4f0ea99ed3515168dfcd_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtMy0xLTEtMA_394cbbe7-bb8e-47b2-9fe0-c3be30f81abe">300,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtNS0xLTEtMA_f639c161-1e6f-4e41-be80-fbfedf2baaaf">926,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkis Acquisition</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46eb1c774ef46438bc4de7a317c1c18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtMS0xLTEtMA_46d6e697-94f4-4311-a610-a1ff100338eb">27,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c81a038dd442ef966fb0c16bf36274_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtMy0xLTEtMA_ccd2a63b-29a4-47b9-9c78-698aed2bdf68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68056af4a5754484b976b39412544f18_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtNS0xLTEtMA_2fe39f2c-665b-4d8b-a20c-5032ef0901c1">27,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctMS0xLTEtMA_21515d10-291e-4667-a3ac-0e731fab4ab4">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctMy0xLTEtMA_ab3c1ce7-42b0-4977-a247-fc5ecbf96fb3">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctNS0xLTEtMA_a4cf9ad6-d59b-4cac-82d6-d1c992f57897">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79dcb769cedf45fd8ca2b400d2d5b642_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtMS0xLTEtMA_951d6f98-d8e9-4621-a526-66785618ae8c">653,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9eec322417b4498975fcd6677b0b74e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtMy0xLTEtMA_f7108902-2c31-42a2-9c4e-2a98c885f246">300,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtNS0xLTEtMA_cae7d252-dd79-4ff9-be14-9cb78c7ec979">954,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMS0xLTEtOTcxMA_85a467cb-aa49-49d6-84e5-ba30b03be420">18,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMy0xLTEtOTcxMA_dd509945-a802-4641-9c8d-87b035436a76">7,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktNS0xLTEtOTcxMA_091d9efc-34ec-4de8-9402-640c1d1911d1">25,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale (See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMS0xLTEtMjMyMw_8e8b5bce-96eb-40cf-853d-7d20d22be5ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMy0xLTEtMjMyNw_e8a1a1c6-448c-4f68-9a56-f9b040e0bfb4">47,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktNS0xLTEtMzIzMA_b479621b-3f6f-4379-a078-8dfbc56cb789">47,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6dbc8b92cd747a69077527fcede8db9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTEtMS0xLTMyMjg_af301179-1d99-4479-a205-8c1c448f39b8">671,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcdcf2f1832a490e8de4583c2ee8ada2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTMtMS0xLTMyMjg_8ea505bf-cdcb-4f70-85e5-7644c589c8cc">260,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTUtMS0xLTMyMjg_ae3ea4ab-5cfd-41a9-ab06-b48955f694a8">932,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjI_6f9b7202-cbb2-4d8c-ad1a-cdbc63fc62ce" continuedAt="i3f7bb8fa792142839a1eda25cf21c694" escape="true"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjg_8b3d650f-7bd4-4e00-8443-36060827db7a" continuedAt="iaca0cfab74624d238eaeb040c8d22a07" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib06f4af4cdf347728b3fd0fe3c5c26be_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjBmY2MyN2Q1MjhhYjQ5OWM4NDlkMDNhYWJmODIxNmQ2XzM4NDgyOTA2OTcyMjA_5cb83371-7403-49d3-8ed9-fb77fda735e8">19</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtMy0xLTEtMjM4Mg_e543d10b-432f-4544-ba7d-262e36ca1046">896,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtNS0xLTEtMjM4OA_6655f560-5563-465e-8b63-78769c7e81e4">248,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtNy0xLTEtNDgwMQ_f5a5b50a-9efe-4657-b56b-45d536b2afc9">648,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icbbe4092d3414952b63ded2528617b83_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOmUwMmU2YmVlN2E1MDQ3Y2Q5MDE3MGIyNTZkZDZhZTUyXzk4OTU2MDQ2NDk5OTg_bc104c15-9503-42d8-9ca9-3d87607727e9">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtMy0xLTEtMjM4Mg_2cd5fc0e-8077-406d-a765-e009f922df0c">213,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtNS0xLTEtMjM4OA_fb66c341-d285-4124-806d-33e5bd06c411">132,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtNy0xLTEtNDgwMQ_57d4122f-0927-48d2-aa33-46723578ac03">80,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9fe9bfb03ab426eb4daedcb791f9292_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjkwYmI5OTE4OGJlNzQ3Yjk4YTFmMzZlZTQ5M2NiZGQ5XzM4NDgyOTA2OTcyMjA_a0ff655f-49e1-4dc8-af17-7b29bb041398">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtMy0xLTEtMjM4Mg_3c16b88f-29ae-4b4c-ac4d-08006d369bce">104,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtNS0xLTEtMjM4OA_007b0d9f-4344-4175-be96-dc56b5028ca6">31,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtNy0xLTEtNDgwMQ_17e5cab6-a099-401c-851c-d6aeb12e3126">72,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzYtMy0xLTEtMjM4Mg_8de3e1ba-0b82-40e7-b6a2-50a288d65d27">170,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzYtNy0xLTEtNDgwMQ_6fab691d-dd21-4691-afab-9cd4e69e527c">170,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic18c09773aab473bab4a6b8ff55ea00b_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctMS0xLTEtMjQxMC90ZXh0cmVnaW9uOmVhMjQ3YTUwM2RhMTQ4ODU5Y2NlYzRmMDg2MzUyMTk2XzM4NDgyOTA2OTcyMjA_c2a44bbe-d706-4b27-af30-20498e8d12a2">27</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctMy0xLTEtMjM4Mg_f7db0daa-a7ca-4c86-b5df-5f500cf937a0">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctNS0xLTEtMjM4OA_9e28be54-38a8-4b6c-9c5e-a3e32f067a9a">15,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctNy0xLTEtNDgwMQ_037386d3-96d2-458c-8b29-b9bd8968c2e3">15,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75c1907d0ffb4c6690f775d97d70d2c6_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjZmY2Q2MzlmZDBjNzQxOWVhMWZhZTExNDkyNDBlMWQzXzM4NDgyOTA2OTcyMjA_cfb5d9b6-a113-451f-ae42-0a9a80ebd65a">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtMy0xLTEtMjM4Mg_110f06c3-2918-4292-91ad-315544198025">9,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtNS0xLTEtMjM4OA_c56386df-062d-4d4c-9033-e9b1af65fed5">7,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtNy0xLTEtNDgwMQ_2275e941-d048-46e4-9961-c705278626ad">2,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktMy0xLTEtNDc5OQ_a5fcd2ce-0d40-4914-9a63-93e52218e6c3">1,424,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktNS0xLTEtNDc5OQ_394f49c3-5c23-4ab3-896c-5e142d45e35d">434,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktNy0xLTEtNDc5OQ_857f69e9-3072-4db2-992f-80742403f3d6">989,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:53.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4933189a9bc343b1b84567e1726af5aa_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmM1YmYzYWYwNmVmNDQ0MzA4OGEwZWZiYWVmNDJkYjQ0XzM4NDgyOTA2OTcyMjA_31661179-3e4b-4f1e-8bf6-8789a697a696">19</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtMy0xLTEtMA_fb71af41-4c5c-44d4-b06a-9763d97c1176">880,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtNS0xLTEtMA_e04d5523-2ad3-4b3c-98e4-f326821e4b84">213,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtNy0xLTEtMA_cdc0fc8d-3463-4a5c-bb4f-077bfa660a4a">666,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie733e2047f5a4b2aa169696427558a08_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjZhODI0YTYxMWE1MjQzMmZhYzYxYTA5ODI2MDI1NWJiXzM4NDgyOTA2OTcyMjA_6aac00d6-2506-4f77-90ba-32ae10fe2e4b">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtMy0xLTEtMA_ed7dbb45-3b8a-4d42-acf9-fa93c3973dc8">222,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtNS0xLTEtMA_41b3c7cb-6d53-401f-9162-e1ee41b6d83f">119,393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtNy0xLTEtMA_ca745838-781a-4736-80e3-70fe1f1d8998">103,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i034043822a11407680de78bc3d1ec452_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtMS0xLTEtMC90ZXh0cmVnaW9uOjMwZTAwNWIxOWJkYzRkOGI4Y2NlOGZiOWFlZDhlZGU3XzM4NDgyOTA2OTcyMjA_c3b69170-47d4-4878-ba9a-b41baafd399e">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ef2091813046c682a8769926db401b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtMy0xLTEtMA_0e4a6e7c-4c8f-47ec-b54a-fefeebf0b568">103,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3ef2091813046c682a8769926db401b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtNS0xLTEtMA_a4c2f031-0fd5-4cba-b23d-6a9da867ec9a">28,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ef2091813046c682a8769926db401b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtNy0xLTEtMA_2fbc1ced-df38-4277-ba52-ef157e76dc5b">75,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03f54a56c22e4237a9643f89c03a66f7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzYtMy0xLTEtMA_7cee1e4f-2475-4e18-b501-d2fe2951d0dc">163,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03f54a56c22e4237a9643f89c03a66f7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzYtNy0xLTEtMA_7740c6be-df8f-4319-9461-e3024a88ee58">163,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb0bc85723e14b2890301593c5ad7ebb_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctMS0xLTEtMC90ZXh0cmVnaW9uOjZiMTBjYjlmZmNjZjQzZTQ5MTUwNDVhNWEzYzViMmYzXzM4NDgyOTA2OTcyMjA_20e2aa40-d4b7-41db-90e8-880a252948e2">27</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctMy0xLTEtMA_26d29cb4-fc40-4e06-9ff0-9cf850a501c3">34,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctNS0xLTEtMA_fdfae897-5d34-4325-abac-294865a061e5">17,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctNy0xLTEtMA_62824f06-251d-4f83-9f0d-1258f4226bac">16,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c7ab6df120c48e7bbf814ae41c07bfa_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtMS0xLTEtMC90ZXh0cmVnaW9uOjgyNTdmNWJmYjE1YjQzNjdhMDk4MDNmZDhiZWQzYmVhXzM4NDgyOTA2OTcyMjA_e77b646c-67db-4d1a-8606-ff30ba83ac86">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtMy0xLTEtMA_abb33ff8-b58c-41f6-917a-2cfba1a3cf92">10,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtNS0xLTEtMA_708c1e57-277f-4821-9700-675dddbd2e29">4,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtNy0xLTEtMA_5bc1d2bc-0f55-46bb-9a1d-340848f405fb">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktMy0xLTEtMA_4e885ba0-726d-4926-ba9e-609e9392b089">1,415,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktNS0xLTEtMA_f7ca2f56-08ed-42b0-8a49-50a0d27adc10">384,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktNy0xLTEtMA_f710dc4d-d5cf-422d-b376-c5db9cb11c14">1,031,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6ad0c4f6e5ae49ffbac802a5f7f77edc"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i3f7bb8fa792142839a1eda25cf21c694" continuedAt="icbe85235220f4b72a2c9f90e319b2b57"><ix:continuation id="iaca0cfab74624d238eaeb040c8d22a07" continuedAt="i2b706d39f3f84610a7b57d42f991b514"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">At December&#160;31, 2020 and 2019, all other included IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="i7077633fc80146898fa719dfec3ebf6c_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzM4NDgyOTA3MjI1NjE_5b485b52-109b-4378-9930-ebc8d424853c"><ix:nonFraction unitRef="usd" contextRef="ie5101596f43440d6ae335163c5bd50ff_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzM4NDgyOTA3MjI1NjE_6ae94cbd-c732-49df-80ce-ce1e24de85b9">1.0</ix:nonFraction></ix:nonFraction> million, which was indefinite-lived. At December 31, 2020, this IPR&amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icbe85235220f4b72a2c9f90e319b2b57"><ix:continuation id="i2b706d39f3f84610a7b57d42f991b514">, for details.</ix:continuation></ix:continuation>  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzEwNDQ1MzYwNDg4MDA5_cfc2538f-0b64-40a8-98a7-9614471c93e5">13.3</ix:nonFraction> million of Intangible assets, net were presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. The Company elected to bypass the qualitative evaluation for its Codman tradename intangible asset and perform quantitative test during the third quarter of 2020. In performing the test, the Company utilized a range of projected sales growth rates, a royalty rate of <ix:nonFraction unitRef="number" contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930" decimals="INF" name="iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4NzA_32a37141-8ec1-421d-b925-20615012ff1a">5.0</ix:nonFraction>%, a tax rate of <ix:nonFraction unitRef="number" contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930" decimals="INF" name="iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4NzY_85fa816d-3f09-4d12-9bd7-90e1c108c1a2">24.0</ix:nonFraction>% and a discount rate of <ix:nonFraction unitRef="number" contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930" decimals="INF" name="iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4ODM_479c78f3-6c68-49ee-8b45-7abe5871788f">11.5</ix:nonFraction>%. The assumptions used in evaluating the Codman tradename for impairment are subject to change and are tracked against historical results by management. Based on the results of the quantitative test, the Company recorded <ix:nonFraction unitRef="usd" contextRef="id1d02ef36bfd440290608745175b9676_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4ODk_7435922a-ab05-4c76-b3a5-517b0a29520d">no</ix:nonFraction> impairment to the Codman tradename intangible asset.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, a contract manufacturing customer of the private label product line received a notification from the FDA ordering them to remove their product from the market. The Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i368c48b7000e48679bf0f4f0b55eb9af_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzQ4NzQ_fd3088c5-fdc8-42f9-8255-e227478ddf5a">5.8</ix:nonFraction> million in intangible asset amortization in the consolidated statement of operations related to the customer relationship intangible asset acquired from TEI Biosciences, Inc. and TEI Medical Inc. (collectively "TEI") due to revised future projections based on the contract termination.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY1Nzk_646b3180-7b8f-4515-a873-7b3e5d8ba72d">74.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY1OTE_4f7555a2-0003-4aab-a9f3-6d3b33c7495d">72.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY2MDc_a00a2ed5-4bb8-40bd-9a4c-0ce7b9c94ee1">71.6</ix:nonFraction> million, respectively. Annual amortization expense is expected to approximate $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY2ODk_ef31e8a6-2535-401f-a8f7-08ed345eb2c6">63.8</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3MDg_2ae44100-fdb2-4c8e-b75a-489b40b261af">61.4</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3Mjc_3b539d90-f7de-4e1d-a384-94549a1f0e48">60.7</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3NDY_6689d547-d8b1-41fd-802c-52a59a095245">60.2</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3NjQ_c017dd8c-e451-43c1-ade2-ad865c7f7b73">60.2</ix:nonFraction> million in 2025 and $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3ODU_38194064-0910-45bb-8cd7-cb567f81eeb7">512.3</ix:nonFraction> million thereafter. Amortization of product technology based intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY4NzY_30ec3989-9869-4fe1-ad8b-956e4ad31a44">46.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY4ODk_b5bae3c0-5390-4f6d-954d-0db05ba45e9d">45.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY5MDU_7808b677-0f9e-4e4e-b2db-5f8c629e6d93">50.4</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, and is presented by the Company within cost of goods sold.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_190"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;<ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4Xzg4OA_0a601274-0f7e-406d-a047-4955ee939b8c" continuedAt="i27b976d4bc324153bf9cb700b66094c4" escape="true">TREASURY STOCK</ix:nonNumeric></span></div><ix:continuation id="i27b976d4bc324153bf9cb700b66094c4"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM0_219210f2-1d9a-4760-97f1-b01468fa5970">4.9</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA3MDAwNjM_ed557994-48db-4927-aa26-b9ea4e616973">2.9</ix:nonFraction> million shares of treasury stock outstanding with a cost of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzExNQ_a0d4c43d-c247-4188-99c2-4d2d5f2a69a9">235.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzEzMQ_473fe8b0-c12e-431b-9d23-45f82242c992">119.9</ix:nonFraction> million, at a weighted average cost per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzE4OA_8f3932b0-c6b3-4a70-99c5-68f14fbd3195">47.86</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA3MDAxNzg_1f3c49c4-0cea-4034-a091-437368bcdc7b">41.87</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ia08ed94918db4fc09d8f42783aacc8b6_I20201207" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0NDk_ca982a33-a4e1-4f4d-a318-7dbfcda127e7">225</ix:nonFraction>&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $<ix:nonFraction unitRef="usd" contextRef="ib238505ff51c45719c413427f70bcbd0_I20201206" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0OTA_ca615a78-7045-451a-81a7-adae471a5bab">225</ix:nonFraction>&#160;million stock repurchase authorization, of which $<ix:nonFraction unitRef="usd" contextRef="ib238505ff51c45719c413427f70bcbd0_I20201206" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0NjM_3edd3021-e9a0-4b27-a06a-2533a7d708d7">125</ix:nonFraction>&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxNTE_f30e338d-6b62-4d90-addc-0ae29f584239">2.1</ix:nonFraction>&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $<ix:nonFraction unitRef="usd" contextRef="i46a618f65cc54536b6ac22edf2a4b181_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkwOTM_2a5c4774-60aa-4e55-91e7-920bc3261744">100.0</ix:nonFraction>&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $<ix:nonFraction unitRef="usd" contextRef="i2f222fedde3d473d8469d82836a431b7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxNjQ_6b37852d-5f79-4f92-8e06-c058c14d0e08">7.6</ix:nonFraction>&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i303b890f4cb5458b9feafec5da48c4c6_I20200205" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxODA_7a77636d-afc0-4270-8964-40eee117cb43">92.4</ix:nonFraction>&#160;million accelerated share repurchase ("ASR") to complete the remaining $<ix:nonFraction unitRef="usd" contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxOTU_9b598df6-0fa6-4ab7-8675-a8abac193d08">100.0</ix:nonFraction>&#160;million of share repurchase. The Company received <ix:nonFraction unitRef="shares" contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMTE_6a7bb597-ff9e-4594-a81c-904179731e7c">1.3</ix:nonFraction>&#160;million shares at inception of the ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMjQ_8593d7fa-386e-4c1d-984c-01faf4659cf3">80</ix:nonFraction>% of the expected total shares. Upon settlement of the ASR in June 2020, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="ic11fc02008134b78802f99d57c698ae8_D20200601-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMjk_c5393fd8-6e4d-4d61-9b51-5351e0b17dce">0.6</ix:nonFraction>&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 32</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0NTg_244df05c-ec29-418d-b059-1fd6ba6020d1" continuedAt="idc6f9369d845401fb6010b9193ee6247" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="idc6f9369d845401fb6010b9193ee6247" continuedAt="i7345ff8f1383448ea0c2571904b60e6c"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODY_0499a9ed-35df-4c6c-97ae-1e5bda35c41d" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMS0xLTEtNjM5OA_5323a09e-fb56-4159-8905-7082cd314a5d">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5677f7e2a974dc7b6ffd0e7f9e6fb9c_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMy0xLTEtNjM5OA_be1f7092-6bc7-4360-9bd0-e97fb26bf22e">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie462e47008de43c29915a7628f16f658_D20180101-20181231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtNS0xLTEtNjM5OA_3ae6d057-cedd-4c76-a30d-99df06643eb7">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtMS0xLTEtNjQwNg_09be1146-1af5-4463-9dbb-f921598d5842">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56f741b7288452bab43bdc3b9a4da17_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtMy0xLTEtNjQwNg_220dba9a-34b3-41e9-b18f-70a5e0a8a724">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bf91d6b7164e5fbd293ba20be27e48_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtNS0xLTEtNjQwNg_d6a6ec53-3425-42e3-9467-b0439e9ce744">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMS0xLTEtMA_c939dd92-7a4f-4616-8d51-f4678c9bf0f2">17,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0c355852c74d3ea007543365176e1c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMy0xLTEtMA_16e2dbcc-5e01-4106-a533-e01adecbae11">19,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901bb4e610764e9ca257b79fa0ec7ada_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtNS0xLTEtMA_7d347f3f-f7e5-4539-9f42-0aa266552352">18,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtMS0xLTEtMA_f4242f37-f2e1-4eb2-8795-00e4402bfded">19,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtMy0xLTEtMA_a4f869a6-ef2d-43fe-a29e-c54035f4298a">21,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtNS0xLTEtMA_771cd07c-17f4-4d29-9ea0-09eab63d1db7">20,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctMS0xLTEtMA_50ec4c46-c664-4202-9148-05ab84412e01">6,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctMy0xLTEtMA_af365e4b-8188-4433-98cc-ba619fb701c5">9,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctNS0xLTEtMA_4b38c69c-6716-4e0c-9ddf-5e229168f701">10,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtMS0xLTEtMA_7c12607e-f42f-47bc-bd58-fedcfcdbf349">13,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtMy0xLTEtMA_e77537c1-9c4d-4a15-bdec-062f033e3ba3">11,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtNS0xLTEtMA_c67f0989-dca7-4ab8-b9ff-f0ba16eecf92">10,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of <ix:nonFraction unitRef="shares" contextRef="i8c85dafb1abd4865944b64fe294a1bf0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUxOQ_d6657bf8-bf5c-4fdb-83c9-12254f1d7c37">3.0</ix:nonFraction> million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i8c85dafb1abd4865944b64fe294a1bf0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzc2NA_55946e83-5e2f-4e81-b982-c7924271fceb">2.0</ix:nonFraction> million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2020, 2019 and 2018, the Company issued <ix:nonFraction unitRef="shares" contextRef="ibebf86aa0e7747829800552078a209b8_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzg3Nw_40abed37-b36c-4af0-b568-b157e307efb0">18,284</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzg4OA_29c8d9ca-1068-4084-93d5-9ea0d9f91b26">12,531</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkwMg_fe78b653-3169-42c2-8c0e-e54cfdcf861b">16,721</ix:nonFraction> shares under the ESPP for $<ix:nonFraction unitRef="usd" contextRef="ibebf86aa0e7747829800552078a209b8_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:EmployeeStockPurchasePlanProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkzMQ_56a223d5-f928-4062-8727-d34ce9969392">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="iart:EmployeeStockPurchasePlanProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkzNQ_8e837bc2-d16e-42a7-a79a-f576490b3cd1">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="iart:EmployeeStockPurchasePlanProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzk0Mg_1cad50f1-c895-4015-acc5-a4a1637adf26">0.7</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under <ix:nonFraction unitRef="plan" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="iart:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzMyOTg1MzQ4OTI4OTg_c44f6644-262d-4edd-a2ea-bde2c523b5ab">three</ix:nonFraction> plans, the 2000 Equity Incentive Plan (the &#8220;2000 Plan&#8221;), the 2001 Equity Incentive Plan (the &#8220;2001 Plan&#8221;), and the 2003 Equity Incentive Plan (the &#8220;2003 Plan,&#8221; and collectively, (the &#8220;Plans&#8221;)).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="i1bdab55a19f54c7cb717d1ca9d9e5ff2_D20100501-20100531" decimals="INF" format="ixt:numdotdecimal" name="iart:IncreaseInAuthorizedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE0NjA_d636364d-a8b1-4a79-bcc8-6057cfd34287">3.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i2367de66733d4c9e86c3fcfb6c69836c_D20170501-20170531" decimals="INF" format="ixt:numdotdecimal" name="iart:IncreaseInAuthorizedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE0Njc_72178666-b6da-4d1d-b763-6dba45fb995c">1.7</ix:nonFraction> million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved <ix:nonFraction unitRef="shares" contextRef="if6ae198d152944a9bff341fb3a413ddf_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE1ODc_530b6d48-b9ad-4565-bb97-98d5cebfe599"><ix:nonFraction unitRef="shares" contextRef="i4a61d7f582cc439487176679b8b9d6c6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE1ODc_7e92eb34-c122-43b7-9a81-7a42f09d1b89">4.0</ix:nonFraction></ix:nonFraction> million shares under each of the 2000 Plan and the 2001 Plan, and <ix:nonFraction unitRef="shares" contextRef="i705ff9d8a2094da5af5170fc081b60f8_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE2NDg_084edf19-c8f5-4b6d-b0f3-fa9c28b4913d">14.7</ix:nonFraction> million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the Plans become exercisable over specified periods, generally within <ix:nonNumeric contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIwNDQ_ffc362d2-054d-437d-a07d-f1f5268a64b2">four years</ix:nonNumeric> from the date of grant for officers and employees, and within <ix:nonNumeric contextRef="i093928b71e5f461b98a025cef7849d83_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIxMDk_af7305d3-5d63-4d77-b063-6fa92dd45dec">one year</ix:nonNumeric> from the date of the grant for members of the Board of Directors. The awards generally expire <ix:nonNumeric contextRef="iaed5ceec7dc240c6b98379fe92fa71b9_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyMDY_42ec3c7d-02b3-4d07-bfac-b0060d396ced">eight years</ix:nonNumeric> from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTI_0bee5ce3-e334-433a-bccf-d7c4674263bf">six</span> to <ix:nonNumeric contextRef="ic58808a8f364461da081a8acfb8e751a_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTg_6630b8c5-d50e-4d36-8d39-42e86ecbe669">ten years</ix:nonNumeric> for directors and certain executive officers. Restricted stock issued under the Plans vests ratably over specified periods, generally <ix:nonNumeric contextRef="ie560a306d89242d79633b548637d6187_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIzOTU_55e50b68-fb9e-4f09-96d0-8fb072817419">three years</ix:nonNumeric> after the date of grant.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a <ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzI5NTk_1ce40ff3-f133-4ed0-ae19-a8828fa7dde6">0</ix:nonFraction>% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7345ff8f1383448ea0c2571904b60e6c" continuedAt="iefbd3718868d4306bf383352477c3a4a"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODc_6d9fe3ca-f58c-4fb6-93f9-130444a13392" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItMS0xLTEtMA_3bb923c8-358a-4b14-bc47-52d3551d7767">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItMy0xLTEtMA_5a3dd455-58b4-44d4-b8ab-8b47f28cb02b">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItNS0xLTEtMA_fcd965e0-5f61-4be0-98a9-7c357a4f2996">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtMS0xLTEtMA_4fd2dd96-d287-4329-87c5-cbef62a2ae6a">27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtMy0xLTEtMA_865cf10a-dc19-4d93-9b3f-980710179dda">28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtNS0xLTEtMA_23f99b3f-0943-4d8a-94d4-2ecaaf08f154">28</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtMS0xLTEtMA_87953036-3775-4bfb-9963-f8deb15a877f">0.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtMy0xLTEtMA_aeee7c3d-22f5-4d91-b672-297a6ed62932">2.51</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtNS0xLTEtMA_673d6634-4872-4c93-a256-8649cdf77848">2.79</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtMS0xLTEtMA_88afc07f-6b41-4e93-93ec-ce87b7fb917f">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtMy0xLTEtMA_c11b692f-3a49-4910-99a6-1c069c1037f2">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtNS0xLTEtMA_b589d8c0-1127-47d4-bddf-d8a9827a086c">8</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtMS0xLTEtNjQzOA_aa8d227f-09f2-421b-965c-63dad567e044">13.03</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtMy0xLTEtNjQzOA_20cd330b-6662-4f62-9e24-8bca9f58e8d3">18.74</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtNS0xLTEtNjQzOA_efba9125-7f79-466d-81e8-cc5f446d5d26">21.78</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODE_79085b43-b534-444e-851d-21c40dfe8c54" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtMS0xLTEtMA_568bfbb5-39f9-440a-8859-d635d77635b9">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtMy0xLTEtMA_1ab998a6-fbe3-4756-8373-c4c5c214dbe2">34.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtNy0xLTEtMA_0c11c8d0-acd6-4df4-b75c-0d07d1b2fecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzYtMS0xLTEtMA_cfc8db04-769b-46ee-860c-94e3e23648ee">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzYtMy0xLTEtMA_bda11aed-f0ae-4e5d-82c3-92bf540dc26c">43.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzctMS0xLTEtMA_21b0d788-8cae-4d22-a2ad-4e8a20576cd7">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzctMy0xLTEtMA_56fe44bc-12cd-4eaf-a1d2-861e7d9f7cac">19.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzgtMS0xLTEtMA_20db93e2-dee6-41c7-b412-894cfc5a3efa">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzgtMy0xLTEtMA_f532e284-b1fc-442e-80df-ff019b9b809b">49.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktMS0xLTEtMA_090b706a-cc8e-4bf1-9b80-c70f6f9742c4">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktMy0xLTEtMA_d60954fa-7156-4642-ad01-6da764a748ba">39.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktNS0xLTEtMA_be155c5c-0061-4362-84df-810608ac24e4">4.41</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktNy0xLTEtMA_2c0b57cb-4ed2-40c9-8ee7-ed67e57cd578">34,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTEtMS0xLTA_ba6ead39-22fd-4214-818b-3da4b333b971">881,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTMtMS0xLTA_39f2daad-d07a-4ad9-99b8-99ef44aaa760">35.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTUtMS0xLTA_72836df6-8193-43af-9f22-070b0b27f0e5">3.20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTctMS0xLTA_dd2c3b3c-4e56-4b41-bc17-852c427e604e">26,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3MDI_c3d9c07c-1e60-40a4-9fe2-a44c4d38412a">3.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="icbab38d90c9b47fdbbcf4d4bb7cbfd50_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3MTQ_edc2b2c7-b66c-426a-9168-7ca897654c50">3.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1180226ca50f46c48ae3ef906f7f99d9_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3Mjk_c3330171-6479-45de-bf20-37fe3f78cf5e">2.6</ix:nonFraction> million in expense related to stock options during the years ended December 31, 2020, 2019 and 2018, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2020, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MjE_10aa06bc-aa09-4cc3-9b52-ea1e332bfb08">8.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MjU_68664021-107b-4827-8c70-e2ed9c8b1583">14.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MzI_b98c0dc0-348b-4c03-8561-9a8f2a16db44">16.9</ix:nonFraction> million, respectively. Cash received from option exercises and employee stock purchase plan was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNTU_07c8c190-ca2b-440e-b3bd-7151eaa0527f">5.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNTk_0b65d575-f1a3-4b5f-805a-bba17edb8e44">6.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNjY_b5d5da50-ecc6-4d9b-bc25-6cea9672f10d">9.4</ix:nonFraction> million, for the years ended December 31, 2020, 2019 and 2018, respectively. The realized tax benefit from options exercised were $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM4NDgyOTA3MDQ5NTE_2c582b51-3db8-4756-a254-c76630e62883">1.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQyOTc_299cefb8-0d2d-4ef8-ab40-c76052fb0e38">3.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQzMTI_b114c14e-7adc-49af-b5b8-3e90b169b6f0">3.1</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i3b3f1452538f40ecaabbbef187076889_I20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ0MTk_238d2fc7-7a18-4143-a415-94732fe969a5">5.1</ix:nonFraction> million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ1OTY_3bb0e0f2-f462-41e1-82bb-5be5cfec248f">two years</ix:nonNumeric>. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0NjU_6858a882-a2ae-429d-bd0a-c628d1a9e0df" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id58d59da5a4945d88d46c8031ef25907_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtMS0xLTEtMA_cb739bfb-080f-4a1f-ba47-52a621bbdfa8">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id58d59da5a4945d88d46c8031ef25907_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtMy0xLTEtMA_1274a28b-36b9-4b26-8b82-73cce8d7a78e">54.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic773caffde25407cabce511afbf4e3d6_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtNS0xLTEtMA_26c65f2d-f9ed-4140-bcd3-0be9381b7227">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic773caffde25407cabce511afbf4e3d6_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtNy0xLTEtMA_91a67d92-3358-4222-93b4-399bfa2e22ee">55.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktMS0xLTEtMA_80912686-2826-4438-9f72-931bd8b02898">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktMy0xLTEtMA_0f677380-8c52-4f38-be17-7815c8c8dc7a">44.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktNS0xLTEtMA_5963d70e-3e1a-46f5-9032-4ba4ce5a1931">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktNy0xLTEtMA_49f18dd7-3724-4c23-9ce4-08ddf11f1b73">43.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEwLTUtMS0xLTA_02f0cec7-6896-4885-a30a-d5e76ed5909f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEwLTctMS0xLTA_5a1e2f62-fe69-4609-ae5f-0235f3794e0e">51.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTEtMS0xLTA_551a662c-a073-4387-bb98-f95ff6e8732e">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTMtMS0xLTA_f69c556c-364e-4dbf-b0bc-182ebbc1b2d3">50.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTUtMS0xLTA_bf293c2b-9e9d-4b62-8ab4-15fff7e0fc7f">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTctMS0xLTA_b023e712-8493-4fa6-929e-34839536377f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTEtMS0xLTA_2176559a-7876-416b-9211-dbf44e393b9c">232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTMtMS0xLTA_b9b6e97a-a683-4ac7-be32-89d52ee5c053">52.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTUtMS0xLTA_c9817143-2e2a-4167-8982-fd466a08e111">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTctMS0xLTA_a8049c08-b37d-4f9e-9f64-a37f6de6c66b">43.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTEtMS0xLTA_07dbd8cf-8e49-4c18-9717-5271b0d5641f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231" decimals="2" format="ixt:zerodash" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTMtMS0xLTA_220c865d-51dd-4d80-ac33-97bcb024b1de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTUtMS0xLTA_e96bc810-b1b6-4d03-9634-bf56482421bd">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTctMS0xLTA_b9882c05-afac-41b1-928e-8c4ca4e66c90">51.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i424d9c8811b649708c4148b20d4b24a3_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTEtMS0xLTA_8eeb5381-6059-4890-9d1f-eab2f10385d8">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i424d9c8811b649708c4148b20d4b24a3_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTMtMS0xLTA_37eae958-fecb-4ab9-a8e3-facb5b72c4b8">50.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id717c22f443f4448bfd741ee42b60e90_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTUtMS0xLTA_dbbce03d-e4ec-4c85-ac17-945e22befe2f">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id717c22f443f4448bfd741ee42b60e90_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTctMS0xLTA_b63cd871-84df-4ff3-b927-9be0dd31d224">47.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iefbd3718868d4306bf383352477c3a4a"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4MjY_3b3b8dcb-b3a4-47c1-93b3-b1f3deab724f">16.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i493a7b5721d64329a45399d533ad986c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4MzA_6e5a9240-84ee-46ed-8f5c-bcfd1fba25ad">18.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec97182214d345158f5fdc86adce0e84_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4Mzc_54607d33-16ca-4418-ae71-ac6ede7672c4">18.1</ix:nonFraction> million in expense related to such awards during the years ended December 31, 2020, 2019 and 2018, respectively. The total fair market value of shares vested and released in 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMTg_f54c5c20-6a6e-48f8-a5d6-a502500d4f6f">17.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i493a7b5721d64329a45399d533ad986c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMjI_cb406ad2-2c2b-4179-8d94-25fd3dd898c3">21.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec97182214d345158f5fdc86adce0e84_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMjk_f4793559-cade-49a0-b473-c94be80a656d">24.8</ix:nonFraction> million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of <ix:nonNumeric contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUzMjE_1ea8b5b8-de69-4455-93ea-3aff2127bda8">three years</ix:nonNumeric>. The fair value of these awards is being expensed on a straight-line basis over the vesting period. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i2a88c7ddb0d4436f9142a1530eb72a9e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU0NzI_25ceafa7-19bd-4824-a14f-1d6d6726b19a">22.6</ix:nonFraction> million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU2ODk_d62b5957-d345-4428-aba2-bdf09cbbeeb6">two years</ix:nonNumeric>. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there were approximately <ix:nonFraction unitRef="shares" contextRef="id09d3023efe741e390f961699ce66f28_I20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU3Mzg_542e589f-936e-4d0c-9985-2258a6339f2c">0.5</ix:nonFraction> million vested Restricted Units and <ix:nonFraction unitRef="shares" contextRef="i3d34a9446c5345f1ba23501963098bb8_I20201231" decimals="-5" name="iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU3Njk_7b095a34-65cb-4e70-89a5-b3fe843fa7c0">0.1</ix:nonFraction> million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is is contingent upon achieving certain revenue and organic revenue growth performance metric.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, there were approximately <ix:nonFraction unitRef="shares" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYxNzM_be36642d-959b-48df-b537-615f5296d612">1.9</ix:nonFraction> million shares available for grant under the Plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYyOTQ_c0337f1e-843f-4551-9220-c5e0c9ac128f">0.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYyOTg_1a1c2c57-87e1-476f-98c7-d7b327ecd40c">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYzMDU_e6dd95fe-bf74-4739-bc61-aa79f043a749">0.4</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div></ix:continuation><div id="i0e66bbc7ee8049f2984ce8179f803ee5_202"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ4MDE_a8eefd8f-a663-4559-99f2-f4a31ed351d3" continuedAt="idf2c6c226dc048baa77660c3476dffbe" escape="true">RETIREMENT BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="idf2c6c226dc048baa77660c3476dffbe" continuedAt="iee92de03857a4989b7b78e1c09dc15cf"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3Njc_9bd2646d-3bad-45d2-9b58-ada619f8b1e3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2020 and 2019 included the following (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzItMS0xLTEtMA_22137c0b-67d4-4b72-8b18-e6663916339f">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzItMy0xLTEtMA_4b0ea691-be3f-42d4-a66d-1eb6d34701e5">3,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzMtMS0xLTEtMA_39ced303-3410-4d36-9ef6-0644d933673c">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzMtMy0xLTEtMA_f73abc2b-5b4e-464f-960a-a570fc1412f2">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzQtMS0xLTEtMA_b7467f45-8871-4358-b32c-130f501e04eb">652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzQtMy0xLTEtMA_a03cad82-c444-4f9f-8c8a-c5765d96aca4">1,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzUtMS0xLTEtMA_a6e05df0-94b2-4e52-8f12-2a569cdc65ee">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzUtMy0xLTEtMA_0658954b-20af-4c55-be2c-d2e19635159e">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzYtMS0xLTEtMA_7e69f16f-fc31-4826-a427-ab9a60a21aae">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzYtMy0xLTEtMA_1eb2477c-91ce-42a7-9730-0958edbb59f1">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzctMS0xLTEtMA_ce1e6b0e-44e8-49dd-8ef4-19b80c189213">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzctMy0xLTEtMA_5e1d4cdc-13cd-4789-a03c-f82c3ad8c8e7">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzgtMS0xLTEtMA_6b85e1cf-89df-4437-a36a-c89ad0359496">4,007</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzgtMy0xLTEtMA_07269d7e-c78f-43f7-bb9b-8f598b65c1f9">3,693</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3NzE_c77e2ff1-ae7c-414f-aca5-b45336a2b5cb" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2020 and 2019, respectively:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzItMS0xLTEtMA_2e81e4e6-56d3-4428-a85e-fd3b87358d12">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzItMy0xLTEtMA_ebe59253-6a76-4443-8c47-9aa8ff2b906c">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzMtMS0xLTEtMA_ee8a38c4-1f49-4002-9eeb-0763d1944b11">2.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzMtMy0xLTEtMA_8aee8c5f-d3ad-4a71-9971-ece7bfb76a4d">3.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzQtMS0xLTEtMA_0f652305-8766-4258-a223-d94155fb459d">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzQtMy0xLTEtMA_a90f6d1b-4400-4a0d-8fff-38e7da881fb8">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzUtMS0xLTEtMTM0MjM_bc22d1a8-c291-47ed-9011-c7d3e2e1405e">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzUtMy0xLTEtMTM0MTk_2a43d7bc-39ba-4cf2-822e-061dd32bf005">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2020 and 2019, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iee92de03857a4989b7b78e1c09dc15cf" continuedAt="ie40a77dbc10641af9b16ab07ffecb623"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3NzI_6134e1ae-37d7-4398-beb1-47c5a644bf53" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2020 and 2019 and a reconciliation of the funded status at December&#160;31, 2020 and 2019, respectively (amounts in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:64.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.287%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzMtMS0xLTEtMA_25346944-77e1-414b-829c-65f66424fc0f">66,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzMtMy0xLTEtMA_8787cf4f-2661-4ab3-b6ad-6f6135f70dd0">52,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzQtMS0xLTEtMA_f76c20ba-047e-4bb7-8646-f3a6ce076928">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzQtMy0xLTEtMA_5ded70ef-c602-44d3-b3ce-11f765135d92">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzUtMS0xLTEtMA_2645be35-fa1a-4f3d-9edf-5233acd66053">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzUtMy0xLTEtMA_0bba8483-f3e8-43cd-b7cd-e3481c80a17e">3,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzYtMS0xLTEtMA_c5003501-b04b-4487-81f5-c89fc3841cd1">3,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzYtMy0xLTEtMA_0cc0198f-2855-49fc-89eb-216272408b87">12,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzctMS0xLTEtMA_139747c5-221d-4ba8-9c1d-1234372613e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzctMy0xLTEtMA_f8f6532b-a4d1-421e-a707-921637d7b8b0">3,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzgtMS0xLTEtMA_803c2bf7-3c5b-4cd3-8a93-d64daccb2c8d">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzgtMy0xLTEtMA_45f52811-ab7b-4a5b-9be5-80a822a7926e">2,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzktMS0xLTEtMA_02144e75-bcc8-4ac8-972c-1558c94c72e0">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzktMy0xLTEtMA_b2b4cd0b-b124-4da7-af4b-08491a5c3097">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEwLTEtMS0xLTA_6cd3fa0d-16b4-4310-b94e-4c037fa4f4c4">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEwLTMtMS0xLTA_c46b3572-bbac-4a9e-9a76-da9517b28a79">395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEyLTEtMS0xLTA_0d186f13-07f0-4d7e-89e1-b61a7f00be9e">1,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEyLTMtMS0xLTA_f5404e7c-a387-46b3-aa24-1d21afcb38a2">635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEzLTEtMS0xLTA_2087c91c-46aa-41f8-88fc-4b280c4d449e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEzLTMtMS0xLTA_4ddc25dd-06f0-48a1-81a4-275b280c28a2">3,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE0LTEtMS0xLTA_814b8aef-d19c-49f0-9e9a-a7f7fc85a215">6,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE0LTMtMS0xLTA_dc4e426b-3d38-4657-8dc7-e5dde27f059c">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE1LTEtMS0xLTA_ac986235-526a-49d7-a0d3-c2c330a419d5">72,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE1LTMtMS0xLTA_4c5c40e2-483b-4c04-b4bc-d2deaece9699">66,972</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIwLTEtMS0xLTA_717bde07-cc69-4554-86e4-fba10e02ae83">30,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIwLTMtMS0xLTA_1d484032-828b-4e21-b383-72f443a13e61">31,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIxLTEtMS0xLTA_1ec4bf87-7a98-414f-9828-11c13fe71714">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIxLTMtMS0xLTA_522b91c5-cb8e-4d20-82d3-042f2abc7ca6">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIyLTEtMS0xLTA_504960b1-dee6-4428-9a99-fdce645cc5ae">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIyLTMtMS0xLTA_7cca303f-ae4a-4d02-a4ca-f5073391f4cf">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIzLTEtMS0xLTA_4f50e7c0-cded-4843-9db5-2a4f46fe9b8b">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIzLTMtMS0xLTA_241b00d9-a6b2-4976-af5d-7104dc39239a">899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI0LTEtMS0xLTA_cf75eda0-1de5-4228-817b-262695e4a3ec">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI0LTMtMS0xLTA_f637e193-b1cf-4d0f-8f69-5492d73804ba">2,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI1LTEtMS0xLTA_8996872c-cbd0-42b1-b908-6d635693c20a">1,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI1LTMtMS0xLTA_6ab09d50-c160-4fcc-a304-398fa6fc12cc">635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI2LTEtMS0xLTA_ed671f10-9465-420a-a98e-e7115cab06e8">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI2LTMtMS0xLTA_a08d9855-92d0-4bf4-aaf7-c1154f2ef7c3">395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI4LTEtMS0xLTA_2be1b5f5-6c64-431d-8fd2-a7d0492c1f1b">2,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI4LTMtMS0xLTA_6876ce65-b3e7-4109-9250-b9418c04367f">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI5LTEtMS0xLTA_16e28dc6-0256-446e-a00a-19a117c94a5d">37,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI5LTMtMS0xLTA_3204f338-77fc-4457-b92b-fd7071b8bf83">30,770</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ4MDM_85634d97-107e-4445-b47d-8dc7acbf2e99" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:65.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.117%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzMtMS0xLTEtMA_ad297ab0-48e6-4558-9ed7-b0d270b41b93">37,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzMtMy0xLTEtMA_3f389333-f256-4447-962b-676341f8d94c">30,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzQtMS0xLTEtMA_7f6a0147-49bc-42ac-9c30-45e552e0edef">72,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzQtMy0xLTEtMA_f603c5ab-c625-4ea7-94d6-be9130bf4741">66,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzUtMS0xLTEtMA_e31def0a-d7be-4d1b-9237-1899e0b39ff0">35,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzUtMy0xLTEtMA_ed6cd6b7-e171-4781-bc3d-0b9cef27f3ca">36,202</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, the Company had a net gain of $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzIxMDE_3b55e470-2a90-4aa9-ae3d-b79b98766fc3">4.6</ix:nonFraction> million and a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net loss of $<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzIxMDg_a98276d9-dacb-46c5-9150-e2283d46ae21">9.0</ix:nonFraction> million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2020, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzI1NzY_acc67cd8-7c26-4e3b-8a9d-c6ceb4ae6f34">61.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzI1ODM_8e570225-f53a-41a5-8cd3-b97570ebc074">61.1</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie40a77dbc10641af9b16ab07ffecb623"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had <ix:nonFraction unitRef="usd" contextRef="i64e70f4e6a1b48118ea9ee130e1f63ce_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQwMjY_5f1eca4d-6e85-4d08-920b-706a519282d9">no</ix:nonFraction> assets at December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, <ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQwNTQ_991d3739-a7d3-4350-a9ab-22083ebfd89a">no</ix:nonFraction> plan assets are expected to be returned to the Company in the next twelve months.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3OTY_e4d0aa3c-7ebc-40de-a810-01cfc9e77fb5" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzItMS0xLTEtMA_7a6db061-08eb-464f-9925-73a3f04ca56d">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzMtMS0xLTEtMA_a441fed0-07fa-4a64-a828-fd6a1e99e47e">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzQtMS0xLTEtMA_0a32702b-c700-44c7-9d61-0d0d81a9231f">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzUtMS0xLTEtMA_4382075b-ec92-47b2-9ff0-dabe30093631">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzYtMS0xLTEtMA_4ebb2355-1ab1-43f7-be23-6cd58230ccf9">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzctMS0xLTEtMA_72d6237c-ef99-4fa3-be5f-e506a7855cd3">10,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, contributions expected to be paid to the plan in 2021 is $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQyOTU_914f04cf-fcea-4f05-964f-c3d62bd0f88d">2.3</ix:nonFraction> million. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2ODc_45b91653-0c80-450c-9b71-384aa4c07ab4">6.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2OTE_f4b881c7-f21e-4557-a6b7-4b3a5420f234">8.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2OTg_75799115-f01c-48de-8965-435accfc1323">8.1</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzEzNzQzODk1MzUzMzYw_7c200354-2e86-4549-a10c-dea4b6a41acd">2.0</ix:nonFraction> million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_205"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMjM_da51f7fd-9ae5-4471-999d-8f8105708570" continuedAt="i3a725122ad0a4e418e0e8d70c652184c" escape="true">LEASES AND RELATED PARTY LEASES</ix:nonNumeric></span></div><ix:continuation id="i3a725122ad0a4e418e0e8d70c652184c" continuedAt="ibe574451e1a3460b90da9151874c2201"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2020. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include <ix:nonFraction unitRef="renewal_option" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="iart:LesseeOperatingLeaseNumberOfRenewalOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzUxMw_3bcaf657-5670-49f4-9c82-249fba3eb800">one</ix:nonFraction> or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2020 and December 31, 2019, was $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNDc_6922e510-dce0-4815-820b-b825dd48bb3d">19.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMyOTg1MzQ4ODc4NjM_73a967d8-754b-4c21-8dc0-6e47576efc16">19.6</ix:nonFraction>&#160;million, respectively, which includes $<ix:nonFraction unitRef="usd" contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNjY_9cb1cf29-748e-412f-b84d-58b8df6f4565"><ix:nonFraction unitRef="usd" contextRef="i6445287799cf40d983f351dc75cf6a15_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNjY_e32e2763-0f5e-473d-b13c-22b64a2d9657">0.3</ix:nonFraction></ix:nonFraction> million, in related party operating lease expense.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibe574451e1a3460b90da9151874c2201" continuedAt="i91b392751c6642309d08c2f6ebe6e79d"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="iart:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMTQ_c58c6db5-aa3f-49b7-bfdd-d22382e2a350" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzMtNS0xLTEtMA_41560786-7b9c-4386-b952-df92dfe39f68">83,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzMtNy0xLTEtMTU1OTU_6807db6f-9f77-4c5d-85ec-087e347e4181">94,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzUtNS0xLTEtMA_c5c4fa3c-8c0b-464b-8027-cfdefb74366b">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzUtNy0xLTEtMTU2MDE_21143301-d1a2-4811-bd08-ec0121f808aa">12,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzYtNS0xLTEtMA_d4ebc41c-9c81-4481-a732-aee1c262f826">88,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzYtNy0xLTEtMTU2MDE_0271648e-72e9-43ef-a200-68d57c950d24">97,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzctNS0xLTEtMA_62b87288-a7fd-4492-bd31-f8948b144235">100,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzctNy0xLTEtMTY3ODA_bec8b249-8c8e-4493-ab96-4c68465fbcea">109,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i328cafabba8048a388b6e3eaae3d3c02_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzExLTUtMS0xLTA_faa72b1c-d55a-4505-a395-6553781c4668">11.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i87b5e7d299f74563945c1f633f7076ef_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzExLTctMS0xLTE1NjA4_4a5c4a5a-1ef8-4b49-a7db-0edd6371fe10">12.8</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc6918309ec745bfa72b3ffa07503e44_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzEyLTUtMS0xLTA_1b2e54fe-2de2-43e4-b041-3d4862820f36">2.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i318233f5e7da424d999484de82e6a8ca_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzEyLTctMS0xLTE1NjE1_1325a24b-8690-4919-af8e-d358fba22539">2.6</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i328cafabba8048a388b6e3eaae3d3c02_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE1LTUtMS0xLTA_bf803ed4-dbad-4d1b-9600-f6a6dcd65451">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87b5e7d299f74563945c1f633f7076ef_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE1LTctMS0xLTE1NjIw_f74c5cdf-9ee9-4a42-8367-41c05f729373">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc6918309ec745bfa72b3ffa07503e44_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE2LTUtMS0xLTA_e78b03e3-e082-4486-bb2e-8fbb2cddd5cb">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i318233f5e7da424d999484de82e6a8ca_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE2LTctMS0xLTE1NjIw_c16c11ca-e19b-4e1e-8ae9-d24a888cdc39">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="iart:CashFlowLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMzU_8228344e-ef96-419d-9342-e76e7a8604c1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows for the year ended December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzMtMS0xLTEtMA_d02b92b8-509f-4bb8-839b-ac3a62fe0911">15,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzMtMy0xLTEtMTU1MzE_55246986-5ca6-490c-8ab2-227cc9b5696f">11,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzYtMS0xLTEtMA_e6d928d5-d191-4bfc-bad7-fbfbef4664b2">6,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzYtMy0xLTEtMTU1Mzc_af5d98d4-b90b-4f9e-b034-a91b8b6f677a">41,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMjY_0c87dcb2-1734-43e2-971e-19b8ad2c3c47" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItMS0xLTEtMA_de5eb68a-daa1-471c-9da2-fb4f90e5992a">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItMy0xLTEtMA_439e873a-fc5b-4e8f-8b00-06071bd94172">13,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItNS0xLTEtMA_a6740db1-1a2a-460c-b255-2b6780ae6e57">13,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtMS0xLTEtMA_99442233-cefc-4747-93ab-33f57823149c">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtMy0xLTEtMA_8a9872e2-b54d-43b7-b583-a0a1f36be993">13,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtNS0xLTEtMA_f18e87ba-a962-4912-b581-e681d7a4207c">14,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtMS0xLTEtMA_0ba28bf5-e7b1-4bfb-9175-96ea26359921">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtMy0xLTEtMA_c5a5ca8f-af5f-42a8-bf8a-6e84e3e0496e">11,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtNS0xLTEtMA_2065be10-a977-490e-9101-8a77158c61cc">11,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtMS0xLTEtMA_4f081e1a-ad57-4a7a-bdce-5ffa3af9c010">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtMy0xLTEtMA_deb71163-17cb-4b80-8956-1d38f6b10acd">10,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtNS0xLTEtMA_a32da338-7d3b-42f3-a239-ee2782b0c403">10,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtMS0xLTEtMA_556f5f86-dd71-4b9a-a9f0-db4e347533f8">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtMy0xLTEtMA_02ff429f-8e30-4530-be33-3084dbf99c4f">9,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtNS0xLTEtMA_f3bc9c70-6757-4513-bb07-bf959f4c6705">9,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctMS0xLTEtMA_b6c25d3f-e57e-41d0-80d0-fbf79ef5f689">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctMy0xLTEtMA_e7d2300c-6849-4b1a-b137-9af78a29d181">77,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctNS0xLTEtMA_d0f019e7-0df7-4cab-a82d-ed1efe9cf213">78,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtMS0xLTEtMA_5e5cef14-f12c-442e-8d99-a377c699b00a">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtMy0xLTEtMA_6a68c146-d588-460c-84fe-c4b7c1c2b41f">136,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtNS0xLTEtMA_24949ea3-ef1a-490e-8568-d696f4106433">138,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzktNS0xLTEtMA_32ee93d6-2b2c-4f0a-b7a2-8e684dfcb619">37,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzEwLTUtMS0xLTA_bdbb4480-b07a-4a90-b084-85b55c75be5d">100,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzExLTUtMS0xLTA_c5c4fa3c-8c0b-464b-8027-cfdefb74366b">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzEyLTUtMS0xLTA_d4ebc41c-9c81-4481-a732-aee1c262f826">88,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzE2MDI_3376bce0-65c7-422e-a0a5-47c2c44a9fd2">no</ix:nonFraction> future minimum lease payments under finance leases at December&#160;31, 2020.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i91b392751c6642309d08c2f6ebe6e79d"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is <ix:nonFraction unitRef="number" contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231" decimals="2" name="iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzIzNzI_b7a3aacb-ce7a-4922-af02-897bbbb2c517">50</ix:nonFraction>% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $<ix:nonFraction unitRef="usd" contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:AnnualRateOfLeaseAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI2NDI_7470192e-1093-4da9-ad32-ecaaaa8f6617">0.3</ix:nonFraction> million per year. The current lease agreement also provides (i) a <ix:nonNumeric contextRef="icd913cb502474113a910bca29ccf36d3_D20200101-20201231" format="ixt-sec:duryear" name="iart:OptionToExtendLeaseYears" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI3MDM_5de3a0e4-3733-40df-97c1-843ddc6d66e7">5</ix:nonNumeric>-year renewal option for the Company to extend the lease from <ix:nonNumeric contextRef="icd913cb502474113a910bca29ccf36d3_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMzE_022c5d69-4e3c-48da-8021-217eb091db33">November 1, 2029 through October 31, 2034</ix:nonNumeric> at the fair market rental rate of the premises, and (ii) another <ix:nonNumeric contextRef="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231" format="ixt-sec:duryear" name="iart:OptionToExtendLeaseYears" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI4NzQ_482fcb1b-171b-4e3f-993f-e48dac67b501">5</ix:nonNumeric>-year renewal option to extend the lease from <ix:nonNumeric contextRef="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMTk_36c2feb9-73c2-497c-98a2-d9fb9002266d">November 1, 2034 through October 31, 2039</ix:nonNumeric> at the fair market rental rate of the premises.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_211"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MjU_f965751f-37b8-4164-bd64-979976f95281" continuedAt="if03ea7ddd3c247b29ef3ccb9f09374f0" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="if03ea7ddd3c247b29ef3ccb9f09374f0" continuedAt="ib571a05a12c64392b5b91933059a7883"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MDc_bf2ba32b-87e0-4686-b4d6-f50105b4e5f0" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtMS0xLTEtMA_390db7a3-4f5b-4767-a9f5-85b84d5755a8">15,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtMy0xLTEtMA_85d61a7a-83fc-44bb-b471-6d772abed001">38,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtNS0xLTEtMA_14d22901-dc26-4efc-851b-3fb9a332be40">21,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtMS0xLTEtMA_79a4751e-f664-4ffc-89dc-55e5dffcb27e">78,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtMy0xLTEtMA_296784ac-66da-4ad4-a324-e2921fc246f4">98,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtNS0xLTEtMA_74a8b9c1-c7cc-42c2-a6d6-3dcd4e57a2a0">78,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtMS0xLTEtMA_aacf195b-229c-4fa9-b848-e47e188f9f91">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtMy0xLTEtMA_78fa880b-4f0c-4183-a565-093f36280346">60,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtNS0xLTEtMA_929eff5d-2ce8-4b7c-aabd-c7c22410b810">57,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> 2017 U.S. Tax Act was signed into law on December 22, 2017. The 2017 Tax Act made significant changes to the previous tax law, which included the reduction of the federal statutory rate from 35% to 21% and the recognition of a one-time repatriation tax on accumulated untaxed earnings of foreign subsidiaries. As of December 31, 2018, the Company finalized its calculations and completed its accounting for the income tax effect of the 2017 Tax Act, for which the finalization adjustments recognized during 2018 were not significant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A number of these provisions continue to have an impact on our effective tax rate, including limitations on the deductibility of executive compensation and the elimination of certain tax deductions. Additionally, the implementation of a territorial tax system, which subjects certain foreign earnings to additional taxation as global intangible low-taxed income, continues to adversely affect income tax expense.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib571a05a12c64392b5b91933059a7883" continuedAt="i652c4b107b5843918f1f354f18f454aa"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc4OTU_02a71051-4e14-4979-88a1-e7c34108722f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItMS0xLTEtMA_26d08af3-f905-40e8-9c1b-e911a5691b84">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItMy0xLTEtMA_ceac2b7e-4464-4443-8fe2-7ed81cfb7793">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItNS0xLTEtMA_cd36cd1b-31b5-4615-aa1f-c6ec9e17fde9">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtMS0xLTEtMA_5fd67e09-8e7c-477a-b8dd-ca2909193402">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtMy0xLTEtMA_e2f11a8f-504d-4359-b9a5-f568581f78d4">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtNS0xLTEtMA_377589da-eb8c-4fdf-ae33-a20df4e21006">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtMS0xLTEtMA_5f788583-6d61-4455-b183-466559648ef8">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtMy0xLTEtMA_de0e68ec-2269-412e-9cc8-64744335bb1c">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtNS0xLTEtMA_8a098eed-7161-4fee-8601-fd1d3af35288">21.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctMS0xLTEtMA_8afdea85-4ec0-4fef-9bf4-147e84ac5958">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctMy0xLTEtMA_921884fc-4dde-4104-8b55-8675eedca419">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctNS0xLTEtMA_8239d47a-0e6e-42cb-88b7-33c1c31ce963">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtMS0xLTEtMA_066badba-87f8-4715-ab6f-18e222927d5f">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtMy0xLTEtMA_ae8d4473-2956-48ec-a650-d9be9b5ddbf6">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtNS0xLTEtMA_0cf24ba4-1388-45cb-94f2-152e5f23f341">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktMS0xLTEtMA_a4f1b14a-d950-48f0-9c8c-c0ed0f111d09">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktMy0xLTEtMA_96409842-18c5-4ece-b35d-5f9d388d4cfa">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktNS0xLTEtMA_64e86161-2f7f-48a9-a589-7a604a0fbc8e">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTEtMS0xLTA_df6c0143-8035-4965-902e-75accf3b4540">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTMtMS0xLTA_617f2141-043a-434a-93ed-f738582d9f81">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTUtMS0xLTA_00fc05fc-6fc7-4362-b121-95904ba09bc1">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTEtMS0xLTA_57fbc99c-adc7-4d7c-ba2e-8a9d8af9dec7">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTMtMS0xLTA_30029484-1725-4100-9b11-0900a9e3ce3d">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTUtMS0xLTA_fd84c1d5-5ee8-427c-8787-72ad3505e162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Changes in valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTEtMS0xLTA_ba0c1c29-ace8-4292-aebe-dc3bb9fc2067">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTMtMS0xLTA_f5372dbb-e909-47ed-aa2f-d613a6100f0e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTUtMS0xLTA_a6087d4b-d4a2-4263-aa60-22bb49548fc2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTEtMS0xLTA_2835d5de-4125-4793-a043-c8b29479fb7b">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTMtMS0xLTA_d75bae3c-052d-4f1b-a73c-f099bbd7248e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTUtMS0xLTA_50377307-ba20-4292-82d9-cfc96eb76975">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTEtMS0xLTA_581d1730-8d28-4f4f-b614-c4f07720ebff">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTMtMS0xLTA_f763b7c3-a84f-4539-9376-93264537db73">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTUtMS0xLTA_1e738de6-38ba-4cd0-beaa-870d624e829c">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTEtMS0xLTA_32989e5b-a60c-474b-8fd8-5db0ca53f9d9">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTMtMS0xLTA_0658e283-f468-4b3e-85e6-84e050a9eb52">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTUtMS0xLTA_5450ae7e-3d48-4651-9bc6-d1c84857cb4e">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTEtMS0xLTA_637c3832-57a0-4e6d-9a66-df9f77d792e4">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTMtMS0xLTA_d5ad7705-bc9a-4e80-a4b5-4756dd258f20">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTUtMS0xLTA_11a90587-310d-4cb1-ae1f-41f7ef39eb79">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTEtMS0xLTA_61e4f09f-871d-4aff-b9f2-a42f681e2cb0">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTMtMS0xLTA_2a443df3-63bf-40fd-8833-b733ba28d7e9">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTUtMS0xLTA_b585e196-6a02-47f6-bb52-2b3ebd2bc1b1">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Carryback of Federal net operating loss ("NOL")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTEtMS0xLTA_25ecc264-2b08-49f3-84f3-2dfb95831ca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTMtMS0xLTA_50aa5c0d-6480-48d7-bd2b-ab0a611dad1b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTUtMS0xLTA_f7859403-797a-4d7a-bf1f-cab7239c6911">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTEtMS0xLTA_20e43678-6cc5-4416-a0a7-a8bca36a6603">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTMtMS0xLTA_0038465b-3ffe-4ef5-8ee9-9de76b22ea47">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTUtMS0xLTA_37f9eeb0-493a-4510-9d44-6f8bd8192075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTEtMS0xLTA_6440e7f6-816d-4410-b81a-9379f5a5028a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTMtMS0xLTA_1640cefd-3cd5-4bdc-a286-07431fb05c4b">15.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTUtMS0xLTA_10b98776-9a37-4468-b3ea-1c6044a8fe15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTEtMS0xLTA_cfed1dc7-8b8c-4c33-948d-2f2abbed5e3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTMtMS0xLTA_27933e6f-a16a-49b8-9c6a-bf17310fbdda">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTUtMS0xLTA_cc485312-78e4-4fcd-8a04-9640c47cacf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign-Derived Intangible Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTEtMS0xLTE3MDQw_f1cf2f6c-f71c-4d73-a576-cdc9348c7ff0">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTMtMS0xLTE3MDUz_519e1296-a493-410a-a1bc-284a8f97650a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTUtMS0xLTE3MDU3_6549f14d-c971-446f-a155-a536aec9184f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Transfer of Intra-entity of certain intellectual property - Rate Differential <br/>on FMV Step-Up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTEtMS0xLTE3MDQw_2a21c146-dba1-40bb-ad01-629b3904b567">63.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTMtMS0xLTE3MDUz_44920e3c-970c-4d9f-92fe-817428cf3dc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTUtMS0xLTE3MDU3_e4c3e800-278c-45f7-83c3-f49b7937b74f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Assets held for sale - Outside Basis Difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTEtMS0xLTE3MDQw_1c41d2c5-331a-492b-baf9-4a2d7f724ebf">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTMtMS0xLTE3MDUz_6bb1bc2c-536b-4023-bf16-87b65fb41fbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" format="ixt:zerodash" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTUtMS0xLTE3MDU3_aea23ee7-133a-4d93-8844-0c6fdbb021f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTEtMS0xLTA_d778e2c7-631c-4a29-93d8-f70bd6d78c0f">43.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTMtMS0xLTA_803aa9be-d100-4d23-a779-6ac2b7479c8e">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTUtMS0xLTA_ab2259e7-6ed9-41c3-9e3b-9f531f89824c">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate was (<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzU5MzQ2_d778e2c7-631c-4a29-93d8-f70bd6d78c0f">43.2</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzE5Mzk_5a50c627-0f43-4a86-8fc8-ab32bf794a0c">16.5</ix:nonFraction>% of income before income taxes for the years ended December&#160;31, 2020 and December 31, 2019, respectively. In 2020, the Company&#8217;s lower worldwide effective tax rate, as compared to 2019, is primarily driven by an $<ix:nonFraction unitRef="usd" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NjQ5_b045c2bb-0f1f-4324-b1fe-7842dbafe1a8">59.2</ix:nonFraction>&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 is <ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" name="iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ5NDc4MDIzNTIxMzU_6e7696e6-f19e-4be5-9067-1852cb6088c4">20.2</ix:nonFraction>%.      </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $<ix:nonFraction unitRef="usd" contextRef="i0506efb6e60a43dc9e261858a7124158_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NjM0_2c56e847-342b-4f8c-99f1-c2dad10d0d91">59.2</ix:nonFraction>&#160;million  deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, the Company&#8217;s foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0Njgx_dad7dabf-899c-4d1e-86e7-324b8659bbce">48.2</ix:nonFraction>&#160;million decrease in income tax expense when compared to the same period in 2019, because of the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (<ix:nonFraction unitRef="number" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0Njk2_e14e6ae4-fb08-427a-bbc5-e4fe1dce79c4">57.1</ix:nonFraction>)%, compared to <ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NzA1_3471c0a8-6079-40bc-b501-15387fa344b2">3.5</ix:nonFraction>% in 2019. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2019, the Company's foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI2NzU_01669a3a-55d8-4c89-a284-0dd467a852bf">5.7</ix:nonFraction> million decrease in income tax expense when compared with 2018, because of geographic and business mix of taxable earnings and losses, among other factors. The 2019 foreign effective tax rate is <ix:nonFraction unitRef="number" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI4NjY_faeff55d-60ed-4103-a9fd-122464e7223a">3.5</ix:nonFraction>%, compared to <ix:nonFraction unitRef="number" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI4ODI_13d667fb-9a58-4257-aed2-1c6139129620">11.6</ix:nonFraction>% in 2018. The Company's foreign tax rate is primarily based upon statutory rates and is also impacted by the tax holiday in Switzerland, described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $<ix:nonFraction unitRef="usd" contextRef="id99ba8984a21448d9a3835880d4febea_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzMyMzE_025856b1-d06e-4fd8-bedb-fa773d93f49e">12.1</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="id99ba8984a21448d9a3835880d4febea_D20190101-20191231" decimals="2" name="iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzMyMzU_91766bcb-becf-4337-a970-bc239a7dbeea">0.14</ix:nonFraction> per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i652c4b107b5843918f1f354f18f454aa" continuedAt="i1dd356df2e154b3281777c365b771f8b"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc4OTY_993d00e1-1044-4ad7-89ba-697ed71be370" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtMS0xLTEtMA_de3fe93f-bb9f-4761-880c-9d233da629c3">6,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtMy0xLTEtMA_27b8cd1b-0031-40c1-a894-442fa2fabf0f">14,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtNS0xLTEtMA_89118acf-0bf0-46b3-98ab-c52fb1ecddc4">3,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtMS0xLTEtMA_f2d8ac74-a481-441e-8c58-6e96c69399f1">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtMy0xLTEtMA_375cbbb7-c949-4855-83fc-314187dee567">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtNS0xLTEtMA_4fba4e24-a30e-4d6a-b68e-7cd6a19df3fd">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtMS0xLTEtMA_6c63bd38-83e4-4cac-9fa0-f049b54f9d32">12,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtMy0xLTEtMA_1bc31ca6-e8ab-4817-b43a-224cc9a6eaab">10,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtNS0xLTEtMA_1f79924a-7223-44c1-b47a-bb11f3eff929">7,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctMS0xLTEtMA_e6422950-fe47-4212-b23c-ac8428bf14da">23,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctMy0xLTEtMA_e2efed82-bfd0-44f9-b803-4549cb21637b">28,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctNS0xLTEtMA_2249065c-16a0-4a03-bb72-8044ea4ac5f6">4,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktMS0xLTEtMA_0d457008-d2c0-4d7e-991a-b22841368284">5,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktMy0xLTEtMA_d19471ac-9d03-4708-b471-f6c5ee74e5ec">10,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktNS0xLTEtMA_9badc71c-c3f8-4185-a6e7-4d2049cd125d">7,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTEtMS0xLTA_4bb8b68e-09aa-4337-b9e8-4612f3f96512">1,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTMtMS0xLTA_b3ca2f9a-3ecb-433a-aace-3a0a1da0e350">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTUtMS0xLTA_1d0f4650-5906-4496-a918-d56763559fd3">3,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTEtMS0xLTA_2de17f9b-1eca-4393-a483-8ce65629f3ce">57,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTMtMS0xLTA_ade54d40-b6eb-49dd-8885-10222f8be805">7,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTUtMS0xLTA_e69239b2-b6f1-45a2-a858-51b9552f3c74">2,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTEtMS0xLTA_6b815c57-07b2-4448-a998-b033cf980caa">64,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTMtMS0xLTA_e09694a3-3e39-4aa2-8144-79846e59f58d">19,046</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTUtMS0xLTA_4b3a90cc-46e8-4302-89b2-6ee380eb9c09">8,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTEtMS0xLTA_97a36ddf-1eeb-46ff-a504-0aa47f8d372c">40,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTMtMS0xLTA_77da2e8d-d2be-469a-86ee-d1ca463764df">9,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTUtMS0xLTA_26bad673-5600-4df0-8e1c-cbdf4a3d996c">3,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MTE_58da98b2-f0ea-478c-8cd8-11faff5cef63" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzQtMS0xLTEtMA_687a306c-c063-4d76-b908-e661e0f18a93">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzQtMy0xLTEtMA_f879a69c-a6b2-4a03-8d2e-d0ac1c3330ea">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzUtMS0xLTEtMA_82ec9246-4e1b-4628-9044-5f2acfbcb099">47,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzUtMy0xLTEtMA_29ddee45-da4b-433e-a2d4-0150acc434ff">39,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzYtMS0xLTEtMA_226d9bc3-0ee4-4ee0-bc57-bfd10094c08a">18,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzYtMy0xLTEtMA_cc2930ad-925c-41c8-8283-46590ffac4a4">19,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzctMS0xLTEtMA_2d0c6759-ec63-4caa-b15c-0ce823f734e4">3,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzctMy0xLTEtMA_e504c37c-da76-49e3-ab96-a3138c9daa71">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzgtMS0xLTEtMA_6f537706-2c03-410c-9bd3-387ca024a9a5">4,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzgtMy0xLTEtMA_814de524-900d-4722-bccd-1eb4bc0d44e7">6,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzktMS0xLTEtMA_0a6a7330-9cd7-4fd7-8318-c33370e43799">6,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzktMy0xLTEtMA_adef64b3-e87e-457f-81f5-76f00f11cd3c">8,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEwLTEtMS0xLTA_ad4a3697-104c-4d76-aca3-1e34582de80f">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEwLTMtMS0xLTA_7eb1891c-3c0d-46cc-bc1b-d40d956b4f99">1,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzExLTEtMS0xLTA_23f8e68a-1b72-4e8f-a559-a616ae7e0ecd">29,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzExLTMtMS0xLTA_597b74d7-f7c2-419b-b687-1bc565714cd6">37,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEyLTEtMS0xLTA_58a5dacf-9477-4cac-bd8e-0be5da4b7791">13,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEyLTMtMS0xLTA_bac7554a-ba7d-4486-9ccb-be6ad8bf5bc5">9,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEzLTEtMS0xLTA_49011697-0039-4882-b6a6-cc4edd81018b">23,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEzLTMtMS0xLTA_668f2a47-cd93-4035-b739-09a001221cbb">8,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE0LTEtMS0xLTA_53e2cf29-24b6-4924-90f4-526d83fd0ca0">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE0LTMtMS0xLTA_d4a664d4-0035-40ec-ba90-db592a3a7859">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsLeasesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE1LTEtMS0xLTA_492d1999-a8eb-4271-90d6-a1d735deac7b">23,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxAssetsLeasesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE1LTMtMS0xLTA_41dd4ef9-8110-46ed-a4c0-bba401699446">12,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE2LTEtMS0xLTA_7f4076ca-0816-4cd5-8d22-60539230dd01">173,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE2LTMtMS0xLTA_5389cf1d-eab7-4d04-a3be-a17fb03610af">148,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE3LTEtMS0xLTA_3b1170ff-dc54-4509-8ebb-9e4231bcf095">9,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE3LTMtMS0xLTA_5ce4000f-1d05-47f5-bf48-667751e879c3">9,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE4LTEtMS0xLTA_128edba2-daf2-41d9-a6fa-38b3ede02e3e">163,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE4LTMtMS0xLTA_ad533b79-bda8-4041-9843-f4406c397122">138,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIwLTEtMS0xLTA_d720a0e0-a7e6-4478-a8d8-3fb523d3b8a5">90,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIwLTMtMS0xLTA_d845e591-52f3-4190-a7de-65cda8d87844">150,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxLiabilitiesLeasesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIxLTEtMS0xLTA_1dfed622-52ce-4983-9ca4-6c6fc377f978">15,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="iart:DeferredTaxLiabilitiesLeasesAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIxLTMtMS0xLTA_8909c3d6-94a7-4573-a88f-c1d92caeafd5">11,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIyLTEtMS0xLTA_974cd264-01b6-453c-b6e2-2bf46200a12f">105,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIyLTMtMS0xLTA_67dd1075-874b-4938-9585-5d2953a303f6">162,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzI0LTEtMS0xLTA_aebd8e4a-9747-4430-a581-3570f2361374">57,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzI0LTMtMS0xLTA_04d983bc-9bc0-4264-a8f6-aec8d2254982">23,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified as it relates to Leases and Other between deferred tax asset and liabilities within this table to conform to the current period presentation. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i1dd356df2e154b3281777c365b771f8b" continuedAt="ib7f4dc3ed64b4461bc5e545a27ba7e6a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company had net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i71e189e172134a198e45306e30524e45_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ3NzY_c5aaeea0-e5b5-40a6-bc56-354c2ffccffd">90.2</ix:nonFraction> million for federal income tax purposes, $<ix:nonFraction unitRef="usd" contextRef="i7e0e6743ee86466485e0e297c82bd874_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ4MjA_f50dcf49-b4c0-4c60-a0da-74e26e55561c">36.7</ix:nonFraction> million for foreign income tax purposes and $<ix:nonFraction unitRef="usd" contextRef="ie8d8ce88e979437bbf5ec18f685dd329_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ4Njc_a795bbe9-fe09-485d-8e1d-d29794067a83">41.6</ix:nonFraction> million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $<ix:nonFraction unitRef="usd" contextRef="i71e189e172134a198e45306e30524e45_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUwMjc_ca8f1155-a24c-4fdf-aa59-b779360c4c39">11.8</ix:nonFraction> million have an indefinite carry forward period. For foreign net operating loss carryforwards, $<ix:nonFraction unitRef="usd" contextRef="i33ca63c7a2bb40df97707e469661c625_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUxNDE_7178445c-9b53-4844-8bda-3b352b359298">0.3</ix:nonFraction> million expire through 2025, and the remaining $<ix:nonFraction unitRef="usd" contextRef="i7e0e6743ee86466485e0e297c82bd874_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUxOTE_6a7635ab-8a34-46d5-9e32-9511174c9c08">36.4</ix:nonFraction> million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation allowance increased by less than $<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ5NDc4MDIzNTIxNzQ_ba3ecaad-39c7-4de1-8dfe-6ccf9272964e">0.1</ix:nonFraction> million, increased by $<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzYwOTU_1e340bd1-d548-4ab3-a12b-b7a044674e8b">2.9</ix:nonFraction> million and decreased by $<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzYxMTU_a9c0e2cb-37dd-40fa-aa76-22ae2593b8af">1.0</ix:nonFraction> million at December 31, 2020, 2019 and 2018, respectively. The 2020 valuation allowance primarily remained unchanged from the prior period.The 2019 overall increase in the valuation allowance primarily resulted from certain assets from the Rebound and Arkis acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested.&#160;Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;As such, the Company has determined the tax impact of repatriating these earnings would <ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ForeignEarningsRepatriated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY2OTk_dba89514-d231-47d4-8d80-274541573c25">no</ix:nonFraction>t be material as of December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MDE_8e203c8b-c633-4da3-bf92-3d12d545a99e" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtMS0xLTEtMA_94318aef-b872-479a-b7ec-ee7c59bf05a8">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtMy0xLTEtMA_806e27c4-acf6-48f6-a511-62f5de0d0b2f">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtNS0xLTEtMA_1a6a70be-9b30-4fb3-93ff-261b4f6d6849">424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtMS0xLTEtMA_614b3378-1e47-499b-bc0d-7bd8c99d291e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtMy0xLTEtMA_74379a8a-4fab-4e54-90a0-eb5329c72db4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtNS0xLTEtMA_add85912-3d12-4203-9f35-ff94007e6434">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtMS0xLTEtMA_415147f0-16f3-473d-ad67-90fc7c968964">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtMy0xLTEtMA_6c5b9be9-ae89-4909-967b-f20b110ccc31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtNS0xLTEtMA_db1e6fc2-6655-4f56-8bd4-7f41f2d420d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Statute of limitations lapses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTEtMS0xLTA_cd2cd9f6-21d1-48d4-b4ac-a0b10d649059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTMtMS0xLTA_599ad838-19a1-4cff-8041-2d96a782cd63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTUtMS0xLTA_1298abfa-1a43-4e8a-972f-c0176e126ae9">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTEtMS0xLTA_fe78ff0e-f711-4b80-8df4-8cfc3a67303b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTMtMS0xLTA_16520d3c-1506-4937-a358-de9a60af1884">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTUtMS0xLTA_685b2a5b-047c-4ded-95aa-84eb1df26ea0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTEtMS0xLTA_17b7c5f5-c942-4320-8a07-7d045a17d51e">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTMtMS0xLTA_4a865924-252e-4830-9a07-eb838c66268f">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTUtMS0xLTA_a2738f3f-0dd4-4b00-a2c7-88dcad6759ee">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY4NTA_dcf19231-6649-4240-bcbe-a6d8b64e262d">0.7</ix:nonFraction> million of the balance at December&#160;31, 2020 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are <ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY5OTI_3a54dcc3-4bc2-4be6-b08a-b19cbde42621">no</ix:nonFraction> amounts within the balance of uncertain tax positions at December&#160;31, 2020 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2020, 2019 and 2018. The Company had minimal interest and penalties accrued for the years ended December 31, 2020 and 2019 and 2018. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib7f4dc3ed64b4461bc5e545a27ba7e6a">The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2016. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 42</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzY3MQ_db59c226-2097-4200-95e0-b53a919e03cb" continuedAt="i3f5de830484b4497b44da71ff4f12093" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i3f5de830484b4497b44da71ff4f12093" continuedAt="ie3deee2e906645d28e59426746c84d8f"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzY2Mw_ddaf7b14-d7a1-4f7d-9ba4-20a8a1ac12bf" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtMS0xLTEtMA_78809713-9839-4ed1-8bd2-3a4dd6269be0">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtMy0xLTEtMA_1185eb2b-ded8-491d-8db2-7cb111cf56e5">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtNS0xLTEtMA_ea135621-9289-4604-b47a-690c22d143c8">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtMS0xLTEtMA_ff0e5e82-e7c8-4c09-9c57-4da6d6c1fcc0">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtMy0xLTEtMA_dd3bd9bc-8fbb-4c91-ae06-bec1bdbed121">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtNS0xLTEtMA_7fa2049f-4093-418f-9b5c-9137321e823d">82,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtMS0xLTEtMA_d7395701-217c-4d2d-829d-21aef2b0e1b5">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtMy0xLTEtMA_f1a05077-bf3c-47c5-85df-5afbc0fe9ad0">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtNS0xLTEtMA_60608407-33b3-4071-8abd-045b3f935822">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTEtMS0xLTA_725128f2-80be-48e7-8928-1ff342730bd7">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTMtMS0xLTA_3976d34f-8b14-4961-b40a-e937688de4ee">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTUtMS0xLTA_f1cc317a-7c1e-491f-8024-8c5ed2fe129c">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTEtMS0xLTA_e8b43db0-5530-4dbc-b109-9bca08d5a28f">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTMtMS0xLTA_9eb75451-f8a4-47b1-978d-4acaac0a073c">85,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTUtMS0xLTA_ddf49179-2c1e-4288-842b-df7ecdaa0ad1">82,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTEtMS0xLTA_ce383842-023e-45aa-9e31-0c20e9bbd62a">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTMtMS0xLTA_26167b42-0f6b-4186-8ac7-67a74b777673">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTUtMS0xLTA_f53a836f-6a20-4bb7-b0a1-71d16d87fb6f">1,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTEtMS0xLTA_7cd18c95-705b-4845-95f6-2e276d6521a4">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTMtMS0xLTA_8e0be29d-05f8-4066-9ee7-a5a9d878f4ad">86,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTUtMS0xLTA_971b2084-a49d-4e63-ab1f-e18df49da644">83,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTEtMS0xLTA_8a342002-8953-4be2-b946-d1af03dd4291">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTMtMS0xLTA_34b88290-9304-4516-bb00-de867b3435c9">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTUtMS0xLTA_bbc0f4fd-710a-4a2b-8667-973bac19433d">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately <ix:nonFraction unitRef="shares" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzM4NDgyOTA2OTc5MTg_8475d71c-808b-4b79-af4d-917fd534a8df">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzM4NDgyOTA2OTc5Mzc_10592f17-76b8-46c8-b1aa-1bf14af4756c">0.4</ix:nonFraction> million shares at December&#160;31, 2020, and 2019 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3deee2e906645d28e59426746c84d8f">Performance Shares and Restricted Units that entitle the holders to approximately <ix:nonFraction unitRef="shares" contextRef="ifd9f45dbd07e4b1b8f8a22de6eb41518_I20201231" decimals="-5" name="iart:AdditionalEPSShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzQxOQ_d9a6e25d-4119-4314-a4fd-c175ef8fd53f">0.5</ix:nonFraction> million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.</ix:continuation> </span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_223"></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzMzOQ_7637520e-4dd4-4571-86d6-6f4fa2126f2a" continuedAt="i3d97a0a5fd20497eac4ce9016927457b" escape="true">ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span></div><ix:continuation id="i3d97a0a5fd20497eac4ce9016927457b"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzM0Ng_563fbb16-6240-4d1f-9c55-9c32d5637149" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2020 and 2019 are presented in the table below, net of tax:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:35.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.853%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i915fe0a79f884cefa4d9cbc4dde21cf6_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItMi0xLTEtMA_209baa9d-84a8-401e-a238-2dcee6fbcb9e">26,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i600d3779342744ec92eb111d87aab117_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItNC0xLTEtMA_bb1dda54-a5ea-4a81-b4d7-6d993343a644">9,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a845487839e48b7893f0fdea00c7b8d_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItNi0xLTEtMA_37021f34-86d7-431b-b877-0a3cf2b5f7c5">40,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9d2265b32274b0abed4046b6e8c8fbf_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItMTAtMS0xLTA_055bf183-1d0e-4fac-a978-a2ad8909a8d8">76,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtMi0xLTEtMA_78e04579-c5fb-41ee-a3e1-cba789ce20ea">74,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtNC0xLTEtMA_b1f9569c-e7ef-4fbb-9fb3-3901f5d32ed4">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtNi0xLTEtMA_00e9cfa0-a8b3-49ba-b2a3-a11f16bfc0e7">53,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtMTAtMS0xLTA_da056ee2-ca93-4bbd-a8f5-5147b7438d00">16,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtMi0xLTEtMA_0a865402-636a-4b3f-8783-bfe8b72d3c3c">18,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtNC0xLTEtMA_c3cd62b0-da91-4cb1-9b4e-0dc1d53451dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtNi0xLTEtMA_1b7a376f-3dd9-4feb-969b-0ddc2f0df9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtMTAtMS0xLTA_b5d88404-0c1e-44e8-b2e8-47bf180788de">18,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtMi0xLTEtMA_d66b2ec0-7f53-437b-83f4-ee47529375fb">55,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtNC0xLTEtMA_0b06e007-efee-4194-9f13-f5e3e369a737">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtNi0xLTEtMA_2c0b5247-f20b-4146-925b-775048f243e6">53,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtMTAtMS0xLTA_2e683b67-d4bc-4402-bf71-d66311e03db5">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc5a0abf78444e0842fe3e1f0f3ca37_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctMi0xLTEtMA_7660345b-d0df-4fe1-9d5c-bb1d10305fcd">82,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b3b046492264f83b1bdda8c4af96853_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctNC0xLTEtMA_03e15d12-9f35-46a4-b323-d1c71bd0c87c">5,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifec541285c404f83866591c6e23fb0e4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctNi0xLTEtMA_58e034a8-5a67-4c12-bd34-eb6ba40b59e0">13,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f66841395594a8eb57dc2f4410517fa_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctMTAtMS0xLTA_26efd2e2-8706-4a43-a2f0-8ac7268807d0">74,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company reclassified a loss of $<ix:nonFraction unitRef="usd" contextRef="ied2d80105ffa4482aed85b57eea1cada_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzIzMg_d74db1e2-c749-4715-a491-7681bf817761">12.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7bdd1096ee664d10a6e61b228ea2a3df_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzk4OTU2MDQ2NTAzODE_cbbc8177-b1ba-4bdc-8f0b-cace48c511c0">6.6</ix:nonFraction>&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 43</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90ZXh0cmVnaW9uOjYzYjlmMGZjZjBlMjRiMTFiYjc1Njg0MWI3MGFlNTg0XzMxNTU_ee866dc6-c2b6-4be6-8a18-c9f6d3b7d6e0" continuedAt="i38eaad09f4624ec7af0be46f7906920e" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i38eaad09f4624ec7af0be46f7906920e"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2020 and 2019 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90ZXh0cmVnaW9uOjYzYjlmMGZjZjBlMjRiMTFiYjc1Njg0MWI3MGFlNTg0XzMxNDg_f32f51e9-6921-4419-936f-dbbe640492bb" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2020 and 2019 is as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538dfb31e082468593d9ba7bb909acfa_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItMi0xLTEtNTIyMA_ce7667b8-624d-4de0-bf59-3b7080d2f789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7690a3012a274b599aaf7c76ca6b957b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItMi0xLTEtMjg4Ng_a99526f3-7888-4243-9f5f-83526fe6e6d4">14,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8333dd78848247469f7bf32fef58b0db_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItNC0xLTEtMjg5MA_15086d46-7282-4704-ab13-dcd41d918dc0">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtMi0xLTEtNTIyNw_e9f66244-8d33-48f1-baca-8db495d0bae1">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77408f824582469ea836cdd585f88b2b_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNC0xLTEtNTI1NA_f97ff33c-5840-4d8c-bc4d-ab904be37d6a">3,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNi0xLTEtNTI1OA_585ef832-82e1-441b-9745-2d961185e4d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtMi0xLTEtNTIzMg_13f2cadb-68ac-4353-a357-aee7f011b853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77408f824582469ea836cdd585f88b2b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtMi0xLTEtMjkxMA_bde0d7fd-8868-4f9d-af42-af801f54780a">951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNC0xLTEtMjkxNA_692f2a80-f2cf-4bf6-b8cf-b50768759d15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4563e0592c40fe8a9fa8580f8985a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzctMi0xLTEtNTI4MA_9ddeed30-9b5e-4a60-a88e-782f6e66b13d">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i199d883ab45d4d4c923d9ec6bdebfc34_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtMi0xLTEtNTA2Ng_47e52075-9de2-4ffc-8dbe-b5c9118d0334">11,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77d428b66b340ff9b3911c6b4f91b35_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtNC0xLTEtNTA2OA_865c47f9-0425-484a-a538-2f5685cb3d56">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0220d6c969a24d77a0ae61fb694918c6_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzItMi0xLTEtMA_d2c924af-21d8-4058-b234-11abe182824c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee18fbfc3a8b42098ed3d5d2cbcb6209_I20181231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzItNC0xLTEtMA_92dfd5e5-6ef1-480a-b370-9ab85307a28e">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions from acquisition of Arkis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzMtMi0xLTEtMA_705afc88-698a-4a8d-9ee0-d1d4820cdeae">13,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzUtMi0xLTEtMA_0b194b09-2a26-487b-b49c-550bc049f3de">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76aeec8929647b3b5f7a4e8e1a3555f_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzUtNC0xLTEtMA_378aa574-5a76-49ce-a3ff-31285e55cebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7690a3012a274b599aaf7c76ca6b957b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzYtMi0xLTEtMA_9a39cba9-4cce-4210-8c74-9781d2eb2e36">14,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8333dd78848247469f7bf32fef58b0db_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzYtNC0xLTEtMA_f7c6dc80-4416-419e-99f3-75fbd48efb3f">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_232"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzIxNjk_966d7090-4ee5-4712-a682-8462acf99345" continuedAt="ie95de5969f14434b972fac08e94b01eb" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ie95de5969f14434b972fac08e94b01eb"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;<ix:nonFraction unitRef="segment" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzc1_8566d549-6372-41fb-956e-dab708eda680">two</ix:nonFraction>&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;<ix:nonFraction unitRef="segment" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzE5MA_20f0eb64-9dd7-4296-bd6e-3493b19f8773">two</ix:nonFraction>&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than <ix:nonFraction unitRef="product" contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="iart:SegmentReportingInformationNumberOfProductsOffered" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzY1OQ_01c365a4-b3ea-4b1e-a7ce-4a4308482459">40,000</ix:nonFraction> instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzIxNjE_b662bc27-663b-4d57-ad76-b5e4e5d91bae" continuedAt="i5d86f96da52240e7bb0622212fa22b35" escape="true">Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i5d86f96da52240e7bb0622212fa22b35" continuedAt="ibfa121b549a54e54aeeee0c4bdb191ae"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtMS0xLTEtMA_0afcc158-9812-4376-b72e-0a85fae68118">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtMy0xLTEtMA_df9a0255-e019-4206-a9b3-63d462f8041e">996,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtNS0xLTEtMA_f4de7c75-d0dc-438c-a714-24102793548b">963,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtMS0xLTEtMA_7e027072-d553-4d9c-bbb8-9efcfd3106cd">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtMy0xLTEtMA_ac5e10b6-d54c-484f-973f-d4e245772fff">521,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtNS0xLTEtMA_5556f0ce-0f86-48fe-958a-0a8b3a6fa2b5">508,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtMS0xLTEtMA_aa527c2b-5135-4191-b85a-3fdb259497d8">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtMy0xLTEtMA_4fcd484e-8459-4445-9286-ee4d52660e69">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtNS0xLTEtMA_b4335d84-21a3-404f-8672-75ff69455a6c">1,472,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a492f361fc641fcb8a66e8610864f1b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtMS0xLTEtMA_b269bbc7-cf98-4871-80ee-063b426e66f4">356,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a577c66303495c9c64b30f3697ad11_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtMy0xLTEtMA_5946781b-cb59-4c58-a318-05280c344f23">395,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2760ceb9e4f12a8d64b4b643f2254_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtNS0xLTEtMA_93cdbfae-055e-4c2c-969e-afec5a27ec4a">363,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebb1da81e224630986e6e6ff2c7c7f3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktMS0xLTEtMA_9853e76d-f80f-40c7-b1cb-6dcb04ff07e5">159,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea59ee130b064410ba6588bc3f86922c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktMy0xLTEtMA_8cde2749-ee45-4e9c-96ea-36b9d9b785bc">144,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c9f30770ba94367a94a9f76eda74407_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktNS0xLTEtMA_7dd4730c-b79d-450c-8812-32e9d319ad96">149,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339f7ff81b9436da44be79de840be6c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTEtMS0xLTA_3ca5cbcc-a0bb-4889-a9d9-25ecaf4ac6c6">516,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d605ea1557460e8056284eeac6508e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTMtMS0xLTA_80195732-d9a3-4bb4-928a-2a230ecbdbf4">539,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0b754b8abd4e25ababaec4ec893e6c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTUtMS0xLTA_17c3cb94-b54b-43cf-ae6c-2a0fdde42b3e">512,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTEtMS0xLTA_6956763e-bba1-4a1e-b720-c1cb26fd1182">27,757</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTMtMS0xLTA_54ad6a26-6ca7-48ed-ac71-aa0916acfbc2">27,028</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTUtMS0xLTA_bc43f529-c3a8-41ff-8948-5156fa07e99e">21,160</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74738422d75348bcba75c40c5f3ddfcb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTEtMS0xLTA_50712e6b-c93e-41a1-8328-5aaefe2cc423">337,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeb51ca4dfba44ab9a951fe9bc3434c2_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTMtMS0xLTA_93139605-ebc6-4198-97fb-dbac3a7ede83">418,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44e1eb3bcc0f40f5950dfd270c3208b3_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTUtMS0xLTA_232ea09e-4646-4b60-9579-806a9b01cee1">380,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTEtMS0xLTA_f4bb206c-dc31-4d5c-9e98-4c5e71294026">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTMtMS0xLTA_5c86358c-5d71-426b-b75f-ed5d8f341f7c">93,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTUtMS0xLTA_89a95241-ecd9-4ae1-8f85-1f95f25530d5">110,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company attributes revenue to geographic areas based on the location of the customer. <ix:continuation id="ibfa121b549a54e54aeeee0c4bdb191ae" continuedAt="ia1dd27e60cb34c689c9b0f4c021d5097">Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </ix:continuation></span></div><ix:continuation id="ia1dd27e60cb34c689c9b0f4c021d5097"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9fed755274b8bab9f12726270620d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtMS0xLTEtMA_724064c8-377c-48e2-aa9d-485f66a20a99">971,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab753bf745234f46a5d7d0762901ed84_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtMy0xLTEtMA_b541814f-6b52-4a89-be57-16378e072fd7">172,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312af3201ee346458bf3076a77de0b3e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtNS0xLTEtMA_2c88f4dc-b248-4477-bc1c-b4204c013fd8">157,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da3dc5527e64b279b398c99855b2504_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtNy0xLTEtMA_ac13579d-fdd4-434f-842d-4cf232666e39">70,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtOS0xLTEtMA_69b2b5e7-b32c-4702-95ab-c255de7f1797">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39dc2f2111394426b38f70b228c05252_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtMS0xLTEtMA_78dede86-7450-4d97-a8db-ef8b303630cd">1,077,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd720fd7705748f5b9f4dd5218b65a36_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtMy0xLTEtMA_c6a6398a-dd0d-46cc-82c0-17153fcaad2a">197,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f314852dfa54284ab10723c587b8b21_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtNS0xLTEtMA_5a33dc7f-7801-4767-97fc-c54fa2daf6e0">157,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c94f499c38242379f9bbbeea658eb17_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtNy0xLTEtMA_c90119f4-510e-40e9-87c8-3d7067812b66">85,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtOS0xLTEtMA_90af57c0-7cab-4a1b-912e-588fa398391a">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f21d5bd0b244efd8b12f153cded75a9_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtMS0xLTEtMA_4390db1a-2887-4ac6-a972-0f924d7d46f1">1,045,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e91b9abbee04f569341599829c2c727_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtMy0xLTEtMA_82b03a9d-66b6-45f3-b9ad-15ad788b5b1b">201,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc989d0ee9f45a6a3f3bd44a0972156_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtNS0xLTEtMA_c7c3736e-3072-487b-9088-19d69d5b0154">144,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6f47f06a0f24932a7f6cda6d309f09f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtNy0xLTEtMA_d7113809-3400-4b06-b4b1-2c8cda06a671">80,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtOS0xLTEtMA_c13d7e1a-8242-41ba-bd7a-b51bc565d1fc">1,472,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cc64b365d84a6ca6fc1c66b40c0afe_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctMS0xLTEtMA_2727a74f-3e8a-47db-ae8b-8171a1225038">324,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffdd35dd74547d58bb2c5c82ed5912f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctMy0xLTEtMA_29cab8cb-5445-4ec9-b143-dab6f9683fad">38,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec02ac258524a4f81b14306dd3256d8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctNS0xLTEtMA_bf0d5f0a-a7d6-419b-a2e7-2b75311b7bcc">13,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec796a8dea1494f959cf4013fc839af_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctNy0xLTEtMA_9f34aa39-05ce-4200-8760-d15f56b2e9d8">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctOS0xLTEtMA_a57b031d-53a6-4324-9b4a-8bc473ed4b5e">382,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i487980db30c14d9298651dad86a5d2cb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtMS0xLTEtMA_ec8c0b93-34f6-4d0d-9cf5-16679318f4ee">383,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d472c1a60c4976af5221d730388b12_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtMy0xLTEtMA_2d04a240-f1ed-47f8-b545-84ce7e5e99ba">47,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11b11343fea42b7b40dc6964a49dc48_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtNS0xLTEtMA_fa633343-6f01-4960-bc76-02fc0b9ff7ac">8,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfda1bfd48c4de2b4ae4d4bdf4a010d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtNy0xLTEtMA_9f21b8a7-f9ea-4851-988c-a575c5ab156e">7,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a841c52734456191bb4acc617e9711_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtOS0xLTEtMA_c73c5a45-f11a-4fa2-99e3-5ce63934f439">446,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes long-lived assets in Puerto Rico.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 45</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_235"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzI4NDU_807266c9-8b1f-4603-95c4-c945dd071a76" continuedAt="i270d8477a94345a085020e653661b4c7" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="i270d8477a94345a085020e653661b4c7"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement (see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited. The Company received an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4NjI_397ece0b-c950-4f76-8f5d-c5aca9b0564f">240.0</ix:nonFraction>&#160;million from Smith and Nephew and concurrently paid $<ix:nonFraction unitRef="usd" contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104" decimals="-5" format="ixt:numdotdecimal" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4Nzg_a421ce13-d109-41bb-8d6d-b16d75287470">41.5</ix:nonFraction>&#160;million to CFO effectively terminating our licensing agreement (see Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ACell Inc. Acquisition</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell, Inc. for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="ic1cbbb9e128841cf9fa63ba54ab3ffa8_D20210120-20210120" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4OTM_5e504d8e-320e-4b48-8bc4-769d961f15f1">300</ix:nonFraction>&#160;million. Under the terms of the definitive merger agreement, the Company paid the consideration for the merger as an upfront cash payment subject to a customary post-closing adjustment for certain working capital. The Company is also required to pay the former shareholders of ACell Inc. up to $<ix:nonFraction unitRef="usd" contextRef="ib8aec2854c5740fcb5bf9baf57f0ef8a_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY5MDc_1ebe8af4-42b8-4361-96a6-419f4ebb6055">100</ix:nonFraction>&#160;million based upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Equity Award Plans</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and <ix:nonFraction unitRef="shares" contextRef="ia880589c0d5d4323b971f4a8272c48aa_I20210219" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ5MDQ1Nzg_abad81fa-87f4-4882-b6e9-8be9de4cb01d">no</ix:nonFraction> further awards may be issued under the plans.</span></div></ix:continuation><div id="i0e66bbc7ee8049f2984ce8179f803ee5_241"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90ZXh0cmVnaW9uOjc0NDdmZWM5MTExNTQ0ODRhODlhNWYyYzFmNjFiYWUyXzQxNg_c599f7b5-1391-4ec0-8e3f-f4790715177b" continuedAt="i627030284efb4d5a9eb8b1c367bbcccb" escape="true">SELECTED QUARTERLY INFORMATION - UNAUDITED</ix:nonNumeric></span></div><ix:continuation id="i627030284efb4d5a9eb8b1c367bbcccb"><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90ZXh0cmVnaW9uOjc0NDdmZWM5MTExNTQ0ODRhODlhNWYyYzFmNjFiYWUyXzQxMw_90a0abc7-f016-4f0b-8f89-ea1dfbf561f3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross margin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Basic (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Diluted (1)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtMS0xLTEtMjk3Mw_35ca30c9-7be2-4023-8406-a0568d645f3d">354,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtMy0xLTEtMjk3Nw_6fdef3fc-659b-4feb-98bc-610b2208d0f8">220,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtNS0xLTEtMjk4MQ_627067fb-5c4c-4fb4-bc3a-34079c528472">9,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtNy0xLTEtMjk4NQ_a9d08f70-f247-4593-ad38-bd4f35268f4a">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtOS0xLTEtMjk4OQ_c094a6a2-4378-47f8-8338-b8cd37d12590">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMS0xLTEtMjk3Mw_50e89bc7-d4d0-4ba1-9879-dc1be71d62bc">258,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMy0xLTEtMjk3Nw_60b99ba1-778e-4853-b632-1a74cfd2f8ca">153,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNS0xLTEtMjk4MQ_51ba1d70-61cc-45ad-938b-c16453ff0243">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNy0xLTEtMjk4NQ_d92ddc1c-45ae-490f-9d06-2accb317d2f5">0.00</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtOS0xLTEtMjk4OQ_07ab067c-64de-4108-b3ca-ce41a21782ad">0.00</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMS0xLTEtMjk3Mw_8a49aefd-095c-4e6c-acbb-be01cc155826">370,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMy0xLTEtMjk3Nw_2615e1b3-dfb5-4c16-a054-a949c5929b28">235,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNS0xLTEtMjk4MQ_08991807-d81d-439e-be87-307ed1fcbeaf">32,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNy0xLTEtMjk4NQ_410aff70-71ab-454c-8f13-c78337dc24b9">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtOS0xLTEtMjk4OQ_1773ea32-5ff8-4b55-aea1-e7cced43b46a">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMS0xLTEtMjk3Mw_3f951200-1502-4338-87e3-93cd0cb4ae17">388,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMy0xLTEtMjk3Nw_8d013519-8b8b-42e9-a0da-dc1de063bbb3">241,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNS0xLTEtMjk4MQ_b01f5b8e-bfe3-472e-9705-315482d8f42f">92,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNy0xLTEtMjk4NQ_11e49536-7d66-46fe-99d6-75596b108b20">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtOS0xLTEtMjk4OQ_96777c84-ef1b-4c8a-a5c2-621e24d5de6b">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMS0xLTEtNTA5NA_97b301da-5202-4746-b6e8-dc8008b815aa">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMy0xLTEtNTA5Ng_17fda659-722f-43bf-be64-0689c9d5342b">851,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtNS0xLTEtNTA5OA_946b1a82-e73c-417c-bd5b-670e048dc4ac">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMS0xLTEtMA_4c7cab4a-ce2f-4737-aeeb-e5d2baaf476d">359,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMy0xLTEtMA_e31615eb-882b-4442-9d5d-3d6cc8d8c9e8">230,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNS0xLTEtMA_f69c1469-20bc-4e8c-89fa-617d5b7796cf">32,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNy0xLTEtMA_ace25758-ef3d-4b47-a5f6-c793b968dd9c">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtOS0xLTEtMA_6b2472a9-ba70-47f4-98a0-8b1681aba211">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMS0xLTEtMA_0906d4e3-dad6-4d59-bd19-2487312ec261">383,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMy0xLTEtMA_025d7a18-cc35-4607-a8fa-2e0f150c7f31">239,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNS0xLTEtMA_a2cf24c5-2cb9-4a7b-b24c-0e2fa40dd1ad">29,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNy0xLTEtMA_fba6caac-1018-4390-887e-ad8dcf38a22c">0.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtOS0xLTEtMA_20bbefb1-2ec2-446c-81d1-f561e74cf246">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMS0xLTEtMA_3cc20bb0-e601-4f2a-a9a5-81cc7e2662b9">379,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMy0xLTEtMA_ae8d1595-50c1-4490-84d8-5f826d4c6f64">236,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNS0xLTEtMA_c137d9d1-d60d-483f-9aa2-02a5018907b7">27,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNy0xLTEtMA_fd8af386-1f4a-43e9-9ddf-9a514a43226f">0.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtOS0xLTEtMA_560841d2-a412-411b-8abf-9d45ec76e607">0.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctMS0xLTEtMA_077721bb-4391-4e61-9650-5ce4aeeb6b45">395,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctMy0xLTEtMA_75669411-c78a-42ea-a924-ab16e2bd384d">245,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctNS0xLTEtMA_004f7c3b-5205-4569-ba89-f842af9e4dea">15,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctNy0xLTEtMA_164a7505-d7e4-4026-aff6-5174262b69ec">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctOS0xLTEtMA_227ac898-7c5c-42fb-9c3b-16c173647248">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMS0xLTEtMA_62a9ff45-5802-4c93-8240-197299cffa3f">1,517,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMy0xLTEtMA_8a443d77-2b65-4f98-b457-dc8a04e0079f">952,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtNS0xLTEtMA_eb9d09c1-0310-4bb2-82c6-8ace011bbcdf">50,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company&#8217;s issuing and repurchasing shares of its common stock during the year.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 46</span></div></div></div><div id="i0e66bbc7ee8049f2984ce8179f803ee5_244"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90ZXh0cmVnaW9uOjc3YTc3MmQ0OTBiOTQ3NGNhZWZlYzczMzQ4OTJmOGRhXzc1Mg_a6fcb9ce-3509-44f1-82cc-b4f5d2b2a4c6" escape="true"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.690%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMS0xLTEtMzAxOA_4473de73-c20a-4748-bff3-cd0a6e8dadc3">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMy0xLTEtMzAyMg_e6f5e4f5-25f0-4d4b-ba2d-306a6ea678f9">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNS0xLTEtMzAyNg_f460f340-c7de-4277-ad42-a2f2bd9dd4c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNy0xLTEtMzAzMA_23215f7e-1997-474c-8384-0616f2adfb0c">1,499</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id717ba89e124459c8d3ed604888d7343_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtOS0xLTEtMzAzNA_4d0eb3b9-8272-4dfd-91fc-72b7e9623bdf">6,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8d0b64387943148ed765fd23753bc5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMS0xLTEtMzAxOA_c79d0aa1-fab9-4784-8915-b59291f4115b">12,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMy0xLTEtMzAyMg_1db1d95f-39e5-4351-829d-5f6661b47579">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNS0xLTEtMzAyNg_65a5f079-623e-4981-9ed5-0ffc59eace0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNy0xLTEtMzAzMA_356f9fb9-54be-41ec-851c-618bd8f2fb06">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd07fac1f2c4ee7b985bcbb9e9e40cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtOS0xLTEtMzAzNA_b651f5e8-6a4a-4f35-9eac-b2924b4efee2">13,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474dfc678b2e48f7b2fd713e31a2915a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMS0xLTEtMA_1654ea18-113e-4d51-98fb-d5c9ecc5ceb7">3,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMy0xLTEtMA_45d5b0c8-05af-41d1-a36e-ac65957d56c7">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNS0xLTEtMA_d573c025-5950-4a3b-9672-60924af07666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNy0xLTEtMA_37f2b98a-7a97-401c-9a35-266a3b11dc72">1,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtOS0xLTEtMA_aa5cfce7-274e-4915-b27c-a3fcc5c35951">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied10a71639c3481ba9aefa7b862c3fbf_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMS0xLTEtMA_8b0ee202-ad37-4e8a-98a8-a27e64a078e2">6,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMy0xLTEtMA_38efb1f2-c894-4529-9f5a-dceeabf933fc">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNS0xLTEtMA_73e2be60-a1a3-4c5d-871a-2e425db01f56">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNy0xLTEtMA_4115fbf6-d137-4ecb-996b-e3bbc7d23f56">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8d0b64387943148ed765fd23753bc5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtOS0xLTEtMA_55ff0569-6e73-43eb-9697-9d1996111361">12,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab29dbb0b9741c09878d1f0e26205c2_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctMS0xLTEtMA_d9113279-cdc8-4589-9a90-0256fae3fe0b">8,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctMy0xLTEtMA_d84262bb-89c1-4c4d-9db3-df77d3e445ad">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctNS0xLTEtMA_6261884d-906e-4136-93fe-0f5bede9372d">4,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctNy0xLTEtMA_11bd16f2-8bd4-4791-92f6-9167ebb2b8e9">1,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474dfc678b2e48f7b2fd713e31a2915a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctOS0xLTEtMA_b49ba2af-cf5d-4b54-aca1-cc837f378524">3,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ad85cfd93e4d96b0dd6c63182cff35_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtMS0xLTEtMA_45d07768-1e72-4745-981f-771b0b20a345">7,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtMy0xLTEtMA_197ccaeb-5fd8-47e3-b6dd-c8023a9d8f4a">894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtNS0xLTEtMA_cfe68cda-877f-4f78-a615-136d2a35f4ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtNy0xLTEtMA_a8ba03bf-970f-46e2-8f1f-c51985b6f67f">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied10a71639c3481ba9aefa7b862c3fbf_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtOS0xLTEtMA_7001acb6-e848-4542-ad85-3151808b9581">6,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The Company transferred sales returns and allowances from accounts receivable, net to accrued expenses and other current liabilities upon adopting Topic 606 on January 1, 2018 using the modified retrospective method.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 47</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1B
<SEQUENCE>2
<FILENAME>iart-20201231xexx21b.htm
<DESCRIPTION>EX-2.1B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ifac543e3a67740e19cc6ba143c7c6848_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AGREEMENT AND PLAN OF MERGER</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">by and among</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ILS OCEAN 12-20 CORP.&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACell, INC.&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">and</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FORTIS ADVISORS LLC, as the Security holders&#8217; Representative</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Dated as of December 15, 2020</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifac543e3a67740e19cc6ba143c7c6848_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 1.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of Transaction</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Merger of Merger Sub into the Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Effect of the Merger</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Closing&#59; Effective Time</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certificate of Incorporation and Bylaws&#59; Directors and Officers.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conversion of Shares</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Treatment of Company Options.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payoff Letters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Further Action</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Closing of the Company&#8217;s Transfer Books</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.10</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exchange&#47;Payment.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.11</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Post-Closing Adjustment to Closing Merger Consideration Amount.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.12</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Earnout Consideration.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.13</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">PPP Forgiveness</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.14</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Post-Closing Distributions.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.15</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Appraisal Rights.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.16</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Securityholders&#8217; Representative.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1.17</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Escrow Agreement.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 2.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Representations and Warranties of the Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Due Incorporation&#59; Subsidiaries&#59; Etc.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certificate of Incorporation and Bylaws</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Capitalization, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Statements.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">28</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Absence of Certain Changes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">28</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Title to and Condition of Assets</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Real Property&#59; Leasehold.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Intellectual Property.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">30</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Regulatory Matters.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">32</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.10</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Material Contracts.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">35</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.11</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Liabilities</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.12</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Compliance with Laws&#59; Export Controls.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.13</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Business Practices</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">39</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.14</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Tax Matters.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">39</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.15</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Employee Benefit Plans and Employee Matters.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">41</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.16</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Environmental Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">46</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.17</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insurance</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">46</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.18</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Legal Proceedings&#59; Orders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">46</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.19</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Authority&#59; Binding Nature of Agreement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">47</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.20</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Vote Required</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">47</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.21</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-Contravention&#59; Consents</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">47</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.22</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Advisor</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">48</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4811-8328-4177 v.14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(continued)</font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.23</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Related Party Transactions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">48</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.24</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Inventory.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">48</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.25</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Customers and Suppliers.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.26</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Takeover Statutes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.27</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Bank Accounts, Books and Records</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.28</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Warranty Matters.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.29</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Accounts Receivable</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">50</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2.30</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Reliance</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">50</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 3.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Representations and Warranties of Parent and Merger Sub</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">50</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Due Incorporation&#59; Subsidiaries</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">50</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Authority&#59; Binding Nature of Agreement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">50</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-Contravention&#59; Consents</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">51</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Litigation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">51</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Merger Sub</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">51</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Reliance.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">51</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Parent Vote Required</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">52</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">3.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Availability of Funds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">52</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 4.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Covenants of the Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">52</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Access</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">52</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conduct of the Business of the Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">53</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Solicitation.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">56</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Additional Financial Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Financing Cooperation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 5.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Additional Covenants of the Parties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Stockholder Consent or Approval.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Regulatory Filings&#59; Reasonable Best Efforts.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">58</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Employee Benefits.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification of Officers and Directors.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">63</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Disclosure</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transfer Taxes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notification of Certain Events</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">PPP Loan Forgiveness</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Tail Policy</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5.10</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Designated Contracts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 6.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conditions Precedent to Obligations of Parent and Merger Sub</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Accuracy of Representations and Warranties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Performance of Covenants</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Stockholder Approval</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Antitrust Clearances</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Restraints</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Governmental Litigation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">67</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(continued)</font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Agreements and Documents</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Estimated Closing Statement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Closing Certificate</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.10</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Company Material Adverse Effect</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.11</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Written Consent and Support Agreements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.12</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Third Party Consent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">6.13</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">PPP Loan Escrow</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 7.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conditions Precedent to Obligation of the Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Accuracy of Representations and Warranties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Performance of Covenants</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Stockholder Approval</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Antitrust Clearances</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Restraints</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Governmental Litigation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Closing Certificate</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">7.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payments, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 8.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">70</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification of Parent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">70</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification of Participating Securityholders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Direct Claim Indemnification Mechanics.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Third Person Claim Indemnification Mechanics.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">72</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Survival</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">74</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Sole and Exclusive Remedy&#59; Limitations.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">75</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">R&#38;W Insurance.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Determination of Indemnification Amounts.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Tax Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">78</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 9.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Termination</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">9.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Termination</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">9.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Effect of Termination</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 10.</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Miscellaneous Provisions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.1</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Amendment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.2</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Expenses</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.3</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Waiver.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.4</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Entire Agreement&#59; Counterparts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.5</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Applicable Law&#59; Jurisdiction</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.6</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Assignability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.7</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Confidentiality</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.8</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Third Party Beneficiaries</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.9</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.10</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Severability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">86</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.11</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Knowledge</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">86</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(continued)</font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.12</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conflict of Interest</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">87</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.13</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Attorney-Client Privilege</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">87</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.14</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Implied Representations</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.15</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Specific Performance</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.16</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Construction.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10.17</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Disclosure Schedule</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ifac543e3a67740e19cc6ba143c7c6848_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">89</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><div id="ifac543e3a67740e19cc6ba143c7c6848_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Certain Definitions</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Form of Written Consent </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Form of Support Agreements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Form of Letter of Transmittal</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Illustrative Example of Adjustment Amount </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Illustrative Calculation of Closing Date Net Working Capital</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Form of Escrow Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Illustrative Calculation of Earnout Payments</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;HCP Attestation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;- &#160;&#160;&#160;&#160;Form of Securityholders&#8217; Representative NDA</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;-&#160;&#160;&#160;&#160;Form of Non-Competition Agreement and List of Signatories </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;- &#160;&#160;&#160;&#160;Severance Amount</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;- &#160;&#160;&#160;&#160;Termination Letter</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="ifac543e3a67740e19cc6ba143c7c6848_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AGREEMENT AND PLAN OF MERGER</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This Agreement and Plan of Merger </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(as may be amended from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of December 15, 2020, by and among&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Integra LifeSciences Holdings Corporation, a Delaware corporation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ILS Ocean 12-20 Corp., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ACell Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fortis Advisors LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware limited liability company, as the Securityholders&#8217; Representative.  Certain capitalized terms used in this Agreement are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Recitals</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.34pt">Parent, Merger Sub and the Company intend to effect a merger of Merger Sub into the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in accordance with this Agreement and the Delaware General Corporation Law, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Upon consummation of the Merger, Merger Sub will cease to exist as a separate corporate entity, and the Company will become a wholly-owned subsidiary of Parent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:25pt">The respective boards of directors of Parent, Merger Sub and the Company have approved this Agreement and approved the Merger and the other transactions contemplated by this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:25pt">As a material inducement to Parent&#8217;s and Merger Sub&#8217;s willingness to enter into this Agreement, promptly after the execution and delivery of this Agreement and in any event within twenty-four (24) hours, the Company shall have obtained (i) the Initial Company Stockholder Vote via Written Consents in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and Support Agreements in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Support Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) from holders representing the Initial Company Stockholder Vote.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.34pt">As a material inducement to Parent&#8217;s and Merger Sub&#8217;s willingness to enter into this Agreement, concurrently with the execution of this Agreement those Persons set forth on Part 1 of Schedule I have entered into a Stockholder Non-Competition and Non-Solicitation Agreement in the form set forth on Part 2 of Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by and between such Person and Parent.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties to this Agreement, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Description of Transaction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Merger of Merger Sub into the Company</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease.  The Company will continue as the surviving corporation in the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and an indirect wholly-owned subsidiary of Parent.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Effect of the Merger</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL.  Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, except as otherwise agreed pursuant to the terms of this Agreement, all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Closing&#59; Effective Time</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise mutually agreed in writing between the Company and Parent, the consummation of the transactions contemplated by this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall take place at the Company&#8217;s offices, at 10&#58;00 a.m. New York time on either (i) January 4, 2021&#59; provided that, all conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) are satisfied on or before December 30, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions) or (ii) otherwise, the date after January 4, 2021 that is the second Business Day after the date on which the last to be satisfied or waived of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) are satisfied (other than  those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions) (the actual date of the Closing, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Subject to the provisions of this Agreement, a certificate of merger satisfying the applicable requirements of the DGCL (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be duly executed by the Company and, concurrently with or as soon as practicable following the Closing (but no later than the Closing Date and no earlier than the confirmation of receipt of the Upfront Payment Amount by the Payment Agent to Parent and the Company), delivered to and filed with the Secretary of State of the State of Delaware in accordance with the DGCL.  The Merger shall become effective upon the date and time of the filing of such Certificate of Merger with the Secretary of State of the State of Delaware, or at such later time as may be mutually agreed in writing by the Company and Parent and specified in the Certificate of Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Certificate of Incorporation and Bylaws&#59; Directors and Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)The certificate of incorporation of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time until amended in accordance with the DGCL, except that the certificate of incorporation shall be amended to change the name of the Surviving Corporation to &#8220;ACell, Inc.&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)The bylaws of the Surviving Corporation shall be amended and restated immediately as of the Effective Time to conform to the bylaws of Merger Sub as in effect immediately prior to the Effective Time until amended in accordance with the DGCL.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)The directors and officers of the Surviving Corporation as of the Effective Time shall be the respective individuals who are directors and officers of Merger Sub immediately prior to the Effective Time, until the earlier of their removal or resignation or until their respective successors are duly elected and qualified, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Conversion of Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any Securityholder&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)any shares of Company Capital Stock then held by the Company (or held in the Company&#8217;s treasury) shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)any shares of Company Capital Stock then held by Parent, Merger Sub or any other Subsidiary of Parent shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">subsections (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PPP Forgiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appraisal Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), each share of Company Preferred Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Preferred Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash (i) at Closing equal to (x) the aggregate number of shares of Company Common Stock into which such share of Company Preferred Stock is convertible pursuant to the Company Charter immediately prior to the Effective Time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> by (y) the Per Share Upfront Merger Consideration and (ii) in the event any Earnout Payment becomes due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (x) the aggregate number of shares of Company Common Stock into which such share of Company Preferred Stock is convertible pursuant to the Company Charter immediately prior to the Effective Time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> by (y) the Per Share Earnout Payment for each such Earnout Payment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">subsections (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Conversion of Shares) and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PPP Forgiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appraisal Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Common Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to the Per Share Upfront Merger Consideration and, in the event any Earnout </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payment becomes due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Per Share Earnout Payment for each such Earnout Payment&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:58.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)each share of the common stock, $1.00 par value per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into one share of validly issued, fully paid and nonassessable common stock of the Surviving Corporation such that immediately following the Effective Time, Parent shall become the sole and exclusive owner of all of the issued and outstanding capital stock of the Company as the Surviving Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)Company Options shall not be continued, assumed or substituted by the Surviving Corporation or the Parent as part of the Merger.  Instead, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PPP Forgiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), contingent on and effective immediately prior to the Effective Time, each Company Option that is outstanding and unexercised immediately prior to the Effective Time, whether under the Equity Incentive Plans or otherwise, whether or not vested or exercisable (other than Company Performance Options), shall become fully vested and exercisable immediately prior to the Effective Time and to the extent not exercised prior to the Effective Time, shall be cancelled at the Effective Time and, in consideration of such cancellation, the holder thereof shall be entitled to receive, without interest, no later than at the time prescribed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a cash payment in an amount equal to (i) the aggregate number of shares of Company Common Stock issuable upon the exercise of such Company Option, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> by (ii)&#160;the amount by which the Per Share Upfront Merger Consideration exceeds the exercise price per share of such Company Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Options Payout Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and in the event any Earnout Payment becomes due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each such Per Share Earnout Payment, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> applicable Taxes required to be withheld pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any Company Option that has an exercise price per share of Company Common Stock that is greater than or equal to the Per Share Upfront Merger Consideration shall be cancelled at the Effective Time for no consideration or payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)Any Company Option that is a Company Performance Option shall be cancelled at the Effective Time for no consideration or payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)The Company agrees that the Company Board shall adopt such resolutions or take such other actions (including obtaining any required consents) prior to the Effective Time as may be required to effect the transactions described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Payoff Letters</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)Prior to the Closing, but no later than five Business Days prior to the Closing Date, the Company shall deliver customary payoff letters in form and substance reasonably acceptable to Parent (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payoff Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for the Closing Date Indebtedness set forth on </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section&#160;1.7 of the Disclosure Schedule and all other indebtedness for borrowed money incurred between the date hereof and the Closing Date other than the Settlement Debt (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Terminated Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which shall provide that upon receipt from or on behalf of the Company of the pay-off amount set forth in the Payoff Letter, (a) the Terminated Indebtedness incurred shall be satisfied, and all obligations of the lenders terminated (other than those that customarily survive in payoff letters) and (b) if any Terminated Indebtedness is secured, all Liens relating to the assets, rights and properties of the Company with respect to such secured Terminated Indebtedness shall be released and terminated without any further action by the secured parties or the Company or its designee shall be entitled to file documents to reflect the release of such Liens. At the Closing, subject to compliance by the Company with its obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and delivery of such Payoff Letters by the lenders pursuant to the immediately preceding sentence and any other information as may be reasonably required to determine amounts required to pay off, discharge and terminate the Terminated Indebtedness, Parent shall, or shall cause, all Terminated Indebtedness to be paid off and&#47;or terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)Immediately after the Closing, Parent shall pay by wire transfer, all Settlement Debt that represents the criminal settlement amount due from the Company under the Settlement Agreement, as expressly accelerated in Paragraph 8(d) of the plea agreement, to the United States in accordance with the Settlement Agreement.  Within 15 days after the Closing, Parent shall pay by wire transfer, all Settlement Debt that represents the civil settlement amount due from the Company under the Settlement Agreement, as expressly accelerated in Section 1(e) of the civil settlement agreement, to the United States and Medicaid Participating States in accordance with the Settlement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Further Action</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If, at any time after the Effective Time, any further action is necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of Merger Sub and the Company, the officers and directors of the Surviving Corporation and Parent shall take such action, so long as such action is not inconsistent with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Closing of the Company&#8217;s Transfer Books</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  At the Effective Time&#58; (a)&#160;all shares of Company Capital Stock outstanding immediately prior to the Effective Time shall automatically be cancelled and retired and shall cease to exist, and all holders of certificates representing shares of Company Capital Stock that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company, and each certificate representing any such Company Capital Stock (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stock Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or uncertificated book-entry shares (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Book-Entry</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall thereafter represent the right to receive the consideration referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) (or if applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appraisal Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)), if any&#59; and (b)&#160;the stock transfer books of the Company shall be closed with respect to all shares of Company Capital Stock outstanding immediately prior to the Effective Time.  No further transfer of any such shares of Company Capital Stock shall be made on such stock transfer books after the Effective Time.  If, after the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective Time, a Company Stock Certificate or a Book-Entry</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is presented to the Payment Agent or to the Surviving Corporation or Parent, such Company Stock Certificate or a Book-Entry shall be cancelled and shall be exchanged as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)Prior to the Closing Date, Parent shall select a reputable bank or trust company reasonably acceptable to the Company to act as payment agent in the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and enter into a payment agent agreement in form and substance reasonably acceptable to the Company.  Prior to the Closing, Parent shall pay the Payment Agent any upfront administration fee of the Payment Agent and shall deposit, or shall cause to be deposited, with the Payment Agent cash in the amount of the Upfront Payment Amount.  As soon as practicable after the Effective Time, but in no event later than three Business Days after the Effective Time, the Payment Agent shall mail to the holders of Company Capital Stock and the Non-Employee Option Holders, in each case as of immediately prior to the Effective Time&#58; (i) a letter of transmittal in substantially the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (which shall include a waiver and release pursuant to which holder of Company Capital Stock and the Non-Employee Option Holders executes a full and unconditional release regarding any and all claims as a Securityholder, as a condition to receiving the Per Share Upfront Merger Consideration, in favor of Parent, Merger Sub and the Surviving Corporation and its subsidiaries and each of their directors, officers, managers, employees and Affiliates) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (ii) instructions for use in effecting the surrender of Company Stock Certificates or Book-Entries, if applicable, in exchange for the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and (iii) instructions for use in effecting the surrender of Company Options held by Non-Employee Option Holders in exchange for the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  As soon as reasonably practicable upon the later of the Closing and the surrender of a Company Stock Certificate or a Book-Entry to the Payment Agent for payment, together with a duly executed Letter of Transmittal, (A) the Payment Agent shall, and Parent shall cause the Payment Agent to, pay the holder of such Company Stock Certificate, or a Book-Entry, as applicable, in exchange therefor, the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) for each share evidenced by such Company Stock Certificate or a Book-Entry, as applicable (other than amounts payable in respect of Employee Options), and (B) the Company Stock Certificate or a Book-Entry, as applicable, so surrendered shall be cancelled.  If any Company Stock Certificate shall have been lost, stolen or destroyed, Parent or the Payment Agent, as applicable, may, as a condition to the payment of the consideration hereunder with respect to each share of Company Capital Stock evidenced by such Company Stock Certificate, require the owner of such Company Stock Certificate to provide a reasonably appropriate affidavit to Parent or the Payment Agent, as applicable.  As soon as reasonably practicable upon surrender to the Payment Agent of a duly executed Letter of Transmittal, the Payment Agent shall, and Parent shall cause the Payment Agent to, pay each Non-Employee Option Holder, in exchange therefor, the cash amounts payable to such Person in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  Notwithstanding the foregoing, Parent and the Company shall use commercially reasonable efforts to cause (x) the Letter of Transmittal to be made available to each holder of Company Stock Certificate and Book-Entry (if applicable), </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and to each Non-Employee Option Holder, in each case, prior to the Effective Time, and (y) such Person&#8217;s Letter of Transmittal to be reviewed and processed prior to the Effective Time, such that, so long as the Payment Agent receives the Letter of Transmittal by the deadline set forth in the Letter of Transmittal and such Person continues to hold the Company Capital Stock or Company Options, as applicable, described in the Letter of Transmittal as of immediately prior to the Effective Time, such Person will be paid the payment in cash described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), as applicable, with respect to such Letter of Transmittal on the Closing Date.  Notwithstanding the foregoing, in the event that any Non-Employee Option Holder fails to deliver a duly executed Letter of Transmittal by the deadline set forth therein, the Company shall provide the Payment Agent such information with respect to such Non-Employee Option Holder as requested by the Payment Agent, and upon receipt of such information by the Payment Agent such Non-Employee Option Holder will be paid the payment in cash described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). All consideration paid upon the surrender of Company Stock Certificates or Book-Entries (or affidavits of loss in lieu thereof as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) in accordance with the terms hereof shall be deemed to have been paid in full satisfaction of all rights pertaining to the shares of Company Capital Stock represented thereby.  No interest will be paid or accrued on any amount payable for shares of Company Capital Stock pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)On the regular payment date for the next full payroll period that occurs at least five Business Days following the Effective Time (or, in the case of any distribution made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)) and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), Parent shall cause the Surviving Corporation to pay to each Employee Option Holder the applicable amount required to be paid pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), with respect to such individual&#8217;s Employee Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)Any portion of the amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Adjustment to Closing Merger Consideration Amount),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) that remains undistributed by the Payment Agent to a Securityholder as of 12 months after the date of deposit of such amounts with the Payment Agent shall be delivered to Parent upon demand.  Notwithstanding the foregoing, (i) any Securityholder who has not theretofore surrendered the documentation contemplated under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall thereafter look only to the Surviving Corporation and only as general creditors thereof for satisfaction of their claims for the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Adjustment to Closing Merger Consideration Amount),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), as applicable, and (ii) neither Parent, the Surviving Corporation nor any of their Affiliates shall have liability to any Securityholder or other Person for any amount properly delivered to a public official pursuant to applicable abandoned property, escheat or similar Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)Neither Parent nor the Surviving Corporation shall be liable to any holder or former holder of Company Capital Stock or Company Options with respect to any amounts </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">properly delivered to any public official pursuant to any applicable abandoned property Law or escheat Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:58.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)Each of Parent, the Company, the Surviving Corporation and the Payment Agent (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Withholding Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) will be entitled to deduct and withhold from the consideration otherwise payable under this Agreement to any Person the amounts such Withholding Agent is required to deduct and withhold under the Code or any other Tax Law.  If any withholding obligation may be reduced or avoided by any holder of Company Capital Stock, or Company Options providing information or documentation to a Withholding Agent, the Withholding Agent shall use commercially reasonable efforts to reduce or avoid such withholding obligation upon receipt from a Securityholder of information or documentation providing for the same.  To the extent that amounts are so withheld and properly paid-over to the applicable Governmental Body in accordance with applicable Law, such withheld and paid over amounts will be treated as having been paid to such Person in respect of which such deduction and withholding was made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)After Parent delivers any payment to the Payment Agent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Adjustment to Closing Merger Consideration Amount),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) in accordance with any Closing Payment Schedule, each Stockholder will be entitled to look only to the Payment Agent (or, solely if applicable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Surviving Corporation) for any payments due and payable to such Stockholder pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Adjustment to Closing Merger Consideration Amount),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) following the delivery of such Stockholders duly executed Letter of Transmittal, pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)Not fewer than five Business Days prior to the Closing Date, the Company shall deliver to Parent the Estimated Closing Statement and the Closing Payment Schedule accompanied by reasonable supporting detail relating to each component (including bank statements dated as of the date that the Estimated Closing Statement is provided, a reconciliation between any differences in the Estimated Closing Date Cash Amount and the bank statement, debt payoff letters (including Payoff Letters) and invoices).  Upon the delivery of the Estimated Closing Statement, the Company will reasonably make available to Parent and its representatives the work papers and other books and records used in preparing the Estimated Closing Statement.  The Company shall consider in good faith any potential adjustments to the Estimated Closing Statement and Closing Payment Schedule raised by Parent prior to the Closing and, make any corresponding changes to the Estimated Closing Statement and the Closing Payment Schedule that the Company reasonably deems appropriate based on Parent&#8217;s proposed adjustments and shall, at least two Business Days prior to the Closing, reissue the Estimated Closing Statement, Closing Payment Schedule and each component thereof along with any such revisions that the Company has determined are appropriate.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)Within 90 days following the Closing, Parent shall prepare and deliver to the Securityholders&#8217; Representative a written statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) setting forth (i)&#160;an unaudited Closing Date Balance Sheet and (ii) in reasonable detail its calculation of (A) the Closing Date Net Working Capital and the Final Net Working Capital Adjustment, (B)&#160;the Closing Date Cash Amount, (C)&#160;the Closing Date Indebtedness, (D) the Closing Date Transaction Expenses and (E) the Settlement Debt.  Subject to applicable Laws relating to the exchange of information and except as required to comply with any COVID-19 Measures, following the Closing, Parent shall provide to the Securityholders&#8217; Representative and its representatives reasonable access, during regular business hours, in such a manner as to not interfere with the normal operation of Parent or the Surviving Corporation (subject to the execution of customary work paper access letters, if requested), to work papers and books and records relating to the preparation of the Closing Statement and to the employees of the Company, who are knowledgeable about the preparation of the Closing Statement, in each case, solely for the purpose of assisting the Securityholders&#8217; Representative and its representatives in their review of the Closing Statement and the calculations contained therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)If the Securityholders&#8217; Representative disagrees with the calculations in the Closing Statement, the Securityholders&#8217; Representative shall notify Parent of such disagreement in writing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) no later than the 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day after delivery of the Closing Statement.  The Dispute Notice must set forth in reasonable detail (i)&#160;any item on the Closing Statement which the Securityholders&#8217; Representative believes has not been prepared in accordance with this Agreement and the Securityholders&#8217; Representative&#8217;s determination of the amount of such item and (ii)&#160;the Securityholders&#8217; Representative&#8217;s alternative calculation of the Closing Date Net Working Capital and Final Net Working Capital Adjustment, the Closing Date Cash Amount, the Closing Date Indebtedness or the Closing Date Transaction Expenses, as the case may be.  The Dispute Notice shall include only disagreements based on mathematical errors or the failure of the Closing Date Net Working Capital, Final Net Working Capital Adjustment, the Closing Date Cash Amount, the Closing Date Indebtedness or the Closing Date Transaction Expenses to be calculated in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Accounting Principles and the definitions contained in this Agreement (including the inclusion or exclusion of items in the definition and the magnitude of the included or excluded items).  Any item or amount that the Securityholders&#8217; Representative does not validly dispute in reasonable detail in the Dispute Notice within such period shall be final, binding and conclusive for all purposes hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)In the event any such Dispute Notice is timely provided, Parent and Securityholders&#8217; Representative shall use commercially reasonable efforts for a period of 30 days after the date of such Dispute Notice (or such longer period as they may mutually agree in writing) to resolve any disagreements with respect to the calculations included in the Closing Statement that were disputed in the Dispute Notice and all such discussions and negotiations related thereto shall (unless otherwise agreed in writing by Parent and the Securityholders&#8217; Representative) be governed by Rule 408 of the Federal Rules of Evidence (as in effect as of the date of this Agreement) and any applicable similar state rule.  If, at the end of such 30-day period (or such longer period as mutually agreed in writing), the Securityholders&#8217; Representative and Parent remain unable to resolve the dispute in its entirety, then the unresolved items and amounts </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">thereof in dispute shall be submitted to Ernst &#38; Young LLP, or, if Ernst &#38; Young LLP is not available or is providing accounting, tax or audit services to Parent or its controlled Affiliates or the Company for which it is receiving material compensation, a nationally recognized financial services firm, reasonably acceptable to Parent and the Securityholders&#8217; Representative, which shall not be the independent accountants, tax advisors (other than with respect to immaterial matters) or auditors of Parent or the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Dispute Auditor shall act as an expert and not an arbitrator in resolving the matters submitted to it.  The Dispute Auditor shall determine, based solely on the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PostClosing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Accounting Principles and the written presentations by the Securityholders&#8217; Representative and Parent, and not by independent review, only those items and amounts that remain then in dispute as set forth in the Dispute Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:58.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)The Dispute Auditor&#8217;s determination of the Closing Date Net Working Capital, the Final Net Working Capital Adjustment, the Closing Date Cash Amount, the Closing Date Indebtedness or the Closing Date Transaction Expenses, as applicable, shall be made within 30 days after the dispute is submitted for its determination and shall be set forth in a written statement delivered to the Securityholders&#8217; Representative and Parent.  A judgment of a court of competent jurisdiction selected pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Applicable Law&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) hereof may be entered following the Dispute Auditor&#8217;s determination solely for the purposes of enforcing the payment of the specific amount provided by the Dispute Auditor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no party shall make any filing to obtain such judgment unless (i) the payment required by such determination shall not have been made and (ii) 15 days shall have elapsed following delivery of the Dispute Auditor&#8217;s determination and&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any filing to obtain such judgment shall respect the confidential nature of the dispute resolution process provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PostClosing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and shall disclose the details of the dispute only to the extent necessary to obtain a judgment for such payment.  The Dispute Auditor have exclusive jurisdiction over, and resorting to the Dispute Auditor as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be the only recourse and remedy of the parties against one another with respect to, those items and amounts that remain in dispute under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and Parent shall not be entitled to seek indemnification or recovery of any attorneys&#8217; fees or other professional fees incurred by Parent in connection with any dispute governed by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  The Dispute Auditor shall allocate its fees and expenses between Parent and the Securityholders&#8217; Representative (on behalf of the Participating Securityholders) in the proportion that Parent&#8217;s position, on the one hand, and the Securityholders&#8217; Representative, on the other hand (based on the aggregate of all differences taken as a whole), bear to the final resolution as determined by the Dispute Auditor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)The Securityholders&#8217; Representative and Parent shall, and shall cause their respective Affiliates and representatives to, cooperate in good faith with the Dispute Auditor, and shall give the Dispute Auditor access to all data and other information it reasonably requests for purposes of such resolution.  In no event shall the decision of the Dispute Auditor assign a value to any item greater than the greatest value for such item claimed by either Parent or Securityholders&#8217; Representative or lesser than the smallest value for such item claimed by either </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent or Securityholders&#8217; Representative.  Any determinations made by the Dispute Auditor pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be final, binding and conclusive on the parties hereto, absent manifest error or common law fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:51.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the net amount, which may be positive or negative, equal to&#58; (i)&#160; (a) the amount of the Final Net Working Capital Adjustment (based on the Closing Date Net Working Capital (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) the Estimated Closing Date Net Working Capital Adjustment (which amount may be positive or negative))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) (a) the Closing Date Cash Amount (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b)&#160;the Estimated Closing Date Cash Amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;(a)&#160;the Estimated Closing Date Indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b)&#160;the amount of Closing Date Indebtedness (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (iv)&#160;(a)&#160;the Estimated Closing Date Transaction Expenses&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b)&#160;the amount of Closing Date Transaction Expenses (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)).  For the avoidance of doubt, an illustrative example of the adjustment pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:48.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)If the Adjustment Amount is zero or a positive number, then within ten Business Days after the final determination of the amount, Parent and the Securityholders&#8217; Representative shall deliver Joint Written Instructions to the Escrow Agent instructing the Escrow Agent to release the Purchase Price Escrow Amount and Parent shall pay the Adjustment Amount to (x) to the Payment Agent for further distribution to the Participating Securityholders that are holders of Company Common Stock or the Non-Employee Option Holders (other than amounts payable in respect of Employee Options) based on each such Participating Securityholder&#8217;s Ownership Percentage and (y) to the Surviving Corporation for the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after receipt by the Surviving Corporation of the applicable amount, Parent shall cause the Surviving Corporation to pay the portion of the Adjustment Amount and Purchase Price Escrow Amount due to the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options for payment by the Surviving Corporation.  Prior to any such distribution of the Adjustment Amount or Purchase Price Escrow Amount to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the Adjustment Amount payable to each Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)If the Adjustment Amount is a negative number and its absolute value is equal to or greater than the Purchase Price Escrow Amount then within ten Business Days after the final determination of such amount, Parent and the Securityholders&#8217; Representative shall deliver Joint </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Written Instructions to the Escrow Agent instructing the Escrow Agent to release (i) the Purchase Price Escrow Amount and (ii) any amount by which the Adjustment Amount exceeds the Purchase Price Escrow Amount from the Retention Escrow Fund, in each case, to Parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">If the Adjustment Amount is a negative number with an absolute value that is lower than the  Purchase Price Escrow Amount (such difference between the Adjustment Amount and the Purchase Price Escrow Amount, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Shortfall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then within ten Business Days after the final determination of such amount, Parent and the Securityholders&#8217; Representative shall deliver Joint Written Instructions to the Escrow Agent instructing the Escrow Agent to release (x) the Adjustment Amount to Parent, and (y) (A) the portion of the Shortfall due to the Participating Securityholders that are holders of Company Common Stock or the Non-Employee Option Holders (other than amounts payable in respect of Employee Options) to the Payment Agent for further distribution to such Participating Securityholders based on each such Participating Securityholder&#8217;s Ownership Percentage and (B) the portion of the Shortfall due to the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options to the Surviving Corporation and (ii) subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after receipt by the Surviving Corporation of the applicable amount, Parent shall cause the Surviving Corporation to pay the portion of the Shortfall due to the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options for payment by the Surviving Corporation.  Prior to any such distribution of the Shortfall to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the Shortfall payable to each Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">On the Closing Date, Parent shall cause the payment of&#58; (i) the Estimated Closing Date Transaction Expenses, if any, to the Persons identified on the Estimated Closing Statement and (ii) the Estimated Closing Date Indebtedness, if any, to the Persons identified on Section&#160;1.7 of the Disclosure Schedule.  The Company shall deliver all applicable wire instructions for the payment of any Estimated Closing Date Transaction Expenses and Estimated Closing Date Indebtedness to Parent at least five Business Days prior to the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Notwithstanding anything to the contrary contained herein, no line item included in the calculation of Closing Date Net Working Capital and Final Net Working Capital Adjustment, the Closing Date Cash Amount, the Closing Date Indebtedness and the Closing Date Transaction Expenses shall be duplicative of any other line item included in such other calculations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Parent shall pay, or cause to be paid, to the Participating Securityholders for each of calendar year 2022, 2023 and 2025 (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Milestone Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) the following earnout payments (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as follows&#58;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:32.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Milestone Year</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Earnout Calculation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Calendar Year 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an amount equal to (i) the Net Revenue of ACell Products in 2022 in excess of $100,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) 2.7 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Payment 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Earnout Payment 1 shall not exceed $50,000,000</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Calendar Year 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an amount equal to (i)(A) the Net Revenue of ACell Products in 2023 in excess of $100,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) 2.7, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) an amount equal to any Earnout Payment 1 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Payment 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the cumulative payment for Earnout Payment 1 and Earnout Payment 2 shall not be less than $0 nor exceed $50,000,000</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Calendar Year 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an amount equal to (x) $25,000,000 if Net Revenue of ACell Products in 2025  is $175,000,000 or (y) if the Net Revenue of ACell Products in 2025 is greater than $175,000,000, an amount, up to $50,000,000 scaling linearly from $175,000,000 to $200,000,000</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An illustrative calculation of Earnout Payments is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto.</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Subject to the Securityholders&#8217; Representative&#8217;s ongoing compliance with the Securityholders&#8217; Representative NDA in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, within 90 days after the end of each Milestone Year, Parent shall (i) deliver, or cause to be delivered, to the Securityholders&#8217; Representative a statement showing (A) gross revenue of the ACell Products (individually and in the aggregate) during the applicable calendar year, (B) Net Revenue of ACell Products (individually and in the aggregate) during the applicable calendar year and (C) a calculation of the amount of Earnout Payment due for any Milestone Year, if any (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) Parent shall, (A) within five Business Days following the delivery of an Earnout Report, pay, or cause to be paid the portion of the Earnout Payment for such Milestone Year due to the Participating Securityholders that are holders of Company Common Stock or the Non-Employee Option Holders (other than amounts payable in respect of Employee Options) to the Payment Agent for further distribution to such Participating Securityholders based on each such Participating Securityholder&#8217;s Ownership Percentage and (B) subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after the final determination of the applicable amount, Parent shall cause the Surviving Corporation to pay the portion of the Earnout Payment for such Milestone Year due to the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any amounts payable by Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be offset and reduced by any amounts payable by the Securityholders to Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), each of which will be set out in any Earnout Report.  Promptly following receipt of each such Earnout Report and prior to any such distribution of any Earnout Payment to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the Adjustment Amount payable to each Participating Securityholder</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Following the Effective Time until December 31, 2025 (such period the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Milestone Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Parent shall and shall cause its Affiliates to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:101.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">use Commercially Reasonable Efforts to market, promote, distribute and sell the ACell Products (other than Excluded Products)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:98.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not take any action that was specifically intended by any Parent Executive to reduce possible Earnout Payments during the Milestone Period&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">keep adequate books and records to permit the tracking of Net Revenue of the ACell Products (including retaining copies of such books and records and other reasonably necessary information) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">For the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Commercially Reasonable Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means allocating a level of marketing, promotion, distribution and sale efforts and resources substantially similar to those allocated to Parent&#8217;s and its Affiliates&#8217; Comparable Products, including (i) maintaining an adequately sized and competitively compensated sales and marketing team, and (ii) providing product management, marketing communications, customer service, reimbursement support and other marketing support&#59; it being understood that Parent and its Affiliates may consider various factors in the allocation of efforts and resources in respect of Comparable Products including the revenue and margin of a product, market demand, supply and manufacturing constraints, quality-control issues, feedback of customers and Health Care Professionals, regulatory issues and any limitations imposed by applicable Law or regulation&#59; provided that Parent and its Affiliates may not consider a change in corporate strategy or the potential payment of any Earnout Payment in respect of the foregoing.  For the avoidance of doubt, the obligation to use &#8220;Commercially Reasonable Efforts&#8221; shall not require Parent to retain any ACell employees, undertake any research, development or pursuit of additional product indications in respect of any ACell Products nor take any action or engage in any business that would not be in compliance with applicable Law. The parties intend the express provisions of this Agreement to govern their contractual relationship and to supersede any standard of efforts or implied covenant of good faith and fair dealing that might otherwise be imposed by applicable Law, any court or other Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">During the period commencing on the date that is six months following the Closing Date until the end of the Milestone Period, Parent shall, and shall cause each applicable Affiliate to, provide, on a semi-annual basis (within 15 days following Parent&#8217;s filing of its first quarter and third quarter 10-Q), a written report to the Securityholders&#8217; Representative regarding the status of resources and activities relating to the marketing, distribution and sale of ACell Products (each such report, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Update Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), including reasonable details with respect to (i) the sales and marketing practices of ACell Products during the prior six-month period, and (ii) the estimated Net Revenue of ACell Products during the applicable six month period, including whether and to what extent any revenue was excluded from Net Revenue pursuant to the HCP Exclusion. Within 15 days after delivery of an Update Report, if the Securityholders&#8217; Representative in good faith requests a meeting with representatives of Parent or any of Parent&#8217;s applicable Affiliates to discuss such report, Parent shall make available for such meeting at least one employee with operating management responsibility for the activities of Parent or any such Affiliate related to the ACell Products to discuss the content of such report and in good faith answer any reasonable questions the Securityholders&#8217; Representative may have. The parties agree that neither Parent, the Surviving Company nor any of their Affiliates shall have any liability to the Securityholders&#8217; Representative, any Securityholder or any other Person in respect of the information contained in the Update Report and any responses to questions and any other information provided pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; provided that the foregoing sentence shall not limit either the rights of the Securityholders&#8217; Representative to request an audit or dispute the Earnout Report as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> based on the information contained in such Update Report or the rights of the Participating Securityholders to receive the Earnout Payment as finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  The Securityholders&#8217; Representative may not request more than one such meeting for any Update Report.  Promptly </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">following the date of this Agreement, and in any event prior to the Closing, Parent and the Company shall jointly develop and agree on a template Update Report that will serve as the basis for all future Update Reports unless otherwise agreed in writing by Parent and the Securityholders&#8217; Representative. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Within thirty days of the delivery of the Earnout Report, if the Securityholders&#8217; Representative determines, in its good faith judgment, that an audit is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in order to deliver an Earnout Dispute Notice with the detail required by the immediately following sentences of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Securityholders&#8217; Representative may submit a written request to Parent for an audit of the Records on the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Securityholders&#8217; Representative provides such an audit request and the Securityholders&#8217; Representative disagrees with the calculations set forth in Earnout Report, the Securityholders&#8217; Representative shall notify Parent of such disagreement in writing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) no later than the 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day following the date on which such audit is complete.  If the Securityholders&#8217; Representative does not provide such an audit request, and the Securityholders&#8217; Representative disagrees with the calculations set forth in Earnout Report, the Securityholders&#8217; Representative shall deliver an Earnout Dispute Notice no later than the 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day after the delivery of the Earnout Report.  The Earnout Dispute Notice must set forth in reasonable detail (i)&#160;any item in the Earnout Report which the Parent believes has not been prepared in accordance with this Agreement and Parent&#8217;s determination of the amount of such item and (ii)&#160;the Securityholders&#8217; Representative&#8217;s alternative calculation of the items set forth in the Earnout Report.  The Earnout Dispute Notice shall include only disagreements based on mathematical errors or the failure of the items set forth in the Earnout Report to be calculated in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the definitions contained in this Agreement (including the inclusion or exclusion of items in the definition and the magnitude of the included or excluded items).  Any item or amount that Securityholders&#8217; Representative does not validly dispute in reasonable detail in the Earnout Dispute Notice within such period shall be final, binding and conclusive for all purposes hereunder absent manifest error or common law fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">In the event any such Earnout Dispute Notice is timely provided, Parent and Securityholders&#8217; Representative shall use commercially reasonable efforts for a period of 30 days after the date of such Earnout Dispute Notice (or such longer period as they may mutually agree in writing) to resolve any disagreements with respect to the calculations included in the Earnout Report that were disputed in the Earnout Dispute Notice and all such discussions and negotiations related thereto shall (unless otherwise agreed in writing by Parent and the Securityholders&#8217; Representative) be governed by Rule 408 of the Federal Rules of Evidence (as in effect as of the date of this Agreement) and any applicable similar state rule.  If, at the end of such 30-day period (or such longer period as mutually agreed in writing), the Securityholders&#8217; Representative and Parent remain unable to resolve the dispute in its entirety, then the Securityholders&#8217; Representative may, within five (5) Business Days following the end of such 30-day period, (i) submit a written request to Parent for an audit of the Records on the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (x) such an audit was not already conducted prior to delivering such Earnout Dispute Notice in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (y) such request is made on the basis of the Securityholders&#8217; Representative&#8217;s good faith belief that such audit is </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">required to resolve any disagreements with respect to the calculations in the Earnout Report or (ii) submit the unresolved items and amounts thereof in dispute to the Earnout Dispute Auditor as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Securityholders&#8217; Representative fails to provide either such notice within such time period, the Earnout Report shall be final, binding and conclusive for all purposes hereunder absent manifest error or common law fraud. Notwithstanding the foregoing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> will not preclude the Securityholders&#8217; Representative from asserting any claim for breach of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">If the Securityholders&#8217; Representative exercises its right to an audit of the Records pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Securityholders&#8217; Representative may cause a certified public accountant employed by a nationally recognized firm that is not providing accounting, tax or audit services to the Securityholders&#8217; Representative or its controlled Affiliates for which it is receiving material compensation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to commence its examination of the Records.  Subject to applicable Laws relating to the exchange of information and except as required to comply with any COVID-19 Measures, Parent shall provide to the Auditor reasonable access, during regular business hours, in such a manner as to not interfere with the normal operation of Parent or the Surviving Corporation (subject to the execution of customary work paper access letters, if requested), to work papers and books and records relating to the preparation of the Closing Statement and to the employees of the Company, who are knowledgeable about the preparation of the Closing Statement, in each case, solely for the purpose of verifying the accuracy of the Earnout Report (including the underlying Net Revenue) furnished by Parent under this Agreement or of any such Earnout Payment made, or required to be made, by Parent pursuant to this Agreement.  All fees and expenses of the Auditor shall be borne (i) if following such audit, the parties agree in writing or the Earnout Dispute Auditor finally determines pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that (x) Net Revenue is at least five percent greater than that set forth in the Earnout Report and (y) the amount to be paid as an Earnout Payment increases by at least $1, solely by Parent and (ii) in all other cases, solely by the Securityholders&#8217; Representative (on behalf of the Participating Securityholders).  The Securityholders&#8217; Representative shall provide notice within 30 days of the end of the 30-day period set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if it wishes to submit any items and amounts to the Earnout Dispute Auditor pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Securityholders&#8217; Representative fails to provide either such notice within such time period, the Earnout Report shall be final, binding and conclusive for all purposes hereunder absent manifest error or common law fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Securityholders&#8217; Representative may, solely as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and 1.12(h), submit any unresolved items and amounts thereof in dispute to Ernst &#38; Young LLP, or if Ernst &#38; Young LLP is not available or is providing accounting, tax or audit services to Parent or its controlled Affiliates or the Company for which it is receiving material compensation, a nationally recognized financial services firm, reasonably acceptable to Parent and the Securityholders&#8217; Representative, which shall not be the independent accountants, tax advisors (other than with respect to immaterial matters) or auditors of Parent or the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Earnout Dispute Auditor shall act as an expert and not an arbitrator in resolving the matters submitted to it.  The Earnout Dispute Auditor shall determine, based solely on the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the written presentations by the Securityholders&#8217; Representative and Parent, and not by independent review, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">only those items and amounts that remain then in dispute as set forth in the Earnout Dispute Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Earnout Dispute Auditor&#8217;s determination of the Earnout Payment shall be made within 30 days after the dispute is submitted for its determination and shall be set forth in a written statement delivered to the Securityholders&#8217; Representative and Parent.  A judgment of a court of competent jurisdiction selected pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Applicable Law&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) hereof may be entered following the Earnout Dispute Auditor&#8217;s determination solely for the purposes of enforcing the payment of the specific amount provided by the Earnout Dispute Auditor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no party shall make any filing to obtain such judgment unless (i) the payment required by such determination shall not have been made and (ii) 15 days shall have elapsed following delivery of the Earnout Dispute Auditor&#8217;s determination and&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any filing to obtain such judgment shall respect the confidential nature of the dispute resolution process provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and shall disclose the details of the dispute only to the extent necessary to obtain a judgment for such payment.  The Earnout Dispute Auditor shall have exclusive jurisdiction over, and resorting to the Earnout Dispute Auditor as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be the only recourse and remedy of the parties against one another with respect to, those items and amounts that remain in dispute under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and Parent shall not be entitled to seek indemnification or recovery of any attorneys&#8217; fees or other professional fees incurred by Parent in connection with any dispute governed by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Earnout Dispute Auditor shall allocate its fees and expenses between Parent and the Securityholders&#8217; Representative (on behalf of the Participating Securityholders) in the proportion that Parent&#8217;s position, on the one hand, and the Securityholders&#8217; Representative, on the other hand (based on the aggregate of all differences taken as a whole) bear to the final resolution as determined by the Earnout Dispute Auditor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Securityholders&#8217; Representative and Parent shall, and shall cause their respective Affiliates and representatives to, cooperate in good faith with the Earnout Dispute Auditor, and shall give the Earnout Dispute Auditor access to all data and other information it reasonably requests for purposes of such resolution.  In no event shall the decision of the Earnout Dispute Auditor assign a value to any item greater than the greatest value for such item claimed by either Parent or Securityholders&#8217; Representative or lesser than the smallest value for such item claimed by either Parent or Securityholders&#8217; Representative.  Any determinations made by the Earnout Dispute Auditor pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be final, binding and conclusive on the parties hereto, absent manifest error or common law fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The right of any Participating Securityholder to receive any amounts with respect to Earnout Payments (i) shall not be evidenced by a certificate or other instrument, (ii)&#160;shall not be assignable or otherwise transferable by such Participating Securityholder other than (A) on death by will or intestacy, (B) pursuant to a court order, (C) by operation of Law (including a consolidation or merger), (D) to or for the benefit of any spouse, children, parents, uncles, aunts, siblings or grandchildren (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Approved Relatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or to a trust established solely for the benefit of such Participating Securityholder and&#47;or his or her Approved Relatives&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such transferee shall, as a condition to such transfer, deliver to Parent </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and the Surviving Corporation a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement or (E) without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity, (iii) does not represent any right other than the right to receive the Earnout Payments pursuant to this Agreement and (iv) shall be contingent upon the Participating Securityholder, their Approved Relatives or any other Person otherwise entitled to such amounts in accordance with the terms hereof, having executed a HCP Attestation in the form set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HCP Attestation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Any attempted transfer of the right to any amounts with respect to any such payment by any holder thereof (other than as specifically permitted by the immediately preceding sentence) shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">For U.S. federal income tax purposes, any Earnout Payments received pursuant to this Agreement shall be treated to the extent permitted by applicable Law as installment payments from an installment sale described in Section 453 of the Code, a portion of which may be treated as imputed interest under the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Any dispute arising out of, resulting from or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be exclusively and definitively resolved, without any recourse to appeal, by final and binding arbitration pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Any Earnout Arbitration shall be instituted and conducted in, and its seat shall be, the city of New York, New York, where the arbitration award shall be rendered.  The arbitration shall be administered by the International Court of Arbitration of the International Chamber of Commerce (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ICC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in accordance with the Rules of Arbitration of the ICC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Arbitration Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as in effect as of the date of commencement of the arbitration, as modified by this Agreement or mutual agreement of the parties.  The arbitration shall be conducted in the English language, though documents or testimony may be submitted in other languages if a translation is provided.  The arbitration panel shall be composed of three (3) arbitrators.  The first (1st) arbitrator shall be nominated by the claimant and the second (2nd) arbitrator shall be nominated by the respondent, each in accordance with  Article 12(4) of the Arbitration Rules.  The third (3rd) arbitrator (who shall act as chairman) shall be appointed by the two (2) party-appointed arbitrators, within fifteen (15) calendar days from the date of confirmation of the second (2nd) party-appointed arbitrator.  If any party fails to appoint an arbitrator within the required period, or if the two (2) arbitrators cannot reach an agreement with respect to the third (3rd) arbitrator within the applicable period, the appointment shall be made by the ICC International Court of Arbitration pursuant to the Arbitration Rules.  To the extent that an Earnout Arbitration involves more than one (1) party as claimant, such claimants shall jointly appoint the first (1st) arbitrator.  To the extent that an Earnout Arbitration involves more than one (1) respondent, such respondents shall jointly appoint the second (2nd) arbitrator.  The parties consent to the consolidation of arbitrations commenced hereunder pursuant to the Arbitration Rules.  Any award of the arbitration panel must be in writing and state the grounds upon which it is based (in each case, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Final Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Final Award shall be final, binding and conclusive on the parties and their successors, and a judgment upon the Final Award may be recognized and enforced in any court of competent jurisdiction.  The fees and expenses of the arbitration and other reasonable and documented costs of the party which has prevailed in such arbitration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Arbitration Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), including reasonable attorney&#8217;s fees, shall be borne as established by the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">arbitration panel.  The Arbitration Fees payable by Parent (if any) shall be paid directly by Parent, and the Arbitration Fees payable by the Securityholders&#8217; Representative (if any, solely on behalf of the Securityholders) shall be paid from the Securityholders&#8217; Representative Reserve.  To the extent the Securityholders&#8217; Representative Reserve is insufficient or unavailable to cover all of the Arbitration Fees payable by the Securityholders&#8217; Representative, Parent may (i) pay any such amounts from the Escrow Account. (ii) pay any such remaining Arbitration Fees directly and in the case of (ii) be entitled to deduct such amounts from any amounts payable to the applicable Securityholders (or to the Payment Agent on their behalf) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement or (iii) if the Securityholders&#8217; Representative was not wholly successful in the Earnout Arbitration, from the Participating Securityholders according to each Securityholder&#8217;s Ownership Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Through the end of calendar year 2025, Parent shall not, and shall cause its Affiliates not to, directly or indirectly, sell, assign or otherwise transfer to any third party, the ACell Business or any material Company Intellectual Property used in or necessary for the development, manufacturing or commercialization of any ACell Products, unless (i) the Securityholders&#8217; Representative has consented in writing to such transaction and Parent continues to be bound by the obligations in this Agreement&#59; or, (ii) the assignee or other transferee is a Qualified Transferee, (iii) such Qualified Transferee expressly agrees in writing to assume the obligations in this Agreement, including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (iv) the Securityholders&#8217; Representative is made an express third party beneficiary of such written agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall restrict or prohibit the Company or any of its Affiliates from taking any actions (including the licensing of such Company Intellectual Property or the provision of access to tangible embodiments of Trade Secrets included in such Company Intellectual Property) reasonably necessary to outsource the manufacture of any ACell Products (or components thereof), without outsourcing the other obligations of Parent under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">PPP Forgiveness</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">.  To the extent that an amount of the PPP Loan is forgiven (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Forgiven Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) following the Closing, Parent shall (A) within five Business Days of such forgiveness provide notice of the same to the Securityholders&#8217; Representative, (B) within five Business Days following the date of the receipt by the Surviving Corporation of the Forgiven Amount from the PPP Loan Escrow Account, pay, or cause to be paid the portion of Forgiven Amount due to the Participating Securityholders that are holders of Company Common Stock or the Non-Employee Option Holders (other than amounts payable in respect of Employee Options) to the Payment Agent for further distribution to such Participating Securityholders based on each such Participating Securityholder&#8217;s Ownership Percentage and (C) subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after the receipt by the Surviving Corporation of the Forgiven Amount from the PPP Loan Escrow Account, Parent shall cause the Surviving Corporation to pay the portion of the Forgiven Amount due to the Participating Securityholders who are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any amounts payable by Parent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">offset and reduced by any amounts payable by the Securityholders to Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  Promptly following receipt of any such notification and prior to any such distribution of any portion of the Forgiven Amount to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the Forgiven Amount payable to each Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Any distributions to be made to the Participating Securityholders after the Closing, including distribution of any remaining balance of the Securityholders&#8217; Representative Reserve or the Escrow Account, shall be released to the Surviving Corporation or the Payment Agent, as applicable, and (i) subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent shall cause the Surviving Corporation to pay (on the regular payment date for the next full payroll period that occurs at least five Business Days after the receipt of the remaining balance of the Securityholders&#8217; Representative Reserve or the Escrow Account from the Securityholders&#8217; Representative or Escrow Agent, as applicable) the cash distribution due to the Participating Securityholders in respect of Employee Options based on each such holder&#8217;s Ownership Percentage attributable to such Employee Options and (ii) the Payment Agent shall pay the Participating Securityholders in respect of Company Common Stock or Non-Employee Options based on each such holder&#8217;s Ownership Percentage attributable to such Company Common Stock or Non-Employee Options.  Prior to any such distribution to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the cash distribution payable to each Participating Securityholder in accordance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Any distribution of cash made to the Participating Securityholders shall be made in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PPP Forgiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) at the time of such distribution as set forth in this Agreement and, in each case, any amounts so payable shall be reduced by (i) any fees or other costs payable to the Payment Agent or Guggenheim Securities, LLC in respect of such payments and (ii) the Sellers Employer Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Appraisal Rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Notwithstanding any other provision of this Agreement to the contrary, shares of Company Capital Stock held by a holder who has made a demand for appraisal of such shares in accordance with Section&#160;262 of the DGCL (any such shares being referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; until such time as such holder fails to perfect or otherwise loses such holder&#8217;s appraisal rights under Section&#160;262 of the DGCL with respect to such shares), will not be converted into or represent the right to receive cash in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), but will be converted into the right to receive such consideration as may be determined to be due with respect to such Dissenting Shares pursuant to the DGCL (and at the Effective Time, such </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dissenting Shares shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and such holder shall cease to have any rights with respect thereto, except the rights set forth in Section&#160;262 of the DGCL)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if a holder of Dissenting Shares (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) withdraws, has failed to perfect or otherwise loses such holder&#8217;s demand for such payment and appraisal or becomes ineligible for such payment and appraisal then, as of the later of the Effective Time or the date on which such Dissenting Stockholder withdraws such demand or otherwise becomes ineligible for such payment and appraisal, such holder&#8217;s Dissenting Shares will cease to be Dissenting Shares (and the right of such holder to be paid the fair value of such holder&#8217;s Dissenting Shares under Section&#160;262 of the DGCL will cease) and will be converted into the right to receive a cash payment determined in accordance with and subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) upon surrender of the certificate representing such shares in accordance with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). The Company shall provide prompt notice of any demands received by the Company for appraisal of shares of Company Capital Stock under Section&#160;262 of the DGCL, any withdrawal of any such demand and any other notice or instrument delivered to the Company prior to the Effective Time related thereto.  Except with the prior written consent of Parent (such consent not to be unreasonably withheld or delayed), the Company shall not make any payment with respect to, or settle or offer to settle, any such demands.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Securityholders&#8217; Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">In order to efficiently administer certain matters contemplated hereby following the Closing, including any actions that the Securityholders&#8217; Representative may, in its sole discretion, determine to be necessary, desirable or appropriate in connection with the matters set forth in this Agreement (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">PostClosing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)), the Securityholders, by the adoption of this Agreement, acceptance of consideration under this Agreement or the completion and execution of the Letters of Transmittal shall be deemed to have designated Fortis Advisors LLC as the representative of the Securityholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Securityholders&#8217; Representative may resign at any time.  In the event the Securityholders&#8217; Representative becomes unable to perform its responsibilities hereunder or resigns from such position, the Securityholders who hold at least a majority in interest of the Ownership Percentages at such time shall be authorized to and shall select another representative to fill such vacancy and such substituted representative shall be deemed to be the Securityholders&#8217; Representative for all purposes of this Agreement and the documents delivered pursuant hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">By their adoption of this Agreement, acceptance of consideration under this Agreement or the delivery of the Letter of Transmittal contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and without any further action of any of the Securityholders or the Company, the Securityholders shall be deemed to have agreed, in addition to the foregoing, that&#58;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:101.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.the Securityholders&#8217; Representative shall be appointed and constitute the exclusive agent and true and lawful attorney-in-fact of each Securityholder, with full power in his, her or its name and on his, her or its behalf to act according to the terms of this Agreement, the Escrow Agreement, the Securityholders&#8217; Representative Engagement Agreement and in general to do all things and to perform all acts including executing and delivering any agreements, amendments, certificates, receipts, instructions, notices or instruments contemplated by or deemed advisable in connection with this Agreement, the Escrow Agreement, the Securityholders&#8217; Representative Engagement Agreement and the agreements ancillary hereto and thereto.  The Securityholders&#8217; Representative hereby accepts such appointment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:98.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.the Securityholders&#8217; Representative shall have full authority to (A)&#160;execute, deliver, acknowledge, certify and file on behalf of the Securityholders (in the name of any or all of the Securityholders or otherwise) any and all documents, including the Escrow Agreement, that the Securityholders&#8217; Representative may, in its sole discretion, determine to be necessary, desirable or appropriate, in such forms and containing such provisions as the Securityholders&#8217; Representative may, in its sole discretion, determine to be appropriate, (B)&#160;give and receive notices and other communications relating to this Agreement and the transactions contemplated hereby (except to the extent that this Agreement contemplates that such notice or communication shall be given or received by the Securityholder individually), (C)&#160;take or refrain from taking any actions (whether by negotiation, settlement, litigation or otherwise) to resolve or settle all matters and disputes arising out of or related to this Agreement, the Escrow Agreement, the Securityholders&#8217; Representative Engagement Agreement and the transactions contemplated hereby and thereby, including the payment of any Adjustment Amount solely from, and to the extent of, the Escrow Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the payment of any amounts in satisfaction of any claims for indemnification made by Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and (D)&#160;engage attorneys, accountants, financial and other advisors, paying agents and other persons necessary or appropriate in the judgment of the Securityholders&#8217; Representative for the accomplishment of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Securityholders&#8217; Representative shall have no obligation to act on behalf of the Securityholders, except as expressly provided herein and in the Securityholders&#8217; Representative Engagement Agreement, and for purposes of clarity, there are no obligations of the Securityholders&#8217; Representative in any ancillary agreement, schedule, exhibit or the Disclosure Schedule&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.Parent shall be entitled to rely conclusively (without further evidence of any kind whatsoever) on the instructions and decisions given or made by the Securityholders&#8217; Representative as to any of the matters described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and no party shall have any cause of action against Parent for any action taken by Parent in reliance upon any such instructions or decisions&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iv.all actions, decisions and instructions of the Securityholders&#8217; Representative shall be conclusive and binding upon each of the Securityholders and their successors as if expressly confirmed and ratified in writing by such the Securityholders, and no Securityholders shall have any cause of action against the Securityholders&#8217; Representative and neither the Securityholders&#8217; Representative Group will not be liable for any action taken, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">decision made or instruction given by the Securityholders&#8217; Representative under this Agreement, the Escrow Agreement or the Securityholders&#8217; Representative Engagement Agreement, except for common law fraud or Willful Breach of this Agreement or the Escrow Agreement on the part of the Securityholders&#8217; Representative&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">v.the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the powers, immunities and rights to indemnification granted to the Securityholders&#8217; Representative Group hereunder&#58; (A) are independent and severable, are irrevocable and coupled with an interest, and shall survive the death, incompetence, bankruptcy or liquidation of any Securityholder and shall be binding on any successor thereto&#59; (B) shall be enforceable notwithstanding any rights or remedies that any Securityholder may have in connection with the transactions contemplated by this Agreement&#59; and (C) shall survive the delivery of an assignment by any Securityholder of the whole or any fraction of his, her or its interest in the Escrow Amount or Earnout Payment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">vi.no Securityholders shall have any cause of action against the Securityholders&#8217; Representative for any action taken, decision made or instruction given by the Securityholders&#8217; Representative under this Agreement, except for common law fraud or Willful Breach of this Agreement or the Escrow Agreement on the part of the Securityholders&#8217; Representative, and all defenses which may be available to any Securityholder to contest, negate or disaffirm the action of the Securityholders&#8217; Representative taken in good faith under this Agreement, the Escrow Agreement or the Securityholders&#8217; Representative Engagement Agreement are waived&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:92.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">vii.the Securityholders&#8217; Representative shall be entitled to&#58; (x) rely upon the Closing Payment Schedule, (y) rely upon any signature believed by it to be genuine, and (z) reasonably assume that a signatory has proper authorization to sign on behalf of the applicable Securityholder or other party&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">viii.the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be binding upon the executors, heirs, legal representatives, successors and assigns of each Securityholder, and any references in this Agreement to a Securityholder or the Securityholders shall mean and include the successors to the Securityholders&#8217; rights hereunder, whether pursuant to testamentary disposition, the laws of descent and distribution or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">At the Closing, Parent shall cause to be deposited, in an account designated by the Securityholders&#8217; Representative, (i) $1,250,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the upfront engagement fee of the Securityholders&#8217; Representative.  The Securityholders&#8217; Representative Reserve may be applied&#58; (i) as the Securityholders&#8217; Representative, in its sole discretion, determines to be appropriate to defray, offset, or pay any charges, fees, costs, liabilities, charges, losses, fines, damages, claims, forfeitures, actions, judgments, amounts paid in settlement or expenses (including fees, disbursements and costs of counsel and other skilled professionals and in connection with seeking recovery from insurers) that the Securityholders&#8217; Representative incurred in connection with the transactions contemplated by this Agreement and the Securityholders&#8217; Representative </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Engagement Agreement, including in connection with the matters contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the evaluation or defense of any claim for indemnification under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or (ii) as otherwise determined by the Advisory Group.  The Securityholders&#8217; Representative will hold these funds in a non-interest bearing account separate from its corporate funds, will not use these funds for its operating expenses or any other corporate purposes and will not voluntarily make these funds available to its creditors in the event of bankruptcy.  The Securityholders&#8217; Representative is not providing any investment supervision, recommendations or advice and shall have no responsibility or liability for any loss of principal of the Securityholders&#8217; Representative Reserve other than as a result of its gross negligence or Willful Breach.  The Securityholders&#8217; Representative is not acting as a withholding agent or in any similar capacity in connection with the Securityholders&#8217; Representative Reserve and has no Tax reporting or income distribution obligations.  Subject to Advisory Group approval, the Securityholders&#8217; Representative may contribute funds to the Securityholders&#8217; Representative Reserve from any consideration otherwise distributable to the Participating Securityholders.  The balance of the Securityholders&#8217; Representative Reserve held pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), if any, shall, at the sole discretion of the Securityholders&#8217; Representative and at such time to be determined in the sole discretion of the Securityholders&#8217; Representative, be distributed in the same manner as the distributions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), as applicable, to the Escrow Agent, the Payment Agent and&#47;or Parent, as applicable, for further distribution to the Participating Securityholders.  Prior to any such distribution of the Securityholders&#8217; Representative Reserve, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the Securityholders&#8217; Representative Reserve payable to each Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Certain Participating Securityholders have entered into an engagement agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Engagement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) with the Securityholders&#8217; Representative to provide direction to the Securityholders&#8217; Representative in connection with its services under this Agreement, the Escrow Agreement and the Securityholders&#8217; Representative Engagement Agreement (such Participating Securityholders, including their individual representatives, collectively hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advisory Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  As between the Participating Securityholders and the Securityholders&#8217; Representative, neither the Securityholders&#8217; Representative nor its members, managers, directors, officers, contractors, agents and employees nor any member of the Advisory Group (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be liable for any act done or omitted hereunder, under the Escrow Agreement or under the Securityholders&#8217; Representative Engagement Agreement as Securityholders&#8217; Representative while acting in good faith, and any act done or omitted to be done pursuant to the advice of counsel shall be conclusive evidence of such good faith except for common law fraud or Willful Breach of this Agreement or the Escrow Agreement by the Securityholders&#8217; Representative.  The Securityholders&#8217; Representative Group shall be indemnified, defended and held harmless and reimbursed by the Participating Securityholders against any Securityholders&#8217; Representative Expenses incurred without bad faith, gross negligence or Willful Breach on the part of the Securityholders&#8217; Representative and </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">arising out of or in connection with the acceptance or administration of its duties hereunder, under the Escrow Agreement or under the Securityholders&#8217; Representative Engagement Agreement and in connection with any Securityholders&#8217; Representative Expenses, at the election of the Securityholders&#8217; Representative, at any time first, from the Securityholders&#8217; Representative Reserve, to the extent any funds remain in such fund, second, from any distribution of the Escrow Amount or any Earnout Payment and otherwise distributable to the Participating Securityholders at the time of distribution, and third, directly from the Participating Securityholders according to each Participating Securityholder&#8217;s Ownership Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no Participating Securityholder shall be liable to the Securityholders&#8217; Representative for any amount in excess of the portion of the Upfront Purchase Price actually paid to such Participating Securityholder.  The Participating Securityholders acknowledge that the Securityholders&#8217; Representative shall not be required to expend or risk its own funds or otherwise incur any financial liability in the exercise or performance of any of its powers, rights, duties or privileges or pursuant to this Agreement or the transactions contemplated hereby.  Furthermore, the Securityholders&#8217; Representative shall not be required to take any action unless the Securityholders&#8217; Representative has been provided with funds, security or indemnities which, in its determination, are sufficient to protect the Securityholders&#8217; Representative against the costs, expenses and liabilities which may be incurred by the Securityholders&#8217; Representative in performing such actions.  The immunities and rights to indemnification shall survive the resignation or removal of the Securityholders&#8217; Representative or any member of the Advisory Group and the Closing or any termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">On or prior to the Closing Date, Parent and the Securityholders&#8217; Representative shall enter into an escrow agreement with the Escrow Agent effective as of the Closing Date, which shall be substantially on the terms attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  In accordance with the Escrow Agreement, Parent shall deliver or cause to be delivered to the Escrow Agent, the Escrow Amount by wire transfer of immediately available funds to the account established pursuant to the Escrow Agreement in which any portion of the Escrow Amount is held for disbursement by the Escrow Agent pursuant to the Escrow Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Escrow Fund shall be available to be paid to Parent as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">No later than ten Business Days after the final determination of any claim pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or the final determination of any adjustment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent and the Securityholders&#8217; Representative shall deliver Joint Written Instructions to the Escrow Agent instructing the Escrow Agent to deliver such amount payable in respect of the claim to Parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Upon each Applicable Escrow Release Date, Parent and the Securityholders&#8217; Representative shall deliver joint written instructions (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Joint Written Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Escrow Agent instructing the Escrow Agent to deliver the Step-Down </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Release Amount or funds remaining in the Purchase Price Escrow Fund, the Retention Escrow Fund or the Special Escrow Fund (as the case may be) (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Applicable Release Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)  (A) no later than five Business Days following the Applicable Escrow Release Date, the Applicable Release Amount due to the Participating Securityholders that are holders of Company Common Stock or the Non-Employee Option Holders (other than amounts payable in respect of Employee Options) to the Payment Agent for payment to the Participating Securityholders based on each such Participating Securityholders&#8217; Ownership Percentage, and (B) no later than five Business Days following the Applicable Escrow Release Date, the portion of the Applicable Release Amount due to the Participating Securityholders that are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options to the Surviving Corporation for payment by the Surviving Corporation onto such Employee Option Holders, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after receipt of the applicable amount by the Surviving Corporation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that, in each case, if there are any claims under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the case of the Purchase Price Escrow Fund or Retention Escrow Fund that are pending on the Applicable Escrow Release Date, the applicable portion of the Applicable Release Amount  that is subject to any claims shall be held back and not be released or paid to Parent or the Payment Agent (on behalf of the Participating Securityholders) until such applicable claims are finally resolved and satisfied, and upon resolution of such claims, Parent and the Securityholders&#8217; Representative shall deliver Joint Written Instructions to the Escrow Agent instructing the Escrow Agent to deliver to the Payment Agent any remaining amount in the Purchase Price Escrow Fund, the Retention Escrow Fund or the Special Escrow Fund (as the case may be) to be distributed to the Participating Securityholders in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Prior to any such distribution of the Applicable Release Amount to the Participating Securityholders, the Securityholders&#8217; Representative shall deliver to Parent and the Payment Agent an updated Closing Payment Schedule (which need not be certified) setting forth the portion of the remaining amount in the Escrow Fund payable to each Participating Securityholder.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the regular payment date for the next full payroll period that occurs at least five Business Days after receipt by the Surviving Corporation of the applicable amount, the Surviving Corporation shall the portion of the Applicable Release Amount due to the Participating Securityholders that are Employee Option Holders based on each such individual&#8217;s Ownership Percentage in respect of such individual&#8217;s Employee Options for payment by the Surviving Corporation to such Employee Option Holders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Applicable Escrow Release Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, (i) with respect to the Purchase Price Escrow Fund, the date upon which the Adjustment is finally determined, (ii) with respect to the Retention Escrow Fund, the date that is 18 months following the Closing Date, (iii) with respect to the Special Escrow Fund, the date that is 18 months following the Closing Date and (iv) with respect to the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Step-Down Release Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, the date that is 12 months following the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Parent shall be treated for Tax purposes as the owners of the Escrow Amount and shall be subject to Tax on all interest and earnings, if any, earned in connection with the Escrow Amount.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Representations and Warranties of the Company</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company represents and warrants to Parent and Merger Sub, except  as set forth in the Disclosure Schedule, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Due Incorporation&#59; Subsidiaries&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has all necessary corporate power and authority to conduct its business in the manner in which its business is currently being conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is qualified to do business as a foreign corporation, and is in good standing, under the laws of all states where the nature of its business requires such qualification, except for any failure to be so qualified or in such good standing, individually or in the aggregate, that would not have a Company Material Adverse Effect. Section&#160;2.1(b) of the Disclosure Schedule contains a correct and complete list of each jurisdiction where the Company is organized and qualified to do business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company does not have any Subsidiary or own any interests (including any securities exercisable or exchangeable for or convertible into interests) in any Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Certificate of Incorporation and Bylaws</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has delivered or otherwise made available to Parent or its representatives copies of the Company Charter and Company bylaws, including all amendments thereto, as in effect on the date hereof, which organizational documents are in full force and effect as of the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Capitalization, Etc</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As of the date of this Agreement, the authorized capital of the Company consists of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">(i) 2,000,000 shares of Series A Convertible Preferred Stock, of which 891,000 are issued and outstanding, which are convertible into 314,517 shares of Company Common Stock, (ii) 2,000,000 shares of Series B Convertible Preferred Stock, of which 1,915,149 shares are issued and outstanding, which are convertible into 2,027,915 shares of Company Common Stock, (iii) 30,000,000 shares of Series C Convertible Preferred Stock, of which 23,393,691 are issued and outstanding, which are convertible into 8,257,838 shares of Company Common Stock, and (iv) 10,000,000 shares of Series D Convertible Preferred Stock, of which 6,428,545 shares are issued and outstanding which are convertible into 2,269,196 shares of Company Common Stock.  The rights, preferences, privileges and restrictions of the Company Preferred Stock are as stated in the Company Charter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">37.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">65,000,000 shares of Company Common Stock, of which 4,861,131 shares are issued and outstanding.  (i) 5,072,537 shares of Company Common Stock are reserved for </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">issuance under the Equity Incentive Plans, of which 2,820 shares of Company Common Stock are subject to outstanding Company Options under the 2002 Equity Incentive Plans, 2,074,276 shares of Company Common Stock are subject to outstanding Company Options under the 2011 Equity Incentive Plans, and 547,375 shares of Company Common Stock are subject to outstanding Company Options under the 2016 Equity Incentive Plans, (ii) 400,981 shares of Company Common Stock remain available for future grant under the Equity Incentive Plans, and (iii) 2,896,287 shares of Company Common Stock have been issued pursuant to the exercise of Company Options and are included in the number of outstanding shares of Company Common Stock set forth above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Closing Payment Schedule, when delivered in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, will contain true and correct information in respect of all items contained therein, except for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> inaccuracies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">39.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except for (i)&#160;the Company Options, (ii)&#160;the conversion privileges of the Company Preferred Stock and (iii)&#160;those rights set forth in Section&#160;2.3(d) of the Disclosure Schedule, (A)&#160;there are no other existing options, restricted stock units, warrants, calls, rights (including conversion rights, preemptive rights, co-sale rights, rights of first refusal or other similar rights) or agreements to which the Company, or to the Company&#8217;s Knowledge, any Company Stockholder or holder of the Company Options, is a party requiring, and there are no securities of the Company outstanding which upon conversion or exchange would require, the issuance, sale or transfer of any additional shares of Company Capital Stock or other equity securities of the Company or other securities convertible into, exchangeable for or evidencing the right to subscribe for or purchase shares of Company Capital Stock or other equity securities of the Company, (B)&#160;there are no obligations, contingent or otherwise, of the Company to (1)&#160;repurchase, redeem or otherwise acquire any shares of Company Capital Stock or (2)&#160;to make any material investment in (in the form of a loan, capital contribution or otherwise), or to provide any guarantee (excluding indemnification obligations) with respect to the obligations of, any Person and (C)&#160;there are no outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">40.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except for those rights set forth in Section&#160;2.3(e) of the Disclosure Schedule, there are no bonds, debentures, notes or other Debt of the Company having the right to vote or consent (or, convertible into, or exchangeable for, securities having the right to vote or consent) on any matters on which the Company Stockholders may vote.  Except as set forth in Section&#160;2.3(e) of the Disclosure Schedule, there are no voting trusts, irrevocable proxies or other Contracts or understandings to which the Company, or, to the Company&#8217;s Knowledge, any Company Stockholder or any holder of the Company Options is a party or is bound with respect to the voting or consent of any shares of Company Capital Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">41.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">All of the outstanding shares of Company Capital Stock have been duly authorized and validly issued, and are fully paid and nonassessable and have been issued and granted  in compliance with all applicable securities Laws.  </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Section&#160;2.3(g) of the Disclosure Schedule sets forth, with respect to each Company Option that is outstanding as of the date of this Agreement&#58; (i) the name of the holder of such Company Option&#59; (ii) the total number of shares of Company Common Stock that are subject to such Company Option&#59; (iii) the exercise price per share of Company Common Stock purchasable under such Company Option&#59; (iv) the vesting schedule or terms of such Company Option&#59; and (v) the expiration date of such Company Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has delivered or otherwise made available to Parent or its counsel (i)&#160;its audited balance sheets as of December 31, 2019 (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and December 31, 2018, (ii)&#160;its audited statements of operations, statements of stockholders&#8217; equity and statements of cash flows for the years ended December 31, 2019 and December 31, 2018 ((i) and (ii) collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Audited Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii) the unaudited balance sheet of the Company and statements of operations as of September 30, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Balance Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unaudited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (all of the foregoing financial statements of the Company and any notes thereto are hereinafter collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company Financial Statements (x) have been prepared in accordance with GAAP and fairly present in all material respects the financial condition of the Company at the dates therein indicated and the results of operations of the Company for the periods therein specified in accordance with GAAP, except as may be indicated in the footnotes to such financial statements. The Company maintains a system of internal accounting controls sufficient, in all material respects, to provide reasonable assurances that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth on Section 2.4(c) of the Disclosure Schedule, the Company has no indebtedness or other obligation for borrowed money, whether current, short-term, long-term, secured or unsecured.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not received a notice from any Governmental Body asserting or threatening that any portion of the PPP Loan is not or may not be eligible for forgiveness or that the PPP Loan does not comply with applicable Laws and requirements. The Company has complied with all applicable Law with respect to such PPP Loan, including properly utilizing (and has documented the utilization of) the proceeds of such PPP Loan in accordance with all applicable Law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Absence of Certain Changes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Since the Balance Sheet Date through the date of this Agreement, (a)&#160;there has not occurred&#160;any event or series of related events that has had a Company Material Adverse Effect&#59; (b)&#160;there has not been any material damage, destruction or other casualty loss with respect to any material asset or property owned, leased or otherwise used by the Company, whether or not covered by insurance&#59; (c) &#160;there has not been any material change in any method of accounting or </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accounting practice by the Company, except as required by concurrent changes in GAAP&#59; (d)&#160;there has not been any change in any material election in respect of Taxes, material change in any accounting method in respect of Taxes, settlement of any material claim or assessment in respect of Taxes, filing of any amended income or other material Tax Returns or consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of income or other material Taxes&#59; (e) there has not been any amendment to the Company Charter or the Company bylaws&#59; (f) there has been no notification, written or otherwise, to or from any government official or authority alleging or otherwise related to any non-compliance by the Company with any obligations of the Company pursuant to the Settlement Agreement&#59;&#160;and (g) the Company has not entered into any arrangement or commitment regarding any of the matters described in subsections (a) through (f) above. Since the Unaudited Balance Sheet Date through the date of this Agreement, (h) there has not been any termination of, or receipt of notice of termination of, any Material Contracts&#59; (i)&#160;there has been no sale, lease, license or other disposition of any material asset (other than the sale or use of Inventory in the ordinary course of business consistent with past practice) or creation or imposition of any Lien, other than Permitted Encumbrances on assets, on any material assets&#59; (j) there has not been any material change in compensation (including bonuses) or wage rate, pension, welfare, fringe or other benefits, severance or termination pay of any director or employee of the Company&#59; (k) except as expressly contemplated by this Agreement and for discussion, negotiations and transactions related to this Agreement or other potential strategic transactions and except for any changes made in response to COVID-19 Measures, the Company has operated its business in the ordinary course consistent with past practices in all material respects&#59; and (l) the Company has not entered into any arrangement or commitment regarding any of the matters described in subsections (h) through (l) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Title to and Condition of Assets</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has good and valid title to all material assets owned by it, other than Intellectual Property which is covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), including all material assets (other than capitalized or operating leases) reflected on the Unaudited Balance Sheet (except for assets sold or otherwise disposed of since the Unaudited Balance Sheet Date in the ordinary course of business consistent with past practice).  Except as set forth in Section&#160;2.6 of the Disclosure Schedule, all of such assets are owned by the Company, free and clear of any Liens (other than Permitted Encumbrances). The tangible assets (including equipment), taken as a whole, are in good working condition, subject to normal wear and tear.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Real Property&#59; Leasehold</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company does not own any interest in real property, except for the leaseholds created under the real property leases (including all amendments, extensions, renewals, guarantees and other agreements with respect thereto) identified in Section&#160;2.7 of the Disclosure Schedule (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leased Real Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and such leases, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Real Property Leases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Leased Real Property listed on Section&#160;2.7 of the Disclosure Schedule comprises all material real property interests used in the conduct of the business and operations of the Company as currently conducted.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is in material compliance with all Real Property Leases, and has a valid and subsisting leasehold interest in all Leased Real Property, in each case free and clear of all Liens, other than Permitted Encumbrances.  There are no subleases or agreements to sublease, or other tenancies in effect with respect to, the Leased Real Property in which the Company has granted any other Person the right to occupy or use any Leased Real Property, and no Person is in physical possession of the Leased Real Property other than the Company.  The Company has not received written notice of (i) any breach or default, or intention to terminate or not renew, any Real Property Lease or (ii) any eminent domain, condemnation or similar proceeding pending or threatened, against all or any portion of any Leased Real Property, and no event has occurred which, with the giving of notice, the passage of time, or both, would constitute a breach or default under any such Real Property Lease.  To the Company&#8217;s Knowledge, no defect exists in any building or other improvement situated on the Leased Real Property that would materially impair the use or occupancy of the Leased Real Property by the Company as currently conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">49.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Section 2.8(a) of the Disclosure Schedule identifies&#58; (i) each item of unexpired Registered IP owned by the Company&#59; and (ii) the jurisdiction in which such item of Registered IP has been registered or filed, the applicable registration or filing date, and the applicable registration, application or serial number (or in the case of Internet domain names, the applicable Internet domain name registrar).  The Company Intellectual Property is subsisting, and to the Company&#8217;s Knowledge, each item of Registered IP included therein that has been issued or granted is valid and enforceable.  Except for as disclosed in Section 2.8(a) of the Disclosure Schedule, there are no pending inventorship challenges, opposition or nullity proceedings or interferences declared, commenced or provoked, or to the Company&#8217;s Knowledge, threatened in the prior three years, with respect to any Patent or trademark included in the Company Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">50.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company solely and exclusively owns all Company Intellectual Property, free and clear of all Liens, other than Permitted Encumbrances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as disclosed in Section 2.8(c) of the Disclosure Schedule, and provided that this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not be construed as a representation of third party Intellectual Property or as to ownership disputes or other challenges to Company Intellectual Property (which are covered in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (d), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Company has sufficient rights to use all Intellectual Property necessary to conduct its business in all material respects, and the consummation of the transactions contemplated by this Agreement will not result in any material limitation on the Company&#8217;s right, title or interest in or to any of such Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">To the Company&#8217;s Knowledge, neither the Company nor the conduct of its business infringes, misappropriates or otherwise violates, or in the prior three years has infringed, misappropriated or otherwise violated, any Intellectual Property rights of any third parties.  For the prior three years, no Person (other than the U.S. Patent and Trademark Office (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">USPTO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or any equivalent foreign governmental administrative agency that deals with </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">patent and&#47;or trademark matters in connection with the prosecution of pending patent and&#47;or trademark applications in the ordinary course) has asserted any written claim (or to the Company&#8217;s Knowledge, any oral claim or threatened any claim) (i) challenging the Company&#8217;s right, interest or title in any of the Company Intellectual Property or (ii) alleging infringement, misappropriation or other violation of any third-party Intellectual Property by the Company.  With the exception of the USPTO&#8217;s or any other equivalent foreign governmental administrative agency that deals with patent and&#47;or trademark matters&#8217; review of pending patent applications in connection with the prosecution of such applications in the ordinary course, none of the Company Intellectual Property is subject to any pending or outstanding injunction, directive, order, judgment or other disposition of dispute that adversely restricts the use, transfer, registration or licensing of any such Company Intellectual Property by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">53.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">To the Company&#8217;s Knowledge, no Person has infringed, misappropriated or otherwise violated, and no Person is currently infringing, misappropriating or otherwise violating, any Company Intellectual Property. During the prior six years, the Company has not asserted any written claim (or to the Company&#8217;s Knowledge, any oral claim or threatened any claim), against any third party alleging infringement, misappropriation or other violation of any Company Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">54.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has taken all reasonable measures to protect the confidentiality and value of all material Trade Secrets included in the Company Intellectual Property or otherwise used or held by the Company and, to the Company&#8217;s Knowledge, such Trade Secrets have not been used, disclosed to or discovered by any Person except pursuant to written, valid and appropriate non-disclosure and&#47;or license agreements which have not been breached.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">55.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">All assignments evidencing proper ownership of Registered IP included in the Company Intellectual Property have been duly executed and timely filed and recorded with the USPTO and such other foreign offices where such recordation is required.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">56.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has obtained from all parties (including current or former employees, officers, directors, consultants and contractors) who have created or developed any material Trade Secrets, unregistered copyrights and unregistered trademarks for or on behalf the Company written, valid and enforceable present assignments of any such Intellectual Property to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">To the actual knowledge of the Specified Persons, the IT Assets owned by the Company are free from material bugs, malicious code, and other material defects, and otherwise&#160;perform as required by the Company in connection with its business.  To the Company&#8217;s Knowledge, no Person has gained unauthorized access to such IT Assets within the prior three years that has resulted or could reasonably be expected to result in material liability to the Company.  The Company has implemented reasonable system change controls and backup and disaster recovery technology processes consistent with industry best practices.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">None of the Company&#8217;s material proprietary software is subject to any obligation or condition under any license that conditions the distribution of such software (or any portion thereof) on (i) the disclosure, licensing or distribution of any source code for any portion of such software, (ii) the granting to licensees of the right to make derivative works or other modifications to such software, (iii) the licensing under terms that allow such software or portions thereof or interfaces therefor to be reverse engineered, reverse assembled or disassembled (other than by operation of Law), or (iv) redistribution of such software at no license fee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">To the Company&#8217;s Knowledge, except for inventions supported by grant no. NCC 9-58 from the National Space Biomedical Research institute through NASA with respect to the SPV-015 patent family, and the Company Intellectual Property subject to certain U.S. government rights and University rights as disclosed in Section 2.8(a) of the Disclosure Schedule, and except for any other funding or use of facilities or personnel that has not resulted in any Governmental Body or any university, college, research institute or other educational institution obtaining ownership rights in (or options to obtain ownership rights in), licenses to (or options to receive licenses to) or other rights to use or exploit any Company Intellectual Property, no funding, facilities or personnel of any Governmental Body or any university, college, research institute or other educational institution has been used to create or otherwise develop any material Company Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">(A) Section 2.8(l)(A) of the Disclosure Schedule identifies each Contract pursuant to which the Company is a licensee of, or is otherwise granted any rights to use any Intellectual Property that is material to the Company&#8217;s business by, a third party (other than (i) non-exclusive licenses (A) to commercially available third party software, including software as a service subscriptions or (B) in vendor agreements or clinical trial agreements entered into in the ordinary course of business, or (ii) pursuant to non-disclosure agreements or material transfer agreements entered into in the ordinary course of business) and (B) Section 2.8(l)(B) of the Disclosure Schedule identifies each Contract pursuant to which the Company is a licensor or otherwise grants any rights to use any material Company Intellectual Property to a third party other than non-exclusive licenses granted in the ordinary course of business of the Company (each such Contract identified in clause (A) and clause (B), an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company, (i) the Company holds all Governmental Authorizations under the FDCA (including Section&#160;510(k)), and all Governmental Authorizations of any applicable Governmental Body that has regulatory authority over the testing, development, design, quality, identity, safety, efficacy, manufacturing, labeling, marketing, distribution, commercialization, sale, pricing, import or export of the products currently sold by the Company, including those listed on Section&#160;2.9(a) of the Disclosure Schedule (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and any such Governmental Body, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Regulatory Agency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), necessary for the lawful operation of the business of the Company in each jurisdiction in which the Company operates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Regulatory Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; (ii) all such Company Regulatory Permits are valid and in </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">full force and effect&#59; and (iii) the Company is in compliance with the terms of all Company Regulatory Permits.  There is no Legal Proceeding pending or, to the Company&#8217;s Knowledge, threatened that would result in the termination, revocation, suspension or the imposition of a restriction on any such Company Regulatory Permit or the imposition of any fine, penalty or other sanction for violation of any such Company Regulatory Permit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company, the business of the Company is being conducted in compliance with, and has appropriate internal controls that are reasonably designed to ensure compliance with (i) the FDCA (including all applicable registration and listing requirements set forth in Section 510 of the FDCA (21 U.S.C. &#167; 360) and 21 C.F.R. Part 807)&#59; (ii) the Patient Protection Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010&#59; (iii) federal Medicare and Medicaid statutes and related state or local statutes&#59; (iv) any comparable foreign Legal Requirements for any of the foregoing (including the GDPR)&#59; (v) the federal Anti-Kickback Statute (42 U.S.C. &#167; 1320a-7(b)), Stark Law (42 U.S.C. &#167;1395nn), the federal criminal False Claims Act (42 U.S.C. &#167;1320a-7b(a)), the federal civil False Claims Act (31 U.S.C. &#167; 3729 et seq.), Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167; 1320d et seq.), as amended by the Health Information Technology for Economic and Clinical Health Act, and any comparable federal, state or local Legal Requirements&#59; (vi) state testing, manufacturing, distribution, commercialization, marketing, licensing, disclosure, gift ban, code of conduct and reporting requirements, including the Physician Payments Sunshine Act (42 C.F.R. Parts 402-403) and equivalent or related state reporting requirements&#59; (vii) Legal Requirements with respect to the protection of Personally Identifiable Information collected or maintained by or on behalf of the Company&#59; (viii) rules and regulations promulgated pursuant to all such applicable Legal Requirements with respect to any of the foregoing, each as amended from time to time&#59; (ix)&#160;any other Law that governs the health care industry or relationships among health care providers, suppliers, distributors, manufacturers and patients (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Healthcare Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; (x) the Federal Trade Commission Act&#59; and (xi) the Settlement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth on Section&#160;2.9(c) of the Disclosure Schedule, the Company is not party to any corporate integrity agreements, monitoring agreements, deferred prosecution agreements, consent decrees, settlement orders or similar agreements with or imposed by any Governmental Body and, to the Company&#8217;s Knowledge, no such action is currently contemplated, proposed or pending.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not, and, to the Company&#8217;s Knowledge, no officer, employee, agent or authorized representative of the Company has, made an untrue or misleading statement of a material fact or a fraudulent statement to any Governmental Body, failed to disclose a material fact required to be disclosed to any Governmental Body, or committed an act, made a statement, or failed to make a statement, in each case, related to the business and which, at the time such disclosure was made, violated the &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; policy of the FDA set forth in 56 Fed. Reg. 46191 (September 10, 1991) or any other applicable, similar policy of another Company Regulatory Agency.  Neither the Company nor any duly authorized representative of the Company has been convicted </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of any crime or engaged in any conduct for which debarment is mandated by 21 U.S.C. &#167;&#160;335a(a) or authorized by 21 U.S.C. &#167;&#160;335a(b) or any similar applicable Laws.  Neither the Company nor any director, officer, employee, or to the Knowledge of the Company, any agent, supplier, licensee or contractor of the Company has been debarred or excluded from participating in any government health care programs or convicted of any crimes or engaged in any conduct for which such Person could be excluded from participating in any government (including federal, state, local or foreign) health care programs, debarred or suspended from participating in federal, state, local or foreign government Contracts, or convicted of any crime or, to the Knowledge of the Company, engaged in any conduct for which such Person could be excluded from participating in any federal health care program under Section 1128 of the Social Security Act of 1935, as amended, or any similar Law or program whether federal, local, state or foreign. No claim, investigation, proceeding, suit or action that would reasonably be expected to result in such an exclusion is pending or, to the Knowledge of the Company, threatened against the Company or any director, officer or employee of the Company or, to the Knowledge of the Company, any agent or authorized representative of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The manufacturing operations conducted by the Company or, to the Company&#8217;s Knowledge, on behalf of the Company (a) are being, and have been conducted in material compliance with all Company Healthcare Laws, including the provisions of FDA&#8217;s current good manufacturing practice regulations at 21 C.F.R. Parts 210-211 and 820 and similar federal, state, local or foreign requirements for the manufacture of the Company&#8217;s Products and (b) have achieved and maintained all applicable quality certifications including all required ISO (International Organization for Standardization) certificates.  Section&#160;2.9(e) of the Disclosure Schedule lists each ISO and quality certification applicable to the Company.  There is no pending, or, to the Company&#8217;s Knowledge, threatened, proceeding to audit, repeal, fail to renew or challenge any such certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">All pre-clinical and clinical investigations conducted or, to the Company&#8217;s Knowledge, sponsored by or on behalf of the Company, used or intended to be used to support any filing or application for a Company Regulatory Permit, have been or are being conducted in compliance with all applicable Legal Requirements administered or issued by the applicable Company Regulatory Agencies, including (i) FDA standards for conducting non-clinical laboratory studies contained in Title 21 part 58 of the Code of Federal Regulations, (ii) FDA standards for the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of clinical trials and the protection of human subjects, including without limitation, Title 21 parts 11, 50, 54, 56 and 812 of the Code of Federal Regulations, (iii) any comparable state, local or foreign Legal Requirements regulating the conduct of pre-clinical and clinical investigations and the protection of human subjects, (iv) federal, state, local or foreign Laws restricting the collection, use and disclosure of individually identifiable health information and personal information and (v) all directions, notices, approvals and restrictions issued by the relevant institutional review board or ethics board, except, in each case, for such noncompliance that, individually or in the aggregate, would not reasonably be expected to be material to the Company.  To the Company&#8217;s Knowledge, no investigator, employee or agent that has participated or is participating in any clinical investigation conducted or sponsored by or on behalf of the Company, or used or intended to be used to support any filing or application for a </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company Regulatory Permit, is or has been disqualified or restricted by the FDA from receiving investigational drugs, biologics or devices or from conducting any clinical investigation that supports an application for a research or marketing permit&#59; has entered into a restricted agreement with FDA&#59; or is or has been subject to any comparable action by any other Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">67.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not been, and is not the subject of, any FDA Form 483 observations, warning letters, untitled letters, inspection or audit reports from any Company Regulatory Agency identifying any major or minor non-compliances, subpoenas, investigations, actions, demands or notices relating to any alleged non-compliance, which would reasonably be expected to be, individually or in the aggregate, material to the Company or to lead to the denial, suspension or revocation of any application or grant for marketing approval with respect to any material Company Product currently pending before or previously approved or cleared by the FDA or such other Company Regulatory Agency.  The Company has not been subject to any adverse audit reports or alleged non-compliance by its customers or other third parties with which it does business, except where such report or allegation of non-compliance would not reasonably be expected to be, individually or in the aggregate, material to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth on Section 2.9(h) of the Disclosure Schedule, for a period of five years prior to the date of this Agreement, for each adverse event and device malfunction requiring the submission of a medical device report under 21 C.F.R. Part 803 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">MDR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or any other filing, submission, notice or report to the FDA or any other Company Regulatory Agency, the Company has reported, filed, or submitted an MDR or other required filing, submission, notice or report in a timely manner, except where a failure to report, file or submit has not had and would not reasonably be expected to be, individually or in the aggregate, material to the Company.  All such reports, filings, submissions or notices were complete and accurate in all material respects on the date filed (or were corrected in or supplemented by a subsequent filing), and any material and legally necessary or required updates, changes, corrections, amendments, supplements or modifications to such filings have been submitted to the applicable Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">69.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth on Section 2.9(i) of the Disclosure Schedule, for a period of five years prior to the date of this Agreement, the Company has not voluntarily or involuntarily initiated, conducted or issued, caused to be initiated, conducted or issued any recall, removal, market withdrawal, replacement, field action, safety alert, warning, &#8220;dear doctor&#8221; letter, investigator notice or other notice or action to wholesalers, distributors, retailers, healthcare professionals or patients (including any action required to be reported or for which records must be maintained under 21 C.F.R. Part 806) relating to any Company Product (collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or is currently considering initiating, conducting or issuing any Recall of any Company Product, except as (with respect to Recalls other than Class I Recalls) has not had and would not reasonably be expected to, individually or in the aggregate, result in a material liability to the Company or otherwise interfere in any material respect with the conduct of its business as it is now being conducted.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">No Company Product is or during the past three years has been (i)&#160;adulterated within the meaning of 21 U.S.C. &#167;351, (ii)&#160;misbranded within the meaning of 21 U.S.C. &#167;352, (iii)&#160;in violation of 21 U.S.C. &#167;&#167;360 or 360e, in each case as would be a material violation of applicable Law, or (iv)&#160;subject to any actions, demands, notices of violation, proceedings or demand letters relating to any alleged hazard or alleged defect in design, manufacture, materials or workmanship, including any failure to warn or alleged breach of express or implied warranty or representation relating to any Company Product manufactured, distributed or sold by or on behalf of the business or relating to alleged noncompliance by, or liability of, to Company under any Company Healthcare Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Section&#160;2.10(a) of the Disclosure Schedule lists each Contract (other than purchase orders) in effect as of the date of this Agreement to which the Company is a party in the following categories (other than any Contract (1) that is a nondisclosure agreement entered into (x)&#160;in the ordinary course of business or (y) solely as a customary confidentiality agreement&#160;in connection with discussions, negotiations and transactions related to this Agreement or other potential strategic transactions or (2)&#160;that is a Company Plan or Company Service Provider Agreement, which shall be governed under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that requires future payments by or to the Company in excess of $250,000 in any calendar year, including any such Contract for the purchase or sale of assets, raw materials, goods, commodities, utilities, equipment, supplies, products or other personal property, or for the provision or receipt of services&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract with a Significant Customer or Significant Supplier&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that permits any Person other than the Company to market, offer, distribute or sell any Company Products or services, including distribution, sales representative and similar agreements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:92.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that permits any Person other than the Company to manufacture and sell any Company Products, including original equipment manufacturer or similar agreements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract related to an acquisition, divestiture, merger, or similar transaction containing representations, covenants, indemnities, purchase price payments, &#8220;earn-outs,&#8221; adjustments or other obligations&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;any guaranty, surety or performance bond or letter of credit issued or posted, as applicable, by the Company&#59; (B)&#160;any Contract evidencing Debt of the Company or providing for the creation of or granting any Lien upon any of the property or assets of the Company (excluding Permitted Encumbrances)&#59; (C)&#160;any Contract (1)&#160;relating to any loan or advance to any Person which is outstanding as of the date of the Agreement (other than advances to employees and consultants in connection with the carrying out of such Person&#8217;s duties for the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">37</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company in the ordinary course of business, which shall not exceed $10,000 individually) or (2)&#160;obligating or committing the Company to make any such loans or advances&#59; (D)&#160;any currency, commodity or other hedging or swap contract&#59; and (E) any Contract under which any Person has guaranteed any liabilities or obligations of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:93pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract creating or purporting to create any partnership or joint venture or any sharing of profits or losses by the Company with any third party&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract for consulting, advisory or similar services with a Health Care Professional&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:101.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any settlement agreement or similar Contract with a Governmental Body&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:98.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract with an Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract creating or purporting to create any obligation to pay or receive any royalty or similar payment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract (A)&#160;containing covenants restricting or purporting to restrict competition which, in either case, have, would have or purport to have the effect of prohibiting the Company or, after the Closing, Parent or the Surviving Corporation from engaging in any business or activity in any geographic area or other jurisdiction&#59; (B)&#160;in which the Company has granted &#8220;exclusivity&#8221; or that requires the Company to deal exclusively with, or grant exclusive rights or rights of first refusal to, any customer, vendor, supplier, distributor, contractor or other Person&#59; (C) that includes minimum purchase conditions, take-or-pay or other requirements imposed on the Company, in either case that exceed $100,000 in any calendar year&#59; (D)&#160;containing a &#8220;most-favored-nation,&#8221; &#8220;best pricing&#8221; or other similar term or provision by which another party to such Contract or any other Person is, or could become, entitled to any benefit, right or privilege which, under the terms of such Contract, must be at least as favorable to such party as those offered to another Person&#59; or (E) covenants restricting or purporting to restrict solicitation which, in either case, have, would have or purport to have the effect of prohibiting the Company or, after the Closing, Parent or the Surviving Corporation from engaging in any solicitation of employees, customers, distributors or activities in any geographic area or other jurisdiction&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract involving commitments to make capital expenditures or to purchase or sell assets involving $250,000 or more individually, other than sales of product in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Real Property Lease&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:92.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that contains any standstill or similar agreement pursuant to which the Company has agreed not to acquire assets or securities of another Person&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that is between the Company and any of its directors, executive officers, employees or to the Knowledge of the Company, any Person beneficially </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">owning five percent (5%) or more of the outstanding Company Capital Stock, other than Company Plans and Company Service Provider Agreements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract that contains a put, call, or similar right pursuant to which the Company could be required to purchase or sell, as applicable, any equity interests of any Person or any assets&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any collective bargaining agreements or agreements with labor unions&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:95.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract (other than those specified in subsection (xvi) above) that was not entered into on an arm&#8217;s length basis&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:92.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Intellectual Property Contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">72.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">With respect to each Material Contract listed or required to be listed in Section&#160;2.10(a) of the Disclosure Schedule&#58; (i)&#160;such Material Contract is, and to the Company&#8217;s Knowledge, with respect to each party thereto other than the Company, valid, binding and enforceable against such party in accordance with its terms, subject to (A)&#160;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (B)&#160;rules of Law governing specific performance, injunctive relief and other equitable remedies&#59; (ii) such Material Contract is in full force and effect&#59; (iii)&#160;the Company is not in material breach or material default of such Material Contract or, with the giving of notice or the giving of notice and passage of time without a cure would be, in material breach or material default of such Material Contract, and to the Company&#8217;s Knowledge, as of the date of this Agreement no other party to such Material Contract is in material breach or material default of such Material Contract&#59; and (iv) as of the date of this Agreement, the Company has not received any written notice of termination or non-renewal of any Material Contract, and the Company has not given, nor does the Company intend nor to the Company&#8217;s Knowledge does any counterparty intend, to provide any notice of termination or non-renewal of any Material Contract.  The Company has delivered or otherwise made available to Parent or its counsel a true and complete copy of each such written Material Contract and a written description of each oral Material Contract in the case of Material Contracts entered into on or before the date of this Agreement, prior to the date of this Agreement and in the case of all other Material Contracts, within two Business Days of the execution thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Liabilities</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has no material liabilities or obligations (whether accrued, absolute, contingent, unknown or otherwise) that would be required to be reflected under GAAP other than&#58; (i) those which are adequately reflected or reserved against in the Company Financial Statements as of the Balance Sheet Date or the Unaudited Balance Sheet&#59; (ii) those which have been incurred in the ordinary course of business since the Balance Sheet Date&#59; and (iii) liabilities and obligations incurred as expressly contemplated in this Agreement or any other Transaction Document.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">39</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Compliance with Laws&#59; Export Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">73.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is in compliance in all material respects with, and during the past three years has been in compliance in all material respects with applicable Laws, and during the past three years the Company has not received any written notices of any violation with respect to such Laws, except for violations that are immaterial, have been cured or are no longer being asserted.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not apply with respect to Tax matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">74.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">During the past three years, the Company has complied in all material respects with its internal privacy policies, and contractual and fiduciary obligations in connection with any collection, use, transfer, disclosure or other exploitation by the Company of any Personally Identifiable Information of any Person.  To the Knowledge of the Company, there are no complaints to or audits, proceedings, investigations or claims pending against the Company by any Governmental Body, or by any Person, in respect of the collection, use, transfer, disclosure or other exploitation of Personally Identifiable Information of any Person in connection with the Company or its business.  During the past three years, the Company has taken all steps reasonably necessary (including implementing and monitoring compliance with adequate measures with respect to technical and physical security) to ensure that all Personally Identifiable Information is protected against loss and against unauthorized access, use, modification or disclosure, and there has been no unauthorized access to or misuse of Personally Identifiable Information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">75.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">For a period of three years prior to the date of this Agreement, the Company has not been in material violation of, has not been investigated for, and has not been charged or notified by any Governmental Body with a material violation of any (i) applicable U.S. export and reexport control Laws or regulations, including the U.S. Export Administration Regulations and the Foreign Assets Control Regulations, (ii) any applicable economic sanctions Laws, regulations and orders or (iii) other applicable import&#47;export controls in other countries in which the Company conducts business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">76.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Neither the Company nor to the Company&#8217;s Knowledge any stockholder, director, officer, agent or Affiliate of the Company is currently the subject or the target of any sanctions administered or enforced by the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the U.S. Department of State, the United Nations Security Council, the European Union or other sanctions authority (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Company has not been located, organized, operating or resident in, or sold into a country or territory that is or was the subject or target of Sanctions, including the Crimea region of the Ukraine, Cuba, Burma (Myanmar), Iran, North Korea, Sudan and Syria.  To the Company&#8217;s Knowledge, the Company does not have, and has not had, a customer, supplier or distributor relationship with or is a party to any Contract with any Person or Entity is&#58; (1)&#160;on any sanctions list maintained OFAC or any other relevant sanctions authority, including OFAC&#8217;s List of Specially Designated Nationals and Blocked persons&#59; (2)&#160;owned or controlled or acting on behalf of a Person on any such sanctions list&#59; (3)&#160;otherwise the target of Sanctions&#59; or (4)&#160;owned or controlled by, or acting on behalf of, one or more Persons that is otherwise the target of Sanctions, in each case to the extent prohibited by applicable Law.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">40</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.01pt">Certain Business Practices</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For a period of three years prior to the date hereof, the Company and its directors, officers, employees or other representatives, in each case, to the extent such action or inaction constitutes a violation of applicable Anti-Corruption Laws, (a)&#160;has not used and is not using any funds for any unlawful contributions, unlawful gifts, unlawful entertainment or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other unlawful expenses&#59; (b)&#160;has not made any direct or indirect unlawful payments, unlawful gifts or unlawful entertainment to any foreign or domestic Government Official or Health Care Professionals&#59; (c)&#160;has not violated and is not violating any Anti-Corruption Laws&#59; (d) has not established or maintained, and is not maintaining, any unlawful or unrecorded fund of monies or other properties&#59; (e)&#160;has not made, and is not making, any false or fictitious entries on its accounting books and records&#59; (f)&#160;has not made, and is not making, any bribe, payoff, influence payment, kickback or other unlawful payment of any nature, and has not paid, and is not paying, any fee, commission or other payment that has not been properly recorded on its accounting books and records as required by the Anti-Corruption Laws&#59; and (g)&#160;has not otherwise given or received anything of value to or from a Government Official, an intermediary for payment to any individual including Government Officials, any political party or customer for the purpose of obtaining or retaining business.  All payments by the Company to, and all payments to the Company from, Health Care Professionals are at and have been at fair market value for the applicable goods and services, plus reasonable and actual expenses, and the Company only purchases or provides such goods or services for which there is a commercially reasonable need for the services. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">77.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has filed all income and other material Company Returns that it was required to file under applicable Laws.  All such Company Returns were correct and complete in all material respects.  All income and other material Taxes due and owing by the Company (whether or not shown on any Company Return) have been paid.  There are no Liens for Taxes (other than Permitted Encumbrances) upon any of the assets of the Company.  No extension of time with respect to any date on which a Company Return was required to be filed by the Company that extends such date beyond the date of this Agreement is in force, and no waiver or agreement by the Company is in force for the extension of time for the payment, collection or assessment of any Taxes beyond the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">78.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not received written notice from any Governmental Body of any audit or other examination of any Company Return (or any other material Tax examination, Tax claim or Tax action relating to the Company) that is presently in progress, pending or threatened and has not been resolved in full.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">79.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not received written notice from any Governmental Body of any material Tax deficiency that is outstanding, assessed or proposed against the Company and has not been resolved in full.  The Company has never received a written claim from any Governmental Body in a jurisdiction in which the Company does not file Company Returns that the Company is or may be subject to taxation by that jurisdiction.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">41</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">80.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has withheld and paid all material Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder or other third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">81.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not been a United States real property holding corporation within the meaning of Section&#160;897(c)(2) of the Code during the applicable period specified in Section&#160;897(c)(1)(A)(ii) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">82.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Within the past three years, the Company has not constituted either a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; in a distribution of stock intended to qualify for tax-free treatment under Section&#160;355 of the Code.  The Company has not engaged in a &#8220;listed transaction&#8221; as defined in Section&#160;6707A(c) of the Code or the treasury regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">83.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company will not be required to include an item of income in, or exclude an item of deduction from, taxable income (in a cumulative amount in excess of its net operating loss carryforward from taxable periods ending on or before the Closing Date), for any Tax period (or portion thereof) ending after the Closing as a result of any&#58; (i) change in method of accounting for a Tax period ending prior to the Closing&#59; (ii) &#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any comparable or similar provisions of applicable Law) executed prior to the Closing&#59; (iii) election pursuant to Section&#160;108(i) of the Code&#59; (iv)&#160;installment sale or open transaction disposition made prior to the Closing&#59; (v) deferral of any Tax obligations pursuant to the CARES Act or similar statutory relief&#59; or (vi)&#160;prepaid amount received prior to the Closing (other than prepaid amounts received in the ordinary course of business).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">84.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has delivered or made available to Parent complete and accurate copies of all U.S. federal income Company Returns for taxable year ending on or after December 31, 2015, and complete and accurate copies of all audit or examination reports and statements of deficiencies assessed against the Company with respect to such Company Returns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">85.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is not a party to any agreement with any third party relating to allocating or sharing the payment of, or liability for, Taxes (other than this Agreement and any contract, such as a loan or a lease, entered into in the ordinary course of business the primary purpose of which is unrelated to Taxes).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">86.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company has not been a member of an affiliated group filing a U.S. federal income Tax Return (other than a group the common parent of which was the Company).  The Company does not have any liability for the Taxes of any other Person (i) under Treasury Regulation Section&#160;1.1502-6 (or any similar provision of state, local, or foreign Law)&#59; (ii) as a transferee or successor&#59; or (iii) otherwise by operation of Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">87.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company is not and has not been, for U.S. federal income tax purposes, an equity holder of a &#8220;controlled foreign corporation&#8221; as defined in Section 957 of the Code (or any similar provision of state, local or foreign Law).</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">88.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">No material unpaid Taxes of the Company have been incurred since the Balance Sheet Date other than (i) the employer portion of any Taxes payable in connection with payments pursuant to this Agreement, (ii) Transfer Taxes, and (iii)  in the ordinary course of business of the Company and consistent with amounts previously paid with respect to such Taxes for similar periods in prior years, adjusted for changes in ordinary course operating results.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">89.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">No material closing agreements, private letter rulings, technical advice memoranda or similar agreements or rulings have been entered into or issued by any Governmental Body after December 31, 2010 with respect to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">90.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">There is no material amount of any property or obligation of the Company, including uncashed checks to vendors, customers or employees, non-refunded overpayments, credits or unclaimed amounts, that is, or may become, escheatable or reportable as unclaimed property to any Governmental Body under any applicable escheatment, unclaimed property or similar Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or otherwise in this Agreement shall be construed as a representation or warranty with respect to (i) the amount, value or availability in any Tax period (or portion thereof) beginning after the Closing Date of any net operating loss, capital loss, Tax credit, Tax basis or other Tax asset or attribute of the Company, or (ii) any Tax position that Parent or any of its Affiliates (including the Surviving Corporation) may take in respect of any Tax period (or portion thereof) beginning after the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">92.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Section 2.15(a) of the Disclosure Schedule sets forth an accurate and complete list of each material Company Plan and each material Company Service Provider Agreement (other than offer letters executed on the Company&#8217;s standard form). For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any employee benefit or compensation plan, program, policy, practice, agreement, Contract, obligation or arrangement (including any material &#8220;employee benefit plan&#8221; as defined in Section 3(3) of ERISA), but excluding any Company Service Provider Agreement, whether or not in writing and whether or not funded, in each case, which is sponsored, maintained or contributed to, or required to be contributed to, by the Company or with respect to which the Company or any of its Subsidiaries would reasonably be expected to have any potential liability.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Service Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any individual offer letter or agreement for employment, consulting, retirement, severance, termination or change in control, deferred compensation, equity-based, incentive, bonus, supplemental retirement, profit sharing, insurance, medical, welfare, fringe or other benefits or remuneration of any kind between the Company and any individual Company employee or service provider, except for any consulting, advisory or similar agreement set forth in Section 2.10(a)(viii) of the Disclosure Schedule. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">With respect to each Company Plan and each Company Service Provider Agreement, the Company has delivered or otherwise made available to Parent or its counsel a copy of&#58;  (i) each writing constituting a part of any written Company Plan or Company Service </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provider Agreement and all amendments thereto, and all trusts or service agreements relating to the administration and recordkeeping of any Company Plan or Company Service Provider Agreement, and written summaries of the material terms of all unwritten Company Plans and Company Service Provider Agreements&#59; (ii) the two most recent Annual Reports (Form 5500 Series or otherwise in a form in accordance with applicable Law) including all applicable schedules, if any, for each Company Plan that is subject to such reporting requirements&#59; (iii) the current summary plan description and any material modifications thereto, if any, or any written summary provided to participants with respect to any plan for which no summary plan description exists&#59; (iv) the most recent determination letter (or if applicable, advisory or opinion letter) from the IRS, if any, and any pending applications for a determination or opinion letter&#59; and (v) all material correspondence to or from any Governmental Body received in the last three years with respect to any Company Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">94.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Each Company Plan and Company Service Provider Agreement has been established and maintained in all material respects in accordance with its terms and applicable Laws, including but not limited to ERISA or the Code.  No &#8220;prohibited transaction,&#8221; within the meaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, and not otherwise exempt under Section 408 of ERISA, has occurred with respect to any Company Plan that would reasonably be expected to result in any material liability.  There are no current actions, suits or claims pending, or, to the Company&#8217;s Knowledge, threatened in writing (other than routine claims for benefits) against any Company Plan or any Company Service Provider Agreement or against the assets of any Company Plan or Company Service Provider Agreement.  There are no audits, inquiries or proceedings pending or, to the Company&#8217;s Knowledge, threatened in writing by any Governmental Body with respect to any Company Plan or Company Service Provider Agreement.  The Company and each ERISA Affiliate have timely made or otherwise provided for all contributions and other payments required by and due under the terms of each Company Plan or Company Service Provider Agreement has accrued such contributions and other payments in accordance with generally accepted accounting principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">95.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth in Section 2.15(d) of the Disclosure Schedule, with respect to each Company Plan intended to be &#8220;qualified&#8221; within the meaning of Section 401(a) of the Code, (i) each such Company Plan has been determined to be so qualified and has received a favorable determination or opinion letter from the IRS with respect to its qualification, (ii) the trusts maintained thereunder have been determined to be exempt from taxation under Section 501(a) of the Code, and (iii) no event has occurred that could reasonably be expected to result in disqualification or adversely affect such exemption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">96.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth in Section 2.15(e) of the Disclosure Schedule and other than as required under Section 4980B of the Code or other applicable Law, no Company Plan or Company Service Provider Agreement provides benefits or coverage in the nature of health, life or disability insurance following retirement or other termination of employment (other than death benefits when termination occurs upon death).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">97.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Each Company Plan or Company Service Provider Agreement to which the Patient Protection and Affordable Care Act and its companion bill, the Health Care and </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Education Reconciliation Act of 2010 (together known as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ACA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), applies is in compliance in all material respects with the ACA, and the rules and regulations promulgated thereunder, and no federal income Taxes or penalties have been imposed or are due for noncompliance with the ACA or for failure to provide minimum coverage to employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Each Company Plan that is a Code Section 125 cafeteria plan has passed non-discrimination testing for each year of existence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">99.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Except as set forth in Section 2.15(h) of the Disclosure Schedule, no payment or benefit which will or may be made by the Company in connection with the Merger with respect to any &#8220;disqualified individual&#8221; (as defined in Code Section&#160;280G and the regulations thereunder) would reasonably be expected to be characterized as a &#8220;parachute payment&#8221; within the meaning of Code Section&#160;280G(b)(2).  There is no Contract, agreement, plan or arrangement (including, for the avoidance of doubt, any Company Plan or Company Service Provider Agreement) to which the Company or any ERISA Affiliates is bound to provide a gross up or otherwise reimburse any employee for excise Taxes paid pursuant to Section&#160;4999 of the Code. The execution and delivery of this Agreement and the consummation of the Merger, either alone or in combination with another event, will not (i) increase the benefits payable under any Company Plan or Company Service Provider Agreement or the amount of compensation due to any current or former employee, director, officer or independent contractor of the Company or any of its Subsidiaries, (ii) result in any acceleration of the time of payment or vesting of any benefits under any Company Plan or Company Service Provider Agreement (other than accelerated vesting of Company Options as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)), (iii) entitle any current or former employee, director, officer or independent contractor of the Company or any of its Subsidiaries to severance pay or termination pay or any material increase in severance or termination pay, (iv)&#160;directly or indirectly cause the Company to transfer or set aside any assets to fund any material benefits under any Company Plan or Company Service Provider Agreement, (v) otherwise give rise to any material liability under any Company Plan or Company Service Provider Agreement, or (vi) limit or restrict the right to merge, materially amend, terminate or transfer the assets of any Company Plan or Company Service Provider Agreement on or following the Effective Time, and, except as provided by terms of this Agreement and applicable Law, Parent may at any time following the Effective Time, and from time to time, amend, terminate or wind up any Company Plan or Company Service Provider Agreement, in whole or in part, without consent from any Person and without incurring any material liabilities, costs or expenses.  Except with respect to any limitations pursuant to applicable Law, the Company has the right to terminate the employment of each employee of the Company at will and to terminate the engagement or service of directors and its independent contractors at will.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">100.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Neither the Company nor any Entity with which the Company is or would be considered a single employer under Section 414(b), (c) or (m) of the Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) has, within the six years preceding the date of this Agreement, sponsored, maintained, participated in, contributed to, been obligated to contribute to or had any obligations or incurred any liability under (i)&#160;any employee benefit plan that is subject to Title IV of ERISA </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or Section 412 of the Code (including any &#8220;defined benefit plan&#8221; within the meaning of Section 3(35) of ERISA), or (ii)&#160;a &#8220;multiemployer plan&#8221; within the meaning of Section 3(37) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">101.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Each Company Plan or Company Service Provider Agreement, that constitutes a &#8220;nonqualified deferred compensation plan&#8221; subject to Section 409A of the Code has been written, executed, and operated in compliance in all material respects with Section 409A of the Code and the regulations thereunder.  The Company does not have any obligation to gross up or otherwise reimburse any person for any Tax incurred by such person pursuant to Section 409A of the Code. Each Company Option has an exercise price that is not less than the fair market value of the underlying Company Common Stock on the date the Company Option was granted as determined in accordance with Section 422 or 409A of the Code, as applicable, has a grant date identical to the date on which the Company Board or compensation committee of the Company actually awarded such Company Option, and is otherwise exempt from Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">102.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">To the Company&#8217;s Knowledge&#58; (i) the Company is, and during the past three years has been, in compliance in all material respects with all applicable Laws, and with any order, ruling, decree, judgment or arbitration award of any arbitrator or any court or other Governmental Body, respecting employment, employment practices, terms and conditions of employment, wages, hours or other labor-related matters, including Laws, orders, rulings, decrees, judgments and awards relating to discrimination, worker classification (including the proper classification of workers as independent contractors and consultants), wages and hours, labor relations, leave of absence requirements, occupational health and safety, privacy, harassment, retaliation, immigration, wrongful discharge or violation of the personal rights of employees, former employees or prospective employees&#59; (ii) the Company has withheld and reported all amounts required by any Law or Contract to be withheld and reported with respect to wages, salaries and other payments to any employee&#59; (iii) the Company has no liability for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Body with respect to unemployment compensation benefits, social security or other benefits or obligations for any employee (other than routine payments to be made in the normal course of business and consistent with past practice)&#59; and (iv) there has not been in the three years prior to the date of this Agreement, nor are there currently, any Legal Proceedings or formal internal investigations conducted by the Company (or any Person at the request of the Company or its governing bodies) concerning any illegal activity, fraudulent or deceptive conduct, discrimination, sexual harassment, whistleblowing or other malfeasance issues with respect to any current or former employee of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">103.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Company is not and has never been a party to or otherwise bound by any collective bargaining agreement, Contract or other agreement or understanding with a labor union or labor organization, or works council or similar body, nor is any such Contract or agreement presently being negotiated, nor, to the Company&#8217;s Knowledge, is there, nor has there been in the last three years, a representation campaign with respect to any of the employees of the Company.  As of the date of this Agreement, there is no pending or, to the Company&#8217;s Knowledge, threatened, labor strike, dispute, walkout, work stoppage, slow-down or lockout involving Company.  Neither the Company nor, to the Company&#8217;s Knowledge, any of its representatives or employees has committed or engaged in any Unfair Labor Practice pursuant to </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the National Labor Relations Act in connection with the operation of the business of the Company.  There are no Legal Proceedings pending, or, to the Company&#8217;s Knowledge, threatened, relating to any Company Plan or Company Service Provider Agreement, collective bargaining obligation or agreement, wages and hours, leave of absence, plant closing notification, employment statute or regulation, privacy right, labor dispute, workers&#8217; compensation policy, safety, retaliation, harassment, immigration or discrimination matter involving any employee, including charges of any Unfair Labor Practices, discrimination, retaliation or harassment complaints, except for such Legal Proceedings which would not reasonably be expected to, individually or in the aggregate, result in any material liability to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">104.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Section 2.15(m) of the Disclosure Schedule sets forth a list of each current employee and independent contractor (who is a natural person) of the Company, including any employee who is on a leave of absence of any nature, including such employee or independent contractor&#8217;s name (or employee identification number), job title, date of hire or commencement of services, location, base salary or hourly rate of compensation and total cash compensation for calendar year 2019.  To the Company&#8217;s Knowledge, no employee or independent contractor of the Company is party to or is bound by any confidentiality, non-competition or non-solicitation agreement that may have an adverse effect on such employee&#8217;s or independent contractor&#8217;s performance of his or her duties or responsibilities as an employee or independent contractor of the Company.  No current executive officer of the Company has provided written notice to Company of his or her intent to terminate his or her employment with Company as of the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">105.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Company has made available to Parent copies of all employee manuals and handbooks, policy statements and other materials in effect as of the date hereof relating to the employment of the employees of the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">106.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Company and its Subsidiaries are in substantial compliance with (1) the applicable health care continuation and notice provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or any state Law governing health care coverage extension or continuation, (2) the applicable requirements of the Family and Medical Leave Act of 1993 and the regulations thereunder, (3) the applicable requirements of HIPAA, (4) the applicable requirements of the Patient Protection and Affordable Care Act and its companion bill, the Health Care and Education Reconciliation Act of 2010, and (5) the applicable requirements of the Cancer Rights Act of 1998.  The Company and its Subsidiaries have no material unsatisfied obligations to any current or former employees or their qualified beneficiaries pursuant to COBRA, HIPAA or any other Law governing health care coverage extension or continuation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">107.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">No Company Plan or Company Service Provider Agreement is maintained outside the jurisdiction of the United States or covers any employees or other service providers of the Company or any of its Subsidiaries who reside or work outside of the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Environmental Matters</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company is and for the past five years, has been in material compliance with all applicable Environmental Laws.  During the past three years, the Company has not received any written notices, demand letters or requests for information from any Governmental Body indicating that the Company is or may be in violation of, or be liable under, any Environmental Law, and the Company is not subject to any pending or, to Company&#8217;s Knowledge, threatened action or investigation by any Governmental Body under any Environmental Law. To the Company&#8217;s Knowledge, no current or prior owner of any property leased or controlled by the Company has received any written notice from a Governmental Body during the past five years that alleges that such current or prior owner or Company is materially violating any Environmental Law.  The Company is in compliance in all material respects with, and has no material liability under, any provisions of leases relating in any way to any Environmental Laws or to the use, management or release of Hazardous Substances under such leases.  All Environmental Permits, if any, required to be obtained by the Company under any Environmental Law in connection with its operation as it is currently being conducted, including those relating to the management of Hazardous Substances, have been obtained by the Company, are in full force and effect, and the Company is in material compliance with the terms thereof.  The Company has not disposed of, arranged for disposal of, or released any Hazardous Substances on, in or under any real property currently owned or operated by the Company that would reasonably be expected to require remediation under Environmental Laws.  The Company has delivered or otherwise made available to Parent or its counsel copies of any environmental investigation, study, test, audit, review or other analysis in its possession in relation to the current or prior business of the Company.  To the Company&#8217;s Knowledge, there is no underground or aboveground storage tank containing Hazardous Substances at any real property currently owned or operated by, or premises leased by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Insurance</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has the insurance of the types and in the amounts set forth in Section&#160;2.17 of the Disclosure Schedule (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Insurance Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Insurance Policies are in full force and effect and all premiums due and payable under such Insurance Policies have been paid on a timely basis.  The Insurance Policies provide coverage to the extent and in the manner required by Law and by any Contract.  The Company has disclosed to the Parent all claims submitted by or on behalf of the Company pursuant to the Insurance Policies.  There is no material claim pending under any of the Company&#8217;s Insurance Policies as to which coverage has been questioned, denied or disputed by the underwriters of such policies.  The Company is not in default under the Insurance Policies and as of the date of this Agreement, the Company has not received any notice alleging default under the Insurance Policies.  As of the date of this Agreement, the Company has not received notice of cancellation, termination, non-renewal or reduction of coverage with respect to any Insurance Policy, and there is no threatened cancellation, termination, non-renewal or reduction of coverage of, or material premium increase with respect to, any of such policies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Legal Proceedings&#59; Orders</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As of the date of this Agreement, there is no pending Legal Proceeding, and no Person has threatened in writing, or to the Company&#8217;s Knowledge, otherwise threatened, to commence any Legal Proceeding&#58; (a) that involves the Company or any of the assets owned or used by the Company or any Person whose liability the Company has retained or assumed, either contractually or by operation of law&#59; or (b) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Merger or any of the other transactions contemplated by this Agreement.  There is no order, writ, injunction, judgment or decree to which the Company or any of the assets owned or used by the Company is subject.  To the Company&#8217;s Knowledge, no officer or other employee of the Company is subject to any order, writ, injunction, judgment or decree that prohibits such officer or other employee from engaging in or continuing any conduct, activity or practice relating to the Company&#8217;s business.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not apply with respect to Tax matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.34pt">Authority&#59; Binding Nature of Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement, and subject to receipt of the Required Company Stockholder Vote, to consummate the Merger and the transactions contemplated by this Agreement.  As of the date of this Agreement, the Company Board (at a meeting duly called and held) has (a)&#160;determined that the Merger is advisable and fair and in the best interests of the Company and its stockholders, (b)&#160;authorized and approved the execution, delivery and performance of this Agreement by the Company and approved the Merger, and (c)&#160;recommended the adoption of this Agreement by the Company Stockholders and directed that this Agreement be submitted for consideration by the Company Stockholders by Written Consent.  This Agreement has been duly executed and delivered by the Company, and assuming due execution and delivery by Parent and Merger Sub, constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to (i)&#160;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">t.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Vote Required</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The adoption of this Agreement and approval of the Merger requires the affirmative vote (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Required Company Stockholder Vote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) of (a) the holders of a majority of the shares of Company Common Stock and Company Preferred Stock outstanding on the applicable record date, voting together as a single class (with the Company Preferred Stock voting on an &#8220;as converted&#8221; basis) and (b) the holders of a majority of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock outstanding on the applicable record date, voting together as a single class, to agree that the Transactions shall not be deemed a liquidation, dissolution or winding up of the Corporation within the meaning of the provisions of paragraph 4 of the Company Charter.  Upon execution and delivery of the Written Consents required within twenty-four hours after the date hereof in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Stockholder Consent or Approval), the Required Company Stockholder Vote shall have been obtained.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">49</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">u.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Non-Contravention&#59; Consents</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in Section&#160;2.21 of the Disclosure Schedule and, with respect to clauses (b) and (c) only, except for violations and defaults that would not, individually or in the aggregate, reasonably be likely to prevent, materially delay or materially impair the consummation of the transactions contemplated by this Agreement, the execution and delivery of this Agreement by the Company and the consummation by the Company of the transactions contemplated by this Agreement will not cause a&#58; (a) violation of any of the provisions of the Company Charter or bylaws of the Company&#59; (b)&#160;violation by the Company of any Law applicable to the Company&#59; or (c) default (or an event that, with or without notice or lapse of time or both would constitute a default) on the part of the Company under, or give to others any rights of termination, acceleration or cancellation of, or result in the creation of a Lien on any of the properties or assets of the Company (other than a Permitted Encumbrance) pursuant to, any Material Contract.  Except as set forth in Section&#160;2.21 of the Disclosure Schedule and except as may be required by the DGCL, the HSR Act or any other Antitrust Law or governmental regulation, the Company is not required to obtain any Consent from any Governmental Body or party to a Material Contract at any time prior to the Closing in connection with the execution and delivery of this Agreement or the consummation by the Company of the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Financial Advisor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Except as set forth in (i) the redacted version of the contract specified in paragraph (a) of Section&#160;2.22 of the Disclosure Schedule that was made available to Parent and (ii) the contract made available to Parent specified in paragraph (b) of Section&#160;2.22 of the Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage or finder&#8217;s fee in connection with the Merger or any of the other transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">w.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.34pt">Related Party Transactions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in Section&#160;2.23 of the Disclosure Schedule, there are no material obligations of the Company to officers, directors, stockholders or employees of the Company other than (a) for payment of salaries and bonuses for services rendered, (b) reimbursement of customary and reasonable expenses incurred on behalf of the Company, (c) benefits due under Company Plans and Company Service Provider Agreements and fringe benefits not required to be listed on Section&#160;2.15(a) of the Disclosure Schedule, (d) agreements relating to outstanding Company Capital Stock, Company Options and (e) as provided in the Company Charter or the bylaws of the Company.  No officer, director or, to the Company&#8217;s Knowledge, Company Stockholder is directly or indirectly interested in any material asset of the Company or any Material Contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">108.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Since the Balance Sheet Date, through the date of this Agreement, the Company has not engaged in (i) any trade loading practices or any other promotional sales or discount activity or other practice with the effect of accelerating sales to the trade or otherwise </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">50</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that would otherwise be expected (in the ordinary course of business consistent with past practice) to occur in later periods, (ii) any practice which would have the effect of accelerating collections of receivables that would otherwise be expected (in the ordinary course of business consistent with past practice) to be in later periods, (iii) any practice which would have the effect of postponing payments by the Company that would otherwise be expected (in the ordinary course of business consistent with past practice) to be made in earlier periods or (iv) any other promotional sales, discount activity, deferred revenue activity or Inventory overstocking or understocking activity, in each case in this paragraph (a), in a manner outside the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">109.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Inventory (net of all reserves for obsolete, excess, slow-moving, damaged and defective inventory) shown on the Unaudited Balance Sheet (i) is owned by the Company free and clear of all Liens, other than Permitted Encumbrances, (ii) is usable and currently marketable condition in the ordinary course of business of the Company and consistent with the Accounting Principles, and (iii) is salable in the ordinary course of business of the Company and (iv) is stored at the Company&#8217;s premises (other than for those items of Inventory which are stored in other locations as set forth Section 2.24(b) of the Disclosure Schedule).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Customers and Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">110.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">To the Knowledge of the Company, no Significant Customer intends to terminate its direct or indirect business relationship with the Company or to limit or alter its relationship with the Company in any material respect.  Section&#160;2.25(a) of the Disclosure Schedule lists each Significant Customer.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Significant Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, together, (i)&#160;the top 20 hospitals, clinics, physician offices or other health care facility end user,(ii)&#160;the top 8 group purchasing organizations, (iii) top 10 distributors, taken as a whole, during the 24-month period ending October 31, 2020 and (iv) the customers, group purchasing organizations and distributors not described in clauses (i)-(iii) that generated the largest revenues for the Company and its Subsidiaries, taken as a whole, during the 12-month period ending October 31, 2020 such that the Persons described in clauses (i)-(iv) represent at least 75% of revenue earned by the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">111.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">To Knowledge of the Company, no Significant Supplier intends to terminate its direct or indirect business relationship with the Company or to limit or alter its relationship with the business in any material respect.  Section&#160;2.25(b) of the Disclosure Schedule lists each Significant Supplier. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Significant Supplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) the top 20&#160;suppliers, measured on the basis of cost of goods or services purchased by the Company, taken as a whole, during the 24-month period ending October 31, 2020 and (ii) any sole source supplier of any input used in the manufacture of the Company&#8217;s products.  The Company has not entered into agreement, commitment, arrangement or understanding with any vendor of products or services which provide for any minimum order quantities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Takeover Statutes</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;control share acquisition&#8221; or other similar anti-takeover statute (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Takeover Statute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is applicable to the Company, the Company Capital Stock, the Merger or other transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">aa.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Bank Accounts, Books and Records</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section&#160;2.27 of the Disclosure Schedule lists each of the Company&#8217;s bank accounts and the authorized signatories thereon. The minute books and stock record books of the Company for the five years prior to the date of this Agreement, all of which have been made available to Parent, are complete and correct in all material respects and have been maintained in accordance with sound business practices. The minute books of the Company contain accurate and complete in all material respects records of all meetings, and actions taken by written consent, of the Company Stockholders, Board of Directors and any committees thereof for the five years prior to the date of this Agreement.  At </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Closing, all of those books and records will be in the possession of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ab.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.33pt">Warranty Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">112.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Other than as set forth in (i) the Company&#8217;s standard forms of purchase agreement, consignment agreement, and order form (a correct and complete copy of each of which have been made available to Parent), (ii) agreements with group purchasing agreements organizations set forth in Section 2.10(a)(ii) of the Disclosure Schedule, and (iii) the distribution agreements set forth in Section 2.10(a)(ii) of the Disclosure Schedule, the Company has not given to any Person any product or related service guaranty or warranty, right of return or other indemnity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">113.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Except as set forth in Section&#160;2.28(b) of the Disclosure Schedule, as of the date of this Agreement, there are no pending or, to the Company&#8217;s Knowledge, threatened, Legal Proceeding alleging that any products or related services are defective or fail to meet any applicable warranties, whether express or implied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ac.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9.68pt">Accounts Receivable</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All Accounts Receivable reflected on the Company Financial Statements, and all Accounts Receivable that have arisen since the Balance Sheet Date, (a) arose out of arm&#8217;s-length bona fide transactions made in the ordinary course of business consistent with past practice, (b) can reasonably be anticipated to be, in the aggregate, paid in full (subject to the adequate reserves for doubtful accounts, calculated in accordance with GAAP, reflected on the Company Financial Statements and net of such returns and payment discounts) in accordance with their terms, and (c) are not being contested or disputed by any third party in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ad.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.33pt">Reliance</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company is not and has not relied on any representations or warranties whatsoever regarding the subject matter of this Agreement, express or implied, except for the representations and warranties expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of Parent and </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of this Agreement.  Such representations and warranties by Parent and Merger Sub constitute the sole and exclusive representations and warranties of Parent and Merger Sub in connection with the transactions contemplated hereunder and the Company understands, acknowledges and agrees that all other representations and warranties of any kind or nature whether express, implied or statutory are specifically disclaimed by Parent and Merger Sub.  In making its determination to proceed with the transactions contemplated by this Agreement, the Company has relied solely upon the representations and warranties of Parent and Merger Sub expressly and specifically set forth in this Agreement and has not relied upon any other information provided by, for or on behalf of Parent, Merger Sub or their Affiliates or representatives.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Representations and Warranties of Parent and Merger Sub</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent and Merger Sub represent and warrant to the Company as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Due Incorporation&#59; Subsidiaries</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent is a corporation duly incorporated, validly existing and in good standing under the laws of Delaware.  Merger Sub is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Authority&#59; Binding Nature of Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent and Merger Sub have all necessary corporate power and authority to enter into and perform their obligations under this Agreement.  The execution, delivery and performance by Parent and Merger Sub of this Agreement have been duly authorized by all necessary action on the part of Parent, Merger Sub and their respective boards of directors.  This Agreement has been duly executed and delivered by Parent and Merger Sub, and assuming due execution and delivery by the Company, constitutes the legal, valid and binding obligation of Parent and Merger Sub, enforceable against them in accordance with its terms, subject to (a) laws of general application relating to bankruptcy, insolvency and the relief of debtors and (b) rules of law governing specific performance, injunctive relief and other equitable remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Non-Contravention&#59; Consents</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The execution and delivery of this Agreement by Parent and Merger Sub and the consummation by Parent and Merger Sub of the transactions contemplated by this Agreement will not&#58; (a)&#160;cause a violation of any of the provisions of the certificate of incorporation or bylaws of Parent or Merger Sub, (b)&#160;cause a violation by Parent or Merger Sub of any Law applicable to Parent or Merger Sub or (c)&#160;cause a default on the part of Parent or Merger Sub under any material contract of Parent or Merger Sub, except, with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> only, for violations and defaults that would not reasonably be expected to materially and adversely impact Parent&#8217;s or Merger Sub&#8217;s ability to consummate the transactions contemplated by this Agreement.  Except as may be required by the DGCL, the HSR Act or any other Antitrust Law or governmental regulation, neither Parent nor Merger Sub is required to obtain any </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">53</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Consent from any Governmental Body or party to a material contract of Parent or Merger Sub at any time prior to the Closing in connection with the execution and delivery of this Agreement or the consummation of the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  There is no Legal Proceeding pending (or, to the knowledge of Parent or Merger Sub, being threatened) against Parent or Merger Sub that would delay, restrain, prevent, enjoin or otherwise prohibit the consummation of the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Merger Sub</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Merger Sub (a) was formed solely for the purpose of engaging in the transactions contemplated by this Agreement, (b) has engaged in no other business activities and (c) has conducted its operations only incident to its formation and performance obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Reliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">114.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Neither Parent nor Merger Sub is relying and neither Parent nor Merger Sub has relied on any representations or warranties whatsoever regarding the subject matter of this Agreement, express or implied, except for the representations and warranties expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of this Agreement.  Such representations and warranties by the Company constitute the sole and exclusive representations and warranties of the Company in connection with the transactions contemplated hereunder and each of Parent and Merger Sub understands, acknowledges and agrees that all other representations and warranties of any kind or nature whether express, implied or statutory are specifically disclaimed by the Company.  Parent hereby acknowledges that it has conducted to its satisfaction an independent investigation of the financial condition, operations, assets, liabilities and properties of the Company.  In making its determination to proceed with the transactions contemplated by this Agreement, Parent has relied on (a) the results of its own independent investigation and (b) the representations and warranties of the Company expressly and specifically set forth in this Agreement, including the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">115.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In connection with the due diligence investigation of the Company by Parent and its Affiliates, stockholders, directors, officers, employees, agents, representatives or advisors, Parent and its Affiliates, stockholders, directors, officers, employees, agents, representatives and advisors have received and may continue to receive after the date hereof from the Company and its Affiliates, stockholders, directors, officers, employees, consultants, agents, representatives and advisors certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information, regarding the Company and its business and operations.  Parent hereby acknowledges that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans, and that Parent will have no claim against the Company, or any of its Affiliates, stockholders, directors, officers, employees, consultants, agents, representatives or advisors, or any other Person, with respect thereto.  Accordingly, Parent hereby acknowledges </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">54</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and agrees that, except for the representations and warranties expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of this Agreement, neither the Company, nor any of its Affiliates, stockholders, directors, officers, employees, consultants, agents, representatives or advisors has made or is making any express or implied representation or warranty with respect to such estimates, projections, forecasts, forward-looking statements or business plans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">No Parent Vote Required</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No vote or other action of the stockholders of Parent is required by applicable Law, the certificate of incorporation or bylaws (or similar charter or organizational documents) of Parent or otherwise in order for Parent and Merger Sub to consummate the Merger and the transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Availability of Funds</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent has and will have, as of the Closing and to the extent required thereafter, sufficient funds on hand and available through existing liquidity facilities (without restrictions on drawdown that would delay the consummation of the transactions contemplated hereby) to (a) pay the Upfront Purchase Price, (b)&#160;pay any and all fees and expenses in connection with the transactions contemplated hereby and any debt or equity financing in connection therewith, (c) repay or refinance all Debt of the Company to the extent such repayment or refinancing is required in connection with the transactions contemplated hereby and (d)&#160;satisfy all of its other payment obligations payable hereunder and under any agreement ancillary hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Certain Covenants of the Company</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Access</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to applicable Laws relating to the exchange of information and except as required to comply with any COVID-19 Measures, during the period from the date of this Agreement through the earlier of the Effective Time or the termination of this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pre-Closing Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and upon reasonable advance notice to the Company, the Company shall (a) provide Parent and Parent&#8217;s representatives with reasonable access during normal business hours to the Company&#8217;s personnel, facilities and existing books and records and (b) furnish promptly to the Parent and Parent&#8217;s representatives such additional available financial and operating data regarding the Company (or copies thereof), as the Parent may from time to time reasonably request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any such access shall be conducted at Parent&#8217;s expense, under the supervision of appropriate personnel of the Company and in such a manner as to maintain the confidentiality of this Agreement and the transactions contemplated hereby in accordance with the terms hereof and not to interfere with the normal operation of the business of the Company or create a material risk of damage or destruction to any material assets or property of the Company.  Any investigation shall be subject to the Company&#8217;s reasonable security measures and insurance requirements and shall not include the right to perform invasive testing.  Nothing herein shall require the Company to disclose any </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">55</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">information to Parent if such disclosure would, in the Company&#8217;s reasonable judgment, (a) jeopardize any attorney-client or other legal privilege or (b) contravene any applicable Law, fiduciary duty or binding agreement entered into prior to the date of this Agreement (including any confidentiality agreement to which the Company is a party).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Conduct of the Business of the Company</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Pre-Closing Period, except (1) as set forth in Section&#160;4.2 of the Disclosure Schedule, (2) to the extent expressly required or permitted by this Agreement or any other Transaction Document, (3) as necessary to ensure that the Company complies with applicable Laws (including COVID-19 Measures), or (4) with Parent&#8217;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed)&#58; (i) the Company shall use commercially reasonable efforts to (A) carry on its business in the ordinary course consistent with past practice, (B) preserve substantially intact its present business organization, and (C) preserve its relationships with material customers, suppliers, distributors, licensors, licensees, Governmental Bodies and others to whom the Company has legal or contractual obligations&#59; and (ii) the Company shall not&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">116.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">amend the Company Charter or the bylaws of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">117.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">split, combine or reclassify any of its capital stock or (except in connection with the conversion of Company Preferred Stock to Company Common Stock or the exercise of Company Options) issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">118.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">issue, deliver, sell, disperse or pledge any shares of Company Capital Stock or securities convertible into, or subscriptions, rights, warrants or options to acquire, or other agreements or commitments of any character obligating it to issue any such shares or other convertible securities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (i) the Company may issue shares of Company Common Stock in connection with the exercise of Company Options or other rights for Company Common Stock, in each case outstanding as of the date of this Agreement in accordance with their terms and, as applicable, the Equity Incentive Plans as in effect on the date of this Agreement and (ii) the Company may issue shares of Company Common Stock in connection with the conversion of Company Preferred Stock outstanding as of the date of this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">enter into or adopt any plan or agreement of complete or partial liquidation or dissolution, or file a voluntary petition in bankruptcy or commence a voluntary legal procedure for reorganization, arrangement, adjustment, release or composition of indebtedness in bankruptcy or other similar Laws now or hereafter in effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">120.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">make any capital expenditures, capital additions or capital improvements, in excess of $200,000 in the aggregate (other than in the ordinary course of business consistent with past practice or in accordance with the budget for capital expenditures previously made available to Parent)&#59;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">56</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">121.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">(i) reduce the amount of any insurance coverage provided by existing Insurance Policies or (ii) fail to maintain in full force and effect, or fail to renew, insurance coverage consistent with past practices&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">122.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">acquire or agree to acquire by merging with, or by purchasing a portion of the stock or assets of, or by any other manner, any business or any Entity, other than as permitted in (e) above&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">123.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">other than in the ordinary course of business, transfer, sell, lease, abandon, allow to lapse, license, or grant any other right to any properties or assets of the Company which are material to the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">124.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">make or change or revoke any material election in respect of Taxes, change any accounting method in respect of Taxes, settle any material claim or assessment in respect of Taxes, or consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of Taxes&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">125.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">increase in any manner the compensation (including bonuses) or wage rate, pension, welfare, fringe or other benefits, severance, or termination pay of any director or employee of the Company, except (i) for increases provided for in any Contracts or Company Plans in effect on the date hereof and set forth in Section 4.2 of the Disclosure Schedule, and (ii) that the Company may make annual cash bonus and commission payments for completed periods based on actual performance in the ordinary course of business consistent with past practices and in accordance with the bonus and commission plans and policies existing on the date of this Agreement and are in the ordinary course of business consistent with past practices, including such payments to its officers&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">126.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">except as required pursuant to the terms of any Company Plan or Company Service Provider Agreement in effect as of the date hereof and set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule, or as otherwise required by applicable Law (1) establish, adopt or materially amend any Company Plan or Company Service Provider Agreement or any arrangement that would have been a Company Plan or Company Service Provider Agreement had it been entered into prior to the date of this Agreement &#59; (2) grant any new awards, or amend or amend or modify the terms of any outstanding awards, under any Company Plan or Company Service Provider Agreement&#59; (3) take any action to accelerate the vesting or lapsing of restrictions or payment, or fund or in any other way secure the payment, of compensation or benefits under any Company Plan or Company Service Provider Agreement&#59; (4) materially change any actuarial or other assumptions used to calculate funding obligations with respect to any Company Plan that is required by applicable Law to be funded or change the manner in which contributions to such plans are made or the basis on which such contributions are determined, except as may be required by GAAP&#59; (5) forgive any loans or issue any loans (other than routine travel advances issued in the ordinary course of business, which shall not exceed $10,000 individually) to any employee of the Company, (6) hire any employee, except to replace an employee whose annual base salary would be $150,000 or less, or (7) terminate the employment of any employee other than for cause&#59;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">127.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">utilize or leverage social insurance programs related to COVID-19&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notwithstanding the foregoing, the Company shall be permitted to take any actions reasonably required in connection with its application for forgiveness of the PPP Loan to the extent such actions do not result in any liability or obligation for the Company or its Affiliates after the Closing that would not be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">128.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">announce, implement or effect any reduction-in-force, lay-off, furlough or other program resulting in the termination of employment of employees (other than terminations of individual employees in the ordinary course of business consistent with past practice)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">129.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">become a party to, establish, adopt, amend, commence participation in or terminate any collective bargaining agreement or other agreement with a labor union, works council or similar organization&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">130.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">make any material changes in its methods of accounting or accounting practices (including with respect to reserves), other than as required by GAAP&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">131.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">waive, release, assign, compromise, commence, settle or agree to settle any Legal Proceeding on terms requiring (1) the Company to take any material action or abstain from taking any material action or (2) the payment of monetary damages in excess of $100,000 that is not covered by insurance&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">132.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">enter into any Contract that would have been a Material Contract had it been entered into prior to this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">133.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">amend, modify or terminate any Material Contract in a manner that would adversely affect the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">134.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">make any loans, advances, guarantees or capital contributions to or investments in any Person (other than business-related advances to its employees in the ordinary course of business consistent with past practice, which shall not exceed $10,000 individually)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">135.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">incur Debt (including the issuance or sale of any debt securities or warrants or other rights to acquire any debt security of the Company), except for Debt for borrowed money incurred pursuant to existing credit facilities as of the date hereof in the ordinary course of business consistent with past practices not to exceed $250,000 in the aggregate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">136.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">declare, set aside, make or pay any non-cash dividend or other non-cash distribution with respect to any of its capital stock or enter into any agreement with respect to the voting of its capital stock&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">137.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">permit any material asset of the Company to become subject to a Lien (other than a Permitted Encumbrance)&#59;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">138.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">make any material change in or to the regular price, credit or distribution policies of the Inventory, or engage in any other activity or practice not consistent with past practice, that would reasonably be considered &#8220;channel stuffing,&#8221; &#8220;trade loading&#8221; or that reasonably would be expected to result in an increase, temporary or otherwise in the demand for inventories but not the use of such Inventory&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">139.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">sell, lease, license, assign, transfer, abandon, allow to lapse, or otherwise dispose of (whether by merger, stock or asset sale or otherwise) any of the Company&#8217;s or any of its Subsidiaries&#8217; assets, rights, securities, properties, interests or businesses (other than Intellectual Property), except for (A) assets, rights, securities, properties, interests or businesses with a fair market value or replacement cost (whichever is higher) not in excess of $100,000 in the aggregate and not otherwise material to the Company&#8217;s or any of its Subsidiaries&#8217; business and (B) sales of inventory and dispositions of obsolete assets in the ordinary course of business consistent with past practice&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">140.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">sell, lease, license, sublicense, assign, transfer, abandon, allow to lapse expire, create or incur any Lien on, or otherwise dispose of, any Company Intellectual Property (other than (A) non-exclusive licenses of Intellectual Property granted by the Company or any of its Subsidiaries in the ordinary course of business consistent with past practice&#59; (B) with respect to immaterial or obsolete Intellectual Property) or disclose any material Trade Secrets of the Company or any of its Subsidiaries or any of its or their respective customers to any other Person (other than in the ordinary course of business consistent with past practice to a Person bound by confidentiality obligations reasonable under the circumstances with respect to such material Trade Secrets)&#59; or (C) sales of Company Products in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">fail to substantially comply with any commitments or obligations in the Settlement Agreement&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">agree or commit to take any of the actions described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses&#160;(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conduct of the Business of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nothing herein shall require the Company to obtain consent from Parent to do any of the foregoing if obtaining such consent might reasonably be expected to violate applicable Law, including Antitrust Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">No Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">143.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">During the Pre-Closing Period, the Company shall not, nor shall it authorize or instruct any of its officers, directors or employees or any investment banker, attorney or other advisor or representative retained by it to (i) solicit, initiate, facilitate, continue inquiries or knowingly encourage the submission of any Takeover Proposal by any Person or (ii) enter into or participate in any discussions or negotiations regarding, or furnish to any Person any non-public information with respect to, or take any other action intended or reasonably expected to facilitate the making of any inquiry or proposal to the Company that constitutes, or is reasonably expected to lead to, any Takeover Proposal by any Person.  Without limiting the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">foregoing, it is understood that any violation of the restrictions set forth in the preceding sentence by any officer, director or employee of the Company or any investment banker, attorney or other advisor or representative of the Company, acting on behalf of, and with the authorization of, the Company, shall be deemed to be a breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">No Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">144.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">During the Pre-Closing Period, neither the Company Board nor any committee thereof shall (i) approve or recommend any Takeover Proposal or (ii) cause the Company to enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement with respect to any Takeover Proposal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">145.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Company shall, and the Company shall direct its representatives to, immediately cease and cause to be terminated any and all existing activities, discussions or negotiations with any Persons conducted heretofore with respect to any offer or proposal that constitutes a Takeover Proposal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">146.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">During the Pre-Closing Period, in addition to the obligations of the Company set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">paragraphs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">No Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Company shall promptly (and in any event within two Business Days after receipt thereof by the Company) advise Parent orally and in writing of any Takeover Proposal submitted to the Company, or any inquiry which could reasonably be expected to result in an Takeover Proposal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Additional Financial Statements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall, within 10 Business Days of the end of the calendar month, deliver to Parent monthly financial statements for each month from the September&#160;30, 2020 until the Closing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Additional Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Company shall prepare each of the Additional Financial Statements on a basis consistent with past practice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Financing Cooperation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#160;The Company shall use its reasonable best efforts to, and shall cause its officers, directors or employees or other advisors or representatives to use their respective reasonable best efforts to, provide all cooperation reasonably requested by Parent in connection with any indebtedness of Parent or its Affiliates, including providing all cooperation as may be requested in order to guarantee or grant a security interest in (and perfect) collateral for such Debt.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Additional Covenants of the Parties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">147.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In accordance with the Company Charter and the Company&#8217;s bylaws and the applicable requirements of the DGCL (including Sections 228 and 262 of the DGCL), the Company shall seek and shall use its reasonable best efforts to (i) promptly (and in any event within 24 hours) after the execution of this Agreement, obtain and deliver to Parent, a written consent of holders of Company Capital Stock approving the adoption of this Agreement and </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">approval of the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) evidencing receipt of the Required Company Stockholder Vote and (ii) as promptly as practicable following the date of this Agreement, but in any event prior to Closing, obtain Written Consents from Securityholders holding at least 75% of the Company Capital Stock issued and outstanding as of the date of this Agreement, in each case in lieu of a meeting pursuant to Section 228 of the DGCL for the purposes of (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">x</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) adopting this Agreement and approving the Merger, (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">y</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) acknowledging that the adoption and approvals are irrevocable and result in the waiver of any right of such stockholders to demand appraisal in connection with the Merger pursuant to the DGCL and (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">z</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) such other matters set forth therein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">148.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If applicable and if requested by Parent, the Company shall (i)&#160;use reasonable best efforts to secure, at least five (5) Business Days prior to the Closing Date, from any Person who is a &#8220;disqualified individual,&#8221; as defined in Section&#160;280G of the Code, and who has a right to any payments or benefits or potential right to any payments or benefits in connection with the consummation of the Merger that would be deemed to constitute &#8220;parachute payments&#8221; pursuant to Section&#160;280G of the Code, a waiver of such Person&#8217;s rights to any such payments or benefits applicable to such Person to the extent that all remaining payments or benefits applicable to such Person shall not be deemed to be &#8220;parachute payments&#8221; pursuant to Section&#160;280G of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Waived 280G Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (ii)&#160;if such waiver is obtained, submit for approval by the Company Stockholders at least five (5) Business Days prior to the Closing Date the Waived 280G Benefits, to the extent and in the manner required under Sections 280G(b)(5)(A)(ii) and 280G(b)(5)(B) of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">280G Stockholder Vote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company shall not pay any of the Waived 280G Benefits if such payment is not approved by the Company Stockholders as contemplated above. If applicable, the Company shall have delivered to Parent true and complete copies of all disclosure and documents that comprise the stockholder approval of each of the Waived 280G Benefits in sufficient time to allow Parent to comment thereon but no less than five (5) Business Days prior to the 280G Stockholder Vote, and shall reflect all reasonable comments of Parent thereon.  If applicable, prior to the Closing Date, the Company shall deliver to Parent evidence satisfactory to Parent that a vote of the Company Stockholders was received in conformance with Section&#160;280G of the Code and the regulations thereunder, or that such requisite stockholder approval has not been obtained with respect to the Waived 280G Benefits, and, as a consequence, the Waived 280G Benefits have not been and shall not be made or provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">149.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">As promptly as possible, but in any event within ten (10) days following the date of this Agreement, the Company shall prepare and deliver to each holder of Company Capital Stock an information statement regarding the transactions contemplated by this Agreement, which shall be in a form reasonably acceptable to Parent (as it may be amended or supplemented from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Information Statement shall be delivered to stockholders of the Company who were entitled to vote upon the adoption of this Agreement, and shall inform such stockholders of the approval of the Merger, the adoption of this Agreement in accordance with Section 228 of the DGCL, and the availability of appraisal rights under the DGCL and shall include (i) a statement to the effect that the Company&#8217;s board of directors had unanimously recommended that the holders of Company Capital Stock vote in favor of the adoption of this Agreement and the approval of the Merger, (ii) a statement that adoption of this Agreement shall constitute, among other things, approval by the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">holders of Company Capital Stock of the Securityholders&#8217; Representative Reserve by the Securityholders&#8217; Representative and the withholding of the Escrow.  The Company shall prepare any other documentation required to be provided to holders of Company Capital Stock pursuant to the DGCL, subject to Parent&#8217;s reasonable review and comment. None of the information supplied or to be supplied by Parent or the Company for inclusion in the Information Statement or any amendment or supplement thereto will contain, as of the date of the delivery of such document, any untrue statement of a material fact, or will omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Regulatory Filings&#59; Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">150.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Subject to the terms and conditions set forth in this Agreement, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each of the parties hereto shall use or have used their respective reasonable best efforts to take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable Antitrust Law to consummate and make effective the Merger by no later than the End Date, including (i) the obtaining of all necessary actions or nonactions, waivers, Consents, clearances, decisions, declarations, approvals and, expirations or terminations of waiting periods from Governmental Bodies and the making of all necessary registrations and filings and the taking of all steps as may be necessary to obtain any such consent, decision, declaration, approval, clearance or waiver, or expiration or termination of a waiting period by or from, or to avoid an action or proceeding by, any Governmental Body in connection with any Antitrust Law, (ii) the obtaining of all necessary consents, authorizations, approvals or waivers from third parties and (iii) the execution and delivery of any additional instruments necessary to consummate the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">151.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Nothing in this Agreement, including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Filings&#59; Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), shall require Parent to agree or be required to (i) negotiate, commit to and effect, by consent decree, hold separate order or otherwise, the sale, lease, license, divestiture or disposition of any assets, rights, product lines, or businesses of the Company, the Parent or any of their respective Subsidiaries, (ii) terminate existing relationships, contractual rights or obligations of the Company, the Parent or any of their respective Subsidiaries, (iii) terminate any venture or other arrangement, (iv) create any relationship, contractual rights or obligations of the Company, the Parent or any of their respective Subsidiaries, (v) effectuate any other change or restructuring of the Company, the Parent or any of their respective Subsidiaries and (vi)&#160;otherwise take or commit to take any actions with respect to the businesses, product lines or assets of the Company, the Parent or any of their respective Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">152.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Subject to the terms and conditions of this Agreement, each of the parties hereto shall (and shall cause their respective Affiliates, if applicable, to)&#58; (i)&#160;within 1 Business Day after the date hereof, make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the transactions contemplated hereby&#59; (ii)&#160;promptly, but in no event later than 1 day after the date hereof, make all other filings, notifications or other Consents as may be required to be made or obtained by such party under foreign Antitrust Law </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in those jurisdictions identified in Section&#160;5.2(c) of the Disclosure Schedule, which contains the list of the only jurisdictions where filing, notification, expiration of a waiting period or Consent or approval is a condition to Closing&#59; and (iii)&#160;cooperate with each other in determining whether, and promptly preparing and making, any other filings or notifications or other Consents required to be made with, or obtained from, any other Governmental Bodies in connection with the transactions contemplated hereby.  Parent and the Company shall use their respective reasonable best efforts to obtain early termination of the waiting period under the HSR Act with respect to the transactions contemplated by this Agreement and any other applicable waiting period, to the extent required, from the applicable Governmental Bodies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">153.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Without limiting the generality of anything contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Filings&#59; Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), during the Pre-Closing Period, each party hereto shall use its reasonable best efforts to (i)&#160;&#160;cooperate in all respects and consult with each other in connection with any filing or submission in connection with any investigation or other inquiry, including allowing the other party to have a reasonable opportunity to review in advance and comment on drafts of filings and submissions, (ii) give the other parties prompt notice of the making or commencement of any request, inquiry, investigation, action or Legal Proceeding brought by a Governmental Body or brought by a third party before any Governmental Body, in each case, with respect to the transactions contemplated hereby, (iii)&#160;keep the other parties informed as to the status of any such request, inquiry, investigation, action or Legal Proceeding, (iv)&#160;promptly inform the other parties of any communication to or from the U.S. Federal Trade Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Antitrust Division of the U.S. Department of Justice (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DOJ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or any other Governmental Body in connection with any such request, inquiry, investigation, action or Legal Proceeding, (v)&#160;upon request, promptly furnish to the other party, subject to an appropriate confidentiality agreement to limit disclosure to outside counsel and consultants retained by such counsel, with copies of documents provided to or received from any Governmental Body in connection with any such request, inquiry, investigation, action or Legal Proceeding (other than Item &#8220;4(c)&#8221; and &#8220;4(d)&#8221; &#8220;documents&#8221; as those terms are used in the rules and regulations under the HSR Act) (documents provided pursuant to this provision may be redacted (1) as necessary to comply with contractual arrangements and (2) as necessary to address reasonable privilege or confidentiality concerns), (vi)&#160;subject to an appropriate confidentiality agreement to limit disclosure to counsel and outside consultants retained by such counsel, and to the extent reasonably practicable, consult in advance and cooperate with the other parties and consider in good faith the views of the other parties in connection with any substantive communication, analysis, appearance, presentation, memorandum, brief, argument, opinion or proposal to be made or submitted in connection with any such request, inquiry, investigation, action or Legal Proceeding and (vii)&#160;except as may be prohibited by any Governmental Body or by any Law, in connection with any such request, inquiry, investigation, action or Legal Proceeding in respect of the transactions contemplated hereby, each party hereto shall provide advance notice of and permit authorized representatives of the other party to be present at each meeting or conference relating to such request, inquiry, investigation, action or Legal Proceeding and to have access to and be consulted in advance in connection with any argument, opinion or proposal to be made or submitted to any Governmental Body in connection with such request, inquiry, investigation, action or Legal Proceeding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that, the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company or Parent as applicable, may participate in any such meeting or discussion described in the foregoing clause in the absence of such other party if, and only to the extent that, (A) the Company or Parent, as applicable, have made every effort in good faith to involve the other party in such meeting or discussion, (B) such other party was provided with reasonable and adequate notice of such meeting or discussion and (C) despite such efforts and reasonable and adequate notice, the involvement of such other party in any such meeting or discussion has become impracticable in the good faith opinion of the party seeking to hold such meeting or discussion.  Each party hereto shall supply as promptly as practicable such information, documentation, other material or testimony that may be reasonably requested by any Governmental Body, including by complying at the earliest reasonably practicable date with any reasonable request for additional information, documents or other materials received by any party or any of their respective Subsidiaries from any Governmental Body in connection with such applications or filings for the transactions contemplated by this Agreement.  Parent shall pay all filing fees under the HSR Act and for any filings required under foreign Antitrust Law, but the Company shall bear its own costs for the preparation of any such filings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">154.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Consistent with its obligations hereunder (including its obligation to enable the parties hereto to expeditiously consummate the Transactions), Parent shall lead all communications and strategy for dealing with the FTC and the DOJ in connection with any review pursuant to the HSR Act and any other antitrust authority with respect to any foreign Antitrust Laws&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Parent shall act reasonably and consult in advance with the Company (and its outside antitrust counsel) regarding such matters and shall consider in good faith, and in Parent&#8217;s reasonable discretion incorporate, the Company&#8217;s reasonable views and feedback. It is further understood and agreed that Parent may withdraw and refile its filing under the HSR Act (and take any equivalent action in respect of the foreign Antitrust Laws) if, in its good faith judgment, it determines (after consultation with the Company and taking the Company&#8217;s views into account), that the taking of such action would be consistent with, and would not undermine, the parties&#8217; efforts to expeditiously consummate the Transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">155.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Parent shall not, before receiving approval under the HSR Act for the Transactions contemplated to this Agreement, acquire or enter into any agreement to acquire, or announce any acquisition of any company, business or assets, that competes with or may compete with the Company, without the prior written approval of the Company. Parent further agrees that it shall not, and shall not permit any of its Affiliates to, directly or indirectly, acquire or agree to acquire any assets, business or any Person, whether by merger, consolidation, purchasing a substantial portion of the assets of or equity in any Person or by any other manner or engage in any other transaction or take any other action, if the entering into of an agreement relating to or the consummation of such acquisition, merger, consolidation or purchase or other transaction or action would reasonably be expected to (i) impose any material delay in the expiration or termination of any applicable waiting period or impose any delay in the obtaining of, or increase the risk of not obtaining, any authorization, consent, clearance, approval or order of a Governmental Body necessary to consummate the Merger and the other transactions contemplated hereby, including any approvals and expiration of waiting periods pursuant to the HSR Act or any other applicable Law, (ii) materially increase the risk of any Governmental Body entering, or increase the risk of not being able to remove or successfully challenge, any </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">permanent, preliminary or temporary injunction or other order, decree, decision, determination or judgment that would delay, restrain, prevent, enjoin or otherwise prohibit consummation of the Merger and the other transactions contemplated hereby or (iii) otherwise materially delay or impede the consummation of the Merger and the other transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">156.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Parent agrees that from and after the Effective Time, Parent and its Affiliates shall assume and honor all Company employment agreements, offer letters, severance, retention and change of control plans, arrangements, policies and agreements and other individual agreements with employees, consultants, advisors or directors of the Company or its Affiliates in accordance with their terms as in effect immediately before the Effective Time.  For a period of not less than one year following the Effective Time, Parent shall provide or shall cause to be provided, to each employee of the Company who continues to remain employed with the Company or its Subsidiaries (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Continuing Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (a) base salary and a target annual cash bonus opportunity, no less favorable than the base salary and target annual cash bonus opportunity generally made available to similarly situated employees of Parent and its Affiliates&#59; and (b) pension and welfare benefits (excluding equity and long-term compensation) that are substantially comparable in the aggregate to those generally made available to similarly situated employees of Parent and its Affiliates&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the foregoing shall not diminish any obligation of the Surviving Corporation pursuant to any employment or other agreement between the Company and any Continuing Employee in existence as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">157.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">For purposes of vesting, benefit accrual and eligibility to participate under the employee benefit plans of Parent and its Affiliates that provide benefits to any Continuing Employees after the Effective Time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Parent shall use commercially reasonable best efforts to cause each Continuing Employee to be credited with his or her years of service with the Company before the Effective Time as if such service had been performed with Parent, except for benefit accrual under any defined benefit pension plans, for purposes of qualifying for subsidized early retirement benefits or to the extent it would result in a duplication of benefits.  In addition, and without limiting the generality of the foregoing&#58; Parent shall use commercially reasonable best efforts to cause (i) each Continuing Employee to be immediately eligible to participate, without any waiting time, in any and all Parent Plans&#59; and (ii) for purposes of each Parent Plan providing medical, dental, pharmaceutical or vision benefits to any Continuing Employee, all pre-existing condition exclusions, waiting periods and actively-at-work requirements of such Parent Plan to be waived for such employee and his or her covered dependents, and (iii) any medical&#47;Rx eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the Company Plan in which such Continuing Employee participated immediately before the Effective Time ending on the date such employee&#8217;s participation in the corresponding Parent Plan begins for which payment has been made to be taken into account under such Parent Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such Parent Plan.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">158.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Parent hereby acknowledges that the transactions contemplated by this Agreement shall constitute a &#8220;change of control&#8221; or &#8220;change in control&#8221; (as applicable) under the Company Plans and Company Service Provider Agreements set forth in Section 5.3(c) of the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">159.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If requested by Parent in writing, the Company shall cause the Company&#8217;s 401(k) Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to be terminated effective the day immediately prior to the Closing Date.  In the event that Parent requests that the Company 401(k) Plan be terminated, the Company shall provide Parent with evidence that such Company 401(k) Plan has been terminated (the form and substance of which shall be subject to review and approval by Parent) not later than four (4) days immediately preceding the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">160.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Prior to the Effective Time and thereafter (as applicable), the Company and Parent shall take any and all actions as may be required, including amendments to the Company 401(k) Plan and&#47;or the tax-qualified defined contribution retirement plan designated by Parent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to (1) permit each Continuing Employee to make rollover contributions of &#8220;eligible rollover distributions&#8221; (within the meaning of Section 401(a)(31) of the Code) in an amount equal to the full account balance distributed or distributable to such Continuing Employee from the Company 401(k) Plan to the Parent 401(k) Plan, and (2) obtain from the IRS a favorable determination letter on termination for the Company 401(k) Plan.  Each Continuing Employee shall have the option to become a participant in the Parent 401(k) Plan on the Closing Date (giving effect to the service crediting provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">))&#59; it being agreed that for each Continuing Employee who does become a participant in the Parent 401(k) Plan there shall be no gap in participation in a tax-qualified defined contribution plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">161.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Prior to making any written or oral communications to the directors, officers or employees of the Company or any of its Subsidiaries pertaining to compensation or benefit matters that are affected by the transactions contemplated by this Agreement, the Company shall provide Parent with a copy of the intended communication, Parent shall have a reasonable period of time to review and comment on the communication, and the Company shall consider any such comments in good faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">162.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Nothing contained herein, express implied, is intended to (1) confer upon any individual (including employees, retirees or dependents or beneficiaries or employees or retirees) or create any right as a third party beneficiary of this Agreement with respect to the compensation, terms and conditions of employment and&#47;or benefits that may be provided to any Continuing Employee by Parent, the Surviving Corporation or any of their Affiliates or under any benefit plan which Parent, the Surviving Corporation or any of their Affiliates may maintain, (2) be treated as an amendment of any particular Company Plan or Company Service Provider Agreement, (3)&#160;prevent Parent, the Surviving Corporation or any of their Affiliates from amending or terminating any of their benefit plans or, after the Effective Time, any Company Plan or Company Service Provider Agreement in accordance their terms or (4) prevent Parent, the Surviving Corporation or any of their Affiliates, after the Effective Time, from terminating the employment of any Continuing Employee.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">163.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">All rights to indemnification by the Company existing in favor of those Persons who are or were directors and officers of the Company as of the date of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Indemnified Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for their acts and omissions occurring prior to the Effective Time, as provided in the Company Charter and the Company&#8217;s bylaws (as in effect as of the date of this Agreement) and as provided in the indemnification agreements between the Company and such D&#38;O Indemnified Persons in the forms made available by the Company to Parent prior to the date of this Agreement, shall survive the Merger and shall not be amended, repealed or otherwise modified, and shall be observed by the Surviving Corporation to the fullest extent available under applicable Law, and any claim made requesting indemnification pursuant to such indemnification rights shall continue to be subject to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the indemnification rights provided under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) until disposition of such claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">164.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">From the Effective Time until the sixth anniversary of the date on which the Effective Time occurs, Parent and the Surviving Corporation shall, to the fullest extent permitted under applicable Law, indemnify, defend and hold harmless each D&#38;O Indemnified Person in his or her capacity as an officer or director of the Company against all losses, claims, damages, liabilities, fees, expenses, judgments or fines incurred by such D&#38;O Indemnified Person as an officer, director or employee of the Company.  Prior to the Effective Time, the Company shall purchase and fully pay the premium for a six-year &#8220;tail&#8221; policy for the existing policy of directors&#8217; and officers&#8217; liability insurance (including tails for the Company&#8217;s existing claims-made employment practices liability policy and fiduciary liability policy, which shall be at Parent&#8217;s expense up to $100,000) maintained by the Company as of the date of this Agreement in the form made available by the Company to Parent prior to the date of this Agreement on terms with respect to coverage, deductibles and amounts no less favorable than the existing policy in effect on the date hereof (such policy, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Parent shall cause the Surviving Corporation to maintain the D&#38;O Policy in full force and effect and continue to honor the obligations thereunder until the sixth anniversary of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">165.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In the event that Parent, the Company or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or Entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, Parent shall ensure that the successors and assigns of Parent, the Company or the Surviving Corporation, as the case may be, shall assume the obligations set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">166.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall survive the consummation of the Merger and are (i) intended to be for the benefit of, and will be enforceable by, each of the D&#38;O Indemnified Persons and their successors, assigns and heirs and (ii) in addition to, and not in substitution for, any other rights to indemnification or contribution that any such D&#38;O Indemnified Person may have by contract or otherwise.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) may not be amended, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">67</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">altered or repealed after the Effective Time without the prior written consent of the affected D&#38;O Indemnified Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Disclosure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company (and after Closing, the Securityholders&#8217; Representative), on the one hand, and Parent, on the other hand, (i) shall consult with each other before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements regarding this Agreement or the Merger, and (ii) shall not issue any press release or make any public statement regarding this Agreement or the Merger, or regarding any of the other transactions contemplated by this Agreement, without the prior written consent of the other party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that each party hereto may, without such consent, issue such press release or public announcement which it in good faith believes, based on advice of counsel, is required by applicable Law or the rules of a national securities exchange or market on which the disclosing party is listed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">it being understood </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that each party shall promptly provide the other parties hereto with copies of any such announcement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Transfer Taxes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent, on the one hand, and the Participating Securityholders, on the other hand, each shall be responsible for 50% of all Transfer Taxes. Parent shall file all Tax Returns related to Transfer Taxes, and the Securityholders&#8217; Representative and the Participating Securityholders shall cooperate with Parent in connection with any such filings.  Notwithstanding anything to the contrary in this Agreement, the Securityholders&#8217; Representative shall have no obligation to prepare or file any such Tax Returns for Transfer Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Notification of Certain Events</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Pre-Closing Period, each party hereto shall promptly notify the other party of, and furnish such other party with any information it may reasonably request with respect to, the occurrence of any event or condition or the existence of any fact that may reasonably be expected to cause, in the case Parent is such notified party, any of the conditions to the obligations of Parent to consummate the Merger set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or, in the case the Company is such notified party, any of the conditions to the obligations of the Company to consummate the Merger set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), not to be satisfied.  A party&#8217;s satisfaction of its obligations in the foregoing sentence shall not limit or otherwise affect the remedies available to the parties pursuant to this Agreement or relieve such party of any of its other obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">PPP Loan Forgiveness</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">167.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">On the Closing Date, upon all conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">the Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) being satisfied (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions) immediately prior to the Effective Time, Parent shall deliver to the Company an aggregate amount in cash equal to the PPP Loan Amount for onward payment by the Company into an escrow account with Silicon Valley Bank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Escrow Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which account shall be created pursuant to an escrow agreement substantially in the form of Silicon Valley Bank&#8217;s form escrow agreement for such matters.  Such amount will be treated as a loan from Parent to the Company, which will be immediately due and payable at Parent&#8217;s request if the Closing does not occur within 1 Business Day of the date that such funds are paid by Parent to the Company.  As soon as reasonably practicable following receipt of the PPP Loan Amount by the Company, the Company shall deliver to Parent evidence that the PPP Loan amount has been deposited to the PPP Loan Escrow Account (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Escrow Funding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">168.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Parent agrees to, and to cause the Company to, use commercially reasonable efforts to cause the PPP Loan to be forgiven&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if the PPP Loan has not been forgiven at least one day before the date on which Parent would need to repay such loan for it not to be recorded as a liability of the Company on September 30, 2021, Parent may take any action necessary to cause the PPP Loan to be repaid from the PPP Loan Escrow Account on or before September 30, 2021. Without prejudice to the generality of the foregoing, Parent agrees to provide prompt notice to the Securityholders&#8217; Representative of any communication received by Parent or the Company from Silicon Valley Bank or the U.S. Small Business Administration in connection with the Company&#8217;s PPP Loan forgiveness application and shall permit the Securityholders&#8217; Representative to direct Parent&#8217;s or the Company&#8217;s response to any such communication (provided that such directions are consistent with applicable Law) and participate in any discussions or negotiations of Parent or the Company with Silicon Valley Bank or the U.S. Small Business Administration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Tail Policy</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall, and shall cause its officers, directors or employees or other advisors or representatives (including, for the avoidance of doubt, the Company&#8217;s insurance broker), to use their respective reasonable best efforts to, provide all cooperation reasonably requested by Parent in connection with Parent&#8217;s procurement of a &#8220;tail&#8221; policy for the existing product liability policy maintained by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Designated Contracts</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall use reasonable best efforts to cause the Contracts set forth on Section 5.10 of the Disclosure Schedules to be terminated and all outstanding amounts thereunder to be paid by the Company and any open disputes with respect thereto to resolved in a manner reasonably acceptable to Parent, acting in good faith. </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">69</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Conditions Precedent to Obligations of Parent and Merger Sub</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligations of Parent and Merger Sub to effect the Merger are subject to the satisfaction (or waiver by Parent), at or prior to the Closing, of each of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Accuracy of Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Specified Representations shall be true and correct, other than any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> inaccuracies as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be so true and correct as of such earlier date).  The representations and warranties of the Company set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Absence of Certain Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) (first sentence only) shall be true and correct as of the date hereof. The other representations and warranties of the Company set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be true and correct (disregarding all qualifications or limitations as to &#8220;materiality,&#8221; &#8220;in all material respects&#8221; or &#8220;Material Adverse Effect&#8221; and words of similar import set forth therein, except (i) in the case of the standard for what constitutes a defined term hereunder and the use of such defined term herein, and (ii) in the case of exceptions or exclusions to representations and warranties listed in the Disclosure Schedule, and (iii) in the case of Disclosure Schedule requiring lists of &#8220;material&#8221; items as of the date hereof) as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be so true and correct as of such earlier date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, have a Company Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Performance of Covenants</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall have performed and complied with, in all material respects, all of its covenants contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Certain Covenants of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Additional Covenants of the Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) at or before the Closing (to the extent that such covenants require performance by the Company at or before the Closing).  Notwithstanding the foregoing, the Company shall have performed and complied with its covenants contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> at or before the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Stockholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall have been duly adopted by the Required Company Stockholder Vote.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Antitrust Clearances</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The waiting period (and any extension thereof) applicable to the consummation of the transactions contemplated by this Agreement under the HSR Act shall have expired or been terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">No Restraints</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the Merger by Parent shall have been issued by any court of competent jurisdiction and remain in effect, and no Law shall have been enacted since the date of this Agreement that makes consummation of the Merger by Parent illegal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">No Governmental Litigation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> There shall not be pending before any court of competent jurisdiction any lawsuit or other Legal Proceeding challenging the Merger that (a)&#160;has been commenced by a Governmental Body and (b)&#160;is likely to result in a judgment in favor of such Governmental Body that will prevent the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Agreements and Documents</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent shall have received the following agreements and documents, each of which shall be in full force and effect&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">169.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">written resignations of all directors of the Company, effective as of the Effective Time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">170.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">the Certificate of Merger, executed by the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">171.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">a (i) certification that meets the requirements of Treasury Regulations Sections 1.897-2(h)(1) and 1.1445-2(c)(3), dated within 30 days prior to the Closing Date and (ii) notice to the Internal Revenue Service, in accordance with the requirements of Treasury Regulations Section&#160;1.897-2(h)(2), together with written authorization for Parent to deliver such notice and a copy of the certification to the Internal Revenue Service on behalf of the Company after the Closing, in each case properly completed and executed by the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">172.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for each instrument of Terminated Indebtedness, a Payoff Letter, executed by each applicable creditor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">173.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">a termination letter substantially in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">174.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">a spreadsheet (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Payment Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), duly certified by an officer of the Company setting forth&#58; (i) the name, address and email address of each holder of Company Capital Stock and Company Options immediately prior to the Effective Time, (ii) a designation, with respect to each holder of Company Options, as to whether such Company Options are Employee Options and whether to be paid through the Company&#8217;s payroll account, (iii) the number of shares of Company Capital Stock (and the Series thereof in the case of Company Preferred Stock) held by each holder thereof immediately prior to the Effective Time (including the number of shares of Company Capital Stock for which Company Options are exercisable), (iv) a calculation of the Closing Merger Consideration Amount and the Per Share Upfront Merger Consideration payable as of the Closing Date, (v) when provided at Closing, the Ownership Percentage for each Securityholder and when provided in respect of a post-Closing </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">distribution, the Ownership Percentage for each Participating Securityholder, (vi) for each Securityholder entitled to receive the Per Share Upfront Merger Consideration, the aggregate payment to such Securityholder rounded to the nearest two decimal places payable thereto for all shares of Company Capital Stock (including in respect of Company Capital Stock for which Company Options are exercisable), held by such Securityholder, (vii) when provided in respect of a post-Closing distribution, a true and accurate calculation of the amount of such distribution to be paid to each Participating Securityholder and (viii) the Settlement Debt as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Estimated Closing Statement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent shall have received the Estimated Closing Statement from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Closing Certificate</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Chief Executive Officer or Chief Financial Officer of the Company shall have delivered to Parent a certificate to the effect that each of the conditions specified above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Performance of Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Company Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is satisfied in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Company Material Adverse Effect</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Since the date of this Agreement, there shall not have been a Company Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Written Consent and Support Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  (a) The Company shall have delivered to Parent, Written Consents executed by holders of at least 75% of Company Common Stock and Company Preferred Stock outstanding on the applicable record date, voting together as a single class (with the Company Preferred Stock voting on an &#8220;as converted&#8221; basis) and (b) the Written Consents and Support Agreements from holders representing the Required Company Stockholder Vote delivered to Parent within twenty-four (24) hours of the execution and delivery of this Agreement shall continue to be in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt"> Third Party Consent</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each of the Consents set forth on Section&#160;6.12 of the Disclosure Schedule shall have been obtained and shall be in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">PPP Loan Escrow</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">72</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2pt"><font style="color:#000000;font-family:'Calibri Light',sans-serif;font-size:13pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall have (a) received from Silicon Valley Bank documentation in form and substance reasonably acceptable to Parent setting forth a calculation of the principal amount of the PPP Loan and all accrued and unpaid interest on, and all other amounts incurred and payable in respect of, the PPP Loan as of the Closing Date, as well as all interest (if any) reasonably expected to be incurred between the Closing Date and September 30, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (b) delivered to Parent evidence reasonably acceptable to Parent that the PPP Loan Escrow Funding has occurred.</font></div><div style="margin-top:2pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Conditions Precedent to Obligation of the Company</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligation of the Company to effect the Merger is subject to the satisfaction (or waiver by the Company), at or prior to the Closing, of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Accuracy of Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The representations and warranties of Parent and Merger Sub set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be true and correct (disregarding all qualifications or limitations as to &#8220;materiality,&#8221; &#8220;in all material respects&#8221; or &#8220;Material Adverse Effect&#8221; and words of similar import set forth therein) as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be so true and correct as of such earlier date), except where the failure of such representations and warranties to be so true and correct would not have a material adverse effect on the ability of Parent or Merger Sub to perform its respective obligations hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Performance of Covenants</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent and Merger Sub shall have performed and complied with, in all material respects, all of their covenants contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Additional Covenants of the Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) at or before the Closing (to the extent that such covenants require performance by Parent or Merger Sub at or before the Closing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Stockholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall have been duly adopted by the Required Company Stockholder Vote.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Antitrust Clearances</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The waiting period (and any extension thereof) applicable to the consummation of the transactions contemplated by this Agreement under the HSR Act shall have expired or been terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">No Restraints</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the Merger by the Company shall have been issued by any court of </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">73</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">competent jurisdiction and remain in effect, and no Law shall have been enacted since the date of this Agreement that makes consummation of the Merger by the Company illegal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">No Governmental Litigation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  There shall not be pending before any court of competent jurisdiction any lawsuit or other Legal Proceeding challenging the Merger that (a)&#160;has been commenced by a Governmental Body and (b)&#160;is likely to result in a judgment in favor of such Governmental Body that will prevent the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Closing Certificate</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An authorized officer of Parent and Merger Sub shall have delivered to Company a certificate to the effect that each of the conditions specified above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Performance of Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is satisfied in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Payments, Etc</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent shall have paid, or caused to be paid, the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">175.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Upfront Payment Amount shall be deposited with the Payment Agent in accordance with wire transfer instructions provided by the Payment Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">176.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The amount of the Securityholders&#8217; Representative Reserve and any upfront engagement fee of the Securityholders&#8217; Representative shall be deposited with the Securityholders&#8217; Representative in accordance with wire transfer instructions provided by the Securityholders&#8217; Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">177.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Estimated Closing Date Indebtedness shall be paid by wire transfer of immediately available funds to the applicable holder of such indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">178.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Estimated Closing Date Transaction Expenses shall be paid by wire transfer of immediately available funds to the applicable third party in accordance with the Estimated Closing Statement and instructions provided by such third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">179.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Escrow Amount shall be deposited with the Escrow Agent in accordance with wire transfer instructions provided by the Escrow Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Indemnification</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Indemnification of Parent</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the other provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the Escrow Agreement, from and after the Closing, Parent and the Surviving Corporation, their Affiliates, and each of their respective officers, directors, employees, agents and other representatives (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be entitled to indemnification against any Damages arising out of or resulting from&#58;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">74</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">180.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">(i) any breach of any representation or warranty made by the Company in this Agreement (other than the Specified Representations) or any failure of any such representation or warranty to be true and correct and as though made on the Closing Date (other than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined as of such specified date)&#59; and (ii) any breach of any Specified Representations or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or any failure of any such Specified Representations or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) to be true and correct and as though made on the Closing Date (other than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined as of such specified date)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">181.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any breach by the Company of any covenant or agreement made by the Company in this Agreement at or before the Closing (to the extent that such covenants require performance by the Company at or before the Closing)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">182.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">(i) any Taxes of the Company allocable to any Pre-Closing Tax Period pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Certain Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and any Tax liabilities (including, for the avoidance of doubt, any Tax liabilities attributable to the amount of non-deductibility of expenses funded by the PPP Loan) arising from or relating to the PPP Loan or the forgiveness of the PPP Loan (including, for the avoidance of doubt, the forgiveness of a portion of the PPP Loan), in each case to the extent not deducted in the determination of the Closing Merger Consideration Amount (as finally determined in accordance with Section&#160;1.11), and (ii) in the event that, as a result of the resolution of any audit or Tax proceeding, any amount that was taken into account in the Transaction Deductions or the PPP Loan Deductions (if any) and applied to reduce Taxes described in the preceding clause (i) is subsequently required to be capitalized or otherwise disallowed, any Tax liabilities attributable to the portion of the Transaction Deductions or PPP Loan Deductions (if any) so capitalized or disallowed&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">183.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any amounts paid to the holders of Dissenting Shares, including any interest required to be paid thereon, that are in excess of what such holders would have received hereunder had such holders not been holders of Dissenting Shares&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">184.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any claim, cause of action, right or remedy, or any Legal Proceeding, asserted at any time by actual or alleged securityholder of the Company relating to the allocation or entitlement to a portion of the consideration paid or to be paid in connection with the Transactions, including any assertion of contractual or employment rights to own or acquire any security&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">185.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any Debt of the Company and Closing Date Transaction Expenses outstanding as of the Effective Time to the extent not deducted in the determination of the Closing Merger Consideration Amount (as finally determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">186.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any inaccuracy, error or omission in the Closing Statement, the Adjustment Amount or the components thereof, including the amounts and payees with respect thereto to the extent not otherwise accounted for in the determination of the Closing Merger Consideration Amount (as finally determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">75</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">187.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any Damages arising out of, or resulting from, any of the items described on Section&#160;8.1(h) of the Disclosure Schedule (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Indemnity Losses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Indemnification of Participating Securityholders</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the other provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), from and after the Closing, Parent shall indemnify the Participating Securityholders and the Securityholders&#8217; Representative, their Affiliates, and each of their respective officers, directors, employees, agents and other representatives (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholder Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in respect of, and hold them harmless against, any Damages suffered by the Securityholder Indemnified Party in connection with, arising out of, resulting from or incident to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">188.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any breach of the representations and warranties of Parent and Merger Sub set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement or any failure of any such representation or warranty to be true and correct as of and as though made on the Closing Date (other than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined as of such specified date)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">189.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">any breach by Parent, Merger Sub or the Surviving Corporation of any covenant or agreement made by Parent, Merger Sub or the Surviving Corporation in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Direct Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">190.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Other than with respect to a Third Person Claim, any Indemnified Party seeking indemnification hereunder shall deliver a written demand (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Demand</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Securityholders&#8217; Representative (if the Indemnified Party is Parent or the Surviving Corporation) or Parent (if the Indemnified Party is a Securityholder Indemnified Party) which contains (i)&#160;a description and, to the extent known, a good-faith reasonable estimate of any Damages incurred or reasonably expected to be incurred by the Indemnified Party, (ii)&#160;a statement that the Indemnified Party is entitled to indemnification under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) for such Damages and a reasonable explanation of the basis therefor and (iii)&#160;a demand for payment in the amount of such Damages&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the failure or delay of the Indemnified Party to deliver an Indemnification Demand promptly to the Securityholders&#8217; Representative or Parent, as applicable, shall not relieve the Securityholders&#8217; Representative or Parent, as applicable, of its obligations hereunder except to the extent the Securityholders&#8217; Representative or Parent, as applicable, shall have been materially prejudiced by such failure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">191.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Upon reasonable request, the Indemnified Party shall furnish the Securityholders&#8217; Representative or Parent, as applicable, with any information to the extent that such information is reasonably necessary in order to evaluate the Indemnification Demand.  If the Securityholders&#8217; Representative or Parent, as applicable, in good faith objects to any claim made by the Indemnified Party in the Indemnification Demand, then the Securityholders&#8217; Representative or Parent, as applicable, shall deliver a written notice (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnification </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">76</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Indemnified Party within 30 days following receipt by the Securityholders&#8217; Representative or Parent, as applicable, of an Indemnification Demand from such Indemnified Party.  The Indemnification Dispute Notice shall set forth in reasonable detail the principal basis for the dispute of any claim made by the Indemnified Party in the Indemnification Demand.  If the Securityholders&#8217; Representative or Parent, as applicable, fails to deliver an Indemnification Dispute Notice prior to the expiration of such 30-day period, then the indemnity claim set forth in the Indemnification Demand shall be conclusively determined in the Indemnified Party&#8217;s favor for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and the Indemnified Party shall be indemnified for the amount of the Damages stated in such Indemnification Demand (or, in the case of any notice in which the Damages (or any portion thereof) are estimated, the amount of such Damages (or such portion thereof) as finally determined) on demand or, in the case of any notice in which the Damages (or any portion thereof) are estimated, on such later date when the amount of such Damages (or such portion thereof) becomes finally determined, in either case, subject to the limitations of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">192.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Securityholders&#8217; Representative or Parent, as applicable, delivers an Indemnification Dispute Notice, then the Indemnified Party and the Securityholders&#8217; Representative or Parent, as applicable, shall attempt in good faith to resolve any such objections raised by the Securityholders&#8217; Representative or Parent, as applicable, in such Indemnification Dispute Notice.  If the Indemnified Party and the Securityholders&#8217; Representative or Parent, as applicable, agree to a resolution of such objection, then a memorandum setting forth the matters conclusively determined by the Indemnified Party and the Securityholders&#8217; Representative or Parent, as applicable, shall be prepared and signed by both parties, and shall be binding and conclusive upon the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">193.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If no such resolution can be reached during the 30-day period following the Indemnified Party&#8217;s receipt of a given Indemnification Dispute Notice, then upon the expiration of such 30-day period (or such longer period as may be mutually agreed in writing), either Parent or the Securityholders&#8217; Representative may seek enforcement of its rights to indemnification under this Agreement, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Applicable Law&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), with respect to such Indemnification Dispute Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">194.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In order to seek indemnification provided for under this Agreement in respect of, arising out of or involving a claim or demand made by any third Person against the Indemnified Party (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Third Person Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Indemnified Party shall deliver a written notice (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Third Person Claim Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Securityholders&#8217; Representative (if the Indemnified Party is Parent or the Surviving Corporation) or Parent (if the Indemnified Party is a Securityholder Indemnified Party), in each case (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) which contains (i)&#160;a description and, to the extent known, a good-faith reasonable estimate of any Damages incurred or reasonably expected to be incurred by the Indemnified Party and (ii)&#160;a statement that the Indemnified Party is entitled to indemnification under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) for such Damages and a </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">77</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reasonable explanation of the basis therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the failure or delay of the Indemnified Party to give such notice to the Indemnitor shall not relieve the Indemnitor of its obligations hereunder except to the extent the Indemnitor shall have been materially and actually prejudiced by such failure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">195.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Upon reasonable request, the Indemnified Party shall furnish the Securityholders&#8217; Representative or Parent, as applicable, with any information to the extent that such information is reasonably necessary in order to evaluate the Third Person Claim Notice.  The Indemnitor shall have 30 Business Days (or such lesser number of days as set forth in the Third Person Claim Notice as may be required by court proceeding in the event of a litigated matter) after receipt of the Third Person Claim Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to notify the Indemnified Party that it desires to defend the Indemnified Party against such Third Person Claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">196.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In the event that the Indemnitor notifies the Indemnified Party within the Notice Period that it desires to defend the Indemnified Party against a Third Person Claim, the Indemnitor shall have the sole and absolute right after the receipt of notice, at its option and at its own expense, to be represented by counsel of its choice and to control, defend against, negotiate, settle or otherwise deal with such Third Person Claim&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Indemnified Party may participate in any such proceeding with counsel of its choice and at its expense&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Indemnitor shall not be entitled to assume or continue control of the defense of any Third Person Claim if (i) the Third Person Claim relates to or arises in connection with any criminal or regulatory proceeding, (ii) based on the advice of outside legal counsel to the Indemnified Party, a conflict (including the availability of different or additional defenses) exists between the Indemnified Party and the Indemnitor in connection with such Third Person Claim or conduct of claim by the Indemnitor would compromise any legal privilege or similar doctrine with respect to the Indemnified Party or any of its Affiliates or (iii) the Third Person Claim primarily seeks (x) an injunction against the Indemnified Party or (y) where the Indemnified Party is a Parent Indemnified Party, equitable relief requiring the taking of action or the refraining from taking actions by Parent.  The Indemnified Party agrees to cooperate fully and in good faith with the Indemnitor in connection with the defense, negotiation or settlement of any Third Person Claim.  To the extent the Indemnitor elects not to defend such Third Person Claim by written notice to the Indemnified Party, the Indemnified Party may retain counsel at the expense of the Indemnitor, which counsel shall be reasonably acceptable to the Indemnitor, and control the defense of such proceeding&#59; provided, however, that the Indemnitor shall be obligated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to pay for only one firm of counsel for all Indemnified Parties in addition to any local counsel who may need to be retained.  The Indemnitor shall not, without the prior written consent of the Indemnified Party (which shall not be unreasonably withheld, conditioned, or delayed), settle, compromise or offer to settle or compromise any Third Person Claim on a basis that would not include an unconditional release of the Indemnified Party and would (i) exceed the balance of the Indemnitor&#8217;s indemnity obligations hereunder if the Indemnified Party is a Participating Securityholder, or exceed the Escrow Amount, if the Indemnified Party is a Parent Indemnified Party, (ii) result in the imposition of a consent order, injunction or decree that would restrict the future activity or conduct of the Indemnified Party or any of its Affiliates, (iii) result in a finding </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">78</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or admission of a violation of Law or violation of the rights of any Person by the Indemnified Party or any of its Affiliates, (iv) impose ongoing obligations on the Indemnified Party following the date of such settlement or compromise or (v) any Third Person Claim from any Governmental Body relating to Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">197.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Indemnitor (i) elects not to defend the Indemnified Party against a Third Person Claim, whether by not giving the Indemnified Party timely notice of its desire to so defend or otherwise or (ii) after assuming the defense of a Third Person Claim, fails to take reasonable steps necessary to defend diligently such Third Person Claim within ten days after receiving written notice from the Indemnified Party to the effect that the Indemnitor has so failed, the Indemnified Party shall have the right but not the obligation to assume its own defense&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">it being understood</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Indemnified Party&#8217;s right to indemnification for a Third Person Claim shall not be adversely affected by assuming the defense of such Third Person Claim. The Indemnified Party shall not settle a Third Person Claim seeking money damages without the consent of the Indemnitor, which consent shall not be unreasonably withheld.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">198.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Indemnified Party and the Indemnitor shall reasonably cooperate in order to ensure the proper and adequate defense of a Third Person Claim, including by providing access to each other&#8217;s relevant business records and other documents and employees (subject to applicable Laws relating to the exchange of information and except as required to comply with any COVID-19 Measures)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">it being understood</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the reasonable costs and expenses of the Indemnified Party relating thereto shall constitute Damages.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">199.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Indemnified Party and the Indemnitor shall use reasonable best efforts to avoid production or other disclosure of confidential information (consistent with applicable Law), and to cause all communications among employees, counsel and others representing any party to a Third Person Claim to be made so as to preserve any applicable attorney-client or work-product privileges.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Survival </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All representations and warranties contained in this Agreement and all claims with respect thereto shall survive the Closing and terminate upon the expiration of eighteen months after the Closing Date, other than the Specified Representations and all claims with respect thereto, each of which shall continue and survive until the end of the Milestone Period.  All covenants and agreements of the parties contained herein shall survive the Closing and remain in full force and effect for the period provided in such covenants and agreements, if any, or until the date that is eighteen months after the Closing Date.  Notwithstanding anything to the contrary herein, in the event that notice of any claim for indemnification under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) has been given pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Direct Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in good faith within the applicable survival period, the representations, warranties, covenants and agreements that are the subject of such indemnification claim (and the right to pursue such claim) shall survive with respect to such claim until such time as such claim is finally resolved.  The right of a Person to any remedy pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall not be affected by any investigation or </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">79</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">examination conducted, or any knowledge possessed or acquired (or capable of being possessed or acquired), by such Person at any time concerning any circumstance, action, omission or event relating to the accuracy or performance of any representation, warranty, covenant or obligation.  For the avoidance of doubt and notwithstanding the foregoing, the survival periods set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Survival of Representations and Warranties) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not control with respect to the R&#38;W Insurance, which shall contain survival periods that shall control for purposes thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Sole and Exclusive Remedy&#59; Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">200.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">From and after the Closing, the indemnification terms set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall constitute the sole and exclusive remedy of the Parent Indemnified Parties for Damages in connection with, arising out, resulting from or incident to the matters set forth in this Agreement.  The parties hereto acknowledge and agree that, from and after the Closing, the remedies available in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> supersede any other remedies available at law or in equity including rights of rescission and claims arising under applicable Law.  From and after the Closing, the parties hereto covenant not to sue, assert any arbitration claim or otherwise threaten any claim other than those described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as being available under the particular circumstances described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">201.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The parties hereby agree that the sole and exclusive source of recovery for indemnification available to Parent Indemnified Parties,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">first, from the Retention Escrow Fund&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.33pt">second (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (1) above), from the R&#38;W Insurance to the extent covered thereby&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">first, from the Retention Escrow Fund&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.33pt">second (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (1) above), from the R&#38;W Insurance to the extent covered thereby&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">third, (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (2) above) by making deductions from any amounts payable to Participating Securityholders (or to the Payment Agent on their behalf) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in each case, on a pro rata basis in accordance with such Participating Securityholder&#8217;s Ownership Percentage&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:93pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be&#58; </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">80</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.01pt">first, from the Purchase Price Escrow Fund&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">second (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (1) above), from the Retention Escrow Fund&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.33pt">third (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (2) above), from the Special Escrow Fund&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.67pt">fourth (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (3) above), from the R&#38;W Insurance to the extent covered thereby&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.01pt">fifth (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (1) through (4) above), by making deductions from any amounts payable to Participating Securityholders (or to the Payment Agent on their behalf) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in each case, on a pro rata basis in accordance with such Participating Securityholder&#8217;s Ownership Percentage&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:89.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.33pt">first, from the Special Escrow Fund&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.67pt">second (for the avoidance of doubt, only after having exhausted the amount available pursuant to clause (1) above) by making deductions from any amounts payable to Participating Securityholders (or to the Payment Agent on their behalf) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in each case, on a pro rata basis in accordance with such Participating Securityholder&#8217;s Ownership Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">202.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Notwithstanding anything to the contrary contained in this Agreement, except for the proviso to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.6(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not limit the Parent Indemnified Parties&#8217; ability to recover Damages against a Participating Securityholder who committed common law fraud or Willful Breach of an agreement to which such Participating Securityholder is a party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that in no event shall any Participating Securityholder&#8217;s liability, including for common law fraud or Willful Breach, exceed the portion of the Upfront Purchase Price, plus the portion of any Earnout Payment, in each case actually received by or entitled to be received by such Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">203.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Notwithstanding anything to the contrary in this Agreement, except with respect to claims based on common law fraud or Willful Breach by Parent or Merger Sub no Securityholder Indemnified Party may recover for any claim for indemnification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Security Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) unless and until the aggregate amount of indemnifiable Damages that may be recovered by the Securityholder Indemnified Parties pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Security Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) equals or exceeds the Parent Deductible, in which event the Securityholder Indemnified Parties shall only be entitled to indemnification for all indemnifiable Damages in excess of the Parent Deductible.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">81</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">204.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Any Damages for indemnification under this Agreement shall be determined without duplication of recovery due to the facts giving rise to such Damages constituting a breach of more than one representation, warranty, covenant or agreement. Indemnification by any Participating Securityholder in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be on a several and not joint basis, in each case in accordance with such Participating Securityholder&#8217;s Ownership Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">205.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Except as expressly provided in this Agreement, the Support Agreements, the Letter of Transmittal or the Written Consent, no current or former stockholder, director, officer, employee, Affiliate or advisor of the Company or any Affiliate of the Company shall have any liability of any nature to any Parent Indemnified Party with respect to the breach by the Company of any representation, warranty, covenant or agreement contained in this Agreement or any other matter relating to the Merger or the other transactions contemplated by this Agreement.  The parties acknowledge that (i) except as set forth in the Support Agreements, Letter of Transmittal and the Written Consent, no current or former stockholder, director, officer, employee, Affiliate or advisor of the Company has made or is making any representations or warranties whatsoever regarding the Company or the subject matter of this Agreement, express or implied, (ii)&#160;except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Company has not made and is not making, and Parent is not relying upon, any representations or warranties whatsoever regarding the Company or the subject matter of this Agreement, express or implied and (iii)&#160;there shall not be any multiple recovery for any Damages.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">R&#38;W Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">206.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Parent shall secure a representation and warranties insurance policy to be effective as of the Closing Date and shall bear all premiums, fees, costs and expenses associated with procuring such representations and warranties insurance policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">R&#38;W Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">207.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">With respect to any claim for Damages under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that may be covered by the R&#38;W Insurance, Parent shall use commercially reasonable efforts to pursue recovery pursuant to the R&#38;W Insurance, including by exhausting any applicable retention amounts to the extent such claim is covered thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Determination of Indemnification Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">208.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Without limiting the effect of any other limitation contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) Damages recoverable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be reduced by an amount equal to the amount of any insurance proceeds (other than proceeds received pursuant to the R&#38;W Insurance), indemnification payments, contribution payments or reimbursements actually received (net of costs of enforcement, deductibles and retro-premium adjustments) by the Indemnified Party or any of its Affiliates in connection with such Damages or any of the circumstances giving rise thereto.  In any case where an Indemnified Party recovers from third Persons any amount in respect of a matter with respect to which an Indemnitor has indemnified it pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), such Indemnified Party shall </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">82</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">promptly pay over to the Indemnitor the amount so recovered (after deducting therefrom the full amount of the reasonable expenses incurred by it in procuring such recovery), but not in excess of the sum of (i) any amount previously so paid by the Indemnitor to or on behalf of the Indemnified Party in respect of such matter and (ii) any amount expended by the Indemnitor in pursuing or defending any claim arising out of such matter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no Indemnified Party shall be required to seek or collect such recoveries prior to being entitled to indemnification hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">209.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Notwithstanding anything to the contrary in this Agreement, except with respect to claims based on common law fraud or Willful Breach by a Participating Securityholder who committed common law fraud or Willful Breach of an agreement to which such Participating Securityholder is a party&#59; no Indemnified Party may recover for any claim for indemnification pursuant to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 8.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  unless and until the aggregate amount of indemnifiable Damages that may be recovered by the Indemnified Parties pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> equals or exceeds the Deductible, in which event the Securityholder Indemnified Parties shall only be entitled to indemnification for all indemnifiable Damages in excess of the Deductible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">210.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The parties agree that any payments made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall constitute an adjustment to the Closing Merger Consideration Amount for Tax purposes and shall be treated as such by the parties hereto for Tax purposes to the greatest extent permitted by Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">211.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">For purposes of determining the amount of losses arising from a breach for which the Parent Indemnified Parties or Securityholder Indemnified Parties are entitled to indemnification under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, all qualifications contained in the representations and warranties of the Company contained in this Agreement that are based on materiality (including all usages of &#8220;material,&#8221; &#8220;Material Adverse Effect&#8221; or similar qualifiers but excluding dollar thresholds, which will not be disregarded) or the knowledge of a Person (including all usages of &#8220;Knowledge of the Company&#8221; or similar qualifiers) will be disregarded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">212.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">No Indemnified Party&#8217;s right to indemnification pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be adversely affected by its waiver of a condition to the Closing set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">213.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Each Indemnified Party hereto shall use commercially reasonable efforts to mitigate any Damages which may be subject to indemnification claims under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Certain Tax Matters</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">214.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Preparation and Filing of Tax Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. From and after the Closing Date, Parent shall, or shall cause its Affiliates to, (i) prepare and timely file all Tax Returns of the Company for any Pre-Closing Tax Period in accordance with the most recent past practice of the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">83</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company (except as otherwise required by applicable Law), (ii) if such Tax Return is an income or other material Tax Return, deliver a draft of such Tax Return to the Securityholders&#8217; Representative for the Securityholders&#8217; Representative&#8217;s review at least forty-five (45) days before the due date (after giving effect to any applicable extensions of time for filing), , providing the Securityholders&#8217; Representative until thirty (30) days prior to the due date (after giving effect to any applicable extensions of time for filing) of such Tax Return to review and comment on such draft, (iii) negotiate in good faith with the Securityholders&#8217; Representative with respect to such Tax Return, and (iv) if the Securityholders&#8217; Representative consents to the filing of such Tax Returns (which consent shall not be unreasonably withheld, conditioned or delayed), Parent shall, or shall cause its Affiliates to, execute and file such Tax Returns as prepared by Parent.  In the event of any disagreement between Parent and the Securityholders&#8217; Representative regarding any Tax Return relating to any Pre-Closing Tax Period that cannot be resolved by the tenth day prior to the due date for such Tax Return, such disagreement shall be resolved by the Dispute Auditor </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in accordance with the dispute resolution procedures (including the allocation of fees and expenses) set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (e), and (f).  If the Dispute Auditor does not resolve any differences between Parent and the Securityholders&#8217; Representative with respect to such Tax Return at least five days prior to the due date therefor, such Tax Return shall be prepared and filed consistent with the past practices of the Company (except as otherwise required by applicable Law) and in accordance with Parent&#8217;s instructions and such Tax Return shall be amended as necessary to reflect the Dispute Auditor&#8217;s resolutions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">215.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Tax Conventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of determining the amount of Taxes allocable to any Pre-Closing Tax Period (including, for the avoidance of doubt, for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)), the determination shall be made (1) in the case of Taxes of the Company based upon income, sales, proceeds, profits, receipts, wages, compensation or similar items that are not imposed on a periodic basis, by assuming that the Straddle Period consisted of two taxable years or periods, one which ended at the close of the Closing Date and the other which began at the beginning of the day following the Closing Date, and items of income, gain, deduction, loss or credit of the Company for the Straddle Period shall be allocated between such two taxable years or periods on a &#8220;closing of the books basis&#8221; by assuming that the books of the Company were closed at the close of the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that exemptions, allowances or deductions that are calculated on an annual basis, such as depreciation deductions, shall be apportioned between such two taxable years or periods on a daily basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no amount of depreciation deductions calculated on an annual basis with respect to property placed in service after the Closing shall be allocated to the Pre-Closing Tax Period, (2) if the PPP Loan (or a portion of the PPP Loan) is ever forgiven, by treating the PPP Loan as if the PPP Loan (or such forgiven portion of the PPP Loan) were forgiven prior to the Closing Date, whether or not the PPP Loan (or such portion) was in fact forgiven prior to the Closing Date, (3) if all or any portion of the PPP Loan is never forgiven, or if applicable Law is changed to permit the deduction of expenses funded with proceeds of the PPP Loan regardless of whether or not it is forgiven, by treating all deductible amounts permitted by applicable Law that were funded with proceeds of the portion of the PPP Loan that is not forgiven, or with respect to which </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">84</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">deductions are permitted by applicable Law regardless of forgiveness, as deductions arising in the Pre-Closing Tax Period (such deductions, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Deductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (4) in the case of Taxes of the Company not described in clause (1) (including property Taxes), by allocating to the portion of any Straddle Period ending on and including the Closing Date the amount of such Tax for the entire taxable period multiplied by a fraction the numerator of which is the number of days in the taxable period ending on the Closing Date and the denominator of which is the number of days in such Straddle Period, (5) by treating all Transaction Deductions as arising in and deducted on income Tax Returns for Pre-Closing Tax Periods (for the avoidance of doubt, whether or not such Transaction Deductions (or net operating losses attributable to the Transaction Deductions) are actually permitted to be taken under applicable Law in such Pre-Closing Tax Period), (6) by treating all PPP Loan Deductions (if any arise in accordance with clause (3) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) as arising in and deducted on income Tax Returns for Pre-Closing Tax Periods (for the avoidance of doubt, whether or not such PPP Loan Deductions (if any) (or net operating losses attributable to the PPP Loan Deductions (if any) are actually permitted to be taken under applicable Law in such Pre-Closing Tax Period), (7) by assuming that the Company makes a timely election under Revenue Procedure 2011-29, 2011-18 I.R.B. 746, to apply the seventy percent (70%) safe-harbor to any third party expenses that are &#8220;success based fees&#8221; as defined in Treasury Regulation Section 1.263(a)-5(f) to the extent permitted by applicable Law, and (8) by applying any net operating losses and other Tax benefits of the Company arising in taxable periods ending (or deemed to end) on or prior to the Closing Date against income arising in Pre-Closing Tax Periods to the extent permitted by applicable Law (other than any net operating losses and other Tax benefits that are or are attributable to the Transaction Deductions or the PPP Loan Deductions (if any), which shall be treated as set forth in clauses (5) and (6) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  For the avoidance of doubt, for purposes of this Agreement, Transaction Deductions and PPP Loan Deductions (if any) in each case arising after 2020, shall be treated as if they can be applied to reduce income Taxes in prior years to the extent that they would have been permitted to be so applied under applicable Law if they had arisen in 2020, or without duplication, 2021. Notwithstanding anything to the contrary, (x) Taxes resulting from any election under Section 338 or Section 336 of the Code (or any comparable provision of applicable Law), (y) Taxes incurred outside the ordinary course of business on the Closing Date after the Closing, and (z) the Parent Employer Taxes with respect to any amounts payable in connection with the transactions contemplated by this Agreement, including payment of the Closing Merger Consideration Amount, any Earnout Payment or other payments or distributions to be made to the Employee Option Holders, shall not be treated as attributable to the Pre-Closing Tax Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">216.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Post-Closing Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Parent will not (and will not permit any of its Affiliates to), (i) amend any Tax Returns of the Company with respect to any Pre-Closing Tax Period, (ii) make or change any Tax election or change any method of accounting that has retroactive effect to any Pre-Closing Tax Period of the Company, (iii) agree to extend or waive the statute of limitations with respect to Taxes of the Company for a Pre-Closing Tax Period, other than automatic extensions of time within which to file Tax Returns, or (iv) initiate discussions or examinations with any Governmental Body (including any voluntary disclosures) regarding Taxes with respect to any Pre-Closing Tax Period, in each such case, except (A) with </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">85</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the prior written consent of the Securityholders&#8217; Representative (which will not be unreasonably withheld, conditioned, or delayed), or (B) if such action will not form the basis for a claim of indemnification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">217.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Refunds. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Participating Securityholders shall be entitled to the amount of any refund or credit of Taxes of the Company with respect to a Pre-Closing Tax Period, which refund or credit is actually recognized by the Parent or its Affiliates (including the Company) after the Closing, net of any Taxes or other costs to the Parent and its Affiliates attributable to obtaining and receiving such refund or credit, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Participating Securityholders shall not be entitled to the amount of any such refund or credit to the extent (i) such refund or credit arises as the result of a carryback of a loss or other Tax benefit arising in a Tax period (or portion thereof) beginning after the Closing Date (taking into account the conventions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b))</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (ii) such refund or credit was included as a Closing Asset in the calculation of the Closing Date Net Working Capital, as finally determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.11 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), (iii) the Participating Securityholders did not actually previously pay or economically bear the Taxes associated with such refund either pursuant to this Agreement or prior to the Closing (including by a payment of such Taxes by the Company prior to the Closing) or otherwise, or (iv) such refund or credit is actually recognized by the Parent or its Affiliates after the final Earnout Payment has been paid (plus any additional period of time during which any Indemnified Party is permitted to make a claim for damages pursuant to any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Parent shall use commercially reasonable efforts to obtain, at the expense of the Participating Securityholders, such refunds and credits (including by making carryback claims to a Pre-Closing Tax Period of the Company to the extent permitted by applicable Law, for the avoidance of doubt, without derogation of the limitations in the proviso of the first sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and to pay, or cause to be paid, to the Payment Agent (for further distribution to the Participating Securityholders) any amount to which the Participating Securityholders are entitled pursuant to the prior sentence within fifteen (15) Business Days following the end of the calendar year of the receipt or recognition of the applicable refund or credit by Parent or its Affiliates. To the extent such refund or credit is subsequently disallowed or required to be returned to the applicable Governmental Body, the Participating Securityholders agree promptly to repay the amount of such refund or credit, together with applicable interest, if any, to Parent. For the avoidance of doubt, notwithstanding anything to the contrary in this Agreement, except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Participating Securityholders shall not be entitled to any payments in respect of the utilization of Tax assets or Tax attributes of the Company in a Post-Closing Tax Period. For the avoidance of doubt, the Participating Securityholders shall not be entitled to recover more than once for the same amount, and therefore&#160;the Participating Securityholders shall not be entitled to a payment under this Section 8.9(d)&#160;to the extent that the amount of a refund or credit has been applied previously to actually reduce the Participating Securityholders&#8217; indemnification obligation pursuant to&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Participating Securityholders shall not be entitled to a payment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> until the later of (x) the initial due date for filing (including ordinary course extenstions) of the last income Tax Return of the Company for any Pre-Closing Tax Period and (y) if an indemnification claim has been made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that has not yet been resolved in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the refund or credit is first </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">86</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applied to reduce the Participating Securityholders&#8217; indemnification obligation with respect to such claim determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and such obligation is reduced to zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">218.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Tax Cooperation.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Securityholders&#8217; Representative agrees to furnish or cause to be furnished to Parent and its Subsidiaries (including the Company), and Parent agrees to furnish or cause to be furnished, and to cause its Subsidiaries (including the Company) to furnish to Securityholders&#8217; Representative at any time after the Closing Date, upon request, as promptly as practicable, such information (including access to books and records) and assistance relating to the Company, as is reasonably requested for the filing of any Tax Returns, for the preparation of any audit and for the prosecution or defense of any pending or threatened audit or assessment, suit, proposed adjustment, deficiency, dispute, administrative or judicial proceeding or other similar claim (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Contest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Tax Contests shall be treated as Third Person Claims under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). Each of Parent, the Company, their Subsidiaries and the Securityholders&#8217; Representative shall retain all books and records in their possession with respect to Taxes of the Company for any Pre-Closing Tax Period for a period of at least seven (7) years following the Closing Date.  Notwithstanding anything to the contrary in this Agreement, the Securityholders&#8217; Representative shall have no obligation to prepare or file any Tax Returns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">219.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The rights and obligations of the Participating Securityholders and Parent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall survive until the end of the Milestone Period plus any additional period of time during which any Indemnified Party is permitted to make a claim for damages pursuant to any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Termination</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Termination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be terminated prior to the Effective Time (whether before or after the adoption of this Agreement by the Required Company Stockholder Vote)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">220.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by mutual written consent of Parent and the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">221.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by either Parent or the Company if the Merger shall not have been consummated by the End Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that a party shall not be permitted to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) if the failure to consummate the Merger by the End Date is attributable to a failure on the part of such party to perform any covenant in this Agreement required to be performed by such party at or prior to the Effective Time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">222.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by either Parent or the Company if a court of competent jurisdiction shall have issued a final and non-appealable order having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that a party shall not be permitted to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) whose failure to fulfill any obligation under this Agreement shall have been a material cause of, or resulted in, the occurrence of such order&#59;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">87</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">223.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by Parent, if the Company shall have materially breached or materially failed to perform any of its representations, warranties, covenants or agreements contained in this Agreement, which material breach or failure to perform (i) would give rise to the failure of a condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Performance of Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and (ii) cannot be or has not been cured within 30 days following receipt by the Company of written notice of such material breach or failure to perform&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Parent shall not have the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) if Parent or Merger Sub is then in material breach of this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">224.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by the Company, if Parent or Merger Sub shall have materially breached or materially failed to perform any of their respective representations, warranties, covenants or agreements contained in this Agreement, which material breach or failure to perform (i) would give rise to the failure of a condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Performance of Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and (ii) cannot be or has not been cured within 30 days following receipt by Parent of written notice of such material breach or failure to perform&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Company shall not have the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) if the Company is then in material breach of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">225.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">by Parent, if the Company fails to deliver the Required Company Stockholder Vote within 24 hours of the date of this Agreement in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Effect of Termination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> In the event of the termination of this Agreement as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), this Agreement shall be of no further force or effect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (i) this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall survive the termination of this Agreement and shall remain in full force and effect and (ii)&#160;nothing herein shall relieve any party from any liability for common law fraud or Willful Breach. No termination of this Agreement shall affect the obligations of the parties contained in the Confidentiality Agreement, all of which obligations shall survive the termination of this Agreement in accordance with their terms.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Miscellaneous Provisions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Amendment</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be amended with the written approval of the board of directors of the Company (or the Securityholders&#8217; Representative following the Closing) and Parent at any time (whether before or after the adoption of this Agreement by the Required Company Stockholder Vote)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that after any such adoption of this Agreement by the Required Company Stockholder Vote, no amendment shall be made which by Law requires further approval of the Company Stockholders without the further approval of such Company </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">88</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stockholders.  This Agreement may not be amended except by an instrument in writing signed on behalf of the Company and Parent (prior to the Closing) or Parent and the Securityholders&#8217; Representative (after the Closing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Expenses</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), all fees and expenses incurred in connection with the preparation, negotiation, execution and performance of this Agreement and the transactions contemplated by this Agreement shall be paid by the party incurring such expenses, whether or not the Merger is consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">No failure on the part of any party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy&#59; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">No party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party&#59; and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Entire Agreement&#59; Counterparts</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement, the Disclosure Schedules, the Confidentiality Agreement, and the other Transaction Documents constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument.  This Agreement may be executed by electronic transmission, which shall be deemed an original.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">Applicable Law&#59; Jurisdiction</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">), Each party agrees that it shall bring any action in respect of any claim based upon, arising out of or relating to this Agreement or any of the transactions contemplated by this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">exclusively in the chosen courts&#59; and solely in CONNECTION with claims arising out of or </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">89</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">relating to this Agreement or any of the transactions contemplated by this Agreement&#58; (a)&#160;each of the parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Chosen courts&#59; (b) each of the parties irrevocably waives the right to trial by jury&#59; AND (c) EACH OF THE PARTIES ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT and THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SECTION&#160;10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Applicable Law&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Assignability</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties hereto and their respective successors and assigns&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, neither this Agreement nor any of the rights hereunder may be assigned (whether by merger, consolidation, sale or otherwise) by the Company (prior to the Effective Time) or Parent without the prior written consent of the other party, and any attempted assignment of this Agreement or any of such rights without such consent shall be void and of no effect (except that Parent may assign this Agreement or any such rights to an Affiliate without the prior written consent of the Company (prior to the Effective Time) or the Securityholders&#8217; Representative (at or after the Effective Time))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent and the Surviving Corporation may assign this Agreement as a whole without such consent in connection with the acquisition (whether by merger, consolidation, sale or otherwise) of Parent or the Surviving Corporation or of that part of Parent&#8217;s or the Surviving Corporation&#8217;s business to which this Agreement relates, as long as (a) Parent provides written notice to the Company (prior to the Effective Time) or the Securityholders&#8217; Representative (at or after the Effective Time) of such assignment, (b) the assignee thereof agrees in writing to assume and be bound as Parent and the Surviving Corporation hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Confidentiality</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent acknowledges that the information provided to it in connection with this Agreement and the other Transaction Documents and the transactions contemplated hereby and thereby is subject to the Confidentiality Agreement, the terms of which are incorporated herein by reference and shall continue in full force and effect until the Closing, at which time the confidentiality obligations under the Confidentiality Agreement shall terminate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, from and after the Closing, the Confidentiality Agreement shall continue to apply in accordance with its terms but only with respect to breaches of the Confidentiality Agreement prior to the Closing.  If this Agreement is, for any reason, terminated prior to the Closing, the Confidentiality Agreement shall nonetheless continue in full force and effect in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Third Party Beneficiaries</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">90</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and 10.12 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conflict of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and, following the Closing with respect to all Persons that held Company Capital Stock, Company Options immediately prior to the Closing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Description of Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Notices</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice or other communication required or permitted to be delivered to any party under this Agreement shall be in writing and shall be deemed properly delivered, given and received (a) upon receipt when delivered by hand, (b) upon receipt of a letter delivered by certified mail return receipt requested, (c) upon confirmation of receipt if sent by electronic transmission (with autoreply not being deemed confirmation of receipt), or (d) one Business Day after being sent by courier or express delivery service&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that in each case the notice or other communication is sent to the address set forth beneath the name of such party below (or to such other address as such party shall have specified in a written notice given to the other parties hereto)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that with respect to notices delivered to the Securityholders&#8217; Representative, such notices must be delivered solely via electronic transmission&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">if to Parent or Merger Sub&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Integra LifeSciences Holdings Corporation</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1100 Campus Road </font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Princeton, NJ 08540</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Eric Schwartz, Executive Vice President, Chief Legal Officer and Secretary</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58; eric.schwartz&#64;integralife.com</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With a copy (which shall not constitute notice) to&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sullivan &#38; Cromwell LLP</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">125 Broad Street</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, NY 10004</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Melissa Sawyer</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;  sawyerm&#64;sullcrom.com</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Integra LifeSciences Holdings Corporation</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1100 Campus Road </font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Princeton, NJ 08540</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Corporate Development</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58; andrea.caruso&#64;integralife.com</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">if to the Company (prior to the Closing)&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ACell, Inc.</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6640 Eli Whitney Drive</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Columbia, Maryland 21046</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Christopher F. Branch, Chief Operating Officer and General Counsel</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58;  chrisbranch&#64;acell.com</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or the Securityholders&#8217; Representative (after the Closing)&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Fortis Advisors LLC</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Notices Department (Project Ocean)</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58;  notices&#64;fortisrep.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the case of notices to the Company (prior to Closing) or to the Securityholders&#8217; Representative (after the Closing), with a copy to (which shall not constitute notice)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cooley LLP</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4401 Eastgate Mall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">San Diego, CA 92121</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; Barbara Borden</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58;  bordenbl&#64;cooley.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.01pt">Severability</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.  If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the parties hereto agree that the court making such determination shall have the power to limit the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.  In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Knowledge</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; of the Company shall mean (a) with respect to all matters other than those involving Intellectual Property, the actual knowledge of a fact or other matter, after reasonable inquiry, of the Knowledge Individuals, it being understood and agreed that a review of one&#8217;s files shall constitute reasonable inquiry&#59; and (b) with respect to matters involving Intellectual Property, the actual knowledge of a fact or other matter, after reasonable inquiry, of the</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vice </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">92</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President of R&#38;D and Clinical Operations of the Company, it being understood and agreed that a review of such Person&#8217;s files and consultation with such Person&#8217;s direct reports taking into account the subject matter in question shall constitute reasonable inquiry.  With respect to matters involving Intellectual Property, Knowledge does not require that the Knowledge Individuals have conducted, obtain or have obtained any freedom-to-operate opinions or similar opinions of counsel or any Intellectual Property clearance searches, and no knowledge of any third-party Intellectual Property that would have been revealed by such inquiries, opinions or searches will be imputed to the Knowledge Individuals or the direct reports of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that any such opinions or searches that have been conducted or obtained prior to the Closing by the Company will not be excluded from the term &#8220;Knowledge&#8221; as a result of this sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.67pt">Conflict of Interest</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Securityholders&#8217; Representative so desires, acting on behalf of the Participating Securityholders and without the need for any Consent or waiver by the Company or Parent, Cooley LLP (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cooley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be permitted to represent the Participating Securityholders after the Closing in connection with any matter, including, without limitation, anything related to the transactions contemplated by this Agreement, any other agreements referenced herein or any disagreement or dispute relating thereto.  Without limiting the generality of the foregoing, after the Closing, Cooley shall be permitted to represent the Participating Securityholders, any of their agents and Affiliates, or any one or more of them, in connection with any negotiation, transaction or dispute (including any litigation, arbitration or other adversary proceeding) with Parent, the Company or any of their agents or Affiliates under or relating to this Agreement, any transaction contemplated by this Agreement, and any related matter, such as claims or disputes arising under other agreements entered into in connection with this Agreement, including with respect to any indemnification claims.  Upon and after the Closing, the Company shall cease to have any attorney-client relationship with Cooley, unless and to the extent Cooley is specifically engaged in writing by the Company to represent the Company after the Closing and either such engagement involves no conflict of interest with respect to the Participating Securityholders or the Securityholders&#8217; Representative consents in writing at the time to such engagement.  Any such representation of the Company by Cooley after the Closing shall not affect the foregoing provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.01pt">Attorney-Client Privilege</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent and the Company agree that any attorney-client privilege, attorney work-product protection, and the expectation of client confidence attaching as a result of counsel&#8217;s (whether external or internal) representation of the Company prior to the Closing and in connection with the transactions contemplated by this Agreement, including the Merger, and all pre-closing information and documents covered by such privilege or protection (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Covered Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), shall belong to and be controlled by the Securityholders&#8217; Representative, and not by the Surviving Corporation, following the Closing, and may be waived only by the Securityholders&#8217; Representative, and not the Surviving Corporation, and shall not pass to or be claimed or used by Parent or the Surviving Corporation.  Absent the consent of the Securityholders&#8217; Representative, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">neither Parent nor the Surviving Corporation shall have a right to access the Covered Materials following the Closing and, in the event Parent or the Surviving Corporation accesses Covered Materials in violation of this sentence, such access will not waive or otherwise affect the rights of the Securityholders&#8217; Representative with respect to the related privilege or protection.  Notwithstanding the foregoing, if a dispute arises between Parent or the Surviving Corporation, on the one hand, and a third party other than (and unaffiliated with) the Participating Securityholders and the Securityholders&#8217; Representative, on the other hand, after the Closing, then the Surviving Corporation may assert such attorney-client privilege to prevent disclosure to such Covered Materials&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Parent and the Surviving Corporation may not waive such privilege without the prior written consent of the Securityholders&#8217; Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">No Implied Representations</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties acknowledge that, except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), none of the parties hereto has made or is making any representations or warranties whatsoever, implied or otherwise.  The Company, the Participating Securityholders and their respective Affiliates and representatives each have not made any representation or warranty, express or implied, as to the accuracy or completeness of any information concerning the Company or the Participating Securityholders contained herein or made available in connection with Parent&#8217;s investigation of the Company, except as expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and there shall be no liability that may be based on such information or errors therein or omissions therefrom.  Except as expressly set forth herein, the Company makes no warranty of merchantability, suitability, fitness for a particular purpose or quality with respect to any of the tangible assets of the Company or as to the condition or workmanship thereof or the absence of any defects therein, whether latent or patent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">Specific Performance</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each of the parties hereto agrees that this Agreement is intended to be legally binding and specifically enforceable pursuant to its terms and that Parent and the Company would be irreparably harmed if any of the provisions of this Agreement are not performed in accordance with their specific terms and that monetary damages would not provide adequate remedy in such event.  Accordingly, in addition to any other remedy to which a non-breaching party may be entitled at law, a non-breaching party shall be entitled to seek injunctive relief to prevent breaches of this Agreement and to specifically enforce the terms and provisions hereof, in each case without posting a bond or undertaking, this being in addition to any other remedy to which they are entitled at law or in equity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">For purposes of this Agreement, whenever the context requires&#58; the singular number shall include the plural, and vice versa&#59; the masculine gender shall include the feminine and neuter genders&#59; the feminine gender shall include the masculine and neuter genders&#59; and the neuter gender shall include masculine and feminine genders.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">94</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Except as otherwise indicated, all references in this Agreement to &#8220;Sections,&#8221; &#8220;Exhibits&#8221; and &#8220;Schedules&#8221; are intended to refer to Sections of this Agreement and Exhibits or Schedules to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Any document uploaded to the online data room utilized for the transactions contemplated by this Agreement prior to 4&#58;00 p.m., New York time, on the date of this Agreement shall be considered &#8220;made available,&#8221; &#8220;furnished,&#8221; &#8220;delivered&#8221; or &#8220;provided&#8221; for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Unless the context requires otherwise, the word &#8220;or&#8221; shall be inclusive such that for example, &#8220;A or B&#8221; shall be deemed to mean &#8220;A or B or both A and B.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:14.33pt">Disclosure Schedule</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Disclosure Schedule has been arranged, for purposes of convenience only, as separate Parts corresponding to the subsections of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of this Agreement.  The representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of this Agreement are subject to (a)&#160;the exceptions and disclosures set forth in the part of the Disclosure Schedule corresponding to the particular subsection of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) in which such representation and warranty appears&#59; (b) any exceptions or disclosures explicitly cross-referenced in such part of the Disclosure Schedule by reference to another part of the Disclosure Schedule&#59; and (c)&#160;any exception or disclosure set forth in any other part of the Disclosure Schedule to the extent it is reasonably apparent that such exception or disclosure on its face is intended to qualify such representation and warranty.  No reference to or disclosure of any item or other matter in the Disclosure Schedule shall be construed as an admission or indication that such item or other matter is material (nor shall it establish a standard of materiality for any purpose whatsoever) or that such item or other matter is required to be referred to or disclosed in the Disclosure Schedule.  The information set forth in the Disclosure Schedule is disclosed solely for the purposes of this Agreement, and no information set forth therein shall be deemed to be an admission by any party hereto to any third party of any matter whatsoever, including of any violation of Law or breach of any agreement.  The Disclosure Schedule and the information and disclosures contained therein are intended only to qualify and limit the representations, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">95</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">warranties and covenants of the Company contained in this Agreement.  Nothing in the Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in this Agreement or create any covenant.  Matters reflected in the Disclosure Schedule are not necessarily limited to matters required by the Agreement to be reflected in the Disclosure Schedule.  Such additional matters are set forth for informational purposes and do not necessarily include other matters of a similar nature.</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">96</font></div><div><font><br></font></div></div></div><div id="ifac543e3a67740e19cc6ba143c7c6848_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have caused this Agreement to be executed as of the date first above written.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Peter Arduini                                    </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Peter Arduini</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;   President and Chief Executive Officer</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ILS OCEAN 12-20 CORP.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Peter Arduini                                    </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Peter Arduini</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;   President and Chief Executive Officer</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have caused this Agreement to be executed as of the date first above written.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Signature Page to Agreement and Plan of Merger&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ACELL, INC.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Patrick A. McBrayer                            </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Patrick A. McBrayer</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;   President and Chief Executive Officer</font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have caused this Agreement to be executed as of the date first above written.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Signature Page to Agreement and Plan of Merger&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORTIS ADVISORS LLC</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Ryan Simkin                                      </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Ryan Simkin</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;  Managing Director</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Signature Page to Agreement and Plan of Merger&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="ifac543e3a67740e19cc6ba143c7c6848_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A.</font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Definitions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Agreement (including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">280G Stockholder Vote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ACA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.15(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ACell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ACell Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the business of the ACell Products, including development, manufacture, commercialization, distribution or sale of the ACell Products.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ACell Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) all products commercialized or distributed by ACell for any indication as of the date of this Agreement, including products under the MicroMatrix&#174;, Cytal&#174;, Gentrix&#174;, or ABRA brands or offered under a private label agreement as of the date of this Agreement and all configurations of such products that are currently under development or are based on currently planned improvements of such products and (ii) all configurations of the Cardion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> products currently under development and currently planned improvements of such products.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounting Principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean GAAP as in effect at the date of the financial statement to which it refers, or if there is no such financial statement, then as of the Closing Date, using and applying the same accounting principles, practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation and estimation methodologies) used and applied by the Company in the preparation of the Audited Company Financial Statements&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that if such accounting principles, practices, procedures, policies and methods and GAAP are inconsistent, GAAP shall control&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Accounting Principles (i) shall not include any purchase accounting or other adjustment arising out of the consummation of the transactions contemplated by this Agreement, (ii) shall be based on facts and circumstances as they exist prior to the Closing and shall exclude the effect of any act, decision or event occurring on or after the Closing, (iii) shall follow the defined terms contained in this Agreement and (iv) shall calculate any reserves, accruals or other non-cash expense items on a pro rata (as opposed to monthly accrual) basis to account for a Closing that occurs on any date other than the last day of a calendar month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) all trade accounts receivable and other rights to payment owed to the Company, and (ii) all other accounts receivable or notes receivable of the Company, in each case, as calculated in accordance with the Accounting Principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Additional Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Additional Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advisory Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any specified Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such specified Person (but excluding, with respect to the Company, any portfolio companies of venture capital or investment funds that are, or otherwise affiliated with, Company Stockholders, which portfolio companies may otherwise be deemed to be &#8220;under common control with&#8221; the Company).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Exercise Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the aggregate exercise price of all Company Options outstanding as of immediately prior to the Effective Time as set forth on the Estimated Closing Statement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the (i) Foreign Corrupt Practices Act of 1977, as amended, and the related regulations and published interpretations thereunder, (ii) the UK Anti-Bribery Act and (iii) other applicable anti-corruption law in other jurisdictions in which the Company conducts business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Antitrust Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, as amended, and all other federal, state and foreign statutes, rules, regulations, orders, decrees, and other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or competition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Release Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.17(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Escrow Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Approved Relatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Arbitration Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Arbitration Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Audited Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Book-Entry</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing of the Company Transfer Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in Maryland or New York City, New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">CARES Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean the Coronavirus Aid, Relief, and Economic Security Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to the Company, as of the Reference Time (but before taking into account the consummation of the transactions contemplated hereby), the aggregate amount of cash, cash equivalents and marketable securities held by the Company, as determined in accordance with the Accounting Principles, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;the aggregate amount of outstanding checks or drafts of the Company that have not posted, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b)&#160;checks received by the Company that have not been posted (after reducing Accounts Receivable or any other related current asset by the amount of such unposted check).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing&#59; Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">28.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Chosen Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the state of Delaware declines to accept jurisdiction over a particular matter, any federal court within the state of Delaware or, in the event each federal court within the state of Delaware declines to accept jurisdiction over a particular matter, any state court within the state of Delaware).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">29.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing&#59; Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">30.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the current assets of the Company in accordance with the Accounting Principles, including Accounts Receivable, prepaid expenses, deferred bank fees, prepaid software licenses, prepaid insurances, long-term deposits (not included in Cash and Cash Equivalents), credit card prepayments and Inventory, but excluding (i) Cash and Cash Equivalents, and (ii) (for the avoidance of doubt) Tax assets and Tax attributes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">31.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Company Share Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">sum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of (a) the aggregate number of outstanding shares of Company Common Stock held by the Participating Securityholders immediately prior to the Effective Time, (b) the aggregate number of shares of Company Common Stock issuable upon the conversion of shares of Company Preferred Stock held by the Participating Securityholders as of immediately prior to the Effective Time, and (c) the aggregate number of shares of Company Common Stock issuable upon the exercise of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company Options (but excluding any Company Performance Options) outstanding as of immediately prior to cancellation immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">32.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing&#59; Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">33.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Balance Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a balance sheet of the Company as of the Reference Time prepared (i) from and in accordance with the books and records of the Company and (ii) in accordance with the Accounting Principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">34.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Cash Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Cash and Cash Equivalents of the Company as of the Reference Time determined in accordance with the Accounting Principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">35.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Debt of the Company as of the Reference Time determined in accordance with the Accounting Principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">36.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Net Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount (which may be positive or negative) equal to (a) the Closing Assets </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) the Closing Liabilities, in each case, as of the Reference Time, determined and calculated in accordance with the Accounting Principles</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> sets forth, for illustrative purposes only, a calculation of the Closing Date Net Working Capital as of November 30, 2020 prepared in accordance with the Accounting Principles.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, without duplication, (i) the aggregate expenses, fees and disbursements of all attorneys, accountants, investment bankers and Securityholders&#8217; Representative of the Company in connection with the negotiation, execution, delivery and performance of this Agreement and any similar expenses, fees and disbursements arising out of or resulting from the negotiation, execution, delivery and performance of this Agreement, (ii) the upfront engagement fee of the Securityholders&#8217; Representative of the Company, (iii) 50% of any Transfer Taxes, (iv) the cost of obtaining the D&#38;O Policy (to the extent unpaid by the Company prior to the Closing) (other than amounts payable in respect of tails for the Company&#8217;s existing claims-made employment practices liability policy and fiduciary liability policy), (v) the Severance Amount and any other bonus or transaction fee, single-trigger change in control, retention, compensatory or similar payment (excluding the payment of the Closing Merger Consideration Amount, any Earnout Payment or other payments or distributions to be made to the Employee Option Holders) that becomes payable to an employee or director of the Company as a result of transactions contemplated hereby (excluding any right to receive severance or right to receive any payments under this Agreement in respect of equity interests other than the Severance Amount) (whether payable prior to, on or following the Closing), in each case (a) determined in accordance with the Accounting Principles and (b) to the extent that such fees, expenses and disbursements have not been paid by the Company prior to the determination of the Company&#8217;s Estimated Closing Date Net Working Capital set forth on the Estimated Closing Statement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that to the extent any Closing Date Transaction Expenses become due and payable, Parent shall promptly pay such amounts to the applicable third party on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">behalf of the Surviving Corporation and provide to the Securityholders&#8217; Representative evidence of such payment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Closing Date Transaction Expenses shall not include Taxes except (x) 50% percent of any Transfer Taxes and (y) the Sellers Employer Taxes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, (i) Parent and its Affiliates (and not the Participating Securityholders) shall be responsible for and shall pay Parent Employer Taxes with respect to any amounts payable in connection with the transactions contemplated by this Agreement, including payment of the Closing Merger Consideration Amount, any Earnout Payment or other payments or distributions to be made to the Employee Option Holders and (ii) the Transaction Bonus Pool, the Accrued 2020 Bonus Pool (including the 2020 ACell Executive Bonus Plan), Additional 2020 Bonus Pool, Crossover Financing Pool, Bonus Retention Pool and the Regional Sales Manager Bonus, to the extent not paid in full prior to the Closing Date, each constitute Closing Date Transaction Expenses. Any amounts paid by the Company prior to Closing in respect of tails for the Company&#8217;s existing claims-made employment practices liability policy and fiduciary liability policy pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be at Parent&#8217;s expense up to $100,000 and shall reduce the aggregate amount of Closing Date Transaction Expenses to that extent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">37.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the current liabilities of the Company in accordance with the Accounting Principles, including accounts payable, accrued vacation, accrued expenses, unearned revenue, accrued expense reports, accrued payable for data, current Tax liabilities (as determined by the Company in good faith in accordance with the Company&#8217;s ordinary course methods for calculating its Taxes, except that current liabilities for income Taxes shall be reduced, but not below zero (0), by taking into account the Transaction Deductions as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Current Tax Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (and excluding, for the avoidance of doubt, contingent liabilities for Taxes)) and any Tax liabilities as of the Closing Date deferred pursuant to the CARES Act or the Payroll Tax Executive Order or similar relief (whether such Tax liabilities are current or otherwise), and benefits payable (other than, for the avoidance of doubt, any double trigger payments payable pursuant to a second trigger occurring following the Closing), but excluding (a) any liability included in the Closing Date Indebtedness and Closing Date Transaction Expenses to the extent actually deducted from the calculation of the Closing Merger Consideration Amount (b) any current liabilities that are non-cash charges or expenses, and (c) the Parent Employer Taxes with respect to any amounts payable in connection with the transactions contemplated by this Agreement, including payment of the Closing Merger Consideration Amount, any Earnout Payment or other payments or distributions to be made to the Employee Option Holders&#59;  it being understood that the foregoing amounts (including, for the avoidance of doubt, the current Tax liabilities) shall be calculated as if the PPP Loan had been forgiven prior to the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">38.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean cash in an amount equal to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">the Upfront Purchase Price&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:21.35pt">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Securityholders&#8217; Representatives Reserve&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Escrow Amount&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:21.35pt">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Estimated Closing Date Cash Amount, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.7pt">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Estimated Closing Date Indebtedness, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.03pt">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Estimated Net Working Capital Adjustment, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Estimated Closing Date Transaction Expenses, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:21.35pt">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Aggregate Exercise Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">39.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Options Payout Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Payment Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.7(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Agreements and Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">40.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.15(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">41.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Commercially Reasonable Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">42.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">43.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">44.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the board of directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">45.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, collectively, the Company Common Stock and the Company Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">46.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s Fourth Amended and Restated Certificate of Incorporation, as filed with the Secretary of the State of Delaware on April 11, 2011, as amended or restated, and in effect immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">47.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the common stock, $0.001 par value per share, of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">48.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">49.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Healthcare Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">50.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean all Intellectual Property owned or purported to be owned by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">51.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any change, effect, event, occurrence, state of facts or development or cause thereof that, individually or in the aggregate is, or would reasonably be expected to, (i) prevent, materially delay or materially impair the ability of the Company to consummate the transactions contemplated by this Agreement or the other Transaction Documents to which it is a party or to otherwise consummate the transactions contemplated by this Agreement or (ii) be materially adverse to the assets, liabilities, financial condition or existing business of the Company (taken as a whole), &#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that with respect to clause (ii), none of the following (individually or in combination) shall be deemed to constitute, or shall be taken into account in determining whether there has been, a Company Material Adverse Effect&#58; (a)&#160;any adverse effect resulting from general business or economic conditions, except to the extent such general business or economic conditions have a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry&#59; (b)&#160;any adverse effect resulting from conditions generally affecting any industry or industry sector in which the Company operates or competes, except to the extent such conditions generally affecting any industry have a disproportionate effect on the Company as compared to any of the other companies in such industry or industry sector&#59; (c)&#160;any adverse effect resulting from hurricanes, earthquakes, floods, tsunamis, tornadoes, mudslides, fires or other disasters, epidemics, pandemics (including COVID-19) and other force majeure events, except to the extent such event has a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry&#59; (d) any adverse effect resulting from the announcement, execution or delivery of this Agreement or the pendency of the Merger (but not for the avoidance of doubt, the consummation of the Merger)&#59; (e)&#160;any adverse effect resulting from any change in GAAP or any change in applicable Laws or the authoritative interpretation thereof&#59; (f) the failure of the Company to meet internal expectations, projections or operating results (but taking into account underlying causes that are not otherwise excluded in (a)-(g) of this definition)&#59; (g) any adverse effect resulting from any action taken by the Company at the Parent&#8217;s direction or with Parent&#8217;s express written consent&#59; or (h)&#160;any adverse effect resulting from any breach by Parent or Merger Sub of any provision of this Agreement or the taking of any other action by Parent or Merger Sub.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">52.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean options to purchase shares of Company Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Performance Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the options listed on Section 1.6(b) of the Disclosure Schedule.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">53.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.15(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">54.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean collectively the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">55.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">56.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Regulatory Agency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">57.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Regulatory Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">58.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean any Tax Return required to be filed by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">59.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Service Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.15(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">60.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stock Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing of the Company&#8217;s Transfer Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">61.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the holders of Company Capital Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">62.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Comparable Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean such comparable products of the Parent or any of its Affiliates that are intended for wound reconstruction or care or for the reinforcement of soft tissue where weakness exists, which may include a variety of hernia repairs, in each case, with similar addressable markets to the ACell Products.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">63.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean that certain Confidentiality Agreement, dated as of September 19, 2020, by and between Parent and the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">64.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consent(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any consent, approval or waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">65.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Continuing Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">66.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any contract, plan, undertaking, arrangement, concession, understanding, agreement, agreement in principle, franchise, permit, instrument, license, lease, sublease, note, bond, indenture, deed of trust, mortgage, loan agreement or other binding commitment, whether written or oral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">67.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cooley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conflict of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">68.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Covered Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Attorney-Client Privilege</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">69.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means&#160;SARS-CoV-2&#160;or&#160;COVID-19,&#160;and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">70.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; workforce reduction, social distancing, shut down, closure, sequester, safety or similar Law, directive, guidelines or recommendations promulgated by any Governmental Body, including the Centers for Disease Control and Prevention, in each case, (a) in connection with or in response to&#160;COVID-19,&#160;including the CARES Act and Families First Act or (b) to ensure the health and safety of any of the Company&#8217;s employees in light of COVID-19.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Current Tax Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Liabilities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">71.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Indemnified Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">72.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">73.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean losses, costs, damages and expenses, including reasonable and documented out-of-pocket attorneys&#8217; fees and expenses and reasonable fees and expenses of other professionals and experts, that have been incurred or properly paid by an Indemnified Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that &#8220;Damages&#8221; shall not include any (i) special, exemplary or punitive damages or (ii) damages (including lost profits) that are not reasonably foreseeable or any diminution in value or losses calculated by any &#8220;multiplier&#8221; calculation methodology, except in each case to the extent (A) paid or payable by an Indemnified Party to a third Person in connection with a Third Person Claim or (B) covered by the R&#38;W Insurance. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">74.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean the outstanding principal amount of, and all interest and other amounts accrued in respect of and all amounts payable at retirement of, (a)&#160;any indebtedness for borrowed money of the Company, (b)&#160;any obligation of the Company evidenced by bonds, debentures, notes or other similar instruments, (c)&#160;any reimbursement obligation of the Company with respect to letters of credit (including standby letters of credit to the extent drawn upon), bankers&#8217; acceptances or similar facilities issued for the account of the Company and any termination or other fees payable in relation thereto, (d) any capital leases, (e) off-balance sheet financing, (f) the Settlement Debt, (g) the PPP Loan (h)&#160;any obligation of the type referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;of another Person the payment of which the Company has guaranteed or for which the Company is responsible or liable, directly or indirectly, jointly or severally, as obligor or guarantor, (h) accrued interest, premium, penalty or other obligation relating to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (i) any dividends declared but unpaid owed to a holder of shares of Company Preferred Stock</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall not include (i) any letters of credit to the extent not drawn upon, (ii) any bank guarantees, (iii) non-cancellable purchase commitments, (iv) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">surety bonds and performance bonds, (v) trade payables or other current liabilities in the ordinary course of business or (vi) any deferred rent.  For purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Description of Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), Debt shall mean Debt, as defined above, outstanding as of the Reference Time (but before taking into account the consummation of the transactions contemplated by this Agreement).  For the avoidance of doubt, Debt shall not include any Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">75.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Deductible</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $250,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">76.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the recitals of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">77.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the disclosure schedule that has been prepared by the Company and delivered or made available to Parent and Merger Sub on the date of the Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The contents of each of the contracts and other documents referred to in the Disclosure Schedule shall be deemed to be incorporated and referred to in the Disclosure Schedule as though set forth in full therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">78.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">79.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">80.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appraisal and Dissenters&#8217; Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">81.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appraisal and Dissenters&#8217; Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">82.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DOJ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Filings&#59; Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">83.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">84.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">85.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">86.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">87.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earnout Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">88.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Closing&#59; Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">89.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Employee Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a Company Option granted to an Person in their capacity as an employee of the Company for applicable employment Tax purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">90.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Employee Option Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean each holder of a Company Option that is an employee of the Company or was an employee of the Company when the Company Option was granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">91.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">End Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the date that is 270 days from the date of this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that each of the Company and Parent shall have the right to extend the End Date by up to 60 days if any of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conditions Precedent to the Obligation of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of the Agreement shall not have been satisfied or waived on or prior to such date upon prior written notice to the other party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">92.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean any corporation (including any nonprofit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, company (including any limited liability company or joint stock company), firm or other enterprise, association, organization or entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">93.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Environmental Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Law or governmental regulation relating to (a) the protection, preservation or restoration of the environment (including, air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource)&#59; (b) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of, any Hazardous Substances&#59; or (c) safety issues (including human and occupational safety and health), in each case as amended and as in effect on the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">94.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Environmental Permit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any material permit, license, review, certification, approval, registration, Consent or other authorization issued pursuant to any Environmental Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">95.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s 2002 Stock Option and Incentive Plan and 2011 Stock Option and Grant Plan, in each case, as amended or restated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">96.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">97.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.15(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">98.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">99.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean such escrow agent as shall be mutually and reasonably agreed upon by Parent and the Securityholders&#8217; Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">100.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">101.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount equal to the aggregate of the Special Escrow Amount, the Purchase Price Escrow Amount and the Retention Escrow Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">102.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, at any given time after the Closing, the funds remaining in the Escrow Account, including any amount of interest actually earned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">103.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Cash Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">104.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">105.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Net Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">106.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">107.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a written statement setting forth (a) an estimated Closing Date Balance Sheet and (b) in reasonable detail (i) the Aggregate Exercise Amount&#59; and (ii) the Company&#8217;s good faith estimate of (1) the Closing Date Net Working Capital (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Net Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and the Estimated Net Working Capital Adjustment, (2) the Closing Date Cash Amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Cash Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (3) the Closing Date Indebtedness (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (4) the Closing Date Transaction Expenses (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (5) the Settlement Debt (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Settlement Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">108.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Net Working Capital Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, as applicable&#58; (a) the amount by which the Target Net Working Capital exceeds the Estimated Closing Date Net Working Capital by more than $100,000 (expressed as a negative amount), (b) the amount by which the Estimated Closing Date Net Working Capital exceeds the Target Net Working Capital by more than $100,000 (expressed as a positive amount), or (c) if the absolute value of the difference between the Estimated Closing Date Net Working Capital and the Target Net Working Capital is $100,000 or less, $0.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">109.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Settlement Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Excluded Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any (i) Cardion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> products, (ii) ABRA products and (iii) other pipeline products of the Company of which no commercial sales have been made as of the date of this Agreement, in each case, including any such products under development, any currently planned improvements thereto or any configurations thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">110.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the U.S. Food and Drug Administration, or any successor agency or authority thereto</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">111.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FDCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Federal Food, Drug, and Cosmetic Act, as amended, and all related rules, regulations and guidance (including, without limitation, the regulations promulgated in title 21 of the Code of Federal Regulations).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">112.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Final Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Final Net Working Capital Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, as applicable&#58; (a) the amount by which the Target Net Working Capital exceeds Closing Date Net Working Capital by more than $100,000 (expressed as a negative amount)&#59; (b) the amount by which the Closing Date Net Working Capital exceeds the Target Net Working Capital by more than $100,000 (expressed as a positive amount)&#59; or (c) if the absolute value of the difference between the Target Net Working Capital and the Closing Date Net Working Capital is $100,000 or less, $0&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Filings&#59; Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">113.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean United States generally accepted accounting principles</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  With respect to the computations pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), GAAP shall mean such principles as in effect as of the Reference Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">114.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">GDPR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Regulation (EU) 2016&#47;679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">115.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Government Official</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a)&#160;any officer or employee of any Governmental Body, (b)&#160;any Person acting in an official capacity on behalf of a Governmental Body, (c)&#160;any officer or employee of a Person that is majority or wholly owned by a Governmental Body, (d)&#160;any officer or employee of a public international organization, such as the World Bank or the United Nations, (e)&#160;any officer or employee of a political party or any Person acting in an official capacity on behalf of a political party or (f)&#160;any candidate for political office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">116.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Governmental Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any (a)&#160;permit, license, certificate, franchise, permission, variance, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Legal Requirement or (b)&#160;right under any Contract with any Governmental Body.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">117.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any national, federal, regional, state, provincial, local, or foreign or other governmental authority or instrumentality, legislative body, court, administrative agency, regulatory body, commission.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">118.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">119.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Substance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any substance listed, defined, designated or classified as hazardous, toxic, radioactive, dangerous, or a &#8220;pollutant&#8221; or &#8220;contaminant&#8221; or otherwise regulated, under any Environmental Law</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;Hazardous Substance&#8221; shall include any substance for which exposure is regulated by any Governmental Body or any Environmental Law, including any toxic waste, pollutant, contaminant, hazardous substance, toxic substance, hazardous waste, special waste, regulated medical waste, petroleum or any derivative or by-product thereof, radon, radioactive material, asbestos, or asbestos containing material, urea formaldehyde foam insulation, lead, mold, mold spores and mycotoxins or polychlorinated biphenyls or other similar substances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">120.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HCP Attestation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">121.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HCP Exclusion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">122.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Health Care Professional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Person (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, hospital or hospital purchase manager, physician, nurse, medical practice group or medical practice group manager, group purchasing organization or third-party payor) that purchases, leases, recommends, uses, prescribes or arranges for the purchase or lease of Company Products or related services or similar products or services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">123.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HSR Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Hart-Scott-Rodino Anti-Trust Improvements Act of 1976, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">124.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ICC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">125.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Demand</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.3(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">126.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.3(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">127.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Person entitled to indemnification under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">128.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">129.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.1(c).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">130.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Initial Company Stockholder Vote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the affirmative vote by written consent of (a) the holders of a majority of the shares of Company Common Stock and Company Preferred Stock outstanding on the applicable record date, voting together as a single class (with the Company Preferred Stock voting on an &#8220;as converted&#8221; basis), (b) the holders of a majority of each series of the Preferred Stock, voting as separate classes on an &#8220;as-converted&#8221; basis and on a total shares outstanding basis, to the conversion of Preferred Stock solely into the right to receive an amount in cash as set forth in this Agreement and (c) the holders of a majority of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock outstanding on the applicable record date, voting together as a single class on an &#8220;as-converted&#8221; basis and on a total shares outstanding basis</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">131.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Insurance Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">132.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the following, anywhere in the world, including registrations and applications therefor, goodwill, common law rights, and moral rights thereto&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">patents and utility models of any kind, patent applications, including provisional applications, statutory invention registrations, inventions, discoveries and invention disclosures (whether or not patented), and all related continuations, continuation-in-part, divisions, reissues, re-examinations, substitutions, and extensions thereof (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">trademarks, service marks, trade names, symbols, logos, trade dress, and all other similar identifiers of origin, whether or not registered, and all pending applications for registration of the same, other than regulatory filings&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">copyrights, works of authorship whether or not published or registered, and all pending applications for registration of the same&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">Internet domain names and URLs&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">trade secrets and other rights in know-how and confidential or proprietary information (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Trade Secrets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">computer programs, software and databases, whether in object or source code form&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">all other intellectual property rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">133.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">134.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a) all Company Products that have received all intended increments of value through manufacturing or other processing and that are being held for resale, and (b) all raw materials, parts, components, work-in-progress, field inventory loaners, sales force inventory, consignment, packaging materials and similar items with respect to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company Products, in each case wherever located and including such items previously ordered or purchased and in transit to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">135.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">IRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean the Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">136.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">IT Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means computers, software, firmware, middleware, servers, workstations, routers, hubs, switches, data communications lines, and all other information technology equipment, and all associated documentation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">137.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Joint Written Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.17(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Escrow Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">138.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">139.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge Individuals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the following Persons&#58;  Patrick McBrayer, Christopher Branch, Matthew Kunst and Bill Hrubes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">140.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any federal, state, local, municipal, foreign or other law, statute, constitution, principle of common law, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">141.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leased Real Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Real Property&#59; Leasehold</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">142.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Body or any arbitrator or arbitration panel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">143.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Legal Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any federal, state, local, municipal, foreign or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of NASDAQ).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">144.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">145.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean all mortgages, licenses, encumbrances, security interests, claims, charges or pledges.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">146.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Material Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">147.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">MDR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">148.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the recitals of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">149.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">150.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Milestone Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">151.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Milestone Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">152.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the amounts, determined in accordance with GAAP and Parent&#8217;s revenue recognition policies, that Parent and its Affiliates record for commercial sales of ACell Products to third parties during the relevant period anywhere in the world, reduced only by the following amounts to the extent allocable to such sales of ACell Products and to the extent consistent with Parent&#8217;s practices for products of like character&#58;  (a) any refunds, credits or allowances actually given or credited to any third party due to rejections, defects, recalls, price adjustments or returns of ACell Products, (b) any discounts, rebates or samples actually given or credited, (c) sales, use, occupation, value-added, consumption, import, export or excise or other Taxes levied on, absorbed, determined or imposed with respect to such sales (excluding income or net profit taxes or franchise taxes of any kind), to the extent paid by Parent or any of its Subsidiaries, (d) freight, duty, insurance or other transportation related costs included therein, (e) amounts written-off by Parent or its Affiliates during such period as uncollectible, (f) warranty expense estimated at the time of shipment, regardless of whether it is in-line with GAAP to include warranty as a deduction from revenue, (g) any deferrals of revenue in accordance with GAAP and Parent&#8217;s revenue recognition policies, , and (h) rebates (or their equivalent) granted by Parent or its Affiliate (including to Governmental Bodies, purchasers, reimbursors, customers, distributors, wholesalers, and group purchasing and managed care organizations and entities (and other equivalent entities and institutions)) which effectively reduce the selling price or gross sales</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  When calculating the Net Revenue for any period, the amount of such sales in foreign currencies shall be converted into United States dollars pursuant to the foreign exchange rate used by Parent in its financial reporting in accordance with GAAP for such period.&#160; If the ACell Product is sold as part of a bundle, combination or kit not all of which would be an ACell Product, then Parent shall calculate in good faith the invoiced price of the ACell Product allocable to Net Revenue in proportion to the ACell Product&#8217;s average selling price as a stand-alone product versus the average selling price of the other components of the bundle, combination or kit as a stand-alone product in commercial quantities pursuant to an arm&#8217;s-length transaction to similar third parties.&#160; If the ACell Product is sold as part of a bundle, combination or kit not all of which would be an ACell Product and the ACell Product or other components of the bundle, combination or kit, is not sold as a stand-alone product, then the Parent or its Affiliates shall calculate in good faith the invoice price of the ACell Product allocable to Net Revenues, based on the ACell Product&#8217;s relative value in relation to the relative value of the bundle, combination or kit. Net Revenue shall exclude all revenue derived from any Participating Securityholder or other Person entitled to receive any amounts hereunder, in their capacity as a Health Care Professional (including Persons listed on Section 1 of the Disclosure Schedule so </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">long as such Person is entitled to receive any amounts hereunder), (A) making use of any ACell Products in any medical procedure or (B) marketing, promoting or otherwise encouraging any other person to use ACell Products (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HCP Exclusion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> a determination as to whether a Participating Securityholder is a Health Care Professional shall be made based on such Participating Securityholder&#8217;s representations under the Letter of Transmittal and any HCP Attestation delivered pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">153.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Non-Dissenting Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean each Company Stockholder that does not perfect or otherwise loses such stockholder&#8217;s appraisal or dissenters&#8217; rights under the DGCL and is otherwise entitled to receive consideration pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conversion of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">154.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a Company Option granted to a Person other than in a capacity as an employee of the Company for applicable employment Tax purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">155.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Option Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean each holder of a Company Option who is not an Employee Option Holder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">156.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">157.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">158.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Ownership Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall, with respect to a Participating Securityholder, be equal to the quotient obtained by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (a) the aggregate number of shares of Company Common Stock held by such Participating Securityholder as of immediately prior to the Effective Time (including, for purposes of this definition, (i) the aggregate number of shares of Company Common Stock issuable upon the conversion of shares of Company Preferred Stock outstanding as of immediately prior to the Effective Time, and (ii) the aggregate number of shares of Company Common Stock underlying Company Options outstanding as of immediately prior to cancellation immediately prior to the Effective Time) by (b) the Closing Company Share Number.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">159.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">160.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.3(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">161.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Deductible</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $2,250,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Employer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean in respect of any payment all employer taxes due in respect of such payment that are not Sellers Employer Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">162.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the CEO and CFO of Parent from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">163.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">164.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">165.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean each Non-Dissenting Stockholder and each holder of Company Options, each as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">166.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">167.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">168.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payoff Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Payoff Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">169.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payroll Tax Executive Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Presidential Memorandum on Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19 Disaster, as issued on August 8, 2020 and including any administrative or other guidance published with respect thereto by any Governmental Body (including IRS Notice 2020-65).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">170.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Earnout Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean for each Earnout Payment that becomes payable the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">quotient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of (a) the Earnout Payment amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Closing Company Share Number.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">171.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Upfront Merger Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a) the Closing Merger Consideration Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Closing Company Share Number.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">172.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Permitted Encumbrances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean&#58; (a) statutory liens for current Taxes or other governmental charges (i) not yet delinquent or (ii) the amount or validity of which is being contested in good faith by appropriate proceedings by the Company and for which appropriate reserves have been established in accordance with GAAP&#59; (b) mechanics&#8217;, carriers&#8217;, workers&#8217;, repairers&#8217; and similar statutory liens arising or incurred in the ordinary course of business for amounts that are not delinquent and that are not, individually or in the aggregate, material in amount or effect on the Company, unless being contested in good faith by appropriate proceedings and for which adequate accruals or reserves have been established&#59; (c) zoning, entitlement, building and other land use regulations or ordinances imposed by Governmental Bodies having jurisdiction over the Leased Real Property that are not violated by the current use and operation of the Leased Real Property&#59; (d) covenants, conditions, restrictions, easements and other similar matters of record affecting title to the Leased Real Property that do not materially impair the occupancy or use of the Leased Real Property for the purposes for which it is currently used or proposed to be used in connection with the Company&#8217;s business&#59; (e) public roads and highways&#59; (f) matters that would be disclosed by an inspection, a current title commitment, or accurate survey of each parcel of real property&#59; (g) liens arising under worker&#8217;s compensation, unemployment insurance, social security, retirement and similar legislation&#59; (h) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">title to any portion of the premises lying within the right of way or boundary of any public road or private road which, individually or in the aggregate, do not materially adversely affect the value or the continued use of the Leased Real Property&#59; and (i) leases or subleases and licenses or sublicenses granted pursuant to Material Contracts entered in the ordinary course of business prior to the date of this Agreement and which have been made available to Parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">173.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any individual, Entity or Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">174.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Personally Identifiable Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (a) any information that alone or in combination with other information can be used to specifically identify an individual person, device or browser, (b) any individually identifiable health information, and (c) any other information whose collection, use, transfer, disclosure or other exploitation is protected by applicable Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Post-Closing Tax Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any taxable period (or portion thereof) beginning after the Closing Date, including the portion of the Straddle Period beginning after the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">175.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">176.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the U.S. Small Business Administration Paycheck Protection Program Note, dated April 21, 2020, by and between the Company and Silicon Valley Bank</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">177.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Deductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9(b)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">178.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Escrow Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">179.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan Escrow Funding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">180.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pre-Closing Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Access</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">181.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pre-Closing Tax Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any taxable period (or portion thereof) ending on or before the Closing Date, including the Closing Date, including the portion of the Straddle Period ending on and including the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">182.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $750,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">183.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price Escrow Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, that portion of the Escrow Fund equal to the Purchase Price Escrow Amount, as such fund may be decreased from time to time pursuant to this Agreement and the Escrow Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">184.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Qualified Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, as of the date of determination, a company that (i) has a market capitalization or shareholders&#8217; equity of not less than $5,000,000,000 and (ii) in the good faith judgment of Parent, is capable of assuming and performing the obligations of Parent under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">185.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Real Property Leases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Real Property&#59; Leasehold</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">186.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.9(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">187.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Reference Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a) if Closing occurs on December 31, 2020, 11.59 p.m. New York time, on the Closing Date and (b) in all other cases, 12&#58;01 a.m., New York time, on the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Reference Time for purposes of calculating Tax liabilities included in Closing Date Net Working Capital shall be 11&#58;59 p.m., New York time, on the Closing Date</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">188.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Registered IP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean all Intellectual Property that is registered, filed, or issued under the authority of any Governmental Body or Internet domain name registrar, including all patents, registered copyrights, registered mask works, registered trademarks, Internet domain names, and all applications for any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">189.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Required Company Stockholder Vote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Vote Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">190.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Retention Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount equal to fifty percent (50%) of the R&#38;W Insurance Retention Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">191.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Retention Escrow Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, that portion of the Escrow Fund equal to the Retention Escrow Amount, as such fund may be decreased from time to time pursuant to this Agreement and the Escrow Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">192.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">R&#38;W Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">R&#38;W Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">193.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">R&#38;W Insurance Retention Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $4,500,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">194.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Compliance with Laws&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Export Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">195.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholder Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification of Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">196.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.35pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean each holder of Company Capital Stock, and each holder of Company Options, each as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">197.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">198.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Engagement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">199.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">200.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">201.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Securityholders&#8217; Representative Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Securityholders&#8217; Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">202.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sellers Employer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean in respect of any payment pursuant to this Agreement (a) to be made to any Person who is at the time of such payment no longer employed by the Surviving Corporation or any of its Affiliates, the entire employer portion of Taxes payable in relation to such Person and (b) in respect of any other Person, the employer portion of Taxes that would have been payable in relation to such Person if such payment had been made on December 31 of the year in which such amounts are paid (calculated assuming the Person remains employed as of such December 31 date and the Tax laws in effect as of the time of the payment will be in effect as of such December 31 date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">203.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series A Convertible Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series A Convertible Preferred Stock, $0.001 par value per share, of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">204.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series B Convertible Preferred Stock, $0.001 par value per share, of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">205.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series C Convertible Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series C Convertible Preferred Stock, $0.001 par value per share, of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">206.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series D Convertible Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series D Convertible Preferred Stock, $0.001 par value per share, of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">207.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Settlement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) the set of agreements including, without limitation, the executed plea agreement, originally dated April 16, 2019, between the United States of America acting through the United States Attorney&#8217;s Office for the District of Maryland and the United States Department of Justice Consumer Protection Branch and the Company, and the attachments thereto including, without limitation, &#8220;Attachment A Statement of Facts &#8211; ACell, Inc.&#59;&#8221; Attachment B, which is entitled &#8220;Settlement Agreement&#8221; between the United States Department of Justice on behalf of the Office of Inspector General of the Department of Human Services on behalf of the TRICARE Program and the United States Department of Veteran </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Affairs, the Company, John Murtaugh and Ali Mahdavi dated May 19, 2019, including the Corporate Integrity Agreement between the Office of Inspector General of the United States Department of Health and Human Services, as referenced in Paragraph 8 therein&#59; and &#8220;Attachment C Compliance Program and Certifications&#8221; and (ii) the settlement agreements between the Company and the State of Florida, executed on May 13, 2019&#59; the Company and the State of Maryland, executed on May 13, 2019&#59; the Company and the State of Wisconsin, executed on May 13, 2019. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">208.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Settlement Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the total amount payable at any time in respect of the Settlement Agreements. For the avoidance of doubt, the actual costs of ongoing compliance by the Company with the Settlement Agreements shall not be deemed to be Settlement Debt. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">209.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the amounts set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">210.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Shortfall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.11(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Merger Consideration Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">211.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Significant Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Customer and Supplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">212.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Significant Supplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.25(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Customer and Supplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">213.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Indemnity Losses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">214.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $2,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">215.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Escrow Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, that portion of the Escrow Fund equal to the Special Escrow Amount, as such fund may be decreased from time to time pursuant to this Agreement and the Escrow Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">216.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Specified Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the following Persons&#58;  Scott Carter and Angie Nauman.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">217.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Specified Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the representations and warranties set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Due Incorporation&#59; Subsidiaries&#59; Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;2.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (first sentence only) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Capitalization, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Authority&#59; Binding Nature of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Advisor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Step-Down Release Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $1,500,000 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> any amounts of the Retention Escrow Fund that have been paid to Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean holders of Company Common Stock and Company Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">218.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Straddle Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any taxable period beginning on or before and ending after the Closing Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">219.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any Person, any partnership, limited liability company, corporation or other business entity of which (a) if a corporation, a majority of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, limited liability company or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">220.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Support Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the recitals to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">221.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Merger of Merger Sub into the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">222.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Takeover Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any proposal or offer from any Person (other than Parent or its Affiliates or their respective representatives) for any acquisition by such Person of a material amount of the assets of the Company (other than an acquisition of assets of the Company in the ordinary course of business consistent with past practice or as expressly permitted under the terms of this Agreement) or an acquisition, directly or indirectly of more than 50% of the total voting securities of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">223.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Takeover Statute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Takeover Statutes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">224.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Target Net Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount equal to $14,460,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">225.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean all federal, state or local and all foreign taxes of any kind whatsoever, including income, gross receipts, goods and services, windfall profits, value added, severance, property, production, sales, use, duty, license, excise, franchise, employment, withholding or similar taxes, together with any interest, additions or penalties with respect thereto and any interest with respect to such additions or penalties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">226.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any return, statement, report, tax filing or form (including estimated Tax returns and reports, withholding Tax returns and reports, any schedule or attachment, and information returns and reports), including any amendments, filed or required to be filed with a Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">227.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Terminated Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Payoff Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">228.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Third Person Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">229.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Third Person Claim Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Third Person Claim Indemnification Mechanics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">230.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Trade Secrets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the definition of &#8220;Intellectual Property&#8221; in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">231.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transaction Deductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all items of loss or deduction to the extent permitted by applicable Law to be deducted against income Taxes in 2020 or 2021 resulting from or attributable to&#58; (a) the exercise or cash out of Company Options, (b) the payment of severance, bonuses or other compensatory payments made in connection with the transactions contemplated by this Agreement&#59; (c) Closing Date Transaction Expenses&#59; (d) any fees, expenses, premiums and penalties with respect to the prepayment of debt and the write-off of the amortization of deferred financing, in each case with respect to Terminated Indebtedness or Settlement Debt&#59; or (e) any liabilities included in Closing Date Net Working Capital or Closing Date Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">232.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means this Agreement, the Escrow Agreement and the other documents, agreements, certificates and other instruments to be executed, delivered and performed by the parties hereto in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">233.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the recitals to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">234.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any sales, use, value added, transfer, stamp, registration, documentary, excise, real property transfer or gain, or similar non-income Taxes incurred as a result of the transactions contemplated in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">235.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Balance Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Update Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Earnout Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">236.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upfront Payment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">the Closing Merger Consideration Amount&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:21.35pt">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the aggregate Closing Options Payout Amount payable to Employee Option Holders in respect of Employee Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">237.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upfront Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $300,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">238.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">USPTO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">239.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Waived 280G Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">240.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Willful Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an act or omission that constitutes a breach of a covenant contained in this Agreement (or in the case of a Participating Securityholder, any agreement to which such Participating Securityholder is a party) and that was taken or omitted to be taken for the purpose of breaching such covenant and was not merely a volitional action or omission but does not require malicious or tortious intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">241.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Withholding Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">242.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.13
<SEQUENCE>3
<FILENAME>iart-20201231xexx413.htm
<DESCRIPTION>EX-4.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id51aa78468ad4df68d6884f954bb4bfa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 4.13</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Company&#8217;s Common Stock Registered</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:8pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the common stock of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;). The description does not purport to be complete and is subject to and qualified in its entirety by reference to the Company&#8217;s amended and restated certificate of incorporation and its amended and restated by-laws, each of which are filed as exhibits to this Annual Report on Form 10-K, and to the provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;).</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Matters</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Authorized Shares</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s authorized capital stock consists of 255,000,000 shares of stock, of which 240,000,000 shares are designated as common stock, par value $0.01 per share, and 15,000,000 shares are designated as preferred stock, no par value. As of December 31, 2020, we had 89,250,981 shares of common stock outstanding, 4,913,416 shares were designated as treasury stock, and no shares of preferred stock outstanding.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of common stock are entitled to receive dividends out of assets legally available therefor at such times and in such amounts as the board of directors may from time to time determine. However, our senior credit facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of our board of directors and will depend upon our financial condition, results of operations, cash flows and other factors that our board of directors deems relevant.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stockholder is entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder. Stockholders do not have cumulative voting rights. The Company&#8217;s board of directors is not classified and each director is elected annually. The voting standard for the election of directors is a majority of votes cast in uncontested elections. In contested elections where the number of nominees exceeds the number of directors to be elected, the vote standard is a plurality of the votes cast. Holders of a majority of the outstanding shares of common stock entitled to vote in any election of directors may elect all of the directors standing for election. </font></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preemptive or Similar Rights</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is not entitled to preemptive rights and is not subject to conversion or redemption.</font></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Right to Receive Liquidation Distributions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of a liquidation, dissolution or winding-up, the holders of shares of common stock would be entitled to share ratably in the distribution of all of our assets remaining available for distribution after satisfaction of all its liabilities and the payment of the liquidation preference of any outstanding preferred stock.</font></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Exchange</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;IART&#8221;. </font></div><div style="margin-bottom:8pt;margin-top:18pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Stock </font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors has the authority to issue up to 15,000,000 shares of Preferred Stock from time to time in one or more series and with such rights and preferences as determined by the Board with respect to each series. The issuance of preferred stock could have the effect of decreasing the market price of our common stock and could adversely affect the voting and other rights of holders of common stock. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Delaware Law </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of Section&#160;203 of the DGCL. Under Section&#160;203, we would generally be prohibited from engaging in any business combination with any interested stockholder for a period of three years following the time that this stockholder became an interested stockholder unless&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to this time, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon consummation of the transaction that resulted in the stockholder&#8217;s becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by persons who are directors and also officers, and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at or subsequent to such time, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8260;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% of the outstanding voting stock that is not owned by the interested stockholder.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section&#160;203, a &#8220;business combination&#8221; includes&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any merger or consolidation involving the corporation and the interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder, subject to limited exceptions&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, Section&#160;203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person. </font></div><div style="margin-bottom:8pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>iart-20201231xexx21.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i35badd657ade4c5ba4b17d56347c6c38_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries of Integra LifeSciences Holdings Corporation</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.939%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">State or Country of Incorporation or Organization</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Arkis Biosciences Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ascension Orthopedics Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ascension Orthopedics, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BIMECO, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioD, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioDlogics, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BioRecovery, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CardioDyne, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cathtec, Incorporated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Caveangle Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Confluent Surgical, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma First Aid Products, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences Canada, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences Europe, Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derma Sciences, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EndoSolutions, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fiber Imaging Technologies, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GMS, Gesellschaft f&#252;r medizinische Sondentechnik mbH</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Financing (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Financing Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ILS Services Switzerland Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">INS Sweden AB</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sweden</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Burlington MA, Inc. (formerly known as Integra Radionics, Inc.)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Canada ULC (formerly known as Canada Microsurgical ULC)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra CI, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cayman Islands</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Euro Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra France Holdings SAS</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra German Holdings GmbH</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra GmbH</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Japan K.K.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Canada) Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences (Shanghai) Co., Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Austria GmbH</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Austria</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Brazil Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Italy S.r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Middle East FZ-LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dubai</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences NR Ireland Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Production Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Sales LLC (f&#47;k&#47;a Integra Healthcare Products LLC)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Services (France) SAS</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Shared Services (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Singapore Pte. Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Spain, S.L.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LifeSciences Switzerland S&#225;rl</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LS (Benelux) NV</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra LS Mexico, S. DE R. L. DE C.V.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Luxtec, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra ME GmbH</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra MicroFrance SAS</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences (International), Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings (UK)&#160;Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings B.V.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Implants (France) SAS </font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra NeuroSciences Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (AUS)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (NZ)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New Zealand</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Receivables LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Sales, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra Selector Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integra York PA, Inc. (formerly known as Miltex, Inc.)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Integrated Shoulder Collaboration, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IsoTis NV</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IsoTis T.E. Facility B.V.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">J. Jamner Surgical Instruments, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jarit GmbH</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">LXU Healthcare, Inc. - Medical Specialty Products</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedEfficiency, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minnesota Scientific, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nantong Derma Medical Products Co., Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Newdeal SAS</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Newdeal, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Holding Corp.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Internacional, S.A. de C.V.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precise Dental Products, Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Precision Dental International, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rebound Therapeutics Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spembly Cryosurgery Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spembly Medical Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tarsus Medical Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Biosciences (UK) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Biosciences Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TEI Medical Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGX Medical Systems, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>iart-20201231xexx23.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i81b11a595df84d758b5acccc566be5a2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23 </font></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We hereby consent to the incorporation by reference in the Registration Statements on Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">S-8 (Nos.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">333-231709, 333-221210, 333-216212, 333-170210, 333-155263, 333-127488, 333-109042, 333-73512, 333-46024, 333-82233 333-58235, and 333-06577) of Integra LifeSciences Holdings Corporation of our report dated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> February&#160;23, 2021 relating to the financial statements, financial statement schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Florham Park, New Jersey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>iart-20201231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3e4744feb18d4ab285fb587fa142f632_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter J. Arduini, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13 a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:4.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>iart-20201231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ife64b372812d47c0a5036cd1c29201a5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carrie L. Anderson, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13 a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:4.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.128%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>iart-20201231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibc5c79222aab4006bedbb4c59e49729c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter J. Arduini, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2020 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:4.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>iart-20201231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3ac4f4c95fb24e56b1af809ad5cbf4d6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carrie L. Anderson, Executive Vice President, Chief Financial Officer and Treasurer of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2020 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Anderson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>iart-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESS" roleURI="http://integralife.com/role/BUSINESS">
        <link:definition>2101101 - Disclosure - BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ASSETSANDLIABILITIESHELDFORSALE" roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE">
        <link:definition>2108103 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ASSETSANDLIABILITIESHELDFORSALETables" roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables">
        <link:definition>2309302 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails">
        <link:definition>2410404 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails">
        <link:definition>2411405 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERS" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS">
        <link:definition>2112104 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSTables" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables">
        <link:definition>2313303 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails">
        <link:definition>2414406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
        <link:definition>2415407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
        <link:definition>2415407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails">
        <link:definition>2416408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
        <link:definition>2417409 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONS" roleURI="http://integralife.com/role/ACQUISITIONS">
        <link:definition>2118105 - Disclosure - ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSTables" roleURI="http://integralife.com/role/ACQUISITIONSTables">
        <link:definition>2319304 - Disclosure - ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSBusinessAcquisitionNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails">
        <link:definition>2420410 - Disclosure - ACQUISITIONS (Business Acquisition, Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2421411 - Disclosure - ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSAssetAcquisitionNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails">
        <link:definition>2422412 - Disclosure - ACQUISITIONS (Asset Acquisition, Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://integralife.com/role/DEBT">
        <link:definition>2123106 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://integralife.com/role/DEBTTables">
        <link:definition>2324305 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://integralife.com/role/DEBTNarrativeDetails">
        <link:definition>2425413 - Disclosure - DEBT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaximumTotalLeverageRatioTableDetails" roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails">
        <link:definition>2426414 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtMaturityDetails" roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails">
        <link:definition>2427415 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTS" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS">
        <link:definition>2128107 - Disclosure - DERIVATIVE INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSTables" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables">
        <link:definition>2329306 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
        <link:definition>2430416 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSNarrativeDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails">
        <link:definition>2431417 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
        <link:definition>2432418 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
        <link:definition>2433419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
        <link:definition>2434420 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
        <link:definition>2435421 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2136108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2337307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>2438422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2439423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
        <link:definition>2440424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCK" roleURI="http://integralife.com/role/TREASURYSTOCK">
        <link:definition>2141109 - Disclosure - TREASURY STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCKNarrativeDetails" roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails">
        <link:definition>2442425 - Disclosure - TREASURY STOCK - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2143110 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2344308 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
        <link:definition>2445426 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2446427 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails">
        <link:definition>2447428 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails">
        <link:definition>2448429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
        <link:definition>2449430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANS" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS">
        <link:definition>2150111 - Disclosure - RETIREMENT BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSTables" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables">
        <link:definition>2351309 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails">
        <link:definition>2452431 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails">
        <link:definition>2453432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails">
        <link:definition>2454433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails">
        <link:definition>2455434 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSNarrativeDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails">
        <link:definition>2456435 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails">
        <link:definition>2457436 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASES" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES">
        <link:definition>2158112 - Disclosure - LEASES AND RELATED PARTY LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESTables" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables">
        <link:definition>2359310 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESNarrativeDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails">
        <link:definition>2460437 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>2461438 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails">
        <link:definition>2462439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
        <link:definition>2463440 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails">
        <link:definition>2464441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://integralife.com/role/INCOMETAXES">
        <link:definition>2165113 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://integralife.com/role/INCOMETAXESTables">
        <link:definition>2366311 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails">
        <link:definition>2467442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2468443 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails">
        <link:definition>2469444 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>2470445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2471446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails">
        <link:definition>2472447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://integralife.com/role/NETINCOMEPERSHARE">
        <link:definition>2173114 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://integralife.com/role/NETINCOMEPERSHARETables">
        <link:definition>2374312 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails">
        <link:definition>2475448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENarrativeDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails">
        <link:definition>2476449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>2177115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>2378313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2479450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails">
        <link:definition>2480451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2181116 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>2382314 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails">
        <link:definition>2483452 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATION" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION">
        <link:definition>2184117 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTables" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables">
        <link:definition>2385315 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
        <link:definition>2486453 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
        <link:definition>2487454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
        <link:definition>2488455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://integralife.com/role/SUBSEQUENTEVENTS">
        <link:definition>2189118 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSNarrativeDetails" roleURI="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails">
        <link:definition>2490456 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELECTEDQUARTERLYINFORMATIONUNAUDITED" roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED">
        <link:definition>2191119 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables">
        <link:definition>2392316 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails">
        <link:definition>2493457 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>2194120 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>2495458 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" abstract="false" name="AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" abstract="false" name="NoncashOrPartNoncashInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SwapTwoMember" abstract="true" name="SwapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" abstract="false" name="AcquiredFinitelivedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" abstract="false" name="AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SupplierRelationShipsMember" abstract="true" name="SupplierRelationShipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SecuritizationFacilityFairValueOfAmountOutstanding" abstract="false" name="SecuritizationFacilityFairValueOfAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_NeurosurgeryMember" abstract="true" name="NeurosurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ScheduleOfAssetAcquisitionTable" abstract="true" name="ScheduleOfAssetAcquisitionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_RegenerativeSkinAndWoundMember" abstract="true" name="RegenerativeSkinAndWoundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche5Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod1Member" abstract="true" name="DebtCovenantPeriod1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche3Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SeniorCreditFacilityMember" abstract="true" name="SeniorCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SwinglineLoanMember" abstract="true" name="SwinglineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractSixMember" abstract="true" name="CrossCurrencyInterestRateContractSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DermaSciencesMember" abstract="true" name="DermaSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ThreeMonthUSDLIBORMember" abstract="true" name="ThreeMonthUSDLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InformationSystemsandHardwareMember" abstract="true" name="InformationSystemsandHardwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_OneMonthEurodollarRateMember" abstract="true" name="OneMonthEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SurgicalInstrumentKitsMember" abstract="true" name="SurgicalInstrumentKitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AdditionalEPSShares" abstract="false" name="AdditionalEPSShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DeferredTaxAssetMember" abstract="true" name="DeferredTaxAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" abstract="false" name="AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_MilestonePaymentTwoMember" abstract="true" name="MilestonePaymentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" abstract="false" name="BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_AssetAcquisitionConsiderationTransferred" abstract="false" name="AssetAcquisitionConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractFourMember" abstract="true" name="CrossCurrencyInterestRateContractFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_MilestonePaymentOneMember" abstract="true" name="MilestonePaymentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CharitableContributions" abstract="false" name="CharitableContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iart_ACellIncMember" abstract="true" name="ACellIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_OneMonthUSDLIBORMember" abstract="true" name="OneMonthUSDLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" abstract="true" name="ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" abstract="false" name="ContractWithCustomerAssetNetOfReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" abstract="false" name="AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InventoryCapitalizedExpenses" abstract="false" name="InventoryCapitalizedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtWeightedAverageInterestRateFromSecuritization" abstract="false" name="DebtWeightedAverageInterestRateFromSecuritization" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_CertainPurchasersMember" abstract="true" name="CertainPurchasersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractTwoMember" abstract="true" name="CrossCurrencyInterestRateContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramCurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_UpThroughTaxYear2025Member" abstract="true" name="UpThroughTaxYear2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_PaymentsForProceedsFromBusinessAcquisitions" abstract="false" name="PaymentsForProceedsFromBusinessAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="iart_RevenueProductWarrantyPeriod" abstract="false" name="RevenueProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_ConsortiumofFocusedOrthopedistsLLCMember" abstract="true" name="ConsortiumofFocusedOrthopedistsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" abstract="true" name="UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_SwapFourMember" abstract="true" name="SwapFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_TrademarksBrandNamesMember" abstract="true" name="TrademarksBrandNamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_TwoThousandThreePlanMember" abstract="true" name="TwoThousandThreePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_PaymentsForOptionIndexToIssuersEquity" abstract="false" name="PaymentsForOptionIndexToIssuersEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" abstract="false" name="DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche4Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AllOtherMember" abstract="true" name="AllOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" abstract="true" name="InterestRateSwapDesignatedFebruary62017Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_RestrictedStockPerformanceStockAndContractStockMember" abstract="true" name="RestrictedStockPerformanceStockAndContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_AccumulatedOtherComprehensiveIncomeLossRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CodmanMember" abstract="true" name="CodmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" abstract="false" name="CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" abstract="false" name="IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_SmithNephewUSDLimitedMember" abstract="true" name="SmithNephewUSDLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" abstract="false" name="RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche3Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractOneMember" abstract="true" name="CrossCurrencyInterestRateContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ReboundTherapeuticsCorporationMember" abstract="true" name="ReboundTherapeuticsCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_IntangibleAssetsAbstract" abstract="true" name="IntangibleAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" abstract="true" name="UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" abstract="false" name="DefinedBenefitPlanPlanAssetsPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" abstract="false" name="AssetAcquisitionDevelopmentMilestonePaymentToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ExtremityOrthopedicsMember" abstract="true" name="ExtremityOrthopedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CompletedTechnologyMember" abstract="true" name="CompletedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_PrivateLabelMember" abstract="true" name="PrivateLabelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" abstract="false" name="GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractFiveMember" abstract="true" name="CrossCurrencyInterestRateContractFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ConcentrationRiskNumberofCustomersOverBenchmark" abstract="false" name="ConcentrationRiskNumberofCustomersOverBenchmark" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_RelatedPartiesMember" abstract="true" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DirectorsandCertainExecutiveOfficersMember" abstract="true" name="DirectorsandCertainExecutiveOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" abstract="false" name="UnrecognizedTaxBenefitsReductionsResultingFromOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumAverageConversionValueOfNotes" abstract="false" name="DebtInstrumentMaximumAverageConversionValueOfNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" abstract="false" name="TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_FoundationPolicyTextBlock" abstract="false" name="FoundationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="iart_EmployeeStockPurchasePlanProceeds" abstract="false" name="EmployeeStockPurchasePlanProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CodmanSpecialtySurgicalMember" abstract="true" name="CodmanSpecialtySurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractThreeMember" abstract="true" name="CrossCurrencyInterestRateContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_FiveYearLeasePeriodTwoMember" abstract="true" name="FiveYearLeasePeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" abstract="false" name="AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandPlanAndTwoThousandOnePlanMember" abstract="true" name="TwoThousandPlanAndTwoThousandOnePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="iart_SegmentReportingInformationNumberOfProductsOffered" abstract="false" name="SegmentReportingInformationNumberOfProductsOffered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" abstract="false" name="IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_OrthopedicsandTissueTechnologiesMember" abstract="true" name="OrthopedicsandTissueTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche3Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" abstract="false" name="PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ScheduleOfAssetAcquisitionLineItems" abstract="true" name="ScheduleOfAssetAcquisitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_PerformanceSharesandRestrictedUnitsMember" abstract="true" name="PerformanceSharesandRestrictedUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod3Member" abstract="true" name="DebtCovenantPeriod3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" abstract="false" name="EffectiveWorldwideIncomeTaxRateReconciliationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_PerformanceStockandContractStockMember" abstract="true" name="PerformanceStockandContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" abstract="false" name="PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" abstract="false" name="EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandPlanMember" abstract="true" name="TwoThousandPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche4Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ThirdPartiesMember" abstract="true" name="ThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_FiveYearOptionLeasePeriodOneMember" abstract="true" name="FiveYearOptionLeasePeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" abstract="true" name="InterestRateSwapDesignatedFebruary62017Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedMarch272017Member" abstract="true" name="InterestRateSwapDesignatedMarch272017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" abstract="false" name="DefinedBenefitPlanBenefitObligationPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_AssetAcquisitionNumberOfAssetsAcquired" abstract="false" name="AssetAcquisitionNumberOfAssetsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" abstract="false" name="IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_OptionToExtendLeaseYears" abstract="false" name="OptionToExtendLeaseYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_AnnualRateOfLeaseAgreement" abstract="false" name="AnnualRateOfLeaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" abstract="false" name="ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DeferredTaxLiabilitiesLeasesAndOther" abstract="false" name="DeferredTaxLiabilitiesLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_SwapOneMember" abstract="true" name="SwapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" abstract="false" name="AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_ArkisBioSciencesInc.Member" abstract="true" name="ArkisBioSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_TwoThousandOnePlanMember" abstract="true" name="TwoThousandOnePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SwapThreeMember" abstract="true" name="SwapThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" abstract="false" name="DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriod4Member" abstract="true" name="DebtCovenantPeriod4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeTableTextBlock" abstract="false" name="CashFlowLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="iart_DebtCovenantPeriod2Member" abstract="true" name="DebtCovenantPeriod2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_IncreaseInAuthorizedShares" abstract="false" name="IncreaseInAuthorizedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DebtAccountsReceivableSecuritizationTerm" abstract="false" name="DebtAccountsReceivableSecuritizationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DeferredTaxAssetsLeasesAndOther" abstract="false" name="DeferredTaxAssetsLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" abstract="true" name="TwoThousandTwentyFiveSeniorConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AustriaFranceAndGermanyMember" abstract="true" name="AustriaFranceAndGermanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche5Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_IntegratedShoulderCollaborationInc.Member" abstract="true" name="IntegratedShoulderCollaborationInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" abstract="false" name="DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>iart-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20201231.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15cc1e28-2f8a-4864-bf5c-29607caa2f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b977fed7-0204-453a-850a-2b87050556df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15cc1e28-2f8a-4864-bf5c-29607caa2f32" xlink:to="loc_us-gaap_OperatingIncomeLoss_b977fed7-0204-453a-850a-2b87050556df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_47219dbf-7f82-43af-bd15-5eb6d315dc7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15cc1e28-2f8a-4864-bf5c-29607caa2f32" xlink:to="loc_us-gaap_InvestmentIncomeInterest_47219dbf-7f82-43af-bd15-5eb6d315dc7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_937027ee-5b39-4c91-bc95-84a7f78494fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15cc1e28-2f8a-4864-bf5c-29607caa2f32" xlink:to="loc_us-gaap_InterestExpense_937027ee-5b39-4c91-bc95-84a7f78494fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1f2e8568-2350-494a-9c34-53499a5eb1ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15cc1e28-2f8a-4864-bf5c-29607caa2f32" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1f2e8568-2350-494a-9c34-53499a5eb1ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_510af11c-8e69-41fa-81cd-ffc4ec3b8eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_510af11c-8e69-41fa-81cd-ffc4ec3b8eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7e4f865d-0f9c-4ecc-a85b-832c926a1623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7e4f865d-0f9c-4ecc-a85b-832c926a1623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_5b9576f4-afcb-45b1-b143-2fce245e693a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_5b9576f4-afcb-45b1-b143-2fce245e693a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3c0de0c7-bb0b-4daf-9f64-874d825cdc5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3c0de0c7-bb0b-4daf-9f64-874d825cdc5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2435c551-ce29-4fa4-8ab3-c2d7ad3d9c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_43921279-9e2f-4a16-a7d0-6f34f2773952" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2435c551-ce29-4fa4-8ab3-c2d7ad3d9c12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_706baa87-1077-4f4a-a394-7d4d43a164e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_899b8ca8-f1e2-4455-9282-d501b30e5f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_706baa87-1077-4f4a-a394-7d4d43a164e3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_899b8ca8-f1e2-4455-9282-d501b30e5f58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_955a3704-450b-4974-aa9a-f5065a43f096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_706baa87-1077-4f4a-a394-7d4d43a164e3" xlink:to="loc_us-gaap_CostsAndExpenses_955a3704-450b-4974-aa9a-f5065a43f096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_589599c4-7d7c-41af-9aba-89191d299df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b21e4e0b-33c9-483f-9028-4bc301c7cccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_589599c4-7d7c-41af-9aba-89191d299df1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b21e4e0b-33c9-483f-9028-4bc301c7cccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b8d4120e-11a0-4c36-af2e-c0c48f3fd7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_589599c4-7d7c-41af-9aba-89191d299df1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b8d4120e-11a0-4c36-af2e-c0c48f3fd7ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_88a94ea7-e683-4727-887b-b73a7c0b34fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_59e11f58-5027-430b-8cd0-e6ec0538c0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_88a94ea7-e683-4727-887b-b73a7c0b34fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_59e11f58-5027-430b-8cd0-e6ec0538c0d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_ab616ada-cece-4b8a-8759-993d60673b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_88a94ea7-e683-4727-887b-b73a7c0b34fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_ab616ada-cece-4b8a-8759-993d60673b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ee3a8b7e-bf7d-499d-94b9-011e95271fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_88a94ea7-e683-4727-887b-b73a7c0b34fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ee3a8b7e-bf7d-499d-94b9-011e95271fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1cfb4da-2412-4baa-b73a-00b5479336eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4bc7855c-28c2-4e7f-ac14-fe79688d73e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1cfb4da-2412-4baa-b73a-00b5479336eb" xlink:to="loc_us-gaap_NetIncomeLoss_4bc7855c-28c2-4e7f-ac14-fe79688d73e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_232f928e-031b-4e68-bf45-5e8d1e25c69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1cfb4da-2412-4baa-b73a-00b5479336eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_232f928e-031b-4e68-bf45-5e8d1e25c69e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05ae2d1e-ef82-4d46-aa06-218a25f52cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_e2f8d5da-0275-49c8-8906-7fa4a4f47b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05ae2d1e-ef82-4d46-aa06-218a25f52cc1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_e2f8d5da-0275-49c8-8906-7fa4a4f47b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_7dace161-2910-4e9e-8535-5265b5ffbfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05ae2d1e-ef82-4d46-aa06-218a25f52cc1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_7dace161-2910-4e9e-8535-5265b5ffbfa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d14a7503-0e39-420f-959d-452c795916c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7b5dd5f-525c-408c-9d97-82e0b09f173f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d14a7503-0e39-420f-959d-452c795916c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7b5dd5f-525c-408c-9d97-82e0b09f173f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_d10830f4-4ba1-4177-9dbb-80460cac2d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d14a7503-0e39-420f-959d-452c795916c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_d10830f4-4ba1-4177-9dbb-80460cac2d3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_56f5b18f-cae4-4c9a-bff5-839724925733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_AssetsCurrent_56f5b18f-cae4-4c9a-bff5-839724925733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_15b6ea4b-9ab4-4af2-81d8-60837c2f7f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_15b6ea4b-9ab4-4af2-81d8-60837c2f7f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7b1ef448-0331-4249-876d-49e54c924686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7b1ef448-0331-4249-876d-49e54c924686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_21edf47b-4370-4b5f-b6da-036a7908a014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_21edf47b-4370-4b5f-b6da-036a7908a014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6fdf430e-63f7-428e-9853-2652642e374e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_Goodwill_6fdf430e-63f7-428e-9853-2652642e374e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_a6c15a53-b277-4464-af2b-a2ab5c56e492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_a6c15a53-b277-4464-af2b-a2ab5c56e492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1bd5cc21-d50b-4f44-afb2-63dc8d49f445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_72f25927-7dea-488d-9c9a-d82ab6906820" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1bd5cc21-d50b-4f44-afb2-63dc8d49f445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_2097cc03-511e-4f95-9e14-99793cbb7f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_SecuredDebtCurrent_2097cc03-511e-4f95-9e14-99793cbb7f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_9d2efe5d-a80c-4b58-95e9-53fc17a2be6b" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_9d2efe5d-a80c-4b58-95e9-53fc17a2be6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2765be11-7c5f-4d79-87fa-664f855f47c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2765be11-7c5f-4d79-87fa-664f855f47c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_60489c96-6ad7-4313-9ff6-7d5133a6f069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_60489c96-6ad7-4313-9ff6-7d5133a6f069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_13d15238-280c-4ec8-a439-e877625081f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_13d15238-280c-4ec8-a439-e877625081f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0f24357d-fab9-405c-8e75-d5bfad5de680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0f24357d-fab9-405c-8e75-d5bfad5de680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a5b1b197-b2a1-4783-ad07-8f9ad9ed7c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a5b1b197-b2a1-4783-ad07-8f9ad9ed7c89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3a647d96-eb64-48bd-a2ec-c5e86c2e9ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df53f9fd-6e01-4920-a782-e8e2d8f8d2be" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3a647d96-eb64-48bd-a2ec-c5e86c2e9ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3a3455ec-adf2-4f6c-98ff-9b7931e9c85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_PreferredStockValue_3a3455ec-adf2-4f6c-98ff-9b7931e9c85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_306fe987-fcdd-4898-a49f-ebfdc620266a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_CommonStockValue_306fe987-fcdd-4898-a49f-ebfdc620266a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b1a4d7b0-c321-4432-bff6-ebf98241ea33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b1a4d7b0-c321-4432-bff6-ebf98241ea33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_290648ed-f0d7-4c88-a2d8-5d81829cd46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_TreasuryStockValue_290648ed-f0d7-4c88-a2d8-5d81829cd46d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31b31106-4d56-4e45-ae1f-a2e6bc5d86b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31b31106-4d56-4e45-ae1f-a2e6bc5d86b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a05b2bec-9a6a-4ee9-93d8-954d6014869b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e1e26b0-7858-427f-932e-4963bed186d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a05b2bec-9a6a-4ee9-93d8-954d6014869b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c46f795a-f6a0-4cdc-b8d5-4f2e63817ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_LiabilitiesCurrent_c46f795a-f6a0-4cdc-b8d5-4f2e63817ec0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_a429bad4-ff0b-4942-80e5-6d6f5514903c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_SecuredLongTermDebt_a429bad4-ff0b-4942-80e5-6d6f5514903c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_4d7ec43f-d031-42be-bf69-6b622357bedb" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_4d7ec43f-d031-42be-bf69-6b622357bedb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_7036d779-4351-4131-a43e-289bfae5aac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_7036d779-4351-4131-a43e-289bfae5aac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f48d928e-8a53-4184-99ed-734c6d52201d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f48d928e-8a53-4184-99ed-734c6d52201d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4c8107e2-728e-45b5-a0ce-69d118c7a57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4c8107e2-728e-45b5-a0ce-69d118c7a57a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_53b7ef84-9bc7-4890-b4af-1c2a8500c14e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ea0bf3a5-c943-431a-9aae-375282e92742" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_53b7ef84-9bc7-4890-b4af-1c2a8500c14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc02b019-d1f4-47a9-939e-3f11f1034b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_19ee8473-3273-4075-99ae-8efdf5ee390e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc02b019-d1f4-47a9-939e-3f11f1034b5c" xlink:to="loc_us-gaap_Liabilities_19ee8473-3273-4075-99ae-8efdf5ee390e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ab390781-b703-45f5-b3c6-a9261eec516c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc02b019-d1f4-47a9-939e-3f11f1034b5c" xlink:to="loc_us-gaap_StockholdersEquity_ab390781-b703-45f5-b3c6-a9261eec516c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e37fb11-0df3-4880-9fc7-0a5f20ad05ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e37fb11-0df3-4880-9fc7-0a5f20ad05ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7d214af8-cdff-4d00-acb5-a75fcf9d6920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7d214af8-cdff-4d00-acb5-a75fcf9d6920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6b83af31-fb2f-4655-ab5f-458351274ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:to="loc_us-gaap_InventoryNet_6b83af31-fb2f-4655-ab5f-458351274ada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4909b553-b600-4381-bf0f-706fed6a7cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4909b553-b600-4381-bf0f-706fed6a7cdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_004ba94e-dc09-439c-acb6-47fef3fcc14f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d7e227dc-481e-4f8d-bd67-7336791f9ef3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_004ba94e-dc09-439c-acb6-47fef3fcc14f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a78f797-696d-4d01-bc01-890c81d427e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2d54c509-34d1-4cd6-8fad-6560cb67fb2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a78f797-696d-4d01-bc01-890c81d427e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2d54c509-34d1-4cd6-8fad-6560cb67fb2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57a12df9-2422-4564-bfbe-ef0a3c5cb373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a78f797-696d-4d01-bc01-890c81d427e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57a12df9-2422-4564-bfbe-ef0a3c5cb373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7e59bb39-2ba3-49e1-88e4-a8f522834699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a78f797-696d-4d01-bc01-890c81d427e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7e59bb39-2ba3-49e1-88e4-a8f522834699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf531eb9-f452-41aa-b45d-df9df25fb057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a78f797-696d-4d01-bc01-890c81d427e8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf531eb9-f452-41aa-b45d-df9df25fb057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0473536-8ad2-455d-82fe-fbaf6ddb068c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0473536-8ad2-455d-82fe-fbaf6ddb068c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_1536a50c-228c-4981-b343-4fbf123d49fc" xlink:href="iart-20201231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_1536a50c-228c-4981-b343-4fbf123d49fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_b63d5e02-81e9-4ef5-af26-93fed0e13127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_b63d5e02-81e9-4ef5-af26-93fed0e13127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_f76d1dd2-7957-496d-954e-abed01d2dab4" xlink:href="iart-20201231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_f76d1dd2-7957-496d-954e-abed01d2dab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_00d09aea-973e-4df0-bb12-7a399456b0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_00d09aea-973e-4df0-bb12-7a399456b0e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_3df001ca-a53e-4685-8a1b-c1644ac98800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb420817-abb0-473e-ab5b-f42bfed1c6fd" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_3df001ca-a53e-4685-8a1b-c1644ac98800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_33ef8dbe-c16a-428f-aa55-493891b250ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_NetIncomeLoss_33ef8dbe-c16a-428f-aa55-493891b250ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_69fbb504-d1d7-411c-931e-85e0473fda59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_69fbb504-d1d7-411c-931e-85e0473fda59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_8d9eb5e7-6e07-40f3-a0ac-2427702a9014" xlink:href="iart-20201231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_8d9eb5e7-6e07-40f3-a0ac-2427702a9014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_9dbd52f3-05a4-43c6-aa87-01f07f04c907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_9dbd52f3-05a4-43c6-aa87-01f07f04c907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210501af-ede9-431d-8bf3-93d2a238ea58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210501af-ede9-431d-8bf3-93d2a238ea58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2f28b491-71a8-43d8-a41a-7e52611b9894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_ShareBasedCompensation_2f28b491-71a8-43d8-a41a-7e52611b9894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_d5a1d7eb-2305-4401-b333-92911b48bc39" xlink:href="iart-20201231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_d5a1d7eb-2305-4401-b333-92911b48bc39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_a33edc5d-64aa-43b9-9b23-d4d0d05181bd" xlink:href="iart-20201231.xsd#iart_NoncashLeaseExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_iart_NoncashLeaseExpense_a33edc5d-64aa-43b9-9b23-d4d0d05181bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_7880577b-e804-4f58-87b4-a88b31efd2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_AccretionExpense_7880577b-e804-4f58-87b4-a88b31efd2b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_468cd914-ce12-4db6-be18-85d2e9d55a34" xlink:href="iart-20201231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_468cd914-ce12-4db6-be18-85d2e9d55a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4572e73c-473c-4173-acb2-ba9257659095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4572e73c-473c-4173-acb2-ba9257659095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a6813fd4-cd3a-43bd-bd99-5ed2112d0071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a6813fd4-cd3a-43bd-bd99-5ed2112d0071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3ded72da-4c1a-4387-8cb7-48d17cee8927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3ded72da-4c1a-4387-8cb7-48d17cee8927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4279856a-4e13-4680-acb9-f312a0c8ef45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4279856a-4e13-4680-acb9-f312a0c8ef45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_22aa882d-2123-46e1-b463-e40331021a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_22aa882d-2123-46e1-b463-e40331021a45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94399085-a701-4fcb-bad1-e65bcd5ffc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94399085-a701-4fcb-bad1-e65bcd5ffc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_73615767-b9ec-4783-8c42-a14e0a15720b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_73615767-b9ec-4783-8c42-a14e0a15720b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1bb324ea-fb1e-4a3a-8df0-47e10f073c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a8a017dc-f7b8-42bc-821b-5271b2eac863" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1bb324ea-fb1e-4a3a-8df0-47e10f073c3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_fda281c1-4d8d-4307-9de5-b9fab54fbc23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_fda281c1-4d8d-4307-9de5-b9fab54fbc23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_be499e80-e3d9-44c6-889b-161230139b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_be499e80-e3d9-44c6-889b-161230139b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_2700ebd6-b10e-4ea6-8dfc-2b485ad7d101" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_2700ebd6-b10e-4ea6-8dfc-2b485ad7d101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_24e4c15c-bcee-4dc9-b11b-35fff41c6baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_24e4c15c-bcee-4dc9-b11b-35fff41c6baf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1dbbbe82-c650-41a9-b555-f20858c9742e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1dbbbe82-c650-41a9-b555-f20858c9742e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3a120978-1310-4c76-98d7-e18c92ae27a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3a120978-1310-4c76-98d7-e18c92ae27a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d8eff3ed-c8bb-4621-bd2c-3a8ed55af8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d8eff3ed-c8bb-4621-bd2c-3a8ed55af8b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6d3e1f2f-2b7f-4ae4-afce-da47e5660e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6d3e1f2f-2b7f-4ae4-afce-da47e5660e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d2ff4cee-c5da-42e2-9720-e334c3ff3a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d2ff4cee-c5da-42e2-9720-e334c3ff3a6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf560592-4065-4912-9d1a-c16b85875b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_cf560592-4065-4912-9d1a-c16b85875b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_232822e4-c196-42da-86bd-061612a42a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eb95efe-7c9f-449e-a3ab-27402b6d6589" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_232822e4-c196-42da-86bd-061612a42a17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/BUSINESS" xlink:type="simple" xlink:href="iart-20201231.xsd#BUSINESS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/BUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d8afae1b-28ee-4383-8219-4f5017212337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_110e0a80-940c-426c-be9a-62ecf8930fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d8afae1b-28ee-4383-8219-4f5017212337" xlink:to="loc_us-gaap_InventoryFinishedGoods_110e0a80-940c-426c-be9a-62ecf8930fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_f116a225-263d-41c9-87e5-d442e43ca09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d8afae1b-28ee-4383-8219-4f5017212337" xlink:to="loc_us-gaap_InventoryWorkInProcess_f116a225-263d-41c9-87e5-d442e43ca09c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_22cc7970-9cc1-4b50-837c-2eeeb4c7c05e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d8afae1b-28ee-4383-8219-4f5017212337" xlink:to="loc_us-gaap_InventoryRawMaterials_22cc7970-9cc1-4b50-837c-2eeeb4c7c05e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_05a87ece-bcc7-4820-b2bd-53d974cf2d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6af786dc-4227-45df-a724-8b856916cdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_05a87ece-bcc7-4820-b2bd-53d974cf2d9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6af786dc-4227-45df-a724-8b856916cdd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_014dc6ff-9cc0-46f5-bfbe-514b58fb73bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_05a87ece-bcc7-4820-b2bd-53d974cf2d9e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_014dc6ff-9cc0-46f5-bfbe-514b58fb73bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALE"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALETables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALENarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_09741d8f-0e46-424d-a2eb-ca0726f68768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_09741d8f-0e46-424d-a2eb-ca0726f68768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_ec73252b-1aae-4315-9a5e-9061a94cd56a" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_ec73252b-1aae-4315-9a5e-9061a94cd56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_36e1fdae-01e4-49c8-9272-bec563f38f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_36e1fdae-01e4-49c8-9272-bec563f38f67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4166bc85-cc88-49c1-af1e-6297349a5645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4166bc85-cc88-49c1-af1e-6297349a5645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0832eb11-c85d-429e-a6c5-6835833e2dc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0832eb11-c85d-429e-a6c5-6835833e2dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_98f43524-a9e4-48c2-91e0-143745f8f655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_98f43524-a9e4-48c2-91e0-143745f8f655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_8cd3b186-c6fa-4ab6-a951-4e510191c527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9f50bf76-902a-4df5-9afe-650a4f2635a5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_8cd3b186-c6fa-4ab6-a951-4e510191c527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_39262492-41ab-49f4-ae76-0a44355bede2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_39262492-41ab-49f4-ae76-0a44355bede2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_7bb932b5-e0f7-458c-9199-a7b820ccab21" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_7bb932b5-e0f7-458c-9199-a7b820ccab21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_1c88d424-36b3-45a6-9f1e-ab1a8872b068" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_1c88d424-36b3-45a6-9f1e-ab1a8872b068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_59b65f17-b62e-4106-88fb-929d5ff52f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_59b65f17-b62e-4106-88fb-929d5ff52f07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_b5097bdc-b004-4b6c-a6b8-11b3c55b06fc" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_85e4542b-42fa-47d3-8e70-300aaf92216c" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_b5097bdc-b004-4b6c-a6b8-11b3c55b06fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSBusinessAcquisitionNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_222f9d67-408f-4b73-b40e-1994afdb3233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_a64f4403-db38-4d1a-ba0c-302ed813cd46" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_222f9d67-408f-4b73-b40e-1994afdb3233" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_a64f4403-db38-4d1a-ba0c-302ed813cd46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_3f3b78fe-74ba-4d27-906f-70d3e3519284" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_222f9d67-408f-4b73-b40e-1994afdb3233" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_3f3b78fe-74ba-4d27-906f-70d3e3519284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3d02d978-ecd8-4bcf-b18e-f0a8d8c3a777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_222f9d67-408f-4b73-b40e-1994afdb3233" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3d02d978-ecd8-4bcf-b18e-f0a8d8c3a777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_27a36b44-d0f0-4b7b-8c55-9a6d53beec51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_222f9d67-408f-4b73-b40e-1994afdb3233" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_27a36b44-d0f0-4b7b-8c55-9a6d53beec51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d3511434-8cc2-421d-b40a-9d8ad7366ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d3511434-8cc2-421d-b40a-9d8ad7366ac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c1919792-74f1-4198-81ef-b4d59d8004b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c1919792-74f1-4198-81ef-b4d59d8004b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f2828995-0878-4788-ad17-7d91ce7a6389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f2828995-0878-4788-ad17-7d91ce7a6389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c5ac0e30-7d37-4045-ac41-46e481fc8712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c5ac0e30-7d37-4045-ac41-46e481fc8712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0d2c0df5-427a-4510-b82f-08dc21f6bef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0d2c0df5-427a-4510-b82f-08dc21f6bef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_862c3336-5648-4e68-b2f0-30482a34b1fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf00ec60-b34a-474a-94aa-7a01a0327e5d" xlink:to="loc_us-gaap_Goodwill_862c3336-5648-4e68-b2f0-30482a34b1fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSAssetAcquisitionNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBT"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8ca50132-4ea9-4f33-b933-00634ab4e246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8ca50132-4ea9-4f33-b933-00634ab4e246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_501209e0-e507-4091-8ac7-30a5210f93eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_501209e0-e507-4091-8ac7-30a5210f93eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_639235f1-f4fa-4692-a87c-30690335a5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_639235f1-f4fa-4692-a87c-30690335a5e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_815ea85e-3d3c-4f47-ab2e-9b0f241d3916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_815ea85e-3d3c-4f47-ab2e-9b0f241d3916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_129c0c92-90e5-47c0-aa3d-f2f3bced62ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a468cfa7-69df-44a2-9c83-38bf11ac5495" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_129c0c92-90e5-47c0-aa3d-f2f3bced62ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_19dbd937-0b6d-49f9-b192-68296058923e" xlink:href="iart-20201231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_5fac957c-c470-4611-8d37-3a84842f5746" xlink:href="iart-20201231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_19dbd937-0b6d-49f9-b192-68296058923e" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_5fac957c-c470-4611-8d37-3a84842f5746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5570d63e-a0ae-403f-abc8-d09c9d66cd32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_19dbd937-0b6d-49f9-b192-68296058923e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5570d63e-a0ae-403f-abc8-d09c9d66cd32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCK"/>
  <link:calculationLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_5f9fecd4-5823-476a-a9bb-e2d9cb601b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b7d08e7d-74c2-4a14-ac9e-850e14daa929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_5f9fecd4-5823-476a-a9bb-e2d9cb601b91" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b7d08e7d-74c2-4a14-ac9e-850e14daa929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59ca0de5-0495-4fe1-983e-bf90e40f3e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_5f9fecd4-5823-476a-a9bb-e2d9cb601b91" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59ca0de5-0495-4fe1-983e-bf90e40f3e1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_5a464ac9-3e2c-45da-a91b-da09cc1e2fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_5a464ac9-3e2c-45da-a91b-da09cc1e2fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_285be76c-0998-4698-8194-c1bb23e70f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_285be76c-0998-4698-8194-c1bb23e70f95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ca2d4e72-c0fd-4ba9-9fa2-3a50894b4a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ca2d4e72-c0fd-4ba9-9fa2-3a50894b4a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_610d63da-eb3d-4bf9-ab78-9043c934044f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_610d63da-eb3d-4bf9-ab78-9043c934044f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4d9205f3-a799-49a2-af8a-6ae78a5c4203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4d9205f3-a799-49a2-af8a-6ae78a5c4203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b2ced8d-86f2-4fc5-83e3-a71f5c2529d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dcd9f8f8-3a81-4dba-a380-d0eae3aad079" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b2ced8d-86f2-4fc5-83e3-a71f5c2529d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_af46063d-45ea-45f3-9d9f-837f07abb5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e90b600b-f309-4b66-8b28-967fc941a07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_af46063d-45ea-45f3-9d9f-837f07abb5c6" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e90b600b-f309-4b66-8b28-967fc941a07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_589385b1-f7b5-4863-8ef1-7fe4d08a48ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_af46063d-45ea-45f3-9d9f-837f07abb5c6" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_589385b1-f7b5-4863-8ef1-7fe4d08a48ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_138dff81-940e-497a-b0f7-ca51146e4fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_138dff81-940e-497a-b0f7-ca51146e4fdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f853c058-ebe0-46e0-9eef-08d805ad6766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f853c058-ebe0-46e0-9eef-08d805ad6766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54951e38-cd71-4109-b4a7-073fdac0d5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54951e38-cd71-4109-b4a7-073fdac0d5d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ce8c26bc-b1b5-4aa3-bc98-0b277763341b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ce8c26bc-b1b5-4aa3-bc98-0b277763341b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_636e29df-398d-4802-abc9-0061c0a862d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_636e29df-398d-4802-abc9-0061c0a862d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e14e6c84-692f-47e7-82b7-115c0840b696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecd2680d-7e34-4800-91b8-f20b445c1811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e14e6c84-692f-47e7-82b7-115c0840b696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7fd3a1d9-72fb-4e12-a3fd-21325ff978f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e90ee189-1b66-4e9a-ad0b-3ddc37bcbb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7fd3a1d9-72fb-4e12-a3fd-21325ff978f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e90ee189-1b66-4e9a-ad0b-3ddc37bcbb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e2eb00ba-ccde-4b0d-8b44-8f5ff4b7c0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7fd3a1d9-72fb-4e12-a3fd-21325ff978f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e2eb00ba-ccde-4b0d-8b44-8f5ff4b7c0ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_11ae7d0e-e4a7-4d77-a842-0b319d2ec543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_efeb7d5a-3893-4260-8d5b-049e775c3fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_11ae7d0e-e4a7-4d77-a842-0b319d2ec543" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_efeb7d5a-3893-4260-8d5b-049e775c3fdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_257f8383-940c-4a6a-acaf-0571688748c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_11ae7d0e-e4a7-4d77-a842-0b319d2ec543" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_257f8383-940c-4a6a-acaf-0571688748c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0db2edbb-3e06-4fd3-a33e-077001618c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0db2edbb-3e06-4fd3-a33e-077001618c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6ad65631-6fdf-4e1e-a80f-851548ebeea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6ad65631-6fdf-4e1e-a80f-851548ebeea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_23565acb-7170-4a05-8f3e-d615a386a302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_23565acb-7170-4a05-8f3e-d615a386a302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_2bf5681c-a663-4e81-981e-3166810d5739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_2bf5681c-a663-4e81-981e-3166810d5739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_3c0c5848-bca3-4285-ab5b-b18a4ee2c21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_3c0c5848-bca3-4285-ab5b-b18a4ee2c21b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_30ed4f51-64c4-4874-a915-01f8d1ef24a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_30ed4f51-64c4-4874-a915-01f8d1ef24a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_0dac5a9b-9034-4bea-b27a-008a383a1595" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_0dac5a9b-9034-4bea-b27a-008a383a1595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_341c4640-7f06-456b-be04-2ec5ccd8e24a" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_341c4640-7f06-456b-be04-2ec5ccd8e24a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_315d961a-3403-4e7a-894d-2646a9d49f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_315d961a-3403-4e7a-894d-2646a9d49f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_cf297bc3-b6a8-419f-b23e-d8349b4c03e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_cf297bc3-b6a8-419f-b23e-d8349b4c03e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4f1318e4-0a34-4884-b129-33d8898dac91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4f1318e4-0a34-4884-b129-33d8898dac91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_d9bd72e6-8b67-4d8c-bc37-ce3ccaa0f3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_d9bd72e6-8b67-4d8c-bc37-ce3ccaa0f3e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_42ebe5be-aa33-45a7-9230-c62a43f91a1f" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_42ebe5be-aa33-45a7-9230-c62a43f91a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_9cfbf400-eb3b-41ac-bd09-8c996b5aa063" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_9cfbf400-eb3b-41ac-bd09-8c996b5aa063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_41b7e0fe-f10b-4650-ac38-594b9e316bdb" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_41b7e0fe-f10b-4650-ac38-594b9e316bdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_37a31ce8-f426-435a-91f1-0024546b15e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_37a31ce8-f426-435a-91f1-0024546b15e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_b325475e-3c05-4e74-a5fd-d7d649b2e633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_b325475e-3c05-4e74-a5fd-d7d649b2e633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_2496b879-8fc3-4f51-b4ad-5a61fc4277b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_2496b879-8fc3-4f51-b4ad-5a61fc4277b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_30f2689a-9cbf-4590-a9da-db2d2045eb63" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_30f2689a-9cbf-4590-a9da-db2d2045eb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_56260431-ba48-4691-bdd6-bee5b9d19291" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_56260431-ba48-4691-bdd6-bee5b9d19291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_6ae196ef-ecd4-415c-aa29-66ae2b84a16d" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88113c84-bda7-401b-9a56-019e7539c0cb" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_6ae196ef-ecd4-415c-aa29-66ae2b84a16d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b84409e5-a971-4683-9bb5-507036684217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_717ec3c9-0a42-4268-bd4f-652f1a81a84c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b84409e5-a971-4683-9bb5-507036684217" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_717ec3c9-0a42-4268-bd4f-652f1a81a84c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a437e0d6-1970-463e-bf31-921aa62947a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b84409e5-a971-4683-9bb5-507036684217" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a437e0d6-1970-463e-bf31-921aa62947a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a4cbc98f-bde8-4bbc-a459-d53b5233e9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b84409e5-a971-4683-9bb5-507036684217" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a4cbc98f-bde8-4bbc-a459-d53b5233e9d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_50b3e011-759f-44e8-ae21-7b0e72eb793c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_54855ddb-a63d-4d0f-8797-26ef52fa24fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_50b3e011-759f-44e8-ae21-7b0e72eb793c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_54855ddb-a63d-4d0f-8797-26ef52fa24fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_893a5122-b982-4465-b29b-c303778aa695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_50b3e011-759f-44e8-ae21-7b0e72eb793c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_893a5122-b982-4465-b29b-c303778aa695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbd03fd5-8f7c-4449-964b-a7f51d84ae9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fea2076-68b6-40bb-b1fe-a877fe3f3f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbd03fd5-8f7c-4449-964b-a7f51d84ae9b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fea2076-68b6-40bb-b1fe-a877fe3f3f93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_82eae5ba-ecc5-405c-965f-e028cc15aeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbd03fd5-8f7c-4449-964b-a7f51d84ae9b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_82eae5ba-ecc5-405c-965f-e028cc15aeb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_77490d60-3c4d-400e-8b93-1a9fe1631831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbd03fd5-8f7c-4449-964b-a7f51d84ae9b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_77490d60-3c4d-400e-8b93-1a9fe1631831" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4f73179a-6e67-4e04-8863-1b82d2446547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_24b0421d-c09f-4167-9323-64a90aa09ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4f73179a-6e67-4e04-8863-1b82d2446547" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_24b0421d-c09f-4167-9323-64a90aa09ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_fb48d0cf-6734-4f5a-bd80-bdf52f2611b8" xlink:href="iart-20201231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4f73179a-6e67-4e04-8863-1b82d2446547" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_fb48d0cf-6734-4f5a-bd80-bdf52f2611b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_8559f170-7716-4207-8ffc-c0dfa3a689c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_8559f170-7716-4207-8ffc-c0dfa3a689c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_a2f953ee-d81b-4f69-8f30-f5a938fb2540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_a2f953ee-d81b-4f69-8f30-f5a938fb2540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_de5096f1-c5ff-4dc4-86b8-1df9773be805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_de5096f1-c5ff-4dc4-86b8-1df9773be805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_b3a1e011-5faa-4033-b472-3f2300088db4" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_b3a1e011-5faa-4033-b472-3f2300088db4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_c1c31ff5-46a0-43e3-8b30-d82bbfb34a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_c1c31ff5-46a0-43e3-8b30-d82bbfb34a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8789c13b-d551-40e9-9727-5bf62ab89e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8789c13b-d551-40e9-9727-5bf62ab89e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_3ee12a3c-b75b-40b2-b41e-efc4acc38dbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_3ee12a3c-b75b-40b2-b41e-efc4acc38dbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ab6f37c0-adb8-4dd6-abea-b99816e7219c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ab6f37c0-adb8-4dd6-abea-b99816e7219c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_55cfff08-c9d2-4307-9644-e1be6d286a96" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_55cfff08-c9d2-4307-9644-e1be6d286a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_9f406e88-26a0-4e31-9c25-53797474837d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_9f406e88-26a0-4e31-9c25-53797474837d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_c28e034a-c6a8-48b2-8fa9-889664ed39d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_c28e034a-c6a8-48b2-8fa9-889664ed39d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_59e96c45-20ad-41cd-a4a7-94c9bf829c3a" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_82241cbb-44ec-4add-b0f4-db21e4daf3b2" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_59e96c45-20ad-41cd-a4a7-94c9bf829c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c39b654e-7055-42dd-b5ce-d8046e79a2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d9345eec-a209-470c-ac3a-817aabab54de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_c39b654e-7055-42dd-b5ce-d8046e79a2f1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d9345eec-a209-470c-ac3a-817aabab54de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b056b09-fb75-4585-9734-28f0e789c5cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_c39b654e-7055-42dd-b5ce-d8046e79a2f1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b056b09-fb75-4585-9734-28f0e789c5cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1085eb04-3d75-4c64-850a-f869d3e3975d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_02c75a08-eeb1-4dc8-a45f-a5c55f8b187f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_1085eb04-3d75-4c64-850a-f869d3e3975d" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_02c75a08-eeb1-4dc8-a45f-a5c55f8b187f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a97a2681-d60f-4f57-80d8-37e2623d273a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_1085eb04-3d75-4c64-850a-f869d3e3975d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a97a2681-d60f-4f57-80d8-37e2623d273a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a3fd61f9-953b-4042-b524-aa910907f657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_34fd731e-7257-4088-be18-d56ba1da4fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a3fd61f9-953b-4042-b524-aa910907f657" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_34fd731e-7257-4088-be18-d56ba1da4fbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1439d216-ea3b-4524-8055-69174d923d45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a3fd61f9-953b-4042-b524-aa910907f657" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1439d216-ea3b-4524-8055-69174d923d45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARE"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARETables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_690f0f7a-6e2c-4b6f-a9dc-3ec2c3897bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_040720a0-7293-4985-85c4-7c8b5396eaf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_690f0f7a-6e2c-4b6f-a9dc-3ec2c3897bad" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_040720a0-7293-4985-85c4-7c8b5396eaf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_53b6be2d-a48b-4729-ba2a-50eb1775e557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_690f0f7a-6e2c-4b6f-a9dc-3ec2c3897bad" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_53b6be2d-a48b-4729-ba2a-50eb1775e557" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_643d0d47-a653-4974-83d2-6d12a345239a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_4ed4ada7-3415-4d59-90df-8589456e6f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_643d0d47-a653-4974-83d2-6d12a345239a" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_4ed4ada7-3415-4d59-90df-8589456e6f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_985182a9-f0b6-4546-8872-20a6f66d787b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_643d0d47-a653-4974-83d2-6d12a345239a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_985182a9-f0b6-4546-8872-20a6f66d787b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITED"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>iart-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20201231.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended" id="i7556ed19b21344b9b4c196947fee1190_DocumentandEntityInformation"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i7a46617f4ee74ef88562bc2c7d0b631f_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="ib9584e5800c64a4faf7fb3db99992c8d_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="idef6e5735fac430a83887feb6e3ab7da_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i79798096f330409dba7a9ea4dde4910d_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i3156929e7d1647cf97465a2732e31eb4_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="i6f14712454ab4350b6098fc4b62fcf83_CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_66d19370-028f-46c4-b2ff-d8da75a58437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_SharesIssued_66d19370-028f-46c4-b2ff-d8da75a58437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_461985e7-43e6-4ce7-900d-c564394ca768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockholdersEquity_461985e7-43e6-4ce7-900d-c564394ca768" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d14f9931-6f2a-454c-ad65-831ae857abe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_TreasuryStockShares_d14f9931-6f2a-454c-ad65-831ae857abe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_1a07d2dd-bd25-487d-bf4a-0be0d03c76a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_1a07d2dd-bd25-487d-bf4a-0be0d03c76a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1c4f8cb-bd11-42f7-b15f-78f9369a8a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_NetIncomeLoss_d1c4f8cb-bd11-42f7-b15f-78f9369a8a9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9511ebdd-9333-4ab7-b9a5-cc7f43f5c1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9511ebdd-9333-4ab7-b9a5-cc7f43f5c1c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bf9010aa-bb4a-400c-9d48-14c702e5c04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bf9010aa-bb4a-400c-9d48-14c702e5c04f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bcbb27a5-5402-4dcd-88ac-c46a447e3eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bcbb27a5-5402-4dcd-88ac-c46a447e3eeb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a341bdad-8137-4267-83b5-04d1d7ef3588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a341bdad-8137-4267-83b5-04d1d7ef3588" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_67c2abf8-addc-4005-ba48-491952848b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_67c2abf8-addc-4005-ba48-491952848b1e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_768177dd-bc67-4a6f-83db-be04cf7b02ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_768177dd-bc67-4a6f-83db-be04cf7b02ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f12f9244-6731-4e34-8137-c956f7fd8ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f12f9244-6731-4e34-8137-c956f7fd8ff3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_76e662c5-edda-42fd-8f0b-938d9f6015b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_76e662c5-edda-42fd-8f0b-938d9f6015b2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1e3c5926-42e0-45e2-894a-12e9071b9b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1e3c5926-42e0-45e2-894a-12e9071b9b62" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_23abff49-0dcd-4e23-aa26-955dae1a90c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_23abff49-0dcd-4e23-aa26-955dae1a90c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b5719b6b-8109-4ac8-8b19-c9861aa38ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b5719b6b-8109-4ac8-8b19-c9861aa38ddb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d136cb89-f2c9-4baf-b873-fad4dfa99196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d136cb89-f2c9-4baf-b873-fad4dfa99196" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_7d1324fc-14c8-4e88-9aaf-28c8eeff8392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c829d90d-3e36-4c3f-be1f-33a42037b86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fad07758-ece4-4f93-9024-ae7030a1eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:to="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e73d4aa-2be4-4001-8869-9a6c08c9ba93_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:to="loc_us-gaap_EquityComponentDomain_7e73d4aa-2be4-4001-8869-9a6c08c9ba93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:to="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_65c7da0b-4ff7-40f4-b33f-d0270342c2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_CommonStockMember_65c7da0b-4ff7-40f4-b33f-d0270342c2f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0807259e-09e9-4883-a4d1-02d384e09fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_TreasuryStockMember_0807259e-09e9-4883-a4d1-02d384e09fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_27f1bc9b-822a-4cdf-9103-1f175b4a2a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_27f1bc9b-822a-4cdf-9103-1f175b4a2a52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9e5c60d4-aa69-46d3-b4b1-f8420451aeeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9e5c60d4-aa69-46d3-b4b1-f8420451aeeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6334aae7-73ac-4b74-ae41-d3f43136531e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_RetainedEarningsMember_6334aae7-73ac-4b74-ae41-d3f43136531e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8378a198-04e7-40fc-bbda-1beb84354977_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8378a198-04e7-40fc-bbda-1beb84354977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_6c13c8ad-cba2-4396-92e4-facf296f98ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_6c13c8ad-cba2-4396-92e4-facf296f98ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4b02d019-9d8b-40ad-bbed-ac3b400824c5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4b02d019-9d8b-40ad-bbed-ac3b400824c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_21510168-dee7-4658-8f51-ea9946f7b88c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_21510168-dee7-4658-8f51-ea9946f7b88c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/BUSINESS" xlink:type="simple" xlink:href="iart-20201231.xsd#BUSINESS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/BUSINESS" xlink:type="extended" id="i3b99f23498684f2ab10654dec226588b_BUSINESS"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="icac7db6cb8e64dc7a6ec5a0d2063ec5c_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i9b0bdcad5f3e4b2e85d353ee0e9911e7_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended" id="ia1d4fda2163d403186a848b26ed54553_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="i3d08f54d40e44530b3259ff64311a6c6_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_640c81d8-19c1-4221-955b-c623795484ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_640c81d8-19c1-4221-955b-c623795484ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2e13dfbf-2a68-40c2-aebf-68010944eccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2e13dfbf-2a68-40c2-aebf-68010944eccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_87c4b6d3-73cf-4465-826a-b83a64363769" xlink:href="iart-20201231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_InventoryCapitalizedExpenses_87c4b6d3-73cf-4465-826a-b83a64363769" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_f2f8b7ea-4af4-424d-9b97-c461b518edb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_f2f8b7ea-4af4-424d-9b97-c461b518edb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f65989cb-b4d7-46aa-bbeb-762d892e4ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Depreciation_f65989cb-b4d7-46aa-bbeb-762d892e4ac3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072bf89b-0e17-4e5a-9ff8-7896dc2a585e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072bf89b-0e17-4e5a-9ff8-7896dc2a585e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_17e64fad-6129-4853-a43b-f3e4dafe7b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_17e64fad-6129-4853-a43b-f3e4dafe7b9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a771690b-7069-453f-a484-ada88bbf0c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_NumberOfReportableSegments_a771690b-7069-453f-a484-ada88bbf0c27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_8fb5624e-ca80-45b7-b795-4e8715d17b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_NumberOfReportingUnits_8fb5624e-ca80-45b7-b795-4e8715d17b25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_ed4aea11-ef28-4392-bba4-4d2795d4ffcf" xlink:href="iart-20201231.xsd#iart_CharitableContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_CharitableContributions_ed4aea11-ef28-4392-bba4-4d2795d4ffcf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_f70d77e5-dbc9-4cc8-b5e9-7aa7770a119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_f70d77e5-dbc9-4cc8-b5e9-7aa7770a119b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a73cdb38-cedd-4db6-9cf6-3b968006d7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_StockholdersEquity_a73cdb38-cedd-4db6-9cf6-3b968006d7c5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7a36f5d-f092-4837-b986-8a6b1ce98ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Assets_b7a36f5d-f092-4837-b986-8a6b1ce98ba1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_256a5e27-84b1-45b7-96b2-a4f853dbd9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Liabilities_256a5e27-84b1-45b7-96b2-a4f853dbd9a0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_ca310475-f6af-496e-a8fa-3bd946d54d39" xlink:href="iart-20201231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_ca310475-f6af-496e-a8fa-3bd946d54d39" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a705736d-4b5a-4d11-81da-527c113ef66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_RestructuringCharges_a705736d-4b5a-4d11-81da-527c113ef66c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_823f8cd8-40f4-4b92-83cb-e665a80d78b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_823f8cd8-40f4-4b92-83cb-e665a80d78b5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_7ce4687c-fee4-4703-8e7b-47fa0b9af900" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_7ce4687c-fee4-4703-8e7b-47fa0b9af900" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_faae6343-0b29-47f2-a324-d8a1235d5b66" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_faae6343-0b29-47f2-a324-d8a1235d5b66" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_28e649a7-6d5b-4a78-a77c-467241252988" xlink:href="iart-20201231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_28e649a7-6d5b-4a78-a77c-467241252988" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1791994d-99d4-45c2-9937-786296d70cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1791994d-99d4-45c2-9937-786296d70cce" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ecec20b4-6f4b-41e1-9867-3bfde44f3de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OperatingLeaseLiability_ecec20b4-6f4b-41e1-9867-3bfde44f3de2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1d926650-4a42-4abd-b863-ad24cea35af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1d926650-4a42-4abd-b863-ad24cea35af6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_7004f464-d5e7-48c4-9744-cf9813b211da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestPaid_7004f464-d5e7-48c4-9744-cf9813b211da" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_129bf471-4244-4af1-a623-f0d9374affbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestPaidCapitalized_129bf471-4244-4af1-a623-f0d9374affbe" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_9ca1b7f4-8823-422e-9788-c4165d6b9c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_IncomeTaxesPaid_9ca1b7f4-8823-422e-9788-c4165d6b9c96" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_6fe2e368-3937-4cee-87f9-8539c16a10ba" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_6fe2e368-3937-4cee-87f9-8539c16a10ba" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_9fc07f6a-fffd-464e-a62c-21f8686c45cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_9fc07f6a-fffd-464e-a62c-21f8686c45cc" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1b42914a-52f2-4fc6-ac28-7d202d1e67a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1b42914a-52f2-4fc6-ac28-7d202d1e67a9" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e45f2d1d-0bc8-46db-ad60-6ad205ac5348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e45f2d1d-0bc8-46db-ad60-6ad205ac5348" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2870619-19a2-473b-b4d1-21e614809b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2870619-19a2-473b-b4d1-21e614809b4f" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa24f76b-d124-4d38-a24d-4ec472315abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa24f76b-d124-4d38-a24d-4ec472315abf" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71b8ad36-7f82-4ef5-8128-27b134214f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71b8ad36-7f82-4ef5-8128-27b134214f2e" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_c2710754-4cf5-4232-9552-4cb27c07cd26" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_c2710754-4cf5-4232-9552-4cb27c07cd26" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f6fd0052-7159-4ba9-be97-56c01a4af81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f6fd0052-7159-4ba9-be97-56c01a4af81d" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_6392a6ad-f2e8-49db-8b01-a395743a8626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_6392a6ad-f2e8-49db-8b01-a395743a8626" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdcf9ba0-3adf-4e79-8c78-26f91f4bd60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdcf9ba0-3adf-4e79-8c78-26f91f4bd60c" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_716252d4-3e32-4307-8f99-8cfecc3bdf22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_716252d4-3e32-4307-8f99-8cfecc3bdf22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8594bcf6-5c2f-4ff6-ad7a-1e27636df156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8594bcf6-5c2f-4ff6-ad7a-1e27636df156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9be08ba-6ebf-4a56-b0f4-51359f23a95b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9be08ba-6ebf-4a56-b0f4-51359f23a95b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_c125a168-b617-4034-ace4-1792b06f4acc" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:to="loc_iart_SmithNephewUSDLimitedMember_c125a168-b617-4034-ace4-1792b06f4acc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a63784c-2696-49c3-9239-f202bbc5b7d4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:to="loc_srt_RangeMember_9a63784c-2696-49c3-9239-f202bbc5b7d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:to="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a95eddc9-4000-420b-ab27-694f817e477e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:to="loc_srt_MinimumMember_a95eddc9-4000-420b-ab27-694f817e477e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2a9b99d9-dd0b-4775-8853-7964eabe2e6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:to="loc_srt_MaximumMember_2a9b99d9-dd0b-4775-8853-7964eabe2e6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a33b623a-4d24-47b7-a643-b5f2915ff99e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a33b623a-4d24-47b7-a643-b5f2915ff99e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ba8bc69b-3e81-43b2-9e0b-b7be5a8e492f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ba8bc69b-3e81-43b2-9e0b-b7be5a8e492f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_37cf7cfe-e669-4288-8170-8595279894c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:to="loc_us-gaap_EquityComponentDomain_37cf7cfe-e669-4288-8170-8595279894c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:to="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54c6413f-14df-4e04-bcd8-e0cb063822e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:to="loc_us-gaap_RetainedEarningsMember_54c6413f-14df-4e04-bcd8-e0cb063822e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_648843fe-e9c6-48bb-bc30-56efc4f78dfd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_648843fe-e9c6-48bb-bc30-56efc4f78dfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_44d1af4a-cde3-451b-9bd5-d4859877326f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:to="loc_us-gaap_SalesRevenueNetMember_44d1af4a-cde3-451b-9bd5-d4859877326f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8_default" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:to="loc_iart_AssetAcquisitionDomain_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:to="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_c7c95e34-cd1a-4158-83f6-8fbf86812fec" xlink:href="iart-20201231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_c7c95e34-cd1a-4158-83f6-8fbf86812fec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5a0720f9-9887-4656-ad2c-bcb29ea95fc6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5a0720f9-9887-4656-ad2c-bcb29ea95fc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_2cccf50d-1181-4878-baee-d1414360c249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:to="loc_us-gaap_ConvertibleDebtMember_2cccf50d-1181-4878-baee-d1414360c249" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b34b5448-f50b-4ceb-8323-01c67e374d39_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b34b5448-f50b-4ceb-8323-01c67e374d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_8dbe25d5-a4d4-4ac2-be63-e0898be9896b" xlink:href="iart-20201231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_8dbe25d5-a4d4-4ac2-be63-e0898be9896b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_0b607c2d-773f-442f-80bf-657d1decfa5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_0b607c2d-773f-442f-80bf-657d1decfa5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_84fefafa-b6a7-4aa3-95a2-3928ea95a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:to="loc_us-gaap_CallOptionMember_84fefafa-b6a7-4aa3-95a2-3928ea95a8d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ae0a064-5f47-49ef-8949-164fd638e5dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ae0a064-5f47-49ef-8949-164fd638e5dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8cc7836c-94a0-4c88-98dc-184a697a0fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_CostOfSalesMember_8cc7836c-94a0-4c88-98dc-184a697a0fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d14a3825-2ae9-4b9a-b161-17efef97f210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d14a3825-2ae9-4b9a-b161-17efef97f210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_db3e0176-880b-4b55-ae2c-5b6ccd368b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_db3e0176-880b-4b55-ae2c-5b6ccd368b1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c2057894-b813-4b72-b573-b9d39afd0f10_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c2057894-b813-4b72-b573-b9d39afd0f10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_38e4fce3-f541-46b7-b90f-4fdb3b9a2b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_38e4fce3-f541-46b7-b90f-4fdb3b9a2b9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended" id="ib95ef9c6c18d43f886fa998598033b67_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended" id="ib0608105ea1747039c7b90549599c25b_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0c850056-9928-418e-b653-cc4a69d613fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0c850056-9928-418e-b653-cc4a69d613fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1695df58-722a-4345-803e-b137571d1bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1695df58-722a-4345-803e-b137571d1bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_619603aa-7308-4e9a-95c4-08ac83e2f5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_619603aa-7308-4e9a-95c4-08ac83e2f5f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_756aa12d-74ef-4eb1-8217-3c0da4f8d6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_756aa12d-74ef-4eb1-8217-3c0da4f8d6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_39cf285c-5bb2-4795-be34-00a35127a4c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_39cf285c-5bb2-4795-be34-00a35127a4c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_16d785d2-fa8f-4200-9d44-e275494cc697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_LandMember_16d785d2-fa8f-4200-9d44-e275494cc697" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7f5f4736-8ab3-441f-bc22-bf6d930f3250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7f5f4736-8ab3-441f-bc22-bf6d930f3250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_2c318e3c-f0da-43ca-baa0-5fc610a1ed7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_2c318e3c-f0da-43ca-baa0-5fc610a1ed7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b6fa17ab-e4a4-45b6-a2f0-3db294cdaa1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b6fa17ab-e4a4-45b6-a2f0-3db294cdaa1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember_219f46fe-a1b4-4849-ab64-bd6dd151ff69" xlink:href="iart-20201231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_iart_SurgicalInstrumentKitsMember_219f46fe-a1b4-4849-ab64-bd6dd151ff69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_c92f6c63-c693-4d5d-8b3f-d78f737eebc8" xlink:href="iart-20201231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_iart_InformationSystemsandHardwareMember_c92f6c63-c693-4d5d-8b3f-d78f737eebc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d6c34a73-e484-41d7-b3c7-b4d059250ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d6c34a73-e484-41d7-b3c7-b4d059250ec7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_88e2e300-a73b-49cb-85ff-1501cca158bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_ConstructionInProgressMember_88e2e300-a73b-49cb-85ff-1501cca158bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:to="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce330b17-6dfa-45af-b631-b1fccbd8859a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:to="loc_srt_RangeMember_ce330b17-6dfa-45af-b631-b1fccbd8859a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:to="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0cb7619a-a3aa-4dfb-9142-6d3b667b80e7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:to="loc_srt_MinimumMember_0cb7619a-a3aa-4dfb-9142-6d3b667b80e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0dfad073-41b2-404a-8e4b-5d15d3798765" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:to="loc_srt_MaximumMember_0dfad073-41b2-404a-8e4b-5d15d3798765" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALE"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="extended" id="i6e4429fcc3ad48c18a8044ea556d138e_ASSETSANDLIABILITIESHELDFORSALE"/>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALETables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="extended" id="i9c7feb20e66548bbba869c59e271afea_ASSETSANDLIABILITIESHELDFORSALETables"/>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALENarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="extended" id="if6474134b95b419c8fec5c75e8e05829_ASSETSANDLIABILITIESHELDFORSALENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0aa8c03a-4dd6-4d05-822d-8ebd45c28b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0aa8c03a-4dd6-4d05-822d-8ebd45c28b5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_1f84e917-f6ac-4030-af86-49566a8e1acd" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_1f84e917-f6ac-4030-af86-49566a8e1acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_49e689c8-2ede-4126-a731-58fd2995497e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_49e689c8-2ede-4126-a731-58fd2995497e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_61486365-76e9-40c0-a4cf-4d0f08819285" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:to="loc_iart_SmithNephewUSDLimitedMember_61486365-76e9-40c0-a4cf-4d0f08819285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d1ae469c-2965-4842-9c0c-0597c68ff5ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d1ae469c-2965-4842-9c0c-0597c68ff5ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_dcc35e08-e0ab-4cc9-bd29-aa0ed609edb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_dcc35e08-e0ab-4cc9-bd29-aa0ed609edb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7ed55659-f74c-44ac-bb61-c90e5bca19fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:to="loc_us-gaap_SubsequentEventMember_7ed55659-f74c-44ac-bb61-c90e5bca19fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_51de22ca-8836-4abb-a678-43731b8f3f25_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_51de22ca-8836-4abb-a678-43731b8f3f25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_96446907-8e32-400a-b69c-86c6e8c84d80" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_96446907-8e32-400a-b69c-86c6e8c84d80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended" id="ib33f3eeac5a14f2a9e99dd35e67a2204_ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_96488bfb-f7f0-4356-93b5-a1bf4f875dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_96488bfb-f7f0-4356-93b5-a1bf4f875dae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_1793eff5-9514-4d2f-82dc-5bccfe9ad80a" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_1793eff5-9514-4d2f-82dc-5bccfe9ad80a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_b32931da-f14e-4745-b4b4-b84724646e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_b32931da-f14e-4745-b4b4-b84724646e80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_56c5ae96-abb1-4717-9b99-5ebf1f755a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_56c5ae96-abb1-4717-9b99-5ebf1f755a74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_467398db-24c2-41c9-80bd-a247fa15aca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_467398db-24c2-41c9-80bd-a247fa15aca3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b39ba91b-267d-4201-abae-8a398bfc4ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b39ba91b-267d-4201-abae-8a398bfc4ba0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_00825276-6026-488f-ab57-5092d894e097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_00825276-6026-488f-ab57-5092d894e097" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8eca1e5c-e709-4204-9a96-fdd9e2d38f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8eca1e5c-e709-4204-9a96-fdd9e2d38f37" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_ebf0fc53-20e3-4298-98a5-b00e8b0f4e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_ebf0fc53-20e3-4298-98a5-b00e8b0f4e0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_291f5ded-6b55-4db6-b8e4-c1501c0aa2a6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_291f5ded-6b55-4db6-b8e4-c1501c0aa2a6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_34602703-3541-413a-82e5-67a7f31262e6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_34602703-3541-413a-82e5-67a7f31262e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_7be09a70-7c97-49fb-add4-fc640c67059f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_7be09a70-7c97-49fb-add4-fc640c67059f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_47f7fd74-46da-4332-84b0-524b023252ff" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_47f7fd74-46da-4332-84b0-524b023252ff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0d2343d-4506-4e1d-92bb-b838b9d7a690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0d2343d-4506-4e1d-92bb-b838b9d7a690" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fb84321-3533-405b-bf84-64746bd380fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fb84321-3533-405b-bf84-64746bd380fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_24ec7da3-311c-43e4-935e-9616d3562c1a" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:to="loc_iart_SmithNephewUSDLimitedMember_24ec7da3-311c-43e4-935e-9616d3562c1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_64fec681-f411-4637-9e18-6c681f836171_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_64fec681-f411-4637-9e18-6c681f836171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8cddd2ec-27c1-44ae-bb55-3f49bf5ba9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8cddd2ec-27c1-44ae-bb55-3f49bf5ba9c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended" id="i8941b53bd3c04d98afe0400ae575c5fb_REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended" id="i64dd3d3ac6a0459cad664a518ba84e91_REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended" id="i80d0bbcb9fe3436ab4993d5d26fa9051_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i1121e9956a5c4bf6a14132a527bb5a03_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e3ecae55-4259-4fc0-8be8-d6ea4d5610a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e3ecae55-4259-4fc0-8be8-d6ea4d5610a8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="ibae310f7216c40b58faf7c4eac3fd48a_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended" id="i4c3c04a36ed949c9be3f3bcb3cfdceb7_REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended" id="i006ee3ced5a545499dbc996414a8bc10_REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a933c9b7-a43f-4e8d-ae4f-64849471f6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a933c9b7-a43f-4e8d-ae4f-64849471f6c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfdc52d0-79a9-4edd-a84e-7647495dedfd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:to="loc_us-gaap_SegmentDomain_cfdc52d0-79a9-4edd-a84e-7647495dedfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:to="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_84a71b77-ad19-4938-8da1-570ac0275331" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_84a71b77-ad19-4938-8da1-570ac0275331" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_8978ec0c-6f22-4150-bedc-fc387f6cb141" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_8978ec0c-6f22-4150-bedc-fc387f6cb141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:to="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_32bc4b09-8246-4de4-83bb-a4f44918002f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:to="loc_srt_ProductsAndServicesDomain_32bc4b09-8246-4de4-83bb-a4f44918002f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:to="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_d1f1d60e-e0b0-4b15-86a7-3027a8a2163f" xlink:href="iart-20201231.xsd#iart_NeurosurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_NeurosurgeryMember_d1f1d60e-e0b0-4b15-86a7-3027a8a2163f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_95cb0966-3e4c-48a4-b348-679bf8ac1745" xlink:href="iart-20201231.xsd#iart_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_InstrumentsMember_95cb0966-3e4c-48a4-b348-679bf8ac1745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_42e417a4-16b7-42cd-89b6-f1c8e61bdb98" xlink:href="iart-20201231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_42e417a4-16b7-42cd-89b6-f1c8e61bdb98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_744094fc-4c53-43f5-b333-f07926fd4367" xlink:href="iart-20201231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_ExtremityOrthopedicsMember_744094fc-4c53-43f5-b333-f07926fd4367" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_fdb3fba1-702e-4bfe-a1bd-5755fe66c598" xlink:href="iart-20201231.xsd#iart_PrivateLabelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_PrivateLabelMember_fdb3fba1-702e-4bfe-a1bd-5755fe66c598" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONS" xlink:type="extended" id="i5941efe302b14002b5a1e2f5e8f7797a_ACQUISITIONS"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSTables" xlink:type="extended" id="i19e9711a880f4d3699d0261f0fe874ed_ACQUISITIONSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSBusinessAcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="extended" id="i03e295173eb741dfa36462021fa82bfe_ACQUISITIONSBusinessAcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ceb2d3b8-1336-4e27-8889-a500380b757e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ceb2d3b8-1336-4e27-8889-a500380b757e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e6dd930b-7219-4606-86f7-f91aa7a5f1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e6dd930b-7219-4606-86f7-f91aa7a5f1b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_7f9187a0-8753-49f9-ab41-05e70c807461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_7f9187a0-8753-49f9-ab41-05e70c807461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_b00cbf56-2975-4136-8a4a-d31b9f7934c6" xlink:href="iart-20201231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_b00cbf56-2975-4136-8a4a-d31b9f7934c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be6e94f-4d9c-4c4f-af9f-217a00e33a58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be6e94f-4d9c-4c4f-af9f-217a00e33a58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_dc4fb944-7e29-4b0c-8454-bda1e12a9ceb" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:to="loc_iart_ArkisBioSciencesInc.Member_dc4fb944-7e29-4b0c-8454-bda1e12a9ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_188f5718-25b0-4fd8-8da8-89571415cf1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_188f5718-25b0-4fd8-8da8-89571415cf1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_92a27061-a520-4c75-92d7-a7da76f84ac5" xlink:href="iart-20201231.xsd#iart_MilestonePaymentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:to="loc_iart_MilestonePaymentOneMember_92a27061-a520-4c75-92d7-a7da76f84ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_246c3bef-bb44-4f5e-ba00-8e5de300a41a" xlink:href="iart-20201231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:to="loc_iart_MilestonePaymentTwoMember_246c3bef-bb44-4f5e-ba00-8e5de300a41a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c723d53d-cb7a-44e4-a457-65644a99eb27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c723d53d-cb7a-44e4-a457-65644a99eb27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1b4279ad-ac17-4e2a-bb1e-4f78ba83e048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1b4279ad-ac17-4e2a-bb1e-4f78ba83e048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c0e390f6-ad6e-4c19-ba38-f4f37b79ccbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c0e390f6-ad6e-4c19-ba38-f4f37b79ccbc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i0b5c6b30d130410eae6277d52b129e83_ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d98fc822-7132-40a3-83da-39e3fb25245f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d98fc822-7132-40a3-83da-39e3fb25245f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_13739c0b-3892-4cd9-878f-df51375b9ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_13739c0b-3892-4cd9-878f-df51375b9ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5c9f75cd-8cf9-4bfe-9e93-5b403b9b4706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5c9f75cd-8cf9-4bfe-9e93-5b403b9b4706" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9a1d32bb-70a5-4263-8d0d-cbbb2c05f2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9a1d32bb-70a5-4263-8d0d-cbbb2c05f2a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:href="iart-20201231.xsd#iart_IntangibleAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_473aa348-7db1-4a5f-b587-0630fbcf1f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_473aa348-7db1-4a5f-b587-0630fbcf1f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_abc06e74-a8b8-4936-8384-9ad62ac9f4d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_Goodwill_abc06e74-a8b8-4936-8384-9ad62ac9f4d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_4a4158b7-9be2-4540-bd8b-92f0a8335f7f" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_4a4158b7-9be2-4540-bd8b-92f0a8335f7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_28cebeff-fe19-4b12-aad8-33064c91f04b" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_28cebeff-fe19-4b12-aad8-33064c91f04b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5b1a2ad3-64f1-4532-acf0-4ed802e73938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5b1a2ad3-64f1-4532-acf0-4ed802e73938" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5339191e-4fae-4b22-af02-acafe499692b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5339191e-4fae-4b22-af02-acafe499692b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_da435aff-eae7-4901-9a57-c8e3c51b88b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_da435aff-eae7-4901-9a57-c8e3c51b88b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fec08cc0-af65-4ea5-a4a7-948f48c8f7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fec08cc0-af65-4ea5-a4a7-948f48c8f7f1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d5d1b8-9fa0-4642-886b-bb23966b0ecc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d5d1b8-9fa0-4642-886b-bb23966b0ecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_f4c6d351-88c2-4fcf-a1e8-7293b923d729" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:to="loc_iart_ArkisBioSciencesInc.Member_f4c6d351-88c2-4fcf-a1e8-7293b923d729" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b57a08d4-51a9-407f-90fe-134a9e386fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b57a08d4-51a9-407f-90fe-134a9e386fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_ae4d404b-8e27-41aa-ac72-eb22e52a93a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:to="loc_us-gaap_LicensingAgreementsMember_ae4d404b-8e27-41aa-ac72-eb22e52a93a2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSAssetAcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="extended" id="i1110e773667d44bbb6311c858f43152f_ACQUISITIONSAssetAcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionConsiderationTransferred_445a2e53-415c-48e9-9204-10c87b8705c7" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionConsiderationTransferred_445a2e53-415c-48e9-9204-10c87b8705c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_9f0c9833-3428-4f18-81a3-0c494946402e" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_9f0c9833-3428-4f18-81a3-0c494946402e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_ed34bc2a-7401-40e1-848b-64b3f356ca8c" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_ed34bc2a-7401-40e1-848b-64b3f356ca8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_a66ae970-c54c-48d6-9dce-8a6ac5db11e4" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_a66ae970-c54c-48d6-9dce-8a6ac5db11e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_819fb29a-9cec-458f-b0e8-f63a159fd07f" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_819fb29a-9cec-458f-b0e8-f63a159fd07f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_d3e87ebb-3c68-41d4-b425-38b50ef8ef17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_d3e87ebb-3c68-41d4-b425-38b50ef8ef17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a07daf87-c32b-4891-91c4-e89b2a3a9db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a07daf87-c32b-4891-91c4-e89b2a3a9db1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_745a09b8-8d8a-428c-b8dd-da1fb1118a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_745a09b8-8d8a-428c-b8dd-da1fb1118a51" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_671f2be7-51f0-47f2-bcb9-febdcca4a5ab" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_671f2be7-51f0-47f2-bcb9-febdcca4a5ab" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_7333ea98-40f3-4c96-a4cd-b116def079db" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_7333ea98-40f3-4c96-a4cd-b116def079db" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b3c4f469-e621-4bae-85c5-e1073111964e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b3c4f469-e621-4bae-85c5-e1073111964e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_18c8014f-b37d-48b7-978a-755d6f3dc521" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_18c8014f-b37d-48b7-978a-755d6f3dc521" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_bedac3d9-0fe9-41bc-817f-95a1f37da40f_default" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:to="loc_iart_AssetAcquisitionDomain_bedac3d9-0fe9-41bc-817f-95a1f37da40f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:to="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_e6a77d7e-8107-402a-abae-74b08cdac997" xlink:href="iart-20201231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_e6a77d7e-8107-402a-abae-74b08cdac997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member_54ed0ce6-8418-4de0-b9d2-ba892b3c0955" xlink:href="iart-20201231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:to="loc_iart_IntegratedShoulderCollaborationInc.Member_54ed0ce6-8418-4de0-b9d2-ba892b3c0955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_559a85a1-09ed-4cee-9d43-be0971fe86ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_559a85a1-09ed-4cee-9d43-be0971fe86ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c972131f-cf73-4b98-a3f9-9d67730c4592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c972131f-cf73-4b98-a3f9-9d67730c4592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a4d94725-7182-4cba-9a58-cc0ce1b0eb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a4d94725-7182-4cba-9a58-cc0ce1b0eb3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember_5ed60da9-7a1d-4c33-bed2-b3aedf9b7c5a" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:to="loc_iart_DeferredTaxAssetMember_5ed60da9-7a1d-4c33-bed2-b3aedf9b7c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_616ab476-f43c-4a82-92db-31131810ba44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_616ab476-f43c-4a82-92db-31131810ba44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9bf6d61a-f025-44b0-84ec-3b6d0f60dce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:to="loc_us-gaap_LicensingAgreementsMember_9bf6d61a-f025-44b0-84ec-3b6d0f60dce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_158ad594-2f22-4b85-a5d7-e854462c13ad_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_158ad594-2f22-4b85-a5d7-e854462c13ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_9435f4e1-7239-4c6f-b4c3-8550c8b69765" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_9435f4e1-7239-4c6f-b4c3-8550c8b69765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_44d44d7e-48a7-4e19-9eaa-0bbc2027330e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:to="loc_us-gaap_SubsequentEventMember_44d44d7e-48a7-4e19-9eaa-0bbc2027330e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d36a6756-4775-4516-81af-1cd121d644bd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d36a6756-4775-4516-81af-1cd121d644bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37405daf-2eff-4357-8267-3854b94ddfa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37405daf-2eff-4357-8267-3854b94ddfa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fffc477e-8b84-46b9-b244-c8a580ccb80a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fffc477e-8b84-46b9-b244-c8a580ccb80a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_2fe344d2-7370-4ebb-ac53-e96de3a36565" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:to="loc_iart_SmithNephewUSDLimitedMember_2fe344d2-7370-4ebb-ac53-e96de3a36565" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBT"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended" id="i581e09e23db948e9aa21b76ce7421df3_DEBT"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended" id="i0ef321a9e9664fbd997f7a8350ad8838_DEBTTables"/>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended" id="i7f3b1402f5424ca89ca81e4cf27e625b_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_05ee519a-9a1a-4437-a2a4-ea931a78e82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_05ee519a-9a1a-4437-a2a4-ea931a78e82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a6216865-92de-4659-a6be-e6c9042d80d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a6216865-92de-4659-a6be-e6c9042d80d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_73de5515-b6fb-45a7-823d-76cdad86d8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_73de5515-b6fb-45a7-823d-76cdad86d8af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_b0860282-61ea-4fdc-99db-57277dd48b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_b0860282-61ea-4fdc-99db-57277dd48b6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c4fc78dc-4096-4722-8e21-821b7fadfa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c4fc78dc-4096-4722-8e21-821b7fadfa71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a58a64f8-9160-46cc-b731-29861703a9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a58a64f8-9160-46cc-b731-29861703a9bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7ca15d79-9ad1-4751-bf62-6c7bceb9a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCredit_7ca15d79-9ad1-4751-bf62-6c7bceb9a064" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_2aab4ff5-e126-48d7-9d55-5275e93966de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_2aab4ff5-e126-48d7-9d55-5275e93966de" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_eaf42142-7a19-4d85-8dfc-39e723ad51eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_SecuredDebtCurrent_eaf42142-7a19-4d85-8dfc-39e723ad51eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c3b81b38-b551-4f58-a98f-4f0641672579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c3b81b38-b551-4f58-a98f-4f0641672579" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_f6463d9b-6b20-42bc-85cb-d14f4d369d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_f6463d9b-6b20-42bc-85cb-d14f4d369d6f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f03dc014-2c6d-45d9-aefa-e1b02bd90744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f03dc014-2c6d-45d9-aefa-e1b02bd90744" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0610ad72-f26c-4098-9c84-79a6b20ea047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0610ad72-f26c-4098-9c84-79a6b20ea047" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_b5d90e79-b655-4133-8637-2cb027fc957e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_b5d90e79-b655-4133-8637-2cb027fc957e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d90e391d-5ab5-4c7d-98d4-a5dd82de4401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d90e391d-5ab5-4c7d-98d4-a5dd82de4401" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_055cd9b7-9db5-4196-b9ac-6c9238a6ca09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_055cd9b7-9db5-4196-b9ac-6c9238a6ca09" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_83b9fbfd-8632-4034-80bd-93e28464d056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_83b9fbfd-8632-4034-80bd-93e28464d056" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_239dfaf3-2fac-43a7-ba6d-1cd71e20a185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentFairValue_239dfaf3-2fac-43a7-ba6d-1cd71e20a185" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bb1aa78-a5a7-423c-879f-c3c104ebf8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bb1aa78-a5a7-423c-879f-c3c104ebf8a1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2ecaea72-de20-48fc-a31e-e4e8cc0766cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2ecaea72-de20-48fc-a31e-e4e8cc0766cf" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_7d29fda1-301b-43aa-91aa-15aafbdbfe77" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_7d29fda1-301b-43aa-91aa-15aafbdbfe77" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e0bee4a9-1b1c-4df9-ad3f-c7b2b349a084" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e0bee4a9-1b1c-4df9-ad3f-c7b2b349a084" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_f9edb499-82d9-4ef6-8ef2-9c719f4fd76b" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_f9edb499-82d9-4ef6-8ef2-9c719f4fd76b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3c01659a-4734-4711-9371-b099511dfee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3c01659a-4734-4711-9371-b099511dfee3" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_7c5b0ce4-f15e-4e16-ad32-be98848498a7" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_7c5b0ce4-f15e-4e16-ad32-be98848498a7" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8968935c-bf5e-4628-ab2b-41190a384a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8968935c-bf5e-4628-ab2b-41190a384a93" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_1ff08536-4bd6-4c68-b6b5-64e38f0be32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_1ff08536-4bd6-4c68-b6b5-64e38f0be32d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3b0f25-21f5-4c2f-85c0-62381ed8b756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3b0f25-21f5-4c2f-85c0-62381ed8b756" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d86f124f-caa5-4aeb-841e-4445d66a3979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d86f124f-caa5-4aeb-841e-4445d66a3979" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_71826c11-e2a3-4061-bbba-bcd376ede948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_71826c11-e2a3-4061-bbba-bcd376ede948" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c9cbfe91-8aaf-48b2-a808-89130e95bf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_InterestExpenseDebt_c9cbfe91-8aaf-48b2-a808-89130e95bf10" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_f9641b43-15b5-46f4-8247-e8f14e630afb" xlink:href="iart-20201231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_f9641b43-15b5-46f4-8247-e8f14e630afb" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtAccountsReceivableSecuritizationTerm_2615d654-a314-40a0-9717-bfb6e16d3284" xlink:href="iart-20201231.xsd#iart_DebtAccountsReceivableSecuritizationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtAccountsReceivableSecuritizationTerm_2615d654-a314-40a0-9717-bfb6e16d3284" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_941a9ac0-b73e-471f-8b8b-c9c01c518df8" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_941a9ac0-b73e-471f-8b8b-c9c01c518df8" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2d1ba47c-f7b2-4e3f-b42e-b1664e71c6b7" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2d1ba47c-f7b2-4e3f-b42e-b1664e71c6b7" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_ab7698ad-a68f-419f-b876-c533ba65d095" xlink:href="iart-20201231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_ab7698ad-a68f-419f-b876-c533ba65d095" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_9b41a116-ff78-4345-a0dc-ef13564e41c4" xlink:href="iart-20201231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_9b41a116-ff78-4345-a0dc-ef13564e41c4" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_27959963-2c51-4536-bbf5-4ed77b26c65d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_27959963-2c51-4536-bbf5-4ed77b26c65d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_9ebc9304-6af5-4956-8a03-ae7aeea8d0dd" xlink:href="iart-20201231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_SeniorCreditFacilityMember_9ebc9304-6af5-4956-8a03-ae7aeea8d0dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_e0eb7529-9f8d-46b9-9d47-574eeceeee96" xlink:href="iart-20201231.xsd#iart_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_TermLoanFacilityMember_e0eb7529-9f8d-46b9-9d47-574eeceeee96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_4946512b-4070-4f11-905f-1a59d82d0646" xlink:href="iart-20201231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_4946512b-4070-4f11-905f-1a59d82d0646" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bf2d9e73-b344-48b7-9a30-a8f61b64656c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:to="loc_us-gaap_CreditFacilityDomain_bf2d9e73-b344-48b7-9a30-a8f61b64656c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:to="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_90e917c0-e4b5-4d17-9f35-7937f49be769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_SecuredDebtMember_90e917c0-e4b5-4d17-9f35-7937f49be769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4d1a4abd-31ca-47e3-8fb8-839e6e2fab69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4d1a4abd-31ca-47e3-8fb8-839e6e2fab69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_e19b74cf-a932-4e7b-8762-b7f591c89918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_e19b74cf-a932-4e7b-8762-b7f591c89918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_6975fb68-9a19-46b1-b77b-dd0d9a1ca904" xlink:href="iart-20201231.xsd#iart_SwinglineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_iart_SwinglineLoanMember_6975fb68-9a19-46b1-b77b-dd0d9a1ca904" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ed9abc08-3625-4031-b3e4-728b0fa9ab21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:to="loc_us-gaap_VariableRateDomain_ed9abc08-3625-4031-b3e4-728b0fa9ab21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:to="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fafab6af-64f4-4f5f-8d41-aac067b89b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_us-gaap_EurodollarMember_fafab6af-64f4-4f5f-8d41-aac067b89b7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ef9a5ecb-d305-4922-80aa-b0e46f68f6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ef9a5ecb-d305-4922-80aa-b0e46f68f6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_5c911d0d-a671-4629-b1f1-2c91b7b47895" xlink:href="iart-20201231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_iart_OneMonthEurodollarRateMember_5c911d0d-a671-4629-b1f1-2c91b7b47895" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1dc53da-64fe-40e6-8543-670e5b0676d6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:to="loc_srt_RangeMember_d1dc53da-64fe-40e6-8543-670e5b0676d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:to="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b97d48a2-76d5-4ba5-b809-96869a308c71" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:to="loc_srt_MinimumMember_b97d48a2-76d5-4ba5-b809-96869a308c71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2dd6db0f-9b74-418c-977c-a3eab1a091ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:to="loc_srt_MaximumMember_2dd6db0f-9b74-418c-977c-a3eab1a091ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6e98c69-d1e7-4c5a-a448-7be939cf289a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6e98c69-d1e7-4c5a-a448-7be939cf289a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_597c8ef5-c65e-4f5d-b877-6e262402df44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_597c8ef5-c65e-4f5d-b877-6e262402df44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42caa70b-76a4-4ef8-ba65-f858f9697ff0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42caa70b-76a4-4ef8-ba65-f858f9697ff0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec603de1-6870-42b3-a85a-a78d250f62d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec603de1-6870-42b3-a85a-a78d250f62d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_7ee9d798-033c-481e-a8a2-ca486dcb2368_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_7ee9d798-033c-481e-a8a2-ca486dcb2368_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_b6bc76a1-528e-44c7-a246-2ba8c610d0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:to="loc_us-gaap_CallOptionMember_b6bc76a1-528e-44c7-a246-2ba8c610d0e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended" id="i1ae5fe831344450fa1c0602e5a0c9dc8_DEBTMaximumTotalLeverageRatioTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_4c047c13-ff27-494a-817e-5dbfd535607b" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_4c047c13-ff27-494a-817e-5dbfd535607b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:to="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_9fe9eceb-1402-4f13-8a38-7c85c563695c" xlink:href="iart-20201231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:to="loc_iart_SeniorCreditFacilityMember_9fe9eceb-1402-4f13-8a38-7c85c563695c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:to="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_21047d4f-ee6c-4243-bde8-45c3e66a89c2_default" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:to="loc_iart_DebtCovenantPeriodDomain_21047d4f-ee6c-4243-bde8-45c3e66a89c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:to="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_9d59ecd2-7044-4437-85b6-e4c1ba5cef38" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod1Member_9d59ecd2-7044-4437-85b6-e4c1ba5cef38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_b51c52e9-499c-4a72-81be-997fa6e1a011" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod2Member_b51c52e9-499c-4a72-81be-997fa6e1a011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_0b9f52e5-149b-48e0-8c89-4dcf0fcec395" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod3Member_0b9f52e5-149b-48e0-8c89-4dcf0fcec395" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_234e29d2-6cf5-4306-8243-b29d35fe6acf" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod4Member_234e29d2-6cf5-4306-8243-b29d35fe6acf" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended" id="i1b73b70da95f4672a323c9e732251d5b_DEBTScheduleofDebtMaturityDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended" id="i90c3bc46fcf443b590cc3c02f507a247_DERIVATIVEINSTRUMENTS"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended" id="i2045e5363f594a3fab616ce7f593830a_DERIVATIVEINSTRUMENTSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended" id="i01fbb72fed414c28879203cd0b1d4ae0_DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_bb95d0c0-492e-4168-8ddf-a65a08973840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_bb95d0c0-492e-4168-8ddf-a65a08973840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_81e96649-f00b-4836-a383-d6581d542eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_81e96649-f00b-4836-a383-d6581d542eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9449b12e-39fd-4b09-aa60-8c3c0be544cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9449b12e-39fd-4b09-aa60-8c3c0be544cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_50905e87-ca82-4bc6-af67-3be45f3cd6c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_50905e87-ca82-4bc6-af67-3be45f3cd6c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e6532e96-d2a0-4bc6-bb14-65fdebe84ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e6532e96-d2a0-4bc6-bb14-65fdebe84ba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4408d70d-4d8f-46c0-8f4a-431384e6cd45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:to="loc_us-gaap_HedgingDesignationDomain_4408d70d-4d8f-46c0-8f4a-431384e6cd45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdbc3990-6036-4eea-adc7-c9d50e68c53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdbc3990-6036-4eea-adc7-c9d50e68c53f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9faac9e1-0156-4df8-a11f-b69cd4752881_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:to="loc_us-gaap_VariableRateDomain_9faac9e1-0156-4df8-a11f-b69cd4752881_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:to="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThreeMonthUSDLIBORMember_ceb9adcc-69c9-47ac-a2e4-1d7ee3a68131" xlink:href="iart-20201231.xsd#iart_ThreeMonthUSDLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:to="loc_iart_ThreeMonthUSDLIBORMember_ceb9adcc-69c9-47ac-a2e4-1d7ee3a68131" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_5e4e01f8-c762-4a6c-a7d7-b110f178454c" xlink:href="iart-20201231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:to="loc_iart_OneMonthUSDLIBORMember_5e4e01f8-c762-4a6c-a7d7-b110f178454c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ef2624e-ed54-4fff-844a-32b9042206a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ef2624e-ed54-4fff-844a-32b9042206a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_de092f63-6f48-428e-bbb1-3ed09c52cacc" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_de092f63-6f48-428e-bbb1-3ed09c52cacc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_e7a2479b-a8a6-4967-84e8-eb07077a5433" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_e7a2479b-a8a6-4967-84e8-eb07077a5433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member_26213333-c41a-40cb-8b21-1b8d19374d50" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedMarch272017Member_26213333-c41a-40cb-8b21-1b8d19374d50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_5ee225f8-321d-4f1a-8749-d54d3087d037" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_5ee225f8-321d-4f1a-8749-d54d3087d037" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_afbc5581-ea91-4622-ac37-a4ee3f402a65" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_afbc5581-ea91-4622-ac37-a4ee3f402a65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_a63130e4-0dd3-4f12-b2f3-74c862f4b9ba" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_a63130e4-0dd3-4f12-b2f3-74c862f4b9ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_104f237c-bfbe-4d83-ab67-118a0f6861d1" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_104f237c-bfbe-4d83-ab67-118a0f6861d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_a3961dac-41d9-42e5-ab26-aedf7007e604" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_a3961dac-41d9-42e5-ab26-aedf7007e604" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_c338452c-c7bc-4628-9d02-86983d05d3e9" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_c338452c-c7bc-4628-9d02-86983d05d3e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_9fe4a3e8-1ac9-4e49-b78a-bbcd1c74b28a" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_9fe4a3e8-1ac9-4e49-b78a-bbcd1c74b28a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_15a5cc94-e568-4ca4-8745-993304f0d4b8" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_15a5cc94-e568-4ca4-8745-993304f0d4b8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_568d01a9-ddce-44fc-91c2-16ac8923e9c7" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_568d01a9-ddce-44fc-91c2-16ac8923e9c7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_a68b7023-fb3b-40ec-bf1e-f0f21f0c4dc9" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_a68b7023-fb3b-40ec-bf1e-f0f21f0c4dc9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_ee343b4b-d3ee-4f00-a0d9-e9ad9b70bc78" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_ee343b4b-d3ee-4f00-a0d9-e9ad9b70bc78" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_d0ddb340-6f68-4d7c-b535-d3463e3dc2be" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_d0ddb340-6f68-4d7c-b535-d3463e3dc2be" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_68b4d238-7e0c-4788-91c4-90b9e180047d" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_68b4d238-7e0c-4788-91c4-90b9e180047d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_5c8773dd-c65a-4ba1-b210-5a2b5586e560" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_5c8773dd-c65a-4ba1-b210-5a2b5586e560" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_7b28ea7e-3953-4908-bd43-1364a5d701b3" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_7b28ea7e-3953-4908-bd43-1364a5d701b3" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i54097fbd6390497cbf4f8b77fcbb3df7_DERIVATIVEINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_131966d9-6344-44c6-9143-fcdec4ebde67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_131966d9-6344-44c6-9143-fcdec4ebde67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_55684bd2-279f-4da2-aafe-85dc86bbef63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_55684bd2-279f-4da2-aafe-85dc86bbef63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eb4b2715-5cd5-44da-ba5d-9fc49ac4447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eb4b2715-5cd5-44da-ba5d-9fc49ac4447d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_50edca66-44fe-4bb6-b9c0-ed942a4ab257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_50edca66-44fe-4bb6-b9c0-ed942a4ab257" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f4c1eef4-4594-4190-bc6b-0d205d6f1b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f4c1eef4-4594-4190-bc6b-0d205d6f1b33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f34a6a68-3e9c-49ac-baaa-54391978e370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f34a6a68-3e9c-49ac-baaa-54391978e370" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b372d23-73e1-4e5d-a6ea-acab509766c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b372d23-73e1-4e5d-a6ea-acab509766c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_271eb9ad-f55f-4d86-8c47-96bfc9b9fc4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_271eb9ad-f55f-4d86-8c47-96bfc9b9fc4c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c4ab7189-0a7e-4212-8895-3aeabcb52273_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c4ab7189-0a7e-4212-8895-3aeabcb52273_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e1b8172a-2d27-415f-a302-d15c15c7d8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e1b8172a-2d27-415f-a302-d15c15c7d8e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_28aa8111-f7bd-4dc3-ae6c-6f8bc6c070b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_28aa8111-f7bd-4dc3-ae6c-6f8bc6c070b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_b3b6561d-3487-480d-8be4-4635d7efe2b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:to="loc_us-gaap_PositionDomain_b3b6561d-3487-480d-8be4-4635d7efe2b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:to="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_82dd41d3-59f5-403b-954e-0d6eb5055ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:to="loc_us-gaap_ShortMember_82dd41d3-59f5-403b-954e-0d6eb5055ccb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e2170593-2e54-41cd-9ea5-8edb2dc32ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:to="loc_us-gaap_LongMember_e2170593-2e54-41cd-9ea5-8edb2dc32ba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b03b685a-9cfd-4e3f-8d80-320c49a0d34a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b03b685a-9cfd-4e3f-8d80-320c49a0d34a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7eac7850-bb6c-4bc0-8513-797a1e96ec52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:to="loc_us-gaap_CashFlowHedgingMember_7eac7850-bb6c-4bc0-8513-797a1e96ec52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2f39c2a8-72c8-4057-956a-f508aa0cb922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2f39c2a8-72c8-4057-956a-f508aa0cb922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5f185eee-9f62-4fad-90ac-0147a1850850_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:to="loc_us-gaap_HedgingDesignationDomain_5f185eee-9f62-4fad-90ac-0147a1850850_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:to="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ed19b97d-c4d3-4b21-9e00-f34b58fb777c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:to="loc_us-gaap_NondesignatedMember_ed19b97d-c4d3-4b21-9e00-f34b58fb777c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_279aacbf-322e-4c89-bc38-5d7320cc0843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_279aacbf-322e-4c89-bc38-5d7320cc0843" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended" id="ic3248e0e81b3496798c9c811ed01cfef_DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_9f26f41c-75a9-4011-a5dc-9f0d0bcaf902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_9f26f41c-75a9-4011-a5dc-9f0d0bcaf902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_aabc1f82-9dde-4979-93a5-7182dad92a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeNotionalAmount_aabc1f82-9dde-4979-93a5-7182dad92a87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_ad89f3a7-4ec6-4cc1-8974-32de4bfb6f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_ad89f3a7-4ec6-4cc1-8974-32de4bfb6f47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2fa7382a-e244-4a01-82df-321a471395b5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2fa7382a-e244-4a01-82df-321a471395b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b17a9a69-673f-46ef-bed4-896d78e85256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:to="loc_us-gaap_CashFlowHedgingMember_b17a9a69-673f-46ef-bed4-896d78e85256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78301c3e-826f-4b78-b862-d1fca90fd4d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_78301c3e-826f-4b78-b862-d1fca90fd4d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_166496b8-60c3-4b04-9ef3-0adff6b58515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_166496b8-60c3-4b04-9ef3-0adff6b58515" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99e1971d-3891-4989-b7e2-61272160215b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99e1971d-3891-4989-b7e2-61272160215b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_988ebf4a-299f-4138-bfcf-273c2c6eea6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_988ebf4a-299f-4138-bfcf-273c2c6eea6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_beb057e6-2c93-4b98-82a6-10864177d09d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:to="loc_us-gaap_PositionDomain_beb057e6-2c93-4b98-82a6-10864177d09d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:to="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_88aed31e-9c0f-42c3-9a40-ef2fb50dd3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:to="loc_us-gaap_LongMember_88aed31e-9c0f-42c3-9a40-ef2fb50dd3dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_595450a8-17df-42c9-872f-19a36bbb998b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:to="loc_us-gaap_ShortMember_595450a8-17df-42c9-872f-19a36bbb998b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c1da6535-f745-4b69-8217-a7defa8a5ce4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c1da6535-f745-4b69-8217-a7defa8a5ce4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapOneMember_02b57946-1181-4c9f-a2c8-b10d6f8ed539" xlink:href="iart-20201231.xsd#iart_SwapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapOneMember_02b57946-1181-4c9f-a2c8-b10d6f8ed539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapTwoMember_5f3ee737-b910-473d-ba95-7819756e6419" xlink:href="iart-20201231.xsd#iart_SwapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapTwoMember_5f3ee737-b910-473d-ba95-7819756e6419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapThreeMember_d213049c-e5ce-47ec-96bd-6811d323483a" xlink:href="iart-20201231.xsd#iart_SwapThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapThreeMember_d213049c-e5ce-47ec-96bd-6811d323483a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapFourMember_8f3202ee-aaf1-4368-bde7-408b29a27d94" xlink:href="iart-20201231.xsd#iart_SwapFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapFourMember_8f3202ee-aaf1-4368-bde7-408b29a27d94" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended" id="i87b1a6e12eb64a8bae74077676709d27_DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_0ad0d0f1-20cf-4114-aabf-41db48d982b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_0ad0d0f1-20cf-4114-aabf-41db48d982b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4b2cfbfa-ef09-416c-90db-a1ddda39502e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4b2cfbfa-ef09-416c-90db-a1ddda39502e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_50817e53-c10d-4922-8896-b93cd19ebed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_50817e53-c10d-4922-8896-b93cd19ebed7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_93ce0c54-6b2d-4a07-81a4-2506b9b5c727_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:to="loc_us-gaap_HedgingRelationshipDomain_93ce0c54-6b2d-4a07-81a4-2506b9b5c727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:to="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8fbf6775-ebf6-4a28-8453-501010fe455e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8fbf6775-ebf6-4a28-8453-501010fe455e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5dcd2e9e-4424-4dc5-8e5a-d38c846c8d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5dcd2e9e-4424-4dc5-8e5a-d38c846c8d05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_be471c5e-b631-4cd2-b43c-e3cd64480736_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_be471c5e-b631-4cd2-b43c-e3cd64480736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_d096ca93-a377-4de5-9505-6282266bd379" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_d096ca93-a377-4de5-9505-6282266bd379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_b3b5e2c1-442f-40c8-ac7e-3e5cade2f0ee" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_b3b5e2c1-442f-40c8-ac7e-3e5cade2f0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_f6047ad6-2071-4fd3-8532-88effca9478e" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_f6047ad6-2071-4fd3-8532-88effca9478e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_b56a0a2a-8b64-49b3-ab17-ce88bce141e8" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_b56a0a2a-8b64-49b3-ab17-ce88bce141e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFiveMember_75af3be1-913e-45fa-8d54-25bfe9d92319" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractFiveMember_75af3be1-913e-45fa-8d54-25bfe9d92319" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractSixMember_38410e39-31ce-47af-8638-72ba61196909" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractSixMember_38410e39-31ce-47af-8638-72ba61196909" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_83cb369a-062c-45b9-bae5-47c2ffc0b375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_83cb369a-062c-45b9-bae5-47c2ffc0b375" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_aa698800-e76f-4e4f-b480-ba397345d790_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:to="loc_us-gaap_PositionDomain_aa698800-e76f-4e4f-b480-ba397345d790_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:to="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e2060004-51ba-4dd0-a6ec-415674cb961b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:to="loc_us-gaap_LongMember_e2060004-51ba-4dd0-a6ec-415674cb961b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_42f49559-98fa-44e3-b0c3-f049e5e17d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:to="loc_us-gaap_ShortMember_42f49559-98fa-44e3-b0c3-f049e5e17d0b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended" id="id37c13730da9419c9b9564928962c896_DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2c9269f0-5423-42a7-9c6a-040cccbe4e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2c9269f0-5423-42a7-9c6a-040cccbe4e55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_22e80f85-2e92-4961-a3bb-a69215f28749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_22e80f85-2e92-4961-a3bb-a69215f28749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_598a9931-a2fa-4037-8258-69cbe31c1087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_598a9931-a2fa-4037-8258-69cbe31c1087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f462a061-fd9a-46c9-8056-c09a586def4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:to="loc_us-gaap_HedgingDesignationDomain_f462a061-fd9a-46c9-8056-c09a586def4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:to="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b572c4b0-f482-40ed-98c2-634cf158091a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b572c4b0-f482-40ed-98c2-634cf158091a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ad57330-f8c8-40a2-9b34-16b22c170d5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ad57330-f8c8-40a2-9b34-16b22c170d5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7430f93f-5ee7-4532-ad96-740c4b9f4dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:to="loc_us-gaap_InterestRateSwapMember_7430f93f-5ee7-4532-ad96-740c4b9f4dc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_be23461f-65e3-4b03-a760-baa2298cbb06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_be23461f-65e3-4b03-a760-baa2298cbb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_744573c9-c210-4396-9a9a-4a70bc1fafeb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_744573c9-c210-4396-9a9a-4a70bc1fafeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1f329104-c5c0-4dd2-ac6a-6004021cfd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:to="loc_us-gaap_CashFlowHedgingMember_1f329104-c5c0-4dd2-ac6a-6004021cfd20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e6f59b51-da1a-419b-b7e7-ead174034e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e6f59b51-da1a-419b-b7e7-ead174034e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_016fc932-fe64-4269-9fcc-55af0baa33f1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_016fc932-fe64-4269-9fcc-55af0baa33f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f60c1431-56fc-4121-982f-ca44441a498c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f60c1431-56fc-4121-982f-ca44441a498c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_51dbcaaf-30bb-4ad0-b7e8-b23b667d25bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_OtherAssetsMember_51dbcaaf-30bb-4ad0-b7e8-b23b667d25bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_be0f459a-5382-4b49-a220-a4b9dd11e1be" xlink:href="iart-20201231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_be0f459a-5382-4b49-a220-a4b9dd11e1be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_44c656a8-1ad6-4fb9-8fe6-e9bb5881846d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_OtherLiabilitiesMember_44c656a8-1ad6-4fb9-8fe6-e9bb5881846d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended" id="i9ae14c2efbce452c93a21f4194ce2c82_DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_064c7b78-60b5-4fcf-a6e6-1c1b0270d91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_StockholdersEquity_064c7b78-60b5-4fcf-a6e6-1c1b0270d91a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9c086335-190a-4b10-9bbd-e43918d5709d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9c086335-190a-4b10-9bbd-e43918d5709d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b46bee9-c480-4eee-9618-bb14ed8a21eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b46bee9-c480-4eee-9618-bb14ed8a21eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a930381b-250c-4814-aa7e-f4a1e9dca3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_65ebf82a-6561-4139-81a4-8db171f16200_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:to="loc_us-gaap_HedgingDesignationDomain_65ebf82a-6561-4139-81a4-8db171f16200_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:to="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8048b148-8063-4d66-b91f-3dc54b2fa360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8048b148-8063-4d66-b91f-3dc54b2fa360" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b2f04ca-9c38-4983-bba1-faa76f231171_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b2f04ca-9c38-4983-bba1-faa76f231171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_55491e79-68b8-4c20-8b81-149176c7141b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:to="loc_us-gaap_InterestRateSwapMember_55491e79-68b8-4c20-8b81-149176c7141b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a75396af-853d-4a8e-ad7c-6c84d8f74c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a75396af-853d-4a8e-ad7c-6c84d8f74c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9e00715-ef26-4efe-aecb-c5ac0d04dee9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:to="loc_us-gaap_EquityComponentDomain_d9e00715-ef26-4efe-aecb-c5ac0d04dee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:to="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47f32be5-df20-457a-a619-a7f71fcd4e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47f32be5-df20-457a-a619-a7f71fcd4e52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffc4b0be-dcad-4064-ad5f-b3475d703ece_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffc4b0be-dcad-4064-ad5f-b3475d703ece_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_207fa34f-36e2-4aa6-a6d4-5d07213bd82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_InterestExpenseMember_207fa34f-36e2-4aa6-a6d4-5d07213bd82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5090f889-24d3-4e83-9b34-34d35938010d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5090f889-24d3-4e83-9b34-34d35938010d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_b6fe417f-be20-4671-9828-9dd46154bf24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_InterestIncomeMember_b6fe417f-be20-4671-9828-9dd46154bf24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_888e2e75-21ad-4a0a-87c4-45c0b1340b90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_888e2e75-21ad-4a0a-87c4-45c0b1340b90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_37e894ec-e98e-4d6e-9b89-7dbcc677393e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:to="loc_us-gaap_CashFlowHedgingMember_37e894ec-e98e-4d6e-9b89-7dbcc677393e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_cb04c6a8-608c-473a-aa15-1ca6ef8f9f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_cb04c6a8-608c-473a-aa15-1ca6ef8f9f03" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended" id="i4a32bfdf79444da4b8ad60dbf2368512_GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended" id="i7180f9bc48a242e0ac6a23499a01d29b_GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i53359b479b0f46dbb35aa21851dccf93_GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_3f9e7deb-515f-4bdb-91fd-500ee5e2431d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_NumberOfReportingUnits_3f9e7deb-515f-4bdb-91fd-500ee5e2431d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_51d395f3-a032-411b-af7c-3fcc7f338c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_51d395f3-a032-411b-af7c-3fcc7f338c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_eca50b2e-9aeb-462c-a1e0-14d62cac1836" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_eca50b2e-9aeb-462c-a1e0-14d62cac1836" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_f648aedd-d5e4-4371-be6b-5e92ded064fb" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_f648aedd-d5e4-4371-be6b-5e92ded064fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_3c06b930-b88c-465c-8139-b84f44d2b919" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_3c06b930-b88c-465c-8139-b84f44d2b919" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_05e95f50-2cc8-4544-9ac9-42594dfe1567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_05e95f50-2cc8-4544-9ac9-42594dfe1567" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_294b5940-ea53-4526-aeaf-575a150ff15f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_294b5940-ea53-4526-aeaf-575a150ff15f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d15b1254-bcb1-4b3c-b86c-262a7b0aedaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_AdjustmentForAmortization_d15b1254-bcb1-4b3c-b86c-262a7b0aedaa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2a7b10fb-b049-493a-8f70-30d7d0215dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2a7b10fb-b049-493a-8f70-30d7d0215dce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_59f65e5a-062e-4193-b2e4-dde007bd7a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_59f65e5a-062e-4193-b2e4-dde007bd7a29" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_61e6de5a-6b90-4916-84f9-4e4e162cf6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_61e6de5a-6b90-4916-84f9-4e4e162cf6c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2da70577-5d05-4dc0-a94b-3764677e14df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2da70577-5d05-4dc0-a94b-3764677e14df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e88a297b-6086-4073-bb1d-742813a5147d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e88a297b-6086-4073-bb1d-742813a5147d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_994c138c-eaad-49ac-a641-0f2cf906d6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_994c138c-eaad-49ac-a641-0f2cf906d6da" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6e026217-3e7c-4785-bc2c-a83c6eee7447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6e026217-3e7c-4785-bc2c-a83c6eee7447" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_45b90146-33ef-478d-a6d1-310b3a3bbaac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:to="loc_srt_NameOfMajorCustomerDomain_45b90146-33ef-478d-a6d1-310b3a3bbaac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:to="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_a00adc52-62f2-45de-a86c-f59c06facad9" xlink:href="iart-20201231.xsd#iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:to="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_a00adc52-62f2-45de-a86c-f59c06facad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cd6c2950-5831-436d-b63c-88717115f770_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:to="loc_srt_ProductsAndServicesDomain_cd6c2950-5831-436d-b63c-88717115f770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:to="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_54d4ebd5-56a9-4250-84cf-8913e0bbf7cc" xlink:href="iart-20201231.xsd#iart_PrivateLabelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:to="loc_iart_PrivateLabelMember_54d4ebd5-56a9-4250-84cf-8913e0bbf7cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d202042-8836-469b-b713-7e00e2ec9ff3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d202042-8836-469b-b713-7e00e2ec9ff3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b6ef4380-2d08-41f1-83ae-5add5b54c65e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b6ef4380-2d08-41f1-83ae-5add5b54c65e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5893e2ec-dd96-4bfc-978b-33de10015576_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:to="loc_us-gaap_SegmentDomain_5893e2ec-dd96-4bfc-978b-33de10015576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:to="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_0e92b6d1-1ee3-4e55-87af-056c1d0646ad" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_0e92b6d1-1ee3-4e55-87af-056c1d0646ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2175afd-9495-414a-8669-b888428bd81d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2175afd-9495-414a-8669-b888428bd81d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_e6714eb6-11ef-442f-b7e7-4318a5554af8" xlink:href="iart-20201231.xsd#iart_CodmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:to="loc_iart_CodmanMember_e6714eb6-11ef-442f-b7e7-4318a5554af8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="ieb5403a815f944c386143b0970a4cf1c_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:to="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_21ece793-5cae-4b0a-87ff-b40674e6f005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_Goodwill_21ece793-5cae-4b0a-87ff-b40674e6f005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ae6b36c0-d6b3-4eaf-8caa-1a502db61afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ae6b36c0-d6b3-4eaf-8caa-1a502db61afb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_947ab1f7-3aca-43b1-8c87-dcebbc6ef8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_947ab1f7-3aca-43b1-8c87-dcebbc6ef8cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_653fa73b-c2b4-424a-81d6-00b71580289b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillTransfers_653fa73b-c2b4-424a-81d6-00b71580289b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5d2da312-d885-4a02-8355-bca5a4d97b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2b11fc34-ff56-4b64-ab70-50e5dd233482_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:to="loc_us-gaap_SegmentDomain_2b11fc34-ff56-4b64-ab70-50e5dd233482_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:to="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_6f84e79d-9d79-4ce0-b5f2-3f53d1fcd294" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_6f84e79d-9d79-4ce0-b5f2-3f53d1fcd294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_a4e39033-28d1-4709-80e2-db5be80c5cb2" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_a4e39033-28d1-4709-80e2-db5be80c5cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c294fa3c-9581-47c0-ba16-8da44f9e8293_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c294fa3c-9581-47c0-ba16-8da44f9e8293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_789455a8-8258-4b13-a36c-22bc5ff00520" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:to="loc_iart_ArkisBioSciencesInc.Member_789455a8-8258-4b13-a36c-22bc5ff00520" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="if5c3b5ef32e143a3a438697e03d040e4_GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1f9ac3d6-b607-422e-89ad-468498e144a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1f9ac3d6-b607-422e-89ad-468498e144a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_36186c2b-e496-4241-9bfb-ec9e5a346f83" xlink:href="iart-20201231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_36186c2b-e496-4241-9bfb-ec9e5a346f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_16135269-17b1-47b0-9a0d-7912e3fdce57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_16135269-17b1-47b0-9a0d-7912e3fdce57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_adbd9e03-a4dc-49fd-a343-a61031e5c28f" xlink:href="iart-20201231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_adbd9e03-a4dc-49fd-a343-a61031e5c28f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ff0aeab1-317c-482c-b296-945d57d4058b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ff0aeab1-317c-482c-b296-945d57d4058b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b0840c8-f789-4b9e-adb0-098f084b91ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b0840c8-f789-4b9e-adb0-098f084b91ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_2c969da3-862c-4ccc-b720-42d0da81c7aa" xlink:href="iart-20201231.xsd#iart_CompletedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_CompletedTechnologyMember_2c969da3-862c-4ccc-b720-42d0da81c7aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e8f0c926-37f5-49bb-8640-6e43f5b92fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e8f0c926-37f5-49bb-8640-6e43f5b92fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_36ca0b4a-a5e1-4255-9367-424dda41eb50" xlink:href="iart-20201231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_TrademarksBrandNamesMember_36ca0b4a-a5e1-4255-9367-424dda41eb50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_154a911f-5c2d-4a64-ab31-cb59ae4c4456" xlink:href="iart-20201231.xsd#iart_SupplierRelationShipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_SupplierRelationShipsMember_154a911f-5c2d-4a64-ab31-cb59ae4c4456" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_8bbdb7e7-73bc-4e12-be11-3d53baf049cb" xlink:href="iart-20201231.xsd#iart_AllOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_AllOtherMember_8bbdb7e7-73bc-4e12-be11-3d53baf049cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_731ddd76-4a97-4f52-b078-f25673e206ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_731ddd76-4a97-4f52-b078-f25673e206ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_287d5f12-0574-4865-af51-931c04fc9d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:to="loc_us-gaap_TradeNamesMember_287d5f12-0574-4865-af51-931c04fc9d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_eb78c500-7501-4576-821f-7eaa2e74e3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_eb78c500-7501-4576-821f-7eaa2e74e3ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_99a6f821-02eb-419d-8995-83cf93b89def_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_99a6f821-02eb-419d-8995-83cf93b89def_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_98ba26e0-79c5-495c-b461-b79079974703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_98ba26e0-79c5-495c-b461-b79079974703" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b143d5b2-ed94-4444-b077-a17ca14b9bb0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b143d5b2-ed94-4444-b077-a17ca14b9bb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_db4b2dd7-aa11-4d7e-a098-3277757dec27" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:to="loc_iart_SmithNephewUSDLimitedMember_db4b2dd7-aa11-4d7e-a098-3277757dec27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCK"/>
  <link:definitionLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended" id="i0dcfa642ae3847feadc8bc78eaaf27bc_TREASURYSTOCK"/>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended" id="i9e93587a18114543ab1e97455e4d5569_TREASURYSTOCKNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e0f4f231-5ef9-4260-b4bf-23aeeddc86bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e0f4f231-5ef9-4260-b4bf-23aeeddc86bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_a00f7ebd-e3b7-4658-8aff-cc9bffe86719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockCommonValue_a00f7ebd-e3b7-4658-8aff-cc9bffe86719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_91349987-9f86-4df3-95c2-7be38bb9f69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_91349987-9f86-4df3-95c2-7be38bb9f69d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3031350e-e24f-4c37-9b75-dbc41adfd415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3031350e-e24f-4c37-9b75-dbc41adfd415" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_75d7ec7e-27e9-4187-a9cc-5a74dce50b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_75d7ec7e-27e9-4187-a9cc-5a74dce50b27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_99dc1ed4-dad2-49b1-a1a0-403fc6492d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_99dc1ed4-dad2-49b1-a1a0-403fc6492d96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a8d874b4-5ec8-4bf9-886f-f8ea78e18e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a8d874b4-5ec8-4bf9-886f-f8ea78e18e0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_ee1f62b7-dd2b-4128-a12b-8bafdfd7ccdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_ee1f62b7-dd2b-4128-a12b-8bafdfd7ccdc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_959d5496-bb58-40e1-bd7d-ea7ef6799936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_959d5496-bb58-40e1-bd7d-ea7ef6799936" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_23a54516-e50d-48bd-bb6d-acc0be7c3b99" xlink:href="iart-20201231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_23a54516-e50d-48bd-bb6d-acc0be7c3b99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e5617323-6d86-4339-b05a-d48f8cfbb755_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e5617323-6d86-4339-b05a-d48f8cfbb755_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_2d19e302-c636-4d40-8bc6-2227c0a97bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:to="loc_us-gaap_ConvertibleDebtMember_2d19e302-c636-4d40-8bc6-2227c0a97bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:to="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97e7b384-ad9d-44cd-82c4-a7d73728d572_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97e7b384-ad9d-44cd-82c4-a7d73728d572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember_b52d0c51-32f3-4e56-aa7f-0bd5075b83c3" xlink:href="iart-20201231.xsd#iart_CertainPurchasersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:to="loc_iart_CertainPurchasersMember_b52d0c51-32f3-4e56-aa7f-0bd5075b83c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended" id="i91aae9297d4c4cdea02fac8296405002_STOCKBASEDCOMPENSATION"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended" id="i954405d1a68b4cf7a3650a2fe7660aa9_STOCKBASEDCOMPENSATIONTables"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended" id="i173218b3122a441e8a73b83717f08881_STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4040b20f-66c2-42f4-9865-0c05e03cd7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4040b20f-66c2-42f4-9865-0c05e03cd7e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fe8a5e4b-7035-4ffa-be2c-cb8460449e32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fe8a5e4b-7035-4ffa-be2c-cb8460449e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2ffc6105-990b-4444-a9ad-282703c6a324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2ffc6105-990b-4444-a9ad-282703c6a324" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2e155914-2343-4b4c-bf41-dd1347637f2f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2e155914-2343-4b4c-bf41-dd1347637f2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_98354499-7fbb-4418-b009-304094174bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_CostOfSalesMember_98354499-7fbb-4418-b009-304094174bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_aac067f3-0c1c-4651-87bd-2e24874b5915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_aac067f3-0c1c-4651-87bd-2e24874b5915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2577cac7-7376-440b-8284-936e78ecf848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2577cac7-7376-440b-8284-936e78ecf848" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i146ce31f09694b769221afcf64fa8950_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2d3d2d9e-558a-44e0-b768-f24b3c923b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2d3d2d9e-558a-44e0-b768-f24b3c923b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3cf01696-ed09-4ea1-a21b-5aa98e64aa3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3cf01696-ed09-4ea1-a21b-5aa98e64aa3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_4cc6c0ad-26b8-440a-824a-df162288d5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_4cc6c0ad-26b8-440a-824a-df162288d5d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_60f3ade0-1883-40c0-9a2f-dd0ea3c31819" xlink:href="iart-20201231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_60f3ade0-1883-40c0-9a2f-dd0ea3c31819" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_5bdf9019-af99-4246-8f7b-5c4cb8d7f97b" xlink:href="iart-20201231.xsd#iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_5bdf9019-af99-4246-8f7b-5c4cb8d7f97b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_edbd97b1-ce6b-4ccd-bb6f-5aea53920972" xlink:href="iart-20201231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_IncreaseInAuthorizedShares_edbd97b1-ce6b-4ccd-bb6f-5aea53920972" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f9b3ad19-10ca-4178-b867-e37f599cb781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f9b3ad19-10ca-4178-b867-e37f599cb781" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e5af7b7e-fe2d-4f21-9d59-6ee1055702c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e5af7b7e-fe2d-4f21-9d59-6ee1055702c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c4f1bd22-e383-4653-889e-71967ec84565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c4f1bd22-e383-4653-889e-71967ec84565" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6d57212f-9e13-4d39-bfbb-8c67fdc89c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6d57212f-9e13-4d39-bfbb-8c67fdc89c00" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6e8f0c2-1384-4f2c-9274-47416acff64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6e8f0c2-1384-4f2c-9274-47416acff64b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_875bbbf0-c81e-4639-a879-1e834fb2598c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_875bbbf0-c81e-4639-a879-1e834fb2598c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6b95002-8616-4d62-abb3-e969cc1d7f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6b95002-8616-4d62-abb3-e969cc1d7f0d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ffcf1787-83af-429c-9a43-b2c3a72ce8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ffcf1787-83af-429c-9a43-b2c3a72ce8b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_afe33b9e-4ae4-44e9-b983-fb7b4865352e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_afe33b9e-4ae4-44e9-b983-fb7b4865352e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d4bca458-6731-4ceb-86a2-000f6e4b1e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d4bca458-6731-4ceb-86a2-000f6e4b1e26" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_e52bb632-44d3-48e6-9e34-09fdf69516ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_e52bb632-44d3-48e6-9e34-09fdf69516ca" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_8b4db4de-4ecf-4cb2-a6b1-bf52615df3ca" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_8b4db4de-4ecf-4cb2-a6b1-bf52615df3ca" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_e00e265d-a225-4dda-a804-9a4833961ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_e00e265d-a225-4dda-a804-9a4833961ab2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7555c973-d5a1-49c8-8cce-ebc1759040bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7555c973-d5a1-49c8-8cce-ebc1759040bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_40d789ec-4ed2-4e11-8041-4c46a899ef8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_EmployeeStockMember_40d789ec-4ed2-4e11-8041-4c46a899ef8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e24ce26b-5275-43a5-ad52-00d09f5ba5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e24ce26b-5275-43a5-ad52-00d09f5ba5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_58e660db-2659-4206-abf7-e6922495b9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_58e660db-2659-4206-abf7-e6922495b9ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_a0243992-ddf4-4f10-a1fa-88b6a6b5d3cf" xlink:href="iart-20201231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_a0243992-ddf4-4f10-a1fa-88b6a6b5d3cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_82d5e7e5-95c7-4a28-8df2-de811b4cc2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_PerformanceSharesMember_82d5e7e5-95c7-4a28-8df2-de811b4cc2c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_43a26cc0-3adc-41b1-be33-8ea81207839d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:to="loc_us-gaap_PlanNameDomain_43a26cc0-3adc-41b1-be33-8ea81207839d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:to="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_fe727b01-ad67-4aca-af18-fd650a25b1fc" xlink:href="iart-20201231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandThreePlanMember_fe727b01-ad67-4aca-af18-fd650a25b1fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_3b18913d-5f7d-4786-a357-e5f2a5a34295" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandPlanMember_3b18913d-5f7d-4786-a357-e5f2a5a34295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_0273f615-19d4-405a-b260-5441da5adec9" xlink:href="iart-20201231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandOnePlanMember_0273f615-19d4-405a-b260-5441da5adec9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_11b2a4ba-ba70-4486-bac4-225402f5be3f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_11b2a4ba-ba70-4486-bac4-225402f5be3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_711c378c-329e-4f2d-845c-c330581b4938" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_srt_DirectorMember_711c378c-329e-4f2d-845c-c330581b4938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_2fcca920-7ef2-4b48-b46f-81878e05a406" xlink:href="iart-20201231.xsd#iart_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_iart_EmployeeMember_2fcca920-7ef2-4b48-b46f-81878e05a406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_17ac3b87-1bfe-4d90-b279-631467824ee1" xlink:href="iart-20201231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_17ac3b87-1bfe-4d90-b279-631467824ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:to="loc_srt_RangeMember_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:to="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ad20d83-a780-44ca-9d9a-5319c370e3f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:to="loc_srt_MinimumMember_5ad20d83-a780-44ca-9d9a-5319c370e3f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b7e1c5a-2385-4c0f-ba3d-97893f4586fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:to="loc_srt_MaximumMember_4b7e1c5a-2385-4c0f-ba3d-97893f4586fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="extended" id="ie048ca0a424b49cebdc811cc9f4dc54d_STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="extended" id="i16fd6b7b5e65456a838f2c2ccef1932e_STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended" id="i2b991552bd3e442fbd2e70260ffe4f57_STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_10a3b279-fbeb-4f61-a89f-bcbab2171c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_10a3b279-fbeb-4f61-a89f-bcbab2171c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e615297-6ca2-4a44-a0b1-2b7dbac7fb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e615297-6ca2-4a44-a0b1-2b7dbac7fb10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_da4b4aca-ec9f-4750-b17a-9ef919bb5cff" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_da4b4aca-ec9f-4750-b17a-9ef919bb5cff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_54fbcb81-5683-456d-b788-99c7697f529a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_54fbcb81-5683-456d-b788-99c7697f529a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f10e468e-c75d-4205-9208-a4cf64154f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f10e468e-c75d-4205-9208-a4cf64154f7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_114e2f51-5902-4e41-95e4-dd7ce6495027" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_114e2f51-5902-4e41-95e4-dd7ce6495027" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e199493-85e3-4fcc-a68d-a4d73122e5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64b1c98e-fe83-4f4f-bb98-c40bec130303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64b1c98e-fe83-4f4f-bb98-c40bec130303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_171cd7f7-d918-4f65-8d6b-3df920d05ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_171cd7f7-d918-4f65-8d6b-3df920d05ce8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_50089bd2-2261-4178-bcaa-6f47d68a99c4" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_50089bd2-2261-4178-bcaa-6f47d68a99c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6c3f62f1-8b51-40ab-8eb5-de7854cf71e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6c3f62f1-8b51-40ab-8eb5-de7854cf71e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0d6cb4c0-34c6-46a6-b1c5-fb3bc25c8b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0d6cb4c0-34c6-46a6-b1c5-fb3bc25c8b8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_049da7a3-a79a-4442-8cf9-8e71bbc495fa" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_049da7a3-a79a-4442-8cf9-8e71bbc495fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d6b6e036-b78f-4d93-bc45-bf6969b3779f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:to="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fe218823-292d-4dd0-975e-de6fb1027e1c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fe218823-292d-4dd0-975e-de6fb1027e1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f215c304-a1bd-44bc-acc0-bb7ae732d566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:to="loc_us-gaap_RestrictedStockMember_f215c304-a1bd-44bc-acc0-bb7ae732d566" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_46377ab3-1c2a-41c3-a3fc-cc27e24c9bf4" xlink:href="iart-20201231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:to="loc_iart_PerformanceStockandContractStockMember_46377ab3-1c2a-41c3-a3fc-cc27e24c9bf4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="extended" id="i36eb1a14217440f8810bc4b9c684c71c_RETIREMENTBENEFITPLANS"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="extended" id="i239b583d36db437c92b6df28e895a421_RETIREMENTBENEFITPLANSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i4d8c53ad04a649379e0543194a91eac2_RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="extended" id="i098718ad322941bd8a8ecc0d875e399e_RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="i37100fe2e66b458dbac178da8dc292a9_RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended" id="i8665ec1f9f2e40949a72582b2350041b_RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended" id="i2facd6340560464980fff3baf747b71e_RETIREMENTBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64ba6c0a-54ba-470e-93ef-420db791cb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64ba6c0a-54ba-470e-93ef-420db791cb46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a6234e97-152f-4621-a885-1ba0c12189c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a6234e97-152f-4621-a885-1ba0c12189c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e9d5f6d-7d5e-4427-b382-900f8bfd4795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e9d5f6d-7d5e-4427-b382-900f8bfd4795" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_dd135ca8-c3a8-43b6-b480-a550f1de5457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_dd135ca8-c3a8-43b6-b480-a550f1de5457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_2d4d1fed-427d-491c-ba76-72daea6e5af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_2d4d1fed-427d-491c-ba76-72daea6e5af0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06041d39-027a-4040-b6f6-c715b91978a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06041d39-027a-4040-b6f6-c715b91978a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_e19eda79-2548-4723-81cb-e45d3b19aa08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_e19eda79-2548-4723-81cb-e45d3b19aa08" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0f206033-e6c8-43ec-8653-cebd8bd3709a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0f206033-e6c8-43ec-8653-cebd8bd3709a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:to="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AustriaFranceAndGermanyMember_0b41dd5b-716a-4f08-a104-e2fb58bd898d" xlink:href="iart-20201231.xsd#iart_AustriaFranceAndGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:to="loc_iart_AustriaFranceAndGermanyMember_0b41dd5b-716a-4f08-a104-e2fb58bd898d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="extended" id="i2be80c6d1224431da4361fb88f73d195_RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended" id="i02dfe98cfdc84091906481c80dfcaad6_LEASESANDRELATEDPARTYLEASES"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended" id="ib3b79728171d4c82a8e8c0e15e7ec7dc_LEASESANDRELATEDPARTYLEASESTables"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended" id="ibf5710dc8fc7483ea94ec1cffe87e3a0_LEASESANDRELATEDPARTYLEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_00d3ca9f-aefb-4fa3-8db8-4cb5046f1209" xlink:href="iart-20201231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_00d3ca9f-aefb-4fa3-8db8-4cb5046f1209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_731cfb0c-2555-473e-8529-ec76add35e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_OperatingLeaseExpense_731cfb0c-2555-473e-8529-ec76add35e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_500af928-11cd-400b-9578-e5c693f648e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_500af928-11cd-400b-9578-e5c693f648e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_fe05d354-7649-4b96-87a6-478574547aca" xlink:href="iart-20201231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_fe05d354-7649-4b96-87a6-478574547aca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_1fa401fd-6915-48f1-9e20-78078daccfdf" xlink:href="iart-20201231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_1fa401fd-6915-48f1-9e20-78078daccfdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_e4120d77-4744-410a-be62-15af972ac84b" xlink:href="iart-20201231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_OptionToExtendLeaseYears_e4120d77-4744-410a-be62-15af972ac84b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_5aa74562-0229-4017-9c32-f4cdff4d09b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_5aa74562-0229-4017-9c32-f4cdff4d09b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_060e1331-eb92-47da-b703-7c1bb851e322_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:to="loc_us-gaap_RelatedPartyDomain_060e1331-eb92-47da-b703-7c1bb851e322_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:to="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_7b4cfa51-5c11-4c23-bad7-817f66ab152e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:to="loc_srt_AffiliatedEntityMember_7b4cfa51-5c11-4c23-bad7-817f66ab152e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_5020849d-d04a-4e27-a3ba-63420f134901_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_5020849d-d04a-4e27-a3ba-63420f134901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_59026bf5-ac54-402f-8d0f-e1b9e7ed6def" xlink:href="iart-20201231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_59026bf5-ac54-402f-8d0f-e1b9e7ed6def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_70ba8ccb-af1c-458a-a190-7408db33e8eb" xlink:href="iart-20201231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_70ba8ccb-af1c-458a-a190-7408db33e8eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="ibc538d1c128a42f6a4a57c84694a98a8_LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4be4c778-e63d-4f6f-be99-7599bfa8eb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4be4c778-e63d-4f6f-be99-7599bfa8eb5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb3d0768-69d1-4925-8b25-d7716f13fa9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb3d0768-69d1-4925-8b25-d7716f13fa9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bfb0a830-a18d-49e4-a637-c7cd39bb5f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bfb0a830-a18d-49e4-a637-c7cd39bb5f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3c206c48-fb17-4b71-8b0d-2e5313e37b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiability_3c206c48-fb17-4b71-8b0d-2e5313e37b85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8c0496b-03cf-4705-9f33-b2124ce8ac72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8c0496b-03cf-4705-9f33-b2124ce8ac72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c0638760-59df-4e4d-80a8-1183a458e48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c0638760-59df-4e4d-80a8-1183a458e48c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_3026544d-ac3c-4539-9d53-65bdef2751c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:to="loc_us-gaap_BuildingMember_3026544d-ac3c-4539-9d53-65bdef2751c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_90b5702c-9348-49fb-ab86-2cc01bd27a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:to="loc_us-gaap_VehiclesMember_90b5702c-9348-49fb-ab86-2cc01bd27a21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended" id="ica068b2f776b4b178c887456025aa1c4_LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended" id="ib611b0edffcc4ef8bd89045fa73badf3_LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d222c911-054b-4be0-8d24-d3a78709c1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d222c911-054b-4be0-8d24-d3a78709c1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb20ad3d-6a87-41fb-a89f-1bf0d7d69c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb20ad3d-6a87-41fb-a89f-1bf0d7d69c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cbac5b5c-f90e-4039-8043-9e29b99763dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cbac5b5c-f90e-4039-8043-9e29b99763dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e39d2-0145-490f-8ca3-50e3bf07a821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e39d2-0145-490f-8ca3-50e3bf07a821" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7ad0e605-0479-4ac5-8c40-52e968a25a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7ad0e605-0479-4ac5-8c40-52e968a25a0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6e0e4369-87c0-4cc0-bf65-6694c492ffdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6e0e4369-87c0-4cc0-bf65-6694c492ffdd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6d9bc505-5864-4916-96d7-8a16702c6639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6d9bc505-5864-4916-96d7-8a16702c6639" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d7a6f2ca-7f51-411b-98ad-287d7c12eaad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d7a6f2ca-7f51-411b-98ad-287d7c12eaad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_18b78dbd-f51f-4313-b330-2c0e2e8b76a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiability_18b78dbd-f51f-4313-b330-2c0e2e8b76a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7b3a1a-dbf6-4e8a-9675-f53899645f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7b3a1a-dbf6-4e8a-9675-f53899645f41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e040d0a0-953d-40e8-bd29-7dd53cdf8888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e040d0a0-953d-40e8-bd29-7dd53cdf8888" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:to="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_38ea09b9-a40d-4af5-b411-5ee9aecda893_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_38ea09b9-a40d-4af5-b411-5ee9aecda893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_fbc0876d-b680-4a8a-8169-338ca7b189a9" xlink:href="iart-20201231.xsd#iart_RelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:to="loc_iart_RelatedPartiesMember_fbc0876d-b680-4a8a-8169-338ca7b189a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_4038bd26-0f8d-402d-873b-14e28f264746" xlink:href="iart-20201231.xsd#iart_ThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:to="loc_iart_ThirdPartiesMember_4038bd26-0f8d-402d-873b-14e28f264746" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="extended" id="i5db8e648469948a28b0a7dd13c89f5ee_LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_81f274cb-fff2-4bdc-8877-a7388d894a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_81f274cb-fff2-4bdc-8877-a7388d894a5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fcf8f317-b329-49d2-9c3b-f79be9ef31b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fcf8f317-b329-49d2-9c3b-f79be9ef31b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_74caa1a5-46c4-46d0-9abf-4d0127bc45d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_74caa1a5-46c4-46d0-9abf-4d0127bc45d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2f9a02b-2d88-4828-a03f-ef0dbf75e839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2f9a02b-2d88-4828-a03f-ef0dbf75e839" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f1d1f69c-5f12-424f-abad-7dce27789565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f1d1f69c-5f12-424f-abad-7dce27789565" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_80622b00-c351-48ef-b855-b92512a84ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_80622b00-c351-48ef-b855-b92512a84ee5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f373e76-8278-47b3-bfe8-7c9c78cd15d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f373e76-8278-47b3-bfe8-7c9c78cd15d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_468ab2eb-3d70-47f5-94eb-7ec7e08ea26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_468ab2eb-3d70-47f5-94eb-7ec7e08ea26b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_738297f5-d489-426e-8977-23a93016f7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiability_738297f5-d489-426e-8977-23a93016f7b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01fb0a09-cfde-4be0-8156-d9880202c169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01fb0a09-cfde-4be0-8156-d9880202c169" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b9f19cc9-3a9a-492d-a2cc-0a592ea38dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b9f19cc9-3a9a-492d-a2cc-0a592ea38dd8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:to="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_d414fe39-6be1-43f5-ae3e-7dcd070c3312" xlink:href="iart-20201231.xsd#iart_RelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:to="loc_iart_RelatedPartiesMember_d414fe39-6be1-43f5-ae3e-7dcd070c3312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_61d1235b-9f0c-456c-abc3-c9c2544efa98" xlink:href="iart-20201231.xsd#iart_ThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:to="loc_iart_ThirdPartiesMember_61d1235b-9f0c-456c-abc3-c9c2544efa98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended" id="i3ee0a3b73246416baf8331800f3f546e_INCOMETAXES"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended" id="i129999481cb84892b53faff5560c310a_INCOMETAXESTables"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended" id="i0da52c11b72d4920a8d145a5f579d993_INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="i526758a9ce7045da9ccf7025f73e76cd_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:href="iart-20201231.xsd#iart_IncomeTaxLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_573793cf-52c9-4e7d-a1ad-f7a1982fd45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_573793cf-52c9-4e7d-a1ad-f7a1982fd45f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_36cc359a-6ca8-462e-8d25-951fca359685" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_36cc359a-6ca8-462e-8d25-951fca359685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_f34ec959-f99b-4a7d-942c-584035a5a0c5" xlink:href="iart-20201231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_f34ec959-f99b-4a7d-942c-584035a5a0c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_2e0ffa4f-78dc-4da4-949e-69930bf5675f" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_2e0ffa4f-78dc-4da4-949e-69930bf5675f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_082e46af-74b4-4c28-8098-7fb5a3e6d3bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_082e46af-74b4-4c28-8098-7fb5a3e6d3bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_dcf1271b-94bd-4d4d-9361-adb6b6ce3d27" xlink:href="iart-20201231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_dcf1271b-94bd-4d4d-9361-adb6b6ce3d27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_935aed9d-1732-482d-9b4c-a5ba13cd35c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_935aed9d-1732-482d-9b4c-a5ba13cd35c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_6d85180a-dc84-4a8d-86a2-1c65797e1559" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_6d85180a-dc84-4a8d-86a2-1c65797e1559" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_2e0b86f4-ec0b-4f20-8426-671e43e7bb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_OperatingLossCarryforwards_2e0b86f4-ec0b-4f20-8426-671e43e7bb10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5f2570f6-6c71-4749-a0d5-61759e58d1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5f2570f6-6c71-4749-a0d5-61759e58d1ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d37f066b-23dc-49f1-b06d-78473ec86248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d37f066b-23dc-49f1-b06d-78473ec86248" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3a4e4ce-6560-48a8-8001-fe76d1495068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3a4e4ce-6560-48a8-8001-fe76d1495068" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_65621d08-13c4-4477-bbe4-028505fa6266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_65621d08-13c4-4477-bbe4-028505fa6266" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cd6e9f73-74a5-470c-b668-cab8098e89b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cd6e9f73-74a5-470c-b668-cab8098e89b5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d235312b-2b39-448f-8568-ab0638d69819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d235312b-2b39-448f-8568-ab0638d69819" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_52c9885f-1b9e-4ef2-b774-efa035c9bced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_52c9885f-1b9e-4ef2-b774-efa035c9bced" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_e1451a8b-ad88-4c18-a4e5-a841430fb084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_e1451a8b-ad88-4c18-a4e5-a841430fb084" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:href="iart-20201231.xsd#iart_IncomeTaxTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_24d9bd02-9bd5-4c62-a05c-096d52c59bcf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_24d9bd02-9bd5-4c62-a05c-096d52c59bcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2b365d56-343f-46d8-80b5-7f4c7e5fad2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_ForeignCountryMember_2b365d56-343f-46d8-80b5-7f4c7e5fad2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_de892fbd-c3f6-4bdd-8fbb-331ea0a2c3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_DomesticCountryMember_de892fbd-c3f6-4bdd-8fbb-331ea0a2c3f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d1c86d12-f90b-43ad-a317-1636b277c5f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d1c86d12-f90b-43ad-a317-1636b277c5f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_18787c81-cedc-42eb-be90-971244ee910f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_18787c81-cedc-42eb-be90-971244ee910f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_c47d96b3-01c1-4b73-9451-3ecfab4a395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_c47d96b3-01c1-4b73-9451-3ecfab4a395f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_5233909b-2f37-4025-8440-962ddc8359c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:to="loc_us-gaap_TaxPeriodDomain_5233909b-2f37-4025-8440-962ddc8359c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:to="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UpThroughTaxYear2025Member_acfceca2-2b17-459f-9c85-2cb0da3378d0" xlink:href="iart-20201231.xsd#iart_UpThroughTaxYear2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:to="loc_iart_UpThroughTaxYear2025Member_acfceca2-2b17-459f-9c85-2cb0da3378d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended" id="i65e484cf267744b5a01aee68d91c21e2_INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended" id="id9af02315c6e44f581f4b82183c13cc9_INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i1b470f9cc6c148d4af79a7d24cceafd1_INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="extended" id="i001abfc7b53549108322930d5d39b794_INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARE"/>
  <link:definitionLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended" id="i6aad262064384af9b8702d9d5f1b0089_NETINCOMEPERSHARE"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARETables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended" id="i74a3f5de5600497db0c105952ca4c10d_NETINCOMEPERSHARETables"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended" id="i4ec1b74edaf849f8a97b74f3d73efa38_NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended" id="ief14414bfdb242f29fec18b5f917faca_NETINCOMEPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f1936f9b-1d25-43e2-af47-9273f2997ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f1936f9b-1d25-43e2-af47-9273f2997ef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares_94e7b53c-6d62-4fbf-a388-e5aa1b186f29" xlink:href="iart-20201231.xsd#iart_AdditionalEPSShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:to="loc_iart_AdditionalEPSShares_94e7b53c-6d62-4fbf-a388-e5aa1b186f29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:to="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_388c3907-2bfc-44d6-a611-e59584162d2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_388c3907-2bfc-44d6-a611-e59584162d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember_c9010b54-1b05-4ba3-b3e6-9a165a6978a1" xlink:href="iart-20201231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:to="loc_iart_PerformanceSharesandRestrictedUnitsMember_c9010b54-1b05-4ba3-b3e6-9a165a6978a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended" id="i900ef6970a044b50822da3e951d91c25_ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended" id="iade3b23da5d047bf9b8ac95d671c6c9e_ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i3701bef011f5478abfcec6ea265175bd_ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:href="iart-20201231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bc84114d-81a3-41f0-b2b7-28f7d5edc6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_StockholdersEquity_bc84114d-81a3-41f0-b2b7-28f7d5edc6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0b8bc9d2-4c31-4ce2-9d8e-7efbc4a3faf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0b8bc9d2-4c31-4ce2-9d8e-7efbc4a3faf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_58cc5a7c-6fd1-439f-bbfb-42a27590ebc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_58cc5a7c-6fd1-439f-bbfb-42a27590ebc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_365ab2f6-6652-4052-9e6b-2015d190ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_365ab2f6-6652-4052-9e6b-2015d190ee24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_24d3b4d3-5e6e-4cb3-b624-70a167eb6bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_537803c6-78d1-4165-9825-8c9478a3720d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:to="loc_us-gaap_EquityComponentDomain_537803c6-78d1-4165-9825-8c9478a3720d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:to="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ff3809a5-7f51-4c01-b363-707b367fc9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ff3809a5-7f51-4c01-b363-707b367fc9b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_eef02342-7e9a-43a4-9f0f-296535b50ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_eef02342-7e9a-43a4-9f0f-296535b50ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_796eabb7-2544-4fc1-951a-7db968b6adf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_796eabb7-2544-4fc1-951a-7db968b6adf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4548002-c675-4af8-86ef-7a83b04192c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4548002-c675-4af8-86ef-7a83b04192c9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="extended" id="i7f5386d5486f4996b988a1c3cb9d71fe_ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_05ce34da-2cc9-47de-816f-3263a72709b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_05ce34da-2cc9-47de-816f-3263a72709b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64b676cf-bc2a-4176-bd95-06b591291940_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:to="loc_us-gaap_EquityComponentDomain_64b676cf-bc2a-4176-bd95-06b591291940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:to="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_021fa6ab-5a3b-4847-b510-a46db5d6c8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_021fa6ab-5a3b-4847-b510-a46db5d6c8a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a905da1f-5a51-462e-afd0-c6b66d70198e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a905da1f-5a51-462e-afd0-c6b66d70198e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_993565d3-c713-4bbd-9e45-57d24b1204df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:to="loc_us-gaap_OtherExpenseMember_993565d3-c713-4bbd-9e45-57d24b1204df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_0fac30ad-2816-451b-a25f-f84e2582f6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:to="loc_us-gaap_InterestIncomeMember_0fac30ad-2816-451b-a25f-f84e2582f6a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i592df97d7fde4a74a37dae4d4477eae4_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended" id="ic6707f207df34df98abf7fb0be3ab08d_COMMITMENTSANDCONTINGENCIESTables"/>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="extended" id="i05e844e8b52c44cc9f34a110c9eb9665_COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e149ab6-c092-4ede-8d84-5a990a3ed1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e149ab6-c092-4ede-8d84-5a990a3ed1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_23ce1971-1031-4c7e-929f-6cec8cbe38f7" xlink:href="iart-20201231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_23ce1971-1031-4c7e-929f-6cec8cbe38f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_113850a3-707a-4981-b657-67b26622b9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_113850a3-707a-4981-b657-67b26622b9b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0c0afd5e-50ac-4b7b-b938-80939cb4c413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0c0afd5e-50ac-4b7b-b938-80939cb4c413" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01492bfc-bc19-46e8-8461-6342417d107a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f9b844cb-050b-4d74-83df-3f25345e1e7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f9b844cb-050b-4d74-83df-3f25345e1e7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_4a44e375-ecca-448f-9fff-d1af8df1acf3" xlink:href="iart-20201231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_4a44e375-ecca-448f-9fff-d1af8df1acf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_36d1e625-4db6-4d27-8981-886af98e9ef4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_36d1e625-4db6-4d27-8981-886af98e9ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_db5fc013-ec50-4560-bf81-49a41ef5fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_db5fc013-ec50-4560-bf81-49a41ef5fe3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2629ab1f-a1a0-48b5-899d-ec496305e6dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2629ab1f-a1a0-48b5-899d-ec496305e6dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_84bd65b5-49b3-4a13-8ba9-8704a12faf93" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:to="loc_iart_ArkisBioSciencesInc.Member_84bd65b5-49b3-4a13-8ba9-8704a12faf93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_6bac9cce-45f1-4db4-b0f7-4c9403008a8f" xlink:href="iart-20201231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:to="loc_iart_DermaSciencesMember_6bac9cce-45f1-4db4-b0f7-4c9403008a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6dbeed2d-fd47-4f11-82e4-7b217a964ec9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6dbeed2d-fd47-4f11-82e4-7b217a964ec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_72a432ce-8556-454e-bb64-2f948b55c1e2" xlink:href="iart-20201231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_72a432ce-8556-454e-bb64-2f948b55c1e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_4aa6efd0-ad79-45e7-8024-619d5d54e16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_4aa6efd0-ad79-45e7-8024-619d5d54e16e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended" id="ib1663ffe01ab4a6f81c63e22e4a47afe_SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended" id="i8b27eaae14de435c897b03acdddd646e_SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended" id="i8e38a591d6a34a16a2b60eea480fb304_SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_0555492d-523a-4083-9bdd-9d3d62b476b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:to="loc_us-gaap_NumberOfReportableSegments_0555492d-523a-4083-9bdd-9d3d62b476b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_34e35b3f-4af9-4cc5-aaa3-5640dca4b518" xlink:href="iart-20201231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_34e35b3f-4af9-4cc5-aaa3-5640dca4b518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:to="loc_us-gaap_SegmentDomain_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:to="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_4a4551c2-fb6a-4f3d-ae38-b6db6519c48e" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_4a4551c2-fb6a-4f3d-ae38-b6db6519c48e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended" id="i99d9e16601d142deb8b749ded48b7ab0_SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7f75df7-32aa-4c98-b0b7-619fdc88ec64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7f75df7-32aa-4c98-b0b7-619fdc88ec64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5f340569-f775-4a0e-bdfb-d2a639c16f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:to="loc_us-gaap_OperatingIncomeLoss_5f340569-f775-4a0e-bdfb-d2a639c16f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1042d2f6-3f1c-46c3-8efb-7db40ab2517b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1042d2f6-3f1c-46c3-8efb-7db40ab2517b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:to="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_08a9a170-df65-4288-b32e-ed4cadb6f2fc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:to="loc_srt_ConsolidationItemsDomain_08a9a170-df65-4288-b32e-ed4cadb6f2fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:to="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9209c99f-a4f2-4c47-8214-21263bef0231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:to="loc_us-gaap_OperatingSegmentsMember_9209c99f-a4f2-4c47-8214-21263bef0231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7cd8ee85-f040-43b8-8c7a-b44806d611a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7cd8ee85-f040-43b8-8c7a-b44806d611a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_63a67af2-cafe-468f-ae17-1f7dac371c1e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:to="loc_us-gaap_SegmentDomain_63a67af2-cafe-468f-ae17-1f7dac371c1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:to="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_a4fdb051-a76e-4791-a592-63ba3810ef73" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_a4fdb051-a76e-4791-a592-63ba3810ef73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_b50fd0e5-4aef-4711-8284-987d71dce889" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_b50fd0e5-4aef-4711-8284-987d71dce889" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended" id="iaea62fc26a12481aa185f1ff9dd498bd_SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4be1e39c-a991-4e80-87f6-45f7ecd94b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4be1e39c-a991-4e80-87f6-45f7ecd94b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_485fc8f3-df90-4237-9abe-b87c7b8b59e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:to="loc_us-gaap_NoncurrentAssets_485fc8f3-df90-4237-9abe-b87c7b8b59e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:to="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:to="loc_srt_SegmentGeographicalDomain_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:to="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7a4cf31d-37d3-403b-84c5-aa01b9f61c0a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_country_US_7a4cf31d-37d3-403b-84c5-aa01b9f61c0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c23712e4-415d-4cdd-867a-5278b1b073ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_srt_EuropeMember_c23712e4-415d-4cdd-867a-5278b1b073ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c31d2ad2-cfdb-4354-bf5c-f71e0792fa40" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_srt_AsiaPacificMember_c31d2ad2-cfdb-4354-bf5c-f71e0792fa40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_1186ac4c-d609-4a7d-bb77-c87b57f311a5" xlink:href="iart-20201231.xsd#iart_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_iart_RestOfWorldMember_1186ac4c-d609-4a7d-bb77-c87b57f311a5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="extended" id="i69f12796ad894e0ba1c249e101f7e4a1_SUBSEQUENTEVENTS"/>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="extended" id="ie34ef70a37174c7884b0703b0c27c060_SUBSEQUENTEVENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c4b88590-2255-4b5f-9e54-8cacf1b31d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c4b88590-2255-4b5f-9e54-8cacf1b31d15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_97920a6b-15d9-4631-86f2-1d6a4dcc60d6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_97920a6b-15d9-4631-86f2-1d6a4dcc60d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e39f4862-33dc-48ab-a507-288f65f0c115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e39f4862-33dc-48ab-a507-288f65f0c115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_31ee58e5-36d7-43f3-9f06-d4258d342369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_31ee58e5-36d7-43f3-9f06-d4258d342369" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9b149798-63d4-4583-8ac9-84af06e51d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9b149798-63d4-4583-8ac9-84af06e51d9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_27c40ea6-2a23-4c17-bb3f-71a152503add_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_27c40ea6-2a23-4c17-bb3f-71a152503add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edb7712f-434c-413b-966f-4ed78331ce43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edb7712f-434c-413b-966f-4ed78331ce43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9c2ac05-d644-492d-a888-b67c2de67e38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9c2ac05-d644-492d-a888-b67c2de67e38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_6b64d893-b50d-47af-8cd1-9c1e1c659824" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:to="loc_iart_SmithNephewUSDLimitedMember_6b64d893-b50d-47af-8cd1-9c1e1c659824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_be730c3b-f48e-464b-a5b7-676f2e2416e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_be730c3b-f48e-464b-a5b7-676f2e2416e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4f2bb48f-e369-44d2-9563-9db0125e14de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:to="loc_us-gaap_SubsequentEventMember_4f2bb48f-e369-44d2-9563-9db0125e14de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_85a4c1e5-f158-4403-887d-42858d9cf84a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_85a4c1e5-f158-4403-887d-42858d9cf84a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_a2f2a261-599c-4752-b6fb-ab9ded147825" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_a2f2a261-599c-4752-b6fb-ab9ded147825" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e004cc97-a363-41cd-b064-16955971ee21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e004cc97-a363-41cd-b064-16955971ee21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_30d2a0fe-ce6a-44a4-986a-a6e0b9bcf4e3" xlink:href="iart-20201231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:to="loc_iart_ACellIncMember_30d2a0fe-ce6a-44a4-986a-a6e0b9bcf4e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_eb92cf69-56ff-4828-8fe0-2793308d48f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:to="loc_us-gaap_PlanNameDomain_eb92cf69-56ff-4828-8fe0-2793308d48f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:to="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember_099196d6-edcc-43af-bd80-d12826453e13" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanAndTwoThousandOnePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:to="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember_099196d6-edcc-43af-bd80-d12826453e13" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITED"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="extended" id="i5cd1515a4eea4b50849990fc8fddb8e2_SELECTEDQUARTERLYINFORMATIONUNAUDITED"/>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="extended" id="i8d8978370b124b51926122eef0a0f353_SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables"/>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="extended" id="i4ee4d8053a14409dbf11ef2cc928c19b_SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"/>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended" id="i4e876774b38e43ffb0c5344d3adfb8f4_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i9e6f6b1ec1b84f7480fc92472e6cac52_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a83c1e3b-9489-4d2a-a398-108a93262c90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a83c1e3b-9489-4d2a-a398-108a93262c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c82eb570-30bb-410c-a8f1-a0da2740aeca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c82eb570-30bb-410c-a8f1-a0da2740aeca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_bf83319b-fd5c-416d-b886-e09ddcdf3a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_bf83319b-fd5c-416d-b886-e09ddcdf3a84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_40aec9b4-1622-4fd4-8c90-6a4116652ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_40aec9b4-1622-4fd4-8c90-6a4116652ccd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a3c87747-7ee7-41f8-a213-6ea70af88848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_c058afb1-99d4-4a03-8871-978b5dc0b645_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_c058afb1-99d4-4a03-8871-978b5dc0b645_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_fd0b0495-26f2-48c0-a467-f8b58d0fc627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_fd0b0495-26f2-48c0-a467-f8b58d0fc627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_6f118e12-3171-4683-946b-b4ee2da46999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_6f118e12-3171-4683-946b-b4ee2da46999" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>iart-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0f201d2d-2c18-47d5-94d7-c2f687d196dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0705b0d8-78d0-47c6-8b39-c27fc4571c11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4d2e4950-c903-4e7e-b07f-5bfaf2c49136_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions expected to be paid to plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_82c4f97c-bcf8-499d-b827-1391c801831e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Projected Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6751da2a-54c2-4db0-81e2-4c38bcb8d1d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_94d6736f-48ee-462f-b835-7aa1195ad942_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_8a46f28d-1006-4196-a19a-9426ee6b9463_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e5efa67e-1303-4eb6-9464-679371dbbef3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_6ea40779-c962-44b1-baf5-964e005bde68_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_ce475564-c69d-49aa-81d8-ffedbac1cbb7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized incremental financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_d5e64c85-7b1e-4a5b-af8a-297233beab20_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized within accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_e9956f5a-2849-458d-a5e6-eedf4aa0318f_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enabling technology license</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c93334a1-bef9-4046-8046-4ac5aac6a1a5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8ead01de-2284-4697-b685-b1e036458f72_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_967b5272-f624-40db-a439-681df8d45c7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_f0233f87-110e-4715-8e8c-059f7a61530f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase and equity component of the convertible note issuance, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0c94659c-3128-49c3-8ecc-3c36acb02c9f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_7d6d0fbd-4113-456f-b423-dfa54aa1fcc2_terseLabel_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2034 Through October 31, 2034</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_label_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two [Member]</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_documentation_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember" xlink:href="iart-20201231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearLeasePeriodTwoMember" xlink:to="lab_iart_FiveYearLeasePeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9d768166-06b3-4308-8573-d67231760e83_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b675db-f0fa-463e-ba03-add4e5fac1ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c329a9a2-328e-4119-818d-81119915725c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f4fba7c4-b039-4bf1-a79a-35d23bc70ad5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans, assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_46a8f557-860d-4b28-824a-62964a9af390_terseLabel_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units</link:label>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_label_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units [Member]</link:label>
    <link:label id="lab_iart_PerformanceSharesandRestrictedUnitsMember_documentation_en-US" xlink:label="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares and Restricted Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember" xlink:href="iart-20201231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceSharesandRestrictedUnitsMember" xlink:to="lab_iart_PerformanceSharesandRestrictedUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_631f3b10-130e-4109-b186-dcdfe7be1cf1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_a4b7e26c-7578-4f67-9d02-5ceb718d2d46_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dcb848c3-e40d-4277-bbd1-26bc56458ce2_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_8b74a5d4-c1e0-4f1c-9762-ec35621697d8_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_72c2bacf-fed4-4225-af80-434bd4047bca_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27f98581-e5bf-4f44-a5a2-097e3085c811_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8584653f-196e-4315-b34e-c02d290e33b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_32f3b411-212d-4b4e-8a9d-43ea125ea81c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7319368d-8638-46cc-87d4-306300491eca_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b35973e3-95da-4a4f-876a-4d6f47d360b5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66fe199-9dd4-488a-a3f3-8782b9036a67_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum lease payments, finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_88b34da4-dbf1-4895-abea-5b4cb478f843_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a939452d-3ba6-4f83-b187-9f74cf5aaaa9_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fa3a48-e3ea-4f9a-bfd4-24044842487b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6cee9169-f909-48e3-90b7-78cc5542fb9c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_74398162-6cc3-4ac1-872b-a8b93f571b52_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonus</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1f49a517-597c-4100-b970-5300a020be0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_468160a3-fb3b-4233-8e11-629ae2192104_terseLabel_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from long-term to current portion</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_label_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_documentation_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:href="iart-20201231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:to="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_20328b9a-2ce3-4937-a103-9021b1049b07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeMember_185fcfe2-72ed-4588-9cea-347d4dea2403_terseLabel_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_iart_EmployeeMember_label_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_iart_EmployeeMember_documentation_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember" xlink:href="iart-20201231.xsd#iart_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeMember" xlink:to="lab_iart_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_e6cf7890-edce-4a5e-9742-356c8923eb0f_terseLabel_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, outstanding borrowings, maximum limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_label_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_documentation_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:href="iart-20201231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:to="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_199db812-5509-4d60-b7c9-6bae14230e2a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_332352c8-844d-4ba7-99bb-a0de033865ce_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0b16f05f-7da1-4f28-9b87-d638d4478aef_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_49707f0b-7d96-46d8-b16c-7d08e5b6c79b_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2211826a-2742-4855-97cb-4731a140d6aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AdditionalEPSShares_a8f9ec0b-2bb0-48a4-93a1-c2eebef027c9_terseLabel_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional EPS shares (in shares)</link:label>
    <link:label id="lab_iart_AdditionalEPSShares_label_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional EPS Shares</link:label>
    <link:label id="lab_iart_AdditionalEPSShares_documentation_en-US" xlink:label="lab_iart_AdditionalEPSShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares" xlink:href="iart-20201231.xsd#iart_AdditionalEPSShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AdditionalEPSShares" xlink:to="lab_iart_AdditionalEPSShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8e99dd6-f3dd-4547-a81f-e71d10fde2ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1b50c37-4a13-4ec8-9a12-5282ee69803c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_d352c0dc-3826-4370-80d5-538599176f3f_terseLabel_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information systems and hardware</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_label_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_documentation_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember" xlink:href="iart-20201231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InformationSystemsandHardwareMember" xlink:to="lab_iart_InformationSystemsandHardwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_80b0f822-a0a7-49bc-9290-57b3459ffb1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b44e2b48-9719-444a-8afe-051ee2ec6057_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation costs related to unvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7a8758c2-0093-4553-b684-1f8654a76bf6_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_1d8ca06b-0b49-45f6-a116-f4093aab59a9_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 4</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 4 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7cc2809e-5c0c-4989-8e71-5c806927b798_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_442c74ae-cc1d-4f74-964d-6914929d221e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_56ed8537-afe6-4ed0-b9c3-efc7b28267b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred to trade receivable of contract asset included in beginning of the year contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_873885f4-fb81-4dfb-85b5-6c49a8fb6ea9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased facilities</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_4aa27a0b-88a2-4929-80e2-79b6012341bc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_aaa6ad87-3406-4703-a78b-3402529ae552_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9aae8a73-35b4-46bc-9e5f-354de7f7a27d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_115f8829-0244-489f-96c1-cfa326fef851_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_796c2832-e32d-4265-9cb3-d4311b976405_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_4e345765-7b87-4ff7-8518-8213a94b4b69_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a19d3a2-6c25-4cba-9179-6e3be1713115_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_da95d219-8a9c-416c-b880-8f3fd03ed5e0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_f12dd985-52a7-4767-a842-90929b2df2a5_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_51b984d9-7b06-42dc-9976-69fa8c2485b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_b3df8eb5-ef38-4fd4-a625-4a7fca8ae775_terseLabel_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical instrument kits</link:label>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_label_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Instrument Kits [Member]</link:label>
    <link:label id="lab_iart_SurgicalInstrumentKitsMember_documentation_en-US" xlink:label="lab_iart_SurgicalInstrumentKitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Instrument Kits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember" xlink:href="iart-20201231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SurgicalInstrumentKitsMember" xlink:to="lab_iart_SurgicalInstrumentKitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandThreePlanMember_121fed53-6adf-47bf-b265-a77bd35b082c_terseLabel_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Three Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand three Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember" xlink:href="iart-20201231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandThreePlanMember" xlink:to="lab_iart_TwoThousandThreePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_08542c28-14b0-4d78-92fb-fd8bb9d288b5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da215e90-2652-40f7-a2dd-9780cbf4bafd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_48838901-9f3c-4d3a-ad20-d982f94e86b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_adc8eb53-6db7-4088-ac08-713427f3d0c7_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_73765f23-ffc9-46ed-9da1-f6800c6ad3cd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_67ec5f96-9d13-4b5f-b9e2-c5a5ff2dda5d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_d0300bfc-650a-4430-8fba-152f733e4d70_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_1e5d0e6b-cccf-4630-8b5f-c9e9528d519e_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_f91f6be2-2eda-44db-8986-70dd61905557_negatedTerseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:to="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3d169161-9bc8-4ced-8a53-2b7865d4b6c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_b8ab497d-f63b-46c8-8c4a-19d2a8cd3e7e_terseLabel_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective foreign income tax rate</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_label_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_documentation_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:href="iart-20201231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:to="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_40a4b892-c66e-4001-926d-6bb762bef734_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_897d2bea-07c9-4d4b-9c34-b027d76916cf_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_bd4360dd-7a50-4c45-abec-0e266b9bab68_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ThirdPartiesMember_7363a58f-c01c-4a52-8275-8197ce13eb0d_verboseLabel_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_label_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_documentation_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember" xlink:href="iart-20201231.xsd#iart_ThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ThirdPartiesMember" xlink:to="lab_iart_ThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_6596156f-2f29-460e-bc90-b6dddf07c2e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_2652de79-604f-4684-8a90-f0fa6ee5e614_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible securities</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DermaSciencesMember_ee5d193f-d259-4bfa-b8b5-a7c506bfe90a_terseLabel_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences</link:label>
    <link:label id="lab_iart_DermaSciencesMember_label_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:label id="lab_iart_DermaSciencesMember_documentation_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember" xlink:href="iart-20201231.xsd#iart_DermaSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DermaSciencesMember" xlink:to="lab_iart_DermaSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_885deafb-6ba4-4b53-a98e-50f7e6557217_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_5a4085d1-afd3-4635-8915-8eeebf289454_terseLabel_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment assessment, tax rate</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_label_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Tax Rate, Percentage</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_documentation_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Tax Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:to="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_37f4823c-925b-494e-83af-1537f0be682e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cea0f325-0d4a-4f62-9f9b-8e3a00679289_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reclassification adjustments for gain (loss) included in net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_718bc5b3-48ed-4181-b92d-ceda0c6e1d83_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recorded in other income, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0dbd7ab0-a072-4432-be2b-a826d2d7bdaf_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_3ae275ea-0c64-45bd-a71e-445488eac959_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles Of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_3583ac9d-5a2e-48f3-a9ae-e16cf0c43e92_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining net assets acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:label id="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c715de4d-c38d-4607-a47f-8f0fca535661_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_c38c286a-2277-4c90-90c2-5118ece27e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_3206cfcf-8b15-4290-860b-610fabb11500_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from stock compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a21bbc6a-7838-4ed8-9eda-112c5a98006c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_694c32c8-1670-4bec-a954-ccd09c18c201_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_feaec164-91b2-497a-95a8-c8c3407dd7d4_negatedLabel_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment and construction in-progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_label_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_documentation_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:href="iart-20201231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:to="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_33c7db71-6b05-4f9a-8673-00ddf3d9ad01_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (See Note 14):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_504bb55c-cf83-43dd-8cc3-f2c308034121_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_244f9f7b-a3a4-4170-b1c3-e58aa3813dee_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_23f2fcb3-189c-4e26-853d-bb79ef72003f_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_9fdb9708-b9a1-4443-afbb-a3d820c0b740_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to assets held for sale (See Note 3. Assets Held for Sale)</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_29fc4ab0-e647-44d5-b4cc-7294e54a6d6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_3de933a2-092d-4c52-951f-35d2aaf129d4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_db909e20-bfbb-4920-b43d-1172d78de50a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c9c9e05c-ef95-4bd6-b282-28610b79d017_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b04454a7-39a8-4ec2-9ab0-9bcf908d3f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts reclassified from accumulated other comprehensive income, net</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_38aa4970-4329-44d2-bdd9-478d1b4d5711_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from AOCL</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fbe2e611-efcd-43ef-9a67-173f1ffc560c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_b75e56b5-3320-4d8f-8274-4821725a9de0_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_e23bcd7d-2299-47da-9523-a07465ba61ed_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_56f10069-9f92-4989-9f0b-60093f0e6c06_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a1d2502c-74e4-42c5-a353-1d74cb339e9e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_e14034d3-7c23-4225-b48b-ae944cfe8364_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-Derived Intangible Income</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Intangible Income, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Intangible Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_f646fe8f-0e4c-49f2-b18c-49e59ce07020_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9b4e094b-4655-4d0a-ae2b-6e6edb736539_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment purchases included in liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_908b1564-f5d0-465d-8204-ba06928a15b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_b9991fd1-ef6f-42c3-893c-8e797f4a60ca_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_43ebdb18-bbda-4032-8fc3-006e9e02d85a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_3c2d8dc4-d125-4acb-9d26-9d2ccadeb7b1_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:to="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df3892f8-762a-4082-a441-db5b379e4e5d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_1ff9c061-a2e2-4f7d-a79c-2767d645a095_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandPlanMember_8a85321c-c3ef-4352-bd25-26cf7889fab3_terseLabel_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2000 Plan</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_label_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandPlanMember" xlink:to="lab_iart_TwoThousandPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_641044d2-4734-4044-949e-1c50a4895bbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2a950b1e-374d-49b5-bd3c-3b8de933a8ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f3a22b51-6868-4ceb-b008-e8079272d36c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_3cd0d493-cd57-496e-a8a8-9e3cbbf8b373_terseLabel_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty period (up to)</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_label_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_documentation_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod" xlink:href="iart-20201231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueProductWarrantyPeriod" xlink:to="lab_iart_RevenueProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0a53f238-6065-4ff2-aa93-01b50febed69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxTable_73560e17-f57e-4e84-b659-f3cb9548d781_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_label_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_documentation_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable" xlink:href="iart-20201231.xsd#iart_IncomeTaxTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxTable" xlink:to="lab_iart_IncomeTaxTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_de553b50-45f1-4582-91fd-2861b46cbb0f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_edb9a3ad-1c23-487f-8a90-f8f3662fa655_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d380bce8-a899-426d-80e5-ae45ddc75d45_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_02514167-1d5a-486c-983c-0826d1c94769_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_78738fc0-8f07-4100-9662-32ffff34079c_terseLabel_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_label_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_documentation_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:href="iart-20201231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:to="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_61ab83d1-c475-4ee1-aada-8de307e00c1f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6cbbe0fb-e4a8-4ab3-a277-57d550546a0c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_32d04bf4-063b-4bc2-8ae6-9331e563b5ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1eb84f02-c417-44f4-9944-88869d5749db_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_74197015-76da-40e9-820b-25f431340601_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3a70de3e-0967-4761-b6a9-b07aaf709407_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_97f95749-25c5-417d-8708-4555cecf5567_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d472f5a4-3925-46da-aa1f-881784d75069_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, indefinite lives, impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_5123b491-9321-4659-8e48-d9781314989c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions from acquisition of Arkis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_1b9a8de4-61ff-4314-b4e7-5e26109f1dcb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Funded Status</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_cd985ad1-24ff-42cd-9328-fb7fa2384140_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3b7fc778-d555-4d81-8dcb-e136e7925332_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_89c55c71-0330-4a29-8e86-b1bdea8b35cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_1bc1621d-45e7-46af-a84a-f42393f3001e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxLineItems_e8e306e0-df15-4de5-8cf7-cf795c249379_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_label_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_documentation_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems" xlink:href="iart-20201231.xsd#iart_IncomeTaxLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxLineItems" xlink:to="lab_iart_IncomeTaxLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_d5682ddd-ea73-4afe-8083-e3907d9b00d0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_34a80d5a-f27f-4406-a742-56d9ea227891_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_b964e061-1957-4542-85cb-e1a1ccccb3ba_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch272017Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 27, 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedMarch272017Member" xlink:to="lab_iart_InterestRateSwapDesignatedMarch272017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionAxis_b8755bb9-3dae-4909-bb0a-e2c0eda6bc26_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_iart_AssetAcquisitionAxis_label_en-US" xlink:label="lab_iart_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_iart_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAxis" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionAxis" xlink:to="lab_iart_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_e63be16b-4e42-4867-bbbb-c88dc354b314_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recorded, settlement of derivative</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_c54f4ac4-03d1-48b7-9655-9fccd8a4ad0d_terseLabel_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_label_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_documentation_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember" xlink:href="iart-20201231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ExtremityOrthopedicsMember" xlink:to="lab_iart_ExtremityOrthopedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_90273fdd-ec76-4fee-a503-90bc61b416ea_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_c143481a-f96e-4572-a152-6ed62f8834f8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_12764b93-496b-4a21-8632-1cd1ad6e8aa6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_73320ed3-ec3b-4140-a791-411a946326a9_negatedTerseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_46398c0c-d4ba-4321-ae76-d64f6f5dfc6d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_3bd5f146-fe20-46fa-867e-584d10870d0b_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3d4a4c06-ed57-4edd-a6e6-57e4b1207b6a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ab09cbf7-bbc0-47e4-9fd7-d7e2a05480ee_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_408b2627-96db-49d7-b791-21e9aa8f9190_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f57dbef3-24f7-4801-8e6e-f2533281c6ec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1b64b60a-9c81-4ece-8b5d-2e8a1d069d8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_24cab1cb-5a2e-4038-b341-9994ffa2e274_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_4d550903-41d5-4262-830b-8d294e8cbd22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_33762db5-f537-48dd-b4c4-2f6bca256587_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_30a0f81d-4d12-4f9d-bde8-2612e3b33427_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_851dd221-29ab-45cc-9d4c-2af9b0d1037f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e120b44b-87d5-4ab4-bd72-937079573eb6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetMember_8b487a40-3761-4bf0-aee4-cd81afaf282f_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset</link:label>
    <link:label id="lab_iart_DeferredTaxAssetMember_label_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Member]</link:label>
    <link:label id="lab_iart_DeferredTaxAssetMember_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetMember" xlink:to="lab_iart_DeferredTaxAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_77d6a575-39d6-4a9e-9e8f-b6b188f630b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_704a1a5b-868d-4da2-bc24-e6f382542d52_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a4891b8c-c4c0-4394-aed6-56e27f00dac1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NeurosurgeryMember_a3ca807a-d56d-4240-8810-01294727ae79_terseLabel_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_label_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_documentation_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember" xlink:href="iart-20201231.xsd#iart_NeurosurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NeurosurgeryMember" xlink:to="lab_iart_NeurosurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_32792796-f9da-4576-995c-445b874693bb_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and production equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3fd61dc4-a708-4064-80c4-9e8b03bad983_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9f66b0d4-b436-4a3c-81fe-3b86fc219250_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2c912e0a-cd9e-43d9-ab81-fa342b74f25f_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_afb6dc33-a975-4077-815e-fc493cf52301_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_6efb2f87-83d0-4a7d-b364-be3f9b5188bb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_37a3d583-00dd-4c8b-a279-1ffee810360b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_61ba29a8-058e-481a-a9c9-4314957652ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ff3ac0fb-3a0a-428e-b2ca-b7aef7a53ae0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dff97d29-0ab3-468f-976e-f148adf3af89_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_b62ddec7-f521-4b76-9168-7db75eaeb94e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_99395b57-6183-4a98-a459-cde7e2c71113_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercised stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fa9f2fe7-0b00-4a1b-aecc-d7e872a9355e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5bc49a3a-d758-454b-8fe7-427c93f8c875_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8c5e80eb-f5b1-4990-a5f9-2291c130d79f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Sales and Profit, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1a387148-d63f-46ac-af7f-c7da7b808234_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Geographic Revenue, by Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b402c550-e73d-4cf8-b93d-bb4901b78dc2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_eaf3a5e3-b203-4422-aa20-c8ac4513e1a4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_4c716ed1-3043-43ae-978e-518c85b1cd32_terseLabel_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective worldwide tax rate</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_label_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:href="iart-20201231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:to="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_f1857a77-e30b-47ff-a504-525ae09558ba_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_16e4e3b8-6c8e-46d1-9343-be6224f596ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_e907e4ca-cfa5-4711-a78c-261604d31d92_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets expected to be returned next twelve months</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_746110be-2f64-418d-998d-43f7bf71bfea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_392f3e08-4abb-4833-add0-ab0e7f8b4371_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d9f540a4-1e42-46d8-86f8-8c462f417e1d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_740dc741-ed6f-4a61-9c66-07a284fdc44b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_e8581edb-1c0e-4e49-9062-cae20bddaa69_terseLabel_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Reconstruction</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_label_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_documentation_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember" xlink:href="iart-20201231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RegenerativeSkinAndWoundMember" xlink:to="lab_iart_RegenerativeSkinAndWoundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_225d311a-8985-4c53-b87f-1ff30ad278c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_3705d058-c938-4371-bc88-d758da977894_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_58f688b0-a078-4888-a4ac-44437d933905_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c904116c-6049-4cea-8d73-76848a0e6bbe_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrecorded benefit reasonably possible to be recognized (less than)</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_6583664e-04dc-4e27-8595-7b6223b45668_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_14595ee6-ffb7-4965-8bc7-9357a2161a66_terseLabel_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_label_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_documentation_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:to="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_785efd18-3610-4142-887c-0da6917b8eeb_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_f823b485-a8f2-4f36-90c4-e6169c654f22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_84d3c810-1009-4476-8b97-7a4765c5fe0d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RelatedPartiesMember_9c29ba77-0920-4099-a4fb-53f13faf4abf_terseLabel_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_label_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_documentation_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember" xlink:href="iart-20201231.xsd#iart_RelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RelatedPartiesMember" xlink:to="lab_iart_RelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_eb0ac8d9-e0b6-4c14-b3cf-1e747695945e_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bed3abad-0596-42de-995e-a1b86ce73bee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2ca6ab8a-577a-4dc4-9e0d-9a5422c6adb6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5829bcd7-9851-4c40-b0be-530b2cefe870_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2bdc5fa0-c4f0-4575-8633-f65f699f0f47_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_01e28ecc-fcd4-4484-b2be-d676c95ed51e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c044086f-c4d0-44a5-a4ae-26ab8d446f3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_2dfa4b68-89ce-4714-87fc-1e8913fe163a_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8afc909d-3ebe-421a-8c9f-2c989d0cdd40_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_63527f19-2574-4840-962a-e18c7d116f75_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_f30df669-d9a8-411f-87f4-7d326a9e76a8_negatedLabel_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development and intangibles</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_label_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_documentation_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:href="iart-20201231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:to="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ed4cacad-0c09-4b7a-8b38-9a42bdcdef57_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b7072c66-4656-497d-9acf-83c8f5e3c2f2_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_26e378b8-ce71-49ae-b88c-c7f941d13f35_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Next five years</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b057ffab-21ee-4609-8ec8-1c32394e64ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_ac8bf6ac-677f-4959-8712-919550856054_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionConsiderationTransferred_d5b151fc-dfba-41a2-af8c-4c44d4e6d7e9_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_iart_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_iart_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:label id="lab_iart_AssetAcquisitionConsiderationTransferred_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionConsiderationTransferred" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionConsiderationTransferred" xlink:to="lab_iart_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentTwoMember_6af6042e-cf1f-4b35-9232-6237ac7fae36_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_label_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember" xlink:href="iart-20201231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentTwoMember" xlink:to="lab_iart_MilestonePaymentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a3bdc2be-dbe8-4b57-b85e-de75484a78b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash taxes paid in net equity settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_f28173d9-f8a8-4a34-b7ae-a020d37eebec_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_0e67080b-a098-45a4-978e-ffed6eed0856_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis Acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_6d247146-ede4-406f-bfde-27865d848d3e_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SELECTED QUARTERLY INFORMATION - UNAUDITED</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_a75d7158-5bae-479d-a9e2-7b14040dd6ac_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_a20ac6e3-4b36-426d-aafc-07b40ed998a1_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_379e89cb-97e3-482b-8e80-f541e5e5a6ff_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_99335338-1614-4248-9462-a34282d20b61_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_8fe01623-5e87-4b9b-a6d6-4f42a9ce838a_terseLabel_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment assessment, royalty rate</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_label_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Royalty Rate, Percentage</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_documentation_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Royalty Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:to="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_86458db3-0824-46d6-9815-d51719244a41_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_14cf5676-c07a-44d1-9678-84de0fb634f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_b53c797d-c927-4298-bbd7-28397daf117c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember_7ef17d02-5923-432e-beb2-d07be9fd1134_terseLabel_en-US" xlink:label="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2000 and 2001 Equity Incentive Plans</link:label>
    <link:label id="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan And Two Thousand One Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan And Two Thousand One Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanAndTwoThousandOnePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:to="lab_iart_TwoThousandPlanAndTwoThousandOnePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_feb29b67-af38-4bc6-a929-d158772d774c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a5ecfd5-a02f-4b40-91d9-c37bffdb9608_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_caefc741-1467-4643-8dc1-74f1082030f0_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bb9ec000-9f5e-484d-8a23-0d56a613d7d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0f1e1dbb-9a16-44b9-ac11-a9385f0514c6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6701162e-e30b-41ad-abaf-96567617e677_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_907e20fd-be0a-4e62-902c-cc5eaa8089c0_terseLabel_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock and Contract Stock</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_label_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock, And Contract Stock [Member]</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_documentation_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock, performance stock and contract stock member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:href="iart-20201231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:to="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4d272efa-b228-4e1a-800b-0d25a86ec893_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_265dba09-464b-413f-9769-dc01af491fcd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_791e6d70-7de0-49b8-9c97-fb954c3f651a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Weighted-Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_36c66a27-7f46-4d7d-8911-a1d1e85b0853_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_3880cfa2-46e8-41d7-9817-b2e2bc8cebf3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_ec64b71b-3d9b-4e4d-b4c9-c1bc18328516_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_8d7671a2-0275-46b7-b5ad-c6ede9b76f7a_netLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwinglineLoanMember_b5d498b7-d7e1-4068-9ae0-a029e12e110e_terseLabel_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_label_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_documentation_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember" xlink:href="iart-20201231.xsd#iart_SwinglineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwinglineLoanMember" xlink:to="lab_iart_SwinglineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_f577e537-6b30-4af6-853e-8c4d68b83d93_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_93f2395e-8957-486d-be90-5346e14c1f3b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_eef33e09-dc24-4091-8156-c83d8797fa0b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_348c918d-202b-45e8-a522-3cef15b45add_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_30439cca-3226-4b3b-9604-1bea3534bd32_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4f3f4002-6a35-4e88-8f92-75dc4957858f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c45b68d7-af97-474f-bd87-60af774dce90_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_a10e9695-6c14-4e3f-ab7f-751e7e1abd27_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4c3b4f6e-62c5-4233-830a-1b03e0550149_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_fd254586-56ae-4eed-b9cc-5bf83694a9ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock purchase warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_c07d62ed-662e-4a41-9c7a-bbf943431360_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrant transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_924908fd-7149-4874-ae75-63ca497dfcf8_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_78951ff9-d74b-4ec2-adaf-905b86158c15_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, net of revenue recognized on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1bb28675-9126-4dd0-9380-bfd0c34f8fe4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_4f2911a0-ec3f-40ee-9cc9-a198bdda71e1_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_32906b1f-b978-4d41-b8ca-0ac5e9ddb35a_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8574608f-f60a-4951-a1ed-7400a45b1013_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_49838755-c6c0-4777-bffd-0b463c52f1cb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREASURY STOCK</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2bf5e833-caff-42ec-bf59-47b0493e414d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_d183f862-11f9-4c00-8a0a-30f92579c431_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_682cd744-68a1-4d67-a988-1cc7a147961e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AustriaFranceAndGermanyMember_550f269e-4c8e-4256-b5dd-199aa00334e9_terseLabel_en-US" xlink:label="lab_iart_AustriaFranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austria, France, and Germany</link:label>
    <link:label id="lab_iart_AustriaFranceAndGermanyMember_label_en-US" xlink:label="lab_iart_AustriaFranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austria, France, And Germany [Member]</link:label>
    <link:label id="lab_iart_AustriaFranceAndGermanyMember_documentation_en-US" xlink:label="lab_iart_AustriaFranceAndGermanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austria, France, And Germany [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AustriaFranceAndGermanyMember" xlink:href="iart-20201231.xsd#iart_AustriaFranceAndGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AustriaFranceAndGermanyMember" xlink:to="lab_iart_AustriaFranceAndGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_d5e9d160-b1bc-4650-b841-1f7f585a0143_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets after valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_109b47db-653f-4b66-b6d7-f4d6305a5570_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases and Other assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Asset And Other Assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Asset And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d70d530b-db88-4ef0-a03f-18bb027ba15a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2817e4d0-1b8e-47ac-a58d-fcf524a302db_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_53a7812e-44f6-4baa-bd02-9487c71c4d6c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_762e4c6d-cff7-4218-bc59-393f1c74a0ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_b36e6427-ddbb-46c6-87ae-5de51ff6fbe6_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Four</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be37274c-6eb6-4ae0-aa89-607ee117b4a8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_87492726-0463-4371-ae36-7dd04191c982_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3b252285-c4bb-43d4-a546-676ad35e2ff6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e03843ba-af03-435d-9820-9ee50c30ae55_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9b054e06-c978-4596-8618-401fc4959041_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, aggregate principal amount issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_dc49606b-1339-4a39-8199-b5adcd39bcaa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_60acd311-e347-4423-a941-3a22a04ac2b9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_21eb3869-7b19-48e9-a8c3-47cf4bdd7a58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_6ffaa4db-0fda-4ffb-9f7b-e0ca4c76fb12_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Intra-entity of certain intellectual property - Rate Differential on FMV Step-Up</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_678b7150-11f7-4a88-b39d-ef9474bd5dd5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7acfb88f-e284-4222-8148-64d2cc2f51ec_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_b9bbf12d-2ae9-4547-8c39-458a8807e677_terseLabel_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_label_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_documentation_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanSpecialtySurgicalMember" xlink:to="lab_iart_CodmanSpecialtySurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_80a9e892-335c-4110-8123-850362d03a2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_31cb18c9-3120-491c-a51f-f70d6e35c8fa_totalLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_cb15c500-dde9-4eff-bbae-039c2d2f3816_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS AND LIABILITIES HELD FOR SALE</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_9235dfb7-e929-4f23-8aaa-efd90a209874_verboseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_f2ec6611-6ba8-4516-9662-ba9bd0c9a897_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Collected from Customers</link:label>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_2cc47ecd-654b-452a-bec6-ee5941cbde94_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_22c50eb1-9045-4f31-8b41-50ac3006e7a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_d4452fb7-3684-40fe-9054-b5410c2576fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_171e04a8-60d6-49d9-812b-139ffaa480e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_51f398ef-2fd5-4f9c-b51c-32eba00b3b73_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2a7888ef-65b6-4eb7-80d3-ddc9d9a0ac21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_3e3f6a3e-abd4-43a7-bb47-47bf10a8b211_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum future purchase price, if circumstances met (not to exceed)</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_71e6cde7-4962-4463-8eaa-943f68e71ab6_terseLabel_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="iart-20201231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8751c8f8-8ef6-4850-9a81-2a430197839b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_2410566a-cfcd-4c0f-9f81-8ab81bae93e4_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_59e66475-0a77-4c00-839c-babc4994f785_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acae7f21-6d04-4a6c-b9ee-c14165fe360f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_91a2156d-1ddd-4a68-985d-a34bdef7f1c6_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, percentage of expected total repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:href="iart-20201231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:to="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4bf8b561-4a7d-4b30-9162-015d07879b53_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57a2318a-b9f0-4bd1-a3c0-2694e3be5a8c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded, net investment hedge, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f9b3bfbd-d5c8-445f-88ca-d12183b70547_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_0fc96cb9-ca46-4d03-acee-90b4b45b1f09_negatedTerseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany profit in inventory</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5925d2e9-4873-4c82-aa6b-8f1aba011214_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a4d68777-d609-462d-b1f7-5fd8cca21f48_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_7873e9c7-7fec-4682-8f29-9a7079e73211_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_d07badba-530b-457e-a237-2b6ca61eec96_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_082da516-4b57-4f0b-a153-56e543201d4f_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination settlement for debt conversion, minimum settled in cash per principal amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_label_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:to="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c7d3d923-e706-4a93-bb7c-182fe097772f_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_44a30e4b-2627-4a62-986d-ffbdbf85b989_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_349baa8a-72c1-47a9-8573-01bae6072db7_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1aa72c90-cfc7-4106-a02f-421f3d343443_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 240,000 authorized shares; 89,251 and 88,735 issued at December&#160;31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f0778c96-c7f5-426f-bf2e-2c6d06952bf6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8414e825-3605-4ed0-97fd-2602f41a4e03_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bd433759-d7ec-48f4-bcc9-b9ec33019ea7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_aa87d1eb-fb95-41f6-adc3-2ed597baf1da_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_5bfb2a96-df36-4f06-940b-9b896834c1b9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings of long-term indebtedness</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_d0656c8f-6d3e-476f-b9a8-03b6295aece2_terseLabel_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products offered (more than)</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_label_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Number Of Products Offered</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_documentation_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products sold by a segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:href="iart-20201231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:to="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_5f7e52cb-87d4-4701-91b5-89c3d2705f4e_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_b2a62918-90e9-48b7-966d-5842db81ecce_terseLabel_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_label_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_documentation_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:href="iart-20201231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_2c02604b-57ea-4fb9-a4e0-c0ce796c2488_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_812f3f8d-27fb-4880-8d47-eb480f2bb4df_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_0fd9d1e3-2c6b-4933-916e-d82a6464f3be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dcc877ea-82dd-4430-95e0-cc1c6ac3d649_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9123affe-98ef-4e3e-ac3d-e40357730c96_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_80a8f4de-736e-4463-992a-7ccab7a6d477_negatedLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not released (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_0cd5dfbb-99de-4c5c-a61e-440a1fba9ec9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d5ec91f4-f0ca-4d38-95c0-ed421df221a5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_46907ea6-97c0-4a0b-bfac-01d63a6a3662_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_b0f81946-f0e5-421f-ba01-263a6b984a13_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TrademarksBrandNamesMember_5b0db05c-f729-4143-ae38-d6e5181950df_terseLabel_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks/brand names</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_label_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names [Member]</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_documentation_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember" xlink:href="iart-20201231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TrademarksBrandNamesMember" xlink:to="lab_iart_TrademarksBrandNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8ce85ef6-abbf-4221-b66f-2d94b3216625_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_37ca859d-10bc-4042-afc1-13f2f7390585_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a0c484eb-b51b-4570-9870-dd653defbcfb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_68ef892a-e3fa-421a-b53a-c3f4ee917717_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_558c6bab-4e6e-40ae-815e-c85ff9f783c1_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax credit (in dollars per share)</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_157f69b0-8baf-40d2-9ae6-691888ae59ab_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CompletedTechnologyMember_2c88bcde-0824-4290-a090-e00dfb857b73_terseLabel_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_label_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Technology [Member]</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_documentation_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember" xlink:href="iart-20201231.xsd#iart_CompletedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CompletedTechnologyMember" xlink:to="lab_iart_CompletedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f7d5f186-8370-4196-9b42-2b830776c3d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4b4d9f6b-6083-4027-9736-83e24d0b14cc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7d4518ee-9246-4699-8b77-3ae9f819ea73_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2af087b4-0b35-43c1-8af0-2540c902ced7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a2987862-c7ae-4a38-894c-51077f50dc89_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to opening retained earnings</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_883110a8-aafa-4ec9-995f-e35e6c9a64c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_16c6942c-64db-460b-aaa8-0e6f6db6aa32_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of business combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_8873eb4e-56cf-4144-bec7-4916efd85f3d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_75aa532e-5f4a-47f2-94b2-e1c4b9b56bbd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_74e38ef7-a3f0-4218-8216-f45b96212eb4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9eb99fea-57e7-418a-a582-5ccb58f24f7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3f4e746e-df1b-414b-8459-ca432036b9f9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment, intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_93a2c7de-997b-4810-b2fe-ee855a617c6e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_2da14254-ad26-4d39-b6fc-13733e4b3f15_terseLabel_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-month USD LIBOR</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_label_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_documentation_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember" xlink:href="iart-20201231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthUSDLIBORMember" xlink:to="lab_iart_OneMonthUSDLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ebbe71db-b27d-48ef-a86a-4061c2488500_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_c7ee9ef2-c3ba-4310-a276-b9cfeb2bf8da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_4e47dd5f-5007-4fa2-a561-9b01ccf68e3f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_f3dbd994-cde3-434f-a4d2-d34f8c36b7d5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Interest</link:label>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Capitalization, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:to="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanMember_ff7d72f6-df5f-49f7-a398-631d97b14fbd_terseLabel_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman</link:label>
    <link:label id="lab_iart_CodmanMember_label_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:label id="lab_iart_CodmanMember_documentation_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember" xlink:href="iart-20201231.xsd#iart_CodmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanMember" xlink:to="lab_iart_CodmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5333624b-4873-4648-aa0b-e8f91009c612_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_12b5c264-bc64-4d4d-84ae-fd4e33bb4c5c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9e9da045-3ed5-478d-9166-8ba145ba562e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_05158369-fec8-4895-afdf-72aaaeba83d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4945dfe9-0a50-4c2b-823c-656daf4fe738_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_df9952e7-9075-42e5-9dc8-75f503f5774c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d3635117-5d6f-4817-8619-3f5bef9e1632_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_48aed14c-3f40-42d9-98f3-198cc2195345_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Shipping and Handling Fees</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_9ae3bf7c-5ac7-4aaa-86ba-6e0dc333f307_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not released (in dollars per share)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_8043d399-d838-47d1-9379-ca453af3ddc7_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_d8366b04-1e0e-4c73-8936-f43416b9c1d5_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_7de46b13-6431-4b2d-9b00-63235d01c0eb_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_67035695-ebe4-4a99-83df-5a4104a56fd9_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c4788995-a8a9-4444-8701-d66eb4f4507e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c2939952-0e83-4ce3-b90e-f9333e40e445_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_cfd7bb9a-b292-4b03-87ff-8487ad15f298_terseLabel_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of customers over benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_label_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_documentation_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:href="iart-20201231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:to="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FoundationPolicyTextBlock_8a942d39-6aa6-44da-8e75-37a3888cb63b_terseLabel_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Foundation</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_label_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block]</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_documentation_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock" xlink:href="iart-20201231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FoundationPolicyTextBlock" xlink:to="lab_iart_FoundationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_ab53b364-14d4-41df-a43a-10774dc3a265_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e233cfdc-75ef-4164-ac33-6bab38544922_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_8f7d7e9c-a01c-425b-9abb-92da9ee0e87d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_ed047ea3-143f-4793-b132-81358819ffad_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_bcd5b85c-b765-41de-8a33-0bedbe155de4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1462cf31-3220-426e-9a94-296b659fa99f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_b967da3d-843b-43df-9dc8-6db8dc2fe7ef_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock" xlink:href="iart-20201231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeTableTextBlock" xlink:to="lab_iart_CashFlowLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0d8d585c-8e77-461c-8f0b-a8d50903d008_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d796a708-c091-48d4-a956-1e710e4ab22e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ab6bb20f-a451-401c-b0a0-9f3e2f4716b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_758ca6b4-41b7-4969-bee7-48eed5f619e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_1d4b12d1-8e8c-4506-bc87-cec8a20db0c0_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_a549428e-8814-4f32-8758-4eaee66c746b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4e0c857d-8589-481a-a685-37768b3c599e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwapTwoMember_15ace669-2409-4525-81ef-77acb109aff4_terseLabel_en-US" xlink:label="lab_iart_SwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Two</link:label>
    <link:label id="lab_iart_SwapTwoMember_label_en-US" xlink:label="lab_iart_SwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Two [Member]</link:label>
    <link:label id="lab_iart_SwapTwoMember_documentation_en-US" xlink:label="lab_iart_SwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapTwoMember" xlink:href="iart-20201231.xsd#iart_SwapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwapTwoMember" xlink:to="lab_iart_SwapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e16d14ab-0f73-4582-897f-57aebcaaa69d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_82ff8028-e2bb-483e-b4c2-b88aa21fb5a5_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_8b9228d8-a43c-4e8e-bf55-a3fb4b7260c2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_17e35a6d-ebd1-47b3-b50f-b485dedd3270_netLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_80804073-9288-49ef-ae7e-c0a358b996e6_terseLabel_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_label_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_6dbb8d4c-ea37-4a83-99b6-e456ec7fe2d6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact of repatriating foreign earnings</link:label>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_label_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Earnings Repatriated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignEarningsRepatriated" xlink:to="lab_us-gaap_ForeignEarningsRepatriated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0d1c8165-ff3d-4ed0-8905-9935ecf557b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_94f68c78-b652-404a-ae1b-aee79e085a99_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7f9a76d8-05db-45a3-9ded-325e8a4db2ca_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6e8b833d-e8c5-4390-8571-48d57f73ae12_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_2e043713-3c8a-424b-b104-d1cb3647377d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_20cc37a2-bfba-4ba9-a23f-c0ece9bc52b3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_44fee752-120c-4ae1-b42c-e58552d0bc99_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_55bef58e-c11d-432c-8b7f-1e5f1490cc22_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_49946cf4-5b2e-4939-844e-4ddc5143c713_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_0faa709b-1c70-4ed6-a4df-8f3422690ace_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contributions made</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_97234539-2fa3-43d9-91b4-aae6e5346f38_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_cdb8acdc-788b-4207-ab8a-05b2d94efd84_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_e5437062-c137-4190-8470-9894be7e7f97_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_101b225e-388e-4f64-bb57-be9a03c652cb_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_1e01173f-1776-49aa-81d0-da5bfb1e8e7d_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_6d79686c-3648-484f-97bf-6bdc26f6a8b8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_e1d4be9d-5ebf-4f82-b97f-d087107b0416_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_a02e6b36-ff8c-4ef8-b389-2927e1f16b60_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_08702a57-e671-42b8-a0e5-837113f77b07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_e6e16514-1392-4d70-b4b3-2e078422dfb8_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_3f1bbb9c-a7d1-4544-9eb1-433b6ad2de84_totalLabel_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:href="iart-20201231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:to="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_17ba5831-6a17-429b-a795-b34a959f7662_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodDomain" xlink:to="lab_iart_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_4bfbcd10-74ce-40a6-a4ce-3011f2bceade_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a940ceb0-14bb-461a-9c7d-05edeca833d2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a3f022a3-f706-4b6e-bbac-be0c8edc680e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied, expected timing</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e590286c-17f3-4cc1-b12c-067121ed252a_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously capitalized financing costs, written-off</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a1f8783e-6f3a-4854-8ff0-d5536d949612_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum selling price of the company's common stock of the conversion price</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:to="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_16552b5d-16ad-43fc-b1e9-3acae81f1649_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4251a271-bd44-49a2-bb4c-f0a291465043_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32fcd558-9a2f-40d1-a547-84d04e25c466_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f503792c-8650-4983-8d32-064b81ccae0d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_8d3fe959-ac04-4213-a797-def6a6809682_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_dc946192-720d-4856-b554-61fde6a3d5c4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_47da7637-b708-4574-9bcc-2fdd9298e89d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_87cb9639-72d2-453f-924c-83b22c274b7e_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_ccf0c4eb-f4c6-46bb-a4f6-ffc13f292cde_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6aaa5cb8-21ff-40de-a448-a9595e6b8810_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_11579fa9-6677-4772-af08-ac62c6184b6f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_06ba605b-2e7b-4488-86d9-6dc086528a20_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4776a814-70b8-4ac0-b593-dc1550d47537_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_10a03909-4613-4cf5-b343-b3263e6614ec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_9ae0881e-f1a8-4e66-9aab-76c335237a39_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_9c5bfeea-21b1-45a6-ba71-970547741893_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntangibleAssetsAbstract_0903a89b-8c86-4bf6-b5d7-8f42f293b23c_terseLabel_en-US" xlink:label="lab_iart_IntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets:</link:label>
    <link:label id="lab_iart_IntangibleAssetsAbstract_label_en-US" xlink:label="lab_iart_IntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Abstract]</link:label>
    <link:label id="lab_iart_IntangibleAssetsAbstract_documentation_en-US" xlink:label="lab_iart_IntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntangibleAssetsAbstract" xlink:href="iart-20201231.xsd#iart_IntangibleAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntangibleAssetsAbstract" xlink:to="lab_iart_IntangibleAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_314705a1-3934-4245-8399-b802e597e05c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_ad5ffe2f-8167-4e1f-aa64-26a0c4b51888_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_37a0012d-6ee6-4393-9e4a-4f6debe9d08e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9359423b-f9b8-45e9-b865-0b0b54f7fbde_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8f7baf7c-bdff-4edd-bd9c-8b5a48164d1a_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5713c0e3-af10-42de-88b6-af2257b47600_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share-Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_11ddb1de-9424-403a-b795-a5b1240ee788_terseLabel_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets, discount rate</link:label>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:href="iart-20201231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:to="lab_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_96cbd6ab-bfb1-4cac-b131-9f8844c10dec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Uncertain Tax Benefits Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d0f58080-48ec-47fc-8f81-3661e24f2245_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1b79129e-91a5-4aab-8ef6-e316c14592b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_779000f8-56da-41c0-aa3b-b631125fca4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Maximum Leverage Ratios</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3a3cf433-c3b9-4097-a579-ad8100fc28d7_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b0f28208-8d17-4eb3-a0a4-b8ebc73b1c92_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_df7ae93d-0884-408e-903f-d69f26581c9f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1ecd7f9c-dddf-45e0-b3e7-97eaef31e09a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d348d28c-a361-49a9-a009-ec44a2422066_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e6981f08-b0b5-4463-9029-a7c955637890_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PrivateLabelMember_d439bbbf-77f1-4a5d-a863-ebd12e006611_terseLabel_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label</link:label>
    <link:label id="lab_iart_PrivateLabelMember_label_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:label id="lab_iart_PrivateLabelMember_documentation_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember" xlink:href="iart-20201231.xsd#iart_PrivateLabelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PrivateLabelMember" xlink:to="lab_iart_PrivateLabelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_af40356d-2285-4798-8fa6-2d4df587eed7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Derivative designated as hedges &#8212; Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AllOtherMember_d161422c-5b23-4870-8e82-164ffa89bf62_terseLabel_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_iart_AllOtherMember_label_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_iart_AllOtherMember_documentation_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember" xlink:href="iart-20201231.xsd#iart_AllOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AllOtherMember" xlink:to="lab_iart_AllOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_4598fa71-b4cd-40a9-93bd-fd79da02123f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of construction in progress</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_c4d7e11d-2e48-4e53-a8e1-6018e53d72ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds(payments) on swaps designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_fa390563-f87b-4024-a7ee-fa226552d91a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a88a2edd-f852-4b96-9b93-3d9e44302fba_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7e6ebc94-3719-4d88-8b5b-44d4d50dea3a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_b8b1a619-d7e8-4b28-b284-b1a888a3fba7_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overnight Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_aa19bb7a-3844-498e-aec8-b8e795be2e07_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1809e56a-795d-4e6e-8ba5-ee01019a1d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fb70d96d-0675-4948-b1ca-6a0b09edf9db_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf626ca0-eaeb-4748-bd0d-43170c3f7f15_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_756a0cd2-1636-4537-abb4-e39ce5c85f30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_02279535-4e76-4b70-9102-2222f674cbdd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f9eed05-9fab-4e6b-b603-b068eaad3f7f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_cefbf5ca-8f06-4a5d-9bcf-0c0edfd69e03_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9dfb70fb-7238-40c5-a265-d9b8e81eefcb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from option exercises and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_3bc96a55-a00a-459f-bb74-5d52575f6289_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, Beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_7d6d7942-508d-41bc-9990-88719d551e41_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_81e73d6c-14c4-43d4-bad3-48b4b34c54f3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b6c5b047-50b2-4b57-9717-7775fc07657f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c43541a8-770c-49f4-84c1-98033486bfdf_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a3085186-52de-4e3b-8f74-c3e50958dd12_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_6e574e16-d07d-4316-bdc1-f71b80669122_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_5a0d4c3b-4cba-4b81-bc65-4594521d46c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_14753312-aa94-4b21-85dd-63b94984c010_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_69ffdb05-1b91-481b-895a-12246887cd4d_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d6322d16-04ab-4253-998c-75cc09dbb29a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_c1586b0b-21df-4723-8d8a-0753af0a8919_terseLabel_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_label_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_documentation_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember" xlink:href="iart-20201231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReboundTherapeuticsCorporationMember" xlink:to="lab_iart_ReboundTherapeuticsCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ThreeMonthUSDLIBORMember_aa16adbd-a02a-4f4c-92f1-6f13ac6bfd61_terseLabel_en-US" xlink:label="lab_iart_ThreeMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3-month USD LIBOR</link:label>
    <link:label id="lab_iart_ThreeMonthUSDLIBORMember_label_en-US" xlink:label="lab_iart_ThreeMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Month USD LIBOR [Member]</link:label>
    <link:label id="lab_iart_ThreeMonthUSDLIBORMember_documentation_en-US" xlink:label="lab_iart_ThreeMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Month USD LIBOR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThreeMonthUSDLIBORMember" xlink:href="iart-20201231.xsd#iart_ThreeMonthUSDLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ThreeMonthUSDLIBORMember" xlink:to="lab_iart_ThreeMonthUSDLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_bb855c28-3e11-4ec2-816f-ef9178e9dd9c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d7d20711-c24c-46f8-8c96-1f3aa711440b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandOnePlanMember_a32a3b67-de90-48b7-8821-f2384811fc19_terseLabel_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2001 Plan</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember" xlink:href="iart-20201231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandOnePlanMember" xlink:to="lab_iart_TwoThousandOnePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d98873f0-20f6-464f-b55b-3c8395d90bd4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_f2ca2245-7139-43aa-b742-28cb3808139d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5e181799-2496-468c-8a66-472d6c22c9c9_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_a1353e18-d8a2-49ae-b3f7-d2b39ba9af94_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="iart-20201231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4250238b-7dc7-427e-bf36-9697e221778c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3d9ad7e5-8699-47f0-a2e9-ec67667a35e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_8f49b425-9100-4960-8e17-81cac25ac338_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a53536a7-4703-42d3-9648-056734c5f869_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_7098a579-9228-4e74-ab17-297df620673f_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low-taxed income ("GILTI")</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_85c67ac2-75f5-4654-98c7-5319f8daa345_terseLabel_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="iart-20201231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_acc7ade9-1727-495f-a3d6-f14330f4de16_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodAxis" xlink:to="lab_iart_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_ac14605d-d002-4a85-b16e-9049b1aced5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_ff28b24f-bd9d-47f3-b1c5-948dc1103dd0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c68120e9-1c05-489e-8d38-677034cadb66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_b3826a50-460a-486e-bf57-cad58c42bf32_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:to="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_621e51cf-5c12-4f5b-8218-25f709fa9d03_terseLabel_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options (or more)</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="iart-20201231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_6024bf61-a26f-46ab-b654-78b4c3b1d4b6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_5e0e94b1-c22c-4117-b715-8e9d0a1b3b9e_terseLabel_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, capitalized expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_label_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_documentation_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses" xlink:href="iart-20201231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InventoryCapitalizedExpenses" xlink:to="lab_iart_InventoryCapitalizedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2744d4ed-5eea-4f61-939e-a76b33d2ed22_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_24c7f03a-b8d0-4939-b58f-279aede24291_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_911de198-e007-49f2-a4ad-763b8692cf1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c57f2d5b-b97a-41e3-8874-30527e76263a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2cb5d99c-052e-423b-989a-660e62c8cd12_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_7b810acc-028d-4c89-9134-c135c34eea60_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense capitalized into property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:to="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_f1188c2f-bca9-496d-be0b-1fc561184397_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible notes issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_d1c5f40d-21c0-481d-a266-8aaac9ab8f4e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from offering of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_2d0a7dcd-c300-4912-89d1-578652cbb1bb_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a3edea7b-7dd1-4457-8d8e-2611e06c37fb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2e9964d8-53e7-4e48-9557-85e7f8c987ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_c2ef81e8-29da-4341-9502-8ea4ff1cb47a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_5bfdf7c6-8320-4a4e-9370-0d15703f5b48_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_bc58c870-b7ae-45c6-88dc-5cf641bd0d58_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Contract Assets and Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_45513dd5-8e90-4db6-9dea-6267c820eac2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fde2d211-be5e-4204-b970-fbc1a8803ccf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1e87d278-439e-49ac-b60c-f4dfa643d672_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ae5a6c3a-04cf-4f7b-8d05-2ea3b43ed42d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2303a67d-2d57-4144-b882-814a03538665_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_6c997674-f50b-4854-904d-34fa79f351bf_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures, and office equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_79f78b9c-e4a9-4a43-8bfb-aff9ba072163_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6067927c-77a3-47dd-9bc6-4476072ae057_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_717af33f-9f7e-480f-bba3-e9951d8a60fa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f289808d-9119-443d-8805-04af74516c2e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_31758ba0-fd76-4924-a17e-4f85902c9339_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d44fb3bc-dcdf-43d1-92b0-9dbff559bbd3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_39c7c3c4-46a5-4b51-b800-799c4faf1a5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_66af160d-48eb-4187-a947-0fc81947cf52_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFiveMember_63f0710b-5a3e-4ffa-8696-24d408a17b77_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Five</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFiveMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Five [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFiveMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFiveMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractFiveMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_6a88c3df-4c0b-4fcd-a68d-3aac2b290438_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6db84148-a215-4da5-98b0-f5d4762875f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_d620672e-4eed-44b6-8d90-a703703da5bc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InstrumentsMember_d40d5237-16ba-48a6-a6b1-0c078bde1356_terseLabel_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_iart_InstrumentsMember_label_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_iart_InstrumentsMember_documentation_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember" xlink:href="iart-20201231.xsd#iart_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InstrumentsMember" xlink:to="lab_iart_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_8356ecd5-5da4-4e44-9f77-6f56d17425f5_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0a9ad0d7-8009-4610-9d86-be9fa399e109_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0bf90969-0bcd-42e4-8158-293cde9be165_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0c03950b-25d6-4632-b036-a04549a46dfa_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestOfWorldMember_66f4e6e8-0c84-43e2-91c2-af6dfb956709_terseLabel_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World</link:label>
    <link:label id="lab_iart_RestOfWorldMember_label_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_iart_RestOfWorldMember_documentation_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from rest of the world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember" xlink:href="iart-20201231.xsd#iart_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestOfWorldMember" xlink:to="lab_iart_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b00896a-5574-4f4b-b382-3235f2cd45eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractSixMember_9af93a95-51a3-489a-96d6-028f4040612e_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Contract Six</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractSixMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Six [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractSixMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractSixMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractSixMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e18426fb-dd3e-4bcf-a12a-ae583d62c8bf_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_d262a924-a59b-446f-9af5-b00f727d1f64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_04628e1e-bbb8-4674-accf-1416709b431e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_1cba6477-cac6-47e9-bc4b-75911fbb2287_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d33efc0e-6216-453f-9f9c-6f9bf0b4462e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c77063de-a9f3-40c4-b248-8a7fc70f1dc1_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3673568-a380-4136-88ff-fe9c6dc15d9d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_58efa500-8fa5-465a-a5d2-4418a88dfe3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_de85742c-2015-483d-810d-26a0775b7d7c_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Compensation</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OptionToExtendLeaseYears_7a717726-6186-4c22-b315-601e19b422cf_terseLabel_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_label_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Extend Lease, Years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_documentation_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears" xlink:href="iart-20201231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OptionToExtendLeaseYears" xlink:to="lab_iart_OptionToExtendLeaseYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6e90ad82-545e-435d-a80d-2a93229c5a1c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_41d0444e-3f5b-4a58-a950-0b8ab33b8c19_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3f446516-9be2-496e-99b7-370c94a99e31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_f8c21894-bf82-417f-ae78-85b42c5a9e0e_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible facilitative costs</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_9896de31-7de2-4afa-9c4c-147dd2c7a64c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_dde4547d-b53a-4513-981a-0afe360858e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, initial conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_2b8de9fc-2b96-4c46-b66f-b11a494110fe_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_94f7be75-8901-487d-9578-13f84fb8166c_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock_6e8fb1d0-76c2-4330-b79c-66e312b9add7_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS</link:label>
    <link:label id="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock_label_en-US" xlink:label="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition Disclosure [Text Block]</link:label>
    <link:label id="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock_documentation_en-US" xlink:label="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:href="iart-20201231.xsd#iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:to="lab_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8465668a-41cf-42a2-86f6-d869d349722a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_0096fb38-43ec-42e4-bba6-6fad6f48ff4a_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_94b4c965-2b4b-46f8-8410-5c29f90ed116_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_23c88851-0ea1-45b7-ac9d-7eebbe88bc0d_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_084614f3-d2cc-4e55-a59e-0089e296500d_negatedTerseLabel_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used in business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_label_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_documentation_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:href="iart-20201231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:to="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_ac5412ca-33b3-48b4-ba68-f2533a85588c_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_bd82690f-776f-4758-a71e-5a56f2012a3f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f61ba66f-6d1b-4fcf-b905-97684cc8763b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_eb7461ec-169d-41d4-bfc3-fdc2144ed8b1_terseLabel_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_label_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_documentation_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ArkisBioSciencesInc.Member" xlink:to="lab_iart_ArkisBioSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_bf3b4011-e666-4444-8dae-9f427e9e1133_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_2c64ea03-bab9-4211-967d-3ddc82e0c69e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4b814b0-c051-4069-a7fe-74d7b8b2a6a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_0db698e3-3080-42b9-9c47-b7a78d7cb8d8_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_label_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Number Of Assets Acquired</link:label>
    <link:label id="lab_iart_AssetAcquisitionNumberOfAssetsAcquired_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Number Of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:to="lab_iart_AssetAcquisitionNumberOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9913141b-5a08-4145-8d9c-881c62eb226b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5b4139c7-c2a6-4eb1-accc-3d04c3692c15_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_773d593a-c5e9-408b-9e31-966bbd8f491d_negatedLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9b8db393-fe14-4726-ba80-cf34618d4bfa_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_72fa1a1c-1133-48fb-8820-9d27774b967b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_83cbe206-1f34-46a8-8503-adb027bc4512_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic And Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_d52e2042-a4ee-4d67-ae5b-75d5c649ef57_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_9750d123-7a5c-4175-a613-7f90dc35c8ef_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_2c20a19d-5c83-4ca0-ad06-0e9cfcd3fe37_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of bond issuance discount</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_b565ebe6-dc39-4039-a954-d9bb531f8983_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_8f5284be-76c9-48a8-90c2-3bd3fda6a5a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_cbeee062-2026-45b9-9bc4-2b8bc1f644e2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_643c0bc9-e30b-49cd-b539-00b64ebe2ad1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Funded Status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_1f74c330-9c30-4a2c-87dd-b1167cfa6ea3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D, indefinite-lived, included in all other</link:label>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Indefinite-lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a097f7c-bddd-41fe-852a-6e84f7021c6d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_525ac344-db19-4630-8894-2732cc1e65b5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_7daec601-3db3-4f18-a6f5-87464d2b5fea_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_7a1837cc-a686-4358-94b0-7773cd3eaa20_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_23197570-28a4-4381-9594-35bd23b493d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_e491aa1a-5ede-470d-af88-a28934b59292_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_897dd3f4-190a-4676-b8c5-4f58204cee26_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8e312063-98fb-482b-b05f-4c161f2445cf_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite Lived Intangible Assets By Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_80157b59-0f4f-445e-8d80-9bdf26add94a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_69d4b525-7931-4269-bd03-cadbc1525ae0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_5cdd35e8-bf8e-4dd3-a6c5-60537bbb4713_terseLabel_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in authorized shares (in shares)</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_label_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Authorized Shares</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_documentation_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase in the number of authorized shares under the Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares" xlink:href="iart-20201231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncreaseInAuthorizedShares" xlink:to="lab_iart_IncreaseInAuthorizedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_070426c2-913d-4961-8b2f-173363c20c76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_20ce0ddd-41e5-43f1-a944-2bdf741631d7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_87e45d99-21b5-4aa8-b14f-c72213db752b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_c986bcd9-8c19-40cf-b577-19fd15281912_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_25822b07-aa9b-4636-9af6-01ad6167d3c9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0e7a7fa4-25c3-4b37-b533-c5bded01174f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_eeb1e6c9-a2cd-4ce0-9ad3-1352008faf88_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d6519ff1-04d0-420c-b14c-68508bec2863_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_2f456495-dc91-4b00-8b65-eef845b130ba_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_77f43a5c-5ec7-416a-b5b5-b3bff65d0ed1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f4fbd980-8dde-4289-9ebb-5a3777bb398e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_02d4a6c7-e2fd-41df-b7d3-659f51ba2f59_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0f995030-a1fe-4cd3-8751-4939c2dd2dde_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount estimated to be reclassified to earnings during next twelve months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3dc9faed-eac1-4ff8-affb-d5839af36559_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_3e6dd76e-a1eb-4b59-bca9-bb057e22f015_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1c024ab6-56f3-4ec9-ba76-cb798eb18c3c_netLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_623c8070-cd8d-4305-bb96-729e550e8bba_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3d13b746-97f9-417f-90a6-59b3b032755a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b526aa76-cb9b-4df6-b6c6-7d66f201093f_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_31c5526b-cc90-45af-a254-01907a7c200e_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_f5dcf6bc-b3db-4216-955f-f4669c7b0f4c_terseLabel_en-US" xlink:label="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing Customer, Notified By FDA To Remove Product From Market</link:label>
    <link:label id="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_label_en-US" xlink:label="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing Customer, Notified By FDA To Remove Product From Market [Member]</link:label>
    <link:label id="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_documentation_en-US" xlink:label="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing Customer, Notified By FDA To Remove Product From Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:href="iart-20201231.xsd#iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:to="lab_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_12b7b09d-97ae-4074-a848-f6a2a2df3e17_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_d3d5e8b2-0fb7-4c46-808d-8e9647a17ebd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value (Liability)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6a0db8be-15d2-4193-92ba-f610df43deb4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_51bc7e72-d770-4cbd-96da-a73a4c9cc204_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_7d86516b-98b9-4561-b9ab-408515bb0632_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Benefit Obligations and Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_52c1a3af-896c-4837-91b0-3c86e60b4544_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of Update No. 2018-02</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CertainPurchasersMember_4ead97e2-528f-4c9e-98a9-beb0364db448_terseLabel_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers</link:label>
    <link:label id="lab_iart_CertainPurchasersMember_label_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers [Member]</link:label>
    <link:label id="lab_iart_CertainPurchasersMember_documentation_en-US" xlink:label="lab_iart_CertainPurchasersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Purchasers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember" xlink:href="iart-20201231.xsd#iart_CertainPurchasersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CertainPurchasersMember" xlink:to="lab_iart_CertainPurchasersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0b6a36e1-4d1e-4cd2-84a5-80891a2a407b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_21260b27-160c-4e06-a128-97ccebb6d8f0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_22473dd9-32b3-4352-8819-62fdc7ac3e55_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db4d08a4-847a-4a63-bdfe-a29c1b1bed20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_706eb483-da4e-4bcd-9542-80ea0db10a61_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_bdb6bfd8-e327-4897-9589-08e0de8aa119_terseLabel_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days from shipment to issue a credit on returned goods</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_label_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue Of Credit, Number Of Days From Shipment</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_documentation_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue of Credit, Number of Days from Shipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:href="iart-20201231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:to="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a468ea86-31f0-4008-bcff-c9f6603b92b3_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ebe78f5c-c8f9-4c74-8c7f-2516127f23d1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Uncertain Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_84d38bb7-f8f2-42b5-a725-4edbfa2b15cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_0c61577a-49df-4709-b3c5-018cdaa9d760_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_e9d86355-1f95-46d6-a2f5-4c2cfa46c115_terseLabel_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_label_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionLineItems_documentation_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems" xlink:to="lab_iart_ScheduleOfAssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_25271702-b4c8-44ae-98e6-e822ed2284fd_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_7e5140b2-699a-409e-9563-49506c82e80d_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa6f8b7c-90ea-4db3-9d5c-44efd24bf3d7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for cost recognition, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentOneMember_d1348bb3-f4b9-41c1-92f6-a9df20fa29a2_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_label_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember" xlink:href="iart-20201231.xsd#iart_MilestonePaymentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentOneMember" xlink:to="lab_iart_MilestonePaymentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_5c86fa83-53cd-49f4-b76b-d2c715bdada3_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_e84bb0f3-8ab9-47cb-865d-b278ef7609a3_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan component of senior credit facility, classified as current</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_debd7d4b-ee35-43ba-aa51-487e98fe20fb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_debf7c30-a928-4a0f-a660-25a350dbde87_terseLabel_en-US" xlink:label="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock-based compensation plans</link:label>
    <link:label id="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_label_en-US" xlink:label="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans</link:label>
    <link:label id="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_documentation_en-US" xlink:label="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:href="iart-20201231.xsd#iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:to="lab_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_69d1543a-eddc-4aee-838e-c69b7640587e_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_75686e46-1008-4f9e-b5e3-47acfbe78ad3_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of revenue included in beginning of year contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_62e25a9a-9b33-4578-ae70-7dd559422c27_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_53b070e2-d5e0-41f0-b254-ea4b83eaf529_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_7300456b-74a3-48b4-9315-61eca3f4748c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7ae78be0-8be7-49d0-bf02-f0fdcbbec95c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized derivative gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_267ff8f9-e037-4863-aa64-a01cd6e272cc_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded in AOCL, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9b3f9e98-fabe-4450-969f-8492b0189db6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtAccountsReceivableSecuritizationTerm_37da5910-8a5d-48ee-a268-7c67fcd5b456_terseLabel_en-US" xlink:label="lab_iart_DebtAccountsReceivableSecuritizationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, term</link:label>
    <link:label id="lab_iart_DebtAccountsReceivableSecuritizationTerm_label_en-US" xlink:label="lab_iart_DebtAccountsReceivableSecuritizationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Accounts Receivable Securitization, Term</link:label>
    <link:label id="lab_iart_DebtAccountsReceivableSecuritizationTerm_documentation_en-US" xlink:label="lab_iart_DebtAccountsReceivableSecuritizationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Accounts Receivable Securitization, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtAccountsReceivableSecuritizationTerm" xlink:href="iart-20201231.xsd#iart_DebtAccountsReceivableSecuritizationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtAccountsReceivableSecuritizationTerm" xlink:to="lab_iart_DebtAccountsReceivableSecuritizationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_0a22345e-611f-4b48-8ba2-d569bb263326_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalization of research and development expenses</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1d6e718e-0c21-4a55-a627-8f662087144f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_dcc40d59-bc06-4385-89f4-7067331e56c1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Selected Quarterly Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e8f81ea4-f354-4ff3-872c-c771fb0c929a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_8e8c0ceb-f1ef-4acf-a5e8-7e49ba41bee8_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_e388c3ce-3f85-4cd5-bfa8-036553de59a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a5056fe5-85e3-418a-b627-0dc5ab79001e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_78fd1eee-d1ac-4db0-b42c-21162724f3bc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_e1a22ab6-95a4-4397-ad2e-d8a0b17526aa_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, base salary, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_ae7658b1-a8c2-4479-a7d3-9193ad6d3224_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory related items</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6fca6974-fa31-4945-8065-f587d61fedf4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b317ea07-e60f-438a-839f-ca55e1ca2211_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_059ffb04-9812-4fc3-ac36-b57961bb6557_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_cff4d731-feae-4b77-b2fe-4022218bb7e5_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_3fe750c8-3955-42cc-9e31-c2a3133749d8_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SupplierRelationShipsMember_fdc4a86f-bd80-4384-b433-dfc00d377bba_terseLabel_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier relationships</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_label_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_documentation_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember" xlink:href="iart-20201231.xsd#iart_SupplierRelationShipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SupplierRelationShipsMember" xlink:to="lab_iart_SupplierRelationShipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_20268ca4-6d92-4068-a147-d996f5ba3892_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_a09a6b95-fb84-4a6b-b5e0-481c5cf5bdfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1dbe2d9b-2c2b-4c26-861b-c7d2b4aaddb8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6d15e882-7c0c-47e0-a809-b799f42eac4b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ecc11a7f-18fe-4dd8-a509-9edde6a044e4_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e876fafe-68e8-4d64-8b52-e113d83feeed_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f1eff2cc-f044-4969-bb01-1c3426c1b602_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1ad1ce0c-421f-4ed1-b0fa-d9c496412974_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_8f258cf4-960b-4eaa-aa36-d75fe2d1f296_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_c22c4228-76fb-4db4-85e5-6f93b013f175_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_c621aee6-9c72-4bde-8ac0-63f43d7f63b8_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a8d40280-8469-4501-90b1-45c81707228c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount under share repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b096da81-56ef-4856-9309-0d0c587aa41b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_01bad63b-1d72-4416-b214-738f7f218713_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_49c6829a-ffc2-4301-ac88-c497e546d867_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7b917f03-977e-444c-98f4-ad4ac19792d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_84d5a138-21bb-435c-ab13-e7085e7096f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_f021d751-b92c-4659-a7c0-1fb43a16611e_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_baf625f7-b52b-42e4-a1c3-84c76f74c0b0_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_3397c869-f110-4f47-8596-ee65bac23728_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_deef1fc9-62bd-4171-86ba-4234691a851c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e627a51c-6655-4df8-9be2-7045b2a4b385_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5cac2f95-9a56-458b-9503-8aa575ac5be9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_a61b1e53-7c53-4218-bd41-5c3284666708_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_0be50605-6197-4d55-91ba-c78e461e4d10_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale - Outside Basis Difference</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_f63a1c68-0334-4028-894a-faa0d84e7028_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_61e24d9b-b496-4a6c-aeda-a0392fad22d3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_42c6a6e2-d063-40c9-b36a-93e9d926f396_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNoParValue" xlink:to="lab_us-gaap_PreferredStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_79c32e97-1dcc-4b4b-89c5-0a5272f8b9c2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_3c71ddf0-ce50-484e-8799-50f62c6f3c0d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other income</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_4c65df6c-e1bf-4769-bb26-623b2a66b719_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_85804302-435f-4513-baba-8ead50831dd9_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:href="iart-20201231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_d1ac7388-4285-4ae3-a082-2248d600f613_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_824b380b-5d4a-4bb4-9def-bd94f067b3a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Employee Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_149a0b43-10c0-4dcf-b292-17fa306c4b76_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_73c0e982-4dc7-4b5b-bd7b-581bb6544d7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_6cdbbff0-2c11-4ec0-ba67-b732f8c61331_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased, amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1af74e93-7dd6-440a-898b-88026790518c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2dd2faab-e491-4546-833a-9fe6c866bb5e_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_41cac5d9-4b88-4689-ae64-46b2aa12abb5_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, net of transferred to trade receivables on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_label_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:to="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0ecc02b6-6b9e-435f-aaa5-60be2fc373ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e1c94ff8-be19-44c4-bd72-92a3bcab05cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_26245ae2-2890-4ac8-aa0b-0f5e872f0724_terseLabel_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_label_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Rate Of Lease Agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_documentation_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement" xlink:href="iart-20201231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AnnualRateOfLeaseAgreement" xlink:to="lab_iart_AnnualRateOfLeaseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_ebd2f62a-4b9b-4e01-b508-2cbc70b39cd1_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Repayment</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9b7f74ce-6a11-45f6-af13-229cf47c336d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_28950666-cfb5-45c6-9777-13a14b9505ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES AND RELATED PARTY LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_80615211-6ee0-42a4-8359-ac78548d5747_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_e5cdf383-c8b5-476e-99c8-74de30073cfa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_2bac48c7-c500-4673-90a4-ae9055001e0c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_c7b17788-4812-4f63-891e-9c6bd4ac4b29_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_ca4fbc6d-bf55-4037-8a5c-c92ae30015b5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_67cd20d5-c771-4a7e-84fc-90f2e6ff8141_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_be86b279-ace1-4c41-81cd-53e4e92e4f63_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_64bce632-28d5-4bd4-90cb-dd013914dcfe_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_177da761-4778-426d-9bab-84c29c3d2764_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_15b02e04-61d5-4b47-aa48-34d70e8952a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e436a4cd-c6d9-42af-8647-41e19776df0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6ec80537-c5b6-4ddb-931f-613d4d70808d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7b5b621f-e65f-4e2b-9058-5d07cf36ed54_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_0ce69bfb-8e96-4b3e-9ef6-bc8e5cecc6df_terseLabel_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP proceeds received</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_label_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Proceeds</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_documentation_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from employees in connection with the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:href="iart-20201231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:to="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_703bfae5-0744-4570-a69c-c021571a667b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_e453504d-c143-4587-b2a4-a223241bc990_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_cc9b790c-9a02-42d5-a406-3a1902cdc66e_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Extremity Orthopedics business, payment for terminating license agreement</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_e7ba395f-09d5-4d7b-9bf0-480070710c49_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_a1d3bd7e-ff1d-4767-9c1f-d98195053730_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d7650f4b-d874-4a71-a333-e8c2284adbb2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3fba42f0-81af-4cf2-9e49-2840a2ecfbfe_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5fdd9dfa-3130-4035-bf39-3c787c9a4dd5_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States (Includes long-lived assets in Puerto Rico)</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_927bf91e-2b58-40aa-82b9-1141f4cc4545_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net period benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3769e67e-b431-479c-9bee-f8745a8442e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_156cf48d-3248-4bbc-8b8d-fce727c6f535_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1d0a1569-f43e-4859-89b3-66d2df4187ab_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_1ac84ee8-dd59-4e17-8d3f-5b32caf3c5a1_terseLabel_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Month Eurodollar Rate</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_label_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_documentation_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember" xlink:href="iart-20201231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthEurodollarRateMember" xlink:to="lab_iart_OneMonthEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ccd9c461-a441-4ebc-b31a-644e52e702cb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8067b8a4-1ba7-4c3b-88ae-c7e6357ef222_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_509ad10e-bec5-4266-adfc-7f79ee1cbed2_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f6d91937-c955-4441-bcd7-343ee1a30574_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_fe6660fa-bd09-42ba-b6af-77cef00d289e_terseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases:</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:to="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_1de39458-b9d4-4441-ba5e-64421b9304f8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_85b0339a-7933-4b06-95cb-1c4a625c4eb1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_27d825a4-da33-4048-8f0c-248c14620411_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_5dace4dc-9f5c-4972-8738-72a17b26b681_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for extended lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_4c39d2c2-c9f6-43f8-9371-85a94d468dd1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_81e8cad3-e8e7-4380-a9ae-3b37b5044703_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_397124e2-2a58-42d0-9e0f-d5147e305039_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_ff7c031c-8261-4b0c-bdbc-4a6fb2b02900_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development milestone payment, to be paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_label_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment To Be Paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:to="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_9a5169fe-5261-481b-ae2b-f695f3adc6b2_terseLabel_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_label_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_documentation_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:href="iart-20201231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:to="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_20499859-d06d-461d-bf5c-5e7aa35775ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4a051f14-d596-4721-a859-1c5ab3dd0ceb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bfac1fba-c3ce-4be6-863a-64db849a9f14_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration and others</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_971f0eb7-5b2d-4cc1-a5dd-b8f924696ade_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ac044348-cd40-4b76-afbb-1cb6a66c247b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0dea2f0d-4a23-45e9-9c02-53451ad6ba16_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_ea30560f-9d57-4f81-a467-50d90d1ccf34_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_263a5f5a-bbee-46db-99c9-4b4f423456d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan - net gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f36fc4ae-b919-4dc7-8a99-4475b63047c6_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_db2881a1-aa17-4cdb-a180-e5b15682e155_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowances of $6,439 and $4,303</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_a4a6c32b-e5ba-4d4a-b7db-415762cf2157_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f7e428a5-9a94-4238-9587-7274aa414c7e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TermLoanFacilityMember_279d82a7-e0a5-4f00-961c-88ca2175c7ae_terseLabel_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_label_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember" xlink:href="iart-20201231.xsd#iart_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TermLoanFacilityMember" xlink:to="lab_iart_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_c807af3f-39f9-4d4f-8804-cadb13153a21_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_0b74e2ac-2565-4da3-9138-4a3645052c01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest crediting rate for cash balance plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_3804cdf9-0f9d-4445-ac88-6855fb01983c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plans transferred in</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_36879f55-f177-48cc-aabd-02c88b262157_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4952f316-f34d-4be1-973a-2e67ad0f69b2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_f3bddb5c-eba9-4888-8b39-f81741d330ad_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Current</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f5be1583-5c91-4e43-a8f2-4cfd49400308_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_3e8ec891-0279-4b17-b43f-588423e387dc_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3799250-ed7b-48fa-800b-c854c01e9a4a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_f5b2ce2a-f1bf-49dd-9811-8dbcef1151cc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit realized from stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_5aa8f7ae-c992-40f5-8ea0-d3cdaff6f7bc_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_cc313090-fbbe-4839-a5c8-c6061e78f9f2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Derivatives designated as hedges &#8212; Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d315982a-cc00-4d59-aeda-8e08adf40a0b_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4ea6fe8b-b385-4da8-91e4-6059c53a06fe_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Extremity Orthopedics business, disposition price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f2482974-a2f4-4c84-a0cf-784108f9f1a3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price received</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_053c012a-f42f-45b1-92ec-beea69b170a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0597fc90-c78d-4199-9eaa-1c24552286be_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_e623ebf5-aa6e-499a-8271-76187c125e4c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashLeaseExpense_9f7dee29-d092-4627-a234-e5d3a6b8d2b4_terseLabel_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_label_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense" xlink:href="iart-20201231.xsd#iart_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashLeaseExpense" xlink:to="lab_iart_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_27455dbe-78e1-4499-8e82-567532cd9bb6_terseLabel_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:href="iart-20201231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_be2ff56e-172b-4348-aa08-fb43ccfd542b_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_8b207334-a41d-4115-8edf-c608fd4141b4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_66ba0e72-d8b6-4c9b-a6a5-ce971f8b07c4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_064ac442-b703-4e64-9900-065cf58fba73_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_b2641c43-33ce-425b-878e-431c3a1f8d21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a67de556-251e-4261-93cb-b5a50918e9ef_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fdd2a040-4020-4927-95ef-01cdfd753f14_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_f29acac3-e38c-4c33-8163-9519ccb64dc4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_faedba48-794c-4d79-8423-c66a0b542c01_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d638e35d-aaf9-41b5-8659-d15bec3459ba_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e7820f82-451b-4ace-b5ff-f14bb9729261_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share-Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8d207dd1-f34d-4801-a3f8-1269de3c687f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionDomain_de804197-3f92-4fe1-8b77-ec792ca6da47_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_iart_AssetAcquisitionDomain_label_en-US" xlink:label="lab_iart_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_iart_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionDomain" xlink:to="lab_iart_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16e25e16-74ab-4f30-915b-b0e151a3adaf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life of option from grant date</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_aa0b118f-75ea-48ee-886f-6dd673937c9d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of product technology</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_68a7e8fd-04c6-4ab6-83d2-4f44205d9d87_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_8c60bd62-d0f3-47cd-b8f9-06de0cecd29c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4e767508-4199-4d1e-ab3e-66a3ab94aff0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1ab3ad02-4909-4ebe-aab1-026833a337b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_da570009-2fd5-4ce5-882b-546f13dc3f42_terseLabel_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security facility, weighted average interest rate</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_label_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_documentation_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:href="iart-20201231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:to="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_24bcf8ae-936b-494d-a587-6c4c57e5c84a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Major Classes of Assets and Liabilities Held For Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_3b9c656a-6c27-4001-b7ce-156b30442cd8_terseLabel_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing period for products shipped with no alternative use and right of payment for performance</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_label_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_documentation_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:href="iart-20201231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:to="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_fd2ff60f-3122-46b5-8a0e-e072222edcc0_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a8c263ca-a62a-41ef-9597-bf874c36448c_netLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense recognized</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_fdd57710-890d-43c3-b83e-c4e77eceb29f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bbd55822-6c6d-40dd-9703-715e09a493b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff6895d1-3221-4069-ab6d-fd3c9d9e4a37_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_096003de-bde0-4ae1-bfae-aa22ffda77d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_cef2de76-4d01-4be4-b8c6-a60f5d4587c7_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_f665e740-561f-43e5-9c72-bac9469d913d_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_adecdeed-9f0a-4e60-879c-438893dc49bc_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_9f12d0ab-ea62-4a8b-8571-1dde4e9ed8fe_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_7f899b61-0d67-44cf-9207-c937a7923b53_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_47195c1e-f957-4819-9b02-14c58ee3ded9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2afc6c27-f61f-41fc-8a02-9d70ab0e9306_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated tax benefit related to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_1ce6466a-d76d-4b0e-847c-5371f7874125_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, fair value of assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_940447a1-5108-4d63-aa50-c8aea76b09ef_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_ed058fb8-0001-48d4-92d1-2036cd8536c4_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_434f5cc5-8cc5-4481-8094-638aa4cfef7b_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_bda5952d-8c36-4ec9-833b-38fcd60861c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract_8bdf07a3-89b5-45bf-b839-461c2ca732a1_terseLabel_en-US" xlink:label="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:to="lab_us-gaap_SelectedQuarterlyFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_06007968-7257-469f-b760-f0660ba4f1c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_074bcbfe-70d8-41ac-8489-4b19164526e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_1d8530fd-0d0d-4f76-b725-e500d3789497_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_478ab4c4-d558-4baa-80ff-ecf7c7aa09b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d33f46d2-71b7-4a96-96ce-e7d54dfaddab_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_f4079456-428b-484e-b2b1-eb6f0cf17cd2_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum average conversion value of notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:to="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_9db1a3de-a578-4e01-9af4-fe50842add94_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3f5de79e-8dfe-48e6-a020-ff76b1a8ca13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c818f3e2-cfc5-4f07-8d36-50f6fa4354b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_1b64a185-42a0-45db-9716-bc7fe1b77f80_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_4b94450f-73a8-43cd-937c-136c2a7960a9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_847b3aab-3ec1-43f2-8034-e1ffb9789b7e_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 4</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cba86fdb-15ba-470b-afa8-ca922aa7d9b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_fed2c2b8-0c2c-4701-9cec-a1d50111ffe6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_2d14ff6f-a962-457f-97bf-1feed2d8224f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b60cfe78-6cf1-4f83-86e9-8fe96b73956a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_3f56c1c8-8cd2-4d29-91bc-e0e94f2b3d00_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3861ff7a-2315-44ac-94d3-d25747aacde8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4997bdfb-9c56-49e6-8e98-c32195daf420_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_69535240-5363-4c9b-aba3-8ff8b45a21dd_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations lapses</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_4b138717-e7fc-40a2-8dfc-5c0693843140_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to acquire, period subsequent to first commercial sale</link:label>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d5dc192e-b0cb-4025-8672-c8941c49cd8f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_8ea351d5-0be5-4560-8800-37fdd1c6d6b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_10318a98-578c-46a6-a281-41c3978640b8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_550aec91-7ab9-4261-b313-ae74756262bd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_16e3738e-6621-4e14-a514-fdf152ccd27f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from computation as their effect would be antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_c337a8f9-ea59-40d4-88c8-8f1b9b256184_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellIncMember_9fbbcffb-58ee-4cc6-a44e-5aa91d16de1f_terseLabel_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:label id="lab_iart_ACellIncMember_label_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc. [Member]</link:label>
    <link:label id="lab_iart_ACellIncMember_documentation_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember" xlink:href="iart-20201231.xsd#iart_ACellIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellIncMember" xlink:to="lab_iart_ACellIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_6206fad6-e44c-4947-b878-4fa938d2fd67_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years' tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_690b28a7-bca0-40b5-9109-e8411d289d11_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_367891e0-e962-4900-9677-b3553a30cc30_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ad0af73d-e0a7-42cf-8ab6-9eb8dfee1d97_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_a0d6d7e6-10ef-432f-be77-faeac61529dd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_b46bbc4c-2a5d-47b2-aa1e-b1b8c62b9bd8_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_ff3bc31e-5d39-4744-be27-57301642cec4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_222e2804-50da-4244-8386-81a46e29c484_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_07245df8-8b0c-43df-aa18-47c5ef80b130_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Charitable Contribution Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b3421e97-bbea-4f04-b107-6ddf118419cd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6590a4a9-9803-4ad1-8dd5-77834242078c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_da9e724f-449d-4b2e-bb60-933b0d512704_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 5</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_721c5128-000c-46b6-981b-b29563b5754d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_e759f7ac-9398-4195-a6fd-4c09eab91803_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_c44ea397-1b8a-4e27-8dd4-965ce6725181_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_61be6b0c-b8f6-47c4-9b66-c2483ecaca93_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5eb110c3-7e7e-4b8b-b07d-0dfec3122b2a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_781ba747-c5d7-41b5-9f6b-c5a4087bbc87_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e2135292-af31-477d-ae8e-b808c09199d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_0bfb1bd6-a484-4396-ae34-a0fd954c86bb_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e799885f-9029-4341-8038-e31171db3c0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_23bfe3b0-008c-43a0-96d4-39281987859f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt proceeds, classified as equity at time of offering</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_c5371a4a-765b-448d-ba5d-63b99a00e301_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_823f51b3-eef9-47c9-af8f-567204033fd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss tax holiday</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Holiday, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwapOneMember_c3f04136-38a5-4454-a249-02900097bbd2_terseLabel_en-US" xlink:label="lab_iart_SwapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap One</link:label>
    <link:label id="lab_iart_SwapOneMember_label_en-US" xlink:label="lab_iart_SwapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap One [Member]</link:label>
    <link:label id="lab_iart_SwapOneMember_documentation_en-US" xlink:label="lab_iart_SwapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapOneMember" xlink:href="iart-20201231.xsd#iart_SwapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwapOneMember" xlink:to="lab_iart_SwapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_bec47b86-e243-4569-b597-1bd403e0a952_negatedLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of option hedge on convertible notes</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_0312269e-e254-42a0-87c0-a23ac86b65bb_verboseLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of call transactions</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_label_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Option Index To Issuers Equity</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_documentation_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Options Indexed to Issuer's Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:to="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e6889d60-0db1-440d-932d-9d19e6c9e608_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_ceebabc3-f866-4533-8d3a-f5d11364ec83_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_d109f41f-abcc-4ed0-bbc6-0c42af0110fe_terseLabel_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_label_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_documentation_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:href="iart-20201231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:to="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_79c9ed31-a94e-4593-85a8-b7ce645997d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwapThreeMember_c0f0e2e5-b595-4e37-b8fe-43fc63a32bd3_terseLabel_en-US" xlink:label="lab_iart_SwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Three</link:label>
    <link:label id="lab_iart_SwapThreeMember_label_en-US" xlink:label="lab_iart_SwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Three [Member]</link:label>
    <link:label id="lab_iart_SwapThreeMember_documentation_en-US" xlink:label="lab_iart_SwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapThreeMember" xlink:href="iart-20201231.xsd#iart_SwapThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwapThreeMember" xlink:to="lab_iart_SwapThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_340b8fc4-d32f-4790-9bc8-298b2ebd7b26_terseLabel_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, fair value of amount outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_documentation_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:href="iart-20201231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:to="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OrthopedicsandTissueTechnologiesMember_b4e8779e-9544-4b5e-b38d-4267e8c8b34e_terseLabel_en-US" xlink:label="lab_iart_OrthopedicsandTissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedics and Tissue Technologies</link:label>
    <link:label id="lab_iart_OrthopedicsandTissueTechnologiesMember_label_en-US" xlink:label="lab_iart_OrthopedicsandTissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedics and Tissue Technologies [Member]</link:label>
    <link:label id="lab_iart_OrthopedicsandTissueTechnologiesMember_documentation_en-US" xlink:label="lab_iart_OrthopedicsandTissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedics and Tissue Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OrthopedicsandTissueTechnologiesMember" xlink:to="lab_iart_OrthopedicsandTissueTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07b825dc-7cef-4b01-bbfb-847e9515b436_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_9d34fc75-fbd6-44a5-a3f2-9767f2f932ea_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CerebroFlo developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_aacbbf01-6951-448f-aeb3-1ebb6eef61dd_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2258172d-65a3-4df6-8b4e-cbefb3a73d0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_ab2d7263-5d3f-4ce1-8f93-bd374849b8b1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_81953eea-a49d-4745-9bf0-495f7b0731b3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_473e7038-a803-47d1-8dde-d047559f6d7b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_4d933a43-eb6e-433b-8ebc-a6ebc88df64c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from note receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_eb42443e-a60c-4e21-b57b-8d68c40ac0c2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in income taxes resulting from:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_58384c21-e019-4b93-a9ae-dd95f5a9d962_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_acb28b15-dc0a-4919-8cde-5aa24e50b53d_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 5</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 5 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_85a22cc3-b7f7-4909-8482-7436c6898cd0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_10f936e0-0898-4824-bc91-683ab4335286_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_7e9a0e59-29c2-4cca-b1c2-b37bbf740a3e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_1c6d79ae-feda-499f-aff8-6090a5998582_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_53304941-c932-4094-bbc2-dca7b0e114b0_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_5608b04b-61b2-4a26-af9d-66b7f8d1edc9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_4c14c57f-c271-4dd2-a124-8f508987ecb6_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2023 and the last day of each fiscal quarter thereafter</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod4Member" xlink:to="lab_iart_DebtCovenantPeriod4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_b2ea3380-db10-4199-b734-4270418737d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase program, payment</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be27e483-8198-4b96-8207-27092c4c7494_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_6bc9491c-2428-4a29-8a36-6fe295d6720d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense) related to items in other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_7d5b4e75-88a3-46e5-83d3-d561e502fa47_terseLabel_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember" xlink:href="iart-20201231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContingentConsiderationLiabilityMember" xlink:to="lab_iart_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_a0950971-902b-42e1-8905-ac8de6525dc8_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_fe5fe282-0153-4714-8b43-247370330e11_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6fa77d62-f115-45a9-873b-08427dd81524_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_d628d271-0a39-4939-b663-5f46f68bbe22_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_af837c23-caa5-4cb3-bdc7-b1455363a2be_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_6fd4e9ac-4c90-4bef-9edf-e8238f9e348f_terseLabel_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, indefinite life, discount rate percentage</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_label_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Discount Rate Percentage</link:label>
    <link:label id="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_documentation_en-US" xlink:label="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Impairment Assessment, Discount Rate Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:to="lab_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_9f92eef4-3e0a-4ef3-af4f-f85cf0e2f436_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_866432c5-9adb-45aa-8c5b-a8a50270f5c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwapFourMember_be31f4cc-2209-40ca-bbee-bc0b29e10a48_terseLabel_en-US" xlink:label="lab_iart_SwapFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Four</link:label>
    <link:label id="lab_iart_SwapFourMember_label_en-US" xlink:label="lab_iart_SwapFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Four [Member]</link:label>
    <link:label id="lab_iart_SwapFourMember_documentation_en-US" xlink:label="lab_iart_SwapFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapFourMember" xlink:href="iart-20201231.xsd#iart_SwapFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwapFourMember" xlink:to="lab_iart_SwapFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_fe1edff6-42b4-46d9-9650-3deb97bd8fa8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_afb5a922-08bb-40bd-8ad4-715ef4986723_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_99dc65d1-df0d-45dd-a38f-a6b225c85b24_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UpThroughTaxYear2025Member_f353c83c-362d-4f73-a1f8-227738455cc2_terseLabel_en-US" xlink:label="lab_iart_UpThroughTaxYear2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expire Through 2025</link:label>
    <link:label id="lab_iart_UpThroughTaxYear2025Member_label_en-US" xlink:label="lab_iart_UpThroughTaxYear2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up Through Tax Year 2025 [Member]</link:label>
    <link:label id="lab_iart_UpThroughTaxYear2025Member_documentation_en-US" xlink:label="lab_iart_UpThroughTaxYear2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up Through Tax Year 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UpThroughTaxYear2025Member" xlink:href="iart-20201231.xsd#iart_UpThroughTaxYear2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UpThroughTaxYear2025Member" xlink:to="lab_iart_UpThroughTaxYear2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_fa0b84dd-8fa4-4461-9698-1990089ca8f4_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development milestone payments commitment (up to)</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_label_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met</link:label>
    <link:label id="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Maximum Contingent Development Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:to="lab_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a0a5feb-e473-4f7f-bd45-5b03de2856c7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a257973-5d1a-4446-b3ce-9b7bd406613c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_fc5da6d4-0f97-4193-8eca-c596a65e8fce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6f5e19fc-a12d-4d68-8a52-2b3237f4939b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates available to the company at its option</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e40bebe8-d522-4d9b-b47d-0452434f5f08_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_d22aa1b8-754b-434b-b862-14744d60ca45_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ad13f1ac-479f-42bb-a978-0c34bd19b573_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_91cae373-4784-444d-9ee7-da6a4e26ce5d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_6dc1ee86-3b4f-4bcb-977d-37c9c4e6656b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_70bae30b-0450-4c08-bf70-9d575bc676e5_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_a5f37593-91e1-40e5-a245-d554f414289e_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_eb4db935-49e8-4d68-a758-22595df943c7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e6d6b736-9af4-40d4-9627-2685e09d89d5_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_3e685b00-a6e2-4ae2-ae93-309b36733e30_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES FROM CONTRACTS WITH CUSTOMERS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_c3b40541-c5f9-4350-a387-139576af0e56_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Execution of July 2020 Amendment through June 30, 2021</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod1Member" xlink:to="lab_iart_DebtCovenantPeriod1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_8c9ee5d2-0f93-4188-96eb-3adf5adcc3a7_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carryback of Federal net operating loss ("NOL")</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Carryback Federal Net Operating Loss, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Carryback Federal Net Operating Loss, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_df9b8edd-09ad-43b1-a7da-ba39a437d00b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_567b6130-6916-44a9-b977-e32a7335fe6c_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4efaf5c2-c4ca-4ef0-9275-0b5611f3c853_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_be5bf7f4-f127-45a8-beab-1b4ea1348628_terseLabel_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISC</link:label>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_label_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Shoulder Collaboration, Inc. [Member]</link:label>
    <link:label id="lab_iart_IntegratedShoulderCollaborationInc.Member_documentation_en-US" xlink:label="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Shoulder Collaboration, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member" xlink:href="iart-20201231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntegratedShoulderCollaborationInc.Member" xlink:to="lab_iart_IntegratedShoulderCollaborationInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_a7429b9f-0f3e-4ecb-8b29-bf0779c06862_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_00a6da30-09a2-4982-a15f-304696b8eb75_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_38b20c7e-c9ee-4146-a947-ec440693770c_terseLabel_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2029 Through October 31, 2034</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_label_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One [Member]</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_documentation_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:href="iart-20201231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:to="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_ba7f56ca-c6cc-4ecd-b3e5-0444a09f4afd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_93cbecf1-38d6-4454-94e6-6b6decc7910f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b68cd189-5388-4433-a280-e5cae769594c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_138aeb15-3e9e-4e64-af91-6dd341a1834d_negatedLabel_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:href="iart-20201231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:to="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f760947b-7497-4617-9551-33bfee033489_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_baf1dd11-2666-4fc9-b743-797c6baf6d7d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6a066775-ef8f-41db-bfa7-eca8fe34b827_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3001b5b0-0f76-4984-ae32-1dd188ab4f8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_84478d93-85ec-41a3-b546-f9362dfb4ad6_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7863d35-c59b-43d2-ae64-6ecedd124186_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_148982f2-0066-42a3-b660-068fd9ae0e4a_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_69683443-d937-4f34-b778-7a9c83120615_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_95f08615-37b9-4518-82ee-86bb30a97503_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c3c145d-dbdd-4316-a1f9-50e061b9357c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_b2581dbe-dae2-432a-9e23-ce2f09bb8087_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CharitableContributions_be2749b0-59e2-4811-97eb-10b811a2b266_terseLabel_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to Integra Foundation</link:label>
    <link:label id="lab_iart_CharitableContributions_label_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:label id="lab_iart_CharitableContributions_documentation_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions" xlink:href="iart-20201231.xsd#iart_CharitableContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CharitableContributions" xlink:to="lab_iart_CharitableContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_26e5321e-bd06-43f8-b3c2-474783657631_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value, options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_e2e24769-87b3-42ea-a757-3503d15b18db_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination Benefits</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a173c130-738d-4185-8a91-e467394fbd62_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_7719ebbb-5c3d-41cb-99c0-c225651f068b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_e31d1de2-68ff-42b0-b7d0-aaf8c104e98b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1422c72f-c601-44cf-a01b-e509c1c434ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_6a90d9b4-4f0f-4003-90a6-b8be9e66684e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, capitalized into construction in progress</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_6a7a1994-71fd-40a6-82f4-0a84c11156bc_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_88bd9b64-2c49-44c6-9b3b-2a11f22294da_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_012831b9-60c1-4f87-b305-790787cd2adf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c22d9607-c076-4b09-ab38-936e6a24062d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23289f68-8931-428c-9f69-75fe9ce2145c_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b9bd6465-d0ac-44e6-94ab-c86bfef8f253_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_9daf3b05-c886-449c-b107-5ec9baa0baac_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_513cb40a-d9fb-49f9-9504-4d353286ee7d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_fa5b27af-5427-46ca-b1af-d40f22652403_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect on net income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_93847317-3f8b-4e21-8741-6ba53dbfbceb_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2022 through June 30, 2023</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod3Member" xlink:to="lab_iart_DebtCovenantPeriod3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b229e97f-bfa8-4c33-8ec5-80d93f746a7b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_abc0b363-e2c9-4baf-ad85-5bae24a57317_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e2c9984c-cf0b-48fe-bc1c-ab6ae30a17e8_verboseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_14ed3d7f-784c-492c-ab44-527ca789264e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_402aade9-8401-4c6b-b8e3-0fe127021e6b_terseLabel_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="iart-20201231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b91d0c74-b4a0-4a28-84a8-30d5b0a18d26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_941a330c-54b5-4d94-be4c-49d4e042a471_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_59ed8a57-f34a-49c4-833f-6521f4ed05c6_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_6558fa8c-4811-4e6b-9966-26f67508bbb9_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_84eb6006-dbc0-4ab1-a645-0e143b625d6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_e2fbcdb2-2124-4f3c-835e-73a412a8cc1f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental financing cost expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_2a37b427-b380-4b51-b67c-9080a89a5686_terseLabel_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_label_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:label id="lab_iart_ScheduleOfAssetAcquisitionTable_documentation_en-US" xlink:label="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable" xlink:to="lab_iart_ScheduleOfAssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_6e70899f-b5a7-4d30-bfd6-171fdbf0b701_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_fc69e1a3-8ee8-46e3-aa87-99f363b0fd42_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_71e9c65d-7c27-48ca-b2ba-fc75c13046d9_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d933146b-4377-4273-b127-d8ea4ad86625_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_a2559d4e-a877-4fe7-9fb9-7b8dac81e23e_terseLabel_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash in-process research and development expense</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:href="iart-20201231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:to="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d23ced64-d07c-4e4a-a877-c2c7ae73d4f8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9e8088be-fb8b-40e4-900e-3005535a2cf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_5c75c2d3-721a-43c5-b149-b51dd2a379d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_64fed3c6-44c2-4c98-aa67-c0926787af4e_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ac3dc6c3-7f0f-45c3-b9f7-2ddcb28cc4c4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3320e72d-5fea-4520-9a66-c94c8bbd3146_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_12447829-8eba-42e5-9071-59c83db5d37d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_c6aa9eaa-8d0f-49b0-881e-773cbcb1eeeb_terseLabel_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock Awards</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_label_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_documentation_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember" xlink:href="iart-20201231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceStockandContractStockMember" xlink:to="lab_iart_PerformanceStockandContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f0d917f-e9a9-4d4a-9803-ccb1cf335e47_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee45b9d3-8af6-4239-be94-b2e5e907514f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_da18e598-cf7a-4dc8-88ea-cd193dfe9fc3_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_967ca314-906a-4fd8-b924-6a6612a7c287_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested but not issued (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:to="lab_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_3c90afe9-c369-4b9c-b611-48bef86848fb_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2021 through June 30, 2022</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod2Member" xlink:to="lab_iart_DebtCovenantPeriod2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d95198e0-3b69-462e-806b-72e4290705a2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 4,914 and 2,865 shares at December&#160;31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_be90423f-be32-4b71-ae6d-58b191c4233b_terseLabel_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited</link:label>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_label_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited [Member]</link:label>
    <link:label id="lab_iart_SmithNephewUSDLimitedMember_documentation_en-US" xlink:label="lab_iart_SmithNephewUSDLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith &amp; Nephew USD Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SmithNephewUSDLimitedMember" xlink:to="lab_iart_SmithNephewUSDLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeAbstract_91330f65-b09a-4d17-a63b-9ba823c39ff7_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract" xlink:href="iart-20201231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeAbstract" xlink:to="lab_iart_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_64966dfe-78ca-440a-904a-780345a82019_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in dollars per share)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4b536291-e6ac-46f5-9b3c-1b6414ce2599_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_442ac9d2-a705-43fe-9674-7cd66615ef72_terseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases:</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases During Period [Abstract]</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases During Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:to="lab_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4d297b81-26d6-4d36-99f7-5c6ebef9dede_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d4323b7e-6c4f-4b89-a94f-b97ff2b9d5ac_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_521cd192-c49c-403c-8d1c-9ca0e823c614_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_abc29d64-4a1f-4ff5-a127-a1330417fe16_terseLabel_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs and expenses associated with debt refinancing</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_label_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_documentation_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:href="iart-20201231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:to="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3ead62e0-fa5a-4755-a4ef-610f97fa3e85_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SeniorCreditFacilityMember_4cfe202a-8d78-40b1-a2c0-9cc939a80672_terseLabel_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_label_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility [Member]</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_documentation_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember" xlink:href="iart-20201231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SeniorCreditFacilityMember" xlink:to="lab_iart_SeniorCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_12d506c2-9416-4544-b2b4-2787b55565cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_159f6f9e-b433-4631-acf1-48d9041c5003_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>iart-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d49e12c7-fc31-4609-b075-8e43ffaaf58f,g:15f4ef03-7050-420f-8ed9-fe0e8841adeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20201231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fecb8551-8b0e-48c3-ac76-c351ae581f5d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentType_fecb8551-8b0e-48c3-ac76-c351ae581f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_1a64fb27-4905-44f3-914f-32ed487432dd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentAnnualReport_1a64fb27-4905-44f3-914f-32ed487432dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7d5d829e-6361-4507-9746-939fe7823d40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentPeriodEndDate_7d5d829e-6361-4507-9746-939fe7823d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dbe7a8f2-8f0c-4dea-a63a-9d51e4d50670" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_CurrentFiscalYearEndDate_dbe7a8f2-8f0c-4dea-a63a-9d51e4d50670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_90bbcf9a-0a92-48cc-a0e7-becd21e88329" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentTransitionReport_90bbcf9a-0a92-48cc-a0e7-becd21e88329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9059a03a-6a58-412d-8713-65f25dd15a88" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityFileNumber_9059a03a-6a58-412d-8713-65f25dd15a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9e480a71-400e-48a1-9b58-1d630a73578f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityRegistrantName_9e480a71-400e-48a1-9b58-1d630a73578f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1cbc5d8c-bd9a-4532-8f99-2e36b5fa9dfb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1cbc5d8c-bd9a-4532-8f99-2e36b5fa9dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3ebfa43d-0cc2-4bb4-b993-593fcc56b439" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityTaxIdentificationNumber_3ebfa43d-0cc2-4bb4-b993-593fcc56b439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_972ddf0b-294c-42c2-80bd-37318a160550" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityAddressAddressLine1_972ddf0b-294c-42c2-80bd-37318a160550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e25c39a1-fcf6-4321-aa4d-31a7b8eb45e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityAddressPostalZipCode_e25c39a1-fcf6-4321-aa4d-31a7b8eb45e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1d878ce0-4e10-4497-9f7d-a983061586da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityAddressCityOrTown_1d878ce0-4e10-4497-9f7d-a983061586da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f34286f4-20b7-4ff4-acac-a363d68ff108" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityAddressStateOrProvince_f34286f4-20b7-4ff4-acac-a363d68ff108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4cc0243f-1f2a-4a0d-a446-25c88b36a508" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_CityAreaCode_4cc0243f-1f2a-4a0d-a446-25c88b36a508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c3eafa9f-1f4c-4223-aa92-f680d52a4f87" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_LocalPhoneNumber_c3eafa9f-1f4c-4223-aa92-f680d52a4f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_fd0d7f90-70d4-4c6e-a626-1007d787e107" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_Security12bTitle_fd0d7f90-70d4-4c6e-a626-1007d787e107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_52afadca-4b1c-4801-bd1c-1d27cca69515" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_TradingSymbol_52afadca-4b1c-4801-bd1c-1d27cca69515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e8de7896-6698-4dbc-bfdd-f867f652c2d6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_SecurityExchangeName_e8de7896-6698-4dbc-bfdd-f867f652c2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_06732972-d6a2-440c-aa90-63fdafbddaab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_06732972-d6a2-440c-aa90-63fdafbddaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a2f02714-a6ed-4c76-9aff-e24ec947b8af" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityVoluntaryFilers_a2f02714-a6ed-4c76-9aff-e24ec947b8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ff4f44e6-80ca-48fc-b8ec-a0f7db41aa21" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityCurrentReportingStatus_ff4f44e6-80ca-48fc-b8ec-a0f7db41aa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3b39d0be-344a-44aa-b27d-1a4832f22767" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityInteractiveDataCurrent_3b39d0be-344a-44aa-b27d-1a4832f22767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_16894022-e2a4-487f-a840-b88ad1be6417" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityFilerCategory_16894022-e2a4-487f-a840-b88ad1be6417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_27ca6e0e-f665-4f01-8c04-f1a249a911fc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntitySmallBusiness_27ca6e0e-f665-4f01-8c04-f1a249a911fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e9799b64-445b-4234-a685-99cdb60a7407" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityEmergingGrowthCompany_e9799b64-445b-4234-a685-99cdb60a7407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_ca0a7096-f587-4d59-92ea-f885c1633920" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_IcfrAuditorAttestationFlag_ca0a7096-f587-4d59-92ea-f885c1633920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_af355d87-3046-4a3b-9291-eb75bbc492f2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityShellCompany_af355d87-3046-4a3b-9291-eb75bbc492f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_a5e390a9-1ce6-4801-88a7-c5d7cf50cda7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityPublicFloat_a5e390a9-1ce6-4801-88a7-c5d7cf50cda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3a6c47c8-d0ac-4f47-97fb-8571f0e758b2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3a6c47c8-d0ac-4f47-97fb-8571f0e758b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7eee533b-3373-40e7-9deb-034ef219efff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7eee533b-3373-40e7-9deb-034ef219efff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eb3a5123-48bd-4255-8a2b-b9edb42e2a99" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_AmendmentFlag_eb3a5123-48bd-4255-8a2b-b9edb42e2a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7346d836-17f9-4a2a-923a-bcc3e7109a99" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentFiscalYearFocus_7346d836-17f9-4a2a-923a-bcc3e7109a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_1b8a3e18-9b73-400c-ba9c-c72eb06a3a5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_DocumentFiscalPeriodFocus_1b8a3e18-9b73-400c-ba9c-c72eb06a3a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fa115244-fc69-4563-b1c8-a2a03655bba3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c72bf8ed-1714-429f-ae98-be22ee019049" xlink:to="loc_dei_EntityCentralIndexKey_fa115244-fc69-4563-b1c8-a2a03655bba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5738b04-6555-4de3-bfe7-6f25f2c93fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5738b04-6555-4de3-bfe7-6f25f2c93fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_db0296fa-2f8f-4cc2-a529-d002ae22dd53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_db0296fa-2f8f-4cc2-a529-d002ae22dd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_24528472-bbd1-4b69-9a0f-aafa30659f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_24528472-bbd1-4b69-9a0f-aafa30659f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_5db13c5c-cced-449a-ab6b-6d4a07cb77eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_5db13c5c-cced-449a-ab6b-6d4a07cb77eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_58d80aef-c684-40d9-9395-77d6a49f0c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_58d80aef-c684-40d9-9395-77d6a49f0c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cebb0231-73c0-4d9a-b595-d051316dd513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cebb0231-73c0-4d9a-b595-d051316dd513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_deccbbbe-83b1-45c4-b989-6116667f2a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_b6740bbe-a5e2-4992-98a8-c26d02b8672a" xlink:to="loc_us-gaap_CostsAndExpenses_deccbbbe-83b1-45c4-b989-6116667f2a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_462a228b-f563-4742-b7be-0a828f4412e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_OperatingIncomeLoss_462a228b-f563-4742-b7be-0a828f4412e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1a0f96b7-717d-4acd-8dec-db83d8edc1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1a0f96b7-717d-4acd-8dec-db83d8edc1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6141afa1-97a4-4e64-bd80-5f3712e8bb14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_InterestExpense_6141afa1-97a4-4e64-bd80-5f3712e8bb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_286933c7-34ec-45aa-9990-7ae28923bf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_286933c7-34ec-45aa-9990-7ae28923bf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b736c857-b87c-4a46-975d-e13ea9a4c129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b736c857-b87c-4a46-975d-e13ea9a4c129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_501329f8-383b-4051-a714-a4b4900e6455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_501329f8-383b-4051-a714-a4b4900e6455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bc299ca-2561-4efd-ab36-1f73db2c501e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_NetIncomeLoss_2bc299ca-2561-4efd-ab36-1f73db2c501e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_451e6eb6-8c98-4ca6-98d3-77b3507f874e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_EarningsPerShareAbstract_451e6eb6-8c98-4ca6-98d3-77b3507f874e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_559fd1e9-46ea-4546-aa44-84ccdcc6cb84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_451e6eb6-8c98-4ca6-98d3-77b3507f874e" xlink:to="loc_us-gaap_EarningsPerShareBasic_559fd1e9-46ea-4546-aa44-84ccdcc6cb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_df02181d-9e84-4712-b9e2-388f176c1399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_451e6eb6-8c98-4ca6-98d3-77b3507f874e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_df02181d-9e84-4712-b9e2-388f176c1399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c219da17-6b45-4eeb-ab89-285bac163633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3043f39d-4b32-403a-9d86-dcb36c38a14c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c219da17-6b45-4eeb-ab89-285bac163633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_775449dc-d07c-467e-8b1d-05d41394f640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c219da17-6b45-4eeb-ab89-285bac163633" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_775449dc-d07c-467e-8b1d-05d41394f640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28c6edf8-18ae-41aa-8940-6e9e8a4638d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c219da17-6b45-4eeb-ab89-285bac163633" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28c6edf8-18ae-41aa-8940-6e9e8a4638d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_be7c742f-98ae-41cf-9bcb-90f025db6550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:to="loc_us-gaap_NetIncomeLoss_be7c742f-98ae-41cf-9bcb-90f025db6550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_317252c8-a2fd-431c-8d3d-d248764689f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_317252c8-a2fd-431c-8d3d-d248764689f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_43cc51db-7e27-44e7-8bff-7f1d0b4067d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_317252c8-a2fd-431c-8d3d-d248764689f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_43cc51db-7e27-44e7-8bff-7f1d0b4067d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_33f66b05-71b7-46cb-ab85-842140f34416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_317252c8-a2fd-431c-8d3d-d248764689f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_33f66b05-71b7-46cb-ab85-842140f34416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f14560a2-b67b-43ee-bff8-e3b74e51819c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_33f66b05-71b7-46cb-ab85-842140f34416" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f14560a2-b67b-43ee-bff8-e3b74e51819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31c53e9b-c6dc-42b3-9818-472db83379ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_33f66b05-71b7-46cb-ab85-842140f34416" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31c53e9b-c6dc-42b3-9818-472db83379ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_ac9f0e4b-5dd5-459b-9fb2-30b1bebb677d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_33f66b05-71b7-46cb-ab85-842140f34416" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_ac9f0e4b-5dd5-459b-9fb2-30b1bebb677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5404bc3f-c046-4f7f-aa83-e8e04b445af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_317252c8-a2fd-431c-8d3d-d248764689f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5404bc3f-c046-4f7f-aa83-e8e04b445af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_04ae73d8-df87-4633-bafe-2aaa03f524bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_04ae73d8-df87-4633-bafe-2aaa03f524bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b690e70e-bc0f-458d-ab6d-a12298d8a92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_04ae73d8-df87-4633-bafe-2aaa03f524bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_b690e70e-bc0f-458d-ab6d-a12298d8a92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_025215f8-f048-4f0e-984f-3362ddc375ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_025215f8-f048-4f0e-984f-3362ddc375ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c137fa4f-2687-4602-99f0-af05abfe52b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_59b1eaf0-3684-47e7-bf4e-6ce0a6f76c0c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c137fa4f-2687-4602-99f0-af05abfe52b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a11fe295-2c72-49ae-8ca1-ac6e62de9f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a11fe295-2c72-49ae-8ca1-ac6e62de9f62" xlink:to="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e7d0ad5-9801-4835-83c2-c8be770b2065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e7d0ad5-9801-4835-83c2-c8be770b2065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fa36c130-a614-4bf6-a5e1-ac54adf0c747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fa36c130-a614-4bf6-a5e1-ac54adf0c747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6dc70821-e917-4ca8-bbab-7ec5e814ba0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_InventoryNet_6dc70821-e917-4ca8-bbab-7ec5e814ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8d2f64f-0d12-4e7d-bb42-499c96303769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8d2f64f-0d12-4e7d-bb42-499c96303769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08d44b22-94eb-4385-a49b-77d4ea9fa370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08d44b22-94eb-4385-a49b-77d4ea9fa370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_da36d6fb-6c92-49d7-8458-990f18cdbe09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4a0b65e6-b591-48f3-9760-4bed754c7575" xlink:to="loc_us-gaap_AssetsCurrent_da36d6fb-6c92-49d7-8458-990f18cdbe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b1974f15-834c-4e71-824d-64a3c7e8e861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b1974f15-834c-4e71-824d-64a3c7e8e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_473befc8-622d-4f5e-be95-736e7d3dc6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_473befc8-622d-4f5e-be95-736e7d3dc6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b3ca8e1-fee1-475c-ab4e-88aab9b47bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b3ca8e1-fee1-475c-ab4e-88aab9b47bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c665171c-ebbd-4db7-b96a-eb4340a8893d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_Goodwill_c665171c-ebbd-4db7-b96a-eb4340a8893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_42c9cd94-4448-4d29-8aed-891b28a741f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_42c9cd94-4448-4d29-8aed-891b28a741f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_13e73d62-1725-4a25-a7d4-ca129aa61f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_13e73d62-1725-4a25-a7d4-ca129aa61f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e8b8e843-f454-4819-8442-84570e33036e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_931a3cbb-2f95-4944-83eb-acdd9206ec79" xlink:to="loc_us-gaap_Assets_e8b8e843-f454-4819-8442-84570e33036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a11fe295-2c72-49ae-8ca1-ac6e62de9f62" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_23807243-ed3b-4d55-bcb3-c1d46d0d96b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_SecuredDebtCurrent_23807243-ed3b-4d55-bcb3-c1d46d0d96b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_e4ea45a6-fb5a-4113-b3ae-f0315c1fefa9" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_e4ea45a6-fb5a-4113-b3ae-f0315c1fefa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f2128bdc-95c7-474e-b459-fc8667c6e2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f2128bdc-95c7-474e-b459-fc8667c6e2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_263cc339-3411-400c-b02a-3b6b59b51ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_263cc339-3411-400c-b02a-3b6b59b51ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_934709b2-8ef2-46d1-9c06-5996e0c18651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_934709b2-8ef2-46d1-9c06-5996e0c18651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5fd84bd3-50cf-4413-9796-f5ddb34b1ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5fd84bd3-50cf-4413-9796-f5ddb34b1ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3861f16a-b86d-460d-9089-05ef6d2d11a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3861f16a-b86d-460d-9089-05ef6d2d11a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_324cd3bf-6695-43b5-b375-b52bf66a2495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_324cd3bf-6695-43b5-b375-b52bf66a2495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b6e79a49-cac6-4dc4-a255-f004b432c646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3254d09c-1454-4dd9-b4b9-4c0bfcfdb8aa" xlink:to="loc_us-gaap_LiabilitiesCurrent_b6e79a49-cac6-4dc4-a255-f004b432c646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_fa6ff16b-ff6d-4be7-9b8e-17485451b0fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_SecuredLongTermDebt_fa6ff16b-ff6d-4be7-9b8e-17485451b0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_7b29d910-a4dc-42e0-a064-ce64e814eda3" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_7b29d910-a4dc-42e0-a064-ce64e814eda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_9eb888f0-b3ae-4cf1-ac49-6b951199d039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_9eb888f0-b3ae-4cf1-ac49-6b951199d039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_208d6f65-7bfa-4c0a-a1d1-f43a6ee44ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_208d6f65-7bfa-4c0a-a1d1-f43a6ee44ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_53619b5e-474c-438e-93b7-5dd7f0a52349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_53619b5e-474c-438e-93b7-5dd7f0a52349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e9ca24b9-1a97-4898-9a5e-030f84bd52a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e9ca24b9-1a97-4898-9a5e-030f84bd52a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f0460cab-d9e7-4824-bf70-6f231b95fcfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_Liabilities_f0460cab-d9e7-4824-bf70-6f231b95fcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f39311eb-9e6b-49dc-b0ef-00a1f15e9d73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_PreferredStockValue_f39311eb-9e6b-49dc-b0ef-00a1f15e9d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_96ce7fd6-f874-423f-bb0a-e24ee43d97f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_CommonStockValue_96ce7fd6-f874-423f-bb0a-e24ee43d97f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5cd6118a-add4-460b-b33c-75363f055530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5cd6118a-add4-460b-b33c-75363f055530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7cc3c4a9-5370-4ff0-8831-ab4380ba5802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_TreasuryStockValue_7cc3c4a9-5370-4ff0-8831-ab4380ba5802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44122470-f37e-49fb-aa12-66dd3e1244fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44122470-f37e-49fb-aa12-66dd3e1244fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d030d87-15a3-43fa-b9e1-0f1f94402aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d030d87-15a3-43fa-b9e1-0f1f94402aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c8a34467-f26d-4069-9ff8-8f5d313e25ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fa6db015-ce18-493d-bf29-1124c97970b5" xlink:to="loc_us-gaap_StockholdersEquity_c8a34467-f26d-4069-9ff8-8f5d313e25ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_100114c7-1cdd-4022-a12e-0ec374f4bc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0bc6d2e9-d4be-4d52-a1fa-5a87ba8d7050" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_100114c7-1cdd-4022-a12e-0ec374f4bc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_36c6ab7f-d3c4-4209-9ecd-946e63ef2b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_36c6ab7f-d3c4-4209-9ecd-946e63ef2b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue_5b5aff32-43d6-4fe5-9d07-dbdadc898cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_PreferredStockNoParValue_5b5aff32-43d6-4fe5-9d07-dbdadc898cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7781401d-720b-4a5e-8737-b53bf1503a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7781401d-720b-4a5e-8737-b53bf1503a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_30b811e4-e79d-4c51-803c-e7a43ef1f6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_30b811e4-e79d-4c51-803c-e7a43ef1f6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_81a7b562-d48c-4baa-8691-81bb156beb6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_81a7b562-d48c-4baa-8691-81bb156beb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_50958f7a-9362-4cfa-9dae-d351c72ec4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_50958f7a-9362-4cfa-9dae-d351c72ec4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d7986820-81d3-443d-b1b2-2f4616e04470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_CommonStockSharesIssued_d7986820-81d3-443d-b1b2-2f4616e04470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_0fd281a0-2ee8-4ea9-8464-693d60f0fcb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_690e35bb-b574-4732-bee1-1c7e9119bb0f" xlink:to="loc_us-gaap_TreasuryStockShares_0fd281a0-2ee8-4ea9-8464-693d60f0fcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a76ea345-94d2-4149-a8ae-84a99cf8553e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a76ea345-94d2-4149-a8ae-84a99cf8553e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_07710a52-172c-4ca2-b5fb-5befcb7e1520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a76ea345-94d2-4149-a8ae-84a99cf8553e" xlink:to="loc_us-gaap_NetIncomeLoss_07710a52-172c-4ca2-b5fb-5befcb7e1520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a76ea345-94d2-4149-a8ae-84a99cf8553e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_cf831fce-909d-4909-ac98-1d213f76da92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_cf831fce-909d-4909-ac98-1d213f76da92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_b19b0cfd-c48d-4fdd-9b08-a911324fb0af" xlink:href="iart-20201231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_b19b0cfd-c48d-4fdd-9b08-a911324fb0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_9ba4413e-6aab-4ebb-8dd7-054cc8094b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_9ba4413e-6aab-4ebb-8dd7-054cc8094b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c129039f-5015-4cee-99d2-fac8c8abd4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c129039f-5015-4cee-99d2-fac8c8abd4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4920c7d3-226e-4613-bf9b-2d76840b6506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_ShareBasedCompensation_4920c7d3-226e-4613-bf9b-2d76840b6506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_2fb18441-e17a-4a52-9a6d-1a093ac124a3" xlink:href="iart-20201231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_2fb18441-e17a-4a52-9a6d-1a093ac124a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_b503ca3c-ee3f-41c0-a4b0-442b47afd9b0" xlink:href="iart-20201231.xsd#iart_NoncashLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_iart_NoncashLeaseExpense_b503ca3c-ee3f-41c0-a4b0-442b47afd9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_81877f0e-7ed2-424c-880c-a6e59966b9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_AccretionExpense_81877f0e-7ed2-424c-880c-a6e59966b9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_14e886c7-6f3c-415f-b702-147b6225ec21" xlink:href="iart-20201231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_14e886c7-6f3c-415f-b702-147b6225ec21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b25d6506-eb7b-4ee8-a070-fa438654fb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f72fb237-9f2d-431a-a1b9-3139e4a015ed" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b25d6506-eb7b-4ee8-a070-fa438654fb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a76ea345-94d2-4149-a8ae-84a99cf8553e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5dd74631-4e92-480e-8126-ed97a1de042c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5dd74631-4e92-480e-8126-ed97a1de042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c4758e8d-d513-4716-98ee-fbc52d3e8e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c4758e8d-d513-4716-98ee-fbc52d3e8e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0b04db53-30c8-4cf6-8ecc-4a48ede9ba0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0b04db53-30c8-4cf6-8ecc-4a48ede9ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d1e504e3-7fb5-44fd-84c7-1132be101c5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d1e504e3-7fb5-44fd-84c7-1132be101c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8dd73cb2-f8a2-4df4-9e0c-7f21ce769d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8dd73cb2-f8a2-4df4-9e0c-7f21ce769d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b4a58d18-10f7-4232-b594-ad9454c998c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b4a58d18-10f7-4232-b594-ad9454c998c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_08548d02-9ae8-4b0e-ad84-2865a9a56868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_08548d02-9ae8-4b0e-ad84-2865a9a56868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99d43587-4590-4107-85a0-141cf820c23e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d53eb687-de4d-4737-8e46-3f565a032b7a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99d43587-4590-4107-85a0-141cf820c23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0a4b10ba-0df4-4eeb-8420-0e445a3f1fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0a4b10ba-0df4-4eeb-8420-0e445a3f1fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_3e2f2479-8e28-4148-9338-1cab56aabeff" xlink:href="iart-20201231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_3e2f2479-8e28-4148-9338-1cab56aabeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_d935c2a5-b8cd-4704-b585-5f8d2d569a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_d935c2a5-b8cd-4704-b585-5f8d2d569a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_e151db22-ceed-483b-a7ae-b6255afd0853" xlink:href="iart-20201231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_e151db22-ceed-483b-a7ae-b6255afd0853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_21f18136-5ef9-4ea6-836c-11cf4fd05c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_21f18136-5ef9-4ea6-836c-11cf4fd05c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_744dd612-a080-4259-adb2-bc6eea7e1682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_744dd612-a080-4259-adb2-bc6eea7e1682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa0810dd-c798-4d3c-aa16-7a1801d6c4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb596adb-df36-44bf-8a2e-e53ced59880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa0810dd-c798-4d3c-aa16-7a1801d6c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_42d42d0f-3d19-458e-9add-7cedd25e250a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_42d42d0f-3d19-458e-9add-7cedd25e250a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_0fdde493-7c09-4368-9b6e-b21e8d542dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_0fdde493-7c09-4368-9b6e-b21e8d542dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_fd68835a-d2db-4539-bf22-feb9cf6ac2e0" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_fd68835a-d2db-4539-bf22-feb9cf6ac2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_776ee1ac-7e51-44a0-8951-84cac92bbeb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_776ee1ac-7e51-44a0-8951-84cac92bbeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_78715101-ddda-44d4-b4b6-9761c4c01cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_78715101-ddda-44d4-b4b6-9761c4c01cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_edf47d99-57f6-49b3-8d4b-2e493d35769d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_edf47d99-57f6-49b3-8d4b-2e493d35769d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20d3b968-2dd5-454c-9cf8-a8ed7bd67a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20d3b968-2dd5-454c-9cf8-a8ed7bd67a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8c5d431a-52a1-4d20-9403-3778513f3077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8c5d431a-52a1-4d20-9403-3778513f3077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4f2bf684-76b7-460a-8516-4535de171834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4f2bf684-76b7-460a-8516-4535de171834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_66498bb5-fd1e-4445-9f3e-09677dfba175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_66498bb5-fd1e-4445-9f3e-09677dfba175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0db2e311-62e4-480b-9779-31c4254b6e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0db2e311-62e4-480b-9779-31c4254b6e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e96d9ce-ddcf-48da-9d93-2f465e4cf72b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8d1d9e6-2d51-44b9-b3f0-f85bdd237107" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e96d9ce-ddcf-48da-9d93-2f465e4cf72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e56e049-8396-4def-822c-2b9be3ca363a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e56e049-8396-4def-822c-2b9be3ca363a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c2bdd03f-08d1-43d2-865d-e4777653c76a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c2bdd03f-08d1-43d2-865d-e4777653c76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_57a57978-c6f9-413a-a15a-3cccf8f1317c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_57a57978-c6f9-413a-a15a-3cccf8f1317c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_550d997e-b362-42ed-9e4b-c2f752bf2465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c8b3b76d-2aea-45e2-a881-7099eac70912" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_550d997e-b362-42ed-9e4b-c2f752bf2465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f227536b-1264-4f61-a18d-c8c271fe43e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f227536b-1264-4f61-a18d-c8c271fe43e2" xlink:to="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e73d4aa-2be4-4001-8869-9a6c08c9ba93" xlink:to="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_65c7da0b-4ff7-40f4-b33f-d0270342c2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_CommonStockMember_65c7da0b-4ff7-40f4-b33f-d0270342c2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0807259e-09e9-4883-a4d1-02d384e09fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_TreasuryStockMember_0807259e-09e9-4883-a4d1-02d384e09fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_27f1bc9b-822a-4cdf-9103-1f175b4a2a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_27f1bc9b-822a-4cdf-9103-1f175b4a2a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9e5c60d4-aa69-46d3-b4b1-f8420451aeeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9e5c60d4-aa69-46d3-b4b1-f8420451aeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6334aae7-73ac-4b74-ae41-d3f43136531e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3fe023a-99ea-406d-92ea-00569074a9ce" xlink:to="loc_us-gaap_RetainedEarningsMember_6334aae7-73ac-4b74-ae41-d3f43136531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8378a198-04e7-40fc-bbda-1beb84354977" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_6c13c8ad-cba2-4396-92e4-facf296f98ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ac6e1cc7-ec37-4246-a11c-538a421bb0f4" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_6c13c8ad-cba2-4396-92e4-facf296f98ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4b02d019-9d8b-40ad-bbed-ac3b400824c5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_21510168-dee7-4658-8f51-ea9946f7b88c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c5129e38-9392-4024-afde-1131daf8a9c3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_21510168-dee7-4658-8f51-ea9946f7b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f439140-ef09-4e12-a6e2-379de8da473c" xlink:to="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8880151e-fcb7-462f-81dc-8b89e61c4112" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_66d19370-028f-46c4-b2ff-d8da75a58437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_SharesIssued_66d19370-028f-46c4-b2ff-d8da75a58437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_461985e7-43e6-4ce7-900d-c564394ca768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockholdersEquity_461985e7-43e6-4ce7-900d-c564394ca768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d14f9931-6f2a-454c-ad65-831ae857abe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_TreasuryStockShares_d14f9931-6f2a-454c-ad65-831ae857abe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_1a07d2dd-bd25-487d-bf4a-0be0d03c76a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_1a07d2dd-bd25-487d-bf4a-0be0d03c76a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1c4f8cb-bd11-42f7-b15f-78f9369a8a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_NetIncomeLoss_d1c4f8cb-bd11-42f7-b15f-78f9369a8a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9511ebdd-9333-4ab7-b9a5-cc7f43f5c1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9511ebdd-9333-4ab7-b9a5-cc7f43f5c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bf9010aa-bb4a-400c-9d48-14c702e5c04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bf9010aa-bb4a-400c-9d48-14c702e5c04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bcbb27a5-5402-4dcd-88ac-c46a447e3eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bcbb27a5-5402-4dcd-88ac-c46a447e3eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a341bdad-8137-4267-83b5-04d1d7ef3588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a341bdad-8137-4267-83b5-04d1d7ef3588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_67c2abf8-addc-4005-ba48-491952848b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_67c2abf8-addc-4005-ba48-491952848b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_768177dd-bc67-4a6f-83db-be04cf7b02ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_768177dd-bc67-4a6f-83db-be04cf7b02ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f12f9244-6731-4e34-8137-c956f7fd8ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f12f9244-6731-4e34-8137-c956f7fd8ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_76e662c5-edda-42fd-8f0b-938d9f6015b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_76e662c5-edda-42fd-8f0b-938d9f6015b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1e3c5926-42e0-45e2-894a-12e9071b9b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1e3c5926-42e0-45e2-894a-12e9071b9b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_23abff49-0dcd-4e23-aa26-955dae1a90c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_23abff49-0dcd-4e23-aa26-955dae1a90c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b5719b6b-8109-4ac8-8b19-c9861aa38ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b5719b6b-8109-4ac8-8b19-c9861aa38ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d136cb89-f2c9-4baf-b873-fad4dfa99196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d136cb89-f2c9-4baf-b873-fad4dfa99196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_7d1324fc-14c8-4e88-9aaf-28c8eeff8392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_SharesIssued_7d1324fc-14c8-4e88-9aaf-28c8eeff8392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c829d90d-3e36-4c3f-be1f-33a42037b86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_StockholdersEquity_c829d90d-3e36-4c3f-be1f-33a42037b86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fad07758-ece4-4f93-9024-ae7030a1eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98a3c1a0-a54a-4fbd-8d4f-7f411d1783a7" xlink:to="loc_us-gaap_TreasuryStockShares_fad07758-ece4-4f93-9024-ae7030a1eadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/BUSINESS" xlink:type="simple" xlink:href="iart-20201231.xsd#BUSINESS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/BUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_97e42d6a-737d-402a-a2ae-5f7a6edcc235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_489bade7-75fc-4a29-bd8f-6ab9921f2bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_97e42d6a-737d-402a-a2ae-5f7a6edcc235" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_489bade7-75fc-4a29-bd8f-6ab9921f2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_578d4d38-990c-4d22-8546-1c7760f68e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_414e43f2-b8bc-41bc-87cb-350a6067cdaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_578d4d38-990c-4d22-8546-1c7760f68e99" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_414e43f2-b8bc-41bc-87cb-350a6067cdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_abd9ce64-a26a-4e79-8a2a-4a96f44b125b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_abd9ce64-a26a-4e79-8a2a-4a96f44b125b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_468113eb-2afe-4cb8-a8ff-d07abf63a0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_468113eb-2afe-4cb8-a8ff-d07abf63a0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_851413d8-c865-4c10-b6e5-43581e5352f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_UseOfEstimates_851413d8-c865-4c10-b6e5-43581e5352f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8a132d0d-b8be-497c-aba9-555e662ef5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8a132d0d-b8be-497c-aba9-555e662ef5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d000d00b-fec7-49ed-878b-361a30e0bf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d000d00b-fec7-49ed-878b-361a30e0bf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c901a3e1-7548-4b9b-9288-4c566b1c5950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c901a3e1-7548-4b9b-9288-4c566b1c5950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_69665884-353a-41d1-adc3-0638ca65d286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_69665884-353a-41d1-adc3-0638ca65d286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6a6dd72d-4361-4a35-8eb1-6b85da8fb16a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6a6dd72d-4361-4a35-8eb1-6b85da8fb16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_7e0acfc2-98e2-46d2-96a6-e34239bb71b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_7e0acfc2-98e2-46d2-96a6-e34239bb71b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_7dd9e035-f266-4a57-b7f7-c7a74e14cde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_7dd9e035-f266-4a57-b7f7-c7a74e14cde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_424f7e35-6327-4eb8-adb4-c5b613060d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_424f7e35-6327-4eb8-adb4-c5b613060d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ea7698b7-3793-4c76-a999-39b19679300a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ea7698b7-3793-4c76-a999-39b19679300a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock_63fba176-4c85-4d2c-b214-ba4057ac2470" xlink:href="iart-20201231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_iart_FoundationPolicyTextBlock_63fba176-4c85-4d2c-b214-ba4057ac2470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_aac39d66-d78f-49ef-98ff-cb2d08e6386c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_aac39d66-d78f-49ef-98ff-cb2d08e6386c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c17f3e65-5e88-469f-8f65-8e7f8dac31ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c17f3e65-5e88-469f-8f65-8e7f8dac31ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_0d8ba488-416b-44a0-9860-0975d29f1ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_0d8ba488-416b-44a0-9860-0975d29f1ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_dc3f66fb-20bc-4541-b5b6-c961657226aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_dc3f66fb-20bc-4541-b5b6-c961657226aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9947285f-748d-40d2-982c-08a92b45ce88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9947285f-748d-40d2-982c-08a92b45ce88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_4197c8ad-9242-4a77-9166-51b9d2e816ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_4197c8ad-9242-4a77-9166-51b9d2e816ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_44b14d8e-277e-485f-a49c-c8eb069e9a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_44b14d8e-277e-485f-a49c-c8eb069e9a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ac26e8f3-b971-4e8b-9a45-c543bb3efa76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ac26e8f3-b971-4e8b-9a45-c543bb3efa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1f846f97-12ee-4682-ac2c-fc1dee2f3339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1f846f97-12ee-4682-ac2c-fc1dee2f3339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cf040592-deb0-4203-bfe8-809a012c7382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cf040592-deb0-4203-bfe8-809a012c7382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7f7d7b9b-df7d-46e0-aad9-5a81d97d374c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7f7d7b9b-df7d-46e0-aad9-5a81d97d374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy_d49ceffc-40c8-4f2e-818a-8d63b9a4b153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_ExtendedProductWarrantyPolicy_d49ceffc-40c8-4f2e-818a-8d63b9a4b153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_016ba4bc-9544-4504-bbd8-3f9dd4717c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2ad7a84-8570-47a4-accc-429950232127" xlink:to="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_016ba4bc-9544-4504-bbd8-3f9dd4717c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3a185689-668d-42ef-9fc5-8c11be961030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_4109c5bf-2599-4422-a3ea-dd0762701f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a185689-668d-42ef-9fc5-8c11be961030" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_4109c5bf-2599-4422-a3ea-dd0762701f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4b62a95e-b47b-4c9c-9035-4f04ba3e1c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a185689-668d-42ef-9fc5-8c11be961030" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4b62a95e-b47b-4c9c-9035-4f04ba3e1c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a74ff441-481b-43bf-b078-51f50a1f37ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a74ff441-481b-43bf-b078-51f50a1f37ac" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_716252d4-3e32-4307-8f99-8cfecc3bdf22" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8594bcf6-5c2f-4ff6-ad7a-1e27636df156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_54508abe-db1a-4302-b3f8-780d456c9ea1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8594bcf6-5c2f-4ff6-ad7a-1e27636df156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9be08ba-6ebf-4a56-b0f4-51359f23a95b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_c125a168-b617-4034-ace4-1792b06f4acc" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcaf70a5-8b7f-4852-bc8c-827bcd5895fe" xlink:to="loc_iart_SmithNephewUSDLimitedMember_c125a168-b617-4034-ace4-1792b06f4acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9a63784c-2696-49c3-9239-f202bbc5b7d4" xlink:to="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a95eddc9-4000-420b-ab27-694f817e477e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:to="loc_srt_MinimumMember_a95eddc9-4000-420b-ab27-694f817e477e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2a9b99d9-dd0b-4775-8853-7964eabe2e6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61d9c150-ef2f-4ba2-a7c0-d2e807597200" xlink:to="loc_srt_MaximumMember_2a9b99d9-dd0b-4775-8853-7964eabe2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a33b623a-4d24-47b7-a643-b5f2915ff99e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ba8bc69b-3e81-43b2-9e0b-b7be5a8e492f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_259852da-7d43-476a-ba01-8605da4b00e5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ba8bc69b-3e81-43b2-9e0b-b7be5a8e492f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_37cf7cfe-e669-4288-8170-8595279894c9" xlink:to="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54c6413f-14df-4e04-bcd8-e0cb063822e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_449ff952-5278-457a-8801-b009600be818" xlink:to="loc_us-gaap_RetainedEarningsMember_54c6413f-14df-4e04-bcd8-e0cb063822e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_648843fe-e9c6-48bb-bc30-56efc4f78dfd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_44d1af4a-cde3-451b-9bd5-d4859877326f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a160f35-184e-480b-9c88-dc7dda962026" xlink:to="loc_us-gaap_SalesRevenueNetMember_44d1af4a-cde3-451b-9bd5-d4859877326f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AssetAcquisitionAxis_7ce9b1aa-81e2-4528-bd70-b5030d5b07c8" xlink:to="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_c7c95e34-cd1a-4158-83f6-8fbf86812fec" xlink:href="iart-20201231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AssetAcquisitionDomain_dccd1ebe-d683-4f73-b186-fd8582e02b11" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_c7c95e34-cd1a-4158-83f6-8fbf86812fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a0720f9-9887-4656-ad2c-bcb29ea95fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_2cccf50d-1181-4878-baee-d1414360c249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e91ea01-81a2-4904-9b77-f4eb519af297" xlink:to="loc_us-gaap_ConvertibleDebtMember_2cccf50d-1181-4878-baee-d1414360c249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b34b5448-f50b-4ceb-8323-01c67e374d39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_8dbe25d5-a4d4-4ac2-be63-e0898be9896b" xlink:href="iart-20201231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fef469e9-5c8e-44a3-8d1d-f925d651b0c1" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_8dbe25d5-a4d4-4ac2-be63-e0898be9896b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_0b607c2d-773f-442f-80bf-657d1decfa5e" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_84fefafa-b6a7-4aa3-95a2-3928ea95a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_a1b48d4b-0148-45eb-997a-7e72e5ca4573" xlink:to="loc_us-gaap_CallOptionMember_84fefafa-b6a7-4aa3-95a2-3928ea95a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1ae0a064-5f47-49ef-8949-164fd638e5dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8cc7836c-94a0-4c88-98dc-184a697a0fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_CostOfSalesMember_8cc7836c-94a0-4c88-98dc-184a697a0fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d14a3825-2ae9-4b9a-b161-17efef97f210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d14a3825-2ae9-4b9a-b161-17efef97f210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_db3e0176-880b-4b55-ae2c-5b6ccd368b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7e041f11-9f8a-4045-9bd3-98352dac8d25" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_db3e0176-880b-4b55-ae2c-5b6ccd368b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2057894-b813-4b72-b573-b9d39afd0f10" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_38e4fce3-f541-46b7-b90f-4fdb3b9a2b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0a0a9c6b-6c12-4e7e-8097-312cf7d25545" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_38e4fce3-f541-46b7-b90f-4fdb3b9a2b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:href="iart-20201231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_eda203a1-c2fc-41d8-a092-5c10572baf57" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_640c81d8-19c1-4221-955b-c623795484ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_640c81d8-19c1-4221-955b-c623795484ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2e13dfbf-2a68-40c2-aebf-68010944eccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2e13dfbf-2a68-40c2-aebf-68010944eccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_87c4b6d3-73cf-4465-826a-b83a64363769" xlink:href="iart-20201231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_InventoryCapitalizedExpenses_87c4b6d3-73cf-4465-826a-b83a64363769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_f2f8b7ea-4af4-424d-9b97-c461b518edb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_f2f8b7ea-4af4-424d-9b97-c461b518edb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f65989cb-b4d7-46aa-bbeb-762d892e4ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Depreciation_f65989cb-b4d7-46aa-bbeb-762d892e4ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072bf89b-0e17-4e5a-9ff8-7896dc2a585e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072bf89b-0e17-4e5a-9ff8-7896dc2a585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_17e64fad-6129-4853-a43b-f3e4dafe7b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_17e64fad-6129-4853-a43b-f3e4dafe7b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a771690b-7069-453f-a484-ada88bbf0c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_NumberOfReportableSegments_a771690b-7069-453f-a484-ada88bbf0c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_8fb5624e-ca80-45b7-b795-4e8715d17b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_NumberOfReportingUnits_8fb5624e-ca80-45b7-b795-4e8715d17b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_ed4aea11-ef28-4392-bba4-4d2795d4ffcf" xlink:href="iart-20201231.xsd#iart_CharitableContributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_CharitableContributions_ed4aea11-ef28-4392-bba4-4d2795d4ffcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_f70d77e5-dbc9-4cc8-b5e9-7aa7770a119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_f70d77e5-dbc9-4cc8-b5e9-7aa7770a119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a73cdb38-cedd-4db6-9cf6-3b968006d7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_StockholdersEquity_a73cdb38-cedd-4db6-9cf6-3b968006d7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7a36f5d-f092-4837-b986-8a6b1ce98ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Assets_b7a36f5d-f092-4837-b986-8a6b1ce98ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_256a5e27-84b1-45b7-96b2-a4f853dbd9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_Liabilities_256a5e27-84b1-45b7-96b2-a4f853dbd9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_ca310475-f6af-496e-a8fa-3bd946d54d39" xlink:href="iart-20201231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_ca310475-f6af-496e-a8fa-3bd946d54d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a705736d-4b5a-4d11-81da-527c113ef66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_RestructuringCharges_a705736d-4b5a-4d11-81da-527c113ef66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_823f8cd8-40f4-4b92-83cb-e665a80d78b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_823f8cd8-40f4-4b92-83cb-e665a80d78b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_7ce4687c-fee4-4703-8e7b-47fa0b9af900" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_7ce4687c-fee4-4703-8e7b-47fa0b9af900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_faae6343-0b29-47f2-a324-d8a1235d5b66" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_faae6343-0b29-47f2-a324-d8a1235d5b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_28e649a7-6d5b-4a78-a77c-467241252988" xlink:href="iart-20201231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_28e649a7-6d5b-4a78-a77c-467241252988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1791994d-99d4-45c2-9937-786296d70cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1791994d-99d4-45c2-9937-786296d70cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ecec20b4-6f4b-41e1-9867-3bfde44f3de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OperatingLeaseLiability_ecec20b4-6f4b-41e1-9867-3bfde44f3de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1d926650-4a42-4abd-b863-ad24cea35af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1d926650-4a42-4abd-b863-ad24cea35af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_7004f464-d5e7-48c4-9744-cf9813b211da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestPaid_7004f464-d5e7-48c4-9744-cf9813b211da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_129bf471-4244-4af1-a623-f0d9374affbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_InterestPaidCapitalized_129bf471-4244-4af1-a623-f0d9374affbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_9ca1b7f4-8823-422e-9788-c4165d6b9c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_IncomeTaxesPaid_9ca1b7f4-8823-422e-9788-c4165d6b9c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_6fe2e368-3937-4cee-87f9-8539c16a10ba" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_6fe2e368-3937-4cee-87f9-8539c16a10ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_9fc07f6a-fffd-464e-a62c-21f8686c45cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_9fc07f6a-fffd-464e-a62c-21f8686c45cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1b42914a-52f2-4fc6-ac28-7d202d1e67a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1b42914a-52f2-4fc6-ac28-7d202d1e67a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e45f2d1d-0bc8-46db-ad60-6ad205ac5348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e45f2d1d-0bc8-46db-ad60-6ad205ac5348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2870619-19a2-473b-b4d1-21e614809b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2870619-19a2-473b-b4d1-21e614809b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa24f76b-d124-4d38-a24d-4ec472315abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa24f76b-d124-4d38-a24d-4ec472315abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71b8ad36-7f82-4ef5-8128-27b134214f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71b8ad36-7f82-4ef5-8128-27b134214f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_c2710754-4cf5-4232-9552-4cb27c07cd26" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_c2710754-4cf5-4232-9552-4cb27c07cd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f6fd0052-7159-4ba9-be97-56c01a4af81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f6fd0052-7159-4ba9-be97-56c01a4af81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_6392a6ad-f2e8-49db-8b01-a395743a8626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_6392a6ad-f2e8-49db-8b01-a395743a8626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdcf9ba0-3adf-4e79-8c78-26f91f4bd60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_4d21c4fa-254f-41e5-9bcd-e8a2ac751454" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdcf9ba0-3adf-4e79-8c78-26f91f4bd60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8d0b8309-298d-4a14-bbe7-7f9d8bab338e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_43ce18b8-6188-4a8a-b958-eb9c3e0cbff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d0b8309-298d-4a14-bbe7-7f9d8bab338e" xlink:to="loc_us-gaap_InventoryFinishedGoods_43ce18b8-6188-4a8a-b958-eb9c3e0cbff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_82ed36c0-075a-43f6-935f-31114352c36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d0b8309-298d-4a14-bbe7-7f9d8bab338e" xlink:to="loc_us-gaap_InventoryWorkInProcess_82ed36c0-075a-43f6-935f-31114352c36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_e0056688-ccf1-40e4-ac04-615bad4a9d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d0b8309-298d-4a14-bbe7-7f9d8bab338e" xlink:to="loc_us-gaap_InventoryRawMaterials_e0056688-ccf1-40e4-ac04-615bad4a9d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_920667bd-0b90-4099-a3e3-5905e504063f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d0b8309-298d-4a14-bbe7-7f9d8bab338e" xlink:to="loc_us-gaap_InventoryNet_920667bd-0b90-4099-a3e3-5905e504063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_df0f69d2-fc4a-48a5-8974-d5931e5e1d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df0f69d2-fc4a-48a5-8974-d5931e5e1d00" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39cf285c-5bb2-4795-be34-00a35127a4c3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_16d785d2-fa8f-4200-9d44-e275494cc697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_LandMember_16d785d2-fa8f-4200-9d44-e275494cc697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7f5f4736-8ab3-441f-bc22-bf6d930f3250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7f5f4736-8ab3-441f-bc22-bf6d930f3250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_2c318e3c-f0da-43ca-baa0-5fc610a1ed7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_2c318e3c-f0da-43ca-baa0-5fc610a1ed7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b6fa17ab-e4a4-45b6-a2f0-3db294cdaa1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b6fa17ab-e4a4-45b6-a2f0-3db294cdaa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInstrumentKitsMember_219f46fe-a1b4-4849-ab64-bd6dd151ff69" xlink:href="iart-20201231.xsd#iart_SurgicalInstrumentKitsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_iart_SurgicalInstrumentKitsMember_219f46fe-a1b4-4849-ab64-bd6dd151ff69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_c92f6c63-c693-4d5d-8b3f-d78f737eebc8" xlink:href="iart-20201231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_iart_InformationSystemsandHardwareMember_c92f6c63-c693-4d5d-8b3f-d78f737eebc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d6c34a73-e484-41d7-b3c7-b4d059250ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d6c34a73-e484-41d7-b3c7-b4d059250ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_88e2e300-a73b-49cb-85ff-1501cca158bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c3bc31f-5352-42e6-94ad-03c78383b903" xlink:to="loc_us-gaap_ConstructionInProgressMember_88e2e300-a73b-49cb-85ff-1501cca158bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:to="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ce330b17-6dfa-45af-b631-b1fccbd8859a" xlink:to="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0cb7619a-a3aa-4dfb-9142-6d3b667b80e7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:to="loc_srt_MinimumMember_0cb7619a-a3aa-4dfb-9142-6d3b667b80e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0dfad073-41b2-404a-8e4b-5d15d3798765" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb7157dd-cff4-40b4-a977-8e3289eb08b8" xlink:to="loc_srt_MaximumMember_0dfad073-41b2-404a-8e4b-5d15d3798765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9e685bf1-8d5a-4ffe-961b-4f10e85bb468" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0c850056-9928-418e-b653-cc4a69d613fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0c850056-9928-418e-b653-cc4a69d613fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1695df58-722a-4345-803e-b137571d1bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1695df58-722a-4345-803e-b137571d1bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_619603aa-7308-4e9a-95c4-08ac83e2f5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_619603aa-7308-4e9a-95c4-08ac83e2f5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_756aa12d-74ef-4eb1-8217-3c0da4f8d6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1f92d5f5-b2a7-4390-8756-7bbc8cb81f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_756aa12d-74ef-4eb1-8217-3c0da4f8d6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALE"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_09f0167d-b22a-4fd7-b1c9-3ba7f3e161a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_49e1fb8c-145b-4d44-a0c5-4335a1f224b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_09f0167d-b22a-4fd7-b1c9-3ba7f3e161a4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_49e1fb8c-145b-4d44-a0c5-4335a1f224b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALETables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7c6e8056-1304-4eba-aec7-ea62d822878c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_9fe85843-467d-4eba-bf5b-9d8d9bb7c85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7c6e8056-1304-4eba-aec7-ea62d822878c" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_9fe85843-467d-4eba-bf5b-9d8d9bb7c85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALENarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_78c02a16-d3ce-43e7-8228-06e629f6a37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_78c02a16-d3ce-43e7-8228-06e629f6a37b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_49e689c8-2ede-4126-a731-58fd2995497e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_61486365-76e9-40c0-a4cf-4d0f08819285" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d63889a8-a9b1-4e9b-9a03-ffd0edb90859" xlink:to="loc_iart_SmithNephewUSDLimitedMember_61486365-76e9-40c0-a4cf-4d0f08819285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1ae469c-2965-4842-9c0c-0597c68ff5ef" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_dcc35e08-e0ab-4cc9-bd29-aa0ed609edb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9d866067-e8d5-456d-82dc-8e40f1fb3de9" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_dcc35e08-e0ab-4cc9-bd29-aa0ed609edb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_11e64a8d-4e84-43e0-a61e-7ffd70e6eb4c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7ed55659-f74c-44ac-bb61-c90e5bca19fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_362fc8b6-4d9b-45ad-bd5d-f1d664bf2d57" xlink:to="loc_us-gaap_SubsequentEventMember_7ed55659-f74c-44ac-bb61-c90e5bca19fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_51de22ca-8836-4abb-a678-43731b8f3f25" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_96446907-8e32-400a-b69c-86c6e8c84d80" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff89063b-dae8-4c0c-9e29-d3a31756245c" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_96446907-8e32-400a-b69c-86c6e8c84d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_78d740fc-4981-4ef4-9376-ddbc0b908d25" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0aa8c03a-4dd6-4d05-822d-8ebd45c28b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0aa8c03a-4dd6-4d05-822d-8ebd45c28b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_1f84e917-f6ac-4030-af86-49566a8e1acd" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8d522b70-629b-44ae-8443-7b31f20e26c4" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_1f84e917-f6ac-4030-af86-49566a8e1acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_767a3ba3-e4cb-4268-bd87-e94aa7dd154d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_767a3ba3-e4cb-4268-bd87-e94aa7dd154d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7fb84321-3533-405b-bf84-64746bd380fe" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_24ec7da3-311c-43e4-935e-9616d3562c1a" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16fb681c-35cf-4608-b50f-2378e95607f4" xlink:to="loc_iart_SmithNephewUSDLimitedMember_24ec7da3-311c-43e4-935e-9616d3562c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_64fec681-f411-4637-9e18-6c681f836171" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8cddd2ec-27c1-44ae-bb55-3f49bf5ba9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_aef4b647-8b01-466f-aa7b-93b5ffdbfb0b" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8cddd2ec-27c1-44ae-bb55-3f49bf5ba9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd3bf162-7b63-438b-80d6-8a30219ebef4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_96488bfb-f7f0-4356-93b5-a1bf4f875dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_96488bfb-f7f0-4356-93b5-a1bf4f875dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_1793eff5-9514-4d2f-82dc-5bccfe9ad80a" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets_1793eff5-9514-4d2f-82dc-5bccfe9ad80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_b32931da-f14e-4745-b4b4-b84724646e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_b32931da-f14e-4745-b4b4-b84724646e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_56c5ae96-abb1-4717-9b99-5ebf1f755a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_56c5ae96-abb1-4717-9b99-5ebf1f755a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_467398db-24c2-41c9-80bd-a247fa15aca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_467398db-24c2-41c9-80bd-a247fa15aca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b39ba91b-267d-4201-abae-8a398bfc4ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b39ba91b-267d-4201-abae-8a398bfc4ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_00825276-6026-488f-ab57-5092d894e097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_00825276-6026-488f-ab57-5092d894e097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8eca1e5c-e709-4204-9a96-fdd9e2d38f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8eca1e5c-e709-4204-9a96-fdd9e2d38f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_ebf0fc53-20e3-4298-98a5-b00e8b0f4e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_ebf0fc53-20e3-4298-98a5-b00e8b0f4e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_291f5ded-6b55-4db6-b8e4-c1501c0aa2a6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_291f5ded-6b55-4db6-b8e4-c1501c0aa2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_34602703-3541-413a-82e5-67a7f31262e6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation_34602703-3541-413a-82e5-67a7f31262e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_7be09a70-7c97-49fb-add4-fc640c67059f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_7be09a70-7c97-49fb-add4-fc640c67059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_47f7fd74-46da-4332-84b0-524b023252ff" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_47f7fd74-46da-4332-84b0-524b023252ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0d2343d-4506-4e1d-92bb-b838b9d7a690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34a5c7ca-f1d7-4b9b-9eae-deedc241eb90" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0d2343d-4506-4e1d-92bb-b838b9d7a690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e1472e6-1e5d-4007-95d9-fe87b2df3da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_98d4f7b3-fc2b-4f22-a0a7-7c5bf79238f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e1472e6-1e5d-4007-95d9-fe87b2df3da7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_98d4f7b3-fc2b-4f22-a0a7-7c5bf79238f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_45588db7-8404-4bbc-8224-19ce4d0fcca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_34b9b2c4-9500-4da6-9162-f8f143a5ba98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_45588db7-8404-4bbc-8224-19ce4d0fcca0" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_34b9b2c4-9500-4da6-9162-f8f143a5ba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_22816473-0bb0-47b6-9da2-cf8a6cbefbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_45588db7-8404-4bbc-8224-19ce4d0fcca0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_22816473-0bb0-47b6-9da2-cf8a6cbefbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b731b179-a1ee-4183-944a-a2859ced1803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_7044afe1-5e07-4b1c-9617-413513c3987e" xlink:href="iart-20201231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b731b179-a1ee-4183-944a-a2859ced1803" xlink:to="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_7044afe1-5e07-4b1c-9617-413513c3987e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_57fdb986-c7d3-495e-b482-f9230cfd4950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b731b179-a1ee-4183-944a-a2859ced1803" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_57fdb986-c7d3-495e-b482-f9230cfd4950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b482b214-501a-4330-8bda-fa2105e5f9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b731b179-a1ee-4183-944a-a2859ced1803" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b482b214-501a-4330-8bda-fa2105e5f9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod_b1aef3b8-272f-454c-893d-7c1e7815280c" xlink:href="iart-20201231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b731b179-a1ee-4183-944a-a2859ced1803" xlink:to="loc_iart_RevenueProductWarrantyPeriod_b1aef3b8-272f-454c-893d-7c1e7815280c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0c3327d4-04f6-4727-b2ef-e86c462b4a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5acd1194-132a-46d2-b866-74ad323ce202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0c3327d4-04f6-4727-b2ef-e86c462b4a24" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5acd1194-132a-46d2-b866-74ad323ce202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0c3327d4-04f6-4727-b2ef-e86c462b4a24" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e3ecae55-4259-4fc0-8be8-d6ea4d5610a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e3ecae55-4259-4fc0-8be8-d6ea4d5610a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_bb3db637-3d0e-4afc-a57d-ec5103583f0f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c53b13a7-3229-4fa0-a0a5-0cc5b20e18a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ee2069f2-9201-4263-ad43-6215a17fbfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8ecf4d7-7ccc-4b0e-a729-df42a4523666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:href="iart-20201231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8ecf4d7-7ccc-4b0e-a729-df42a4523666" xlink:to="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_459a49e6-6dd7-4e7f-89e2-b2ef9345f43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_459a49e6-6dd7-4e7f-89e2-b2ef9345f43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_1e850604-282b-434b-9f64-06aa767cbaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_1e850604-282b-434b-9f64-06aa767cbaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_ff031a43-dd7d-473b-b1c6-1b422e889ff1" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:to="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_ff031a43-dd7d-473b-b1c6-1b422e889ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_31a779cb-c98f-4359-8828-0a08335f72e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_b48d0b51-a1f9-4115-81e9-2e8465d74d11" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_31a779cb-c98f-4359-8828-0a08335f72e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:href="iart-20201231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8ecf4d7-7ccc-4b0e-a729-df42a4523666" xlink:to="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_780e0eb0-658d-41a8-a56a-7adf195865d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:to="loc_us-gaap_ContractWithCustomerLiability_780e0eb0-658d-41a8-a56a-7adf195865d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5941d4ca-6f2c-458d-9e84-caf47730b2ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5941d4ca-6f2c-458d-9e84-caf47730b2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_acf9aca2-4a95-41dd-93e4-864c5ed9eb3d" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:to="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_acf9aca2-4a95-41dd-93e4-864c5ed9eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_d82cc11c-c0ef-4d3b-8085-22af02ad34c0" xlink:href="iart-20201231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:to="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_d82cc11c-c0ef-4d3b-8085-22af02ad34c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f0452a91-ef21-4b1b-9020-e0997473a881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_18fce50a-a45e-411f-938e-d3d5e1277900" xlink:to="loc_us-gaap_ContractWithCustomerLiability_f0452a91-ef21-4b1b-9020-e0997473a881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf6f809e-5bd9-4582-b1ef-d790148bb170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf6f809e-5bd9-4582-b1ef-d790148bb170" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cfdc52d0-79a9-4edd-a84e-7647495dedfd" xlink:to="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_84a71b77-ad19-4938-8da1-570ac0275331" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_84a71b77-ad19-4938-8da1-570ac0275331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_8978ec0c-6f22-4150-bedc-fc387f6cb141" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1fc9788d-b147-4169-8905-967cc04575ab" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_8978ec0c-6f22-4150-bedc-fc387f6cb141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:to="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_32bc4b09-8246-4de4-83bb-a4f44918002f" xlink:to="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_d1f1d60e-e0b0-4b15-86a7-3027a8a2163f" xlink:href="iart-20201231.xsd#iart_NeurosurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_NeurosurgeryMember_d1f1d60e-e0b0-4b15-86a7-3027a8a2163f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_95cb0966-3e4c-48a4-b348-679bf8ac1745" xlink:href="iart-20201231.xsd#iart_InstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_InstrumentsMember_95cb0966-3e4c-48a4-b348-679bf8ac1745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_42e417a4-16b7-42cd-89b6-f1c8e61bdb98" xlink:href="iart-20201231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_42e417a4-16b7-42cd-89b6-f1c8e61bdb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_744094fc-4c53-43f5-b333-f07926fd4367" xlink:href="iart-20201231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_ExtremityOrthopedicsMember_744094fc-4c53-43f5-b333-f07926fd4367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_fdb3fba1-702e-4bfe-a1bd-5755fe66c598" xlink:href="iart-20201231.xsd#iart_PrivateLabelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d3bfcb2-8a10-487f-bd06-204ccada1bd0" xlink:to="loc_iart_PrivateLabelMember_fdb3fba1-702e-4bfe-a1bd-5755fe66c598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3ebec1c2-3d74-46c5-a9e2-a0d4c37e8059" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a933c9b7-a43f-4e8d-ae4f-64849471f6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e174e546-b949-440c-8a8d-c01c8e9eda05" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a933c9b7-a43f-4e8d-ae4f-64849471f6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_04ab4441-e9d7-4b22-a471-dca2e7376f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock_cfca0fb8-72d9-4a33-a88c-ae56742b65d7" xlink:href="iart-20201231.xsd#iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_04ab4441-e9d7-4b22-a471-dca2e7376f16" xlink:to="loc_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock_cfca0fb8-72d9-4a33-a88c-ae56742b65d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_323f0cd0-3573-4a92-90cc-ccc2cc6f8b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_71519938-da68-4594-aee0-7c24ef7b9dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_323f0cd0-3573-4a92-90cc-ccc2cc6f8b29" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_71519938-da68-4594-aee0-7c24ef7b9dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSBusinessAcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e72c06e7-4bc1-4704-8cbd-4d2eebb2719e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e72c06e7-4bc1-4704-8cbd-4d2eebb2719e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1be6e94f-4d9c-4c4f-af9f-217a00e33a58" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_dc4fb944-7e29-4b0c-8454-bda1e12a9ceb" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7304081c-c4ac-43e9-acd9-90ba2a11d2fd" xlink:to="loc_iart_ArkisBioSciencesInc.Member_dc4fb944-7e29-4b0c-8454-bda1e12a9ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_188f5718-25b0-4fd8-8da8-89571415cf1d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_92a27061-a520-4c75-92d7-a7da76f84ac5" xlink:href="iart-20201231.xsd#iart_MilestonePaymentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:to="loc_iart_MilestonePaymentOneMember_92a27061-a520-4c75-92d7-a7da76f84ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_246c3bef-bb44-4f5e-ba00-8e5de300a41a" xlink:href="iart-20201231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3624add6-4586-4611-9b40-6e4477d362c8" xlink:to="loc_iart_MilestonePaymentTwoMember_246c3bef-bb44-4f5e-ba00-8e5de300a41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c723d53d-cb7a-44e4-a457-65644a99eb27" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1b4279ad-ac17-4e2a-bb1e-4f78ba83e048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1b4279ad-ac17-4e2a-bb1e-4f78ba83e048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c0e390f6-ad6e-4c19-ba38-f4f37b79ccbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4409a041-9f41-4519-92e1-401d3dd8d100" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c0e390f6-ad6e-4c19-ba38-f4f37b79ccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d66a5eb6-eb4b-41cb-b021-57f1b1301f61" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ceb2d3b8-1336-4e27-8889-a500380b757e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ceb2d3b8-1336-4e27-8889-a500380b757e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e6dd930b-7219-4606-86f7-f91aa7a5f1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e6dd930b-7219-4606-86f7-f91aa7a5f1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_7f9187a0-8753-49f9-ab41-05e70c807461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_7f9187a0-8753-49f9-ab41-05e70c807461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_b00cbf56-2975-4136-8a4a-d31b9f7934c6" xlink:href="iart-20201231.xsd#iart_AcquiredFinitelivedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f9f66205-8755-491e-a380-9b8a71412816" xlink:to="loc_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate_b00cbf56-2975-4136-8a4a-d31b9f7934c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_87fe0789-d4b1-421c-a674-92c63546a6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_87fe0789-d4b1-421c-a674-92c63546a6fd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62d5d1b8-9fa0-4642-886b-bb23966b0ecc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_f4c6d351-88c2-4fcf-a1e8-7293b923d729" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_89ffc30e-5b93-4e08-a85b-829bcbe41e9e" xlink:to="loc_iart_ArkisBioSciencesInc.Member_f4c6d351-88c2-4fcf-a1e8-7293b923d729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bed2d20f-24cd-498d-9f03-7aac2a9ac5d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b57a08d4-51a9-407f-90fe-134a9e386fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b57a08d4-51a9-407f-90fe-134a9e386fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_ae4d404b-8e27-41aa-ac72-eb22e52a93a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_385e8f54-7411-45f5-9da1-a6b9e8e39b84" xlink:to="loc_us-gaap_LicensingAgreementsMember_ae4d404b-8e27-41aa-ac72-eb22e52a93a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_758db2c3-7cbc-4f3f-9a2d-a45cf476455d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d98fc822-7132-40a3-83da-39e3fb25245f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d98fc822-7132-40a3-83da-39e3fb25245f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_13739c0b-3892-4cd9-878f-df51375b9ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_13739c0b-3892-4cd9-878f-df51375b9ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5c9f75cd-8cf9-4bfe-9e93-5b403b9b4706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5c9f75cd-8cf9-4bfe-9e93-5b403b9b4706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9a1d32bb-70a5-4263-8d0d-cbbb2c05f2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9a1d32bb-70a5-4263-8d0d-cbbb2c05f2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:href="iart-20201231.xsd#iart_IntangibleAssetsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_473aa348-7db1-4a5f-b587-0630fbcf1f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IntangibleAssetsAbstract_7de91394-ce9d-447f-b10d-aa4fe9bffff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_473aa348-7db1-4a5f-b587-0630fbcf1f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_abc06e74-a8b8-4936-8384-9ad62ac9f4d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_Goodwill_abc06e74-a8b8-4936-8384-9ad62ac9f4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_4a4158b7-9be2-4540-bd8b-92f0a8335f7f" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_4a4158b7-9be2-4540-bd8b-92f0a8335f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_28cebeff-fe19-4b12-aad8-33064c91f04b" xlink:href="iart-20201231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities_28cebeff-fe19-4b12-aad8-33064c91f04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5b1a2ad3-64f1-4532-acf0-4ed802e73938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5b1a2ad3-64f1-4532-acf0-4ed802e73938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5339191e-4fae-4b22-af02-acafe499692b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5339191e-4fae-4b22-af02-acafe499692b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_da435aff-eae7-4901-9a57-c8e3c51b88b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_da435aff-eae7-4901-9a57-c8e3c51b88b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fec08cc0-af65-4ea5-a4a7-948f48c8f7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3df1e851-e033-4d13-93a1-3d63cfb4fbc3" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fec08cc0-af65-4ea5-a4a7-948f48c8f7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACQUISITIONSAssetAcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3b27c8c0-0202-4a2d-9006-570ba321b9de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3b27c8c0-0202-4a2d-9006-570ba321b9de" xlink:to="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AssetAcquisitionAxis_bedac3d9-0fe9-41bc-817f-95a1f37da40f" xlink:to="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_e6a77d7e-8107-402a-abae-74b08cdac997" xlink:href="iart-20201231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_e6a77d7e-8107-402a-abae-74b08cdac997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntegratedShoulderCollaborationInc.Member_54ed0ce6-8418-4de0-b9d2-ba892b3c0955" xlink:href="iart-20201231.xsd#iart_IntegratedShoulderCollaborationInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AssetAcquisitionDomain_827073eb-5193-4bba-b8ec-458d7289e76e" xlink:to="loc_iart_IntegratedShoulderCollaborationInc.Member_54ed0ce6-8418-4de0-b9d2-ba892b3c0955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_559a85a1-09ed-4cee-9d43-be0971fe86ac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c972131f-cf73-4b98-a3f9-9d67730c4592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fe6d891-aa61-4090-9df9-5ebc22b06b16" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c972131f-cf73-4b98-a3f9-9d67730c4592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e6dbf61d-5ba2-4005-ad44-7f9a97d9ad6a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a4d94725-7182-4cba-9a58-cc0ce1b0eb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a4d94725-7182-4cba-9a58-cc0ce1b0eb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetMember_5ed60da9-7a1d-4c33-bed2-b3aedf9b7c5a" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2f26d41d-c1c8-47e4-93b8-b23563b31973" xlink:to="loc_iart_DeferredTaxAssetMember_5ed60da9-7a1d-4c33-bed2-b3aedf9b7c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_616ab476-f43c-4a82-92db-31131810ba44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9bf6d61a-f025-44b0-84ec-3b6d0f60dce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1bcb7d3-d446-4830-a24f-e08f6b49a255" xlink:to="loc_us-gaap_LicensingAgreementsMember_9bf6d61a-f025-44b0-84ec-3b6d0f60dce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_158ad594-2f22-4b85-a5d7-e854462c13ad" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_9435f4e1-7239-4c6f-b4c3-8550c8b69765" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8eb1308-edbf-41bd-a447-945e04bb5aab" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_9435f4e1-7239-4c6f-b4c3-8550c8b69765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d26239fb-de1c-4ae1-85c6-63f1cbd93e5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_44d44d7e-48a7-4e19-9eaa-0bbc2027330e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_79ceda32-3518-4de9-85cd-180bd8f8e203" xlink:to="loc_us-gaap_SubsequentEventMember_44d44d7e-48a7-4e19-9eaa-0bbc2027330e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d36a6756-4775-4516-81af-1cd121d644bd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37405daf-2eff-4357-8267-3854b94ddfa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3ef0455-3aba-463a-a465-075b469fda4c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37405daf-2eff-4357-8267-3854b94ddfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fffc477e-8b84-46b9-b244-c8a580ccb80a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_2fe344d2-7370-4ebb-ac53-e96de3a36565" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5d4f3610-bb67-458d-8baa-f647da5682f3" xlink:to="loc_iart_SmithNephewUSDLimitedMember_2fe344d2-7370-4ebb-ac53-e96de3a36565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:href="iart-20201231.xsd#iart_ScheduleOfAssetAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionTable_87111b8c-a5dd-4227-87ad-c2a0fc38aeed" xlink:to="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionConsiderationTransferred_445a2e53-415c-48e9-9204-10c87b8705c7" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionConsiderationTransferred_445a2e53-415c-48e9-9204-10c87b8705c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_9f0c9833-3428-4f18-81a3-0c494946402e" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet_9f0c9833-3428-4f18-81a3-0c494946402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_ed34bc2a-7401-40e1-848b-64b3f356ca8c" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionNumberOfAssetsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionNumberOfAssetsAcquired_ed34bc2a-7401-40e1-848b-64b3f356ca8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_a66ae970-c54c-48d6-9dce-8a6ac5db11e4" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_a66ae970-c54c-48d6-9dce-8a6ac5db11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_819fb29a-9cec-458f-b0e8-f63a159fd07f" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_819fb29a-9cec-458f-b0e8-f63a159fd07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_d3e87ebb-3c68-41d4-b425-38b50ef8ef17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_d3e87ebb-3c68-41d4-b425-38b50ef8ef17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a07daf87-c32b-4891-91c4-e89b2a3a9db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a07daf87-c32b-4891-91c4-e89b2a3a9db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_745a09b8-8d8a-428c-b8dd-da1fb1118a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_745a09b8-8d8a-428c-b8dd-da1fb1118a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_671f2be7-51f0-47f2-bcb9-febdcca4a5ab" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet_671f2be7-51f0-47f2-bcb9-febdcca4a5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_7333ea98-40f3-4c96-a4cd-b116def079db" xlink:href="iart-20201231.xsd#iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet_7333ea98-40f3-4c96-a4cd-b116def079db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b3c4f469-e621-4bae-85c5-e1073111964e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b3c4f469-e621-4bae-85c5-e1073111964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_18c8014f-b37d-48b7-978a-755d6f3dc521" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ScheduleOfAssetAcquisitionLineItems_fdad757b-3a70-44af-91e7-5cf664068e7f" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_18c8014f-b37d-48b7-978a-755d6f3dc521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0eff86cf-0a9a-4ad7-8b80-93da871e5f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ff27d740-09e7-4665-b7e4-1ebf856d4923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0eff86cf-0a9a-4ad7-8b80-93da871e5f5b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ff27d740-09e7-4665-b7e4-1ebf856d4923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8a344bff-7b2e-415e-b50b-4b7d34b42639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7c108057-b678-477f-888d-248c0696446e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8a344bff-7b2e-415e-b50b-4b7d34b42639" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7c108057-b678-477f-888d-248c0696446e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30b7391a-2a2f-4255-9c93-a24d6f394548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8a344bff-7b2e-415e-b50b-4b7d34b42639" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30b7391a-2a2f-4255-9c93-a24d6f394548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_67627502-3579-410f-8c0f-d3c0af802754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67627502-3579-410f-8c0f-d3c0af802754" xlink:to="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_27959963-2c51-4536-bbf5-4ed77b26c65d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_9ebc9304-6af5-4956-8a03-ae7aeea8d0dd" xlink:href="iart-20201231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_SeniorCreditFacilityMember_9ebc9304-6af5-4956-8a03-ae7aeea8d0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_e0eb7529-9f8d-46b9-9d47-574eeceeee96" xlink:href="iart-20201231.xsd#iart_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_TermLoanFacilityMember_e0eb7529-9f8d-46b9-9d47-574eeceeee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_4946512b-4070-4f11-905f-1a59d82d0646" xlink:href="iart-20201231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_727c0ea7-9a87-450b-a771-afc4d1a56234" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_4946512b-4070-4f11-905f-1a59d82d0646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_bf2d9e73-b344-48b7-9a30-a8f61b64656c" xlink:to="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_90e917c0-e4b5-4d17-9f35-7937f49be769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_SecuredDebtMember_90e917c0-e4b5-4d17-9f35-7937f49be769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4d1a4abd-31ca-47e3-8fb8-839e6e2fab69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4d1a4abd-31ca-47e3-8fb8-839e6e2fab69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_e19b74cf-a932-4e7b-8762-b7f591c89918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_e19b74cf-a932-4e7b-8762-b7f591c89918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_6975fb68-9a19-46b1-b77b-dd0d9a1ca904" xlink:href="iart-20201231.xsd#iart_SwinglineLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0fe289bf-a5a8-494f-a6f7-ab8cd8929dd6" xlink:to="loc_iart_SwinglineLoanMember_6975fb68-9a19-46b1-b77b-dd0d9a1ca904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ed9abc08-3625-4031-b3e4-728b0fa9ab21" xlink:to="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fafab6af-64f4-4f5f-8d41-aac067b89b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_us-gaap_EurodollarMember_fafab6af-64f4-4f5f-8d41-aac067b89b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ef9a5ecb-d305-4922-80aa-b0e46f68f6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ef9a5ecb-d305-4922-80aa-b0e46f68f6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_5c911d0d-a671-4629-b1f1-2c91b7b47895" xlink:href="iart-20201231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d2535878-e9c0-4165-aed5-903ee41b9011" xlink:to="loc_iart_OneMonthEurodollarRateMember_5c911d0d-a671-4629-b1f1-2c91b7b47895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d1dc53da-64fe-40e6-8543-670e5b0676d6" xlink:to="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b97d48a2-76d5-4ba5-b809-96869a308c71" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:to="loc_srt_MinimumMember_b97d48a2-76d5-4ba5-b809-96869a308c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2dd6db0f-9b74-418c-977c-a3eab1a091ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7897339a-605c-45f6-9f0d-8996e4f1b3ee" xlink:to="loc_srt_MaximumMember_2dd6db0f-9b74-418c-977c-a3eab1a091ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6e98c69-d1e7-4c5a-a448-7be939cf289a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_597c8ef5-c65e-4f5d-b877-6e262402df44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14a4364f-8d19-4923-b1d1-3e918c21f69d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_597c8ef5-c65e-4f5d-b877-6e262402df44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42caa70b-76a4-4ef8-ba65-f858f9697ff0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec603de1-6870-42b3-a85a-a78d250f62d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e284daa1-8d84-4ed2-abe1-ce986f7c6d6c" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec603de1-6870-42b3-a85a-a78d250f62d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_7ee9d798-033c-481e-a8a2-ca486dcb2368" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_b6bc76a1-528e-44c7-a246-2ba8c610d0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d2700013-2f9c-4ac5-9642-fd7671a6634c" xlink:to="loc_us-gaap_CallOptionMember_b6bc76a1-528e-44c7-a246-2ba8c610d0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_261878b6-b8b5-440c-ba02-7f0ebf75bac5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_05ee519a-9a1a-4437-a2a4-ea931a78e82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_05ee519a-9a1a-4437-a2a4-ea931a78e82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a6216865-92de-4659-a6be-e6c9042d80d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a6216865-92de-4659-a6be-e6c9042d80d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_73de5515-b6fb-45a7-823d-76cdad86d8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_73de5515-b6fb-45a7-823d-76cdad86d8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_b0860282-61ea-4fdc-99db-57277dd48b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_b0860282-61ea-4fdc-99db-57277dd48b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c4fc78dc-4096-4722-8e21-821b7fadfa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c4fc78dc-4096-4722-8e21-821b7fadfa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a58a64f8-9160-46cc-b731-29861703a9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a58a64f8-9160-46cc-b731-29861703a9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7ca15d79-9ad1-4751-bf62-6c7bceb9a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCredit_7ca15d79-9ad1-4751-bf62-6c7bceb9a064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_2aab4ff5-e126-48d7-9d55-5275e93966de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_2aab4ff5-e126-48d7-9d55-5275e93966de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_eaf42142-7a19-4d85-8dfc-39e723ad51eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_SecuredDebtCurrent_eaf42142-7a19-4d85-8dfc-39e723ad51eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c3b81b38-b551-4f58-a98f-4f0641672579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c3b81b38-b551-4f58-a98f-4f0641672579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_f6463d9b-6b20-42bc-85cb-d14f4d369d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_f6463d9b-6b20-42bc-85cb-d14f4d369d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f03dc014-2c6d-45d9-aefa-e1b02bd90744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f03dc014-2c6d-45d9-aefa-e1b02bd90744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0610ad72-f26c-4098-9c84-79a6b20ea047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0610ad72-f26c-4098-9c84-79a6b20ea047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_b5d90e79-b655-4133-8637-2cb027fc957e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_b5d90e79-b655-4133-8637-2cb027fc957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d90e391d-5ab5-4c7d-98d4-a5dd82de4401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d90e391d-5ab5-4c7d-98d4-a5dd82de4401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_055cd9b7-9db5-4196-b9ac-6c9238a6ca09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_055cd9b7-9db5-4196-b9ac-6c9238a6ca09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_83b9fbfd-8632-4034-80bd-93e28464d056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_83b9fbfd-8632-4034-80bd-93e28464d056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_239dfaf3-2fac-43a7-ba6d-1cd71e20a185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentFairValue_239dfaf3-2fac-43a7-ba6d-1cd71e20a185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bb1aa78-a5a7-423c-879f-c3c104ebf8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bb1aa78-a5a7-423c-879f-c3c104ebf8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2ecaea72-de20-48fc-a31e-e4e8cc0766cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2ecaea72-de20-48fc-a31e-e4e8cc0766cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_7d29fda1-301b-43aa-91aa-15aafbdbfe77" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_7d29fda1-301b-43aa-91aa-15aafbdbfe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e0bee4a9-1b1c-4df9-ad3f-c7b2b349a084" xlink:href="iart-20201231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e0bee4a9-1b1c-4df9-ad3f-c7b2b349a084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_f9edb499-82d9-4ef6-8ef2-9c719f4fd76b" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_f9edb499-82d9-4ef6-8ef2-9c719f4fd76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3c01659a-4734-4711-9371-b099511dfee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3c01659a-4734-4711-9371-b099511dfee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_7c5b0ce4-f15e-4e16-ad32-be98848498a7" xlink:href="iart-20201231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_7c5b0ce4-f15e-4e16-ad32-be98848498a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8968935c-bf5e-4628-ab2b-41190a384a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8968935c-bf5e-4628-ab2b-41190a384a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_1ff08536-4bd6-4c68-b6b5-64e38f0be32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_1ff08536-4bd6-4c68-b6b5-64e38f0be32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3b0f25-21f5-4c2f-85c0-62381ed8b756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3b0f25-21f5-4c2f-85c0-62381ed8b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d86f124f-caa5-4aeb-841e-4445d66a3979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d86f124f-caa5-4aeb-841e-4445d66a3979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_71826c11-e2a3-4061-bbba-bcd376ede948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_71826c11-e2a3-4061-bbba-bcd376ede948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c9cbfe91-8aaf-48b2-a808-89130e95bf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_us-gaap_InterestExpenseDebt_c9cbfe91-8aaf-48b2-a808-89130e95bf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_f9641b43-15b5-46f4-8247-e8f14e630afb" xlink:href="iart-20201231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_f9641b43-15b5-46f4-8247-e8f14e630afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtAccountsReceivableSecuritizationTerm_2615d654-a314-40a0-9717-bfb6e16d3284" xlink:href="iart-20201231.xsd#iart_DebtAccountsReceivableSecuritizationTerm"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtAccountsReceivableSecuritizationTerm_2615d654-a314-40a0-9717-bfb6e16d3284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_941a9ac0-b73e-471f-8b8b-c9c01c518df8" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramCurrent"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramCurrent_941a9ac0-b73e-471f-8b8b-c9c01c518df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2d1ba47c-f7b2-4e3f-b42e-b1664e71c6b7" xlink:href="iart-20201231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2d1ba47c-f7b2-4e3f-b42e-b1664e71c6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_ab7698ad-a68f-419f-b876-c533ba65d095" xlink:href="iart-20201231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_ab7698ad-a68f-419f-b876-c533ba65d095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_9b41a116-ff78-4345-a0dc-ef13564e41c4" xlink:href="iart-20201231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7a0e802-8460-4fcc-bb31-eb57a3c5a968" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_9b41a116-ff78-4345-a0dc-ef13564e41c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_338c153e-a77a-4aad-a3bb-bc4a5427e0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_338c153e-a77a-4aad-a3bb-bc4a5427e0ed" xlink:to="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7d08f-e514-4678-a3ff-b1f9fc71f35e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_9fe9eceb-1402-4f13-8a38-7c85c563695c" xlink:href="iart-20201231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12a9517d-eadd-4c76-a52f-1dc5f51312f8" xlink:to="loc_iart_SeniorCreditFacilityMember_9fe9eceb-1402-4f13-8a38-7c85c563695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:to="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodAxis_21047d4f-ee6c-4243-bde8-45c3e66a89c2" xlink:to="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_9d59ecd2-7044-4437-85b6-e4c1ba5cef38" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod1Member_9d59ecd2-7044-4437-85b6-e4c1ba5cef38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_b51c52e9-499c-4a72-81be-997fa6e1a011" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod2Member_b51c52e9-499c-4a72-81be-997fa6e1a011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_0b9f52e5-149b-48e0-8c89-4dcf0fcec395" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod3Member_0b9f52e5-149b-48e0-8c89-4dcf0fcec395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_234e29d2-6cf5-4306-8243-b29d35fe6acf" xlink:href="iart-20201231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_e9b978e2-1de1-4512-bbeb-0932d67f9bc7" xlink:to="loc_iart_DebtCovenantPeriod4Member_234e29d2-6cf5-4306-8243-b29d35fe6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59f656e7-44df-4569-a1d5-64238f4f5528" xlink:to="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_4c047c13-ff27-494a-817e-5dbfd535607b" xlink:href="iart-20201231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_81621f1f-4d5f-45b0-97ec-cddf5263e006" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_4c047c13-ff27-494a-817e-5dbfd535607b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_24f0b8bf-5566-4295-aa3e-aa21ac09840d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_24f0b8bf-5566-4295-aa3e-aa21ac09840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_70b04155-1919-411a-95d6-ce40c5728629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_70b04155-1919-411a-95d6-ce40c5728629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9124d892-5007-4b95-9213-943bc57e6e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9124d892-5007-4b95-9213-943bc57e6e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_9341081f-c7c4-411f-8641-3572da0b502b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_9341081f-c7c4-411f-8641-3572da0b502b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_bdfaeae3-8665-4678-914b-cfd0c580b09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_bdfaeae3-8665-4678-914b-cfd0c580b09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9f843c6f-53d9-4a1d-921f-cf599a4bcb0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e756c1df-8454-42e2-8078-c6e3a1a776db" xlink:to="loc_us-gaap_LongTermDebt_9f843c6f-53d9-4a1d-921f-cf599a4bcb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_35c848a7-dd0c-4e15-97e7-5d2d9cd187dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fd72e049-42bd-4220-8f19-589033be0791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_35c848a7-dd0c-4e15-97e7-5d2d9cd187dd" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fd72e049-42bd-4220-8f19-589033be0791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f8f9a39-d4d3-466b-b8cb-b2c9ad6b50bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_dd2466ae-8069-4979-959c-a02d918dcbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f8f9a39-d4d3-466b-b8cb-b2c9ad6b50bc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_dd2466ae-8069-4979-959c-a02d918dcbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f934e5f3-0dc4-486a-b232-53f8491366e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f8f9a39-d4d3-466b-b8cb-b2c9ad6b50bc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f934e5f3-0dc4-486a-b232-53f8491366e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_021294d0-8d86-4a57-adf6-2cef9be71e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f8f9a39-d4d3-466b-b8cb-b2c9ad6b50bc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_021294d0-8d86-4a57-adf6-2cef9be71e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8e70ee5d-7765-4274-b692-efda19693a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8e70ee5d-7765-4274-b692-efda19693a6b" xlink:to="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_50905e87-ca82-4bc6-af67-3be45f3cd6c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e6532e96-d2a0-4bc6-bb14-65fdebe84ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8a62308e-0e78-47ea-9501-360e707b430f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e6532e96-d2a0-4bc6-bb14-65fdebe84ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4408d70d-4d8f-46c0-8f4a-431384e6cd45" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdbc3990-6036-4eea-adc7-c9d50e68c53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae4e8842-0895-4588-bf00-66ff5679d59e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdbc3990-6036-4eea-adc7-c9d50e68c53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9faac9e1-0156-4df8-a11f-b69cd4752881" xlink:to="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThreeMonthUSDLIBORMember_ceb9adcc-69c9-47ac-a2e4-1d7ee3a68131" xlink:href="iart-20201231.xsd#iart_ThreeMonthUSDLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:to="loc_iart_ThreeMonthUSDLIBORMember_ceb9adcc-69c9-47ac-a2e4-1d7ee3a68131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_5e4e01f8-c762-4a6c-a7d7-b110f178454c" xlink:href="iart-20201231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c8d30133-23f5-424b-808f-16849f8ead61" xlink:to="loc_iart_OneMonthUSDLIBORMember_5e4e01f8-c762-4a6c-a7d7-b110f178454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef2624e-ed54-4fff-844a-32b9042206a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_de092f63-6f48-428e-bbb1-3ed09c52cacc" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche1Member_de092f63-6f48-428e-bbb1-3ed09c52cacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_e7a2479b-a8a6-4967-84e8-eb07077a5433" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedFebruary62017Tranche2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedFebruary62017Tranche2Member_e7a2479b-a8a6-4967-84e8-eb07077a5433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch272017Member_26213333-c41a-40cb-8b21-1b8d19374d50" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedMarch272017Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedMarch272017Member_26213333-c41a-40cb-8b21-1b8d19374d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_5ee225f8-321d-4f1a-8749-d54d3087d037" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_5ee225f8-321d-4f1a-8749-d54d3087d037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_afbc5581-ea91-4622-ac37-a4ee3f402a65" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_afbc5581-ea91-4622-ac37-a4ee3f402a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_a63130e4-0dd3-4f12-b2f3-74c862f4b9ba" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_a63130e4-0dd3-4f12-b2f3-74c862f4b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_104f237c-bfbe-4d83-ab67-118a0f6861d1" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche4Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche4Member_104f237c-bfbe-4d83-ab67-118a0f6861d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_a3961dac-41d9-42e5-ab26-aedf7007e604" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche5Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche5Member_a3961dac-41d9-42e5-ab26-aedf7007e604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_c338452c-c7bc-4628-9d02-86983d05d3e9" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_c338452c-c7bc-4628-9d02-86983d05d3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_9fe4a3e8-1ac9-4e49-b78a-bbcd1c74b28a" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_9fe4a3e8-1ac9-4e49-b78a-bbcd1c74b28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_15a5cc94-e568-4ca4-8745-993304f0d4b8" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_15a5cc94-e568-4ca4-8745-993304f0d4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_568d01a9-ddce-44fc-91c2-16ac8923e9c7" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_568d01a9-ddce-44fc-91c2-16ac8923e9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_a68b7023-fb3b-40ec-bf1e-f0f21f0c4dc9" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_a68b7023-fb3b-40ec-bf1e-f0f21f0c4dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_ee343b4b-d3ee-4f00-a0d9-e9ad9b70bc78" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_ee343b4b-d3ee-4f00-a0d9-e9ad9b70bc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_d0ddb340-6f68-4d7c-b535-d3463e3dc2be" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_d0ddb340-6f68-4d7c-b535-d3463e3dc2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_68b4d238-7e0c-4788-91c4-90b9e180047d" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche3Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche3Member_68b4d238-7e0c-4788-91c4-90b9e180047d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_5c8773dd-c65a-4ba1-b210-5a2b5586e560" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche4Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche4Member_5c8773dd-c65a-4ba1-b210-5a2b5586e560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_7b28ea7e-3953-4908-bd43-1364a5d701b3" xlink:href="iart-20201231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche5Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_df15ebd5-9402-4655-b542-371187242e0c" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche5Member_7b28ea7e-3953-4908-bd43-1364a5d701b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3557a315-9f95-402c-a532-24c4a53b2cbe" xlink:to="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_bb95d0c0-492e-4168-8ddf-a65a08973840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_bb95d0c0-492e-4168-8ddf-a65a08973840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_81e96649-f00b-4836-a383-d6581d542eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_81e96649-f00b-4836-a383-d6581d542eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9449b12e-39fd-4b09-aa60-8c3c0be544cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e91e004d-ff89-4cec-9d73-12d225b243b0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9449b12e-39fd-4b09-aa60-8c3c0be544cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_408db378-71c9-46f0-9ec5-05a0fde1b2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_408db378-71c9-46f0-9ec5-05a0fde1b2c5" xlink:to="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4ab7189-0a7e-4212-8895-3aeabcb52273" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e1b8172a-2d27-415f-a302-d15c15c7d8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e1b8172a-2d27-415f-a302-d15c15c7d8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_28aa8111-f7bd-4dc3-ae6c-6f8bc6c070b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da800e4e-247d-4ea1-8818-ad9f2e98f347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_28aa8111-f7bd-4dc3-ae6c-6f8bc6c070b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_b3b6561d-3487-480d-8be4-4635d7efe2b7" xlink:to="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_82dd41d3-59f5-403b-954e-0d6eb5055ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:to="loc_us-gaap_ShortMember_82dd41d3-59f5-403b-954e-0d6eb5055ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e2170593-2e54-41cd-9ea5-8edb2dc32ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_a9e880cd-e73e-43e5-a883-88d574dfd4c8" xlink:to="loc_us-gaap_LongMember_e2170593-2e54-41cd-9ea5-8edb2dc32ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b03b685a-9cfd-4e3f-8d80-320c49a0d34a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7eac7850-bb6c-4bc0-8513-797a1e96ec52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:to="loc_us-gaap_CashFlowHedgingMember_7eac7850-bb6c-4bc0-8513-797a1e96ec52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2f39c2a8-72c8-4057-956a-f508aa0cb922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a9513535-55cb-4cb7-927f-29aec8566df2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2f39c2a8-72c8-4057-956a-f508aa0cb922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f185eee-9f62-4fad-90ac-0147a1850850" xlink:to="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ed19b97d-c4d3-4b21-9e00-f34b58fb777c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:to="loc_us-gaap_NondesignatedMember_ed19b97d-c4d3-4b21-9e00-f34b58fb777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_279aacbf-322e-4c89-bc38-5d7320cc0843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1949438-f777-4524-a365-c47f0b969a12" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_279aacbf-322e-4c89-bc38-5d7320cc0843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_219edc17-129c-40c4-bdae-e7183dbadc1d" xlink:to="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_131966d9-6344-44c6-9143-fcdec4ebde67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_131966d9-6344-44c6-9143-fcdec4ebde67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_55684bd2-279f-4da2-aafe-85dc86bbef63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_55684bd2-279f-4da2-aafe-85dc86bbef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eb4b2715-5cd5-44da-ba5d-9fc49ac4447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eb4b2715-5cd5-44da-ba5d-9fc49ac4447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_50edca66-44fe-4bb6-b9c0-ed942a4ab257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_50edca66-44fe-4bb6-b9c0-ed942a4ab257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f4c1eef4-4594-4190-bc6b-0d205d6f1b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f4c1eef4-4594-4190-bc6b-0d205d6f1b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f34a6a68-3e9c-49ac-baaa-54391978e370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f34a6a68-3e9c-49ac-baaa-54391978e370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b372d23-73e1-4e5d-a6ea-acab509766c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b372d23-73e1-4e5d-a6ea-acab509766c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_271eb9ad-f55f-4d86-8c47-96bfc9b9fc4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08528e0a-3843-404b-a824-cbf40fbdfb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_271eb9ad-f55f-4d86-8c47-96bfc9b9fc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_71bf0d51-027e-4c7b-bb78-01d2f66fa7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_71bf0d51-027e-4c7b-bb78-01d2f66fa7a5" xlink:to="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fa7382a-e244-4a01-82df-321a471395b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b17a9a69-673f-46ef-bed4-896d78e85256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0d2cddd7-43f5-4bb6-969d-36deb64c579f" xlink:to="loc_us-gaap_CashFlowHedgingMember_b17a9a69-673f-46ef-bed4-896d78e85256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_78301c3e-826f-4b78-b862-d1fca90fd4d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_166496b8-60c3-4b04-9ef3-0adff6b58515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa9ab6ab-ab13-4818-80a4-ff2622451b7f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_166496b8-60c3-4b04-9ef3-0adff6b58515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99e1971d-3891-4989-b7e2-61272160215b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_988ebf4a-299f-4138-bfcf-273c2c6eea6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c0ba54-5e96-4346-a3f8-7c1b065d7d58" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_988ebf4a-299f-4138-bfcf-273c2c6eea6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_beb057e6-2c93-4b98-82a6-10864177d09d" xlink:to="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_88aed31e-9c0f-42c3-9a40-ef2fb50dd3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:to="loc_us-gaap_LongMember_88aed31e-9c0f-42c3-9a40-ef2fb50dd3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_595450a8-17df-42c9-872f-19a36bbb998b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_ce3577fc-a86f-4549-8779-f0003de81f03" xlink:to="loc_us-gaap_ShortMember_595450a8-17df-42c9-872f-19a36bbb998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c1da6535-f745-4b69-8217-a7defa8a5ce4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapOneMember_02b57946-1181-4c9f-a2c8-b10d6f8ed539" xlink:href="iart-20201231.xsd#iart_SwapOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapOneMember_02b57946-1181-4c9f-a2c8-b10d6f8ed539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapTwoMember_5f3ee737-b910-473d-ba95-7819756e6419" xlink:href="iart-20201231.xsd#iart_SwapTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapTwoMember_5f3ee737-b910-473d-ba95-7819756e6419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapThreeMember_d213049c-e5ce-47ec-96bd-6811d323483a" xlink:href="iart-20201231.xsd#iart_SwapThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapThreeMember_d213049c-e5ce-47ec-96bd-6811d323483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwapFourMember_8f3202ee-aaf1-4368-bde7-408b29a27d94" xlink:href="iart-20201231.xsd#iart_SwapFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26672333-5618-4f6a-aafa-578a480bd14e" xlink:to="loc_iart_SwapFourMember_8f3202ee-aaf1-4368-bde7-408b29a27d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_145a04b5-d8ae-4fc0-8be8-67a767b025e0" xlink:to="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_9f26f41c-75a9-4011-a5dc-9f0d0bcaf902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_9f26f41c-75a9-4011-a5dc-9f0d0bcaf902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_aabc1f82-9dde-4979-93a5-7182dad92a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeNotionalAmount_aabc1f82-9dde-4979-93a5-7182dad92a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_ad89f3a7-4ec6-4cc1-8974-32de4bfb6f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_36af3f4d-b5d6-4ec0-8bd8-0042be8817be" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_ad89f3a7-4ec6-4cc1-8974-32de4bfb6f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0ccf90ba-3312-4109-8c7f-beb99493d65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0ccf90ba-3312-4109-8c7f-beb99493d65d" xlink:to="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93ce0c54-6b2d-4a07-81a4-2506b9b5c727" xlink:to="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8fbf6775-ebf6-4a28-8453-501010fe455e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_40c4e819-748e-4346-8819-148cd1b44ea5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8fbf6775-ebf6-4a28-8453-501010fe455e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7835845-899c-4aa7-b44b-b1a8dfdcd2aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5dcd2e9e-4424-4dc5-8e5a-d38c846c8d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3a875255-5286-435a-8276-41280ac26289" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5dcd2e9e-4424-4dc5-8e5a-d38c846c8d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_be471c5e-b631-4cd2-b43c-e3cd64480736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_d096ca93-a377-4de5-9505-6282266bd379" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_d096ca93-a377-4de5-9505-6282266bd379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_b3b5e2c1-442f-40c8-ac7e-3e5cade2f0ee" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_b3b5e2c1-442f-40c8-ac7e-3e5cade2f0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_f6047ad6-2071-4fd3-8532-88effca9478e" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_f6047ad6-2071-4fd3-8532-88effca9478e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_b56a0a2a-8b64-49b3-ab17-ce88bce141e8" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_b56a0a2a-8b64-49b3-ab17-ce88bce141e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFiveMember_75af3be1-913e-45fa-8d54-25bfe9d92319" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractFiveMember_75af3be1-913e-45fa-8d54-25bfe9d92319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractSixMember_38410e39-31ce-47af-8638-72ba61196909" xlink:href="iart-20201231.xsd#iart_CrossCurrencyInterestRateContractSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_iart_CrossCurrencyInterestRateContractSixMember_38410e39-31ce-47af-8638-72ba61196909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_83cb369a-062c-45b9-bae5-47c2ffc0b375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ae7ff3a5-cea3-4b1d-a2ce-3e986fc2b8a9" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_83cb369a-062c-45b9-bae5-47c2ffc0b375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_aa698800-e76f-4e4f-b480-ba397345d790" xlink:to="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e2060004-51ba-4dd0-a6ec-415674cb961b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:to="loc_us-gaap_LongMember_e2060004-51ba-4dd0-a6ec-415674cb961b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_42f49559-98fa-44e3-b0c3-f049e5e17d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c13c9adb-4eda-49dc-a165-5ddff9204614" xlink:to="loc_us-gaap_ShortMember_42f49559-98fa-44e3-b0c3-f049e5e17d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f241fdde-2566-4be3-b9fc-240d6cf1881c" xlink:to="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_0ad0d0f1-20cf-4114-aabf-41db48d982b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_0ad0d0f1-20cf-4114-aabf-41db48d982b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4b2cfbfa-ef09-416c-90db-a1ddda39502e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4b2cfbfa-ef09-416c-90db-a1ddda39502e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_50817e53-c10d-4922-8896-b93cd19ebed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_73ee231c-bb2f-4aa9-9766-6f7758ed2d2b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_50817e53-c10d-4922-8896-b93cd19ebed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4381dc42-9dda-4a22-8e4a-b9a252fe8d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4381dc42-9dda-4a22-8e4a-b9a252fe8d09" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f462a061-fd9a-46c9-8056-c09a586def4c" xlink:to="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b572c4b0-f482-40ed-98c2-634cf158091a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1de8f185-172f-48af-9785-c921c7b5b545" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b572c4b0-f482-40ed-98c2-634cf158091a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ad57330-f8c8-40a2-9b34-16b22c170d5f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7430f93f-5ee7-4532-ad96-740c4b9f4dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:to="loc_us-gaap_InterestRateSwapMember_7430f93f-5ee7-4532-ad96-740c4b9f4dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_be23461f-65e3-4b03-a760-baa2298cbb06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c9f182a4-3b1c-4afe-81a6-647b484adc8a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_be23461f-65e3-4b03-a760-baa2298cbb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_744573c9-c210-4396-9a9a-4a70bc1fafeb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1f329104-c5c0-4dd2-ac6a-6004021cfd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:to="loc_us-gaap_CashFlowHedgingMember_1f329104-c5c0-4dd2-ac6a-6004021cfd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e6f59b51-da1a-419b-b7e7-ead174034e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c159946-a9ce-4b59-a0e7-5ade63b4911e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e6f59b51-da1a-419b-b7e7-ead174034e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_016fc932-fe64-4269-9fcc-55af0baa33f1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f60c1431-56fc-4121-982f-ca44441a498c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f60c1431-56fc-4121-982f-ca44441a498c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_51dbcaaf-30bb-4ad0-b7e8-b23b667d25bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_OtherAssetsMember_51dbcaaf-30bb-4ad0-b7e8-b23b667d25bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_be0f459a-5382-4b49-a220-a4b9dd11e1be" xlink:href="iart-20201231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_be0f459a-5382-4b49-a220-a4b9dd11e1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_44c656a8-1ad6-4fb9-8fe6-e9bb5881846d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d85b8a0a-53d4-4a61-80cb-ce2203051db3" xlink:to="loc_us-gaap_OtherLiabilitiesMember_44c656a8-1ad6-4fb9-8fe6-e9bb5881846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_95359bc0-b535-4d37-baca-63b007d07b30" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2c9269f0-5423-42a7-9c6a-040cccbe4e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2c9269f0-5423-42a7-9c6a-040cccbe4e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_22e80f85-2e92-4961-a3bb-a69215f28749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_22e80f85-2e92-4961-a3bb-a69215f28749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_598a9931-a2fa-4037-8258-69cbe31c1087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e190357f-aaae-4d2d-9599-e42d756cd8cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_598a9931-a2fa-4037-8258-69cbe31c1087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f94b493-8b13-44d6-a0d7-3ad0a0bbfe2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f94b493-8b13-44d6-a0d7-3ad0a0bbfe2d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_65ebf82a-6561-4139-81a4-8db171f16200" xlink:to="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8048b148-8063-4d66-b91f-3dc54b2fa360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_19bfcee2-9071-433a-8c42-6370d5baaf70" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8048b148-8063-4d66-b91f-3dc54b2fa360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2f04ca-9c38-4983-bba1-faa76f231171" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_55491e79-68b8-4c20-8b81-149176c7141b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:to="loc_us-gaap_InterestRateSwapMember_55491e79-68b8-4c20-8b81-149176c7141b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a75396af-853d-4a8e-ad7c-6c84d8f74c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bedf7997-f297-4b51-aa76-8ac60aa184e7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a75396af-853d-4a8e-ad7c-6c84d8f74c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e00715-ef26-4efe-aecb-c5ac0d04dee9" xlink:to="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47f32be5-df20-457a-a619-a7f71fcd4e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ceb7fcb-98ef-47d7-bd93-82fb3882c7e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47f32be5-df20-457a-a619-a7f71fcd4e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc4b0be-dcad-4064-ad5f-b3475d703ece" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_207fa34f-36e2-4aa6-a6d4-5d07213bd82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_InterestExpenseMember_207fa34f-36e2-4aa6-a6d4-5d07213bd82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5090f889-24d3-4e83-9b34-34d35938010d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5090f889-24d3-4e83-9b34-34d35938010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_b6fe417f-be20-4671-9828-9dd46154bf24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d55a4fb5-969c-4ee7-a781-3507f62a2e37" xlink:to="loc_us-gaap_InterestIncomeMember_b6fe417f-be20-4671-9828-9dd46154bf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_888e2e75-21ad-4a0a-87c4-45c0b1340b90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_37e894ec-e98e-4d6e-9b89-7dbcc677393e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:to="loc_us-gaap_CashFlowHedgingMember_37e894ec-e98e-4d6e-9b89-7dbcc677393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_cb04c6a8-608c-473a-aa15-1ca6ef8f9f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d6b1a41-943a-47d3-a614-ec4b62446906" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_cb04c6a8-608c-473a-aa15-1ca6ef8f9f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ffdd3c83-62d0-4e51-af66-becec2331db2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ae122f9d-98fc-4cd1-a326-8d33d988754c" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_064c7b78-60b5-4fcf-a6e6-1c1b0270d91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_StockholdersEquity_064c7b78-60b5-4fcf-a6e6-1c1b0270d91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9c086335-190a-4b10-9bbd-e43918d5709d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9c086335-190a-4b10-9bbd-e43918d5709d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b46bee9-c480-4eee-9618-bb14ed8a21eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b46bee9-c480-4eee-9618-bb14ed8a21eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a930381b-250c-4814-aa7e-f4a1e9dca3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_139fcd93-73b2-47b0-bf8b-8f4d762a51de" xlink:to="loc_us-gaap_StockholdersEquity_a930381b-250c-4814-aa7e-f4a1e9dca3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6998717b-bc92-4f8b-bf11-7bbed646b8ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cfdc42b6-17fd-488a-a851-1eeec10103b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6998717b-bc92-4f8b-bf11-7bbed646b8ff" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cfdc42b6-17fd-488a-a851-1eeec10103b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a7c0ea1-ec0e-4878-99d3-2e1764c89dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3736f991-1fa8-4b72-9162-5d483c30ac3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a7c0ea1-ec0e-4878-99d3-2e1764c89dde" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3736f991-1fa8-4b72-9162-5d483c30ac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_353c3af6-4dda-4075-8227-aa1dd7f28fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a7c0ea1-ec0e-4878-99d3-2e1764c89dde" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_353c3af6-4dda-4075-8227-aa1dd7f28fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6eb1a2ea-9e8f-4867-b913-6fa4d899b276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a7c0ea1-ec0e-4878-99d3-2e1764c89dde" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6eb1a2ea-9e8f-4867-b913-6fa4d899b276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab9af4ab-ebb5-47c0-a548-17401be2a9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab9af4ab-ebb5-47c0-a548-17401be2a9c4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_45b90146-33ef-478d-a6d1-310b3a3bbaac" xlink:to="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_a00adc52-62f2-45de-a86c-f59c06facad9" xlink:href="iart-20201231.xsd#iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3dc7a016-611f-4d81-848b-a11abef15396" xlink:to="loc_iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember_a00adc52-62f2-45de-a86c-f59c06facad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cd6c2950-5831-436d-b63c-88717115f770" xlink:to="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_54d4ebd5-56a9-4250-84cf-8913e0bbf7cc" xlink:href="iart-20201231.xsd#iart_PrivateLabelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5271fc09-3960-46c6-820a-cc280932c032" xlink:to="loc_iart_PrivateLabelMember_54d4ebd5-56a9-4250-84cf-8913e0bbf7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d202042-8836-469b-b713-7e00e2ec9ff3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b6ef4380-2d08-41f1-83ae-5add5b54c65e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf3b89c0-00cf-4ba8-91e4-9b4167f0db6b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b6ef4380-2d08-41f1-83ae-5add5b54c65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5893e2ec-dd96-4bfc-978b-33de10015576" xlink:to="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_0e92b6d1-1ee3-4e55-87af-056c1d0646ad" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5038cb8-391b-4e70-9fe2-37ecf931782c" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_0e92b6d1-1ee3-4e55-87af-056c1d0646ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2175afd-9495-414a-8669-b888428bd81d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_e6714eb6-11ef-442f-b7e7-4318a5554af8" xlink:href="iart-20201231.xsd#iart_CodmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d732ea79-0e78-49b1-9a24-904a305c23f8" xlink:to="loc_iart_CodmanMember_e6714eb6-11ef-442f-b7e7-4318a5554af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c76c0e78-0ca0-4ccc-b057-cd5ce6aad635" xlink:to="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_3f9e7deb-515f-4bdb-91fd-500ee5e2431d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_NumberOfReportingUnits_3f9e7deb-515f-4bdb-91fd-500ee5e2431d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_51d395f3-a032-411b-af7c-3fcc7f338c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_51d395f3-a032-411b-af7c-3fcc7f338c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_eca50b2e-9aeb-462c-a1e0-14d62cac1836" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage_eca50b2e-9aeb-462c-a1e0-14d62cac1836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_f648aedd-d5e4-4371-be6b-5e92ded064fb" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage_f648aedd-d5e4-4371-be6b-5e92ded064fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_3c06b930-b88c-465c-8139-b84f44d2b919" xlink:href="iart-20201231.xsd#iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage_3c06b930-b88c-465c-8139-b84f44d2b919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_05e95f50-2cc8-4544-9ac9-42594dfe1567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_05e95f50-2cc8-4544-9ac9-42594dfe1567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_294b5940-ea53-4526-aeaf-575a150ff15f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_294b5940-ea53-4526-aeaf-575a150ff15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d15b1254-bcb1-4b3c-b86c-262a7b0aedaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_AdjustmentForAmortization_d15b1254-bcb1-4b3c-b86c-262a7b0aedaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2a7b10fb-b049-493a-8f70-30d7d0215dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2a7b10fb-b049-493a-8f70-30d7d0215dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_59f65e5a-062e-4193-b2e4-dde007bd7a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_59f65e5a-062e-4193-b2e4-dde007bd7a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_61e6de5a-6b90-4916-84f9-4e4e162cf6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_61e6de5a-6b90-4916-84f9-4e4e162cf6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2da70577-5d05-4dc0-a94b-3764677e14df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2da70577-5d05-4dc0-a94b-3764677e14df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e88a297b-6086-4073-bb1d-742813a5147d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e88a297b-6086-4073-bb1d-742813a5147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_994c138c-eaad-49ac-a641-0f2cf906d6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_994c138c-eaad-49ac-a641-0f2cf906d6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6e026217-3e7c-4785-bc2c-a83c6eee7447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d54f14f-3675-4b49-9105-6eb3681f2b29" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6e026217-3e7c-4785-bc2c-a83c6eee7447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb3094af-547a-4e2b-ac80-5f2743b8a84b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb3094af-547a-4e2b-ac80-5f2743b8a84b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2b11fc34-ff56-4b64-ab70-50e5dd233482" xlink:to="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_6f84e79d-9d79-4ce0-b5f2-3f53d1fcd294" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_6f84e79d-9d79-4ce0-b5f2-3f53d1fcd294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_a4e39033-28d1-4709-80e2-db5be80c5cb2" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c907d532-63ab-461b-b35e-b90fe269e5af" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_a4e39033-28d1-4709-80e2-db5be80c5cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c294fa3c-9581-47c0-ba16-8da44f9e8293" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_789455a8-8258-4b13-a36c-22bc5ff00520" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_452f06d8-66da-4027-bbd9-257d108b7f8a" xlink:to="loc_iart_ArkisBioSciencesInc.Member_789455a8-8258-4b13-a36c-22bc5ff00520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5b3a011f-0a72-4668-9417-0e0372e9b6f1" xlink:to="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c1eb0c40-5e0b-49ff-b66c-f9d0ba91be84" xlink:to="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_21ece793-5cae-4b0a-87ff-b40674e6f005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_Goodwill_21ece793-5cae-4b0a-87ff-b40674e6f005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ae6b36c0-d6b3-4eaf-8caa-1a502db61afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ae6b36c0-d6b3-4eaf-8caa-1a502db61afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_947ab1f7-3aca-43b1-8c87-dcebbc6ef8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_947ab1f7-3aca-43b1-8c87-dcebbc6ef8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_653fa73b-c2b4-424a-81d6-00b71580289b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_GoodwillTransfers_653fa73b-c2b4-424a-81d6-00b71580289b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5d2da312-d885-4a02-8355-bca5a4d97b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_64f7e475-67b5-48b2-81be-1804e3179fb1" xlink:to="loc_us-gaap_Goodwill_5d2da312-d885-4a02-8355-bca5a4d97b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_33349a7d-54ce-42d9-9a4b-60c87c686140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_33349a7d-54ce-42d9-9a4b-60c87c686140" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b0840c8-f789-4b9e-adb0-098f084b91ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_2c969da3-862c-4ccc-b720-42d0da81c7aa" xlink:href="iart-20201231.xsd#iart_CompletedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_CompletedTechnologyMember_2c969da3-862c-4ccc-b720-42d0da81c7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e8f0c926-37f5-49bb-8640-6e43f5b92fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e8f0c926-37f5-49bb-8640-6e43f5b92fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_36ca0b4a-a5e1-4255-9367-424dda41eb50" xlink:href="iart-20201231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_TrademarksBrandNamesMember_36ca0b4a-a5e1-4255-9367-424dda41eb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_154a911f-5c2d-4a64-ab31-cb59ae4c4456" xlink:href="iart-20201231.xsd#iart_SupplierRelationShipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_SupplierRelationShipsMember_154a911f-5c2d-4a64-ab31-cb59ae4c4456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_8bbdb7e7-73bc-4e12-be11-3d53baf049cb" xlink:href="iart-20201231.xsd#iart_AllOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_361d480b-e297-49a5-aa61-aa1f5c9b9d98" xlink:to="loc_iart_AllOtherMember_8bbdb7e7-73bc-4e12-be11-3d53baf049cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_731ddd76-4a97-4f52-b078-f25673e206ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_287d5f12-0574-4865-af51-931c04fc9d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:to="loc_us-gaap_TradeNamesMember_287d5f12-0574-4865-af51-931c04fc9d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_eb78c500-7501-4576-821f-7eaa2e74e3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b20b9478-9896-4d41-b403-e4df8a719bdb" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_eb78c500-7501-4576-821f-7eaa2e74e3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6f821-02eb-419d-8995-83cf93b89def" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_98ba26e0-79c5-495c-b461-b79079974703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b6d8edef-3af3-485d-b3ee-185a9af4f1f2" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_98ba26e0-79c5-495c-b461-b79079974703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b143d5b2-ed94-4444-b077-a17ca14b9bb0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_db4b2dd7-aa11-4d7e-a098-3277757dec27" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ddb47f5-fb2b-469d-a9d9-1a671866221c" xlink:to="loc_iart_SmithNephewUSDLimitedMember_db4b2dd7-aa11-4d7e-a098-3277757dec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2f634a83-ba72-4aad-b154-1d63d2690c64" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1f9ac3d6-b607-422e-89ad-468498e144a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1f9ac3d6-b607-422e-89ad-468498e144a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_36186c2b-e496-4241-9bfb-ec9e5a346f83" xlink:href="iart-20201231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_36186c2b-e496-4241-9bfb-ec9e5a346f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_16135269-17b1-47b0-9a0d-7912e3fdce57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_16135269-17b1-47b0-9a0d-7912e3fdce57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_adbd9e03-a4dc-49fd-a343-a61031e5c28f" xlink:href="iart-20201231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_adbd9e03-a4dc-49fd-a343-a61031e5c28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ff0aeab1-317c-482c-b296-945d57d4058b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_91364eec-1434-46cf-97b1-e0336d5159be" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ff0aeab1-317c-482c-b296-945d57d4058b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCK"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dbea23cb-f48a-49c5-b3a2-7a3b8784cdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_5fa77749-5dbd-4151-b7fb-2d57d0d52de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dbea23cb-f48a-49c5-b3a2-7a3b8784cdc0" xlink:to="loc_us-gaap_TreasuryStockTextBlock_5fa77749-5dbd-4151-b7fb-2d57d0d52de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c3074689-4f5b-4a62-8e78-3ace2c01539c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c3074689-4f5b-4a62-8e78-3ace2c01539c" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5617323-6d86-4339-b05a-d48f8cfbb755" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_2d19e302-c636-4d40-8bc6-2227c0a97bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d992eac6-420b-459c-9c96-07b3fa9bbf58" xlink:to="loc_us-gaap_ConvertibleDebtMember_2d19e302-c636-4d40-8bc6-2227c0a97bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:to="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_97e7b384-ad9d-44cd-82c4-a7d73728d572" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CertainPurchasersMember_b52d0c51-32f3-4e56-aa7f-0bd5075b83c3" xlink:href="iart-20201231.xsd#iart_CertainPurchasersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2df2574c-4925-4e32-8e27-b31220e7c894" xlink:to="loc_iart_CertainPurchasersMember_b52d0c51-32f3-4e56-aa7f-0bd5075b83c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_13a0b735-d40b-459a-94c6-9f60d240b408" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e0f4f231-5ef9-4260-b4bf-23aeeddc86bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e0f4f231-5ef9-4260-b4bf-23aeeddc86bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_a00f7ebd-e3b7-4658-8aff-cc9bffe86719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockCommonValue_a00f7ebd-e3b7-4658-8aff-cc9bffe86719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_91349987-9f86-4df3-95c2-7be38bb9f69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_91349987-9f86-4df3-95c2-7be38bb9f69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3031350e-e24f-4c37-9b75-dbc41adfd415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3031350e-e24f-4c37-9b75-dbc41adfd415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_75d7ec7e-27e9-4187-a9cc-5a74dce50b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_75d7ec7e-27e9-4187-a9cc-5a74dce50b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_99dc1ed4-dad2-49b1-a1a0-403fc6492d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_99dc1ed4-dad2-49b1-a1a0-403fc6492d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a8d874b4-5ec8-4bf9-886f-f8ea78e18e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a8d874b4-5ec8-4bf9-886f-f8ea78e18e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_ee1f62b7-dd2b-4128-a12b-8bafdfd7ccdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_ee1f62b7-dd2b-4128-a12b-8bafdfd7ccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_959d5496-bb58-40e1-bd7d-ea7ef6799936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_959d5496-bb58-40e1-bd7d-ea7ef6799936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_23a54516-e50d-48bd-bb6d-acc0be7c3b99" xlink:href="iart-20201231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_65fc1055-95ee-42d6-b927-c79060564db1" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_23a54516-e50d-48bd-bb6d-acc0be7c3b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f43a37e-fc5b-46bb-aeb3-3dd88f391874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_224f3e9b-cef0-4d50-983d-1f42a0644ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f43a37e-fc5b-46bb-aeb3-3dd88f391874" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_224f3e9b-cef0-4d50-983d-1f42a0644ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89c90bcd-e8e2-42f4-8f42-8e0c816ab964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_96a99701-d99f-490c-82d9-dad1af9cd09e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89c90bcd-e8e2-42f4-8f42-8e0c816ab964" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_96a99701-d99f-490c-82d9-dad1af9cd09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_07c67b74-fded-4ea2-a0ef-dfc429308823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89c90bcd-e8e2-42f4-8f42-8e0c816ab964" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_07c67b74-fded-4ea2-a0ef-dfc429308823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_473ac702-02d5-4392-b57d-b19b5013ac19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89c90bcd-e8e2-42f4-8f42-8e0c816ab964" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_473ac702-02d5-4392-b57d-b19b5013ac19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_8a718954-dceb-4493-8497-388d114b9456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89c90bcd-e8e2-42f4-8f42-8e0c816ab964" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_8a718954-dceb-4493-8497-388d114b9456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f932b7f1-877e-4ce0-b780-6cf170fd698f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f932b7f1-877e-4ce0-b780-6cf170fd698f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e155914-2343-4b4c-bf41-dd1347637f2f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_98354499-7fbb-4418-b009-304094174bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_CostOfSalesMember_98354499-7fbb-4418-b009-304094174bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_aac067f3-0c1c-4651-87bd-2e24874b5915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_aac067f3-0c1c-4651-87bd-2e24874b5915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2577cac7-7376-440b-8284-936e78ecf848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01928298-2f9d-449b-82c5-c232f8a230cc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2577cac7-7376-440b-8284-936e78ecf848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fc9f1b8-0327-470e-9cd4-f4a0fa3228ce" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4040b20f-66c2-42f4-9865-0c05e03cd7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4040b20f-66c2-42f4-9865-0c05e03cd7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fe8a5e4b-7035-4ffa-be2c-cb8460449e32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fe8a5e4b-7035-4ffa-be2c-cb8460449e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2ffc6105-990b-4444-a9ad-282703c6a324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8600eec-f470-4755-af23-c21ee462d25d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2ffc6105-990b-4444-a9ad-282703c6a324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d84d553e-e47d-4a94-b48b-1df0fd872acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d84d553e-e47d-4a94-b48b-1df0fd872acb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7555c973-d5a1-49c8-8cce-ebc1759040bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_40d789ec-4ed2-4e11-8041-4c46a899ef8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_EmployeeStockMember_40d789ec-4ed2-4e11-8041-4c46a899ef8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e24ce26b-5275-43a5-ad52-00d09f5ba5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e24ce26b-5275-43a5-ad52-00d09f5ba5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_58e660db-2659-4206-abf7-e6922495b9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_58e660db-2659-4206-abf7-e6922495b9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_a0243992-ddf4-4f10-a1fa-88b6a6b5d3cf" xlink:href="iart-20201231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_a0243992-ddf4-4f10-a1fa-88b6a6b5d3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_82d5e7e5-95c7-4a28-8df2-de811b4cc2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e9e09da-ee58-4076-9bd6-1cfa342509ab" xlink:to="loc_us-gaap_PerformanceSharesMember_82d5e7e5-95c7-4a28-8df2-de811b4cc2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_43a26cc0-3adc-41b1-be33-8ea81207839d" xlink:to="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_fe727b01-ad67-4aca-af18-fd650a25b1fc" xlink:href="iart-20201231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandThreePlanMember_fe727b01-ad67-4aca-af18-fd650a25b1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_3b18913d-5f7d-4786-a357-e5f2a5a34295" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandPlanMember_3b18913d-5f7d-4786-a357-e5f2a5a34295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_0273f615-19d4-405a-b260-5441da5adec9" xlink:href="iart-20201231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_37cbfb0a-c1c7-482a-aa1c-a915aaaaa4b0" xlink:to="loc_iart_TwoThousandOnePlanMember_0273f615-19d4-405a-b260-5441da5adec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_11b2a4ba-ba70-4486-bac4-225402f5be3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_711c378c-329e-4f2d-845c-c330581b4938" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_srt_DirectorMember_711c378c-329e-4f2d-845c-c330581b4938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_2fcca920-7ef2-4b48-b46f-81878e05a406" xlink:href="iart-20201231.xsd#iart_EmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_iart_EmployeeMember_2fcca920-7ef2-4b48-b46f-81878e05a406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_17ac3b87-1bfe-4d90-b279-631467824ee1" xlink:href="iart-20201231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_413dda13-765a-4c80-80f6-a98a22d1399d" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_17ac3b87-1bfe-4d90-b279-631467824ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b5521c3e-ae82-4e5d-a5a8-aeadb5eb158f" xlink:to="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ad20d83-a780-44ca-9d9a-5319c370e3f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:to="loc_srt_MinimumMember_5ad20d83-a780-44ca-9d9a-5319c370e3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b7e1c5a-2385-4c0f-ba3d-97893f4586fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_721696f2-f7c1-4708-826f-331fc8bae7a6" xlink:to="loc_srt_MaximumMember_4b7e1c5a-2385-4c0f-ba3d-97893f4586fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b65062-2b8e-4b9d-b26a-fdc2283dea71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2d3d2d9e-558a-44e0-b768-f24b3c923b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2d3d2d9e-558a-44e0-b768-f24b3c923b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3cf01696-ed09-4ea1-a21b-5aa98e64aa3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3cf01696-ed09-4ea1-a21b-5aa98e64aa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_4cc6c0ad-26b8-440a-824a-df162288d5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_4cc6c0ad-26b8-440a-824a-df162288d5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_60f3ade0-1883-40c0-9a2f-dd0ea3c31819" xlink:href="iart-20201231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_60f3ade0-1883-40c0-9a2f-dd0ea3c31819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_5bdf9019-af99-4246-8f7b-5c4cb8d7f97b" xlink:href="iart-20201231.xsd#iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_5bdf9019-af99-4246-8f7b-5c4cb8d7f97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_edbd97b1-ce6b-4ccd-bb6f-5aea53920972" xlink:href="iart-20201231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_IncreaseInAuthorizedShares_edbd97b1-ce6b-4ccd-bb6f-5aea53920972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f9b3ad19-10ca-4178-b867-e37f599cb781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f9b3ad19-10ca-4178-b867-e37f599cb781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e5af7b7e-fe2d-4f21-9d59-6ee1055702c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e5af7b7e-fe2d-4f21-9d59-6ee1055702c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c4f1bd22-e383-4653-889e-71967ec84565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c4f1bd22-e383-4653-889e-71967ec84565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6d57212f-9e13-4d39-bfbb-8c67fdc89c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6d57212f-9e13-4d39-bfbb-8c67fdc89c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6e8f0c2-1384-4f2c-9274-47416acff64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6e8f0c2-1384-4f2c-9274-47416acff64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_875bbbf0-c81e-4639-a879-1e834fb2598c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_875bbbf0-c81e-4639-a879-1e834fb2598c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6b95002-8616-4d62-abb3-e969cc1d7f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6b95002-8616-4d62-abb3-e969cc1d7f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ffcf1787-83af-429c-9a43-b2c3a72ce8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ffcf1787-83af-429c-9a43-b2c3a72ce8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_afe33b9e-4ae4-44e9-b983-fb7b4865352e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_afe33b9e-4ae4-44e9-b983-fb7b4865352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d4bca458-6731-4ceb-86a2-000f6e4b1e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d4bca458-6731-4ceb-86a2-000f6e4b1e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_e52bb632-44d3-48e6-9e34-09fdf69516ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_e52bb632-44d3-48e6-9e34-09fdf69516ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_8b4db4de-4ecf-4cb2-a6b1-bf52615df3ca" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod_8b4db4de-4ecf-4cb2-a6b1-bf52615df3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_e00e265d-a225-4dda-a804-9a4833961ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39908fbf-2ea1-40b4-9abb-65bfdc0d4870" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_e00e265d-a225-4dda-a804-9a4833961ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b9d1f3b8-9584-41bd-a4f9-1f66a91c345c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b9d1f3b8-9584-41bd-a4f9-1f66a91c345c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54e0ac54-16fc-4bf1-b109-4ccc444b1ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54e0ac54-16fc-4bf1-b109-4ccc444b1ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d863e53-5112-4d8c-860c-cec90c059e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d863e53-5112-4d8c-860c-cec90c059e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f88d449e-8cff-4989-af2c-87bc9805d43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f88d449e-8cff-4989-af2c-87bc9805d43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9b23011b-edc4-479d-b109-4288ac840c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91724abc-f147-4e9e-9e56-339b66ee8bfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9b23011b-edc4-479d-b109-4288ac840c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a47e3883-cf28-4211-8784-e3df295b690b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a47e3883-cf28-4211-8784-e3df295b690b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_cf427b2b-d38a-4a46-aeb7-e3dd2a0d1414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_cf427b2b-d38a-4a46-aeb7-e3dd2a0d1414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_58c5d3f7-c3d0-475a-922a-b5b97d1ca3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_58c5d3f7-c3d0-475a-922a-b5b97d1ca3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a065aeb9-286d-46e8-949e-ea462252eb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a065aeb9-286d-46e8-949e-ea462252eb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7ebedcc-f9f3-418c-bb4b-48658eba40cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_edc4a0a3-881a-48c0-ad79-6d45030c28f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7ebedcc-f9f3-418c-bb4b-48658eba40cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e5ac524-711f-4b68-b404-843ba92eb078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e5ac524-711f-4b68-b404-843ba92eb078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7ffde480-2b0e-45d3-b1ec-a67fa8d64d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7ffde480-2b0e-45d3-b1ec-a67fa8d64d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_487f4af5-71de-4c41-9ea3-bdc356f917f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_487f4af5-71de-4c41-9ea3-bdc356f917f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c6365178-5de6-4462-9c9a-7e732fc2ae95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c6365178-5de6-4462-9c9a-7e732fc2ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1d66ca99-d71e-4089-8ef2-9a9544bb67f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1d66ca99-d71e-4089-8ef2-9a9544bb67f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6be2459a-1909-42be-b9b7-2563dc4e6d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e4b6e78d-bdd3-49b4-97c5-5b53029951cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6be2459a-1909-42be-b9b7-2563dc4e6d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee62833f-64ea-44cc-94a9-392a73fe43a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee62833f-64ea-44cc-94a9-392a73fe43a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bc3f3f85-9248-42ff-9019-1e8e5aabf8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bc3f3f85-9248-42ff-9019-1e8e5aabf8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe182cfc-4799-4a91-8609-8acd22f43729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe182cfc-4799-4a91-8609-8acd22f43729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f18a3ab-21f4-4638-8030-42a7f59c7053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f18a3ab-21f4-4638-8030-42a7f59c7053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bd05a7-70c8-4b0c-9b52-99c7cda285fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bd05a7-70c8-4b0c-9b52-99c7cda285fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_11e669b8-6735-4b27-99f6-2c693884c906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2ce7e60-9ae2-4bbf-9000-b72b3d9716b9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_11e669b8-6735-4b27-99f6-2c693884c906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_957588b8-ab02-44dc-bed8-ea1042347397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_957588b8-ab02-44dc-bed8-ea1042347397" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:to="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fe218823-292d-4dd0-975e-de6fb1027e1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f215c304-a1bd-44bc-acc0-bb7ae732d566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:to="loc_us-gaap_RestrictedStockMember_f215c304-a1bd-44bc-acc0-bb7ae732d566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_46377ab3-1c2a-41c3-a3fc-cc27e24c9bf4" xlink:href="iart-20201231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d895d69d-e9b2-4199-954d-a572c2e3454b" xlink:to="loc_iart_PerformanceStockandContractStockMember_46377ab3-1c2a-41c3-a3fc-cc27e24c9bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061bdd63-a2f1-49e4-833e-047a2218b81a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_10a3b279-fbeb-4f61-a89f-bcbab2171c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_10a3b279-fbeb-4f61-a89f-bcbab2171c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e615297-6ca2-4a44-a0b1-2b7dbac7fb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e615297-6ca2-4a44-a0b1-2b7dbac7fb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_da4b4aca-ec9f-4750-b17a-9ef919bb5cff" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_da4b4aca-ec9f-4750-b17a-9ef919bb5cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_54fbcb81-5683-456d-b788-99c7697f529a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_54fbcb81-5683-456d-b788-99c7697f529a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f10e468e-c75d-4205-9208-a4cf64154f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f10e468e-c75d-4205-9208-a4cf64154f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_114e2f51-5902-4e41-95e4-dd7ce6495027" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod_114e2f51-5902-4e41-95e4-dd7ce6495027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e199493-85e3-4fcc-a68d-a4d73122e5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d90a8d50-c2fe-4bc7-b909-6ff5fcf2e755" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e199493-85e3-4fcc-a68d-a4d73122e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2bae96bd-058c-4f27-ae6b-0197d3146c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64b1c98e-fe83-4f4f-bb98-c40bec130303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64b1c98e-fe83-4f4f-bb98-c40bec130303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_171cd7f7-d918-4f65-8d6b-3df920d05ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_171cd7f7-d918-4f65-8d6b-3df920d05ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_50089bd2-2261-4178-bcaa-6f47d68a99c4" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_50089bd2-2261-4178-bcaa-6f47d68a99c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6c3f62f1-8b51-40ab-8eb5-de7854cf71e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6c3f62f1-8b51-40ab-8eb5-de7854cf71e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0d6cb4c0-34c6-46a6-b1c5-fb3bc25c8b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0d6cb4c0-34c6-46a6-b1c5-fb3bc25c8b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_049da7a3-a79a-4442-8cf9-8e71bbc495fa" xlink:href="iart-20201231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue_049da7a3-a79a-4442-8cf9-8e71bbc495fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d6b6e036-b78f-4d93-bc45-bf6969b3779f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e19d11b0-057f-4c80-a167-e6ef2784ba1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d6b6e036-b78f-4d93-bc45-bf6969b3779f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aba5f24c-cfc8-49c8-ad86-2b6817c49f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3efdbe18-fcfe-4061-96a3-2db740a6daa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aba5f24c-cfc8-49c8-ad86-2b6817c49f54" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3efdbe18-fcfe-4061-96a3-2db740a6daa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_bef15f4c-89fd-4f9a-ae7c-9cc3a4cfb662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_bef15f4c-89fd-4f9a-ae7c-9cc3a4cfb662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_be7bc2e5-f823-4379-9271-d6549ad191e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_be7bc2e5-f823-4379-9271-d6549ad191e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_6d4f23a5-b69b-42a7-afb1-657132009b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_6d4f23a5-b69b-42a7-afb1-657132009b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_37751eb2-c3be-432a-8b05-af20cb310972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_37751eb2-c3be-432a-8b05-af20cb310972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_51bd353e-fcb8-4958-9d99-0d0a12f23091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3eb67f03-e067-4c7a-934c-dcde604e376b" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_51bd353e-fcb8-4958-9d99-0d0a12f23091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e3351340-8700-463e-acb0-c5c5e5b78603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e3351340-8700-463e-acb0-c5c5e5b78603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_9482dfa2-cfc1-42d6-91a0-2e28e28efe11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_9482dfa2-cfc1-42d6-91a0-2e28e28efe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_445d645d-1381-4712-858c-5160f9e1084a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_445d645d-1381-4712-858c-5160f9e1084a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7c79539-97c8-4ff5-864a-01890f7cdfa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7c79539-97c8-4ff5-864a-01890f7cdfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c8794356-5828-4262-a8d1-e1b69d6313d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c8794356-5828-4262-a8d1-e1b69d6313d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0993265b-274c-430d-9614-83e5b8ff798e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0993265b-274c-430d-9614-83e5b8ff798e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_81089267-a42e-4f65-b955-4e5c87d11745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f071ff04-9d3f-4869-8316-27c3f7703065" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_81089267-a42e-4f65-b955-4e5c87d11745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a871467a-334e-4bec-871d-aa7ced11659b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ee7af7b7-b66b-403f-baac-62c6ff7a8781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a871467a-334e-4bec-871d-aa7ced11659b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ee7af7b7-b66b-403f-baac-62c6ff7a8781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_8cf8140c-a67e-4047-988d-c45695a902fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a871467a-334e-4bec-871d-aa7ced11659b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_8cf8140c-a67e-4047-988d-c45695a902fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_b0bb8b9d-1168-4dfb-8b24-9d4759250808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a871467a-334e-4bec-871d-aa7ced11659b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_b0bb8b9d-1168-4dfb-8b24-9d4759250808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_085a0314-4808-418f-8fd9-697889bc327e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a871467a-334e-4bec-871d-aa7ced11659b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_085a0314-4808-418f-8fd9-697889bc327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a9c5d45a-b264-4e28-a14d-7be33f832e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a9c5d45a-b264-4e28-a14d-7be33f832e35" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0e5ccdbe-3e34-46dc-96f4-cc44b0efcc35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0e5ccdbe-3e34-46dc-96f4-cc44b0efcc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_54759a90-4ddd-4c92-b589-05e14e927cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_54759a90-4ddd-4c92-b589-05e14e927cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_48632b75-4960-4b63-b34c-3e2c609b3c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_48632b75-4960-4b63-b34c-3e2c609b3c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_ec619df4-810a-4253-95d7-e2d1de446e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_ec619df4-810a-4253-95d7-e2d1de446e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_db8798bf-2b95-4ce2-821d-e74abb03a1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_db8798bf-2b95-4ce2-821d-e74abb03a1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_55b15bf3-cc0a-4f45-97e9-8b9e52879520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_55b15bf3-cc0a-4f45-97e9-8b9e52879520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_470ff818-6107-4d87-ac4a-ac0c25477a69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_470ff818-6107-4d87-ac4a-ac0c25477a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_f3721eb3-af22-4249-a767-04942b90cc14" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_f3721eb3-af22-4249-a767-04942b90cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a5c0c57f-2768-4692-873f-38d6b89006cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a5c0c57f-2768-4692-873f-38d6b89006cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_8e099e45-64ec-4cd8-97c3-a17d3275c8ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_8e099e45-64ec-4cd8-97c3-a17d3275c8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_7f47a24e-a4ea-4770-b674-54442528b737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_7f47a24e-a4ea-4770-b674-54442528b737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_44114d42-5073-4110-bea3-f1730435b9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_17b84d40-7ab7-41c8-8387-3975fea5694a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_44114d42-5073-4110-bea3-f1730435b9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a9c5d45a-b264-4e28-a14d-7be33f832e35" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_930e57c2-e3cb-4d89-bc0b-f24e1e5c4cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_930e57c2-e3cb-4d89-bc0b-f24e1e5c4cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_c138c915-05f9-403c-bcc9-df316cd39c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_c138c915-05f9-403c-bcc9-df316cd39c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_41d31770-4a49-43f4-94ae-42c636844e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_41d31770-4a49-43f4-94ae-42c636844e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_7ea22a08-12cc-4aa2-bc09-1b90b16f5b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_7ea22a08-12cc-4aa2-bc09-1b90b16f5b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3e2feded-2614-4502-b395-f117cb8ceb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3e2feded-2614-4502-b395-f117cb8ceb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a32ee829-613d-4760-a252-770d50089e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a32ee829-613d-4760-a252-770d50089e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_7a609ecd-c2d1-4507-9ff2-bf5b17b4178a" xlink:href="iart-20201231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_7a609ecd-c2d1-4507-9ff2-bf5b17b4178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c5bc0403-4ac0-4782-aeac-4ccd10591554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c5bc0403-4ac0-4782-aeac-4ccd10591554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_45d0d0de-3c0f-4a1d-9b9c-ce338be0ccc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e06bef10-e731-4211-b7e4-7776037f665d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_45d0d0de-3c0f-4a1d-9b9c-ce338be0ccc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6765b3ae-8243-4036-8a36-dd12a82324a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_b613d74d-ca9a-46f9-be68-ab4141f10ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6765b3ae-8243-4036-8a36-dd12a82324a5" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_b613d74d-ca9a-46f9-be68-ab4141f10ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4f5bd511-b904-4c60-9a05-19bc8217cce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_b613d74d-ca9a-46f9-be68-ab4141f10ae5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4f5bd511-b904-4c60-9a05-19bc8217cce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_138164ed-659a-43a7-bf33-e0d6c759c936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_b613d74d-ca9a-46f9-be68-ab4141f10ae5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_138164ed-659a-43a7-bf33-e0d6c759c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_173229f0-9c62-4e15-8171-43b9ac71964d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_b613d74d-ca9a-46f9-be68-ab4141f10ae5" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_173229f0-9c62-4e15-8171-43b9ac71964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_924f0f77-3fbd-43dc-8f27-a35eba76d1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_924f0f77-3fbd-43dc-8f27-a35eba76d1d1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f206033-e6c8-43ec-8653-cebd8bd3709a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6a17bead-50be-4858-b1e6-69a0ac2a94fa" xlink:to="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AustriaFranceAndGermanyMember_0b41dd5b-716a-4f08-a104-e2fb58bd898d" xlink:href="iart-20201231.xsd#iart_AustriaFranceAndGermanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_bf9cd304-4b13-44ce-819a-f4ac17ab6967" xlink:to="loc_iart_AustriaFranceAndGermanyMember_0b41dd5b-716a-4f08-a104-e2fb58bd898d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6a44a0f-9ca9-484e-a78c-08e177e33dc3" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64ba6c0a-54ba-470e-93ef-420db791cb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64ba6c0a-54ba-470e-93ef-420db791cb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a6234e97-152f-4621-a885-1ba0c12189c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a6234e97-152f-4621-a885-1ba0c12189c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e9d5f6d-7d5e-4427-b382-900f8bfd4795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e9d5f6d-7d5e-4427-b382-900f8bfd4795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_dd135ca8-c3a8-43b6-b480-a550f1de5457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_dd135ca8-c3a8-43b6-b480-a550f1de5457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_2d4d1fed-427d-491c-ba76-72daea6e5af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_2d4d1fed-427d-491c-ba76-72daea6e5af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06041d39-027a-4040-b6f6-c715b91978a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06041d39-027a-4040-b6f6-c715b91978a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_e19eda79-2548-4723-81cb-e45d3b19aa08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1ac335c2-6949-454c-b3dd-271c90c5880e" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_e19eda79-2548-4723-81cb-e45d3b19aa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae0e689b-fc26-455a-adde-7430d0f476a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae0e689b-fc26-455a-adde-7430d0f476a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5d0a00d1-2507-4cc4-bac5-181c3b18ef97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5d0a00d1-2507-4cc4-bac5-181c3b18ef97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_180175f2-ba4b-469c-9736-cfc037c9be65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_180175f2-ba4b-469c-9736-cfc037c9be65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_3e3df7b3-4891-461a-bbe5-5777675636ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_3e3df7b3-4891-461a-bbe5-5777675636ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_68d75c2a-5802-47d0-a842-e1852c8c2e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_68d75c2a-5802-47d0-a842-e1852c8c2e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f030ca9e-ec02-4f0a-9199-b779e2ee835b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83d1f34e-f713-4e03-aecd-2a4adf132dec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f030ca9e-ec02-4f0a-9199-b779e2ee835b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5ebcd9d1-9158-409f-b7b6-00e98ad53ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_e4fb2af3-354a-459f-a792-01cfc3422521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5ebcd9d1-9158-409f-b7b6-00e98ad53ead" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_e4fb2af3-354a-459f-a792-01cfc3422521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a158a4d2-08d9-4ad8-bb5c-bd7e875fd43c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_02f734ca-2c75-43ce-8c3a-e62a61c63560" xlink:href="iart-20201231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a158a4d2-08d9-4ad8-bb5c-bd7e875fd43c" xlink:to="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_02f734ca-2c75-43ce-8c3a-e62a61c63560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock_f387fff5-5534-4489-8fef-7a2c43e263d2" xlink:href="iart-20201231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a158a4d2-08d9-4ad8-bb5c-bd7e875fd43c" xlink:to="loc_iart_CashFlowLesseeTableTextBlock_f387fff5-5534-4489-8fef-7a2c43e263d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a601be54-034e-453a-8905-5295f375f47a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a158a4d2-08d9-4ad8-bb5c-bd7e875fd43c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a601be54-034e-453a-8905-5295f375f47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3282c3a6-f060-47d7-bf07-db1ee8f76bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3282c3a6-f060-47d7-bf07-db1ee8f76bd0" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_060e1331-eb92-47da-b703-7c1bb851e322" xlink:to="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_7b4cfa51-5c11-4c23-bad7-817f66ab152e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d424d9a0-f104-4c00-98ff-d5ab879a756b" xlink:to="loc_srt_AffiliatedEntityMember_7b4cfa51-5c11-4c23-bad7-817f66ab152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_5020849d-d04a-4e27-a3ba-63420f134901" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_59026bf5-ac54-402f-8d0f-e1b9e7ed6def" xlink:href="iart-20201231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_59026bf5-ac54-402f-8d0f-e1b9e7ed6def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_70ba8ccb-af1c-458a-a190-7408db33e8eb" xlink:href="iart-20201231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7e84c90d-6e1d-451d-8b39-87f69a064ca1" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_70ba8ccb-af1c-458a-a190-7408db33e8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8905c013-966d-42eb-b2c8-c71a1a2f5f39" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_00d3ca9f-aefb-4fa3-8db8-4cb5046f1209" xlink:href="iart-20201231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_00d3ca9f-aefb-4fa3-8db8-4cb5046f1209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_731cfb0c-2555-473e-8529-ec76add35e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_OperatingLeaseExpense_731cfb0c-2555-473e-8529-ec76add35e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_500af928-11cd-400b-9578-e5c693f648e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_500af928-11cd-400b-9578-e5c693f648e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_fe05d354-7649-4b96-87a6-478574547aca" xlink:href="iart-20201231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_fe05d354-7649-4b96-87a6-478574547aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_1fa401fd-6915-48f1-9e20-78078daccfdf" xlink:href="iart-20201231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_1fa401fd-6915-48f1-9e20-78078daccfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_e4120d77-4744-410a-be62-15af972ac84b" xlink:href="iart-20201231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_iart_OptionToExtendLeaseYears_e4120d77-4744-410a-be62-15af972ac84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_5aa74562-0229-4017-9c32-f4cdff4d09b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_abb08f78-6898-4690-a2fc-2b3340a84d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_5aa74562-0229-4017-9c32-f4cdff4d09b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5113ee0f-2137-49fc-9ea8-fde08da5e9f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5113ee0f-2137-49fc-9ea8-fde08da5e9f3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1e80bf3b-7d6a-4a92-aee2-a104838ab2cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_3026544d-ac3c-4539-9d53-65bdef2751c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:to="loc_us-gaap_BuildingMember_3026544d-ac3c-4539-9d53-65bdef2751c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_90b5702c-9348-49fb-ab86-2cc01bd27a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c44ae2-fbed-4c8b-89be-089a5aa05483" xlink:to="loc_us-gaap_VehiclesMember_90b5702c-9348-49fb-ab86-2cc01bd27a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_5d2ac69e-f00f-4ecd-8152-3bb173d5dc8c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4be4c778-e63d-4f6f-be99-7599bfa8eb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4be4c778-e63d-4f6f-be99-7599bfa8eb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb3d0768-69d1-4925-8b25-d7716f13fa9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb3d0768-69d1-4925-8b25-d7716f13fa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bfb0a830-a18d-49e4-a637-c7cd39bb5f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bfb0a830-a18d-49e4-a637-c7cd39bb5f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3c206c48-fb17-4b71-8b0d-2e5313e37b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseLiability_3c206c48-fb17-4b71-8b0d-2e5313e37b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8c0496b-03cf-4705-9f33-b2124ce8ac72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8c0496b-03cf-4705-9f33-b2124ce8ac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c0638760-59df-4e4d-80a8-1183a458e48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85bf971b-5fc0-4594-93e9-677d6633ed6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c0638760-59df-4e4d-80a8-1183a458e48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3dd13650-c2ff-4156-bf63-f561316f81c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract_6c524f77-c03b-4b57-97ee-71a1316ba44a" xlink:href="iart-20201231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3dd13650-c2ff-4156-bf63-f561316f81c5" xlink:to="loc_iart_CashFlowLesseeAbstract_6c524f77-c03b-4b57-97ee-71a1316ba44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_03a245c7-724f-4364-8b11-db5f4b2f8246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_CashFlowLesseeAbstract_6c524f77-c03b-4b57-97ee-71a1316ba44a" xlink:to="loc_us-gaap_OperatingLeasePayments_03a245c7-724f-4364-8b11-db5f4b2f8246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_312909c8-45ab-4afc-b701-7c7d4bacdac4" xlink:href="iart-20201231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3dd13650-c2ff-4156-bf63-f561316f81c5" xlink:to="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_312909c8-45ab-4afc-b701-7c7d4bacdac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c4d10bf6-bb07-4968-a6ad-d9732881dc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_312909c8-45ab-4afc-b701-7c7d4bacdac4" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c4d10bf6-bb07-4968-a6ad-d9732881dc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1bc045f3-3716-42e6-88bc-7b5ad568fbb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1bc045f3-3716-42e6-88bc-7b5ad568fbb7" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:to="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_38ea09b9-a40d-4af5-b411-5ee9aecda893" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_fbc0876d-b680-4a8a-8169-338ca7b189a9" xlink:href="iart-20201231.xsd#iart_RelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:to="loc_iart_RelatedPartiesMember_fbc0876d-b680-4a8a-8169-338ca7b189a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_4038bd26-0f8d-402d-873b-14e28f264746" xlink:href="iart-20201231.xsd#iart_ThirdPartiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_145a9750-e01c-4237-8632-e2f55566057f" xlink:to="loc_iart_ThirdPartiesMember_4038bd26-0f8d-402d-873b-14e28f264746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_47ea27b3-b0be-47c5-a857-2d5dc31a503b" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d222c911-054b-4be0-8d24-d3a78709c1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d222c911-054b-4be0-8d24-d3a78709c1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb20ad3d-6a87-41fb-a89f-1bf0d7d69c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb20ad3d-6a87-41fb-a89f-1bf0d7d69c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cbac5b5c-f90e-4039-8043-9e29b99763dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cbac5b5c-f90e-4039-8043-9e29b99763dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e39d2-0145-490f-8ca3-50e3bf07a821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e39d2-0145-490f-8ca3-50e3bf07a821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7ad0e605-0479-4ac5-8c40-52e968a25a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7ad0e605-0479-4ac5-8c40-52e968a25a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6e0e4369-87c0-4cc0-bf65-6694c492ffdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6e0e4369-87c0-4cc0-bf65-6694c492ffdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6d9bc505-5864-4916-96d7-8a16702c6639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6d9bc505-5864-4916-96d7-8a16702c6639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d7a6f2ca-7f51-411b-98ad-287d7c12eaad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d7a6f2ca-7f51-411b-98ad-287d7c12eaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_18b78dbd-f51f-4313-b330-2c0e2e8b76a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiability_18b78dbd-f51f-4313-b330-2c0e2e8b76a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7b3a1a-dbf6-4e8a-9675-f53899645f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7b3a1a-dbf6-4e8a-9675-f53899645f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e040d0a0-953d-40e8-bd29-7dd53cdf8888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7e340377-aca5-4e9d-9566-9f1b172b098a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e040d0a0-953d-40e8-bd29-7dd53cdf8888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3cfe3a4b-9cf5-4f12-ab8f-b4e3ae829de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3cfe3a4b-9cf5-4f12-ab8f-b4e3ae829de5" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:to="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f6ce792e-0cfe-4cb7-a66e-83df839dd0f0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_d414fe39-6be1-43f5-ae3e-7dcd070c3312" xlink:href="iart-20201231.xsd#iart_RelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:to="loc_iart_RelatedPartiesMember_d414fe39-6be1-43f5-ae3e-7dcd070c3312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_61d1235b-9f0c-456c-abc3-c9c2544efa98" xlink:href="iart-20201231.xsd#iart_ThirdPartiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e6c955c1-4ccd-4507-ad7a-add5343bceb5" xlink:to="loc_iart_ThirdPartiesMember_61d1235b-9f0c-456c-abc3-c9c2544efa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_33957d0e-9afd-41bd-b946-463440199be3" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_81f274cb-fff2-4bdc-8877-a7388d894a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_81f274cb-fff2-4bdc-8877-a7388d894a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fcf8f317-b329-49d2-9c3b-f79be9ef31b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fcf8f317-b329-49d2-9c3b-f79be9ef31b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_74caa1a5-46c4-46d0-9abf-4d0127bc45d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_74caa1a5-46c4-46d0-9abf-4d0127bc45d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2f9a02b-2d88-4828-a03f-ef0dbf75e839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2f9a02b-2d88-4828-a03f-ef0dbf75e839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f1d1f69c-5f12-424f-abad-7dce27789565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f1d1f69c-5f12-424f-abad-7dce27789565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_80622b00-c351-48ef-b855-b92512a84ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_80622b00-c351-48ef-b855-b92512a84ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f373e76-8278-47b3-bfe8-7c9c78cd15d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f373e76-8278-47b3-bfe8-7c9c78cd15d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_468ab2eb-3d70-47f5-94eb-7ec7e08ea26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_468ab2eb-3d70-47f5-94eb-7ec7e08ea26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_738297f5-d489-426e-8977-23a93016f7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiability_738297f5-d489-426e-8977-23a93016f7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01fb0a09-cfde-4be0-8156-d9880202c169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01fb0a09-cfde-4be0-8156-d9880202c169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b9f19cc9-3a9a-492d-a2cc-0a592ea38dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_8a9dddbe-e6cb-41b5-9923-4091d4569f8a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b9f19cc9-3a9a-492d-a2cc-0a592ea38dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_df493849-8ffb-4d24-8abe-b05935081127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_32f1c0f2-c642-4e37-b8f6-3256c348bee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_df493849-8ffb-4d24-8abe-b05935081127" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_32f1c0f2-c642-4e37-b8f6-3256c348bee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_6afae5f0-d5ce-4c74-a6b2-de599eed2a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_6afae5f0-d5ce-4c74-a6b2-de599eed2a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_848a66f7-8956-4cfb-96cf-a0e803df2120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_848a66f7-8956-4cfb-96cf-a0e803df2120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7af3c58c-f1f5-419b-8c6e-847d9dc19a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7af3c58c-f1f5-419b-8c6e-847d9dc19a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_50b27f39-e369-4eff-a329-6f88c85090f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_50b27f39-e369-4eff-a329-6f88c85090f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_dc92940f-611f-4a01-b105-1b49d0eaa830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0d70bcf-0e8f-4bd0-9181-771342d45c48" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_dc92940f-611f-4a01-b105-1b49d0eaa830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e3173fce-ff2a-4591-b27a-34f0165caefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2b61bee7-d6fc-4066-898c-016d0ecf723b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3173fce-ff2a-4591-b27a-34f0165caefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2b61bee7-d6fc-4066-898c-016d0ecf723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_47522aad-f9a5-4ace-99fd-a934356a057c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3173fce-ff2a-4591-b27a-34f0165caefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_47522aad-f9a5-4ace-99fd-a934356a057c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7a56150c-ddf8-43f4-a962-d89589f88275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3173fce-ff2a-4591-b27a-34f0165caefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7a56150c-ddf8-43f4-a962-d89589f88275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d90c0905-041d-4ffb-9dbc-5fbf76eff8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:href="iart-20201231.xsd#iart_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d90c0905-041d-4ffb-9dbc-5fbf76eff8da" xlink:to="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_24d9bd02-9bd5-4c62-a05c-096d52c59bcf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2b365d56-343f-46d8-80b5-7f4c7e5fad2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_ForeignCountryMember_2b365d56-343f-46d8-80b5-7f4c7e5fad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_de892fbd-c3f6-4bdd-8fbb-331ea0a2c3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_DomesticCountryMember_de892fbd-c3f6-4bdd-8fbb-331ea0a2c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d1c86d12-f90b-43ad-a317-1636b277c5f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f906a690-90d8-48d0-88b6-4b6ec629186c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d1c86d12-f90b-43ad-a317-1636b277c5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_18787c81-cedc-42eb-be90-971244ee910f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_c47d96b3-01c1-4b73-9451-3ecfab4a395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4e482b95-487f-4fa2-bc49-244146b7acd3" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_c47d96b3-01c1-4b73-9451-3ecfab4a395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_5233909b-2f37-4025-8440-962ddc8359c7" xlink:to="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UpThroughTaxYear2025Member_acfceca2-2b17-459f-9c85-2cb0da3378d0" xlink:href="iart-20201231.xsd#iart_UpThroughTaxYear2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_77312393-de88-4bb7-b10f-2946a5502ce1" xlink:to="loc_iart_UpThroughTaxYear2025Member_acfceca2-2b17-459f-9c85-2cb0da3378d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:href="iart-20201231.xsd#iart_IncomeTaxLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_491f0b34-d764-4d09-95f9-8c5ec0054ddd" xlink:to="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_573793cf-52c9-4e7d-a1ad-f7a1982fd45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_573793cf-52c9-4e7d-a1ad-f7a1982fd45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_36cc359a-6ca8-462e-8d25-951fca359685" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_36cc359a-6ca8-462e-8d25-951fca359685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_f34ec959-f99b-4a7d-942c-584035a5a0c5" xlink:href="iart-20201231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_f34ec959-f99b-4a7d-942c-584035a5a0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_2e0ffa4f-78dc-4da4-949e-69930bf5675f" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_2e0ffa4f-78dc-4da4-949e-69930bf5675f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_082e46af-74b4-4c28-8098-7fb5a3e6d3bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_082e46af-74b4-4c28-8098-7fb5a3e6d3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_dcf1271b-94bd-4d4d-9361-adb6b6ce3d27" xlink:href="iart-20201231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_dcf1271b-94bd-4d4d-9361-adb6b6ce3d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_935aed9d-1732-482d-9b4c-a5ba13cd35c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_935aed9d-1732-482d-9b4c-a5ba13cd35c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_6d85180a-dc84-4a8d-86a2-1c65797e1559" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare_6d85180a-dc84-4a8d-86a2-1c65797e1559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_2e0b86f4-ec0b-4f20-8426-671e43e7bb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_OperatingLossCarryforwards_2e0b86f4-ec0b-4f20-8426-671e43e7bb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5f2570f6-6c71-4749-a0d5-61759e58d1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5f2570f6-6c71-4749-a0d5-61759e58d1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d37f066b-23dc-49f1-b06d-78473ec86248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d37f066b-23dc-49f1-b06d-78473ec86248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3a4e4ce-6560-48a8-8001-fe76d1495068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_b3a4e4ce-6560-48a8-8001-fe76d1495068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_65621d08-13c4-4477-bbe4-028505fa6266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_65621d08-13c4-4477-bbe4-028505fa6266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cd6e9f73-74a5-470c-b668-cab8098e89b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cd6e9f73-74a5-470c-b668-cab8098e89b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d235312b-2b39-448f-8568-ab0638d69819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d235312b-2b39-448f-8568-ab0638d69819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_52c9885f-1b9e-4ef2-b774-efa035c9bced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_52c9885f-1b9e-4ef2-b774-efa035c9bced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_e1451a8b-ad88-4c18-a4e5-a841430fb084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_daac8f61-8fd5-4490-ab19-1296790f1123" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_e1451a8b-ad88-4c18-a4e5-a841430fb084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_77c2b9ab-fc54-4161-a348-a3ffb5aa71ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a44170f-27ee-47a8-996f-4711b272b38e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77c2b9ab-fc54-4161-a348-a3ffb5aa71ca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a44170f-27ee-47a8-996f-4711b272b38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77c2b9ab-fc54-4161-a348-a3ffb5aa71ca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9e67da95-c0d1-4f20-830b-00ae2007206c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9e67da95-c0d1-4f20-830b-00ae2007206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c677016f-9e97-4aa9-9751-a2ee54de3a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c677016f-9e97-4aa9-9751-a2ee54de3a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_2fd161d4-fe6a-4b24-896e-69be1fdff050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_2fd161d4-fe6a-4b24-896e-69be1fdff050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_175cde8a-ed3a-4cc1-8738-1036f10000c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_175cde8a-ed3a-4cc1-8738-1036f10000c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_32c340d9-2641-4ca0-8b28-36252145b74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_32c340d9-2641-4ca0-8b28-36252145b74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_3a5f7c95-47d6-4368-9eb5-75af0d4c77f5" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_3a5f7c95-47d6-4368-9eb5-75af0d4c77f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_3b9cfa8c-63ea-45af-9113-3bcb2c3d864f" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_3b9cfa8c-63ea-45af-9113-3bcb2c3d864f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b402998f-4afa-4de5-8fa4-9522eda082ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b402998f-4afa-4de5-8fa4-9522eda082ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_3e37615c-8f9d-4902-9c29-02aca09ed86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_3e37615c-8f9d-4902-9c29-02aca09ed86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4684338d-7b86-400b-967d-0b238ca1c3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4684338d-7b86-400b-967d-0b238ca1c3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0ea1d5e4-d480-47af-8d5a-b20dab870b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0ea1d5e4-d480-47af-8d5a-b20dab870b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_46beed07-bc91-486f-b8c8-0b731e5d7fb2" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent_46beed07-bc91-486f-b8c8-0b731e5d7fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_6c008e51-9de0-484f-abb2-9b5694c17eea" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_6c008e51-9de0-484f-abb2-9b5694c17eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_bd1f8ceb-26ce-4b9f-b097-12f9bb1d833b" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent_bd1f8ceb-26ce-4b9f-b097-12f9bb1d833b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_06ca2492-5922-4ebd-bfbb-2c22d9d4136b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_06ca2492-5922-4ebd-bfbb-2c22d9d4136b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_e77a970e-296b-496c-a332-65f03b3282b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays_e77a970e-296b-496c-a332-65f03b3282b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_3d8ae5a4-a906-4c45-a609-b9e287744170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_3d8ae5a4-a906-4c45-a609-b9e287744170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_82ee31ef-331e-40ee-b9d6-57ad947b12e8" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent_82ee31ef-331e-40ee-b9d6-57ad947b12e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_5ca202ab-759b-4fe0-961a-8b17c7ffcb34" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_5ca202ab-759b-4fe0-961a-8b17c7ffcb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_338b0d53-ac4f-42df-8a0b-051684bd4433" xlink:href="iart-20201231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1cdac790-54b1-4566-be68-3ab8bc58093f" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_338b0d53-ac4f-42df-8a0b-051684bd4433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d8adfed-10cf-4a72-8f04-1ac752538ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77c2b9ab-fc54-4161-a348-a3ffb5aa71ca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d8adfed-10cf-4a72-8f04-1ac752538ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6fac3580-c7d8-4836-9d23-d622566dfe49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fac3580-c7d8-4836-9d23-d622566dfe49" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c0d07ed8-a678-4203-92a0-291a07c85775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c0d07ed8-a678-4203-92a0-291a07c85775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b5cb963b-69f0-4936-bda9-07a8fed3d52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b5cb963b-69f0-4936-bda9-07a8fed3d52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_63fbb4df-e2a7-4377-97de-714592158769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_63fbb4df-e2a7-4377-97de-714592158769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_04527965-9864-478e-a8e1-644cb325bbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8c4223d9-69ff-4625-8595-6a79b5f9170d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_04527965-9864-478e-a8e1-644cb325bbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fac3580-c7d8-4836-9d23-d622566dfe49" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_886a8dda-2345-4a4b-af36-d049307bae0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_886a8dda-2345-4a4b-af36-d049307bae0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b24a81b2-8118-4ea4-9c8a-65d87de55547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b24a81b2-8118-4ea4-9c8a-65d87de55547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3e0fa272-2c3b-4c2d-8e43-6c3af7a4f816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3e0fa272-2c3b-4c2d-8e43-6c3af7a4f816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbff58d1-e01c-4440-9151-9b4b38906fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ed9075f-474b-4ec3-a41d-4e34bb4ef183" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fbff58d1-e01c-4440-9151-9b4b38906fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d4339948-257f-409a-af37-24ce3cc23583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fac3580-c7d8-4836-9d23-d622566dfe49" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d4339948-257f-409a-af37-24ce3cc23583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_75ed529a-d045-43f6-ae9e-8f9efdca82ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75ed529a-d045-43f6-ae9e-8f9efdca82ec" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6c46948f-4cd1-4b67-a3ec-949097a63a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6c46948f-4cd1-4b67-a3ec-949097a63a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_a61ebb5a-dfcb-44c3-a9e9-c9123e2004a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_a61ebb5a-dfcb-44c3-a9e9-c9123e2004a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_51a6f9fe-87ff-4365-a758-74cb4c3c1d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_51a6f9fe-87ff-4365-a758-74cb4c3c1d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_bb63ef50-6a74-468e-9875-744fe0cfdbd0" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_bb63ef50-6a74-468e-9875-744fe0cfdbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_a890e1ec-95db-4684-b29f-e888afcd1b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_a890e1ec-95db-4684-b29f-e888afcd1b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_43c47d12-28b0-4da6-88a7-b2c88792269d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_43c47d12-28b0-4da6-88a7-b2c88792269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2037f7dc-34a5-4b80-bb2e-ee562ed7020f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2037f7dc-34a5-4b80-bb2e-ee562ed7020f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1565c780-cabe-4297-a7b4-469be2f1e870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1565c780-cabe-4297-a7b4-469be2f1e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_0e3582d3-e9c5-4f9c-aed1-c1ab9422206e" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_0e3582d3-e9c5-4f9c-aed1-c1ab9422206e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_9fade281-2941-4457-ab17-d7d15f8ac29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_9fade281-2941-4457-ab17-d7d15f8ac29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_9c60c345-c8e0-4d3f-abad-8e8e1b5a841c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_9c60c345-c8e0-4d3f-abad-8e8e1b5a841c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_1c09cd7e-6ef8-46fd-aee2-e4aa65025e76" xlink:href="iart-20201231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_1c09cd7e-6ef8-46fd-aee2-e4aa65025e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e6aeccf4-036a-436d-878d-246635a5f2f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_e6aeccf4-036a-436d-878d-246635a5f2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_03698ad7-778d-4bbe-bb6b-e6707a135dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_03698ad7-778d-4bbe-bb6b-e6707a135dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_14fa2f78-e3af-424a-8c24-c68a6eb18716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_4ca83446-8b1a-470d-8b6f-b5d2b8052a7b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_14fa2f78-e3af-424a-8c24-c68a6eb18716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_62e4105b-1b89-42c8-8ac2-2e245c2a2a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75ed529a-d045-43f6-ae9e-8f9efdca82ec" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_62e4105b-1b89-42c8-8ac2-2e245c2a2a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_d01387b2-70f6-4174-ae4d-f693cf335a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_62e4105b-1b89-42c8-8ac2-2e245c2a2a90" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_d01387b2-70f6-4174-ae4d-f693cf335a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_15f5002b-c2c5-4d82-8f34-54f7b587f31e" xlink:href="iart-20201231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_62e4105b-1b89-42c8-8ac2-2e245c2a2a90" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_15f5002b-c2c5-4d82-8f34-54f7b587f31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1565bb76-bbf6-463a-8177-aec57a5d13b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_62e4105b-1b89-42c8-8ac2-2e245c2a2a90" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1565bb76-bbf6-463a-8177-aec57a5d13b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_919fb589-0767-4adc-ac36-ab3207475557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75ed529a-d045-43f6-ae9e-8f9efdca82ec" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_919fb589-0767-4adc-ac36-ab3207475557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0b269888-230a-460a-9c98-dbcccad2b97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75ed529a-d045-43f6-ae9e-8f9efdca82ec" xlink:to="loc_us-gaap_DeferredTaxLiabilities_0b269888-230a-460a-9c98-dbcccad2b97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7eed7793-5a3f-485b-8ecd-42676229fe89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7eed7793-5a3f-485b-8ecd-42676229fe89" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_16e43515-bb6e-49fd-b440-004e408aa7e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_16e43515-bb6e-49fd-b440-004e408aa7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_0231d7c7-2db1-4fc8-b119-d16ad7d74914" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:to="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_0231d7c7-2db1-4fc8-b119-d16ad7d74914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1be96a0d-82c8-4457-81be-0be6d89eba07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_0231d7c7-2db1-4fc8-b119-d16ad7d74914" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1be96a0d-82c8-4457-81be-0be6d89eba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_850e6297-be4b-4f26-bbf5-f57928dc7772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_0231d7c7-2db1-4fc8-b119-d16ad7d74914" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_850e6297-be4b-4f26-bbf5-f57928dc7772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_d956daa8-9cbc-429f-aa7d-b61d2cb2606a" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:to="loc_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_d956daa8-9cbc-429f-aa7d-b61d2cb2606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_73b4ccbb-9d93-4158-a0f5-8cf39a81faa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract_d956daa8-9cbc-429f-aa7d-b61d2cb2606a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_73b4ccbb-9d93-4158-a0f5-8cf39a81faa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_b2820b71-231c-4c1e-98fa-9cad310af291" xlink:href="iart-20201231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:to="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_b2820b71-231c-4c1e-98fa-9cad310af291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_52e45247-5012-4f4e-9e03-26f812291b57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32cfcb03-335d-42f1-a63c-8f3446814bf3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_52e45247-5012-4f4e-9e03-26f812291b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_13876a0a-2816-43a2-9709-0353aa60c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_87a87557-7d14-4402-a9a5-88c8e056e336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13876a0a-2816-43a2-9709-0353aa60c3d6" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_87a87557-7d14-4402-a9a5-88c8e056e336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_64b277ec-0fc3-43fe-97ab-b2e98d114011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_472cd744-5229-41f0-a4b0-1f43bbb042f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_64b277ec-0fc3-43fe-97ab-b2e98d114011" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_472cd744-5229-41f0-a4b0-1f43bbb042f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_84606f42-95d9-49ce-bcbf-cf9292a2fe06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ce8c6128-36a2-4d09-9f04-a3287b3e62ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84606f42-95d9-49ce-bcbf-cf9292a2fe06" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ce8c6128-36a2-4d09-9f04-a3287b3e62ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c69085a-ab06-4553-9a64-3afd31e2790e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ce8c6128-36a2-4d09-9f04-a3287b3e62ba" xlink:to="loc_us-gaap_NetIncomeLoss_2c69085a-ab06-4553-9a64-3afd31e2790e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a660e6c1-ef33-445c-8d9f-d9c8b341177d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ce8c6128-36a2-4d09-9f04-a3287b3e62ba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a660e6c1-ef33-445c-8d9f-d9c8b341177d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4808b798-1360-449b-8e3d-ac001a9b8a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ce8c6128-36a2-4d09-9f04-a3287b3e62ba" xlink:to="loc_us-gaap_EarningsPerShareBasic_4808b798-1360-449b-8e3d-ac001a9b8a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84606f42-95d9-49ce-bcbf-cf9292a2fe06" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d8e0c88-33eb-4b64-adb1-6b60b1a3c787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:to="loc_us-gaap_NetIncomeLoss_6d8e0c88-33eb-4b64-adb1-6b60b1a3c787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48beaa1d-9960-4723-b27a-7dd311b9da3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48beaa1d-9960-4723-b27a-7dd311b9da3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_e6ba019a-eecb-42de-a190-484f212f87ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_e6ba019a-eecb-42de-a190-484f212f87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b624b32c-7ff9-499e-98bb-0e74b12c5f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_e6ba019a-eecb-42de-a190-484f212f87ee" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b624b32c-7ff9-499e-98bb-0e74b12c5f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e8fc9ff-9488-45b6-ad00-d28dc1da5498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_e6ba019a-eecb-42de-a190-484f212f87ee" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e8fc9ff-9488-45b6-ad00-d28dc1da5498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_df527cba-e96e-4e05-9b38-e09c5053a7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0206e217-c81c-4ec1-bec9-8f0a277caf48" xlink:to="loc_us-gaap_EarningsPerShareDiluted_df527cba-e96e-4e05-9b38-e09c5053a7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ebd306a3-e46c-4595-b10f-3a8aab452353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ebd306a3-e46c-4595-b10f-3a8aab452353" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:to="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_388c3907-2bfc-44d6-a611-e59584162d2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceSharesandRestrictedUnitsMember_c9010b54-1b05-4ba3-b3e6-9a165a6978a1" xlink:href="iart-20201231.xsd#iart_PerformanceSharesandRestrictedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_513d0450-2e9d-4523-b7b4-cacb8c81e4c7" xlink:to="loc_iart_PerformanceSharesandRestrictedUnitsMember_c9010b54-1b05-4ba3-b3e6-9a165a6978a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70e302f4-5a75-4965-9f3a-5b534b8a2304" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f1936f9b-1d25-43e2-af47-9273f2997ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f1936f9b-1d25-43e2-af47-9273f2997ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AdditionalEPSShares_94e7b53c-6d62-4fbf-a388-e5aa1b186f29" xlink:href="iart-20201231.xsd#iart_AdditionalEPSShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9dce5646-9b52-4024-a71b-6537885e50ad" xlink:to="loc_iart_AdditionalEPSShares_94e7b53c-6d62-4fbf-a388-e5aa1b186f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7e7505c0-fffb-4f14-bfb9-7c0630db2e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fe1e4674-d72e-46b7-83ba-16bd698a0887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e7505c0-fffb-4f14-bfb9-7c0630db2e38" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fe1e4674-d72e-46b7-83ba-16bd698a0887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2d2141c4-f943-43b2-827f-1d7be4c57a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3db5cdfa-fbc9-4732-8bbe-3fc5b219ab0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2d2141c4-f943-43b2-827f-1d7be4c57a1a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3db5cdfa-fbc9-4732-8bbe-3fc5b219ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_231a6dcd-0a4e-4b5f-b5b7-841871927147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_231a6dcd-0a4e-4b5f-b5b7-841871927147" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_537803c6-78d1-4165-9825-8c9478a3720d" xlink:to="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ff3809a5-7f51-4c01-b363-707b367fc9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ff3809a5-7f51-4c01-b363-707b367fc9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_eef02342-7e9a-43a4-9f0f-296535b50ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_eef02342-7e9a-43a4-9f0f-296535b50ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_796eabb7-2544-4fc1-951a-7db968b6adf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_796eabb7-2544-4fc1-951a-7db968b6adf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4548002-c675-4af8-86ef-7a83b04192c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5cbdc46c-996b-4aef-a06c-4b655e5d144d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4548002-c675-4af8-86ef-7a83b04192c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f49acf12-9ede-414c-a366-86c7c07e5862" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:href="iart-20201231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_16cf45e1-a3e5-4223-b371-2fdbeba5dd82" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bc84114d-81a3-41f0-b2b7-28f7d5edc6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_StockholdersEquity_bc84114d-81a3-41f0-b2b7-28f7d5edc6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0b8bc9d2-4c31-4ce2-9d8e-7efbc4a3faf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0b8bc9d2-4c31-4ce2-9d8e-7efbc4a3faf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_58cc5a7c-6fd1-439f-bbfb-42a27590ebc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_58cc5a7c-6fd1-439f-bbfb-42a27590ebc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_365ab2f6-6652-4052-9e6b-2015d190ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_365ab2f6-6652-4052-9e6b-2015d190ee24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_24d3b4d3-5e6e-4cb3-b624-70a167eb6bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_dad9708c-f42b-447b-90ba-2804cf0ce5f2" xlink:to="loc_us-gaap_StockholdersEquity_24d3b4d3-5e6e-4cb3-b624-70a167eb6bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e22a732e-5150-4833-9c36-b4ad1a17c0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e22a732e-5150-4833-9c36-b4ad1a17c0bb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64b676cf-bc2a-4176-bd95-06b591291940" xlink:to="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_021fa6ab-5a3b-4847-b510-a46db5d6c8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_969a96c6-ec1e-4701-8b2a-4fd0775283f6" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_021fa6ab-5a3b-4847-b510-a46db5d6c8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a905da1f-5a51-462e-afd0-c6b66d70198e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_993565d3-c713-4bbd-9e45-57d24b1204df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:to="loc_us-gaap_OtherExpenseMember_993565d3-c713-4bbd-9e45-57d24b1204df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_0fac30ad-2816-451b-a25f-f84e2582f6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_32164665-9531-40ac-afed-8bcbb8b0ccd6" xlink:to="loc_us-gaap_InterestIncomeMember_0fac30ad-2816-451b-a25f-f84e2582f6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8b671a59-077c-4313-8e3a-2f43dc008281" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_05ce34da-2cc9-47de-816f-3263a72709b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_913ea062-6c1d-4178-91d1-aa4915604500" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_05ce34da-2cc9-47de-816f-3263a72709b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_72f17fae-2298-4873-86e5-320d6920cf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ca604ca9-6e34-48f7-a0fb-b74235711b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_72f17fae-2298-4873-86e5-320d6920cf75" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ca604ca9-6e34-48f7-a0fb-b74235711b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8bd4aa7a-34e1-45a8-b476-074ce24fcb66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c33cd869-604d-4526-b98a-e977bca567f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8bd4aa7a-34e1-45a8-b476-074ce24fcb66" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c33cd869-604d-4526-b98a-e977bca567f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_349f7b86-05e7-4bf4-a03c-78d1b78a9749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_349f7b86-05e7-4bf4-a03c-78d1b78a9749" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f9b844cb-050b-4d74-83df-3f25345e1e7e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_4a44e375-ecca-448f-9fff-d1af8df1acf3" xlink:href="iart-20201231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_65714a07-d36c-4155-9e53-8d10cc9edca2" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_4a44e375-ecca-448f-9fff-d1af8df1acf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36d1e625-4db6-4d27-8981-886af98e9ef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_db5fc013-ec50-4560-bf81-49a41ef5fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58b41b36-8010-476b-bae7-dbee14a76707" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_db5fc013-ec50-4560-bf81-49a41ef5fe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2629ab1f-a1a0-48b5-899d-ec496305e6dc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_84bd65b5-49b3-4a13-8ba9-8704a12faf93" xlink:href="iart-20201231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:to="loc_iart_ArkisBioSciencesInc.Member_84bd65b5-49b3-4a13-8ba9-8704a12faf93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_6bac9cce-45f1-4db4-b0f7-4c9403008a8f" xlink:href="iart-20201231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e656bc-ac00-45a1-8f77-045a4fe745c9" xlink:to="loc_iart_DermaSciencesMember_6bac9cce-45f1-4db4-b0f7-4c9403008a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbeed2d-fd47-4f11-82e4-7b217a964ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_72a432ce-8556-454e-bb64-2f948b55c1e2" xlink:href="iart-20201231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_72a432ce-8556-454e-bb64-2f948b55c1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_4aa6efd0-ad79-45e7-8024-619d5d54e16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd4d65a1-1cfb-4538-8603-1e197b04615d" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_4aa6efd0-ad79-45e7-8024-619d5d54e16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a66a1cc8-085b-46f0-9fa4-c7a73e2dd0c7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f6e895ef-e0dc-4235-ba69-0483c137e996" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e149ab6-c092-4ede-8d84-5a990a3ed1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e149ab6-c092-4ede-8d84-5a990a3ed1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_23ce1971-1031-4c7e-929f-6cec8cbe38f7" xlink:href="iart-20201231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_23ce1971-1031-4c7e-929f-6cec8cbe38f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_113850a3-707a-4981-b657-67b26622b9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_113850a3-707a-4981-b657-67b26622b9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0c0afd5e-50ac-4b7b-b938-80939cb4c413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0c0afd5e-50ac-4b7b-b938-80939cb4c413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01492bfc-bc19-46e8-8461-6342417d107a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d61e598a-56d4-46b7-927a-49277683b0a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01492bfc-bc19-46e8-8461-6342417d107a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_95eb348e-5133-4557-a8ae-f38f7d5e7506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_4b1e6bc0-f078-4b6e-b0b3-8af950022ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_95eb348e-5133-4557-a8ae-f38f7d5e7506" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_4b1e6bc0-f078-4b6e-b0b3-8af950022ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_77e6715b-f4a1-4e87-93c7-ff6408145377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8e2e2d73-7780-4870-b3ff-1ea2615c5b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_77e6715b-f4a1-4e87-93c7-ff6408145377" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8e2e2d73-7780-4870-b3ff-1ea2615c5b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2b638659-81a3-42c1-bdc0-6df2bce1ee8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_77e6715b-f4a1-4e87-93c7-ff6408145377" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2b638659-81a3-42c1-bdc0-6df2bce1ee8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_63e2b55e-8a75-41ad-b5e7-c9bfce2f7e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63e2b55e-8a75-41ad-b5e7-c9bfce2f7e98" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70ed04c4-dd50-49dd-99ef-9bd74e2b1d05" xlink:to="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_4a4551c2-fb6a-4f3d-ae38-b6db6519c48e" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8594616f-e5fc-467c-a390-eb3bf7bb36a4" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_4a4551c2-fb6a-4f3d-ae38-b6db6519c48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2eaf1e04-6313-4691-bdf2-55c7a556c4a1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_0555492d-523a-4083-9bdd-9d3d62b476b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:to="loc_us-gaap_NumberOfReportableSegments_0555492d-523a-4083-9bdd-9d3d62b476b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_34e35b3f-4af9-4cc5-aaa3-5640dca4b518" xlink:href="iart-20201231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_81dbecf9-018e-4a9a-a144-a2f30db1151c" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_34e35b3f-4af9-4cc5-aaa3-5640dca4b518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dd2ced94-0d36-4088-bee9-fe3bb759a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dd2ced94-0d36-4088-bee9-fe3bb759a3a9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:to="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_08a9a170-df65-4288-b32e-ed4cadb6f2fc" xlink:to="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9209c99f-a4f2-4c47-8214-21263bef0231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:to="loc_us-gaap_OperatingSegmentsMember_9209c99f-a4f2-4c47-8214-21263bef0231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7cd8ee85-f040-43b8-8c7a-b44806d611a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4ed2231f-403f-48b5-a44b-25d2b0aa167e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7cd8ee85-f040-43b8-8c7a-b44806d611a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63a67af2-cafe-468f-ae17-1f7dac371c1e" xlink:to="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_a4fdb051-a76e-4791-a592-63ba3810ef73" xlink:href="iart-20201231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_a4fdb051-a76e-4791-a592-63ba3810ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OrthopedicsandTissueTechnologiesMember_b50fd0e5-4aef-4711-8284-987d71dce889" xlink:href="iart-20201231.xsd#iart_OrthopedicsandTissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_250c7ba4-f6b3-4a55-9aac-7b29e1ec4de0" xlink:to="loc_iart_OrthopedicsandTissueTechnologiesMember_b50fd0e5-4aef-4711-8284-987d71dce889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59bf84d6-7e04-4d72-881d-1a6f53bec832" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7f75df7-32aa-4c98-b0b7-619fdc88ec64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_cc2a3a86-791c-4c4d-839c-0de7f0dffc9d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7f75df7-32aa-4c98-b0b7-619fdc88ec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5f340569-f775-4a0e-bdfb-d2a639c16f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_832472d8-c346-43c5-a895-1d1e2c05f906" xlink:to="loc_us-gaap_OperatingIncomeLoss_5f340569-f775-4a0e-bdfb-d2a639c16f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1042d2f6-3f1c-46c3-8efb-7db40ab2517b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7512c9cc-5173-4718-a7cd-b222d59b75cb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1042d2f6-3f1c-46c3-8efb-7db40ab2517b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a123cb44-af0c-4bfe-b749-96dd74ba2a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a123cb44-af0c-4bfe-b749-96dd74ba2a30" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:to="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8ce5a645-ad40-437f-a24c-1c6c0e76fa6d" xlink:to="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7a4cf31d-37d3-403b-84c5-aa01b9f61c0a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_country_US_7a4cf31d-37d3-403b-84c5-aa01b9f61c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c23712e4-415d-4cdd-867a-5278b1b073ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_srt_EuropeMember_c23712e4-415d-4cdd-867a-5278b1b073ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c31d2ad2-cfdb-4354-bf5c-f71e0792fa40" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_srt_AsiaPacificMember_c31d2ad2-cfdb-4354-bf5c-f71e0792fa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_1186ac4c-d609-4a7d-bb77-c87b57f311a5" xlink:href="iart-20201231.xsd#iart_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b660097-7983-4347-9163-5e132015b9b1" xlink:to="loc_iart_RestOfWorldMember_1186ac4c-d609-4a7d-bb77-c87b57f311a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff9856de-a6eb-4bc0-9018-b109e5059387" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4be1e39c-a991-4e80-87f6-45f7ecd94b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4be1e39c-a991-4e80-87f6-45f7ecd94b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_485fc8f3-df90-4237-9abe-b87c7b8b59e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fa2eba9c-c5a8-4395-802a-db31d8860453" xlink:to="loc_us-gaap_NoncurrentAssets_485fc8f3-df90-4237-9abe-b87c7b8b59e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a62827ac-123b-4c8c-8691-2584f1159cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_0ced8f51-df8c-42d7-9107-5f2085ced706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a62827ac-123b-4c8c-8691-2584f1159cfa" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_0ced8f51-df8c-42d7-9107-5f2085ced706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SUBSEQUENTEVENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_55aed45b-9648-4c0e-bc57-4ffe97a5a9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_55aed45b-9648-4c0e-bc57-4ffe97a5a9e3" xlink:to="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27c40ea6-2a23-4c17-bb3f-71a152503add" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edb7712f-434c-413b-966f-4ed78331ce43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4dfa43f1-2a7c-4840-b579-eacb4cf5568d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edb7712f-434c-413b-966f-4ed78331ce43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9c2ac05-d644-492d-a888-b67c2de67e38" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SmithNephewUSDLimitedMember_6b64d893-b50d-47af-8cd1-9c1e1c659824" xlink:href="iart-20201231.xsd#iart_SmithNephewUSDLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acf14005-c798-41dd-a8db-ffbf3b0bcb73" xlink:to="loc_iart_SmithNephewUSDLimitedMember_6b64d893-b50d-47af-8cd1-9c1e1c659824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_be730c3b-f48e-464b-a5b7-676f2e2416e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4f2bb48f-e369-44d2-9563-9db0125e14de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2ec5f335-088b-425c-a1e8-7cf845cb8ec3" xlink:to="loc_us-gaap_SubsequentEventMember_4f2bb48f-e369-44d2-9563-9db0125e14de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_85a4c1e5-f158-4403-887d-42858d9cf84a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_a2f2a261-599c-4752-b6fb-ab9ded147825" xlink:href="iart-20201231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2d66342c-953c-4513-b400-539a6ceb330e" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_a2f2a261-599c-4752-b6fb-ab9ded147825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e004cc97-a363-41cd-b064-16955971ee21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_30d2a0fe-ce6a-44a4-986a-a6e0b9bcf4e3" xlink:href="iart-20201231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74dd59e1-b61f-4649-91c6-518aad4ccae8" xlink:to="loc_iart_ACellIncMember_30d2a0fe-ce6a-44a4-986a-a6e0b9bcf4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_eb92cf69-56ff-4828-8fe0-2793308d48f8" xlink:to="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember_099196d6-edcc-43af-bd80-d12826453e13" xlink:href="iart-20201231.xsd#iart_TwoThousandPlanAndTwoThousandOnePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_63634334-d2c2-4c5c-8602-33f17e7b4656" xlink:to="loc_iart_TwoThousandPlanAndTwoThousandOnePlanMember_099196d6-edcc-43af-bd80-d12826453e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d77b1037-33ed-49c7-b265-e670159466d8" xlink:to="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c4b88590-2255-4b5f-9e54-8cacf1b31d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c4b88590-2255-4b5f-9e54-8cacf1b31d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_97920a6b-15d9-4631-86f2-1d6a4dcc60d6" xlink:href="iart-20201231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_97920a6b-15d9-4631-86f2-1d6a4dcc60d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e39f4862-33dc-48ab-a507-288f65f0c115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e39f4862-33dc-48ab-a507-288f65f0c115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_31ee58e5-36d7-43f3-9f06-d4258d342369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_31ee58e5-36d7-43f3-9f06-d4258d342369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9b149798-63d4-4583-8ac9-84af06e51d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0955c8d7-d76b-46f8-892d-5183d2d933fa" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9b149798-63d4-4583-8ac9-84af06e51d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITED"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_a66563a8-ff7b-43b0-aef1-f31dcb22bda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_e40166a7-96da-43cd-8b88-7817a6e6595f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_a66563a8-ff7b-43b0-aef1-f31dcb22bda9" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_e40166a7-96da-43cd-8b88-7817a6e6595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_5af3fc17-c651-4c53-8a87-8ec12518b5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_d038710c-4ee5-4216-a665-080c58bc7c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_5af3fc17-c651-4c53-8a87-8ec12518b5f1" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_d038710c-4ee5-4216-a665-080c58bc7c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelectedQuarterlyFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_51a5a112-8020-44af-ac21-851892975d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_51a5a112-8020-44af-ac21-851892975d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f477eabc-547f-4086-a4c7-8f47f5907e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:to="loc_us-gaap_GrossProfit_f477eabc-547f-4086-a4c7-8f47f5907e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eefc0cd6-07f7-4018-9c69-d2880f59827d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:to="loc_us-gaap_NetIncomeLoss_eefc0cd6-07f7-4018-9c69-d2880f59827d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c1ccbfd4-7b1a-4046-b691-ef29e637bc32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:to="loc_us-gaap_EarningsPerShareBasic_c1ccbfd4-7b1a-4046-b691-ef29e637bc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_89abf71b-5dd2-488c-b303-03c29333efbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SelectedQuarterlyFinancialInformationAbstract_1073728d-be91-42db-8656-867930d2483f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_89abf71b-5dd2-488c-b303-03c29333efbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_60a57316-d1c9-4864-bfcb-5e3b5e87c278" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_a230e533-c288-4f9f-a59d-13fa3ebfee04" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_60a57316-d1c9-4864-bfcb-5e3b5e87c278" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_a230e533-c288-4f9f-a59d-13fa3ebfee04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="iart-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_c83588a4-6db7-4574-82a8-6c9779d383cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_c83588a4-6db7-4574-82a8-6c9779d383cb" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c058afb1-99d4-4a03-8871-978b5dc0b645" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_fd0b0495-26f2-48c0-a467-f8b58d0fc627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_fd0b0495-26f2-48c0-a467-f8b58d0fc627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_6f118e12-3171-4683-946b-b4ee2da46999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_468e541a-037b-47e0-8715-87c6d694267a" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_6f118e12-3171-4683-946b-b4ee2da46999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7bb98f26-4897-4c20-933a-97dadac7976d" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7f73fd45-d7bd-498b-8748-98bae6bd58ce" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a83c1e3b-9489-4d2a-a398-108a93262c90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a83c1e3b-9489-4d2a-a398-108a93262c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c82eb570-30bb-410c-a8f1-a0da2740aeca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c82eb570-30bb-410c-a8f1-a0da2740aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_bf83319b-fd5c-416d-b886-e09ddcdf3a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_bf83319b-fd5c-416d-b886-e09ddcdf3a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_40aec9b4-1622-4fd4-8c90-6a4116652ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_40aec9b4-1622-4fd4-8c90-6a4116652ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a3c87747-7ee7-41f8-a213-6ea70af88848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_43534b21-5dc2-4bdc-8c1b-01453791c2fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a3c87747-7ee7-41f8-a213-6ea70af88848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iart-20201231_g1.jpg
<TEXT>
begin 644 iart-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" $8 ?(# 2(  A$! Q$!_\0
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M+VT;:RJ4J=56FKEQG*'PL]^T'QGHWB$*MG<B.X/6WF^5_P .Q_#-;U?,8RK
MJ2".01VKNO#/Q,O]+V6VLAKZU' DS^]0?7^+\>?>O'KY:U[U)W\CNIXM/29[
M%15/2]6LM9L5N]-G6:)NN.JGT([&KE>0TT[,[DTU=!1112&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4R66."%I9G5(T&69C@ 4D\\5M
M\UPXCCC&YF8\ 5YAXG\3S:W*8(-T5DI^5.[GU;_"N/%XN&&C=ZOHCMP>#GBI
MV6BZLZO7M7GEM86T]Q]BN$R)T/+^H]OI7,>74/AS6DLRVG:C\VGW!Y)ZPMV8
M?U_SG5OK"6RF:)B#D91^H8=C1A,5'$T^9;]0QF$EA:G*]NC,&35K"*:YB:8F
M2UV>:JQLQ&\X4# Y)/&!DU8L[^"6>%[.7<_EK<(54\*3\I/''(/!YX/H:Q;;
MP]?6UQ<B\:.^@-J@S$IADFE61WSN\S*MN.[/ Y&,8J;2=+U/3=66+G[&4!D8
M%"A.W  S^\R#@#/&T<_-DGL.(]#O-MS'#?1#"W"Y8#^%AU%5,5)HC^=!-I[G
ME_WD6>S#J/Q']:0C!P:^(S;"*CB.=;2U^?4]C"U>:%GNBN+6!1*%AC'G'=+A
M1^\. ,GUX '/84S^SK/[1#/]D@\Z!=D4GEC=&N,84]0/85<6-G;"*S'T S5N
M/2KN3GR]H_VCBO.IT*U3^&F_0Z)3A'XF4,43C_B1:U_V#9__ $&M=="E(^>5
M!] 33I- \RPO;8W&/M5L\&[9G;N&,]>?I7L9=EV(I8JG5G&R3\CDQ%>G*E**
M>K/G_%&*])?X0SC_ %>KQM_O0$?^S&LVZ^%FNPY,#VMR.P20J?U 'ZU^LQQE
M![2/D70J+H<1BC%;&H>&=9TK)OM.GC4=7"[E_P"^AD5EXKHC.,E>+N9.+6C(
M\48J3%&*JXB/%&*DQ1BBX%W1M;O] OA=:;,8WZ,IY5QZ,.]>S>%?&-EXFM]J
MX@O4&9+=C^J^H_E7AF*EM;B>RNH[FTE:*:-MR.IP0:X\3A85U?9]S>E6E3?D
M?2%%<KX,\9Q>([?[/=;8M1B7+(.!(/[R_P!1755\Y4IRIRY9;GK1DIJZ"BBB
MLR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&8*I9B  ,DGM2UQOC;7_
M "T.E6C_ #,/W[ ]!_=_'O6%>M&A3<Y'1AZ$J]10B8OBSQ(VKW!M;1B+*,]O
M^6I]3[>E<WMJ3%&*^/JU)5IN<]S[2C2A1@H0V1'MKJO#NJ)>VRZ/J,F&!_T2
M9OX3_</L>WY>E<SBC%7AZTJ%13B1B*$,13<)'730/!,T4J[74X(J/;5G2[\>
M(++R)SC4K=?E8_\ +=!_4?Y[XV--T G$M\,#J(O7Z_X5]?1JQK04XGQE:C.C
M-PGN9>FVEW-=))9H<QL#O/"CZFNH.EV[W#2R G<<[<\ U<1%C0*BA5'0 8 I
M:*E&G5M[17L9QG*/PL:D:1KMC4*/0#%.HHK1))61(4444P"BBB@ K$U?PAHN
MM F[LU24_P#+:'Y'_,=?QS6W151G*#O%V$XJ2LSR77?AE?V"M-I$GVZ$<F/&
M)%_#HWX?E7$R1/%(R2HR.IPRL,$'Z5](5A^(O">G>(H?])3RKD#Y+B,?,/8^
MH]C^E>I0S&2TJ_><=3"IZP/"<48K:U_PS?\ AVZ$=Z@:-R?+F3E7_P #[5DX
MKV8SC-<T7H<#BXNS(\48J3%&*8AUK<3V5U'<VLC131-N1UZ@U[;X1\3Q>)-+
M#-M2\B $\0_]"'L?TKQ#%:&B:O<Z%JT5]:?>3AD/1U/537)BL.J\--UL;T:K
MIR\CWZBJNF:C;ZMIL-[9MNBE7(]0>X/N#Q5JOFVFG9GJIW5T%%%%(84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% %#6M432-+EN6P7QMC4_Q,>@_K^%>42R//,\L
MK%W=BS,>Y-=%XQU(WVKFWC;,-M\N >"W<_T_"N>VU\QF%?VM7E6R/JLNP_L:
M7,]Y$>*,5)MHVUYUCT[D>*<D;22*D:EG8X51R2:=MKO/"7AU;2%-0O$S<.,Q
MJP_U:^OU-=&'P\J\^5'-B<3'#T^9_(E\->%DTH+=7@#WA' [1>P]_>NDHHKZ
MNE2A1AR06A\A6K3K3YYO4****U,@HHHH **** "BBB@ HHHH **** *VH:?:
MZI926E]$LL,@Y4]O<>A]Z\=\5^%)O#EZ-I:6SE/[J4CI_LGW_G7M=5M0L+;4
M[&2TO8Q)#(,$'M[CT-=6&Q,J,O(QJTE47F?/N*,5L>(M!FT#5GM)<M&?FADQ
M]]?7Z^M96*^BC)27,MCRG%IV8S%&*?BC%4([+X=>(?[/U(Z7=/BWNF_=DGA)
M/_K]/KBO5J^>!E6!4X(.00>E>W^%M9&N>'X+IB#,H\N8>CCK^?!_&O&S"C9^
MT77<[\+4NN1FQ1117E':%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'6+_^S=)GN1]Y
M5P@]6/ J]7(>.+W_ (][)3_TU<?H/ZUSXFK[*DY+<Z<+2]K6C%['&MEF+,22
M3DD]Z3%/Q1BOD['V%QF*,4_%.5&=PJ#+,< #N:+!<V?"FC#4=0\^=<V]N02#
M_$W8?U__ %UZ)5+2-/73-+AME W 9<CNQZU=KZG"4%0II=7N?)8S$.O5;Z+8
M****ZSC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$\5Z"FOZ*\*@?:8
MLO Q[-Z?0]/_ -5>+O&T;LCJ593@@]0:^@Z\N^(FC?8M86_A7$5W][ Z2#K^
M8Y_.O4P%:S]F_D<>)IW7.CB\48J3%&*]@X"/%=E\.-5-IKCV$C8BNU^4'LZ\
MC],C\JY'%2VEQ)97D-S"<20N'7Z@YK.K!5(./<N$N629[Y14-I<I>64-S%]R
M:-77Z$9J:OEWIH>P%%%% !1110 4444 %%07XN#IUR+(XN?*;R3QP^#MZ\=<
M=:R/#*>(%^U?\)')O^YY/$8QUW?<_#K5J%XN5UI]Y+E9VL:ZWMJ\<,B7,+).
MVV)A(")#@G"GN< ]/0T^:>&VB,MQ*D48(!>1@HR3@#)]20/QKC]*BN6AT#2F
MLKJ.XTVZ>6Y>2!EB50DB@B0C:^2ZX"DG&<XP:H0VVNVVG6;I)J\DUQ:(]SYD
MDK%9!<Q<8/W#L+Y QD DYY-04>ATR::*V@>:XD2**,;GD=@JJ/4D]*X":RO;
M&WU&"Q_M.#S-7W7,FRZF_P!'*L59-KJS?/MW&-MV/O<#%1:S;:A/HDMK<2:S
MJ&=+VV;06T\0DEWR;Q*AR<[/+ \PDG!(RQH [Z]U*QTU8SJ-[;V@D;:AGE5-
MY]!D\FK-<SXN0JT%S;Q7;7L4,RP>79FYAE#;=T,J@$@-M'/RXP?F['!2TO+/
M3[Z'[/J5O<3ZF'N'!O9EBC*,P9/*<&3YOE.QNX+=!0!Z)17GEI;:NIM-0>+4
M?[7DT)TA:3S=HN5!PLBYV XQ]_@GGDT(E[%H,C?VCJ]P%G206OV#4(G?",#&
M9"SR*&.T[@=JE1P=Q! /0Z*BM&9K.%I(VB8QJ6C=MS(<=">Y'K4M !1110 4
M444 %%%% !1110 4444 %%%% !1110 5YMXCN/M6OW3@Y56\L?\  >/YYKT>
M6010O(>B*6/X5Y2[&1V=CEF.2?>O)S.7NQB>QE</>E,CQ1BG8HQ7B6/>N-Q6
MYX3L?M6MK(PREN/,/UZ#_'\*Q<5W'@RV\K2I9R.9I.#[#_Z^:Z\'3YZROTU.
M+&U?9T';KH=%1117TQ\L%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5C>+--_M3PU=0JN9(U\V/_>7G]1D?C6S151DX24ET%)<RLSP#%&*T=;LO
M[/UR\M0,+'*P4?[.<C]"*HXKZ>,DU='CM6=AF*,4_%&*8CUCP%>_:_"L*$Y:
MW=HC_,?H1^5=)7 ?#*XP^H6Q/4)(H_,'^E=_7SN*CRUI(]6B[TT%%%%<YJ%%
M%% !1110 4444 %%9^F:Y9:ON-@;AT R))+66-&&<?*S* WX$UH4 %%%% !1
M15"VUO3KM[Y;>Y#'3W*7.5*^61UZCD<'D<<&@"_15+3=7L]6MXY]/>26*2/S
M$D,+JI&2O5@.<@\=?;D5+%?6\YN1%)N^RR&.;Y2-K!0V/?A@>/6@"Q15/3]6
MLM51FL)O-"JC$[&7 = Z]0.JL#4E_?V^F6,EW>N4@CQN949SR0!@*"3R1T%
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M.<CCCK0!I#Q/I?VY+)[@BY9HT*K#(45G4,H+[=HR#QG&>G7BDUWQ FB26:M
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M#CH<]%OL=51117O'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>RJ-=#Z/#U?:TT^O43%&*6BN<Z"2WGDM;A)H3AT.0:[S3[Z/4+-9XN,\,O\
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M%<1"2"19$;HR'(->5.G.F[21VQG&6P^BBBLR@HHHH **** "BBB@ H) !).
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>iart-20201231_g2.jpg
<TEXT>
begin 644 iart-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !   RP%$2
M  0    !   RP        8:@  "QC__; $,  @$! @$! @(" @(" @(#!0,#
M P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,# P'"0X/#0P."PP,
M#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$(!(4'O@,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
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M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
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MB?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\
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MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
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M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
MQ%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'
M_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^
M)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4
M <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_
M .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_
MB?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\
M"@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=
M3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 1
M7<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"
M@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3
M_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$
M4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_
M )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG
M_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!
MPW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\
MY^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)
M_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P *
M T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/
M_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=
MS10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\*
MT?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_
M +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11
M_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\
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M_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G4_\
MOXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_
M  H#1_\ GYU/_OXG_P 17<T4 <-_PH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?
MG4_^_B?_ !%=S10!PW_"@-'_ .?G4_\ OXG_ ,11_P * T?_ )^=3_[^)_\
M$5W-% '#?\* T?\ Y^=3_P"_B?\ Q%'_  H#1_\ GYU/_OXG_P 17<T4 <-_
MPH#1_P#GYU/_ +^)_P#$4?\ "@-'_P"?G4_^_B?_ !%=S10!PW_"@-'_ .?G
M4_\ OXG_ ,11_P * T?_ )^=3_[^)_\ $5W-% '#?\* T?\ Y^=3_P"_B?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Y!\?_ /D<K7_KR7_T.2O7Z\@^/_\ R.5K_P!>
M2_\ H<E '3? #_D3;K_K];_T".NYKAO@!_R)MU_U^M_Z!'7<T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!\?\ _D<K7_KR7_T.
M2O7Z\@^/_P#R.5K_ ->2_P#H<E '3? #_D3;K_K];_T".NYKAO@!_P B;=?]
M?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!S_C#QE)X:US1;2.&.1=4G\EV8D%!N09'_?7Z
M5T%<-\5?^1R\(_\ 7[_[/%7<T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!E^--??POX9NKZ.-97MPI"L< Y8#^M6/#VIMK.A6=XRJC74*2E1T
M4D XK'^+G_).]2_W4_\ 1BU>\"?\B7I/_7I%_P"@B@#6HHHH **** "BBB@
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MCWXL_P"OD?\ H<E '<T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7/ZCXRDLOB'8:*(8VBO(#,9"3N4@2'&/^ #\ZZ"N&U[_DO&B_\ 7DW\IJ .
MYHHHH **** "BBB@ HHHH **** "O(/C_P#\CE:_]>2_^AR5Z_7D'Q__ .1R
MM?\ KR7_ -#DH Z;X ?\B;=?]?K?^@1UW-<-\ /^1-NO^OUO_0(Z[F@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH X;XJ_\ (Y>$?^OW_P!GBKN:X;XJ_P#(Y>$?^OW_ -GBKN: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOXN?\D[U+_=3_P!&+5[P
M)_R)>D_]>D7_ *"*H_%S_DG>I?[J?^C%J]X$_P"1+TG_ *](O_010!K4444
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M)_R)>D_]>D7_ *"*H_%S_DG>I?[J?^C%J]X$_P"1+TG_ *](O_010!K4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7#?#'_ )'OQ9_U\C_T.2NY
MKAOAC_R/?BS_ *^1_P"AR4 =S1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<-KW_)>-%_Z\F_E-7<UPVO?\EXT7_KR;^4U '<T444 %%%% !111
M0 4444 %%%% !7D'Q_\ ^1RM?^O)?_0Y*]?KR#X__P#(Y6O_ %Y+_P"AR4 =
M-\ /^1-NO^OUO_0(Z[FN&^ '_(FW7_7ZW_H$==S0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <-\5?^
M1R\(_P#7[_[/%7<UPWQ5_P"1R\(_]?O_ +/%7<T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!S?Q<_Y)WJ7^ZG_HQ:O>!/^1+TG_KTB_\ 015'
MXN?\D[U+_=3_ -&+5[P)_P B7I/_ %Z1?^@B@#6HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N&^&/_ "/?BS_KY'_H<E=S7#?#'_D>_%G_ %\C
M_P!#DH [FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;Q+_P E
MOT+_ *]F_E+7<UPWB7_DM^A?]>S?REH [FBBB@ HHHH **** "BBB@ HHHH
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M%J]X$_Y$O2?^O2+_ -!% &M1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<-\,?^1[\6?]?(_P#0Y*[FN&^&/_(]^+/^OD?^AR4 =S1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<-XE_Y+?H7_ %[-_*6NYKAO$O\
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M^+?_ ",OA7_K]_\ 9HZ[F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_HQ:O>!/^1+TG_KTB_]!%4?BY_R3O4O]U/_ $8M7O G_(EZ3_UZ1?\ H(H
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M%%% !1110 4444 <-\6_^1E\*_\ 7[_[-'7<UPWQ;_Y&7PK_ -?O_LT==S0
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MB@ HHHH **** "O(/C__ ,CE:_\ 7DO_ *')7K]>0?'_ /Y'*U_Z\E_]#DH
MZ;X ?\B;=?\ 7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".NYH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^X/[<P'_ #]C]Y]D45\;_P##\GX+_P#/KXV_\%D7_P >H_X?D_!?_GU\;?\
M@LB_^/4?ZIYS_P! T_N#^W,!_P _8_>?9%%?&_\ P_)^"_\ SZ^-O_!9%_\
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M[<P'_/V/WGV117QO_P /R?@O_P ^OC;_ ,%D7_QZC_A^3\%_^?7QM_X+(O\
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M@J'WA_J-G_\ T"3^X^D**^;_ /AZ5\,_^>'B?_P!3_XY1_P]*^&?_/#Q/_X
MI_\ '*/]=,B_Z"H?>'^HV?\ _0)/[CZ0HKYO_P"'I7PS_P">'B?_ , 4_P#C
ME'_#TKX9_P#/#Q/_ . *?_'*/]=,B_Z"H?>'^HV?_P#0)/[CZ0HKYO\ ^'I7
MPS_YX>)__ %/_CE'_#TKX9_\\/$__@"G_P <H_UTR+_H*A]X?ZC9_P#] D_N
M/5])_P"2\:I_UY+_ "BKN:^2;'_@H]\/;;XGWFL-#XB^R7%N(E LTWYPG4>9
M_LFNF_X>E?#/_GAXG_\  %/_ (Y1_KID7_05#[P_U&S_ /Z!)_<?2%%?-_\
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M\_V373?\/2OAG_SP\3_^ *?_ !RC_73(O^@J'WA_J-G_ /T"3^X^D**^;_\
MAZ5\,_\ GAXG_P# %/\ XY1_P]*^&?\ SP\3_P#@"G_QRC_73(O^@J'WA_J-
MG_\ T"3^X^D**^;_ /AZ5\,_^>'B?_P!3_XY1_P]*^&?_/#Q/_X I_\ '*/]
M=,B_Z"H?>'^HV?\ _0)/[CZ0HKYO_P"'I7PS_P">'B?_ , 4_P#CE'_#TKX9
M_P#/#Q/_ . *?_'*/]=,B_Z"H?>'^HV?_P#0)/[CZ0HKYO\ ^'I7PS_YX>)_
M_ %/_CE'_#TKX9_\\/$__@"G_P <H_UTR+_H*A]X?ZC9_P#] D_N/I"BOF__
M (>E?#/_ )X>)_\ P!3_ ..4?\/2OAG_ ,\/$_\ X I_\<H_UTR+_H*A]X?Z
MC9__ - D_N/I"BOF_P#X>E?#/_GAXG_\ 4_^.4?\/2OAG_SP\3_^ *?_ !RC
M_73(O^@J'WA_J-G_ /T"3^X^D**^;_\ AZ5\,_\ GAXG_P# %/\ XY1_P]*^
M&?\ SP\3_P#@"G_QRC_73(O^@J'WA_J-G_\ T"3^X^D**^;_ /AZ5\,_^>'B
M?_P!3_XY1_P]*^&?_/#Q/_X I_\ '*/]=,B_Z"H?>'^HV?\ _0)/[CVSXN?\
MD[U+_=3_ -&+5[P)_P B7I/_ %Z1?^@BOFWQY_P4N^'/B3PG>6-O#XD$TX4+
MOLD"\,#_ ,]/:K7AG_@IS\-](\.V-K-#XE\RW@2-]MDA&0 #C]Y1_KID7_05
M#[P_U&S_ /Z!)_<?3U%?-_\ P]*^&?\ SP\3_P#@"G_QRC_AZ5\,_P#GAXG_
M / %/_CE'^NF1?\ 05#[P_U&S_\ Z!)_<?2%%?-__#TKX9_\\/$__@"G_P <
MH_X>E?#/_GAXG_\  %/_ (Y1_KID7_05#[P_U&S_ /Z!)_<?2%%?-_\ P]*^
M&?\ SP\3_P#@"G_QRC_AZ5\,_P#GAXG_ / %/_CE'^NF1?\ 05#[P_U&S_\
MZ!)_<?2%%?-__#TKX9_\\/$__@"G_P <H_X>E?#/_GAXG_\  %/_ (Y1_KID
M7_05#[P_U&S_ /Z!)_<?2%%?-_\ P]*^&?\ SP\3_P#@"G_QRC_AZ5\,_P#G
MAXG_ / %/_CE'^NF1?\ 05#[P_U&S_\ Z!)_<?2%%?-__#TKX9_\\/$__@"G
M_P <H_X>E?#/_GAXG_\  %/_ (Y1_KID7_05#[P_U&S_ /Z!)_<?2%%?-_\
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MP\3_ /@"G_QRC_73(O\ H*A]X?ZC9_\ ] D_N/I"BOF__AZ5\,_^>'B?_P
M4_\ CE'_  ]*^&?_ #P\3_\ @"G_ ,<H_P!=,B_Z"H?>'^HV?_\ 0)/[CZ0H
MKYO_ .'I7PS_ .>'B?\ \ 4_^.4?\/2OAG_SP\3_ /@"G_QRC_73(O\ H*A]
MX?ZC9_\ ] D_N/I"BOF__AZ5\,_^>'B?_P  4_\ CE'_  ]*^&?_ #P\3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0
MOV</^1NU+_L'-_Z.AKSVO0OV</\ D;M2_P"P<W_HZ&OS'QF_Y(C,O^O3_-'Z
M'X3_ /)89?\ ]?%^IZ]1117^4I_I:%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y]_X*/?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ KT+]G#_D;M2_[!S?^CH:\]KT+]G#_ )&[4O\
ML'-_Z.AK\Q\9O^2(S+_KT_S1^A^$_P#R6&7_ /7Q?J>O4445_E*?Z6A1110
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M -%W%?;^'/\ R46&_P"WO_2)'P?B;_R36)_[<_\ 3D3[\HHHK^K3^0PHHHH
M**** "BBB@ HHHH *\@^/_\ R.5K_P!>2_\ H<E>OUY!\?\ _D<K7_KR7_T.
M2@#IO@!_R)MU_P!?K?\ H$==S7#? #_D3;K_ *_6_P#0(Z[F@ HHHH ****
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M9(U4E3]J&0<<<"OLKX#?&;3?VA?A#H?C32+/5=/TW7X#/!;ZE (+N$!V0B1
MS '*GHQ!&""<U>^%'_)+?#7_ &"K7_T2M=!0!^2_[''C;]HO]L/XD?$[X=^'
M?B-KF@^&[/Q)+=:SXJO+Z:]OM*M_,D2&QL@SYCWE&;"% !']Y0-KV/VA-9^,
MW_!'7]H3PGJ-C\1/$WQ:\)>.$GB&EZ]=RR&XGCVJ8VW-)L?,L3+)'M+?,I&
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M,:I?M'>%?CA_P2'N?#_Q T?XK>)OBE\.IK^/3]8T?Q%+).;</N8;=SN$#;6
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M:G@Y.3=G+F5O=3Z)76^^NVPNAZA#X=^.VO#4)H[?[=;H\$DK!5< +P"?H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?5'_!*W_DJ.K?[D7_HNXKY7KZH_X)6_\E1U;_<B_P#1
M=Q7V_AS_ ,E%AO\ M[_TB1\'XF_\DUB?^W/_ $Y$^_****_JT_D,**** "BB
MB@ HHHH **** "O(/C__ ,CE:_\ 7DO_ *')7K]>0?'_ /Y'*U_Z\E_]#DH
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MXC_\$X?B=IGQD\3>*OA3^T!XD\#67BS4)=4O=%N['^T+2&XE):1X@T@0 DG
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M@XI.22;UNU';K;HKV2O8****]X\T**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZH_X)6_\
M)4=6_P!R+_T7<5\KU]4?\$K?^2HZM_N1?^B[BOM_#G_DHL-_V]_Z1(^#\3?^
M2:Q/_;G_ *<B??E%%%?U:?R&%%%% !1110 4444 %%%% !7D'Q__ .1RM?\
MKR7_ -#DKU^O(/C_ /\ (Y6O_7DO_H<E '3? #_D3;K_ *_6_P#0(Z[FN&^
M'_(FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?/O\ P4>_Y-S\3?\ 8MZO_P"DM?A[
M7[A?\%'O^3<_$W_8MZO_ .DM?A[7[=X4_P"Z5_\ $OR/SOC3^/3]'^84445^
MK'Q84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>A?LX?\C=J7_8.;_T=#7GM>A?LX?\ (W:E_P!@YO\ T=#7YCXS
M?\D1F7_7I_FC]#\)_P#DL,O_ .OB_4]>HHHK_*4_TM"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *^J/^"5O_)4=6_W(O\ T7<5\KU]4?\ !*W_ )*C
MJW^Y%_Z+N*^W\.?^2BPW_;W_ *1(^#\3?^2:Q/\ VY_Z<B??E%%%?U:?R&%%
M%% !1110 4444 %%%% !7D'Q_P#^1RM?^O)?_0Y*]?KR#X__ /(Y6O\ UY+_
M .AR4 =-\ /^1-NO^OUO_0(Z[FN&^ '_ ")MU_U^M_Z!'7<T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'S[_P4>_Y-S\3?]BWJ_P#Z2U^'M?N%_P %'O\ DW/Q-_V+>K_^DM?A[7[=
MX4_[I7_Q+\C\[XT_CT_1_F%%%%?JQ\6%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7H7[.'_ "-VI?\ 8.;_ -'0
MUY[7H7[.'_(W:E_V#F_]'0U^8^,W_)$9E_UZ?YH_0_"?_DL,O_Z^+]3UZBBB
MO\I3_2T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !#]ZQ_T4[3?_!(__P >H_XA^]8_Z*=IO_@D?_X]7Z:44?\ $0<]_P"?R_\
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M<]_Y_+_P&'_R(?ZKY;_)^,O\S\R_^(?O6/\ HIVF_P#@D?\ ^/4?\0_>L?\
M13M-_P#!(_\ \>K]-**/^(@Y[_S^7_@,/_D0_P!5\M_D_&7^9^9?_$/WK'_1
M3M-_\$C_ /QZC_B'[UC_ **=IO\ X)'_ /CU?II11_Q$'/?^?R_\!A_\B'^J
M^6_R?C+_ #/S+_XA^]8_Z*=IO_@D?_X]1_Q#]ZQ_T4[3?_!(_P#\>K]-**/^
M(@Y[_P _E_X##_Y$/]5\M_D_&7^9^9?_ !#]ZQ_T4[3?_!(__P >H_XA^]8_
MZ*=IO_@D?_X]7Z:44?\ $0<]_P"?R_\  8?_ "(?ZKY;_)^,O\S\R_\ B'[U
MC_HIVF_^"1__ (]1_P 0_>L?]%.TW_P2/_\ 'J_32BC_ (B#GO\ S^7_ (##
M_P"1#_5?+?Y/QE_F?F7_ ,0_>L?]%.TW_P $C_\ QZL7QU_P0LU;P1HZ7C?$
M?3[@-*(MHT9UQD$YSYI]*_4ZN)^/?_(EP_\ 7VG_ *"]'_$0<]_Y_+_P&'_R
M(?ZKY;_)^,O\SX 3_@W]UAT5O^%G:;\PS_R!'_\ CU+_ ,0_>L?]%.TW_P $
MC_\ QZOTR@_U"?[HIU'_ !$'/?\ G\O_  &'_P B'^J^6_R?C+_,_,O_ (A^
M]8_Z*=IO_@D?_P"/4?\ $/WK'_13M-_\$C__ !ZOTTHH_P"(@Y[_ ,_E_P"
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M]8_Z*=IO_@D?_P"/4?\ $/WK'_13M-_\$C__ !ZOTTHH_P"(@Y[_ ,_E_P"
MP_\ D0_U7RW^3\9?YGYE_P#$/WK'_13M-_\ !(__ ,>KHOAI_P $-M6^'^LW
M-TWQ%T^Z%Q;&WVC1W3;ET;/^M/\ <Q^-?HE17EYWQ1F6;X"KEN/J<U*JN62M
M%77JDFODSTLGRW#Y7C:>88)<M6F[Q=V[/T=T_FCX?_X=%:E_T/%C_P""QO\
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ME_T/%C_X+&_^.5]P44?\0SX=_P"?#_\  Y__ "0?\12XE_Y_K_P"'_R)\/\
M_#HK4O\ H>+'_P %C?\ QRC_ (=%:E_T/%C_ ."QO_CE?<%%'_$,^'?^?#_\
M#G_\D'_$4N)?^?Z_\ A_\B?#_P#PZ*U+_H>+'_P6-_\ '*/^'16I?]#Q8_\
M@L;_ ..5]P44?\0SX=_Y\/\ \#G_ /)!_P 12XE_Y_K_ , A_P#(GP__ ,.B
MM2_Z'BQ_\%C?_'*/^'16I?\ 0\6/_@L;_P".5]P44?\ $,^'?^?#_P# Y_\
MR0?\12XE_P"?Z_\  (?_ ")\/_\ #HK4O^AXL?\ P6-_\<H_X=%:E_T/%C_X
M+&_^.5]P44?\0SX=_P"?#_\  Y__ "0?\12XE_Y_K_P"'_R)\/\ _#HK4O\
MH>+'_P %C?\ QRC_ (=%:E_T/%C_ ."QO_CE?<%%'_$,^'?^?#_\#G_\D'_$
M4N)?^?Z_\ A_\B? OBK_ ()>ZAX7U'2[=O&%G-_:4WDAAIS+Y?*C/^LY^]^E
M;7_#HK4O^AXL?_!8W_QROJ?XM_\ (R^%?^OW_P!FCKN:/^(9\._\^'_X'/\
M^2#_ (BEQ+_S_7_@$/\ Y$^'_P#AT5J7_0\6/_@L;_XY1_PZ*U+_ *'BQ_\
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MC_B&?#O_ #X?_@<__D@_XBEQ+_S_ %_X!#_Y$^'_ /AT5J7_ $/%C_X+&_\
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M ,.BM2_Z'BQ_\%C?_'*/^'16I?\ 0\6/_@L;_P".5]P44?\ $,^'?^?#_P#
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M\%C?_'*^X**/^(9\._\ /A_^!S_^2#_B*7$O_/\ 7_@$/_D3X?\ ^'16I?\
M0\6/_@L;_P".4?\ #HK4O^AXL?\ P6-_\<K[@HH_XAGP[_SX?_@<_P#Y(/\
MB*7$O_/]?^ 0_P#D3X?_ .'16I?]#Q8_^"QO_CE'_#HK4O\ H>+'_P %C?\
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M=-/1MK9L\_-./L\S'"RP>+K*5.5KKEBMFFM4D]TCN:***^N/C0HHHH ****
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MS?REKN:X;Q+_ ,EOT+_KV;^4M '<T444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCWXL_P"OD?\ H<E=S7#?#'_D>_%G_7R/_0Y* .YHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N&U[_DO&B_]>3?RFKN:X;7O^2\:+_UY-_*:@#N
M:*** "BBB@ HHHH **** "BBB@ KR#X__P#(Y6O_ %Y+_P"AR5Z_7D'Q_P#^
M1RM?^O)?_0Y* .F^ '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_ - CKN:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#AOBK_R.7A'_K]_]GBKN:X;XJ_\CEX1_P"OW_V>*NYH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_BY_P D[U+_ '4_]&+5
M[P)_R)>D_P#7I%_Z"*H_%S_DG>I?[J?^C%J]X$_Y$O2?^O2+_P!!% &M1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<-\,?^1[\6?\ 7R/_ $.2
MNYKAOAC_ ,CWXL_Z^1_Z')0!W-%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5PWB7_DM^A?]>S?REKN:X;Q+_P EOT+_ *]F_E+0!W-%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5Q/Q[_Y$N'_ *^T_P#07KMJXGX]
M_P#(EP_]?:?^@O0!VD'^H3_=%.IL'^H3_=%.H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#AO@+_R+5]_U^M_Z"M=S7#? 7_D6K[_K];_T%:[F
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .&TG_DO&J?\ 7DO\
MHJ[FN&TG_DO&J?\ 7DO\HJ[F@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .&^+?_(R^%?^OW_V:.NYKAOBW_R,OA7_ *_?_9HZ[F@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .;^+G_ "3O4O\ =3_T8M7O G_(
MEZ3_ ->D7_H(JC\7/^2=ZE_NI_Z,6KW@3_D2])_Z](O_ $$4 :U%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5PWPQ_Y'OQ9_P!?(_\ 0Y*[FN&^
M&/\ R/?BS_KY'_H<E '<T444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7#:]_R7C1?^O)OY35W-<-KW_)>-%_Z\F_E-0!W-%%% !1110 4444 %%%
M% !1110 5Y!\?_\ D<K7_KR7_P!#DKU^O(/C_P#\CE:_]>2_^AR4 =-\ /\
MD3;K_K];_P! CKN:X;X ?\B;=?\ 7ZW_ *!'7<T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ KAOAC_R/?BS_KY'_H<E=S7#?#'_ )'OQ9_U\C_T.2@#N:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KAM>_P"2\:+_ ->3?RFKN:X;7O\
MDO&B_P#7DW\IJ .YHHHH **** "BBB@ HHHH **** "O(/C_ /\ (Y6O_7DO
M_H<E>OUY!\?_ /D<K7_KR7_T.2@#IO@!_P B;=?]?K?^@1UW-<-\ /\ D3;K
M_K];_P! CKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/Q[_ .1+A_Z^T_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 <-\!?^1:OO\ K];_ -!6NYKAO@+_ ,BU??\ 7ZW_ *"M=S0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '#:3_R7C5/^O)?Y15W
M-<-I/_)>-4_Z\E_E%7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!PWQ;_P"1E\*_]?O_ +-'7<UPWQ;_ .1E\*_]?O\ [-'7<T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!S?Q<_Y)WJ7^ZG_ *,6KW@3_D2]
M)_Z](O\ T$51^+G_ "3O4O\ =3_T8M7O G_(EZ3_ ->D7_H(H UJ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KAOAC_ ,CWXL_Z^1_Z')7<UPWP
MQ_Y'OQ9_U\C_ -#DH [FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *X;7O^2\:+_P!>3?RFKN:X;7O^2\:+_P!>3?RFH [FBBB@ HHHH **** "
MBBB@ HHHH *\@^/_ /R.5K_UY+_Z')7K]>0?'_\ Y'*U_P"O)?\ T.2@#IO@
M!_R)MU_U^M_Z!'7<UPWP _Y$VZ_Z_6_] CKN: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#AOBK_P C
MEX1_Z_?_ &>*NYKAOBK_ ,CEX1_Z_?\ V>*NYH **** "BBB@ HHHH ****
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M$_W13J;!_J$_W13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MX;X"_P#(M7W_ %^M_P"@K7<UPWP%_P"1:OO^OUO_ $%:[F@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .&TG_DO&J?]>2_RBKN:X;2?^2\:I_U
MY+_**NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#AOBW_P C
M+X5_Z_?_ &:.NYKAOBW_ ,C+X5_Z_?\ V:.NYH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#F_BY_R3O4O]U/_ $8M7O G_(EZ3_UZ1?\ H(JC
M\7/^2=ZE_NI_Z,6KW@3_ )$O2?\ KTB_]!% &M1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<-\,?\ D>_%G_7R/_0Y*[FN&^&/_(]^+/\ KY'_
M *')0!W-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PVO?\EXT7
M_KR;^4U=S7#:]_R7C1?^O)OY34 =S1110 4444 %%%% !1110 4444 %>0?'
M_P#Y'*U_Z\E_]#DKU^O(/C__ ,CE:_\ 7DO_ *')0!TWP _Y$VZ_Z_6_] CK
MN:X;X ?\B;=?]?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!PWQ5_Y'+PC_ -?O_L\5=S7#
M?%7_ )'+PC_U^_\ L\5=S0 4444 %%%% !1110 4444 %%%% !1110 4444
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M5[P)_P B7I/_ %Z1?^@B@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N&^&/_ "/?BS_KY'_H<E=S7#?#'_D>_%G_ %\C_P!#DH [FBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *X;7O^2\:+_UY-_*:NYKAM>_Y
M+QHO_7DW\IJ .YHHHH **** "BBB@ HHHH **** "O(/C_\ \CE:_P#7DO\
MZ')7K]>0?'__ )'*U_Z\E_\ 0Y* .F^ '_(FW7_7ZW_H$==S7#? #_D3;K_K
M];_T".NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** .&^*O_(Y>$?\ K]_]GBKN:X;XJ_\ (Y>$?^OW
M_P!GBKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOXN?\D[
MU+_=3_T8M7O G_(EZ3_UZ1?^@BJ/Q<_Y)WJ7^ZG_ *,6KW@3_D2])_Z](O\
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M3_T8M7O G_(EZ3_UZ1?^@BJ/Q<_Y)WJ7^ZG_ *,6KW@3_D2])_Z](O\ T$4
M:U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PWPQ_Y'OQ9_U\C_
M -#DKN:X;X8_\CWXL_Z^1_Z')0!W-%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5PVO?\EXT7_KR;^4U=S7#:]_R7C1?^O)OY34 =S1110 4444
M%%%% !1110 4444 %>0?'_\ Y'*U_P"O)?\ T.2O7Z\@^/\ _P CE:_]>2_^
MAR4 =-\ /^1-NO\ K];_ - CKN:X;X ?\B;=?]?K?^@1UW- !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!PWQ5_Y'+PC_P!?O_L\5=S7#?%7_D<O"/\ U^_^SQ5W- !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 <W\7/\ DG>I?[J?^C%J]X$_Y$O2?^O2
M+_T$51^+G_).]2_W4_\ 1BU>\"?\B7I/_7I%_P"@B@#6HHHH **** "BBB@
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M/_\ R.5K_P!>2_\ H<E>OUY!\?\ _D<K7_KR7_T.2@#IO@!_R)MU_P!?K?\
MH$==S7#? #_D3;K_ *_6_P#0(Z[F@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\-+_  X_Z*!X)_\ !Y:__%U_/C11_P 0IP__ $$2_P# 5_F'^NM7_GTOO?\
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MZZU?^?2^]_Y']!W_  TO\./^B@>"?_!Y:_\ Q='_  TO\./^B@>"?_!Y:_\
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M1_Q"G#_]!$O_  %?YA_KK5_Y]+[W_D?T'?\ #2_PX_Z*!X)_\'EK_P#%T?\
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M_#C_ **!X)_\'EK_ /%U_/C11_Q"G#_]!$O_  %?YA_KK5_Y]+[W_D?T'?\
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M_P"+H_X:7^''_10/!/\ X/+7_P"+K^?&BC_B%.'_ .@B7_@*_P P_P!=:O\
MSZ7WO_(_H._X:7^''_10/!/_ (/+7_XNC_AI?X<?]% \$_\ @\M?_BZ_GQHH
M_P"(4X?_ *")?^ K_,/]=:O_ #Z7WO\ R/Z#O^&E_AQ_T4#P3_X/+7_XNC_A
MI?X<?]% \$_^#RU_^+K^?&BC_B%.'_Z")?\ @*_S#_76K_SZ7WO_ "/Z#O\
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MZZU?^?2^]_Y']!W_  TO\./^B@>"?_!Y:_\ Q='_  TO\./^B@>"?_!Y:_\
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M_P -+_#C_HH'@G_P>6O_ ,71_P -+_#C_HH'@G_P>6O_ ,77\^-%'_$*</\
M]!$O_ 5_F'^NM7_GTOO?^1_0=_PTO\./^B@>"?\ P>6O_P 71_PTO\./^B@>
M"?\ P>6O_P 77\^-%'_$*</_ -!$O_ 5_F'^NM7_ )]+[W_D?T'?\-+_  X_
MZ*!X)_\ !Y:__%T?\-+_  X_Z*!X)_\ !Y:__%U_/C11_P 0IP__ $$2_P#
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M_P P_P!=:O\ SZ7WO_(_H._X:7^''_10/!/_ (/+7_XNC_AI?X<?]% \$_\
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MW_\ X@EA?^@J7_@*_P S]??^%V>#/^AN\,?^#2#_ .*H_P"%V>#/^AN\,?\
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M#/\ H;O#'_@T@_\ BJ/^%V>#/^AN\,?^#2#_ .*K\@J*/^(R8G_H&C_X$_\
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M2PO_ $%2_P# 5_F?K[_PNSP9_P!#=X8_\&D'_P 51_PNSP9_T-WAC_P:0?\
MQ5?D%11_Q&3$_P#0-'_P)_Y!_P 02PO_ $%2_P# 5_F?K[_PNSP9_P!#=X8_
M\&D'_P 51_PNSP9_T-WAC_P:0?\ Q5?D%11_Q&3$_P#0-'_P)_Y!_P 02PO_
M $%2_P# 5_F?K[_PNSP9_P!#=X8_\&D'_P 51_PNSP9_T-WAC_P:0?\ Q5?D
M%11_Q&3$_P#0-'_P)_Y!_P 02PO_ $%2_P# 5_F?K[_PNSP9_P!#=X8_\&D'
M_P 51_PNSP9_T-WAC_P:0?\ Q5?D%11_Q&3$_P#0-'_P)_Y!_P 02PO_ $%2
M_P# 5_F?K[_PNSP9_P!#=X8_\&D'_P 51_PNSP9_T-WAC_P:0?\ Q5?D%11_
MQ&3$_P#0-'_P)_Y!_P 02PO_ $%2_P# 5_F?K[_PNSP9_P!#=X8_\&D'_P 5
M1_PNSP9_T-WAC_P:0?\ Q5?D%11_Q&3$_P#0-'_P)_Y!_P 02PO_ $%2_P#
M5_F?K[_PNSP9_P!#=X8_\&D'_P 57-Q^,M'\7_'326TG5=-U18;,B0VERDXC
M)6?&=I./QK\IJ^J/^"5O_)4=6_W(O_1=Q7O<,>)E?-<SI8"=!14[ZJ3=K1;[
M>1\]Q5X6X?*,JJYA#$2DX6T<4KWDH[W\S[\HHHK]>/Q@**** "BBB@ HHHH
M**** "O(/C__ ,CE:_\ 7DO_ *')7K]>0?'_ /Y'*U_Z\E_]#DH Z;X ?\B;
M=?\ 7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".NYH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /GW_ (*/
M?\FY^)O^Q;U?_P!):_#VOW"_X*/?\FY^)O\ L6]7_P#26OP]K]N\*?\ =*_^
M)?D?G?&G\>GZ/\PHHHK]6/BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "O?OA#_P DOT7_ *YR_P#H
M^6O :]^^$/\ R2_1?^N<O_H^6OYB^EA_R2&'_P"PF'_INL?T1]&?_DJ:W_7B
M?_IRD=%1117^>A_= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?5'_!*W_DJ.K?
M[D7_ *+N*^5Z^J/^"5O_ "5'5O\ <B_]%W%?;^'/_)18;_M[_P!(D?!^)O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *]^^$/_)+]%_ZYR_^CY:\!KW[X0_\DOT7_KG+_P"CY:_F+Z6'
M_)(8?_L)A_Z;K']$?1G_ .2IK?\ 7B?_ *<I'14445_GH?W0%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7U1_P2M_Y*CJW^Y%_Z+N*^5Z^J/^"5O_)4=6_W(O\
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M/B;]B[]@O1_'GQ&\/V,GQ$NDM]-DTBVF"VK:E('8@NC. @2.1SM9L[=H(SD
M'T[7SY_P5)^.?BC]G#]B'Q=XP\&ZDND>(M-DL4M;LVT5QY(DO((G^2560Y1V
M'*G&<]<&O&M.\7?MW1>&;'QC_8_P?U6WN(TNF\*1-)#>^6P#;-[,$5\'_GNV
M#V/2NR_X+532W'_!,CQK)/#]GFD?2FDBW;O+8W]ME<]\'C- 'M/[&'Q$UCXM
M_LF_#OQ/X@NA?:WKV@6E[?7 B2+SYGB4LVQ %7)YPH '8"O3:_,S]DC]I?\
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MOA[&Q;1V\3.HU'Q'&#CS K.%1& R/NK@G$CXR/2/^":__!1'4OVO+GQ3X/\
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M\*^(XFTV*VMUU:^2.%6-I]FD5X_-B?( + JV.1UY%=/_ ,+A_;Z_Z)3\%_\
MP+?_ .6% 'VEXQM]*N_"&JQ:ZMF^AR6<R:@MWC[.UN4(E$F[C9LW9SQC-?@1
MX(;PS9_'C0['5KKQ4W[+\WQ#N'LVN5*VLVS8NZ3W$+P"0_?\IF( ;(K]4_\
M@H]X ^.W[0?[./A?P!X'T&PAO/&2PQ^-M1CU*&"WTF(+&984$D@D>-I"V2@8
ME(RN#OK?^*O_  31\'^,/V HO@CIL<5NNBV0ETC49$'F1ZF@9OM;X[R2,^\#
M^"5P,<8 /0_VR[N;2_V*?BA-HBQ^9!X,U-K3R2 J@6<N"F..!R ..!7Y]_\
M!+;P=^U%JO[(NEW'PE\4?"+2O",E_=[;?6X;EKY9Q(1(9"ENZ\X&,,?EV].E
M?8'_  39\ ?%+P[^RG)\/OC=X;AMYM#WZ/922W]O?+JVF,FU5?RG?&Q2T>&P
M2@3C()/@?P\_91_:5_X)I>+O$5C\%=/\-_%'X9ZY>-J$.D:G=I:W>GL<#J\D
M?[P(JH65G5P@.Q6P  6/''_!/K]I[]HC]H+X6^+OB5XP^$<EO\.-:AU&*31O
MM<=R(Q<032 *;95=OW"[0S* 2>>:R_\ @N!;K?\ [47[,5KJAW>'[G794GC9
M0T; W>GB7(/!^0@8/8GU->V_!+QQ^UY\5/B_H,WC+P;X!^&?@2SN/.U2!+Q+
M_4=0BV-^[1DEE5<L5[1D8/)^Z>G_ ."E_P"P9!^WC\$;?2;.]M])\6>'[@WV
MAW\ZL8T<@"2&3;R(Y %RP!*E$.#@@@'T97RA_P %N$9_^":WCXJK$+-IA8@=
M!_:-L.?S'YUY9X;^('[?VD^%+?P>WP_\!W%]!"MJ/%UU?V[OMQ@3N@N<-(,<
MGR3G@F,YR?H2_P#V0]>^*G[ 5Y\)?B-XLD\1>)]8TR6+4->PS@WC3M<1. V"
MT<4GEJ!A<I&!A<X !N_\$^+E+K]A?X0M&VY1X1TU"?=;9%/Z@U\D?"[_ )6+
MOB1_V+L/_IKTZH?V=?!O[<7[+_PYC^%6B^$? .KZ+IAE@TCQ-J&HQR+80ER>
M )ED9 6W(KPE@#@@@!5V/V*?^"<_Q0_9Q_X*+W'CGQ1?3>+=)U'P[*VI^)YK
MR$F\U.?RS+&D.[S@BL"%9D VJ.F0H *__!QO_P FN^!O^QI'_I)/7Z'5\Q_\
M%8/V+]:_;<_9ACT'PS-9Q^)-"U2/6+".YD\N.\*Q2Q/ 7P0I99203QN102 2
M13_8;^(7[47B;QE#I?QD\!^&/"_AG1]),+ZE#=QS7VJ7B^4J'$5Q(H!7S&8A
M0I)X(QB@#P__ ((]?\GZ?M7?]C%)_P"G&^JM_P %6M/D_9'_ &]/@O\ M"6*
M/#IL]TFC>(&B'WE3*MGU:2TEF4?]>XKU/_@G#^R+X^_9^_:V_:$\4>+-%CTW
M0_&^MO=:)<K>P3_;HC>7<H?9&[,GR2H<2!3STX->L?\ !2/]EF;]L']D3Q-X
M1TZ&&7Q HCU'1?-<(HO(6W*NYN%WH9(\G  D.2.M 'R__P %$VC_ &T_^"DW
MP7^"-I(M]X=T%1XC\0"-@T4D;_O61^W_ ![P@*>G^ECKFN@_X.(;R]M?V*/#
MT5N-MG<>+[5+H@_PBTNV4$>FX _55]:D_P""0?["?Q(^!/CWQE\0?C!8?9?%
MVI6%IH.F++?07DRV<*(K,SPNZ\K#;(/FW8B.>O/U%^V/^RUH_P"V1^S[KG@3
M6)?L8U!5FLKY8_,?3KI#NBF"Y&<'(9<C<C,N1G- 'S3\/_A]^V\/ >B?V/XV
M^ <>D_8(/L2?9[SY8/+7RQ_QZ=EQ5[]BG]@KXQ?"[]N;Q5\9OBAXB\!WUWXH
MT5].N8?#K7'[Z0FU"DI)#&JJ%M@2022W;DD<G\(9OVU_V0/!ECX#M_A[X+^*
MV@Z"@L=)U9-7BMIE@4 1(QDFB8HJ@ ;HP0!@L1BOH?\ 8ZO_ -H?Q/XBUS6/
MC58^"_#>EW%O%%I.A:*WG36TH9B\DLFZ0'*[1@2,"<G:O< ]]K\W?^"D'_*9
M+]FO_MP_].,U?I%7P;_P4Z_8Y^,GQ4_:X^&?Q0^%&DZ+K%SX*LT COKR.%8K
MB*Y>9-ZNZ;D;>/NMGY3G'&0#[RK\V?\ @OI+K5U\3_V=['3)+&#[1K-X;>2]
MRUJ+KS;!8S, "?+7=DX!)!?@UUO_  L#_@H-_P!"-\+/_ B'_P"2Z]E_;D_8
M>N/V_/V6M%T;7)M/\.?$'2XX-2M;R)3);65\8@)X,@EC YRN021M1OFVX(!P
M?_"OOV\/^AZ^ ?\ X#WG_P B5I?\$R?V$OB)^R9\1OBKXH^(&M^$M0OOB1=P
M7S0: \[0I,);F61CYL4>T9N"%50W!/(P,\;X/^+?[=/PLT"V\.ZA\)?!/CVZ
ML8OL\.OKK=O!]K"\"28&X3+$8YV1D^F<U]&?LAVWQGU7P=KEU\</^$3AU35+
MH&PTK0E)ATZV\L!HW<DEF+9/WWP/XN<  ^>] _X*,_&3]LCXA^(=-_9U\ ^$
MYO"OAFY:SN?$_BZYE6WNWP<>7%$R,I.,@?O#M*EPFX"O#?B59_%[3_\ @KW\
M &^,%UX%N=?DCC^QOX6%PL"VWF7/RR><JMOWE^F1@CWKMO@!^SO^T]_P3&\0
M^*O"_P ./ _AWXK^ =>U'[=87$NJPV4]LYPBF0221E6,:H'&UDR@(<<@V[?]
MB3]HKX@?MZ_"7XP?$)M%U0VETTFJV6EW,45EX2M8]QBMXP\F^8L7<L4#_,>6
M(P: (_\ @NZ8[WXS?LUV&I(IT&ZU^Z^V[\;&7S].5@V>,;&;KUR?2OT=KYQ_
MX*<?L*+^W=\ 8]%L;RWTWQ5H%R=1T6ZG4F-I-A5X'(Y5) 1E@"59$." 0?"O
M"^J_M[>(/!\/P]O?#G@C06\A;&7QY-?12W*0XVF8+'.Y:; /S" '.#M4D-0!
MD?\ !)B-8?\ @I/^U@B*JHOB&\5548  U2[X%>?_ !2L_BMXG_X+I^/+?X:Z
MEX1TCQ=:Z- +";Q$LDEFMK]@LRX39&Y\P[F/W<#+C->Z?\$L_P!@/QQ^QA^T
M?\6KCQ"DU]X=U>*VATK7)[N&2;6F5W>25HU=I(R2V2) #D]6Y-;W[??[ /C3
MQY\=O#OQP^"NK:=HOQ/\,Q"&>UO $@UF-0RK\Y!4/Y;O$P<;70J-R;!D YGX
MH_L[?MM_&'X;Z]X4USQI\!YM'\16$VG7B1Q7B.8I4*-M;[)PV#D'L<5TFG?L
MUZ[^R+_P1E\<^ ?$FI:;JFJZ-X2U]Y)=/9VMD$PN9@J,ZJS >9R2HY)X[G)3
MX_?MS:Y!_9D7P/\ AWI&H9\N35KC6HI+.//\:Q+=ESZ]6QW':O=/B;\,/B!\
M0O\ @G_XF\(Z_<:9KWQ*UOP?>Z?</9%;>UN[Z6WD4*A8(JJ68*&8*.YP* /*
M?^"%.E6VG_\ !.SPY-!;PPS7VIZC-<.B!6G<7+QAF/<A$1<GLH':O8/VZ/V/
M=)_;A_9^OO!.J7LNES?:([_3;]$\S[%=QAE1RF1O4J[J5R.'."#@CE_^"5?P
M$\5?LT_L5>&_"/C335TCQ#8W-[-<6@N8KCREDN9'3YXF9#E6!X8XSZUT?[:4
M/QLM_"&BZE\$9O#T^M:7?&74=(UA$\G6+8H1Y:NV-C!]IX>/(S\W&" ?(1_:
MD_:5_P""6>DZ38_%[0--^)OPOLY8]/C\2:9,3>6L?"H&<[3N"\ 3QC>V%\WO
M7KW_  5]\;Z;\3/^"3_B/Q'H\_VK2=?@T;4;*;:5\V&:]M9(VP>1E6!P>17F
M?Q[\&?M>?\%!/A__ ,*U\3?#GP;\+?"NHW4+ZSJTFK17C2K#(L@5$CFD;&]0
MP 7#%5'F*,D^W?MT?L?ZSXK_ ."9EU\(?AU8-K&I:5I^DZ=IMO+<16[W4=I<
M6Y9F>1EC#%(F8Y(!.>Y% '<_\$X;>.V_8,^$BQQI&I\,63D*N 6:,$GZDDDG
MN2:^6_AROV?_ (.(_'WE_+YWA:(R8_C_ - L.OY#\J^P_P!C+X<ZO\(?V3_A
MWX7U^V6SUK0= M+*^@6591#,D2AEW*2K8.1E20>Q->">$/V3?'FD_P#!97Q3
M\69]%C7P#JGAY+.WU(7L!+S"UM8C'Y._S0=T3\E-N!UYH \N_:C_ .5@#X*_
M]B['_P"@ZI6I_P '&7_)H7@__L<(?_2*\KMOCS^R+X^\;?\ !7SX7_%33=%C
MN/ OAW1%M=1U$WL"&VE47PV>4SB5L^?'RJD?-U&#CB?^#C+_ )-"\'_]CA#_
M .D5Y0!]V?#VWCM/ .AQ11I'%'I]NB(B[511&H  [ >E?GW\!8(H/^#A7XJ#
M1=OV/_A'RU]Y8PH8VNG&3IU/GD9S_%GZU>\+0?MK?LI> [3P;X-T+PI\6_#/
MV:-- UV^GCBO-/@9,I%,DEQ$247@%MZC &\C"CU7_@F+^P)XA_9FO?%GQ"^)
M6I6^M?%3XA2&7498B)%T^-I#*\0D& S22;6?: @\M%7(7) /KFBBB@ HHHH
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M CKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* "BBB@ HHHH **** "BBB@#Y]_X*/?\FY^)O^Q;U?\ ]):_#VOW"_X*/?\
M)N?B;_L6]7_]):_#VOV[PI_W2O\ XE^1^=\:?QZ?H_S"BBBOU8^+"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *]^^$/_)+]%_ZYR_^CY:\!KW[X0_\DOT7_KG+_P"CY:_F+Z6'_)(8
M?_L)A_Z;K']$?1G_ .2IK?\ 7B?_ *<I'14445_GH?W0%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7U1_P2M_Y*CJW^Y%_Z+N*^5Z^J/^"5O_)4=6_W(O\ T7<5
M]OX<_P#)18;_ +>_](D?!^)O_)-8G_MS_P!.1/ORBBBOZM/Y#"BBB@ HHHH
M**** "BBB@ KR#X__P#(Y6O_ %Y+_P"AR5Z_7D'Q_P#^1RM?^O)?_0Y* .F^
M '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_ - CKN: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y]
M_P""CW_)N?B;_L6]7_\ 26OP]K]TOV\O"VH>.?@[JFB:3;->:IK&C:E8V=NK
M!6GFE@"(@)( )9@,D@<U^5G_  ZV^/G_ $3G4O\ P,M/_CM?L7AGF.$PV%K1
MQ%6,&Y*W-)*^GFSX/B["UJM:FZ4'+1[)OKY'@%%>_P#_  ZV^/G_ $3G4O\
MP,M/_CM'_#K;X^?]$YU+_P #+3_X[7Z9_;V6?]!%/_P./^9\A_9N+_Y]2_\
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MEG_013_\#C_F']FXO_GU+_P%_P"1X!17O_\ PZV^/G_1.=2_\#+3_P".T?\
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M1_;V6?\ 013_ / X_P"8?V;B_P#GU+_P%_Y'@%%>_P#_  ZV^/G_ $3G4O\
MP,M/_CM'_#K;X^?]$YU+_P #+3_X[1_;V6?]!%/_ ,#C_F']FXO_ )]2_P#
M7_D> 45[_P#\.MOCY_T3G4O_  ,M/_CM'_#K;X^?]$YU+_P,M/\ X[1_;V6?
M]!%/_P #C_F']FXO_GU+_P !?^1X!17O_P#PZV^/G_1.=2_\#+3_ ..T?\.M
MOCY_T3G4O_ RT_\ CM']O99_T$4__ X_YA_9N+_Y]2_\!?\ D> 45[__ ,.M
MOCY_T3G4O_ RT_\ CM'_  ZV^/G_ $3G4O\ P,M/_CM']O99_P!!%/\ \#C_
M )A_9N+_ .?4O_ 7_D> 45[_ /\ #K;X^?\ 1.=2_P# RT_^.T?\.MOCY_T3
MG4O_  ,M/_CM']O99_T$4_\ P./^8?V;B_\ GU+_ ,!?^1X!17O_ /PZV^/G
M_1.=2_\  RT_^.T?\.MOCY_T3G4O_ RT_P#CM']O99_T$4__  ./^8?V;B_^
M?4O_  %_Y'@%%>__ /#K;X^?]$YU+_P,M/\ X[1_PZV^/G_1.=2_\#+3_P".
MT?V]EG_013_\#C_F']FXO_GU+_P%_P"1X!17O_\ PZV^/G_1.=2_\#+3_P".
MU2N/^":WQPM=8AT^3X?Z@MY<+OCC^UVN6'/_ $UQV/Y4?V]EG_013_\  X_Y
MA_9N+_Y]2_\  7_D>&T5[_\ \.MOCY_T3G4O_ RT_P#CM'_#K;X^?]$YU+_P
M,M/_ ([1_;V6?]!%/_P./^8?V;B_^?4O_ 7_ )'@%%>__P##K;X^?]$YU+_P
M,M/_ ([1_P .MOCY_P!$YU+_ ,#+3_X[1_;V6?\ 013_ / X_P"8?V;B_P#G
MU+_P%_Y'@%%>_P#_  ZV^/G_ $3G4O\ P,M/_CM'_#K;X^?]$YU+_P #+3_X
M[1_;V6?]!%/_ ,#C_F']FXO_ )]2_P# 7_D> 45[_P#\.MOCY_T3G4O_  ,M
M/_CM'_#K;X^?]$YU+_P,M/\ X[1_;V6?]!%/_P #C_F']FXO_GU+_P !?^1X
M!17O_P#PZV^/G_1.=2_\#+3_ ..T?\.MOCY_T3G4O_ RT_\ CM']O99_T$4_
M_ X_YA_9N+_Y]2_\!?\ D> 45[__ ,.MOCY_T3G4O_ RT_\ CM'_  ZV^/G_
M $3G4O\ P,M/_CM']O99_P!!%/\ \#C_ )A_9N+_ .?4O_ 7_D> 45[_ /\
M#K;X^?\ 1.=2_P# RT_^.T?\.MOCY_T3G4O_  ,M/_CM']O99_T$4_\ P./^
M8?V;B_\ GU+_ ,!?^1X!17O_ /PZV^/G_1.=2_\  RT_^.T?\.MOCY_T3G4O
M_ RT_P#CM']O99_T$4__  ./^8?V;B_^?4O_  %_Y'@%%>__ /#K;X^?]$YU
M+_P,M/\ X[5/6_\ @FI\</#EHMQ>_#_4+>%F"!C=VIY.3CB7V-']O99_T$4_
M_ X_YA_9N+_Y]2_\!?\ D>&45[\O_!+?X^,,CX<ZES_T^6G_ ,=I?^'6WQ\_
MZ)SJ7_@9:?\ QVC^WLL_Z"*?_@<?\P_LW%_\^I?^ O\ R/ **]__ .'6WQ\_
MZ)SJ7_@9:?\ QVC_ (=;?'S_ *)SJ7_@9:?_ !VC^WLL_P"@BG_X''_,/[-Q
M?_/J7_@+_P CP"BO?_\ AUM\?/\ HG.I?^!EI_\ ':/^'6WQ\_Z)SJ7_ (&6
MG_QVC^WLL_Z"*?\ X''_ ##^S<7_ ,^I?^ O_(\ HKW_ /X=;?'S_HG.I?\
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M $3G4O\ P,M/_CM']O99_P!!%/\ \#C_ )A_9N+_ .?4O_ 7_D> 45[_ /\
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M]7<V_P"@6I_X!+_(/]9LH_Z"J7_@R/\ F>1T5ZY_PPE\6O\ H3+[_P "8/\
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M/_CE'_#"7Q:_Z$R^_P# F#_XY1_J[FW_ $"U/_ )?Y!_K-E'_052_P#!D?\
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M7A'_ *_?_9XJ[FN&^*O_ ".7A'_K]_\ 9XJ[F@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .;^+G_).]2_W4_]&+5[P)_R)>D_]>D7_H(JC\7/
M^2=ZE_NI_P"C%J]X$_Y$O2?^O2+_ -!% &M1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<-\,?^1[\6?]?(_P#0Y*[FN&^&/_(]^+/^OD?^AR4
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M HHHH **** "BBB@ HHHH X;2?\ DO&J?]>2_P HJ[FN&TG_ )+QJG_7DO\
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MPVO?\EXT7_KR;^4U '<T444 %%%% !1110 4444 %%%% !7D'Q__ .1RM?\
MKR7_ -#DKU^O(/C_ /\ (Y6O_7DO_H<E '3? #_D3;K_ *_6_P#0(Z[FN&^
M'_(FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*6@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB?CW_R)</\
MU]I_Z"]=M7$_'O\ Y$N'_K[3_P!!>@#M(/\ 4)_NBG4V#_4)_NBG4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!PWP%_Y%J^_Z_6_]!6NYKAO@
M+_R+5]_U^M_Z"M=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'#:3_P EXU3_ *\E_E%7<UPVD_\ )>-4_P"O)?Y15W- !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <-\6_^1E\*_\ 7[_[-'7<UPWQ;_Y&7PK_
M -?O_LT==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-_%S_
M ))WJ7^ZG_HQ:O>!/^1+TG_KTB_]!%4?BY_R3O4O]U/_ $8M7O G_(EZ3_UZ
M1?\ H(H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOAC_R/
M?BS_ *^1_P"AR5W-<-\,?^1[\6?]?(_]#DH [FBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *X;7O^2\:+_UY-_*:NYKAM>_Y+QHO_7DW\IJ .YH
MHHH **** "BBB@ HHHH **** "O(/C__ ,CE:_\ 7DO_ *')7K]>0?'_ /Y'
M*U_Z\E_]#DH Z;X ?\B;=?\ 7ZW_ *!'7<UPWP _Y$VZ_P"OUO\ T".NYH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** .&^*O_(Y>$?^OW_V>*NYKAOBK_R.7A'_ *_?_9XJ[F@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** .;^+G_ "3O4O\ =3_T8M7O
M G_(EZ3_ ->D7_H(JC\7/^2=ZE_NI_Z,6KW@3_D2])_Z](O_ $$4 :U%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5PWPQ_Y'OQ9_P!?(_\ 0Y*[
MFN&^&/\ R/?BS_KY'_H<E '<T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7#>)?^2WZ%_U[-_*6NYKAO$O_ "6_0O\ KV;^4M '<T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7$_'O_D2X?\ K[3_ -!>NVKB?CW_
M ,B7#_U]I_Z"] ':0?ZA/]T4ZFP?ZA/]T4Z@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .&^ O_(M7W_7ZW_H*UW-<-\!?^1:OO^OUO_05KN:
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M-NO^OUO_ $".NYKAO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444
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MOUO_ $".NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_BY_R3O4O]U/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!PWQ5_P"1R\(_]?O_ +/%7<UPWQ5_Y'+PC_U^_P#L\5=S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '-_%S_DG>I?[J?\ HQ:O>!/^1+TG
M_KTB_P#015'XN?\ ).]2_P!U/_1BU>\"?\B7I/\ UZ1?^@B@#6HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N&^&/\ R/?BS_KY'_H<E=S7#?#'
M_D>_%G_7R/\ T.2@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KAO$O\ R6_0O^O9OY2UW-<-XE_Y+?H7_7LW\I: .YHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N)^/?\ R)</_7VG_H+UVU<3\>_^1+A_Z^T_
M]!>@#M(/]0G^Z*=38/\ 4)_NBG4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!PWP%_Y%J^_P"OUO\ T%:[FN&^ O\ R+5]_P!?K?\ H*UW- !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 <-I/_)>-4_Z\E_E%7<U
MPVD_\EXU3_KR7^45=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% '#?%O_ )&7PK_U^_\ LT==S7#?%O\ Y&7PK_U^_P#LT==S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '-_%S_DG>I?[J?\ HQ:O>!/^1+TG
M_KTB_P#015'XN?\ ).]2_P!U/_1BU>\"?\B7I/\ UZ1?^@B@#6HHHH ****
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M10 4444 %%%% !1110 5PWPQ_P"1[\6?]?(_]#DKN:X;X8_\CWXL_P"OD?\
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M10 4444 %%%% !1110 5PWPQ_P"1[\6?]?(_]#DKN:X;X8_\CWXL_P"OD?\
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MB@ KAOAC_P CWXL_Z^1_Z')7<UPWPQ_Y'OQ9_P!?(_\ 0Y* .YHHHH ****
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M?%O_ )&7PK_U^_\ LT==S0 4444 %%%% !1110 4444 %%%% !1110 4444
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MGX]_\B7#_P!?:?\ H+T =I!_J$_W13J;!_J$_P!T4Z@ HHHH **** "BBB@
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M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#?#'_D>_%G_7R/\
MT.2NYKAOAC_R/?BS_KY'_H<E '<T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7#:]_R7C1?^O)OY35W-<-KW_)>-%_Z\F_E-0!W-%%% !1110 4
M444 %%%% !1110 5Y!\?_P#D<K7_ *\E_P#0Y*]?KR#X_P#_ ".5K_UY+_Z'
M)0!TWP _Y$VZ_P"OUO\ T".NYKAO@!_R)MU_U^M_Z!'7<T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH *XGX]_\B7#_ -?:?^@O7;5Q/Q[_ .1+A_Z^T_\ 07H
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M'XN?\D[U+_=3_P!&+5[P)_R)>D_]>D7_ *"* -:BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *X;X8_\CWXL_P"OD?\ H<E=S7#?#'_D>_%G_7R/
M_0Y* .YHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&U[_DO&B_
M]>3?RFKN:X;7O^2\:+_UY-_*:@#N:*** "BBB@ HHHH **** "BBB@ KR#X_
M_P#(Y6O_ %Y+_P"AR5Z_7D'Q_P#^1RM?^O)?_0Y* .F^ '_(FW7_ %^M_P"@
M1UW-<-\ /^1-NO\ K];_ - CKN: "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ+*>H-R_^-*OC#5D7 U34@!P +E^/UK-HH]G#L@YY=S2_P"$RUC_ *"NI?\
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MTO\ A,M8_P"@KJ7_ ($O_C35\6ZJC,RZGJ"LW4BX?G]:SZ*/9P[(.>7<TO\
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M5U+_ ,"7_P :S:*/9P[(.>7<TO\ A,M8_P"@KJ7_ ($O_C1_PF6L?]!74O\
MP)?_ !K-HH]G#L@YY=S2_P"$RUC_ *"NI?\ @2_^-'_"9:Q_T%=2_P# E_\
M&LVBCV<.R#GEW-+_ (3+6/\ H*ZE_P"!+_XTT^+=5:0,=3U#<O0_:'R/UK/H
MH]G#L@YY=S2_X3+6/^@KJ7_@2_\ C1_PF6L?]!74O_ E_P#&LVBCV<.R#GEW
M-+_A,M8_Z"NI?^!+_P"-'_"9:Q_T%=2_\"7_ ,:S:*/9P[(.>7<TO^$RUC_H
M*ZE_X$O_ (T?\)EK'_05U+_P)?\ QK-HH]G#L@YY=S2_X3+6/^@KJ7_@2_\
MC1_PF6L?]!74O_ E_P#&LVBCV<.R#GEW-+_A,M8_Z"NI?^!+_P"-'_"9:Q_T
M%=2_\"7_ ,:S:*/9P[(.>7<TO^$RUC_H*ZE_X$O_ (T?\)EK'_05U+_P)?\
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M*ZE_X$O_ (T?\)EK'_05U+_P)?\ QK-HH]G#L@YY=S2_X3+6/^@KJ7_@2_\
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MRUC_ *"NI?\ @2_^-'_"9:Q_T%=2_P# E_\ &LVBCV<.R#GEW-+_ (3+6/\
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M&NN^!G_)4-/_ .N=Q_Z(DKXSQ&IQ7">:-+_F'K_^FI'UG <F^)LN3_Y_T?\
MTY$^@/\ A)M2_P"@A??]_P!O\:/^$FU+_H(7W_?]O\:HT5_DC[6?=G^GWLH=
ME]Q>_P"$FU+_ *"%]_W_ &_QH_X2;4O^@A??]_V_QJC11[6?=A[*'9?<7O\
MA)M2_P"@A??]_P!O\:/^$FU+_H(7W_?]O\:HT4>UGW8>RAV7W%[_ (2;4O\
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M_&C_ (2;4O\ H(7W_?\ ;_&J-%'M9]V'LH=E]Q>_X2;4O^@A??\ ?]O\:/\
MA)M2_P"@A??]_P!O\:HT4>UGW8>RAV7W%[_A)M2_Z"%]_P!_V_QH_P"$FU+_
M *"%]_W_ &_QJC11[6?=A[*'9?<7O^$FU+_H(7W_ '_;_&FKXAU!&9EOKQ6;
MJ1,W/ZU3HH]K/NP]E#LON+W_  DVI?\ 00OO^_[?XT?\)-J7_00OO^_[?XU1
MHH]K/NP]E#LON+W_  DVI?\ 00OO^_[?XT?\)-J7_00OO^_[?XU1HH]K/NP]
ME#LON+W_  DVI?\ 00OO^_[?XT?\)-J7_00OO^_[?XU1HH]K/NP]E#LON+W_
M  DVI?\ 00OO^_[?XT?\)-J7_00OO^_[?XU1HH]K/NP]E#LON+W_  DVI?\
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MGB93BN&L2TE]C_TY$^_****_JH_D8**** "BBB@ HHHH **** "O(/C_ /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX!^!?[3'@_X3ZXVM?\)3XV%N;%K>T$EK%Y\SP0^:Y8$;I$9?E5L<$X'->V4
M%%%% !1110 4444 ?/O_  4>_P"3<_$W_8MZO_Z2U^'M?N%_P4>_Y-S\3?\
M8MZO_P"DM?A[7[=X4_[I7_Q+\C\[XT_CT_1_F%%%%?JQ\6%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 44S[1'YOE[T\S^[GG\J?1=/8 HHHH **1G"*68A5'))[4H;<,CD'H:
M"BFRS+;Q-)(RI&@+,S' 4#N33;:ZCO8%EADCFC?E71@RM]"*GF5^7J.SM<DH
MHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5UWP,_Y*AI_P#USN/_ $1)7(UUWP,_Y*AI_P#USN/_
M $1)7QGB-_R2>:?]@U?_ --2/K. O^2FR[_K_1_].1/<J***_P BC_40****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M78?Q'(!Z=<?\%KY-*T&/Q1J/P!^,%C\/ID65?$3V'[DHQ 5^5$6TY&&\W!/
MSBOL#X+_ !G\-_M!_#32_%_A'4XM6T'6(S);7"*5/!*LK*P#*RL"I4@$$&OD
MW5_^"C?Q0U_1+K3;W]D'XF76GWL#VT]O)(6CFB=2K(P^SX*E201Z&JO_  0O
M^$/C[X)_!;QQH_C/PSKWA:QFUX7>D6FJQM')M:$+(55N<?)'S@ G/O0!TWQF
M_P""NND^%/BMKO@GX>?#+XA_%KQ!X7NY++5AHFGR?9[.:-BDB;E1W)5E92?+
M"DCAB.:U/V3O^"K7A?\ :-^,4GPYU[PIXH^&OCX*S0Z3KL.PW)5-[QJ2%99
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
MN^!G_)4-/_ZYW'_HB2N1KKO@9_R5#3_^N=Q_Z(DKXSQ&_P"23S3_ +!J_P#Z
M:D?6<!?\E-EW_7^C_P"G(GN5%%%?Y%'^H@4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *Z[X&?\E0T__KG<?^B)*Y&NN^!G_)4-/_ZYW'_HB2OC/$;_ ))/
M-/\ L&K_ /IJ1]9P%_R4V7?]?Z/_ *<B>Y4445_D4?ZB!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !77? S_ )*AI_\ USN/_1$E<C77
M? S_ )*AI_\ USN/_1$E?&>(W_))YI_V#5__ $U(^LX"_P"2FR[_ *_T?_3D
M3W*BBBO\BC_40**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MJC_@E;_R5'5O]R+_ -%W%?*]?5'_  2M_P"2HZM_N1?^B[BOM_#G_DHL-_V]
M_P"D2/@_$W_DFL3_ -N?^G(GWY1117]6G\AA1110 4444 %%%% !1110 5Y!
M\?\ _D<K7_KR7_T.2O7Z\@^/_P#R.5K_ ->2_P#H<E '3? #_D3;K_K];_T"
M.NYKAO@!_P B;=?]?K?^@1UW- !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!\^_\%'O^3<_$W_8MZO\
M^DM?A[7[A?\ !1[_ )-S\3?]BWJ__I+7X>U^W>%/^Z5_\2_(_.^-/X]/T?YA
M1117ZL?%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %==\#/^2H:?\ ]<[C_P!$25R-==\#/^2H:?\ ]<[C_P!$25\9XC?\
MDGFG_8-7_P#34CZS@+_DILN_Z_T?_3D3W*BBBO\ (H_U$"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 >"_\%"],N=:^ NO6=G;SW=Y=Z!JL,$$,9DDFD:WPJ*HY9B2
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M*_H.HH_XBMB/^@>/_@3_ ,@_U*I?\_7]R_S/Y\?^&:/B1_T3_P ;?^"*Z_\
MB*/^&:/B1_T3_P ;?^"*Z_\ B*_H.HH_XBMB/^@>/_@3_P @_P!2J7_/U_<O
M\S^>ZY_9Q^(=G"TDW@/QG%&O5GT2Y51^)2EB_9N^(EQ$LD?@'QHZ.,JRZ'<D
M,/4'97[V?%S_ ))WJ7^ZG_HQ:O>!/^1+TG_KTB_]!%'_ !%;$?\ 0/'_ ,"?
M^0?ZE4O^?K^Y?YGX#_\ #-'Q(_Z)_P"-O_!%=?\ Q%'_  S1\2/^B?\ C;_P
M177_ ,17]!U%'_$5L1_T#Q_\"?\ D'^I5+_GZ_N7^9_/C_PS1\2/^B?^-O\
MP177_P 11_PS1\2/^B?^-O\ P177_P 17]!U%'_$5L1_T#Q_\"?^0?ZE4O\
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M-'Q(_P"B?^-O_!%=?_$4?\,T?$C_ *)_XV_\$5U_\17]!U%'_$5L1_T#Q_\
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M\;?^"*Z_^(K^@ZBC_B*V(_Z!X_\ @3_R#_4JE_S]?W+_ #/Y\?\ AFCXD?\
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M$_\ (/\ 4JE_S]?W+_,_GQ_X9H^)'_1/_&W_ ((KK_XBC_AFCXD?]$_\;?\
M@BNO_B*_H.HH_P"(K8C_ *!X_P#@3_R#_4JE_P _7]R_S/Y\?^&:/B1_T3_Q
MM_X(KK_XBC_AFCXD?]$_\;?^"*Z_^(K^@ZBC_B*V(_Z!X_\ @3_R#_4JE_S]
M?W+_ #/Y\?\ AFCXD?\ 1/\ QM_X(KK_ .(KJO@O^SK\0M/^)%A-<>!/&4$2
MI."\FBW*J,P2 <E.Y('XU^\E%>1Q!X@5LURO$Y7.BHJO3G3;3;:4XN-TK:VO
M<]3(^'89;F.'S&,W)T9PFDU:_))2M?SM8_(+_A2?C/\ Z%'Q/_X*Y_\ XFC_
M (4GXS_Z%'Q/_P""N?\ ^)K]?:*_E;_B#>&_Z"9?^ K_ #/Z2_XC;BO^@6/_
M ($_\C\@O^%)^,_^A1\3_P#@KG_^)H_X4GXS_P"A1\3_ /@KG_\ B:_7VBC_
M (@WAO\ H)E_X"O\P_XC;BO^@6/_ ($_\C\@O^%)^,_^A1\3_P#@KG_^)H_X
M4GXS_P"A1\3_ /@KG_\ B:_7VBC_ (@WAO\ H)E_X"O\P_XC;BO^@6/_ ($_
M\C\@O^%)^,_^A1\3_P#@KG_^)H_X4GXS_P"A1\3_ /@KG_\ B:_7VBC_ (@W
MAO\ H)E_X"O\P_XC;BO^@6/_ ($_\C\@O^%)^,_^A1\3_P#@KG_^)H_X4GXS
M_P"A1\3_ /@KG_\ B:_7VBC_ (@WAO\ H)E_X"O\P_XC;BO^@6/_ ($_\C\?
M;CX1>++-XUF\+^(HFF.U ^FS*7/H,KSU%2_\*3\9_P#0H^)__!7/_P#$U^HG
MQ;_Y&7PK_P!?O_LT==S1_P 0;PW_ $$R_P# 5_F'_$;<5_T"Q_\  G_D?D%_
MPI/QG_T*/B?_ ,%<_P#\31_PI/QG_P!"CXG_ /!7/_\ $U^OM%'_ !!O#?\
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M:*/^(-X;_H)E_P" K_,/^(VXK_H%C_X$_P#(_(+_ (4GXS_Z%'Q/_P""N?\
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MCXG_ /!7/_\ $T?\*3\9_P#0H^)__!7/_P#$U^OM%'_$&\-_T$R_\!7^8?\
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M_P! L?\ P)_Y'Y!?\*3\9_\ 0H^)_P#P5S__ !-'_"D_&?\ T*/B?_P5S_\
MQ-?K[11_Q!O#?]!,O_ 5_F'_ !&W%?\ 0+'_ ,"?^1^07_"D_&?_ $*/B?\
M\%<__P 37TG_ ,$S_!NL>$/BIJ2ZMI.I:6TT<9C%W:O 9 ([C.-P&?PK[JKA
MM>_Y+QHO_7DW\IJ]GA_PSH95F%/'PKN3A?1Q2O>+7?S/%XC\4L1F^75,OGAU
M%3MJI-VM)2VMY'<T445^G'Y2%%%% !1110 4444 %%%% !7D'Q__ .1RM?\
MKR7_ -#DKU^O(/C_ /\ (Y6O_7DO_H<E '3? #_D3;K_ *_6_P#0(Z[FN&^
M'_(FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <-\5?^1R\(_\ 7[_[/%7<UPWQ5_Y'
M+PC_ -?O_L\5=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-
M_%S_ ))WJ7^ZG_HQ:O>!/^1+TG_KTB_]!%4?BY_R3O4O]U/_ $8M7O G_(EZ
M3_UZ1?\ H(H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOA
MC_R/?BS_ *^1_P"AR5W-<-\,?^1[\6?]?(_]#DH [FBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *X;Q+_R6_0O^O9OY2UW-<-XE_P"2WZ%_U[-_
M*6@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB?CW_R)</\
MU]I_Z"]=M7$_'O\ Y$N'_K[3_P!!>@#M(/\ 4)_NBG4V#_4)_NBG4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!PWP%_Y%J^_Z_6_]!6NYKAO@
M+_R+5]_U^M_Z"M=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'#:3_P EXU3_ *\E_E%7<UPVD_\ )>-4_P"O)?Y15W- !1110 4444 %%%%
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M** "BBB@ HHHH **** .&^ O_(M7W_7ZW_H*UW-<-\!?^1:OO^OUO_05KN:
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M-NO^OUO_ $".NYKAO@!_R)MU_P!?K?\ H$==S0 4444 %%%% !1110 4444
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MOUO_ $".NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .&^*O\ R.7A'_K]_P#9XJ[FN&^*O_(Y>$?^
MOW_V>*NYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_BY_R3
MO4O]U/\ T8M7O G_ ")>D_\ 7I%_Z"*H_%S_ ))WJ7^ZG_HQ:O>!/^1+TG_K
MTB_]!% &M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<-\,?^1[
M\6?]?(_]#DKN:X;X8_\ (]^+/^OD?^AR4 =S1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<-XE_Y+?H7_7LW\I:[FN&\2_\EOT+_KV;^4M '<T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7$_'O\ Y$N'_K[3_P!!
M>NVKB?CW_P B7#_U]I_Z"] ':0?ZA/\ =%.IL'^H3_=%.H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#AO@+_R+5]_U^M_Z"M=S7#? 7_D6K[_
M *_6_P#05KN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X;2?
M^2\:I_UY+_**NYKAM)_Y+QJG_7DO\HJ[F@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** .&^+?\ R,OA7_K]_P#9HZ[FN&^+?_(R^%?^OW_V:.NY
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_BY_R3O4O]U/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!PWQ5_P"1R\(_]?O_ +/%7<UPWQ5_Y'+PC_U^_P#L\5=S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '-_%S_DG>I?[J?\ HQ:O>!/^1+TG
M_KTB_P#015'XN?\ ).]2_P!U/_1BU>\"?\B7I/\ UZ1?^@B@#6HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N&^&/\ R/?BS_KY'_H<E=S7#?#'
M_D>_%G_7R/\ T.2@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KAO$O\ R6_0O^O9OY2UW-<-XE_Y+?H7_7LW\I: .YHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N)^/?\ R)</_7VG_H+UVU<3\>_^1+A_Z^T_
M]!>@#M(/]0G^Z*=38/\ 4)_NBG4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!PWP%_Y%J^_P"OUO\ T%:[FN&^ O\ R+5]_P!?K?\ H*UW- !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 <-I/_)>-4_Z\E_E%7<U
MPVD_\EXU3_KR7^45=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% '#?%O_ )&7PK_U^_\ LT==S7#?%O\ Y&7PK_U^_P#LT==S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '-_%S_DG>I?[J?\ HQ:O>!/^1+TG
M_KTB_P#015'XN?\ ).]2_P!U/_1BU>\"?\B7I/\ UZ1?^@B@#6HHHH ****
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M-VC.4+*"5/MZ5)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M#9H4N(RDBK(C=589!HC18D555551@ #  IU% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %1Q6L<$CLD<:-(<L54 M]:DHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ J-K6-YUE:.-I%&%<J-P^AJ2B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "H[BVCNTVRQQR+G.'4,,U)1
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!';VL=HI6*.
M.-2<D(H7)J2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (Q:
MQK.THCC$K#!?:-Q'UJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** (YK6.X96DCCD:,Y4LH.T^U2444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 V:%+B,I(JR(W56&0:(T6)%555548  P *=10 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !4<5K'!([)'&C2'+%5 +?6I**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M88IGZ _9A_9S\/\ [*/P1T/P/X;BVV&CPXDG90);Z=N99Y/]IVR?0#"C@
M[ZBBB@ HHHH **** "BBB@ HHHH **;+)Y43-M9]H)VKU;V%?E3_ ,% (_VD
M/VD_V5O&7Q&\=D?"7X=:#'"^G^"HG8ZAJPDNHH0;T@J<#S-V'P,H,1#.\@'Z
ML45X+_P2]F>X_P""?OPI:1FD;^PXQECDX#,!^E>3_P#!8/\ :W\6?"70_!/P
MO^&]Y)I_CSXJWXL(;R%MLUE 9$B&QNJ/))*JAP"559",-M( /M*BOSWNO^#?
M_P *O\/S?1_$+QQ_PM/R1<C7WO4^S-?;?O;/+\WR]W?S/,'7<>E=;_P1?_:]
M\4?&KX<^+_ /Q!O+F_\ &7POO1:2W=RQDN;FW8R(!(W)DDCDBD0MU(,><G)(
M!]MT5^97[%W[+.G_ /!5SX>>.OBY\3=>\42^(M4U^[L/#HL]3DA@\,0QQ1M%
MY$:G;E3+C# @A 3\S,3[W_P1M_:,UKXQ?L//?>--6:]O/!>K7FBSZI>R_--!
M#'%,LDLC==B3;2Y[1@DDY- 'U=K/B+3_  Y'"^H7UG8+<2B")KB98A+(>B+N
M(RQ[ <FKE?!'P2T^X_X*H_MCM\5-5AF_X4K\)[QK3P=8S*5CUW45(+WK*1RJ
MD*V#CI$O42@_>] !1110 4444 %%%% !1110 445\7?'_P#X)9>*/VR?CEXC
MU?XF_%GQ#'X#:Y"Z#X:T*3RTMK<*O,AD4Q"3<&SB-R>#O_A !]HT5^1O[1OP
M9\2?\$1OC?X!\5?#WQMXBU?X?^([QK;4-&U.4-O6-E:2*14"QON1V*.L:LC
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MNNM974XXRTW4O&LD<C* >0&=C[T ?=U%>:^%-,L?V.?V6O+UG7M7\0:;\/\
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M_P#!2GXC? 72]8UC4_A[_P (_%XCT6TU"Y>Y?2)/]'#1(S=$/G./<)'G+9)
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MO&T']HV,5I?1Q)86DOS1'$D3@%E(<(@6-58#:>P!^F5%?FS^Q1X\\9?L"?\
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M +3WCVQFM=+C\S3?ASHMR.-/LU+*;PKT\QLN >[-(PX$1'W)0 4444 %%%%
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M7XY_$BZ\/>(/CW\6(HO"G@WPUX?266SM!^Z "A_GD"F.%F 'WE"[R9LC[_\
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M-_M2?LDVG['O_!&SQYX*\)^9<:A!IT%WJ]^B$2ZG,;JW-W,W?:8E=0"3MC4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\U_'W_@DE\"_VB_&MUXCUKPI)I^N7\AFO
M+K2;V2S^V.>K/&I\LL3R6"AF/))KT#]F3]BSX:_L@:3<VO@'PS:Z1-? "[O7
MD>XO+H#D!Y9"6V@\[00H/(%>J44 <7^T%\#]-_:/^$>K^"]8U#6M-TG7(Q#>
M/I=PMO<2Q;@6CWE6PK8PPQRI(Z$UJ?"CX6Z'\$_AOHOA/PW8QZ?H>@VJVEI
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MWMK:WC$<-O$@"JB*,!550  . !5JB@ HHHH **** "BBB@ HHHH *^7OB/\
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MDCUZ]B^SR:I?WDM[=+%Q^[1I&(1> #L )  ).!CVRB@ HHHH **** "BBB@
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MPJ@(&9V"@=7/MCMOB;\,/#_QF\":EX9\4Z39ZYH.KQ>3=V=RFZ.5<@@^JLK
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MFQ6NIZG-<6J$'(S'D!Q_LR;@>X-?5UI:16%K'!!''##"@CCCC4*L:@8  '
M'&!4E% 'E/AO]CCPAX?_ &H-8^+\S:MJWC35;06,4VH7"S0:5  %V6L84>6"
MHP3DG#/S\[9]0O["#5;&:UNH8;FUN8VBFAE0/'*C##*RG@@@D$'@@U-10!\Q
MZ+_P1Z_9]T'Q_'X@A\#^88;G[;#ILVHW,NFQ39R7%NSE"#P-C93"@;<#%?3@
M&!110 4444 %%%% !7D'Q_\ ^1RM?^O)?_0Y*]?KR#X__P#(Y6O_ %Y+_P"A
MR4 =-\ /^1-NO^OUO_0(Z[FN&^ '_(FW7_7ZW_H$==S0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7D'Q_P#^1RM?^O)?_0Y*]?KR
M#X__ /(Y6O\ UY+_ .AR4 =-\ /^1-NO^OUO_0(Z[FN&^ '_ ")MU_U^M_Z!
M'7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!\
M?_\ D<K7_KR7_P!#DKU^O(/C_P#\CE:_]>2_^AR4 =-\ /\ D3;K_K];_P!
MCKN:X;X ?\B;=?\ 7ZW_ *!'7<T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5Y!\?_P#D<K7_ *\E_P#0Y*]?KR#X_P#_ ".5K_UY
M+_Z')0!TWP _Y$VZ_P"OUO\ T".NYKAO@!_R)MU_U^M_Z!'7<T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9OC+Q?I_P_\ "&K:]J]Q]CTG0[.:_O9_+:3R
M8(D,DC[5!9L*I.%!)QP":TJ\W_;)_P"30OBM_P!B?J__ *135T82DJM>%*6T
MFE][L9UIN%.4UT39YM_P]T_9Y_Z*#_Y0M2_^1Z/^'NG[//\ T4'_ ,H6I?\
MR/7XF45^Y?\ $+<J_P"?E3[X_P#R!^<?ZY8W^6'W/_Y(_=CX1?\ !1?X-_'?
MXAZ?X4\*>,?[5U_5?,^RVO\ 9-]!YOEQ/*_SR0J@PB,>6&<8&20*]LK\3/\
M@D7_ ,I#/A[_ -Q'_P!-MW7[9U^9\:9#A\HQL<-AG)IP4O>:;NW)=$M-#Z_A
M_,ZN.P[JU4DU)K2_9/JWW/AW_@HG_P %<=9_8J_:(T_P/HO@.U\4*VBKK%Y-
M-?/!)M)FRJ!4; 1(2Y8YZG@;<GZJ_9M^.^D_M-_ KPSX\T56CT_Q)9+<B%G#
MM;2 E)86(X+1R*Z$CJ5-?!?[6/@[3_B)_P %Y/A[X?U:!;K2]<\(3V%Y">DL
M,MCJB.OXJQ%='_P14\9ZA\$/B+\6/V<_$<Y;4O ^K2ZCI1?@W%N7$4K*.R'_
M $>51W^T,>*^1/</T'EF6")I)&5(T!9F8X"@=237YX_#_P#X+JS?%#]K_0?!
M.D> [=_!?B3Q$OA^PUF2^<7%R&F6(7(79MQ\Z.8^2 P&[->U?\%AOVDY/V>?
MV+M;M]-DD7Q'XZ<>&]+2(_O1YZGSG4#GB$. 1R'=/45\0_$;]FZ/]D_]KG]B
M_P &-&D>I6C:==:JR_QWLVJ"2?GOM9B@/]U%H _82BO*OVP?B1\2/AK\++>;
MX4^"[?QMXOU/48M/AM[J<0VMA&R2,UU,2R9C4HJXWKS(#GC!^6OB7_PWA\)O
M .I>-KCQ-\*-<M]'@DU&Z\/V-F7E$**'94+0(7*@/E1-D[?E+D@4 ??5?$_[
M#G[4?CSXK?\ !23X]^"O$'B&?4?"_A.6==)L&@A1+()=B-<,J!C\G'S$YZ]:
M]P_8$_:[@_;:_9KTKQPNGKI-^\TMCJ5FCEXX+F(C=L8\E&5D<9Y ?!R1D_)_
M_!-G_E+M^T[_ -=[K_TO% 'Z,45\A_MC?MW>.+#]HK3?@;\#=#TG7OB1>6RW
MNIZAJ3_Z!H$!&[YU!'SA"KDDD .@"NS@#S7XP?M!_M:?\$_["S\=?$NX\!?$
M[X??:(K?5X=%A-K<:8'8*&5O*C(!9@JL1("< A-P- 'Z#45C_#SQ[I?Q3\!Z
M-XET6X6[TC7K**_LYA_RTBE0.I(['!&1V.16Q0 4444 <O\ %CXR^&_@?X=A
MU;Q1J7]EZ?<7*VD<OV>6;=*RLX7$:L?NHQR1CCKTKS[_ (>&_![_ *'#_P I
M5[_\9KBO^"L'_)NVB_\ 8QP?^DUU7Y\U^.\:>(68Y1F;P6&A!Q23]Y2;U]))
M?@?M7 OAOEF=96L=BIU%)RDK1<4M/6+?XGZ=_P##PWX/?]#A_P"4J]_^,UVO
MP@_:'\'_ !Z_M#_A$]8_M;^R?+^U?Z)/!Y7F;]G^L1<YV-TSC'.,BOR/K[2_
MX)!?\U#_ .X;_P"W=<W"/B1F>:9M2P&(A349\UW%23TC*2M>36Z['5QEX8Y7
ME.3ULPPU2HYPY;*3BUK.,7>T$]GWW/M*OSRU;_@KA\8O'7[0GQ \%_#'X*VO
MB^'P+JMQITSK>2-/LBG>$2N!@+O:-B ,XZ9.,G]#:_,#_@EM\3O#?PS_ ."A
M'[3TWB3Q#H?A^*ZUV[2!]2OXK19F&I71(4R,-Q&1P/6OVL_"SWG]GO\ ;+_:
M3\?_ !ET'1O&/[/C>&?#.H7!BO\ 51=/_H*;6/F?,2#@@<=\U]C5R?A/X\^!
MO'NM)INA>,_">M:A(K.EK8:O;W,S*HR2$1RQ ')..*\1_P""@_[>.I?LQWWA
M?P/X#T&+Q=\5_'\GDZ+ILCXAM5+;!<3 $$J6R -R@[')8!#D ^FJ*^!?BGXL
M_;=_9I\"7'Q&UO5OA?XST71(C?:SX<T^T9);>V7YI&1_*C9MB EB)"5QD+(!
M7TM\%_VN-._:0_8Y;XI>&8OLK3:1=W)M)V$K6-W C[X7(QNVNG!P-RE3@9H
M]DHK\R_V5/\ @HW^TI^W#X M_#GP[T'PTOBJPFEDU_Q=JUN8-)T^-F/D0QQK
MNS*0,D[7./X, M4NC?\ !5KXQ?L8?&?7/AS\?O#EIXMUMK$76@3^'H%274IY
M.((EV *T4C!EW",2(RL-K\  'Z7T5^<OQO\ V@/VW?@7\.9?BYK>G?#R'PK;
M%+F^\*6\'G76E6[,H!F. YQD!BDS%<DE5 ./MK]EC]H'3_VI_P!GOPK\0-+M
MVL[7Q)9^<ULS[S:S([131;L#=LE1UW8&=N<#.* /0**^);[6?VW/C]K5]J'A
M^U^'/P=\/PSR)86FLYN]0NHP6"-)B.8 G S\L9 .0I[L_8[_ &Y_BMHW[9-Y
M\ ?CKI^AR>*)+-[S2-9TA"D-^$B\WI@*R-&DC!@J%6C967/W0"W_ ,%E?VG/
M'7[-7A/X9S>!_$$_A^;7/$)M+YXH(I#<1! =A\Q6P,D],5]I5^>/_!P3_P B
M3\'?^QJ;_P!%K7W-\:_B_HOP!^$^O^,O$5Q]FT;P[9O>7+#EG X5%'=W8JBC
MNS =Z .HHKX%^&'Q@_;"_;C\+R>.O =Q\//A7X)U%W;0K76(6NKV^B4[5=V\
MF3Y20WS[4S@%4*D,?0/V"OV]O%_Q+^-7B;X*_&'0]/T'XI>$83<>?9-BUUB
M;#O5<D*VR2-QM)#JY(5-I% 'UU1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D
M'Q__ .1RM?\ KR7_ -#DKU^O(/C_ /\ (Y6O_7DO_H<E '3? #_D3;K_ *_6
M_P#0(Z[FN&^ '_(FW7_7ZW_H$==S0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\@^/\ _P CE:_]>2_^AR5Z_7D'Q_\ ^1RM?^O)?_0Y* .F^ '_ ")M
MU_U^M_Z!'7<UPWP _P"1-NO^OUO_ $".NYH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KR#X__P#(Y6O_ %Y+_P"AR5Z_7D'Q_P#^
M1RM?^O)?_0Y* .F^ '_(FW7_ %^M_P"@1UW-<-\ /^1-NO\ K];_ - CKN:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )+Q?_$T44 '_"X?$?\ T$?_ "7B_P#B:/\ A</B/_H(_P#DO%_\3110 ?\
M"X?$?_01_P#)>+_XFC_A</B/_H(_^2\7_P 3110 ?\+A\1_]!'_R7B_^)H_X
M7#XC_P"@C_Y+Q?\ Q-%% !_PN'Q'_P!!'_R7B_\ B:/^%P^(_P#H(_\ DO%_
M\3110 ?\+A\1_P#01_\ )>+_ .)H_P"%P^(_^@C_ .2\7_Q-%% !_P +A\1_
M]!'_ ,EXO_B:/^%P^(_^@C_Y+Q?_ !-%% !_PN'Q'_T$?_)>+_XFC_A</B/_
M *"/_DO%_P#$T44 '_"X?$?_ $$?_)>+_P")H_X7#XC_ .@C_P"2\7_Q-%%
M!_PN'Q'_ -!'_P EXO\ XFC_ (7#XC_Z"/\ Y+Q?_$T44 '_  N'Q'_T$?\
MR7B_^)H_X7#XC_Z"/_DO%_\ $T44 '_"X?$?_01_\EXO_B:/^%P^(_\ H(_^
M2\7_ ,3110 ?\+A\1_\ 01_\EXO_ (FC_A</B/\ Z"/_ )+Q?_$T44 '_"X?
M$?\ T$?_ "7B_P#B:/\ A</B/_H(_P#DO%_\3110 ?\ "X?$?_01_P#)>+_X
MFC_A</B/_H(_^2\7_P 3110 ?\+A\1_]!'_R7B_^)H_X7#XC_P"@C_Y+Q?\
MQ-%% !_PN'Q'_P!!'_R7B_\ B:/^%P^(_P#H(_\ DO%_\3110 ?\+A\1_P#0
M1_\ )>+_ .)H_P"%P^(_^@C_ .2\7_Q-%% !_P +A\1_]!'_ ,EXO_B:/^%P
M^(_^@C_Y+Q?_ !-%% !_PN'Q'_T$?_)>+_XFC_A</B/_ *"/_DO%_P#$T44
M'_"X?$?_ $$?_)>+_P")H_X7#XC_ .@C_P"2\7_Q-%% !_PN'Q'_ -!'_P E
MXO\ XFC_ (7#XC_Z"/\ Y+Q?_$T44 '_  N'Q'_T$?\ R7B_^)H_X7#XC_Z"
M/_DO%_\ $T44 '_"X?$?_01_\EXO_B:/^%P^(_\ H(_^2\7_ ,3110 ?\+A\
M1_\ 01_\EXO_ (FC_A</B/\ Z"/_ )+Q?_$T44 '_"X?$?\ T$?_ "7B_P#B
M:/\ A</B/_H(_P#DO%_\3110 ?\ "X?$?_01_P#)>+_XFC_A</B/_H(_^2\7
M_P 3110 ?\+A\1_]!'_R7B_^)H_X7#XC_P"@C_Y+Q?\ Q-%% !_PN'Q'_P!!
M'_R7B_\ B:/^%P^(_P#H(_\ DO%_\3110 ?\+A\1_P#01_\ )>+_ .)H_P"%
MP^(_^@C_ .2\7_Q-%% !_P +A\1_]!'_ ,EXO_B:/^%P^(_^@C_Y+Q?_ !-%
M% !_PN'Q'_T$?_)>+_XFC_A</B/_ *"/_DO%_P#$T44 '_"X?$?_ $$?_)>+
M_P")H_X7#XC_ .@C_P"2\7_Q-%% !_PN'Q'_ -!'_P EXO\ XFC_ (7#XC_Z
M"/\ Y+Q?_$T44 '_  N'Q'_T$?\ R7B_^)H_X7#XC_Z"/_DO%_\ $T44 '_"
MX?$?_01_\EXO_B:/^%P^(_\ H(_^2\7_ ,3110 ?\+A\1_\ 01_\EXO_ (FC
M_A</B/\ Z"/_ )+Q?_$T44 '_"X?$?\ T$?_ "7B_P#B:/\ A</B/_H(_P#D
MO%_\3110 ?\ "X?$?_01_P#)>+_XFC_A</B/_H(_^2\7_P 3110 ?\+A\1_]
M!'_R7B_^)H_X7#XC_P"@C_Y+Q?\ Q-%% !_PN'Q'_P!!'_R7B_\ B:/^%P^(
M_P#H(_\ DO%_\3110 ?\+A\1_P#01_\ )>+_ .)H_P"%P^(_^@C_ .2\7_Q-
M%% !_P +A\1_]!'_ ,EXO_B:/^%P^(_^@C_Y+Q?_ !-%% !_PN'Q'_T$?_)>
M+_XFC_A</B/_ *"/_DO%_P#$T44 '_"X?$?_ $$?_)>+_P")H_X7#XC_ .@C
M_P"2\7_Q-%% !_PN'Q'_ -!'_P EXO\ XFC_ (7#XC_Z"/\ Y+Q?_$T44 '_
M  N'Q'_T$?\ R7B_^)H_X7#XC_Z"/_DO%_\ $T44 '_"X?$?_01_\EXO_B:/
M^%P^(_\ H(_^2\7_ ,3110 ?\+A\1_\ 01_\EXO_ (FC_A</B/\ Z"/_ )+Q
M?_$T44 '_"X?$?\ T$?_ "7B_P#B:/\ A</B/_H(_P#DO%_\3110 ?\ "X?$
M?_01_P#)>+_XFC_A</B/_H(_^2\7_P 3110 ?\+A\1_]!'_R7B_^)H_X7#XC
M_P"@C_Y+Q?\ Q-%% !_PN'Q'_P!!'_R7B_\ B:/^%P^(_P#H(_\ DO%_\311
M0 ?\+A\1_P#01_\ )>+_ .)H_P"%P^(_^@C_ .2\7_Q-%% !_P +A\1_]!'_
M ,EXO_B:/^%P^(_^@C_Y+Q?_ !-%% !_PN'Q'_T$?_)>+_XFC_A</B/_ *"/
M_DO%_P#$T44 '_"X?$?_ $$?_)>+_P")H_X7#XC_ .@C_P"2\7_Q-%% !_PN
M'Q'_ -!'_P EXO\ XFC_ (7#XC_Z"/\ Y+Q?_$T44 '_  N'Q'_T$?\ R7B_
M^)H_X7#XC_Z"/_DO%_\ $T44 '_"X?$?_01_\EXO_B:/^%P^(_\ H(_^2\7_
M ,3110 ?\+A\1_\ 01_\EXO_ (FC_A</B/\ Z"/_ )+Q?_$T44 '_"X?$?\
MT$?_ "7B_P#B:/\ A</B/_H(_P#DO%_\3110 ?\ "X?$?_01_P#)>+_XFC_A
M</B/_H(_^2\7_P 3110 ?\+A\1_]!'_R7B_^)H_X7#XC_P"@C_Y+Q?\ Q-%%
M !_PN'Q'_P!!'_R7B_\ B:/^%P^(_P#H(_\ DO%_\3110 ?\+A\1_P#01_\
M)>+_ .)H_P"%P^(_^@C_ .2\7_Q-%% !_P +A\1_]!'_ ,EXO_B:/^%P^(_^
M@C_Y+Q?_ !-%% !_PN'Q'_T$?_)>+_XFC_A</B/_ *"/_DO%_P#$T44 '_"X
M?$?_ $$?_)>+_P")H_X7#XC_ .@C_P"2\7_Q-%% !_PN'Q'_ -!'_P EXO\
MXFC_ (7#XC_Z"/\ Y+Q?_$T44 '_  N'Q'_T$?\ R7B_^)H_X7#XC_Z"/_DO
M%_\ $T44 '_"X?$?_01_\EXO_B:/^%P^(_\ H(_^2\7_ ,3110 ?\+A\1_\
M01_\EXO_ (FC_A</B/\ Z"/_ )+Q?_$T44 '_"X?$?\ T$?_ "7B_P#B:/\
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MH_X7#XC_ .@C_P"2\7_Q-%% !_PN'Q'_ -!'_P EXO\ XFC_ (7#XC_Z"/\
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2.':'\I1\H/3"X'5CS110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>iart-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iart="http://integralife.com/20201231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iart-20201231.xsd" xlink:type="simple"/>
    <context id="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18ce1819527143ad9240d8c63f2a1b8c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifce09928a8cc4ee6b297ba253c589b14_I20210219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7fac4ecd14854b13af640b05c1490ec6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7a841c52734456191bb4acc617e9711_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc7bd740dcb34aa28922e7b305fe46a9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1b1715655e084da08f6d9ab45911c30b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i5702024fe01646a99a5c8c9d326d73b8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i06366190454d4344b400d993f2607508_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i46bce481a126499b834dce55ac892b0a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib76545c6be754fe480f77ca7f4e7d426_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i025e2bc5ebd44e56b9b8bbabc7eaffbb_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i917e1a0f095e414696fff9407e57d2ab_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i430afd434f8f4e0b920162b510d18135_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3389b103d9454724bfcbe626c43e56b1_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if6003d7368ff432dba6f6c8d16fda86c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id2f87c2a02444565be0fe283d70f915f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i27e538c5631943ab9dc9c1111151d639_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib9bf134b357c4919a6ed50721d05bef5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2dd3b20ac1684e6890f3b832a8159d60_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if693bb2c04eb453dab7357baad063eab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3052346d0d1e442993b001a9e6866d9c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07b4835211dd45938131096fbda835e5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i884dd79183f04dbd8d842cc6dd3f195f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i440a16199b1a46eab8f2b708f7afaf8c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i979d19139f0248f7be2e1547901b2e99_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if9d2265b32274b0abed4046b6e8c8fbf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3fe917d8b4db45fca1b875cfe91360b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3690ff275714417291e650f8a4240643_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic74b0cb7135c471fb7477ac4e8075cf4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i497e63eb02a0453ab237c03dcd73f5c8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9db0a5177566492e8f23fe58e51f50f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia4b32ed643324b139a34db4854dda958_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1df7e9b7d0f848bfb4d01ca0a5a26007_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f66841395594a8eb57dc2f4410517fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ea2b70053244d36874db3dfcc9d258a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ad1ea87dcac4b829d2588d82938711d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic061214734524284b9c2541bfba9d676_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18fa80bc94ee43818c76548c1fd3568f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id3ee32a6e3c2419ba466a1eb81b4f062_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8f8ec1a3743483194234c2451da620d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i46c49ccb94924cfa94f6a78e004703f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17b901b49949495faaa89878c46c3086_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53b55ca139a647439102e704399dd5ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff2b20b5fc6546aba122baf9aa9b536c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8231a181e67848db899ebd091030a9dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92fd388308054b95b72691d24cfafc71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe61dd55956c46e7be4abd99ed4d4eca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9629a17bb5ca4cecba3ac552967e78f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c6c62a5f0c34c8d9e968867f9fdbc20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3db348720f7447a190b76b7b33df0e2a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50891c775ac2413498b01c0f0be08a09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec5b9cac723b4b70971c2953732ddfed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i61b51f4ea22f452dad1d082f51094afb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bcc60f2ada445349c7587d684b4d230_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:SurgicalInstrumentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f95eb36b67d4b5991bd8922a0d99122_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5e95fa808684df59048d6ca1ca85347_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9426879a0034a178a96eb71152c9db4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d5fad11b772466095bd787febda3045_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e1c7b54ac414cadbec5a89aae8c910f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2edb072a4ba4101a8dce01c004fa0a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i900361f2b62f48298b6b5a2e45b6e3d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie58a11695b3447a89cd0f3f1254e39ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i999b358cac9a43668d1ccf8e82ea992b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ab2eadc90de4c8bb070c20656a5fbed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83fed34960cd4b7783e4140052f46fee_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i38390ecc6ebf4364b0eaad6d1de33927_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="icd4d43ed9aaa4295bc161260fc7b793c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9485be95a6c24efca36864f26dd854fa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iade82fb3205f44c5a097aba1eb4be42d_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i07472adf71764b7291b105f7455877fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie811913eab234ddc8c4112b2e8a244a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2156cb0dcc194220a546b328fa630c07_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:SmithNephewUSDLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i6977fff2340446e5b9fddb49366b8f03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa620d0c12614afdb67624c661a4bb74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib860ee74ea084f9ba7268bd39ee3150c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42d8dcf211fa42229071773bf3eec9bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idabf7271b67c4332a6789f4f602fb426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1647e4d8490d449bbdd63555d13bff5f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5fdf88a449ea464f8b834eda1ecc3784_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i552e291806f3436eb7cc1d37dea5b0ca_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic8aeedc7aea74a4ca21f9bb6fe08f272_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d87508b86884995a4852692cd256f3c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i71eebee9e7bc45b89edecf002f3b63c3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i43ad1d30cc6b413e8157213aa0027a9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie71dda56b32044428763726b23029626_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i96624b2de4ce4641be5e012372eafc14_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i38654dd730af46f2b20f7e1f70f9cb97_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73807d89fa8f442f9bcd07bd546c66fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79bfb53150fc49a6be6633a165cc595d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i53063f0ec44441beaf67e6134faf51ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id364004a8c804fdf9bb65e44092e258c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51536a40efdc4ab2ad8c26840f07e52e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iab11d9606b8c493e897237f5afc49895_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i04d98108080747959bd511b7c066fcd3_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i29ef932d028d41118f879bbe261bf689_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="ifa338878261f40e2ba360dfc8fe15384_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i7e089d0cd7be41ef953212d6a49bfc21_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="idf8459aff7b64dc6a0ccd87d609c74b1_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="iddac580fb69647188ee6543fba4be5ed_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="id88f287fd2124c55ba6e236730478cee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i118da3e2985e4e5d8bd87b7884e68786_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieffdc4cad57b47f4b1fd3d56ceefa79c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="ic2e05e186ade4bdfa5df3778adab6e61_I20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-09</instant>
        </period>
    </context>
    <context id="iccfedde3073f4a829d00d679dffc6b6b_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="i45c9ff50901a4a85ad2ef0c19c9c5530_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="iabdc38db0fd442a69aa920353ffe2441_D20190909-20190909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:DeferredTaxAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-09</endDate>
        </period>
    </context>
    <context id="i6fa850870800416cb442b162e112d697_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i20a2549c743743298aa4d44d68f4239e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-04</startDate>
            <endDate>2019-01-04</endDate>
        </period>
    </context>
    <context id="i54369f3ad8944d81a87891c2071ad9e0_I20190104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-04</instant>
        </period>
    </context>
    <context id="i2460cb74a44d40809765b3973c5e5005_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="iart:AssetAcquisitionAxis">iart:IntegratedShoulderCollaborationInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="ie5c97a92749542e68b530970e7f0bae2_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="id2741743d8a14b23aa6c8c40f03c28fa_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i822435be5fe4477c9241a3f93cf99a87_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="iffd6869fdd4b488e8e7e6aad20f49ad8_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="iaffaed4533cd4d7f923869baf4414f46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8a2c2dd31e44bce86f8e4abfb0af083_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a539237847c4312a3c668310be66ce7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i298c0a2f362f453e873de725dc394c2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49f96e7c8d5e48878ac299da142f760c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4830065b1af74874a4c52fb3bafa551f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4c96b9a4f97464e96a052e5709abec5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf265712ad124ba89a2f02239c34e380_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6e31801eea246ef887ebfaca154f1e0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56827768c653452f9319641e79b282e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83699ed312514c98a332a62de3af0841_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i65fa74c6109b4c1681870661fed5fbc5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3103df919ce14fd6a69dd88d8c19042a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b21d0525850444caddaeaa48e4a223f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabe1597bfefe488e9ef0166c6fc025d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e0a93f507a747b688ad749cb942864f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e5c954d5edc4790bc0a3e952a5fa55e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06f9c93552d04276a8fec11d2ad465b6_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="ia97ea17415c04e59a282e2ba0da43d2c_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3493c77a931f4e3ab849649297db9345_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecc2ed32dcfc40b0983a4a55b9ff5c6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12ccafd7c32d435e937a09b89142d9c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:ThreeMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic68e8212dd194d45aa7eefc82e905835_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:ThreeMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcdababe54704b90bc657174386789e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedFebruary62017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7b0554dce964957a691c822f1f3043e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib885eed1bf1b439dbc39829817261b39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch272017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a06f7aaf6154a9698fb47226200c829_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib208df2927f640368f449fd7a1bab824_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9903cb1395540e6935aa24e96754aa8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic79dd3445c4749509e1d9ed68b515d6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6d1c6073cff140ba89c5d30979e23572_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50fd52cb301e4ea99eebffb661ac3237_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if978c4aaca6e44a4bbe6ada7c5392621_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i68595196347b44cbac22b32806b9b6a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7aaf1027151e43ceb191ea669249f7e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1969a1e3586d4414bbe07f86c1051136_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife3e874c024d4214a79490debf6accc5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife27494f1af045df91344528d6d7bcd9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i40a7efef2b48401aba4a5a87989794ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66bb8b17ef654169a3a82f9faae899f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifccb72845f5c4cabb5085a4a21a261ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fb9c27423b0432ca325ac7ec1736f68_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c52c77498d84321911b79b005966e55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3f7517e74e44d0094f93c18a90e6827_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74c6f3f64c6944fab4ab95454984b3ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7848c2a813504ed493eda06395e04483_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic51105541e884bc88363f2c16b76284b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id21c8a2fa5834558b130cf3274625a05_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99730906a9c94d02acef61305dbefc02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id66609e8dad741d88f6e535da2241aee_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76071dabaf7a463f9b7a7648e7452343_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="i5431ea3c598245fb8a0ff97ff620359f_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="i80156bc966174b7491215c549eab3021_I20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="idd2b8368f50349cf9cd91e15a4474d2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22b15ef56d7f41dea561d0d6c48e9900_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib92168257e704b7ba6330782524c310d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d930dc104ea4e35be06d768b767f67a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide7cbf63723a4f00aabbbd3146cc357d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f663fff566d4cffa41b7ce376813595_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e053946dbfa4feb8860666b23d97916_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa2afcc89a124c74a254bd7642ca84b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c0daaf7584842a682f9d005209fecb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iddf34cd2c7ad4523bd4a9e5bdb8a433e_I20201002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-02</instant>
        </period>
    </context>
    <context id="ica2f97b5e5ef49c59e8f51a58cdce3c9_D20201002-20201002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-02</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="i95c4cb8967c4415791e71b38671c9b83_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id36e756e95b544b0a0fb7875d3ba1806_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92773db83f15438fafd773f6fb0a4f69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i07c262926c3642dc99cf046a2be2277b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i11ae94eb73344fe4baa3eb613e126fd6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2b7b0af6afdc4c7cb5bb5d039bd634a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73bd05d1164d4fcab0652f994e052939_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iart:SwapThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia57db2cc4d5949e0b6b05067d6981e47_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i48478e34f29c4b82be39b744c2f0b79c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7e15c52a94e4723b18f36e548f5062b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf914a28f9c1424fb32fb39c3ed8a539_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bf7eee990834d3a938377a8f728b7a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54146d4c72e64bd8ac7ba073c9652d05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34576a32def44b2f86955da60a86e5a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibcbce85f34d34671b93acf1d523b3e35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idea77615dc3f4d0d97ccc1e74db31850_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2309435ccb874b0c9e92d1729715a5ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f2e3f206fd240638c356c5f147eb7cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7d463a647b74dbbac5a09c81ac5bbf8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib76b40dac61b4789a4966e9e25feb6e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99a46df5051a4c80a3e36d832eac8967_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82ac6be413b64bc6bf1f3f04ce303568_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28578860967b41c294978d5e0297abf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd250c3fbece43cca3832888e0a8c8d4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if88e234e4f3a4e5c85212a69688f3faa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91abedb43abe4a5ea0f381a1428eaea3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf11bff9c64b4754a527c74b53924753_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14091819c033463cad6998b7b746e5fc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieea2b1c6283949ceaa1fd9a23141822b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55642fef06114bbbaa0e9b54ee498dcc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2518cd8291254b57a41eaca854f8ee2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i983ae52a561a4268998a536714c2506d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d848444c85b4f3aa4d2887527d13238_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i788742cc668e4a9e99a0ea702ad3d42e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a622203039f4ebc8dabf0964e1920eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8694924571d49acaf88ce860616d9a7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f485cf6d3cb439c9abb0271be10b04a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95a498ed728646b99350fc4768d04511_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8596a5dc2a9407fb48a1259cc8b60a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54f26f3f5ca842b9bcfeb28c25b7245d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icbc58818c04f441f891165122cbb127a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a3d3833f9944c22a925b20ef544e53c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b73e364f8cb4e7097673c44db096076_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8df7db3ed850456e8523c316fdcffbe8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8f198bdda2744619e39ee6d06daf04a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd87cdab9fc241a1834dc1c837593ca0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if0efb49fa37042d0a1c94e20bee2ffad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1cfb7d1b2ba444ab717d976ea2463a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cf7770e24164a6cb82df37fedffd4dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f21d2308620492c8147ea5fb1a29c9d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5dacd48e9fb84225a7df20fc991135c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3e3ca927bf2472499ec316b98adc47c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60dcf124861c4dcd8c60d1b9a2d582cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5a69f1e2f244056a1abc1ef23d1d66e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id965015cdd944376a9330f2a1a1b4e90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1d6723512224dd2a550d187cc37550d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i81895cd4fe274608b53fe6fac2745d58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43732e30fc6543ff8f68d243116e4edb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib70bb386c50747c78872c44b364b546c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31f677197bca449f96127ace53983925_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iac16087789404550974baece7b19f37c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd343399440746e3bd50a65789b34828_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07cfdd65748d4ca59460e1d27696d43c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1c34edcc03241479e1fdf702a89833c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8a6eb3108674eb19a2f94ab9501e524_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25f07babdbf146d2bdd61ee3648d7f8b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c32a29f20594ea08849b5c78a01c303_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45b8d6aac1514b89b77c76b4631e8a4d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e783237cfd44078b28b484e0a4a54e9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i21a72c6dbaf94f4986204acdd33b9437_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6a4bc84478844f9292b2a97d07b3b406_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i30d9addf58ff4b909342306f36c7c6c5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icf741411a24e4f0ea99ed3515168dfcd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib46eb1c774ef46438bc4de7a317c1c18_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26c81a038dd442ef966fb0c16bf36274_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68056af4a5754484b976b39412544f18_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79dcb769cedf45fd8ca2b400d2d5b642_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9eec322417b4498975fcd6677b0b74e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6dbc8b92cd747a69077527fcede8db9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcdcf2f1832a490e8de4583c2ee8ada2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib06f4af4cdf347728b3fd0fe3c5c26be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84f1f16c648d4e59b8f700fb4215b8de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbbe4092d3414952b63ded2528617b83_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8651611aee6c43578f75fe1703fd12b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9fe9bfb03ab426eb4daedcb791f9292_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e04a4dac0194a64b97de520023edd3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic18c09773aab473bab4a6b8ff55ea00b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0eb7106a152b4473997f284c52bd417a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75c1907d0ffb4c6690f775d97d70d2c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic6cf137b302d469180a56297d93fb47a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4933189a9bc343b1b84567e1726af5aa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie733e2047f5a4b2aa169696427558a08_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i034043822a11407680de78bc3d1ec452_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id3ef2091813046c682a8769926db401b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i03f54a56c22e4237a9643f89c03a66f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb0bc85723e14b2890301593c5ad7ebb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88bd7cfc94f24140a0e0f7f140778b39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c7ab6df120c48e7bbf814ae41c07bfa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f217e07c0494603be881cbbb3995d4e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7077633fc80146898fa719dfec3ebf6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie5101596f43440d6ae335163c5bd50ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57f050bd2ac1429b8c14a8f6b606813a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id1d02ef36bfd440290608745175b9676_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i368c48b7000e48679bf0f4f0b55eb9af_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iart:ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia08ed94918db4fc09d8f42783aacc8b6_I20201207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-07</instant>
        </period>
    </context>
    <context id="ib238505ff51c45719c413427f70bcbd0_I20201206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-06</instant>
        </period>
    </context>
    <context id="i46a618f65cc54536b6ac22edf2a4b181_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f222fedde3d473d8469d82836a431b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:CertainPurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i303b890f4cb5458b9feafec5da48c4c6_I20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-02-05</instant>
        </period>
    </context>
    <context id="i0150909d1797401a995dc4ea8c351908_D20200205-20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-05</endDate>
        </period>
    </context>
    <context id="ic11fc02008134b78802f99d57c698ae8_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if5677f7e2a974dc7b6ffd0e7f9e6fb9c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie462e47008de43c29915a7628f16f658_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie56f741b7288452bab43bdc3b9a4da17_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if1bf91d6b7164e5fbd293ba20be27e48_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0f0c355852c74d3ea007543365176e1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i901bb4e610764e9ca257b79fa0ec7ada_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c85dafb1abd4865944b64fe294a1bf0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibebf86aa0e7747829800552078a209b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1bdab55a19f54c7cb717d1ca9d9e5ff2_D20100501-20100531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-05-01</startDate>
            <endDate>2010-05-31</endDate>
        </period>
    </context>
    <context id="i2367de66733d4c9e86c3fcfb6c69836c_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="if6ae198d152944a9bff341fb3a413ddf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a61d7f582cc439487176679b8b9d6c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i705ff9d8a2094da5af5170fc081b60f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i093928b71e5f461b98a025cef7849d83_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaed5ceec7dc240c6b98379fe92fa71b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4708887913eb44ee9d09a54ce6c2ef29_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic58808a8f364461da081a8acfb8e751a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie560a306d89242d79633b548637d6187_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbab38d90c9b47fdbbcf4d4bb7cbfd50_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1180226ca50f46c48ae3ef906f7f99d9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3b3f1452538f40ecaabbbef187076889_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id58d59da5a4945d88d46c8031ef25907_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic773caffde25407cabce511afbf4e3d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i424d9c8811b649708c4148b20d4b24a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id717c22f443f4448bfd741ee42b60e90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i493a7b5721d64329a45399d533ad986c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iec97182214d345158f5fdc86adce0e84_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2a88c7ddb0d4436f9142a1530eb72a9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id09d3023efe741e390f961699ce66f28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d34a9446c5345f1ba23501963098bb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64e70f4e6a1b48118ea9ee130e1f63ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">iart:AustriaFranceAndGermanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6445287799cf40d983f351dc75cf6a15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i328cafabba8048a388b6e3eaae3d3c02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87b5e7d299f74563945c1f633f7076ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc6918309ec745bfa72b3ffa07503e44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i318233f5e7da424d999484de82e6a8ca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1747a2e124d4e99bb909cc9389b61af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee52a1107e0348d3bebdc40d768c9567_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd913cb502474113a910bca29ccf36d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0506efb6e60a43dc9e261858a7124158_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id99ba8984a21448d9a3835880d4febea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i71e189e172134a198e45306e30524e45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e0e6743ee86466485e0e297c82bd874_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8d8ce88e979437bbf5ec18f685dd329_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33ca63c7a2bb40df97707e469661c625_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iart:UpThroughTaxYear2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd9f45dbd07e4b1b8f8a22de6eb41518_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceSharesandRestrictedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i915fe0a79f884cefa4d9cbc4dde21cf6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i600d3779342744ec92eb111d87aab117_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a845487839e48b7893f0fdea00c7b8d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d55f040424d496588091e3d160b684b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5bc5a0abf78444e0842fe3e1f0f3ca37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b3b046492264f83b1bdda8c4af96853_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifec541285c404f83866591c6e23fb0e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied2d80105ffa4482aed85b57eea1cada_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7bdd1096ee664d10a6e61b228ea2a3df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i538dfb31e082468593d9ba7bb909acfa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7690a3012a274b599aaf7c76ca6b957b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8333dd78848247469f7bf32fef58b0db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77408f824582469ea836cdd585f88b2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a4563e0592c40fe8a9fa8580f8985a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i199d883ab45d4d4c923d9ec6bdebfc34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia77d428b66b340ff9b3911c6b4f91b35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0220d6c969a24d77a0ae61fb694918c6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iee18fbfc3a8b42098ed3d5d2cbcb6209_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib76aeec8929647b3b5f7a4e8e1a3555f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a492f361fc641fcb8a66e8610864f1b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77a577c66303495c9c64b30f3697ad11_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ca2760ceb9e4f12a8d64b4b643f2254_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iaebb1da81e224630986e6e6ff2c7c7f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea59ee130b064410ba6588bc3f86922c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6c9f30770ba94367a94a9f76eda74407_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:OrthopedicsandTissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0339f7ff81b9436da44be79de840be6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83d605ea1557460e8056284eeac6508e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d0b754b8abd4e25ababaec4ec893e6c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i74738422d75348bcba75c40c5f3ddfcb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibeb51ca4dfba44ab9a951fe9bc3434c2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44e1eb3bcc0f40f5950dfd270c3208b3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0ab9fed755274b8bab9f12726270620d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab753bf745234f46a5d7d0762901ed84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i312af3201ee346458bf3076a77de0b3e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7da3dc5527e64b279b398c99855b2504_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39dc2f2111394426b38f70b228c05252_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd720fd7705748f5b9f4dd5218b65a36_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f314852dfa54284ab10723c587b8b21_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0c94f499c38242379f9bbbeea658eb17_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f21d5bd0b244efd8b12f153cded75a9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5e91b9abbee04f569341599829c2c727_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iadc989d0ee9f45a6a3f3bd44a0972156_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id6f47f06a0f24932a7f6cda6d309f09f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i56cc64b365d84a6ca6fc1c66b40c0afe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ffdd35dd74547d58bb2c5c82ed5912f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ec02ac258524a4f81b14306dd3256d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ec796a8dea1494f959cf4013fc839af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i487980db30c14d9298651dad86a5d2cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51d472c1a60c4976af5221d730388b12_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic11b11343fea42b7b40dc6964a49dc48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5bfda1bfd48c4de2b4ae4d4bdf4a010d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1cbbb9e128841cf9fa63ba54ab3ffa8_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="ib8aec2854c5740fcb5bf9baf57f0ef8a_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="ia880589c0d5d4323b971f4a8272c48aa_I20210219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanAndTwoThousandOnePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="i378458edd8554ba79827a3b035c5b627_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbaa46b7b57a494184351280ab176862_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id717ba89e124459c8d3ed604888d7343_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c8d0b64387943148ed765fd23753bc5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2fd07fac1f2c4ee7b985bcbb9e9e40cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i474dfc678b2e48f7b2fd713e31a2915a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i634cc8f5164246f487b40cd525f33427_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied10a71639c3481ba9aefa7b862c3fbf_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5ab29dbb0b9741c09878d1f0e26205c2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i44ad85cfd93e4d96b0dd6c63182cff35_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>iart:Segment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>iart:reporting_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="customer">
        <measure>iart:Customer</measure>
    </unit>
    <unit id="asset">
        <measure>iart:asset</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="plan">
        <measure>iart:plan</measure>
    </unit>
    <unit id="renewal_option">
        <measure>iart:renewal_option</measure>
    </unit>
    <unit id="product">
        <measure>iart:product</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV80LTEtMS0xLTA_a44cff47-9258-4985-bd22-43bf8c0df7eb">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV82LTEtMS0xLTA_d3a03359-9fda-4e79-a468-c8447c0d03fe">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV83LTEtMS0xLTA_298ba369-f1e8-42c5-a78f-1f03eaffb7bc">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV80L2ZyYWc6YzNjZjg1ZjIxZmU3NDBlMzhiOWUwNmFkYTM2NWUzM2MvdGFibGU6ZmVkZjVjMGYxMTkwNGMyNWI0NTNkYWI2MTEwMzgxZTEvdGFibGVyYW5nZTpmZWRmNWMwZjExOTA0YzI1YjQ1M2RhYjYxMTAzODFlMV8xMC0xLTEtMS0w_8d27f640-8c2e-4527-ac9d-0f46b44954d6">0000917520</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTAtMS0xLTQ4MTQ_60a2b1eb-e906-4b52-95c5-e75f107ed1c2">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="icd4d43ed9aaa4295bc161260fc7b793c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">P1M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6977fff2340446e5b9fddb49366b8f03_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzEtMS0xLTEtMA_d4ec7142-cfe6-4eda-bc0f-3c82444d2879">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ifa620d0c12614afdb67624c661a4bb74_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzItMS0xLTEtMA_7d917124-4a1f-40f8-b4ac-bad98f6ad59d">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib860ee74ea084f9ba7268bd39ee3150c_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzMtMS0xLTEtMA_a495badd-7248-49ef-82fd-71a70201b519">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i42d8dcf211fa42229071773bf3eec9bb_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzQtMS0xLTEtMA_1e871729-d456-45db-b303-e4ddedf87d8b">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzUtMS0xLTEtMA_ae441da0-f957-4b29-8001-8f54328b3ab3">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="idabf7271b67c4332a6789f4f602fb426_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjYvZnJhZzo4ZTU0ZDhkMGYyMjQ0OWVjOTI0NjM5ZTFjYTBiMjkyZS90YWJsZTo1ZTg0MDFmMzQyZTc0NWQ1OTBmOWJjMmE1NzU2NTFlYy90YWJsZXJhbmdlOjVlODQwMWYzNDJlNzQ1ZDU5MGY5YmMyYTU3NTY1MWVjXzYtMS0xLTEtMA_34472128-7e9b-4f9c-88e0-a37b386d8ec5"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i4708887913eb44ee9d09a54ce6c2ef29_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTI_0bee5ce3-e334-433a-bccf-d7c4674263bf">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMS0xLTEtMA_e38351f4-5b5d-425e-a077-34e94f0c666d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMi0xLTEtMA_4e90cd51-3d1f-4d71-b49b-57f61a74be5f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzItMy0xLTEtMA_e6c4b7be-5d0b-44b0-81ba-ab1afb430d4a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMS0xLTEtMA_a6fc0fb3-3635-45bb-932f-45c3435aa8b4"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMi0xLTEtMA_dc88d4cd-6509-4146-b975-09f787bb29fa"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTQvZnJhZzpjYWYwYzEwZGE4Y2I0OTUwYTdmYTJhZWMyN2ZiMTUwZC90YWJsZToxNDljYWIyY2UxYmE0ZGRjOTlkOTVjMGI5YWI1NGJmMS90YWJsZXJhbmdlOjE0OWNhYjJjZTFiYTRkZGM5OWQ5NWMwYjlhYjU0YmYxXzMtMy0xLTEtMA_f77ec525-9514-4d9a-945c-5736ce249b76"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <dei:DocumentType
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI3_5792f7bb-424c-46f1-9c48-c6ab8b4775c9">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6M2E0ZmE3MDFlZTUxNGU3NTkxYmQ0MTdlZjA1NzZiODAvdGFibGVyYW5nZTozYTRmYTcwMWVlNTE0ZTc1OTFiZDQxN2VmMDU3NmI4MF8wLTAtMS0xLTA_5f197cfc-e615-4350-b7d9-9b4faf9e6b17">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18xMDk5NTExNjMxMDA3_4f87b79c-f1d3-4883-a7af-913a07e5895a">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18xMDk5NTExNjMxMDA3_e387a1eb-bdc9-4ecd-acba-80870238d35a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6NzkxNGU4N2M1YWQ1NGU4NGEyMTBmZTk1YmZlYTBiMGYvdGFibGVyYW5nZTo3OTE0ZTg3YzVhZDU0ZTg0YTIxMGZlOTViZmVhMGIwZl8wLTAtMS0xLTA_4df9fde3-3729-472d-9613-a3792860c713">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIx_744259fe-9e71-41a0-a75c-7ac451933483">0-26224</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIy_e30ec496-8126-486e-adb2-eea0f5e8c6b9">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8wLTAtMS0xLTA_5967d9be-ba33-43a3-afc2-265ebc54a7ca">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8wLTQtMS0xLTA_4c09c422-0c09-40c9-9f19-ab5f86afc3e2">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8zLTAtMS0xLTA_05a1ee74-ec56-4696-93b5-9fac4a4e37d2">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl8zLTQtMS0xLTA_4d9a6043-a4e3-4755-9ae4-cdbe703065b2">08540</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl80LTAtMS0xLTA_f7768684-8f74-4638-af63-1ca0fbcf3b49">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6ODNiZGU1YjU2ZmEyNDkyZjg1NzlmNTY4ZGE0ODIwZmIvdGFibGVyYW5nZTo4M2JkZTViNTZmYTI0OTJmODU3OWY1NjhkYTQ4MjBmYl80LTItMS0xLTA_d5c58022-866c-4145-ac7f-74285a8b9313">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODIz_21da938f-d114-459f-95b2-60e17ded6fca">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE3_39b9d158-7ac7-4177-9c39-760b6ed4d075">275-0500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTAtMS0xLTA_64801ed8-7eac-4684-8f3f-51b33167ddcc">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTEtMS0xLTA_a3db5686-9894-4d89-93c3-2f9bb12808b8">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6MzE4OTdlYjAyNzMxNDlhNmFmZThmNTU1NDI5YTc5MDQvdGFibGVyYW5nZTozMTg5N2ViMDI3MzE0OWE2YWZlOGY1NTU0MjlhNzkwNF8xLTItMS0xLTA_51a7e9de-4ec4-49d7-b8ce-3ac92e99f264">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI0_db8eff97-9c95-42a1-b664-51a1d986e874">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE4_370690c3-2215-4653-a854-b45e74e2e139">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODE5_1460a25c-3517-4908-aacd-1ba4f70a0e3e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI1_bb86f443-101c-4030-9471-9c42eda4849f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN18wLTAtMS0xLTA_9f92cb49-5aa1-4b15-a467-8368dc5b2780">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN18yLTMtMS0xLTA_ae6d013c-5eef-4472-a842-9e7d75fc1502">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGFibGU6YTcyODYwNmQzYzgwNGVmMWIzZTU1MmJmMzM0MDljZDcvdGFibGVyYW5nZTphNzI4NjA2ZDNjODA0ZWYxYjNlNTUyYmYzMzQwOWNkN180LTEtMS0xLTA_37ae44af-0f7b-4087-93a9-91b60ec54656">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18zMjk4NTM0ODg2Njgx_4c3cec57-7f39-4b1a-b997-e90a420c539b">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18zMjk4NTM0ODg2Njky_47e1432d-4d38-42cf-9bbd-a7c8393fd067">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i18ce1819527143ad9240d8c63f2a1b8c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yMzc1_706ea729-279a-4ca3-8c28-06440024feb6"
      unitRef="usd">3370200000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ifce09928a8cc4ee6b297ba253c589b14_I20210219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yNTky_8a2e3d85-ace1-455b-a9dd-c34bf674b741"
      unitRef="shares">84369946</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xL2ZyYWc6ZDAwNGMwOGY0NTE3NDI2NGIyMTBjNDZlZWZmYjFjZWMvdGV4dHJlZ2lvbjpkMDA0YzA4ZjQ1MTc0MjY0YjIxMGM0NmVlZmZiMWNlY18yODI2_dd5a317c-cca1-4f6b-9ae4-dae815b346b6">Certain portions of the registrant&#x2019;s definitive proxy statement relating to its scheduled May&#160;14, 2021 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtMS0xLTEtMA_6e23a300-48e1-41fc-9ac0-ca11732c40e7"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtMy0xLTEtMA_f2f0f910-1b58-4cc0-8a1b-78e790197fb0"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMtNS0xLTEtMA_6e18fb04-6de8-4bc3-b991-4da297c28510"
      unitRef="usd">1472441000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtMS0xLTEtMA_a08ab441-746d-40e3-ba7b-de20830fd3f2"
      unitRef="usd">520834000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtMy0xLTEtMA_ab7a124b-b9d4-4b6e-9c1b-db71f2df799e"
      unitRef="usd">564681000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzUtNS0xLTEtMA_115cd0dc-3533-4721-9459-aaa7a86dc3ad"
      unitRef="usd">571496000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtMS0xLTEtMA_498dd407-1521-4a74-aaec-0047240ffa61"
      unitRef="usd">77381000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtMy0xLTEtMA_81076463-05b1-4f6a-87ee-e0c504bece7b"
      unitRef="usd">79573000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzYtNS0xLTEtMA_4f6e8245-84e4-49b8-b0ed-ffe9522f3d1c"
      unitRef="usd">78041000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctMS0xLTEtMA_60cb5f6b-3991-4326-872d-dd9f317b75f8"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctMy0xLTEtMA_16daf3e8-135e-4e70-bd2e-07bce730fe52"
      unitRef="usd">64916000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzctNS0xLTEtMA_607f12cc-b13e-4ec8-b2a9-7d397f047b50"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtMS0xLTEtMA_1b573a25-da10-43a8-9e51-3b68ed774f60"
      unitRef="usd">594526000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtMy0xLTEtMA_8ccbb6a5-d0ae-4375-876a-d7602d59f4da"
      unitRef="usd">687599000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzgtNS0xLTEtMA_f47303f1-eafe-4790-bcdf-73b30010f5a3"
      unitRef="usd">690746000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktMS0xLTEtMA_1942ccd1-e55c-41d5-87e0-35eb5be363b7"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktMy0xLTEtMA_fb49ebb8-b1d7-4713-b784-785057202dd6"
      unitRef="usd">27028000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzktNS0xLTEtMA_af973649-9399-4d4f-bafe-cca18dea2af7"
      unitRef="usd">21160000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTEtMS0xLTA_703c353b-7716-4b24-9fd9-7e59c1976338"
      unitRef="usd">1220498000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTMtMS0xLTA_bd30fa7e-5cab-4f39-a412-fc3f83d2ab6d"
      unitRef="usd">1423797000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEwLTUtMS0xLTA_57c103b7-5bff-4c7c-a32b-a5570146acd1"
      unitRef="usd">1361443000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTEtMS0xLTA_43f19192-e989-46d3-aca5-3707a25c16c2"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTMtMS0xLTA_d2277fef-90c3-42fe-b293-00545a5b032e"
      unitRef="usd">93760000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzExLTUtMS0xLTA_08af56bd-c59d-4ea3-af13-5a169a7250a1"
      unitRef="usd">110998000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTEtMS0xLTA_0a2e6e5c-adae-4651-b040-585c6fbb2fea"
      unitRef="usd">9297000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTMtMS0xLTA_9055baad-37cd-41f1-af79-9861bccce8c7"
      unitRef="usd">10779000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEyLTUtMS0xLTA_46fc1565-3f12-45c1-8db9-41f6dc3681e9"
      unitRef="usd">2800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTEtMS0xLTA_b171c940-bae3-47a7-b1f3-ce51bf5e0755"
      unitRef="usd">71581000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTMtMS0xLTA_61661f30-522b-4f11-8e72-159cd03c7cae"
      unitRef="usd">53957000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzEzLTUtMS0xLTA_5608265b-7f2e-478b-9171-b5381158ae2d"
      unitRef="usd">64683000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTEtMS0xLTA_22ff29f9-f10d-470a-b5ed-61ce6f921c8c"
      unitRef="usd">4434000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTMtMS0xLTA_424e2183-feb5-4423-a654-076fd1541149"
      unitRef="usd">9522000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE0LTUtMS0xLTA_a5411999-fb34-4cab-885c-d2c1896204f9"
      unitRef="usd">8288000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTEtMS0xLTA_a499f1ee-1269-47cd-aaf9-1c8065cccfe2"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTMtMS0xLTA_3014c59d-08db-4ef6-b6b7-f627568e7d5e"
      unitRef="usd">60104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE1LTUtMS0xLTA_1d79285f-2829-46ed-ae8e-f7be0996a914"
      unitRef="usd">57403000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTEtMS0xLTA_d96bbac1-890e-420f-9016-05e8d0ace25f"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTMtMS0xLTA_698f0c03-ed7c-4e18-9007-feab2fa80b2e"
      unitRef="usd">9903000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE2LTUtMS0xLTA_f37c45b1-5cba-4c1b-a12c-8de397a6e9e9"
      unitRef="usd">-3398000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTEtMS0xLTIyNDY_3cf60f5f-b8b9-4229-af4b-b64ab3a2b670"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTMtMS0xLTIyNDY_298af82d-8013-49ff-b4e1-05f0d78a0da9"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzE3LTUtMS0xLTIyNDY_5dc979c8-5fee-44d2-9f08-b9b46812d91b"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTEtMS0xLTA_9cba329c-5ae7-4e97-9464-568fc7f50e3f"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTMtMS0xLTA_dab2b364-9955-4453-af87-f4499a5b4637"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzIyLTUtMS0xLTA_5bea97d4-9eef-4d51-80a4-c383966e0e7d"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTEtMS0xLTA_952a678d-192f-4a36-a588-97a4832cb3a4"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTMtMS0xLTA_4219b512-3c23-4338-9e3b-e76cadeb57e9"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzI3LTUtMS0xLTA_bad1a15a-12c9-4dc7-9d81-ec3d510ac65f"
      unitRef="usdPerShare">0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTEtMS0xLTA_6ebbd697-d8a8-438f-9215-6334dff432d2"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTMtMS0xLTA_492097b4-513b-4318-a8bf-4ce081c86231"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMyLTUtMS0xLTA_8c4a1dcc-e59f-4850-bd48-c02b5003941b"
      unitRef="shares">82857000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTEtMS0xLTA_6ec6da91-e794-4604-babf-ea5826106b67"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTMtMS0xLTA_a843ed34-5dfc-4382-91c1-1f64d05ae4d4"
      unitRef="shares">86494000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMjcvZnJhZzpmYTYyMzcyMzVhZWQ0ZGJlYjAyMjdjNmU2MDkxMGEzOC90YWJsZTozZDJhYzFkMzk2NmQ0YzRhYjBiNTZhYjZlN2ZkMzhjNS90YWJsZXJhbmdlOjNkMmFjMWQzOTY2ZDRjNGFiMGI1NmFiNmU3ZmQzOGM1XzMzLTUtMS0xLTA_a5387611-9aa7-487c-a012-6b226f4bd058"
      unitRef="shares">83999000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtMS0xLTEtMA_3a19097a-e9ab-4ee7-b841-1f617fef3de5"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtMy0xLTEtMA_298af82d-8013-49ff-b4e1-05f0d78a0da9"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzMtNS0xLTEtMA_5dc979c8-5fee-44d2-9f08-b9b46812d91b"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtMS0xLTEtMA_7aea4bf4-9d4c-47c0-a7f9-cf058130ec41"
      unitRef="usd">53363000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtMy0xLTEtMA_c1695be3-519f-4753-a777-1b0592b24fcd"
      unitRef="usd">-174000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzUtNS0xLTEtMA_81a3fb1e-41be-4bc0-b7c5-e49a82d7964a"
      unitRef="usd">-19159000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtMS0xLTEtMA_e720e55e-65e4-419d-96f4-3cfd214b9243"
      unitRef="usd">-96837000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtMy0xLTEtMA_93771409-f66e-4480-9be6-84bc9f89d989"
      unitRef="usd">-13671000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzgtNS0xLTEtMA_19d05ab6-d3be-4869-82de-e2f949bd2d04"
      unitRef="usd">11709000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktMS0xLTEtMA_120e6cb0-f0e2-4d96-8bb9-f04a4c132347"
      unitRef="usd">-24442000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktMy0xLTEtMA_a241953c-12a1-4064-9f7c-623836e25de4"
      unitRef="usd">14865000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzktNS0xLTEtMA_862e1ac6-0977-49c2-b2a4-3ea1bc4c1dfa"
      unitRef="usd">13400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTEtMS0xLTA_1341f364-1620-4c51-a46c-c7bdaf15274f"
      unitRef="usd">-72395000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTMtMS0xLTA_3b341f2a-12df-4f12-bd8b-95b40a2b1eec"
      unitRef="usd">-28536000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEwLTUtMS0xLTA_327d6539-841a-439f-9ae5-41d2dd9413be"
      unitRef="usd">-1691000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTEtMS0xLTA_58181765-af31-4662-8700-84acbb5f524c"
      unitRef="usd">4604000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTMtMS0xLTA_b6fa6f05-8a9e-4d02-948c-5920a8041517"
      unitRef="usd">-8973000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzEyLTUtMS0xLTA_07210faf-10ad-4a4a-9cae-705681c58cc1"
      unitRef="usd">-643000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTEtMS0xLTA_11036e91-28bd-470b-88b9-07ccae29a2fb"
      unitRef="usd">-14428000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTMtMS0xLTA_e37578b2-5aa9-4323-85b3-566b27049ed6"
      unitRef="usd">-37683000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE0LTUtMS0xLTA_d748daaf-04ad-4950-a614-27a974a643aa"
      unitRef="usd">-21493000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTEtMS0xLTA_cc9705d8-f138-42cd-9010-fd2d9186d8f7"
      unitRef="usd">-16771000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTMtMS0xLTA_bd1ddee4-6531-44e4-9066-1d6887321421"
      unitRef="usd">-6724000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE1LTUtMS0xLTA_1fb01380-7519-4708-a373-a1a7871eb32e"
      unitRef="usd">143000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTEtMS0xLTA_4e6388fc-0d72-4c89-92d2-1272f358cede"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTMtMS0xLTA_4eabb087-e4b5-441b-a7a5-d29a7f70f6d0"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE2LTUtMS0xLTA_75851bcf-ebeb-4d5d-9c38-0bc24a2b2072"
      unitRef="usd">-21636000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTEtMS0xLTA_71a37ab3-1e0b-4fa7-8538-8259b6840e86"
      unitRef="usd">136235000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTMtMS0xLTA_c68494c9-6227-4789-a4d4-74813e1a5cff"
      unitRef="usd">19242000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzAvZnJhZzpiYWQwZGE2ZDQwMGM0ZGRmYTg4MzBkYTNhZjk1MWM4NC90YWJsZTowZmY3NDU0YzgzNTM0NDQxOThiOGMwNzY1ODNlZGNiYi90YWJsZXJhbmdlOjBmZjc0NTRjODM1MzQ0NDE5OGI4YzA3NjU4M2VkY2JiXzE4LTUtMS0xLTA_d694595a-63af-4940-acf7-bcb81d833c41"
      unitRef="usd">39165000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzUtMS0xLTEtMA_95efdb9f-ca80-4a5b-9182-513a57e937b9"
      unitRef="usd">470166000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzUtMy0xLTEtMA_f7e50d14-1afa-4a32-b91f-56d263986713"
      unitRef="usd">198911000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMC0xLTEtMC90ZXh0cmVnaW9uOjE0N2Q0NzE2M2M2NDQ1YjJhOWJhMWM1ZWZlMmY2YjNhXzM4NDgyOTA2OTcyOTQ_de24deb6-ebd2-4177-a617-7212892b28aa"
      unitRef="usd">6439000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMC0xLTEtMC90ZXh0cmVnaW9uOjE0N2Q0NzE2M2M2NDQ1YjJhOWJhMWM1ZWZlMmY2YjNhXzM4NDgyOTA2OTcyODc_ee3fce4f-1242-41ee-90e6-ed883f0b129b"
      unitRef="usd">4303000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMS0xLTEtMA_bc9b7f53-3642-4541-aba8-5a3c0ab3a4a8"
      unitRef="usd">225532000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzctMy0xLTEtMA_4f62c0c9-9d35-4b92-8947-4df20115db74"
      unitRef="usd">275296000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzgtMS0xLTEtMA_27b2a151-a62a-4b7a-b1e4-a0559dbf2ba4"
      unitRef="usd">310117000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzgtMy0xLTEtMA_f7e99319-4231-4e3b-839b-65c956ced617"
      unitRef="usd">316054000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTEtMS0xLTM0OTQ_41b04db5-2ba3-433c-bb61-b061bcc204c4"
      unitRef="usd">162105000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTMtMS0xLTM0OTQ_ca227ed2-5c11-4761-b039-a20eace54d00"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTEtMS0xLTA_f0a1cabb-5d21-4eeb-8753-39a328858de2"
      unitRef="usd">69282000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEwLTMtMS0xLTA_e70e5b48-06a7-420a-9538-435daac9f722"
      unitRef="usd">67907000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEyLTEtMS0xLTA_16462f5f-28db-4a7b-9d51-76a7df6ade18"
      unitRef="usd">1237202000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEyLTMtMS0xLTA_03850edf-f3ec-42dd-9903-2f8fb6cdef55"
      unitRef="usd">858168000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEzLTEtMS0xLTA_67bf677f-4c91-4d4b-b002-818dd2913cb4"
      unitRef="usd">287529000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzEzLTMtMS0xLTA_90e9bd9a-b6c2-485c-a543-5416c1e659ab"
      unitRef="usd">337404000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE0LTEtMS0xLTA_61f77528-3ea9-47cf-a18a-205c327a8a7e"
      unitRef="usd">83635000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE0LTMtMS0xLTI5Mg_d90544ac-2aa2-4b31-9e18-1115ece204e0"
      unitRef="usd">94530000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE1LTEtMS0xLTA_9322414e-15ea-4669-98ed-3fde9ed4ca29"
      unitRef="usd">989436000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE1LTMtMS0xLTA_0fb41df7-3375-4466-9313-292e499744eb"
      unitRef="usd">1031591000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE2LTEtMS0xLTA_380e4bcb-b1b8-4f20-a0eb-85f07a7576cd"
      unitRef="usd">932367000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE2LTMtMS0xLTA_d9876959-45c6-4949-8e31-45f5cd7df1e2"
      unitRef="usd">954280000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE3LTEtMS0xLTA_e25617fb-f435-462f-8f7b-a87ad76768ec"
      unitRef="usd">73690000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE3LTMtMS0xLTA_3098ccac-cb90-4be8-b833-2e795a12388a"
      unitRef="usd">12623000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE4LTEtMS0xLTA_af98c96d-2116-4320-be16-b5473f945c82"
      unitRef="usd">11277000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzE4LTMtMS0xLTA_e83852e1-0ad5-4c8d-a8cc-d9fe833e336a"
      unitRef="usd">14644000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIwLTEtMS0xLTA_0a7f013a-8e77-406a-af18-4ace042383a0"
      unitRef="usd">3615136000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIwLTMtMS0xLTA_2e0a1db0-3c8a-4800-a60e-77feec720561"
      unitRef="usd">3303240000</us-gaap:Assets>
    <us-gaap:SecuredDebtCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIzLTEtMS0xLTA_3f6b5815-f888-42a3-b2a9-04288edf2f7e"
      unitRef="usd">33750000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzIzLTMtMS0xLTA_36cbfe0e-e3f3-449c-b11c-8232bc4432e2"
      unitRef="usd">45000000</us-gaap:SecuredDebtCurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTEtMS0xLTg5MTY_c36eeba2-bb5a-4d8c-8746-60512e4e42a2"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgramCurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTMtMS0xLTg5MDc_a21cb525-74d2-4ec2-816f-b4bf08f0e602"
      unitRef="usd">0</iart:SecuredLongTermDebtSecuritizationProgramCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI0LTEtMS0xLTA_42ce1fdc-e6eb-4133-a871-2dde1076b6fb"
      unitRef="usd">12818000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI0LTMtMS0xLTMwNg_675fb697-8303-4505-85f0-aaadbe11d582"
      unitRef="usd">12253000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTEtMS0xLTA_410bea87-03ed-4eaf-9a5b-a62530cb0fc9"
      unitRef="usd">54608000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI1LTMtMS0xLTA_553a8e23-4174-4bbb-8f75-4ff97e2fa85a"
      unitRef="usd">113090000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI2LTEtMS0xLTA_19df6c87-8eb5-4923-9a94-d00a29f66e44"
      unitRef="usd">5275000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI2LTMtMS0xLTA_a773a2d7-b3d7-4166-8186-bc6adcd39131"
      unitRef="usd">4772000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI3LTEtMS0xLTA_65dc1875-dcb8-4aa9-a7aa-e0559c97200d"
      unitRef="usd">76117000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI3LTMtMS0xLTA_743114d2-a27e-44de-99e2-3d6508f64d1e"
      unitRef="usd">79385000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMwLTEtMS0xLTM1MDk_7f2cc82e-724d-4f76-a805-3423dce1f884"
      unitRef="usd">11751000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMwLTMtMS0xLTM1MDk_3dd6f7c0-e2fa-4b4b-80fd-c71a57349dbb"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI5LTEtMS0xLTA_4113cbad-20f9-43f8-8013-6246122f26d6"
      unitRef="usd">94194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzI5LTMtMS0xLTA_c879ad71-98f7-4164-b175-78277ee21c60"
      unitRef="usd">76809000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMxLTEtMS0xLTA_5d0db366-c980-4595-82d9-401d3ee2ad18"
      unitRef="usd">401013000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMxLTMtMS0xLTA_e049c86e-cc1d-4fa9-b1bf-e6a0ab902b00"
      unitRef="usd">331309000</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMyLTEtMS0xLTA_1e0ae6f6-d914-47d6-a741-4063dd584a91"
      unitRef="usd">933387000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMyLTMtMS0xLTA_6d892471-e2c6-41e8-b539-369cf7628350"
      unitRef="usd">1198561000</us-gaap:SecuredLongTermDebt>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMzLTEtMS0xLTA_f38f0dea-2586-469e-94f6-425af244f310"
      unitRef="usd">0</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzMzLTMtMS0xLTA_3ad579cd-30b3-43c9-8cca-f174ee82c0df"
      unitRef="usd">104500000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTEtMS0xLTU5Njg_232d62b8-218c-4119-ad3d-a4f9aa079edc"
      unitRef="usd">474834000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTMtMS0xLTU5NzI_34d59efb-734b-4619-995e-5487f72e6625"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM0LTEtMS0xLTA_95504e7b-69e1-4f02-a663-a01ea44d3d1c"
      unitRef="usd">88118000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM0LTMtMS0xLTMxNQ_39703b82-8afe-43b2-8657-b623b14ad207"
      unitRef="usd">97504000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM1LTEtMS0xLTA_7e1b3932-2f6f-41fd-b943-2a3fde2276c8"
      unitRef="usd">16190000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM1LTMtMS0xLTA_cd995a9b-cd71-4e77-a129-6bce9be01648"
      unitRef="usd">36553000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTEtMS0xLTA_6547f88e-79ef-4a5b-9cfa-8cb1658311c2"
      unitRef="usd">186727000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM2LTMtMS0xLTA_51e488c8-f665-4f79-9161-0f1e3d48a612"
      unitRef="usd">118077000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM4LTEtMS0xLTA_643b6313-25b5-4a9a-b19e-e659d3056998"
      unitRef="usd">2100269000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzM4LTMtMS0xLTA_9041a5ef-3a91-4797-95af-c4fabcb7cbf5"
      unitRef="usd">1886504000</us-gaap:Liabilities>
    <us-gaap:PreferredStockNoParValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzA1_2311f43d-649f-443d-9df5-37305fd6aa0a"
      unitRef="usdPerShare">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockNoParValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzA1_87f2c975-570e-48d9-b7a1-5da0b9c745e1"
      unitRef="usdPerShare">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3Mjk5_3e7158ab-d7a7-4858-bb68-ddf5b8a4d5f8"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3Mjk5_90e19347-4873-49ed-bc66-746a3f8bfd03"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzIw_0ab6e322-990a-4873-94bc-2b8d1c4c4bfc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTgwMjA5ZGZlODQ0ODcyOWRkZGNkNTNlNjI0Njk0ZF8zODQ4MjkwNjk3MzIw_7784eee0-68ab-4070-b97b-582520c0f0f2"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTEtMS0xLTA_27f35ade-80a5-4a53-9ff8-e2afc4e46f20"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQxLTMtMS0xLTA_2bf15f32-f27c-4b68-9a99-1c1aaba3452c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzQ3_3a577f46-a734-4e98-b3ae-6c1cdeecaca4"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzQ3_660f3e91-8ec1-41af-bc0a-66fbeee6fd81"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzU3_6ad36637-b680-474d-9e77-8adf7a93fa99"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzU3_aae4f977-ecf0-4199-a29a-1082ce111587"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3Mzc0_5ca2325c-2aa0-4695-8490-70064ff52091"
      unitRef="shares">89251000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmQ2M2U1YjdmZGM0MzM0YTViNGVhZTBmZmFjMDJlNl8zODQ4MjkwNjk3MzY4_729f91c9-8144-4fc6-9422-31d4bcb83739"
      unitRef="shares">88735000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTEtMS0xLTA_b7b77ef0-f969-414a-af9a-adc3632f47e5"
      unitRef="usd">893000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQyLTMtMS0xLTA_63566050-3486-4616-a516-50e739f65ec2"
      unitRef="usd">887000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQzLTEtMS0xLTA_46acadeb-c7c2-4eb3-afc4-a5220a87d5fc"
      unitRef="usd">1290909000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQzLTMtMS0xLTA_b55a4c77-b3b0-488e-be0c-400a9ee13cda"
      unitRef="usd">1213620000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo2M2U3M2UwNjMwZjA0NzY1OGY0YzllMWE5MjA5NzE3ZF8zODQ4MjkwNjk3MzIw_8259c176-7ae7-4db9-89cb-42824a1fb2b6"
      unitRef="shares">4914000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo2M2U3M2UwNjMwZjA0NzY1OGY0YzllMWE5MjA5NzE3ZF8zODQ4MjkwNjk3MzEz_63800b79-c3a4-468c-bd16-b89d995a41d2"
      unitRef="shares">2865000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTEtMS0xLTA_8d5c31d0-7176-4382-a51c-a079ac4a1a67"
      unitRef="usd">235141000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ0LTMtMS0xLTA_1def3fdc-19b3-480f-9880-fc386ecbef6d"
      unitRef="usd">119943000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ1LTEtMS0xLTA_3ac007fd-e741-4d97-8456-b1dd146dfa25"
      unitRef="usd">-74059000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ1LTMtMS0xLTA_b250db75-8f20-4953-b72d-57268314f91d"
      unitRef="usd">-76402000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ2LTEtMS0xLTA_4c7e25a2-4d06-4873-9c28-c8cb0f9c4712"
      unitRef="usd">532265000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ2LTMtMS0xLTA_524853ce-7589-4e3a-ba82-8e9c59004004"
      unitRef="usd">398574000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ3LTEtMS0xLTA_82111e70-5297-4973-9ace-e14579942057"
      unitRef="usd">1514867000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ3LTMtMS0xLTA_9f5c95af-f47a-4797-a828-7470fd93b1d6"
      unitRef="usd">1416736000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ4LTEtMS0xLTA_2a8ef2eb-b88c-4b0a-bf1d-28f9f3cd4165"
      unitRef="usd">3615136000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzMvZnJhZzoyMGMxYmVkMGU0ZTA0Y2Q0YjcyNTJkZDM3YTRhNmIyYy90YWJsZTozNzUzMTMwMjliZGQ0OTE0OTJjMGMyYzU2YWQ4YTA4Ni90YWJsZXJhbmdlOjM3NTMxMzAyOWJkZDQ5MTQ5MmMwYzJjNTZhZDhhMDg2XzQ4LTMtMS0xLTA_fa564ddc-ada1-4c37-8df3-ad7be0284e53"
      unitRef="usd">3303240000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtMS0xLTEtMA_365fa077-ee55-49ca-8515-7451179b6394"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtMy0xLTEtMA_6a7fc0fd-910e-4bb5-91dd-9c951d42b777"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQtNS0xLTEtMA_2ea053f3-63f4-4f63-b757-c0615bfc7d4d"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctMS0xLTEtMA_ddf6c939-a4f1-4984-9030-981dbb8d3e42"
      unitRef="usd">116031000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctMy0xLTEtMA_33de4092-631c-4e43-9f56-861ce6660fd2"
      unitRef="usd">109462000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzctNS0xLTEtMA_4f9bb9e2-7762-47c2-9a11-053ee4ab2ef3"
      unitRef="usd">110730000</us-gaap:OtherDepreciationAndAmortization>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtMS0xLTEtMA_104cade0-debe-4e93-a6ca-8fb75d018e16"
      unitRef="usd">519000</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtMy0xLTEtMA_8bfcba55-76f2-4051-bc87-22460fb32c28"
      unitRef="usd">64916000</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzgtNS0xLTEtMA_b97622b3-2bae-4eb3-8bd1-28b00c35faef"
      unitRef="usd">0</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTEtMS0xLTA_be2570b1-e43b-462d-88c4-a4baede7e6c8"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTMtMS0xLTA_130b4441-7c92-4951-b8f9-250ec4a7dc6a"
      unitRef="usd">5764000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEwLTUtMS0xLTA_2e505e51-f323-4ab9-be48-79b4babe1313"
      unitRef="usd">4941000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTEtMS0xLTA_b7a83b07-d704-47fa-859b-7b2d6a273ba8"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTMtMS0xLTA_42352c84-0758-4d55-9b58-767464935be4"
      unitRef="usd">-19046000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzExLTUtMS0xLTA_d6fd2292-8471-444b-aaa8-6c27b2a8ccd5"
      unitRef="usd">-8184000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTEtMS0xLTA_4525a4c8-3669-4262-a43e-e9d5eeb99c1a"
      unitRef="usd">19590000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTMtMS0xLTA_1c767200-568f-4c71-b9d3-f16900611eae"
      unitRef="usd">21255000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzEzLTUtMS0xLTA_735993e3-c4fe-4284-9fa9-be15175591d9"
      unitRef="usd">20779000</us-gaap:ShareBasedCompensation>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTEtMS0xLTA_36a26cdf-993c-4bc6-ad2f-edd5db9f9599"
      unitRef="usd">12076000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTMtMS0xLTA_f65bb2d0-0f11-4bca-8e96-47864fc8860f"
      unitRef="usd">5390000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE0LTUtMS0xLTA_51020510-008d-4ec9-85b1-7fbd3641f56f"
      unitRef="usd">6270000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:NoncashLeaseExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTEtMS0xLTA_2f6d473d-76fe-46d8-8cc2-a700d62184a9"
      unitRef="usd">2955000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTMtMS0xLTA_5c60bc87-1d70-44a7-a8b1-0c9db106b99f"
      unitRef="usd">5060000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE1LTUtMS0xLTA_3d4c0a6c-37bf-4d69-b5af-112ac69103e8"
      unitRef="usd">0</iart:NoncashLeaseExpense>
    <us-gaap:AccretionExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTEtMS0xLTM1MjA_99d0f3e1-e6a8-4a31-9e07-4f18b8ed6322"
      unitRef="usd">15415000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTMtMS0xLTM1MjA_ed41c464-6588-4304-b59c-053c2020a601"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE2LTUtMS0xLTM1MjA_da8f1ed5-1cc1-41a2-b21d-0381bd7d1357"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTEtMS0xLTA_2736088c-b688-4a67-9611-ecdb07c9a1d5"
      unitRef="usd">-7855000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTMtMS0xLTA_31bc1939-960e-4ed4-9660-9a0b784aeaa5"
      unitRef="usd">-1821000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzE3LTUtMS0xLTA_a24f9f11-a1cb-49cb-a877-b6471751dacf"
      unitRef="usd">-1385000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTEtMS0xLTA_5e69ce73-5a2c-44e3-bf0a-1eda6d4e8098"
      unitRef="usd">951000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTMtMS0xLTA_4ff6e3a9-5061-473a-8faa-c174983292e1"
      unitRef="usd">1119000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzIwLTUtMS0xLTA_04a5b041-7765-4df9-ac6d-5cfc55bc1a3a"
      unitRef="usd">1214000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTEtMS0xLTA_cdeee94a-8042-4912-948c-ebee8da6b801"
      unitRef="usd">-52105000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTMtMS0xLTA_30b4bdf4-a31f-4fdb-9966-ddd28563d063"
      unitRef="usd">9428000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI0LTUtMS0xLTA_0add5289-ba57-4322-b882-41ff007ad704"
      unitRef="usd">17021000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTEtMS0xLTA_891062c0-082c-44df-b8f7-9cdc3aa24647"
      unitRef="usd">48348000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTMtMS0xLTA_d5f289da-84a2-42ff-b981-751212b7efbe"
      unitRef="usd">43308000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI1LTUtMS0xLTA_d399a201-d5a7-4721-af34-b1bb9512b0af"
      unitRef="usd">-8300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTEtMS0xLTA_68040b3c-8748-4493-b92b-4424f773c8f2"
      unitRef="usd">-1632000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTMtMS0xLTA_50f544b5-31af-496b-8f16-51665dfa46b0"
      unitRef="usd">-13071000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI2LTUtMS0xLTA_e1bd6380-1097-45a9-b32d-94a9f86e336c"
      unitRef="usd">-3933000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTEtMS0xLTA_d9bb2fc0-1ac3-4e4c-bd0f-8bb77e33c4ed"
      unitRef="usd">-13735000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTMtMS0xLTA_5922362e-1eb6-4ceb-a43e-d44c79f4a8db"
      unitRef="usd">-13156000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI3LTUtMS0xLTA_92fba39e-bc5c-42b8-b812-7e678f204301"
      unitRef="usd">-1052000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTEtMS0xLTA_69878665-641e-4507-9b12-314fc05eb12a"
      unitRef="usd">-57512000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTMtMS0xLTA_fe4d4db1-22ba-44ad-8895-a8e938b804a7"
      unitRef="usd">14666000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI4LTUtMS0xLTA_ab0ba3fa-c3cb-42c7-95d5-5607202eff7d"
      unitRef="usd">3588000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTEtMS0xLTA_58301abd-8541-49d8-9ecc-1d7476e907e4"
      unitRef="usd">-37000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTMtMS0xLTA_45b4beb9-680f-4eda-b38e-281122e6dfdd"
      unitRef="usd">-607000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzI5LTUtMS0xLTA_8c30de06-a619-4472-ac25-26f8fbe58831"
      unitRef="usd">1504000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTEtMS0xLTA_082ecd8d-fb69-4e02-a20c-65de9d29f8b4"
      unitRef="usd">-2889000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTMtMS0xLTA_7f1a814d-c1e2-4ec2-a357-384d72f4afff"
      unitRef="usd">-2059000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMwLTUtMS0xLTA_10c01fbc-9c2e-4daa-ad59-dee849be4753"
      unitRef="usd">391000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTEtMS0xLTA_7b214dcf-07c7-47b8-8ba5-9c47bf69b20b"
      unitRef="usd">203832000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTMtMS0xLTA_e9feef92-1240-4571-9e60-df90aa18dca4"
      unitRef="usd">231433000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzMzLTUtMS0xLTA_67b0dad8-be03-4692-a687-9927310579f4"
      unitRef="usd">199683000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTEtMS0xLTM1Mzk_30d484df-24d4-4960-9fe5-d65efcfe378c"
      unitRef="usd">38890000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTMtMS0xLTM1Mzk_202caf7e-f39e-4658-9368-48e57b1824c7"
      unitRef="usd">69537000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTUtMS0xLTM1Mzk_b30a84ac-b47a-46ad-b5a2-0622ed8b08c9"
      unitRef="usd">77741000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTEtMS0xLTM1NDg_1c422887-cc90-46ae-821c-ed9196c557bf"
      unitRef="usd">25000000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTMtMS0xLTM1NDg_c9423f2c-70f4-494a-97c4-34df8627a785"
      unitRef="usd">64995000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM5LTUtMS0xLTM1NDg_9fb6e149-d221-4012-ba52-fa1172c7c579"
      unitRef="usd">0</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTEtMS0xLTA_fb3a4982-94ad-4b5e-81cb-35461526d1dd"
      unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTMtMS0xLTA_c032ed07-7d6f-408b-aae7-aa62ea5287d9"
      unitRef="usd">752000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM3LTUtMS0xLTA_861d808f-4cef-4462-86ef-34c90d7364b4"
      unitRef="usd">910000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTEtMS0xLTA_a1df2a68-563a-4f6d-b87f-f6a854b85484"
      unitRef="usd">0</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTMtMS0xLTA_76782f56-8c18-4653-8534-4570bad53b06"
      unitRef="usd">30509000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzM4LTUtMS0xLTA_1932d73b-d541-459d-99d0-a35c6ba4c662"
      unitRef="usd">-26704000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTEtMS0xLTA_3b5c1b1e-9dbe-440e-a0d3-f4ca999af6f6"
      unitRef="usd">3657000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTMtMS0xLTA_8419e907-def2-4863-b421-82c9e7d92a18"
      unitRef="usd">37000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQwLTUtMS0xLTA_3aa39733-6ecf-4529-a3e8-2f8516acc4c3"
      unitRef="usd">422000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTEtMS0xLTA_16396a50-fa5f-49e2-a486-4a9edc170076"
      unitRef="usd">7840000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTMtMS0xLTA_b3900b18-3dcd-4978-a7d5-64c5c0f1da58"
      unitRef="usd">-1584000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQzLTUtMS0xLTA_ea8c6dbf-8112-44c8-ba56-213c07963ccc"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTEtMS0xLTA_1c0b1141-e75d-46bf-906c-c7494a46922c"
      unitRef="usd">-68073000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTMtMS0xLTA_0370c8c8-d4f0-44da-a108-0c95e152b958"
      unitRef="usd">-162668000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ3LTUtMS0xLTA_da990f4d-b7c0-47e8-a904-0ec602b6c51c"
      unitRef="usd">-49705000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTEtMS0xLTA_f137800f-3ce3-472c-aae3-6e0581b5f62a"
      unitRef="usd">171500000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTMtMS0xLTA_02017051-216c-4347-97c3-53b10847815a"
      unitRef="usd">236900000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzQ5LTUtMS0xLTA_e884fead-6df7-4ce7-8699-afa9f03fb6ba"
      unitRef="usd">171200000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTEtMS0xLTA_03f9f349-b969-479e-a17e-004e94483ba9"
      unitRef="usd">441000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTMtMS0xLTA_19d2716c-5f6b-4ebf-af9e-c06775cb59bf"
      unitRef="usd">246100000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUwLTUtMS0xLTA_7359fa8d-c988-419d-ac64-5ae578511362"
      unitRef="usd">660000000</us-gaap:RepaymentsOfSecuredDebt>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTEtMS0xLTM2NTM_0d6e4b38-4f91-402b-981c-19d54c850f8b"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTEtMS0xLTM2NTM_83e16c8d-7617-41f2-8765-d864064b3ecf"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTMtMS0xLTM2NTM_cc273f1c-9e32-45da-8cd0-f3017baa7e49"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTMtMS0xLTM2NTM_d1bcce99-e785-4126-a63d-69668bc83818"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTUtMS0xLTM2NTM_b80e048b-5ae0-4c69-9764-da48bc7bfe7c"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUzLTUtMS0xLTM2NTM_db6084c5-3311-4018-94e7-aa5526c47288"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTEtMS0xLTM2NTA_a43853c1-8c19-4ebd-8b7c-95af9aeaca30"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTEtMS0xLTM2NTA_f03d4e25-7222-411d-8245-27a07263b0d5"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTMtMS0xLTM2NTA_ddb71dca-0d27-47ef-8212-c910b86238ba"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTMtMS0xLTM2NTA_de55fc9a-4046-4fb8-929e-45151528b6ab"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTUtMS0xLTM2NTA_0c6ba471-bfe2-4d21-a6f6-c8e1a2c1dfba"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU0LTUtMS0xLTM2NTA_4def7990-6ba0-4e91-901e-ecd7b79b97e5"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTEtMS0xLTM2NTc_1e2db41d-18ec-4919-ab4a-628f879ec196"
      unitRef="usd">44563000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTMtMS0xLTM2NTc_52072296-c293-4329-b7b7-79956232a222"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU1LTUtMS0xLTM2NTc_fabab5d5-ea09-4676-a64b-af7d2fc2c1cb"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTEtMS0xLTM2NjA_bb7ac002-2305-48ab-bda8-72334515004a"
      unitRef="usd">24347000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTMtMS0xLTM2NjA_81a21489-074b-416a-9d23-f94c7018ea7a"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU2LTUtMS0xLTM2NjA_4efd1c49-22a5-4b8a-9063-fa4ab409fe1d"
      unitRef="usd">5037000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTEtMS0xLTM2Njc_208a25b3-29d7-4c08-ae9d-60bf5a7920c4"
      unitRef="usd">100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTMtMS0xLTM2Njc_0da58d3d-b866-4d55-b257-93c1d754f783"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU3LTUtMS0xLTM2Njc_e058d85a-f34a-4c40-9209-598c4742a787"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTEtMS0xLTM2NzA_d0e720fa-907a-4917-a755-263869210b45"
      unitRef="usd">5232000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTMtMS0xLTM2NzA_8daaded1-9267-4b1b-b7c6-41edfb654ebe"
      unitRef="usd">6948000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTUtMS0xLTM2NzA_fb9e34f0-ea7f-496a-85c2-dc71fcaeeccb"
      unitRef="usd">9392000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTEtMS0xLTA_0297ab81-fbb9-41d6-af48-159b36545dab"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTMtMS0xLTA_670c1547-0807-403a-905e-fa8eb39ad350"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUxLTUtMS0xLTA_bb904fea-b350-48d6-b838-153c658e3f5f"
      unitRef="usd">38196000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTEtMS0xLTA_5ef688bd-12eb-40a8-8b44-451d7a3c6922"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTMtMS0xLTA_af42c01d-bd6d-4b49-8e10-7ec4e53a1f22"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzUyLTUtMS0xLTA_5be73991-14e7-435e-896f-4002616db98e"
      unitRef="usd">349590000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTEtMS0xLTA_ff4d34a5-55c2-4408-acfc-8703297424dd"
      unitRef="usd">5075000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTMtMS0xLTA_956e0c8f-ad3c-4685-8142-09211e955755"
      unitRef="usd">6514000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU4LTUtMS0xLTA_652074d4-338b-463c-8e94-1ad3e5720864"
      unitRef="usd">7821000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTEtMS0xLTA_5bd8c264-93a5-49d8-81b0-ef7149ce8772"
      unitRef="usd">121625000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTMtMS0xLTA_256a9f3c-66c8-4c39-a17c-efb7a4ae1a9d"
      unitRef="usd">-8766000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzU5LTUtMS0xLTA_a71cf0fd-e9d0-49b3-b38c-4fc3571b8852"
      unitRef="usd">-180872000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTEtMS0xLTA_0ad91694-cbdf-45e8-81f4-25abc6802899"
      unitRef="usd">13871000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTMtMS0xLTA_d1f18256-d3ab-4540-9da7-e5b0f98f3452"
      unitRef="usd">74000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYwLTUtMS0xLTA_8359bf78-c311-486b-a21c-25c83ed40a88"
      unitRef="usd">-5203000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTEtMS0xLTA_a3371af9-ddca-4c4e-b3a0-9a42edf5929f"
      unitRef="usd">271255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTMtMS0xLTA_58cc2d94-e753-46bd-8b47-60a6b42098f8"
      unitRef="usd">60073000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYxLTUtMS0xLTA_2c433c06-e447-496c-8278-c9b16b159e3f"
      unitRef="usd">-36097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTEtMS0xLTA_5562ccc3-a305-4cb0-b13b-b3ee34fb6eeb"
      unitRef="usd">198911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTMtMS0xLTA_5e125685-43e7-4942-9eef-7b9b239a8060"
      unitRef="usd">138838000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYyLTUtMS0xLTA_543c4e32-f741-424c-bf87-1eace5248599"
      unitRef="usd">174935000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTEtMS0xLTA_a56f936a-f815-442f-8c1e-12535428ffa9"
      unitRef="usd">470166000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTMtMS0xLTA_ba852d9f-0eea-4681-976d-dc74fc1bc514"
      unitRef="usd">198911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xMzkvZnJhZzo0NDkyMjM2MmU0NTk0NzE4OTZmZTA3OGRmY2E5MzkxYy90YWJsZToxYTk5MzMyYTYzYzE0MWQ0YTkzY2FhYTNlNGQ1Mjg3OS90YWJsZXJhbmdlOjFhOTkzMzJhNjNjMTQxZDRhOTNjYWFhM2U0ZDUyODc5XzYzLTUtMS0xLTA_18126690-f0b7-43b5-a9c3-0a2781e08800"
      unitRef="usd">138838000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesIssued
      contextRef="i5702024fe01646a99a5c8c9d326d73b8_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEtMS0xLTgzOA_ed4c49a6-e8bd-4855-baf0-d1110f9abe22"
      unitRef="shares">81306000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5702024fe01646a99a5c8c9d326d73b8_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTMtMS0xLTMxMDM_6e9a2306-8766-49b5-bff6-ac7f75446398"
      unitRef="usd">813000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i06366190454d4344b400d993f2607508_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTUtMS0xLTMxMDM_5795fd62-9c6b-40dd-9917-ba595aecd7f8"
      unitRef="shares">2927000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i06366190454d4344b400d993f2607508_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTctMS0xLTMxMDM_841e9559-96ed-4f7d-b2b5-8d8b098164a3"
      unitRef="usd">-121644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46bce481a126499b834dce55ac892b0a_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTktMS0xLTMxMDM_9c7c6c6b-6a7f-4e5b-8b6f-1b72b113ea54"
      unitRef="usd">821758000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib76545c6be754fe480f77ca7f4e7d426_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTExLTEtMS0zMTAz_d4bafece-ccee-4720-acd8-d9f9b773263f"
      unitRef="usd">-23807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i025e2bc5ebd44e56b9b8bbabc7eaffbb_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEzLTEtMS0zMTAz_924eeb5d-cfe5-4474-99c9-6f4aa6b4c246"
      unitRef="usd">285186000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTE1LTEtMS0zMTAz_bf4a9324-d486-4a85-add2-49041a5731ee"
      unitRef="usd">962306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i917e1a0f095e414696fff9407e57d2ab_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTEzLTEtMS0w_5559d6dd-58bb-4e3b-b173-f3b8164a68b8"
      unitRef="usd">1854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i430afd434f8f4e0b920162b510d18135_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQxLTE1LTEtMS0w_1c2bbdf5-d187-4e2c-aae1-e9c2b8b6c017"
      unitRef="usd">1854000</us-gaap:StockholdersEquity>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQyLTEzLTEtMS0w_717290b9-297e-4dd1-bd0f-18d39d105945"
      unitRef="usd">532000</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQyLTE1LTEtMS0w_5d76a4ab-6d6b-4f46-bf48-1425c23d6537"
      unitRef="usd">532000</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:NetIncomeLoss
      contextRef="i1e3bc797f46945f48c45cc043360a8db_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQzLTEzLTEtMS0w_cd5804dc-db6e-4bd2-9fc3-a266c4a85f6f"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQzLTE1LTEtMS0w_aa6b45b1-b33f-42c7-be7d-960b336f39e9"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3389b103d9454724bfcbe626c43e56b1_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ0LTExLTEtMS0w_004dc687-9611-4305-96ab-2a09f81f44ae"
      unitRef="usd">-21636000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ0LTE1LTEtMS0w_52d7aa7d-f0e4-4702-a348-9c3cf85193a8"
      unitRef="usd">-21636000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ1LTktMS0xLTA_d4969dee-a5d6-4d48-a6c0-466d8b5c4be0"
      unitRef="usd">553000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ1LTE1LTEtMS0w_e9017574-ab4f-49a7-9c30-ff17cc4d5223"
      unitRef="usd">553000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTEtMS0xLTA_746f7f8f-5dd3-470b-961c-ab3452c043c5"
      unitRef="shares">700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTMtMS0xLTA_9313933f-a4de-4421-8c7b-dec4a6f54e87"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTUtMS0xLTA_0e10eae5-6f3b-4d67-9912-3e4b618dc275"
      unitRef="shares">46000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i069dd60562d345c6ab7a4eb941a3f03d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTctMS0xLTA_ef032430-d5be-4f06-91b1-eefb88692885"
      unitRef="usd">1030000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTktMS0xLTA_4aad5765-13e6-475d-b654-84cd276be803"
      unitRef="usd">52000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ2LTE1LTEtMS0w_c20b3fa7-3cbf-4638-9ef2-7af7af312ccd"
      unitRef="usd">1086000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTEtMS0xLTA_58b3ee98-7332-4483-b81d-b367451c899d"
      unitRef="shares">6038000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTMtMS0xLTA_0fe6d063-8850-4eba-918c-69209e739ee4"
      unitRef="usd">60000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTktMS0xLTA_6f4f60ab-fb22-4c59-80b9-8ef7299becd8"
      unitRef="usd">349529000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ3LTE1LTEtMS0w_67a78fc9-f22d-4518-a647-eec6a879eb57"
      unitRef="usd">349589000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7744c8c50a7e43a59252e74065780ab1_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTMtMS0xLTA_3b6a7740-5b44-4584-a4c1-c58e55fbb770"
      unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie6ef171c8b4249cfa07fe86c803b7059_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTktMS0xLTA_c268803e-a23b-47ea-a432-2a7c692235a2"
      unitRef="usd">20709000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ4LTE1LTEtMS0w_edd12b4c-a778-499c-aa60-d4dcee272007"
      unitRef="usd">20712000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="if6003d7368ff432dba6f6c8d16fda86c_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTEtMS0xLTA_7fed10ec-9002-417d-a022-2b3ed7ad207c"
      unitRef="shares">88044000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if6003d7368ff432dba6f6c8d16fda86c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTMtMS0xLTA_43845e53-495e-483f-adef-7e349b06fa1e"
      unitRef="usd">880000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="id2f87c2a02444565be0fe283d70f915f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTUtMS0xLTA_98680687-f281-4bf8-882a-3900f9a11c7a"
      unitRef="shares">2881000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="id2f87c2a02444565be0fe283d70f915f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTctMS0xLTA_7b89adfc-2d21-4dd5-bd48-91abebd11fb8"
      unitRef="usd">-120615000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i27e538c5631943ab9dc9c1111151d639_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTktMS0xLTA_77adaaf5-d570-46eb-b975-e0a209baf074"
      unitRef="usd">1192601000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9bf134b357c4919a6ed50721d05bef5_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTExLTEtMS0w_94ab765c-53ab-427c-944d-c90790eb41fb"
      unitRef="usd">-45443000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2dd3b20ac1684e6890f3b832a8159d60_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTEzLTEtMS0w_e6be55ad-0a04-4eff-821b-0f86ffd6629e"
      unitRef="usd">348373000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzQ5LTE1LTEtMS0w_1a885618-b725-4e61-ae5e-1a40b186fd33"
      unitRef="usd">1375796000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if693bb2c04eb453dab7357baad063eab_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUwLTEzLTEtMS0w_e84d07b9-19c0-4de9-b53c-f231e8131665"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUwLTE1LTEtMS0w_648d0965-f9e0-4ffb-8cd0-70625941ff72"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3052346d0d1e442993b001a9e6866d9c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUxLTExLTEtMS0w_ca13c8fb-a19c-4c98-9b86-66b3e314f0cb"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUxLTE1LTEtMS0w_f5a9707d-dbab-4f3c-bfcc-a2f4ec159093"
      unitRef="usd">-30959000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTEtMS0xLTA_8ef14d45-02c4-4b5e-854e-6ca9b540ac36"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTktMS0xLTA_5df8a2a5-5f27-4ee1-92b6-ebc64960c5df"
      unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUyLTE1LTEtMS0w_83f3cc5f-6d0f-4eac-85bc-0a83ecb6b59a"
      unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTEtMS0xLTA_5706559c-1e74-457d-aa71-b40b778f4489"
      unitRef="shares">674000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3591c70d5f86455aa2d61047b36e9e69_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTMtMS0xLTA_24c92d27-dce6-47bd-8013-8d80cf7b4998"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTUtMS0xLTA_a8ca05a6-ed99-4f64-a76e-d0be9f2db40f"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iab83821c8fb34c67a8dcff80caccb4f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTctMS0xLTA_69628fdd-26c7-4b9b-a56f-29a6a639e17b"
      unitRef="usd">672000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTktMS0xLTA_86c90669-3572-46db-b9f7-bd767fbb4e51"
      unitRef="usd">-961000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzUzLTE1LTEtMS0w_5dd941d9-e8bb-4094-8cd5-e1b993062cb1"
      unitRef="usd">-282000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i07b4835211dd45938131096fbda835e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU0LTktMS0xLTA_c16c658d-0a59-41b5-8d55-85bedb52de71"
      unitRef="usd">21264000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU0LTE1LTEtMS0w_70e2d931-2c04-4d5f-9a97-ba274d373fb8"
      unitRef="usd">21264000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="i884dd79183f04dbd8d842cc6dd3f195f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTEtMS0xLTA_311e648b-913a-4242-acc7-dd02052a2749"
      unitRef="shares">88735000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i884dd79183f04dbd8d842cc6dd3f195f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTMtMS0xLTA_d488ee2b-1444-4f15-8982-bd01d9d0b74e"
      unitRef="usd">887000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i440a16199b1a46eab8f2b708f7afaf8c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTUtMS0xLTA_f826732f-7805-4799-9fd8-9be63909c9ec"
      unitRef="shares">2865000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i440a16199b1a46eab8f2b708f7afaf8c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTctMS0xLTA_ed11af48-cde4-4386-a8ce-1036c0ab5d12"
      unitRef="usd">-119943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i979d19139f0248f7be2e1547901b2e99_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTktMS0xLTA_6d2ace6b-7ada-4a2f-a7c1-cb2ac6f03d63"
      unitRef="usd">1213620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9d2265b32274b0abed4046b6e8c8fbf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTExLTEtMS0w_ded7fe47-d059-421f-880c-6e15497f8dc1"
      unitRef="usd">-76402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3fe917d8b4db45fca1b875cfe91360b5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTEzLTEtMS0w_6840a322-fa3c-4b6b-afa5-99b9bdbd1119"
      unitRef="usd">398574000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU1LTE1LTEtMS0w_a9b56ead-2437-4d0a-a1e5-0ec4cba3253c"
      unitRef="usd">1416736000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3690ff275714417291e650f8a4240643_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU3LTEzLTEtMS0xMTE1_ce2aec9b-4fd6-41a3-a9df-9453add476ec"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU3LTE1LTEtMS03MDMw_3dce961e-a97f-41f9-bf6e-06e69115c69e"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic74b0cb7135c471fb7477ac4e8075cf4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU4LTExLTEtMS0xMTE1_c79dcc05-9589-49a4-bf0d-6f09778ab39d"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU4LTE1LTEtMS03MDMw_8a78ed9b-57f3-4c48-beb4-0dad9d85a1fa"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTEtMS0xLTExMTU_378373fe-d2f9-4e8a-8073-ea2261097881"
      unitRef="shares">13000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTktMS0xLTExMTU_0038f6e7-a4cd-4cf4-888a-e62991407097"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzU5LTE1LTEtMS03MDMy_abd29fa3-cd7f-416a-ac36-e00d511a6868"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTEtMS0xLTExMTU_7a94d9f3-cf4d-41d4-9294-b043e7256874"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTMtMS0xLTExMTU_241f088f-0384-4ef4-9134-21d48d3f7af7"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTUtMS0xLTExMTU_dc0b005c-8bdb-453e-a090-2435bd0d7ad7"
      unitRef="shares">11000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTctMS0xLTExMTU_87f65a3d-82a9-4097-bdb4-81fa6e38cff3"
      unitRef="usd">526000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTktMS0xLTExMTU_5d69ea58-cdd3-4d39-9f3f-0cb9fad611d1"
      unitRef="usd">-1066000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYwLTE1LTEtMS03MDM2_c5601b67-0bd2-43f5-b886-45f8f393405f"
      unitRef="usd">-538000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifc5f7605cd59426291c2b65b795a501a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTMtMS0xLTExMTU_95a253b0-1f9b-4e27-a3f8-7bb3a870bac5"
      unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTktMS0xLTExMTU_b8c9bd9f-5689-4deb-a15e-0f2d77938a2f"
      unitRef="usd">19397000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYxLTE1LTEtMS03MDM5_e5675716-f451-4551-979a-596eac52e464"
      unitRef="usd">19401000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYyLTktMS0xLTExMTU_01525c37-847f-4f70-a86e-4429a23e5e59"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYyLTE1LTEtMS03MDQy_56ac0589-fd2b-4b98-bb57-872c56e929ab"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTUtMS0xLTExMTU_79f2cf22-c942-4f30-adfe-b93e98599468"
      unitRef="shares">2060000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i46c21f5bdf5440dfaaa7885c18c52c6b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTctMS0xLTExMTU_4baa57bc-9850-4bfb-9702-f62367d41696"
      unitRef="usd">115724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i97eb638c5fc048ad98ca2a44a41e4cd1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTktMS0xLTExMTU_9e598e61-cf63-427b-9b15-9064fabafbb1"
      unitRef="usd">-15724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzYzLTE1LTEtMS03MDQ1_4fc7eab1-56f9-48b1-b292-2df97e859ba4"
      unitRef="usd">100000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i497e63eb02a0453ab237c03dcd73f5c8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTEzLTEtMS0xMTE1_ec268b4e-7a76-4209-a079-9ed8c9d4a6a0"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9db0a5177566492e8f23fe58e51f50f2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY0LTE1LTEtMS00ODEy_a1444cab-7aa4-4d31-ba90-96a62d54794a"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ia4b32ed643324b139a34db4854dda958_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTEtMS0xLTMxMzM_87c743eb-ab82-45b1-9615-57523d3ca110"
      unitRef="shares">89251000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia4b32ed643324b139a34db4854dda958_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTMtMS0xLTMxMzM_f435730e-4e37-46ea-8a27-474e6d634f41"
      unitRef="usd">893000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTUtMS0xLTMxMzM_9a2ab862-3ec5-4f0d-8b99-fedbce6b4c48"
      unitRef="shares">4914000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i90957d345ee24bb0af9c1fdcebe0f67f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTctMS0xLTMxMzM_728c1199-44ba-4da9-9bf5-7fc73ed8de84"
      unitRef="usd">-235141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1df7e9b7d0f848bfb4d01ca0a5a26007_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTktMS0xLTMxMzM_a50fef0b-ffc4-46b1-a34a-49711105b4c7"
      unitRef="usd">1290908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f66841395594a8eb57dc2f4410517fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTExLTEtMS0zMTMz_d2dbc2e8-b545-41fd-9090-a86879a3132d"
      unitRef="usd">-74059000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ea2b70053244d36874db3dfcc9d258a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTEzLTEtMS0zMTMz_e7fef87a-9ad6-4969-a4d9-59806715f23c"
      unitRef="usd">532266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDIvZnJhZzo1ZjZiZTM2NGQ4ZjM0NzRhODhiOThhNzA3ZGUwZDJjYi90YWJsZTowMTU3NjQ2NjZlZjM0MGNlOTI2OGFjZTQ5NzMxYTg2Yy90YWJsZXJhbmdlOjAxNTc2NDY2NmVmMzQwY2U5MjY4YWNlNDk3MzFhODZjXzY1LTE1LTEtMS0zMTMz_b7f3bb0b-0317-42f5-b33c-7b87d2c08796"
      unitRef="usd">1514867000</us-gaap:StockholdersEquity>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNDgvZnJhZzo1MGM5N2IyNzIyYWY0ZjJiOTkwNDJmOWU0ZGE3ZGM5OS90ZXh0cmVnaW9uOjUwYzk3YjI3MjJhZjRmMmI5OTA0MmY5ZTRkYTdkYzk5XzU1OQ_45087ea8-113d-4f50-a915-d4e1ca5a22a7">BUSINESSIntegra LifeSciences Holdings Corporation (the &#x201c;Company&#x201d;) was incorporated in Delaware in 1989. The Company, a worldwide leader in medical devices, is dedicated to limiting uncertainty for surgeons through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Its products are used primarily in neurosurgery,  reconstruction and general surgery. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzE1_de234cc3-77ea-427d-bdf4-4f6a65c92f76">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany accounts and transactions are eliminated in consolidation. See Note&#160;5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;USE OF ESTIMATES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (&#x201c;COVID-19&#x201d;) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#x2019;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECLASSIFICATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors.  The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, were $3.6 million, $2.1 million, and $0.6 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2020 or 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical instrument kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $37.9 million of  property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense associated with property, plant and equipment was $42.1 million, $42.6 million, and $44.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $6.7&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CAPITALIZED INTEREST&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2020 and 2019, respectively, the Company capitalized $2.3 million and $3.1 million of interest expense into property, plant and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired Company are expensed as incurred. The operating results of the acquired business are reflected in the consolidated financial statements after the date of acquisition. Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. Contingent consideration is recognized at the estimated fair value on the acquisition date. Subsequent changes to the fair value of contingent payments are recognized in selling, general and administrative expense in consolidated statements of operations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#x2019;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 17, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company acquires a business, the assets acquired, including IPR&amp;amp;D, and liabilities assumed are recorded at their respective fair values as of the acquisition date. The Company's policy defines IPR&amp;amp;D as the fair value of those projects for which the related products have not received regulatory approval and have no alternative future use. Determining the fair value of intangible assets, including IPR&amp;amp;D, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LONG-LIVED ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INTEGRA FOUNDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $0.8 million, $0.3 million and $0.8 million to the Integra Foundation during the years ended December&#160;31, 2020, 2019 and 2018, respectively. These contributions were recorded in selling, general, and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a foreign currency forward contract that is not designated as a hedging instrument for accounting purposes. This contract is recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FOREIGN CURRENCY &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction losses of $1.6 million, $0.3 million and $1.7 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next  twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. The Tax Cuts and Jobs Act (the &#x201c;2017 Tax Act&#x201d;), enacted in December 2017, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;imposed a toll tax on a deemed repatriation of undistributed earnings of foreign subsidiaries. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661"&gt;one&lt;/span&gt; to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue From Contracts With Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RESEARCH AND DEVELOPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2020, the Company incurred restructuring costs of $4.9&#160;million in cost of goods sold, $1.2&#160;million in selling, general and administrative and $0.3&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations. As of December&#160;31, 2020, the restructuring costs of $6.4&#160;million were included in other liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;STOCK-BASED COMPENSATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the &#x201c;Plan&#x201d;). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed  by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Leases (Topic 842) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(the New Lease Standard). The New Lease Standard requires that lessees recognize virtually all of its leases on the balance sheet by recording a right-of-use asset and lease liability (other than leases that meet the definition of a "short-term lease"). This update became effective for all annual periods and interim reporting periods beginning after December 15, 2018. The Company adopted the New Lease Standard as of January 1, 2019 using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. The Company elected the &#x2018;package of practical expedients&#x2019; which permits the Company not to reassess the prior conclusions about lease identification, lease classification and initial direct costs under the new standard. The Company also &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;elected the use-of-hindsight practical expedient. As most of the leases do not provide an implicit rate, the Company used the collateralized incremental borrowing rate based on the information available at the lease implementation date in determining the present value of the lease payments. The adoption of the New Lease Standard had an initial impact on the consolidated balance sheet due to the recognition of $76.4&#160;million of lease liabilities with corresponding right-of-use assets ("ROU") of $67.3&#160;million for operating leases. The difference between lease liabilities and right-of-use assets is primarily attributed to unamortized lease incentives which is amortized over the term of each respective lease. Refer to Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases and Related Party Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. The ASU became effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU&#160;2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance for the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued&#160;ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill.  The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted.  The Company will adopt ASU No. 2019-12 effective January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively.  The Company does not expect this guidance to have a material impact on our results or financial position.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU became effective immediately and may be applied prospectively to contract modifications made and hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;relationships entered into or evaluated on or before December 31, 2022.&#160;In January of 2021, the FASB also issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform- Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU No. 2020-04. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.&#160;The Company will adopt this standard on January 1, 2021 using the modified retrospective method. The estimated impact includes the convertible debt instrument being accounted for as a single liability measured at its amortized cost and elimination of the non-cash interest expense as the Company will not separately present the equity embedded conversion feature in such debt. The Company also expects to adopt the if-converted method for earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC&#x2019;s regulations. The Company will adopt ASU 2020-10 as of the reporting period beginning January 1, 2021. The adoption of this update is not expected to have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have a significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for interest during the years ended December&#160;31, 2020, 2019 and 2018 was $47.3 million (net of $2.3 million that was capitalized into construction in progress), $48.9 million (net of $3.1 million that was capitalized into construction in progress) and $58.3 million (net of $2.3 million that was capitalized into construction in progress), respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2020, 2019 and 2018 was $29.8 million, $16.2 million and $10.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;NON-CASH INVESTING  AND FINANCING ACTIVITIES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment purchases included in liabilities at December&#160;31, 2020, 2019 and 2018 were $1.6 million, $11.0 million and $5.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company achieved the first developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). In addition, the Company recorded $5.0&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzU2_7bf75c87-c0ed-4b67-8bc6-97509f192970">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDg0_6779724d-0a1b-4cb1-9ce5-63ff842d867a">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany accounts and transactions are eliminated in consolidation. See Note&#160;5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mjc3_2daeb533-d0db-42ec-b767-7cd1b400469c">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzcz_4f1e4510-0e91-49ce-baf0-f8fa02b965df">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECLASSIFICATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDI4_fb5369a3-6cc3-4d03-a012-049d23123680">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzc0_c1e704fe-e3a5-4c05-887e-3c570111eb51">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors.  The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3NzQyMjc_feefacd4-2dc4-49f3-a622-c2a3bc370f7f"
      unitRef="usd">3600000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM3ODU_b36fd92f-3ccc-412c-8b31-2c869500644b"
      unitRef="usd">2100000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM3OTM_a37863e3-cd7c-4397-8229-3d33d9575e22"
      unitRef="usd">600000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzcw_923677d3-0c52-4875-9acc-6857911c079e">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzg3_fcbb8d76-e0b7-47e4-9c30-17ddbe3f425c">Inventories consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzMtMS0xLTEtMA_ae5e5bb3-5786-4c80-aebd-9f0d94932f84"
      unitRef="usd">180301000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzMtMy0xLTEtMA_0b438f9a-7f62-4578-96f7-cf729d8c5efd"
      unitRef="usd">201870000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzQtMS0xLTEtMA_9c1d2f96-1477-415f-8924-9b92a48969e3"
      unitRef="usd">53336000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzQtMy0xLTEtMA_4d3a5765-5bb2-403a-b4bc-add0f6d2061f"
      unitRef="usd">48333000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzUtMS0xLTEtMA_18fbe6fb-3bad-4ce3-9781-c3f21bc5d813"
      unitRef="usd">76480000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzUtMy0xLTEtMA_3b75cf8d-8f5f-459b-9ceb-cdf7768e3fc4"
      unitRef="usd">65851000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzYtMS0xLTEtMA_dcd5d87c-10e9-4d23-9902-65d5fc22791d"
      unitRef="usd">310117000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5MDBkOWI1ODQ2NmQ0NThjOTU0NTVmOGRiOWNkZDMyNi90YWJsZXJhbmdlOjkwMGQ5YjU4NDY2ZDQ1OGM5NTQ1NWY4ZGI5Y2RkMzI2XzYtMy0xLTEtMA_469d8580-b8f6-4821-a59c-6e07cbd656cb"
      unitRef="usd">316054000</us-gaap:InventoryNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3Njk1NDc_b6ba09a4-4c7a-4ef1-8c2f-075eacd24172"
      unitRef="usd">52800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <iart:InventoryCapitalizedExpenses
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzU0OTU_11783260-3763-43dc-9421-e170f7452419"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <iart:InventoryCapitalizedExpenses
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzU0OTU_fc09db84-208f-4369-8372-6b97abe5e71a"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDY5_d433fdd2-b0a3-446b-9c75-60b390aa462e">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDMw_661d5895-54e1-4425-b736-cd6d63787e05">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical instrument kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic061214734524284b9c2541bfba9d676_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzMtMS0xLTEtMA_257f01d2-5830-4488-9e52-9be135addc3a"
      unitRef="usd">1541000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i18fa80bc94ee43818c76548c1fd3568f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzMtMy0xLTEtMA_9175929c-7de3-485c-a2f6-7c416217ad01"
      unitRef="usd">1476000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id3ee32a6e3c2419ba466a1eb81b4f062_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtMS0xLTEtMA_8bdf2d7e-5a11-411c-8a02-bad36b24e7b8"
      unitRef="usd">17345000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib8f8ec1a3743483194234c2451da620d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtMy0xLTEtMA_f0f4c044-aa90-4e1e-a36e-b0af57f22611"
      unitRef="usd">16262000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i46c49ccb94924cfa94f6a78e004703f5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOmIxNDJjNWY2MDc3ZjQ0NTg5Nzg2ZDNiNjkwOGM2ZTMyXzM4NDgyOTA2OTcyMjA_19c35535-dbe9-4112-a0a2-005bacfae88a">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i17b901b49949495faaa89878c46c3086_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOmIxNDJjNWY2MDc3ZjQ0NTg5Nzg2ZDNiNjkwOGM2ZTMyXzM4NDgyOTA2OTcyMjQ_ce3e511d-b905-49ca-aff8-d965537e3f84">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i53b55ca139a647439102e704399dd5ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtMS0xLTEtMA_202c8c0d-2bea-4230-b856-928c6d7d3426"
      unitRef="usd">144852000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iff2b20b5fc6546aba122baf9aa9b536c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtMy0xLTEtMA_ab51b9ae-b244-40f4-82a9-4fee24c70adb"
      unitRef="usd">114941000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8231a181e67848db899ebd091030a9dd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjMzU2NGMxZDJhZjRkOWFhMTI0OGVhYjNhZWJhODhjXzM4NDgyOTA2OTcyMjA_eb35ecd8-7cac-4b3b-8fce-33799d31efdb">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i92fd388308054b95b72691d24cfafc71_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjMzU2NGMxZDJhZjRkOWFhMTI0OGVhYjNhZWJhODhjXzM4NDgyOTA2OTcyMjQ_5466ddd1-4117-49a2-b675-90dca7960c9c">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibe61dd55956c46e7be4abd99ed4d4eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtMS0xLTEtMA_297b4df5-0ed6-49a9-a328-90c50a3a16ed"
      unitRef="usd">166973000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9629a17bb5ca4cecba3ac552967e78f7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtMy0xLTEtMA_ca281eff-797e-4d32-b358-c40e8750fe71"
      unitRef="usd">155313000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0c6c62a5f0c34c8d9e968867f9fdbc20_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjI5MDgxYmMxNjJlMTQ1OWE5ZGI5Yzc5ZTNjYzQ0ZjU5XzM4NDgyOTA2OTcyMjA_9babca06-45f2-48c9-a589-0038a5f59549">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3db348720f7447a190b76b7b33df0e2a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjI5MDgxYmMxNjJlMTQ1OWE5ZGI5Yzc5ZTNjYzQ0ZjU5XzM4NDgyOTA2OTcyMjQ_816b82ff-76ff-4b3a-ad4e-c6d117c3e19c">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i50891c775ac2413498b01c0f0be08a09_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctMS0xLTEtMA_2773b5a4-5dc6-427c-b80f-7401ada87a97"
      unitRef="usd">1164000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iec5b9cac723b4b70971c2953732ddfed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctMy0xLTEtMA_9dd100f4-c35f-4216-acd2-fa3c574f277c"
      unitRef="usd">33104000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i61b51f4ea22f452dad1d082f51094afb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjc0M2E0NTk1M2Q4OTRhN2E5ZjU3MjRmNmU5ZDA0NDJjXzM4NDgyOTA2OTcyMjA_0fc62416-01bc-429f-815b-9525436e6cb7">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1bcc60f2ada445349c7587d684b4d230_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjc0M2E0NTk1M2Q4OTRhN2E5ZjU3MjRmNmU5ZDA0NDJjXzM4NDgyOTA2OTcyMjQ_ff3efb91-cdc9-4907-9357-8b579c4fc51e">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5f95eb36b67d4b5991bd8922a0d99122_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtMS0xLTEtMA_ccc1cb6a-06de-4987-b74e-6402362a5b5a"
      unitRef="usd">143770000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia5e95fa808684df59048d6ca1ca85347_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtMy0xLTEtMA_d3ba318d-688a-4162-8e09-0f033b1902ab"
      unitRef="usd">138398000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia9426879a0034a178a96eb71152c9db4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjc0MzdjYjc2YmU4YzQ1ZDFiNDM3YWEwZWFmNWE4OGI3XzM4NDgyOTA2OTcyMjA_1fb1baf2-df0a-4242-8d1b-3ba16c16775e">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5d5fad11b772466095bd787febda3045_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjc0MzdjYjc2YmU4YzQ1ZDFiNDM3YWEwZWFmNWE4OGI3XzM4NDgyOTA2OTcyMjQ_4e412b74-2046-4a01-9293-587793e83c00">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6e1c7b54ac414cadbec5a89aae8c910f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktMS0xLTEtMA_e3d8b62a-b20b-49ff-8dde-0fb326e04460"
      unitRef="usd">20843000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if2edb072a4ba4101a8dce01c004fa0a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktMy0xLTEtMA_1b819813-f625-4a7a-a0ac-7547ee335816"
      unitRef="usd">22145000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i900361f2b62f48298b6b5a2e45b6e3d3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktNS0xLTEtMC90ZXh0cmVnaW9uOmE4YmRhZmE0YTM3OTRhYTlhYTg2NTg5YTBjMjY3NWFmXzM4NDgyOTA2OTcyMjA_9c5a178a-1ea9-4a0f-8ac0-4c150515e689">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie58a11695b3447a89cd0f3f1254e39ee_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzktNS0xLTEtMC90ZXh0cmVnaW9uOmE4YmRhZmE0YTM3OTRhYTlhYTg2NTg5YTBjMjY3NWFmXzM4NDgyOTA2OTcyMjQ_9ea6740c-7d1b-4bdb-bbd9-b8ae175721dc">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i999b358cac9a43668d1ccf8e82ea992b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEwLTEtMS0xLTA_72ec8e7c-193e-4304-abda-0f91b35c855c"
      unitRef="usd">73890000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ab2eadc90de4c8bb070c20656a5fbed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEwLTMtMS0xLTA_6d529d39-d6c2-45b3-9472-3b9b20d88e8f"
      unitRef="usd">140366000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzExLTEtMS0xLTA_39f51f14-aefe-4eb6-9197-23f95a79a5f0"
      unitRef="usd">570378000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzExLTMtMS0xLTA_c003f9b4-1fcb-44a8-b3b3-079359953245"
      unitRef="usd">622005000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEyLTEtMS0xLTA_907849a6-d51b-46c4-b0ba-42d62f4d4d65"
      unitRef="usd">282849000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEyLTMtMS0xLTA_810a60e8-620a-45f8-9c4a-1492437c67e6"
      unitRef="usd">284601000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEzLTEtMS0xLTA_21f52426-880c-48d6-8e19-84743987d93c"
      unitRef="usd">287529000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90YWJsZTo5NDY2MWRhNzIwN2Q0NzNiYjg4MjI4NDFhZjc3MmQ4OC90YWJsZXJhbmdlOjk0NjYxZGE3MjA3ZDQ3M2JiODgyMjg0MWFmNzcyZDg4XzEzLTMtMS0xLTA_3183589a-cf06-463a-a9ac-05fefbac85de"
      unitRef="usd">337404000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM4NDgyOTA3NzQyMjA_0e8973bb-6192-4f47-a019-478b3f477bb4"
      unitRef="usd">37900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0Mjc_73227133-2cb3-4d9f-b51e-772a69ba875e"
      unitRef="usd">42100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0MzE_5aa87239-0675-4e44-901c-d198d6e25674"
      unitRef="usd">42600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzY0Mzk_e3ef5caa-b44e-438f-a87a-a9d8294e7f33"
      unitRef="usd">44100000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTAwNTY_d67775fb-ce51-4048-a0f5-7776b7533364"
      unitRef="usd">6700000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:InterestCapitalizationPolicyPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDMy_467952ec-8312-4ace-8dae-b607f6bad878">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</us-gaap:InterestCapitalizationPolicyPolicyTextBlock>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzcwNjc_90225a42-cb2e-44ea-9d76-6fef64e07b09"
      unitRef="usd">2300000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzcwNzQ_8adf286f-750c-4439-b132-94dd6f10b2ed"
      unitRef="usd">3100000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mjk1_660638e2-5549-4469-abd5-d804360027dd">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired Company are expensed as incurred. The operating results of the acquired business are reflected in the consolidated financial statements after the date of acquisition. Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. Contingent consideration is recognized at the estimated fair value on the acquisition date. Subsequent changes to the fair value of contingent payments are recognized in selling, general and administrative expense in consolidated statements of operations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#x2019;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.&lt;/span&gt;&lt;/div&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NTAz_d31e5f25-4a65-4dc4-bbd0-98128c266907">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 17, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company acquires a business, the assets acquired, including IPR&amp;amp;D, and liabilities assumed are recorded at their respective fair values as of the acquisition date. The Company's policy defines IPR&amp;amp;D as the fair value of those projects for which the related products have not received regulatory approval and have no alternative future use. Determining the fair value of intangible assets, including IPR&amp;amp;D, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwMjM2_54425559-0a20-4e07-bd57-909a79251c82"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportingUnits
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwMjY0_77d62e45-ebe6-40c6-9aba-151a24208255"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDk2_46a84fb6-fd35-4e5e-bec5-f3bf544910b7">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <iart:FoundationPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzAw_6c3dc0e8-6c1c-48e3-8b34-d3f3db05e6c7">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</iart:FoundationPolicyTextBlock>
    <iart:CharitableContributions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTQ4_cc82e0c6-4028-42a8-8bf6-9c230d2a47fd"
      unitRef="usd">800000</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTYw_b434e56f-d219-4640-8c06-bd87ead84fad"
      unitRef="usd">300000</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE0NTY3_d6f5ae24-ee7a-4917-8839-aac2aa7e3531"
      unitRef="usd">800000</iart:CharitableContributions>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDkw_97ca2790-8119-4c26-9705-f36391370498">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;The Company entered into a foreign currency forward contract that is not designated as a hedging instrument for accounting purposes. This contract is recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzc3_fe349d97-87ea-45da-81a2-e65fd33419d8">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDgy_4f5f1dc9-c1d0-4895-acf6-a35e8de3d419"
      unitRef="usd">-1600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDg2_03592272-f5be-4ba7-ae3b-c435a4fd1aab"
      unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzE4NDkz_99a2f16f-6dbf-4ca8-9d39-2513df15dc73"
      unitRef="usd">-1700000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDUz_5338bf8c-f474-475d-beb1-892f54cd2287">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next  twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzIy_6c8e407f-1268-4e32-b3b0-cd553e103628">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661"&gt;one&lt;/span&gt; to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;&lt;/span&gt;&lt;/div&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i83fed34960cd4b7783e4140052f46fee_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyNjEw_3792437f-116e-4543-9559-a17b3d7b8a8c"
      unitRef="usd">1900000</us-gaap:StockholdersEquity>
    <us-gaap:Assets
      contextRef="i38390ecc6ebf4364b0eaad6d1de33927_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyOTgy_1b995972-b725-4ceb-973d-27c2bc86485b"
      unitRef="usd">7100000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i38390ecc6ebf4364b0eaad6d1de33927_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIyOTg5_efd882c7-090c-4d45-b43f-b8ee3e97cde3"
      unitRef="usd">5200000</us-gaap:Liabilities>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="i9485be95a6c24efca36864f26dd854fa_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTU2_f54cae76-26a4-4f18-93c5-d83a46a4e101">P3M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDM2_41624739-6ec5-4d2b-9791-4fc89c5674c9">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzY4_1ba06053-f2bc-44f8-8ae4-a31a5435f5d1">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0NDU_9d08794d-f946-470a-a6b2-9fc08602f0d0"
      unitRef="usd">4900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0NzI_cd236007-e5cf-4bcc-b7d7-bbb70f41efc7"
      unitRef="usd">1200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc0OTk_526660d6-198d-471d-94ac-c9f315edd39a"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5Njc1MjY_168932fe-b09a-4565-8649-7a98b1b991a1"
      unitRef="usd">6400000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDEw_30209152-8419-4fbf-9cb9-e119dab82791">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2MzIw_fa6fa6cd-7e98-4c6d-b62b-ab0634faeb97">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the &#x201c;Plan&#x201d;). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed  by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzczMjg_a652ee3c-3801-492f-8963-0c0a7c4c7e4a"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="id5d3e3cb5bef4173bbab5c891dafc781_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzczMzM_a314f10a-7ff3-45d6-85a1-1b9073f39aeb"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2Mzkz_7bc8f9dd-1d59-4174-a5e5-2497615e9a89">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</us-gaap:ConcentrationRiskCreditRisk>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_89fb03b3-58b3-44ca-a4f1-f9541d226323"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_bc877e5e-578a-4f11-8ae5-ec4cd2a5ad9a"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyMzU_c50472e0-9a71-439d-ba22-88156907eb00"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i618574f624c74453a9e288d42b4a5c6f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_08b2443a-be3a-4521-a06a-f1c5435b0618"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i407768382efe4440a8e9d92d1972e76f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_a9f7f076-d5c3-4765-8444-9fc37d374208"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9adbb8d22894463dab2cacbdcf11ff0b_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5MzcyNDU_ca81f5c8-5142-4044-b138-4a3fa84db0be"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM2NDkx_e241d7ea-4991-4d28-b159-1a1fd60144e3">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Leases (Topic 842) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(the New Lease Standard). The New Lease Standard requires that lessees recognize virtually all of its leases on the balance sheet by recording a right-of-use asset and lease liability (other than leases that meet the definition of a "short-term lease"). This update became effective for all annual periods and interim reporting periods beginning after December 15, 2018. The Company adopted the New Lease Standard as of January 1, 2019 using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. The Company elected the &#x2018;package of practical expedients&#x2019; which permits the Company not to reassess the prior conclusions about lease identification, lease classification and initial direct costs under the new standard. The Company also &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;elected the use-of-hindsight practical expedient. As most of the leases do not provide an implicit rate, the Company used the collateralized incremental borrowing rate based on the information available at the lease implementation date in determining the present value of the lease payments. The adoption of the New Lease Standard had an initial impact on the consolidated balance sheet due to the recognition of $76.4&#160;million of lease liabilities with corresponding right-of-use assets ("ROU") of $67.3&#160;million for operating leases. The difference between lease liabilities and right-of-use assets is primarily attributed to unamortized lease incentives which is amortized over the term of each respective lease. Refer to Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases and Related Party Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. The ASU became effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU&#160;2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance for the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued&#160;ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill.  The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted.  The Company will adopt ASU No. 2019-12 effective January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively.  The Company does not expect this guidance to have a material impact on our results or financial position.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU became effective immediately and may be applied prospectively to contract modifications made and hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;relationships entered into or evaluated on or before December 31, 2022.&#160;In January of 2021, the FASB also issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform- Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU No. 2020-04. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.&#160;The Company will adopt this standard on January 1, 2021 using the modified retrospective method. The estimated impact includes the convertible debt instrument being accounted for as a single liability measured at its amortized cost and elimination of the non-cash interest expense as the Company will not separately present the equity embedded conversion feature in such debt. The Company also expects to adopt the if-converted method for earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC&#x2019;s regulations. The Company will adopt ASU 2020-10 as of the reporting period beginning January 1, 2021. The adoption of this update is not expected to have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have a significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="iade82fb3205f44c5a097aba1eb4be42d_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5NzQ1NDk_1d70d7c6-4e4c-42de-a767-4f3ad4415a98"
      unitRef="usd">76400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iade82fb3205f44c5a097aba1eb4be42d_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzMyOTg1MzQ5NzQ1NjQ_528b7960-6d6c-4aec-a94e-91b3fda885d2"
      unitRef="usd">67300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InterestPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MTYy_cfd0c658-dee5-48c6-824e-7a59ab6bb6a0"
      unitRef="usd">47300000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MTcz_a8e99b72-b65c-4dfc-877f-ae4dbee4d00c"
      unitRef="usd">2300000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MjI5_94f5baf2-1230-4b98-8f75-6f23b4340ae2"
      unitRef="usd">48900000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MjQw_afd4a954-1412-4d9a-a313-dcc4f2515339"
      unitRef="usd">3100000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1Mjk5_87280c90-0c77-4fde-9300-748ddf244976"
      unitRef="usd">58300000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1MzEw_bd60684f-6b6b-46ac-b89f-9567725ef645"
      unitRef="usd">2300000</us-gaap:InterestPaidCapitalized>
    <us-gaap:IncomeTaxesPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDYy_df970c03-b565-4b33-b320-6682f072547e"
      unitRef="usd">29800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDY2_c253b2a0-fc13-4e2c-8785-d94129bb2a16"
      unitRef="usd">16200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzM1NDcz_705d5a7b-d006-425f-8253-69b27725ef93"
      unitRef="usd">10400000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTEw_b1a4bd3d-7e17-4ad7-ac64-4950c40229ff"
      unitRef="usd">1600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTE1_cc0656f0-6d83-4633-96c9-7fccfd37256d"
      unitRef="usd">11000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzEwNDQ1MzYwNTI4NTIz_62fd182a-534c-44a5-9110-d4da2f0024cc"
      unitRef="usd">5400000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i07472adf71764b7291b105f7455877fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTE3NzM_e55de66c-9cb6-4a3e-89a7-887de959175a"
      unitRef="usd">5000000.0</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ie811913eab234ddc8c4112b2e8a244a5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzQ5NDc4MDIzOTE4Njg_7faa3d4c-9074-4492-ae70-2e1c67df1065"
      unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzMyOTg1MzQ4OTgyMDI_4f4c73fe-4fb6-4cf0-9706-ccd7859441b9">ASSETS AND LIABILITIES HELD FOR SALE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 29, 2020, the Company and certain of its subsidiaries entered into an agreement to sell its Extremity Orthopedics business to Smith &amp;amp; Nephew USD Limited for approximately $240&#160;million in cash. The transaction includes the sale of the Company&#x2019;s upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. In connection with the transaction, the Company will pay $41.5&#160;million to the Consortium of Focused Orthopedists,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; LLC (&#x201c;CFO&#x201d;) pursuant to the terms of certain agreements between Integra and CFO relating to the development of shoulder arthroplasty products.  On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp;amp; Nephew USD Limited and received an aggregate purchase price of $240.0&#160;million. Refer to Note 18. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for details of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considered the assets and liabilities associated with the Extremity Orthopedics business to be accounted as held for-sale as the six criteria under ASC 260 were met during the third quarter of 2020. Upon designation of the assets and liabilities as held for sale, the Company recorded the assets at the lower of their carrying value or their estimated fair value, less &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimated costs to sell. Goodwill was allocated to the assets and liabilities held for sale using the relative fair value method of the Extremity Orthopedics business to the Company's Orthopedics and Tissue Technologies reporting unit. The fair value of the business less costs to sell exceeded the related carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Extremity Orthopedics business was treated as a single disposal group and presented separately in the consolidated balance sheet as assets and liabilities held for sale as of December&#160;31, 2020. These balances are presented as current assets and liabilities as they are expected to be sold within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major classes of assets and liabilities classified as a held for sale consisted of the following as of December&#160;31, 2020 (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzM4NDgyOTA3MTIwNjI_5b4dc0fa-d101-4141-a787-ba2a079bec10"
      unitRef="usd">240000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzM4NDgyOTA3MTIwNzY_7059f4ad-ffb7-4cdd-883e-c019ade622c1"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0XzMyOTg1MzQ4OTk4Mjg_4f90f366-b704-48cf-a1bd-bc962c492c69"
      unitRef="usd">240000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90ZXh0cmVnaW9uOjM4NjZjNGYzN2E3MjRjNjg5M2U1ODkwZDhmODJmNTA0Xzg3OTYwOTMwMzcwODM_bf81776c-3726-4228-8544-e30202385368">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major classes of assets and liabilities classified as a held for sale consisted of the following as of December&#160;31, 2020 (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzAtMS0xLTEtMzI5MQ_82fa667f-eb7a-4339-804b-3a406cd8863b"
      unitRef="usd">713000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEtMS0xLTEtMzI5MQ_35dbebf2-778a-4090-b99a-4a061bc5cd2b"
      unitRef="usd">3186000</iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzItMS0xLTEtMzI5MQ_b2a720aa-de26-4815-84dd-2820e514fb4d"
      unitRef="usd">6589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzMtMS0xLTEtMzI5MQ_5af5e384-0036-487b-8991-73477d448a4d"
      unitRef="usd">13332000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzQtMS0xLTEtMzI5MQ_b5fcba46-bd64-422a-a165-0b5376bdb0ef"
      unitRef="usd">37893000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzUtMS0xLTEtMzI5MQ_eb504341-940c-4037-961b-d8ecfe1648f5"
      unitRef="usd">47546000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzYtMS0xLTEtMzI5MQ_b11ae817-6428-48eb-aa67-1ea1e6d30ac8"
      unitRef="usd">52845000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzctMS0xLTEtMzI5MQ_7d4a84ae-b3e6-4fe4-8122-cc6bca6dee3f"
      unitRef="usd">162104000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzgtMS0xLTEtMzI5Nw_90be9fda-a042-47d6-adcb-35ec09c5572f"
      unitRef="usd">336000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzktMS0xLTEtMzI5Nw_e61ae7da-907c-400b-ba4f-5aea292e2bd7"
      unitRef="usd">539000</iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <iart:DisposalGroupIncludingDiscontinuedOperationAccruedCompensation
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEwLTEtMS0xLTMyOTc_d846b4eb-53f5-4c13-91a4-4acb785f4ffb"
      unitRef="usd">1767000</iart:DisposalGroupIncludingDiscontinuedOperationAccruedCompensation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzExLTEtMS0xLTMyOTc_3c856ebf-bfdb-4fa4-a369-e6bb5d99d1e9"
      unitRef="usd">3440000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEyLTEtMS0xLTMyOTc_c88fed74-ee6f-4a34-bb45-876790dcd0e1"
      unitRef="usd">5669000</iart:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTcvZnJhZzozODY2YzRmMzdhNzI0YzY4OTNlNTg5MGQ4ZjgyZjUwNC90YWJsZTo2NmU5ZmUyZWEwMzQ0Zjg4ODcxNTE1NTg3Y2ExNDEzNS90YWJsZXJhbmdlOjY2ZTlmZTJlYTAzNDRmODg4NzE1MTU1ODdjYTE0MTM1XzEzLTEtMS0xLTMyOTc_8490707b-e036-4268-bab0-3d8da05c906a"
      unitRef="usd">11751000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTQ_40e6d359-e059-4437-b9fa-8f95b5d1be83">REVENUES FROM CONTRACTS WITH CUSTOMERS&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Summary of Accounting Policies on Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable of contract asset included&lt;br/&gt;     in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the short-term portion of the contract liability of $5.3 million and the long-term portion of $6.7 million were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company is expected to recognize revenue of approximately $5.3 million in 2021, $2.9 million in 2022, $1.5 million in 2023, $0.8 million in 2024, $0.6 million in 2025, and $0.9 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Shipping and Handling Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Taxes Collected from Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2020, 2019 and 2018 (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 17, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of revenues based on the location of the customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzE3NDc_b8d57d6d-befe-49ab-bee6-afff07ba3b24">P90D</iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTA_323ebd6c-7eaa-4347-bbf3-59042f4d7634">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable of contract asset included&lt;br/&gt;     in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzMtNS0xLTEtMA_4334161c-d4a1-41f8-bb1e-0fed95325bcc"
      unitRef="usd">8680000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzQtNS0xLTEtMA_da9dacfb-b5ea-43d1-8ecb-8b179bac2c0b"
      unitRef="usd">8680000</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzUtNS0xLTEtMA_ac0d09b4-9437-438a-ad5d-e51a9308283d"
      unitRef="usd">7430000</iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzYtNS0xLTEtMA_c1a4f4d3-9379-4b94-81b5-11973b2ffa02"
      unitRef="usd">7430000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzktNS0xLTEtMA_df5eb685-248a-4e97-afc2-3d518786fb83"
      unitRef="usd">11946000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzEwLTUtMS0xLTA_47a21c8b-b2c4-40e4-a2f8-ae58f158628b"
      unitRef="usd">3925000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzExLTUtMS0xLTA_2eb33697-dea8-43f4-a06d-142dd697a6be"
      unitRef="usd">3856000</iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation>
    <iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzEzLTUtMS0xLTA_7f0ff34e-21fa-497f-bc7f-c0b68c143c99"
      unitRef="usd">84000</iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTplODM1OGUyYTI2Nzk0ZjQ1YTc1MTQ1NzNlMDMxZTBhNS90YWJsZXJhbmdlOmU4MzU4ZTJhMjY3OTRmNDVhNzUxNDU3M2UwMzFlMGE1XzE0LTUtMS0xLTA_7eed5719-2f28-470d-8c50-dbb07ac53b1d"
      unitRef="usd">11961000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMwMjI_6d765f32-f0e7-4d2d-b268-b0a6a912b486"
      unitRef="usd">5300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMwNjI_9b02b3c8-1e20-4b01-9878-ac179e1199c4"
      unitRef="usd">6700000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6977fff2340446e5b9fddb49366b8f03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyNjY_fd0faec0-2755-42b8-ba21-54db5a2b10b3"
      unitRef="usd">5300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ifa620d0c12614afdb67624c661a4bb74_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyNzg_9952f71a-e5f1-4ea4-9973-137837cf31af"
      unitRef="usd">2900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib860ee74ea084f9ba7268bd39ee3150c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMyOTA_e4d6d9ba-3489-43f6-bf62-c040070f9008"
      unitRef="usd">1500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i42d8dcf211fa42229071773bf3eec9bb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMDI_95ba4c23-bd78-4c66-8c19-b20a11370b75"
      unitRef="usd">800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6a63d7d94c254cd3a0300883cf0b6fd6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMTQ_4afc7642-327c-40ac-915e-05cdff14217a"
      unitRef="usd">600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="idabf7271b67c4332a6789f4f602fb426_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzMzMzA_cb151f28-31b7-496b-8e77-233af29e4052"
      unitRef="usd">900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ExtendedProductWarrantyPolicy
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTM_6734de1a-fcf2-4869-a049-7c173b59e0ca">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ExtendedProductWarrantyPolicy>
    <iart:RevenueProductWarrantyPeriod
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzQwNDQ_f56d2d0b-0ccb-4e35-be24-b109b0415b05">P2Y</iart:RevenueProductWarrantyPeriod>
    <us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NTk_5494042e-d730-4677-9ea1-a294a69d3b21">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90ZXh0cmVnaW9uOmZmZWYzMDUzNTBiODQ1NmVhYWZjMzhjMWZjMmNmMGZhXzU5NjA_bb413d1b-a5ad-41e0-9eed-35cf82684721">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2020, 2019 and 2018 (amounts in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1647e4d8490d449bbdd63555d13bff5f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNC0xLTEtMA_06ca3160-d7bc-4b91-9d2d-72e931d27297"
      unitRef="usd">716339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fdf88a449ea464f8b834eda1ecc3784_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNS0xLTEtMA_47ce7f59-856a-4cfb-a2a2-3b76afc69134"
      unitRef="usd">767793000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i552e291806f3436eb7cc1d37dea5b0ca_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzItNi0xLTEtMA_52f251ec-88e4-414e-a768-1fe37f6cd4c7"
      unitRef="usd">740268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8aeedc7aea74a4ca21f9bb6fe08f272_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNC0xLTEtMA_ae25f46a-9cd4-4796-bae4-2520b4387f11"
      unitRef="usd">178492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d87508b86884995a4852692cd256f3c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNS0xLTEtMA_d22afbe0-1c50-41e3-846a-cbe3c10674b6"
      unitRef="usd">228413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71eebee9e7bc45b89edecf002f3b63c3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzMtNi0xLTEtMA_54b66d0a-6e71-4af1-9786-ff62fc5074df"
      unitRef="usd">223661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNC0xLTEtMA_0c4c5926-4a86-4c46-bd19-7b8889128bf9"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNS0xLTEtMA_e09029f2-1f6d-413f-af2d-e7c714476dab"
      unitRef="usd">996206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzQtNi0xLTEtMA_2445b91f-dbe1-4cff-a7ba-5efcbd8a3ba8"
      unitRef="usd">963929000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43ad1d30cc6b413e8157213aa0027a9d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNC0xLTEtMA_a486dcaf-6ca0-4c7d-abb9-12f48854bf60"
      unitRef="usd">293038000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie71dda56b32044428763726b23029626_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNS0xLTEtMA_4fdb30e4-dfe8-424e-8408-3f4be174ee4c"
      unitRef="usd">322739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96624b2de4ce4641be5e012372eafc14_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzYtNi0xLTEtMA_6c949fd0-b39e-4759-82ba-4b9699d79d08"
      unitRef="usd">311565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38654dd730af46f2b20f7e1f70f9cb97_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNC0xLTEtMA_57b49eaa-60b0-4068-83d8-a165705c5296"
      unitRef="usd">78316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73807d89fa8f442f9bcd07bd546c66fd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNS0xLTEtMA_e085de6a-3d0a-4b95-b30e-2c06a449fc27"
      unitRef="usd">90082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79bfb53150fc49a6be6633a165cc595d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzctNi0xLTEtMA_7710670b-7088-46ba-a0a3-eb9c5f18c720"
      unitRef="usd">90588000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53063f0ec44441beaf67e6134faf51ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNC0xLTEtMA_a185b2c1-42a3-4c4c-b348-5139a4e4d003"
      unitRef="usd">105683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id364004a8c804fdf9bb65e44092e258c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNS0xLTEtMA_c779be7b-1796-4d45-9e5f-e6662ed336f9"
      unitRef="usd">108530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51536a40efdc4ab2ad8c26840f07e52e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzgtNi0xLTEtMA_6e420fea-5556-40ad-9e90-6fb4224d1be3"
      unitRef="usd">106359000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNC0xLTEtMA_16909e49-440d-41d0-aae2-c7d642501e93"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNS0xLTEtMA_c37058b9-cff8-4837-8f61-c9a51a6d3e33"
      unitRef="usd">521351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzktNi0xLTEtMA_cf7c3d4d-6ccc-4cf7-811c-eb62bac5e1cf"
      unitRef="usd">508512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTQtMS0xLTA_30a71820-ca31-41bf-8508-5e4a145a4775"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTUtMS0xLTA_a81a6a4a-da3e-4cf3-885c-b0c3a369f056"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjMvZnJhZzpmZmVmMzA1MzUwYjg0NTZlYWFmYzM4YzFmYzJjZjBmYS90YWJsZTo0OWZmN2NkYjRjZWU0YWJiYWNiZjY5YjMxMWQ3MzQzOS90YWJsZXJhbmdlOjQ5ZmY3Y2RiNGNlZTRhYmJhY2JmNjliMzExZDczNDM5XzEwLTYtMS0xLTA_922a6674-3861-4075-9e2b-b8725958e95f"
      unitRef="usd">1472441000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjMzODE_4a9436c5-94a9-46fc-856f-e35dd23afc9a">ACQUISITIONS &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Arkis BioSciences Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo&#xae; external ventricular drainage (EVD) catheter with Endexo&#xae; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CerebroFlo developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enabling technology license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of  $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of December&#160;31, 2020 was $15.1 million. The Company recorded $3.4 million in accrued expenses and other current liabilities and $11.7 million in other liabilities at December&#160;31, 2020 in the consolidated balance sheets of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pro forma results are not presented for this acquisition as they are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Rebound Therapeutics Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#x201c;Rebound&#x201d;), developers of a single-use medical device known as the AURORA Surgiscope&#xae; System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#x201c;Rebound transaction&#x201d;). Under the terms of the Rebound transaction, the Company made an upfront payment of  $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million IPR&amp;amp;D expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as IPR&amp;amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Integrated Shoulder Collaboration, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed  $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $41.5&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 18. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for details of the transaction.&lt;/span&gt;&lt;/div&gt;</iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iab11d9606b8c493e897237f5afc49895_D20190729-20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzE3NQ_2b860ba9-f093-42f6-92da-135c1ec9f775"
      unitRef="usd">30600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzI0Mw_14526504-a440-4b31-b52c-5f4dd8ddc674"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQxOQ_f12cd322-2acc-4811-ac64-aff5f44d7c9a"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzIyODgx_9e08b662-bd59-41aa-93bf-58cf6f4a4551">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CerebroFlo developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enabling technology license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzItMS0xLTEtMA_c4af76ed-1028-49b3-8173-8c49a699972b"
      unitRef="usd">90000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzMtMS0xLTEtMA_5b40a499-01c7-4ad6-9bb9-832d4730f2da"
      unitRef="usd">751000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzQtMS0xLTEtMA_36384354-c9ca-40f3-93a2-462080dd27ef"
      unitRef="usd">457000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzUtMS0xLTEtMA_99c5effd-0ed1-425a-8808-38ba3cef6dea"
      unitRef="usd">1697000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i04d98108080747959bd511b7c066fcd3_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzctMS0xLTEtMA_3eeca3c7-5649-40ec-a1f0-e4ee9c05edc2"
      unitRef="usd">20100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i29ef932d028d41118f879bbe261bf689_D20190729-20190729"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzctMi0xLTEtMA_61529be1-52a4-4bcb-b546-4ba7e053ac35">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifa338878261f40e2ba360dfc8fe15384_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzgtMS0xLTEtMA_575e9db6-8056-41da-b80d-7d40506b1fd3"
      unitRef="usd">1980000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7e089d0cd7be41ef953212d6a49bfc21_D20190729-20190729"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzgtMi0xLTEtMA_2e837962-d7bb-4ab9-9c24-87a01df55e74">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzktMS0xLTEtMA_bcd048a7-4921-4304-99ac-2630f9598149"
      unitRef="usd">27153000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEwLTEtMS0xLTA_f0edfa57-c03f-4494-95bd-fdc1b27154dc"
      unitRef="usd">52228000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEyLTEtMS0xLTA_b38078f4-ae5f-46a7-b328-a2579280f46e"
      unitRef="usd">2926000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzEzLTEtMS0xLTA_9d6c9f62-b63a-426f-b312-6877930304b0"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzE0LTEtMS0xLTA_997f9983-5ed5-4b68-8b30-f0c59bc4ec39"
      unitRef="usd">5603000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90YWJsZTpjOGMyYjU3ZmE4MzQ0ZGRlYmJkZDNmNWViNTRkNmMxOC90YWJsZXJhbmdlOmM4YzJiNTdmYTgzNDRkZGViYmRkM2Y1ZWI1NGQ2YzE4XzE1LTEtMS0xLTA_2150be6f-8897-457d-9e6b-b74ec4c3729f"
      unitRef="usd">30599000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:AcquiredFinitelivedIntangibleAssetsDiscountRate
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzIxMTk_2ec28038-f6e1-4d6f-9629-7a56b82e4e6c"
      unitRef="number">0.145</iart:AcquiredFinitelivedIntangibleAssetsDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ2MjI_60408f7a-4169-4079-b213-e10366a8ac37"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idf8459aff7b64dc6a0ccd87d609c74b1_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ2ODI_23e50338-e82d-42b7-95b2-92c6ed91de00"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iddac580fb69647188ee6543fba4be5ed_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzQ3MjE_e38d8aae-71fb-45a6-8c27-0bcb594b3805"
      unitRef="usd">15500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i4fcfaca18ae9416ebda0a5198561cbe6_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MzgxMzg_67d285c2-cc5f-437d-a739-85533d76f680"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="id88f287fd2124c55ba6e236730478cee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NDMx_6cb528ae-370e-413a-ab06-fd9b19e9f590"
      unitRef="usd">15100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i118da3e2985e4e5d8bd87b7884e68786_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NTYx_645dd263-e4fd-48e1-ab23-54f0dac044ef"
      unitRef="usd">3400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="ieffdc4cad57b47f4b1fd3d56ceefa79c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzEwOTk1MTE2MzE4NTcz_6d48dbb5-0ccc-49a3-a95a-6715b0c2ebdf"
      unitRef="usd">11700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <iart:AssetAcquisitionConsiderationTransferred
      contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwMDQ_c4ab4eee-7db1-40fd-be2b-32418a8003fb"
      unitRef="usd">67100000</iart:AssetAcquisitionConsiderationTransferred>
    <iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet
      contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNDM_d716d8af-b279-4928-9e72-194e321eeab9"
      unitRef="usd">35000000.0</iart:AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet>
    <iart:AssetAcquisitionNumberOfAssetsAcquired
      contextRef="ic2e05e186ade4bdfa5df3778adab6e61_I20190909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzYyMTM_14329d61-73dd-49e4-96cc-d75578587101"
      unitRef="asset">1</iart:AssetAcquisitionNumberOfAssetsAcquired>
    <iart:AssetAcquisitionConsiderationTransferred
      contextRef="iccfedde3073f4a829d00d679dffc6b6b_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNTg_6851181f-24ee-4c4f-8352-dd5dbbc1ee48"
      unitRef="usd">59900000</iart:AssetAcquisitionConsiderationTransferred>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwNzM_49077b74-777a-48ff-9cd3-32898e5cb1c9"
      unitRef="usd">7200000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i45c9ff50901a4a85ad2ef0c19c9c5530_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIwOTA_ba73e801-74d3-40aa-83cd-5439f4392016"
      unitRef="usd">2100000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="iabdc38db0fd442a69aa920353ffe2441_D20190909-20190909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxMDU_0866f765-e2d5-4aa8-bc58-9abce219e8f1"
      unitRef="usd">4200000</iart:AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i07472adf71764b7291b105f7455877fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxNjA_c7a3ec02-ab41-4715-96a4-6a8bb4dbcec1"
      unitRef="usd">5000000.0</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i6fa850870800416cb442b162e112d697_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjIxNzI_c8e6aa13-0715-4d0c-916b-c1b26ffd9fe4"
      unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentInProcess>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i20a2549c743743298aa4d44d68f4239e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjQyMDM_6f53a850-2b73-4872-8419-045a1651ff07"
      unitRef="usd">20000000.0</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i20a2549c743743298aa4d44d68f4239e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzMyOTg1MzQ5MjQyMTg_04a7b3e4-1f06-44e5-a75f-e4eab8e16d18"
      unitRef="usd">20000000.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2MjA_0e69765b-c3de-4ecd-8914-e824b71391e4"
      unitRef="usd">1700000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet
      contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzc4MTQ_73cc1645-478e-41ac-965b-72553d40d129">P4Y</iart:AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet>
    <iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet
      contextRef="i6e12b10c049b4bb1ad88958c12af93f5_D20190104-20190104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2MzQ_92828104-34f0-4a94-b550-316e312a9151"
      unitRef="usd">80000000.0</iart:AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet>
    <iart:AssetAcquisitionNumberOfAssetsAcquired
      contextRef="i54369f3ad8944d81a87891c2071ad9e0_I20190104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzgxMjU_c8a6a0c3-3e8c-4906-a1bd-2369b40dd089"
      unitRef="asset">1</iart:AssetAcquisitionNumberOfAssetsAcquired>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2460cb74a44d40809765b3973c5e5005_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzM4NDgyOTA3MjI2NDg_ab9eb6d2-f915-4391-8e6a-3884ba88aed3"
      unitRef="usd">1700000</us-gaap:ResearchAndDevelopmentExpense>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNjkvZnJhZzo3NzU2Yjg0NjZmMjE0ZmQ4OWQwMTFkNmM0NzhhNGFmZS90ZXh0cmVnaW9uOjc3NTZiODQ2NmYyMTRmZDg5ZDAxMWQ2YzQ3OGE0YWZlXzg3OTYwOTMwNjIyNjc_33147a39-15e7-4feb-89c8-c301e34908ad"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MTY_6d6978d8-4f96-4e96-a2c7-227e16129c0e">DEBT&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amendment to the Sixth Amended and Restated Senior Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60.0 million sublimit for the issuance of standby letters of credit and a $60.0 million sublimit for swingline loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment does not increase the Company&#x2019;s total indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the July 14, 2020 amendment, the Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Execution of July 2020 Amendment through June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021 through June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Senior Credit Facility bear interest, at the Company&#x2019;s option, at a rate equal to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;the highest of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the prime lending rate of Bank of America, N.A. or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the one-month Eurodollar Rate plus 1.00% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable rates are based on the Company&#x2019;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA as defined by the July 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will pay an annual commitment fee (ranging from &#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#x2019;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2020, the Company was in compliance with all such covenants and is expected to be in compliance over the next year. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment,  the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 and 2019, there was $97.5 million and $375.0 million outstanding, respectively, under the revolving portion of the Senior Credit Facility at weighted average interest rates of 1.5% and 3.2%, respectively. At December&#160;31, 2020 and 2019, there was $877.5 million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at weighted average interest rates of 1.5% and 3.2%, respectively. At December&#160;31, 2020, $33.8 million million of the Term Loan component of the Senior Credit Facility is classified as current on the consolidated balance sheet as the first mandatory repayment is due June 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit facility and Term Loan component at December&#160;31, 2020 were approximately $98.4 million and $883.6 million, respectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit outstanding as of December&#160;31, 2020 and 2019 totaled $1.6 million and $0.8 million, respectively. There were no amounts drawn as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year-ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. At December&#160;31, 2020, the carrying amount of the liability component was $485.9&#160;million, the remaining unamortized discount was $89.1&#160;million, and the principal amount outstanding was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2020 was $638.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;specified corporate transactions occur. As of December&#160;31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#x2019;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#x2019;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#x201c;hedge participants&#x201d;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2020, the Company recognized cash interest related to the contractual interest coupon of $2.6&#160;million and amortization of the discount on the liability component of $15.4&#160;million for a total interest charge of $18.0&#160;million on the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securitization Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#x201c;SPE&#x201d;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") is for an initial three-year term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2020, the Company was in compliance with the covenants and none of the termination events had occurred. The Company&#160;had $112.5 million and $104.5 million of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 1.3% and 2.8% as of December&#160;31, 2020 and 2019, respectively. At December&#160;31, 2020, the total amount outstanding under the Securitization Facility is classified as current on the consolidated balance sheet as the total amount is due on December 21, 2021.&lt;/span&gt;&lt;/div&gt;The fair value of the outstanding borrowing of the Securitization facility at December&#160;31, 2020 was approximately $112.3 million.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzUwMA_5b159131-f960-465a-bd36-45ff2b2ab017"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie5c97a92749542e68b530970e7f0bae2_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU1Ng_d45ea2e2-dec5-4ea7-95e9-04715b1e1f99"
      unitRef="usd">877500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id2741743d8a14b23aa6c8c40f03c28fa_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU4NQ_f96132f1-f7e3-4517-b071-0643a4d60698"
      unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i822435be5fe4477c9241a3f93cf99a87_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzYzMg_5bc3e5ae-b9ab-4cda-bd55-107cfd85c300"
      unitRef="usd">60000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iffd6869fdd4b488e8e7e6aad20f49ad8_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzY5Ng_af22b96c-5cc6-4e28-aa47-8cd73aeb6b94"
      unitRef="usd">60000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU0MTY_c3df3627-e2c6-4ccb-95e1-1788bef1d222">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the July 14, 2020 amendment, the Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Execution of July 2020 Amendment through June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021 through June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="iaffaed4533cd4d7f923869baf4414f46_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjE3MjhjODcxNTkxYTQwZTNhYTliNzAxNjFjZDkwOTQ2XzM4NDgyOTA2OTcyMzY_bd2204e0-25ad-48d1-b3a7-038379436a51"
      unitRef="number">5.50</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="ia8a2c2dd31e44bce86f8e4abfb0af083_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzQtMi0xLTEtMC90ZXh0cmVnaW9uOjRkOTgxMmZhZTI4NjQyYzZhZGRmNGJhZjg3MWRjNzU4XzM4NDgyOTA2OTcyMzY_a4daebb0-ffc7-4dc4-9cd7-d35eec8aea07"
      unitRef="number">5.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i1a539237847c4312a3c668310be66ce7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzUtMi0xLTEtMC90ZXh0cmVnaW9uOjQ0MTM0ZGUxMTViOTRjNDY4YTU5MDIyZjMzOGU5M2RlXzM4NDgyOTA2OTcyMzY_088a1d8b-1020-450a-8bab-c0f9ba67ba31"
      unitRef="number">4.50</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i298c0a2f362f453e873de725dc394c2e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozNTFkYjdmZjNlNzE0ZmExYWI4NDU1MjM5ODE5MzU3NS90YWJsZXJhbmdlOjM1MWRiN2ZmM2U3MTRmYTFhYjg0NTUyMzk4MTkzNTc1XzYtMi0xLTEtMC90ZXh0cmVnaW9uOmM3ZTlhMmZlMDIwNjQxYWFiZTZmYjhhNTI3Y2RjMThiXzM4NDgyOTA2OTcyMzY_ea0b41f8-f263-4387-af1a-12ec7b319f2a"
      unitRef="number">4.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i49f96e7c8d5e48878ac299da142f760c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzExODM_c53af0d2-0343-4378-a0f4-b4a3ca875569"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4830065b1af74874a4c52fb3bafa551f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzExODk_cab6564c-b0d4-4886-883b-046cfd91f824"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib4c96b9a4f97464e96a052e5709abec5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzEzMjU_b35b707c-eece-4070-ae81-9396942a7f91"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibf265712ad124ba89a2f02239c34e380_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE1MjA_489600e6-930c-4be9-bfd2-a268d95a1654"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="id6e31801eea246ef887ebfaca154f1e0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE5MzQ_f0dfaf91-316f-41b0-b89a-dd061397dceb"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i56827768c653452f9319641e79b282e3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzE5NDA_c9332c9d-e013-41a6-9e88-e24fdaa3e237"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="if083dfbe37d746388c9f9ceb06c1fbc4_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2NjU_6ba288c0-c2cf-410d-b759-1ae910344701"
      unitRef="usd">4600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i83699ed312514c98a332a62de3af0841_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2Nzk_18965f97-bece-4710-b25b-e5b03b4f26eb"
      unitRef="usd">1200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i65fa74c6109b4c1681870661fed5fbc5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg2OTI_09abcc0d-1859-4543-b0c6-15e4cd3eaf4f"
      unitRef="usd">3300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LineOfCredit
      contextRef="i3103df919ce14fd6a69dd88d8c19042a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIxMDI_824ce291-d5b3-4900-a4b3-a39dc8bb063c"
      unitRef="usd">97500000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIxMDk_1806172b-0928-472a-8a92-c30a8c890fa3"
      unitRef="usd">375000000.0</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i3103df919ce14fd6a69dd88d8c19042a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyMzY_a4106c47-1549-454d-80ed-56a3570fa802"
      unitRef="number">0.015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ia7cd5cb8d3314ec9a225c67ceac068ea_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyNDM_052aa2c5-bb93-4661-af87-5638bbb27e48"
      unitRef="number">0.032</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LineOfCredit
      contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyODU_242215db-5853-4159-a259-1c08b9a852c9"
      unitRef="usd">877500000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzIyODU_dde9c67e-c769-43f3-bbbf-283f77fe91a8"
      unitRef="usd">877500000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzI0MTU_d034f992-3688-441f-be83-0841a8bf8d74"
      unitRef="number">0.015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ib4b8af88f8b54019b9acc90f7f12cf41_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzI0MjI_7ba0b2f5-12ab-4d4b-a06a-9feafd0c0f50"
      unitRef="number">0.032</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:SecuredDebtCurrent
      contextRef="i9b72f14bc0ba43b48a2bf06b568d3561_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDg5NDk_419304dc-2298-4f2d-895e-60ea4b5554f0"
      unitRef="usd">33800000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i7b21d0525850444caddaeaa48e4a223f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDkxMDU_dd025116-6d35-425d-aa9a-13579852a82f"
      unitRef="usd">98400000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="iabe1597bfefe488e9ef0166c6fc025d0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDkxMTM_10ed25af-cd70-4ad7-8554-648a7b25c1b6"
      unitRef="usd">883600000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i8e0a93f507a747b688ad749cb942864f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDk4MTY_8aedb020-f18b-4f68-b6d0-103187b9122a"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i5e5c954d5edc4790bc0a3e952a5fa55e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MDk4MzI_6afb22b6-089e-4d4b-9841-fc7d72675466"
      unitRef="usd">800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCredit
      contextRef="i8e0a93f507a747b688ad749cb942864f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MjM_348e3eb7-8025-40f2-a57a-ec7964bde347"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzU0MDc_5252e9eb-5234-4e9c-962e-f5aa9a51845b">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year-ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzQtMS0xLTEtMA_59e54dea-e123-4b3c-a0cf-7ca073deab5d"
      unitRef="usd">33750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzUtMS0xLTEtMA_2f522f3b-5fa0-4367-bb56-2a7b525a5e39"
      unitRef="usd">45000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzYtMS0xLTEtMA_42d4a90e-b261-4598-ac4e-be0d183e416f"
      unitRef="usd">61875000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzctMS0xLTEtMA_d893a6ba-a7ec-4387-8306-78ef77826e5d"
      unitRef="usd">67500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzgtMS0xLTEtMA_598fad83-49a7-4bb6-a4ad-ce0cdbf95796"
      unitRef="usd">669375000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90YWJsZTozODhlNDM2ZjNlOGY0ZTA3Yjc0YTM5OWE0YzQ0YjQ1NC90YWJsZXJhbmdlOjM4OGU0MzZmM2U4ZjRlMDdiNzRhMzk5YTRjNDRiNDU0XzktMS0xLTEtMA_adc29018-5880-42b5-a313-763c41713b2f"
      unitRef="usd">877500000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNTM_facb2556-42e3-4355-804d-2033c22b0bf7"
      unitRef="usd">575000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNjk_fb2b92d6-e976-44bb-8e7e-42d1ee6d6249"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyNzU_b70f898e-4016-43a9-96cf-d3dc9672064b"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyODE_b1cc6ac4-f9af-4bf1-a49d-3868bf23bb3a"
      unitRef="usd">104500000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUyOTc_3099cca2-b770-4525-b524-55f8c7702dec"
      unitRef="number">0.042</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzMDM_12e163b6-cf0a-4151-9841-8f7aeb0ededa"
      unitRef="usd">13200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNDE_9aa43b24-a596-49f7-8121-1b5feb9a3a7f"
      unitRef="usd">485900000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNTc_0cf5e8e7-6d17-444d-a655-56759f6debc1"
      unitRef="usd">89100000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTUzNzI_f181f51c-8a96-4fca-a7f9-a82acb3f6044"
      unitRef="usd">575000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia21f31dfbd6b4c09bf3eb6de3c3fa3ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0MDk_e5fbb5bb-a352-4680-8238-425ecafa1bdd"
      unitRef="usd">638100000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0MjU_cd490924-fb6c-4ccc-b9bb-5d022103a1cd"
      unitRef="number">13.5739</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NDI_e3651ee2-27ce-481b-9cbb-5a80773b7a9d"
      unitRef="usdPerShare">73.67</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod
      contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NTA_d40c90cc-8e1f-4012-9645-9a4f1c001b12"
      unitRef="number">1.30</iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod>
    <iart:DebtInstrumentMaximumAverageConversionValueOfNotes
      contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0NjM_14a7858e-24e4-4176-a433-6e8fdb904dd9"
      unitRef="number">0.98</iart:DebtInstrumentMaximumAverageConversionValueOfNotes>
    <iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount
      contextRef="ia97ea17415c04e59a282e2ba0da43d2c_I20201209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MTkyMDM_2666dbc4-5a60-4533-8686-eea9c3bb6ef1"
      unitRef="usd">1000</iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ib086a6b0266f4a3d9cde5404c0e96a74_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0OTA_f0d88e7e-3958-4acb-a960-7b6b7314d9c5"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU0OTY_bb42dd5b-a45a-4265-bb14-b6eed6e04845"
      unitRef="usd">104200000</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ie00e3a65fd7c4e4d8caaa24529a28421_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1MTI_f801929f-8907-4e28-9649-f71167f960e2"
      unitRef="usd">44500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i3493c77a931f4e3ab849649297db9345_D20200204-20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1Mjc_ad4027c0-edde-403f-81b2-2d2a9d3c764e"
      unitRef="usdPerShare">73.67</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i06f9c93552d04276a8fec11d2ad465b6_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1MzU_faa377d9-64aa-436f-8a9a-c60aac0a48ff"
      unitRef="usdPerShare">113.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1Nzk_0ebff5c1-8473-4ccd-86ba-d3690960c354"
      unitRef="usd">2600000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU1OTM_6c85a651-f8f7-450e-8184-b25bfa6e1ab9"
      unitRef="usd">15400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="i6bc03eecb62a48199826dc0af78ac801_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTU2MDg_8f60c196-9204-4eb5-9491-d12e87367dee"
      unitRef="usd">18000000.0</us-gaap:InterestExpenseDebt>
    <iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4MDI_51ad6c43-9dde-4d99-9cee-31b4b6db68e1"
      unitRef="usd">150000000.0</iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit>
    <iart:DebtAccountsReceivableSecuritizationTerm
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzMyOTg1MzQ5MDQ0MTc_41a846d1-1a18-47fc-b3c6-ade7bd550b67">P3Y</iart:DebtAccountsReceivableSecuritizationTerm>
    <iart:SecuredLongTermDebtSecuritizationProgramCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQzMDY_09d11ac8-de76-4826-85c9-18ad3523b167"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgramCurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQzMTM_1a155a56-5a89-4493-8904-5e4882d8c8b0"
      unitRef="usd">104500000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQ0MTU_2b80fd0f-0939-4184-9720-05cee1920a2e"
      unitRef="number">0.013</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzQ0MjI_8c2d858f-7012-4277-aa67-aa76483b6d47"
      unitRef="number">0.028</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:SecuritizationFacilityFairValueOfAmountOutstanding
      contextRef="iecc2ed32dcfc40b0983a4a55b9ff5c6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNzUvZnJhZzo5YzYzMTQwMzEwMzc0YTk0Yjg1MDM3N2NkOWM3MjI0OC90ZXh0cmVnaW9uOjljNjMxNDAzMTAzNzRhOTRiODUwMzc3Y2Q5YzcyMjQ4XzM4NDgyOTA3MTg1MDc_07cf76b2-3e62-409b-a509-0394e5c54fdc"
      unitRef="usd">112300000</iart:SecuritizationFacilityFairValueOfAmountOutstanding>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MDQxMDc_295f5adb-4185-42e3-bd31-83ff50d550d3">DERIVATIVE INSTRUMENTS&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2020 and 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 6, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 6, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 27, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total interest rate derivatives designated as cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,875,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,325,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#x201c;AOCL&#x201d;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $9.7&#160;million to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company recognized a $0.2&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations. The fair value of the foreign currency forward contracts was $0.2&#160;million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of the Company&#x2019;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Currency Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF denominated intercompany loan into U.S. dollars. The CHF denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,335)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,262)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 20, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,843)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $33.3&#160;million. As a result of the settlement, the Company recorded a loss of $0.3&#160;million in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with an aggregate notional amount of $66.7&#160;million. The original maturity dates were October 2, 2020 however, as the intercompany loan settlement was consummated, the cross-currency swap was settled simultaneously. As a result of the settlements, the Company recorded a loss of $0.4&#160;million in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2020 and 2019, the Company recorded a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;loss of $21.7 million and loss of $4.0 million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;slation to offset the gains or losses recognized on the intercompany loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020 and 2019, the Company reco&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rded a loss of $17.1 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a gain of $9.3 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020 and 2019, the Company recor&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ded gains of $5.8 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $7.0 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2020 within the next twelve months is $3.3 million. As of December&#160;31, 2020, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign currency on foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,884)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,794)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $167.5&#160;million and 128.3&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $7.8&#160;million in AOCL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, the Company settled a cross-currency swap designated as a net-investment hedge of with an aggregate notional amount of $30.0&#160;million. The original termination date was September 30, 2021. As a result of the settlement, the Company recorded a gain of $1.6&#160;million in AOCL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2020 and 2019, the Company recorded a loss of $14.9 million and a gain of $20.5 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2020 and 2019, the Company recorded a gain of $7.6 million and $9.6 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2020 within the next twelve months is $3.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#x2019;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#x2019;s credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt"&gt;At December 31, 2020 and 2019, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.9&#160;billion and $1.3&#160;billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statements of operations during the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MTE_fb42cee9-d01b-4997-ba91-7fdf6279fd17">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2020 and 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 6, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 6, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 27, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total interest rate derivatives designated as cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,875,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,325,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,335)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,262)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 20, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,843)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,884)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,794)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2019 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receive GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMS0xLTEtNDkwMw_938ec99c-85c5-41e1-92eb-2ff496c27274"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic68e8212dd194d45aa7eefc82e905835_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMi0xLTEtMA_d2383556-e9b1-4555-9a30-7f08c8637497"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMTAtMS0xLTA_6fbb8b00-29c8-4ad3-a014-5c55c7991526"
      unitRef="number">0.01834</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i12ccafd7c32d435e937a09b89142d9c0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTMtMS0xLTE5MDM_fda0b55a-7694-4579-9832-c2d4a6df4582"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic68e8212dd194d45aa7eefc82e905835_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzItMTItMS0xLTA_75c8b83e-12fe-43fa-a22c-3e2c318bcc99"
      unitRef="usd">-2000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idcdababe54704b90bc657174386789e0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMS0xLTEtNDkwMw_5750cb3d-237e-4b60-aadc-6accb58422a6"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMi0xLTEtMA_e032ddef-8ee0-4963-b66c-841424a78701"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="idcdababe54704b90bc657174386789e0_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTAtMS0xLTA_ed04262b-3b5b-4219-b40d-96dcdea27914"
      unitRef="number">0.01652</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idcdababe54704b90bc657174386789e0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTMtMS0xLTE5MDM_4e92559d-9744-4e02-a4e9-6fd9eb8417c6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idcfac39d6b254e6eb9fcc320246ce2e0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzMtMTItMS0xLTA_f168921d-a0a5-49d5-99ef-7e0697464971"
      unitRef="usd">12000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMS0xLTEtNDkwMw_642ea148-2ec1-4e45-8013-2e6bb1f8997a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib885eed1bf1b439dbc39829817261b39_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMi0xLTEtMA_c34439e5-e719-43b9-a73a-6e1991567360"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTAtMS0xLTA_62acccba-2a7f-471a-afeb-19489d1b9578"
      unitRef="number">0.01971</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib7b0554dce964957a691c822f1f3043e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTMtMS0xLTE5MDM_386ccb37-5caf-4707-b061-c7840a135653"
      unitRef="usd">-929000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib885eed1bf1b439dbc39829817261b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzQtMTItMS0xLTA_a209c979-486d-4ce2-a66b-ef5367d9b65d"
      unitRef="usd">-581000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMS0xLTEtNDkwMw_0c233132-3043-4b3f-bd82-7179aed18e73"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib208df2927f640368f449fd7a1bab824_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMi0xLTEtMA_154a4e14-cfd0-4fe9-8384-5e00ed5d270e"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTAtMS0xLTA_d8deb8bc-6f24-420c-aeb6-ff19c95526b9"
      unitRef="number">0.02201</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8a06f7aaf6154a9698fb47226200c829_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTMtMS0xLTE5MDM_65b00885-eec0-4015-8853-5bd416942d09"
      unitRef="usd">-6152000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib208df2927f640368f449fd7a1bab824_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzUtMTItMS0xLTA_ad42c368-f722-4fa7-b846-765709dc9c60"
      unitRef="usd">-2880000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMS0xLTEtNDkwMw_4b1d1615-ab32-4564-94f8-508c6ca04d2d"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic79dd3445c4749509e1d9ed68b515d6a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMi0xLTEtMA_2f28267f-ebb4-4a07-9bd4-46e67f1508e2"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTAtMS0xLTA_65c27c42-331b-4f7c-8310-46cffecbf5a3"
      unitRef="number">0.02201</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id9903cb1395540e6935aa24e96754aa8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTMtMS0xLTE5MDM_582ef10c-99ea-4ad2-bed0-834ad6efc170"
      unitRef="usd">-6405000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic79dd3445c4749509e1d9ed68b515d6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzYtMTItMS0xLTA_71f0ac30-077b-4df6-9f34-032b7b5ed726"
      unitRef="usd">-2880000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMS0xLTEtNDkwMw_2491df9f-c507-42f8-8c3f-3fb9c33ad208"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMi0xLTEtMA_15bbbac8-2567-41b9-8bfa-40bba412d3a5"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTAtMS0xLTA_9db13fcd-010c-4713-a2b6-13a2555602ea"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i6d1c6073cff140ba89c5d30979e23572_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTMtMS0xLTE5MDM_c2e0ae09-6a27-4cff-bea9-26029e6d35bb"
      unitRef="usd">-7724000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i860a3533fe7c49d7b12b2ed8a75c96f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzctMTItMS0xLTA_fb723ff2-b6c6-436a-8d1e-cd001bce4754"
      unitRef="usd">-3517000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMS0xLTEtNDkwMw_668d8e9c-2c92-4717-ad86-409e8ef31f8f"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if978c4aaca6e44a4bbe6ada7c5392621_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMi0xLTEtMA_bd4fd4ce-3fc2-424e-927a-31382858c743"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTAtMS0xLTA_86a3b115-607f-414d-a618-19caa6c0313b"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i50fd52cb301e4ea99eebffb661ac3237_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTMtMS0xLTE5MDM_ecf752f1-100a-4da4-bc1c-95fe63f99b96"
      unitRef="usd">-3778000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if978c4aaca6e44a4bbe6ada7c5392621_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzgtMTItMS0xLTA_d8135be1-3742-4c19-90be-20af33683f6d"
      unitRef="usd">-1778000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEtMS0xLTQ5MDM_2be8c880-d1ec-4a9f-8b1e-d4b95f1aba71"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7aaf1027151e43ceb191ea669249f7e4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMi0xLTEtMA_0e2ab300-660b-4d6e-baa8-444cb744342f"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTAtMS0xLTA_dd7a45c7-fd75-4fd5-a7e9-7cd2fa055eac"
      unitRef="number">0.02313</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i68595196347b44cbac22b32806b9b6a6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEzLTEtMS0xOTAz_16fd14c0-ce09-4b4e-9c26-5f1acb20db42"
      unitRef="usd">-16243000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7aaf1027151e43ceb191ea669249f7e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzktMTItMS0xLTA_c10865ce-8882-426f-a195-c2278df12071"
      unitRef="usd">-6595000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEtMS0xLTQ5MDM_febbbba0-e2f3-4046-894f-768d4442b47e"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife3e874c024d4214a79490debf6accc5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTItMS0xLTA_bdf2f74f-06ed-43cd-abee-bc991dad900f"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEwLTEtMS0w_553a0284-4237-406e-b613-787f86acfe8e"
      unitRef="number">0.03220</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1969a1e3586d4414bbe07f86c1051136_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEzLTEtMS0xOTAz_5998c1ed-34bd-4825-994a-930cc15990a5"
      unitRef="usd">-9836000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ife3e874c024d4214a79490debf6accc5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEwLTEyLTEtMS0w_ba7e4d1e-84bb-4b37-88c1-6bcb52a7b39e"
      unitRef="usd">-5750000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEtMS0xLTQ5MDM_1c2cade7-b278-4dda-a666-85fc2805b0c6"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTItMS0xLTA_e16c63dc-b358-4902-af32-4d937585a27b"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEwLTEtMS0w_75741633-2542-48e3-a04d-b6895acfe32b"
      unitRef="number">0.03199</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ife27494f1af045df91344528d6d7bcd9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEzLTEtMS0xOTAz_c1686a76-3ce8-44dc-b30e-49092d76de55"
      unitRef="usd">-9826000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8d0c0dc3de1e49bcaa5fbae58113d072_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzExLTEyLTEtMS0w_ec7bfa71-558e-43d8-8d6d-67dc080d24c2"
      unitRef="usd">-5747000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEtMS0xLTQ5MDM_3ed333c1-db44-41c8-9b8e-661f8cab70d6"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTItMS0xLTA_7d8dd247-c025-46a2-a1e4-834c39411247"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEwLTEtMS0w_23ed0576-b42d-49ad-aabe-15e637096c36"
      unitRef="number">0.03209</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i40a7efef2b48401aba4a5a87989794ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEzLTEtMS0xOTAz_80f2dd27-e612-4c07-b50a-83e10f449783"
      unitRef="usd">-9783000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i0d161bfa7b8b446bb204ec8b4bb77926_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEyLTEyLTEtMS0w_52c17d12-ba8a-49fd-9d13-00cbda79dc4d"
      unitRef="usd">-5807000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEtMS0xLTQ5MDM_bd3a442b-eacd-4e07-874c-1f49a995c66a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i66bb8b17ef654169a3a82f9faae899f8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTItMS0xLTA_d318e780-41f3-4ab3-a9e1-65ff626d6a4e"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEwLTEtMS0w_b2771c42-c350-47ab-b6cd-1ce080b216de"
      unitRef="number">0.02885</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7033d566ef834a0fa8b62ab00fa9ba47_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEzLTEtMS0xOTAz_d691abfd-6c88-4107-ab6e-4eae55858166"
      unitRef="usd">-10407000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i66bb8b17ef654169a3a82f9faae899f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzEzLTEyLTEtMS0w_38a88d12-5ad7-4de6-8c1f-ef8fe622e5ab"
      unitRef="usd">-4930000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEtMS0xLTQ5MDM_c1d0573a-4c3c-44e5-b058-bdd52a7a1053"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTItMS0xLTA_c415b015-8121-427b-963b-4ec29848a0c3"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEwLTEtMS0w_5e3920fe-5fef-409e-910b-cfc4645bb802"
      unitRef="number">0.02867</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ifccb72845f5c4cabb5085a4a21a261ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEzLTEtMS0xOTAz_999f236f-b1d3-4930-a644-c05532bfc019"
      unitRef="usd">-10431000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib47a262df26f4ae39bfd5ccb9bce0d62_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE0LTEyLTEtMS0w_74aabefc-8eef-4a40-b4c1-b031a7ec5cca"
      unitRef="usd">-4691000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEtMS0xLTYwMjY_d7ce6c1b-6819-4e54-934a-59ea7f529924"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8fb9c27423b0432ca325ac7ec1736f68_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTMtMS0xLTcxMDk_65460907-322b-43f4-b0c3-e43771efe537"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTExLTEtMS02MDgz_33ad8908-7ea6-4eaf-858a-a87daec141b6"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3d39ac508fab4bdeb2da7e6a4a18f147_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEzLTEtMS02MDU4_cefd447f-1012-45eb-9c3d-8bffca7723f3"
      unitRef="usd">-382000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8fb9c27423b0432ca325ac7ec1736f68_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTE1LTEtMS03MTEy_22124be6-0e02-4232-b694-c2e4d8ed0c08"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTEtMS0xLTYwMjY_8f410105-b294-4670-885a-26b72bd91e09"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2c52c77498d84321911b79b005966e55_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTMtMS0xLTcxMDk_e6143f71-41ce-44e1-887a-c48de2220057"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTExLTEtMS02MDgz_32c16598-6b6d-4ee4-aeb1-c17d85556b5e"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4073eb12095c4b5c8d1ae5e07cbc1ac9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTEzLTEtMS02MDU4_863c375a-cc18-4167-8bb6-ed7e5cc932e4"
      unitRef="usd">-162000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i2c52c77498d84321911b79b005966e55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE3LTE1LTEtMS03MTEy_c2c38d4b-db31-4412-ab11-f031b08d46b7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTEtMS0xLTYwMjY_bb1b3abb-b44e-4433-a41d-885093aa9f4f"
      unitRef="usd">225000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib3f7517e74e44d0094f93c18a90e6827_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTMtMS0xLTcxMDk_61b7139f-28e8-4b6b-9e54-7b47b5d00c5b"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTExLTEtMS02MDgz_c1dae1de-0a19-4a8f-9050-ca735a23d5bb"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i103258e9ad5744a4a3c94d5cbf58b5c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTEzLTEtMS02MDU4_76223587-b132-4421-b24d-99c5bd6fad9e"
      unitRef="usd">-846000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib3f7517e74e44d0094f93c18a90e6827_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE4LTE1LTEtMS03MTEy_9ddb296e-750e-4423-a174-f2dab65e65bf"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTEtMS0xLTYwMjY_9886f641-e976-40c7-96e2-3a59f1e66290"
      unitRef="usd">225000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i74c6f3f64c6944fab4ab95454984b3ac_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTMtMS0xLTcxMDk_0565cdb3-b720-4d5f-ba53-4e2aaced96dd"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTExLTEtMS02MDgz_ec55ac0a-d563-47d1-b7db-4c3d428e448f"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i6dd98fc7085545c3b7513d7d9a57d8c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTEzLTEtMS02MDU4_f1d7e30b-7fd0-4bf3-92e6-6a6715001cea"
      unitRef="usd">-679000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i74c6f3f64c6944fab4ab95454984b3ac_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE5LTE1LTEtMS03MTEy_00830ba8-112b-49fb-ab35-e729ab6bae4f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7848c2a813504ed493eda06395e04483_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTEtMS0xLTYwMjY_ff101b7e-5dcb-40e4-ab08-ae918bd09fe9"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTMtMS0xLTcxMDk_6941c7c3-9b84-4ad9-a431-f1d8d0589d4b"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7848c2a813504ed493eda06395e04483_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTExLTEtMS02MDgz_9d7e1b0e-5fdd-4f22-8e23-3752c819718a"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7848c2a813504ed493eda06395e04483_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTEzLTEtMS02MDU4_58f031ae-7353-438b-80c1-ba3912097d44"
      unitRef="usd">-187000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9b8d2914f1dd4fa5b0a7cc6c279d143b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzIwLTE1LTEtMS03MTEy_b9c55cf7-58dd-4ea5-a9df-3dcd4085f27b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic51105541e884bc88363f2c16b76284b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEtMS0xLTQ5MDM_f69e3c93-0fb4-434c-b1bc-11e9532a1f71"
      unitRef="usd">1875000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id21c8a2fa5834558b130cf3274625a05_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTItMS0xLTA_08009db7-4d59-46ec-a3a8-0dbc74b0104c"
      unitRef="usd">1325000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic51105541e884bc88363f2c16b76284b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE2LTEzLTEtMS0xOTA3_0ceb5c6f-890c-4f80-bdc3-06f9596007b2"
      unitRef="usd">-93769000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id21c8a2fa5834558b130cf3274625a05_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo2YzQyNjAxNzJhY2I0NTZmOGQ3MmM1NGM1ZmJlYmEyMS90YWJsZXJhbmdlOjZjNDI2MDE3MmFjYjQ1NmY4ZDcyYzU0YzVmYmViYTIxXzE1LTEyLTEtMS0w_13366676-4c34-4121-ac46-56e538894172"
      unitRef="usd">-45145000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i99730906a9c94d02acef61305dbefc02_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1MDk_a42ccee6-7fef-4450-bbcc-21d6d5e66c2f"
      unitRef="usd">9700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="id66609e8dad741d88f6e535da2241aee_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1MjQ_d0e3b2fb-c281-4ea8-bbb4-e5d7eab47215"
      unitRef="usd">-200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i99730906a9c94d02acef61305dbefc02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTg1Mzg_c304cec0-707e-405c-90dd-80079837677f"
      unitRef="usd">200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i76071dabaf7a463f9b7a7648e7452343_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM2Njg_a618d49f-ca45-4ca6-872d-697de776e70c"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5431ea3c598245fb8a0ff97ff620359f_I20171002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM2ODU_916f8455-7f18-46b2-90bf-d986814713b9"
      unitRef="chf">291200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i80156bc966174b7491215c549eab3021_I20201221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzkzNDU4NDg4Njg0MDc_86226aa3-f2b1-43f4-b39b-33e7dd4f0aa9"
      unitRef="usd">471600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i80156bc966174b7491215c549eab3021_I20201221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3Mjg1MDI_731d933e-d3e4-4ea2-8922-ea2445535e27"
      unitRef="chf">420100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="idd2b8368f50349cf9cd91e15a4474d2e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTYtMS0xLTA_824e7ae6-efd7-47be-84f3-fe0826ef627e"
      unitRef="number">0.0185</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idd2b8368f50349cf9cd91e15a4474d2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTktMS0xLTA_70fb3c6a-a23e-4123-95aa-cb73a84d834c"
      unitRef="chf">48533000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i22b15ef56d7f41dea561d0d6c48e9900_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEyLTExLTItMS00OTEz_197ba609-ff98-4e89-9b62-b481ab536413"
      unitRef="usd">-4335000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib92168257e704b7ba6330782524c310d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEzLTYtMS0xLTA_8d48027b-cb6a-461a-8799-945544b37a4a"
      unitRef="number">0.0446</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib92168257e704b7ba6330782524c310d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzEzLTktMS0xLTA_3a4f7868-202f-48c1-8747-26a94e7af858"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTYtMS0xLTA_a7ebcadc-b272-4eb4-85cf-804f4bd23c22"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic0f75e6d56bc4b499001789a8ec6fe76_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTktMS0xLTA_575df18b-6a53-4d6c-b36c-5d55c4607f4f"
      unitRef="chf">145598000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8d930dc104ea4e35be06d768b767f67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIxLTExLTItMS00OTEz_9e46e20f-c11d-4950-9d15-01437f74cd91"
      unitRef="usd">-11262000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ide7cbf63723a4f00aabbbd3146cc357d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIyLTYtMS0xLTA_7b9f9ea6-2a89-47ab-a2c6-a86d0aa49019"
      unitRef="number">0.0452</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ide7cbf63723a4f00aabbbd3146cc357d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzIyLTktMS0xLTA_a17d0bad-b2d5-4124-995d-f7b2282480a2"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i8f663fff566d4cffa41b7ce376813595_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTYtMS0xLTYxMzE_b7036ff2-a12a-40f3-b6e1-1437f57803d1"
      unitRef="number">0.0300</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8f663fff566d4cffa41b7ce376813595_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTktMS0xLTYxMzc_9263d05a-7905-4b03-b9e1-c02452070a3f"
      unitRef="chf">420137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9e053946dbfa4feb8860666b23d97916_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE4LTExLTEtMS02MTQ1_0de53e7e-1aef-41fd-a2bb-e5e21dc37ef2"
      unitRef="usd">-7843000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iaa2afcc89a124c74a254bd7642ca84b5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE5LTYtMS0xLTYxMzE_ef512740-2119-46c7-9a57-4bd5f730c06a"
      unitRef="number">0.0398</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaa2afcc89a124c74a254bd7642ca84b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzE5LTktMS0xLTYxMzc_6b1941ca-9662-4c25-95c4-f4f953f985da"
      unitRef="usd">471640000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i5c0daaf7584842a682f9d005209fecb7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZToxYTc5NTJhYjNiNTc0NGMwYjI0MDgyZDE3OGJhYzlkNy90YWJsZXJhbmdlOjFhNzk1MmFiM2I1NzQ0YzBiMjQwODJkMTc4YmFjOWQ3XzI0LTExLTEtMS00OTEx_13c44eb8-aeeb-45e4-a23d-0a9db82f05e6"
      unitRef="usd">-23441000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iddf34cd2c7ad4523bd4a9e5bdb8a433e_I20201002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4OTU2MDQ2ODE5NTM_499cc75c-0deb-49b3-8115-b260a38b7135"
      unitRef="usd">33300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="ica2f97b5e5ef49c59e8f51a58cdce3c9_D20201002-20201002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4OTU2MDQ2ODIwMjA_91eccb94-9c8c-43ef-990e-cbe4e524e8d5"
      unitRef="usd">-300000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i95c4cb8967c4415791e71b38671c9b83_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtNi0xLTEtODE4Nw_4a825071-dac3-4fb2-b538-80ad27ee4a97"
      unitRef="number">0.0175</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i95c4cb8967c4415791e71b38671c9b83_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtOS0xLTEtODE2NA_2c8fe3b4-0e35-48a6-b853-5066e801584b"
      unitRef="chf">32355000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id36e756e95b544b0a0fb7875d3ba1806_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzMtMTEtMS0xLTgxNDg_e78d9571-5fe4-4671-9330-125f52a4c897"
      unitRef="usd">-101000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i92773db83f15438fafd773f6fb0a4f69_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzQtNi0xLTEtODE4Nw_929df526-5eb3-401a-8151-23c9266880f6"
      unitRef="number">0.0438</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i92773db83f15438fafd773f6fb0a4f69_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzQtOS0xLTEtODE2NA_fa9632a7-57a7-4413-98ed-b770f1547369"
      unitRef="usd">33333000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTYtMS0xLTgxOTI_dc4efdf6-3bf9-48cc-936c-aae81991443d"
      unitRef="number">0.0185</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8b46e323438e4dcfbf6cdef22187aa1d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTktMS0xLTgxNzc_779153ef-a534-41c6-8b6c-70edc11ab1d9"
      unitRef="chf">48533000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i07c262926c3642dc99cf046a2be2277b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEyLTExLTEtMS04MTU0_23983ccc-2d65-4836-b60d-28b5211f2401"
      unitRef="usd">-119000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i11ae94eb73344fe4baa3eb613e126fd6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEzLTYtMS0xLTgxOTI_c65c15fe-f2d4-42d4-a4ec-f6d6c1ea4b25"
      unitRef="number">0.0446</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i11ae94eb73344fe4baa3eb613e126fd6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzEzLTktMS0xLTgxNzc_93cceb94-6223-4468-a475-c1285eb8bcb8"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTYtMS0xLTgxOTc_467d6356-23c3-4d17-aa46-2923a27eed4c"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9e2d6700c64b4d949a7531d3cb761ef6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTktMS0xLTgxODI_be95c9d4-b7b4-4f18-b9a3-6b874dab9a9b"
      unitRef="chf">145598000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i2b7b0af6afdc4c7cb5bb5d039bd634a4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE1LTExLTEtMS04MTU5_ee024f8b-3f5a-4f0b-956b-d0c967e0b73f"
      unitRef="usd">-289000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i73bd05d1164d4fcab0652f994e052939_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE2LTYtMS0xLTgxOTc_b3d88cda-81c6-485b-a195-b6fcc362ba6d"
      unitRef="number">0.0452</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i73bd05d1164d4fcab0652f994e052939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE2LTktMS0xLTgxODI_5fd3eb90-515f-4ffb-8166-5722f75d8ca1"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTozNDNjOWNhZjU0MWE0M2RhYjljNTRkMjkyNmYwNjZjYS90YWJsZXJhbmdlOjM0M2M5Y2FmNTQxYTQzZGFiOWM1NGQyOTI2ZjA2NmNhXzE4LTExLTEtMS04Mzgx_b5322313-5115-4a2c-b788-27cc8e165f64"
      unitRef="usd">-509000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic039bf78ef66411cbfdd1ae5d90219dd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMDA_adb5ae2a-47dd-4f2d-8dc1-fc3c74618bef"
      unitRef="usd">66700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="ia57db2cc4d5949e0b6b05067d6981e47_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMTU_a91bb964-86e9-4f22-a1f8-c28e9b3224f8"
      unitRef="usd">-400000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzUzNTY_8c468750-4c7f-4b81-a996-6dea50b603f3"
      unitRef="usd">-21700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzUzNjg_8a242458-cbb9-4c5c-afc6-30e907cdf361"
      unitRef="usd">-4000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTQ1NDM_fcc2d2ef-e472-43bb-b314-2671cc12c8ed"
      unitRef="usd">-17100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzU2MjY_13603da6-90c1-44dd-a635-a9e3f6546b28"
      unitRef="usd">9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie76b0a28894d4ac4aabeca3edc5adc32_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTQ1ODk_4c7c318c-1efa-4e20-af03-e02fdb4caba5"
      unitRef="usd">5800000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i9ac55e98d6cd48a3a51bdffa7fcd8b07_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzU3OTg_03704b98-d301-4084-8ecf-8e7739f4c759"
      unitRef="usd">7000000.0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i48478e34f29c4b82be39b744c2f0b79c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzYwOTE_382a049c-c74e-4bb6-8a12-221e2b1ba0eb"
      unitRef="usd">3300000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ia7e15c52a94e4723b18f36e548f5062b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtNi0xLTEtMA_71ce51b8-782a-47c2-9621-cbc468621a51"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia7e15c52a94e4723b18f36e548f5062b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtOS0xLTEtMA_6ee5cd88-ec45-4b89-9c88-bc8128578158"
      unitRef="eur">44859000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idf914a28f9c1424fb32fb39c3ed8a539_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzMtMTEtMi0xLTQ5MTc_cbbe832a-f26c-47ca-9e97-71cc3a5a5489"
      unitRef="usd">-1884000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzQtNi0xLTEtMA_71612f67-7e4d-495a-ba25-d8f8302a0f54"
      unitRef="number">0.0301</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i80b8b765f8954f04ae6c1aef27f4eb50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzQtOS0xLTEtMA_c593c3e0-9c90-4b22-87b0-58033f4622f7"
      unitRef="usd">52000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1bf7eee990834d3a938377a8f728b7a0_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtNi0xLTEtMA_1ea31a55-8742-48ac-b62e-babc70b65fc8"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1bf7eee990834d3a938377a8f728b7a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtOS0xLTEtMA_28a891c2-0ea3-431b-995f-25baf8986058"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i54146d4c72e64bd8ac7ba073c9652d05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzYtMTEtMi0xLTQ5MTc_040a2def-7620-479e-bac6-dc7d5174d296"
      unitRef="usd">-450000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i34576a32def44b2f86955da60a86e5a0_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzctNi0xLTEtMA_96478712-143a-4173-b491-19b82bede99a"
      unitRef="number">0.0257</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i34576a32def44b2f86955da60a86e5a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzctOS0xLTEtMA_f0f215e7-0df8-4c68-85d4-10f130eb4065"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ibcbce85f34d34671b93acf1d523b3e35_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktNi0xLTEtMA_157a0e8e-c902-4bc2-b232-898ab4f3be46"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibcbce85f34d34671b93acf1d523b3e35_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktOS0xLTEtMA_0546cc83-453c-4c23-bc41-03ac682b067c"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idea77615dc3f4d0d97ccc1e74db31850_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzktMTEtMi0xLTQ5MTc_547d1c43-c359-40c6-bff3-72c4600e01cd"
      unitRef="usd">92000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i2309435ccb874b0c9e92d1729715a5ba_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzEwLTYtMS0xLTA_00fc8a71-61d2-490a-a256-e5278edebd2b"
      unitRef="number">0.0219</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2309435ccb874b0c9e92d1729715a5ba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzEwLTktMS0xLTA_25623d47-18be-4c06-bc2f-d0fa6523728e"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3f2e3f206fd240638c356c5f147eb7cb_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTYtMS0xLTYxNzA_ce9d78f4-2873-4225-a02b-7830a8966cce"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3f2e3f206fd240638c356c5f147eb7cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTktMS0xLTYyNzc_37505f84-9b71-4eb8-aef4-cf0e790c88ff"
      unitRef="chf">222300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if7d463a647b74dbbac5a09c81ac5bbf8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTExLTEtMS02MjY2_fb4f1db7-f4f9-4674-a06a-42782a2c09e9"
      unitRef="usd">-3794000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib76b40dac61b4789a4966e9e25feb6e5_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE5LTYtMS0xLTYxNzA_bdf89ada-7720-4b8f-92aa-1aa528576d7d"
      unitRef="number">0.0110</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib76b40dac61b4789a4966e9e25feb6e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE5LTktMS0xLTYyNzc_b7107096-a7ab-4bbb-9c9a-4a4b15d1cf3c"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODU2NGI5YTEyMzM0MGQ5YmJlNjM1MjNiZTk3MjYwOC90YWJsZXJhbmdlOjg4NTY0YjlhMTIzMzQwZDliYmU2MzUyM2JlOTcyNjA4XzE4LTExLTEtMS0yMTA5_a59c7734-a77f-476e-9db7-8175db1c8d2e"
      unitRef="usd">-6036000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyMjk_0c954a2d-7d7f-4244-8908-2ec5a8549a12"
      unitRef="usd">167500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNDU_7c3b91d4-1766-4849-ad75-72827b3fae5a"
      unitRef="gbp">128300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNjA_c8fecbbd-892a-4b61-bda6-da4071578201"
      unitRef="usd">-7800000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i82ac6be413b64bc6bf1f3f04ce303568_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtNi0xLTEtMjEwMDY_dcf6b9ff-47e5-420f-b18b-4d2a82cfdf86"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i82ac6be413b64bc6bf1f3f04ce303568_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtOS0xLTEtODQwMg_2c25599d-bebb-453c-8179-97d7ff118d4b"
      unitRef="eur">44859000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i28578860967b41c294978d5e0297abf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzMtMTEtMS0xLTg0MzE_8604ff52-b4c7-44c3-acbe-f1a8c92d585b"
      unitRef="usd">2459000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="icd250c3fbece43cca3832888e0a8c8d4_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzQtNi0xLTEtMjEwMDY_0f3efdfa-f0f3-4d0f-8ac4-9934fa0b976f"
      unitRef="number">0.0301</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icd250c3fbece43cca3832888e0a8c8d4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzQtOS0xLTEtODQwMg_fd5e87fe-7bb2-4677-ba18-f90867a30314"
      unitRef="usd">52000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if88e234e4f3a4e5c85212a69688f3faa_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtNi0xLTEtMjEwMTA_c7d47658-0f01-4a4e-9d58-9054c29a6138"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if88e234e4f3a4e5c85212a69688f3faa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtOS0xLTEtODQxMA_3c17036b-1f18-40be-81a2-acaf2cf64a2f"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i91abedb43abe4a5ea0f381a1428eaea3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzYtMTEtMS0xLTg0MzQ_614a5479-a1cd-4151-8586-08e39afa4e36"
      unitRef="usd">3087000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzctNi0xLTEtMjEwMDg_3eecf4b1-fee1-4528-abd4-de31f0a85f74"
      unitRef="number">0.0257</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i45348c8e2b7d4df8a37e25ddcf8d8e85_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzctOS0xLTEtODQxMA_3f48f5e6-68d6-46ba-a395-c9980bc6b81a"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="idf11bff9c64b4754a527c74b53924753_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktNi0xLTEtMjEwMTI_17feb1e7-41ae-460b-8562-7009a97df80c"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idf11bff9c64b4754a527c74b53924753_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktOS0xLTEtODQxNQ_46416957-b559-4edf-ab4b-24269aca80c5"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i14091819c033463cad6998b7b746e5fc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzktMTEtMS0xLTg0Mzc_f036d051-f7d5-4022-8140-35c3c9de188d"
      unitRef="usd">2032000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ieea2b1c6283949ceaa1fd9a23141822b_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEwLTYtMS0xLTIxMDEy_267627f0-44a6-4e25-822b-c10f5ad091bd"
      unitRef="number">0.0219</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieea2b1c6283949ceaa1fd9a23141822b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEwLTktMS0xLTg0MTU_1a7ef4d9-5747-4788-be7d-721eda8acb51"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTYtMS0xLTIxMDE0_88be7338-4114-4349-b048-ec136db61cd4"
      unitRef="number">0.0167</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5ffa5cd88d854b7b96fd69eca3193ab7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTktMS0xLTg0MTg_11b3a003-e124-462c-a969-7dcd8def1632"
      unitRef="gbp">128284000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i55642fef06114bbbaa0e9b54ee498dcc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEyLTExLTEtMS04NDQw_097a1d58-97a7-4d21-bcc8-ac97b8821d51"
      unitRef="usd">-154000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEzLTYtMS0xLTIxMDE0_493c40a9-b410-4230-b09c-7cedf346558d"
      unitRef="number">0.0271</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i15c544c2fe6c4e5dab9b6a75d3594d79_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzEzLTktMS0xLTg0MTg_5e1c6682-6aaa-48e3-8759-8985951983ef"
      unitRef="usd">167500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i2518cd8291254b57a41eaca854f8ee2b_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTYtMS0xLTIxMDE4_b9ca4030-6e67-40a4-bb97-aae64388df1d"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2518cd8291254b57a41eaca854f8ee2b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTktMS0xLTg0MjI_2476815a-e258-4a65-8bcf-8f234e507db8"
      unitRef="chf">165172000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i983ae52a561a4268998a536714c2506d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE1LTExLTEtMS04NDQz_69246346-7821-487e-b815-48184762b937"
      unitRef="usd">1221000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i8d848444c85b4f3aa4d2887527d13238_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE2LTYtMS0xLTIxMDE2_61b67f46-b5a6-4e63-8bed-a25ceccd080f"
      unitRef="number">0.0167</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d848444c85b4f3aa4d2887527d13238_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE2LTktMS0xLTg0MjI_83fcd3ff-128d-4bbd-a937-778d15af1bcc"
      unitRef="gbp">128284000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i788742cc668e4a9e99a0ea702ad3d42e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo4ODVhZThhYjUxNGU0MmNlOGZmN2RlNDFiMDQ4YTk0OC90YWJsZXJhbmdlOjg4NWFlOGFiNTE0ZTQyY2U4ZmY3ZGU0MWIwNDhhOTQ4XzE4LTExLTEtMS0xMjAxOQ_6038e26d-6ad7-41fa-9132-77ebeb74f9fb"
      unitRef="usd">8645000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i788742cc668e4a9e99a0ea702ad3d42e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTgxMTM_ae4cdebb-afe2-48c8-92ef-a2220c6b03cb"
      unitRef="usd">30000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives
      contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTgxMjg_4c0a3c7c-8326-4783-9980-7be92d81ca06"
      unitRef="usd">-1600000</us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUyNzE_22385d12-138d-4d4e-a155-3aea91d39564"
      unitRef="usd">-14900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUyNjQ_115f7238-f014-4c30-8ea9-f512ea65314f"
      unitRef="usd">20500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i12538452e5e2470ea7cca00f03ad335b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzMzU_0e630ca2-6fc1-4b47-a4fc-d22df2d35400"
      unitRef="usd">7600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i640a3f73ae3d4aad84745f43e7a9d59c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzMjg_b6affe47-2e2a-47d4-a039-532a9c6e0e70"
      unitRef="usd">9600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i99a46df5051a4c80a3e36d832eac8967_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzM4NDgyOTA3MTUzNDI_e855f121-68b6-4ba4-99fa-40bc5e44f99c"
      unitRef="usd">3400000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MDk_ccc0fc88-b361-49bd-b262-8c9795ce15ae">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt"&gt;At December 31, 2020 and 2019, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.9&#160;billion and $1.3&#160;billion, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0a622203039f4ebc8dabf0964e1920eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzYtMS0xLTEtMA_69c251e5-7275-44c7-b0f1-54a2d2e65476"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie8694924571d49acaf88ce860616d9a7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzYtMy0xLTEtMA_8098de71-fbf1-4640-a3b7-fb719997fbbb"
      unitRef="usd">12000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9f485cf6d3cb439c9abb0271be10b04a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzctMS0xLTEtMA_4ebbb445-4f99-446d-8081-bdefee250e53"
      unitRef="usd">7623000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i95a498ed728646b99350fc4768d04511_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzctMy0xLTEtMA_9fbfc648-0c20-4348-be71-3154e0e2abbb"
      unitRef="usd">5032000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id8596a5dc2a9407fb48a1259cc8b60a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzktMS0xLTEtMA_560ae77c-a009-42d0-b6f4-a515a2c184e2"
      unitRef="usd">5297000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i54f26f3f5ca842b9bcfeb28c25b7245d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzktMy0xLTEtMA_bf39e01e-acb1-4ab5-8bf2-1f7abe1827e0"
      unitRef="usd">7952000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icbc58818c04f441f891165122cbb127a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzEyLTEtMS0xLTA_43a9ec95-5d64-4d3f-977c-b865b0e3896e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3a3d3833f9944c22a925b20ef544e53c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzEyLTMtMS0xLTA_b01baf93-fd9c-460e-af61-c1442d6c2f0e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7b73e364f8cb4e7097673c44db096076_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE1LTEtMS0xLTA_c186cfb0-d99c-4a19-84dd-ad11c575d218"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8df7db3ed850456e8523c316fdcffbe8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE1LTMtMS0xLTA_e1bb8f9d-3354-4e33-a317-526539310094"
      unitRef="usd">3465000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic8f198bdda2744619e39ee6d06daf04a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE2LTEtMS0xLTA_acb9cdc2-f918-4098-bf60-c143875e6ce9"
      unitRef="usd">12920000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="idd87cdab9fc241a1834dc1c837593ca0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzE2LTMtMS0xLTA_7358bacf-ddf8-40e9-a95e-ddcd9534c19d"
      unitRef="usd">16461000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if0efb49fa37042d0a1c94e20bee2ffad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIxLTEtMS0xLTA_25742978-dd0a-4a03-8687-2490bbd1cfd6"
      unitRef="usd">22033000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id1cfb7d1b2ba444ab717d976ea2463a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIxLTMtMS0xLTA_2c133509-0291-47cf-9200-cd4180ef6e49"
      unitRef="usd">6635000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6cf7770e24164a6cb82df37fedffd4dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIyLTEtMS0xLTA_efa9ee4d-ffaf-4deb-b2d7-dfe1cadb7129"
      unitRef="usd">4335000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4f21d2308620492c8147ea5fb1a29c9d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzIyLTMtMS0xLTA_2143d1bb-c6be-4d4b-a864-629c1c8316c7"
      unitRef="usd">101000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5dacd48e9fb84225a7df20fc991135c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI0LTEtMS0xLTY3NDE_12b116cf-8e10-46e0-bbcb-8583ddfd59e8"
      unitRef="usd">1884000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia3e3ca927bf2472499ec316b98adc47c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI0LTMtMS0xLTY3NDY_d26091cd-5ea4-4a9a-9118-b18d47f414d2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i60dcf124861c4dcd8c60d1b9a2d582cf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI1LTEtMS0xLTA_0af18620-04eb-42bc-9199-fca61e37ce2e"
      unitRef="usd">71736000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id5a69f1e2f244056a1abc1ef23d1d66e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI1LTMtMS0xLTA_724d9cee-1a2b-449c-8a01-b746a363951e"
      unitRef="usd">38522000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id965015cdd944376a9330f2a1a1b4e90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI2LTEtMS0xLTA_4522cbcc-85a4-4240-bcd2-b3ebc745f68e"
      unitRef="usd">26728000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id1d6723512224dd2a550d187cc37550d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI2LTMtMS0xLTA_35fa106f-fb9c-47b6-9c46-57fb58cd9a54"
      unitRef="usd">5440000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i81895cd4fe274608b53fe6fac2745d58_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI4LTEtMS0xLTA_0f9113ae-d12c-4e55-b4e8-d988c00f676d"
      unitRef="usd">9449000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i43732e30fc6543ff8f68d243116e4edb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI4LTMtMS0xLTA_5218bd07-50e8-4733-bc1e-ab27d87d9295"
      unitRef="usd">2772000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic8f198bdda2744619e39ee6d06daf04a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI5LTEtMS0xLTA_b382d00a-16ee-4b1b-b912-f18148fb7115"
      unitRef="usd">136165000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idd87cdab9fc241a1834dc1c837593ca0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo5MjE4MTNiZWZmNGE0Mjg2YWU0MGFiMWY3NjJiZTQxMi90YWJsZXJhbmdlOjkyMTgxM2JlZmY0YTQyODZhZTQwYWIxZjc2MmJlNDEyXzI5LTMtMS0xLTA_fbf86230-0feb-4ede-98b4-17a88f60c4d2"
      unitRef="usd">53470000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib70bb386c50747c78872c44b364b546c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyNzQ_7f01ef8f-adbb-4fae-95d6-43f8105f01ca"
      unitRef="usd">1900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i31f677197bca449f96127ace53983925_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzMyOTg1MzQ5MTcyODg_8c54a48a-7570-472a-94ee-c45e876b7cf5"
      unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90ZXh0cmVnaW9uOmQ0NzI4NzJhYTI4MjRmZWQ4NTY5ZWVhNzkzMDFjYTlkXzk4MTg_ab664587-75cd-4a97-bd2c-d4f980f35adf">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statements of operations during the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="iac16087789404550974baece7b19f37c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtMS0xLTEtMA_e16a4a12-06cc-4619-b5bf-eecfff3e4fb0"
      unitRef="usd">-45145000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtMy0xLTEtMA_44e66347-9dd1-48ba-b5d9-eece24e105fb"
      unitRef="usd">-64778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic60a4ad3dfc6403a9163ad1e5f2a546a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtNS0xLTEtMA_54018e76-ebbf-4af3-85b1-c56bbf1ea76c"
      unitRef="usd">-16154000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ibd343399440746e3bd50a65789b34828_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzQtNy0xLTEtMA_37bb0580-2014-4aa3-8c15-0f6e47a4c416"
      unitRef="usd">-93769000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07cfdd65748d4ca59460e1d27696d43c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtMS0xLTEtMA_1ba4f50b-fc3f-4490-af72-8870636806ab"
      unitRef="usd">177000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtMy0xLTEtMA_67d210fe-ff53-4fbc-843b-d2fb7d26c1e6"
      unitRef="usd">-17147000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7fc8734239c44ef8a78ac0fe0138c4b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtNS0xLTEtMA_ec2d6184-645b-4654-af81-68efbbe49ac4"
      unitRef="usd">-15897000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ib1c34edcc03241479e1fdf702a89833c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzUtNy0xLTEtMA_d5f104bc-68ec-40ff-8b14-be9b1d20c8af"
      unitRef="usd">-1073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8a6eb3108674eb19a2f94ab9501e524_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctMS0xLTEtMA_bee72e39-173e-43c3-9a49-5975a6adb02c"
      unitRef="usd">10229000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctMy0xLTEtMA_be41dd74-b863-4a49-9296-f0ed329ae45a"
      unitRef="usd">-14911000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8e362cf9b5eb438eaa30aa6286002bfb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctNS0xLTEtMA_3ef1e93d-9c03-4e0f-bb68-3a1c529faacf"
      unitRef="usd">7609000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i25f07babdbf146d2bdd61ee3648d7f8b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzctNy0xLTEtMA_3394f1f3-59f3-429d-8a83-f7e997dba421"
      unitRef="usd">-12291000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtMS0xLTEtMA_48d8a86f-c5d9-4709-a01f-b28370ba527d"
      unitRef="usd">-34739000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtMy0xLTEtMA_334ce07a-0325-4186-8f81-2d6ab0ecbefe"
      unitRef="usd">-96836000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtNS0xLTEtMA_f50c8616-8e07-4110-ae23-c4ff4b174ed8"
      unitRef="usd">-24442000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i9c32a29f20594ea08849b5c78a01c303_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzgtNy0xLTEtMA_4cb737ca-0969-4f72-8754-383f28e8d926"
      unitRef="usd">-107133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45b8d6aac1514b89b77c76b4631e8a4d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTEtMS0xLTA_6d4bd751-dbfa-4ed5-bbd1-b1c1cd03f63f"
      unitRef="usd">619000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTMtMS0xLTA_2b0b6fef-52ac-4d0a-9bd9-186da6518f8e"
      unitRef="usd">-43493000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i39277c4198ca4bb19fddeb67224ac163_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTUtMS0xLTA_8b95c76a-c9e1-4160-a1e3-76627c02d4dc"
      unitRef="usd">2271000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="iac16087789404550974baece7b19f37c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzExLTctMS0xLTA_97f7b070-e80f-4e07-9b7a-7908e9fc3ecf"
      unitRef="usd">-45145000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e783237cfd44078b28b484e0a4a54e9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTEtMS0xLTA_2342e2bb-b72d-4289-af47-049a02d519e9"
      unitRef="usd">-6190000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTMtMS0xLTA_e026a2ed-77fb-482b-a8b0-0245fbab6070"
      unitRef="usd">9334000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i25dcf34a68ea44f6814afacdf6e4d8cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTUtMS0xLTA_1e93f613-f8b8-456e-89ed-e98056e81ef2"
      unitRef="usd">2967000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i07cfdd65748d4ca59460e1d27696d43c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzEyLTctMS0xLTA_d7f85491-25c0-414f-8928-7f9db38824fb"
      unitRef="usd">177000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21a72c6dbaf94f4986204acdd33b9437_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTEtMS0xLTA_646ff5fd-a202-4ead-889a-bbf37dcda406"
      unitRef="usd">-632000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTMtMS0xLTA_7902dde9-ecdb-4477-9afa-6c91d4f6fa97"
      unitRef="usd">20488000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ida753e739c474c6999b0cc56a471ead1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTUtMS0xLTA_931f5269-acb4-4dbd-ac85-6569888a5f8b"
      unitRef="usd">9627000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="id8a6eb3108674eb19a2f94ab9501e524_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE0LTctMS0xLTA_ffb34260-00a2-4e92-87bb-e7c2b2c68e31"
      unitRef="usd">10229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6a4bc84478844f9292b2a97d07b3b406_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTEtMS0xLTA_2245a7db-0faf-47f5-af41-658ad802daca"
      unitRef="usd">-6203000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTMtMS0xLTA_79aafd7d-fcd4-41b1-a399-030a73e7dd0e"
      unitRef="usd">-13671000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib1578fefdb4c4507b1740314a36370fd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTUtMS0xLTA_3edcac70-0beb-4f8e-a469-2b7cdd6e8fb2"
      unitRef="usd">14865000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ib1534a64c25f4f448f2e526fa8cbe9d0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODEvZnJhZzpkNDcyODcyYWEyODI0ZmVkODU2OWVlYTc5MzAxY2E5ZC90YWJsZTo0YzgyOGIyNzNiMjk0MzBlOTg0ZWVjNzI4M2E5MWYzMS90YWJsZXJhbmdlOjRjODI4YjI3M2IyOTQzMGU5ODRlZWM3MjgzYTkxZjMxXzE1LTctMS0xLTA_177cddab-b05d-4ccc-b243-c10e9f2c087f"
      unitRef="usd">-34739000</us-gaap:StockholdersEquity>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjk_cb09cb34-0a89-46b7-b88c-7784e92a4eb5">GOODWILL AND OTHER INTANGIBLE ASSETS &lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative test estimates the fair value of its three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to perform a qualitative analysis for its three reporting units as of July 31, 2020. The Company determined, after performing qualitative analysis, that there was no evidence that it is more likely than not that the fair value of any identified reporting unit was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Arkis Acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to assets held for sale (See Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Assets Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(434,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;At December&#160;31, 2020 and 2019, all other included IPR&amp;amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, $13.3 million of Intangible assets, net were presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. The Company elected to bypass the qualitative evaluation for its Codman tradename intangible asset and perform quantitative test during the third quarter of 2020. In performing the test, the Company utilized a range of projected sales growth rates, a royalty rate of 5.0%, a tax rate of 24.0% and a discount rate of 11.5%. The assumptions used in evaluating the Codman tradename for impairment are subject to change and are tracked against historical results by management. Based on the results of the quantitative test, the Company recorded no impairment to the Codman tradename intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2019, a contract manufacturing customer of the private label product line received a notification from the FDA ordering them to remove their product from the market. The Company recorded an impairment charge of $5.8 million in intangible asset amortization in the consolidated statement of operations related to the customer relationship intangible asset acquired from TEI Biosciences, Inc. and TEI Medical Inc. (collectively "TEI") due to revised future projections based on the contract termination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2020, 2019 and 2018 was $74.5 million, $72.8 million and $71.6 million, respectively. Annual amortization expense is expected to approximate $63.8 million in 2021, $61.4 million in 2022, $60.7 million in 2023, $60.2 million in 2024, $60.2 million in 2025 and $512.3 million thereafter. Amortization of product technology based intangible assets totaled $46.7 million, $45.8 million and $50.4 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, and is presented by the Company within cost of goods sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzU0Ng_98fd4294-765f-424a-b933-d2ef9a3734bb"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3Xzc5Mw_98fd4294-765f-424a-b933-d2ef9a3734bb"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjY_44608630-7fc2-4210-a64f-dc9ac4803d07">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Arkis Acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to assets held for sale (See Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Assets Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i30d9addf58ff4b909342306f36c7c6c5_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtMS0xLTEtMA_82b09dff-1150-42a7-bceb-4685a268996a"
      unitRef="usd">625760000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icf741411a24e4f0ea99ed3515168dfcd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtMy0xLTEtMA_394cbbe7-bb8e-47b2-9fe0-c3be30f81abe"
      unitRef="usd">300715000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzUtNS0xLTEtMA_f639c161-1e6f-4e41-be80-fbfedf2baaaf"
      unitRef="usd">926475000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib46eb1c774ef46438bc4de7a317c1c18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtMS0xLTEtMA_46d6e697-94f4-4311-a610-a1ff100338eb"
      unitRef="usd">27600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i26c81a038dd442ef966fb0c16bf36274_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtMy0xLTEtMA_ccd2a63b-29a4-47b9-9c78-698aed2bdf68"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i68056af4a5754484b976b39412544f18_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzYtNS0xLTEtMA_2fe39f2c-665b-4d8b-a20c-5032ef0901c1"
      unitRef="usd">27600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctMS0xLTEtMA_21515d10-291e-4667-a3ac-0e731fab4ab4"
      unitRef="usd">140000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctMy0xLTEtMA_ab3c1ce7-42b0-4977-a247-fc5ecbf96fb3"
      unitRef="usd">65000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzctNS0xLTEtMA_a4cf9ad6-d59b-4cac-82d6-d1c992f57897"
      unitRef="usd">205000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i79dcb769cedf45fd8ca2b400d2d5b642_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtMS0xLTEtMA_951d6f98-d8e9-4621-a526-66785618ae8c"
      unitRef="usd">653500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie9eec322417b4498975fcd6677b0b74e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtMy0xLTEtMA_f7108902-2c31-42a2-9c4e-2a98c885f246"
      unitRef="usd">300780000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzgtNS0xLTEtMA_cae7d252-dd79-4ff9-be14-9cb78c7ec979"
      unitRef="usd">954280000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMS0xLTEtOTcxMA_85a467cb-aa49-49d6-84e5-ba30b03be420"
      unitRef="usd">18475000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMy0xLTEtOTcxMA_dd509945-a802-4641-9c8d-87b035436a76"
      unitRef="usd">7158000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktNS0xLTEtOTcxMA_091d9efc-34ec-4de8-9402-640c1d1911d1"
      unitRef="usd">25633000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillTransfers
      contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMS0xLTEtMjMyMw_8e8b5bce-96eb-40cf-853d-7d20d22be5ed"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktMy0xLTEtMjMyNw_e8a1a1c6-448c-4f68-9a56-f9b040e0bfb4"
      unitRef="usd">-47546000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzktNS0xLTEtMzIzMA_b479621b-3f6f-4379-a078-8dfbc56cb789"
      unitRef="usd">-47546000</us-gaap:GoodwillTransfers>
    <us-gaap:Goodwill
      contextRef="ic6dbc8b92cd747a69077527fcede8db9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTEtMS0xLTMyMjg_af301179-1d99-4479-a205-8c1c448f39b8"
      unitRef="usd">671975000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifcdcf2f1832a490e8de4583c2ee8ada2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTMtMS0xLTMyMjg_8ea505bf-cdcb-4f70-85e5-7644c589c8cc"
      unitRef="usd">260392000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToyZWMyMGMxOWM5Nzc0NzI3ODk1YWRiZjE0YzQ4MzNjOC90YWJsZXJhbmdlOjJlYzIwYzE5Yzk3NzQ3Mjc4OTVhZGJmMTRjNDgzM2M4XzExLTUtMS0xLTMyMjg_ae3ea4ab-5cfd-41a9-ab06-b48955f694a8"
      unitRef="usd">932367000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjI_6f9b7202-cbb2-4d8c-ad1a-cdbc63fc62ce">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(434,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;At December&#160;31, 2020 and 2019, all other included IPR&amp;amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;, for details.</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzcwMjg_8b3d650f-7bd4-4e00-8443-36060827db7a">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(434,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;At December&#160;31, 2020 and 2019, all other included IPR&amp;amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;, for details.</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib06f4af4cdf347728b3fd0fe3c5c26be_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjBmY2MyN2Q1MjhhYjQ5OWM4NDlkMDNhYWJmODIxNmQ2XzM4NDgyOTA2OTcyMjA_5cb83371-7403-49d3-8ed9-fb77fda735e8">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtMy0xLTEtMjM4Mg_e543d10b-432f-4544-ba7d-262e36ca1046"
      unitRef="usd">896478000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtNS0xLTEtMjM4OA_6655f560-5563-465e-8b63-78769c7e81e4"
      unitRef="usd">248088000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i84f1f16c648d4e59b8f700fb4215b8de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzMtNy0xLTEtNDgwMQ_f5a5b50a-9efe-4657-b56b-45d536b2afc9"
      unitRef="usd">648390000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icbbe4092d3414952b63ded2528617b83_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOmUwMmU2YmVlN2E1MDQ3Y2Q5MDE3MGIyNTZkZDZhZTUyXzk4OTU2MDQ2NDk5OTg_bc104c15-9503-42d8-9ca9-3d87607727e9">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtMy0xLTEtMjM4Mg_2cd5fc0e-8077-406d-a765-e009f922df0c"
      unitRef="usd">213270000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtNS0xLTEtMjM4OA_fb66c341-d285-4124-806d-33e5bd06c411"
      unitRef="usd">132838000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i8651611aee6c43578f75fe1703fd12b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzQtNy0xLTEtNDgwMQ_57d4122f-0927-48d2-aa33-46723578ac03"
      unitRef="usd">80432000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic9fe9bfb03ab426eb4daedcb791f9292_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjkwYmI5OTE4OGJlNzQ3Yjk4YTFmMzZlZTQ5M2NiZGQ5XzM4NDgyOTA2OTcyMjA_a0ff655f-49e1-4dc8-af17-7b29bb041398">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtMy0xLTEtMjM4Mg_3c16b88f-29ae-4b4c-ac4d-08006d369bce"
      unitRef="usd">104209000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtNS0xLTEtMjM4OA_007b0d9f-4344-4175-be96-dc56b5028ca6"
      unitRef="usd">31767000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i7e04a4dac0194a64b97de520023edd3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzUtNy0xLTEtNDgwMQ_17e5cab6-a099-401c-851c-d6aeb12e3126"
      unitRef="usd">72442000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzYtMy0xLTEtMjM4Mg_8de3e1ba-0b82-40e7-b6a2-50a288d65d27"
      unitRef="usd">170226000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i1bb06e0c6fa7411d860e959fcb5383fd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzYtNy0xLTEtNDgwMQ_6fab691d-dd21-4691-afab-9cd4e69e527c"
      unitRef="usd">170226000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic18c09773aab473bab4a6b8ff55ea00b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctMS0xLTEtMjQxMC90ZXh0cmVnaW9uOmVhMjQ3YTUwM2RhMTQ4ODU5Y2NlYzRmMDg2MzUyMTk2XzM4NDgyOTA2OTcyMjA_c2a44bbe-d706-4b27-af30-20498e8d12a2">P27Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctMy0xLTEtMjM4Mg_f7db0daa-a7ca-4c86-b5df-5f500cf937a0"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctNS0xLTEtMjM4OA_9e28be54-38a8-4b6c-9c5e-a3e32f067a9a"
      unitRef="usd">15203000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i0eb7106a152b4473997f284c52bd417a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzctNy0xLTEtNDgwMQ_037386d3-96d2-458c-8b29-b9bd8968c2e3"
      unitRef="usd">15008000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i75c1907d0ffb4c6690f775d97d70d2c6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtMS0xLTEtMjQxMC90ZXh0cmVnaW9uOjZmY2Q2MzlmZDBjNzQxOWVhMWZhZTExNDkyNDBlMWQzXzM4NDgyOTA2OTcyMjA_cfb5d9b6-a113-451f-ae42-0a9a80ebd65a">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtMy0xLTEtMjM4Mg_110f06c3-2918-4292-91ad-315544198025"
      unitRef="usd">9995000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtNS0xLTEtMjM4OA_c56386df-062d-4d4c-9033-e9b1af65fed5"
      unitRef="usd">7057000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ic6cf137b302d469180a56297d93fb47a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzgtNy0xLTEtNDgwMQ_2275e941-d048-46e4-9961-c705278626ad"
      unitRef="usd">2938000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktMy0xLTEtNDc5OQ_a5fcd2ce-0d40-4914-9a63-93e52218e6c3"
      unitRef="usd">1424389000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktNS0xLTEtNDc5OQ_394f49c3-5c23-4ab3-896c-5e142d45e35d"
      unitRef="usd">434953000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZTpiODEwNmZkM2VjYTg0YjA1YTZmZTkyNWQ0NTkzOThlNy90YWJsZXJhbmdlOmI4MTA2ZmQzZWNhODRiMDVhNmZlOTI1ZDQ1OTM5OGU3XzktNy0xLTEtNDc5OQ_857f69e9-3072-4db2-992f-80742403f3d6"
      unitRef="usd">989436000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4933189a9bc343b1b84567e1726af5aa_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmM1YmYzYWYwNmVmNDQ0MzA4OGEwZWZiYWVmNDJkYjQ0XzM4NDgyOTA2OTcyMjA_31661179-3e4b-4f1e-8bf6-8789a697a696">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtMy0xLTEtMA_fb71af41-4c5c-44d4-b06a-9763d97c1176"
      unitRef="usd">880623000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtNS0xLTEtMA_e04d5523-2ad3-4b3c-98e4-f326821e4b84"
      unitRef="usd">213702000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i6ced1f3b4b9b42cb92d04a85d56b37fb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzMtNy0xLTEtMA_cdc0fc8d-3463-4a5c-bb4f-077bfa660a4a"
      unitRef="usd">666921000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie733e2047f5a4b2aa169696427558a08_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjZhODI0YTYxMWE1MjQzMmZhYzYxYTA5ODI2MDI1NWJiXzM4NDgyOTA2OTcyMjA_6aac00d6-2506-4f77-90ba-32ae10fe2e4b">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtMy0xLTEtMA_ed7dbb45-3b8a-4d42-acf9-fa93c3973dc8"
      unitRef="usd">222575000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtNS0xLTEtMA_41b3c7cb-6d53-401f-9162-e1ee41b6d83f"
      unitRef="usd">119393000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i6248d53e4c3743c4a2ccf55bb7182eb3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzQtNy0xLTEtMA_ca745838-781a-4736-80e3-70fe1f1d8998"
      unitRef="usd">103182000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i034043822a11407680de78bc3d1ec452_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtMS0xLTEtMC90ZXh0cmVnaW9uOjMwZTAwNWIxOWJkYzRkOGI4Y2NlOGZiOWFlZDhlZGU3XzM4NDgyOTA2OTcyMjA_c3b69170-47d4-4878-ba9a-b41baafd399e">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="id3ef2091813046c682a8769926db401b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtMy0xLTEtMA_0e4a6e7c-4c8f-47ec-b54a-fefeebf0b568"
      unitRef="usd">103873000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id3ef2091813046c682a8769926db401b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtNS0xLTEtMA_a4c2f031-0fd5-4cba-b23d-6a9da867ec9a"
      unitRef="usd">28514000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="id3ef2091813046c682a8769926db401b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzUtNy0xLTEtMA_2fbc1ced-df38-4277-ba52-ef157e76dc5b"
      unitRef="usd">75359000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i03f54a56c22e4237a9643f89c03a66f7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzYtMy0xLTEtMA_7cee1e4f-2475-4e18-b501-d2fe2951d0dc"
      unitRef="usd">163126000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i03f54a56c22e4237a9643f89c03a66f7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzYtNy0xLTEtMA_7740c6be-df8f-4319-9461-e3024a88ee58"
      unitRef="usd">163126000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icb0bc85723e14b2890301593c5ad7ebb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctMS0xLTEtMC90ZXh0cmVnaW9uOjZiMTBjYjlmZmNjZjQzZTQ5MTUwNDVhNWEzYzViMmYzXzM4NDgyOTA2OTcyMjA_20e2aa40-d4b7-41db-90e8-880a252948e2">P27Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctMy0xLTEtMA_26d29cb4-fc40-4e06-9ff0-9cf850a501c3"
      unitRef="usd">34721000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctNS0xLTEtMA_fdfae897-5d34-4325-abac-294865a061e5"
      unitRef="usd">17947000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i88bd7cfc94f24140a0e0f7f140778b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzctNy0xLTEtMA_62824f06-251d-4f83-9f0d-1258f4226bac"
      unitRef="usd">16774000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5c7ab6df120c48e7bbf814ae41c07bfa_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtMS0xLTEtMC90ZXh0cmVnaW9uOjgyNTdmNWJmYjE1YjQzNjdhMDk4MDNmZDhiZWQzYmVhXzM4NDgyOTA2OTcyMjA_e77b646c-67db-4d1a-8606-ff30ba83ac86">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtMy0xLTEtMA_abb33ff8-b58c-41f6-917a-2cfba1a3cf92"
      unitRef="usd">10869000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtNS0xLTEtMA_708c1e57-277f-4821-9700-675dddbd2e29"
      unitRef="usd">4640000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i3f217e07c0494603be881cbbb3995d4e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzgtNy0xLTEtMA_5bc1d2bc-0f55-46bb-9a1d-340848f405fb"
      unitRef="usd">6229000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktMy0xLTEtMA_4e885ba0-726d-4926-ba9e-609e9392b089"
      unitRef="usd">1415787000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktNS0xLTEtMA_f7ca2f56-08ed-42b0-8a49-50a0d27adc10"
      unitRef="usd">384196000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90YWJsZToxMjYxMDEwMDk5MjA0NjBlODE1MWM3ZjQwNjM5ZDg0ZC90YWJsZXJhbmdlOjEyNjEwMTAwOTkyMDQ2MGU4MTUxYzdmNDA2MzlkODRkXzktNy0xLTEtMA_f710dc4d-d5cf-422d-b376-c5db9cb11c14"
      unitRef="usd">1031591000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i7077633fc80146898fa719dfec3ebf6c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzM4NDgyOTA3MjI1NjE_5b485b52-109b-4378-9930-ebc8d424853c"
      unitRef="usd">1000000.0</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="ie5101596f43440d6ae335163c5bd50ff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzM4NDgyOTA3MjI1NjE_6ae94cbd-c732-49df-80ce-ce1e24de85b9"
      unitRef="usd">1000000.0</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i2ad1ea87dcac4b829d2588d82938711d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzEwNDQ1MzYwNDg4MDA5_cfc2538f-0b64-40a8-98a7-9614471c93e5"
      unitRef="usd">13300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage
      contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4NzA_32a37141-8ec1-421d-b925-20615012ff1a"
      unitRef="number">0.050</iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage>
    <iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage
      contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4NzY_85fa816d-3f09-4d12-9bd7-90e1c108c1a2"
      unitRef="number">0.240</iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage>
    <iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage
      contextRef="i57f050bd2ac1429b8c14a8f6b606813a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4ODM_479c78f3-6c68-49ee-8b45-7abe5871788f"
      unitRef="number">0.115</iart:IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="id1d02ef36bfd440290608745175b9676_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzMyOTg1MzQ5MDc4ODk_7435922a-ab05-4c76-b3a5-517b0a29520d"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i368c48b7000e48679bf0f4f0b55eb9af_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzQ4NzQ_fd3088c5-fdc8-42f9-8255-e227478ddf5a"
      unitRef="usd">5800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AdjustmentForAmortization
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY1Nzk_646b3180-7b8f-4515-a873-7b3e5d8ba72d"
      unitRef="usd">74500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY1OTE_4f7555a2-0003-4aab-a9f3-6d3b33c7495d"
      unitRef="usd">72800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY2MDc_a00a2ed5-4bb8-40bd-9a4c-0ce7b9c94ee1"
      unitRef="usd">71600000</us-gaap:AdjustmentForAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY2ODk_ef31e8a6-2535-401f-a8f7-08ed345eb2c6"
      unitRef="usd">63800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3MDg_2ae44100-fdb2-4c8e-b75a-489b40b261af"
      unitRef="usd">61400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3Mjc_3b539d90-f7de-4e1d-a384-94549a1f0e48"
      unitRef="usd">60700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3NDY_6689d547-d8b1-41fd-802c-52a59a095245"
      unitRef="usd">60200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3NjQ_c017dd8c-e451-43c1-ade2-ad865c7f7b73"
      unitRef="usd">60200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY3ODU_38194064-0910-45bb-8cd7-cb567f81eeb7"
      unitRef="usd">512300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY4NzY_30ec3989-9869-4fe1-ad8b-956e4ad31a44"
      unitRef="usd">46700000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY4ODk_b5bae3c0-5390-4f6d-954d-0db05ba45e9d"
      unitRef="usd">45800000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xODQvZnJhZzo5ZDI3NzgzYThjN2E0N2I1OTI2ZjI0ZTZmNzllZGMyNy90ZXh0cmVnaW9uOjlkMjc3ODNhOGM3YTQ3YjU5MjZmMjRlNmY3OWVkYzI3XzY5MDU_7808b677-0f9e-4e4e-b2db-5f8c629e6d93"
      unitRef="usd">50400000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:TreasuryStockTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4Xzg4OA_0a601274-0f7e-406d-a047-4955ee939b8c">TREASURY STOCK&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and 2019, there were 4.9 million and 2.9 million shares of treasury stock outstanding with a cost of $235.1 million and $119.9 million, at a weighted average cost per share of $47.86 and $41.87, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#x2019;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $125&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#x2019;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the ASR, which represented approximately 80% of the expected total shares. Upon settlement of the ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM0_219210f2-1d9a-4760-97f1-b01468fa5970"
      unitRef="shares">4900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA3MDAwNjM_ed557994-48db-4927-aa26-b9ea4e616973"
      unitRef="shares">2900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzExNQ_a0d4c43d-c247-4188-99c2-4d2d5f2a69a9"
      unitRef="usd">235100000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzEzMQ_473fe8b0-c12e-431b-9d23-45f82242c992"
      unitRef="usd">119900000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzE4OA_8f3932b0-c6b3-4a70-99c5-68f14fbd3195"
      unitRef="usdPerShare">47.86</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA3MDAxNzg_1f3c49c4-0cea-4034-a091-437368bcdc7b"
      unitRef="usdPerShare">41.87</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia08ed94918db4fc09d8f42783aacc8b6_I20201207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0NDk_ca982a33-a4e1-4f4d-a318-7dbfcda127e7"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib238505ff51c45719c413427f70bcbd0_I20201206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0OTA_ca615a78-7045-451a-81a7-adae471a5bab"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ib238505ff51c45719c413427f70bcbd0_I20201206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzMyOTg1MzQ4OTA0NjM_3edd3021-e9a0-4b27-a06a-2533a7d708d7"
      unitRef="usd">125000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxNTE_f30e338d-6b62-4d90-addc-0ae29f584239"
      unitRef="shares">2100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i46a618f65cc54536b6ac22edf2a4b181_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkwOTM_2a5c4774-60aa-4e55-91e7-920bc3261744"
      unitRef="usd">100000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2f222fedde3d473d8469d82836a431b7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxNjQ_6b37852d-5f79-4f92-8e06-c058c14d0e08"
      unitRef="usd">7600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i303b890f4cb5458b9feafec5da48c4c6_I20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxODA_7a77636d-afc0-4270-8964-40eee117cb43"
      unitRef="usd">-92400000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkxOTU_9b598df6-0fa6-4ab7-8675-a8abac193d08"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMTE_6a7bb597-ff9e-4594-a81c-904179731e7c"
      unitRef="shares">1300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="i0150909d1797401a995dc4ea8c351908_D20200205-20200205"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMjQ_8593d7fa-386e-4c1d-984c-01faf4659cf3"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ic11fc02008134b78802f99d57c698ae8_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTAvZnJhZzo2MGYyMTg3MzQ1YjE0ODE4OTFhMzYwMmMwOGFkM2QyOC90ZXh0cmVnaW9uOjYwZjIxODczNDViMTQ4MTg5MWEzNjAyYzA4YWQzZDI4XzM4NDgyOTA2OTkyMjk_c5393fd8-6e4d-4d61-9b51-5351e0b17dce"
      unitRef="shares">600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0NTg_244df05c-ec29-418d-b059-1fd6ba6020d1">STOCK-BASED COMPENSATION&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE STOCK PURCHASE PLAN &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#x2019;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2020, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2020, 2019 and 2018, the Company issued 18,284 shares, 12,531 shares and 16,721 shares under the ESPP for $1.1 million, $0.7 million and $0.7 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EQUITY AWARD PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under three plans, the 2000 Equity Incentive Plan (the &#x201c;2000 Plan&#x201d;), the 2001 Equity Incentive Plan (the &#x201c;2001 Plan&#x201d;), and the 2003 Equity Incentive Plan (the &#x201c;2003 Plan,&#x201d; and collectively, (the &#x201c;Plans&#x201d;)).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options issued under the Plans become exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTI_0bee5ce3-e334-433a-bccf-d7c4674263bf"&gt;six&lt;/span&gt; to ten years for directors and certain executive officers. Restricted stock issued under the Plans vests ratably over specified periods, generally three years after the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#x2019;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $3.2 million, $3.0 million and $2.6 million in expense related to stock options during the years ended December 31, 2020, 2019 and 2018, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2020, 2019 and 2018 were $8.7 million, $14.6 million and $16.9 million, respectively. Cash received from option exercises and employee stock purchase plan was $5.2 million, $6.9 million and $9.4 million, for the years ended December 31, 2020, 2019 and 2018, respectively. The realized tax benefit from options exercised were $1.7 million, $3.0 million and $3.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, there was approximately $5.1 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Awards of Restricted Stock, Performance Stock and Contract Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested but not released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $16.4 million, $18.1 million and $18.1 million in expense related to such awards during the years ended December 31, 2020, 2019 and 2018, respectively. The total fair market value of shares vested and released in 2020, 2019 and 2018 was $17.3 million, $21.1 million and $24.8 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, there was approximately $22.6 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, there were approximately 0.5 million vested Restricted Units and 0.1 million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is is contingent upon achieving certain revenue and organic revenue growth performance metric.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, there were approximately 1.9 million shares available for grant under the Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized into inventory, share based compensation costs of $0.4 million, $0.3 million and $0.4 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODY_0499a9ed-35df-4c6c-97ae-1e5bda35c41d">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if2fb153e77db42c681bdf078a9cd15e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMS0xLTEtNjM5OA_5323a09e-fb56-4159-8905-7082cd314a5d"
      unitRef="usd">344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if5677f7e2a974dc7b6ffd0e7f9e6fb9c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMy0xLTEtNjM5OA_be1f7092-6bc7-4360-9bd0-e97fb26bf22e"
      unitRef="usd">317000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie462e47008de43c29915a7628f16f658_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtNS0xLTEtNjM5OA_3ae6d057-cedd-4c76-a30d-99df06643eb7"
      unitRef="usd">449000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i680ed1f9c86649b4862345f20ec88809_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtMS0xLTEtNjQwNg_09be1146-1af5-4463-9dbb-f921598d5842"
      unitRef="usd">1471000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie56f741b7288452bab43bdc3b9a4da17_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtMy0xLTEtNjQwNg_220dba9a-34b3-41e9-b18f-70a5e0a8a724"
      unitRef="usd">1785000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if1bf91d6b7164e5fbd293ba20be27e48_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzQtNS0xLTEtNjQwNg_d6a6ec53-3425-42e3-9467-b0439e9ce744"
      unitRef="usd">1609000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7dba9945bb734bf0b1f741904d8a73d4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMS0xLTEtMA_c939dd92-7a4f-4616-8d51-f4678c9bf0f2"
      unitRef="usd">17776000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f0c355852c74d3ea007543365176e1c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtMy0xLTEtMA_16e2dbcc-5e01-4106-a533-e01adecbae11"
      unitRef="usd">19153000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i901bb4e610764e9ca257b79fa0ec7ada_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzMtNS0xLTEtMA_7d347f3f-f7e5-4539-9f42-0aa266552352"
      unitRef="usd">18721000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtMS0xLTEtMA_f4242f37-f2e1-4eb2-8795-00e4402bfded"
      unitRef="usd">19591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtMy0xLTEtMA_a4f869a6-ef2d-43fe-a29e-c54035f4298a"
      unitRef="usd">21255000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzYtNS0xLTEtMA_771cd07c-17f4-4d29-9ea0-09eab63d1db7"
      unitRef="usd">20779000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctMS0xLTEtMA_50ec4c46-c664-4202-9148-05ab84412e01"
      unitRef="usd">6221000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctMy0xLTEtMA_af365e4b-8188-4433-98cc-ba619fb701c5"
      unitRef="usd">9420000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzctNS0xLTEtMA_4b38c69c-6716-4e0c-9ddf-5e229168f701"
      unitRef="usd">10430000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtMS0xLTEtMA_7c12607e-f42f-47bc-bd58-fedcfcdbf349"
      unitRef="usd">13370000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtMy0xLTEtMA_e77537c1-9c4d-4a15-bdec-062f033e3ba3"
      unitRef="usd">11835000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0YzRiN2E4Y2QzMzI0ZWVhYTU1OTBjMTg3YTA0MTE4ZS90YWJsZXJhbmdlOjRjNGI3YThjZDMzMjRlZWFhNTU5MGMxODdhMDQxMThlXzgtNS0xLTEtMA_c67f0989-dca7-4ab8-b9ff-f0ba16eecf92"
      unitRef="usd">10349000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8c85dafb1abd4865944b64fe294a1bf0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUxOQ_d6657bf8-bf5c-4fdb-83c9-12254f1d7c37"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i8c85dafb1abd4865944b64fe294a1bf0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzc2NA_55946e83-5e2f-4e81-b982-c7924271fceb"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ibebf86aa0e7747829800552078a209b8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzg3Nw_40abed37-b36c-4af0-b568-b157e307efb0"
      unitRef="shares">18284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzg4OA_29c8d9ca-1068-4084-93d5-9ea0d9f91b26"
      unitRef="shares">12531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkwMg_fe78b653-3169-42c2-8c0e-e54cfdcf861b"
      unitRef="shares">16721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="ibebf86aa0e7747829800552078a209b8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkzMQ_56a223d5-f928-4062-8727-d34ce9969392"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="i2e584d529ab84ecfb2426025f6dab480_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzkzNQ_8e837bc2-d16e-42a7-a79a-f576490b3cd1"
      unitRef="usd">700000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="i1f22e12c4e8d484891cd8e6b501262ba_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1Xzk0Mg_1cad50f1-c895-4015-acc5-a4a1637adf26"
      unitRef="usd">700000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzMyOTg1MzQ4OTI4OTg_c44f6644-262d-4edd-a2ea-bde2c523b5ab"
      unitRef="plan">3</iart:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <iart:IncreaseInAuthorizedShares
      contextRef="i1bdab55a19f54c7cb717d1ca9d9e5ff2_D20100501-20100531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE0NjA_d636364d-a8b1-4a79-bcc8-6057cfd34287"
      unitRef="shares">3500000</iart:IncreaseInAuthorizedShares>
    <iart:IncreaseInAuthorizedShares
      contextRef="i2367de66733d4c9e86c3fcfb6c69836c_D20170501-20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE0Njc_72178666-b6da-4d1d-b763-6dba45fb995c"
      unitRef="shares">1700000</iart:IncreaseInAuthorizedShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="if6ae198d152944a9bff341fb3a413ddf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE1ODc_530b6d48-b9ad-4565-bb97-98d5cebfe599"
      unitRef="shares">4000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i4a61d7f582cc439487176679b8b9d6c6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE1ODc_7e92eb34-c122-43b7-9a81-7a42f09d1b89"
      unitRef="shares">4000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i705ff9d8a2094da5af5170fc081b60f8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzE2NDg_084edf19-c8f5-4b6d-b0f3-fa9c28b4913d"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIwNDQ_ffc362d2-054d-437d-a07d-f1f5268a64b2">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i093928b71e5f461b98a025cef7849d83_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIxMDk_af7305d3-5d63-4d77-b063-6fa92dd45dec">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="iaed5ceec7dc240c6b98379fe92fa71b9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyMDY_42ec3c7d-02b3-4d07-bfac-b0060d396ced">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ic58808a8f364461da081a8acfb8e751a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTg_6630b8c5-d50e-4d36-8d39-42e86ecbe669">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie560a306d89242d79633b548637d6187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIzOTU_55e50b68-fb9e-4f09-96d0-8fb072817419">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzI5NTk_1ce40ff3-f133-4ed0-ae19-a8828fa7dde6"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODc_6d9fe3ca-f58c-4fb6-93f9-130444a13392">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItMS0xLTEtMA_3bb923c8-358a-4b14-bc47-52d3551d7767"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItMy0xLTEtMA_5a3dd455-58b4-44d4-b8ab-8b47f28cb02b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzItNS0xLTEtMA_fcd965e0-5f61-4be0-98a9-7c357a4f2996"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtMS0xLTEtMA_4fd2dd96-d287-4329-87c5-cbef62a2ae6a"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtMy0xLTEtMA_865cf10a-dc19-4d93-9b3f-980710179dda"
      unitRef="number">0.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzMtNS0xLTEtMA_23f99b3f-0943-4d8a-94d4-2ecaaf08f154"
      unitRef="number">0.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtMS0xLTEtMA_87953036-3775-4bfb-9963-f8deb15a877f"
      unitRef="number">0.0089</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtMy0xLTEtMA_aeee7c3d-22f5-4d91-b672-297a6ed62932"
      unitRef="number">0.0251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzQtNS0xLTEtMA_673d6634-4872-4c93-a256-8649cdf77848"
      unitRef="number">0.0279</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtMS0xLTEtMA_88afc07f-6b41-4e93-93ec-ce87b7fb917f">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtMy0xLTEtMA_c11b692f-3a49-4910-99a6-1c069c1037f2">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzUtNS0xLTEtMA_b589d8c0-1127-47d4-bddf-d8a9827a086c">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtMS0xLTEtNjQzOA_aa8d227f-09f2-421b-965c-63dad567e044"
      unitRef="usdPerShare">13.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtMy0xLTEtNjQzOA_20cd330b-6662-4f62-9e24-8bca9f58e8d3"
      unitRef="usdPerShare">18.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0MzBjOWY1OTgxNDE0YjgzYmFiZDRiZDkyZDUzNmVlMC90YWJsZXJhbmdlOjQzMGM5ZjU5ODE0MTRiODNiYWJkNGJkOTJkNTM2ZWUwXzYtNS0xLTEtNjQzOA_efba9125-7f79-466d-81e8-cc5f446d5d26"
      unitRef="usdPerShare">21.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0ODE_79085b43-b534-444e-851d-21c40dfe8c54">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtMS0xLTEtMA_568bfbb5-39f9-440a-8859-d635d77635b9"
      unitRef="shares">1284000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtMy0xLTEtMA_1ab998a6-fbe3-4756-8373-c4c5c214dbe2"
      unitRef="usdPerShare">34.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzQtNy0xLTEtMA_0c11c8d0-acd6-4df4-b75c-0d07d1b2fecd"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzYtMS0xLTEtMA_cfc8db04-769b-46ee-860c-94e3e23648ee"
      unitRef="shares">349000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzYtMy0xLTEtMA_bda11aed-f0ae-4e5d-82c3-92bf540dc26c"
      unitRef="usdPerShare">43.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzctMS0xLTEtMA_21b0d788-8cae-4d22-a2ad-4e8a20576cd7"
      unitRef="shares">236000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzctMy0xLTEtMA_56fe44bc-12cd-4eaf-a1d2-861e7d9f7cac"
      unitRef="usdPerShare">19.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzgtMS0xLTEtMA_20db93e2-dee6-41c7-b412-894cfc5a3efa"
      unitRef="shares">51000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzgtMy0xLTEtMA_f532e284-b1fc-442e-80df-ff019b9b809b"
      unitRef="usdPerShare">49.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktMS0xLTEtMA_090b706a-cc8e-4bf1-9b80-c70f6f9742c4"
      unitRef="shares">1346000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktMy0xLTEtMA_d60954fa-7156-4642-ad01-6da764a748ba"
      unitRef="usdPerShare">39.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktNS0xLTEtMA_be155c5c-0061-4362-84df-810608ac24e4">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzktNy0xLTEtMA_2c0b57cb-4ed2-40c9-8ee7-ed67e57cd578"
      unitRef="usd">34560000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTEtMS0xLTA_ba6ead39-22fd-4214-818b-3da4b333b971"
      unitRef="shares">881261000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTMtMS0xLTA_39f2daad-d07a-4ad9-99b8-99ef44aaa760"
      unitRef="usdPerShare">35.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTUtMS0xLTA_72836df6-8193-43af-9f22-070b0b27f0e5">P3Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTo0OTMxMjdmNGVlZTQ0YTUwYmI1ODRlZmFjOWY2MjhmZi90YWJsZXJhbmdlOjQ5MzEyN2Y0ZWVlNDRhNTBiYjU4NGVmYWM5ZjYyOGZmXzExLTctMS0xLTA_dd2c3b3c-4e56-4b41-bc17-852c427e604e"
      unitRef="usd">26197000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3MDI_c3d9c07c-1e60-40a4-9fe2-a44c4d38412a"
      unitRef="usd">3200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icbab38d90c9b47fdbbcf4d4bb7cbfd50_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3MTQ_edc2b2c7-b66c-426a-9168-7ca897654c50"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1180226ca50f46c48ae3ef906f7f99d9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM3Mjk_c3330171-6479-45de-bf20-37fe3f78cf5e"
      unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MjE_10aa06bc-aa09-4cc3-9b52-ea1e332bfb08"
      unitRef="usd">8700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MjU_68664021-107b-4827-8c70-e2ed9c8b1583"
      unitRef="usd">14600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM5MzI_b98c0dc0-348b-4c03-8561-9a8f2a16db44"
      unitRef="usd">16900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNTU_07c8c190-ca2b-440e-b3bd-7151eaa0527f"
      unitRef="usd">5200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNTk_0b65d575-f1a3-4b5f-805a-bba17edb8e44"
      unitRef="usd">6900000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQxNjY_b5d5da50-ecc6-4d9b-bc25-6cea9672f10d"
      unitRef="usd">9400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzM4NDgyOTA3MDQ5NTE_2c582b51-3db8-4756-a254-c76630e62883"
      unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQyOTc_299cefb8-0d2d-4ef8-ab40-c76052fb0e38"
      unitRef="usd">3000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQzMTI_b114c14e-7adc-49af-b5b8-3e90b169b6f0"
      unitRef="usd">3100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3b3f1452538f40ecaabbbef187076889_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ0MTk_238d2fc7-7a18-4143-a415-94732fe969a5"
      unitRef="usd">5100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i14d3e8485c104373921084ba3a66b7ec_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ1OTY_3bb0e0f2-f462-41e1-82bb-5be5cfec248f">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzY0NjU_6858a882-a2ae-429d-bd0a-c628d1a9e0df">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested but not released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id58d59da5a4945d88d46c8031ef25907_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtMS0xLTEtMA_cb739bfb-080f-4a1f-ba47-52a621bbdfa8"
      unitRef="shares">460000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id58d59da5a4945d88d46c8031ef25907_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtMy0xLTEtMA_1274a28b-36b9-4b26-8b82-73cce8d7a78e"
      unitRef="usdPerShare">54.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic773caffde25407cabce511afbf4e3d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtNS0xLTEtMA_26c65f2d-f9ed-4140-bcd3-0be9381b7227"
      unitRef="shares">192000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic773caffde25407cabce511afbf4e3d6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzYtNy0xLTEtMA_91a67d92-3358-4222-93b4-399bfa2e22ee"
      unitRef="usdPerShare">55.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktMS0xLTEtMA_80912686-2826-4438-9f72-931bd8b02898"
      unitRef="shares">286000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktMy0xLTEtMA_0f677380-8c52-4f38-be17-7815c8c8dc7a"
      unitRef="usdPerShare">44.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktNS0xLTEtMA_5963d70e-3e1a-46f5-9032-4ba4ce5a1931"
      unitRef="shares">234000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzktNy0xLTEtMA_49f18dd7-3724-4c23-9ce4-08ddf11f1b73"
      unitRef="usdPerShare">43.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEwLTUtMS0xLTA_02f0cec7-6896-4885-a30a-d5e76ed5909f"
      unitRef="shares">14000</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEwLTctMS0xLTA_5a1e2f62-fe69-4609-ae5f-0235f3794e0e"
      unitRef="usdPerShare">51.93</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTEtMS0xLTA_551a662c-a073-4387-bb98-f95ff6e8732e"
      unitRef="shares">42000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTMtMS0xLTA_f69c556c-364e-4dbf-b0bc-182ebbc1b2d3"
      unitRef="usdPerShare">50.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTUtMS0xLTA_bf293c2b-9e9d-4b62-8ab4-15fff7e0fc7f"
      unitRef="shares">31000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzExLTctMS0xLTA_b023e712-8493-4fa6-929e-34839536377f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTEtMS0xLTA_2176559a-7876-416b-9211-dbf44e393b9c"
      unitRef="shares">232000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTMtMS0xLTA_b9b6e97a-a683-4ac7-be32-89d52ee5c053"
      unitRef="usdPerShare">52.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTUtMS0xLTA_c9817143-2e2a-4167-8982-fd466a08e111"
      unitRef="shares">157000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzEzLTctMS0xLTA_a8049c08-b37d-4f9e-9f64-a37f6de6c66b"
      unitRef="usdPerShare">43.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTEtMS0xLTA_07dbd8cf-8e49-4c18-9717-5271b0d5641f"
      unitRef="shares">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue
      contextRef="ieb406490fde246d0a2d16de1f404c1a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTMtMS0xLTA_220c865d-51dd-4d80-ac33-97bcb024b1de"
      unitRef="usdPerShare">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTUtMS0xLTA_e96bc810-b1b6-4d03-9634-bf56482421bd"
      unitRef="shares">55000</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue
      contextRef="iab95a23c342946efa1bb0c0b8413a905_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE0LTctMS0xLTA_b9882c05-afac-41b1-928e-8c4ca4e66c90"
      unitRef="usdPerShare">51.84</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i424d9c8811b649708c4148b20d4b24a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTEtMS0xLTA_8eeb5381-6059-4890-9d1f-eab2f10385d8"
      unitRef="shares">472000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i424d9c8811b649708c4148b20d4b24a3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTMtMS0xLTA_37eae958-fecb-4ab9-a8e3-facb5b72c4b8"
      unitRef="usdPerShare">50.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id717c22f443f4448bfd741ee42b60e90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTUtMS0xLTA_dbbce03d-e4ec-4c85-ac17-945e22befe2f"
      unitRef="shares">197000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id717c22f443f4448bfd741ee42b60e90_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90YWJsZTpiNmQzNjAzZTY4OWQ0N2I1YTQ1Yzc4MGQwODM1YTMzZC90YWJsZXJhbmdlOmI2ZDM2MDNlNjg5ZDQ3YjVhNDVjNzgwZDA4MzVhMzNkXzE1LTctMS0xLTA_b63cd871-84df-4ff3-b927-9be0dd31d224"
      unitRef="usdPerShare">47.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4MjY_3b3b8dcb-b3a4-47c1-93b3-b1f3deab724f"
      unitRef="usd">16400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i493a7b5721d64329a45399d533ad986c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4MzA_6e5a9240-84ee-46ed-8f5c-bcfd1fba25ad"
      unitRef="usd">18100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec97182214d345158f5fdc86adce0e84_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzQ4Mzc_54607d33-16ca-4418-ae71-ac6ede7672c4"
      unitRef="usd">18100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMTg_f54c5c20-6a6e-48f8-a5d6-a502500d4f6f"
      unitRef="usd">17300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i493a7b5721d64329a45399d533ad986c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMjI_cb406ad2-2c2b-4179-8d94-25fd3dd898c3"
      unitRef="usd">21100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iec97182214d345158f5fdc86adce0e84_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUwMjk_f4793559-cade-49a0-b473-c94be80a656d"
      unitRef="usd">24800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzUzMjE_1ea8b5b8-de69-4455-93ea-3aff2127bda8">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i2a88c7ddb0d4436f9142a1530eb72a9e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU0NzI_25ceafa7-19bd-4824-a14f-1d6d6726b19a"
      unitRef="usd">22600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ied76ebfb00b047c8af6e6818eb52c5a1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU2ODk_d62b5957-d345-4428-aba2-bdf09cbbeeb6">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod
      contextRef="id09d3023efe741e390f961699ce66f28_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU3Mzg_542e589f-936e-4d0c-9985-2258a6339f2c"
      unitRef="shares">500000</iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod>
    <iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod
      contextRef="i3d34a9446c5345f1ba23501963098bb8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzU3Njk_7b095a34-65cb-4e70-89a5-b3fe843fa7c0"
      unitRef="shares">100000</iart:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYxNzM_be36642d-959b-48df-b537-615f5296d612"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYyOTQ_c0337f1e-843f-4551-9220-c5e0c9ac128f"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYyOTg_1a1c2c57-87e1-476f-98c7-d7b327ecd40c"
      unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzYzMDU_e6dd95fe-bf74-4739-bc61-aa79f043a749"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ4MDE_a8eefd8f-a663-4559-99f2-f4a31ed351d3">RETIREMENT BENEFIT PLANS&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED BENEFIT PLANS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2020 and 2019 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,007&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,693&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2020 and 2019, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2020 and 2019 and a reconciliation of the funded status at December&#160;31, 2020 and 2019, respectively (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plans transferred in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,770&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the periods ended December&#160;31, 2020 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2019, the Company had a net gain of $4.6 million and a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net loss of $9.0 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2020, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $61.5 million and $61.1 million as of December&#160;31, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The benefit plans in France and Germany had no assets at December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, no plan assets are expected to be returned to the Company in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, contributions expected to be paid to the plan in 2021 is $2.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED CONTRIBUTION PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#x2019;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $6.7 million, $8.6 million and $8.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFERRED COMPENSATION PLAN&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2020 was $2.0 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3Njc_9bd2646d-3bad-45d2-9b58-ada619f8b1e3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2020 and 2019 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,007&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,693&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzItMS0xLTEtMA_22137c0b-67d4-4b72-8b18-e6663916339f"
      unitRef="usd">4029000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzItMy0xLTEtMA_4b0ea691-be3f-42d4-a66d-1eb6d34701e5"
      unitRef="usd">3815000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzMtMS0xLTEtMA_39ced303-3410-4d36-9ef6-0644d933673c"
      unitRef="usd">219000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzMtMy0xLTEtMA_f73abc2b-5b4e-464f-960a-a570fc1412f2"
      unitRef="usd">517000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzQtMS0xLTEtMA_b7467f45-8871-4358-b32c-130f501e04eb"
      unitRef="usd">652000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzQtMy0xLTEtMA_a03cad82-c444-4f9f-8c8a-c5765d96aca4"
      unitRef="usd">1047000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzUtMS0xLTEtMA_a6e05df0-94b2-4e52-8f12-2a569cdc65ee"
      unitRef="usd">-274000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzUtMy0xLTEtMA_0658954b-20af-4c55-be2c-d2e19635159e"
      unitRef="usd">-259000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzYtMS0xLTEtMA_7e69f16f-fc31-4826-a427-ab9a60a21aae"
      unitRef="usd">-787000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzYtMy0xLTEtMA_1eb2477c-91ce-42a7-9730-0958edbb59f1"
      unitRef="usd">-65000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzctMS0xLTEtMA_ce1e6b0e-44e8-49dd-8ef4-19b80c189213"
      unitRef="usd">102000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzctMy0xLTEtMA_5e1d4cdc-13cd-4789-a03c-f82c3ad8c8e7"
      unitRef="usd">-602000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzgtMS0xLTEtMA_6b85e1cf-89df-4437-a36a-c89ad0359496"
      unitRef="usd">4007000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3YmIyNTY2NDk4NjA0Y2QxODZjYjBkNDYxNjIwYjQyNy90YWJsZXJhbmdlOjdiYjI1NjY0OTg2MDRjZDE4NmNiMGQ0NjE2MjBiNDI3XzgtMy0xLTEtMA_07269d7e-c78f-43f7-bb9b-8f598b65c1f9"
      unitRef="usd">3693000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3NzE_c77e2ff1-ae7c-414f-aca5-b45336a2b5cb">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzItMS0xLTEtMA_2e81e4e6-56d3-4428-a85e-fd3b87358d12"
      unitRef="number">0.0034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzItMy0xLTEtMA_ebe59253-6a76-4443-8c47-9aa8ff2b906c"
      unitRef="number">0.0040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzMtMS0xLTEtMA_ee8a38c4-1f49-4002-9eeb-0763d1944b11"
      unitRef="number">0.0204</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzMtMy0xLTEtMA_8aee8c5f-d3ad-4a71-9971-ece7bfb76a4d"
      unitRef="number">0.0333</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzQtMS0xLTEtMA_0f652305-8766-4258-a223-d94155fb459d"
      unitRef="number">0.0214</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzQtMy0xLTEtMA_a90f6d1b-4400-4a0d-8fff-38e7da881fb8"
      unitRef="number">0.0225</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzUtMS0xLTEtMTM0MjM_bc22d1a8-c291-47ed-9011-c7d3e2e1405e"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjOWMxYmYyY2I4M2U0YTY2OWM5MGMyYTA4Nzg3MTFjNC90YWJsZXJhbmdlOmM5YzFiZjJjYjgzZTRhNjY5YzkwYzJhMDg3ODcxMWM0XzUtMy0xLTEtMTM0MTk_2a43d7bc-39ba-4cf2-822e-061dd32bf005"
      unitRef="number">0.0093</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3NzI_6134e1ae-37d7-4398-beb1-47c5a644bf53">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2020 and 2019 and a reconciliation of the funded status at December&#160;31, 2020 and 2019, respectively (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plans transferred in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,770&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzMtMS0xLTEtMA_25346944-77e1-414b-829c-65f66424fc0f"
      unitRef="usd">66972000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzMtMy0xLTEtMA_8787cf4f-2661-4ab3-b6ad-6f6135f70dd0"
      unitRef="usd">52542000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzQtMS0xLTEtMA_f76c20ba-047e-4bb7-8646-f3a6ce076928"
      unitRef="usd">219000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzQtMy0xLTEtMA_5ded70ef-c602-44d3-b3ce-11f765135d92"
      unitRef="usd">517000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzUtMS0xLTEtMA_2645be35-fa1a-4f3d-9edf-5233acd66053"
      unitRef="usd">4029000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzUtMy0xLTEtMA_0bba8483-f3e8-43cd-b7cd-e3481c80a17e"
      unitRef="usd">3815000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzYtMS0xLTEtMA_c5003501-b04b-4487-81f5-c89fc3841cd1"
      unitRef="usd">-3347000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzYtMy0xLTEtMA_0cc0198f-2855-49fc-89eb-216272408b87"
      unitRef="usd">12188000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzctMS0xLTEtMA_139747c5-221d-4ba8-9c1d-1234372613e5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzctMy0xLTEtMA_f8f6532b-a4d1-421e-a707-921637d7b8b0"
      unitRef="usd">-3133000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzgtMS0xLTEtMA_803c2bf7-3c5b-4cd3-8a93-d64daccb2c8d"
      unitRef="usd">77000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzgtMy0xLTEtMA_45f52811-ab7b-4a5b-9be5-80a822a7926e"
      unitRef="usd">2664000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzktMS0xLTEtMA_02144e75-bcc8-4ac8-972c-1558c94c72e0"
      unitRef="usd">883000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzktMy0xLTEtMA_b2b4cd0b-b124-4da7-af4b-08491a5c3097"
      unitRef="usd">899000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEwLTEtMS0xLTA_6cd3fa0d-16b4-4310-b94e-4c037fa4f4c4"
      unitRef="usd">388000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEwLTMtMS0xLTA_c46b3572-bbac-4a9e-9a76-da9517b28a79"
      unitRef="usd">395000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEyLTEtMS0xLTA_0d186f13-07f0-4d7e-89e1-b61a7f00be9e"
      unitRef="usd">1537000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEyLTMtMS0xLTA_f5404e7c-a387-46b3-aa24-1d21afcb38a2"
      unitRef="usd">635000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEzLTEtMS0xLTA_2087c91c-46aa-41f8-88fc-4b280c4d449e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzEzLTMtMS0xLTA_4ddc25dd-06f0-48a1-81a4-275b280c28a2"
      unitRef="usd">3199000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE0LTEtMS0xLTA_814b8aef-d19c-49f0-9e9a-a7f7fc85a215"
      unitRef="usd">6115000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE0LTMtMS0xLTA_dc4e426b-3d38-4657-8dc7-e5dde27f059c"
      unitRef="usd">639000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE1LTEtMS0xLTA_ac986235-526a-49d7-a0d3-c2c330a419d5"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzE1LTMtMS0xLTA_4c5c40e2-483b-4c04-b4bc-d2deaece9699"
      unitRef="usd">66972000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIwLTEtMS0xLTA_717bde07-cc69-4554-86e4-fba10e02ae83"
      unitRef="usd">30770000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIwLTMtMS0xLTA_1d484032-828b-4e21-b383-72f443a13e61"
      unitRef="usd">31103000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIxLTEtMS0xLTA_1ec4bf87-7a98-414f-9828-11c13fe71714"
      unitRef="usd">2882000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIxLTMtMS0xLTA_522b91c5-cb8e-4d20-82d3-042f2abc7ca6"
      unitRef="usd">-152000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIyLTEtMS0xLTA_504960b1-dee6-4428-9a99-fdce645cc5ae"
      unitRef="usd">2274000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIyLTMtMS0xLTA_7cca303f-ae4a-4d02-a4ca-f5073391f4cf"
      unitRef="usd">2189000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIzLTEtMS0xLTA_4f50e7c0-cded-4843-9db5-2a4f46fe9b8b"
      unitRef="usd">883000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzIzLTMtMS0xLTA_241b00d9-a6b2-4976-af5d-7104dc39239a"
      unitRef="usd">899000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI0LTEtMS0xLTA_cf75eda0-1de5-4228-817b-262695e4a3ec"
      unitRef="usd">56000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI0LTMtMS0xLTA_f637e193-b1cf-4d0f-8f69-5492d73804ba"
      unitRef="usd">2645000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI1LTEtMS0xLTA_8996872c-cbd0-42b1-b908-6d635693c20a"
      unitRef="usd">1537000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI1LTMtMS0xLTA_6ab09d50-c160-4fcc-a304-398fa6fc12cc"
      unitRef="usd">635000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI2LTEtMS0xLTA_ed671f10-9465-420a-a98e-e7115cab06e8"
      unitRef="usd">388000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI2LTMtMS0xLTA_a08d9855-92d0-4bf4-aaf7-c1154f2ef7c3"
      unitRef="usd">395000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI4LTEtMS0xLTA_2be1b5f5-6c64-431d-8fd2-a7d0492c1f1b"
      unitRef="usd">2997000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI4LTMtMS0xLTA_6876ce65-b3e7-4109-9250-b9418c04367f"
      unitRef="usd">406000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI5LTEtMS0xLTA_16e28dc6-0256-446e-a00a-19a117c94a5d"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTpjYjVmZTcxZmRmMGE0ZGQ1ODNiZGIzZGM1OTljODA2Yy90YWJsZXJhbmdlOmNiNWZlNzFmZGYwYTRkZDU4M2JkYjNkYzU5OWM4MDZjXzI5LTMtMS0xLTA_3204f338-77fc-4457-b92b-fd7071b8bf83"
      unitRef="usd">30770000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ4MDM_85634d97-107e-4445-b47d-8dc7acbf2e99">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzMtMS0xLTEtMA_ad297ab0-48e6-4558-9ed7-b0d270b41b93"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzMtMy0xLTEtMA_3f389333-f256-4447-962b-676341f8d94c"
      unitRef="usd">30770000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzQtMS0xLTEtMA_7f6a0147-49bc-42ac-9c30-45e552e0edef"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzQtMy0xLTEtMA_f603c5ab-c625-4ea7-94d6-be9130bf4741"
      unitRef="usd">66972000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzUtMS0xLTEtMA_e31def0a-d7be-4d1b-9237-1899e0b39ff0"
      unitRef="usd">-35044000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZToyY2YwZTkzMDQ3MmY0MWNmOWE1NzQyNTA2NmQxZTg2Yi90YWJsZXJhbmdlOjJjZjBlOTMwNDcyZjQxY2Y5YTU3NDI1MDY2ZDFlODZiXzUtMy0xLTEtMA_ed6cd6b7-e171-4781-bc3d-0b9cef27f3ca"
      unitRef="usd">-36202000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzIxMDE_3b55e470-2a90-4aa9-ae3d-b79b98766fc3"
      unitRef="usd">4600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzIxMDg_a98276d9-dacb-46c5-9150-e2283d46ae21"
      unitRef="usd">-9000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzI1NzY_acc67cd8-7c26-4e3b-8a9d-c6ceb4ae6f34"
      unitRef="usd">61500000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzI1ODM_8e570225-f53a-41a5-8cd3-b97570ebc074"
      unitRef="usd">61100000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i64e70f4e6a1b48118ea9ee130e1f63ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQwMjY_5f1eca4d-6e85-4d08-920b-706a519282d9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQwNTQ_991d3739-a7d3-4350-a9ab-22083ebfd89a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ3OTY_e4d0aa3c-7ebc-40de-a810-01cfc9e77fb5">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzItMS0xLTEtMA_7a6db061-08eb-464f-9925-73a3f04ca56d"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzMtMS0xLTEtMA_a441fed0-07fa-4a64-a828-fd6a1e99e47e"
      unitRef="usd">1626000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzQtMS0xLTEtMA_0a32702b-c700-44c7-9d61-0d0d81a9231f"
      unitRef="usd">1694000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzUtMS0xLTEtMA_4382075b-ec92-47b2-9ff0-dabe30093631"
      unitRef="usd">1789000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzYtMS0xLTEtMA_4ebb2355-1ab1-43f7-be23-6cd58230ccf9"
      unitRef="usd">2101000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90YWJsZTo3ZDcwZjI1NDA5ZTc0MTZiYTg0OTY5ODBjYTJkYWIwZi90YWJsZXJhbmdlOjdkNzBmMjU0MDllNzQxNmJhODQ5Njk4MGNhMmRhYjBmXzctMS0xLTEtMA_72d6237c-ef99-4fa3-be5f-e506a7855cd3"
      unitRef="usd">10429000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQyOTU_914f04cf-fcea-4f05-964f-c3d62bd0f88d"
      unitRef="usd">2300000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2ODc_45b91653-0c80-450c-9b71-384aa4c07ab4"
      unitRef="usd">6700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2OTE_f4b881c7-f21e-4557-a6b7-4b3a5420f234"
      unitRef="usd">8600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzQ2OTg_75799115-f01c-48de-8965-435accfc1323"
      unitRef="usd">8100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDIvZnJhZzpjOTIwMDY0NGZhNDI0M2U1YTQzYzg0ZWNhMGY1OWNiNi90ZXh0cmVnaW9uOmM5MjAwNjQ0ZmE0MjQzZTVhNDNjODRlY2EwZjU5Y2I2XzEzNzQzODk1MzUzMzYw_7c200354-2e86-4549-a10c-dea4b6a41acd"
      unitRef="usd">2000000.0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMjM_da51f7fd-9ae5-4471-999d-8f8105708570">LEASES AND RELATED PARTY LEASES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2020. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expense for the year ended December&#160;31, 2020 and December 31, 2019, was $19.7 million and $19.6&#160;million, respectively, which includes $0.3 million, in related party operating lease expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows for the year ended December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no future minimum lease payments under finance leases at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#x2019;s former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <iart:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzUxMw_3bcaf657-5670-49f4-9c82-249fba3eb800"
      unitRef="renewal_option">1</iart:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:OperatingLeaseExpense
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNDc_6922e510-dce0-4815-820b-b825dd48bb3d"
      unitRef="usd">19700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMyOTg1MzQ4ODc4NjM_73a967d8-754b-4c21-8dc0-6e47576efc16"
      unitRef="usd">19600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNjY_9cb1cf29-748e-412f-b84d-58b8df6f4565"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i6445287799cf40d983f351dc75cf6a15_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzEyNjY_e32e2763-0f5e-473d-b13c-22b64a2d9657"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <iart:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMTQ_c58c6db5-aa3f-49b7-bfdd-d22382e2a350">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzMtNS0xLTEtMA_41560786-7b9c-4386-b952-df92dfe39f68"
      unitRef="usd">83635000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzMtNy0xLTEtMTU1OTU_6807db6f-9f77-4c5d-85ec-087e347e4181"
      unitRef="usd">94530000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzUtNS0xLTEtMA_c5c4fa3c-8c0b-464b-8027-cfdefb74366b"
      unitRef="usd">12818000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzUtNy0xLTEtMTU2MDE_21143301-d1a2-4811-bd08-ec0121f808aa"
      unitRef="usd">12253000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzYtNS0xLTEtMA_d4ebc41c-9c81-4481-a732-aee1c262f826"
      unitRef="usd">88118000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzYtNy0xLTEtMTU2MDE_0271648e-72e9-43ef-a200-68d57c950d24"
      unitRef="usd">97504000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzctNS0xLTEtMA_62b87288-a7fd-4492-bd31-f8948b144235"
      unitRef="usd">100936000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzctNy0xLTEtMTY3ODA_bec8b249-8c8e-4493-ab96-4c68465fbcea"
      unitRef="usd">109757000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i328cafabba8048a388b6e3eaae3d3c02_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzExLTUtMS0xLTA_faa72b1c-d55a-4505-a395-6553781c4668">P11Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i87b5e7d299f74563945c1f633f7076ef_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzExLTctMS0xLTE1NjA4_4a5c4a5a-1ef8-4b49-a7db-0edd6371fe10">P12Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifc6918309ec745bfa72b3ffa07503e44_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzEyLTUtMS0xLTA_1b2e54fe-2de2-43e4-b041-3d4862820f36">P2Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i318233f5e7da424d999484de82e6a8ca_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzEyLTctMS0xLTE1NjE1_1325a24b-8690-4919-af8e-d358fba22539">P2Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i328cafabba8048a388b6e3eaae3d3c02_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE1LTUtMS0xLTA_bf803ed4-dbad-4d1b-9600-f6a6dcd65451"
      unitRef="number">0.046</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i87b5e7d299f74563945c1f633f7076ef_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE1LTctMS0xLTE1NjIw_f74c5cdf-9ee9-4a42-8367-41c05f729373"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ifc6918309ec745bfa72b3ffa07503e44_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE2LTUtMS0xLTA_e78b03e3-e082-4486-bb2e-8fbb2cddd5cb"
      unitRef="number">0.023</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i318233f5e7da424d999484de82e6a8ca_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTphZjA0Y2RkY2FhN2E0NmVhOTBmNjk0YTg2ZjkzYjA4MC90YWJsZXJhbmdlOmFmMDRjZGRjYWE3YTQ2ZWE5MGY2OTRhODZmOTNiMDgwXzE2LTctMS0xLTE1NjIw_c16c11ca-e19b-4e1e-8ae9-d24a888cdc39"
      unitRef="number">0.032</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <iart:CashFlowLesseeTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMzU_8228344e-ef96-419d-9342-e76e7a8604c1">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows for the year ended December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:CashFlowLesseeTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzMtMS0xLTEtMA_d02b92b8-509f-4bb8-839b-ac3a62fe0911"
      unitRef="usd">15226000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzMtMy0xLTEtMTU1MzE_55246986-5ca6-490c-8ab2-227cc9b5696f"
      unitRef="usd">11469000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzYtMS0xLTEtMA_e6d928d5-d191-4bfc-bad7-fbfbef4664b2"
      unitRef="usd">6027000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZToyZTEwOWViNTUzMTY0ODVhYWI2YjRlZjA5M2M3OWEzYS90YWJsZXJhbmdlOjJlMTA5ZWI1NTMxNjQ4NWFhYjZiNGVmMDkzYzc5YTNhXzYtMy0xLTEtMTU1Mzc_af5d98d4-b90b-4f9e-b034-a91b8b6f677a"
      unitRef="usd">41423000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMjY_0c87dcb2-1734-43e2-971e-19b8ad2c3c47">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItMS0xLTEtMA_de5eb68a-daa1-471c-9da2-fb4f90e5992a"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItMy0xLTEtMA_439e873a-fc5b-4e8f-8b00-06071bd94172"
      unitRef="usd">13458000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzItNS0xLTEtMA_a6740db1-1a2a-460c-b255-2b6780ae6e57"
      unitRef="usd">13754000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtMS0xLTEtMA_99442233-cefc-4747-93ab-33f57823149c"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtMy0xLTEtMA_8a9872e2-b54d-43b7-b583-a0a1f36be993"
      unitRef="usd">13992000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzMtNS0xLTEtMA_f18e87ba-a962-4912-b581-e681d7a4207c"
      unitRef="usd">14288000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtMS0xLTEtMA_0ba28bf5-e7b1-4bfb-9175-96ea26359921"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtMy0xLTEtMA_c5a5ca8f-af5f-42a8-bf8a-6e84e3e0496e"
      unitRef="usd">11054000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzQtNS0xLTEtMA_2065be10-a977-490e-9101-8a77158c61cc"
      unitRef="usd">11350000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtMS0xLTEtMA_4f081e1a-ad57-4a7a-bdce-5ffa3af9c010"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtMy0xLTEtMA_deb71163-17cb-4b80-8956-1d38f6b10acd"
      unitRef="usd">10254000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzUtNS0xLTEtMA_a32da338-7d3b-42f3-a239-ee2782b0c403"
      unitRef="usd">10550000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtMS0xLTEtMA_556f5f86-dd71-4b9a-a9f0-db4e347533f8"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtMy0xLTEtMA_02ff429f-8e30-4530-be33-3084dbf99c4f"
      unitRef="usd">9645000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzYtNS0xLTEtMA_f3bc9c70-6757-4513-bb07-bf959f4c6705"
      unitRef="usd">9941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctMS0xLTEtMA_b6c25d3f-e57e-41d0-80d0-fbf79ef5f689"
      unitRef="usd">1130000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctMy0xLTEtMA_e7d2300c-6849-4b1a-b137-9af78a29d181"
      unitRef="usd">77784000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzctNS0xLTEtMA_d0f019e7-0df7-4cab-a82d-ed1efe9cf213"
      unitRef="usd">78914000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ic1747a2e124d4e99bb909cc9389b61af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtMS0xLTEtMA_5e5cef14-f12c-442e-8d99-a377c699b00a"
      unitRef="usd">2610000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iee52a1107e0348d3bebdc40d768c9567_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtMy0xLTEtMA_6a68c146-d588-460c-84fe-c4b7c1c2b41f"
      unitRef="usd">136187000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzgtNS0xLTEtMA_24949ea3-ef1a-490e-8568-d696f4106433"
      unitRef="usd">138797000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzktNS0xLTEtMA_32ee93d6-2b2c-4f0a-b7a2-8e684dfcb619"
      unitRef="usd">37861000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzEwLTUtMS0xLTA_bdbb4480-b07a-4a90-b084-85b55c75be5d"
      unitRef="usd">100936000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzExLTUtMS0xLTA_c5c4fa3c-8c0b-464b-8027-cfdefb74366b"
      unitRef="usd">12818000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90YWJsZTowZjc1ZTE0YTExZTM0ZDM0OGY5NWY4YjdiNGVmNDVlNS90YWJsZXJhbmdlOjBmNzVlMTRhMTFlMzRkMzQ4Zjk1ZjhiN2I0ZWY0NWU1XzEyLTUtMS0xLTA_d4ebc41c-9c81-4481-a732-aee1c262f826"
      unitRef="usd">88118000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzE2MDI_3376bce0-65c7-422e-a0a5-47c2c44a9fd2"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector
      contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzIzNzI_b7a3aacb-ce7a-4922-af02-897bbbb2c517"
      unitRef="number">0.50</iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector>
    <iart:AnnualRateOfLeaseAgreement
      contextRef="i4b1e1b9215a448b48d1f5502765dee58_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI2NDI_7470192e-1093-4da9-ad32-ecaaaa8f6617"
      unitRef="usd">300000</iart:AnnualRateOfLeaseAgreement>
    <iart:OptionToExtendLeaseYears
      contextRef="icd913cb502474113a910bca29ccf36d3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI3MDM_5de3a0e4-3733-40df-97c1-843ddc6d66e7">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="icd913cb502474113a910bca29ccf36d3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMzE_022c5d69-4e3c-48da-8021-217eb091db33">November 1, 2029 through October 31, 2034</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <iart:OptionToExtendLeaseYears
      contextRef="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzI4NzQ_482fcb1b-171b-4e3f-993f-e48dac67b501">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="iaa0ac2369381479dafc57859ee7e56e7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMDUvZnJhZzpkNDRmYWJmNzhjNGY0YzI4YTMwMDRiYmIwN2JhMDAxMC90ZXh0cmVnaW9uOmQ0NGZhYmY3OGM0ZjRjMjhhMzAwNGJiYjA3YmEwMDEwXzMwMTk_36c2feb9-73c2-497c-98a2-d9fb9002266d">November 1, 2034 through October 31, 2039</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MjU_f965751f-37b8-4164-bd64-979976f95281">INCOME TAXES&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (Loss) before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; 2017 U.S. Tax Act was signed into law on December 22, 2017. The 2017 Tax Act made significant changes to the previous tax law, which included the reduction of the federal statutory rate from 35% to 21% and the recognition of a one-time repatriation tax on accumulated untaxed earnings of foreign subsidiaries. As of December 31, 2018, the Company finalized its calculations and completed its accounting for the income tax effect of the 2017 Tax Act, for which the finalization adjustments recognized during 2018 were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A number of these provisions continue to have an impact on our effective tax rate, including limitations on the deductibility of executive compensation and the elimination of certain tax deductions. Additionally, the implementation of a territorial tax system, which subjects certain foreign earnings to additional taxation as global intangible low-taxed income, continues to adversely affect income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Changes in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Carryback of Federal net operating loss ("NOL")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Swiss tax holiday&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign-Derived Intangible Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Transfer of Intra-entity of certain intellectual property - Rate Differential &lt;br/&gt;on FMV Step-Up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Assets held for sale - Outside Basis Difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our effective tax rate was (43.2)% and 16.5% of income before income taxes for the years ended December&#160;31, 2020 and December 31, 2019, respectively. In 2020, the Company&#x2019;s lower worldwide effective tax rate, as compared to 2019, is primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 is 20.2%.      &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#x2019;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;mpany recorded a $59.2&#160;million  deferred tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in Switzerland related to the amortizable tax basis in the transferred intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2020, the Company&#x2019;s foreign operations generated a $48.2&#160;million decrease in income tax expense when compared to the same period in 2019, because of the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (57.1)%, compared to 3.5% in 2019. The Company&#x2019;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2019, the Company's foreign operations generated a $5.7 million decrease in income tax expense when compared with 2018, because of geographic and business mix of taxable earnings and losses, among other factors. The 2019 foreign effective tax rate is 3.5%, compared to 11.6% in 2018. The Company's foreign tax rate is primarily based upon statutory rates and is also impacted by the tax holiday in Switzerland, described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $12.1 million ($0.14 per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period amounts were reclassified as it relates to Leases and Other between deferred tax asset and liabilities within this table to conform to the current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company had net operating loss carryforwards of $90.2 million for federal income tax purposes, $36.7 million for foreign income tax purposes and $41.6 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $11.8 million have an indefinite carry forward period. For foreign net operating loss carryforwards, $0.3 million expire through 2025, and the remaining $36.4 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s valuation allowance increased by less than $0.1 million, increased by $2.9 million and decreased by $1.0 million at December 31, 2020, 2019 and 2018, respectively. The 2020 valuation allowance primarily remained unchanged from the prior period.The 2019 overall increase in the valuation allowance primarily resulted from certain assets from the Rebound and Arkis acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested.&#160;Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Statute of limitations lapses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $0.7 million of the balance at December&#160;31, 2020 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are no amounts within the balance of uncertain tax positions at December&#160;31, 2020 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2020, 2019 and 2018. The Company had minimal interest and penalties accrued for the years ended December 31, 2020 and 2019 and 2018. &lt;/span&gt;&lt;/div&gt;The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2016. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MDc_bf2ba32b-87e0-4686-b4d6-f50105b4e5f0">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (Loss) before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtMS0xLTEtMA_390db7a3-4f5b-4767-a9f5-85b84d5755a8"
      unitRef="usd">15082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtMy0xLTEtMA_85d61a7a-83fc-44bb-b471-6d772abed001"
      unitRef="usd">-38359000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzMtNS0xLTEtMA_14d22901-dc26-4efc-851b-3fb9a332be40"
      unitRef="usd">-21218000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtMS0xLTEtMA_79a4751e-f664-4ffc-89dc-55e5dffcb27e"
      unitRef="usd">78438000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtMy0xLTEtMA_296784ac-66da-4ad4-a324-e2921fc246f4"
      unitRef="usd">98463000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzQtNS0xLTEtMA_74a8b9c1-c7cc-42c2-a6d6-3dcd4e57a2a0"
      unitRef="usd">78621000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtMS0xLTEtMA_aacf195b-229c-4fa9-b848-e47e188f9f91"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtMy0xLTEtMA_78fa880b-4f0c-4183-a565-093f36280346"
      unitRef="usd">60104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTpiZmIwN2M4NGU0MWM0NWY5OThlZjkyN2M1ZTE3MjJmOC90YWJsZXJhbmdlOmJmYjA3Yzg0ZTQxYzQ1Zjk5OGVmOTI3YzVlMTcyMmY4XzUtNS0xLTEtMA_929eff5d-2ce8-4b7c-aabd-c7c22410b810"
      unitRef="usd">57403000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc4OTU_02a71051-4e14-4979-88a1-e7c34108722f">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Changes in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Carryback of Federal net operating loss ("NOL")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Swiss tax holiday&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign-Derived Intangible Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Transfer of Intra-entity of certain intellectual property - Rate Differential &lt;br/&gt;on FMV Step-Up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Assets held for sale - Outside Basis Difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItMS0xLTEtMA_26d08af3-f905-40e8-9c1b-e911a5691b84"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItMy0xLTEtMA_ceac2b7e-4464-4443-8fe2-7ed81cfb7793"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzItNS0xLTEtMA_cd36cd1b-31b5-4615-aa1f-c6ec9e17fde9"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtMS0xLTEtMA_5fd67e09-8e7c-477a-b8dd-ca2909193402"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtMy0xLTEtMA_e2f11a8f-504d-4359-b9a5-f568581f78d4"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzQtNS0xLTEtMA_377589da-eb8c-4fdf-ae33-a20df4e21006"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtMS0xLTEtMA_5f788583-6d61-4455-b183-466559648ef8"
      unitRef="number">-0.079</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtMy0xLTEtMA_de0e68ec-2269-412e-9cc8-64744335bb1c"
      unitRef="number">-0.200</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzUtNS0xLTEtMA_8a098eed-7161-4fee-8601-fd1d3af35288"
      unitRef="number">-0.218</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctMS0xLTEtMA_8afdea85-4ec0-4fef-9bf4-147e84ac5958"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctMy0xLTEtMA_921884fc-4dde-4104-8b55-8675eedca419"
      unitRef="number">-0.056</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzctNS0xLTEtMA_8239d47a-0e6e-42cb-88b7-33c1c31ce963"
      unitRef="number">-0.078</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtMS0xLTEtMA_066badba-87f8-4715-ab6f-18e222927d5f"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtMy0xLTEtMA_ae8d4473-2956-48ec-a650-d9be9b5ddbf6"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzgtNS0xLTEtMA_0cf24ba4-1388-45cb-94f2-152e5f23f341"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktMS0xLTEtMA_a4f1b14a-d950-48f0-9c8c-c0ed0f111d09"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktMy0xLTEtMA_96409842-18c5-4ece-b35d-5f9d388d4cfa"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzktNS0xLTEtMA_64e86161-2f7f-48a9-a589-7a604a0fbc8e"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTEtMS0xLTA_df6c0143-8035-4965-902e-75accf3b4540"
      unitRef="number">-0.012</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTMtMS0xLTA_617f2141-043a-434a-93ed-f738582d9f81"
      unitRef="number">-0.012</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzExLTUtMS0xLTA_00fc05fc-6fc7-4362-b121-95904ba09bc1"
      unitRef="number">-0.062</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTEtMS0xLTA_57fbc99c-adc7-4d7c-ba2e-8a9d8af9dec7"
      unitRef="number">0.014</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTMtMS0xLTA_30029484-1725-4100-9b11-0900a9e3ce3d"
      unitRef="number">0.008</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEyLTUtMS0xLTA_fd84c1d5-5ee8-427c-8787-72ad3505e162"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTEtMS0xLTA_ba0c1c29-ace8-4292-aebe-dc3bb9fc2067"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTMtMS0xLTA_f5372dbb-e909-47ed-aa2f-d613a6100f0e"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzEzLTUtMS0xLTA_a6087d4b-d4a2-4263-aa60-22bb49548fc2"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTEtMS0xLTA_2835d5de-4125-4793-a043-c8b29479fb7b"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTMtMS0xLTA_d75bae3c-052d-4f1b-a73c-f099bbd7248e"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE0LTUtMS0xLTA_50377307-ba20-4292-82d9-cfc96eb76975"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTEtMS0xLTA_581d1730-8d28-4f4f-b614-c4f07720ebff"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTMtMS0xLTA_f763b7c3-a84f-4539-9376-93264537db73"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE1LTUtMS0xLTA_1e738de6-38ba-4cd0-beaa-870d624e829c"
      unitRef="number">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTEtMS0xLTA_32989e5b-a60c-474b-8fd8-5db0ca53f9d9"
      unitRef="number">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTMtMS0xLTA_0658e283-f468-4b3e-85e6-84e050a9eb52"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE2LTUtMS0xLTA_5450ae7e-3d48-4651-9bc6-d1c84857cb4e"
      unitRef="number">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTEtMS0xLTA_637c3832-57a0-4e6d-9a66-df9f77d792e4"
      unitRef="number">0.025</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTMtMS0xLTA_d5ad7705-bc9a-4e80-a4b5-4756dd258f20"
      unitRef="number">0.076</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE3LTUtMS0xLTA_11a90587-310d-4cb1-ae1f-41f7ef39eb79"
      unitRef="number">0.035</iart:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTEtMS0xLTA_61e4f09f-871d-4aff-b9f2-a42f681e2cb0"
      unitRef="number">0.024</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTMtMS0xLTA_2a443df3-63bf-40fd-8833-b733ba28d7e9"
      unitRef="number">0.030</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE4LTUtMS0xLTA_b585e196-6a02-47f6-bb52-2b3ebd2bc1b1"
      unitRef="number">0.016</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTEtMS0xLTA_25ecc264-2b08-49f3-84f3-2dfb95831ca5"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent>
    <iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTMtMS0xLTA_50aa5c0d-6480-48d7-bd2b-ab0a611dad1b"
      unitRef="number">0.001</iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent>
    <iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzE5LTUtMS0xLTA_f7859403-797a-4d7a-bf1f-cab7239c6911"
      unitRef="number">-0.037</iart:EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTEtMS0xLTA_20e43678-6cc5-4416-a0a7-a8bca36a6603"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTMtMS0xLTA_0038465b-3ffe-4ef5-8ee9-9de76b22ea47"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIwLTUtMS0xLTA_37f9eeb0-493a-4510-9d44-6f8bd8192075"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTEtMS0xLTA_6440e7f6-816d-4410-b81a-9379f5a5028a"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTMtMS0xLTA_1640cefd-3cd5-4bdc-a286-07431fb05c4b"
      unitRef="number">0.157</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIxLTUtMS0xLTA_10b98776-9a37-4468-b3ea-1c6044a8fe15"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxHolidays>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTEtMS0xLTA_cfed1dc7-8b8c-4c33-948d-2f2abbed5e3d"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTMtMS0xLTA_27933e6f-a16a-49b8-9c6a-bf17310fbdda"
      unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzIyLTUtMS0xLTA_cc485312-78e4-4fcd-8a04-9640c47cacf9"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTEtMS0xLTE3MDQw_f1cf2f6c-f71c-4d73-a576-cdc9348c7ff0"
      unitRef="number">-0.008</iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTMtMS0xLTE3MDUz_519e1296-a493-410a-a1bc-284a8f97650a"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTUtMS0xLTE3MDU3_6549f14d-c971-446f-a155-a536aec9184f"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTEtMS0xLTE3MDQw_2a21c146-dba1-40bb-ad01-629b3904b567"
      unitRef="number">-0.633</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTMtMS0xLTE3MDUz_44920e3c-970c-4d9f-92fe-817428cf3dc6"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI3LTUtMS0xLTE3MDU3_e4c3e800-278c-45f7-83c3-f49b7937b74f"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTEtMS0xLTE3MDQw_1c41d2c5-331a-492b-baf9-4a2d7f724ebf"
      unitRef="number">0.028</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTMtMS0xLTE3MDUz_6bb1bc2c-536b-4023-bf16-87b65fb41fbe"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI4LTUtMS0xLTE3MDU3_aea23ee7-133a-4d93-8844-0c6fdbb021f5"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTEtMS0xLTA_d778e2c7-631c-4a29-93d8-f70bd6d78c0f"
      unitRef="number">-0.432</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTMtMS0xLTA_803aa9be-d100-4d23-a779-6ac2b7479c8e"
      unitRef="number">0.165</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo4NjRkNjA5YzQzN2U0MDEyOGUxMmMzNWNmMWFmMDliYy90YWJsZXJhbmdlOjg2NGQ2MDljNDM3ZTQwMTI4ZTEyYzM1Y2YxYWYwOWJjXzI2LTUtMS0xLTA_ab2259e7-6ed9-41c3-9e3b-9f531f89824c"
      unitRef="number">-0.059</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzU5MzQ2_d778e2c7-631c-4a29-93d8-f70bd6d78c0f"
      unitRef="number">-0.432</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzE5Mzk_5a50c627-0f43-4a86-8fc8-ab32bf794a0c"
      unitRef="number">0.165</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NjQ5_b045c2bb-0f1f-4324-b1fe-7842dbafe1a8"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ5NDc4MDIzNTIxMzU_6e7696e6-f19e-4be5-9067-1852cb6088c4"
      unitRef="number">0.202</iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="i0506efb6e60a43dc9e261858a7124158_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NjM0_2c56e847-342b-4f8c-99f1-c2dad10d0d91"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0Njgx_dad7dabf-899c-4d1e-86e7-324b8659bbce"
      unitRef="usd">-48200000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0Njk2_e14e6ae4-fb08-427a-bbc5-e4fe1dce79c4"
      unitRef="number">-0.571</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzEzNzQzODk1MzY0NzA1_3471c0a8-6079-40bc-b501-15387fa344b2"
      unitRef="number">0.035</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI2NzU_01669a3a-55d8-4c89-a284-0dd467a852bf"
      unitRef="usd">-5700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI4NjY_faeff55d-60ed-4103-a9fd-122464e7223a"
      unitRef="number">0.035</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzI4ODI_13d667fb-9a58-4257-aed2-1c6139129620"
      unitRef="number">0.116</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="id99ba8984a21448d9a3835880d4febea_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzMyMzE_025856b1-d06e-4fd8-bedb-fa773d93f49e"
      unitRef="usd">12100000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare
      contextRef="id99ba8984a21448d9a3835880d4febea_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzMyMzU_91766bcb-becf-4337-a970-bc239a7dbeea"
      unitRef="usdPerShare">0.14</iart:EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc4OTY_993d00e1-1044-4ad7-89ba-697ed71be370">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtMS0xLTEtMA_de3fe93f-bb9f-4761-880c-9d233da629c3"
      unitRef="usd">6184000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtMy0xLTEtMA_27b8cd1b-0031-40c1-a894-442fa2fabf0f"
      unitRef="usd">14597000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzQtNS0xLTEtMA_89118acf-0bf0-46b3-98ab-c52fb1ecddc4"
      unitRef="usd">-3880000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtMS0xLTEtMA_f2d8ac74-a481-441e-8c58-6e96c69399f1"
      unitRef="usd">5029000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtMy0xLTEtMA_375cbbb7-c949-4855-83fc-314187dee567"
      unitRef="usd">3447000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzUtNS0xLTEtMA_4fba4e24-a30e-4d6a-b68e-7cd6a19df3fd"
      unitRef="usd">1609000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtMS0xLTEtMA_6c63bd38-83e4-4cac-9fa0-f049b54f9d32"
      unitRef="usd">12553000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtMy0xLTEtMA_1bc31ca6-e8ab-4817-b43a-224cc9a6eaab"
      unitRef="usd">10905000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzYtNS0xLTEtMA_1f79924a-7223-44c1-b47a-bb11f3eff929"
      unitRef="usd">7057000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctMS0xLTEtMA_e6422950-fe47-4212-b23c-ac8428bf14da"
      unitRef="usd">23766000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctMy0xLTEtMA_e2efed82-bfd0-44f9-b803-4549cb21637b"
      unitRef="usd">28949000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzctNS0xLTEtMA_2249065c-16a0-4a03-bb72-8044ea4ac5f6"
      unitRef="usd">4786000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktMS0xLTEtMA_0d457008-d2c0-4d7e-991a-b22841368284"
      unitRef="usd">-5079000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktMy0xLTEtMA_d19471ac-9d03-4708-b471-f6c5ee74e5ec"
      unitRef="usd">-10889000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzktNS0xLTEtMA_9badc71c-c3f8-4185-a6e7-4d2049cd125d"
      unitRef="usd">-7202000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTEtMS0xLTA_4bb8b68e-09aa-4337-b9e8-4612f3f96512"
      unitRef="usd">-1760000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTMtMS0xLTA_b3ca2f9a-3ecb-433a-aace-3a0a1da0e350"
      unitRef="usd">-666000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEwLTUtMS0xLTA_1d0f4650-5906-4496-a918-d56763559fd3"
      unitRef="usd">-3048000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTEtMS0xLTA_2de17f9b-1eca-4393-a483-8ce65629f3ce"
      unitRef="usd">-57299000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTMtMS0xLTA_ade54d40-b6eb-49dd-8885-10222f8be805"
      unitRef="usd">-7491000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzExLTUtMS0xLTA_e69239b2-b6f1-45a2-a858-51b9552f3c74"
      unitRef="usd">2066000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTEtMS0xLTA_6b815c57-07b2-4448-a998-b033cf980caa"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTMtMS0xLTA_e09694a3-3e39-4aa2-8144-79846e59f58d"
      unitRef="usd">-19046000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEyLTUtMS0xLTA_4b3a90cc-46e8-4302-89b2-6ee380eb9c09"
      unitRef="usd">-8184000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTEtMS0xLTA_97a36ddf-1eeb-46ff-a504-0aa47f8d372c"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTMtMS0xLTA_77da2e8d-d2be-469a-86ee-d1ca463764df"
      unitRef="usd">9903000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZToxNWM2MTgzMmIwZWE0NjEwYTA2ZjZmNzg2NWQxNTdiMS90YWJsZXJhbmdlOjE1YzYxODMyYjBlYTQ2MTBhMDZmNmY3ODY1ZDE1N2IxXzEzLTUtMS0xLTA_26bad673-5600-4df0-8e1c-cbdf4a3d996c"
      unitRef="usd">-3398000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MTE_58da98b2-f0ea-478c-8cd8-11faff5cef63">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzQtMS0xLTEtMA_687a306c-c063-4d76-b908-e661e0f18a93"
      unitRef="usd">2207000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzQtMy0xLTEtMA_f879a69c-a6b2-4a03-8d2e-d0ac1c3330ea"
      unitRef="usd">2426000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzUtMS0xLTEtMA_82ec9246-4e1b-4628-9044-5f2acfbcb099"
      unitRef="usd">47034000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzUtMy0xLTEtMA_29ddee45-da4b-433e-a2d4-0150acc434ff"
      unitRef="usd">39548000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzYtMS0xLTEtMA_226d9bc3-0ee4-4ee0-bc57-bfd10094c08a"
      unitRef="usd">18319000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzYtMy0xLTEtMA_cc2930ad-925c-41c8-8283-46590ffac4a4"
      unitRef="usd">19134000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzctMS0xLTEtMA_2d0c6759-ec63-4caa-b15c-0ce823f734e4"
      unitRef="usd">3403000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzctMy0xLTEtMA_e504c37c-da76-49e3-ab96-a3138c9daa71"
      unitRef="usd">3206000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzgtMS0xLTEtMA_6f537706-2c03-410c-9bd3-387ca024a9a5"
      unitRef="usd">4883000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzgtMy0xLTEtMA_814de524-900d-4722-bccd-1eb4bc0d44e7"
      unitRef="usd">6017000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzktMS0xLTEtMA_0a6a7330-9cd7-4fd7-8318-c33370e43799"
      unitRef="usd">6160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzktMy0xLTEtMA_adef64b3-e87e-457f-81f5-76f00f11cd3c"
      unitRef="usd">8347000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEwLTEtMS0xLTA_ad4a3697-104c-4d76-aca3-1e34582de80f"
      unitRef="usd">1665000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEwLTMtMS0xLTA_7eb1891c-3c0d-46cc-bc1b-d40d956b4f99"
      unitRef="usd">1805000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzExLTEtMS0xLTA_23f8e68a-1b72-4e8f-a559-a616ae7e0ecd"
      unitRef="usd">29335000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzExLTMtMS0xLTA_597b74d7-f7c2-419b-b687-1bc565714cd6"
      unitRef="usd">37418000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEyLTEtMS0xLTA_58a5dacf-9477-4cac-bd8e-0be5da4b7791"
      unitRef="usd">13044000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEyLTMtMS0xLTA_bac7554a-ba7d-4486-9ccb-be6ad8bf5bc5"
      unitRef="usd">9781000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEzLTEtMS0xLTA_49011697-0039-4882-b6a6-cc4edd81018b"
      unitRef="usd">23798000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzEzLTMtMS0xLTA_668f2a47-cd93-4035-b739-09a001221cbb"
      unitRef="usd">8105000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE0LTEtMS0xLTA_53e2cf29-24b6-4924-90f4-526d83fd0ca0"
      unitRef="usd">203000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE0LTMtMS0xLTA_d4a664d4-0035-40ec-ba90-db592a3a7859"
      unitRef="usd">235000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE1LTEtMS0xLTA_492d1999-a8eb-4271-90d6-a1d735deac7b"
      unitRef="usd">23205000</iart:DeferredTaxAssetsLeasesAndOther>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE1LTMtMS0xLTA_41dd4ef9-8110-46ed-a4c0-bba401699446"
      unitRef="usd">12496000</iart:DeferredTaxAssetsLeasesAndOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE2LTEtMS0xLTA_7f4076ca-0816-4cd5-8d22-60539230dd01"
      unitRef="usd">173256000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE2LTMtMS0xLTA_5389cf1d-eab7-4d04-a3be-a17fb03610af"
      unitRef="usd">148518000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE3LTEtMS0xLTA_3b1170ff-dc54-4509-8ebb-9e4231bcf095"
      unitRef="usd">9897000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE3LTMtMS0xLTA_5ce4000f-1d05-47f5-bf48-667751e879c3"
      unitRef="usd">9865000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE4LTEtMS0xLTA_128edba2-daf2-41d9-a6fa-38b3ede02e3e"
      unitRef="usd">163359000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzE4LTMtMS0xLTA_ad533b79-bda8-4041-9843-f4406c397122"
      unitRef="usd">138653000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIwLTEtMS0xLTA_d720a0e0-a7e6-4478-a8d8-3fb523d3b8a5"
      unitRef="usd">90274000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIwLTMtMS0xLTA_d845e591-52f3-4190-a7de-65cda8d87844"
      unitRef="usd">150879000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIxLTEtMS0xLTA_1dfed622-52ce-4983-9ca4-6c6fc377f978"
      unitRef="usd">15585000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIxLTMtMS0xLTA_8909c3d6-94a7-4573-a88f-c1d92caeafd5"
      unitRef="usd">11704000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIyLTEtMS0xLTA_974cd264-01b6-453c-b6e2-2bf46200a12f"
      unitRef="usd">105859000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzIyLTMtMS0xLTA_67dd1075-874b-4938-9585-5d2953a303f6"
      unitRef="usd">162583000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzI0LTEtMS0xLTA_aebd8e4a-9747-4430-a581-3570f2361374"
      unitRef="usd">57500000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTozYzYxYjE2NGI1MTA0ZTc5OWFjYTc3NTI2ZjNmYWZlOC90YWJsZXJhbmdlOjNjNjFiMTY0YjUxMDRlNzk5YWNhNzc1MjZmM2ZhZmU4XzI0LTMtMS0xLTA_04d983bc-9bc0-4264-a8f6-aec8d2254982"
      unitRef="usd">23930000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i71e189e172134a198e45306e30524e45_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ3NzY_c5aaeea0-e5b5-40a6-bc56-354c2ffccffd"
      unitRef="usd">90200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7e0e6743ee86466485e0e297c82bd874_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ4MjA_f50dcf49-b4c0-4c60-a0da-74e26e55561c"
      unitRef="usd">36700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie8d8ce88e979437bbf5ec18f685dd329_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ4Njc_a795bbe9-fe09-485d-8e1d-d29794067a83"
      unitRef="usd">41600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i71e189e172134a198e45306e30524e45_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUwMjc_ca8f1155-a24c-4fdf-aa59-b779360c4c39"
      unitRef="usd">11800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i33ca63c7a2bb40df97707e469661c625_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUxNDE_7178445c-9b53-4844-8bda-3b352b359298"
      unitRef="usd">300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i7e0e6743ee86466485e0e297c82bd874_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzUxOTE_6a7635ab-8a34-46d5-9e32-9511174c9c08"
      unitRef="usd">36400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzQ5NDc4MDIzNTIxNzQ_ba3ecaad-39c7-4de1-8dfe-6ccf9272964e"
      unitRef="usd">-100000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzYwOTU_1e340bd1-d548-4ab3-a12b-b7a044674e8b"
      unitRef="usd">2900000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzYxMTU_a9c0e2cb-37dd-40fa-aa76-22ae2593b8af"
      unitRef="usd">-1000000.0</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY2OTk_dba89514-d231-47d4-8d80-274541573c25"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzc5MDE_8e203c8b-c633-4da3-bf92-3d12d545a99e">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Statute of limitations lapses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtMS0xLTEtMA_94318aef-b872-479a-b7ec-ee7c59bf05a8"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtMy0xLTEtMA_806e27c4-acf6-48f6-a511-62f5de0d0b2f"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1b1715655e084da08f6d9ab45911c30b_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzMtNS0xLTEtMA_1a6a70be-9b30-4fb3-93ff-261b4f6d6849"
      unitRef="usd">424000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtMS0xLTEtMA_614b3378-1e47-499b-bc0d-7bd8c99d291e"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtMy0xLTEtMA_74379a8a-4fab-4e54-90a0-eb5329c72db4"
      unitRef="usd">53000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzUtNS0xLTEtMA_add85912-3d12-4203-9f35-ff94007e6434"
      unitRef="usd">273000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtMS0xLTEtMA_415147f0-16f3-473d-ad67-90fc7c968964"
      unitRef="usd">26000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtMy0xLTEtMA_6c5b9be9-ae89-4909-967b-f20b110ccc31"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzYtNS0xLTEtMA_db1e6fc2-6655-4f56-8bd4-7f41f2d420d0"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTEtMS0xLTA_cd2cd9f6-21d1-48d4-b4ac-a0b10d649059"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTMtMS0xLTA_599ad838-19a1-4cff-8041-2d96a782cd63"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEwLTUtMS0xLTA_1298abfa-1a43-4e8a-972f-c0176e126ae9"
      unitRef="usd">21000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTEtMS0xLTA_fe78ff0e-f711-4b80-8df4-8cfc3a67303b"
      unitRef="usd">0</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTMtMS0xLTA_16520d3c-1506-4937-a358-de9a60af1884"
      unitRef="usd">53000</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzExLTUtMS0xLTA_685b2a5b-047c-4ded-95aa-84eb1df26ea0"
      unitRef="usd">0</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTEtMS0xLTA_17b7c5f5-c942-4320-8a07-7d045a17d51e"
      unitRef="usd">702000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTMtMS0xLTA_4a865924-252e-4830-9a07-eb838c66268f"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icc7bd740dcb34aa28922e7b305fe46a9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90YWJsZTo2MzYzOTE4NzQzOWQ0ZWI3ODIyZDVmYzQzZWFhMmY5OC90YWJsZXJhbmdlOjYzNjM5MTg3NDM5ZDRlYjc4MjJkNWZjNDNlYWEyZjk4XzEyLTUtMS0xLTA_a2738f3f-0dd4-4b00-a2c7-88dcad6759ee"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY4NTA_dcf19231-6649-4240-bcbe-a6d8b64e262d"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTEvZnJhZzpiZDA3MTFkODAzNzc0ZmVkOTcxMzQxZmM2ODJiNzk1Zi90ZXh0cmVnaW9uOmJkMDcxMWQ4MDM3NzRmZWQ5NzEzNDFmYzY4MmI3OTVmXzY5OTI_3a54dcc3-4bc2-4be6-b08a-b19cbde42621"
      unitRef="usd">0</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzY3MQ_db59c226-2097-4200-95e0-b53a919e03cb">NET INCOME PER SHARE&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock of approximately 0.3 million and 0.4 million shares at December&#160;31, 2020, and 2019 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. &lt;/span&gt;&lt;/div&gt;Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzY2Mw_ddaf7b14-d7a1-4f7d-9ba4-20a8a1ac12bf">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtMS0xLTEtMA_78809713-9839-4ed1-8bd2-3a4dd6269be0"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtMy0xLTEtMA_1185eb2b-ded8-491d-8db2-7cb111cf56e5"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzQtNS0xLTEtMA_ea135621-9289-4604-b47a-690c22d143c8"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtMS0xLTEtMA_ff0e5e82-e7c8-4c09-9c57-4da6d6c1fcc0"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtMy0xLTEtMA_dd3bd9bc-8fbb-4c91-ae06-bec1bdbed121"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzYtNS0xLTEtMA_7fa2049f-4093-418f-9b5c-9137321e823d"
      unitRef="shares">82857000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtMS0xLTEtMA_d7395701-217c-4d2d-829d-21aef2b0e1b5"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtMy0xLTEtMA_f1a05077-bf3c-47c5-85df-5afbc0fe9ad0"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzgtNS0xLTEtMA_60608407-33b3-4071-8abd-045b3f935822"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTEtMS0xLTA_725128f2-80be-48e7-8928-1ff342730bd7"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTMtMS0xLTA_3976d34f-8b14-4961-b40a-e937688de4ee"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzExLTUtMS0xLTA_f1cc317a-7c1e-491f-8024-8c5ed2fe129c"
      unitRef="usd">60801000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTEtMS0xLTA_e8b43db0-5530-4dbc-b109-9bca08d5a28f"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTMtMS0xLTA_9eb75451-f8a4-47b1-978d-4acaac0a073c"
      unitRef="shares">85637000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzEzLTUtMS0xLTA_ddf49179-2c1e-4288-842b-df7ecdaa0ad1"
      unitRef="shares">82857000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTEtMS0xLTA_ce383842-023e-45aa-9e31-0c20e9bbd62a"
      unitRef="shares">577000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTMtMS0xLTA_26167b42-0f6b-4186-8ac7-67a74b777673"
      unitRef="shares">857000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE3LTUtMS0xLTA_f53a836f-6a20-4bb7-b0a1-71d16d87fb6f"
      unitRef="shares">1142000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTEtMS0xLTA_7cd18c95-705b-4845-95f6-2e276d6521a4"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTMtMS0xLTA_8e0be29d-05f8-4066-9ee7-a5a9d878f4ad"
      unitRef="shares">86494000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE4LTUtMS0xLTA_971b2084-a49d-4e63-ab1f-e18df49da644"
      unitRef="shares">83999000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTEtMS0xLTA_8a342002-8953-4be2-b946-d1af03dd4291"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTMtMS0xLTA_34b88290-9304-4516-bb00-de867b3435c9"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90YWJsZTphNDI1ZGJkMTBkOTY0ZjM3ODhhZTJjYjM0OTQ3YThhZS90YWJsZXJhbmdlOmE0MjVkYmQxMGQ5NjRmMzc4OGFlMmNiMzQ5NDdhOGFlXzE5LTUtMS0xLTA_bbc0f4fd-710a-4a2b-8667-973bac19433d"
      unitRef="usdPerShare">0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzM4NDgyOTA2OTc5MTg_8475d71c-808b-4b79-af4d-917fd534a8df"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzM4NDgyOTA2OTc5Mzc_10592f17-76b8-46c8-b1aa-1bf14af4756c"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <iart:AdditionalEPSShares
      contextRef="ifd9f45dbd07e4b1b8f8a22de6eb41518_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMTcvZnJhZzo0NTJiY2E1YTBkODg0ODdkOWFmNzQ1Y2Q5YmVlNmE5NS90ZXh0cmVnaW9uOjQ1MmJjYTVhMGQ4ODQ4N2Q5YWY3NDVjZDliZWU2YTk1XzQxOQ_d9a6e25d-4119-4314-a4fd-c175ef8fd53f"
      unitRef="shares">500000</iart:AdditionalEPSShares>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzMzOQ_7637520e-4dd4-4571-86d6-6f4fa2126f2a">ACCUMULATED OTHER COMPREHENSIVE LOSS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2020 and 2019 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2020, the Company reclassified a loss of $12.2 million and $6.6&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzM0Ng_563fbb16-6240-4d1f-9c55-9c32d5637149">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2020 and 2019 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i915fe0a79f884cefa4d9cbc4dde21cf6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItMi0xLTEtMA_209baa9d-84a8-401e-a238-2dcee6fbcb9e"
      unitRef="usd">-26625000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i600d3779342744ec92eb111d87aab117_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItNC0xLTEtMA_bb1dda54-a5ea-4a81-b4d7-6d993343a644"
      unitRef="usd">-9709000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a845487839e48b7893f0fdea00c7b8d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItNi0xLTEtMA_37021f34-86d7-431b-b877-0a3cf2b5f7c5"
      unitRef="usd">-40068000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9d2265b32274b0abed4046b6e8c8fbf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzItMTAtMS0xLTA_055bf183-1d0e-4fac-a978-a2ad8909a8d8"
      unitRef="usd">-76402000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtMi0xLTEtMA_78e04579-c5fb-41ee-a3e1-cba789ce20ea"
      unitRef="usd">-74394000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtNC0xLTEtMA_b1f9569c-e7ef-4fbb-9fb3-3901f5d32ed4"
      unitRef="usd">4604000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtNi0xLTEtMA_00e9cfa0-a8b3-49ba-b2a3-a11f16bfc0e7"
      unitRef="usd">53363000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzMtMTAtMS0xLTA_da056ee2-ca93-4bbd-a8f5-5147b7438d00"
      unitRef="usd">-16427000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtMi0xLTEtMA_0a865402-636a-4b3f-8783-bfe8b72d3c3c"
      unitRef="usd">-18770000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtNC0xLTEtMA_c3cd62b0-da91-4cb1-9b4e-0dc1d53451dd"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtNi0xLTEtMA_1b7a376f-3dd9-4feb-969b-0ddc2f0df9b7"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzQtMTAtMS0xLTA_b5d88404-0c1e-44e8-b2e8-47bf180788de"
      unitRef="usd">-18770000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0c0f69df375e45a0a95b01777d5edac4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtMi0xLTEtMA_d66b2ec0-7f53-437b-83f4-ee47529375fb"
      unitRef="usd">-55624000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d55f040424d496588091e3d160b684b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtNC0xLTEtMA_0b06e007-efee-4194-9f13-f5e3e369a737"
      unitRef="usd">4604000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ica84d5eebc4e41eea6c3b60d1e4cc2b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtNi0xLTEtMA_2c0b5247-f20b-4146-925b-775048f243e6"
      unitRef="usd">53363000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzYtMTAtMS0xLTA_2e683b67-d4bc-4402-bf71-d66311e03db5"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i5bc5a0abf78444e0842fe3e1f0f3ca37_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctMi0xLTEtMA_7660345b-d0df-4fe1-9d5c-bb1d10305fcd"
      unitRef="usd">-82249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b3b046492264f83b1bdda8c4af96853_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctNC0xLTEtMA_03e15d12-9f35-46a4-b323-d1c71bd0c87c"
      unitRef="usd">-5105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifec541285c404f83866591c6e23fb0e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctNi0xLTEtMA_58e034a8-5a67-4c12-bd34-eb6ba40b59e0"
      unitRef="usd">13295000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f66841395594a8eb57dc2f4410517fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90YWJsZTozMWQwMjBkYjhhNDY0OWE1YmNmNDIzMTY3YmFlZDI1YS90YWJsZXJhbmdlOjMxZDAyMGRiOGE0NjQ5YTViY2Y0MjMxNjdiYWVkMjVhXzctMTAtMS0xLTA_26efd2e2-8706-4a43-a2f0-8ac7268807d0"
      unitRef="usd">-74059000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ied2d80105ffa4482aed85b57eea1cada_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzIzMg_d74db1e2-c749-4715-a491-7681bf817761"
      unitRef="usd">-12200000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i7bdd1096ee664d10a6e61b228ea2a3df_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjMvZnJhZzo0ZDg5OTI5NTkzMjY0YTBmOGFhY2I2NmQ3OTNhN2Q3ZC90ZXh0cmVnaW9uOjRkODk5Mjk1OTMyNjRhMGY4YWFjYjY2ZDc5M2E3ZDdkXzk4OTU2MDQ2NTAzODE_cbbc8177-b1ba-4bdc-8f0b-cace48c511c0"
      unitRef="usd">-6600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90ZXh0cmVnaW9uOjYzYjlmMGZjZjBlMjRiMTFiYjc1Njg0MWI3MGFlNTg0XzMxNTU_ee866dc6-c2b6-4be6-8a18-c9f6d3b7d6e0">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2020 and 2019 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2020 and 2019 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Arkis (See Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Related to Acquisition of Arkis (See Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions from acquisition of Arkis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90ZXh0cmVnaW9uOjYzYjlmMGZjZjBlMjRiMTFiYjc1Njg0MWI3MGFlNTg0XzMxNDg_f32f51e9-6921-4419-936f-dbbe640492bb">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2020 and 2019 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Arkis (See Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Related to Acquisition of Arkis (See Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions from acquisition of Arkis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i538dfb31e082468593d9ba7bb909acfa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItMi0xLTEtNTIyMA_ce7667b8-624d-4de0-bf59-3b7080d2f789"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7690a3012a274b599aaf7c76ca6b957b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItMi0xLTEtMjg4Ng_a99526f3-7888-4243-9f5f-83526fe6e6d4"
      unitRef="usd">14210000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8333dd78848247469f7bf32fef58b0db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzItNC0xLTEtMjg5MA_15086d46-7282-4704-ab13-dcd41d918dc0"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtMi0xLTEtNTIyNw_e9f66244-8d33-48f1-baca-8db495d0bae1"
      unitRef="usd">3415000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i77408f824582469ea836cdd585f88b2b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNC0xLTEtNTI1NA_f97ff33c-5840-4d8c-bc4d-ab904be37d6a"
      unitRef="usd">-3415000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNi0xLTEtNTI1OA_585ef832-82e1-441b-9745-2d961185e4d6"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtMi0xLTEtNTIzMg_13f2cadb-68ac-4353-a357-aee7f011b853"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i77408f824582469ea836cdd585f88b2b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtMi0xLTEtMjkxMA_bde0d7fd-8868-4f9d-af42-af801f54780a"
      unitRef="usd">-951000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0b8f756d858f4d5ebbde9c8cc1f46b06_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzUtNC0xLTEtMjkxNA_692f2a80-f2cf-4bf6-b8cf-b50768759d15"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1a4563e0592c40fe8a9fa8580f8985a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzctMi0xLTEtNTI4MA_9ddeed30-9b5e-4a60-a88e-782f6e66b13d"
      unitRef="usd">3415000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i199d883ab45d4d4c923d9ec6bdebfc34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtMi0xLTEtNTA2Ng_47e52075-9de2-4ffc-8dbe-b5c9118d0334"
      unitRef="usd">11746000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia77d428b66b340ff9b3911c6b4f91b35_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTplZTU3OTEzYzBhYTA0ZmRhOTAyNjZkNzcyZjdkYTU0MC90YWJsZXJhbmdlOmVlNTc5MTNjMGFhMDRmZGE5MDI2NmQ3NzJmN2RhNTQwXzYtNC0xLTEtNTA2OA_865c47f9-0425-484a-a538-2f5685cb3d56"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0220d6c969a24d77a0ae61fb694918c6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzItMi0xLTEtMA_d2c924af-21d8-4058-b234-11abe182824c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iee18fbfc3a8b42098ed3d5d2cbcb6209_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzItNC0xLTEtMA_92dfd5e5-6ef1-480a-b370-9ab85307a28e"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzMtMi0xLTEtMA_705afc88-698a-4a8d-9ee0-d1d4820cdeae"
      unitRef="usd">13100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ieca9ba86d50e4b26848a1947f1e0a0a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzUtMi0xLTEtMA_0b194b09-2a26-487b-b49c-550bc049f3de"
      unitRef="usd">-1110000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ib76aeec8929647b3b5f7a4e8e1a3555f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzUtNC0xLTEtMA_378aa574-5a76-49ce-a3ff-31285e55cebb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7690a3012a274b599aaf7c76ca6b957b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzYtMi0xLTEtMA_9a39cba9-4cce-4210-8c74-9781d2eb2e36"
      unitRef="usd">14210000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8333dd78848247469f7bf32fef58b0db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMjYvZnJhZzo2M2I5ZjBmY2YwZTI0YjExYmI3NTY4NDFiNzBhZTU4NC90YWJsZTo4OTY0MGE4MGZlNmE0ZTk2OTRkMWViMGE5ZjJhMGE5NS90YWJsZXJhbmdlOjg5NjQwYTgwZmU2YTRlOTY5NGQxZWIwYTlmMmEwYTk1XzYtNC0xLTEtMA_f7c6dc80-4416-419e-99f3-75fbd48efb3f"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzIxNjk_966d7090-4ee5-4712-a682-8462acf99345">SEGMENT AND GEOGRAPHIC INFORMATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,028)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,160)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Includes long-lived assets in Puerto Rico.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzc1_8566d549-6372-41fb-956e-dab708eda680"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzE5MA_20f0eb64-9dd7-4296-bd6e-3493b19f8773"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <iart:SegmentReportingInformationNumberOfProductsOffered
      contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzY1OQ_01c365a4-b3ea-4b1e-a7ce-4a4308482459"
      unitRef="product">40000</iart:SegmentReportingInformationNumberOfProductsOffered>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90ZXh0cmVnaW9uOmI3NTViMTRjNDU1NTRjMWE5MWQ2N2E5MDcxYzk0MGUyXzIxNjE_b662bc27-663b-4d57-ad76-b5e4e5d91bae">Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedics and Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,028)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,160)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Includes long-lived assets in Puerto Rico.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtMS0xLTEtMA_0afcc158-9812-4376-b72e-0a85fae68118"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26c0515670af42c58ae7069afcd7747d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtMy0xLTEtMA_df9a0255-e019-4206-a9b3-63d462f8041e"
      unitRef="usd">996206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7774956f31dc421da3393ecf2b4ecc15_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzQtNS0xLTEtMA_f4de7c75-d0dc-438c-a714-24102793548b"
      unitRef="usd">963929000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78aae43e7b2c4a9c959268bd150d24e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtMS0xLTEtMA_7e027072-d553-4d9c-bbb8-9efcfd3106cd"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a555208c32f4e68acd3322fdd2341f4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtMy0xLTEtMA_ac5e10b6-d54c-484f-973f-d4e245772fff"
      unitRef="usd">521351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d4d78e16438458d8f827d0d8ea60a7d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzUtNS0xLTEtMA_5556f0ce-0f86-48fe-958a-0a8b3a6fa2b5"
      unitRef="usd">508512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtMS0xLTEtMA_aa527c2b-5135-4191-b85a-3fdb259497d8"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtMy0xLTEtMA_4fcd484e-8459-4445-9286-ee4d52660e69"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzYtNS0xLTEtMA_b4335d84-21a3-404f-8672-75ff69455a6c"
      unitRef="usd">1472441000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7a492f361fc641fcb8a66e8610864f1b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtMS0xLTEtMA_b269bbc7-cf98-4871-80ee-063b426e66f4"
      unitRef="usd">356657000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i77a577c66303495c9c64b30f3697ad11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtMy0xLTEtMA_5946781b-cb59-4c58-a318-05280c344f23"
      unitRef="usd">395019000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2ca2760ceb9e4f12a8d64b4b643f2254_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzgtNS0xLTEtMA_93cdbfae-055e-4c2c-969e-afec5a27ec4a"
      unitRef="usd">363336000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaebb1da81e224630986e6e6ff2c7c7f3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktMS0xLTEtMA_9853e76d-f80f-40c7-b1cb-6dcb04ff07e5"
      unitRef="usd">159630000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iea59ee130b064410ba6588bc3f86922c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktMy0xLTEtMA_8cde2749-ee45-4e9c-96ea-36b9d9b785bc"
      unitRef="usd">144638000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c9f30770ba94367a94a9f76eda74407_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzktNS0xLTEtMA_7dd4730c-b79d-450c-8812-32e9d319ad96"
      unitRef="usd">149510000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0339f7ff81b9436da44be79de840be6c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTEtMS0xLTA_3ca5cbcc-a0bb-4889-a9d9-25ecaf4ac6c6"
      unitRef="usd">516287000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i83d605ea1557460e8056284eeac6508e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTMtMS0xLTA_80195732-d9a3-4bb4-928a-2a230ecbdbf4"
      unitRef="usd">539657000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5d0b754b8abd4e25ababaec4ec893e6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEwLTUtMS0xLTA_17c3cb94-b54b-43cf-ae6c-2a0fdde42b3e"
      unitRef="usd">512846000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTEtMS0xLTA_6956763e-bba1-4a1e-b720-c1cb26fd1182"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTMtMS0xLTA_54ad6a26-6ca7-48ed-ac71-aa0916acfbc2"
      unitRef="usd">27028000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzExLTUtMS0xLTA_bc43f529-c3a8-41ff-8948-5156fa07e99e"
      unitRef="usd">21160000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74738422d75348bcba75c40c5f3ddfcb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTEtMS0xLTA_50712e6b-c93e-41a1-8328-5aaefe2cc423"
      unitRef="usd">-337160000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibeb51ca4dfba44ab9a951fe9bc3434c2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTMtMS0xLTA_93139605-ebc6-4198-97fb-dbac3a7ede83"
      unitRef="usd">-418869000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i44e1eb3bcc0f40f5950dfd270c3208b3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEyLTUtMS0xLTA_232ea09e-4646-4b60-9579-806a9b01cee1"
      unitRef="usd">-380688000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTEtMS0xLTA_f4bb206c-dc31-4d5c-9e98-4c5e71294026"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTMtMS0xLTA_5c86358c-5d71-426b-b75f-ed5d8f341f7c"
      unitRef="usd">93760000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZTo1OGRiY2RiMjYyNjE0MjEwYTQxNDYxZDRjZTRmMzFjNy90YWJsZXJhbmdlOjU4ZGJjZGIyNjI2MTQyMTBhNDE0NjFkNGNlNGYzMWM3XzEzLTUtMS0xLTA_89a95241-ecd9-4ae1-8f85-1f95f25530d5"
      unitRef="usd">110998000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ab9fed755274b8bab9f12726270620d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtMS0xLTEtMA_724064c8-377c-48e2-aa9d-485f66a20a99"
      unitRef="usd">971975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab753bf745234f46a5d7d0762901ed84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtMy0xLTEtMA_b541814f-6b52-4a89-be57-16378e072fd7"
      unitRef="usd">172689000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i312af3201ee346458bf3076a77de0b3e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtNS0xLTEtMA_2c88f4dc-b248-4477-bc1c-b4204c013fd8"
      unitRef="usd">157174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7da3dc5527e64b279b398c99855b2504_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtNy0xLTEtMA_ac13579d-fdd4-434f-842d-4cf232666e39"
      unitRef="usd">70030000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzMtOS0xLTEtMA_69b2b5e7-b32c-4702-95ab-c255de7f1797"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39dc2f2111394426b38f70b228c05252_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtMS0xLTEtMA_78dede86-7450-4d97-a8db-ef8b303630cd"
      unitRef="usd">1077379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd720fd7705748f5b9f4dd5218b65a36_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtMy0xLTEtMA_c6a6398a-dd0d-46cc-82c0-17153fcaad2a"
      unitRef="usd">197468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f314852dfa54284ab10723c587b8b21_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtNS0xLTEtMA_5a33dc7f-7801-4767-97fc-c54fa2daf6e0"
      unitRef="usd">157391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c94f499c38242379f9bbbeea658eb17_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtNy0xLTEtMA_c90119f4-510e-40e9-87c8-3d7067812b66"
      unitRef="usd">85319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzQtOS0xLTEtMA_90af57c0-7cab-4a1b-912e-588fa398391a"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f21d5bd0b244efd8b12f153cded75a9_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtMS0xLTEtMA_4390db1a-2887-4ac6-a972-0f924d7d46f1"
      unitRef="usd">1045887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e91b9abbee04f569341599829c2c727_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtMy0xLTEtMA_82b03a9d-66b6-45f3-b9ad-15ad788b5b1b"
      unitRef="usd">201354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadc989d0ee9f45a6a3f3bd44a0972156_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtNS0xLTEtMA_c7c3736e-3072-487b-9088-19d69d5b0154"
      unitRef="usd">144253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6f47f06a0f24932a7f6cda6d309f09f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtNy0xLTEtMA_d7113809-3400-4b06-b4b1-2c8cda06a671"
      unitRef="usd">80947000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifccacca7f3aa4d53a0c352eb41f6fe38_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzUtOS0xLTEtMA_c13d7e1a-8242-41ba-bd7a-b51bc565d1fc"
      unitRef="usd">1472441000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NoncurrentAssets
      contextRef="i56cc64b365d84a6ca6fc1c66b40c0afe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctMS0xLTEtMA_2727a74f-3e8a-47db-ae8b-8171a1225038"
      unitRef="usd">324893000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5ffdd35dd74547d58bb2c5c82ed5912f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctMy0xLTEtMA_29cab8cb-5445-4ec9-b143-dab6f9683fad"
      unitRef="usd">38812000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0ec02ac258524a4f81b14306dd3256d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctNS0xLTEtMA_bf0d5f0a-a7d6-419b-a2e7-2b75311b7bcc"
      unitRef="usd">13121000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6ec796a8dea1494f959cf4013fc839af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctNy0xLTEtMA_9f34aa39-05ce-4200-8760-d15f56b2e9d8"
      unitRef="usd">5577000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i7fac4ecd14854b13af640b05c1490ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzctOS0xLTEtMA_a57b031d-53a6-4324-9b4a-8bc473ed4b5e"
      unitRef="usd">382403000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i487980db30c14d9298651dad86a5d2cb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtMS0xLTEtMA_ec8c0b93-34f6-4d0d-9cf5-16679318f4ee"
      unitRef="usd">383652000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i51d472c1a60c4976af5221d730388b12_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtMy0xLTEtMA_2d04a240-f1ed-47f8-b545-84ce7e5e99ba"
      unitRef="usd">47325000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic11b11343fea42b7b40dc6964a49dc48_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtNS0xLTEtMA_fa633343-6f01-4960-bc76-02fc0b9ff7ac"
      unitRef="usd">8598000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5bfda1bfd48c4de2b4ae4d4bdf4a010d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtNy0xLTEtMA_9f21b8a7-f9ea-4851-988c-a575c5ab156e"
      unitRef="usd">7143000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia7a841c52734456191bb4acc617e9711_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzIvZnJhZzpiNzU1YjE0YzQ1NTU0YzFhOTFkNjdhOTA3MWM5NDBlMi90YWJsZToyNmM2MWMzNDI1MDU0OTQyYTU3YWUzM2VjOTMxYzY5Ny90YWJsZXJhbmdlOjI2YzYxYzM0MjUwNTQ5NDJhNTdhZTMzZWM5MzFjNjk3XzgtOS0xLTEtMA_c73c5a45-f11a-4fa2-99e3-5ce63934f439"
      unitRef="usd">446718000</us-gaap:NoncurrentAssets>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzI4NDU_807266c9-8b1f-4603-95c4-c945dd071a76">SUBSEQUENT EVENTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Sale of Extremity Orthopedics Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement (see Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Held for Sale), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp;amp; Nephew USD Limited. The Company received an aggregate purchase price of $240.0&#160;million from Smith and Nephew and concurrently paid $41.5&#160;million to CFO effectively terminating our licensing agreement (see Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;ACell Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2021, the Company acquired ACell, Inc. for an acquisition purchase price of $300&#160;million. Under the terms of the definitive merger agreement, the Company paid the consideration for the merger as an upfront cash payment subject to a customary post-closing adjustment for certain working capital. The Company is also required to pay the former shareholders of ACell Inc. up to $100&#160;million based upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Equity Award Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2156cb0dcc194220a546b328fa630c07_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4NjI_397ece0b-c950-4f76-8f5d-c5aca9b0564f"
      unitRef="usd">240000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="ib7ba010bdc694d8db602d10b1e80f400_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4Nzg_a421ce13-d109-41bb-8d6d-b16d75287470"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic1cbbb9e128841cf9fa63ba54ab3ffa8_D20210120-20210120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY4OTM_5e504d8e-320e-4b48-8bc4-769d961f15f1"
      unitRef="usd">300000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ib8aec2854c5740fcb5bf9baf57f0ef8a_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ4OTY5MDc_1ebe8af4-42b8-4361-96a6-419f4ebb6055"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia880589c0d5d4323b971f4a8272c48aa_I20210219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yMzUvZnJhZzpjN2FkZDc3NDI2ZDk0MWQxYTdiNjg0OTg0ZDU2MmM4Yi90ZXh0cmVnaW9uOmM3YWRkNzc0MjZkOTQxZDFhN2I2ODQ5ODRkNTYyYzhiXzMyOTg1MzQ5MDQ1Nzg_abad81fa-87f4-4882-b6e9-8be9de4cb01d"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90ZXh0cmVnaW9uOjc0NDdmZWM5MTExNTQ0ODRhODlhNWYyYzFmNjFiYWUyXzQxNg_c599f7b5-1391-4ec0-8e3f-f4790715177b">SELECTED QUARTERLY INFORMATION - UNAUDITED&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share - Basic (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share - Diluted (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company&#x2019;s issuing and repurchasing shares of its common stock during the year.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90ZXh0cmVnaW9uOjc0NDdmZWM5MTExNTQ0ODRhODlhNWYyYzFmNjFiYWUyXzQxMw_90a0abc7-f016-4f0b-8f89-ea1dfbf561f3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share - Basic (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share - Diluted (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company&#x2019;s issuing and repurchasing shares of its common stock during the year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtMS0xLTEtMjk3Mw_35ca30c9-7be2-4023-8406-a0568d645f3d"
      unitRef="usd">354324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtMy0xLTEtMjk3Nw_6fdef3fc-659b-4feb-98bc-610b2208d0f8"
      unitRef="usd">220848000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtNS0xLTEtMjk4MQ_627067fb-5c4c-4fb4-bc3a-34079c528472"
      unitRef="usd">9180000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtNy0xLTEtMjk4NQ_a9d08f70-f247-4593-ad38-bd4f35268f4a"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i378458edd8554ba79827a3b035c5b627_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzMtOS0xLTEtMjk4OQ_c094a6a2-4378-47f8-8338-b8cd37d12590"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMS0xLTEtMjk3Mw_50e89bc7-d4d0-4ba1-9879-dc1be71d62bc"
      unitRef="usd">258665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMy0xLTEtMjk3Nw_60b99ba1-778e-4853-b632-1a74cfd2f8ca"
      unitRef="usd">153187000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNS0xLTEtMjk4MQ_51ba1d70-61cc-45ad-938b-c16453ff0243"
      unitRef="usd">-369000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNy0xLTEtMjk4NQ_d92ddc1c-45ae-490f-9d06-2accb317d2f5"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic78309fd04df4b2792d85bf84d06b4fc_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtOS0xLTEtMjk4OQ_07ab067c-64de-4108-b3ca-ce41a21782ad"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMS0xLTEtMjk3Mw_8a49aefd-095c-4e6c-acbb-be01cc155826"
      unitRef="usd">370232000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMy0xLTEtMjk3Nw_2615e1b3-dfb5-4c16-a054-a949c5929b28"
      unitRef="usd">235421000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNS0xLTEtMjk4MQ_08991807-d81d-439e-be87-307ed1fcbeaf"
      unitRef="usd">32337000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNy0xLTEtMjk4NQ_410aff70-71ab-454c-8f13-c78337dc24b9"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2569b01568ef456587b025f83b33ff2d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtOS0xLTEtMjk4OQ_1773ea32-5ff8-4b55-aea1-e7cced43b46a"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMS0xLTEtMjk3Mw_3f951200-1502-4338-87e3-93cd0cb4ae17"
      unitRef="usd">388647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMy0xLTEtMjk3Nw_8d013519-8b8b-42e9-a0da-dc1de063bbb3"
      unitRef="usd">241578000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNS0xLTEtMjk4MQ_b01f5b8e-bfe3-472e-9705-315482d8f42f"
      unitRef="usd">92744000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNy0xLTEtMjk4NQ_11e49536-7d66-46fe-99d6-75596b108b20"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtOS0xLTEtMjk4OQ_96777c84-ef1b-4c8a-a5c2-621e24d5de6b"
      unitRef="usdPerShare">1.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMS0xLTEtNTA5NA_97b301da-5202-4746-b6e8-dc8008b815aa"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMy0xLTEtNTA5Ng_17fda659-722f-43bf-be64-0689c9d5342b"
      unitRef="usd">851034000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtNS0xLTEtNTA5OA_946b1a82-e73c-417c-bd5b-670e048dc4ac"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMS0xLTEtMA_4c7cab4a-ce2f-4737-aeeb-e5d2baaf476d"
      unitRef="usd">359690000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtMy0xLTEtMA_e31615eb-882b-4442-9d5d-3d6cc8d8c9e8"
      unitRef="usd">230778000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNS0xLTEtMA_f69c1469-20bc-4e8c-89fa-617d5b7796cf"
      unitRef="usd">32756000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtNy0xLTEtMA_ace25758-ef3d-4b47-a5f6-c793b968dd9c"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbaa46b7b57a494184351280ab176862_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzQtOS0xLTEtMA_6b2472a9-ba70-47f4-98a0-8b1681aba211"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMS0xLTEtMA_0906d4e3-dad6-4d59-bd19-2487312ec261"
      unitRef="usd">383645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtMy0xLTEtMA_025d7a18-cc35-4607-a8fa-2e0f150c7f31"
      unitRef="usd">239974000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNS0xLTEtMA_a2cf24c5-2cb9-4a7b-b24c-0e2fa40dd1ad"
      unitRef="usd">29736000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtNy0xLTEtMA_fba6caac-1018-4390-887e-ad8dcf38a22c"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ea6ff6891e148ea8ce0c28e1af9e77e_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzUtOS0xLTEtMA_20bbefb1-2ec2-446c-81d1-f561e74cf246"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMS0xLTEtMA_3cc20bb0-e601-4f2a-a9a5-81cc7e2662b9"
      unitRef="usd">379095000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtMy0xLTEtMA_ae8d1595-50c1-4490-84d8-5f826d4c6f64"
      unitRef="usd">236459000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNS0xLTEtMA_c137d9d1-d60d-483f-9aa2-02a5018907b7"
      unitRef="usd">-27610000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtNy0xLTEtMA_fd8af386-1f4a-43e9-9ddf-9a514a43226f"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i78db905cc3e148d683b18d8da231dafa_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzYtOS0xLTEtMA_560841d2-a412-411b-8abf-9d45ec76e607"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctMS0xLTEtMA_077721bb-4391-4e61-9650-5ce4aeeb6b45"
      unitRef="usd">395127000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctMy0xLTEtMA_75669411-c78a-42ea-a924-ab16e2bd384d"
      unitRef="usd">245665000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctNS0xLTEtMA_004f7c3b-5205-4569-ba89-f842af9e4dea"
      unitRef="usd">15319000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctNy0xLTEtMA_164a7505-d7e4-4026-aff6-5174262b69ec"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7daeebf2c726437896e5d42c7b2266cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzctOS0xLTEtMA_227ac898-7c5c-42fb-9c3b-16c173647248"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMS0xLTEtMA_62a9ff45-5802-4c93-8240-197299cffa3f"
      unitRef="usd">1517557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtMy0xLTEtMA_8a443d77-2b65-4f98-b457-dc8a04e0079f"
      unitRef="usd">952876000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i3ed83f1544b1450f8a1fd71087b1ef0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDEvZnJhZzo3NDQ3ZmVjOTExMTU0NDg0YTg5YTVmMmMxZjYxYmFlMi90YWJsZToyZTgzNWU5NzNkNmM0N2ZhYWYwZmNhZDA2ZTIzNzkwZS90YWJsZXJhbmdlOjJlODM1ZTk3M2Q2YzQ3ZmFhZjBmY2FkMDZlMjM3OTBlXzgtNS0xLTEtMA_eb9d09c1-0310-4bb2-82c6-8ace011bbcdf"
      unitRef="usd">50201000</us-gaap:NetIncomeLoss>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90ZXh0cmVnaW9uOjc3YTc3MmQ0OTBiOTQ3NGNhZWZlYzczMzQ4OTJmOGRhXzc1Mg_a6fcb9ce-3509-44f1-82cc-b4f5d2b2a4c6">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II &#x2014; VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The Company transferred sales returns and allowances from accounts receivable, net to accrued expenses and other current liabilities upon adopting Topic 606 on January 1, 2018 using the modified retrospective method.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMS0xLTEtMzAxOA_4473de73-c20a-4748-bff3-cd0a6e8dadc3"
      unitRef="usd">4303000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMy0xLTEtMzAyMg_e6f5e4f5-25f0-4d4b-ba2d-306a6ea678f9"
      unitRef="usd">3635000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNS0xLTEtMzAyNg_f460f340-c7de-4277-ad42-a2f2bd9dd4c7"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i9c82fbdd1dfa4ff597d0ece0e9b5aaaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNy0xLTEtMzAzMA_23215f7e-1997-474c-8384-0616f2adfb0c"
      unitRef="usd">1499000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id717ba89e124459c8d3ed604888d7343_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtOS0xLTEtMzAzNA_4d0eb3b9-8272-4dfd-91fc-72b7e9623bdf"
      unitRef="usd">6439000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0c8d0b64387943148ed765fd23753bc5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMS0xLTEtMzAxOA_c79d0aa1-fab9-4784-8915-b59291f4115b"
      unitRef="usd">12069000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMy0xLTEtMzAyMg_1db1d95f-39e5-4351-829d-5f6661b47579"
      unitRef="usd">1617000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNS0xLTEtMzAyNg_65a5f079-623e-4981-9ed5-0ffc59eace0b"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i963ab4965b694b1ab2ca7c95c80d6a68_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNy0xLTEtMzAzMA_356f9fb9-54be-41ec-851c-618bd8f2fb06"
      unitRef="usd">-139000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2fd07fac1f2c4ee7b985bcbb9e9e40cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtOS0xLTEtMzAzNA_b651f5e8-6a4a-4f35-9eac-b2924b4efee2"
      unitRef="usd">13825000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i474dfc678b2e48f7b2fd713e31a2915a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMS0xLTEtMA_1654ea18-113e-4d51-98fb-d5c9ecc5ceb7"
      unitRef="usd">3719000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtMy0xLTEtMA_45d5b0c8-05af-41d1-a36e-ac65957d56c7"
      unitRef="usd">2126000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNS0xLTEtMA_d573c025-5950-4a3b-9672-60924af07666"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i634cc8f5164246f487b40cd525f33427_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtNy0xLTEtMA_37f2b98a-7a97-401c-9a35-266a3b11dc72"
      unitRef="usd">1542000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzQtOS0xLTEtMA_aa5cfce7-274e-4915-b27c-a3fcc5c35951"
      unitRef="usd">4303000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied10a71639c3481ba9aefa7b862c3fbf_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMS0xLTEtMA_8b0ee202-ad37-4e8a-98a8-a27e64a078e2"
      unitRef="usd">6973000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtMy0xLTEtMA_38efb1f2-c894-4529-9f5a-dceeabf933fc"
      unitRef="usd">3848000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNS0xLTEtMA_73e2be60-a1a3-4c5d-871a-2e425db01f56"
      unitRef="usd">1291000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i598af0a069ca4733b335e5c40a4e70ec_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtNy0xLTEtMA_4115fbf6-d137-4ecb-996b-e3bbc7d23f56"
      unitRef="usd">43000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0c8d0b64387943148ed765fd23753bc5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzUtOS0xLTEtMA_55ff0569-6e73-43eb-9697-9d1996111361"
      unitRef="usd">12069000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5ab29dbb0b9741c09878d1f0e26205c2_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctMS0xLTEtMA_d9113279-cdc8-4589-9a90-0256fae3fe0b"
      unitRef="usd">8882000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctMy0xLTEtMA_d84262bb-89c1-4c4d-9db3-df77d3e445ad"
      unitRef="usd">557000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctNS0xLTEtMA_6261884d-906e-4136-93fe-0f5bede9372d"
      unitRef="usd">-4649000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id2ed77969f5e4d15a963bdc087bfcf6c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctNy0xLTEtMA_11bd16f2-8bd4-4791-92f6-9167ebb2b8e9"
      unitRef="usd">1071000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i474dfc678b2e48f7b2fd713e31a2915a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzctOS0xLTEtMA_b49ba2af-cf5d-4b54-aca1-cc837f378524"
      unitRef="usd">3719000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i44ad85cfd93e4d96b0dd6c63182cff35_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtMS0xLTEtMA_45d07768-1e72-4745-981f-771b0b20a345"
      unitRef="usd">7961000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtMy0xLTEtMA_197ccaeb-5fd8-47e3-b6dd-c8023a9d8f4a"
      unitRef="usd">-894000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtNS0xLTEtMA_cfe68cda-877f-4f78-a615-136d2a35f4ab"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i9f5a0735c3414cf58b45a00e20de75cf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtNy0xLTEtMA_a8ba03bf-970f-46e2-8f1f-c51985b6f67f"
      unitRef="usd">94000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied10a71639c3481ba9aefa7b862c3fbf_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8yNDQvZnJhZzo3N2E3NzJkNDkwYjk0NzRjYWVmZWM3MzM0ODkyZjhkYS90YWJsZTo0YTYzZDlmNzAzMjk0ZjRmOGUwYTljZWUxYjUwYjliOC90YWJsZXJhbmdlOjRhNjNkOWY3MDMyOTRmNGY4ZTBhOWNlZTFiNTBiOWI4XzgtOS0xLTEtMA_7001acb6-e848-4542-ad85-3151808b9581"
      unitRef="usd">6973000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627871367272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 19, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,370.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,369,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;14, 2021 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627922461416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
<td class="nump">$ 1,472,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">520,834<span></span>
</td>
<td class="nump">564,681<span></span>
</td>
<td class="nump">571,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">77,381<span></span>
</td>
<td class="nump">79,573<span></span>
</td>
<td class="nump">78,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,916<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">594,526<span></span>
</td>
<td class="nump">687,599<span></span>
</td>
<td class="nump">690,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">27,757<span></span>
</td>
<td class="nump">27,028<span></span>
</td>
<td class="nump">21,160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,220,498<span></span>
</td>
<td class="nump">1,423,797<span></span>
</td>
<td class="nump">1,361,443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">151,370<span></span>
</td>
<td class="nump">93,760<span></span>
</td>
<td class="nump">110,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">9,297<span></span>
</td>
<td class="nump">10,779<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(71,581)<span></span>
</td>
<td class="num">(53,957)<span></span>
</td>
<td class="num">(64,683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">4,434<span></span>
</td>
<td class="nump">9,522<span></span>
</td>
<td class="nump">8,288<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">93,520<span></span>
</td>
<td class="nump">60,104<span></span>
</td>
<td class="nump">57,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="num">(40,372)<span></span>
</td>
<td class="nump">9,903<span></span>
</td>
<td class="num">(3,398)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding (See Note 14):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
<td class="nump">82,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">85,228<span></span>
</td>
<td class="nump">86,494<span></span>
</td>
<td class="nump">83,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627877672120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in foreign currency translation adjustments</a></td>
<td class="nump">53,363<span></span>
</td>
<td class="num">(174)<span></span>
</td>
<td class="num">(19,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gain (loss) on derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized derivative gain (loss) arising during period</a></td>
<td class="num">(96,837)<span></span>
</td>
<td class="num">(13,671)<span></span>
</td>
<td class="nump">11,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Less: Reclassification adjustments for gain (loss) included in net income</a></td>
<td class="num">(24,442)<span></span>
</td>
<td class="nump">14,865<span></span>
</td>
<td class="nump">13,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Unrealized loss on derivatives</a></td>
<td class="num">(72,395)<span></span>
</td>
<td class="num">(28,536)<span></span>
</td>
<td class="num">(1,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Defined benefit pension plan - net gain (loss) arising during period</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="num">(8,973)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Total other comprehensive loss, before tax</a></td>
<td class="num">(14,428)<span></span>
</td>
<td class="num">(37,683)<span></span>
</td>
<td class="num">(21,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense) related to items in other comprehensive loss</a></td>
<td class="nump">16,771<span></span>
</td>
<td class="nump">6,724<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
<td class="num">(21,636)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income, net of tax</a></td>
<td class="nump">$ 136,235<span></span>
</td>
<td class="nump">$ 19,242<span></span>
</td>
<td class="nump">$ 39,165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627877740248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 470,166<span></span>
</td>
<td class="nump">$ 198,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowances of $6,439 and $4,303</a></td>
<td class="nump">225,532<span></span>
</td>
<td class="nump">275,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">310,117<span></span>
</td>
<td class="nump">316,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">162,105<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">69,282<span></span>
</td>
<td class="nump">67,907<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,237,202<span></span>
</td>
<td class="nump">858,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">287,529<span></span>
</td>
<td class="nump">337,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="nump">83,635<span></span>
</td>
<td class="nump">94,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">989,436<span></span>
</td>
<td class="nump">1,031,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">932,367<span></span>
</td>
<td class="nump">954,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">73,690<span></span>
</td>
<td class="nump">12,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">11,277<span></span>
</td>
<td class="nump">14,644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,615,136<span></span>
</td>
<td class="nump">3,303,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of borrowings under senior credit facility</a></td>
<td class="nump">33,750<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent', window );">Current portion of borrowings under securitization facility</a></td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">12,818<span></span>
</td>
<td class="nump">12,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">54,608<span></span>
</td>
<td class="nump">113,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">5,275<span></span>
</td>
<td class="nump">4,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">76,117<span></span>
</td>
<td class="nump">79,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">11,751<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">94,194<span></span>
</td>
<td class="nump">76,809<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">401,013<span></span>
</td>
<td class="nump">331,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term borrowings under senior credit facility</a></td>
<td class="nump">933,387<span></span>
</td>
<td class="nump">1,198,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent', window );">Long-term borrowings under securitization facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">104,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">474,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">88,118<span></span>
</td>
<td class="nump">97,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">16,190<span></span>
</td>
<td class="nump">36,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">186,727<span></span>
</td>
<td class="nump">118,077<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,100,269<span></span>
</td>
<td class="nump">1,886,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 240,000 authorized shares; 89,251 and 88,735 issued at December&#160;31, 2020 and 2019, respectively</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,290,909<span></span>
</td>
<td class="nump">1,213,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 4,914 and 2,865 shares at December&#160;31, 2020 and 2019, respectively</a></td>
<td class="num">(235,141)<span></span>
</td>
<td class="num">(119,943)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">532,265<span></span>
</td>
<td class="nump">398,574<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,514,867<span></span>
</td>
<td class="nump">1,416,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 3,615,136<span></span>
</td>
<td class="nump">$ 3,303,240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873883736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowances</a></td>
<td class="nump">$ 6,439<span></span>
</td>
<td class="nump">$ 4,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNoParValue', window );">Preferred Stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, authorized shares (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares (in shares)</a></td>
<td class="nump">240,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">89,251,000<span></span>
</td>
<td class="nump">88,735,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost; shares (in shares)</a></td>
<td class="nump">4,914,000<span></span>
</td>
<td class="nump">2,865,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870358200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">116,031<span></span>
</td>
<td class="nump">109,462<span></span>
</td>
<td class="nump">110,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment', window );">Non-cash in-process research and development expense</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">64,916<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Non-cash impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,764<span></span>
</td>
<td class="nump">4,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(64,138)<span></span>
</td>
<td class="num">(19,046)<span></span>
</td>
<td class="num">(8,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">19,590<span></span>
</td>
<td class="nump">21,255<span></span>
</td>
<td class="nump">20,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees', window );">Amortization of debt issuance costs and expenses associated with debt refinancing</a></td>
<td class="nump">12,076<span></span>
</td>
<td class="nump">5,390<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">2,955<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of bond issuance discount</a></td>
<td class="nump">15,415<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress', window );">Loss on disposal of property and equipment and construction in-progress</a></td>
<td class="nump">7,855<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration and others</a></td>
<td class="nump">951<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">52,105<span></span>
</td>
<td class="num">(9,428)<span></span>
</td>
<td class="num">(17,021)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(48,348)<span></span>
</td>
<td class="num">(43,308)<span></span>
</td>
<td class="nump">8,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">13,071<span></span>
</td>
<td class="nump">3,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other non-current assets</a></td>
<td class="nump">13,735<span></span>
</td>
<td class="nump">13,156<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other current liabilities</a></td>
<td class="num">(57,512)<span></span>
</td>
<td class="nump">14,666<span></span>
</td>
<td class="nump">3,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(607)<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="num">(2,889)<span></span>
</td>
<td class="num">(2,059)<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">203,832<span></span>
</td>
<td class="nump">231,433<span></span>
</td>
<td class="nump">199,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(38,890)<span></span>
</td>
<td class="num">(69,537)<span></span>
</td>
<td class="num">(77,741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets', window );">Acquired in-process research and development and intangibles</a></td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(64,995)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">752<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForProceedsFromBusinessAcquisitions', window );">Cash used in business acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,509)<span></span>
</td>
<td class="nump">26,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property and equipment</a></td>
<td class="nump">3,657<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities', window );">Net proceeds(payments) on swaps designated as net investment hedges</a></td>
<td class="num">(7,840)<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(68,073)<span></span>
</td>
<td class="num">(162,668)<span></span>
</td>
<td class="num">(49,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from borrowings of long-term indebtedness</a></td>
<td class="nump">171,500<span></span>
</td>
<td class="nump">236,900<span></span>
</td>
<td class="nump">171,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on debt</a></td>
<td class="num">(441,000)<span></span>
</td>
<td class="num">(246,100)<span></span>
</td>
<td class="num">(660,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Purchase of option hedge on convertible notes</a></td>
<td class="num">(104,248)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes issuance</a></td>
<td class="nump">575,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of stock purchase warrants</a></td>
<td class="nump">44,563<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(24,347)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,037)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercised stock options</a></td>
<td class="nump">5,232<span></span>
</td>
<td class="nump">6,948<span></span>
</td>
<td class="nump">9,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Net cash paid for contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(38,196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">349,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash taxes paid in net equity settlement</a></td>
<td class="num">(5,075)<span></span>
</td>
<td class="num">(6,514)<span></span>
</td>
<td class="num">(7,821)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">121,625<span></span>
</td>
<td class="num">(8,766)<span></span>
</td>
<td class="num">(180,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">13,871<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="num">(5,203)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">271,255<span></span>
</td>
<td class="nump">60,073<span></span>
</td>
<td class="num">(36,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">198,911<span></span>
</td>
<td class="nump">138,838<span></span>
</td>
<td class="nump">174,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 470,166<span></span>
</td>
<td class="nump">$ 198,911<span></span>
</td>
<td class="nump">$ 138,838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs And Debt Refinanced Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash, In Process Research And Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashOrPartNoncashInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForProceedsFromBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Business Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForProceedsFromBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire In Process Research And Development And Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627797746872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,306,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period at Dec. 31, 2017</a></td>
<td class="nump">$ 962,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 813<span></span>
</td>
<td class="num">$ (121,644)<span></span>
</td>
<td class="nump">$ 821,758<span></span>
</td>
<td class="num">$ (23,807)<span></span>
</td>
<td class="nump">$ 285,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period (Accounting Standards Update 2014-09) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,854<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, Beginning of Period, Treasury Stock (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,927,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect', window );">Adoption of Update No. 2018-02</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">60,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(21,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 1,030<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,038,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity offering</a></td>
<td class="nump">349,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">20,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,044,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2018</a></td>
<td class="nump">1,375,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 880<span></span>
</td>
<td class="num">$ (120,615)<span></span>
</td>
<td class="nump">1,192,601<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
<td class="nump">348,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,881,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">50,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(30,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 21,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2019</a></td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="nump">$ 887<span></span>
</td>
<td class="num">$ (119,943)<span></span>
</td>
<td class="nump">1,213,620<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
<td class="nump">398,574<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2019</a></td>
<td class="num">(2,865,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,865,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">19,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Share repurchase and equity component of the convertible note issuance, net</a></td>
<td class="nump">$ 42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (in shares)</a></td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,060,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115,724)<span></span>
</td>
<td class="nump">15,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2020</a></td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 893<span></span>
</td>
<td class="num">$ (235,141)<span></span>
</td>
<td class="nump">$ 1,290,908<span></span>
</td>
<td class="num">$ (74,059)<span></span>
</td>
<td class="nump">$ 532,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2020</a></td>
<td class="num">(4,914,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,914,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accumulated other comprehensive income (AOCI) for reclassification to retained earnings of tax effect from remeasurement of deferred tax pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL116659650-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795122312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">BUSINESS</a></td>
<td class="text">BUSINESSIntegra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company, a worldwide leader in medical devices, is dedicated to limiting uncertainty for surgeons through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Its products are used primarily in neurosurgery,  reconstruction and general surgery. The Company sells its products directly through various sales forces and through a variety of other distribution channels.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795395992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BASIS OF PRESENTATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany accounts and transactions are eliminated in consolidation. See Note&#160;5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">USE OF ESTIMATES </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. The novel coronavirus (&#8220;COVID-19&#8221;) pandemic and the resulting adverse impacts to global economic conditions, as well as our operations, may impact future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors.  The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for doubtful accounts net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, were $3.6 million, $2.1 million, and $0.6 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2020 or 2019. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,849)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284,601)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $37.9 million of  property, plant and equipment, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipment was $42.1 million, $42.6 million, and $44.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company wrote-off certain construction in progress of $6.7&#160;million related to a manufacturing project that the Company decided to discontinue. The Company determined that the carrying amounts of these assets were not recoverable.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAPITALIZED INTEREST</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2020 and 2019, respectively, the Company capitalized $2.3 million and $3.1 million of interest expense into property, plant and equipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired Company are expensed as incurred. The operating results of the acquired business are reflected in the consolidated financial statements after the date of acquisition. Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. Contingent consideration is recognized at the estimated fair value on the acquisition date. Subsequent changes to the fair value of contingent payments are recognized in selling, general and administrative expense in consolidated statements of operations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#8217;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company acquires a business, the assets acquired, including IPR&amp;D, and liabilities assumed are recorded at their respective fair values as of the acquisition date. The Company's policy defines IPR&amp;D as the fair value of those projects for which the related products have not received regulatory approval and have no alternative future use. Determining the fair value of intangible assets, including IPR&amp;D, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LONG-LIVED ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INTEGRA FOUNDATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $0.8 million, $0.3 million and $0.8 million to the Integra Foundation during the years ended December&#160;31, 2020, 2019 and 2018, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a foreign currency forward contract that is not designated as a hedging instrument for accounting purposes. This contract is recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FOREIGN CURRENCY </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction losses of $1.6 million, $0.3 million and $1.7 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next  twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. The Tax Cuts and Jobs Act (the &#8220;2017 Tax Act&#8221;), enacted in December 2017, </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imposed a toll tax on a deemed repatriation of undistributed earnings of foreign subsidiaries. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company incurred restructuring costs of $4.9&#160;million in cost of goods sold, $1.2&#160;million in selling, general and administrative and $0.3&#160;million in research and development related to employee terminations associated with a future plant closure in the consolidated statement of operations. As of December&#160;31, 2020, the restructuring costs of $6.4&#160;million were included in other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">STOCK-BASED COMPENSATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the &#8220;Plan&#8221;). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed  by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the New Lease Standard). The New Lease Standard requires that lessees recognize virtually all of its leases on the balance sheet by recording a right-of-use asset and lease liability (other than leases that meet the definition of a "short-term lease"). This update became effective for all annual periods and interim reporting periods beginning after December 15, 2018. The Company adopted the New Lease Standard as of January 1, 2019 using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. The Company elected the &#8216;package of practical expedients&#8217; which permits the Company not to reassess the prior conclusions about lease identification, lease classification and initial direct costs under the new standard. The Company also </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elected the use-of-hindsight practical expedient. As most of the leases do not provide an implicit rate, the Company used the collateralized incremental borrowing rate based on the information available at the lease implementation date in determining the present value of the lease payments. The adoption of the New Lease Standard had an initial impact on the consolidated balance sheet due to the recognition of $76.4&#160;million of lease liabilities with corresponding right-of-use assets ("ROU") of $67.3&#160;million for operating leases. The difference between lease liabilities and right-of-use assets is primarily attributed to unamortized lease incentives which is amortized over the term of each respective lease. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Related Party Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. The ASU became effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance for the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill.  The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted.  The Company will adopt ASU No. 2019-12 effective January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively.  The Company does not expect this guidance to have a material impact on our results or financial position.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU became effective immediately and may be applied prospectively to contract modifications made and hedging </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships entered into or evaluated on or before December 31, 2022.&#160;In January of 2021, the FASB also issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU No. 2020-04. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.&#160;The Company will adopt this standard on January 1, 2021 using the modified retrospective method. The estimated impact includes the convertible debt instrument being accounted for as a single liability measured at its amortized cost and elimination of the non-cash interest expense as the Company will not separately present the equity embedded conversion feature in such debt. The Company also expects to adopt the if-converted method for earnings per share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC&#8217;s regulations. The Company will adopt ASU 2020-10 as of the reporting period beginning January 1, 2021. The adoption of this update is not expected to have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have a significant effect on the Company's financial position, results of operations or cash flows.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2020, 2019 and 2018 was $47.3 million (net of $2.3 million that was capitalized into construction in progress), $48.9 million (net of $3.1 million that was capitalized into construction in progress) and $58.3 million (net of $2.3 million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2020, 2019 and 2018 was $29.8 million, $16.2 million and $10.4 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING  AND FINANCING ACTIVITIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2020, 2019 and 2018 were $1.6 million, $11.0 million and $5.4 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company achieved the first developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). In addition, the Company recorded $5.0&#160;million as in-process research and development expense in the consolidated statements of operations. The obligation was included in accrued liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795358520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ASSETS AND LIABILITIES HELD FOR SALE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">ASSETS AND LIABILITIES HELD FOR SALE</a></td>
<td class="text">ASSETS AND LIABILITIES HELD FOR SALE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2020, the Company and certain of its subsidiaries entered into an agreement to sell its Extremity Orthopedics business to Smith &amp; Nephew USD Limited for approximately $240&#160;million in cash. The transaction includes the sale of the Company&#8217;s upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. In connection with the transaction, the Company will pay $41.5&#160;million to the Consortium of Focused Orthopedists,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> LLC (&#8220;CFO&#8221;) pursuant to the terms of certain agreements between Integra and CFO relating to the development of shoulder arthroplasty products.  On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited and received an aggregate purchase price of $240.0&#160;million. Refer to Note 18. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for details of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the assets and liabilities associated with the Extremity Orthopedics business to be accounted as held for-sale as the six criteria under ASC 260 were met during the third quarter of 2020. Upon designation of the assets and liabilities as held for sale, the Company recorded the assets at the lower of their carrying value or their estimated fair value, less </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated costs to sell. Goodwill was allocated to the assets and liabilities held for sale using the relative fair value method of the Extremity Orthopedics business to the Company's Orthopedics and Tissue Technologies reporting unit. The fair value of the business less costs to sell exceeded the related carrying value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Extremity Orthopedics business was treated as a single disposal group and presented separately in the consolidated balance sheet as assets and liabilities held for sale as of December&#160;31, 2020. These balances are presented as current assets and liabilities as they are expected to be sold within twelve months. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities classified as a held for sale consisted of the following as of December&#160;31, 2020 (amounts in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796611368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES FROM CONTRACTS WITH CUSTOMERS</a></td>
<td class="text">REVENUES FROM CONTRACTS WITH CUSTOMERS<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>     in beginning of the year contract asset </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the short-term portion of the contract liability of $5.3 million and the long-term portion of $6.7 million were included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company is expected to recognize revenue of approximately $5.3 million in 2021, $2.9 million in 2022, $1.5 million in 2023, $0.8 million in 2024, $0.6 million in 2025, and $0.9 million thereafter.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shipping and Handling Fees</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2020, 2019 and 2018 (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Orthopedics and Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified between categories within the Codman Specialty Surgical segment to conform to the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795365528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock', window );">ACQUISITIONS</a></td>
<td class="text">ACQUISITIONS <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, the Company acquired Arkis BioSciences Inc. ("Arkis") for an acquisition purchase price of $30.6 million (the "Arkis Acquisition") plus contingent consideration of up to $25.5 million, that may be payable based on the successful completion of certain development and commercial milestones. The contingent consideration had an acquisition date fair value of $13.1 million. Arkis was a privately-held company that marketed the CerebroFlo&#174; external ventricular drainage (EVD) catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arkis Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the intangible assets was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of the cash flows an asset would generate over its remaining useful life. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each asset (including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, and working capital/contributory asset charges), the appropriate discount rate to select in order to </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of 14.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the Arkis Acquisition to the Codman Specialty Surgical segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. One of the key factors that contributes to the recognition of goodwill, and a driver for the Company's acquisition of Arkis, is the planned expansion of the Endexo technology with the existing products within the Codman Specialty Surgical segment. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level&#160;3 measurement as defined using the fair value concepts in ASC 820. The resultant probability-weighted cash flows are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue estimates and changes in probability assumptions with respect to the likelihood of achieving the various contingent payment obligations. Adverse changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of  $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of December&#160;31, 2020 was $15.1 million. The Company recorded $3.4 million in accrued expenses and other current liabilities and $11.7 million in other liabilities at December&#160;31, 2020 in the consolidated balance sheets of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results are not presented for this acquisition as they are not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Rebound Therapeutics Corporation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2019, the Company acquired Rebound Therapeutics Corporation (&#8220;Rebound&#8221;), developers of a single-use medical device known as the AURORA Surgiscope&#174; System ("Aurora") which enables minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery (the &#8220;Rebound transaction&#8221;). Under the terms of the Rebound transaction, the Company made an upfront payment of  $67.1 million and are committed to pay up to $35.0 million of contingent development milestones upon achievement of certain regulatory milestones.&#160;The acquisition of Rebound was primarily concentrated in one single identifiable asset and thus, for accounting purposes, the Company has concluded that the acquired assets do not meet the accounting definition of a business. The initial payment was allocated primarily to Aurora, resulting in a $59.9 million IPR&amp;D expense. The balance of approximately $7.2 million, which included $2.1 million of cash and cash equivalents and a net deferred tax asset of $4.2 million, was allocated to the remaining net assets acquired. The deferred tax asset primarily resulted from a federal net operating loss carry forward. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company achieved the first developmental milestone which triggered a $5.0 million obligation to be paid to former shareholders of Rebound. The Company recorded $5.0 million as IPR&amp;D expense in the consolidated statements of operations. The obligation was included in accrued expenses and other current liabilities at December 31, 2019 in the consolidated balance sheets. The milestone was paid during the first quarter of 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Integrated Shoulder Collaboration, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2019, the Company entered into a licensing agreement with Integrated Shoulder Collaboration, Inc ("ISC"). Under the terms of the agreement, the Company paid ISC $1.7 million for the exclusive, worldwide license to commercialize its short stem and stemless shoulder system. A patent related to short stem and stemless shoulder systems was issued to ISC during the first quarter of 2019. ISC is eligible to receive royalties on sales of the short stem and stemless shoulder system. The Company has the option to acquire ISC at a date four years subsequent to the first commercial sale, which becomes mandatory upon the achievement of a certain sales thresholds of the short stem and stemless shoulder system, for an amount not to exceed  $80.0 million. The transaction was accounted for as an asset acquisition as the Company concluded that it acquired primarily one asset. The total upfront payment of $1.7 million was expensed as a component of research and development expense and the future milestone and option payments will be recorded if the corresponding events become probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the Company's Extremity Orthopedic business, on January 4, 2021 the Company paid $41.5&#160;million to CFO pursuant to the terms of certain agreements between the Company and CFO relating to the sale of shares of ISC effectively terminating our licensing agreement with ISC. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for details of the transaction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795371368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60.0 million sublimit for the issuance of standby letters of credit and a $60.0 million sublimit for swingline loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2020, the Company entered into an amendment (the "July 2020 Amendment") to the February 2020 Amendment of the Senior Credit Facility to increase financial flexibility in light of the unprecedented impact and uncertainty of the COVID-19 pandemic on the global economy. The July 2020 amendment does not increase the Company&#8217;s total indebtedness.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 14, 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus 1.00% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA as defined by the July 2020 amendment, for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from &#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2020, the Company was in compliance with all such covenants and is expected to be in compliance over the next year. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment,  the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, there was $97.5 million and $375.0 million outstanding, respectively, under the revolving portion of the Senior Credit Facility at weighted average interest rates of 1.5% and 3.2%, respectively. At December&#160;31, 2020 and 2019, there was $877.5 million outstanding, respectively, under the Term Loan component of the Senior Credit Facility at weighted average interest rates of 1.5% and 3.2%, respectively. At December&#160;31, 2020, $33.8 million million of the Term Loan component of the Senior Credit Facility is classified as current on the consolidated balance sheet as the first mandatory repayment is due June 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's revolving credit facility and Term Loan component at December&#160;31, 2020 were approximately $98.4 million and $883.6 million, respectively. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2020 and 2019 totaled $1.6 million and $0.8 million, respectively. There were no amounts drawn as of December&#160;31, 2020.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Year-ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Repayment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,875</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million, and that amount is being amortized to interest expense using the effective interest method through August 2025. The effective interest rate implicit in the liability component is 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. At December&#160;31, 2020, the carrying amount of the liability component was $485.9&#160;million, the remaining unamortized discount was $89.1&#160;million, and the principal amount outstanding was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2020 was $638.1&#160;million.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified corporate transactions occur. As of December&#160;31, 2020, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, the Company recognized cash interest related to the contractual interest coupon of $2.6&#160;million and amortization of the discount on the liability component of $15.4&#160;million for a total interest charge of $18.0&#160;million on the 2025 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") is for an initial three-year term and may be extended. The Securitization Agreement governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2020, the Company was in compliance with the covenants and none of the termination events had occurred. The Company&#160;had $112.5 million and $104.5 million of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 1.3% and 2.8% as of December&#160;31, 2020 and 2019, respectively. At December&#160;31, 2020, the total amount outstanding under the Securitization Facility is classified as current on the consolidated balance sheet as the total amount is due on December 21, 2021.</span></div>The fair value of the outstanding borrowing of the Securitization facility at December&#160;31, 2020 was approximately $112.3 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795442712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,691)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total interest rate derivatives designated as cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,875,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,325,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies amounts recorded in AOCL to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $9.7&#160;million to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD") and intercompany receivables denominated in Japanese Yen ("JPY"). The contracts are not designated as hedging instruments. The Company recognized a $0.2&#160;million loss from the change in fair value of the contracts, which was included in other income, net in the consolidated statement of operations. The fair value of the foreign currency forward contracts was $0.2&#160;million as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF denominated intercompany loan into U.S. dollars. The CHF denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,335)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,262)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,843)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $33.3&#160;million. As a result of the settlement, the Company recorded a loss of $0.3&#160;million in other income, net in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with an aggregate notional amount of $66.7&#160;million. The original maturity dates were October 2, 2020 however, as the intercompany loan settlement was consummated, the cross-currency swap was settled simultaneously. As a result of the settlements, the Company recorded a loss of $0.4&#160;million in other income, net in the consolidated statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the years ended December&#160;31, 2020 and 2019, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss of $21.7 million and loss of $4.0 million, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation to offset the gains or losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded a loss of $17.1 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a gain of $9.3 million, respectively, in AOCL related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company recor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ded gains of $5.8 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $7.0 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to other income, net from AOCL as of December&#160;31, 2020 within the next twelve months is $3.3 million. As of December&#160;31, 2020, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,884)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,794)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $167.5&#160;million and 128.3&#160;million Pound Sterling respectively as a result of an intra-entity transfer of certain intellectual property rights to a subsidiary. The original settlement date was September 30, 2025. As a result of the settlement, the Company recorded a loss of $7.8&#160;million in AOCL.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company settled a cross-currency swap designated as a net-investment hedge of with an aggregate notional amount of $30.0&#160;million. The original termination date was September 30, 2021. As a result of the settlement, the Company recorded a gain of $1.6&#160;million in AOCL.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the year ended December&#160;31, 2020 and 2019, the Company recorded a loss of $14.9 million and a gain of $20.5 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2020 and 2019, the Company recorded a gain of $7.6 million and $9.6 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of December&#160;31, 2020 within the next twelve months is $3.4 million.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative designated as hedges &#8212; Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt">At December 31, 2020 and 2019, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.9&#160;billion and $1.3&#160;billion, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statements of operations during the years ended December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:26.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,836)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,203)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,671)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796599976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of its three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to perform a qualitative analysis for its three reporting units as of July 31, 2020. The Company determined, after performing qualitative analysis, that there was no evidence that it is more likely than not that the fair value of any identified reporting unit was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2020 and 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkis Acquisition</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,600&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,600&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954,280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale (See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434,953)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:53.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,702)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,196)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">At December&#160;31, 2020 and 2019, all other included IPR&amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details.  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, $13.3 million of Intangible assets, net were presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. The Company elected to bypass the qualitative evaluation for its Codman tradename intangible asset and perform quantitative test during the third quarter of 2020. In performing the test, the Company utilized a range of projected sales growth rates, a royalty rate of 5.0%, a tax rate of 24.0% and a discount rate of 11.5%. The assumptions used in evaluating the Codman tradename for impairment are subject to change and are tracked against historical results by management. Based on the results of the quantitative test, the Company recorded no impairment to the Codman tradename intangible asset.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, a contract manufacturing customer of the private label product line received a notification from the FDA ordering them to remove their product from the market. The Company recorded an impairment charge of $5.8 million in intangible asset amortization in the consolidated statement of operations related to the customer relationship intangible asset acquired from TEI Biosciences, Inc. and TEI Medical Inc. (collectively "TEI") due to revised future projections based on the contract termination.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2020, 2019 and 2018 was $74.5 million, $72.8 million and $71.6 million, respectively. Annual amortization expense is expected to approximate $63.8 million in 2021, $61.4 million in 2022, $60.7 million in 2023, $60.2 million in 2024, $60.2 million in 2025 and $512.3 million thereafter. Amortization of product technology based intangible assets totaled $46.7 million, $45.8 million and $50.4 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, and is presented by the Company within cost of goods sold.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627903612264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">TREASURY STOCK</a></td>
<td class="text">TREASURY STOCK<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019, there were 4.9 million and 2.9 million shares of treasury stock outstanding with a cost of $235.1 million and $119.9 million, at a weighted average cost per share of $47.86 and $41.87, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 7, 2020, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2022. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $125&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, the Company repurchased 2.1&#160;million shares of Integra&#8217;s common stock as part of the previous share repurchase authorization. The Company utilized $100.0&#160;million of net proceeds from the offering of the Convertible Senior Notes to execute the share repurchase transactions. This included $7.6&#160;million from certain purchasers of the convertible notes in conjunction with the closing of the offering. On February 5, 2020, the Company entered into a $92.4&#160;million accelerated share repurchase ("ASR") to complete the remaining $100.0&#160;million of share repurchase. The Company received 1.3&#160;million shares at inception of the ASR, which represented approximately 80% of the expected total shares. Upon settlement of the ASR in June 2020, the Company received an additional 0.6&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the transaction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869993096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2020, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2020, 2019 and 2018, the Company issued 18,284 shares, 12,531 shares and 16,721 shares under the ESPP for $1.1 million, $0.7 million and $0.7 million, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under three plans, the 2000 Equity Incentive Plan (the &#8220;2000 Plan&#8221;), the 2001 Equity Incentive Plan (the &#8220;2001 Plan&#8221;), and the 2003 Equity Incentive Plan (the &#8220;2003 Plan,&#8221; and collectively, (the &#8220;Plans&#8221;)).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the Plans become exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xOTYvZnJhZzozMjdlZjk3MDY1NDM0M2Q0YjBhMzEyNDE5Mzg0N2QwNS90ZXh0cmVnaW9uOjMyN2VmOTcwNjU0MzQzZDRiMGEzMTI0MTkzODQ3ZDA1XzIyNTI_0bee5ce3-e334-433a-bccf-d7c4674263bf">six</span> to ten years for directors and certain executive officers. Restricted stock issued under the Plans vests ratably over specified periods, generally three years after the date of grant.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.78</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.41</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881,261&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.19&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,197&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $3.2 million, $3.0 million and $2.6 million in expense related to stock options during the years ended December 31, 2020, 2019 and 2018, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2020, 2019 and 2018 were $8.7 million, $14.6 million and $16.9 million, respectively. Cash received from option exercises and employee stock purchase plan was $5.2 million, $6.9 million and $9.4 million, for the years ended December 31, 2020, 2019 and 2018, respectively. The realized tax benefit from options exercised were $1.7 million, $3.0 million and $3.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $5.1 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.02&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $16.4 million, $18.1 million and $18.1 million in expense related to such awards during the years ended December 31, 2020, 2019 and 2018, respectively. The total fair market value of shares vested and released in 2020, 2019 and 2018 was $17.3 million, $21.1 million and $24.8 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $22.6 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there were approximately 0.5 million vested Restricted Units and 0.1 million vested performance share units held by various employees for which the related shares have not yet been issued. The final determination of the number of shares to be issued is made by the Company's Compensation Committee of the Board of Directors which is is contingent upon achieving certain revenue and organic revenue growth performance metric.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, there were approximately 1.9 million shares available for grant under the Plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $0.4 million, $0.3 million and $0.4 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795342200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT BENEFIT PLANS</a></td>
<td class="text">RETIREMENT BENEFIT PLANS<div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2020 and 2019 included the following (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,047)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,007</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,693</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2020 and 2019, respectively:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2020 and 2019, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2020 and 2019 and a reconciliation of the funded status at December&#160;31, 2020 and 2019, respectively (amounts in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, the Company had a net gain of $4.6 million and a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net loss of $9.0 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2020, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $61.5 million and $61.1 million as of December&#160;31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had no assets at December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, no plan assets are expected to be returned to the Company in the next twelve months.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, contributions expected to be paid to the plan in 2021 is $2.3 million. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $6.7 million, $8.6 million and $8.1 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, employees participating in the Company's deferred compensation plan began to defer their compensation. This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2020 was $2.0 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795122312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES AND RELATED PARTY LEASES</a></td>
<td class="text">LEASES AND RELATED PARTY LEASES<div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2020. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2020 and December 31, 2019, was $19.7 million and $19.6&#160;million, respectively, which includes $0.3 million, in related party operating lease expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows for the year ended December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,861&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at December&#160;31, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795104888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> 2017 U.S. Tax Act was signed into law on December 22, 2017. The 2017 Tax Act made significant changes to the previous tax law, which included the reduction of the federal statutory rate from 35% to 21% and the recognition of a one-time repatriation tax on accumulated untaxed earnings of foreign subsidiaries. As of December 31, 2018, the Company finalized its calculations and completed its accounting for the income tax effect of the 2017 Tax Act, for which the finalization adjustments recognized during 2018 were not significant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A number of these provisions continue to have an impact on our effective tax rate, including limitations on the deductibility of executive compensation and the elimination of certain tax deductions. Additionally, the implementation of a territorial tax system, which subjects certain foreign earnings to additional taxation as global intangible low-taxed income, continues to adversely affect income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Changes in valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Carryback of Federal net operating loss ("NOL")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign-Derived Intangible Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Transfer of Intra-entity of certain intellectual property - Rate Differential <br/>on FMV Step-Up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Assets held for sale - Outside Basis Difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate was (43.2)% and 16.5% of income before income taxes for the years ended December&#160;31, 2020 and December 31, 2019, respectively. In 2020, the Company&#8217;s lower worldwide effective tax rate, as compared to 2019, is primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 is 20.2%.      </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $59.2&#160;million  deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, the Company&#8217;s foreign operations generated a $48.2&#160;million decrease in income tax expense when compared to the same period in 2019, because of the intra-entity transfer of certain intellectual property, geographic and business mix of taxable earnings and losses, among other factors. The 2020 foreign effective tax rate is (57.1)%, compared to 3.5% in 2019. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2019, the Company's foreign operations generated a $5.7 million decrease in income tax expense when compared with 2018, because of geographic and business mix of taxable earnings and losses, among other factors. The 2019 foreign effective tax rate is 3.5%, compared to 11.6% in 2018. The Company's foreign tax rate is primarily based upon statutory rates and is also impacted by the tax holiday in Switzerland, described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company finalized negotiations related to tax holidays in Switzerland, on a federal, cantonal, and communal level. The Company received a federal tax credit in Switzerland of $12.1 million ($0.14 per share), which may be used over a seven-year period, ending in 2024. The Company also received a reduction in its rate for the cantonal and communal level taxes during the third quarter of 2019, pursuant to tax reform in Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,046)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,398)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,583)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,930)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period amounts were reclassified as it relates to Leases and Other between deferred tax asset and liabilities within this table to conform to the current period presentation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company had net operating loss carryforwards of $90.2 million for federal income tax purposes, $36.7 million for foreign income tax purposes and $41.6 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $11.8 million have an indefinite carry forward period. For foreign net operating loss carryforwards, $0.3 million expire through 2025, and the remaining $36.4 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation allowance increased by less than $0.1 million, increased by $2.9 million and decreased by $1.0 million at December 31, 2020, 2019 and 2018, respectively. The 2020 valuation allowance primarily remained unchanged from the prior period.The 2019 overall increase in the valuation allowance primarily resulted from certain assets from the Rebound and Arkis acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested.&#160;Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;As such, the Company has determined the tax impact of repatriating these earnings would not be material as of December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Statute of limitations lapses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $0.7 million of the balance at December&#160;31, 2020 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. There are no amounts within the balance of uncertain tax positions at December&#160;31, 2020 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2020, 2019 and 2018. The Company had minimal interest and penalties accrued for the years ended December 31, 2020 and 2019 and 2018. </span></div>The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2016. All significant state and local matters have been concluded through fiscal 2015. All significant foreign matters have been settled through fiscal 2012.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795404744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately 0.3 million and 0.4 million shares at December&#160;31, 2020, and 2019 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div>Performance Shares and Restricted Units that entitle the holders to approximately 0.5 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795345544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2020 and 2019 are presented in the table below, net of tax:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:35.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,427)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,624)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,249)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company reclassified a loss of $12.2 million and $6.6&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795337416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2020 and 2019 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2020 and 2019 is as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.075%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions from acquisition of Arkis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796458088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC INFORMATION</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,160)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795427176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, upon the terms and conditions set forth in the Divestiture agreement (see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company completed its previously announced sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited. The Company received an aggregate purchase price of $240.0&#160;million from Smith and Nephew and concurrently paid $41.5&#160;million to CFO effectively terminating our licensing agreement (see Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ACell Inc. Acquisition</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell, Inc. for an acquisition purchase price of $300&#160;million. Under the terms of the definitive merger agreement, the Company paid the consideration for the merger as an upfront cash payment subject to a customary post-closing adjustment for certain working capital. The Company is also required to pay the former shareholders of ACell Inc. up to $100&#160;million based upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Equity Award Plans</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795416504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED QUARTERLY INFORMATION - UNAUDITED<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Selected Quarterly Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">SELECTED QUARTERLY INFORMATION - UNAUDITED</a></td>
<td class="text">SELECTED QUARTERLY INFORMATION - UNAUDITED<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:34.237%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross margin</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Basic (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Diluted (1)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company&#8217;s issuing and repurchasing shares of its common stock during the year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelectedQuarterlyFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795408968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.690%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The Company transferred sales returns and allowances from accounts receivable, net to accrued expenses and other current liabilities upon adopting Topic 606 on January 1, 2018 using the modified retrospective method.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870466296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis Of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles Of Consolidation</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany accounts and transactions are eliminated in consolidation. See Note&#160;5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, in-process research and development ("IPR&amp;D"), valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from the prior year's financial statements have been reclassified in order to conform to the current year's presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash And Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div>The Company evaluates the collectability of accounts receivable based on a combination of factors.  The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, $52.8&#160;million of inventories, net was presented separately as "Assets held for sale" in conjunction with the sale of the Extremity Orthopedics business. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div>The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant And Equipment</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock', window );">Capitalized Interest</a></td>
<td class="text">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired Company are expensed as incurred. The operating results of the acquired business are reflected in the consolidated financial statements after the date of acquisition. Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. Contingent consideration is recognized at the estimated fair value on the acquisition date. Subsequent changes to the fair value of contingent payments are recognized in selling, general and administrative expense in consolidated statements of operations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. The fair value of development, regulatory, and commercial milestone payments reflects management&#8217;s expectations of the probability of payment and increases or&#160;decreases as the probability of payment or expectation of timing of payments changes. The fair value of sales-based payments is based upon probability-weighted future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payments changes.</span></div>If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill And Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350 and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company acquires a business, the assets acquired, including IPR&amp;D, and liabilities assumed are recorded at their respective fair values as of the acquisition date. The Company's policy defines IPR&amp;D as the fair value of those projects for which the related products have not received regulatory approval and have no alternative future use. Determining the fair value of intangible assets, including IPR&amp;D, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.</span></div>Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FoundationPolicyTextBlock', window );">Integra Foundation</a></td>
<td class="text">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;</span></div>The Company entered into a foreign currency forward contract that is not designated as a hedging instrument for accounting purposes. This contract is recorded at fair value, with the changes in fair value recognized into other income, net on the consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next  twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div>The Company continues to indefinitely reinvest substantially all of its foreign earnings. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;</span></div>Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research And Development</a></td>
<td class="text">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Employee Termination Benefits</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div>The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Benefits</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Company adopted the Integra LifeSciences Deferred Compensation Plan (the &#8220;Plan&#8221;). Under the Plan, certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div>This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the Plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the Plan. Any amounts set aside to defray the liabilities assumed  by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div>The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the New Lease Standard). The New Lease Standard requires that lessees recognize virtually all of its leases on the balance sheet by recording a right-of-use asset and lease liability (other than leases that meet the definition of a "short-term lease"). This update became effective for all annual periods and interim reporting periods beginning after December 15, 2018. The Company adopted the New Lease Standard as of January 1, 2019 using a modified retrospective transition. Under this method, financial results reported in periods prior to January 1, 2019 are unchanged. The Company elected the &#8216;package of practical expedients&#8217; which permits the Company not to reassess the prior conclusions about lease identification, lease classification and initial direct costs under the new standard. The Company also </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elected the use-of-hindsight practical expedient. As most of the leases do not provide an implicit rate, the Company used the collateralized incremental borrowing rate based on the information available at the lease implementation date in determining the present value of the lease payments. The adoption of the New Lease Standard had an initial impact on the consolidated balance sheet due to the recognition of $76.4&#160;million of lease liabilities with corresponding right-of-use assets ("ROU") of $67.3&#160;million for operating leases. The difference between lease liabilities and right-of-use assets is primarily attributed to unamortized lease incentives which is amortized over the term of each respective lease. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Related Party Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. The ASU became effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 is not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU&#160;2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans, including removing certain previous disclosure requirements, adding certain new disclosure requirements, and clarifying certain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption was permitted. The Company adopted this guidance for the year ended December 31, 2020. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued&#160;ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, relating to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (e.g., a service contract). Under this guidance, a customer will apply the same criteria for capitalizing implementation costs as it would for an arrangement that has a software license. The new guidance also prescribes the balance sheet, income statement, and cash flow classification of the capitalized implementation costs and related amortization expense, and requires additional quantitative and qualitative disclosures. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020 using a prospective transition method. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill.  The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted.  The Company will adopt ASU No. 2019-12 effective January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively.  The Company does not expect this guidance to have a material impact on our results or financial position.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting.&#160;This amendment applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.&#160;This ASU became effective immediately and may be applied prospectively to contract modifications made and hedging </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships entered into or evaluated on or before December 31, 2022.&#160;In January of 2021, the FASB also issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform- Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarified certain optional expedients and exceptions to entities that are affected because of the reference rate reform. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU No. 2020-04. The Company is currently assessing the impact that this ASU will have on its consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years.&#160;The Company will adopt this standard on January 1, 2021 using the modified retrospective method. The estimated impact includes the convertible debt instrument being accounted for as a single liability measured at its amortized cost and elimination of the non-cash interest expense as the Company will not separately present the equity embedded conversion feature in such debt. The Company also expects to adopt the if-converted method for earnings per share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC&#8217;s regulations. The Company will adopt ASU 2020-10 as of the reporting period beginning January 1, 2021. The adoption of this update is not expected to have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have a significant effect on the Company's financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Shipping and Handling Fees</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to all contracts which were not completed as of January 1, 2018. Results of operations for the reporting periods after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of Topic 606 resulted in an increase to the opening retained earnings of $1.9 million, which was recorded net of taxes as of January 1, 2018 to reflect the change in timing of the recognition of revenue related to the Company's private label business from point in time to over time during the manufacturing process and goods in transit for which control was transferred to customers at the time of shipment. The total assets and liabilities increased by $7.1 million and $5.2 million, respectively, as of January 1, 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjBlNjZiYmM3ZWU4MDQ5ZjI5ODRjZTgxNzlmODAzZWU1L3NlYzowZTY2YmJjN2VlODA0OWYyOTg0Y2U4MTc5ZjgwM2VlNV8xNTEvZnJhZzozMjU5MDk0OGU2NmU0MzdhOTkwMjllZWU4NjNiZjBkMC90ZXh0cmVnaW9uOjMyNTkwOTQ4ZTY2ZTQzN2E5OTAyOWVlZTg2M2JmMGQwXzIzOTUw_4eada68f-193f-4f31-b9ee-0adf3dd01661">one</span> to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized. &#160;&#160;</span></div>Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally ninety days. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock', window );">Taxes Collected from Customers</a></td>
<td class="text">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FoundationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foundation [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FoundationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for interest capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCapitalizationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 32<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=121321036&amp;loc=SL82860478-203043<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873234360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">Inventories consisted of the following: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical instrument kits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,849)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284,601)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795384456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ASSETS AND LIABILITIES HELD FOR SALE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Major Classes of Assets and Liabilities Held For Sale</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities classified as a held for sale consisted of the following as of December&#160;31, 2020 (amounts in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627797255944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Contract Assets and Contract Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable of contract asset included<br/>     in beginning of the year contract asset </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2020, 2019 and 2018 (amounts in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wound Reconstruction</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extremity Orthopedics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Orthopedics and Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873562488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CerebroFlo developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling technology license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795449320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Maximum Leverage Ratios</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the July 14, 2020 amendment, the Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of July 2020 Amendment through June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021 through June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Contractual Repayments of Debt</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Year-ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Repayment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,875</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870901400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2020 and 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 6, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 27, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,691)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total interest rate derivatives designated as cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,875,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,325,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,335)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,262)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,843)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,884)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,794)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2019 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,459&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receive GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative designated as hedges &#8212; Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt">At December 31, 2020 and 2019, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.9&#160;billion and $1.3&#160;billion, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statements of operations during the years ended December&#160;31, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:26.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,836)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,203)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,671)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,739)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870552200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2020 and 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkis Acquisition</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,600&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,600&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954,280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to assets held for sale (See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434,953)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:53.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,702)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,196)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">At December&#160;31, 2020 and 2019, all other included IPR&amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span>, for details.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434,953)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:53.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,702)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,196)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">At December&#160;31, 2020 and 2019, all other included IPR&amp;D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&amp;D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Held for Sale</span>, for details.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627793924952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary Of Employee Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary Of Weighted-Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.78</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary Of Stock Option Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.41</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881,261&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.19&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,197&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but not released</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.02&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795216936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2020 and 2019 included the following (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,047)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,007</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,693</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Assumptions Used</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2020 and 2019, respectively:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Benefit Obligations and Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2020 and 2019 and a reconciliation of the funded status at December&#160;31, 2020 and 2019, respectively (amounts in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plans transferred in</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Schedule of Funded Status</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627798745768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CashFlowLesseeTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows for the year ended December&#160;31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,861&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869319416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (Loss) before income taxes consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Changes in valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Carryback of Federal net operating loss ("NOL")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Swiss tax holiday</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign-Derived Intangible Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Transfer of Intra-entity of certain intellectual property - Rate Differential <br/>on FMV Step-Up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Assets held for sale - Outside Basis Difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,046)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,398)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,583)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,930)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Uncertain Tax Benefits Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Statute of limitations lapses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796549064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic And Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796803048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2020 and 2019 are presented in the table below, net of tax:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:35.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,427)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,624)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,249)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795179432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2020 and 2019 is as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.075%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Related to Acquisition of Arkis (See Note 5)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of Derma Sciences</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions from acquisition of Arkis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796606584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Net Sales and Profit, by Segment</a></td>
<td class="text">Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,160)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: <div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Geographic Revenue, by Area</a></td>
<td class="text">Net sales and profit by reportable segment for the years ended December&#160;31, 2020, 2019 and 2018 are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedics and Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,028)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,160)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: <div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes long-lived assets in Puerto Rico.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796819768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Selected Quarterly Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Selected Quarterly Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:34.237%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross margin</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Basic (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share - Diluted (1)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,201&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company&#8217;s issuing and repurchasing shares of its common stock during the year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelectedQuarterlyFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627874422280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>Customer </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_InventoryCapitalizedExpenses', window );">Inventory, capitalized expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,100,000<span></span>
</td>
<td class="nump">42,600,000<span></span>
</td>
<td class="nump">44,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Write off of construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalizedAdjustment', window );">Interest expense capitalized into property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CharitableContributions', window );">Contributions to Integra Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Increase to opening retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,514,867,000<span></span>
</td>
<td class="nump">$ 1,416,736,000<span></span>
</td>
<td class="nump">1,514,867,000<span></span>
</td>
<td class="nump">1,416,736,000<span></span>
</td>
<td class="nump">1,375,796,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962,306,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Increase to total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,615,136,000<span></span>
</td>
<td class="nump">3,303,240,000<span></span>
</td>
<td class="nump">3,615,136,000<span></span>
</td>
<td class="nump">3,303,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Increase to total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,269,000<span></span>
</td>
<td class="nump">1,886,504,000<span></span>
</td>
<td class="nump">2,100,269,000<span></span>
</td>
<td class="nump">1,886,504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,936,000<span></span>
</td>
<td class="nump">109,757,000<span></span>
</td>
<td class="nump">100,936,000<span></span>
</td>
<td class="nump">109,757,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,635,000<span></span>
</td>
<td class="nump">94,530,000<span></span>
</td>
<td class="nump">83,635,000<span></span>
</td>
<td class="nump">94,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,300,000<span></span>
</td>
<td class="nump">48,900,000<span></span>
</td>
<td class="nump">58,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest paid, capitalized into construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,800,000<span></span>
</td>
<td class="nump">16,200,000<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,916,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases included in liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">11,000,000.0<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,248,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,563,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, aggregate principal amount issued</a></td>
<td class="nump">$ 575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt, interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt, initial conversion rate</a></td>
<td class="nump">13.5739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">113.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2025 Notes | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Initial strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid', window );">Development milestone payment, to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark', window );">Concentration risk, number of customers over benchmark | Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Increase to opening retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,266,000<span></span>
</td>
<td class="nump">398,574,000<span></span>
</td>
<td class="nump">$ 532,266,000<span></span>
</td>
<td class="nump">$ 398,574,000<span></span>
</td>
<td class="nump">$ 348,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285,186,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Increase to opening retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Increase to total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Increase to total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Increase to opening retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,845,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,845,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CharitableContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charitable contributions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CharitableContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number of Customers Over Benchmark</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ConcentrationRiskNumberofCustomersOverBenchmark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InventoryCapitalizedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory, Capitalized Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InventoryCapitalizedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalizedAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalizedAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120519210&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869288680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 180,301<span></span>
</td>
<td class="nump">$ 201,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">53,336<span></span>
</td>
<td class="nump">48,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">76,480<span></span>
</td>
<td class="nump">65,851<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 310,117<span></span>
</td>
<td class="nump">$ 316,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627911578904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 570,378<span></span>
</td>
<td class="nump">$ 622,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(282,849)<span></span>
</td>
<td class="num">(284,601)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">287,529<span></span>
</td>
<td class="nump">337,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">1,541<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 17,345<span></span>
</td>
<td class="nump">16,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 144,852<span></span>
</td>
<td class="nump">114,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 166,973<span></span>
</td>
<td class="nump">155,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 1,164<span></span>
</td>
<td class="nump">33,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember', window );">Surgical instrument kits | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 143,770<span></span>
</td>
<td class="nump">138,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 20,843<span></span>
</td>
<td class="nump">22,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 73,890<span></span>
</td>
<td class="nump">$ 140,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_SurgicalInstrumentKitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873190536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details) - Smith &amp; Nephew USD Limited - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 04, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of Extremity Orthopedics business, disposition price</a></td>
<td class="nump">$ 240.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember', window );">Consortium of Focused Orthopedists, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of Extremity Orthopedics business, payment for terminating license agreement</a></td>
<td class="nump">$ 41.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869931336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details) - Smith &amp; Nephew USD Limited - Disposal Group, Disposed of by Sale, Not Discontinued Operations<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets', window );">Right of use asset - operating leases and Other assets</a></td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">6,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">13,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">37,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="nump">47,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">52,845<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">162,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation', window );">Accrued compensation</a></td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">3,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">5,669<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 11,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accrued Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Asset And Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873314056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment', window );">Number of days from shipment to issue a credit on returned goods</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Short-term portion of contract liability</a></td>
<td class="nump">$ 5,275<span></span>
</td>
<td class="nump">$ 4,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of contract liability</a></td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RevenueProductWarrantyPeriod', window );">Product warranty period (up to)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return Policy, Issue of Credit, Number of Days from Shipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Product Warranty Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627871089240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627794087752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, Beginning of period</a></td>
<td class="nump">$ 8,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Transferred to trade receivable of contract asset included in beginning of the year contract asset</a></td>
<td class="num">(8,680)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable', window );">Contract asset, net of transferred to trade receivables on contracts during the period</a></td>
<td class="nump">7,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, End of Period</a></td>
<td class="nump">7,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, Beginning of Period</a></td>
<td class="nump">11,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Recognition of revenue included in beginning of year contract liability</a></td>
<td class="num">(3,925)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation', window );">Contract liability, net of revenue recognized on contracts during the period</a></td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, End of Period</a></td>
<td class="nump">$ 11,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Net Of Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase From Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627799474872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 388,647<span></span>
</td>
<td class="nump">$ 370,232<span></span>
</td>
<td class="nump">$ 258,665<span></span>
</td>
<td class="nump">$ 354,324<span></span>
</td>
<td class="nump">$ 395,127<span></span>
</td>
<td class="nump">$ 379,095<span></span>
</td>
<td class="nump">$ 383,645<span></span>
</td>
<td class="nump">$ 359,690<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
<td class="nump">$ 1,472,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
<td class="nump">996,206<span></span>
</td>
<td class="nump">963,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Neurosurgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716,339<span></span>
</td>
<td class="nump">767,793<span></span>
</td>
<td class="nump">740,268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,492<span></span>
</td>
<td class="nump">228,413<span></span>
</td>
<td class="nump">223,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
<td class="nump">521,351<span></span>
</td>
<td class="nump">508,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies | Wound Reconstruction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,038<span></span>
</td>
<td class="nump">322,739<span></span>
</td>
<td class="nump">311,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,316<span></span>
</td>
<td class="nump">90,082<span></span>
</td>
<td class="nump">90,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies | Private Label</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,683<span></span>
</td>
<td class="nump">$ 108,530<span></span>
</td>
<td class="nump">$ 106,359<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_NeurosurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_NeurosurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_PrivateLabelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_PrivateLabelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870087832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS (Business Acquisition, Narrative) (Details) - Arkis - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 29, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of business combination</a></td>
<td class="nump">$ 30,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">25,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="nump">$ 15,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate', window );">Acquired intangible assets, discount rate</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Milestone Payment One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Milestone Payment Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcquiredFinitelivedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-lived Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcquiredFinitelivedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627911558952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 29, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IntangibleAssetsAbstract', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 932,367<span></span>
</td>
<td class="nump">$ 954,280<span></span>
</td>
<td class="nump">$ 926,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IntangibleAssetsAbstract', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">27,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">52,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">2,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="nump">13,100<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">5,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">30,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | CerebroFlo developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IntangibleAssetsAbstract', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 20,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Enabling technology license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IntangibleAssetsAbstract', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627871983912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Asset Acquisition, Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 09, 2019 </div>
<div>USD ($) </div>
<div>asset</div>
</th>
<th class="th">
<div>Jan. 04, 2019 </div>
<div>USD ($) </div>
<div>asset</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">IPR&amp;D expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 64,916,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,031,591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989,436,000<span></span>
</td>
<td class="nump">1,031,591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember', window );">Consortium of Focused Orthopedists, LLC | Subsequent Event | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of Extremity Orthopedics business, payment for terminating license agreement</a></td>
<td class="nump">$ 41,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionConsiderationTransferred', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet', window );">Contingent development milestone payments commitment (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionNumberOfAssetsAcquired', window );">Number of assets acquired | asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid', window );">Development milestone payment, to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">IPR&amp;D expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | Deferred Tax Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">Remaining net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound | IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionConsiderationTransferred', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member', window );">ISC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member', window );">ISC | Enabling technology license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ScheduleOfAssetAcquisitionLineItems', window );"><strong>Schedule Of Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionNumberOfAssetsAcquired', window );">Number of assets acquired | asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Upfront payment, intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet', window );">Option to acquire, period subsequent to first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet', window );">Maximum future purchase price, if circumstances met (not to exceed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Maximum Contingent Development Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionNumberOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Number Of Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionNumberOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ScheduleOfAssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Asset Acquisition [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ScheduleOfAssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_DeferredTaxAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_DeferredTaxAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionAxis=iart_IntegratedShoulderCollaborationInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627874256904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,750,000<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,834,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,248,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,563,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit', window );">Securitization facility, outstanding borrowings, maximum limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtAccountsReceivableSecuritizationTerm', window );">Securitization facility, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent', window );">Current portion of borrowings under securitization facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent', window );">Long-term borrowings under securitization facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtWeightedAverageInterestRateFromSecuritization', window );">Security facility, weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding', window );">Securitization facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,500,000<span></span>
</td>
<td class="nump">$ 375,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember', window );">Swingline Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Previously capitalized financing costs, written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Incremental financing cost expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Overnight Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | One-Month Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes, aggregate principal amount</a></td>
<td class="nump">$ 575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes, interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt proceeds, classified as equity at time of offering</a></td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate</a></td>
<td class="nump">13.5739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod', window );">Maximum selling price of the company's common stock of the conversion price</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes', window );">Maximum average conversion value of notes</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount', window );">Combination settlement for debt conversion, minimum settled in cash per principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 113.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Cash interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Initial strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtAccountsReceivableSecuritizationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt, Accounts Receivable Securitization, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtAccountsReceivableSecuritizationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Average Conversion Value Of Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumAverageConversionValueOfNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtWeightedAverageInterestRateFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt, Weighted Average Interest Rate, From Securitization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtWeightedAverageInterestRateFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securitization Facility, Fair Value Of Amount Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuritizationFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120519210&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869615032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Maximum Total Leverage Ratio Table) (Details) - Senior Credit Facility<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Execution of July 2020 Amendment through June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">5.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2021 through June 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2022 through June 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2023 and the last day of each fiscal quarter thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873746344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Schedule of Debt Maturity) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 33,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">61,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">669,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Principal Repayment</a></td>
<td class="nump">$ 877,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627797889848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 1,875,000,000<span></span>
</td>
<td class="nump">$ 1,325,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">(93,769,000)<span></span>
</td>
<td class="num">(45,145,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">3-month USD LIBOR | Interest Rate Swap Designated February 6, 2017 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.834%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated February 6, 2017 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.652%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated March 27, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.971%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (929,000)<span></span>
</td>
<td class="num">(581,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.201%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (6,152,000)<span></span>
</td>
<td class="num">(2,880,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.201%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (6,405,000)<span></span>
</td>
<td class="num">(2,880,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.423%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (7,724,000)<span></span>
</td>
<td class="num">(3,517,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.423%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (3,778,000)<span></span>
</td>
<td class="num">(1,778,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 13, 2017 Tranche 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.313%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (16,243,000)<span></span>
</td>
<td class="num">(6,595,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (9,836,000)<span></span>
</td>
<td class="num">(5,750,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.199%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (9,826,000)<span></span>
</td>
<td class="num">(5,747,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated October 10, 2018 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.209%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (9,783,000)<span></span>
</td>
<td class="num">(5,807,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 18, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.885%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (10,407,000)<span></span>
</td>
<td class="num">(4,930,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 18, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.867%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (10,431,000)<span></span>
</td>
<td class="num">(4,691,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 15, 2020 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (382,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 15, 2020 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.404%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (162,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 15, 2020 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (846,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 15, 2020 Tranche 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (679,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR | Interest Rate Swap Designated December 15, 2020 Tranche 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.404%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">$ (187,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_ThreeMonthUSDLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_ThreeMonthUSDLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedFebruary62017Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedFebruary62017Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedFebruary62017Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedFebruary62017Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch272017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch272017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627874037592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Narrative) (Details)<br> &#163; in Millions, SFr in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Loss recorded in other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,442,000<span></span>
</td>
<td class="num">$ (14,865,000)<span></span>
</td>
<td class="num">$ (13,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96,837,000)<span></span>
</td>
<td class="num">(13,671,000)<span></span>
</td>
<td class="nump">$ 11,709,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,920,000<span></span>
</td>
<td class="nump">12,920,000<span></span>
</td>
<td class="nump">16,461,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96,836,000)<span></span>
</td>
<td class="num">(13,671,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,875,000,000<span></span>
</td>
<td class="nump">1,875,000,000<span></span>
</td>
<td class="nump">1,325,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contract | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="nump">7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Loss recorded in other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,700,000<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,100,000)<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 33,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives', window );">Loss recorded, settlement of derivative</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Net Investment Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,500,000<span></span>
</td>
<td class="nump">167,500,000<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives', window );">Loss recorded, settlement of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded, net investment hedge, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,900,000)<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869209080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 1,875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,325,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">(93,769,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,145,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,300,000<span></span>
</td>
<td class="nump">66,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">(23,441,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(509,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">(4,335,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(119,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">(11,262,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (289,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Swap, Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">$ (7,843,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Long | Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 32,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Long | Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.85%<span></span>
</td>
<td class="nump">1.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.85%<span></span>
</td>
<td class="nump">1.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Long | Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 145,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 145,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Long | Swap, Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 420,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Short | Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.38%<span></span>
</td>
<td class="nump">4.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Short | Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">4.46%<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Short | Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">4.52%<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap | Short | Swap, Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">3.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 471,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iart_SwapFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869566264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)<br> &#8364; in Thousands, &#163; in Thousands, SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">$ (1,884,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,459,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">$ (450,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,032,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (154,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 128,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Five | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 165,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Five | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 128,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Contract Six</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">$ (3,794,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Contract Six | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 222,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Contract Six | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">167,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 128,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value (Liability)</a></td>
<td class="num">$ (6,036,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873660120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)<br> &#163; in Millions, SFr in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">$ 12,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,461,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">136,165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,470,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,325,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">22,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,635,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">71,736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,522,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,300,000<span></span>
</td>
<td class="nump">66,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">7,623,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,032,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">4,335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">26,728,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,440,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">167,500,000<span></span>
</td>
<td class="nump">&#163; 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">5,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,952,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,465,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">1,884,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Derivative designated as hedges &#8212; Liabilities</a></td>
<td class="nump">$ 9,449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,772,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627868933640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="nump">$ 1,375,796<span></span>
</td>
<td class="nump">$ 962,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(96,837)<span></span>
</td>
<td class="num">(13,671)<span></span>
</td>
<td class="nump">11,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">1,514,867<span></span>
</td>
<td class="nump">1,416,736<span></span>
</td>
<td class="nump">1,375,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(76,402)<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
<td class="num">(23,807)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(17,100)<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(96,836)<span></span>
</td>
<td class="num">(13,671)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="num">(24,442)<span></span>
</td>
<td class="nump">14,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(34,739)<span></span>
</td>
<td class="num">(6,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(107,133)<span></span>
</td>
<td class="num">(34,739)<span></span>
</td>
<td class="num">(6,203)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Interest expense | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(45,145)<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(64,778)<span></span>
</td>
<td class="num">(43,493)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="num">(16,154)<span></span>
</td>
<td class="nump">2,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(93,769)<span></span>
</td>
<td class="num">(45,145)<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Other income, net | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">177<span></span>
</td>
<td class="num">(6,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(17,147)<span></span>
</td>
<td class="nump">9,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="num">(15,897)<span></span>
</td>
<td class="nump">2,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(1,073)<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="num">(6,190)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Interest income | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">10,229<span></span>
</td>
<td class="num">(632)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(14,911)<span></span>
</td>
<td class="nump">20,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCL into Earnings</a></td>
<td class="nump">7,609<span></span>
</td>
<td class="nump">9,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">$ (12,291)<span></span>
</td>
<td class="nump">$ 10,229<span></span>
</td>
<td class="num">$ (632)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627799480776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,764,000<span></span>
</td>
<td class="nump">$ 4,941,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,500,000<span></span>
</td>
<td class="nump">72,800,000<span></span>
</td>
<td class="nump">71,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Expected annual amortization expense, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Expected annual amortization expense, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Expected annual amortization expense, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Expected annual amortization expense, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Expected annual amortization expense, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Expected annual amortization expense, thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,700,000<span></span>
</td>
<td class="nump">$ 45,800,000<span></span>
</td>
<td class="nump">$ 50,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_CodmanMember', window );">Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage', window );">Impairment assessment, royalty rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage', window );">Impairment assessment, tax rate</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage', window );">Intangible assets, indefinite life, discount rate percentage</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible assets, indefinite lives, impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember', window );">Contract Manufacturing Customer, Notified By FDA To Remove Product From Market | Private Label | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Impairment Assessment, Discount Rate Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Impairment Assessment, Royalty Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Impairment Assessment, Tax Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_CodmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_CodmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_PrivateLabelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_PrivateLabelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627877070184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">$ 954,280<span></span>
</td>
<td class="nump">$ 926,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">25,633<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale (See Note 3. Assets Held for Sale)</a></td>
<td class="num">(47,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">932,367<span></span>
</td>
<td class="nump">954,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Arkis Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">653,500<span></span>
</td>
<td class="nump">625,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">18,475<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale (See Note 3. Assets Held for Sale)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">671,975<span></span>
</td>
<td class="nump">653,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Arkis Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">300,780<span></span>
</td>
<td class="nump">300,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">7,158<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to assets held for sale (See Note 3. Assets Held for Sale)</a></td>
<td class="num">(47,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">$ 260,392<span></span>
</td>
<td class="nump">300,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies | Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Arkis Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870250296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,424,389<span></span>
</td>
<td class="nump">$ 1,415,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(434,953)<span></span>
</td>
<td class="num">(384,196)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">989,436<span></span>
</td>
<td class="nump">1,031,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Codman trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">170,226<span></span>
</td>
<td class="nump">163,126<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">170,226<span></span>
</td>
<td class="nump">163,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIndefiniteLivedIntangibleAssets', window );">IPR&amp;D, indefinite-lived, included in all other</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember', window );">Completed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">19 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 896,478<span></span>
</td>
<td class="nump">$ 880,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(248,088)<span></span>
</td>
<td class="num">(213,702)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 648,390<span></span>
</td>
<td class="nump">$ 666,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 213,270<span></span>
</td>
<td class="nump">$ 222,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(132,838)<span></span>
</td>
<td class="num">(119,393)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 80,432<span></span>
</td>
<td class="nump">$ 103,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember', window );">Trademarks/brand names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">28 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 104,209<span></span>
</td>
<td class="nump">$ 103,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31,767)<span></span>
</td>
<td class="num">(28,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 72,442<span></span>
</td>
<td class="nump">$ 75,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember', window );">Supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">27 years<span></span>
</td>
<td class="text">27 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 30,211<span></span>
</td>
<td class="nump">$ 34,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(15,203)<span></span>
</td>
<td class="num">(17,947)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 15,008<span></span>
</td>
<td class="nump">$ 16,774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 9,995<span></span>
</td>
<td class="nump">$ 10,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,057)<span></span>
</td>
<td class="num">(4,640)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 2,938<span></span>
</td>
<td class="nump">$ 6,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627874258888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 05, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
<th class="th"><div>Dec. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,100,000<span></span>
</td>
<td class="nump">$ 119,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.86<span></span>
</td>
<td class="nump">$ 41.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount under share repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase program, payment</a></td>
<td class="nump">$ 92,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased, amount</a></td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Certain Purchasers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from offering of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_CertainPurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_CertainPurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873793224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 19,591<span></span>
</td>
<td class="nump">$ 21,255<span></span>
</td>
<td class="nump">$ 20,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total estimated tax benefit related to stock-based compensation expense</a></td>
<td class="nump">6,221<span></span>
</td>
<td class="nump">9,420<span></span>
</td>
<td class="nump">10,430<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net effect on net income</a></td>
<td class="nump">13,370<span></span>
</td>
<td class="nump">11,835<span></span>
</td>
<td class="nump">10,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,471<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 17,776<span></span>
</td>
<td class="nump">$ 19,153<span></span>
</td>
<td class="nump">$ 18,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627894538232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2010 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>plan </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of stock-based compensation plans | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,591<span></span>
</td>
<td class="nump">$ 21,255<span></span>
</td>
<td class="nump">$ 20,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value, options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">14,600<span></span>
</td>
<td class="nump">16,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Cash received from option exercises and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">9,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit realized from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember', window );">2003 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncreaseInAuthorizedShares', window );">Increase in authorized shares (in shares) | shares</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember', window );">2000 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember', window );">2001 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,284<span></span>
</td>
<td class="nump">12,531<span></span>
</td>
<td class="nump">16,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EmployeeStockPurchasePlanProceeds', window );">ESPP proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod', window );">Vested but not issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember', window );">Restricted Stock, Performance Stock and Contract Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,400<span></span>
</td>
<td class="nump">18,100<span></span>
</td>
<td class="nump">18,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="nump">$ 24,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod', window );">Vested but not issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EmployeeStockPurchasePlanProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from employees in connection with the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EmployeeStockPurchasePlanProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncreaseInAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of authorized shares under the Plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncreaseInAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869953464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">0.89%<span></span>
</td>
<td class="nump">2.51%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option from grant date</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 13.03<span></span>
</td>
<td class="nump">$ 18.74<span></span>
</td>
<td class="nump">$ 21.78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873573576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited or Expired (in shares)</a></td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">1,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year (in shares)</a></td>
<td class="nump">881,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</a></td>
<td class="nump">$ 34.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted (in dollars per share)</a></td>
<td class="nump">43.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised (in dollars per share)</a></td>
<td class="nump">19.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</a></td>
<td class="nump">49.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</a></td>
<td class="nump">39.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</a></td>
<td class="nump">$ 35.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Contractual Term in Years, Outstanding at end of year</a></td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Contractual Term in Years, Exercisable at end of year</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 34,560<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable at end of year</a></td>
<td class="nump">$ 26,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627868946376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod', window );">Vested but not released (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 54.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">44.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">50.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">52.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue', window );">Vested but not released (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 50.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember', window );">Performance Stock and Contract Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares', window );">Adjustments for performance achievement related to award target (in shares) | shares</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod', window );">Vested but not released (in shares) | shares</a></td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 55.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">43.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue', window );">Adjustments for performance achievement related to award target (in dollars per share) | $ / shares</a></td>
<td class="nump">51.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">43.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue', window );">Vested but not released (in dollars per share) | $ / shares</a></td>
<td class="nump">51.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 47.66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796769736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 4,029<span></span>
</td>
<td class="nump">$ 3,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(652)<span></span>
</td>
<td class="num">(1,047)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="num">(102)<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net period benefit cost</a></td>
<td class="nump">$ 4,007<span></span>
</td>
<td class="nump">$ 3,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873695656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.34%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">2.04%<span></span>
</td>
<td class="nump">3.33%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.14%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Interest crediting rate for cash balance plans</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.93%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627922480280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change In Projected Benefit Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, beginning of year</a></td>
<td class="nump">$ 66,972<span></span>
</td>
<td class="nump">$ 52,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">4,029<span></span>
</td>
<td class="nump">3,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(3,347)<span></span>
</td>
<td class="nump">12,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Plan settlements</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(2,664)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contribution</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payment</a></td>
<td class="num">(1,537)<span></span>
</td>
<td class="num">(635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Plans transferred in</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Effect of foreign currency exchange rates</a></td>
<td class="nump">6,115<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, end of year</a></td>
<td class="nump">72,869<span></span>
</td>
<td class="nump">66,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change In Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, beginning of year</a></td>
<td class="nump">30,770<span></span>
</td>
<td class="nump">31,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">2,882<span></span>
</td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">2,274<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(2,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(1,537)<span></span>
</td>
<td class="num">(635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Effect of foreign currency exchange rates</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, end of year</a></td>
<td class="nump">$ 37,825<span></span>
</td>
<td class="nump">$ 30,770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanBenefitObligationPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanPlanAssetsPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in benefit obligation of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627895470904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract', window );"><strong>Reconciliation Of Funded Status</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 37,825<span></span>
</td>
<td class="nump">$ 30,770<span></span>
</td>
<td class="nump">$ 31,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="nump">72,869<span></span>
</td>
<td class="nump">66,972<span></span>
</td>
<td class="nump">$ 52,542<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Unfunded benefit obligations</a></td>
<td class="nump">$ 35,044<span></span>
</td>
<td class="nump">$ 36,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627894999096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Gain (loss) recognized within accumulated other comprehensive loss</a></td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="num">$ (9,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">61,500,000<span></span>
</td>
<td class="nump">61,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="nump">37,825,000<span></span>
</td>
<td class="nump">30,770,000<span></span>
</td>
<td class="nump">$ 31,103,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount', window );">Plan assets expected to be returned next twelve months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contributions expected to be paid to plan</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contributions made</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan, fair value of assets</a></td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=iart_AustriaFranceAndGermanyMember', window );">Austria, France, and Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (t)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=iart_AustriaFranceAndGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=iart_AustriaFranceAndGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627895423960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">1,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">1,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">1,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">2,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Next five years</a></td>
<td class="nump">$ 10,429<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627873362408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options (or more) | renewal_option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="nump">$ 19,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Future minimum lease payments, finance leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector', window );">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AnnualRateOfLeaseAgreement', window );">Annual rate of lease agreement</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2029 Through October 31, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2029 through October 31, 2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2034 Through October 31, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2034 through October 31, 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AnnualRateOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual rate of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AnnualRateOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_OptionToExtendLeaseYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Option to extend lease, years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_OptionToExtendLeaseYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearOptionLeasePeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearOptionLeasePeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearLeasePeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=iart_FiveYearLeasePeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627798529256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 83,635<span></span>
</td>
<td class="nump">$ 94,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">12,818<span></span>
</td>
<td class="nump">12,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">88,118<span></span>
</td>
<td class="nump">97,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 100,936<span></span>
</td>
<td class="nump">$ 109,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Leased facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">11 years 7 months 6 days<span></span>
</td>
<td class="text">12 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Leased vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870483512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 15,226<span></span>
</td>
<td class="nump">$ 11,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>ROU assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 6,027<span></span>
</td>
<td class="nump">$ 41,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627797884200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 13,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">14,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">11,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">9,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">78,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">138,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">37,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">100,936<span></span>
</td>
<td class="nump">$ 109,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current lease liabilities</a></td>
<td class="nump">12,818<span></span>
</td>
<td class="nump">12,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">88,118<span></span>
</td>
<td class="nump">$ 97,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember', window );">Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember', window );">Third Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">13,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">13,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">11,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">9,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">77,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 136,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627871097272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 13,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">14,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">11,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">9,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">78,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">138,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">37,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">100,936<span></span>
</td>
<td class="nump">$ 109,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current lease liabilities</a></td>
<td class="nump">12,818<span></span>
</td>
<td class="nump">12,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">88,118<span></span>
</td>
<td class="nump">$ 97,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember', window );">Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember', window );">Third Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">13,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">13,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">11,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">9,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">77,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 136,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870979320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Income Before Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States operations</a></td>
<td class="nump">$ 15,082<span></span>
</td>
<td class="num">$ (38,359)<span></span>
</td>
<td class="num">$ (21,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations</a></td>
<td class="nump">78,438<span></span>
</td>
<td class="nump">98,463<span></span>
</td>
<td class="nump">78,621<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 93,520<span></span>
</td>
<td class="nump">$ 60,104<span></span>
</td>
<td class="nump">$ 57,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627798250664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43.20%)<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent', window );">Effective worldwide tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (48,200,000)<span></span>
</td>
<td class="num">$ (5,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations', window );">Effective foreign income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57.10%)<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">11.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease', window );">Valuation allowance, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="num">$ (1,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignEarningsRepatriated', window );">Tax impact of repatriating foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Amount of unrecorded benefit reasonably possible to be recognized (less than)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Penalties and interest accrued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">36,700,000<span></span>
</td>
<td class="nump">36,700,000<span></span>
</td>
<td class="nump">36,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">36,400,000<span></span>
</td>
<td class="nump">36,400,000<span></span>
</td>
<td class="nump">36,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Expire Through 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Deferred income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="nump">59,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Federal tax credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare', window );">Federal tax credit (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">90,200,000<span></span>
</td>
<td class="nump">90,200,000<span></span>
</td>
<td class="nump">90,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">11,800,000<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 41,600,000<span></span>
</td>
<td class="nump">$ 41,600,000<span></span>
</td>
<td class="nump">$ 41,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Worldwide Income Tax Rate Reconciliation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignEarningsRepatriated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignEarningsRepatriated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iart_UpThroughTaxYear2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iart_UpThroughTaxYear2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869127752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Increase (decrease) in income taxes resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign operations</a></td>
<td class="num">(7.90%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
<td class="num">(21.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits from stock compensation</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(5.60%)<span></span>
</td>
<td class="num">(7.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets', window );">Charitable contributions</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Nondeductible meals and entertainment</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent', window );">Intercompany profit in inventory</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent', window );">Nondeductible facilitative costs</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowances</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther', window );">Uncertain tax positions</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent', window );">Global intangible low-taxed income ("GILTI")</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent', window );">Nondeductible executive compensation</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent', window );">Carryback of Federal net operating loss ("NOL")</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(3.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays', window );">Swiss tax holiday</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(15.70%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment', window );">IPR&amp;D expense</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">22.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent', window );">Foreign-Derived Intangible Income</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent', window );">Transfer of Intra-entity of certain intellectual property - Rate Differential on FMV Step-Up</a></td>
<td class="num">(63.30%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent', window );">Assets held for sale - Outside Basis Difference</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(43.20%)<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Carryback Federal Net Operating Loss, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Intangible Income, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627876360184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6,184<span></span>
</td>
<td class="nump">$ 14,597<span></span>
</td>
<td class="num">$ (3,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">5,029<span></span>
</td>
<td class="nump">3,447<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">12,553<span></span>
</td>
<td class="nump">10,905<span></span>
</td>
<td class="nump">7,057<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">23,766<span></span>
</td>
<td class="nump">28,949<span></span>
</td>
<td class="nump">4,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(5,079)<span></span>
</td>
<td class="num">(10,889)<span></span>
</td>
<td class="num">(7,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(1,760)<span></span>
</td>
<td class="num">(666)<span></span>
</td>
<td class="num">(3,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(57,299)<span></span>
</td>
<td class="num">(7,491)<span></span>
</td>
<td class="nump">2,066<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(64,138)<span></span>
</td>
<td class="num">(19,046)<span></span>
</td>
<td class="num">(8,184)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">$ (40,372)<span></span>
</td>
<td class="nump">$ 9,903<span></span>
</td>
<td class="num">$ (3,398)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869542024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Doubtful accounts</a></td>
<td class="nump">$ 2,207<span></span>
</td>
<td class="nump">$ 2,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory related items</a></td>
<td class="nump">47,034<span></span>
</td>
<td class="nump">39,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">18,319<span></span>
</td>
<td class="nump">19,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation', window );">Accrued vacation</a></td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses', window );">Accrued bonus</a></td>
<td class="nump">4,883<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">6,160<span></span>
</td>
<td class="nump">8,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">1,665<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">29,335<span></span>
</td>
<td class="nump">37,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment', window );">Capitalization of research and development expenses</a></td>
<td class="nump">13,044<span></span>
</td>
<td class="nump">9,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Unrealized foreign exchange loss</a></td>
<td class="nump">23,798<span></span>
</td>
<td class="nump">8,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contributions carryforward</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxAssetsLeasesAndOther', window );">Leases and Other</a></td>
<td class="nump">23,205<span></span>
</td>
<td class="nump">12,496<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">173,256<span></span>
</td>
<td class="nump">148,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(9,897)<span></span>
</td>
<td class="num">(9,865)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets after valuation allowance</a></td>
<td class="nump">163,359<span></span>
</td>
<td class="nump">138,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangible and fixed assets</a></td>
<td class="num">(90,274)<span></span>
</td>
<td class="num">(150,879)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DeferredTaxLiabilitiesLeasesAndOther', window );">Leases and Other</a></td>
<td class="num">(15,585)<span></span>
</td>
<td class="num">(11,704)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(105,859)<span></span>
</td>
<td class="num">(162,583)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets</a></td>
<td class="nump">$ 57,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total net deferred (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,930)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxLiabilitiesLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxLiabilitiesLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869909320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Uncertain Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, beginning of year</a></td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract', window );"><strong>Gross increases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior years' tax positions</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract', window );"><strong>Gross decreases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations lapses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, end of year</a></td>
<td class="nump">$ 702<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Decreases During Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increases During Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Reductions Resulting From Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsReductionsResultingFromOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627871459352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 92,744<span></span>
</td>
<td class="nump">$ 32,337<span></span>
</td>
<td class="num">$ (369)<span></span>
</td>
<td class="nump">$ 9,180<span></span>
</td>
<td class="nump">$ 15,319<span></span>
</td>
<td class="num">$ (27,610)<span></span>
</td>
<td class="nump">$ 29,736<span></span>
</td>
<td class="nump">$ 32,756<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
<td class="nump">82,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 92,744<span></span>
</td>
<td class="nump">$ 32,337<span></span>
</td>
<td class="num">$ (369)<span></span>
</td>
<td class="nump">$ 9,180<span></span>
</td>
<td class="nump">$ 15,319<span></span>
</td>
<td class="num">$ (27,610)<span></span>
</td>
<td class="nump">$ 29,736<span></span>
</td>
<td class="nump">$ 32,756<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
<td class="nump">85,637<span></span>
</td>
<td class="nump">82,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares for diluted earnings per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,228<span></span>
</td>
<td class="nump">86,494<span></span>
</td>
<td class="nump">83,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 1.09<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627796680776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from computation as their effect would be antidilutive (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember', window );">Performance Shares and Restricted Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AdditionalEPSShares', window );">Additional EPS shares (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AdditionalEPSShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AdditionalEPSShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceSharesandRestrictedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869209592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="nump">$ 1,375,796<span></span>
</td>
<td class="nump">$ 962,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(16,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="num">(18,770)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
<td class="num">(21,636)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">1,514,867<span></span>
</td>
<td class="nump">1,416,736<span></span>
</td>
<td class="nump">1,375,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(26,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(74,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="num">(18,770)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="num">(55,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(82,249)<span></span>
</td>
<td class="num">(26,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Pension Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(9,709)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">(5,105)<span></span>
</td>
<td class="num">(9,709)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(40,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">53,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="nump">53,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="num">(40,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(76,402)<span></span>
</td>
<td class="num">(45,443)<span></span>
</td>
<td class="num">(23,807)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="num">(30,959)<span></span>
</td>
<td class="num">(21,636)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">$ (74,059)<span></span>
</td>
<td class="num">$ (76,402)<span></span>
</td>
<td class="num">$ (45,443)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AccumulatedOtherComprehensiveIncomeLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627876737320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Loss reclassified from AOCL</a></td>
<td class="nump">$ 18,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Loss reclassified from AOCL</a></td>
<td class="nump">18,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives | Other Expense</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Loss reclassified from AOCL</a></td>
<td class="nump">12,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives | Interest Income</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Loss reclassified from AOCL</a></td>
<td class="nump">$ 6,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627870417224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details) - Contingent Consideration Liability - Level 3 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Arkis | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">3,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Loss from change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">3,415<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Arkis | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">14,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="num">(3,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions from acquisition of Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Loss from change in fair value of contingent consideration liabilities</a></td>
<td class="nump">951<span></span>
</td>
<td class="nump">1,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">11,746<span></span>
</td>
<td class="nump">14,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Derma Sciences | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Loss from change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627795411048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>product </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_SegmentReportingInformationNumberOfProductsOffered', window );">Number of products offered (more than) | product</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SegmentReportingInformationNumberOfProductsOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of products sold by a segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SegmentReportingInformationNumberOfProductsOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627872001848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 388,647<span></span>
</td>
<td class="nump">$ 370,232<span></span>
</td>
<td class="nump">$ 258,665<span></span>
</td>
<td class="nump">$ 354,324<span></span>
</td>
<td class="nump">$ 395,127<span></span>
</td>
<td class="nump">$ 379,095<span></span>
</td>
<td class="nump">$ 383,645<span></span>
</td>
<td class="nump">$ 359,690<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
<td class="nump">$ 1,472,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,370<span></span>
</td>
<td class="nump">93,760<span></span>
</td>
<td class="nump">110,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,757)<span></span>
</td>
<td class="num">(27,028)<span></span>
</td>
<td class="num">(21,160)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
<td class="nump">996,206<span></span>
</td>
<td class="nump">963,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember', window );">Orthopedics and Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
<td class="nump">521,351<span></span>
</td>
<td class="nump">508,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516,287<span></span>
</td>
<td class="nump">539,657<span></span>
</td>
<td class="nump">512,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356,657<span></span>
</td>
<td class="nump">395,019<span></span>
</td>
<td class="nump">363,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopedics and Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,630<span></span>
</td>
<td class="nump">144,638<span></span>
</td>
<td class="nump">149,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (337,160)<span></span>
</td>
<td class="num">$ (418,869)<span></span>
</td>
<td class="num">$ (380,688)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_OrthopedicsandTissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627869999016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 388,647<span></span>
</td>
<td class="nump">$ 370,232<span></span>
</td>
<td class="nump">$ 258,665<span></span>
</td>
<td class="nump">$ 354,324<span></span>
</td>
<td class="nump">$ 395,127<span></span>
</td>
<td class="nump">$ 379,095<span></span>
</td>
<td class="nump">$ 383,645<span></span>
</td>
<td class="nump">$ 359,690<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
<td class="nump">$ 1,472,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">382,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,403<span></span>
</td>
<td class="nump">446,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States (Includes long-lived assets in Puerto Rico)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">971,975<span></span>
</td>
<td class="nump">1,077,379<span></span>
</td>
<td class="nump">1,045,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">324,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,893<span></span>
</td>
<td class="nump">383,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,689<span></span>
</td>
<td class="nump">197,468<span></span>
</td>
<td class="nump">201,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">38,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,812<span></span>
</td>
<td class="nump">47,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,174<span></span>
</td>
<td class="nump">157,391<span></span>
</td>
<td class="nump">144,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">13,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,121<span></span>
</td>
<td class="nump">8,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember', window );">Rest of the World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,030<span></span>
</td>
<td class="nump">85,319<span></span>
</td>
<td class="nump">$ 80,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 5,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,577<span></span>
</td>
<td class="nump">$ 7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iart_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627876289032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Narrative) (Details) - Subsequent Event - USD ($)<br></strong></div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Feb. 19, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">2000 and 2001 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate purchase price received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Smith &amp; Nephew USD Limited | Consortium of Focused Orthopedists, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of Extremity Orthopedics business, payment for terminating license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanAndTwoThousandOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandPlanAndTwoThousandOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_SmithNephewUSDLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627876439928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED QUARTERLY INFORMATION - UNAUDITED (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract', window );"><strong>Selected Quarterly Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 388,647<span></span>
</td>
<td class="nump">$ 370,232<span></span>
</td>
<td class="nump">$ 258,665<span></span>
</td>
<td class="nump">$ 354,324<span></span>
</td>
<td class="nump">$ 395,127<span></span>
</td>
<td class="nump">$ 379,095<span></span>
</td>
<td class="nump">$ 383,645<span></span>
</td>
<td class="nump">$ 359,690<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
<td class="nump">$ 1,517,557<span></span>
</td>
<td class="nump">$ 1,472,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">241,578<span></span>
</td>
<td class="nump">235,421<span></span>
</td>
<td class="nump">153,187<span></span>
</td>
<td class="nump">220,848<span></span>
</td>
<td class="nump">245,665<span></span>
</td>
<td class="nump">236,459<span></span>
</td>
<td class="nump">239,974<span></span>
</td>
<td class="nump">230,778<span></span>
</td>
<td class="nump">851,034<span></span>
</td>
<td class="nump">952,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 92,744<span></span>
</td>
<td class="nump">$ 32,337<span></span>
</td>
<td class="num">$ (369)<span></span>
</td>
<td class="nump">$ 9,180<span></span>
</td>
<td class="nump">$ 15,319<span></span>
</td>
<td class="num">$ (27,610)<span></span>
</td>
<td class="nump">$ 29,736<span></span>
</td>
<td class="nump">$ 32,756<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
<td class="nump">$ 50,201<span></span>
</td>
<td class="nump">$ 60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Per Share-Basic (in dollars per share)</a></td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Per Share-Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.09<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelectedQuarterlyFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelectedQuarterlyFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140627876544056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 4,303<span></span>
</td>
<td class="nump">$ 3,719<span></span>
</td>
<td class="nump">$ 8,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">3,635<span></span>
</td>
<td class="nump">2,126<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,649)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(1,499)<span></span>
</td>
<td class="num">(1,542)<span></span>
</td>
<td class="num">(1,071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">6,439<span></span>
</td>
<td class="nump">4,303<span></span>
</td>
<td class="nump">3,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax assets valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">12,069<span></span>
</td>
<td class="nump">6,973<span></span>
</td>
<td class="nump">7,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">1,617<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,291<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">139<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 13,825<span></span>
</td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="nump">$ 6,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>120
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M=6I_5TT=V"%)1,9:;3/?F@]DHF$R;<(9:*SW98,-I8R3C(_%VV9)G.+,X\#
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MR9#!0"7421I&KPD>U6L08H> @38QW*'5&J! KN'J9W2J=<,+W;:@'.BJ$6R
MBP;4AKT >Q@D2 =3 0K:L 6"<A /C.\3R5(4*7 ,.**YS?XD> W3I*J0!' K
MT[)N8H/=MB"6OPDW.L:"4>XG5U.#P.=X.E/8]/OK*=%A<GU]^_ODYA) TX?;
M^^CJ]O/[AP^?KP>??ZB23 VKVTIY0IE1"JR[U*E#*:0@2KH9"S@:AI6PLU%
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MF>R@4GDBR ^>.S1K\W;:;AG<L[,?%7P+G&@6&0L2C1%>XCUAGBZ1Y1 3BQ&
M5S13A>8+G\&D;%"8Z4"2% I9+ZEV/JT694869D7OIXQ=X.'0STS>0W08M4J
M$&_*=V?"1&"#;48@G'D'!DD3!/$)DPPH'%P!*DD,:MS>3>\?_A%'=]<4 @)C
M$^WMNT\ *1!@ 21M /!O\T2,0SP27D,("3RIBF?!-C/ JW;3FN5WW8[%SG.2
M"%SL&%AD9F0&M?HCL/PB\0@X#".HAQCF$EQ!R(7EA;T<;:T0'J*/QKI?V LY
MBJ[AYJIU"6P'*X(YE;/DQ3NJO#%Q;XQ]^#=X-T+Q$XE(L#,MY?811>#Q3?('
M'GXFHIZC/?Z$(&^\PR.O 5P7#)$#"R;&$X@Q$UT)SY.($9-=QHI(B<(;[&4+
M=NRPH_4A>U@=V,_YTE"-@ 9%4R0+]\%>8#3*RV7SE)!J).;D\$&Y0+FA&!:0
M!P%]+"VZ26H#N>VGO3 @KM(+K\[!DLV2"D#;)5P?#&30^9^<'1V> G2:R?"'
MGV'XN2QG] SK.CN%(H45$@45,$S'Q*)KE-2",^N]*/,SG_0UO=2!G->$]J-Q
M?'8ZIG]/+\ZC]ZW.<1Z>>B&_A4PPOHA/3L\B0(S'Y\?1&6Q3[(,]7#H^/048
M>AR-QZ?Q6YAK?'ALWO@$2 Q.HN+ HJ>\'2W&Y^?QVXN3:'QV%I^,3Z(3]_:\
MK1C6.&]D]!75X#@>GY]&)R?Q^.@T.CT\D^=G!>=ZX 3U#O#ZAK<)S)41EXQ/
M3^(+@-KC$P#5;]_ 2B_DU0]M56@$66@C?,,?Q.(%ZU&GRELOX.4WIR?1\7$\
M1B(=CLWLER6MDO9WR#&A5852Z.(D?O,6)@5V.3D_%[1^=@&_7;R)SF&@HZ,S
MH&T-QSS9)[!>'K\YAGG?OL*?3N/SH_&K[_.8,0&.WUS$9\=OT00XN8A/C_::
M "<7H[>^";!]?O3_?XR"*Y^61I5W\<9W=TR;?7$:F-/XZWG'NCX]=4_\EYC7
M5VP*L]79 D$0-E8-RW]^WX=J3Q50YA!]'@8^I1Y?BGW)? GOOS@?7=C5>N@E
MZ1CB8H\X[XB9#F&$N&P\W! J4<\@M^];%.D%D#F\(UJ!)"#[9<E]PO[%R\G=
M[&%R/?M?TZMH=O,PO9_.'V@NXR<6%5$8-6967L<N^((PRC *24!R") N]'6%
MT2UQ1RO*D]U< ]9,8J/@E+!:\Q+S'6BMC6*OJ&%[\D<P0V8D?BS+&(I++@F1
M%3VFC<Z#SS7G:C0)(<2< XUD:HB_+MNQHB,;JF$>A.V-HM_1^U64$C=TJM;Z
M:FDXBC6;V6)'YPY-RL*NR-M-[<&D)THS0_+A::Y"D@FK_(3AM 8W0^>T ,U(
M7I::?:?/7B5SB=Z&ERB\(?ZR7QR/3BS_T_T]\:XOQ^9YOT9HP!_*[TN*432Y
M! @[GW%8ZU["F6BB.FA#_G^Q+CAK1HO;LLM972=]-3A>,@BP7/X,F^LC3JG!
M28TXE5E#5.1.S1_"0-NEE]L2=W-6V.X6J6PFZV2<<.189<:?:@)"+B 5\Q4Q
MP5$TI#G0##M WXT8UG+?Q+.(]B&Z9PQ,#L/CQJO?75L0%ZAM4'6$@2R3MV0,
MU,(8>F2#LE3%2VLIA0-:H[FRKMFL#V7E[(#,WH$&XY@3$M_XDJ,(?STC)EDV
M0HA,8CK>87J<8!-3#"DDYA$<B @];80,0"H@C:KX220-?)J!+8V)31*'[F:F
M@/2H/.ZDA#)%%FZP;[>>-0^<Y"25Z27QA)$ NW2I$286*VZW[CY"0\SGBZ+'
MY4@LP!@@4X&EQ3"$26PH(^0J+SUCF^R<U>;-_V->_# E#J6Q.]'@R@?[MW/[
M.MS/GA,/-N>)6#L^]KP#L; WZ*B*6 FD(-"L!)O6C!Z3N236(T5IT'\IN3+N
M(=I<)>Z?3(2)R4GR\X'8>:F!S&)V=Q-:_M6%NC"G<VVX*">YQIP<%FVZ\$*S
M,H[1].A78[\)P!WY15R<>UXD ]A.0[-@SN/*>Z8VC#6T]2'"(EOS7\B)Y,U\
M:'6K7 ])Q>MD"^[?2?_Y']O K".Z/#DKG@$"H8 )$)<XR>92@I[7,_B4ETK:
M-^5%6%#RBS\<;AU@CLV6":0#A:R'7HO]*"^&#-/@7H6"BI05S#$LJ0@K.0>'
M-3^:/;+GSM"7=.F3\T8ZD5;[@J<C_ J?PGX60:"0*/9I':)ZF @C0"]+SI\9
MS,E%LF]* BW6\AY%'V]OKWZ?75^3-^_VX6_3>\3JDYN/,\HGF<^GDDD3JG'&
M@\/*VV,H'SEY(&:O&O_HG3MR(J!E-F7*,/$0TT)H$ Q]&.^0<P_VXNAM@?%W
M%%% NJ)%M4C11*+'LF+E :I2+_UA0$FB!ZG$K*%*UZ&E]!,A(]B/<5A+')KM
M'RMD?$[V!$+"0!)&=<F''6>]_S+Q+,44!A1C-\T$:>*(VJ6-0))FK:O,6J=
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M:BM'H7O5/]+LK7Z&=(9]F'+8<8VZ# &[-+EM;Q/2B&5TY5/*QW\U^_();'6
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M+>E'4=5OZ;VL2UCZTQ+<%9X#'AV(1%T[^ZC@1JF?Z%_9= 13:,W^!KE<^')
M]Z".Y3)>).,KD^NF $_."<LJ.8F]_'[\X3@;'[WUU-2H@Y@M6A6N7F8, D63
M!ZJM"VN+T/TV@C(;3/X,?(;PI6UTP7B8ZVRMA0])RI+_\=_6*1\Z/%Y2/Z ;
MI&&-:9O6EA4)APD=+LX6Z5,M(,9T/)AU:D#.-,IX\%1-Q4F_L^@H7.^[='SP
M?;J]O:2?681L]/;RW5V\&K_]A>K&^4:D58P4I*L\P^QJH5MG+*,,6RD-V >Y
M<2*F!RRT;0UC09@6HY /V ?J6!Q >EFD5A&(@>+\MS -=@N:QLI$ VAJ3J_C
M$XO3FD(E_WKL8R@4J*;2J"LT?1]4:)Q\)GPH88Y?+;G$N$[AGP=E&Z]YM8QM
M3(X7N[+Y1PJ9*3N92S KDE_ :X.29LGS$GL,2*@\!N02'W1%/J"/<@VY$..]
MQ?CQ\8"6L*+\TK"BUP]Q,=@HA<02:;\K];WR209YSAW[:Q'MR^.$AX!)5*W$
M2FG("N?@L<V58/)=17Y;AA7P\AP*QJ0]E5)'%_\:U12M(=4CY0ZZ."6H,5P,
MB^4E9?,1P8.2*BQHT;A80YQ(J5Q!7U 2F,'9<;L:T"<N"GA<;4QLY+N\7\VG
M(Q.7]K >L#;6%7]3),2[U!@2N')H.,X],;4'H1NLEVN?<\554:ZUP&U\VR?-
MNCR_RBWLMVN1 _K-VB*:>0MV0FN;QU&M<5Y)Y" +8NV33,EW#W(O/BM9VF*G
MS+>7;T^2G_S!*&9QK[P'Z+W,2V.UW3 ;)[DI,H?&J) *;8] &[F+$?4X4('D
M8R[E3OJ8! MUH'*"_09]UA #1%MY@E@9*%3LMO8-;^TQD;A?QA+ULA8N[2QM
M\V!WH,47$6<EM$ SH/2Q+/SWK8F('L3G2]IA=Y\P,0L8O04%BI-[5# K;YQC
M4[]>PF#X%.?)QQK[12H6F Z4DT\YBZW4*(,J?HTEZ2KQ%\CEFH$CN5<BQ!%J
MK782'N85&X?GH.VR8B^$.^(F^'+*]+.HN!GXI"Y:+"+Z7][0!]2-4$5,PS G
M9F*!Z?XNPM%X0O'<P &PE:7G]"O9] 6'X%J*'<1=A&BG3OKCXSE(H7W&9B<>
M=V_F_=GQ">]<PFS42N^\UB<#Z/&D/YEDH,@1PE.?L$<Q'\"CZ:HZ[28\<G+4
M/SZ9/-MX>M2?3>? Y:9LXX?2+.L?3V=T;P,JL(U^J.IXGO7'HVE+?7\U)I,Y
M7;9J1)>E)A?3[08^O23%;')"BSQW3>PY%6N<>N2X?S0_.I3D(&)_BL^KV^\(
MT)_/3]JL7C?"&.%F8WKI$WJX=WZII-O$4QJW!E1+.LIT3[N#X"*=?YZ'IU/D
M'\)ME.'>LL;4T> (YRZ73F;I)M@ZGH96-N!L%2]+'&:EXP%XO[;86-L;#M =
MC\__#U!+ P04    " #2BE=2;KQMN@8+   7'0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6RU66MOVS@6_2M$4& [@.+X_2C: FF:;CN8-D&23K%8
M[ =:HFU.)5$EI3B>7[_G7E(/.TXZ6,P"12-3Y'V<^Z9>;XW][C9*E>(A2W/W
MYF13EL6KLS,7;U0F7<\4*L>;E;&9+/'3KL]<895,^%"6G@W[_>E9)G5^\O8U
MKUW;MZ]-5:8Z5]=6N"K+I-V]4ZG9OCD9G-0+-WJ]*6GA[.WK0J[5K2J_%M<6
MO\X:*HG.5.ZTR855JS<GYX-7[\:TGS?\KM76=9X%:;(TYCO]^)2\.>F30"I5
M<4D4)/[<JPN5ID0(8OP(-$\:EG2P^UQ3_\"Z0Y>E=.K"I-]T4F[>G,Q/1*)6
MLDK+&[/]J((^$Z(7F]3Q_V+K]XYG)R*N7&FR<!@29#KW?^5#P*%S8-Y_XL P
M'!BRW)X12_E>EO+M:VNVPM)N4*,'5I5/0SB=DU%N2XNW&N?*MS>7OU]^^7IY
M*S[<7'T6%U=?[F[.+^YNQ;=/=Q_%Q=?;NZO/ES>WK\]*\*(39W&@^\[3'3Y!
M=S 4GTU>;IRXS!.5[!,X@Y"-I,-:TG?#9RF^5W%/C :1&/:'_6?HC1K-1TQO
M])3FZE[EE1(K:S)Q 5DM/ 3HEQMQP;@K*_Y]OG2\_I]G&(X;AF-F./[;H?X[
MZ(I;'W;"K,1Y')LJ+W6^%M<FU;%63B!":D1N5&S6N>:HJ=>T0PCR\I\J$56!
M5^5&"8"3NQ60 M68,(0#X[$ IMIA(QZ2*BY!'HE V7L=@U5I^&P<4'9"(SKQ
M+R.A\$J6%.X4M\YO-,@!B;*2):*5"Y,5,M\)]5#X78:D4XAOHJ4>XHW,US M
MN)8;XU0KA\R31I">N%:6\UH>*W&U3/6:63AQU_+XAQ-%9Y?I[&*Y7"DH]Z4,
M; V')6@[>*R-2?9Y"R@$"ZPT0-)YK2;[FHM$45FH +F-A=Y8@"(ZOS=>ZHYT
M KM$;H33L,Q*QQ( 9DA(^A1Y#[FS;*EZUVY [XG;SIE?JV1-VYWXZI"+3RG1
M)<*:G00MY46'HR 9TP^KA'*E1D[$)K\U& 8XWVO'Z-0><80WD^NX4P# R4P1
MV-HDW@MHT<NP"Q*U=H0,SJ1@O^MZ!*Q% 5NJM8Y%(6V9LZI=Q&K)#Z1P-2<L
M>9?W'-G58Y-E50ZHV -9F8"&@G$V< )C\3:%)KY.8EO$]+V'@HZ3*;F^57D"
M@=[K%=Q$Y>0)2U5NE>("58&$586Q=*+F$(X2->_,C,U6[5F!\)#)'T"XQ3-
MB5_;C8XWM+8#-RBCQ/?<;"&B?X'@+G<%*9!Z-%<F1;4F)_Y1 41E>^)CHV2Z
MBU##<<SS\VZSD8B]W)2@#U4Z[O@4^%:5E<W)UT&4G1]8L.=XX!+M.$D)2:)(
M1JIR)!()V,!Z+U.8*E- IN.*'8MXQ)FDP4GK-1<KH&W(-6[4$O)TN>R[=\LS
M,XCU5']7 .F0H9)QZ]^-W_<.$HG76124<P$B0M>A[8+'P)]@)0T<@X,+N)I,
MS3HD#7: .@%$H/.CTI9!O*?&A_;("A)9_:=W4<JHR3UG+.!+:=#GW""!3]'$
MJ">^UKE\CP*D$[%5B::2F*8P*[S$5=#6)U45<IHGB&4*"N+**H54#C:)W#E?
M8CG"-[H@?^DXWEHA1-GQ<M0UA!^=V'<:N()5:VD37PX40H=+R@K<5CJ'EC[=
M9M"$4IY>'2L2T*C-A@ H5H57M$DU(5[J>-RK;P1Q8]]"[CBW[D/1+7$U9A!(
M[)2T]!(V_'GR#LEGK]K"/H&C:QT?!EVJNNHE<$[+B2%O6<H5 O<G5?IH<>[4
MB*8O.G=L5Z#PFY9+G6I8ZN:(K(VI.^73ZGL*L50N%4"A@ (2'G:*-<H:P;>3
MQ[T!())@X%#42.::%5F\3M3FGO3$J,#D: >J9N)/-@:7K #,GE9))T4BVTKM
MT[2O;4V>B"MKR<A\$"]\S]0IUB@_.@DE,.50XS:\)Z[X/.8FZEA:.1T:A5TM
M@5@I#YPW7X4FN3&"D&NKN'K# E],?HIN"!OD,CU^C M^D:K3X,"/R33 !"M)
MUX GW5ZP.(CL5E3R0T0<[7R"E3Q05&9W/7$NJ&Y1\C&KUNND'[Y\DJ<D&\NR
M-?,S])>JD:6QUJI"LJGCU!WTI-*UQDYK'_7QUI:SDD'T$RB?8EMRM^@.^[#@
M,K[UJ7T^F-HUL<^AIFC&$9A05+8$(O64\DK<&:1Q\=+GP\#!5 XTW2^'P76Q
MQS<2O\J\HH8]$!,OQ#R:SOOBKFXR XY6)G4B8.TZC=>AU[]D"K\\8H7$N]>^
M'J?,0T+;TR65K4MC<+Q9-![U'Q%_! LT.=C9YI2+1R8\!L1@$"W&T[U!A7-#
MF%4Z0;Y$)YCG)"<VL*T>.XEX.8H6P\DO1YD':&K:^VGY.3!&T7PR%1^0EY'>
M0S:)=Q[CU%?I^?@HRV. D<;3@3@O'[^-0FE%])TBXV>'<7A$8;QY,>F-1(8R
MQ7<CN8^$U.3K1S1>3'NS9B>WG5V D1<MM07/9-":K]Y[VUW]"TGUG O^$\K7
MV4OO%\C&6&VI0,]0H.X]<'>'IF,/!H@!FJ#\8MA;'*P.L3KH30Y61UCM]^8'
MJV->G1ZL3GQCBS<M;4)"<:'&/(;FJ" GHET?\5]*/SY0PM]KH=-&O[HF42YR
MW=.;^C1?>@7DJ1RNJG0%UF$R1#^+$K7A+D'ZW@W)G&KU\<0,*X1$!LNE7H:V
M4C\C1==G( =5C&>JQ/YPV*E5VXW*NPT,E[]T1RR:7H9FF8,TUNDG?#VP*F47
MVY-V9?D&CZJ!]=6 _?=PPMQ7IG%<5[9S/LVE/7$=.OEOTD(>-L&%LJ7436"V
M+5*&1IN&E43=^P[?,R#1,H,$9SBYN!VFN\S'4*XJ:UQEUWPNO(E8N$110^EU
M]TU(:)$HNIOB23*@96) ]BY(ZL&:I]QM*[SOV*F%40^EROT@4!6,\-9P;NUT
M^@ES734W&1[X#KFZ\ZLO=\C2/_>_X[-D=W#JL/A_C(M= 8(7<*N4_0^Y\"]D
MO3OY0'Z#_L7+[R\KFY![(B^HA]!CUM;(E(2O^ NAY[HS]$</G"H@O/.N+^'4
M<)Z<S@*?,"26N[9_7QH:7S%\!31Y5#)YK3'[$4P+"]"04P?SJ3<86Z@CBC]<
MJQM"CV[*P)'5D9U8?J^=7*]I-J3-]57EL8X/?;[C1KCIQ9.]LX%1)O^@)&;@
MM,IURKY/;NSBIT_T>O3_8,'RXV'^1,_W2OR+>I#+XS2>>0G2S[Q\BIWX4J<)
MA?YI-IA&H]%"S*:S:+88B=FX'PVG<_$I=Z6M_* PF,VC\6*(CF,XQ--@Q$^C
M:(KFPS>S%R9!7(I;LB??E]W666B^&$?ST4 L%M-HV)^*Q93ZJH7X!LD2;M:8
MD3?T<#&*^J.Y&*&RSB#4"!W.9#H1EP\(P8S,?66A2$&9T0E(-1J 8C_JSX?T
M9S*?(\/ZP?(W'BP'_0F:VQ'^SJ,)FLM!']I.%D'J+C&RT1W?9H@[%6]RDYHU
MQ>-X-H-(,S%!"S":#,2$* V&@4)=A-"+1:/9()H#.7J>#&;19#+CY_%L&(W'
M Y(,_A(:P=HRW#JAL*4(+W_Q6]\TT$RT1E0I5U^C^/+P%-!.\64MEU_#-XYM
MG?-!%U@'MP_)\U8IC), #!+CAZ=!8/Q3F;65Q8:)?VJO,$7$?I\H5*UT/Q[V
M;GUYJNMVG'6$'OMJ<M;Y6(4]:_XD1[,;0/+?K9K5YJO?N?_8U6[WGPP_HU)K
MC(NI6N%HOS>;G CK/\/Y'Z4I^-,74A0$XL>-PE!C:0/>KPS@"#^(0?,M].U_
M 5!+ P04    " #2BE=2"@31V#$/  #Y*0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6R=6MMRVS@2_164QSN;5"FR+G9LYU;EV,F.MV:2;)S,/&SM
M T1"$L84P0"@;<W7[^D&2(*RY#CSDE@DT.A[GV[PU:VQUVZIE!=WJZ)TK_>6
MWE<O#@Y<ME0KZ8:F4B7>S(U=28^?=G'@*JMDSIM6Q<%D-'I^L)*ZW'OSBI]]
MLF]>F=H7NE2?K'#U:B7M^JTJS.WKO?%>\^"S7BP]/3AX\ZJ2"W6E_-?JD\6O
M@Y9*KE>J=-J4PJKYZ[VS\8NWA[2>%_RNU:U+_A8DR<R8:_IQF;_>&Q%#JE"9
M)PH2_]VH<U441 AL?(LT]]HC:6/Z=T/]/<L.66;2J7-3_*%SOWR]=[(G<C67
M=>$_F]M?5)3GB.AEIG#\K[@-:Z?3/9'5SIM5W P.5KH,_\N[J(=DP\EHQX9)
MW#!AOL-!S.6%]/+-*VMNA:75H$9_L*B\&\SIDHQRY2W>:NSS;\[.__/U\NKR
MR^7'#U>O#CPHTO.#+.Y^&W9/=NP>3\1OIO1+)]Z5N<K[! [ 2LO/I.'G[>1!
MBA<J&XKI>" FH\GH 7K35KXITYONH/>V=GCBG#@WJYDN);F"$_\]FSEOX1'_
M>^"(P_:(0S[B\&^J\/&[Q9F]UDZ\U>8JTZK,E!.7)?3QL13_KHNUF)R27L;X
MUR\5253)<@W'_E9KJ_)=NY_L\8N]IP(Q+&09-CC-45'5-EO"JT5E=::$F8O]
MZ6CX'*Y6%/3^"9T4"(BS;A^(547M1 ;KZW*A2D]_.ITKRRHF0G4EO!'[DZ/A
M44..&)<>_KL6,QPIUW)6*(ZJ7& 3G>7J#)R[>5V XJHJ5$,N4]8CR2#D;I!*
MJA6=*<N<5JV4S;0LZ!2%B(&]A^(+:.WD;BGS347DTBLQE]J*&UG401/CZ7#<
ML#Z,ZKV53DC2U@TV%.MG2U4P#VR**)V]5AX2L9&453-KWA?FYY_&QX<OA;KS
MRI9@]@9L0>=U(:W(+21##A1/WOU^\51D$ENQ#+G +SFT[IKM7F7+TA1FL1X0
M&PJ)J61-Y+FF_ ;U.+THZ72#I)G7,"KQ41F/9:0D<H+V $-Q4(<$F4-J;/)+
MBU"!;4/&#Z([IWQT /(TTONO6LYT@4/A9WA?K^BY%^])A;^S"LD$]SP'NG<P
MOB+M9Z8N25'$$L7I@EE-K;)2?FER,D9<C45D6]",KZQBGES0O0R,RI31(F%4
M1D;A1U+,FMR0=;F!- #7M"HSBU+_%60"5Q"J<PZB0SQM<DL^%#QO;@J4.Y:(
M73S4/-!SO&FNR0-2@@VU1_(?F+IW^ OQGBF3_H,X?W!9HN1P ^>'A_VJYW"S
M"_ GK2,]0(NUPSGNJ3B7;BGVQ>E(? 1UN$EM+3M7X.KX:"P^6> !Z^%]52%C
M!)(%0CP>'AV+"S57EGCW\J[9.1X\/SU&-O*R7&C21WC^(@F/)JYI8^OCR':#
M\6@DQD=BK8C?=R74R6KMUA1(7"4RV'AP>H*EAW'IOXS);Q&[8G(\&!]-Q1?C
MH9E-!1]-!I/)"1R4O<LU.6E _F9K+%!W%5%W+*EAM:0&F0Q.)\^1BG<DFO&4
M^>_I)-U^-'@^FHH/ZK[G[HOI:'!T>IIJ+88A.1CRG$9T4O#T<A9YA=[4,R>M
MG (>" );NEC3)7P?RZK*&IDM!^)VJ;.ET)3C;EHG8F7K;Y0?*,BP]@8BDDI:
M/IJS^]Q0CB4.NA0?DB/4;+W.=$4N1!K.?*S,D4Q&GCA'"+F.QJVID6JA9%(N
MR,.AA89P5A'X)(EJIZAN%'#QH;@BP2*YE;&(0>1%/=>9#!Y=KZIPI"YA5#*=
M#A4H+3"\W[BHR$XEM"LKZCPDU\X8)18EO%-B4] KNV3W*Q![$D@0X[3-XM@2
MJ6  %W)\LI,%_?S\LUQ5+R_X,7X"T7($D#\&;=*O^)(>$@SF1[+2</D#JH)6
MSVIO[#H>C9)O%\H]#4""K8^*1EK-M>-($*QC),, H$DWQL*MZ=%*25?;(+K5
M[KJG019P7GM:T&I"H,HHN1JT.<ZY1KV=0G[^Z60R/G[IV'XB6V<<AJ'"5Y"2
MRQOH(%4)C7J;^;9BL%"<BHC:YK$A)3=PJ29/E!N"@I'QX?#H'R2>M)9.BBD6
MK8XC5H-/DPG;Q&NYD&S&&M?=.2N-%13)6P654-79$@'!LT,<T'XX2\GBP$/@
MW3A>%BG.J<L(AORZ<=I.9MCRS]#R  5],.SJ5C(<A.M3<5M O#*$,FVM@2]L
ML6:?2L*"]01FH #P&JS=* UON@,E*L[:$32B;%L:=B\DPZ%X'[1%X=,F3QC$
M@3PE6%]#%J@7#91C3'B#MC -4T#>.<!($E]Q];#+[JEI)8INQNL6S6NK"G[
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M'V$ZV78/5'D))T0,$&>*]W"=9/RU;I>33Z$L%T/Q6<U0"7(B;V6ED%TSNC,
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M'3YB[W ;7%#<]_,$V4"KX1:+^]*%5:J;NSSN/!3YRZOSO=WULJ7:YX*EQD[
MV 3%-F,]8+NB)EPPH$EBD=^BQ+3W;=2>M%T16E&^C'%+@_:.80=%"/U1$#QT
M#>N.,0DZ01Q-5])IV_'(S>$^2Z,9#MN(_8<#9'PZY%6 @^C+@Q_QG#Y3!'JL
M6<N"XY8F4-S>1:T]6IPO&U64-INJ"8N8V)D'NJ6.4S\:GX3+2E?/'"H,Z:,)
M'99BH^UL:M9,A?YM!:8"EF!O#[6X!SMD"SR"7'Z)RD&A^*,B#MJO1\+(A
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M-; T*Q*S-GQ./U)>JD]([2#]5U@9?J)^]MR][W+WC;G[*7#WE;G[^*#CFO4
MNPPX41.:?ZGAJO,):V>JEN/EA-B8CB<3\%PB<:YP;O-\:-<,NR:/[)H-[IJK
MQ:-GS=G!2!UIY. 5$7N8CA#3:U'*[UXI6 ,_6=/'19>1=X6UK$8'/TUDX;&8
M6.G(4@QJ*A=(-]6@<Q0E:90?1^0%6FDPD0[8S8SYEX^U+1+\"N)?:?F 8QRM
M5N>T0J_7<&>UMD6F*J!$/HK^+=/:R?ZR3%%'*.<R1V<VRC><96D/*>(9;4*6
M7CX['RG(;CQS6X0XCH-:7V(=_W3/Z(X*M'<FN+3-.15\0OA;RA/0I>.CN&B5
ME/N RQ*%="DY2=:AO&N+JA+JW2] KG\'<AT)ZQ,8_QFXXCVH-1 I%$OKB^=@
MI20!YK*KR/7SC.#9@9KY!!']VZ&*4 N E CC)B$W[1OZZ>@_"V:,Q SR*[@]
MB\[[VTEA;.XV5=$FJC(UG)FK=4H_QI&CA 7G,I( 45?^2=;GRK!CWX B)*B%
M[QK9D2R:W^&9#VNX,*5BL+C:X^3CN\_?/MRHC@]ZFPVDX5%3%TMHOTB(WW51
M6Z;(J>5.[P6B4]Z 7!*]:.=]U'&/DHG*L.-2E^<UI\T,M9.97^M]_YV,ITOV
MW\EX/B'_'3+;?_^ P49ACT<S+5(A.5<A570RQ5%H(1(=222&>($G5A0$YE^B
M8QB2$$6%*@%%XZ]0+"/G=.6:TKGGA;^-;\>\UR0FLH!+(R ^@C/$%)(5*8HD
M$"I/L=7QICM0*Q B;>VBW),3\".SMH6,T0X:#!1_R<W3(0Q#-<Q0[<T09PRA
M! M#3O:#/CVPHA]*<"(%;Z7W]E+*8?(YX*W:(3$?K>Q'\$^?NS@J3>5M<;H8
MOVA@&WFT*(!L7+C*2]$_1XIS'(5:^D@1(>GN;<'9:TTX==8]"Q#JCK2>]EG:
M9R$!B,<7@186Z3F4.9 @,1^'.8] '-9Z3M%S.@>"[G#&0(O64WI_6B/<;/RX
M5CH"55MCDT.!;@8\C)4YFTRO1Y+2V,E.K[M] JTXG5\N.TB\J"N&[CAP1/F2
MW P>G:(=& KLLK _8M;JL"X&J. +"@A,QTA4Q-)\/'O6/_R/2-AOA7Y(GK9?
MHBA"57RR _A_DF@$<\S'5PWW'1?[S_BD9 KTYP0=0SUQ;2UODUS>R_IH+CA_
MR)#/EV4)H0Q21%5AJ8:B^'"M,11JN@]_)86N(V.1(M.:44C'!&V9<(\SCH)T
MM'JP1H=4,91G82:K]QONZZOQHA\$5U?S-J_M6PHBN:Y03H@F&O;. @JH';$:
MJ005G>HC?F4XL@:@I6#7:5MY@Q&RR'[7U;[C]$8 G?03&#%Y65<"P6)2)W0J
MY@.^7Q%DY+V>-JP625>-_IK@'6K$RL\.0G]@-1;HKJ-0ED+>HHXH5;-@JHY9
MMP8^;^,MF J+/%OP#\C"_B$_,!XC9CO,!63$=9?P5^ *8:D-L00]HF&N8"U&
M9^&;S#&8&J\"\3"P#1)WCNER "%IP(NHCY)_UHX4]GM=T#_ SC&403P9:M -
M(;* *_H*^^E@FM%U;L&DQ].4P"HJ']-.$67_F[1!/^!]E-KHK[SPX N19Z/[
M_-B)8VIO>8A)\+")6/=$'CF6Z\C7:S*6[\_<2_5W@(KG,CD[E/=+,_CZVB2+
ML\^4<%"\(:X[EU;X5,WGHTNTL-SB+I:CR60BC>N+Z>CJ<DF?%^K%Y6@IOR_5
MBQ?7(]0K[$26YY\IW?02C,]A7M*#)/('$B?)7!Q,4)>L7*3\BI&CW_Y+09';
MG;<.SJIH0D;V7_9J[N,C0YJG3JB0'#V6&&7UR,"+/_*3$]\[M+](^\"#3A;N
MIMX@%M1T*;*Q,_8Z^4ZG#EZ8#[0SW'EDU(9PG#F=F>?2C*0\^XJ0WR+KJ,9R
M8X8O*3(&E1L202?DY&6-!"(IT>)K0D-K;NJC&'DM:6$P Q^X;.._+(J(U@$@
MU!U"@T6L=>*#G@!!O_[IWVM?OYDJ=<V>*!"G9IS%*&(Z6;0H8N0S)>E"[ +W
M6&F.^8P8^)<@\49I'BCZHD#490Q!::I9E&D$1-*,=KPIVCGSP!:V@R&@'YLJ
MS#^:W-EQ;O"W .8X G6-:Z1]!.E/YWWXW0);=)GN&(!A5 '[[[QVZC;4AAAE
M92^NEN/K5MD2N'11*/UDJ^-07#W2NQY/]TTT%$.=],#[>M$WA%BJ?LP,XPJB
M]&)^U;)P$&N4.!T'*@4"]?PTIRY6J=DP[-]O6]OB%G="G>?:#"7HJ=OBN0MY
M@3I_FA541?R]A1?06R7C5*(BMZ(\;>J.0[@(AEDW3+V\G%\'ZA3AIU-.Q_O:
M= /Z.9.+@J;R$[ 88H(++>T_O03:NN1C^,3#-.45 &DDH?2O/V)CXSHCH\9\
M S(]5T:XHEL\[DO"4?M#CHZ^D'L0Q#HG^Z::1J33^>19V'3 =Z<+DX'.*W4V
M:PX.30"J;M(R((H<TN. &A&5G"P9TR E-I/1ZZN&JW!,A[MC7NOYC<+XZ7!P
M2@.UG"H!))F?<Z9'#I"<R!S(2+@S(Y"Y\BMZ=K9@V0FI2')%SBX9B9(.<A?%
MWL5CN#V2Q3!2&0'3Y(%[QW*A#/-&_6 8I7'.\I H(.)ND.4L6D1+ZK0Z>-P'
MMEB9%F1%E!.^6&HXNOZA^]%/W W=UF69AG[_<]!B8*ZP9H-4"4LW%['27PE:
MVT<(\,'JGMRP>S!)]1Z*H&O/S@5G90FY(I(W,E;V_G@P9>]DO%87_3FBL82-
M:*8+,5,9)E$@00A-=W$Y6_+H")_6Q=NB@,W*[<XQ9@9BKD0MBG'MKNNFAP[*
M]93=P_7\C98E'G \J7.^UIR='W@)G0[.5R0''7_;\D9 /WJ4-7&"V\:U/\AD
M_$8B5Y %X:B5]C)S2'&.?B1U#J@ V4_( -DCMX6&1@B,U9^+-/'M1@-[Y.3F
MNMGRU0($MH1L;,]D\G. 62RWU!$:GY(.^M,;8]MZ-YTTF1 _[TOB;R#84>/8
MUOY]A#HO(Y-T+H'JTH\9V,IH>24G1SS1C[PMP5R^&;S8:?(3I$AA1O+VHM7$
MT& \2AT/1+TVDMY5[5Y:YUQ%2MEZ-=]OBZ;P=/4Q,,'SE[8#@OB,9WT1H$97
M>.Z_78#?VWJ6(.)PZB[<)@216%=Y4?E:1A@YX^@[.L+L7L$/^?1@8HO)(7I)
MF^>P '$1N7OGP8@OFB)KTIV?4*_70'1AWB5&D[H?W,X.(@;Z3AEE-GFUU0G,
M7T9P1?(QP =^,'WE[4M3U*8H'W#:@/46JH;APK',1Q?Q4#?-LA?=2>&Z;1[D
MMI"N\P:4</2 0^Y,3NTGS1A$&PQ>./Q*3RH<=*B%%M$.,M&0=AK\[]/U/G=(
M-;QDPU>7@%^5-=^U1RN<>QC?-)U9EZ@(&>S;V_FX>1CM]=%G7IGGB4GE?KW%
MHF[OHB<,K5B<@F=?@YI_C*E![8G; /;.%P/F[/$J[]91P3[*]5A]Z(SH[W5*
MTRAY[>W(C*0?C?#(8I-SA\,)NNWW*.^UKS7$G:E.LP8-42GN>SK;&ROYQJEW
MQ]"T4,7Q[I%H39>=&:F4S/#&2#@8T'TC>'YZU;U".+31+?4^IF&EF;)TU$97
MH_#,WM7&].J)5WWB6'H2"6D_B^@=M=Y_]VR0D9-S?QL@G<P071KY^:2?%!GD
M-W'O9E&Z/502QCX$:Y^360%N^*;<<$Q&@I<E/9;DT#1O).Y\,KS]\C%DO^;]
M*P*WA -M75;Q#E2S@IJYWNB^X62WU_0 >?,TA5ZIVHT&KDQQ(K-.U^6]R;.#
MBMQ:"M+QGI6!A)0JX\,W:&2L/NV_=#%JCLRBG1\H:+GB'-*YSU7M$"_MOM.F
M0D>-J@DLDW*N"R\%#)"35-%BL6/W$N%UHV&7]5T2=2TL&75M].J:1"G"9K(_
M6SA&J7U/\VS?+YM'<$PC!:?34E=;/'U.][K<QW"HDSZ!>\+[C(,GMP?VVX=C
M#%*Z@;^[QO'[U]!R^R%[])WDP9M\'^OY9S*@XW>@!7L>[&[NXXP[SCB)N:&1
MF#6N:;AL>--.1B)T^6*IYC$ #N=HH=R^@G"T(^UZ]Y&+>4G&765TVM@!Q0"O
M)T$Q21^-T!-4HMG^M6QO /F(NXK6Y*7;XQ[[Q&VE7%;.Y;)R-KYZ]N1=QH_=
M9K(VN&H,S.*ZKY0-<_Y_O[WL'=[.]!M69U-_;SGTLO=%YVWY3*/6T?\)\!XF
M+\XWOS;_[>!&WK9OE\O_6?@9I9(B*=5K;)V,+Y<GXK;A2U64_.[]JJB -OCC
M5D=0$"W \W6!I.^_T '-?\9X^V]02P,$%     @ THI74M7-I'''$@  Z4<
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M#-HDRSN54[A28\A[#S]RUJBW79S0%-U>P%&;JD.;SCPXL!,@33F8BSPZR]M
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M9G@@!4,&^'ZK4<[-#07HCKC+?P%02P,$%     @ THI74I<P::\K#0  +R4
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MJ,S^W B.=*$!>+]2\*^_H07J?PMX_U]02P,$%     @ THI74HF2\F)?!P
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M,G]$P./HD8!0W?ZT @4>@@3QZG&#*(<W>]G4FF7&)'#(2MNBS25IHBU)UYF
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M/KYH<&K$# :1S$2R#N:S%4\N;2 P O$^ 4;(/\*"JS2M6^RZD:EMIA.>4R=
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MVRA49#6<;5P1[H.QH\P%!-;35%PU#P/"N)C8R>S8X&KL,)3-U^&@6Z  ZHN
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MW"D4%34MP/MM537^AA!T7^8^_Q]02P,$%     @ THI74J_D@GN- P  2 @
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M5"DN8P]4V[?:A9&UZQ4[::CSN&E!K1Z5%:#S7$IS7-@+^C\/J[\!4$L#!!0
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M"WJ 45D%.E])&ER'A770/.FC/P%02P,$%     @ THI74BUFR=F !@  FA
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MZJ15FDC?6X/@C3,,^):-_/L;(&[.D1RXN>X@^=YOR,O4M KAV14X3\,@#$/
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M@M="TP1\7RAEQP=:8/??A8O_ E!+ P04    " #2BE=2Y]B7TX $  "I"0
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M&9BA<0T;I]N^6=QK1ZVG7Y;4Z]%X!3K?:.W&C2>8_AZ._@902P,$%     @
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MV*+<&D7_<K(SX]O9QXOY_>4%+!9P"@^3R_O)W>+Z"B97<_A\/[E<O/^ZN/H
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M-3VH4-D-]'\NI=E/K(/VB3;^!U!+ P04    " #2BE=2K:+DS%\R  ")MP
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MJKDX U^52;J!MTRM&JJTW+VP8)U6.&<R+ T"1*#R4P)&.*0I?/PQB/##(8B
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M^28\Z?$]%N\@"CP(_= _X2_J*8B<O^@8!?B(HD%8*5G#A+ JNBI4!K.!B2L
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MP4'M &0OE;+'C0MP^H1-?P-02P,$%     @ THI74M05ZX&1 P  !@@  !D
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M"J_=(<WW8;$/)+&ARUT:A/:&,E_N52$.O#&?*VKWYA7!DD'I!@<#[M"00_B
M1,GP44#JXRWN2NK(N 1Q9-EO"[VR-X^-%@>"FBB%9,"HE-OT"&7&;GKTN#V#
M.A#?0FES!A4^;RMX)_WA&Z40SI@AI!,':(2>;W7Z%LWU/0GR"D:=( #"'G8^
M2V5V*,VC@LE2.Y)Z/L=;4'E@HW>MTJX@-&R]^I^KXMY^X !>B29>?@70C#;?
M4(S*3P>>II<?8'R,"J@L-4G5%):R@0]%;5%^U% ^F'QA/R2XRXW)Y_9VIB*(
M$C@!_I_FN:D?$*#YLN3H#U!+ P04    " #2BE=2)*%UK]X%  "V$@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6SM6%MOVS84_BL'7M Y !=3U+U-
M CB7MAG2)(B]]6'8 RW1-E=)=$FJ3O;K=TC;BKLF3C<,>\I+3$H\]^]\1^'A
M4NE/9BZ$A;NZ:LQ1;V[MXO5@8(JYJ+DY4 O1X)NITC6WN-6S@5EHP4LO5%<#
M1FDRJ+EL>L>'_MF-/CY4K:UD(VXTF+:NN;X_$95:'O6"WN;!K9S-K7LP.#Y<
M\)D8"?O+XD;C;M!I*64M&B-5 UI,CWK#X/5)XL[[ []*L31;:W"13)3ZY#87
MY5&/.H=$)0KK-'#\^2).154Y1>C&Y[7.7F?2"6ZO-]K?^M@QE@DWXE15'V5I
MYT>]K >EF/*VLK=J^5ZLXXF=OD)5QO^%Y>IL@A:+UEA5KX5Q7\MF]<OOUGG8
M$LCH$P)L+<"\WRM#WLLS;OGQH59+T.XT:G,+'ZJ71N=DXXHRLAK?2I2SQ^^N
MK\\^7EQ>PO#J#*['[\]OX>)J/+QZ=W%R>0[#T>A\/(+^F$\J8?8/!Q9-.L%!
ML59_LE+/GE ?,/B@&CLW<-Z4HOQ:P0!][1QF&X=/V$Z-9Z(X@# @P"BC._2%
M70)"KR]\*@%*E4M95<";$BX:RYN9Q&!A:(RP!LZD*2IE6BW@M^'$6(TP^GV'
MV:@S&WFST1-F1]A=98MVU!1.YVA4&) -G'*M[V4S@V&MVL:ZMQL''TO^3ANN
MGU^;!2_$40\;U@C]1?2.MXS9N8!B8Y!W!F>;C. 1EV2?&4:#')8"T\ -3%6%
MS6Q>PZDJ:][ :"$*R2M[#Z-6SV3!*[C6=H[,4<K">/FQ-*85,!;%O%&5FDET
M8:PLGNQ?.$]4:_"8V8>'>ECXF3<M,@7X:J/]/4A83-*$XBJDE*1!C*N<)21*
M8QCJ3]+ L/C<2B-]R[.4))3"JQ\R%K WFRUV,_9J@]VEM6B*>\"B-J;B7B2(
M*"0QFHN_\@11)^J)T&ODK7R)0Q+3SI?,K?(X(BQ[SD;F_4U)$&>  25A"&/W
M?HH&K,(,>^C-155BJI%!.>*D/Q("KI05$!YLP/E^<V+D3NRC_4VH>]"/4A)'
MR?[V<D=$S'F?I ')4Y=3EE 2YLQ%%#(2)BGLP'S<83[^?LRK>J$:T6 4N+M
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M74!)EB"H(I)$=!\21$>^*AZ6/,U2EZHPBTB0>]8*",5RQ7G@E0P?8ZS-8"+
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M+W-H965T-#,N>&UL[5=-;^,V$/TK V,/R8*-)5&?@6/ ^=BL#TD,V]M%4?1
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MVC#]+5VE:T=N("A]G%:"7F?+!<H[>I2?8]A!] AV1CGIH3NBX[..@&7'.W6
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M96@*C2SU0;D(HT:C$^:,RZ#?]7OWNM]5I15<XKT&4^8YTYLA"K7N!<U@O_'
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M0>T<Z'RAE-T;;OA5OZ[^'U!+ P04    " #2BE=2)!D[4O8#  "@"P  &0
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MM ?,_D((_3RQ75O=I8_^ 5!+ P04    " #2BE=2Z[G^MCD$  !9#P  &0
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MUX/Q ,5L0_-$?Q.'WU@94&#L12)1Q2\ZE'/= 8IRI45:@H%!RK/C/WTN$]$
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M<8W=6DG=]UNFN"'0^/\NU)L2VHR$C'#@]812"PXF5I_W0M.DC +V\N,.T$F
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M)O/V3#:^N_^51LEO0P(KK"\2JI9D#=')('1Q>>I;O>;3=KK+(]J>;[<MZ]W
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M&L!YR+WM]N'93*XV-J2L3N7,0[/@R!J$!YEF1\0 )N+KD!(TP_(8!$K@X!G
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MY:JNZEO.-W3 8<?\.6]!8&]Q;M?PQ7FUWDALNH8 BE")<PP$=@R_E&Z!OEQ
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M])V!RAZ@_4Q*LYG8UM=\N0S^ E!+ P04    " #2BE=2:DGA5T\"  #Y!0
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MCT=VC::;:-'8R[T1&EN%'9;8FT&: -S?"J$_)J9?]-T^>P=02P,$%     @
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M(UZ\T6T)&56"W9IF$5QN(T '(O@\%4U@H3. +&0]3@;@Y.=3#4K?C#*@TR;
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M+(P;B-\?@X"_W,1O\!U>A1W^!U!+ P04    " #2BE=2C^&+R3\(  "Y0
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M8?HO>.9MC1:8KL/(7W%PW(.5ZVU^.]]X(#( !$L B /0:P N 6 .P%7/8'*
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M:>)&FKAQ?5P^;D*;K.8> 1M8N_4"2*@E$4DK\W#7/BL&Y_&@D\5+")G5=*W
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M(FD$ID0LP3N50> ]C194 !7/>ZD>E4CEX^.*<I+'6;P&)P&5)$[4U1GX=!^
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M2PL^:FDI&;@B/*^*YK6E:ZA?MFTWJZ$!E\O<J(.<%@SHO2C_P+_@A=H%M8Y
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M)9/=;%X*R-_GG(OGEW*"YA*N_S]02P,$%     @ THI74M:9]LM6!   =A
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M 7R_Y,"I&NA;6/U3P^1?4$L#!!0    ( -**5U)E:^EMS@,  (<-   9
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MX9%4@A!N>*Z6$J[R!)-# D_KJL6%.W'CL)4QQKD+G> CA'[H-R0T>3$\N&B
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M[^8C_# 97*WB>#K_WU.);5Y!R&8H:C<[6.ED.E*G"RV6R53Z(C3.N,GC@M&
M27, W\^$T-N%,9#_8V/P'U!+ P04    " #2BE=2$1TF(KL$  #^%0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6R]F%UOXC@4AO^*A?:BE:9);(>O
M$46BM+,[6G6*2J=S[28&LDUBUC8P(^V/7SM)8VBP2Z&[-Y"$^/CU\?'C%P\V
MC#^+!:42_,S27%RV%E(N/_N^B!8T(\)C2YJK7V:,9T2J6S[WQ9)3$A>-LM1'
M0=#Q,Y+DK>&@>#;APP%;R33)Z80#L<HRPG]=T91M+ENP]?+@/IDOI'[@#P=+
M,J=3*K\O)US=^764.,EH+A*6 TYGEZT1_'R%0]V@>.,QH1NQ=0WT4)X8>]8W
M7^/+5J 5T91&4H<@ZFM-QS1-=22EX^\J:*ON4S?<OGZ)_J48O!K,$Q%TS-(?
M22P7EZU>"\1T1E:IO&>;/V@UH+:.%[%4%)]@4[T;M$"T$I)E56.E($OR\IO\
MK!*QU0#;&J"J 2ITEQT5*J^)),,!9QO ]=LJFKXHAEJT5N*27,_*5'+U:Z+:
MR>'TX6[\Y\75:'IS#<9WMY.;;]/1P]>[;^!L6LX38#/P2(6D,2!Y#+[GZ_+F
M7GWQ)-*74\FBYT]@0GE1)7E$7Q[I%F.62ZZ27SX[!V?75)(D%>= + BG B0Y
M>%BPE5 OBX$OU:"T-#^J!G!5#@!9!@ 1N%4]+ 2XR6,:[P;P53;JE*"7E%PA
M9\1K&GD PT\ !2CX#?B5SO+3$1_7*<=%_- 2_W7FP&A#^.NA[T0.Z\AA$1G;
M)O,MB>TZ4-LIL9YE(L$3G2=YGN1S70F_*.'@3,U8F8US\ _8EY<RS64?G:(/
M38?U,.P$ W^]1UBG%M9Q"ON=DUSK.E1"IR$!]3K[)71K"5VGA+$N\#0E&BKB
M8"'=AI"+$.T7TJN%]-ZHHY0J'AV>C%Y3 \(6$?U:1-\IHD+#TTJ"G$G%Z7=J
MZC<T62H$!H9HP<'%2Q6 WENV5?B=NNU:T@2W. N=:_-'L3\H5:,UY6J_ T4I
M P5M"KZ0A(-'DJZHAB@HEK%C%4-D.D4GKN.8J5+F BQ5OT5*=&X,]/;FI^RS
MMY6?=NAA:,F0P2)T<W%[;1\CJXRN9\_,6^AU>Q9=!JHP?.>"/T9=V%37#CQH
MRYHA-72C>H<"QPAK[Q&&O*!K$69(#=VH=I'A&)U-E-M(84@.W2AWD>(8B=WF
MP@B\P(8.PWGH!GW#6.WQ56^;"&B0#ONGV0AD6(P.9_'Q1@(UB0S[EK0B0V0$
M/]1+5.%VS 0.+2H,HI$;T:/X+^7RU?\<*8":95UO]623:)'0-=4_ZO5#M%K)
M -%3#23A<_6O[6#UJ)E#FWB#;.1&]G%>J JZ8T1LVP<RF$9N3+_;#E7Q=F3
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M%6@0AKQ07L(5N;P#0QG75\/ H'"[?9#6(J>5R/B,R"@F#U*8O29SD4'V+T&
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ME;X56T?N!<%Q[I0F#G+=P$DQ98/).'^V$),QSU1"&5D((+,TQ>)S2A)^N!_
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M<$1G195/DG)B9%;<ZI?2T!NA&,;TC$-E-]#W2$KS.+$*ZH?A]#]02P,$%
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M2K_F[##3#VX0QD"OKSA7^XEYTC5/^,F_4$L#!!0    ( -**5U*#IN'TN (
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MT8VJ7!#]]T*G-,LJ3SJ.?R].!XUF97A]_>K]<SUY/9EG(NF49W^RK3J,!LD
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M1!]ZJP&Z?\>Y>FU4Y_'F^\OX/U!+ P04    " #2BE=2>0(\^SD$  ")$0
M&0   'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6RUF%V/VC@4AO^*A7K12MM)
M;.=S!$@4IMJ1Z"X"9E>KU5YXP(#5)&9M9VC__3J!2>C83MB+WI X]CGO\4G.
M8YOAB8NO\D"I M_RK)"CP4&IX[WGR<V!YD3>\2,M=,^.BYPHW11[3QX%)=O:
M*,\\Y/N1EQ-6#,;#^ME"C(>\5!DKZ$( 6>8Y$=\_T8R?1@,X>'VP9/N#JAYX
MX^&1[.F*JJ?C0NB6UWC9LIP6DO$""+H;#2;P?HIK@WK$'XR>Y-4]J*;RS/G7
MJO&X'0W\*B*:T8VJ7!!]>:%3FF65)QW'OQ>G@T:S,KR^?_7^N9Z\GLPSD73*
MLS_95AU&@V0 MG1'RDPM^>E7>IE06/G;\$S6O^!T&>L/P*:4BN<78QU!SHKS
ME7R[).+*  8. W0Q0+<:X(L!KB=ZCJR>UHPH,AX*?@*B&JV]53=U;FIK/1M6
M5*]QI83N9=I.C></D]7#"DQ^FX'EPWRR?IB!Q62Y_@M<.CZ"SZ4J!05?6,'R
M,@=SJI,&%N2[?I<*/!5;*L#O1RJ(8L7^W"O!0C NP(+JRQ:\GU%%6"8_:&=/
MJQEX_^X#> =8 =8'7DI2;.704WHJ54#>YA+VIW/8R!'VC&[N (:_ .0CWV(^
MO=D<IC^:>SJ!3191DT54^\,.?V\2L 43*:F2X.^Y'@@>%<WE/QTRN)'!M4S@
MD-&3A;9<G:WBVJJJVY<QQ'$8#+T7BUC0B 5]8L@F=K:*KL4"E"1VL; 1"_O$
ML$TL-,4@#GV[6-2(17UB@4TL,L7\T"46-V)QGUAH$XL-L30-H%TK:;223JWU
M@6J4[Q05-L7$4(R3%#J^DK213+LEN2)9!:8:#ED-A^,9#M:R3LT<XR1.8WL4
MT&\QYG?&,:=2WH/'_%@J77ZLT#F@4EG!XALAX#B)'*F'5R"%-V3BG(&,D6>6
M,<6HG6W0\J7Y*8Z:&"X0@V9A^VD<NK+5X@JB&[(U+86H('Y;S,B,&24P>1NR
M;1@*L2/BEGRP&WUS7NP_ZI>:WQ@M-L)($FA&:Y)3I]=WU 1LT0F[V;FD&:F^
MPP419H0_^FP)"<.?N<; EHZP%X_650::?$1IY$A5BT?8RT?K,@--0+K56D#"
M;D*ZUAEHPM&MUK(1=L/1M=! DX).-=0B$'4CT+72(!-X;K46=Z@'=YUK#;(0
M#F+'4HJNMEG=W/J_JPTR:80BZ JCA1'JAM'ZP,0MQ8U:8*#@9Q8W:BF">C=:
MUN)&EIT6#D+'M@ZU,$&],+&6-[)LMG":(H=>BQ/4BQ-K@2,3)U#O[ARD1RU0
M4"]0K"6.3*! 79\NO18IJ!<I]B(WD9)&06B7PRU3<#=3NJL<FV2)XSAQ3!*W
M;,&W;*5N+W-LV2?A""9O]TG>U3FY^I/B"Q%[5DBML-.&_EVLBT"<S_WGAN+'
M^NC\S)4^B->W!TKTD;<:H/MWG*O71G4:;_Y]&?\'4$L#!!0    ( -**5U)\
MSA[TQ0(  &('   9    >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;(U5WV^;
M,!#^5RRTAU9:RV]"J@0I"9W6AVY5TVZ3ICTX< E6P<YLDW3__6Q#6)J0K"_@
M,_=]=]\=/H^VC+^( D"BUZJD8FP54JYO;%MD!5187+,U4/5ER7B%I3+YRA9K
M#C@WH*JT/<>)[ H3:B4CL_? DQ&K94DH/' DZJK"_,\42K8=6ZZUVW@DJT+J
M#3L9K?$*YB"?UP]<67;'DI,*J"",(@[+L35Q;])(^QN';P2V8F^-M)(%8R_:
MN,O'EJ,3@A(RJ1FP>FU@!F6IB50:OUM.JPNI@?OK'?LGHUUI66 !,U9^)[DL
MQE9LH1R6N"[E(]M^AE9/J/DR5@KS1-O6U[%05@O)JA:L,J@(;=[XM:W#'L"-
M3@"\%N = H(3 +\%^.\%!"T@,)5II)@ZI%CB9,39%G'MK=CTPA33H)5\0G7;
MYY*KKT3A9'+W9?;U_A8]37[<SM'%7/U5>5T"8DMT1S-6 9J"^K=@9SWA5Q"7
MZ"(%B4FI5E?H>9ZBBP^7Z ,B%#T5K!:8YF)D2Y6=CF%G;2;3)A/O1":NA^X9
ME85 MS2'_"V!K61UVKR=MJEWEC&%[!KY[D?D.9[3D]#LW7!WV -/WP^/SZCQ
MNT[YAL\_U:FN R@E(BN9J%5??DX60G)U>GZ="1%T(0(3(C@1XID2"3F:2RQ!
M(#5:.-:'L[>9#=/ ,.G9LDG<T(F]D;W9K_"QUY4?^^'PK5O:X^:YGB[;ID=.
MV,D)S\I1@T$=>_H?(0U'M!=[$ =^?"#DV&L8!Y%_H*./*_+<?AE1)R,Z*Z-M
M_*(YB*2QI#Z(?7*BHU(._5#__F_D''M%CNL$!W*.O<)!X/@'<NR]Z5,!7YDI
M+E#&:BJ;P]KM=A?%Q,S'@_VIND":>?^/IKE][C%?$2I0"4M%Z5P/5*%Y,]$;
M0[*UF7$+)M7$-,M"78+ M8/ZOF1,[@P=H+M6D[]02P,$%     @ THI74O[(
M7=7G!0  TQH  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULK5E;;]LV
M%/XKA+$"#I#:%N5KX1B((QOKT$O0M-V 80^T1-O<)-(CJ3HI]N-W*"F2'-.T
MBCH/L2[G?#PW?>=0FNZ%_$=M*=7H,8FYNFEMM=Z]Z795N*4)41VQHQSNK(5,
MB(93N>FJG:0DRI22N(M[O6$W(8RW9M/LVKV<346J8\;IO40J31(BG^8T%ON;
MEM=ZOO");;;:7.C.ICNRH0]4?]G=2SCKEB@12RA73' DZ?JF=>N]6?J^4<@D
MOC*Z5[5C9%Q9"?&/.7D;W;1ZQB(:TU ;" (_W^@=C6.#!';\6X"VRC6-8OWX
M&7V9.0_.K(BB=R+^G45Z>],:MU!$UR2-]2>Q_Y46#@T,7BABE?U'^T*VUT)A
MJK1("F6P(&$\_R6/12!J"H!C5\"% FZJX!<*_DN%X0F%?J'0?ZG0/Z$P*!0&
M316&A<(PBWT>K"S2 =%D-I5BCZ21!C1SD*4KTX8 ,VXJZT%+N,M 3\_>?KC[
M^'Z!/M_^L7A [0]$2F)2?87: =6$Q>H*O49?'@+4_N5JVM6PHM'KA@7Z/$?'
M)] ]]%YPO55HP2,:6?3OW/K^.?W@S/K8 ="%4)7QPL_QFF,G8D###O*]:X1[
MN&=SZ.?4@Y]37S16]R86]65S];$CEGY9>WZ&YY^J/1Z*A*+/Y!']^0[NH;>:
M)NHO!W*_1.YGR/T3R(OUFF:4A32 0TE36ZS=&.V^W\&]5[:J7[@UO6%GT'ME
MB^^9%0>=R=&"!_X/2O\'3J0BLL;Y%>5TS?0UTI)PM:82,0Z'KRG73#^9$V!U
M"%9*8K23T+&D?KI&)!$IU[;ZSA<>90N;MO5M-IA &X._:?>;Q>1A:?*P8<J@
M%<41L* [>6XTW#.Y<T1R5)HU:F@6JV)J;(*V&@H>LI@1TR*O$71Y:&/\2"YB
M "%-N$E\;>[" * H:D<T/[IR1#L8'47[=7_\(MQY25HD!R-'7L9E ,8- W#"
M09O9;LCV8-3Q3CQ9;DW_U(/E5O.\SM!9#9,R&!,GT%<2IR2?B&*8R0@/Z36"
M1X:)R)996V@FQWGR;/D\EL,3B]SR)-Z)O'N]:C+H.9TUO,R2'<Q^2*RAW'=$
M2U/L?%.6 B62P[FR=N8<?5BS[)1)M6'%<YKTA9NG;L/9=QK5V4TAO24:F".-
MHV>;:9,>,"\6K,=O9 GS72$W/",7G)<[=!U7KF.GZ[<91YA,I%D0),PSS^XC
M4VZ"DU7\A'9"*;:*P6L!MU$M7NV8JBQ0W#[)84>^BB"<%0F<(H>N5V."YSM=
MOZ><Q)I1A0B/LHXEJ=*P*0EE:IT*YP6@TY>S(L%YD<5YD:53Y# BU7CCN2>%
M$Q&AC[#A5%9&+@"=OIP5618BHP:^5*.*YYY5E@67&+JY3?562)A+'%SM51.%
M-[SP?.E58X'GG@L^ NOG7!C# X="V#@] 2ONB8QL;#@OX.K!]8=VIFDJ&321
M/'2O:OJ>NV.ZW+M&7&BDTM7?P*^&9J#LF,S:HM7SL<7*OM7SII)!$\E#SZL.
M[[E;O+4<T7]H89R$8MI*D6ZV9@,V<&TGJRZ+>Q<N4ERU2^QNE^XL-LX@/NYI
MOBU_#>6"\W*'_E8]$KM[Y*G</>R9_DYE#&3IBFO5D/"E-ZZXHG;LIO: PFY!
MTJ@^9E]X#S?'QTSOWL3ABLWQ&3:G$=1<G)D-4W#$; 8L\/$NTL.>RX"*]+%[
MYW=L &HSCB(1QT0J,ZPCM272.IPO"NQQO;]UO/X)FZIF@=W-HK#)51\5,^/Q
MI6NOXC[LYKX?;6H%7+V.)CW;[O2NL6301/+P;5-%M;Y[0W/!IN8?;VX\;VSS
MO+%DT$3RT/.J$?CN1O"@S9L(,RN^$R$\'+^EDJF(A<?N'2Y0,:^/+UR5?NTM
MH7O\_]&J+.#JY-+WAM;<-)4,FDCF[G5K[^(3*C?95Q.PVG!Q_IJYO%I^F;G-
MOD>\N!YX;Y;Y]Y4*)O_<\Y[(#>,*Q70-D+W."-A4YE]0\A,M=MD;_Y706B39
MX982X" C /?70NCG$[- ^1UK]C]02P,$%     @ THI74FK@7RLS!@  I1P
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MWAM\Y;@W1W-P2C9*/;K%73H*(D<(!2;6(3 :GG"&0C@@HO&SQ@R:D,[Q>'Y
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MTVR$SCZ=HT^(<C1?BT01'JFNIXUI%J 79F8,4C."$C-P@"9&\UJA6QY!="C
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MZ=87[WSWR'*'4@-=[L?I+]CE6+T#W&TL>)"3I06!%V;_]'<>B ."U%$34$Y
M58)Q@H!S FY+,'*"T99@Y@2S+8'D!-*68.4$JRW!S@EV6X*3$YPJ@9Q*G+[/
MG-YV#%@DNY;MDY1]NF&:;RV;6.FL'%)!>]V([T"4X*5><I%.[90O)Z,7)JMP
M)B+YUI,\T9N-'IY'+W/0?QF"A]'KPWO_[7$\ ..7^]?WY_Y\_/H"+EYD,9A1
MG\6 A@OP%O&E)\#'%WAG&QX)^N$S,&,KN33%);@8,D$]/[X$5^#G; @N?ER"
M'\ +P7S-M['DQUU-2+N3T34WM_$NLQ&=L!&#9QZ*=0Q&X8(M%/Q),Q^B!@%-
M!JR(&MI'[0XU*@Z9>PTP_ ,@'>D*@P;-]!G;2+I^DCYLID^V82-]U$Q_IE&C
M\?>M?8>.@O[0VG<E_;&U[TKZN+7O2OKDO+P_G1>Z:7NZW3"+<;'V<:J'3Z8B
M7;2@6-\-FD:A::2:Q@G-.1?4E]OS)PNW5<%L965\*^4G/<)G#]LV,:RN]GFX
M@A0P2T<8'<.&=1@R;4+,8]A(H68:&!G'L'L%S#$AJMCVH++-T9W*H(\J3S$Q
M*K"QRC:'./HQ;%*'06Q!F]C'N"<%SH26:5:<F"IPAH4, Q:XHPE@%A/ ;#6I
MLFVB84:10I TSJC7#8NH\,*5W$5<'C#5JLT4R+'/<KY40E.'.=@B%=14(09U
MQ['5<;$*-ZQ&-_J!W"N]?VC2>ZI<L&JC7B'+JF;M20G346423%4P" ]</?+!
M+GRP&WT8\$5 0S#;,->COO@"LVVT\ESJ-Z39*;2=;RM&4"^[&_V\<C3)!0Y#
M93N&C6$E\ J<XQ"DDTKD53B"'>2H0P\/&C78O XBL98?7PO/S?JPN1?'6P;F
MS%V'W.<KKSEDJ!P'?5\BRJT&XG,3@6N!,RQ+Q]45H,"9"&(35A.AP.FVK.8G
M$E'N<+!YBRL+4AZJQ@B5=1-^4^&$9>6$YY=.6"]W)B3(KH5=@<,.J6TK2CUD
M&^1$V,OZ"9L+:#WLX%_P?RH2+,L=M+\I)665@\[Y*7%J(<0FJ87Z285SS+2U
M/$Z) D<PQB=2@LKJBIJKJS(EY]4I5-9#!+\G.:@L?0B=G9Q<XKC7D!6^VFNH
M<(9!<'6G5N)DTWEBJT9EQ47-%7? (_EY3@5+L\#%FD5-02K+'S*^*>YEZ4/F
M^7$W:_WJ%98-<+5]>U(!#2@_,:K+0JEHZ\2N=GK:P?%*P*)5>F@8 Y=O0Y%]
M;15/BX/)?GH\4WE^!V_&4/%\ F^FV;%C*9^=@LKOU947QL!G2SF4?FU)FZ/L
M8#&[$7R3'NY\<"%XD%ZN&5VP* '(]TO.Q?XF&: XWNW]!U!+ P04    " #2
MBE=2MPBNU $%   M%@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6R]
M6%MOXC@8_2L6FH=6FFEBQXF3BB+1<BF7M@C:G8?5/J1@(#M)S"2FS/S[=2X$
M8DP:J9U]@5S..?X^^]B?X^:.13_B-:4<_ K\,+YIK#G?7&M:/%_3P(VOV(:&
MXLV218'+Q6VTTN)-1-U%2@I\#>FZI06N%S9:S?39)&HUV9;[7D@G$8BW0>!&
MOV^ISW8W#=C8/YAZJS5/'FBMYL9=T1GE+YM)).ZT0F7A!32,/1:"B"YO&FUX
M/48I(47\Y=%=?'0-DE1>&?N1W P6-PT]B8CZ=,X3"5?\O=$[ZON)DHCC9R[:
M*-I,B,?7>_5>FKQ(YM6-Z1WSOWL+OKYIV VPH$MWZ_,IV]W3/"$ST9LS/TY_
MP2['Z@TPW\:<!3E91!!X8?;O_LH[XH@@=-0$E!.03,!G"$9.,.H2<$[ =0EF
M3C#K$JR<8-4ED)Q ZA+LG&#7)3@YP9$)UKF!T_<CI]=M Q:#?3+:9RG[X8;I
M>&N9L5)7=ESNMIH1VX$HP0N]Y"*U=LH79O3"9!;.>"3>>H+'6[-N_Z'[^ S:
MCQW0[S[UI^W)_> .#!Y[3].']O/@Z1%</#/N^F!*WVBXI>#U-WAP_V41Z%.V
MBMS-VIN#ME@ +L%%AW+7\^-+\ V\S#K@XLLE^ *\$#ROV39VPT7<U+B(.6E9
MF^?QW6;QH3/Q&>"!A7P=@VZXH L%?UC-AZA"0!.=5?08VO?8+:I4[-#Y%3#@
M5X!TI"L"NJNFS^A&T/6S]$XU?;@-*^G=:OJ#&U4&WZN=.W04]'[MW)7T^]JY
M*^F#VKDKZ<./C?OH8UTWKD^W*UQL%//>2/6,LT.Q$K64BUF]81'WPA48A%E-
M3VKCWV,!!P-.@_B?BL9PT1A.&\-G&LL6D"A;0+Z"D'+50I!ID%0CV3R\M0S;
MMC!I:F_'TTL!(SHR4!G6.84AT[8LLPSK*M1,;"!<AO44,,>$2(JMKXK-T1VI
MT7M5IH:%)=A %9MC.7H9-CR%08- V[++N)$"9T)BFE(28P4.$X0Q+' E$YB%
M"<P:)O!9N/KFBXW7 KAQ3+FR)&1"5JE_$-8-:5!.81A;!$IY#^NIC=Y5*V5M
M%5E;E5F_A!X7N<ZXRVD,+@;AW-\NQ-5)/R1U<K*E$6=@ZLW99<6T(T7;Y,_/
M<;MHS/[X'!_:)YWL$.@0R?FC4QC4"1%S2;*J"H=-VR;J07.*7)S/LJIS:BZ$
M;4>VJ@(F9KPI+5K#>FJC=]5*64/]L!?4*_/N;B/Q>5=A!GBTK81_WGL0'9I#
MG^"^7*3D%X(L6[+52(5S")97U+$")\JS*"!G!N)0G*'Q60;,E<IFL*'DK)X"
MAHF!I(DWK*<V>E>MG/=AGP"K-PKMV'/!Q)U[2V]>Y8M#S8'F_V##PV(/JU?[
MFC:T3NUE$DBPW,M*G.% V88*',;(-,X,QZ%^0/)I-B2G,1@00=F&IS#;=.2*
M74]L])Y8.>M#(8/5E6Q*8P[8$O U!=]9Y%=]-,)#28'.GW<B.BSEJ'HIK^?$
M7.2X!XFN&](.<Z2 V:8!Y6J<PXYWCK;NX#/%&!UJ"8*?9<-<Z3@$L<&5=K@]
M!8I +%7982VMT7M:6<[:T0E-0*-5>NX8@SG;ACS[:"N>%F>;[?2$1WI^"Z\'
M4/%\"*_'V<GE03X[2!6?O2LO%#M.NA1-Z5=$K)A1=C:9W7"V2<^'7AGG+$@O
MU]1=T"@!B/=+QOC^)FF@."%N_0=02P,$%     @ THI74A*Z8EO" P  Z0H
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M[25*,IRSA.2 XLU8F\+/(72D@4*\)/C SIZ!E/)*R'<Y6$1CS9",<(K77+I
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M,ZES_,E->>'Z)C(IR1E(\4:X-&Y=L="TO,.4 TYVZE3_2KBX(ZC'6-S[,)4
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M8G#A?!0"KC]9IUKA7*)U&%W!:D+1Z"13(6,LJU,&;ES#/L6)D2/)?&%:)=+
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M&U7U/YO'"SM%PNK/DN%?4$L#!!0    ( -**5U*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ THI74BQUECHP!P
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M2K8!F&T4;0-0VRC;!N"V4;@-0&ZC=!N W4;Q-@"]K>IM 7I;U=L"]+;5CVV
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M4$L! A0#%     @ THI74A$+R4AZ!   Y0X  !@              ("!6!0
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( -**5U(CCJU8
M= <  .D>   8              " @0@9  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " #2BE=2F=36GB #  "O"0  &
M@(&R(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ THI7
M4@H"5<GX"0  3"L  !@              ("!""0  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( -**5U(O9SHU;@@  $ J   8
M      " @38N  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" #2BE=2/YFW"1P#  !^!@  &               @(':-@  >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ THI74I/9;S8)*P  V80  !@
M             ("!+#H  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( -**5U+NWB&)?08  "H/   9              " @6ME  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ THI74FZ\;;H&"P
M%QT  !D              ("!'VP  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " #2BE=2"@31V#$/  #Y*0  &0              @(%<
M=P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( -**5U(Q
MV&'^GQ   )@Q   9              " @<2&  !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ THI74M7-I'''$@  Z4<  !D
M     ("!FI<  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M" #2BE=2AER.[^$,  "@(@  &0              @(&8J@  >&PO=V]R:W-H
M965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( -**5U)PO)13G00  .X*   9
M              " @;"W  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L!
M A0#%     @ THI74I<P::\K#0  +R4  !D              ("!A+P  'AL
M+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #2BE=2-9?BZ(T+
M   B(   &0              @('FR0  >&PO=V]R:W-H965T<R]S:&5E=#$X
M+GAM;%!+ 0(4 Q0    ( -**5U*)DO)B7P<  +,2   9              "
M@:K5  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ THI7
M4D\_P[?K#P  I2L  !D              ("!0-T  'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " #2BE=2K^2">XT#  !("   &0
M        @(%B[0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( -**5U)MY@!YE ,  -X'   9              " @2;Q  !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ THI74BUFR=F !@  FA
M !D              ("!\?0  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " #2BE=2>G'Y\TX'  !I$   &0              @(&H^P
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( -**5U+GV)?3
M@ 0  *D)   9              " @2T# 0!X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ THI74OG>F:L9!   20@  !D
M ("!Y <! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #2
MBE=21AK6+DL$  "N"0  &0              @($T# $ >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( -**5U*MHN3,7S(  (FW   9
M          " @;80 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#
M%     @ THI74HR^F=<I!   Q @  !D              ("!3$,! 'AL+W=O
M<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #2BE=2KSL=S7$#   ]
M!P  &0              @(&L1P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM
M;%!+ 0(4 Q0    ( -**5U*C#UH:E 0  +,*   9              " @51+
M 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ THI74KO*
MX A7 P  S@8  !D              ("!'U ! 'AL+W=O<FMS:&5E=',O<VAE
M970S,BYX;6Q02P$"% ,4    " #2BE=2U!7K@9$#   &"   &0
M    @(&M4P$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M -**5U+X#D6"7 D  &4B   9              " @757 0!X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ THI74B2A=:_>!0  MA(  !D
M             ("!"&$! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " #2BE=2F.7QC"<&   ;#P  &0              @($=9P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( -**5U)4^>YY(P8
M ,@0   9              " @7MM 0!X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ THI74FH^.,)^!   60L  !D              ("!
MU7,! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #2BE=2
MH[5G&8((   :%0  &0              @(&*> $ >&PO=V]R:W-H965T<R]S
M:&5E=#,Y+GAM;%!+ 0(4 Q0    ( -**5U*NHKK$(0,  "@'   9
M      " @4.! 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%
M  @ THI74I_JZ3=F P  #P<  !D              ("!FX0! 'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #2BE=27\:+0YP#   _"0
M&0              @($XB $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+
M 0(4 Q0    ( -**5U+M0V_G=00  &\-   9              " @0N, 0!X
M;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ THI74C?40ODG
M!   )@@  !D              ("!MY ! 'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"% ,4    " #2BE=2"#A\A8D+  "0.P  &0
M@($5E0$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( -**
M5U(SBA=,IP(  'H&   9              " @=6@ 0!X;"]W;W)K<VAE971S
M+W-H965T-#8N>&UL4$L! A0#%     @ THI74I,/RO@A!@  U2(  !D
M         ("!LZ,! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
M    " #2BE=2>_GHO>,"  #&!@  &0              @($+J@$ >&PO=V]R
M:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( -**5U(D&3M2]@,  * +
M   9              " @26M 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL
M4$L! A0#%     @ THI74G"*(9S; @  &P<  !D              ("!4K$!
M 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #2BE=2CA-$
MGJ,#  "Z%0  &0              @(%DM $ >&PO=V]R:W-H965T<R]S:&5E
M=#4Q+GAM;%!+ 0(4 Q0    ( -**5U*TL6BQ5@,  !4*   9
M  " @3ZX 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @
MTHI74CR]QR0,!0  @18  !D              ("!R[L! 'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6Q02P$"% ,4    " #2BE=2T'7"&$$#  "Q"P  &0
M            @($.P0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4
M Q0    ( -**5U+KN?ZV.00  %D/   9              " @8;$ 0!X;"]W
M;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ THI74GL(BG*O!0
M^1<  !D              ("!]L@! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX
M;6Q02P$"% ,4    " #2BE=2WZM0G>,)   (-P  &0              @('<
MS@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( -**5U(0
M^4K8O0(  ,4(   9              " @?;8 0!X;"]W;W)K<VAE971S+W-H
M965T-3@N>&UL4$L! A0#%     @ THI74FI)X5=/ @  ^04  !D
M     ("!ZML! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -**5U*>9ZI4^P4  /PD   9              "
M@6?[ 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ THI7
M4L12?*'N!0  H!T  !D              ("!F0$" 'AL+W=O<FMS:&5E=',O
M<VAE970V-2YX;6Q02P$"% ,4    " #2BE=2O K@*9D$  "F$0  &0
M        @(&^!P( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0
M   ( -**5U)!E+^E9P0  *D1   9              " @8X, @!X;"]W;W)K
M<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ THI74F=]R+O%!0  D!L
M !D              ("!+!$" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q0
M2P$"% ,4    " #2BE=2UIGVRU8$  !V$   &0              @($H%P(
M>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( -**5U)E:^EM
MS@,  (<-   9              " @;4; @!X;"]W;W)K<VAE971S+W-H965T
M-S N>&UL4$L! A0#%     @ THI74A!U3J:>!P  6RD  !D
M ("!NA\" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #2
MBE=2*BB29S0#   5"@  &0              @(&/)P( >&PO=V]R:W-H965T
M<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( -**5U(X0?;K8@0  .00   9
M          " @?HJ @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#
M%     @ THI74A$=)B*[!   _A4  !D              ("!DR\" 'AL+W=O
M<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #2BE=2U?NX#3X#   1
M"0  &0              @(&%- ( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM
M;%!+ 0(4 Q0    ( -**5U*OWJB:WP(  . '   9              " @?HW
M @!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ THI74L3A
M(T7-!   W!(  !D              ("!$#L" 'AL+W=O<FMS:&5E=',O<VAE
M970W-RYX;6Q02P$"% ,4    " #2BE=2@I-2HH4"  "8!@  &0
M    @($40 ( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    (
M -**5U)F([#DI0,  #4+   9              " @=!" @!X;"]W;W)K<VAE
M971S+W-H965T-SDN>&UL4$L! A0#%     @ THI74AH V%.# @  /08  !D
M             ("!K$8" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"
M% ,4    " #2BE=2N/'ZX!L$   D#@  &0              @(%F20( >&PO
M=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( -**5U(W,7PY; ,
M ,X+   9              " @;A- @!X;"]W;W)K<VAE971S+W-H965T.#(N
M>&UL4$L! A0#%     @ THI74H.FX?2X @  DP8  !D              ("!
M6U$" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " #2BE=2
MN]M!'#<$  "+$0  &0              @(%*5 ( >&PO=V]R:W-H965T<R]S
M:&5E=#@T+GAM;%!+ 0(4 Q0    ( -**5U)Y CS[.00  (D1   9
M      " @;A8 @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%
M  @ THI74GS.'O3% @  8@<  !D              ("!*%T" 'AL+W=O<FMS
M:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " #2BE=2_LA=U><%  #3&@
M&0              @($D8 ( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+
M 0(4 Q0    ( -**5U)JX%\K,P8  *4<   9              " @4)F @!X
M;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ THI74LWW1$EZ
M P  ^@L  !D              ("!K&P" 'AL+W=O<FMS:&5E=',O<VAE970X
M.2YX;6Q02P$"% ,4    " #2BE=2.X="6+\$   X$0  &0
M@(%=< ( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( -**
M5U)K'O3Y.P,  %X*   9              " @5-U @!X;"]W;W)K<VAE971S
M+W-H965T.3$N>&UL4$L! A0#%     @ THI74I3F["CL!   I!4  !D
M         ("!Q7@" 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4
M    " #2BE=2CTDO*<("   8!P  &0              @('H?0( >&PO=V]R
M:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( -**5U(I]FRO( 4  "$8
M   9              " @>&  @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL
M4$L! A0#%     @ THI74J?77]S8 @  \ @  !D              ("!.(8"
M 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"% ,4    " #2BE=20=6G
M33$$  ! $   &0              @(%'B0( >&PO=V]R:W-H965T<R]S:&5E
M=#DV+GAM;%!+ 0(4 Q0    ( -**5U):\TQ4@ (  .L%   9
M  " @:^- @!X;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @
MTHI74M?=*/'\!   ZA4  !D              ("!9I " 'AL+W=O<FMS:&5E
M=',O<VAE970Y."YX;6Q02P$"% ,4    " #2BE=2MPBNU $%   M%@  &0
M            @(&9E0( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4
M Q0    ( -**5U(2NF);P@,  .D*   :              " @=&: @!X;"]W
M;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( -**5U(Q0"\"M@0
M ,42   :              " @<N> @!X;"]W;W)K<VAE971S+W-H965T,3 Q
M+GAM;%!+ 0(4 Q0    ( -**5U*RU$UM" 0  %4.   :              "
M@;FC @!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( -**
M5U(8AB%ZIP(  #D1   -              "  ?FG @!X;"]S='EL97,N>&UL
M4$L! A0#%     @ THI74I>*NQS     $P(   L              ( !RZH"
M %]R96QS+RYR96QS4$L! A0#%     @ THI74BQUECHP!P  24,   \
M         ( !M*L" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -**5U+M
M2,2UY (  /$[   :              "  1&S @!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( -**5U+1-?Q97P(  -<Y   3
M      "  2VV @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !N &X /!X
' +VX @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>498</ContextCount>
  <ElementCount>657</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>163</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/BUSINESS</Role>
      <ShortName>BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE</Role>
      <ShortName>ASSETS AND LIABILITIES HELD FOR SALE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONS</Role>
      <ShortName>ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - DERIVATIVE INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTS</Role>
      <ShortName>DERIVATIVE INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2136108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - TREASURY STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCK</Role>
      <ShortName>TREASURY STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2143110 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2150111 - Disclosure - RETIREMENT BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANS</Role>
      <ShortName>RETIREMENT BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2158112 - Disclosure - LEASES AND RELATED PARTY LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2165113 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2173114 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2177115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2181116 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2184117 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2189118 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2191119 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED</Role>
      <ShortName>SELECTED QUARTERLY INFORMATION - UNAUDITED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2194120 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables</Role>
      <ShortName>ASSETS AND LIABILITIES HELD FOR SALE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSTables</Role>
      <ShortName>ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBT</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2337307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2351309 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2359310 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2366311 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2374312 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2378313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2382314 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2385315 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2392316 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables</Role>
      <ShortName>SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails</Role>
      <ShortName>ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails</Role>
      <ShortName>ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - ACQUISITIONS (Business Acquisition, Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails</Role>
      <ShortName>ACQUISITIONS (Business Acquisition, Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - ACQUISITIONS (Asset Acquisition, Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails</Role>
      <ShortName>ACQUISITIONS (Asset Acquisition, Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - DEBT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails</Role>
      <ShortName>DEBT (Maximum Total Leverage Ratio Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTScheduleofDebtMaturityDetails</Role>
      <ShortName>DEBT (Schedule of Debt Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2435421 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - TREASURY STOCK - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCKNarrativeDetails</Role>
      <ShortName>TREASURY STOCK - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2453432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2456435 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2457436 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2460437 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2461438 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2462439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2463440 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2464441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2467442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2468443 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2469444 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2470445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2471446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2472447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2475448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2476449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails</Role>
      <ShortName>NET INCOME PER SHARE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2479450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2480451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2483452 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2486453 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2487454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2488455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2490456 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2493457 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails</Role>
      <ShortName>SELECTED QUARTERLY INFORMATION - UNAUDITED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="iart-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2495458 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>102</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="iart-20201231.htm">iart-20201231.htm</File>
    <File>iart-20201231.xsd</File>
    <File>iart-20201231_cal.xml</File>
    <File>iart-20201231_def.xml</File>
    <File>iart-20201231_lab.xml</File>
    <File>iart-20201231_pre.xml</File>
    <File>iart-20201231xexx21.htm</File>
    <File>iart-20201231xexx21b.htm</File>
    <File>iart-20201231xexx23.htm</File>
    <File>iart-20201231xexx311.htm</File>
    <File>iart-20201231xexx312.htm</File>
    <File>iart-20201231xexx321.htm</File>
    <File>iart-20201231xexx322.htm</File>
    <File>iart-20201231xexx413.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iart-20201231_g1.jpg</File>
    <File>iart-20201231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>126
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 44,
   "contextCount": 498,
   "dts": {
    "calculationLink": {
     "local": [
      "iart-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iart-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 974,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 14,
    "http://integralife.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 19
   },
   "keyCustom": 88,
   "keyStandard": 569,
   "memberCustom": 83,
   "memberStandard": 79,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE",
     "role": "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE",
     "shortName": "ASSETS AND LIABILITIES HELD FOR SALE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia880589c0d5d4323b971f4a8272c48aa_I20210219",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2490456 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)",
     "role": "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
     "shortName": "SUBSEQUENT EVENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia880589c0d5d4323b971f4a8272c48aa_I20210219",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2493457 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Details)",
     "role": "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails",
     "shortName": "SELECTED QUARTERLY INFORMATION - UNAUDITED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a1fb52b3da94218a1d36ab4a7802fe4_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2495458 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i5ab29dbb0b9741c09878d1f0e26205c2_I20171231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - ACQUISITIONS",
     "role": "http://integralife.com/role/ACQUISITIONS",
     "shortName": "ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:BusinessCombinationAndAssetAcquisitionDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - DEBT",
     "role": "http://integralife.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - DERIVATIVE INSTRUMENTS",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTS",
     "shortName": "DERIVATIVE INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - TREASURY STOCK",
     "role": "http://integralife.com/role/TREASURYSTOCK",
     "shortName": "TREASURY STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143110 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150111 - Disclosure - RETIREMENT BENEFIT PLANS",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANS",
     "shortName": "RETIREMENT BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158112 - Disclosure - LEASES AND RELATED PARTY LEASES",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES",
     "shortName": "LEASES AND RELATED PARTY LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2165113 - Disclosure - INCOME TAXES",
     "role": "http://integralife.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173114 - Disclosure - NET INCOME PER SHARE",
     "role": "http://integralife.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2177115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2181116 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2184117 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2189118 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://integralife.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2191119 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED",
     "role": "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED",
     "shortName": "SELECTED QUARTERLY INFORMATION - UNAUDITED",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2194120 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE (Tables)",
     "role": "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables",
     "shortName": "ASSETS AND LIABILITIES HELD FOR SALE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - ACQUISITIONS (Tables)",
     "role": "http://integralife.com/role/ACQUISITIONSTables",
     "shortName": "ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - DEBT (Tables)",
     "role": "http://integralife.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables",
     "shortName": "DERIVATIVE INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351309 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSTables",
     "shortName": "RETIREMENT BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359310 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables",
     "shortName": "LEASES AND RELATED PARTY LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2366311 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://integralife.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2374312 - Disclosure - NET INCOME PER SHARE (Tables)",
     "role": "http://integralife.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2378313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2382314 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2385315 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2392316 - Disclosure - SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)",
     "role": "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables",
     "shortName": "SELECTED QUARTERLY INFORMATION - UNAUDITED (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i2156cb0dcc194220a546b328fa630c07_I20210104",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details)",
     "role": "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
     "shortName": "ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i2ad1ea87dcac4b829d2588d82938711d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details)",
     "role": "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
     "shortName": "ASSETS AND LIABILITIES HELD FOR SALE - Assets and Liabilities Held For Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i2ad1ea87dcac4b829d2588d82938711d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i6977fff2340446e5b9fddb49366b8f03_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i6977fff2340446e5b9fddb49366b8f03_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i1647e4d8490d449bbdd63555d13bff5f_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "iab11d9606b8c493e897237f5afc49895_D20190729-20190729",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - ACQUISITIONS (Business Acquisition, Narrative) (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
     "shortName": "ACQUISITIONS (Business Acquisition, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "iab11d9606b8c493e897237f5afc49895_D20190729-20190729",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "ACQUISITIONS (Schedule of Assets Acquired and Liabilities Assumed) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i4fcfaca18ae9416ebda0a5198561cbe6_I20190729",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - ACQUISITIONS (Asset Acquisition, Narrative) (Details)",
     "role": "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
     "shortName": "ACQUISITIONS (Asset Acquisition, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i99c5b7aacd7b4b99aee39512a8234819_D20190909-20190909",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:AssetAcquisitionConsiderationTransferred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SecuredDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - DEBT (Narrative) (Details)",
     "role": "http://integralife.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "iaffaed4533cd4d7f923869baf4414f46_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "role": "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
     "shortName": "DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "iaffaed4533cd4d7f923869baf4414f46_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)",
     "role": "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails",
     "shortName": "DEBT (Schedule of Debt Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ic51105541e884bc88363f2c16b76284b_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i12ccafd7c32d435e937a09b89142d9c0_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "id66609e8dad741d88f6e535da2241aee_D20201001-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i80156bc966174b7491215c549eab3021_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i5c0daaf7584842a682f9d005209fecb7_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i80156bc966174b7491215c549eab3021_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "idf914a28f9c1424fb32fb39c3ed8a539_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i80156bc966174b7491215c549eab3021_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ic8f198bdda2744619e39ee6d06daf04a_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435421 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "iacfb8fe155e2425ca6bbc17b660c2f50_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - TREASURY STOCK - Narrative (Details)",
     "role": "http://integralife.com/role/TREASURYSTOCKNarrativeDetails",
     "shortName": "TREASURY STOCK - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i5702024fe01646a99a5c8c9d326d73b8_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i5702024fe01646a99a5c8c9d326d73b8_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "id58d59da5a4945d88d46c8031ef25907_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "id58d59da5a4945d88d46c8031ef25907_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453432 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456435 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BUSINESS",
     "role": "http://integralife.com/role/BUSINESS",
     "shortName": "BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457436 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460437 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461438 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i328cafabba8048a388b6e3eaae3d3c02_I20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462439 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463440 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464441 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details)",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Prior Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467442 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468443 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469444 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470445 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471446 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7fac4ecd14854b13af640b05c1490ec6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472447 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i1b1715655e084da08f6d9ab45911c30b_I20171231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475448 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "role": "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476449 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)",
     "role": "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
     "shortName": "NET INCOME PER SHARE (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ia7a841c52734456191bb4acc617e9711_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2480451 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "ied2d80105ffa4482aed85b57eea1cada_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i538dfb31e082468593d9ba7bb909acfa_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483452 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7cd43a1f671d4371beadf9bdbd2a1cdc_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "if89f6f340811499ea8dfa25b7d90e0d5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2486453 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i4966037ecbfa4093b6fa72d3212e8f0e_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iart:SegmentReportingInformationNumberOfProductsOffered",
      "reportCount": 1,
      "unique": true,
      "unitRef": "product",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2487454 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i0339f7ff81b9436da44be79de840be6c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i7a845d0bc35242358fda1e54e6b3f11b_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2488455 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20201231.htm",
      "contextRef": "i0ab9fed755274b8bab9f12726270620d_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 163,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States (Includes long-lived assets in Puerto Rico)"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iart_ACellIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell, Inc.",
        "label": "ACell, Inc. [Member]",
        "terseLabel": "ACell, Inc."
       }
      }
     },
     "localname": "ACellIncMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities.",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AccumulatedOtherComprehensiveIncomeLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossRollForward",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_AcquiredFinitelivedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-lived Intangible Assets, Discount Rate",
        "label": "Acquired Finite-lived Intangible Assets, Discount Rate",
        "terseLabel": "Acquired intangible assets, discount rate"
       }
      }
     },
     "localname": "AcquiredFinitelivedIntangibleAssetsDiscountRate",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AdditionalEPSShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the basic and diluted calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares",
        "label": "Additional EPS Shares",
        "terseLabel": "Additional EPS shares (in shares)"
       }
      }
     },
     "localname": "AdditionalEPSShares",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AllOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other [Member]",
        "label": "All Other [Member]",
        "terseLabel": "All other"
       }
      }
     },
     "localname": "AllOtherMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AnnualRateOfLeaseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rate of lease agreement.",
        "label": "Annual Rate Of Lease Agreement",
        "terseLabel": "Annual rate of lease agreement"
       }
      }
     },
     "localname": "AnnualRateOfLeaseAgreement",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ArkisBioSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arkis BioSciences Inc. [Member]",
        "label": "Arkis BioSciences Inc. [Member]",
        "terseLabel": "Arkis"
       }
      }
     },
     "localname": "ArkisBioSciencesInc.Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net",
        "label": "Asset Acquisition, Assets Acquired And Liabilities Assumed, Net",
        "terseLabel": "Remaining net assets acquired"
       }
      }
     },
     "localname": "AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Consideration Transferred",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Development Milestone Payment",
        "label": "Asset Acquisition, Development Milestone Payment To Be Paid",
        "terseLabel": "Development milestone payment, to be paid"
       }
      }
     },
     "localname": "AssetAcquisitionDevelopmentMilestonePaymentToBePaid",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Maximum Contingent Development Milestone Payments",
        "label": "Asset Acquisition, Maximum Contingent Development Milestone Payments, If Circumstances Met",
        "terseLabel": "Contingent development milestone payments commitment (up to)"
       }
      }
     },
     "localname": "AssetAcquisitionMaximumContingentDevelopmentMilestonePaymentsIfCircumstancesMet",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met",
        "label": "Asset Acquisition, Maximum Future Consideration Transferred, If Circumstances Met",
        "terseLabel": "Maximum future purchase price, if circumstances met (not to exceed)"
       }
      }
     },
     "localname": "AssetAcquisitionMaximumFutureConsiderationTransferredIfCircumstancesMet",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetAcquisitionNumberOfAssetsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Number Of Assets Acquired",
        "label": "Asset Acquisition, Number Of Assets Acquired",
        "terseLabel": "Number of assets acquired"
       }
      }
     },
     "localname": "AssetAcquisitionNumberOfAssetsAcquired",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met",
        "label": "Asset Acquisition, Option To Acquire, Period Subsequent To Commercial Sale, If Circumstances Met",
        "terseLabel": "Option to acquire, period subsequent to first commercial sale"
       }
      }
     },
     "localname": "AssetAcquisitionOptionToAcquirePeriodSubsequentToCommercialSaleIfCircumstancesMet",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_AustriaFranceAndGermanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Austria, France, And Germany [Member]",
        "label": "Austria, France, And Germany [Member]",
        "terseLabel": "Austria, France, and Germany"
       }
      }
     },
     "localname": "AustriaFranceAndGermanyMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_BusinessCombinationAndAssetAcquisitionDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisition Disclosure [Text Block]",
        "label": "Business Combination And Asset Acquisition Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionDisclosureTextBlock",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Expenses And Other Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CashFlowLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Table Text Block]",
        "label": "Cash Flow, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_CertainPurchasersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Purchasers [Member]",
        "label": "Certain Purchasers [Member]",
        "terseLabel": "Certain Purchasers"
       }
      }
     },
     "localname": "CertainPurchasersMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Asset [Roll Forward]",
        "label": "Change In Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability [Roll Forward]",
        "label": "Change In Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CharitableContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charitable contributions",
        "label": "Charitable contributions",
        "terseLabel": "Contributions to Integra Foundation"
       }
      }
     },
     "localname": "CharitableContributions",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CodmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman [Member]",
        "label": "Codman [Member]",
        "terseLabel": "Codman"
       }
      }
     },
     "localname": "CodmanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CodmanSpecialtySurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman Specialty Surgical [Member]",
        "label": "Codman Specialty Surgical [Member]",
        "terseLabel": "Codman Specialty Surgical"
       }
      }
     },
     "localname": "CodmanSpecialtySurgicalMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CompletedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Completed technology.",
        "label": "Completed Technology [Member]",
        "terseLabel": "Completed technology"
       }
      }
     },
     "localname": "CompletedTechnologyMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ConcentrationRiskNumberofCustomersOverBenchmark": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers Over Benchmark",
        "label": "Concentration Risk, Number of Customers Over Benchmark",
        "terseLabel": "Concentration risk, number of customers over benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskNumberofCustomersOverBenchmark",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_ConsortiumofFocusedOrthopedistsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consortium of Focused Orthopedists, LLC [Member]",
        "label": "Consortium of Focused Orthopedists, LLC [Member]",
        "terseLabel": "Consortium of Focused Orthopedists, LLC"
       }
      }
     },
     "localname": "ConsortiumofFocusedOrthopedistsLLCMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Liability [Member]",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Manufacturing Customer, Notified By FDA To Remove Product From Market [Member]",
        "label": "Contract Manufacturing Customer, Notified By FDA To Remove Product From Market [Member]",
        "terseLabel": "Contract Manufacturing Customer, Notified By FDA To Remove Product From Market"
       }
      }
     },
     "localname": "ContractManufacturingCustomerNotifiedByFDAToRemoveProductFromMarketMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "terseLabel": "Contract liability, net of revenue recognized on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.",
        "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CrossCurrencyInterestRateContractFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Five [Member]",
        "label": "Cross Currency Interest Rate Contract Five [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Five"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractFiveMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Four [Member]",
        "label": "Cross Currency Interest Rate Contract Four [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Four"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractFourMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract One [Member]",
        "label": "Cross Currency Interest Rate Contract One [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractOneMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Six",
        "label": "Cross Currency Interest Rate Contract Six [Member]",
        "terseLabel": "Cross-Currency Interest Rate Contract Six"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractSixMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Three [Member]",
        "label": "Cross Currency Interest Rate Contract Three [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractThreeMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Two [Member]",
        "label": "Cross Currency Interest Rate Contract Two [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractTwoMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtAccountsReceivableSecuritizationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Accounts Receivable Securitization, Term",
        "label": "Debt, Accounts Receivable Securitization, Term",
        "terseLabel": "Securitization facility, term"
       }
      }
     },
     "localname": "DebtAccountsReceivableSecuritizationTerm",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_DebtCovenantPeriod1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 1 [Member]",
        "label": "Debt Covenant Period 1 [Member]",
        "terseLabel": "Execution of July 2020 Amendment through June 30, 2021"
       }
      }
     },
     "localname": "DebtCovenantPeriod1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 2 [Member]",
        "label": "Debt Covenant Period 2 [Member]",
        "terseLabel": "September 30, 2021 through June 30, 2022"
       }
      }
     },
     "localname": "DebtCovenantPeriod2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 3 [Member]",
        "label": "Debt Covenant Period 3 [Member]",
        "terseLabel": "September 30, 2022 through June 30, 2023"
       }
      }
     },
     "localname": "DebtCovenantPeriod3Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 4 [Member]",
        "label": "Debt Covenant Period 4 [Member]",
        "terseLabel": "September 30, 2023 and the last day of each fiscal quarter thereafter"
       }
      }
     },
     "localname": "DebtCovenantPeriod4Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "label": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "terseLabel": "Combination settlement for debt conversion, minimum settled in cash per principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "label": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "terseLabel": "Debt Instrument, Covenant, Maximum Leverage Ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "label": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "terseLabel": "Maximum average conversion value of notes"
       }
      }
     },
     "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "terseLabel": "Maximum selling price of the company's common stock of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtWeightedAverageInterestRateFromSecuritization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Weighted Average Interest Rate, From Securitization",
        "label": "Debt, Weighted Average Interest Rate, From Securitization",
        "terseLabel": "Security facility, weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRateFromSecuritization",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DeferredTaxAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset [Member]",
        "label": "Deferred Tax Asset [Member]",
        "terseLabel": "Deferred Tax Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DeferredTaxAssetsLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leases And Other",
        "label": "Deferred Tax Assets, Leases And Other",
        "terseLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasesAndOther",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "terseLabel": "Capitalization of research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxLiabilitiesLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Leases And Other",
        "label": "Deferred Tax Liabilities, Leases And Other",
        "negatedLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasesAndOther",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanBenefitObligationPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "negatedTerseLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPremiumsPaid",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "terseLabel": "Defer payment and taxation, base salary, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanPlanAssetsPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "label": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "negatedLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPremiumsPaid",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.",
        "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DermaSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derma Sciences [Member]",
        "label": "Derma Sciences [Member]",
        "terseLabel": "Derma Sciences"
       }
      }
     },
     "localname": "DermaSciencesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DirectorsandCertainExecutiveOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Certain Executive Officers [Member]",
        "label": "Directors and Certain Executive Officers [Member]",
        "terseLabel": "Directors and Certain Executive Officers"
       }
      }
     },
     "localname": "DirectorsandCertainExecutiveOfficersMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationAccruedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accrued Compensation",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedCompensation",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Asset And Other Assets",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Asset And Other Assets",
        "terseLabel": "Right of use asset - operating leases and Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseAssetAndOtherAssets",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current",
        "terseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "label": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "terseLabel": "Sale of Extremity Orthopedics business, payment for terminating license agreement"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "label": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "terseLabel": "Effective foreign income tax rate"
       }
      }
     },
     "localname": "EffectiveForeignIncomeTaxRateReconciliationContinuingOperations",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 21.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "terseLabel": "Assets held for sale - Outside Basis Difference"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Carryback Federal Net Operating Loss, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Carryback Federal Net Operating Loss, Percent",
        "terseLabel": "Carryback of Federal net operating loss (\"NOL\")"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCarrybackFederalNetOperatingLossPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "negatedTerseLabel": "Intercompany profit in inventory"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Deferred income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 19.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Intangible Income, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Intangible Income, Percent",
        "terseLabel": "Foreign-Derived Intangible Income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIntangibleIncomePercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "terseLabel": "Nondeductible facilitative costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Per Share",
        "terseLabel": "Federal tax credit (in dollars per share)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditForeignPerShare",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Global Intangible Low-Taxed Income, Percent",
        "terseLabel": "Global intangible low-taxed income (\"GILTI\")"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomePercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 20.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "terseLabel": "Transfer of Intra-entity of certain intellectual property - Rate Differential on FMV Step-Up"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "label": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective worldwide tax rate"
       }
      }
     },
     "localname": "EffectiveWorldwideIncomeTaxRateReconciliationPercent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_EmployeeStockPurchasePlanProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from employees in connection with the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Proceeds",
        "terseLabel": "ESPP proceeds received"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanProceeds",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ExtremityOrthopedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extremity Orthopedics [Member]",
        "label": "Extremity Orthopedics [Member]",
        "terseLabel": "Extremity Orthopedics"
       }
      }
     },
     "localname": "ExtremityOrthopedicsMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "terseLabel": "Transfers from long-term to current portion"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_FiveYearLeasePeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Lease Period Two",
        "label": "Five Year Lease Period Two [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2034 Through October 31, 2034"
       }
      }
     },
     "localname": "FiveYearLeasePeriodTwoMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FiveYearOptionLeasePeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Option Lease Period One",
        "label": "Five Year Option Lease Period One [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2029 Through October 31, 2034"
       }
      }
     },
     "localname": "FiveYearOptionLeasePeriodOneMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FoundationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foundation [Policy Text Block].",
        "label": "Foundation [Policy Text Block]",
        "terseLabel": "Integra Foundation"
       }
      }
     },
     "localname": "FoundationPolicyTextBlock",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "label": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "negatedLabel": "Loss on disposal of property and equipment and construction in-progress"
       }
      }
     },
     "localname": "GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Line Items]",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Table]",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncreaseInAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of authorized shares under the Plan.",
        "label": "Increase In Authorized Shares",
        "terseLabel": "Increase in authorized shares (in shares)"
       }
      }
     },
     "localname": "IncreaseInAuthorizedShares",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Impairment Assessment, Discount Rate Percentage",
        "label": "Indefinite-Lived Intangible Assets, Impairment Assessment, Discount Rate Percentage",
        "terseLabel": "Intangible assets, indefinite life, discount rate percentage"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsImpairmentAssessmentDiscountRatePercentage",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Impairment Assessment, Royalty Rate, Percentage",
        "label": "Indefinite-Lived Intangible Assets, Impairment Assessment, Royalty Rate, Percentage",
        "terseLabel": "Impairment assessment, royalty rate"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsImpairmentAssessmentRoyaltyRatePercentage",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Impairment Assessment, Tax Rate, Percentage",
        "label": "Indefinite-Lived Intangible Assets, Impairment Assessment, Tax Rate, Percentage",
        "terseLabel": "Impairment assessment, tax rate"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsImpairmentAssessmentTaxRatePercentage",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_InformationSystemsandHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information Systems and Hardware [Member]",
        "label": "Information Systems and Hardware [Member]",
        "terseLabel": "Information systems and hardware"
       }
      }
     },
     "localname": "InformationSystemsandHardwareMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_IntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Abstract]",
        "label": "Intangible Assets [Abstract]",
        "terseLabel": "Intangible assets:"
       }
      }
     },
     "localname": "IntangibleAssetsAbstract",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IntegratedShoulderCollaborationInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Shoulder Collaboration, Inc. [Member]",
        "label": "Integrated Shoulder Collaboration, Inc. [Member]",
        "terseLabel": "ISC"
       }
      }
     },
     "localname": "IntegratedShoulderCollaborationInc.Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 4 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 4"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche4Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 5 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 5"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche5Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 1",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 2",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 3",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche3Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 4",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 4 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 4"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche4Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 5",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 5 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 5"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche5Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedFebruary62017Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated February 6, 2017 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated February 6, 2017 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedFebruary62017Tranche1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedFebruary62017Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated February 6, 2017 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated February 6, 2017 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedFebruary62017Tranche2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedMarch272017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated March 27, 2017 [Member]",
        "label": "Interest Rate Swap Designated March 27, 2017 [Member]",
        "terseLabel": "Interest Rate Swap Designated March 27, 2017"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedMarch272017Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InventoryCapitalizedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Capitalized Expenses",
        "label": "Inventory, Capitalized Expenses",
        "terseLabel": "Inventory, capitalized expenses"
       }
      }
     },
     "localname": "InventoryCapitalizedExpenses",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options (or more)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_MilestonePaymentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment One [Member]",
        "label": "Milestone Payment One [Member]",
        "terseLabel": "Milestone Payment One"
       }
      }
     },
     "localname": "MilestonePaymentOneMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_MilestonePaymentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment Two [Member]",
        "label": "Milestone Payment Two [Member]",
        "terseLabel": "Milestone Payment Two"
       }
      }
     },
     "localname": "MilestonePaymentTwoMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NeurosurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurosurgery [Member]",
        "label": "Neurosurgery [Member]",
        "terseLabel": "Neurosurgery"
       }
      }
     },
     "localname": "NeurosurgeryMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_NoncashOrPartNoncashInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Or Part Noncash, In Process Research And Development",
        "label": "Noncash Or Part Noncash, In Process Research And Development",
        "terseLabel": "Non-cash in-process research and development expense"
       }
      }
     },
     "localname": "NoncashOrPartNoncashInProcessResearchAndDevelopment",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_OneMonthEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month Eurodollar Rate [Member]",
        "label": "One Month Eurodollar Rate [Member]",
        "terseLabel": "One-Month Eurodollar Rate"
       }
      }
     },
     "localname": "OneMonthEurodollarRateMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OneMonthUSDLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month USD LIBOR [Member]",
        "label": "One Month USD LIBOR [Member]",
        "terseLabel": "1-month USD LIBOR"
       }
      }
     },
     "localname": "OneMonthUSDLIBORMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OptionToExtendLeaseYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend lease, years.",
        "label": "Option To Extend Lease, Years",
        "terseLabel": "Option to extend lease, years"
       }
      }
     },
     "localname": "OptionToExtendLeaseYears",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_OrthopedicsandTissueTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopedics and Tissue Technologies [Member]",
        "label": "Orthopedics and Tissue Technologies [Member]",
        "terseLabel": "Orthopedics and Tissue Technologies"
       }
      }
     },
     "localname": "OrthopedicsandTissueTechnologiesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PaymentsForOptionIndexToIssuersEquity": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Options Indexed to Issuer's Equity",
        "label": "Payments For Option Index To Issuers Equity",
        "negatedLabel": "Purchase of option hedge on convertible notes",
        "verboseLabel": "Cost of call transactions"
       }
      }
     },
     "localname": "PaymentsForOptionIndexToIssuersEquity",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsForProceedsFromBusinessAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Business Acquisitions",
        "label": "Payments For (Proceeds From) Business Acquisitions",
        "negatedTerseLabel": "Cash used in business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsForProceedsFromBusinessAcquisitions",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "label": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "negatedLabel": "Acquired in-process research and development and intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director"
       }
      }
     },
     "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_PerformanceSharesandRestrictedUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Shares and Restricted Units",
        "label": "Performance Shares and Restricted Units [Member]",
        "terseLabel": "Performance Shares and Restricted Units"
       }
      }
     },
     "localname": "PerformanceSharesandRestrictedUnitsMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PerformanceStockandContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock and Contract Stock [Member]",
        "label": "Performance Stock and Contract Stock [Member]",
        "terseLabel": "Performance Stock and Contract Stock Awards"
       }
      }
     },
     "localname": "PerformanceStockandContractStockMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PrivateLabelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Label [Member]",
        "label": "Private Label [Member]",
        "terseLabel": "Private Label"
       }
      }
     },
     "localname": "PrivateLabelMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReboundTherapeuticsCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebound Therapeutics Corporation [Member]",
        "label": "Rebound Therapeutics Corporation [Member]",
        "terseLabel": "Rebound"
       }
      }
     },
     "localname": "ReboundTherapeuticsCorporationMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RegenerativeSkinAndWoundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regenerative Skin And Wound [Member]",
        "label": "Regenerative Skin And Wound [Member]",
        "terseLabel": "Wound Reconstruction"
       }
      }
     },
     "localname": "RegenerativeSkinAndWoundMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RelatedPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Member]",
        "label": "Related Parties [Member]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from rest of the world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of the World"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestrictedStockPerformanceStockAndContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock, performance stock and contract stock member",
        "label": "Restricted Stock, Performance Stock, And Contract Stock [Member]",
        "terseLabel": "Restricted Stock, Performance Stock and Contract Stock"
       }
      }
     },
     "localname": "RestrictedStockPerformanceStockAndContractStockMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment",
        "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment",
        "terseLabel": "Number of days from shipment to issue a credit on returned goods"
       }
      }
     },
     "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "label": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "terseLabel": "Manufacturing period for products shipped with no alternative use and right of payment for performance"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Product Warranty Period",
        "label": "Revenue, Product Warranty Period",
        "terseLabel": "Product warranty period (up to)"
       }
      }
     },
     "localname": "RevenueProductWarrantyPeriod",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "ROU assets obtained in exchange for lease liabilities:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ScheduleOfAssetAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Asset Acquisition [Table]",
        "label": "Schedule Of Asset Acquisition [Line Items]",
        "terseLabel": "Schedule Of Asset Acquisition [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAssetAcquisitionLineItems",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ScheduleOfAssetAcquisitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Asset Acquisition [Table]",
        "label": "Schedule Of Asset Acquisition [Table]",
        "terseLabel": "Schedule Of Asset Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfAssetAcquisitionTable",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Current",
        "label": "Secured Long-Term Debt, Securitization Program, Current",
        "terseLabel": "Current portion of borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramCurrent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "label": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "terseLabel": "Long-term borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuritizationFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securitization Facility, Fair Value Of Amount Outstanding",
        "label": "Securitization Facility, Fair Value Of Amount Outstanding",
        "terseLabel": "Securitization facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "SecuritizationFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SegmentReportingInformationNumberOfProductsOffered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products sold by a segment",
        "label": "Segment Reporting Information, Number Of Products Offered",
        "terseLabel": "Number of products offered (more than)"
       }
      }
     },
     "localname": "SegmentReportingInformationNumberOfProductsOffered",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_SeniorCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Credit Facility.",
        "label": "Senior Credit Facility [Member]",
        "terseLabel": "Senior Credit Facility"
       }
      }
     },
     "localname": "SeniorCreditFacilityMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans",
        "terseLabel": "Number of stock-based compensation plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested But Not Issued In Period",
        "terseLabel": "Vested but not issued (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButNotIssuedInPeriod",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "terseLabel": "Adjustments for performance achievement related to award target (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments for performance achievement related to award target (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period",
        "negatedLabel": "Vested but not released (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriod",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested but Not Released in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested but not released (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedbutNotReleasedinPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_SmithNephewUSDLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smith &amp; Nephew USD Limited [Member]",
        "label": "Smith &amp; Nephew USD Limited [Member]",
        "terseLabel": "Smith &amp; Nephew USD Limited"
       }
      }
     },
     "localname": "SmithNephewUSDLimitedMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SupplierRelationShipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Relation Ships [Member]",
        "label": "Supplier Relation Ships [Member]",
        "terseLabel": "Supplier relationships"
       }
      }
     },
     "localname": "SupplierRelationShipsMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SurgicalInstrumentKitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Instrument Kits [Member]",
        "label": "Surgical Instrument Kits [Member]",
        "terseLabel": "Surgical instrument kits"
       }
      }
     },
     "localname": "SurgicalInstrumentKitsMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwapFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap, Four",
        "label": "Swap, Four [Member]",
        "terseLabel": "Swap, Four"
       }
      }
     },
     "localname": "SwapFourMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap One [Member]",
        "label": "Swap One [Member]",
        "terseLabel": "Swap One"
       }
      }
     },
     "localname": "SwapOneMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwapThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap Three [Member]",
        "label": "Swap Three [Member]",
        "terseLabel": "Swap Three"
       }
      }
     },
     "localname": "SwapThreeMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap Two [Member]",
        "label": "Swap Two [Member]",
        "terseLabel": "Swap Two"
       }
      }
     },
     "localname": "SwapTwoMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwinglineLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Loan [Member]",
        "label": "Swingline Loan [Member]",
        "terseLabel": "Swingline Loan"
       }
      }
     },
     "localname": "SwinglineLoanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ThirdPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Parties [Member]",
        "label": "Third Parties [Member]",
        "verboseLabel": "Third Parties"
       }
      }
     },
     "localname": "ThirdPartiesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ThreeMonthUSDLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Month USD LIBOR [Member]",
        "label": "Three Month USD LIBOR [Member]",
        "terseLabel": "3-month USD LIBOR"
       }
      }
     },
     "localname": "ThreeMonthUSDLIBORMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TrademarksBrandNamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks Brand Names.",
        "label": "Trademarks Brand Names [Member]",
        "terseLabel": "Trademarks/brand names"
       }
      }
     },
     "localname": "TrademarksBrandNamesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "terseLabel": "Securitization facility, outstanding borrowings, maximum limit"
       }
      }
     },
     "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_TwoThousandOnePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand One Plan [Member]",
        "label": "Two Thousand One Plan [Member]",
        "terseLabel": "2001 Plan"
       }
      }
     },
     "localname": "TwoThousandOnePlanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandPlanAndTwoThousandOnePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Plan And Two Thousand One Plan",
        "label": "Two Thousand Plan And Two Thousand One Plan [Member]",
        "terseLabel": "2000 and 2001 Equity Incentive Plans"
       }
      }
     },
     "localname": "TwoThousandPlanAndTwoThousandOnePlanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Plan [Member]",
        "label": "Two Thousand Plan [Member]",
        "terseLabel": "2000 Plan"
       }
      }
     },
     "localname": "TwoThousandPlanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand three Plan [Member]",
        "label": "Two Thousand Three Plan [Member]",
        "terseLabel": "2003 Plan"
       }
      }
     },
     "localname": "TwoThousandThreePlanMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Decreases During Period [Abstract]",
        "label": "Unrecognized Tax Benefits, Decreases During Period [Abstract]",
        "terseLabel": "Gross decreases:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesDuringPeriodAbstract",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "label": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "terseLabel": "Gross increases:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_UnrecognizedTaxBenefitsReductionsResultingFromOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "label": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromOther",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_UpThroughTaxYear2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up Through Tax Year 2025 [Member]",
        "label": "Up Through Tax Year 2025 [Member]",
        "terseLabel": "Expire Through 2025"
       }
      }
     },
     "localname": "UpThroughTaxYear2025Member",
     "nsuri": "http://integralife.com/20201231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r434",
      "r689",
      "r690",
      "r692",
      "r792",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.",
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r209",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r229",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r209",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r229",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r73",
      "r140",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r160",
      "r167",
      "r258",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r160",
      "r167",
      "r258",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r160",
      "r167",
      "r258",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r240",
      "r369",
      "r375",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r469",
      "r472",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r706",
      "r754",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r469",
      "r472",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r706",
      "r754",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r240",
      "r369",
      "r375",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r236",
      "r369",
      "r373",
      "r707",
      "r753",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r236",
      "r369",
      "r373",
      "r707",
      "r753",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r406",
      "r469",
      "r472",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r706",
      "r754",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r406",
      "r469",
      "r472",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r706",
      "r754",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r237",
      "r238",
      "r369",
      "r374",
      "r756",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r237",
      "r238",
      "r369",
      "r374",
      "r756",
      "r779",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r803",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r242",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r155",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "negatedTerseLabel": "Accelerated share repurchase program, payment"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r562",
      "r563",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r23",
      "r53"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable, trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r20",
      "r35",
      "r243",
      "r244"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowances of $6,439 and $4,303"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r303",
      "r304"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion of bond issuance discount"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r78",
      "r84",
      "r86",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r295"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r84",
      "r94",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r80",
      "r83",
      "r84",
      "r744",
      "r766",
      "r770"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r79",
      "r84",
      "r86",
      "r157",
      "r158",
      "r159",
      "r604",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r84",
      "r86",
      "r604",
      "r660",
      "r661",
      "r662",
      "r663",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Items"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r517",
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r127",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r560",
      "r561",
      "r562",
      "r563",
      "r709",
      "r710",
      "r711",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Share repurchase and equity component of the convertible note issuance, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r474",
      "r476",
      "r523",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r476",
      "r508",
      "r522"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "netLabel": "Share-based compensation expense recognized",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Net effect on net income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r42",
      "r249",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r109",
      "r127",
      "r670"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r101",
      "r127",
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Incremental financing cost expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r127",
      "r274",
      "r283"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization",
        "verboseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r138",
      "r217",
      "r224",
      "r231",
      "r254",
      "r600",
      "r605",
      "r655",
      "r726",
      "r741"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Increase to total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r71",
      "r138",
      "r254",
      "r600",
      "r605",
      "r655"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r12",
      "r15",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r12",
      "r15",
      "r292",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r478",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]",
        "verboseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r615",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis Of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and building improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Leased facilities"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r466",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r466",
      "r470",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r589",
      "r590",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price of business combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r126",
      "r596"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration and others"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r588",
      "r591",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration, liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r581",
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Contingent consideration, fair value",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r581",
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r581",
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r136",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r17",
      "r156",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/BUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r132",
      "r133",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment purchases included in liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r18",
      "r48",
      "r129"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r25",
      "r130",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash And Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r123",
      "r129",
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r123",
      "r658"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant strike price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 89,251 and 88,735 issued at December\u00a031, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r89",
      "r91",
      "r92",
      "r98",
      "r733",
      "r750"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r97",
      "r112",
      "r732",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r240",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r240",
      "r653",
      "r654",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r195",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r198",
      "r199",
      "r240",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles Of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r346",
      "r348",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract asset, End of Period",
        "periodStartLabel": "Contract asset, Beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "negatedTerseLabel": "Transferred to trade receivable of contract asset included in beginning of the year contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r346",
      "r347",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability, End of Period",
        "periodStartLabel": "Contract liability, Beginning of Period"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r346",
      "r347",
      "r370"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities",
        "verboseLabel": "Short-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r346",
      "r347",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Recognition of revenue included in beginning of year contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Long-term convertible securities"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r233",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r105",
      "r707"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of product technology"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r307",
      "r308",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Employee Termination Benefits"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r407",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap",
        "verboseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r556",
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r556"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r556",
      "r566",
      "r568"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r556",
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r727",
      "r729",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rates available to the company at its option"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Debt proceeds, classified as equity at time of offering"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Initial conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r59",
      "r333",
      "r334",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt, initial conversion rate",
        "verboseLabel": "Initial conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r671",
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible notes, aggregate principal amount",
        "verboseLabel": "Debt, aggregate principal amount issued"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r58",
      "r327",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt, interest rate",
        "verboseLabel": "Convertible notes, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r60",
      "r141",
      "r333",
      "r335",
      "r336",
      "r337",
      "r670",
      "r671",
      "r673",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r670",
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate on debt"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan, fair value of assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r557",
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Capitalized incremental financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r557",
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r127",
      "r139",
      "r557",
      "r566",
      "r567",
      "r568"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r31",
      "r32",
      "r547",
      "r728",
      "r739"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r557",
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.",
        "label": "Deferred Tax Assets, Charitable Contribution Carryforwards",
        "terseLabel": "Charitable contributions carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsCharitableContributionCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory related items"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r553",
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "verboseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses",
        "terseLabel": "Accrued bonus"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "Doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Unrealized foreign exchange loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r532",
      "r550"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total net deferred (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangible and fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r84",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Gain (loss) recognized within accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r397",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r383",
      "r422",
      "r451",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Recognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r383",
      "r423",
      "r452",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.",
        "label": "Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount",
        "terseLabel": "Plan assets expected to be returned next twelve months"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r431",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Interest crediting rate for cash balance plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations, end of year",
        "periodStartLabel": "Projected benefit obligations, beginning of year",
        "terseLabel": "Benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r392",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payment"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Plans transferred in"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change In Projected Benefit Obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change In Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r399",
      "r407",
      "r409",
      "r455",
      "r457",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "netLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Next five years"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r417",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Contributions expected to be paid to plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r383",
      "r421",
      "r450",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r396",
      "r407",
      "r409",
      "r410",
      "r457"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Plan assets at fair value, end of year",
        "periodStartLabel": "Plan assets at fair value, beginning of year",
        "terseLabel": "Benefit plans, assets",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r382",
      "r405",
      "r457"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "negatedTotalLabel": "Unfunded benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]",
        "terseLabel": "Reconciliation Of Funded Status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r383",
      "r388",
      "r420",
      "r449",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r418",
      "r447",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net period benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r401",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r384",
      "r425",
      "r454"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r386",
      "r419",
      "r448",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total contributions made"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r127",
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]",
        "verboseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r72",
      "r74",
      "r618",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total Derivatives designated as hedges \u2014 Assets",
        "verboseLabel": "Derivative fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r72",
      "r74",
      "r618",
      "r705"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total Derivative designated as hedges \u2014 Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair Value (Liability)",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed Rate",
        "verboseLabel": "Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r616",
      "r619",
      "r625",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r613",
      "r616",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r613",
      "r616",
      "r625",
      "r630",
      "r631",
      "r635",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r608",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "netLabel": "Notional Amount",
        "terseLabel": "Aggregate Notional Amount",
        "verboseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r607",
      "r609",
      "r610",
      "r613",
      "r614",
      "r621",
      "r625",
      "r632",
      "r634",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r144",
      "r607",
      "r609",
      "r613",
      "r614",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "CerebroFlo developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r369",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r291",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Aggregate purchase price received",
        "verboseLabel": "Sale of Extremity Orthopedics business, disposition price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r292",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r16",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "verboseLabel": "ASSETS AND LIABILITIES HELD FOR SALE"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r466",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r99",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r173",
      "r175",
      "r180",
      "r181",
      "r182",
      "r186",
      "r187",
      "r734",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net income per common share (in dollars per share)",
        "terseLabel": "Per Share-Basic (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r99",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r175",
      "r180",
      "r181",
      "r182",
      "r186",
      "r187",
      "r734",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net income per common share (in dollars per share)",
        "terseLabel": "Per Share-Diluted (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r183",
      "r184",
      "r185",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Increase (decrease) in income taxes resulting from:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Changes in valuation allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent",
        "terseLabel": "Charitable contributions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "terseLabel": "Nondeductible meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 18.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent",
        "terseLabel": "IPR&amp;D expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r525",
      "r534"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits from stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Research and development credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays": {
     "auth_ref": [
      "r534",
      "r570"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 17.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Percent",
        "negatedTerseLabel": "Swiss tax holiday"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxHolidays",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation costs related to unvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for cost recognition, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r508"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total estimated tax benefit related to stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit realized from stock options exercised"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r162",
      "r170",
      "r172",
      "r192",
      "r258",
      "r332",
      "r338",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r665",
      "r761",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "auth_ref": [
      "r136",
      "r315",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.",
        "label": "Extended Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r457",
      "r646",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r407",
      "r409",
      "r414",
      "r457",
      "r646",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r457",
      "r646",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r647",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r647",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedLabel": "Loss from change in fair value of contingent consideration liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r649"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions from acquisition of Arkis"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r457",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r615",
      "r621",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Overnight Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Future minimum lease payments, finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Expected annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Expected annual amortization expense, 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Expected annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Expected annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Expected annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Expected annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r275",
      "r278",
      "r282",
      "r286",
      "r708",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Acquired Finite Lived Intangible Assets By Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r275",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r656",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "negatedTerseLabel": "Foreign currency transaction loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignEarningsRepatriated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.",
        "label": "Foreign Earnings Repatriated",
        "terseLabel": "Tax impact of repatriating foreign earnings"
       }
      }
     },
     "localname": "ForeignEarningsRepatriated",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Currency Forward Contract"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r465",
      "r467",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures, and office equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r616"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) recognized in other income"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives": {
     "auth_ref": [
      "r616",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.",
        "label": "Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives",
        "negatedLabel": "Loss recorded, settlement of derivative"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyFairValueHedgeDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r266",
      "r267",
      "r725"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Arkis Acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r271",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill And Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Transfer to assets held for sale (See Note 3. Assets Held for Sale)"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r104",
      "r138",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233",
      "r254",
      "r655"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r613",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r127",
      "r287"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Non-cash impairment charges",
        "verboseLabel": "Impairment charge"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r127",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible assets, indefinite lives, impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r127",
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Write off of construction in progress"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r142",
      "r569"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r142",
      "r569"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r142",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r466",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r11",
      "r13",
      "r14",
      "r15",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r535",
      "r545",
      "r552",
      "r564",
      "r571",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Penalties and interest accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r171",
      "r172",
      "r215",
      "r533",
      "r565",
      "r573",
      "r752"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r136",
      "r529",
      "r530",
      "r545",
      "r546",
      "r551",
      "r558",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "terseLabel": "Federal tax credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r124",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r176",
      "r177",
      "r178",
      "r182"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r277",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r277",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r273",
      "r280"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible asset"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCapitalizationPolicyPolicyTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for interest capitalization.",
        "label": "Interest Capitalization, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Interest"
       }
      }
     },
     "localname": "InterestCapitalizationPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestCostsCapitalizedAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.",
        "label": "Interest Costs Capitalized Adjustment",
        "terseLabel": "Interest expense capitalized into property, plant, and equipment"
       }
      }
     },
     "localname": "InterestCostsCapitalizedAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r95",
      "r211",
      "r668",
      "r672",
      "r735"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r109",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Cash interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included.",
        "label": "Interest Income [Member]",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest Income"
       }
      }
     },
     "localname": "InterestIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r116",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Interest paid, capitalized into construction in progress"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount estimated to be reclassified to earnings during next twelve months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "netLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r19",
      "r69"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r24",
      "r70",
      "r136",
      "r189",
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "verboseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "verboseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r108",
      "r210"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Period for extended lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES AND RELATED PARTY LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r55",
      "r138",
      "r225",
      "r254",
      "r601",
      "r605",
      "r606",
      "r655"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Increase to total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r41",
      "r138",
      "r254",
      "r655",
      "r730",
      "r746"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r57",
      "r138",
      "r254",
      "r601",
      "r605",
      "r606",
      "r655"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r12",
      "r15",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALEAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r10",
      "r12",
      "r15",
      "r292",
      "r298"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Enabling technology license"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r30",
      "r729",
      "r740"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of credit facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r30",
      "r325",
      "r729",
      "r743"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Principal Repayment"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r146",
      "r320"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r146",
      "r320"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r146",
      "r320"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r146",
      "r320"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r146",
      "r320"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r60",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and production equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r123",
      "r125",
      "r128"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r15",
      "r87",
      "r90",
      "r96",
      "r128",
      "r138",
      "r161",
      "r165",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r179",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233",
      "r254",
      "r655",
      "r731",
      "r748"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r84",
      "r94"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r217",
      "r223",
      "r227",
      "r230",
      "r233"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r677"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liabilities",
        "totalLabel": "Total lease liabilities",
        "verboseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r677"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Less: Current lease liabilities",
        "terseLabel": "Current portion of lease liability - operating leases",
        "verboseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r677"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Long-term lease liabilities",
        "terseLabel": "Lease liability - operating leases",
        "verboseLabel": "Non-current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r679",
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r676"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use asset - operating leases",
        "verboseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r684",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r331",
      "r640",
      "r641",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r330",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "verboseLabel": "Initial strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r615",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r598",
      "r599",
      "r603"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r598",
      "r599",
      "r603"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive loss, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "totalLabel": "Unrealized loss on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r76",
      "r80",
      "r617",
      "r623",
      "r637"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "netLabel": "Gain (loss) recorded in AOCL, change in fair value",
        "terseLabel": "Unrealized derivative gain (loss) arising during period",
        "verboseLabel": "Amount\u00a0of Gain (Loss) Recognized\u00a0in AOCL"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r80",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "verboseLabel": "Amount\u00a0of\u00a0Gain\u00a0(Loss) Reclassified from AOCL into Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r80",
      "r85",
      "r624"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedLabel": "Loss recorded in other income, net",
        "terseLabel": "Less: Reclassification adjustments for gain (loss) included in net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recorded, net investment hedge, change in fair value"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r88",
      "r91",
      "r598",
      "r599",
      "r603"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive loss, net of tax",
        "verboseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r426"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Defined benefit pension plan - net gain (loss) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r81",
      "r97",
      "r533",
      "r572",
      "r574",
      "r659",
      "r662",
      "r665",
      "r732",
      "r749"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Income tax benefit (expense) related to items in other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r106",
      "r127",
      "r293"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other Expense"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.",
        "label": "Other Indefinite-lived Intangible Assets",
        "terseLabel": "IPR&amp;D, indefinite-lived, included in all other"
       }
      }
     },
     "localname": "OtherIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r615",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities",
        "verboseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Net cash paid for contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "negatedTerseLabel": "Net proceeds(payments) on swaps designated as net investment hedges"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Cash taxes paid in net equity settlement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r115",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Upfront payment, intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r406",
      "r408",
      "r414",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r457",
      "r459",
      "r462",
      "r464",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r136",
      "r441",
      "r460",
      "r461",
      "r464",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r478",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNoParValue": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, No Par Value",
        "terseLabel": "Preferred Stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock; no par value; 15,000 authorized shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21",
      "r46",
      "r47"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from note receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from convertible notes issuance",
        "verboseLabel": "Net proceeds from offering of convertible senior notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from borrowings of long-term indebtedness"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r117",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Cash received from option exercises and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of stock purchase warrants",
        "verboseLabel": "Proceeds from warrant transactions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sales of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r117",
      "r512"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercised stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r51",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r294"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r296",
      "r747"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r49",
      "r136",
      "r296",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment Balances and Corresponding Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r26",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease.",
        "label": "Property Subject to or Available for Operating Lease [Domain]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Domain]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r100",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "SELECTED QUARTERLY INFORMATION - UNAUDITED"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITED"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r84",
      "r94"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedLabel": "Loss reclassified from AOCL",
        "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive income, net"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Uncertain Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r434",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r434",
      "r689",
      "r692",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Payments on debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r527",
      "r793"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r136",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research And Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development",
        "verboseLabel": "IPR&amp;D expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r127",
      "r305",
      "r307",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring costs incurred"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r37",
      "r338",
      "r520",
      "r745",
      "r765",
      "r770"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r162",
      "r170",
      "r172",
      "r258",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563",
      "r761",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r437",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r465",
      "r467",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r437",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r465",
      "r467",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r208",
      "r209",
      "r222",
      "r228",
      "r229",
      "r236",
      "r237",
      "r240",
      "r368",
      "r369",
      "r707"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Total revenue",
        "terseLabel": "Total revenue, net",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails",
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "verboseLabel": "Revenue Recognition and Shipping and Handling Fees"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r372",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Performance obligations expected to be satisfied"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Performance obligations expected to be satisfied, expected timing"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.",
        "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]",
        "terseLabel": "Taxes Collected from Customers"
       }
      }
     },
     "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r683",
      "r687"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r198",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r84",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r443",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Benefit Obligations and Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary Of Employee Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r60",
      "r141",
      "r333",
      "r335",
      "r336",
      "r337",
      "r670",
      "r671",
      "r673",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r441",
      "r442",
      "r445",
      "r446",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r616",
      "r625",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r607",
      "r609",
      "r610",
      "r613",
      "r614",
      "r621",
      "r625",
      "r632",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r11",
      "r13",
      "r14",
      "r15",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Major Classes of Assets and Liabilities Held For Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic And Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r476",
      "r507",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r275",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r24",
      "r43",
      "r44",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Contractual Repayments of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Funded Status"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesPriorPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r51",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "verboseLabel": "Summary of Selected Quarterly Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SELECTEDQUARTERLYINFORMATIONUNAUDITEDTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r217",
      "r220",
      "r226",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r217",
      "r220",
      "r226",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Net Sales and Profit, by Segment",
        "verboseLabel": "Schedule of Geographic Revenue, by Area"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r491",
      "r496",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r478",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r484",
      "r496",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Summary Of Weighted-Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r544",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Uncertain Tax Benefits Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r28",
      "r727",
      "r742"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of borrowings under senior credit facility",
        "verboseLabel": "Term loan component of senior credit facility, classified as current"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-term Debt, Noncurrent",
        "terseLabel": "Long-term borrowings under senior credit facility"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r240",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r217",
      "r221",
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r239",
      "r240",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Net Sales"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Profit"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelectedQuarterlyFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selected Quarterly Financial Information [Abstract]",
        "terseLabel": "Selected Quarterly Financial Information [Abstract]"
       }
      }
     },
     "localname": "SelectedQuarterlyFinancialInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service periods of performance stock, restricted stock and contract stock awards, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancellations (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancellations (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of year (in shares)",
        "periodStartLabel": "Unvested at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for purchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value, options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited or Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r486",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r475",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r136",
      "r478",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r502",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of option from grant date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, End of Period (in shares)",
        "periodStartLabel": "Balance, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Amount of unrecorded benefit reasonably possible to be recognized (less than)"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r317",
      "r319",
      "r597",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r240",
      "r271",
      "r299",
      "r306",
      "r310",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r64",
      "r157",
      "r158",
      "r159",
      "r162",
      "r170",
      "r172",
      "r192",
      "r258",
      "r332",
      "r338",
      "r517",
      "r518",
      "r519",
      "r562",
      "r563",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r665",
      "r761",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r192",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Equity offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock through employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Equity offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r338",
      "r477",
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Stock repurchase program, authorized amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining amount under share repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Accelerated shares repurchased (in shares)",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r33",
      "r34",
      "r332",
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Accelerated shares repurchased",
        "terseLabel": "Accelerated shares repurchased, amount"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r34",
      "r39",
      "r40",
      "r138",
      "r251",
      "r254",
      "r655"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period",
        "terseLabel": "Increase to opening retained earnings",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r666",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r666",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r666",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r666",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSAssetAcquisitionNarrativeDetails",
      "http://integralife.com/role/ASSETSANDLIABILITIESHELDFORSALENarrativeDetails",
      "http://integralife.com/role/SUBSEQUENTEVENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r693",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accumulated other comprehensive income (AOCI) for reclassification to retained earnings of tax effect from remeasurement of deferred tax pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect",
        "terseLabel": "Adoption of Update No. 2018-02"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r250",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Codman trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock outstanding (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r65",
      "r340",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r63",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r63",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Balance, End of Period, Treasury Stock (in shares)",
        "negatedPeriodStartLabel": "Balance, Beginning of Period, Treasury Stock (in shares)",
        "terseLabel": "Treasury stock, at cost; shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "TREASURY STOCK"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCK"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r63",
      "r340",
      "r343"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 4,914 and 2,865 shares at December\u00a031, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r560",
      "r561",
      "r562",
      "r563",
      "r709",
      "r710",
      "r711",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r528",
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance, end of year",
        "periodStartLabel": "Balance, beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior years' tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Statute of limitations lapses"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r193",
      "r194",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax assets valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r147",
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Period",
        "periodStartLabel": "Balance at Beginning of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)",
        "terseLabel": "Valuation allowance, period increase (decrease)"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Leased vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r174",
      "r182"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding (See Note 14):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r173",
      "r182"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Previously capitalized financing costs, written-off"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 14
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e12803-110250"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "32",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121321036&loc=SL82860478-203043"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(t)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90193-114008"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90198-114008"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90205-114008"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90205-114008"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519491&loc=d3e90476-114009"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121578510&loc=d3e41551-112718"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r794": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r795": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r796": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r797": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r798": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r799": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r800": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r801": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r802": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r803": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r804": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r805": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r806": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r807": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL116659650-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>127
<FILENAME>0000917520-21-000018-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-21-000018-xbrl.zip
M4$L#!!0    ( -**5U)IBW89H!T% (B=-P 1    :6%R="TR,#(P,3(S,2YH
M=&WLO=EV&T>R+GR_G\)'_UKGZJ"=0^3DO]MG:=[R%DE9HJRF;GI%1D:2D$"
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M/?S][3_?/7JWL_O\[;] /&ST3>$G6P=0)<+.B7F@L%1;BB# ZUN_/M%;WP(
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ML@01B08QLAJ@#=E&7R*3N_7K-YF)(+I /$YM.0,PIZ(2BIY@3X:K2?\AA+R
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M;SR!;0Z+WCRIKL2]7+V@V7,5K4\Q@X%$%56H'#U%97-0+FV@H*\KW%N]<$,
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M6W[MHEJB+5?DR1MT59$%BB5Q\C'Z4%,MF8S:5(7\/3+K;?FG.P]*MA"#434
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M3?82I4>38O;9H6%PV;,M76C6LF:5<=<#AM5K8W81M?9BQ&U+ML=$155;M7'
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M!X*LG) HJ1JJ-E1!=YN<FPJ )6J D(TNRAD771MS1E@*,B*T-6]C;%U_#?
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MTBTUU_TP<ID5FR9KQ]7Y$JH$"XS.ZZ**)_'O4E*JYV[/K)Y9WU5]EHSVT;C
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MZ>OA[,YP\HR&XLGQ3.SJWY9E5=>*TZM7TL93U*AL+ 7 <$W>5PF>M,^BITV
M'E.=U4&K!Y>/K?=R!73! 41Q H+/-H$V\K3>;(7528&&5"@'GXA+!5=+)#02
MWJEBBLL>3(<*$==!_5])T1\G9K+&@ X9(,44G#ARWH>051;783-DM%*7;IDM
M;4JFF).A$B"@3RK(W0Q5",:QY-2A*K[U(M02*^:$/52-F"MK$)(2N3"X:,DP
M1RQH-D-&JR34,DOEE1=_HP*5:B$$$[.M156VY,CXS!TJ>7XP' _G_'CXALNC
ML=R/_6$>\>W9C.>S.Z=;^&HRO3O"V:<\.SP:\9S+>\&=;F+I<Q3?L6I/;2L1
ML$LYUJ!4S6!T*V[E]2?DFHKV2AA).3.H9(H%#<F9[&WA8IR)7CR4:#>5D>\7
MI8YG\\DA3S]>L[OB:&]%M/1.>ZV1V1/8EM<7SY-U4**!M80)&T;+:Y;OU7 S
M54ZY9F51M*?G# 6YA7A)+Q;Q-I6;"Y6Z.\7"ASA]/;LS%9=G&P^O.@NS&EX&
M5H B6)+ I>TBS"D4EKNOC.52+&X8+Z]1ME?"29W%AV5%OF( K4OTBI-+E;*S
M453I^HOKT;AP_1Y5NI!:EV1%.I)*(5@4_1ELEO^C%W>T.L>H5)?:3'P[QYX=
M'\E)/QB^9YOJV"C.02N/6IQ7$#&G%*J)0/*T@ X;J4"O2;A7PLK@2"<5).R7
MF)"\3ZJ&X(J8O:"*(;_1K+P]&BT*DS:1B.2I:ANR5:: 3SHJ=-Z(7),526\F
M$:].GE>SO3A9JV/"E,F"S3I'<#Y(%&@\5H?8H26_-4W2K'X5T!,776V62$*B
M1LK)%(DPHBO.9QMJ!R9*K:EHKV8],%C+1D$0^D$VB-HG^1=,<"ZBZM(B_#KG
M9]: E@9B<9:!; !+@(9( I$LSFLTG.V&T7)E^;<E<E-94&"C,:@UJ."C*ARB
MF,ZBF<"93>7FBO)OJ^%EL5R-W/&HK0)//AJ,P:=D?,F@]$::R^O.ORV5D]6!
MQ!5D#(.Q <56VAH3*8O>U[#^XEKS_-LRRV>RRA1=,):U^#8Q*:NT2Y8<EL Y
M;[3^7$'^;34*-,9< E5*4%N_>86*50VU64PQEC:M/R/75KA7PDI' ;,O51M%
M$#GD7%NK"09-*N2ZV3F Z\F_K6A'5S4ZL JDH,TULIECU)2S<#"YTH72TG62
MY]4,RA&=Z*VM%)4&'U.L&'0JE<ERKKX#\Z>^VWMY-'XRG1#/9D]YQCBE@]N"
M='[#H\G1E>^(76*ZQNGFPO@*%D 5CVRMTUY<FC:!K];USW%W48!+S("[4)53
MN1@D#2;E*']AK#Y[Y24$/%^D4,FJ=17@?][K<E;,?<7"4&E@U1*$4711AJOU
M>=%*SB35!B^#DWN6DP\72X'A?"FPE\K7%OW"I1?]/A'ACS@=/HH7F8/<5(;H
M0\I55:@J.\<Y83WW)N'<FU1^_40X$P&):BO'--^9/N/IFR'Q1[)[LNAMPH\Q
M\]?V1%R-H_,CJ=1+_?BS+SP_^Z?+*N>-67!\7.7OX^EPO']QX/9D<</+G=,'
M]V[O3I[RX>0-G]_'!]/)X19.7_,UM$Z 2SO:RB\'\Z@BEP1)QY*ADDHE5C A
M6D2BF/V%$Z#"54/].ZRH"DM0W-G8Z)2KU6D")RXL@;9R"VI0F?+9R(/%'?#K
M> ?\$NX >/1:_ 9'Y,")!?/84I*E&H2LH^Y0%<OCR7A_SM/#>YSGNZ='_)G6
MF8S?\'3>%%0[8!,+5TPUQE0NA6V!8$L$+Y0VT7H$JW/H@"QG"VU]W)IJ'<DM
M.VUIXH\5N4@0A^,GQ^*VXTR4_+(,V8W'CE4VQR0N#V71 S&GRBCAO"L(XAC1
MN2V0/V[=-*$23>B6L2*CG4IB W5(0=P\;,DF L9($AFGLPJ&LSLP6*-;\3ER
M/KX97_&</S[T1\KEM!;?06Z(A)V00XS*U)2*"^131+ZX;_XB^+D&S_D[[IN_
M?,2Q).^K.A_$T>#6P0X*A>QK+8I#3>QK3M2A_/6E6C;>G<SF._49CC9S_9W!
M&P:)']O&;4LF)>TP>!.K]N)>G15 Q0MQKG6SJS439[R\../RQ.E\:UJ6@XD1
MG&E[+FPN9'-JFYQTV#1V?CD9>KENX9WD:]6Y)EU\#MH#NYJ+23:C49E-8-@X
MOJY2P"MAL*I*/#<7G2&QK[;ME H.K/5.!\]ZX^SK,QZ-AN/]ASSF*8Y$S+?+
MX7 \G,VGBX[&YY+>2-LK4LP9V&L5A,N)T+B00ZJHF (6W#0NKX>H5\+J2%%B
MTIHUY@+1NP20/50V"5 TNEK_A<O;;W%:_IQCN']X-)J<LHA^0J\[L@B9.=?H
M46@6 H1H4E3*R>T*4>QHRK$#":?52F7U>1_#+D)Q)F&.P%2S >.5<=47<7FC
MZI"57+T(5V/]=#6&M2'@*"H18M)4(OOLA'!>(I<.6;\U$.%U6;7C\?!,?D<C
M'+^7QR'C['C*9]GN]L[%IR_>N'C>/OYE-&0AKG.H4W5 @22^"443II(DRJEG
MFSU$39^A01ZL+QJ>R.__; %@]^UD]V!RO&@>=S!E;H=<,2!$+;M+ F)QZ'+4
MLO6AL/?!V@*4./X_]KZT.6UD7?BOJ'*WI,IXM+2VS'FGBM@XX[GQ,H8D-_DR
MU>IN&24"<22P0W[]^SR]2 +CQ).Q#3B<<V^. :G5ZF?? ^:EP)T#=*IZ@3)>
M0@/%< ?%[T$QO#L4PWN#8AI0X<01=T"^$D+C)$T]XJ2)1XGC<;X%67;?!M[9
M^(% ]S!%XS1P>)CZD<L8\6(2 6<,,-,G2F(>L&#;H;%%H @QYR+FTDP@G/HT
M]8&)I<R.G"2PTVC;0?& 7.UAND&A@PQ41Y\Y-O%"+W8=.R()Q5JT)!3LB1ER
M9Q/TJ3Q%<\Z. 781Z'R@ZY' 2>*(@C''1!I&!.AM&]I@8@K(()OFXBP]'O/L
M*N,SFBM@XD^'62G8M/A>I<0.7^Z6 B@X8(=@(6<NL5D "..%V*[1Q8J.)-YN
M?)%LV4!RAS#W@3 DM*,H"F/'$PDA0L3<CBD8FB)@KDC=;4&8"SJ^% U3.<G&
MV6@VNH\DY&^AHN%=J"+H5+;>%\%FZ+0_2].,W6-&V\^-ILR/(CNB4>H%!.0@
MIZ!9THB"!1V)T'?HEJ#INI%I%:G0+_=!*CLTU5DF-O7L@$>Q2UP>QH'G)3Z)
M B_D@1-M0\;N=P!Y(:IIF;&IX!*4;\?9M+KHOWV*P&0)3;R(QS:+$Q*F/$E8
M2CA)DI E*?>?6BCE,:AR30$5)[)=-V#4M\&(8B2BPA-I; =IB)FM\1,+J#P*
M(->2+. E7NH0W_6]*"6V8)0F22)28*S8!2O:@KE'ZX3?@WB:N!]Q/T:7'XF)
MSZ.( X5%MN> \>#']A;T/;J;H-N2/@ L##U&TY0+UR=VR&C"A.\X-$U2(CP>
M;!TX5*FK*-.B'-$Q4Q2"&K(N =TFX B<:4]B&Z%# FY3ESL!%P[P,L(<2IZ<
M=O@4M4*:Q#YU/>81-R:!2"E.7F!V$A''H['M;R\0UT1JZP<I<0F/610Y3@+D
M&=H1(PZ)$M<&9=\EU-M:M>(19=A]JA2A$S+730GQX/\!$"D/B2,$<1,<:K)]
M*:%KEV'W"!S!PT#@["<[L4G((IH&(HB<2"2^RWRZ3?7EJZ"T1#'+0.O^#-PP
M]FB8^*'K\(!X;DR)[V']I^=1'D?!-M59;#R$UU3:R&)L[NUBE@#Q'3]*_92S
M**"<"5M$9'O](1L(X;4X2EP:12SD/ $5AGA!&CO$I8[OX4PBE\9;,.MT(P'[
M,.J.'7,/I^JE M4<#^S#.'"".&8B"%)W"W*GUATJ>!"P>, ;:4Q(P'Q@DJF3
M@-'G Q<./#N.DF1[P=(FFR$MMV9J7D!$:*=$!&!Q$[#5(@&,3#C TYPT\-@6
M\+0+,<U*60:(J83]23&NBG*Q(E UCYTAX="C$F$$7.VU0'!M\.3FNO:A%&-Q
M3?._"NG"7ET%L7B-6?'.]1 D<823Q*[C4[0-2<2=U/=M-PQ\+H2_335JLF&>
MX.?8&&D P*Y <F'_O%?S]B]-J+Z;IEF>X0\]^2)/T?H("/'=* Q!_*7$!H/#
M2SW?X2ST68JS%+?(^MAL\*ZI%[@;,9K2)*&132+J15$2"$]0*D#>,MO=?"9^
M7A;POM,YLO I,.?>OV>9;+WP:GY3UKZ:9;#J^')S6?=B,3;8_2+D;ARG(?$#
M+R8^0^'JI1A@%>GF1X\V#CKW&#Y*&0ZO!/53,(!.DM+03;PTI7;HVYX@Y(G1
MSCLQS-B#="-Z&'O!B5P@%*0?*@,*<4PBPD7D@L8*3.^)T<YC0.<^X^).2$**
M9=6$$Q''21+;,6.Q%\5)X- -KMS[3@?-EBJ1;0VM@)Z.L^OL4-@>*/!>(A+.
M0-L+@XC%?A!N+30&PZS<,E@P'CL>2\""(B%Q,(;MV FC+E!'Z@5\&RJ,EAE8
M?Y9\$FPZ*,[*[A7-<IKDXJ@HS^!',+7'EV_ UFQ#[2B[$A\$+57BE?SU7![@
MV?C>JDPVVQA84RH%M2ESO0"XL$/"F-.4^6'DQT*$P@_$-F5+_U/4:R'=X+K8
M(=W#(9WMVV#)@-49V)1XG,7"#9S(CV@(NH%C_$>.NP5(IWJ+#>B7[FPZ+,K,
M@+*>YE"4(KL<2WE5?@^8_^"IC1"L&YI=9U5U)#BV,\,K6^W,BO'1H/O@B(7M
M]!\9L4#C3V@41X2Z#@&M)J9>Y&'9$B>I2,0VS:_;(=8F^<Q"1SA1+)S0=3Q"
MG3@2Q/> B7FV[Q+X>W.UY;OBTR'\6DTS=C>$VA3-&:P7$83$$R(*2!"0R(<O
MW#ADD9OP*-P"?\R]TOFF@$5$/&(BBD0<QL3#,:*^8#@2)?(Y]]PM*!+Y'EAD
M-]'NF&/H,/]C5F85S]@6U8QX'J.!QT+J)@E8_6D<AG8H2! '@<,"]PDPM(<1
MD/ \92*T#(BWD\&P+&:70_@1#0DX.7]+T"#E<4I\GG $?N(D41I1U^4B$ DH
MXL[V95C<R/.5Z15TS)M,&)D$LR7PB1T_%38-XS2*"!,IQ2SYA!'.A>NP= MJ
MB>JVR^C*GLX/BM&D&,/'I0%V7<9FHYDTB%_3;/RFJ*I3,3V@U? H+ZY_%_Q2
M@*$LMF88;&#;W O#&">?$2)8[(K$<1S022B%/[:@)N_O ^X0A\<*_DJ,X0^9
M7U-U^:=9-1UM#]PB&A&?1&'DQ0)G5T:QEV*Q&+5M%B81?XIPDVXI-3=RZ^!E
M,SL-8IYZH0]F&+5I[">V$X8A]P6G;)OJ^3:?4Z[?<^AQWT]M8F-TE\0!NG9B
M1WC<">PDB$CRI,']R/QU_=!F%/NH"P$*C\#J,QHP+PEL[@C"F+L5PQ<WGBNO
M'\I^PI!Q)]A/$50E.R)N*CSA@-P%(]7;X$CT]G#NAS%.$B^Q24!BUPU(&GE@
M/W).(T9H&@>1OP4UNQO/@Q_&Z!?,)XX;^0P$*< M"@(_=E@@7"]-;+$%3M.-
MY:8/5._K<BP%]-,4\^U=*GCD)WX( M%A>A33DQ6#_XA3WGE?=QH1=38=BK+W
M&-/=UB.(0V#?CAT'0@0!@;]H( (G<=U(4)=Z/-TB/+L3/(\QA4Q44W7Q?:'2
MYBL#Z\<TWXMXFG@.*'LN 54A]GB<T%!FA%*6;D&B[JM9!7I 57490+G*EJO'
MRL]9]2HK^BP38R8JP+#]^\*O5S17CFTAIJL*UQ@K9X)K-E5UQURRK8-9B<CT
M)J-)EF=WR(V\\WZ.:%:^H_E,O)J;U><'.:VJ]HQY 'XVOH0-P%]5QH5*%JBO
M?X"]U'_^#G#&(9WS-SBB<RE&9"XZ'D]FTTI>X6V)YRL,8NQSZKC4#4GBQS&E
M:<C"@-$@B?TPV0(:NA63%R3N:3%F#X:]ZZ/C'=VLAVXBS_,X#Z,(-&D2DB!.
MPR3UW%2D?I38?$<W6X>]WZ;A0ZS<-@2\(Y@?$#2,$X\Z:1 Z\$?H)(+R-$YX
MPEVP/_DV#;+9:6V;2+\;2DSK-Y/"D-A1"F+*1S,I%A3'%'+N1WX:18F[3=&N
M39!9.UUO1VW?2B5(HC3T Q[Y48IAQR3A(F818TY*@L0.=M2VM3B_TQ WA\P<
MBFTMA.W'+B-V*B(:IQ1HSDZC./+I%D2?=EKD)M+XAA+<P\P6C6,>11Y-B,\)
M#K-V/1X+%H#$2E+F;0,-;8"$VNF#/QO=T##DQ(V2($@\D#UIG'BQXP#=D#1V
M$F\+JEXV@6XV"7MWFMV#$HSMNC8/6!S$U"4\#*E-1>"D21"3V(G4?/?-[DZ]
M"02S$S1;03?+S;__47<E)TI1%:-10EP[C@3WN,]=EK D@,\[NMDV[-T)FH<E
M&$:Q=4? ?5N0Q TB$E$G)F'J"!N$#MFBSAV;0#D[B;/!!+3^=B9)&% A6!2[
M<4#"Q$O\-*1$1,*AGN_[Z8[:MA;G=W)JK616M^&?E 6?L>GJ_OOZ1[/&G1OO
M Y'&;NJ!!<8" O\D$0T"$06.'04D=;8A(*RZ=XZK(L^XI(#CJ1@MY4;7K?KZ
M:ME[P]0Z-]M0B7G  J'R$4Z&$"RC.783+"\S1O.G&(H!>]X/0Q8$GNV1V&<Q
M8%7BV8!@<4BYXVR!&-BAT^9H%2ZC;AC83"2Q &[DTH@#/I$D(%[JNOXVS#3;
MH=-*=%K+ #4JDL3A-'*$ZQ(Y\BD0\-\T=5G(PG2;NB+?!;)GY7183 3/&+8K
M&F15-1,#P8;C(B\N[T%9?0C4WDJI)ZBOAE8E=D"(8R<4^T@DS$NC(';=;1JN
MN<.K#1)_ 8M3SPY#0*B8>$$(_](X#0/!:4B('6Z!^-OAU0;*0=OS (W2-'(2
MQ"M."4E$&',1$3L1P3;DWV\@+-<C>R*/![8OJ./[(0EL$=E^X$9$",H"WX[$
M%LB>#83E>OB]S^TD]$D2T803X?HT@?\*1M"OZFFZW'!^OXFP7 N/#4GH1<1U
M>>A[!'3!A(;8'87YJ<=YRIZ*8^V@*"<%0%.<%F,-SJ?(91.1^ ZCA*<)"$N:
MQ#3VG53$H.,3CS#WB7#91X?F>O@L(<(1B9<P9J?$3OW8MWG*W=!FGFM'B?=$
M^.SC0W,]VBR08RJ S_K8MB!*\*/CAFX   U<FV\)IZTMI->BN"SI9(A>. 50
MICJ.OWS;?UI<E8*VXR4XE=3U2$H"ZO.0VV'@ B<5/-J&5JO?@1S^W)OA&*FG
M*!4]QZ4IL$Q'"(\$Q(\2=%<$F!,M[,033P-^W2JCYY3! ]A3!&+(J<<9,D\1
MD,0-,8,]8G$<^7[B^O83($(]4K.:GJ7O"UCJ*4+1BSES4]=Q'"\FQ T2+TI#
M&UNM,=MW_6U14-<J!->CC'(>NG;*P]#V0Q*E/F@OA'/?=:(D\*D7;#_D'DL(
MKLEIDWH.B7R7I]0G;@3&H6.'KL?\* 1EU-V6E(=-$8+K :+-8E! XYAYD4M<
M+XS3.$D2[ _N1R)QPNT'XN,*P?5 T0,!R/V$@]P#$S_E4>*XJ>-[C*-Y2.,M
ML>O7*P378L/[(G:2F"+)V23U@]@CC@\ZJ!LSEX7N-D0Z-T4(KB>SAK,XBKDM
M!$[_H@'U4B_AA% [#EW'#YX&_!Y/"*X%B#Q(29C: ;53E\2>2\,T8)P&W+/C
M%/YO^X'XR$)P/:PT8#+I-O Y**/8O#5E#@N"A-C,IJG8W(KTM<B^!RER]M.4
M<\\'TX[X).1^E"0N\UGD"NZ#\IAN+0P>4HH]3+FY8+9+F>N#A48HP907AWAV
M@$-CL3/75D/B0>71@X C$"R, QIQ01T")E?LQRPEMN.E+/)BNKV$\?"2Y4'@
M0:(PCFR>>#9S"(_=. I\AU,>82S&91O<NGC-PN(>N^'"@9/090X-;$;B,*"I
M[X(=&WJV%Z$%N[4P>!QA<8^08 Y(!\<C7BHH<9,0YUBS( Y <,2<D6BK(?%(
MPN(^"2-).77@'Q(QPH6;$"H()PE/P:YT[ V>G+I!PN)>R8,E21(+QXTBXK T
M3FG@)=0G-/'2E$8R4@C6(<@G\\>F :9.1Y\EE?CW#&[J7<$_S;3O6RYXG%KJ
M[H'(\^/Q0X>9T2;M-.?YK0#ETJ7_)(,NHH*YD4^8'Q([90E0=YR K M36Z21
M'-"SPYE-PIF6PKF$!O^D7UX4V7X4,YO[G'BNE\2A ^P\<D$#(A$U:. Z\0X-
M%I^+DR%/Z4BT8#^X+@;#8H;5,OAK=\Q;WYR-!7[YT'CA=ISX'O#""R/B1X+S
MR/=)0L$J<4/J);;G,S\)W.7!O+;W\$+_[[+5OY7W87OW-- XC- [RVT"6A%F
M[[@XR3&-"+>Q!Z4IY2'FW +OP?GK#YP;N?NY!1WO/L21ZP=Q8CM^$(F4^ $&
MZVW7QY&S'N@RKDD:#<VYQ1MY;N'=SRV^GW-+$DI) *:1CYU#B!,1SP=]T*:)
M$P91L)QGM(%T^O="T_=%IZ&@09H&4>P(AT2"1DS8H X)AZ:Q"$-3ID7,N6T>
MG>)AW)%.\=)[HM,PXDEL^XQY>&X\P)G0$8\X!:N/TY3J<PO-N6T>G>)AW)%.
M\=)[HM.04R$2;&S@!@2$:QP(4+C@8^*Z0:#*C\!VMA\QH>7OGYMC/WH*24B=
M-/'=Q.,T)JX348=[ 4T(#2/;3=4DZ\WT.1@]$?M@J9YE>5Y<8R<S;-M_(2I1
M7HGJIKI:7W94E >EX-D4)\=NB4LB9I&;XI!AGE*2IGX<<EL :Q5QXE/XSQ8D
M+V\ZW-:?V\Q#)TQHA(XG0GP .?<$#VP211$//>)M;M!HTV'[,"%7 )"-+9JB
M,":8&RMX&/@I=SVL]F'^TV.A-Z\_2P]%*DH W8!^Z5:5>(@BYX?AJ $. 8D#
M'SNR)PY-7$9#%OLLLGE @^@)<]0U@7']#-9-N1VFE#F@+Q(APB2._(2AJS\6
MQ&;\Z3'8M5/L?<;P0\)3%H11X@H2I:#AIR Q/>$YU(T=GVY^9_C-%X_WV)<\
M\ AC4>H[ 7%)D)((P\R,^ZZ?>AYQMZ'48-/AMOY*!,$=FX9.X,7,(Y&3T)B*
ME(9)%+C,2Y/TZ='DVCGJ/9*H'T<TM:D=Q(R2T$.?L"^P>PLE(@3[\@F3Z ;H
M0&LJXP---^9)8B=Q2!QFQU$8<2>UA1NXML]4%E;XE$"]!BD:WAN)<A>LRC .
MXM07A(.6 W9+PID-TC1EZ5:TRMITN*V_E($0RB.?I3SV ,AQD-B<!RSPG,AE
M::J&ZSTMFER_%+T_$@72I';H^: !.82E?I00^ (8JLU%"%!]PB2Z"5+TX2GV
ME^S+RU)4Q:R$\U ?AX)RN7F>7?WV+_C'5&$$09*P4(C()G'JQA%A(G+".(UL
M3PC_+X1\<T\UG>< XU$V[@Q%=CF<OB3N?NA/IK]>9WPZ?.G8]G\]DY?^]J]J
M0L>__2LI?X$%U-]JG9NKT?(2%IP6DY<>K(2OT*%Y=CE^R>!,1?E,K64N9T5>
ME"__PY;_^36%=^ZD=)3E\Y?_,P $J:Q3<6U=%",Z_I^]BHZK#N!"EJH+J^RK
M>.D$\!3Y\5J]0PCKY-E8F'=R7'R+MZ?'@]ZAU1]T![W^XBNT-K\IN^WW#MY>
M' ^.>WVK>WIH]?[OX/?NZ>N>=7!V<G+<[Q^?G:[Q%>P[O<+[;O_WX]/7@[/3
M/>OPP +ECL0;M&FR<M/__1].8/^Z\>AQ='9Q8OT+^,"X&)_.1K (LS2[N! I
M,((TBM,@]8@=.0Z)8T$CGE+73T(>V\+F_BKOLC6FR/&YR%X>%FPVTDEWS[0B
MZ+V;)X?%U1OWXNJ#=S+CGWI7'U_'G\X^O<I//WW,/HQ.O(_OWY*3PS_]CY^.
M_;/#BT\?!Y=?3K_FH[/#[E?XS7GCG>8?OA;7'P<?W ^C/SZ=NN]R^,T^>_]A
M?C:XM#^X</^ P?V7UR?PV^F[Z,L;]^/\PWL6?#SL7I^^/KD^>_W!/AWTO-/#
M8_?T]?'\9/#JT^GAQ_SC^X^C#Y^./GU\?W+%7[\C_/<_\H]N?I5\FGP^@6=\
M^-HE'S_]Z<#Z]LFG#_:'3\=?3EZ?V*>C=_G'T<?LY#WLS8GF9X?'WE]^&+MI
MF"0=XA+6(4'J=&)&H@X+: +B-02Q&C_[S;$[_RNY<0.%WZQ;<:?%%\FC\,5[
MP?C6KD$NW/<>XSMA^_,36GZVSL;BQ?>VF133:3%Z&=QROE.:Y,+<DA0EB- .
MO$-.)Y5X:?[XE6?5)*=S4,GD5N1-OUZ)<HJ%!7I). \M(^-X/_(]%)-3D,=3
M;I;7$G1?2M!?IOSF;P1$;7#KK_:^<^MOWUHU]O9M0NZT["]RQVK7\/9XM/_O
MF??,W#"AG&?CRY?NY(OE+)YH+M+IBB.Y.WITRXSFUMMQQ@HNK)/^;3CL?@^'
ME89RWYPP+<H1G<+=\,:@]KY,BB)/*.B8TZ3XLHI1=L?C&<TOQ*0HIUO),(^R
MY/7;X,3MV1]'/>_D\"C_.'C[Y?3U6^]T\/G+A]&?]LF YQ\_=9W3KQ\SV(.^
MYQT\RQ]_'!1?/PPN1A\&[/KD/>QC .L,F',V.,H^'O[Y!?8].CF$M4;'Y.0H
MNGXSZ$Y/^O87^-^__-2)0Y:RC@@<OT,\W^X@<#IQ0E),V@L2)T0V%8<D^'69
MW=8,0>/Z?:%QK?+>'SM>1N4;O,[Q 96[IZ=ONV^LB][YV<7 .G][T7_;/1U8
M@S,+5,(!Z'V6XUEG%Y;C/^<OK+,C:_![SVIIB[6FV#T8X,].[)$EA;TF_5\D
M:UN'FG,WOG]4E-9T**PTJP ^UES0T@*;27#K_G6?%L6_Y%A0!BL..9WC0\5X
M%<F?2VNMIVRXK:3Y'U:2OIP<?O9A_2^GGT[@[Z[W%TFC, ECUDD=[G5(%'D=
M&M*T$SL>M4/A1[%/'Y9/+T!M$6(':GSHD42C#P#0'= DT(07A=0122?A+.X0
MP7B'LH1V(CL*;=>+N(= .Q1,^6O0<;'(??<L!,6M/'GM;.4N&N\:^%I1WEV/
MW6FM.ZWUP;3600G;EX6.6Z^YGG[]C-HJ.75/G _O_W3DWZ][>,_HX^"S\V'T
M,?\P>)6=O/ZPK+EZ9U);O?0^?'TW_'CX%O^V/PR0B7[,SP;OLH^C=\.3U\?7
M'_-%S97P-$ZY\#I>Z +_#%W>B0,'))\7QFX4V"QT/*VYDD?37!]9:968/+CH
MGO:/I7;Z,(KK[2KK[8[IS=5GIS796<KE;Z5E,;*47/KG_UK3PGI &7=']^\]
MO,==G%+Q6EQIJU^Y<<Y;1\=O>M;IV?Y#.FE[,D)UE.4"5@<%;2NY]S]RU'[Y
M"SBKZ\>IZ,0B=#K$H78'YS]U0LJ(#RS$(Q&P8+OC!JY+[NZKW4KG[,:$VAX<
MYR_$958A%YUBH?[/A_=S,-ULP4@<="+'#<#>#D2'\L3M"$'MU!<1"Y+XV6_'
ML(_7%UWKS?%1KW]PW#L] $'[^]F;P^/3UWWKX.SB?)DDSBZZ@[4&%^\8$>C]
M'ZH)I]V3'NH*%[W7QWU40@96MV_USWL'QT?'O4/K^-0Z'L"+_MZ]&/0N;H\>
M;!>Y/X9QZ ?.CQB'KK?ON/$/68??MAP=]T?O?/3-NOMN?/\&,@GV ]?_<0,Y
MOHM5H9#_,>R*[RI4CV,A5]@[;%(65RAA%IV&2M(<CYD>[@;:NNPT=J :'AX4
M?#L%CS*7SPY/LX^OWSH?/KUU/XYZ\]/#SW-8V\$]G0X^D(^O>S8(FNN/H^-E
M<YF<N']\_@AF\>D UAT<VV>#/^ ]WGJP5^?TT_#SA\&?Y.33J]&')7/9CP,
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MI03\2T L#BM9_8E QS!V=C5(@(N>U=!5QSE0*#XP* 8L<]\Z@X?>ODR]'<6
M1Y,R0SI&;*@O;G!R!-1N>HLT"*H02-(BT$Q!N21#T5Y$[F2 U*O?S2!\U=H!
M'A/JZQ+A<#DD2<1#AH>B& I2Z]XB<=14@$1V"5R1 ;-*\,YJ MB=6VD^R[CU
M_-E!_^C9"X1,.Y]/DI8U*L;9M"B1=:B-X5\CV;*I@YP5/QI^A/!*BSPK*L7S
M ) U?8IR;A6JXQS<4<VRJ687#-OQXAE*(IW!T^! [@@6.!1^.]5RF7P#M"<
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MT0$<A@#37G*.NO>C)/V:?!;YC7&O,MB@<F5)R,.WRM0RG%@1G5#6YJ%@8I0
MKP%STVY<QS*\*'5:P"<*%C>J"<U&$,LDF8,JTCT0>8YWLGWD#C5ONUIRT-96
M.U-'HBW)%K?8TQO%AI7*H&YLX3UM#RN[K6J[_."H4R5(X,QO\WE(KEMI6]HT
M[FTB*FCL.N&O56-[:@?(=,%[8+0CY9UN^_25^CV3YF>US+L:LQ.VG *B)TH4
MU"BAM:^TSE25UP%(*^#'(*-6[51OT,A+"4T%Q&M1*X=<F>1HA1L#7#E'F?33
MM3W1TK7OVDZ\9W7+SW!6K[*BTC$F!5Y=IYM(3PP<0$DG C@76XH\2>L<0*&
MB8X6[>!6XJW&CH6C12NRK:SN_WB@<&,8U7FM3)^U!2N>(C[S7*/O,?91Y,I]
MUHBX=? Q:4>60B.,UD9:$#,$UPY8U#X6X!*@%66=QF&(>&P<,PC?6N_2RZ1H
M[0(/,-[T5<N+-)44)8^#,L"/JEY'QU.:993^4(HEGQS0[50Z17/E\01!F:7
M(6'Y4H!6,Y9:4^.KDJ1T))+2^.$43>5T-F9&#G='XZSH?6$B_^__<$+RJW6>
M@_)UGE,D+*RE O$+U)I.K1/@K[!#L:>#-E^F5LNGVG)KUFQL6G.2%=Y99#U2
MI</A!ZOI'=C^1 7:9.&]\@VC/\'H=(X-^[AN H'JQ5HL0)X )A_)/<*2[<M;
MX)'/E@<^4U9@-9UQ[7F[I#)<54LC<97)^M7VZYDG U\?8X]B[7]KAR:TX@HO
ME8T2$)M*_B <OY?F9#)N?HI,)W)[IM-ZDY;6QZV_>5ZUG&_DYWNQX%-!;$4[
MP<(CDI33&'I2^ZBY>Q/9,O=(YW5QW5&2?T_^K5Y[,8ARDQ,J=VI6Z9U()O'C
M9L_:;/Z-CV+4_GUOT]S[W:H2&CW>9$I31([Z._IP\4W[%*N6MM[COS%:&DZ'
M%:4:=C:DX['(0?C58:NUZF,J#?&]- X6G"IM<9RUU4>E >EPZH(SM\E?6=#N
MI.-+!CJ9>OE*)3^Q G->M"';]HY)US.($""=.C+0Z+67\I>6+PH^ V.#9^&6
M5>!-,][%C!4=A)/JC_3=R>R6?6GUE&.M3N9SR4ID?,88P2J&QQH@PC(R"E*U
M%3WT'XZ5#J1#?+6N.**?U5DTH<J6AM*<3U%>TG'[74?T"\H#L;R!A1BD%"OC
MXEIM&M/?RT(^K?5:BP"XX6.'Q6<E1O5; &WE3C61T9F2'CK8*2WE2H;D6\K<
M@K8H0P?2,3>;% H76CXHU%IYU5:Z;XJK/17]Q0-4X5\QO@0EHP5<XX"4RI',
M@NG(& 7NH:1L^B18B''8]FJ'[5K=49IOM*-%B<#DH<] +A3).P%<[\!)LIQ6
M,BL"E?.RIHD%3_U2=+YL=Z_1G@O Q!KB$N,Q/^+*A*DP/T5(&M18O3IP5*E6
M$]HQW5+$:O=%VV.P9U5S6'94*U),1ZB*VF1 10.4-TU"!B%YT<I!P-W/8,M=
M31XUCYE-,PQY2D>,D$,RT80![*]38<"Z&[52#.K74$$'*MNAR?7Q\:@(2FVS
MS9)O))2BG%=&;3[?+E_WM_/5K7[O]4GO=/#=Q/6->J=OQ[,T3\[;60+: X$Y
MB0L,TV2VML"L?;6-FQ[=<MJA\>"IB^]%G1?;N!RSILT^>E%IR8VE\ZW]*&K5
MC:TN!5+%9)BQA=5DU97US RB?9 AM,_V=+I.N&GZ?%\G9N+67S<'M##58(TN
M/^F-W))$IX?>WS=W YQ>*7KC"A@XERD_#?54=6N)K=)G5O/M6UG,$^#?WT[;
MKOF;=,8::;RWF$>SE+^\J)48K?EF)K<*&MW,X*TS3)7=)16?V0C9FW0+2Z<L
M7-'1^<]7HBZRN"4]NBR*T>(UG9MITDIMPD0Q]10P'%1:)0?FJGX$*4)!CV--
M:D4U,SYJ50B"A1S6=#:2+>[5IVS\:5;6R>+%0JHXOJ=T\TIG4%U<(A,QI;-8
M;A9/4F[5<'TEL21$K%6'CL)4);&9/'9XA9)6Q1CCJDH @O32X:E,VAT )15G
MTSMZ_NSXX!RSV.N$]3UK..>H5DZ&%'W[37[[GLX\5TM4*IRG#4.ME,I09BZT
M9BV#N%:)X; Z@7"Y\&,A4J+\AMNE JXFMXM"1P8P7*%B,;7;5.([!:94R-!M
MG:"(55HY'6%OS!5)BR9MIK& I2^[HT,'VHH E%&E5\6L4@'C=-5B"VX1X\5=
M5:'1+HR0*2U8=J+C[0(Q"A$!CDC!G&E7AB0T>/(0Z0!>U&2XS*9"D5W] !4\
MN&&)--4)VG'P=K^_W^2?(\:-"K"JZCP;?'VQ6!XT! B4^F]C<A1R",632*A!
MAJX5YY839BRF,JVP+CVHXU#&:U7)&A<KA]<2.OO?K*/\,4"(VAJ]F:DO;=\;
MI0#2<Z,@4$-<,ART&%!? ,S. 2OUYN W(/39!--!V)!*C&E[F>!WM>N,CC4M
M(*/7J"(?KQ<T%6K2BM\6J/Y-I>0.ELUVO/>WL?GO%+%4JFRR*D;"Y!NE%-@0
M"'7C<##>3FUOWJQAA5\XO'&IBUF7ZLP6TVE6I<24&3PBPS1 Y<%=Y#V3'/:3
ML;WEO&/I*Y8KYPJO56G:0M1^BKYD4Q2I>*8I,JUF*$$K68F*5 )<$F6]^;EA
MY:#!) (V &L74U +F*S)6JA?6HBN-TN#.B+3^%4]ZIZ%CKW)4&Y85JNVBZ4
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ME?Z[6*VU($20'8KSV?R7_GR,M6IMK[OU1S&4R*RR_?2G6RA@15[@) >B.<D
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MTS<")!G6=U)3SY[K4G0-,VS,)'O@II88#Y$PZL)2W$<?;/_"&E"PM+)*G]9
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MF* 7C8OW>5,X[[*POGY&K_VVG+^=$>.,O^SZ;-.6[L"$!.=BKRD614-G 3X
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MJ*RI6>=?HY);MB0\6Y2--R5@%W9 "8K+)!2TG#K#7(//$X0.9,Z%G30O^Y4
MY-PCN06S0B]BNC/+MSC9OS;$))W7%WR0LBJAYZTO07QMZ7&;G.GHR+J>UG6.
M!#"G.5Q<BN@G<P93,U">Z&7:/,_G=4_7YO8N(E=/?2.G7&=L>>\75/"00</.
MQ#->QODY#:#&RFX_QG,QP*HEE$V9*VR/.D>)!+ SF#V&3F&+>F S0Z?RWK"7
M"8J,YK-K=6MSKHGA7NVE>*\ [<JHN3531)N@O+*.^P.I/)/ZVC^WJ;O-C5P$
M5]*J5AO[F'N"ZP( +/)3RX/BF9G$Z]QK#@KQ/R-7/9+!R@1$R6NR7,FY>V 2
M+@+B5NAC51HQG: =Y4[A &;7!GRQ:SY[$ZG&^01KZF$M4@R16&,$,KQ,4?<Q
M_KO%]?@1*>,?_.=3VTY!Y2'?:,%9DC2&<4O'!M/,NBG,8*I6U&'/$UH/>(!I
M6NEWBZA7PTTPVJL#SYAIL.B8UGJ@EVIOK<F]02]6:%Z@G]AO#4P-V:RF0 :I
M7+=SBF5QCHM$/5K[R6NTXXM0(NVNL"S'=H'D#=T:Y\(:+3(Z*.G9L?,@BHV[
MZK+U"UDV,B&-YZJOE_35V\J9_2O2S0&=^KY]4?P<[FF1/FD-<D,&)>'G&(Z@
M-M@_=<%X0FV4EN-BW\KXT,!HAD<B!Z^4=B5D5PC#%1\0@D=?-6O#G$A/OX4Z
MQH$)WRWPJ&!8B8FA*4E,.O>M L)C 94Z>M6;\\6_K-LKZ.(_/ #_7K2%DC[!
MFY/DY)=7R8^_O'[ZXOCU'>USO6$_Z$D NAB)5 )2*1QWHN7P3KSHY6V&4Z]E
M85NFJAFLC1D!=3E.@?SG%Q4KTW8"*:1<+N-9TWC$A)R H"5D.F!)4;>ABT8P
M9VDV#1 SV^J93$\.MK^_EZ?R6&=MIZAYG Z@:A'KX(Z]>OQ4G@4$7IH[.$Q7
M@MI[&!UT[Z(ACKV9 50;<N9_O7>"WI>F1.]U #8J(.H1=4?SS_=ZL*>ZX-'M
M>>'<];A%W#317+=)G6F/&($\QE7S90/F=="J7BPYWF'0:5WM>1+37 W+>6'0
MT;OE\>&71QP-QIR)@\16H%",/Z:DLA&AN*$&-^<:53L6];*L$W4F);V60OD;
M'8%-X=UG'&$DKS;?S)>% 4;N5L)M<(P'>FG$6ZOL-P2;GHK6>B@3R2TI/?CJ
M C(B38&$:AZOCMW\W<Y.[JC[ _Q5EAI K;5O6)+.2NIZQ+[F:E%@72-);!7.
M=$;<?:#$I'O)1R&<FO7Y:>&N3[OS8R)M/MU)M94\KP\DV1 ZP)T=K5A7,QS)
MT@\,''(XD1.ZH:]#BWC4X,@FX;%ZF>]VYX>?2,'84,?-&L2*'A^GT@X!?F/(
M@^X>_?JG.T4!FHCMA*2A@2_R(39O^K(3&TOTG.'OEI% 9GNX9YT7K<G^!IE
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MZAM,QVS!T]M)'/_?AUWZ9,\N!"<1Y;[OB-3(WTT]:+)]?3MPN.K*92)-FNO
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M'A'N&-1B XGDSLN.<M86KTAY6H84VP*@>\^&3@7"EB@@)7-OS3V)*4-5%*K
M3BOIQ=0=!$QC?I[WVC-FIZ"?!%XB=Z]BX&A\)H(GSZOZ%IE))$<" IAV?Z\+
MHV^D*<!]!I4D+$] K8-?'SS2F+Z5:RX(_"J9)P2U,#\W HB_+SGR9^WNGK#&
M.'4S[CGK7U@GA:0QI&,M3AS73-$X0=>*V@GOE<+OL@O3_Q2B(M]**AD*#HP^
M(VL^'GJ_1[00J?H@Q):KBBV@5[!#!H%EXA<B1\]W#Y\V!=>,)B:&#4'T*_X4
M,.LJ18<[,@5*;:^WHG=(M!NUD+C:?( K @2/+OAT8;\XUL;A#HS25U@M+EUH
M:6*@+K^8>_30!JO^,8"_(2<;K\LM!R!82!"\9[&*2Y"FF]P7GYJ]N-0ZO'KZ
M^A^ODU?'SP[?'#])WIPD)[^\<C_^_(O[Q<FK_TJ.7_SSZ:N3%\^/7[RYWQR%
M-[2:P!;DM3*63W0Q2BH5K+S#+L9V32E88=KBU6^:*CDG.;5<PP%W:8)TXO3[
MS*SJ.,MEN- 'Q)LA.B<?-M/">N!7@TU8UC.*W]7E3H/'Q'Z%K]8OJ6?,>83:
M&S>E)+^?_.RG6]IEF4Z@+0AE$JT5M*.2!'ILFH;-M G_"ZE8/B3\\I.TNQ!I
MJ%)27[EHK#"Z7]3#6EO6^JQOE=&!.^*XX0O")YU)]A>K]1FX-:61.2^(R(ZK
MT_ :!_WFOK6\52)>^[XJ]\4T1$$./HW[_]Q?T2 ;M<DK^P-R'$(3C"2%\>K=
MOSB-ROW=SG4O+,7T)N*<RKRF:;Z'L;9=M$(%9:P =WX-J+?MR]W(G?V<G=BK
M5'RQMBMTF+TF&DT!9KUT@T$+X&7C-O7<C]@AI?QS;MR@63QT@_P%?5XH-P^/
M#H7Z\LL4GJXZ/<OL@C;(<RB&/'IX\% ]&.C3<N4-4)\V<'(8K:!8,L,?![1L
MW"W#I0:7F.[8ES!8;/P.,&$!$P<[P,050\1GB%+9Q%WXJ8?"D>$B M'S,N\I
M*:.)=<MMPQIUPBZ@$I"*._PR%1/%U\M)5V+)(I"B*0K#2 BSA:CI*2MICJ/%
MG&M$AE6 ]?;3PU-<6>-G651IH'<GM#$L(GT9!!$WAD%H4>2P2IQ' NL$SYVX
MI21\6K?('L=\?H,2)Y,Z@<V$W1AGL-(HT2B_MS4$*(FF0]^)7>#<;:P2!#=J
ME;D2@89;%X<1YI!S6<$5]IVV30UI8S5^,1<'OX_^S=34_<UE"+"J!.1,7I8[
M0RW7"*K96.Y*."")R,"IY")4<G40OAJ>U[_40UZ+2U20KTA>H7 UF/[."O&!
MSX VK?M9X!*!M9\\O,L9523(U<5DE;BCCU40POXU9HV5-.7D@A'"[0%[2ZH3
M(;!9 DT(OP(<7:&V<3ZA%"7H Q%;EIOATX9$: %W+B+@ 37>-^%)9#B"WKK_
M+C Q"+MNQ-AZ#RS)S:O; S%$JLJX'4/$\4*N$S&7#6A?@T,N*7LH'%,^"!B4
MRD>N A39'LQ&U'U,EQ@QPG&T,=8MC)WA#RG/\OW^X_M'5'5B2G!I3-T3Y]DG
M606*D38F]FFKI82F/*W1;QGFG6)FWX9Y:N+84T5YQ0?+3T\.$Y79E'JQKJWP
ME:R%B]"W@D82Q_PEY3X/TN0IF>R#_>1'G6V8Y(,?;!S]RC_AOO+8OZG!1,/V
MFM*3A)\GC3<?G.D3)%$!IJ@@<]UZC)J("K/30[*@)NC'5N!Q" 2(1E>0U!L0
MJD83D"9(*LH?5&T[JMK:_&:T"=M8?<)R@IE'0C""W8=\L,&8#1LAF"+$7>Y)
MTY_^Y0EO]*-Z-=,LJRWQ2IX!EI>A%[&4\YK0%V[G]ER:M$\T4JMZ<U9XU41Z
MJ)EFL\V(B# 3E_**3$ ; N>Z;'%9=2>=Y84<,%%1C7Y95&=T82^_LJIS+Y/+
MY4[5JALS5+ "9LH4&4'^DJU3XRP+I052PN5AN!;L$9,H!4:H8[0RJ407Q-=L
M_U90$PDXWU5I/GJP5(@W6W'7R&+**PRF..0-:'?!;]=)\>QS)6N*35! ID:&
M<"P!-"(CX=-]>/O0_!(>1-0'@>MA:#;@?8;M:Z!^&1BY_(*4Z^XGD7ZK$044
MR(]TJ7BE+QXSMQKHWS'M=P3[*IR;Z8WH0NCP@P,ZM@)<6I?;I#[_PRFLBIX[
M57.#[9_7\S[X43Q35,F -[,(BZ'MG%$M6K//H[6M&BT^LX?W.U5<K^'CEBU,
M3T*\*C^%H8*M\V57W=5<Y[6#(@;2'S/J#;B#3.&AX1 XRY9>1)3> =U-OQ4>
M2Y]G798(:4<@.I)/MD7Y+XD:&4M:G@K9GQI#8$O<)=)P=S<H&84JYBLHM<_=
M><B6I"'?&8IV,KNI 2!XQ=18,K$D<B5VQO'(,$*V=6 X4RGJY@%9Y0*5MM2.
M&1E4XE<OPC6K@HPAL:<)#[!;!]YNFUEW4[,J$1LS ;%<)PY"(/85:$5%-<]T
MD]E8(V-^QTW=RWG@&Q?]:PU&LRV5 5X62CNUEO%:\-=G%F(D9H>A:2H>#$QP
M&P;A\_+DQJYY\,5$;GE;6R#Y9)/>^X1_YAWUQ7#?!P8JS3%(S%2J\GL %98-
M_ JW+@ 8F_*)AN+G$R%PW/$70N"121+89;CC93>*#PEJALB6G/!0.'NKYXVW
M2V>"W#&D/P%I/67NC,K330/\]UW5Q 9P/]?TT$^E(3_N&Q>SN4=Z+LZM.)ZO
M3,E'*E/$B$MEEB!-Y+_\2T6&Y@N)%XY_T3P^L^B*+,72^2S+0<<!I3J/?W&>
M]6I&X ,4$=@C=;]U<8=S^3'?P/KGT!$CW406!;&)CQDKKE*O#;W:<_>A1]^D
MR:.'CPZTO9>>^.CDGT^?[!U\G[A9R(G31LA]XXO1DQTMG2U.GAHB^39IYV=%
MWI/?2)^([J$2',>_/#E\?OPD>>(,+K6UT]?,!Q_MN['BS5O:<$YJ9)5I#FG/
MAJ1R45Q2#,,1&I3A4"8KXM]D7DTYOM"S1RW5R, )(6BV*+J!+8-8$6GGM=X.
MZ58.;M/(-.V+!%.I]V856O;],@THCXXU-B0WE:[S1;E?4(F4WC>7%OL:FO+T
MK/JI*<4\(C:,=$+]HO0PS4/GOGZIP)+24C7^,VM*"J"#>XD(@R.4NMH;1IUT
M?5C9*-EUO7VD'#$D.R_ZHUN0=5<8YDMP!^\I G;?[=M05'MP@$^>B]AE)E1@
M&05G1C1IK,M8EM4$@ !>I01:\<JZK(;B.P$UWS;;> E'74THNVMUO+0AH)&K
M&\I&:-'AT%UG[Q_E_"V)LJ$PZZQ%_)&?W',49.*HZ^%PWL5__1LGZI_ZFL)+
M0G29%A%1+=1?'7(*^^#[[YV1XW('E6S)FKC8"]:$S6\;[H$Y\2D/&OQ.6E*H
M9.Q#!W=:]+DTUO7"!9ZY4:Q/:=OR5JR\G^6C+K>SR]I(9/*]>1W0?/25,Z_P
M8-S@^S $&PC!R50$E;H-V"&(T();5Z,7#G@#U85KY0JXUD1\DV>K#$R%B&%3
M;AM!S06!#,.;J8=.RC#;*DFZKI!8G]+)P#=4*B,FI2W>45C?%HFL9M]%JN(7
MC*GF=:HIH#6$"^8#(?2@4VHQ&4./D='-4]L0VS6.?6A1W(0"=*=-=?T*_:.[
M6J'?\3F^+P67B2UK='G3$</B<Z(^$/EH&TFT+L!2=VJWIN]')NQ5TP46D\O-
M0=U<90W$RIRK20X-#[@O9\C4(OS@?M[1LGVP->%3%3Q1;CH[F>F2=9SANVR9
M"\T7$'\0EQM:E(]]AL)?(_M=\-:[6=.]*J2&UTZ1"$JDBG94X15I]E'=# TC
M%$:O'-HXJ3O0!=#&,W5@3R/5%@A(@/QA$$A^GKF3W85:N<A\7F@J!EU13596
MVS>NBRQ(XW.I885_\ !?N73#[R<O^Z;MQ6$;/X_V+5"@QCSO*$T8@.;P.QR#
M7V%EM 577&_<8D9=]T@<B;./_+0B8MMYT[NK;-BS&CM2DU53&<T!Q3FI>!(V
M(N9:"/&C-M"Y_7/JHH9_J7.C(3K)P12^?,%RMRH2P[$;=69K)XY$ =0J=U&9
M,?"UQ$N 72TW>MC."]6QOSP@B0$&(?PA$H1,6T7=XIR'5$)<,>7Y"T^KW7>G
MY<+33DC=V+G[2Y);+WE'J&^>)D-<@X?;V-R?A<(8-,H0K$4VRF.S4H"WF Z_
MVJ026:<#G-(J< X,8NY$VFQ]5^3G9.M46T.V+HK&XR@;Z/GY)I0;1+5V$\]J
M)X5.(QB5)OHO#0_X!W2[IW$FBG!JW@B J=KY/&Z%NJ-IH*1(Z3 D9:92 IRJ
M2WY&O6N);)V%*X>L3?+%@Y^?O'SUX$O-WHAN.!?=N=2W7/+74BVC(UIT"X4@
M\:G'6?**YKHN6V':;^[.*'&%/H'IISTBJJVZJ<K,V4RJ;KL+OI0AEP#\T<.#
M[WP2]NCHY6%(P_JJ6NM"4F*5T]!Y L+MILC%.&=12B!834S*?O*BKH;),1HG
M26@Y.W%Z6C0<Y(+;94WO\=6?Z-_2Q>&V:X_*+2NO<N9PD&P#B:))2EKC9_"-
M?I=ZZY/*F3L?TRNEHA65:SE'LQH&S\C=!KXQ),"K2&V=$]1"6*2)'',K7ZDC
M6AA@U@,&*%K-7AR2F-?!.,/0=0$98-U(?1$L-[QT_.5YZ;R(TY1Q"1WKL<AQ
M;4VI],AR1> ^4V()XJ@$I[359IY+"ZF<!B$TQ;HWE<> .BO&+52?)IDD5"M?
MGV&,H$E')0N"N+C#>E3G&\EX;:TN^OY='%#<B)!K7WQP>T353T =[G8&:A/)
MMH'&- ;<P&E$G?J4FMZ76<7@',C=" 62F=\ZX@[CW/3[8VX5VA&+K']:/7,W
MQ(D>;<&*@3 :'IC2+#HS34*7[.LZSVT%KY-[>37A/"OFE*HT!TLVA:#Y-#?E
MI>.9P9DV(SBKSTO>F3&=OX[IQY+C9=;PCTE9'A&'7%S*,.E/H+;5((%'7//,
M,LK<AA -<YB9SL5Q&?MSFN)V?YPM237&>&*;LEB2GJB6-VF'-#4[+D@L9P#P
MR>4M=7@J/%)S(?+E[VT+YW&] ?%X^]9%A43QH:'UQUT=][L%_/*LB^8SQ7[Q
M HH[]6*UJ)SUJ!JK1V6 VFY=N%.N[3;FEQ-:YZF[DUN<YW5))Y2;;*:,:02?
MW17@?&08:(RW]&C?P;,-+?BD^>'5BO#@T<-'#U/&,[Y3]=?'W^\__I/:,O6C
MXPL-3PR&]5[CEB\C6/*-SINX2$E*=3$:>2KA0([QH"%"LS?:CN ^GW$:(6+B
MS_KNK&X$?/!J\O<*M22.=@*1S!1 :)K.I9TF]KD7E%@AK\J^)A=W25^@);U:
M2=(%RF$7')2MB@'XMR#58:2K(@*C;-YSP\7?,]I-]':_%D0\I+%KR.#[*-N+
M)%PR 8954]Y;DT<Z?V4EO?<>UY"=,J$^33=]N=4E0=6#TQ(M3&3BW60NZW76
MG6U2PUW&DHKN)7]\?<RL>.2)7N@ $KQ^DS+VX93>,-<6(1=:  B!YV6ZDJQ2
M,BG1<3AJW-+YU\)9^&[O[]G;>I8\T<N23J350Z9P1B<-KU;5\FP$S>1,XZ]@
MY#HQJ3K,_R$/HE2_OWAP\O38A?V-<YI<$/2OHC5M="VYMCC3* ARAA& 4O"K
MTY7<&*0A7X#W<$:L:+W2LD=@?DYII%^)S_>M5)V-.L.0+5^:8;(%&]=%4V A
M8WVJ/<HJ63$RU["186O!,_'2HB2TZ95(5<U0-HY@!C;CM@B.Q5O;9N'F]2]O
M7A_OT2/9I21+)EI1<\*/T>U;(ZW6;=:<#XFL+=:,UIUY%;F/T$:RYF@_>5(4
MZV2Q+-Z1L>(C!_:0K[4H:.T[7\0C]D!_:XB%P^DC%3G F>H+MS#W<%=*89S6
MC?9H#)^ G1\&2C<L^1WWH 0&MVA+B%LEQ\^TK:%[?9%5S$OM'"GPF"US)D[K
M"O>PWL*0J+M[FB_WW<(D;9^S8HG(<WWS(RLZJ^(ATL:2:X5,*0O!%"2%3NER
MIBX(=-**2YFTS""GO=YQA!='YCSD92B\CQ 5H'V:9:,HYX8\;DQ/UXU2X*;)
M! W#^7MG=.Z[03L:3Z\6/7">I\G165EE:?(F*R_D>#]L3H$:=+_E^B$#6T?(
M-,UR6@'6L,)G&HAZNEEM-[F@K4F'WIPIT=F.<$ECKJC# %:%7T+WXC/9FV)R
MC)>VF2GV:F-O-N"XU-J 39'H@M%:Q49N^,S!]%[CF?>3(UZ.U!=SX96E(]-W
M5A*+AV]*\YQ/TB]>J,T<?X+6PW\[&^[^O6]_P.CL$$060?3XKB*([HQ5J.A0
M<BN'W Y:T+*>T>5#BA X@WQ#9<00Q7LR5>O!9L-;$6\ZHHK8@$A*3PXY8\QB
MWM/=)]M@)&4OG6ZQF#T3Z4MMU59><8,F40D8ZV+9?69W$QU,E7W@#5L.VF5;
M1BV-6"O=8YV5,Q2K6'78#8*>W&,C.74 ?V+'TP=*)X_2GQQV:;),O+ZKG" %
M=YK.MD]KM*^*;B[IU9@.V^TP@Y(YZKYG= >E*QAG]."6T[Y;%]/T"_^-0_,"
M35UO1(R#7IM^!>4R^H'_L/<C2E.:5/J8^>OT@6]9)[OC(033/ (\0W-^R<Z\
MY-R^Y*2,)1SQOQV]^<M+"!#P/RF@S'PUSD1%M0?8B1DV=P9;#.]%PDU4N30@
M(3I !D7AXK0UY9MK)F'[G+;@297\O7?NX*-'U&MU\'7J9UK;QZA3K2L[2M8_
M*[J.14&*4PY+W4ETR<)\=/#HZT??W^+3_UC63Y)GY#,GSYX=_;E-OGA OWKP
MY4<M]ZQJ*MZ[+QC)5&HQ<TO/IR^&\JTU4,3H.@- IBD1:4J:PR-KW.[C[4$M
M7)2]X[;6UX+!>?R-=M6!B\^6G3!4%X)!0'YG5G*XT2;.>!55*WJ>%T1D8'IT
MD*D-;_1I<PE/XQ*>5LD+9][0).@VR;>C30+8#]I63OLR!ZA$^\EMP2UR$7A/
MI=K?9]+P1Y(@,NS.4P='>LV3XZ_)\Y+3M,^SJES[I>0^_[=Z54M?T"]MH0V&
MEF"2+?!/>+>?Y=T4(L7IO*E/>(+O5D<J,)%)_,;&(W0D>A780MHA-_XKU]A/
M(SGD:^XGV45^6PV8$SQ1BR1)H8*,!)W<$#$)\?) 5\+T6A-_V 6T4='JU*NP
MV75?@'=J4?U6X^E6?GC*IMNXQ?N..DJ[,T3^]L;D#36%Y-<0-E :G7.*> @?
M&!C7M%RA4C3 C'*_.$^R3(D;UZ(54@@%^YJ7@W;9-5]PP8R-@M3S#[DG^=0-
M4%J%3U1R0,6:#E4=RM.MPHUYHD:Z;KYOBYYM>J!&]:*I-7C-UTH]1T%(3&:>
M+T2?,LHI!O2. ,("IKRS6AW8(2'(M+/B"V6:6O82)C(2TETFK'.V$J@Q-16G
M*-]PTWFD^J$44>&>XYB9W+"2.AVM PF^T87.?MH3%_'#UCX^0 /X0_31+T'J
M<>86P<&?)!4<Q"0#(O)>%_)_-R6>)J 9'A+HP3OF6#'(."NTO0XH7EFE1JL[
M)&C/LG^YA4F'12@0Q'V)GFN)% W:6(7. "X]=I()P(6Q\7H=3-]/]KG=O:F\
MDOIN0*JF\4W$P*9H6#8KEB)OT,,>2/$\$O:L4&#.,G!C:7)G8BJ'I$$%.BD$
MU II3BI3]=B8D88MX8UXYJ<62&@ZT40WRC99V^VSTR#9:;:&<ZS0'"5MNLZ
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MV6E%7H;4MU1 &<V=4$CLN[D@#&:+RI8%]I99%&H?)6;HXM,[Y+C(U/KF&^[
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M6X:6FO/7A>)D 7I9$@H57T)M>"*4UXR&3&UN^AS>0)-D;-XI4P&'4VI021S
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M(.]ULWJZWVP-WA\UVW7Y5Q7GI=3U:"XWEV*X#KO5A(\B%X^LO&"YT@@GZ/I
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M5MMJO@4;8^Z*&ZXK]L0-;BS&9N&7K;<X:2SOPW%F*>*@Z_O!C9.&?MIOM56
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M$.I2+>+)*&4%YYD)TQ[U:LU4+<U!+APU#9[!347[D7@'_X+VW0W5?JEV%+Y
M'IF*D,P^YX?<%62_=N8S&5+(Q 6NSV-\PUB17VT'KZ)@[)2.N?0Z:RHFY+S$
MT5+8&@^['(R=,+P##L&JQ;)>.YNANU!!!H8?_Y,X8<P5-D4RF,[FQ( K,;C&
MM!A4NE'HSF:" >F.,O)@Y"'B;FH4L!LB6&?9RT.]3J,WAP:>T-RKLWR*%&_#
MY99)T##0D(J\SE*;9Z!$8:[DULGFX2C#XGZSH#'8P"S@;QGD1>&&))OD\6,R
M&]BL'R);KJ"&*;9T_$#F;&_,E,V5 .M:UKS'\91ASP=VJ7!!9=VF)U-:+U)(
MVZ&*4IXAM/1(]\&\UYU4&M[,YW;D962N'6Q1,)VLH\T(@NAUP[,WZW6Y^[RZ
M\*9U9#HJE%-7_* TYAMA&Z7$/%/9<D7Y@+!9$<&3SJFM(N:+<M=JL2!4TQQF
M8LTZQ6H<X<<Z8Y0*0C=ZF;T<E*9(K^'T[Q=OU' 1GD)48F -5X;Y9'J%%09W
MCL=5L+YJR23AT3==CGG=S*4]@)H]"P?5UQ?G@%B1G*M)/=&Y.T"4AJ"4 *%5
M&$ZVB-IXLV0:P=%!5@4FG;"NJ[.&<FJQHQ5C7E<\![4%!=*6*[2U$W.!VBBI
MJ(2?.L:4Z*-^O5;/>M/,] 92OUB-57T'*4P@=6BSY6]TG[[LQJFZG.IA*$!I
MI Q(FMI_OI,Y^5_=HWP$8H+,+#)=S*. <Y?*@>QHA-ZTP)?/KM6,33AKVD]N
M+IC*? 8Y8&<P?SO2*<%:87&+0M"R_)F9  /P([1("+L#".:+-)>6(SQ&AIC<
M]/NSE HD1'&"$#\&ND@8N\D"!_\HP2[TL(3"\^G3F3:VSSY>*KLSEXB$_;N=
M] !HZ:48V&C9/1+Q+6:,J];:2$O,5F+O))<?<W KTS.@..U%IT-LF^O$XGEX
M]C0AG77($YOEJ7::^YVG>OGU^N+SQ?]WBHFJUNF7#];%E^OSWZ_DO\^N+_YY
M<7UQ/MR4TIT2!WQS.2^48R-1[DU1J!-\2"P;-4(R 8A\'=1MG*Z0M'VA45ID
M !VJ#'P4!JI;FK0A<L5F)DI!!N#10(MPE%<(ZVC32@@[A5ED0;F U\ZOONI+
M1*%ZP=%,9#'*C4AQ?VQ"P<32F1N0[4$2&> 11F*^\3VC2RO^/UF".)CHNF<"
M#G&6,&^97<[%%<7M[#/%(IS$3[58JJG*6&HINI$"I<D1)E+:QLU) 8EEW25Y
M!]0&4R5"HHL-5/\&TN)XD>9.I!16JXRRE2<26D2E0$G$(<Q*)9%9))@V%">=
MQXB3'<F.J_/AMT_70^ORHW7Y]9QEQH.9[7L@$\\UA.4P66"NQ%ZMJ5CX?1$Q
M]3M9B&VJ/2A@VVJESDD"$@ ]K=/#$!&(*0PP3MC<SC9$..K434\@OE:O=?JK
MKVTZ'[ E2FU\-CK4!21M8\MA@4W(GL:?G2A#Q%5/5-9I3MF>/H%&W6()J410
M)RU9NJ38GL'79!B.O;?H6%7P=)PP4T\;;*2UZZJ(%B3B"3KAL894"4=#141Y
M2IT-$ZZK1$":.VDSF1C.LG@UF)G>](RSUY@3655L]:!QT!FD_,1+DV!Y&;L@
M7K\!:IDF@8FF>8?R4;==&V25[E6')8+1$=:'=CT51&TD"8(QJ=L9-Q.!8JY:
MR^<_-&8B8[WK[;0W9*;<&9X(!&=F9+&C=MW(K##I0)'<M)6;\IZZ"& BB4G&
MI%QTFJ^;9Y55/*%5+N!$>E4BQA<P>^)"#*2@:3F=HH4*4W;2">B22 3C2AW"
M:)BIQ! 5:2["F<X@42N8-569ROM"CK[")-F1,_X^(X")$RE*IO2_]R\I6/1L
MS6XV&HL2R$/H_5*UY2IJ E?G%B"1(F !QF1>[J2.$/,I"=_.^Z:5GRJ5Q4QE
MZ90UE>7!*W+G+'X?>Z:-&97\-=#%<X>98/-2T:SP [&3LYM!VY1-&E,YD@+#
M*8G@L#PLA"=%D46%$^BW<,B'P9+%R39BV*_&&,5\_7'3^\:6[CTEW;EB^*AA
MMWH-4XT$\80N/(ZO.^J6HH9<M>XOJH^POI#T<%+"ZVM&>;$+0%<G\*L[6<@I
ML24U-#'K'(X'2M+OI$+AXM#VU4@99O&+[)9$5KZ<MI@HP  2@B,!7&.4?,ER
M;'U/IST[MY*^A2_@U?P,++4U NLF [.FH.4Z FV>4,/2923>J;^\G[@('7;W
MSO6)\^BE]P0\#CLJQX3/2/$W:-=ZK2Y*P#B$_T_4\%(XUD@X_AI/5G_7;H/A
M,EC[ZWJML?9W]PV+N:;U_M,/VZP-VJWG&+;5[#S/;#<;]E?:-]X[;'X"#/?7
M-ZTWZR^B\5@(N(@D6OF[NM4@GX?ZD!ZC^_ 8D@<E&\,X%GGC+!2AZI?(T;G?
MJ$\WES_PX^]7](T\N_('GEI:#Q[R7Y!F\)%DQQ\@,/1IKBA52*DAR]854FW-
MH5)5>I!#&\V'!SD0VAZS[2[-CB"!H29I_??S"H(MQM@+6J*6L/8L']YB&X-7
MM-C7O+,_*V<+5HVM3%YFS0^;3K3HLV""&+A#;N6KFV#G-WV;)=>M?5CXT4\M
MT5Q:B*.6:FWM>L-N-OHY^/A'K!-O^"W76W',7G),OV7WF]V*8RJ.V91C!BV[
MVVA5'%-QS(9KZS2:=JM?WQW'_*Q!MP\,9&9NHG_VFKLA7*N$)E=$&Y.^8/F'
M=HJ*EECN4]1L-.Q>K['E*2KFY">7NQ7'E)%C.@.[4Q]4'%-QS*8<T^W8S>ZV
MUD#%,:^98QIVO]W<'<<\D:^.OMTK.2-=4PZ##.)OJTAG V<M6/(D2# ,OD7D
M[-#.VU.2IMSGM LVV*"_K2[PA/1Y1FN_XNS7S-F]=LMNM3H59U><?6B<W>G;
M_5XELRO./CC.[K7M9G-;JZ$$G$W6QJ^4"5K^+-==0_"L5&JL9&'K*J"C1JM>
M:V6*F^Y+QF[T?[$?K R171U#,?5DL>X&94'9MJN<\+UP)R>R722F1<L<;.MO
M"4RFQ1C=]1S2[0]L!B"H'0P5!\%N"9A<^G7]9:/V2J94YR!^K-NY\ M(UFIB
M1GJ>")&#&!#4B8 KRS M.U=B3L\MA>QJ3[4"F%NN?X,-'\PY9@$@(N?6"IVE
M.UFI1%<;A.@B*N^=JI@E2"*6XX4(5D$@%RHAGAK4SH7CQ?,QUEW*+IQAE%;@
M^8%_@AB&"/LGQS)>1U2^<,(-G.&(4^]$H]Z.\^H1&@6!UPB.0E5FY'>_9GT0
MT=*-53M+3I97RS(V-4L1W4!P)#P$6R'D&\8PNL.O<ZEZM(+'R-QI5)_3XO!3
ME-(_A2$<QJ)"(,*YX\_PRZ%#6%4%,Y15#6GU9;I 22U"JL3R@V=)U=^AK"DH
M7[A/V'1JK4UJ/IH%YZNH[.%B;8F0K;  E#20Q3T2W<=-YX>R =MB<DV<,PX1
M*! +A*;8+'+N$GAD=JI^6E**GVNOSI9%(K9*7ZF7,QI+&WCU6&N"<H$_#\RI
M&\QF6O_DL,)S$D0+TU%"%;/,X=ZJ&!F%@3.18^F"0?EM:J^E6UZ3#'RX%!#;
MVA34W$1J="7RYL)#"0MS6WK.6.B.D+1:.D2>.Z7V6X^O[=YEX1H=CPMUE9F)
M?MB_5='G^,W9</CFK:K$M-.CHNJ#BJJ"%,]-K&:K5O]ETQK-WP*)/_0E+P(O
ML&@T8;Y/=SR:4_MG\WXQ#HUQ6#;Z^D.B @A1=,76>H7K*Q0"0X(F<;G')\EY
M:Q'X;AR$W"=(H@JEY)O#7BDLV8D[<R6,Z=GPHUE%6/ BZ".Y]^ZI4=QH[NK:
M0Z(S2NFM4JKE%];0?J/-MR5LB^OKBC?$;EUFUF>G9%_]^C;KRRI N0IR5#6"
MB.; U#84#]<G6"P6 @K5A<956+%Z^J-D,A/<Q9FW:J7 'VN]4;.)@K$K.R!+
M_J=+V5 Y3+TQT\5;=I.5-\;270IU+V&'=3658(EG)O%3(!ZIA41219"3UQ"Z
MV16X"')' %<+!,(.[Q0C,TX-L'+Q\53E[T6[)318 #8ATH1,&^9N=*+L%!E"
MU]J;-ZFI96:525/752K0(T Z'K#)]N8"V" S"*Z"R^OKG[D*0*/:^"K(2,H_
M"9SB"D?7T/SV&D0ZG/U7[F5A?7* SS-MYD!74I=&L;!R#3-JPZD^=&\ U=(Q
M4W(TUE#CX8M#+<_++B]W;9QDQ3^J-CE)IX:5L M%5"9RKND;J;_+&%((0N(Y
MA>*^8$F6QS96BDRF03050E_TW?41.22\$6I79:=V#;OU\@?VI<[EGT(+>MF
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MD0 1)Q"H2V@D_4BBIH/X(I,FDJL?\^K?/4M/SWR]8?&L<V&/1X+$/@>&!9R
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M)#H_#H!UC3?PFHBX6_F:V<..&WU#+-_AL>'A^UY0_;R9^:@)=Z9C]\*!Q<;
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M2KO72V_/_%+ZM<Z3KV0]HY2&#_[$HF,LAN3VQ4 R9SRW@6 2*SL6*17A>EO
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M4DB*&0"_T4 BY@E:->O>/8O2-MAH*3G/4E4 6Q7 OIIBJZH MBJ K0I@RU\
M>Q"$VWV!Z_XG5JUK=%FEI!LI@[429F64-5A89<)OQ5G-BK->, S]4LE&KZRC
MZ/YF@^^R<TE9SUE5,9"K7JWMI@%16?FCTJAWTDAU?YNWM%M;GZ"G@2HHZPFJ
MNOOD&*13,<B^JKH[T5WOP^%_966GC\Z3/]"C4VFON6+[QZ:Z'RA_5-KK!A$8
MAB=9C;H_@5?XZ1M8E8\/._7:X*?\>B_=JJFLA_4EG,FO@B&[/QG"J!CR^4NA
MGJX11AF<S,T4YFKU'K%E)Z5QX$<NX\:$:P*1MJ4]U;85/>Q;D3U9S+YJZ5=S
M542=0:UCUNHT^K4N%^MT!P.CU$/F8>:*=OKP>L-\)E_%E*;E81<VF6'-?5DF
MEA? /W6&ITS##/P3[@%%;=O@0\F85S"=PGHX59)S(/%;:?XW#Y96)(745&IM
MRC5FCT8B_Q&'_C#:Q\4"NP9A"AX])":T?B!EVF/K-@B_6_,@"8&X<Y<R/J>A
M$/]%8J<C8Q\ZF?D)0WK!G<#F1KZ8NC&3!B@KHLAH9N2&$\K[O(,M#V_<L6Q#
M@4GN(<PS"&4!B_X&95YC&GPHJ#X+.XS)WF&V7)%,1P7.LBVD%#<KPYS9[X+;
M!H7!+'1D9S-'-0W"^<"9V*:@X27/'XVX$:AU<R7>_R$]9MLT\"F->%F7O)!F
MB6Y<W6=YV#'+0U9? )_"<U//B?F] &XI_ANEX0<^/.98D8<SR9; -8TJ/E-6
MY"4#9KN>4:.H.]5C341I#RCD916=TTS)K<]4/SS8$2JGHY\:E1@>4@%K$J.E
M&POZ\'CN>)[PL1_8^LJZ)V'OI[NHJA9-JRV:^OO1HJGD O#"/_D:!GC=6.MD
MX3Z*PI5P_A:B+]6*CKKM?,FV[BPGKT//B:18S!7XKL[ B;G!9"H#K\0(;0RN
M"F%]0VJ"P9B*F"9F13BK ?])0 \  0R?R%9$EVQ[MN1#'2;\W5!E3XO#A%M5
MII2JK&.#8.AC+NNL'C]H&7HX=O-=>_-*=F4U%9C;HZ:&:SK*<HVET516%3K)
M[IJV5+OA<PLWBD@)Q5>DD2*5_OP734W=9'8^4MAW]08)Y:W3SG/CX5,GD7,#
M/XBL!= $)@Z:A//=T/^EHI$[KUD+XJ>4@AUWY=OZ!M#1HU.*'IT618]*O>)[
MS]QI@>UK'8L?R@92K8M#@3UALVW"5_KZT9G4C;1/UC32?JL-6:PN/&KVTG+H
MK,W<-*J+=3'C =#\3T$=;(TZ;&WQZCK'3(MB/(VW0BO_2!QNOBHE5@"V<:Z_
M;:;?<@UX5_W4>-1HX"IN N^&7"T\MP7(!/AX2%UJ08"Z4F+!C1S32""/)\+R
MG84TML%JQC;6$V[CB]V"5UNNHZ$\'@N/JJ"S;A?J=\MML65QGN/["?Y1R)^I
MC;X-?]H6Z!>6P=L@YT"UCX@W%:7-[P&!@K%+DR73B80_<F>JOK!?@>H*C:L!
MOWYZ!J+=NO#'->)J3^ P\*N_.;"P\,Y"%Q&<@L9;W,X1?'D)\_WA8I]J,!F/
MNBWC6/"!@0OMJ-M(L6SDCYOXX_J*!ZK%/V[F?MPN_G&'5G+4:30-1!K<?4&6
MP;/T['V^<U<LR[\$_DGJ9H.=P;[BN.P#+83%WO2I.]5-UZN4J*KQZN:EG%7=
M:55>6-6=5HQ1U9V^6-UIU7BU.GJ/E,F'PR%5:]4G3P<&HX;"9J@/5PU5][JU
MI=T</+(QU!XU;:AXKDQK:]3M7N^1&9M5<X5=2_U\_?+KR.L_[C7L3K^QHCX\
M<UI_57FQ^0YU6O:@TRO1#E5ZY/W]F2DTPDJDC?CFKZU.UVX_MIE6B52O ]^D
M@=UI/A(TYF $RSV"LM&L-3ME%C*<$O]0'.>1?6F*RS2V\J\=FC7R] 0JMWPX
M[O3L?J>^M=;Q= 3:L599'97JJ&QX5%HMN]OI'LQ1*5-Q6HF2_=A+<)'U#>]O
MJEG.V_WHK-F&4?M6D#1;G/-=V#@ YD--)Q3(/[8B.-$]*:);9TD%*4 Z3A*+
MJ'<4E[I0-ME<3&;<.^,?[0=2 LN=5\H;<UX$J%?R]*H'>&W[H@+5'D(RF]GT
M[?'<9K:= &Y!+7KL1'/*TL[,T^!.['GC8&L5E>4<^"1;46 /A8^IX5^"6.8\
M&NT%LGF"F"!YNN 5XX-7\#7ZK1SB#!;CQM;I+!0">7I/^A]MR>+L(;F0'I(O
M8IM2F;+R^(K7Y]$2M7-_&<(6$C7QTP8GZWML<3&%==0R<JIGF'),E0&.Y8D9
MF)J1B&./>)*R6MV;;)&-49:X8:YD:;A1IGM>.S\.HBOG)8@8,9V*,57%($.6
MLN<;4#QV?EC4]@JS_8_;K5KS[2_$C(TN=@@#5I6ZR4@@SZI_Q;A1F:9&>-?;
MJJ\5K-J[JX% %220K4:KN-WC2U!@+2>NNR=7.;%4FX8U\'2'(>("FB-T=TU!
M:_.QMYU%EQGWX^3B=Q 5@8\=F(RB?&%]\UVZ\_!I>%),J*8+7T[B '$"D"ED
M/Z>4E16[U*S+PI_#I!)O8MU@CC.)+A*,, S].1&JYID:TBT"_!O)[*E" L"!
M/.?68K&(/YAC;S8LG%[.9;.\41)AW42$C:+H!_ 2R5?XAD_54_A#+\ ""BI=
M(&P*6" .AIH/?XQ+M/#SD8DK@ N>NQ$1 6@E^\*1C,U]AG:"RS34BZIX U8,
MMXD'VPJ+G@HJA\2E<8W-P_GZ99)HU/+LPD\34F4[X4SANRJA(+4N#IT38$ B
M!):'3KGF4Y71H(KG>< Y6$*R#-%Y"D^2K<RX&#YI>"[\*TI&L',NW*HL;H:@
MP?U7A!YL'>SLW/6X+EY_90+6N1_$JC8.]T=O&]ZG[\UI$V)T[WV$HT;&M^[2
MV]4!.HOE2;*DDA_8P)$3N9'%M5.!K )RW! XWDNT7JJF$W*!U=K%9M$#)H*M
M+V25[+ )\9?#-4F)3X6+J"M/O>#66I3N;B&&F0@O)1/7#CE<]I@VR,-6=[?8
M#1%E$%P>P1WUYI3_5*M5_\;CFD1BFGB6AZ6=NO*QB,)9TJ((#$G?!]5NH)#Z
M=7-8XX3NJ$,LD4P#J609/=^53Q5!(4^G+"E+TAYDO?6JX:M$8AADR5%F)(9M
MKX:=BX!*1?@9%0%++F%;L>*0WKL-0F\"#"5REH6IQ*/"AZ6(A46+S7JM_LM/
MN.-VKOF>QCMMX%WL."C;Y2MM!%,[FSL3ZVB@<"PU2-J4M M92XM5BN1:<U!-
MBAB5C &4D'&/&CV-_&X,P*UJ=[DI!4?'N.WC-=X>-E]6WRVDB(:10@4Q=GS9
MP3;Q60!147,IN6 =>[[4]U7IN>%7:^:YL+RT2TM_=D$[U%]!JROF1X]L=NS-
M7L#]> <P$(\I R8!O(&6T4AXKL"K(P:Y $8/C(ZMFMGF6*"+QW._XW41 W?3
M&_$<K*EY '<V#LUWEH0%N";U._7B%TVWVN$UIR-U%[.UBEX<PH&19K+:3P7=
MI!"7"%TH_.YFX&ZBYXQ2['ROJIM_\YO_5M"%C]&/-"T--5UK[(3A'9SA6R><
MD/5\-*CG;6$\XLH9:&B7RR0$XPZ5[:-6M]8K>$<&- K>8>R*=D/A%INOD;.R
M\*44'U5B?RC5FA]FV:-F^N!BT^B.C)>84*T4IF'8Q]6!T#ZXE&X=RO?;])M
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M /F*Q49]\;!!!$20RCV'>8\G+$PX!0%99 $55"!\=0UOY(9W#.D"H#6-H^!
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M B$^"GZ\=V%S (XBDL!GX0<?!!("N^?4Q+E\$H5T>+CGBTZSL,9Y?NQE8XP
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MVH^-G&O4J!>\3\J4_$E2\HFDY*NRB'!-(L*5(B(H3]B/%7J*U!D_]TP(6T$
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M7,?<F?B>+4B";ZC^1OXZGG\FDKWF+&,Y9"/)O%'^',KDH9B-&S4]J[C7H\R
MA-+D^%LXXU<T@MJ\1M(K:S(9*1X/_@[<A\)5MCH]/P&[.W,.+OG>*Y'API9&
M.:%JD#/?'4"B([%/N:J6IWIP/T"#[Z!P5<*JID&>"U$\'*2R@2]T=U5[XTM?
M3A^4P9<BZENM]E Y:&/_47G-+4,-4Z:WDC8NU"!*":,9ROA+3EK5G+__DL84
M=>24*L#N?&'MR$^(_-Y330J%;0(6&#,.D'YS626BC$J8(BAW((CZ;NR7JBQ:
M.U<'J [FMU/&QE^R3@%/'<D3\TLA"]("01G56$(JA=T#9,9MYCO>J+]&(0>1
M,&*\$RCXOD)3^0,XP9&B+&HLD'\+TX-F<.V0,>=W19/$PG\% Q%5><,*>Y$B
M)BR;<+"2ZY;<68'_G053'LXHZG91(%2"=TNG*7MT\W"GDH6)QX,@&F!UB>+X
MRS<*8U.>D,3#=[P8$TZ*6%8W+$Q5[-%/>-2$4'J(&TD%5T*6FGY&0H1Q!Y)F
M*N,RVR;"K<?3U6%^_B@"P(7W<[.++/K")X?9V93$5X;:\C1.BV#>(B".N#ER
M6"\ ]H?&+6'?HT1I7@8\+WU35T.BI,DGPIU,D9[U57CXVG%3::X#8:Y??8T;
M&DLIY7_VV!WX02EE3S\(,YLO_&R,DI+42&1?]<!)FI1,+C=*\(V73X-=@LM]
MV$,1!%'_#*!H\JN!^HO$IM0A4!W]'XQ1](!! 0UQ2.'VA-QE7(\6HB5/6Q1/
MIB-3C+'X@<3J6TG8O-"[3/FDO"ZDBB+H,"^!0O,;@"Q+(R#IL#P,1> 84BD#
MDD)* 0M<;N4%G'C MS!M20,K55TN$KJ4Y-,\O*' #01[@G8^MH,7*7/1NB1-
MBB"Y/$.7CK$B=[$Q^F7B:;Z[N!&R1F7-RBXHQ\.+W.720&&(*UF:N0FS*#&@
MP(N\KLC0J1^>1[B=VQHK4Q(^9[*E\SHX0A8D32])<G5#Y 73!(4)L(2GM3H,
MQ8,NXH5(ZPG.*&_D$*N-0VH4('[F\@@<45P,!^)),ZA@W&%4YMJ1NNW* Y%+
MSMZ="'^],AH112@?RM5I"OX+59Y)*Y9'!<*+A$V/=NZ!"66AT"KY8P_YP/W.
M>">7 7=.P"9@E 6C& ON<B/U(G5#$7HA%AUW3,JFN15"2-7R>U4OD97E>:X-
M(BLN/X6Y6A^&,4-5*(3%%[Q!E+##T(JQ+Z*B\U#B&Z6 39[\)X/$DC*[2S*L
MM.'CI;\UKYM YG]D,":TTQ:*8-&K!LZ<Z]&O*.!G(7$UP%U&A$)/(!-UR-B
M6UDP;9+7]Y#R&9872V._") 7RX$WROK^5A>U(*RW@X8'<J.[QDT$:XM?DQ%)
MU->O/@W&) U"\&OARQO6+GO3N QE) RN;9:@](E>.+%.2C4=W+H\AC"6#7Y@
M';XS-N''H;KA>51 +>5P""=3?**4(*-55..]&]0P)I%M-6;F(8.H9S7]^4;O
M];0DVVE_&VVZK#UIR+*3LT63$9#)3(,!4_7,%36!,*<TE:YH3VH/-+?13(5[
M@VB5ZT]S: %3"_!,TPNY7PS$05A=6!J\S4TY5<N\,?E2/&18:%E8,EFBF&%*
MDR".1N:C@CZIUDY^7*BZ-%XQNTA*?K1DQ?)8#)4S6-0/DJ_@,Q%,+W>@N_6;
MTS1*466#B/'M071%MU J*Y#(N#*Y(TMNB*R<+=EB,86TKD[788;!7Z!LE*>;
M>"N4#MCE%*+?N;:MA*2#XNV/Q6D +,S\(MD6I#X07V/T%V9QDKO"BP+[!>\3
M3P$1E%%'),93*41Q]?P[ <'\8O(NB*0X2N)2LM*%^S/OS%5DOF"#QBP/\R)E
M7M08K!;(4X53 2UYYA)7!?E-:H\N'HR9*X+TNR]#URD,_$;1\Z0MH51XCTM\
M05"QV11^?7JH, RKWG\_!)V3C!E4A1)$@P9:FEP,>_7PY0UA "PUET++CZRA
M1.O [M RQ%A2>/0EHHKI^?4]%BHK.!4R-R51\<0"L=S/>T7-!KDR6I6>)7(L
M^0. DF3'/_3J)RS@R"0L_QC>RB.6:NVM8HVDML<[*4I0S97THK^(5,VS<.C>
M1Q3PCZ_G)?U1B:HY)+E_2>0J"UD2E\G@X0YJ]>7\QY(YA3N::AXN0XGD^C9(
M,@7FRS,A2+#B*HEL)-7@4$^X3;XR.>%&7C51&(.%Y;>FQE+3^&61Z83SK/(6
M<JU*L4@H'KW:A-B&\N+<JEJ)"Z7QXQIB=3LWSHM24UZX< 9%M4DL0O\4>U<D
MNL( 882+C!YO,@RAK<,0UB\Y?!/5_3]*(_+NZ^^J."F=B<@TA[S4C["'R+8%
MD\"5E6(I/RH/SRIX/_SQ.>8Q;K^",APVC)]!,,;'4R%&8 C_83$\!H3I?XA@
M >%:Y5@JV"+G)%77A1R'$BU5=L>&&<G+6%(P'U&%4U%/!&Y\2]P A1Q1XP?'
MAZGD!%MH*O5Q$B(6F#^!E^0RQ$J4*A"7*C;GU9C+P85R.95J@PV9:B)L2OF*
MYSG1>?4QJC4FM(.\;&]>.,\ME]ZEBM'WN0M273R^B6IQLMP84CRW,6? ,ON>
M=C^2YA:>_)S;#+F9C:+H\6>T@V"Q-^#26:+8_Q:0F)L4Z>44S3WC"RJY?QI<
MT*A&8I?>F^?\R&P 45$1B#]F(WS[?6[*$P^8\LZ(>4,$2J\1[X@\6+6#"+Q5
M("!/&Z_6'X^94:X IHJO>6LV'XM'PE_W9&\7]6XI5AM>QX/8\<@6'CYJ.5(L
M>A[#RH7MHOISS7 *\;208P=949:?#F@UFK0P<)2/ZP.&U1>QNR)\I#POZMHB
MDS=NHW @2_@ G:(KG4?%BF-\<H)D>X+_&5+]<#@A5!)!1M+R NU89S@2XDLQ
MT@.AJ<6H61 (7VQE#1FWF=!-%?!&,P97MM1'Y9G<2N&=W)%;+=Y2@VDN+P\J
MF -12KG@LS*7TO#*=J"B07I>#[)444Z-Q54BC*HU)$5 6C&_IO&;B#6GG''A
M_E&3:1M"C9/GJK1XLK,0YA>Z%!R%J(JV[CLL<,3/-LT629]2@Y3V:^CR\<0R
M49"@3/S)TVG$D_P#R4.X$0["$H$-:S@HUUIS0S69*G#SXBQ)DXH%K]K:Y[1\
M[4P8Q 7E^MO<25SD._EP1F)O-*TKH.'-/%*4) %A+:]I("XOFRS*)7YRMAU,
M90E&62XK;]0E9SA;%3*94#_%\J6'@FA%]?B\_(B$+;63 I4;+B1 .EJ<I B>
M,,I+$)+$(IXY+'R]A9PG ++8XZ(C1_4)I1YB0N C\861#%1/A_1*V[3Z#:5$
M%:S<\\R=E>W*]5N1X"]U9LQ^PIZ9@3M)V$_RPP>T[@7N]"<_I+6GFVIZF O5
MLM]O=LTN:I>B0;IXO% \FZ1XRF[CI=^Z9M.T6G-_-IO6W-\6/=:RF_UNYUF/
M7?Q;VW$V,]CNLH^M:=8N-RN,0K;ZE4LVMC>Q#WS=T_O+-(WGY#>W;?PKMPLS
MZSUN^4';TE+/[6+[Y!XL\0QQU!$:X"$&1>X9<I7W:^<0+)?8JY<MA5YKL=96
M?_?.A><QIIR+FJ4,V##=TD+.2"RTD)]4%7?NBMI/3WIIXC*-FG6)<4@[M3!F
MTVE52I"4V>#+5P)_I179[97X\[- K7(6YN+6FR2MEJE):UG2VJYLLP\8?K;0
MAO8L4*]9A3TY7';37!6WZ[?\4,[/\\7WPR00I^DXFD"TD+S"*EX)>[[:)S;/
MK7F)T+R'Q\=N6L^4BP_T^&Q4]-U+ K';FD"T +O"*I[+7%R>9$89Q#)@E>+^
M9!P'^=3>F$!K-5=5%@];7-'R;-6:T-?TL5ZX/2;'XBY'9)[D<<X8Q)0EQKNQ
M'V;)>\-NBVSA2>23-SZ<%Y8R$Z!(@4J1K(Z8.ZJIV2]&K6!Z9D.D(E':HY);
M,#!^-)L6]AT)J$Q/'B;_3HF9?Y^G"H6E* E>C9KRIN9&0U GR[Q$U9QXS:@(
MBO$ICLNB$(<?[:8CAW80T2>_\W*$O-I%'/L#C'X4)<5E!-.]6DQ^7AQE_C?R
M59'S.O- RN9+*">WB#J8*=E:Q.%1M"C6^')+Z?$UL:=S@E5O*'@(<P7S:IXS
MK\-]E47-1=\AF;0_<RVV]8"++///,N)$UC(1?_*8JR.9\E%$4JC1/2)X+ ^N
MJ L12T7P&%!-*/._18Q%J5!+M==6L>I^HDPK#UG+X]X8AE_CDT7H<1[,ALD=
MJ2]:8<FV7Z+0)$V#YTOX0*U[$VJS8F#]=1IYWT5SH%-%4]^/R3Z9ES>9!(NJ
MQ?+2H\H2J,8*)#Z@K/Q:GDM.^3FRA1U1D!J5+:M&*8E0L[5O18C\G-<:KB@3
M<3WO OF2?/!&-%'N+%K+R)*%L2OIN]RVK"BT>^N'T5BD A8U#:G2:[G=0C[=
M9*4Q41@4/)A @/\N?X##2-&6%'*N_"+:<P'_0NY7^H6R\($Q$[/DG#L_];1+
MB4^%DTJG7=9YPD?P2O "3<K%B7CE#I9_(C: 90HH-8M@>O[.U70T7%"&KZ[V
M4IYP5\[PVH&F$@?<6N**>3R1\!PXJLA5/1D  </GDZ(D_34(<P,DP/U8A"<:
M=:J=E^Q=JT=XG8W'F$ $A^!:*5"A;,8WT=1AN]4*99O;I:H5QI+,7$%;2KL#
M@(DPPH)I/$MCEL+\P?_^X)NLT[F]];J,]<Q6?VCW>RV/]:QN?]@S'<;:_^HZ
M/^Q)+OV<<L,W9U\XT'1/-H1YST:)O_]V\O7F_.;DYOP?9\;)UT\&?'$A__YT
M?GUZ<7G]V]79M7'R\?*W&^/+R=7?SFZ,J_/KO^U^LN+OK-HX1M8;5AK(E*L3
M*,769!F=^F+VHNY J=>,2'1$K5AD4B^1YLS;2-2E6-]$HC@KU^**W@X\TSC/
MN4BH7P>EC.1]6?/"='7]*.0JS.MX03J44D"/]ST0'="C@/IU^\A4YC5@&/*.
M [PBEBP;7]=#XS K@GP6I',J2>=,DD[1<8\<B5=(?SK17$TT[^QJHODNH9HL
MBCY3_3UO+ZQ@'ND/V#QJIISD$PBW ,EJ\*JQ -Z*B@V\&$O,E%I,RE 7CXC/
MHEH,IH1<^#*E(>N H0+(&^S A,^R.$J,=S^<_7;UP_N&\1$T9Q\&-D&+.'[_
M\\=O^/WU@X_=13 K';\]_>4S?GL*4#SP8;L'F(*"E;TI7QW1=\I@]E_8(XIS
MH)@E48(/=_\#:.UB\5@7R_*?9%AS.U">0*,]I68F\(S,#46)[ASR:Y9#5.[%
M,RH:DL@^J[?<K,=[ (A:OP$5R> E07%9*E56(VSO@BW0[D$,=47W*U"'8<$R
MK&'.FRLEG!/!6MW)@E%%G:=\:,,@0Q->WI6@M"V5?0BC< A2H2BN*A[A"UXE
MDYZH1DAM$Z4Y'<YD%G?$&R'.IR79MD:JX2(Q=^S^NU2'$Y_MIYG05'\OBFKZ
M>4?(HKHQKB>:*<6?\]M8%2^EXZ@T.ZNT)>/E#>?FG.>U/L.RL69<W%9TFI1V
MC-PXRIMA\?98KB@!2@0BBQ[N!U]>B).?:UMS*10U0R&2,')*438KE\5F#F,N
M[LRE=[>XB>\,53U%GPFH26F113][**;D"I%EUAJ5PS<S 2*[X]P,KW;[*]6H
M(PNPVC_MMG*OL+%)@]\J*R6.8>*.U9Y2_%17>R-W=TU#+]IQ&N<*M&Q3':?B
MP+P]GYK"?0@G5&U(\0#,. 5TDFTM>3%V+&\VH#-VA[90[DE!3:K2#+/H5 %(
M71$0E.Y[#57\43"0GXJBJV#%I8CX&S"J+UF<EX5M''DSR5*%BE, !MEXO;&
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M'OO"D;ZS3<MY#VB89-+W*)0S4#B(IJ^1"T0QGN#+^,X%>'#S0XD7WP!D#AZ
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M%;-/#_[7[CC'7K?7:76XV:<2O;CVFN,S"/7R(,9E\&C5?W))R6X1A.D.=CL
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M!BC5]>.ADR&N,% 4KOA*QKMI]XI:'6\<GQ\&&VGL9:^C&=7=K>AU<[%<>VG
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MU-LYS/:'7DSR )7A8_QJ'W@*]*MW<>(_MOJE?KH].JIS:'YDO\/**5JOSMU
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MR[W!W@'^\?YP9["W^3D/E!F&,>(J$,1)X9 V#B-G")&,.HZ#7-L@#29)0^5
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MRSRF/!UW8\TKX E_YRJGL\W K:K)R]ZEE^C?B7+9+]Y%J6QV_$'H?6NYT#\
M^:3->*;-^*]I-X[!REC899'DN4<<!]B,C;3(!XH5PX5G!5W;$!0W%.,+VHJ?
MP1KY*6F^>B@OTQN1H+PX*$^<#L9*0RBWH$U[#GIU'I!V!*!L)2FH+R00-$ Y
MYXU<+4JK3E"N(927:3LG*"\,RE,F,B'">>P=8H(Q!(8P09H+C8PQTJC<.V8\
M0%F"D:SS&D%Y06;PB[ 3/H9^,#UW4IUKJ$X#Q2,GC[(6;IF'%>2EI4:#*^D
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MCI%0PN6%M:#&&-!:&O06]V-*7EX9'"_3\$@X7AB.)]:'QD)88SQBTOG8-(N
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MV19EPNJT4/>+;9#0[E"B6U&@9:JJC8,JA1;\VQ!2X9L9:0Y/FQTL-S1WOD!
M=K$YE\N1\;1 P7OAK2XTL""8';2!94I'7V6(+^V\28+X4B ^U2TJ%]92CQ$N
M"(D0-[%9?(ZX5#DOG%(Y+F)B&)O?L9 07F.$+\,@20A?'L(GMHH@H'3!7PAC
MY1$/3B,E+$&RL)[E(%^1 \+S!I5U0OCKB6:,3YVT ]CH(XLDQ3*>W]X8GHE[
M'^4R#"\G)IJ-B<B57K]%[KED/IYN#8CG7B'E'$5&8NQS2A0WT6O2T,GYN=(
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MS$HPSM'D@:ZL9XA'[I$+."'MG%) 5I['4.DGBM7IM'7QFSY1@Z0 ?"4 GS%
M#*5,THA(=!)Q']VH47?@W"N3.!"YJP!.Q-(=\PK :PSPFA@@!> K ?C4X# T
M.<M,1,X+CSAU&CF0'E)1*ITHY@Q79T2Q6-JC6"(DRQ[.N++7.7NPV0 H]H;Q
MJS&3F<-"SRUPLN8LK%4>Y7@]DO!.)^R,1/QJ*L;"<XOQ')^+G!BMM)0"24XB
M A55(>. YQCA8+^("#_;K6VAFH+<)KJ2!EY?L&],FE:!^ ^!^$SKW\@##PZ$
M1YW-W;P"TMH(9'4T3#N-N56@RO"FE*6[]U/&>3U.>Q2<KQ3G,Q4>'0:3)5GD
M6:[P2#ULY2(()"16H*/! E<AQTB$OIVF66(D:RI@ "/RG"]MAFRP=^6QS)!O
M$=1$-G^V!A>[PS[,4.S=5-8IS+08,XFY,GR:86(=Z!V"$\1-T,A$[W-[4:YD
M-%A%#LRD2O;X$X7Q*L,@!<;KA?%,W3SAN(O.(*EQRO7C+7),1T2!G"F-,J0
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M# $)[1SBD3GDB&(H,5>E%$GM]-8V:6IQ.Z>H,$%A@OMR;ABV*6<9)IUXQ,X
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M+84(GCH16&4U)UY0Q3@7$C#O'+?>2Z*B4804(J@)$4QS&7+9>1EM0)0SA7C
M%ED2!<+1<^^ (@3SV4#@1#856U7IB!]+!<_@Q,Y1'#1:57^:9<[H/*D>UTLE
MW)76YD7L1>Q%[$7L1>Q%[$7L1>Q%[$7L]?<X,&EP2E0)13@GBAH2974V@U..
M)6?Y4 ;%XT,9%"_E>@";:]H2M'@=%O,ZL!GWXZ?#TWURYB.UT9O<[C-(Q(EE
MR)J0D.&"P9+E2N9$)<)84YNER]T53G@^G)"T23(QCC4AW)AH=4B6"J>"P1$'
M43BA1IPP\42RP[W#CV<L^&@DB< $*@$G)(-<DA%A&:4A1'AIXH9QPKI/73T"
M-JO6V57AH)O>V8TVX.&F0<; ?GJ0FW)C"YN5\G-%2D5*14I%2D5*14I%2C_,
MUO$Y^=([19CP7)'D%%?*>AXUSAE8?)6V3J7F[<YJ>5/3!^R@XW1J/[WN]O(C
M[PP&O98;#BRHTJ?=U[87.X-B'2UF'?&9G,VQQT29X#T6R AM$#>6@W6$ Y()
M&Z6T=<R$?+2+W7&:HT"^UI OQ+P)4JJI$ZH0\]J)>=YMI:W2,1B'A$H,<<\U
M<M%QA(,-)FAA2;+U(^9UI\EM<"_8P05,Q/E%(XX[*8]_?37NI=RX:MO.$G6%
MGE[YM#O+"20ODI)8^" ,IY(:XJF3P(E&6(&)_08G+MIA[MZVU\51OR#CB6E9
MH7U01=^>,:5SF;.( DV@B49M$1@<#$5+J22@C6I-LI^^1M7/2CG$4K2R2*E(
MJ4BI2.FAU0^BDTR#$N,QUZ#9:V^IY=QR$KD/Y#M,NN]O/'2O\E)TEX5UE[_G
M=!>,F4XR*F1!:&"L)8ZT!@4F@D)J",<*U)>M;6GJ5+JU0+D0;I%2D5(=M\45
M>#K+MO@H)OVL$_/ZS+I 3;(,^5#EWDF+K&<210Q"),1*+77=]L5'*&F^J2[,
MU.TU/L3^ )XY?]:?:?EG/]I>F&;KC7QWC8^MP<5%;(?JFP/[*?:7KYS^A(BP
M#A[.TIUT!53X[N.7WDUE#0\F 1,F#A8""1P9:CARF+.HJ)!:\:UM@>L4S"GQ
MVQ5K-<LA>3&MIN!X13@^G,,QY21AK1,"BY\C'L'2-X1Q1 '1.K!<P18L_:7/
M$104UP3%=]<PEYZ2)%Q(@G,,IHFU2FOAB?:">NG*EEQ/*+^=@W+PV&%@8Z1=
M<(@+%I'%!N>J12!:')0-*I<R+EA^(EB^HQ#Y<D N._*CP-C/P5BK)(5E 6EJ
M#>(X-TT+CB--DI61:9\2 \V:KJK.6,'QFG"\2.G@%<31'EA#N(#]QX)]/M F
M@C31BMQ^(##$ \N=2!AHX]Z99(,D).0DH2:6M^&^<)7A@O1:QV^*E(J4BI26
M*KB_?)CM9M<L6^/Z/<RSP39ZYH7$Q$F%L L4<98$<EI+L&R33LR F$4"19CI
M>NR,SZ"B[LE,0,S/K/5EZNMN'B.5[(Q-D-)CQC%*:_IZ[2V?OHQZ@&"I8 XC
MDG)QM4@5LBQII)QC5BL,.!!;VW7*XBB8+\Q<I%2D5,?]<P7.RN_V49:MM79;
MZ[Q'TVEO7# )"9D+<(3HD"4B(IQH4,HP;2E8;<0TF5FZT7KAA,+<14I%2ILH
MI9K622G[:^WVUSFWJ#B+0N92[A(E+@CB OXPRE@DC(Q@MM+():\V6(Z73O79
MX&,(C^4>;?3B3<D3VPF-6#7@J]REW0[ JJKU>Q$SPJM'SX64.]U!;+3&IQ*J
M,P:E%'")Q!4I%2D5*14I%2EM@(Y>-Q_8J._O[D3K.$Z[4WUC+[I2T'!!/?SZ
M5HD,(JCP3"'-\U'@I#"R6D;$.366LBBB,%O;G#8%,R53=[-P7]BY2*E(Z=G[
MN<H>NO(]=-:7]?OUF9#6XURH/07J$'=&(^<$[*F*>B&C@:W4U7 3?0:I?COP
MR.W8LX,8)L4NIHZM4!+^2D"E2*E(:97I_#_L9/IBY]_>3%GN]LGULN,OMN-_
M_O*,NC*)^D0I\H93L)H96,TA1>0,BT8+8W@NH$6;6.(ELOH+J.L"ZA]R1'TE
M@"[1Z(?A>?ZP.G?6"N4\ O!B4."30T9ABI*D3*K B30RUYP0345OIU,71-<5
MT1MQ5+T@>Z7(GO=OFRB,CI(@GR1#G"I MB,"&2QYLLXFY_+)]+N!793P6J.[
MF$I%2D5*&WD^O>R0C[A#SGFOR1E/7D7K"!(R=WC2\).CAB(:$BA%8,TZFS,Q
M,6[""JR'\OL,LC#G[@G7\*CU"5VT0HB=G\H:__H:QZ].=\9:X._P#K^?26RI
M(]&A"'H?V'>"(B.\0%&)1+"*@7BZM;T3NE<5]W53X^U5L(/8..J^: "#290;
MG(W7>4EI+<'I(J4BI2*E(J4BI2*E(J4BI4V6TD)A+[ ()8L.4XNY8-91ICQF
MP0?%DO#Z[ "T9;-H1;J+;CO$7G^4J%8,^H6-G?W/D[XFAV#<GT5/I78\(F45
M6#L4&V2Q,LC$H+T)W$J+M[;I4L9\ 6E]06J"PU80I824W-"H$V4I"AT%20(G
M6D#Z*""=>-WP\=[^]9DEG'-O'8#4\EPRF2!G#49&6DF#X,IP6R.0/H-<T5]L
M>W1P>2_Z>.EBK\%(LY$]V,ODB;IN#V"#1B_V$X/I#]UA/BV=WV?RZ:![]5.6
M3+_;;H71)YM'48NEQ%GN&(U!<L8H=X09RWAP7 L>@C6BTB26SH2K;CRJ=UL8
M:S'&(M-6:8>?#C\?GFGE%6>Y#I+3%''A"' 5$4@H05E@WA("6H4V32I65;!A
M%=A94]1PV4==)MI8*.8.)>AA_')/ZYBB^RS')(=S3)(X$XKAB'AD"G$9+=*6
MPD^*1QDDXXF3S"1+-UTL-%)H9 79^P8;H0+C(D:@$K"MDO$D!1]=Q$FJM I5
MY;07;7_8NZ[HIF3I/Y!GWL[QC+$4=!5)$8M>()YP0-H9@U(,SD?IN.=Z:YLW
M#5E!3F\AF4(R#_?8/(AAEL@Y+@K-<D3CYXA&4>T) 6;AW%G$0;]$QB6!5/**
MQ:!#U'QKFS+1)/RV;52HIE#-VLPB$I**QJF D^;:)<<#)MYB*RR5&*O[F:80
MS#H)YN\Y@K$"IYBP0REY#A:3(PC,6: :HP@A6( JDWOB-JG!38-O=Q(J=E/A
MF36K-*"W2,T),T(8;G5TH.!XFCB'Y4I4LD6EJ1GC['\:>WP_'YX>?CX+%(PD
M&C5R@H/Q!-HH,KD-M]52*V,9831L;2O>Q.)V39.BTA2J69M*HZ*E3F$L&.4\
M,%B>/#@6DO<F4*&_PC2%8-9*,)_G""8J4&FTLLC8($&3D099'@P21F.IB$B4
M^=P7D3;I'5V#BT93:&;--).LY]$'DF-(CC";),<."T^XP='+0C,UH1DR1S-.
M)>8<F$Z8$84XS>U7&?-(.:T"]1B4F5S:H2D(;VJYJEX^CTDT5:K.OP86;@=_
MA]:'[?^N_AB]@>O]:WJ&:?+AY'TN;>^\U:D>S,PCUT> 0F_5("7X6RBE&:6G
M%[%A?>X]8#O7,#U5IX%^([<I@(=IP9.=]VR[<65[D[X$_:HS036Q5>VWU.K8
MCF_!H/X ?E$53'QQ:QJ^:X[&3\;I"R7@Z:^Z_:KHXD^]V+:#UH?X\\=6&%Q,
M^&7FB^/%@*=?L0Z><#BX_RMU$<#+!FKH^1F9_3,_<<5..$KIG%<Q:LQ-HD9S
M'S51)FG,8A1GA(NMR;<N>I/7N++G$;E>M'\CF^ M?[+MC_:ZO_6O^<4)*_.+
MR:_/O*D[Y^W@Z'3_US<[C5<'+_=/=@_VCW;W3QK_<_QJ[^#HUY/&[O&;U\=O
M=DX/CH_N76UU>9.CXU-X]--C>.BCD^-7!WL[I_M[C9<'1SM'NP<[KQHGI_"+
MP_VCTY,%4/7=;WL?)+]WT>FM^\EN#,N\G&;H3U3*TV/,-'G1&&LE1\-+N(1?
MP>'[>37CEV$?[MKO[\6^[[6J(Z\[G?"+[;?ZQ^EU#\BS,ZAZ(9W"77]I@T[R
MZ,K'^8WR<?CKH3BB!]='GP^NW_WY#O_U_C=0//[^>+3WV^7QGV_Q7[_N@P)R
M*(Y/#/[KWQ?87_[1L7^:X?'[MQ_???Z;O7M_P [?P[7>O[D\O(1G/-W!AY?O
MQ%^G;_Y^=QK^AC'BWY_?DN/?S[@ [0 F&!'" N))8&0-$2CP2'QVF%.K1DIB
MJS.,82>K>,KB1%R [VG&*;?:&RZEB,(+ZYT 6<"DVZN\UGO#N+7]R]N3@Z/]
MDY.)WC&6^3>WZ'M7[>RFG6L#M]+U(VT:>16/)Z=:3:,U],T)VCX8[>>-5ZT4
M3WPK=CP\T_^ 5@P[?[^QV^U==7NC"_XC=R#*AXPH_GEWI!U4_R(__[/QT?9!
M,_#CT: "M#J-/=BB/V:M 7XF1IL7C:Q9C+_9;-C&QVZO'6!3B8UVM*"BY8&7
M,615"W3ZW ZLWVRT^O!S_EV^ZJ#;:+<N83L'K60(3]H;6-!'KK/.W^@/>^<1
MM!!02$!'/+^H&B;!96*[>Y4UD&8#YG@(9L6@*FK1K!HM@33_CM7E0)/QW?X
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M>:$P(216R6U?)"<(KH+FD4O->4J@9J1(,-!1XE1(HYXJ\YR^V=G;G^14G#1
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MWV:W/YZJ1.E4,$8XI5AT4&B"Z-I@1Z%N217L2 *[36\YUT:>HK9@BI4"-9+
M^[VZ:XVL1N?%LVJH [>Q%X#*<JG@<9] 5]D*OJ-,7!FT^6'"<C8!;=JLDQ[/
M0)L*_C-CDRD8!*!KV;7!WW;&%S#JZ^!J FH5&6L=")">S"IK=3D4*F^^' KO
M?\A10W]'*D..!XS&8#]KR2*54I6!4AI%#H8W"K^%"-V'R0PF*.D/]:OQZ.P5
M;+2TJMG)^$]E+0ZP*_03/H=OTOZN@'GLW\#O5_V3=Z<RR_,\U9P(E4:$AK0
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M_9/]P_[Q/57'GSS!6U7'(U7-AM82'/O H?F+"3B=J-0((^91Y0.5;D%]<TK
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M@OZDA@THK2WH,J4&M3A8\6C?8:-K :!,4EJC23L7,K2:%HHA]WO=4&G:G."
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MDUP3*EA!2IF4)$ZC1,)AEB)/D$DL=E%L:&+BW8 VDK1H(GJOQ@JH^E[MES)
M<%^>!/0CF]CLF_F=L,\;\Z"_^_;F-$V2@NM"$$US2FB>2L(5CTA1QCJE0L9Q
ML9#$G^5)F48YQ[:J-&.:I6G)6%H*IGC&V$(2_V,Q;??[.X<'>\')]O^[?PK
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MIH;4.+R!S?UG9F"1VJ@,=0-GQ+]APOP*@]>SD3E-L.'*'"3S!,-Z1TI)FX^
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M8_8-0W6]T7V1(9MZD5+5 ;"F%TQ;N;9AK<H*(5N)B&F_/A&XJ1JOQV%1!>Q
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M(LMHR6F1Q0FP[#A4HBB*L-S0R@^B%7C^:1IG61;*C$1E(8&'1)*4E DB2IT
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M%K5_N"@*_\N3ZAF<^JEEZ;;R"?L1$V^UU99:B[H"%[&#-?E@Z7.1[_JZ?ZZ
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MYKS;YP/04R;B_-IJ.Z[-O)<5Y@4#YS8WX@2MGE9-P+7K:>6TV@L70P;1<8G
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MR1!A4C'I(B,F;KRD6]?;C\X) %U. *P2. 0)-\2*1VV-! _ >J9#8*3 ;BT
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M_J"1MZ=Z([B4'_QZ#]FXUQ3\=+SZK\S@Y&O.Y/Z@Q1T_9GG& [,3[$E3$""
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MVWCSJ_3NNWOFXUX68X;]:9;QNQHR+*8(*V9)#5><WG'J;,GV[ &[YTW=&&
M@&>)GW&&P3:1O[7GS]-D>E*?J#W/VHD$=$+GV.ZZWAE\[/R\WS/N9+/QY:3M
M3AKMQ&;Z>4S'E0M$V_^;F$ 3CR-\]G/;YQ3[>!SUO6='DQAWTP@FA+\E#6KC
MW"3Q;Y^G$]\I8^_*CB%CNCMG!B>-V.E]&4RN\:4WZOC&<>BF?!1<'E2HT8:'
MZX<ST^ZF)QKE6BN(T6+8:KQ/#U9=[JS7#XW$@ K0[4S)J3$Z.R]OV>Z>A$RT
M475!F:8;SM_O#:J)G$Q)^E;:LRQI5">+T84/38T]<6<&F-=<D#3YJ;S8+^UZ
MVS-_K6Z>L0FZ/\AW'H"]@!_?_5]S=O[;3OXU_#@(G5RUF_8WRME,/U5OIE]^
MZ?4_Y5^9\Z0F_TD&M-^VHV&O?UG=VIV :(?!KR61?%[]\WX[S:IO#W(FO9'G
M>-A+MX/527.3(2_]ZCY].V8WV3@M/=GS7LE)^*(?.B81TTZH /\U2]I8J2&>
M?,580-G1\.:O+.(M_![J^;J!&A3/3=+4WR?C+<AS<QR0[0?S"9D( WYA.E_,
MY6#C/[/ !!@T-X^K,P6+.YSL[;=V_WBWW7BS]WKW_:N]W?U7N^\;_W/P9F=O
M_X_WC5<'[_XZ>+>=>E_<B,:K\B3[!RT8>NL !KW__N#-WLYV:W>G\7IO?WO_
MU=[VF\;[%ORBN;O?>M_X9=QQX]=KCW6SG;VEQ\>=/3OF>GQX[R665@4A"+>R
M,%(9(3&#<-5$0HH[>GRLK+T["R:UJ,E8U6\//LT@=@;4.!JF#XR1%T8(6G6V
M.:9.'0QJ.)\ \/_]_Q0E\K=!MA<-=^GR-G+)+W\.J)J)L^$Z70]H?W:>O,F:
M!#F#:&8J25>;O^T#FXZLU)RWIAJ,C)+M-G.F :;RQK@-XBN;&(\>(73;VW\]
MLXT\6X#=652 O5.-\QT,<QQU(?I,PZZOH$^^:+8^'='@J,),H2@"08 D$6E!
M-9*F$%;1P(-PJ89Z00^'?R5C;_K]I <5KW#5WJWR\))#,V8;[F?F[GG/,_/-
MQ^Q"9/6M1*<?0&$3S?<"?[#T\TJO,'T?7*=N5C;PE\#72]WE.M,]($;=JE'$
M\+)VX28:"9[-:<B/,]AJ[/>RX]<WN3D..(*)3?P8'J];.K;IJV5'H<OL84TY
MB5D'8# P 3#6$HMJA8!W)C<T7=.Y'*26 .U.I]'M96>K>PP.Z>MRMI(S.2Y-
M ;@8P.53^<IP!,\"TSOJP+2E?AF?#?AK4TYKY[(1^[VS*6^S^G353FPNSOV1
MHKAKE>TK_7#W!E;3R;WQ8"6/JP=L9,>X%+7A0H;^ZHT[6S5N->I)2]%<CE(N
M4IN5<80UTQYE.&F>5 96Z2/=26YWFG*_FP2O H+ZRDE7LT#F&*:RHA#%#"XA
M6CMNAZG;IJQ:F#3'2!]--SD#T"AC%T 5!^IRT!V';Y\"B#YH2*]?=1(8AS1A
M4$](-<*Z=TP]H:5%!^.54*P_1JQJ!?X]F&%*A^_E"=^LIRQ1DG7+HC*8GZD>
MAF7WC>F3D[DI1SD9[4'V% !Z_,@-E^NP.;5LTW.>XO%2V\L1M&<'#C\"<".?
M.GL,,_RF!ZV"^[1M>3[J0R"5NN0\V#=9&3"8JD]YM; ^Y9988G5T?YR.&2PD
M[)]+I-S<;<O"<U4IB7&2)76BZ=FJM*,:4K;.,\D>&$)2"E]:E5IU:^LRJ!1G
MZDK3GG06=Y#(VDCG1I_M3^"1G?3JGB G[?"YS$V,!S\UW+)AT]1C5FY^OGQ[
MZFFF\S;M[OEH.,AFM6=A%3[GO@25<E6^1!KW\&0TF$8ITWB3LCJEB60SM\JI
ML3B7%YL:%HS>A?-A9B'??O^JH2@NAU[J8QK5PMF>3F'U9YR%\C8IKS65> DQ
M)C\EN5K=;G(%VBGJA=7(/M-68WM8!AOP4+U^QI<D)ILUEM\E':4[DINGY,?*
M%F9A$C%C=W99\B-/O3.Y1';H2ERJA"JEMLIJRYPJ&O7S2%):/%]_,(1_ZA L
ML036,O!J<J?KZ<-[/EOI+E7PF(5Y:OSCJ*5L4%R*=9K2E&B;O3E,1IU8*SLH
M3_6TG=.+J6_.*<C88UQ&0])[X.ZU>[.-]<[-Y=DUK=GV8,A@FJ>&,..H#F$H
M5V47G5OG;VJJ)\_FLN]=366Z<K?TNLT@W'G!*6$KH</U^NGY>]V<XRQSCFDF
MJO6'W]4.[/+0?<>6Q<I _O8@QS8+&A+--O%L#^IF266882Y+?>CU(<QI#&#N
MPDFO W,]&'LIWZS-8H[!UWT6GZ81'6V>[AT)S+&*TB!8E$0>)#6RE# 4"&9"
M&&4<DW<T6ISMJ5A!V0U-%"==$Y=M>NBCXH4V,4HKN'?"8.>\DEY@[22W9"U
MWUZ #G;VCB@+!69,H:"H1YQ:F<Y\4:2I$\%KX@-.):C7RT_'XC/76#/O/<T)
MRG*2XHTK%(Y6:,$E42H$47 6K>$V%,&O)>6;2PJ#:Q\%IKPR)B!)HD6\, (I
M1R7"UME"\W2T(_,EW=K3M7)KP%OM7%;9IP4)XVG/Z,8@!"P8+$AJ>#D,R[J
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MUQYU.J.SRGG8S*+_N3T8P<I<5;_R;7/<[<$2N6H#<OSP*1V2;%0WP# &,,@
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MW0&,O-0Q2VP(Q/# A;4*'M9K&@T6FHGEVXSN.ONX(-(](-+.<+==(]+NRZ-
M&;P=(5$TCB N1!Y!QS!2"6NO)5/<J(T7 B^=6O"88#31@_L$HWOR*A_3L;Z=
MYDY&U,B*>U</X5;^L(OW^UDWMA@N*_<]*W>KQ-CJ*T?OMG)+/8GU<?Z7[NQ=
MS?\75UO5BOZ<WMC;G&V\:V-9#UZ._/V71S(YIQW&B!J?9YP$ABPF'(';+[PR
MA@@J\SYOO:2%[I.X^4\@\?_?4_ =MR//?DPFY);/WFBA>7".9+ZASLT4R=0F
MY:DH)9;0Y,YDR<&$,!%YJ%H*%CLA+%+2<(A/E$%&,XH\O$\K0^)"T_MF2VY-
MKC\&CW+SS13X>U[P]].#TS(9_W+9"?Q4(.\1?,:=B<^HA-=.LX@(31%QEBRR
ME'K$(O6,:.>],1LO%N<Q_=PLC+MSYFXT-GB-,G?D7C)W<\^]4KB[9.W6/-Q=
MQ+'@@W761<$5YLY@YZ501'&FI=(FEEQ7([#L[7RN2RB!O6,!4:8 SIS$R-K@
MD;3>.Z$YI5;>F_>V'$,>U$=[<O5=D^Q0\,EZ9H)T5/ HHS/)0TB&*9<^TEI]
M2W:H$3J\.YT=BACBYA 3TC%BQ(UDR$GID>80/W.KM,*D&M-['^FA[]+?U=)#
MM]7?[W-=FL?3WTMZZ+DNWO>GA\K*K9H>>G*#VTA_>6EZ:#67N:2''I;=O$P/
MQ3SB4E*'F!,.<4H,<AP'9"2\N6BI,H3G]) 45XU??F3/>&W20P4D'C*H+LF1
MIXNNYY(C/!HJA ',4#R/8<,46?@=DBF8Z,!)5[Z$U\]"D5<)KQ$K*OL(%O^2
MW$]$:D-)0!9; =%T$,@8"*Y5Q!(T6'*C<C3=$'/_7+;@W ^17^K6;@=53CDL
M! \^&I!WH:PTQ&M*$TD,<Q:_9PA>80+O%;P^S+/YDM-H"=>(1D_ W> ":4P8
M_%,Z1Y(V1ME[8P.;MW/EX75X3=A\I[6(,1"7B./@=CCP/30UFB@JB6.FL/F-
MT>&WTVR^9QQ>5Q0H*F(09\X@JYA%,I)<C2I5-8BD"?I;-GO<175W;=\?MZ@J
M&Q;NO'3S3:K*ZJW*YY/B-C\LG[^:YUSX_(<EY*:V>U#KO7<64:L2XHI89%-T
MB!BN#3A+\,ITYO,AR&^&;[PV?/ZS!HF[5/NN!A&EVO=18^HY#I]I":C!%!+>
M9MC "CDL"?)*<VP)$U*PC1>&FN^O^7U6L?3:Z.Q*P731V<<U\Y<DOJ78>*,@
M?M8R(.XC159*AV(23*I@G!1AXX70BT;^2?2U5.*77..]DG_:8IF4M4D2P:V1
M1B?'%:628@R^ABD$?F. ZW">P,>>,D881=D;1-RQA%S0%"FBC 4;I*,"7X/<
M3[>7YU@OL"X$/L4Z)&JH2I)C)G7BW*2@+''6:<H+@=\8'?XP3>!GQ.61<.13
MP(BG:)!FFB,1,8Y!!*IP;(;^EG+\E5AHPDI5^=U9:-NM]C+4#+XN:[=Z_H/2
MXCL_+(N_FOM<6/R'I>0N6?R@0W3:>203Y8A3[)&-3J*4"(3]0E#I\@;\+7A'
MS7"0UX;%?]8@<1=&<#6(F&$$5_#2"UEX7S'W',$OA<-8:X%B]."T8R(0_(LA
MX0(GTG :,""*W"1+]OG<GC)\CM'VNBCT:N%V4>A&*/2'6?8_<.KA#:($@ P1
MN%7(:2Z1DD)A$[SQN82.;FJ]&'\_B3*7 OZ2L+S?O4;&8.8=8> ,<QRE8<):
MRJ.1"KP5JPO_WQCH\O/\/W<D$/ JD74,T$M(C@Q/&@FLO?06\T##O?&'S['H
M8$WX?Z],"(QSX;GB1F 323 Q2.T$$4':PO\W1H</I_E_FJBF4B44G>.(6ZR0
M@2@"<1GAMZ"W.M)FZ&\IX']\_O^YKMY]\/_/=>WNA_]_<KO;2-]Y>5>>E=SG
MPO\_+&,W5<4O/%6>4\08<1#@*X\T(QA,K,]#IET2EMT3_U^J^)\/2-R%+EP-
M(@I=V @T\0O\O] T)H)][O5A\Q@8BEP,&& %?I8Q>:)PYO\Y%LTH&2X*?=]-
M^%<*MXM"-T*A#V?[\Y.$K6<88:7 /0A)(I,81YA1IYR(0>693M_+_Y?Z_U+_
MWXP89A',9"!>8L7 '28<.ZN-%X%AHTRD3"A:^/_&0->G>?Z?<D-",@EY@17B
M-&FD/4N()6<\8^":8-V,=MYK6I&P)OR_EM@RP5B*$.J:H!RACL:@K1+>R$0*
M_]\8'?:S]?_.@<1J1(4$_27.(.T2!!48?LT)#<R*9NAOJ?\O]?^/UX6F,R;_
M35FX%=OW\.(T/RSQOYK?7(C_AZ7J+HE_$QQAR0>$,U?'%6'(4B<1898*(22F
MT6;BGU/6#,]X;8C_9PT2=^$)5X.(PA,V DT^+1#_GD9L(S9(6@K>.KQ5Y*(U
MB *6F"@# V]^XX7:5'1Q_GLI_/\1%'JU.+LH=",4VL_V[G>*LI0H<M)+Q)FT
M2 <2D0\8$^<C5X)OO&";(@=O35#F4OA?TICW2AH*G(*@WC%,(@<[9F)T*3DI
MB?6,,E6(_\9 UY>%SOU2!QV-1]0;FH,;A6S0@&/81!T3(TFGC1<-J!M>TTJ$
M->']DU':<VN]E9%SRYV+T@:KO&"&2EIX_^:H\*=IWM\%G@+W$;'D07TIC\A0
M91$C3%,MM%><-4)]2]E_*?M?&]K_^2[<]]+^3VYO&^DR+Z7]5_.:"^W_L$3=
M)>VOI66.$($DSEW["0_(2J(1,=Y:Z3&86'=/M'^I]W\^('$7EG UB"@L82/0
MY,L"[1]]4H(F@D 2+.+!<N0\\<B(%"5+QC@C,U.HE&Y&B7!1Z'M6Z-7"[*+0
MC5#H3S.T?]"$"1<)8HI#Y.V)00:[B"BVB3&I69*Y8T9SE+G4^Y<DYOW6^VMA
M!#&2<>4X][ (E#I&-9;..&EEH?T; UVOOU9\805=;RM?A+JHO=88!1(]XM8D
MI!V)*' '[@BQSN:)X[0!!<-K6HFP)L1_[B9*,%5$0(C!?'3@?D0KI:'<)!5+
MP__F*/&7:>(?1VHA+L1(2IRW&\J(G+4:\8S$BG/&:6J&_I:"_U+POTX-?Y[K
MVLTW_"EU_P]=][^2_UP2  ]+V4TU_ _*<N$52D$)Q%,0R*IHD/*!)HN%B-;G
M!  CI>Z_@,3#U/VO!!&%+VP$FE1!]\4X\-X_>'EQ1&0*A'N,?*[^YRZ7ZW@J
M48ZXO:,X.)[;=,I-RA<QI53^_P@JO5K 752Z$2K]928%X G64OB(M-:Y^$XF
M9(D1"$!:Z9 (Q9E#DYN X<U0YE+Y7Q*:]\H>@FMB+(E,:!DX)SF?B572$C1#
M$,)*"J YT/7ZVWP*($67FX9@%&EBB&,ND38\(24UO$Q.'5>@Q$H\>>WPFA8E
MK$D&($46M0*GE/+ *>%6&6YPB"Y)Z[T7)0/0'!V&B.+2_7 AT:1 8;&, 8$O
M&9!U,2+GC2'!!H-Q:H3^KE_M_U.J[KX?]JH$ %[3KO5/N7B7I?\4EX5;L?1?
MK*?/W$A[NY3Y7\UM+LS_ W-UXR*9KT=",(NISF-^F0+7.&?7)6%(Z?R:K$]1
M@Z"Q+4H;8EG7AOI_<I18%YYP-8PH/&$SX.3; O4OC-&>@*/.N -O75.!C.$6
M&8:])_ ISATZS:9FLAGUPD6C[[OX?Z5 NVAT,S0Z.P?G$P?!615Y[O*C 9@1
M=^ E:%!O))UW@EKEF &S+#:5*-W^UXOZ?]:)S#NA&57<\$1LPER$9$B>8T)U
MD$$Y'TRA_IN#7>?SU#_QU-L0%7)4:<1#L,A**9$6R5.-A<->WA=U^!R+$1I)
M12SI0ABPQ\&S$$GDQGEK17(V"@T!1L!U6]%"_3=#A[]-4_^12"]9\,A!?(C
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M?"]D]^*MV,U_;W\YLISF:$@BE6)"G N,G/,>41)D$%%*3]/&"[.U6'M9YXQ
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M*CG;^;K[^>61(=%[9S@R7GO$64S(&!R1=Y%'07G4 >0,WR1F&1-[($I]^ $
M"K"O&X?YEUF\0$@JHU7!VV (?V71R]+5.XW]"C '6[.F8LX"U>_)>&<9CXHE
M[+@7&#2$"$RX(-%PFD@MCO"=&%YFT7$V:N\E_(DI=\08;@5F&$PZ5HD&MG%[
MDV2:9)(.IE3V.'9"M<BIUP%S =[ O'WI9ZN0C<P@FQ98]''58/T"ZT'9Q+1^
M"G &VQ_9C4']\GIG<*-A\/,OJUGR*Y>M\C<F?E'MX/A\_=-!_&7\PZ_CP17M
M;K4(U9?FO1FXS*_C6?=X"]?<\XAT&9U_]/%6]=&<3U9_1LD6E?K*C_$66?$S
M(\U*W[SN9HG<XIP]P,T*=O5%G\7-ZBTJY)K<J]S"<K5UO7X%C%8/L ),\_L7
M+;RES>UN]@8FMIGT\;,Z]*:I[0][@VLQP'Q2[3\VV<MFES_)6[M^N/5:+.[K
ME*+/X4%K&_RE6R0TGN4J'4Q1'&6=KEZGJE"I]>Z>5FAA?OV5*/GCK.#+":$U
M)HE:-4OT2"*W7JN5N8Y617:T?OJC;5V[TQZ>_[S,/LP5*YA'+U:XE8B62ZZ,
M#<U^RN=:N5QV$)?NN@U?U.LW93]FF<:/6 V?BR*]TT8JSSD1RI"HB&-:*N*-
MTRSGU8@IU?!5WO]B;WOO\_[?>\<?/W_ NW^_QKOTW?'AY\[GO8-W7W8_?SG?
M.SG\"O?_^?#]?-Y_%X[=%8?TS<G>P=MOAP=O+S[^]J:]__<NV?OM+=SO#OWX
M^27=.]D[_M_%[G"OC:N\/]POW_MZQ*VF BN"@O4,\>0H<H)II+$-5,7(K5&Y
MP:XJ#7;+YN$'VSR\&E24<OBG )#]]Q, H7LOCZC7*3+'$8Y,(*ZM1$X+A@26
M,FI,A.9NXP6CFTPL0LAZ%\-_QS;(6Y=(/JFSM% BN?+C_CB[H@.340D9C7!Y
MYABV.#FEE0C,6:*QO!JJ)H4>S[6V\=$@:K>N:P28@F?>_G04E0Y&@),C4N2(
M@U5!AC&,"!5)4,N]KIP<?(NZQK+ON>Q[+I'>O/M&E6(!_+1$!&<ZV13@%TDF
M@$>>I"F1WN.CX-OY2,]0$P#M)!+10:2'\_!,(@BBS!LJI=8XR=PAF)5MSV7;
M\P-M>UX-*$J<]Q3P,1?G)6LDHU8AH> /B-(9,CH&Y)3"^6TJ)DVNSMYD[*K"
MV76-\\JFYW+H=8?>4(<T+ND%A8C7G[T<N9Y'%@%X\B/+*WCF1Q8!>.9'%@%X
M\B/+*WCF1SY7MKK4NI5:MX8O*B4-)G'7/@.B'9>14<:9CCSXY)+T(29*B5;6
MDE R((]/8;Z>&I#XZ1M\=A0\CRDDB9A+!G'M/3)Y'K2U41-C".<LY&(W78K=
M2K';PTW*6 DK2A+D:1#DRV4ER84_4LH0D3N&6,$XXL1+I!T@B,(Q>$*L(R&/
M6=6;XH?+@LSI<!F4,5%HK#R5U%#IF>0T>&-\PEQ:ZB*E2KE2$M8$19ZTNX-G
M^("/*#.:>?  :)"Y;I5)Y"0.B&HG*"&)<EQ-C3>E)JPI-K;4A#73Q5D:$8$Q
MC(9'IQCC/$7NK&712<(BH3*%*^ID2T3TH#!X,1\1>2D\$2FB1 /X,_D/RZ-'
M20;I2;3<49&+PK@L$5$I"GN8HK#5D*+$0T^#'[/QD $7*N9>BI)2ACB7&O!#
M">0)U2(Z[;S3&R_*Y/@&5R^50Q^T*NS9>>DE%U9R80U?5$H;[+NN?>1G(@U2
M8>PE=SP8;JP2C 3FG9(DIA+Y/87G1F8C/W_$I0J2"9GW_X#G%HA"UG+XIZ',
MYLX/@?N<"S,E%U9R80_7^&$EK"BQW],@R&7L!_=VY*(1W@2.G'(<\40T<L8R
M))U6/%CXV3A $"XVQ9)1JNL=_)5DV%5L#@5IP#9)FX+G7GDGG!,!,^/ W'#+
M2S*L"9H\DPP31S%BRI-VB"5A096Q0T9(AP+V1JJ(G6)IXP75)1G6&"-;DF'-
M]'&6AD2*N8!%($3RP).W#DM!DS$\8D$-*PT2G@(&Z7Q(Y%C0VH?<%\%+Q+5P
MR!(CD)/)>R:ILS+D9)B@)20JR;"'28:MAA0E('H:_)@-B$0*+#J#D2 B@1>5
M'"")E$@H2I,207N;2XI*-JS!69MRZ(-FPWYHE[P,AB_G6-MSW/2],AB^#(:_
MY4S<3/8EI6.2DA/B70J!V"B"P928<,W^EL( /I+KRF<8P(M/WXZ<8!3>" /?
ME0C$+?7(*:T15=[K2*1(DN="KELP@(^A+JNZNK<:_?Y=P^"OGIG[8//A;SCQ
M2)$YW5("3G/:&[3S4_W2CYU*?RYGR>90=>J+HUO!EU^Q#M['V?#JKRR0=H^/
M5]6\X#<MU*)R=DFF_SSN7WJKGR)R_6B_()O@AG^QG:_V?+#Q[]F7 ^]A;AV;
MLP0+ [*J)=C9.WC]V[N7K3]VWKQ^_VKG]=ZKU^];_]W_8WMG[[?WK5?[[_[<
M?_?R8&=_[TK!:<J3[.T?P*T?[,--[[W?_V-G^^7!Z^W6FYV]EWNO=E[^T7I_
M +_8?;UW\+[UTV0<]L\+CW6ULEPS@-LR*5DV:)(;SH32U@E/B%:2)$*-F1_
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M^0#,_F.#:XCU0ZN+F-HO >X"5MG0*NIG\!_L=8_A84+_UW</,S]O'-K*;KY
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M87^[V3[XZZR>^T+J9Y]%'?I?;]9W;.0^1.>039&BO"D&,C0F9"FEV$N'F0=
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MH<KZ*)C1S%!Q \TL[W^&[W]K?7='>\$MUQ8IH3#BBEID.)CBGHNHE73*IVR
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MGJ81<BEWC7)A%1A].-F$N$HBYZX1X'_:!@U6H?4VYZY1/(-U7;-0FZ>N"%1
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M1@<[L)-.BBDX'CLV>JW^P;D?I&HV"_AE6;LUWC$:.4Z'E3N.NOW*R?&N4C%
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M&(1VC'='-L>36]"[D7GS4_AL3>/@V&P=8W6WFL\!,+.RHH']9XCU%44&[.[
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MCSSA:(V)@0DBB-0A^5#@YP7AY_0<?ICAWKD(H.-T1%PYBDR*&'GF(L-)$^N
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M(R>X12FF&%W"3LBA6J'5*XS>>.6L?A=_P!/R>N4/>#;6GO '6.YIPHP@G((
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M*9^C*^V8J0R\Y63H"1>?#-1XQU'RN<5 Q!*9E# R/FF!+=AZN<4 XZMJH1*
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M>5\TVB=-7S"!UXK)B<366),X.X%9E"/"6$ !I:^KB#]M:RBFRGG +"<K\&4
MG'F1DI  Z3)PYL$ _(:CY1<O0K\#L#AG[L!'&8/7@'%'MU]<"#>NEK^-IM[O
M 9F>P]QMT8&GEUQXTFD?#EXH\V6WV.^T3V$!,G<#[\.%[3/; O[,'^3KKQ0?
M /,@;BY)$*$2%M@%:CWAU#@-_UB=I)-8:L+L0()@,$4F)<AV_<.49_P&(V#[
M8J/SW]UN_NWS8-J?8=9_Q4YV+=G]>"$Q$'US(J.6YP(BXY.H;7I>/]_88]0R
M13A!.GJ"."4!.4,%HE@2 5(])6)7UL4<<^&_,V'T[*]E(XJ&_541Q%4$L;NG
M1;*:R(!8PB9G*%%D7,@M$2/Q)$=8VUQBA<^CB!*_;!&RXM8'Q%TRRM@<SKLB
MC_GDL;-9V^/*>*430[EL,^(F1J1SWSYE711@#RBMRVY>:[-=^OY[($)!TO6/
M3LJ:5T6_"R(').](6 Z%UHR@O"S)00_M]ET665D"^X-2CI7$!]_ ;?Y'EF_[
MMGD,8O.@V>VU._D4K #=M=\"2>S."G@ ;&X>;JWXP^9YM =JP>B:H7(Z(X:G
MI6DG9IT![KY+^6L2,(V)29<"YY@:++%67! EG)%*YAQ0('!5YH!>0>F74T*!
MDTYA(J":7S:NQI2^DV:XX())2F?.U>?)^,V3_H\]Q9DPE%ID'<Z%ZY5$CEF!
M8-\<MM0(BL/*^G%[UK2:(%T@U[D4?ED5? V:^U^==N@#BY9'T0,K:7"\,.U"
MG*//EVP,O!9+=;C9#IE[07._A /7Z^P2%Z<',8,+7 O\W!D"1;<T2IL=WS_J
M]O*=I5<3GM#+>K7-6OA@'O^W6WC;Z9QE6,H %0$TSHKC=B][#S/C_XR=?'@^
MP+7)38:IYYN:QS_;K6R)^(P6%\K[Q:#VJ!230Z09F  PS<$O.5S@9$0O\.+1
MVW)!^L<C^0I_I'ZOW\DC=@^*U&J?=DL;(-]1OO7TXP;O,/6T^,O'& ;6R_4#
MK\X;JYE?[;C;#+$#]^25F5B6<L,G5B7^ B"&"6X<3W[::H/Q!.,<1=OMYU'L
M8#9Y9MWNU&QG]R,_JC2M$@PW^&P5KFGY0;QAD5T(^\7UZY7W+N]//W\_9V+Y
MC?:/2XMI:#@.2') *[WIG6][W^]T;\N\<H&9=W-L;()\:1]?LC;+\\)2K&64
MR]*TG^"7P4U^U(A^N'LGG>;/S%TM4!):V=@L82$_,Z]N+$' 9O)IILR&I<W<
M:1^5]W[8W"C**)CA;(XR2W3B43N+8YAQYV*\BUMRRSM T"F#_4).VRGJ T3H
M#$S@N[A$F=2>:Z=@!R+74AF7<.*Y*Y&(SM@T+.+ AT4<L)P6X'?RC5XGOC^,
M1?<;]H-^ KOETUX*#&OM!4K!Y\X3R2!-A4"14L65#B&)TI#55WL^F\=S/#(3
M(<LC_L^0ER.Q2H@!$=*+ ]Y/17ODINX."KL./$3E/2.6F"SX.N=Q_C_]9D;!
MDI@;6]O%'\UVUS=C%E.K@.U^K835_$TMEF)Q\.%O@ O9)P6T ')R!;Y?^4<1
M ")+;OG9[([!;^CL*6?I)C7?"VX&+C]J'I?3? UZR&38>7D(>-R-Q6_-T3G#
M4 SG+3N!"P<X[]O=WM S-M!ALCSMQ^X_2ATDKU99DJ.(QQE4KCIGR=P_"K#0
MY?'G76 F:9-DRAF.A'!CHM4A62J<"F",XR"&=@(9V@GSCF"FL60CY(W(Q/JA
MW9D;C/_VT&.7U,]_[$DN'2,:(^5RK6Q!!+):,?B311&TLXJ";J_X'+-V?$I^
M)Q$2<]]K(CAWA N<M"4I* )VH",QX3BW#E"UMW?=VYW&UAY/2@AA*0*488A;
MZY UV8,1F&/,*VY$WEMZG6C(/'PGUO4>+!.K$K.6!\$L]DS0Z'*YD129+K=7
MC[975]M[K^VE8)KO60S&=\RMY)P#P8]=0,9RC["/RAEO>(P$MI>LS6;"C%FW
M$[LG(^F9+91\4C0M^T=RXU(<B3T!"?$+M@W4VSO%QX&VS*,/A&L!$,!LDC!U
M+#P@/8Y>7GVJ?OO$JXGI;PUF7X?G-\I0EUH9Z?*FB2?[=&)B)&J;JR(RH"!,
M$N!^4F5B%>.@S5,O5]8ENT%MA+TB=\/_E]G_7=!9&J?MM[SMK+:YOT=MY)Q@
M#,:"H[G';$1."8NX-@ZV@4IB$VP[69LMA7EIV^G2;/M!)\:WO?&'?H\YP0RH
MSRBI$'-WJH LTQP9+K@!%2S;\[#Q>&TV$?W2QK-EV?@/[7[G3>][?7-W3TIM
M@N *@2Y/<M&W@#2F'@EJA;'8",I%N>_TIGWG2[/O<.W;WO?#3WL>$Q6"]BB"
M38<X\P39$"G\T%)XE913[';[+NYL [S,UF_DW+)J_V'_=S:_[C%-#,>2(VP(
M!KO>.:1]4,@[(572)$:G5M8%H==%1.8SJUCF[(%I,&D33/B'>M$?'+=;[?VS
MH4]M]E"KU^[!7MS1CGQL%]"@($X^W^UN'(<OL?.SZ6/W2[LUOSC#&Z2;,@J&
M 8,RHPTR6AK$4\RXH1TR0D9N R.6\Y5U+J_1$U[8'U1M](T;G0U )YR-S&,$
M>B$ 1)(!]I@'A ,@M;-@ IH &WWMN<&+.X>JO;YIKT4-A('26#NIP+I/)BO_
M'*P^&AP227M)393!@#(@\'56W[V]_],^IM7!X?AD.I0[FPHL&B8FC<XA]O/F
MEBE+ETYDKLW(O_\9S;SLY3QP23@X2NF<5S%JS$VB1G,?-5$F:<QB%'N 5"MW
M/?V6)T]?KW]^VK=9&]9NN*9N_[T$\327-CIEB,/9EU[;_VC R'^TX)>7YL7&
MQH@7:>WC[EFML<]JYY_([N$6WMG<XCN-#P<YQ:1V5#O=^?CA1XU^.MN9*8J_
M>PIS K[VY_7-OYNUQB=XSKZH?=LZKQ]NG.V>;_#=;Y_.@=?YO\_W^<[&'K82
MUDB!7I84L"(&V+48S#-NA(BY+IS3?B;96SFC9.#.,\J)8"X9G\_@G938<,]7
MB@@ =Y+K"73Z<66]\7EKX\O7S[O%E\;.^_\W6\IBDK3G9Y;=], [$?<"G8>6
M834WIH.7:N\@Z>=*X=8]L !@3V3X3#$,X.)1^_C+\'F+(LF>G7MJ>(\20PE.
M%)%@+.)*8F14(LB5F?;)"J, ??G:;"'<*8WE;GMZS[I'U9[>9D_'2=R;&[FT
MT5X,0BAC..(ZMPDQ5"%K<^5,$#P\2B)-=EO0Z[9XL(ME!-9PR0%F8,V+=K^7
MPQ[+R(<R9-)>*!DOX=V80Q!_YSB^-TP/6[_JG_8L#B!B6$">9KE(="[6X"GB
M@0:1J)7&&B !)M9F2U'=VS)Y0BY_\YMZ7ONTQQ5+43N,/*$QMV1WR 3*$ <3
MA%).O2E[CQ!S#6>#Z= #GAU(^!S0F,-M]^. B4]B9\#Y-[+S7[%3 N_C.ISH
MM92P,8QNVQA,.9NMXVDL2J;!\U-&5HAU8H;E0IY>NARDHG!F=X% H!.>7&#$
M"!#J:DW/"6.XD<VOV.P'.IVJS7Z@K(?Y[^^1Q#PWGN> %5#G,.-@"IE\6*&8
MU,X'KQSL/%F;4QS[4N#*'<+.%\$8(0*,D9WC<?D8-:X>$XL_VK832D,%J,CW
MVIUN8?N]@W:G#,6?=)64(:XG_8X_L-U8#)(F[B3U<K2'X8: LL63QR;DCIA*
M,PNB3[L+52;7'[LZ#>OZ,.Z2)3Y?S/*O3GN_8X\V+EYHHXQ!)6]80%XD7,'8
M&[B^^6//6Z.I90R!S@O\D'@^K"<:J>"2#Y90%16H0'0V)G-@TTY4M)@@E__Y
M/YH2]7N9E'.4%>6\,X-D@9/!KN1":.W3[C4TEE-.1@KV20X:!NKJ]D9)2F4>
M O!(&?L-_PX&G[A]1,<7D67-SB KZ8(3<F1)OJW9'6KM5]X-7[1LSF$:)%K$
MG\UV_VYAQHXR+;!(21#/A2* 180!_2>%G7<!7Y"_K,C_N<@?_@/RET18!?2.
MN<@QR19I8L$2##9R1:QPUMV&_*\GH-7,'H,26<M!-)_CD6T>@_4ZII[Q-14=
M78+1P]H>:'F!84I0-!8C[K(S 4N;0QZ954%A'0!&R8UTU"D7/EL<8S$\S( K
MT0[HJ#G(HLB E$.5!Z<<X^)Q9?;G:;.;4\K*5-@!].7\DYD2<LNFS%Q.FINJ
M*'?#0=%T0OF(EN_JHGN$6('[LF88O/A?96)DY<^;:/O[XU>]L;67&(Z,Z8"D
MD]F%8S"@>/ (VTA-$II3EITY<UPYEZ#\PJFW#1L/:#A7F<DIM">VTQNG7PZU
M@H%GX"I),)TP>5$FZ"Y2@4N063I)X;W@@L';6D]I#(E:,#$U>4P2!'%0YBY_
M '7K??NXK'3N6G$SNEY%>P/:.]UIU/:H%9XKQ9'$%NS+* 0R)"ID*,X'6Y*H
M',I",)Y3T65&C\YEX$Z&"S].N&VG-,C/O="T+[:C^!*/F^U.6;^M.X#\Z/ME
MIGV<I<=>!\!W\.SN4/V]*$5\IYJ%B5*:0.Y%%KAB07,)1AW53-KL=%,5'3XS
M!AY^VI..*2UH0"*I'%)E*-(12^2QR!5^ L@HO;*NYJ3I3%-A274>5AF4D6)$
M.9V+2@%^@O:.2Z*[J@2A;[6[$T0[(N*U8N>X^!!=IV\[9X68)Z/+&O6#&+]V
M8>\6YX69TP8G[AT@I'8F19NB%\%R[?GHV 3^7UPFR"ZH-_#;'2ASP_O8R@G)
M<2"3Q_*Z^R7V>JU21_O+GI7)Y9W/.1/_I*+9$<W"_/:4S57,<W!"\J Z4X61
M-F5ES1@C(<H[SE;6#9T3,31-M':\%;.H]]O*QI?/*_\H2QD!A;7B$!X[(TOG
M3A2&B< &FT"441P3FSO?>@[:H&>"&*R'V <4AJXBM4=1 ]_Z@<\E:FI\W3-.
M&-#))<+)2L2M4TA+E3.-K;.>&!8R MY2$E^FHIER%X.R&G<S(1:%=BH38I)X
MX'FYKKMR0#\*I3)X41@.=$,\,ICGW6*@TOE<UWTVCGVN"6%S]20?3WH3#E)
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MPO5[F31A^%%SU-G9M(=#7?%U)PZ9,60&FV1>"\P.WW;[P##EM6O%1N^B>OM
M4#(R:O+['!QSMS9SC\0PHWWYT.Y\A'L7J<OO<_.-I_6-/0&;):-F^2PI(1XU
M ?5*4^25H9PJDGQT*^OT%GPS:-([0?F95RY:^_:GT'FMV!SWF3LKNPG$J6X"
ME^DQ>T_*DA!9<Y_NF#CDE[M1K(N %=):#+8^5YH:C;$0--=AIM@X?8,7_9G
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M]1]M6/;2Y3W"^H$,&_J9Q[@4?YWDF-[K2,O&K+]'KX*G''L)M,642:#C):N
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MKJD,YK ES7S-N[(V.:S*[Z?-T#L8%::8N'$H$/#X%NNZ[5:_=_4M$Y(B'PT
MK+V,H/A0H(*Q2XLT\?.@,YK1"6@$R $A_$"EJOC.MD[M67?EG],B$J3AI75<
MG"68KPMNUQM;'S]O%']N?]CZ\GY[J_Y^ZTOQOSM_;F[7/WXIWN]\_FOG\T9C
M>Z=^I5ZP*&]2WVG U!L[,.GZEYT_MS<W&EN;Q8?M^D;]_?;&G\67!GQ0VZHW
MOA2_#;D@AG_,O-;5%2(&/R_QT$"$*<9%2AH 73/.=;384Z%RUV8G<91^(+;+
M)VYDHS F%Y@B6DL=.)B6+L&-3%"NE&>6VXN @+D&Z;VD_B4Q[P]BZ+?B\-!T
M-CLJ(^C00LA2?: %C"5[(ZNX#9C1'RVX\,T)\EV<#_1E,"DRG_,B=$Z[=Q(9
ME@PB#'/.+4AW SI.!'WG)/-)IQ]7EE2CSK(GM5NM]FF678-+8T 6-&( QH'Z
M.I2VIR!4P=("*=8<"$;0 7PN;Y&9!61: CUQH(Z_N^>AZ94K4Q:.&8NELE)-
M#IVU)]WX;O3+[V"XG;3LV;OF<?F>Y4V7R]+ 8X;(;<R:%BR#]["6[W#X(:ZO
ME;A^J;;.X#MAUBBE5WZ-U\B5WUTW+"%KDJE[#7O]=X)5DY7\ZJ\GA[VAN/.-
M)=R)F+EV3HVV@3A]GHID^B896VHPNV6U@JVI:@4%(ZM31:8>NC@39?BNJC8U
MI^#48B]<EL-7MNZYXPN_L84CIEJX^RV<O@M;OHHF6YM3#I+;T,U5;[T,A/#0
M*I*52W%1+)%1B<G:^1^',#[9R7/9W(+K]\]WCSXTLR7R??/'V??-K^?UH[];
MM?>72TQ^.J]]K,%<OL*[;(&U\KFYLUEOPC4_ZA__]6.G ?\V:A3>Z_3?Y]N3
MQ=>9<X8RKQ$3VJ)<RADYSQ42-# A2%!*JKG>R(=PUUT0N>+0QZV[77'H4G#H
MN"*WL"P'P@DDM..(\P <JJU#\)=*5'N'J:LX=)$X]('%F"L.708.G2C3G'PP
M4D2,1)($9"C\9K0U2,&V*\L3-6;^B=[#%/0E[!@U>V)Y=B^4NOG5EQ]$'J:(
MTR>%D&]#%_#&P /\]\5N5EAR=RRI3>KC/ 4: $Y0H%HASJA!6GF!O(M)4DMM
ME!:L^]F,K?N)^TN,="]Q_P:8\8$Z=\6,R\2,8]5;2^$3P18%3PSBP3!D'$L@
MW3%L/E$FA,R,NF+&)5*O*V9<(F:<T+(I2Z;D/FQX3NG1%IEL#-/HK4U89WB^
M!3.^!3_XYV;W1S$;Y?88#H%7"2@/4[7YDP)*WLL/L)7;PYVL<.3N./)I4L/6
MR@B&F41,J5P5(3D$]CE#28?HB+!:J90+7.K9EDHO[E)[S5SX0!V[XL(EX,*Q
M:FUCC,JS@"C-M4F"(<A)11$URLH8)#6,YMX;8K:\=,6%BZM<5URX^%PXH5-+
MQ8*4.4]; ^]Q#P8N*#X2:<F-#TDIS77F0G63+'Q3SNM1?L8PO;!,%QE7"7AS
M#NW'"U*?DS6=\W4?+6?_NM.P1NP<+6L"]?,BR-<I;5K;Y+%*2(*(0#QF%QF+
M'OD(>IM*SI"L3:N9C.MA'G;E)7L<=KN7\ERQVY*PVUAM]H0X:6A"S'*#N"$8
MC%<K$?%8&D\P4XE6[/;TTNT^6G+%;LO!;A/ZL1/:!.TQ(H0JQ%6.O0HAH:"M
MT519K*5?6=>W8+?G=CLO=ON1DL%&1R7%*(]LLM+619K86-&^2.6^E)?YZBWX
M:QLI_14[)1PL:OC(,(NT;#C;'77:NW1*5GZY"?M^ 6%+WP3E>4%K]T(EK\-]
M.QM[%O:;4I4/RQ(8]I0X9*3P2+)@@Y J8LY7U@E;PVQ.N>G*O?:TS+DPX205
M<SX/<YY-,2?%/C"&'9)2 G,F^&$BY4@[;TT2.NK <AO?-37;Q;=BSB>7G(L2
M7E(QY[,P9WU:<L;D+""N0"HIL+"E#$B3J)'W(G$N@PBY_R$E:VHVTF16X_]G
M65]@L@+/A)EP11F5::U\7BF2YR\.,DFZD\5!-G++G&;OK"H(LKFUIPS6PG&&
MG,A'*IQ'I 4)B!+/<4A1>\&O*PBR");9G'H?P[H:_2,P)&&0[C5UPX8G(G9(
M%??MB[ D)3ZX6%.BJII13?;IZI'<;D)#Y]+H@A$OBU++>W 9CD>^M-,^O>JV
MI:BL<.&V&JI@Q=:HLN%?N6KB+13T-[E*[]N#=CU]VRJR-SK7A]J]Y:G$6UBP
MC?W]3MS/OL]M6*CF<1<TNU*AG^=&7@Y.?Z1+G^>=EX)(!BW.'HEC'G=[[K&^
MSQ?A8VZQNH.9@2'?'E3:?E<V%<A772J9_ECUB):"XG[;SF7\VGT8(G3_\;B4
M]UA5FU[!(Y>=%MY"5LU.O]?MP:MGF]CVBG_9X[[MG!5DM;BVO!N]VRK@8LY:
ME!T+%VHQ[M8_U"JK.?&"*L:YD,00Y[CU7A(5C2(D]P^=/>= [#G:APY1?6)W
MZ\/ Z*$CE2VI.VOD2-UIU'[!?4?UCW^WOC?@^L;7T]VC;0+S:WT_^I"=K+1V
M>'#TO3GC2!7EN'07?_\&<]G\?%!O_-'</?S*8:RCW6_9R0KS_OC]Z%*.C9#:
M)><$8B89Q#FV2&MA4)!,Y))23#BSLDY6J9X]X?B?_T,D_OTR.]T12$HFPK=G
MH<<\3GDPMR\<\OW70W;C#KNP4$!V]0G1_=#LT0^&)A#KTJG0R"-1.B1>S8'0
ML^'8.-R26&>,MA(E%QGB*J=&,,60YUYX2GAPD:ZL,[ZF9\,HEA['7KD&4QY=
MT-^K;5KL;;H.GY]$RSR/G7:PW8,GA.L+#]_K.K%_+H"NCP$:>T*\SBV4?)"(
MA\214\(C'+ *Q-$4?;A@]06"Z!OLY=$))DPV7@\7U9735[Z%1,2/E\*@[R((
MYKSNL@N"N1Z'!\8_9Z'PE&%<E7/A3IB_.^E<\ D0WV&.E#0.<1DCTA)[9'AD
MD3+)=8Q9*9_-6;XCWL^'AB?5]6Z;;?7&6'R!\ARZ#PG7K SS!V' 6.]SP1)B
M8T )VXAX% %IZADRU"7!<? T)V9QML8J%%@V%+B?85YMTUO;IK=PYC@2&/=3
M]I?7Z_/;2VO[.>!CN]OMQ[#9[\#B#<3Y(/YF,@#^8H,JC?Y.TMQ/:O24.!R4
MUDC[+,T#I<A2&T"N:TNQ4-('M;(.JOV,+)^)2*D<MXO"PJ]!F1]Q=Z7//PD"
M3#2YD2ER[CPBU&>^MPE9$B@8]B3"[B?E+>CSQ*S1V38:U0G.8@-!==!6;=.3
MZ/-+Z+K_T.ZDV,QY$>U.L?7KI-EY<W[\%U?M'^C('VYAOQ,K;_[])/_^E.Z/
M@S,L4A1BE(@3KY#C!"2_X3YY85E,=F5]3AG@VZO^E6NH4OWOK/K/8?-*^7],
M"!@K_TDP&JGFR)'D$><T(HU#0BEA8IQQ&ANWLL[-&J&5,W_)H.#%O<35-BW%
M-KT%9_ZE!*+-Z&-.-"G8(Z0079EEMHS4>#<+027K>?2!<"VX(\PFR;'#PH,B
M@:.7.>QSOF%0)1<MB;KP8])BP 8[A:5%WNN8&_@0E'4$Y!4&%=(H3GVN;;C*
M^.QYP?V\&[=CKF=R3]T\F;LF)#T .Q8.8^^<JG3+EU]2P+S:X+H?:E9)3,N"
MEV/S*DAL!$\6*2(DXI)39 /8T3)8);E57#N[LL[,&A457C[^Z,ND<2U/*Y<;
MX>-S/++-8_A\HO!0KCNT[%VBG@M )JO@1R*$SUDU6!+$F:1(\Y"0)EAB;3WE
M$10NOL;)3(7+!U2KK?2<2L]Y0#+@<EF%5V0$5M;A+<%JK.U0CYU0WB$> T4<
M>X-TC K%(%6$+X)0.F>'K KY6*$D3ZON5*F"5:K@0^.'R[*YC^9R'*[#D.R'
M)7P9D'=H]_.#2M*O')*++'HFZ*)R2-Y#Y&P-Q$VI(X.";&6T@9G<S#CD;BL<
M=&/M$ N6.\:8,XJLK&M-5JF<#62XWZ'+8W#?,YVI/72JM];SGQJ8%@[>;V\%
M/.;2+"E6+[PO= *4*U_HHT)U[0*JF4DT6!M0P,HB;H-!QC@-/V+BW%JK) ;S
M0*R1QTH<?<- _9S/7B8]<NG<K%<CTU5NUF5O-OI\V/3U IL4U4R&)$%Y- QQ
M$$,(T(HBK$ 8.:H2C@*P:2('YD%^UDH[J[2SA=+.7LB,?AQ<G/;@DLJ>OC,0
M^@L@#(%ZYIC/A3TDXHX3Y#Q12 OJ.5518AY7UJE<)4:] BWM;IWBICMGB5MV
MSAJLQFPKN4<9^!E!Y*(_V; !6=&)OKU_##>'XMINCY? A?# H@9D\01SIIBA
M!&ON++-2.A7]36E%XC*4;+1:;6]!,9IO!>9&[,?=L>TFEQ06[M\CKP;C;^]Y
M%HS'RB,"7(PXMAQTG$B1Y=S#EFA.J"UUG!F^+H"06O#+ZIWVV3OKF 85VAO'
M50K.^<0#=TYYEX+ -[3:K?;Y/OO<^+07@Z>.YF0N*0''J;3($*F1\E8;)07W
M(MO9:[-G<*-]+NSQ'5F::$RI]%;@Q*7GVD86D\$RJ61,,#<T;JVV^CY;??@#
M6)HQ3!1!DN>.J2)$Y!+%B*D465+:)Y&E]=IL-.[%5C>/BSA83<#S5E[RHM<N
M)GM*=HM0UF$IFT]F$[=;Q., U\T<:>6?Q)34D[=Y%4;LGL3<D3*VSM:*+#N:
M%QVV?F9EK6BGBZ?$43V7K$1>^;"!CG'%$XO3V(EWHMR'YKB*YS\Y&F?%-=H]
MV[HB?N$-LH2H'6[M$6PMELXC^ =8PN?*=$Y0%"V)C%&7'-8KZWIM5GN]GY1[
M8$/YBH 6BX"^[DDMP=BE!!&L'.*:@O'C%4:11M"?M"-"YQ;Q_#I0O:O\?&#C
M\XJ(%HJ(SK?WG-$>!P^2F&L@(H\96-"2(&-UHI;(X'A.E)%KLT<=8QB:EI[O
M;?<@FUP1_@81V6D?C7H^CP1GMZ2[>'32:I_%.)3A)_V./X"M+$Y:8"V>VN["
MBL>_.FT?8^A^@%?+]=_LL1\U0N]^S0T!MX]S8S9X_8WC*_3"O^ =@2Y]JY\]
M Y/%XMXP17[Z56]\W0/#3WL01,A;ZG)?*% 5F0LY,X%$D)6"JK2R+A[-^GM.
MN5A1SM-1SH\][*0(0@F4B&6(.Y&0QL(BYRQ1,3@=,Y9=!V4++0\KXGDRXCG<
MW7- .L$*4)^\SUU"C$/.4X&DC]9(11/!867=K,TVHQO#SG7FX%ULSTZTK=);
MV;._"A>/8VKV)@7II GZ$H;D-%UN#>7XE]CYV?1Q/N4U[*\_!B^2R7>DF@'Y
M5C18*F.\OKD/\]E@^5WJC:T]ZH6F3A#$ +@&;<5@ESCR2DJ&HZ2ZU.X7R3RL
MR.+1H0GFXO>H,3XFH (<:"Y\F32RCN=D=@G:4'(8!,TC^TD?0:Y5U/#HU) _
MVW, VY[PB)0-'G%C$W("B(-%@QV1QLE4>LUG@X@OJ.'>;LM+PNH5'!-N=+-G
M=XZ0AO4!P9K-4'MRTFG_ LKNP3O?#5,=("H75#"=P([QUCKG8B):826U-E=$
M)]R/>>KMXY^QFZ.NL@^D6SH[)K]_W^[VZNW>;H3)C8Y#WS(SY;_W*-.!)J^
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M5UQH=K:O<U3R38O!7W]CF.I5LE$W[UB^0HTFC?.#PPRZR@>-E*<2\<@<TM:
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M*X]U,Q-#^?.2#I56-G)LE0K.$RS!YB3C2&X]H3()KI.4W;CVSPOX?T-$T+\
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MGC;ZL)3.!F>15DDCKG*5BI,)$1TII8:J(%).%YEMKOW\7(DE3/'4C+Z")HM
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M\(,+9I!A2L(/*N$O%9QB*^NT3'PM(+*L#4H+B#P,B$PL-A(5TR%*Q+2SB/N
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M"WBC,;+<Y;1N(4.@0@,A\FSG6[>'+WA3\.:N8WD%;Y84;Z9"?L0:++1"C."
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M*S"RY#&]GWF@"[C<+[A,+#6FDHG18<0- TM-$ RXPCF22;N@B:%8+<[;_%0
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MU\V?"$D,-'Q#S<JZ6L5BF6*BSR'BL-_IVU;EAZQ_PQ$CO\ZS?6JAWKF?_^D
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M!Z:H7UGG>!5^N7U\97&R]#A:/Q14??:HNJ0-<PJ6+@I+)QX$I8*E40<4J(N
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M2ZY+P"\O:[J\M-WN"5SGN^V&8N[,ATL'TXH%I3(8YQG"@$Z@742,7"[_=BD
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M>$1I).-A0+#8^'.!OZ]//D^'S.MH0?^OHTR[_</8+0Z8I0DK#4FST0XU80J
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M 1*]X(1JX3G.(*JE%(9X&2E+#D=^-8@6[+Q'[)RHH$)'G&<@(F&E0MP#BKK
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M[U'JHR]P5@FE.-8)]"R1/70YFHQ)'X+0(FGMZ&U*'=S^5&\AA@4DAJE^!L1
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M6JK.?C<UDUHUYG;-/H?43,24A$)7$PJ5A$PE(=,S3<ATC5ZRV$+XT$F'GO0
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M<FZEPJ1<\ S"F_GL'?P"QL@@=B\#"R;,Q?Y.&B,KJW\3J"U0:O0'1Y8G^UH
MK@0W2#)%P9),#ADA(PHVUXR. 3"&5]:&7WHW6)('G9ZSG:I_-JS59+8']6;-
M^/-!-03YZ<?!J#.L=R[:\(\;#4#,!@,0TF&O_L0?MF.J>B=U@$SWH)[L09:D
M8_LI]E<K$,(B:<LI:9NY_"3%"4<G.3(A*,2ID<@%D#7&#7,$K!2EV/=D[28A
M ^%J]ZM\Z>=Q-)7M1YB_@>^W70R5BYW>E]6?UO*G'@64O:,OF)S:>.UN@!Z\
M0$0_&BOG36@JS[PY#]^%BV-#^&IMJ8X7BP!M5[LG,9\R'YY6NR,85!#_Z=3!
M,E)'+0RJW]J_U_S0C*-^5G4.8O_TC!T:U9?#MC^$NSH=F-@JC3J=*G<CT\A)
MOQ=&'J0 T%EU9V_/8E%_4($0U+ZERF>I&(SR+C(P3CL'85<@2^.5.OYWU*ZW
ME!M5&/7'A):C^*9/:%0^]J/+WPQ.VK#X5:DS:H?) EB_3XB?VS["E; ^@MSV
M;3<?KS_N 3?UL@MT]AFY>],K!L/:*_KM4D?J:WYK3\9FJSL %64L\M</S7$/
M7F]X"&-^(SM.7N82.W+0K#!3T;MD.08DRF05#8P2&C4 ]H[L^)WJ<Y>5VZWN
M^+YVK4_5I/G79+QW4H+Q#L^8,??(SMM]3#R3PG+D6+2(.Q*157DGS7*&:Z^^
M,"MK'#?P-8'N((A3H:E.[# K;6.^'$RAF/_H9#!G\3P#$ZS&ASV0\B',;Z.:
M(FIL@L('F?5LIU&=]$+;#ONG8VG^'.%;  9<V4LI Z$P[L,R[DY_> BZ4VC[
M\2RWQA37BOZP"UT[R OC%>ZM^;"7P9;#QC(S#CZUN_7]7[)S?<*#C<KU@'+S
MQT<]X+<JM;].3)SCDX[-K 1W9:(:G8#Z-A:LWA?X#>:M'X_K97G2R$'?IDRH
M8XKN?QXW.XS= ,U=HMV?EZ%'M9/Z0'!V.'ZQ'HQ*'Q:?83SH]4\OKGJ?;;_=
M&PU@D*(?95]@ P8V)V:!7PY'>?T$G;DWZN>_V^=D60U.!\-X/)[F3CS(J]&H
M6X,>QK5>,V"EZLZN3HWI<@+?#0YA)43.#F+VFA^?Q.Y@W*SO#99TR,]MAADC
M(XOC=(2O51T'(&=QD'DMU"ICMS>L!\3VZPN!!\="/YY"%[T=#6(]<: ,#"U(
M_/ESSUN%ANJU.$08V4Q8XU6Y;@3ZE8=Y*A]GLU8K,*-L4^<</="=@PC0F#"T
M#<?M;ANHO'87YX_^!5=/'MW+N@B,X2@!ZX]J/6-&%B[H$%/[/?1@\/.[3A]W
M]CH7VZG%H6[B.[T97P1#-;PP#5.BF4S'K_>;^<,81IVXD[ZC9/QY.OGR>?O2
M-O>=E-1YJI"4S"$><B&SH, :$Y%'$0QQ-E[VI8F@93(R6$$IQU$YAR6EH"3"
M5%''Q&5?6C,.JP'H;F,) D)/[6'E3J]!8BW\67Q.HP6$Q L9X<:6W[14Q3C,
ML6XQGYBOP68S>D"2OPQ>?-\[]UTJNS9=Y+7^O!\/Q,6! [6:4.($-U; Z'(;
MX3_LN0M@\Y)\4/&7I(\T9E5A]3/9(X5>593//W4B6=68_9(\CS_7ZM/J[.TF
M;!FS1]YT3/2Z0):S=R)B.;,7[M4<>#4KYL\DYUO^67R*F>]N6W+ISDGOOMO.
M9*F[VM13&MC;G8 H WOW@=7/DW]F5I&G,YV_;77'KST\!-,8=.G![_<[2/5S
M)\I@)'^=QZ!N\45V8;;]+89D8A=6V6C9S4;++SV/7]J8VVF]\2D&\\C2]EV*
MN7$G[#ZY39[H\8VG>0SCGCML=SH"]RY^CMU1?-7O'>=$Z+EW^:3&R]$ ABKV
M-[]F]S,,\7H.O!C$T+)?%^<@QD^ZPR8',<C.ZW?M/?JNO7VT=]J$>[>/\N&)
MMU^;&WM?/]9]?'>\_>W54?/T\D&,]_SCZ_\<?7R]!?=MT>W6V]/MUI^'S8U-
MW#R"9[YN=IJO][[!,]D_W]X.MW?/\T?8Y#T1&AE-*.(L.]$4C0A;+9*-4A.B
M5]:TX0W-[ET/?,%R'!7*>KJ41:7'@@BI<"YM[X6V46%I0-J#4ER%>:;7*Y3U
M )1U>IZ[.1F+J1 HPL0A3K%$UCB&) M<TJ0Q)W%ES1C9@*\*917*6A+*4D!,
M1LC$2/"<DF 9,RSZ1!V/>8VN*4M/*>N'N>@+93TR937/M:S$0U1>"11P\*!E
M:8^L(AQ13C!5A@FN'5"69 U#S0)1UES+D"RTD7N+X*,;72K//OM83C@5.8O*
M4<^M\488*K4+1.! >:3%/EPFYGH_:Q^J" 2%%45!"(9X,!XYY\!<C,FGP B6
M/JRL<:4:F*GE3R96,@S>A'%IA1 4:\]HXE%JZP-CE*80*.,DS35?><'X V#\
MW*"R7D2"G02,<Y\+^R9D%$LH '5SH10%=6)E35#28.+>/J""\07&>.!!Z4@D
M:*A<Z*"3I@I45AVMQ';B-"D6R-)@?,8" ?*6"?N(<-(Y3W"*R AMLY_7,2N3
MI4X QK%N"$(7".//9YNMU1O6Q[9J6%PQ-FZ9X.CY%>6Z\_L_&;:^YZG@PM8+
MQ=9[LU:7M8(J3QT2A(F<'HT@IX5%+ 5'A>%&!9VSNC-%&EKJ^29)>_SB7/-)
M+UFX\/EP(8M!LT0$YXYP 3J.)2DH@K5R)$XB%(IUND1<>&Z=\N0#V*01@4EB
M$.=<($-!AXV1!T&EQ%&:S(6"J(80]_9!%2XL7+C<7)B\M_ _E9BU !%FL6>"
M1L<)J(N1Z6+%+Q<7SECQCC,F@N:($LL0QSPA+17-:7.3-%P(*WWF0JYH@_-Y
MQ6O]<BY\Q@';?]7G2N\3K3TS.Y?R&L].SV/'4#_97CX?!U6) W_V$4J6&YJ8
M),E+T":\TU;*J"7869(GXN;I<=J9IF+8ZGI0)7*9L*(YW$ES.)CU*#DJ34ZM
MC7PR.M<))$CC&!&6S'$JHY2)KZPQ(1MR;C;4$IE)A9(6Z=WN%#1IA5)>2H89
M-\(;8";',)"44380,D_'3Z&D.5#2N6-'&"Z5)@YYEQT[7FAD&=$("ZK!9.4\
M40:49$2C/A==**E0TE)0$O66*HE]=":"5D2M#L!)W$G.$J6"S]/_4BCI_I0T
MXU\QS >7+*A%0D2@).J1D28BFZ(7,*O1<PN4)%F#L44Z6E+BM$N<]BV8R4;G
M2+":1$HY:$Q&@^(?94K4*Z\2*_;;(C'3IUG[S6C!HI(!)8T3XA@L.4>\0S)X
MAWE*6$6QLD:$:<C[%TTK,9J+B^%HA8F1,.RPY)Q@9Z70VGF6M#24^F+P+!B&
MSPT>[4.DBIN\=2T0CR9K%]$B)IT)QBDM7-Z]X1PP?.^8GH+AQ<6P]"8QK!2
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M 2)31, [NHG>]+)6M@Y@:"XH[>M]6)@.ZOD:O,N_[:2=T1#,ICCXVW9&\=_
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MO'/44,>>#.*+Z2]_A/8 V/ST1;M;4U1]TS5GWB8A%\:L*JQRU,7DU-VD^4E
MQFH=D'$I:&G\'>.KE*D;O\:KY,;OOM<L(:M2R)]J]OO?"<9*9Y>GLWA5LIN_
M7L#.WJ[9:P^XDO.(V#OF8OTU$:_Z1_I.':?UVU;>M^Z-H(DP:%3QJX\GPVR@
MCGTD5;!#^_N-YUO9E5>^19;.I;_T!^>;I]P-BWS\?NO+?.4/!F%I(/ ]W\1$
M@[J#^%_SNN.5?W%>>)J!>>*2:E3=./PU %^*P:AW&*JQXO:,AZ$9AWFKL7<<
MJ]\Z,"*_B/.78BS^@M6O=FR!+?BG'8"1]ALIXS$>CXUVCI$/5T9D3LFT%R2+
MT%T7BNNR:]]E%"9V8+8;\SF10:_3#E5^H?ME/[]M)9#2PP?IX4*W\4!U)Q[U
M=-^K=G]PLZ[S[$\T,J6YT#$$+01W5AE-E64.,^&%D^/2E3/>1\R>:3V<GW57
M3D\_0A^^-3^\%\UOS4_-XVW<I!\/]S[L??EXW#S\N+%./[:VOC6_??KR<??R
MZ<?_0-^VR<?6)[9-W]*];_G9KPX_'OUYO$=??=K>^-C9/MIF.ZT_._]\VSY/
M[',$UW_9AVFT#'N#E(L4<4P9TAQ+9+&0.LA<SS+G=Q:\P>B]RU>6D\L%YQGG
MM7GU5[^7VL."W[OB]_0<O\TO^S*%F%CR2 KC$$_1(:,=_$FPHQ3K@),&593B
MAN:+=(*YX'>)\=N,PZW:+?!F-A"S(/AV"&Z>K\!\^^U^WAR6*CDD//> 8,>1
M\\SF.I3*>$$U5W1ES32(OBG8;(GQ>V_,+IPY<?NLPM>]XO+2T5^Q7[N#YDM+
M]#+U;-I^%T9K,'U<[8I;F(BRI:&@<R6"-]_N6Q.P3@JC1+E"7!B&;& :N< 3
M$U3JQ.W*&EXE]RZN4!BH,- 38Z")\[MPT!TY:&=&#=IYN^^QX59:BCA,V#A;
MJ6:9@[0/3 5"A<$+QT%/:X/C>LCMQIS:X*<<I+<M#;%</'/Y4)S2#)L4, ^)
M.ZH,!:9Q2?. I>/)3_B%3_E%,EP<I O+2V\O.T@%CMKD>-  $XI@ <F)'95!
MP1,7%0F2.K^R1H5N2'GO-,J+5_:EX/PQ<%X<I/? [R4'*78YT3E!2NF8$[,R
MY"2CB%C%?0HT:0^V#1&L0?03+-OTQ/'[V\,">  O#+\5?^@\ 7O)'RH(H#4H
MC"3Q'G%A S),.^2)Y(*EA"EG*VM,FBM@O1*.M8PXO9_UL&0(O<%DOR=2Z8U
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M&J+9GZX73N&?P^%Q9^W_!U!+ P04    " #2BE=2[_$>*]LC  !1BP$ $0
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MK1O: [4 L]NTG;RAX@.1"%7L-68URG-X-XDIQ$L"Q(1C/JO,)#9%;-L70)'
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M=>4Z%H3(8'>D9/L&-=G"?9JJ==1^Q$F#*7ML#QZ'C><OW6:WWQD,GW*5A,N
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MM ?SM*[&)@B('PJWY'G!]R%49\X#HT%5Z=2Q)K;]BT3+<@7&CD:SRE;!!#L
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MGQ4 ^/D*)LT!\5RHO_SM_P%02P,$%     @ THI74GRC+A7//0  3:4" !4
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M.*L$X5IQ+3D((YL\ FW"\:ZRS2IP?"NZ5N/J 628+C*K5_&[UV(W\#HRY1%
MX"770^J20\L#\;@F%94&5%U:\/EQ2.MP7G\_G*]$^[H^CQ6&R3BNM%<6DHJ1
MLY*2%4K*3X$2.$IIBC9)AS]0S=P7=]&L(P'F^Y& W2E>C?G'0Q^&H^%\"-=V
M2\I*9)<3T8#L08FCQ!O+"5C@R6:;>&ART-^'LGL^/M(6T@&$^=7B.'4F1BJ(
M8@R0R$X1!TP2YXP3,023=9/%W8?2)]MW1RFXGVF_$]UW%N[BB[H"<3P9?[B
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MZXB._3Y%IPX7ZM4[G$_B/SY.1DC2V;(HR, " ZX#)<:B 2>YR<0)CA:_TR)
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MTKT HUN;V@^]./C2K:0\PV<32B9^B&B<(#[%#0L<?+2Z2X_^LZ].6Q'C6U6
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M%P((-892IIF-NHGZ6@%[G_2L1G)YKP)OQQRO5S=Z#>"+1HQX-Q_C:*,;U^)
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MDD0,0DZVV>B4SB8GF[/8]5;UU^;1%@I:0*.MX_9'Z?\]#$?E^G)XW3]*::P
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MO=EEC=C0L#>E/,(QW+&$I<0%ZPV3C%LV-]FCG2N+5:"VO929??9Q_RYT>^/
MUG$?7>(T[8IQ/?"]X61F .M$"!Q/ $N8$*5/-3?$6NN(5Y2B(()1IDHWV75
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M:%M+8SL6XSD88Z--N5<HTUX :_HF- %6,Y"R%-E^0B:MZ.]E3FPA_ I>ZG*
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MLVF^3(LW9*??P^R_\4;%D;&0DQ9@1!&@=$8*84R"HGUBACX[Y&[W+@:#-%X
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ML$,8]]#UE-W.PD2DX22IH!1=S\)JT]=HR6@,=<Y"2N6:='<_J?L"O=S>Z[Y
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M4$ZBH409D]#)Q4XERT?T+O>TP*_7^3A?YY9$?AIG;AULHGP.-M1*3A] *27
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M[]]<?OSC[/KMY?N[6)HU 7CLD<??\&\%>NOZOF=:BYP39> EZ&Q9T&@]XKD
MTD!.@Q;PNY3TX7TPFCVXNM0;],.PGIL$D)B,20H5;/F@!(2(_]-2/RK[(WMB
M//+T+L8=M'U%=59:C3JP25A0CD4-I:>%!NXU30FDI=D+*A_CI^-!!U>K>NZ/
MZ6L9 3O^_':<)],O6^7NEJ&5%[+#8\<F(L$! 28E 9X%C9XQQ:HD;YJ ._9
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M:1UP"FC>LM*=4#(5B0PQ$JL-$,6-]<Q3(U)G51P_O_@YTWB4$#O>@<]F0_@
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MY^Q[[NVOVP7  R4Y13D !@8&X,W=!KB=!L@ <+"Q[V%CX=S#OH>+@X.+3T*
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M/TRE]BH91UKKR+_?/>++K]P= ,)#3;*&7>O45,9BN7W;U2DI0&RJ,P#^J]Z
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MFH;*IV4MQ*(\^;;<@BS18KG_^W)S IK,,;_YDM6;B:5*]KT1@ %_A0LI0OA
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M$$'6=VC8E"?X* 1MS.\X>1SO"XX5%2.RO01'OXJ=J$?@TZ,G[B0H[B(,C*]
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MS=5>$(<,%NU1BR;7HIYG^US(P;UO4MJ26!3IJV/L\%)OI7!W9MY^3>43V48
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M'Z:J421,J>C.(//XB&-:ZXTZFV8T!5RC8T^T,!/>56C%;%@=&T7.@U:LW9)
M<=6DE)42 H0W4,N3+RF>J[\\<L;24D"3V8\%']G3L)/UTH=G'N0S)>XQB,1-
M;Z?90.\>"C'B"1W9[4+DX.#''1:W3U@(2]\4^T):77H^3)/56S3^RJJ0J033
M^.9!;6?=U^"'M6]@8 EHCA5R,_0S:,ZLYG$>Z%FK$DN1<>32% ^+O;%IZ\K1
MTKC-)#.]P=N<#@>X'NDSZ1\$F#TE>G1;$<Z;/W9SIQ;94'87JL@T%?#0-6]9
M5#TS#[D?]TI?VS/_[*&W[IY;>JZP!>[*=#^)"*(:FKY6KLNI^ X/%DNPP*S'
M.+OOWSQIM /'P,E^-'N:D;QC]Y>WTU_D\<]49.@<9.(P*QEWG&P8, 1F9 B=
M95I%B9#8L$UM<T!7F,-Y _;/BN.IN0$ 5>,-CGP8&XA9\FQ+K0>?1ST2B.>+
MY:J:/\:8+^G^4%JFJ!^89]<0?@ ;JK-,V[5OR)RVP1),%RS8W)"O1U$KP7$K
MJ75Z6^^0DKUPSK=EX]B>9]*\MQ^[-56_5V6ZLHS#O0)I8J03Z;E?I^-]RIWB
M]FW48[1]SG=>-YE*-H@V2MD;YZ&&5QZR%A6-=_8^M'J)YNO140 E_;I,GX9H
M0Z&<%7AA)( _N]B&U[G>B'J?LMO8>ZC>TB70XZCQ =N[ ;O>JV[4=^*51PC+
MM($A^P\WX$;[HQ5,$EBH0>C^2->&@;/M>!B(SZ2Z8K*=CT$#&+K6*%JQ2[>K
M?AR\IZ?.,Y-&.?.7PUH7:">EX+K,[4_.'D+::J@=EDYM+R\&7L=U2]0\P<OM
M?-U0?#57/T&[% ;8GXU\TI2AYPF=./7+5A.=R$CW$:I,;<^8LV(Q9IULV\E\
M59MU$?$M6:3+^(B(YISN\?)25M6F/*Q R;,]/M$K2%K]W08K-PB<UWN 5UI%
M&:A_DA(@$;'R=EV,SC-]S9Q&ZF,B(?9%NJ:HM;^$B$O+W<\ZG.';=K;NF7(;
M=R6F)D;CBZ7XGWEH.>L9]:$&F7%2:!Q49:C"ZZ;<(!-M03-MB@_*U-['U1/S
MUE^3Q;M-B>GZ:^:DU,Z 4C_.UGR)SN3WR8G/CN=<CDYQ59?(N]SBL%NK/DQ!
MIHO#JO55ZW"RHZF?(D7J1$/&)Q:UN-93IRQXJ[I+*3$2UIR&9K6V'Q[2)Y.%
MF<BG5):2AQQMH=$+C.[1J7"U!H8BYQGCXX;Q+Z@,VZXM7X8K>>HD4O*[AYU:
M-E]EF-,XDTM.FH[D#8.BM6[5BEC=I@)!Y[:3N2_J,"?J)Q+78K<="5K;'<KA
MWD+0M34BLKF)N<>D)CVQL C!#!H*N[Y)>;D___;NP3%47>YG";^51>-/#(/T
M]\J7E)?N:+H5/1WY0OO+L..PH[U!E=C1*.\ '<TM$WEZ;2FY$BT2'[YNG9/Y
M3U[Z9&(OO6]S;<M "BDL+3#_3#":?PS7FDCZ5!;HL<1RQM$_H<PAZ>/R5=)J
M_,D%;3>CGSM#/#8I+N=Y/D7T\ERY%^D<Z9)[]:AF>_,MG>I*->]=E0-F.S.O
M9,KHBXAGI=C'1UI=^XR,+#W1^XL2+]FR*$O!)[3EL\'D6<4;&YV2RN4W>P@-
MAC R,CC7.8^\G@%]Z=()'TW+DDV8P5T*SVP/WMOV3+-CW<9T&/B%,=CR)/7=
M#J>CP1<93SH25"XJ*K9^&78H"/ID62MXXIEOV.5DFJB.GM\VG\:<'/T[ U9'
MT^N3=T+\SOQMI$3/C.AE]<(Z4=9IULS"9@Y.*D/%:5.RF9(/CU\NLV5;L5'U
MK(>G0Z*>J;Y%??)1?8N\"NTL6G:RLHO,F8-W+]49!![5=-0\*5+LL<Y9PH!:
M1/$=+(,DZFUDVI1%@_!^]GD? H_NBWOV)>BM6</%G'%]V4R: 5V\$1*A&A\J
M(,\4[<DA1:O*"EPZ=SJV0^HX"^6!C])MCN4CIDGJKE<[)?>7'2NM"PAX'!KH
M%!!@T/-EQ.G=E%66LS3I@>+KXZ\;[]QY^C%1.;[[TW2>Q,FKR2<WAXQ!Z3'4
M^LD0ZG72GB:EK7(W,J16M;/O'TBU#C?,"SM\^R; *FBFO+/L@2=G#;?>J?L/
M+2@6T?*%QWQD&LP$6DP^Y95GM;D3SP6_PV\-YM#?5A'_]/B3^KL)EGD2HI?B
M0S7M3=H0N)H?U_R7G%4P$P>M,(8!40T#&+@JQ>"UQ4@TS]OL1P,YP.[8(K"-
M.', ZTV1@S2?Z3)R8"!QD_NT.K?AA#G=]Z<]2@6E@GBZ;_W22\RW<Y3#[=PP
MD&L( VOHV/?4>NHX ]6+C-7CF=N)?_?VS/_QMLX8C_>H43D+S"2'#4.(_=JP
M"^\0">&18P(,G.Y% K::YEZ5W6 YUWVP.7$Z;AR] F'J\TH8&.QDZ)K&!DC0
M$]!U-3\Z*.3OD+X)1$=??;O;+YO<!QV6E&.\0J3@$!5A?G=D,0RTX6:NBA'O
MZJF#!KBWWP"3G^0PW;_C3K-_4?I6IA\VSY5[#[,N.7H(7P3#!8Q$JY%QD-8J
M E0@U3#Q63R64'&,L?U?<6+,HB7_WR5A-.VT&QJ\I;(*PU9FG[7+.;)BZK!Q
MN*ZTU;O^-%:)D#QK>I>(_""&!P:*T2YE#.YA.43_L;,GY(P0YA[6X[JU\Y<B
MR1M)'8D5\5_&=3&1%Z."*ZZ\+-]Z5L0QJQ%?CKL/4CC;TV! 71'Q&H4B,$#Y
MC.Y$O3*# ARC8,!+ P:Z&F?,U5V(E-5VQ&DZ@;P>'!7CG,&'PX!8E]08>A<,
MS,O> ,[OU'A= +IS0Q]A;!KLV(EP0(UA6 G>H41,+[1UU.\:WP@E]Q#*J97T
MZG<$JM_("1B(C7X, QTA,$"=0'U3'4,F%DN]N7>$#F&HJ]#3JV% ?Y3833\/
M7>S%T-6FGH&U.O4@^1 ,S+X=/K\ZCT@]#?H!P2D(E*(O0]%O@D^G;48]D"'O
M'I."-M*:T/V)Y@3J9A!2UIA7%T%;/ [:Q.$* ^@(B)D3.H!N=,N>1O.!]Z<C
M8& U8Q U?BR#2%^#_GK0P9RJ,(_O(N:<BU49!G"(?V+R0TPLZG.!,1T72'A'
M1WZYZ3&!G=G::@.M0/WZ%OG<ZO#UA\613-X/8:"Z!P8\BQ"TSSF!V0[IEF)Z
M/4RH>&BY7+*S<=$4[S!%0N>^U9M0[X,.G\*9\=$CQR[AR/N&C8UJAVU8BZOV
M2#NLJ>#N3W7LOL@WECQN^2<O*7Z'Q'V<_XTD/O^-6CZ97Z/A0 (W6*Q:#?:-
MPL#K,S#PUN\_4J72W&9[O*/132/5(ER+(J#KGY&C]*)/PZ[W:I'\F#.-D.*1
M..]-QN_PE"RV*$K_W:+D@*)N=$Q.=*XKTT!S94Q:?GCGA1ER8I+."[Q&&((R
M9Z+GG%'\G2$MF3_\_UIZ_I?J3S)O&8:\O\JXD%_!5*[87:5#)G9[W$&'4M6]
MU9'N$A,*\\[!_6->>*Z%V!E-0CP$TD5SPLYJ^O79KAW]MJWQBE^/YERT$(L2
M_1N_T\AR]-5Y^I2L:-DW](/UP_3[@8HZP<,/ #LHPZ6I>5XW"FAS#U6N_9>J
M2BP5T0&6/8T%J$$Y.6T*KVXN[[I2XJ7:3WMZ:M.A#!BP0P5Y^.N9FCJ5\(7;
M>":'=WVV._HTYUP*C\/G4,ON:BVQRBO3IGL>GO$ZE6F>5_(I#ZUA#UVB@I 0
M3Q)80S%#)*3TUX,U8C.E9H0E0?()(OUJ04<L 6']S8M%A#$DVNVP0R0.VX#N
MW&HK14?4DLJ"GEZ+_$ZU-T#"8+42++12X-=WX3D"&@C]SHCX%)J!E J:%R*T
M?.01.A6D"L+ ] :DRH1BPA@#[$"$J%L7H1ZIUBB"P;D.396TF3VF0T$"4>&8
MSC(86!J$#%_B"YOXO&YX0YLBUB#4FT"HIX903P6ALY^Z!69<"9&[CC3"[*O\
M_2E:D-\M%'V=W.S122\1,=J(XT#*(.U=KX:!4$YJP"DM1*R:(29$K!9 #"S5
MUTT1!E10$"L:.O27T^&Z%=@1D>O3'+S#'D/]1;(QA;26#TR/8G_SP.P=#%B.
MI^#GM6#8,*-+CP@Z!N5'3*N;5*$HJZA.D!N:S@'2;X/%1SLQTQ"!O!R)$A'Y
MFDN-N'EC#9M:BABFW23B-!G)NA<&1E41^=;R!_MF$$.U$3%4.$X8F$,/[/S.
M?.2>E?-J/[ /:>YU'PR4L]+5=R#A/6X0!H!9%7%#SR<)>@[C,5<0(Z&F(H04
M05ICQL' 9A2%^V4$!.+I2U!T?Z1O\T5#?#[;W0O5%^GP(SJ\GKW'QLMT=K>E
M?9XCQ><!L?78M8V^#RI[1N/0@WMIQ 2K><*?./\$]T6-7K1L"Z:#-]T0<5]/
M&Y2VDVBW)BD)#RJMN>_R6^X8>B[D5NT2=0#IE\YGA2:LI;.2U?GUN?[GV>R;
M%*_N#IP.FY3[_G'_WY?O4L*BFB^:N^_3X1F&'>F)E ,GEV5D0BCUS?LM==VC
ME=%[L?<K5W6]Z_H"94XUSCT*^4_%.QR]J.6+UNZ[=#"]3I.$*@Q1+_I*T>D?
M+8\,LAI</\<NE.97V7HG\&K5@]Z"1ZD"IK-'5<;"0/,=<&MRWO:.4Q%2Q66\
M-Q(JY=NK(W7MZVNSLBZ/C>FH5.\6E'SNG%MQO,<R]41*I.7Q.Y]$<F(#) :Q
M03_I64^+-P-]OP.+-P/]1+Q>O!GH>QL%_LZWQ2S>##2/UXLW _V+S^'XZV\&
M2IWG4G]\]VG4G]PO_!3]O>L2N9E2?K1'>OX-B+.WJOZS%U:S(U!^^PPOPU5N
M-!PI/^="S!I6NQ]V8>Z5EWD6G1[*2 \B.!GNB9#7.%.KZJ\WU%[^]<+:!3BQ
M.4J)8";,]#K\5\S$LY!7@JS$(*W2I%F9HL<B%GWNXP)8?0L<W44UG&7UI=DK
M5^=ZU)^=U7BPW+D6'"PGW&U$C,\_GAK^N+#A/$#[RF/NU=)WF>KG'^U(FJ^R
M?^EKW]]+5X@\8/=5,I;A 0-#E-F;0?_)N^99Y;Y_?_!QC^]@(G%FHQ\A\+DX
M9_8HS-]?-"R^ !_X^VNCD?*_A[S?N?Y[3OMS0:UCXYQKI?N9,WZ[F/;#K_?4
M+L"#S5%'!# 11K=CO@(FB07P^DKK[Z?4YSXM@,GK$/=_GHS_RN7:6=LPUYW^
MS%R>$Z'FS'U^\L<5_"P'L7YSK_O+N?[TQR[!YD^V9#WY+B(ZLBSS1_A[+LB9
M#9A^?\/PD05XO]_OQ4#*_P[O+N#.\'F =CAYSG72-:SFOX6>2<]_#447X+[F
MZ.,5(A/8;53P&UPR6 "_21FX:2G^1$2@1@,08S[G:0&,GG>C^\NYWO2G9O2>
M5[-8'X'3^"W0L5GL__OG[U3PD^PT_^9.]_GN],=N@?C]V0&]/T%$C]@M?H2_
MYZ*<L-E9E=]/)2S$!\ZY8 VIX'> =P%7AL_!LQ-M<V:-'G'4_1IZ'CO]6RBZ
M "\V3R=)!4N0^C/=?X-,*0N( HO,T:.FLKJ(5/7P(%;]]T\+*#S_1O=O_.I/
MSFXK5P3R(ZC:5)O^>#8"^-WC=XK/1;5A@Q/S)X\><41UL-+]LS&S40G+;. ^
M1VU_&!;\%8GYFYG;;QSK#_W#7L+W)PGBOH^-]O$W_'!^;@[DD<B9/Z&P &\X
M9WIH=G;F=\AW 3.$<Y#M8-;<R:-]0O&_QI^/"W\-1Q?@S.:I)8*>EB(-6-"^
MHB=5HP4$@[YU8'>^!0Z1JHK9F???/RV@\/S)VV_<ZT_.[M8I!/WS0OE1T]JS
ML< _GKY3>"ZZE6@>G#^!M$]H[@)+JL <I?UA>/!7)-9YT[>RWSC7'WH(._![
MTP0\&G^"CSQEG_QPBFX.ZID-D^?.*2S &\Z='YJ-P7X'@!<P2S@'X39;S9L]
M\E0\]&L@JOU;7+H ;S97*2WG+<+\."9D1[Q3N7,C&I&JN[/3[W,>%U!\WEUG
MW[C7GYS?F2-(""#%N"8W&HF8H-\]?:?PXK+HOWVI;'%9='%9='%9].^\5+:X
M++JX+/K3+XLJP4#7P42K6*IWD5Q$Q&JCDZVGE.JK9;SD24%&F]Z_<]8'UFAV
M,!D02 F0(%B[CZP+<6X'J;ECZ&_OF1N1U_ >Z).QT(_6X# (#V!(?9Q^-J;R
M<$G\F?5;[22^@*I$<AT,<*#['SF+P0!K.(%N@OKF%U!%QK 9!HJW(LZJY@"!
MS -=](%RD29P6B-@]X+KF-UPF<B):!+B-E\;3OO-#!I"[E*O$ 3#8 6+M.CR
M,!![O0-'%T8@#L7^FU\<Z-1:#?K^!V@&"\(^)DPO:C %,SU>, 5IC O! +L4
MN0L*8/4"R=<0#I?4?O-+\UB7.HK"AJCW.)<4?2EX#TS-!/OJ:,1I5(T37890
MA)T1%T: 8&$/'@9X-;[Y!5,=Q W^C@9G_J-(\(K(#0.71OPB'BYI$/$K>[@J
M_.#Q-X^S+[_S<!@23G66F RE.MET,';L57+OR+#/#-R5E7V9+3K.2ZZY8_M_
M,%D6)>/_A 2V( ?Z$LYOLD"6<B#4>;"PMDSVM72ZI4&%H/6=&&*5QYJ?:3"+
M_/P;D*"9MU.J58Q$)_#)G&PN,^6X9)9]NH[=XL/3!YH-(V6VT\VD13/UL_'T
MWTX"6X+@K)F:\?/N#":6F;+?+ZE;DS9H\,XV<_JU"UTD%DOUD0=GED= 2PCO
MT,U&A+$!]Q$ZMG\7JA5#>NT#=G8XBSV"@7M?F]:! =\(JBT,J#,7HJE*2)S8
M.3A-^5X5BA _AE3&X.9D@8&.401\W8K[YA=\7VD NI.;! /]FS!4!-3OA $3
M"QBH3I@BC*(?C5#-03_4^!&EM3#@78F!=F#G_T# \<^^V'#,#P&[_F"'!+V(
MX9 , RH1[0A.AKSGXTOTO&?([5(<M%$'!7DA898G?HQSH@E/G\&X(B'O#,>W
MH^U?), _08!/>"]TAFX1 UW4G&S;A6?=7^7\CB6R\47H'KS2*T?<HFXNFJ=_
ME@2TS 2H%LU9WV6=<*5=@7PEVW)G\L:FE*RU-ZFL'HJHBCS=GT@__A,-Q.>>
M[#(;YO;7+XJZI-BJUO99/DZQKOC8Y85JX(>N61(+5L- N50M./B ,*-B1$\L
M795YQ51+5S9&RJ+'0&:(T7 GL,<5Z=WV@HL#'CPUIXRC=+<_8X0&R2FFF(;>
ML+IHTTOG;($!JLG#53 0DU>$HLIXPT! ',1[T1O=;TTN@]@W(+U('F4+@*R1
M49?[(Z.^A-!2EXXE(O^PX@S8O^TK&7=/3,TK] 0&?%HZJF<$\J41TAU"4Y_2
MO1#.!=[#S2S#0@A#WJ+GE)?HC"@96='N[%>TG3- 27%;T;6<"HLCSU5S570$
M@GWST/,[B7^[37QNE[RA#>&\D%?"5\*B,2#)T7DWY#NR"NRHXX2V81<K^*^L
MP-!C*]V,'-3GF;F<1#'T[0D)VYF4]&9V$H,_E2K1A?8>IJ,2RL1N*<D$AZ?Y
M&C1T+-6I+11('C5 [,2NLV _/YJ*Z/[LJY&B/D@32;,Z7]U,7(C.+%;PWU=!
MZFY2&6+'6JG-)6LT.[$<98+-0&E5TOZ8T@$%H8_-/2F(.S]7C+AS&9 L!JDB
MKEEK)>*:CWYUS3@\@9RGQ <#:DZ^:+(Y*PSP:-!W5"\#:SZ1L'1^)'>)83?/
M8@W_Q36<^NBQJY:.H=1K6HGIUSNH^[[S9T^HT!$1O5CJ> =;2MB:_!E+%;6A
MAPD9,]X2QDU*7#]*=YYW:]Z=X!F]E$?Q<_RGE'6T:RCE$M-UI-' IZEG5AV(
M)UD)'GW5'?>*7DT0CPU@.--/_[PK)2KN,."%!<MSJ%%0R2L,#&A:DB<)5P@=
M<<11:X\M,)!F8P@#=49T97Q;_E88L,=#HM.H:$HB96 &_6YV^">HS_\%6PS_
M-@GO056#@<T$=1A(O8K XFG+U_.!)71VY@18OA&!O,_O@0.Y9>,:M3CH<"1Q
MHA.<N1I2.WNE@POJT[]BR]><A#D.%DJ W4\^$[\@G8_](M'C\NTISS:D:OK=
M$S8T!&$?"B'/"D"Y+ (5LM'CW;JST@ZEH&^_^3DWJ?81OUW=FUH)L2G#P):^
M3AO:N@F0(8HO:F7DO<%-'4:<&29DFL@/"N/BZ,B(\8W86_\*A?S;I*F1&^A1
MK7',3)\4A W/7_:*1N*DAS)XH9Q*&(CKP?=*)?C10]>#M!5^4-0S\( [8G>[
MDQ!C9HK$THE;A7BX]3!],8R:?\5+=G/VD?SM[XU3V<U((G0DMQ)?$UOKNDB<
M-SPX/A/7R ZZRJ=B/TS8V4@FD,;N;=:RV7K^Q%O1%XJ4ZW>P,,"YGXHT=M"N
M:X0N4(7T@Z='92_5^Q$="<B]?2XT*6FG7H*$ZK:/ZY^TR51\.[P];GN\SY&Z
M0_N]3GCNNB;&,Q7L1SM/WT!1R;SX>(# 4R!@P1\<L\O8J+7-.;+"//6\(UM(
MK*3/_?LWF?9M#@4><4P5Y=Z=*?,;LMGQK+O^BW5*5Z3Q20$[8T7Q[7Q*YY(V
M7VQ--:PBD(\1L"@>] 6IZXZ0$M7RXJ//CKGL[]U4S9^TE%^!@?/N,1>PYV[N
MC[O"\#@I=V5UXRLM1-LZHE ?]GHH2 ;,7&YBBJW/+^S;$WL5=P8]['_]J.V4
MJH=A)# C'$#&4,7 $KP_3@"\4(D6H!_/KLG(JUZ=AS$/#U^'M9IT5WHRVAWA
M%E0YVO5X=8Q2**NW.2$;789M2^Q<1K"D[>WWX*K-9R5%E3Z/*%$1VS&8I),/
M#1S9T[A-;>GR(>ZD"_L+Q9E'%"0Z<9XH\A&T_^RY,A95Z [\\$I2->>EF2G_
M32>5E/&7 CO+],2N'#_]KF5'Q=OE']0\$U1.-PX3LOV&DV.@-T3F"Q3K9(O6
M!$;QX/D$<_.=_A,K?5FZ'#D:])?>?WYEV4Y-P--5FX>\+(1B-SE.,?39[F9C
MWD'TS<K:7;HCEES\UNQ5^)J50&'/QV>&J*UAQO+3JF_Q^HQXT*I:P$T><<P7
MM2E>S6\J26A^2<>'UK=2"C=[E6H4!+>JVZL8/TBZ<*J#=#=D'TI?[Q1J*)TB
M=81:19-U9BUI?=%:]M0YJFC2*+JU+>;0@?1]P33NT/U?S#PU9YJ]J!*31$K$
M371'RL,=5!$E_@UD:[^X,E>;36WRKW;)1L?WV4=-AN0ZK6^K%YI^Q'F%D0!:
MHIB@MP7<]1,$E*54[$!NPNC Y&C*@V;%A&W5%<7/]K$%:HH(NMSFC#/L)M)Y
MZ\:Z6,*SGE,CF]^DT26QQ>)N>V7OVPSSB=)$NG]9*8QN&F>^+3&,:D'I,Y[@
M/<1.295JRY&J<#>@PHW^XP?M[*VSRYZ[3PHX3M]_.R2^!/-A;/(I-8K2W$4H
MKN:@5I,2FKW=T"3%++]##?'9+V\-=VAO8LK=M^[HVY@I#1\@^-WC@F!\*'@:
MW>9=BLX@#JM2Z@NA3=DUG74>0I]'SB?(AJ6720>:?%*C-5T\7799_"K0ASZ<
M0-OL\0G:0\D>GJ*H=>"*C:V6-?45E1KC.:O,K$3S3K7%7[^KTF=5,MSKJQIX
M6F*BTU.E*#:?%6(SIIE^A$K0+U*3.H=W*/+EJ]LZ+8N**W+V(85V'OQ8$G92
M<R7;82K+U=C4%JC!$,<" V>$%#MQ)7>S,QNMQL5EE8_6Z_I5?%(J_,6@-BZM
MV"<^6&E=Z="#ZS7,'R_AO=R8*=63-8PG;A*H8LZE5) $>KN))HFU9EBAC,S/
MO6K8CI7.N<+AQ'R[K'S5SGV E[L9M )QQ$N! D;R%[I>!U' V0/%2C]*%BP5
MLM3RQX;L\A.O>\-W_ZZ$Y[.$!^QOU7;:>G(F)O<26H]!;"O$AABTBVY2U,,/
M>;0-T#</HN2.*?B%7CZ0GK\R"[T]NR.U*YR/5= !GR QY@2Q(<A[:R@C$@:&
MBQ"KN?L(ZP /MR$6^HC*VN-#XW1CRZ6$9UKN2-RM$ZY@';7*:Z^L0"++TV5[
M6V/T[T>QLB4"#Y8P#7$;%DYB5H,VG*N=E:B=S46$%4,IO7[#5YP/]FRA7<,N
M#>-\CW8^OBKIOO'VP*UOA0=@@&6<D2M#;$ON8)0^S[6[I+*EQEK=-R\^/9RV
MF?K6?C-S3X& @*^JX;'HG W"T^IN9SJ)MS!9O*4C0I:WZ?\?>V\>3V7;[8'?
MH@A1)+-=$<I4YGFG0A)"R+@5$D*3[++94N:I9,@0F3,G8Z9M%AYDGH=MDYF]
MC1M[^-V>]_W]SE//^[Q/Y_S.><]YSNF/^^-SW=9][^M:ZUIK?=>ZKOM:4"S4
MJXH+;G0%%=_>OMOP0&',/I#+FRJ1]91N-3W4)8B'NTDJ81<TIS7GE87@5ILM
M)7AFW$)=%<]''$.^?;^)='Y2Y TQ('CT0<H'F_M'WYT=,.BVT_:XQE@RF\="
MK" #CMR035;\H?N3Q"N=19H+_GU-5[H-=3EA9A]N R4*N@;&T9ZRE&S-^ZIN
M8=.7CNS>'X!?&9]4R\"NU#QM\KD=!--".SR2WGE?>%SN7.[F*VNZSAOE,]EW
MX>\89D@'MW;-\;N8O*7*W8MPA0:.GJ>^OHA#.68F=R*S;*CX6P17<H_351XQ
M)UWN/]7*%=0_V+L="')+!>_OC'/;["4F*QH[.-ZW=9@,;.Q%EY0VO=UG!AMI
M>8__/$+I>;]1)2^5##@S#J^8X*EQU'50.A('_#:$ V&"*[QM2G=Z:M@NO2Z2
MY]&$>!A#,PWGR_W!@V\ 2L!=7=4#2= GIJ+NB@T4U.;C9R9%GV-;FW@.%L5(
M9*LD1B=7=-]RI7M9+VAQ)7C81K?4-NC5^G@(TC[+W&J3J9]T%LZCZ5;:7>OZ
ME!2U^;[U9"L7PZ2<P>5I/KW<Q+(L^JUWC#9)*$EE1F2-)O(.&1BVK7XJ'8UU
MJU7FCJU_*I5L!B\WJWBADMZ@H"7H-;0_\JIU_?OZZ3?YLC29FNZG=B^0AI7Y
MB8$HRTI(4\*1"JB50+UF2DFW=9=(&IW]4/BS :_9]GU4(>H*Q@4E=WCE (AV
M?T<"]GI"B(<@,0YZ"\(*KZLI"YOC.=EMG:]I6N#(TA3&5^$EL'W*\&+X8ZZ,
MQH?]!RH<M'&N2Z.L/G<15L10+-*@I#18-+;VE>3+L>V[E'?'?CD"HR:Y%3-:
M=96+X46N=XT@:\05'?BPQ'@[R!6[DZ/EK59(QX@.!(_$>9[N73;$I3YE$5(S
MBH&@,TF7Z)ZS,+0_=6FCVO_DVE=X>,'=\RP/GM1Z4EL*=3NL26Q>)H(BN],1
M BL0\ )G-F?-#D,$>H7J3O&0 1GPJ[A:?4AO4] S3,AZ--@35^[P,*@0^6C7
ME\#\G$1[8K)CB'<R-,CC&.(Z=MK7Q^,4_)S)$Z;/XA==:"_G?Y:64.9FQRA$
M#)I;4P'4Q[GS&L2&LB:=GX,S1(>:(-U)XC"WKZ+H%V$"<1!3H)N/IMZEU(Z8
MY&85GOJ6JAO+@.7'_L[>59U&U)X!9D1-9(PS>- /#,\ZHB$L=G1N;GQ][?U>
M%\0\,+ZT[]SCE6D3)C<P("QHV+6%IV^>P'.B\YCPVMP\#FWZ]??FHGAU2YXD
M'Y:J6)7^DILB?<OB ;SC*,7&*18LC""%7(+M&M]HPS!ZD2BQ'3Y5/(T-A8]Q
M$N][$.ILLFO["KPO68HKST_$7<9_7@_%\Z,(1]7UB'FB"/T),L"%]V \2-#&
M*GJ[:-(8)/O "76<\KP%\I).^^0C;T9>.#CJ#>Q\_'M\PYB _ ?A\(C8[\.)
MS15:Y*@0&?#W4)]!V!&>>H2N@8 /9:@L_*_XFOUO5V*/F+[6A_A)G8W'N,+@
M=4J![>LM5TZWF)YHD%X,\#B)\XE&RT9L<'YV1'24L4W'SB:_WC;T>(:#U9$$
M>H[U=5PS%N7C.RGIS(Y,FY#H*B4#+TC'0B>EEK;\BTHC5S72S@W7'1_=6].Q
M36R\)S&K8^'PY76MB9GKRQ'1MU;<#9]^><!W)CO.RHLZ%=%N'MIV#A<B&O!"
ML'DV)>4KQGTY1J,HT]#C[N:Y&W=YV,N8'T1<*K)O.;U9E-LU6)X$.8+':&"#
M7O&G/N'.NGKP?$O3/>ZGE,8H;)FB&!E0N8-<&28#.*F"'+BI%HY3K7]3NL3Q
MV 5VJT,E2O>W#:D#%4^A$VCA#]:NQ:IV/QYJO,%XRN/Q;#).%A+\Z+:4A+W>
M6Q/QE Q5V)A^F8;Y6/LH2>W&C8FTY(,9GRHE[Q>MI.8&AS+ ,1JX1V%IL4^X
MNR]0W,NLNZ,D_\Q@8\5_A]''A?'CV/RUNGOGPFG;C18*N3RD?O%HKV)SA-:5
M<&1_SI+.X+]&X9F?(5N]%"F W1>-/58[;H+=S+__A%Y_U!QVN>2 *OWEH71J
MI8]MVS&KV.@Q*[]$[U!A7L./X45Z]W6#8[JC%9JE-@O[W4-:!CV.19BTKX:?
M+LWA*'=V=W3@3[CX)5L,W2N,*2V)E'OWQDG]8L3-17M?/X*M%=HA4-8I_J+2
M>KS9.37OT8XOCZ<>KIC95A.=N"G15:D/7:2'.3F;'Y\C?>V1A>C!-_AS$5*=
MRXJF.:V3;7KB'\WVQ3P2(0/")TA;/6L=GY0:7*YU9$[.WL3X!!C8IPKT7CB]
MV^5ASCN*XK?2%_&F+3(WW#Z^6"8G\Y$(LUE5:!%,JGJ/N_ O^"SF_[N^CT,I
M?I^1V0Z<NPG>\8&0:L&_:0N03H@:<ON, [+?GPS,M:BKJAXUVIY%/OIW[?Q_
M2(+B<]#CWL4:]R</671<U7@XG1UT-0R3VV-68#7 DU1&BT'H8)EKQZ1QD_!
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M-,Y6I1X:>0BSCPJ</L.E>O^DI]$OMT]<"(/SLKUC9 1G@Q*R>0<$!)OG-,A
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M2+6HQX79;1^GW778H7A]V8B"F::6#(B,[O,0 1*#.!EX?0&+)(8<)@-S+-.
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M*4!HYP[)Z'<K!#]KVOVWUSG[6=/N9TV[GS7M_B?7.?M9T^YG3;N_?$T[6><
MU*H<7)V$0F["]^SRMR[U3[?=4,;B0=3&MP("4!?H^JW>E7W(SU$IH-!38#LT
MF= _*O1[E"+GS_8B?5^[=Z\>.!O(U*W)CIUMR Y7^ ]XP4.3L&V1'5:BF\QJ
M)/C\-Z6<OU __-,N?%NLN=Q^TD,)[$$4(]$]G>2U3C&D\K?:ZG?_5FK]!YS8
M-TH)8B;8]K&\7S$3RP_(6]91@*2YMW)NH4E( BWZM\T?$'4@<E4<;[0GZCM[
MQ<*_]:A_=5'G(9OAG<B%9E1X+VA\_JW5\X\?-OH.T%9Z?+M%+9RB&P%ZU%?2
M"[]6VC[_:SWZ[U3V7[)9Z=XX"W+J 3:4Z$$&%G%[-:V_=:I_7K%;YH\KWU_W
M^ -,)$AI\F<(_%N<LU<(_!SXZI6&A(U5Z+J<X _X0,YZU*KINMC.IO.T"/C\
M;R'O.X:O?_K[WX+:Q[WU!#>P Z*0G5T=XOY9RL*_EU0?^%N%]1_P8-^H(PB8
M4*LBL%\!D] /R/K>D XA*E@?G$[;JJ U_Z;U T(^!KI_&VS>KU+NW+,-W[K3
MO[*4+?:@_MX&WM?(TWLNYK?M]__X!=_CV:?$)]1-9&";*P?4:>3>[Z;A*<"
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M+R;/RBO>THR-IKAK[6U@P"Z\6'_F/578>19<? 1HU">PRQF\#C#L>Y* 0-W
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MHT=+U?XNA$SJL-UCB3M])05\FFMF9EJTBA_+>8P'0S0$OM # 'Z&=+ H<9@
M!?M4[M%E<B"*8VA.A*O_UM"Y8DDK5V9/UG=T,[*4'V39N*Y1?X$5.B])8%?0
MZ4MMV/(:^:VZ826WQGA!?^A'A-JF89=6<I;6R3/9(8J]G+W^-&HRMJ]CEE!.
M8L.<FD1?93IUC!9,O4>JU5B*[5%O<<$KWM>(@$6V2 R@AF02FDK "T()::Z;
MH-/)/8;:,;YOGD[@8B4#_!!;,F"E%47R__3ND',0%&N,.H1_6#\4&87%5"N+
MXTN'& G>>>L*CTGM^4I-<1G\BY;3Q2]DT3&5#IO<X* \X0*;RUC'Z2T?4F^:
M@[R*0:^DZ5+2?,?CQZ5G+L,'O"A#KQY.#YB%WD)Z5T'P%W>%X*Q7L%^C'%('
M-9.&+*Y^R&M37*T-Y<L=-1[TYTNX^050%L';):M@]4D,1W '7J-G20UI\%:U
MR$G2$'#L^*KQJ=8P@'0:S;A0=G'A/"2EYR\69%LX8BH=KN%F0HUJA\R[C8?/
MQZZD!Q'J+9ED%\4/*$3.I#[5@J>_L,7M[ZA/8$;>4K_=SV3V.:SC@<<-UE_N
M6KI-/%82PN#+602SE9G'IK,4--0([:>E)W-RR_C7NW8&MC[*GRXK6J_@39=N
M+G% :<?;@N"/?OJ=,*>AEL9M+O\*-$JY\MR.D8LC]6!.<NA#:&2BZ[E6Z0/B
M[@MMBNJY> RZH6R>M5_^<8[E1XHS*3>O4#;9Z%%;/IG)>2SO6\^I  %QIO/#
M3=<7&AP\[&_6=7+AA/F/"$,#GX@;G4G8U:#K*2GAL#.HRF2[G(W*W=<AR<&9
M[V;TAS(4^-]N=&OIV6USK32XZR%9%HH]CG1/V80M^CNGP+9M#L]0+_1#ED,V
MU#>M.24=C=U$6D KA>AKJLFCUW&VNI\[#Y7.R"F)JP^Q"EK-5)+HYXE5MV\B
M1H.:SYR-[/]",IB\.=>;]?:F!,>67G9F8<*@5\"41=DGJ(R3;[+A-1\8C$['
M@$&S:M5Q#:HE7/'*RN*CCE\"NTVGRX&(PDK17W0V71YD";VMB.,B Y"YC73X
M/D;\10_A^2I(T1/MR+[:>;;HP"<BJ[949* ">:4;9_O,Y1R&C:#RKL.6>^OU
ME,ZA+\ZB-DLM:_'Q;ZFEO#,#5WSUQNRWNH?'X<D6#:DIQ^81I4V4GD^.WWRZ
M1=D3DZW*CKZOPVH1JQ=LK-73;:(E^>[M\HH+"YUSWIN,Z\'V9[SE^%/WLS!T
MEU7D?)P?*6>M.CXO@3B/D_0X"O*LY*IFIC9JM>T C4Z>MM+]68>R[D>SCP)I
M'!TQ-]Z5G/=[_H%EAL33>Y?$?%ZRV_&]@_+Q"HA]U;%73[JLR0!\AQ[7GPMO
M<QD[A&L(#;EK'=/1KO:,\"DQ6KJ9^>F1CEF'X<\X20'_MU<O]?>=<>8DG#-5
M4<KC'#/LCRY>SY^Y+6FO%FYU16Q0/6]-9C/A]9#,G-6M ,&\;,7S?[8Y]S_C
MRBV?L"5$'(*2/HT@9_V%7GW7QBBJD8$P'4D00MN3@1U[];Y[K(3P05<B,GDO
M=^$6<507-J5+2OH/[7!W;ESQE2]I$*,?FI._C;J/GK7^=,A=JE3Y[A='2RL]
MFL8;>0A+GDK&EXBK1"^"T#N"?$_1(?[=&R6]A>7&8KR?XB?D6SHSD''[V=KE
M<\_UQT>L,P8Z%0E!Z.:9[VSFP^SS3<N'3%MVF>PNO,W45J.0Y5;O<<E[0Y+%
MCV,,2R868I4>UBXDPCUL&A.E7V:XWKM).E??YET]LXR+BV.&O;OWF%<R/%']
MH+\WF]J5N99S#ZI(*PU*DIH&W1?7<J7J;,X&+6#.%N3H77ML+QX67&BQ57?(
MQ5F]7[^+#-PD _X<Z?4)7IJB.8K]KB;FBY$G)_5,-%[I<FO*X Y#G)X2DA77
MS,C TB',$G+2ME$(XCW&W,/7=?75DYT&PJ45?]KEP5>?.6GC:4;,C8[;*J4O
M1KV'J\U,;+Q%/9\N#6OO;!G):?$N8XZ38#^/$>"ELK8$&%G0%EP]!%O774LX
ML8+;(6W$OJNB[Z,9#+6</6%\V*GQ@;8N $ 2\S3%:CJSWF)P]](R=D^=5KE^
MY5Q0K(:<0&K$2-B* X_AS> <S1.M'QYFG(D?K)6(D)X^K:I:PE:4,QIN6M:U
M-?_T$0RK@]R7X]-8BJ,<C??H<^JYPID[(>VXL&2:4#CNG^=!3_IEZZ)F1=FN
M3<6QG;LR(8-O]AG0>_LH/WA'&$$T2=42SN/$&E>>R2O  Z_W5BA,.O(,=B]=
MN^AT)%'O_!*'],A+\8.\<KPL<S%O0V)W33PZ:(],%13C#GULYL0\-+D:BG<:
M/GGXJ35EMU23?T9(\%U1!:EZ837VZT;WG32D;D]V:^1(%65WCGJG>T;06\#"
M;\9S'IU34--0+5Q.YNNVVQUZ:#%7J<.);\*R7L%S8B]JXM)];7N$*PS2E K7
MQHF9:@Y]+]^[MVB/, U64QZWG)%:AC"19 <)XG@%B/_*$1.WK#M#75^XI.I7
MCPNQK83,E ()]FM*L FC>B@''*J#'0^6(@-TPWBHZNI4V:>"-8]^5Q#!/Y@0
MK.8J8>.%2@N)Z>#48G&:#5LP)L5+;3;8F>JV3<<#@U\2BMMI]EU[>V-Y^-G"
M!R2=4:+)"PD:_4CQO))-_=C7@8[-&@WZJ:P.GZY<,=3\?]A[S["FUG5=.#21
MHA%I(B4B(")-D=Z"A28B18K4J$@7D-Y"@BB]"0@("A$!$0$C'0$)2&\B78HD
M=*0FE!!(X8MK[W-]<^I<>\US7>?LL];:\\?X,0:,=XSWJ??SCC?/C8F?>BX
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M_9%X(D,K_WQ):W'\#,LBDZR#O'A4Q /MZX_Z*H-0:Z5$URE*ZVXV]]"[!E!
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M&*JW0GFI40<5E]XB'V13YF09$>O*495]NF(SI>,)EP\-GO-(.?S4G#@TM?P
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M)<'UUCJ/I<YL4JZ2<=?1P37C/U&+R#L9S\@DG^N('[YU[Z209C0G5>1: #H
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M#^<,F!>*F#5^'^ZVW2$R[U"?\=B35D;FK54PX-*Y> @7I1N.U<TGUU#8G \
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MP/J458MJ^XQ'D:HS6N:1I1K (1UT$K)_F0"D'#U,,"URI<ZS^A').[=9HCR
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MD0A-7IWX'+;+"J)W:PXKSI[3=B$F__*E&RR*<@()0*]2(1.F#B:<,MT7OGT
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MZI2+G[)_EUU5!%_\(UK5B-L:MP;3S#\O-G=;@#'%\"I=7/ZVEQX6A%G;LB+
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M2TAI5G9'Y2]GG\,-EWVW# E/';"^=N<I\KDXO?#;0)%0T0@'PXLIB3^VG'E
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M&@SC6M<A8^+0)X*5:)WH(\,K :NP*Q=SQ(-\]\EG2D4M50AP.T66L'/+:WV
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M(APCAI;U0BN/Z:N^MB@'8W>]37;-MO+>C=G.^RNDB)K'3'VZM!<8 GAV8Q.
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M"'\A_&\AE/D19^A&W[:)#CZYNH%Q&X]#BWYWD *<!T4MN5@3_P-02P,$%
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M>8Z,-*I?<UK;7=_ES+=[^"?=#E);HL['D612!# )!(<HPABF3! 8HH0C+DB
M/*,(RP/WGAH!=-)9V'0[8!E8XOTA&/A%7FU!]^A L0.#A27:'XZ1#$=S6.Q,
MN\.*G[3$=BX9SW Z+.N6G7/D*SWXIS-X\J*\7:C77I25^J'[:R%X$V&>D7FS
M-?XK^:$3+-:!7!^RIZR:B9C)!*<>%)P)B$@D8)J@ (91S' :A()Z1IVC'<HT
M-;YKN_]F_]V<2$G"6@<G5^9H119<K^HT+XK\N_JIO )/C5I@KK6QH ='4VK
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M'>\+073J>O>595SG^T+$]MSO2^_7(ZK@FO-,G_&1^<VG+TW&SXQ@F0JF+,J
M4D_Q'D$P#96GS0(AJ)!>D#"C.E/'!I@:GZU%!$K&+JE,]SQJ?C1L='043X/S
M^0M1&MJRVP:HD>]"4"R.OR\$9Z2S[ V0VB<H6[#YDBL[5SU)U:, E)09JS<*
M>#9?:@.8D3E;SMLP$QU1J[Z6%8#KBLFY!%F7(4D%(\M2@$4.Y+)HVF?FBS+C
M-56HB[,2\*4 A9CKK2:]4N@!LXT,2_W[<J$NF+_4H;QMPN7IJ;0[-C\Q3R?/
MP ]=-]Z!]@FIMTZG3WUOY*Z-;<N?NW4XTL=E'6#(L$A3SF,H0ZZ#4E$""?8E
M%(G/?4]R$5 R8@O&8W+:O+WC]5/<$/-X2T6K%6&XB>8^C3P6)A 1/X1(, Q3
MHF,2 JP6Z3C%7LA&:XKH;IJ'[W"X,\F[30XG,KUF;L^K3MC )H>#GH.KKH(;
M>EZ!1M,)] T\-PF3: )X5,C?1T>_<Q@[:\]W=J >KMGMHNY;KV_\Y:6LQ%.I
M[OP7-9@:<)51H.,_/,Y@B(,8HC#Q(/9X!*,01VGJ)[$,S:.Y#0:<FNNV(3(H
M&YEK _NQE=K"23&!V\"3<PSBP#2[B=^7#?PZ@?LDO1@]M^;>GV- 1_(&+P?6
MSO>R0.FD+V9RG_%\,PNMMGPUF^N&/52HFXZIIVJ&/>I)' 20>$29[2EE, U2
M#T8)#5&42DE]NU@]2P&FQMSJT4/#'"*L('=[>- 'R"D>&F@=QC\UV$7O-4X+
M5C),\I1@%Z&^IP-[]^G9YK!-7/PBBF\9.U+O:=5TNC:"R_N\(O/-S]_F9?4Q
MK_Y+5+J*P\,B^V_!9Q0A$5"$89KX*40($8B)%-"+?"$"P6(OLJJB,)BD4Z/,
M6FBP7!0K"?4V[MHU9KE.GMK8 UZV.K=E\RQ[(P[V )CQ\B2F=<1=CH/%]%;Z
M=9L:6B&=(@)>1 76.EV!ZR==N=AA<\2AX7?:)G$P8<=MF#@TYGNM$P<?L&=
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M1X_G,3E)CB<N'X\:S^NP18P&7^^=-L^$3BK53\;GK/S[)U'H/Y 'X<\\'*&
M!1CZ2#=]Y F&:2 IE!Q3FO( 8VIUY'5JL*D1Y):LH%#"7NGTCU9<Z]3UXR";
MN=BNH!N8/[=1^URC]ND\:GVRSL_"X3C!_/AX8^>2G]7\0-KX^6LNZ%=(SW='
MHKO=D6Y^/&>-0)_J-F\S3@(_$JD'E?450.3)!)* <Y@FV&-4(DJD56*',\FF
MQDQK^4#3(>]*%]S0]34L#\W=S9WA-N%KS,C07O7E/>DVYK-1SW$C.I>(.V]
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M!5;:@5J]J]6._XM1>9&!9]*F5,$KS>A8-0[&GEG+(@D#H'^ZNH++ 4<LRS
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MC^HA;2.E(@]1&D4,,HE#B$+.(68LA#)@H8>]$/F!7=R:W?A3X\;W9RJ_U#J
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MB@[N)-@0'JRE!YWX/2*P;2;$8$M[()B'/GZ;"L(6N]H#(3W2MK9#Q.WVM7O
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MIS&BL4=@RK /D6 "8AIQ& A,?.[%*<=6OK35Z%/CS WAZRVS+?'!6G[PM=/
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M[X.4_1[[:1R<;K<?&6K<G??3^NYMPI_Y>N_]^'S^+5L\-.WDWA-6%WML#>6
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M9#V!-#1+V>-CS#\&".RXI6C(I1#L7Q]6/_Y-W5WQBOKAD$ZZGCP*51BHUM"
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M>B&-@S0B@HG .##>?ORI\=.NC<MS+:CZN904_/:D2SSJ0L4VS<<=IJ2;H48
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M>1VPXQ6M?$,6NC>++C'7*D]ID^W< 6U I(<3BJ!'PPBBD/D0JU_!($(>2[V
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M@UZ_\U/CC/NU=VAZ],UW77M-YD73Q) %::C#BZ$G<*@V\B*$-%5;>IF&NNV
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MK!QGQ\*>'!#SH3EF<G"[]!0;#O:QNHYYAM^Q-UD__+J[ESD^<\3^9OVT/>R
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M5ZQZV%6=2%QM69U^^LBV5:>*Q]95]^77A0"<ZRXE8H1%A#FD<1I"1"C1&ZV
M0,D1HA&*HB!-W5)3+HSH\JZ/DZ)2UY0R=I)L6DVQ2ZVF>H$M4X)#TV#(Y/U
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M@4!<&PJ(,PH1PR%D/$W,\2=*HE"@E"<N)L/YH:;V^=[P?V[S(N_AZ>B T\X
M\ /2P%]T(R1H2PDJ,<&?]7_OY<\->*=?[G]X7/POP^-SR>\8;=2%_K+6KY=W
MBSO<%_4/=?^H>WWK/$19$L=A!"DER)0"#"%.A(!IS @B&/$@M$I$??W@J7%!
M(QLPPMDOX@=875Z_^R(P\(=NI[S3HGU*TRO6ZX/'C;94GU*BO4J?_+W[!W?+
MU?IF*W*-YLUF(XOJ^.33@C[,4Z*48$$"0T9"B'"H]_,DH5!;T2C%...6%::Z
MAYG:QWC[_M-74(L*6K("(ZS]Q]F!Z^5/U0]:0Y\E] +*Z4.^C,,5GW7'PT?[
MR"\KV/[D+:[N&;MB,H-^7RWKPS>S53>._KKJT5RD<10)O9L.D,E,C)(8ZI>#
MPRSA/"""L8@X=5/I'FYJA%"EQ.6EB#/3J<HQ7J0;6SN3W1]B Y-"!59;TEWZ
M8"WL^3*A[E$;5JAX#<?H'G'<. LK[8\"*.SNZM&D^*MDJ^U2W.OGTV>YW>1<
M;PW6SZOJ!+$N-LW#!*<L8%!O[A5$611#+#"%@;;TJ0HH)B&Q;EUL,^+4V*26
MV:&-KQ6NW30R"%H#,TDM+FC+"UH"]^F(; 6E0Y]DWY".U#WY>FC=FBJ[P-39
M:MGJ0>,U8';1ZZ ML].-/:CX7J,H_[I:;A[_^/;A\^V[NZ_UNTUIF%+!!*1!
M1"%2B$,2J1"F*HPI-_$5:6A-O^=&F1KEQO#)" FTE* 4TX$QSB)I0;@^\!F8
M9$L1P5\/X>G#K&=Q<F!3'WB-Q* ]<7.CS4MX=%+EV9O'H\=+\A]0XL6+^^UL
M[]>2%MOU2YG%UW2883A)>(1A+,,0(LDCB,-40:E(F&%)A"#<93M[8HRI46 C
M8M5]P&T#>PI"NUWKE< ,S7T'F S0_Z5#?9][TE/#C+H1[=#S]>ZSZ]+>P?CF
MF?*#K/Y[N[SA7!M7F^(+?3%%;6Z60O_->BM%NQ6MR$049/KSYY&V@5"J,,2<
MI#!4,:7Z[Q$*G*HZ]!-C:C31R R>*Z%G@%8R UGY!ZIJ#:O2R<.WZ[4YM^G=
M2KCGU-EQS_ 3,K1[O58 _-*H\"O(EV W1;4:Y834B@S3//@Z)#T'Z/>19.S@
M_"O0.A&8?\W3^FP=?ZSN'U?;0K]6=TMI2B$T6\<XHC%+,R@D"4P^:@8QCD*H
MHA@C'(:*.WCNSHTR-4+4HX7@BW41FFX$;;:,'G 9VFSZL0*-C$ +6<+3:\MX
M#B>7+:,'O,;:,O;#S7'+> &/[BWCN9M'W#)>D/]PRWCIXIZY#DV^:!/@5,<Q
M%S<_<VTX$HRS6 4:/Y5JPQ$IR)*$P9CCF"2"!$P@IR2'KM&F1H>-;.!/(YUK
M"D,GKG96G3>T!B9)6Z#<,Q-L /":DM YX+BY"#:Z'R4A6-W4CRG^1A?;*OF\
MJ?-2:'OLJRSD^KLLZN*;*N(TBE "LS F$.GM)609BF"$.8MQ@/7?.O7ILQET
M<KSQ\3UHRN'/0!C!@,S 3I%]F9QJ>]GHTK,>JM6LV-&-;ZR'9IV!8'9F*1?<
M?)*5U;BC<I8+$J^IR^G>GJ5331WHLGA&&1?R955LUG*3KRO&K-O;?<@+OE@5
MV[4T\?9EN/T\D2$.,T)@A(@Q@S"'F*:IB>@0*8\B3KC5;O!:0:;&=%\_WM]^
M_?C7C[_?@W<??__XZ?8>?/E\\_LWQR*F?:?%CM;& 'M@JONZDQ<T H,_!TD'
MN18LK\5!^\HR;MW/*Q$[*NEY[?-ZN,'>/YHZM;?+4P7C&D_;R]?58O%IM3:-
M>N8TC)-8DR(4F$80$2HABU4&1<1BPBBABECM"WN-/C46W!5'W GKX!=RAM["
MKS8DH ,S724ZN%V"':I_/RPYN5, _&E4 +4.+KXX9\P=?'1#8C^2[VZ .7#S
MZ_7%L-/?Y_S0\?R ??4]\ _V?LBU#3A=>J[L;3<4)4$48P8SP3.(HDRO("I.
M(4E))J,HS#+L%)9RI3Q36U/:/1JKF2WJ\]#.YD6=U78'F4=+3^9XLS.TUZ$U
M,7U:20V3Q>T)WV$:9?83Z8W:8UZ%W_FFF-<]MB=%7VK$>:X/Y\=_;O5:<;O4
M.X_2WBA*D>\U#=6= ?XF"ZW([;(JFOYWF3\\ZC_??)=K^B!_T\_??-":?J+Y
MVGAUY#P6A(I,)A"GA$"4J0#22!(H>9JE:4;C1#H5OIB,9E-;-K[*A2Q;D/RB
M%PNA%WNZ+DP; 5 8.,XGHTW\_;%<9*8B[Y26*XO^SIWMG6>@0@>TX*D7NXT&
MJ&YF4\Q A9$Q4BJ49J#!"=1 @1(I8* "!JO26>^A",)DY]_K<CH9Y<9=F">C
M]KDE?G("]HTL+GL)%84Y<=%W/]XLQ0?Y72Y6ST:Z.E@)*T28WKJ93MH!1"0-
M()9A!G'(*8\2RN,8NP426XPZM47V]LO7?Z%/S__^P34 V 9ANZ7..VX#+T.W
M>E6H! :-Q.6I;$OF 5(2G%#R&[IK,_#(D;H.6!P'YKK<W(^ =D1VNWS>;HK/
MYO%Q$XV;Q$F<TDQO'8(8HDC$D*0(PR!),],F1NE]A0OM=(PU-;(I90.Q&]5T
M86E',)X0&IA6]E:DZ:]H!)V!&K !Z,0"$Y\DTC7<J-1AH?=KPK"YI<<YY4>E
M)-_L/";W].=7;0)]E4:1?)&7II?^R_=Z2,U0_^^*%3=\<Z>B(,Q^6ZP87=PN
M-_K]R=E"?E[],)7]1?4D;6.9/HGS+""8)AF!)(HP1#)#D#)MWT0D$RJ- DTW
M5B7Y1Y%V:E15":UW@(W48+'Z 3=&[KJ@$/CE__QV^_G^]O]8>B+&F72+$]4I
M3>7 G+I3M=4.!1AMP:&ZL_(71F.@509&9Z"5!G<*&+5GH'X=]IH#K3HL=:\?
M/0.U^E-Z&QS.>J?T5HQT-CRIM\/M5'FLV>H\A1Y<B/%.K<?"\^"4>[1!>U@G
M96M-,VPK.?&SWC1)^>K,%"<\S2B/8):H!*(T09!@GL$D#HG"@M(861V'.(TZ
M-6OAV_;Y>5%ZR#0-O*.+LG'LMT<I-^V6%PXK@S7\%NO]$* .O&Y7(I=LVQ+:
M[(>,V"ZGSU= Z[!X#@'Q2(N@/ZC=5C!7R#I7(NN'C;>BN.IWL#(XW]R#X3](
MMGF_^BZ7=+FIW/)E-A_E/*-"$AAF4081212DL4BA"E$<!PH)&:;6?'YZC*FQ
MMY$2-&+6)WY.>9)=>%H0]/4H#4S'@P+D0+/7 S42J?8!S(T^NZ'H),LSMXY'
MC=VR'Q#AA4O[IHEKZOPJG_5L/YJ3S _;=;Y\J!Y?GF\:%@Q1&B0"BB"((*(X
M@2Q,)20!(BS4DRX2.E_*!Q,#=>^2,GYI9*N7F50O\]'X UH)G,N%*3NL=[1E
M^$T!UGLUR@B=ZJ]=PW(N3X52$6:12=871)AXJUA/!4\@05CP, QB(:Q:B7B>
M@S%W%V65LS;>HI39!$,98AD2?;L3%K^8#KR:57"VI 65N+M8GTIBGYG_MNCX
M3?^_..K(-0!L43@N!&!]9[\%X8-4^5**.B'-E",Q_U1&>).E]H7F8LY3'$:!
M,8YYD$"$B818Q!BF61;$B%/!TK3'LF [_D07AUT:Y[.6T8V!K)&WXR&O0(YE
M6Y<B@UJ\LK;0K*HP5,D] SM\OW3AZTQ+KF#Y)"?KL4>E*%=$7A.5\_W]Z.KC
MSXU<"BF^K%=BRS=_IR9 ;_-2=Q)D,8Y2F@10&[!4<U1JDI&2#&IV2C!'$5.Q
M4R_GSM&F9BK50H):2N?"EMW0VI&0-\"&/ARMY02O0'N9C=*LT0HFGYS3/>"H
M1&.E^VMVL;NIAR>P\BS>-6UE/INLB]^W)K[E3GW5M/6#+NHPWGD:A3()N8()
M#_6^6"4,XBC$,$I4%A!%B0AB:^^@_;A3HYE*2I,VMZ[D!*M*4/#+:@V>5M;I
M*:[X6W@3AT%U8"ZJA)Z!G=B@E'L&:J3O%*AE;Y(TAL'7P1DY#,XC.2@]XNWF
MMW1'K=.7Z?"X\?R;[CH>^#Q[W#Y "2ECN3;-J=,@0DRE(:11JK1=21EDYJ _
MP\RT  \%8E9G0JX#3XWV:[EW&S*/I:':<-N9F4. .##+-_B5=73+M+M#J<MM
M;S&.^>D*WVC%H-IC3Z?XTPE$G(H]G;J_AZEZN_RN'[9:O[RGS_F&+O+_D:)N
M@%C,$QE(@ICI#!%QB,(P@RP+$V@:PP0T9#$CTMHX[1II:KRTDW4&^%[:7><'
M!U.I$U\+X],7:@,340NPEJ#@HV? '*Q)7\"-9#_V!=#-6+0!I=,\['S > :A
MC1X')J#5#;ZZ[C1]9>NN,.V&+5&&D$!2P$1*TW10FX D)A+2+&5Q+"(I(B=?
MHLO@4R/9RF!9KI9P@/8Y'7-@9PT.A>S@1'RR5<ZN%W4#]4CM<2YC-FQ3G([Q
MW[@5SF5D+C? L7A&[_-;J1\I=G'TK4?_+C?S"/%,!3&%# N3Z1\3R!*L8)01
M*H6,4$2L>J=:CC<UYFK$!1OZLS]I70+9^H36%W3#'\Q6J+62@PXBI+6X7@]C
M;7#Q? ;;.>381Z\V^I\X<;6ZK2^OK//OM,K0V94VT?O;_Y#B(5\^W)CDG7*H
M4P6]21@*&1(,91"80&H508JH@%D:,YR2B*O0J4_A-<),CI$^?KW]V\W][=\^
M@MO?O]U__<.477>LM'[5Y-B2U3B0#\YDC1H'A:^,%Z[6!.Q5 7M=!BK+[@-5
MOSQXA3PCD^3UR!TSJ(=G]MV*-NF+58B,)NR//_EB*_2XOZU6XD>^6,QYDJE(
M) PRDNDM:"ACB'&&8!PD42:S-$ICZK8%O3SHU.BRE5A,ZYBP98?QT1_LB+-$
M$,*A!E="%,4,$DPH3-- IA''7(31_+M<L]5;P=T>?#S !X#:=EOO%[[!M_,[
MW)K@12TQ^&4G,VB$/A\?T6,;;X^1W^V[Q;@C;]OMD3C>KCO<VYOOI7[;-N]7
MQ:9H>39OQ']OB\U36;.&X3"@7!-0A 5$'!-(PAA!'L8)CY&4-'5*]K@\Y 2Y
MOI2X.;TY.-')EYL5>%ZOGN7:A.D]ZSLWL]*0D__<YF7],F>JNC0EUD3E$>CA
M::K"N)3VX 1C+Z]7@K+$QC,]71IU;'*R1.$$-=G>V3,0QA0$E*+XI(5^OUIJ
M&V-CB- D'\Y5&&+,(P49I\14"160R8#!4/$DU;]#,<F<8E_.CS4U*FI$!68R
M =\+"Y:KC>GA4!1;4^G",0RF VP1\D2A0, HY*93>2A,R%$*,:64$\JP0M+-
M_O0$]SAFI[&5G@] 7RDER]RTE3J8@$(N\]6ZF@=_\-M1O2=(!^;XPY>W)2<P
M@GJ,([J,AM?0H8[AQHT6NJSW48"0Q2W]"/P]7=0QD75AT$@$-!-<0!Z7M9W#
M"&(B0IAD.$WT+I>%S,GY^GJ J5&UD:^.U'6C@R/D[#C@&CP&_O!;4 Q0-_6<
MXCZ_\:,Q1OVPSVGX^FL^>UV_3W@7[[QO(#.GL1229J:OEOYV$4HRB 66,-*&
MEPQ2'F=*?\4K;0[:?<4GQG#ZD'<C#1AEL@O(KZJ,NGW-IT",)"$I$A@FL<P@
MD@A#DA@D$YDIS G.I),#]5H0QPC5\0ZB'2M>"<W Q+A'Y:"7ES]N[%#?)SV>
M&F94ANS0\S5)=EW:<Z]:M=TH[I2QFV[K+5BY-9[S2"H<2@PC(BA$,0KUIQYH
MTT=2I%3(&<IV56LLMT_G1[-ZLP^+$0R]7ZU[_>B]DC %F)K]J=XY%<[)&ATP
M6VZ3KH1NI&U2+:4!K:Q:U0A:^<8\[I,NP^%UG]0QW+C[I,MZ'^V3+&[IZ8%_
M>J;YVCS\;OTA+YY7!5W<J<^KY</G_+L4E>=?4U7E]G]])%"E;U3_WH=2)$P)
ME?$4XEC/!*)(0A)G>DY$F&1!K!*&W-KH^)=Q:O:)40:6VM3'9(Y.^P%FT=++
M_[9S,_2QP$X[_5&!1C_#C$<39EIT-$>:)PX]QTA@&W NO!Y##"#FN.<6P^%\
M=- QX% ]'6LG&G"7H[5JT[Z\JIO,>((YUBL RZB$*#%+ Q8<)ERE*&0B$(G3
M@M!#AJD1_ID.V+N6]'419G.0N_L[FY0';W-FZ?4;=B:&=@PVR/[0XH-&_MFK
M69@=S\!+=<3^57*9?R_+80_9_OH*D+TZ(7N(,:Z?LC].1Z[,*Q[5CU?_1M>Y
M>9YI^%!6049)$L9"E,G*VHH6+(5$2 K3*,TXC@))N5.FW>L!IL:(C7Q5OQ67
M6M)G(;3CL&N &9B@G#!QYI5SBOLDC:,Q1F6$<QJ^_MS/7M>SG'2]N-^I=]LB
M7\JBN.'_W.9%7M9H>??2^E/)(7,E9"2B,(1,)B;*-D FN#F BO&08AS$G%LU
M9NLKP-2XH&T=-1J M@HST]6[]1?U^NM(&,[S9$<H0Z(_,.'X!]Z]-G)/]+Q6
M2G:58=RZR3T1.JJBW/<YUYU3?%JM]Z6;[]3[U=/3:EE6=)Z'$F<BRC!$IJ8
M(I1#E@8<*B0435$LTBSJ44WY\L@]CB[&J*/\I9;5?(X;DS.]7;^ P@C<[^RB
M WJW(XPKD1SY)$.MUJWJ[N66NQ08?.N$LO>)QF5TACC8Z!CU3<XW+J-P[IC#
MXLZ>AIFI#?_.5(S7SS3!]&51G!M3-O6A+$KU[F5_22W-S0^Z%N6__B:+S:[,
M?#BG,J$ICRD,$%<0J8Q!+(($1I+&#,52H$@X&6T>A9N:05>*"+Y7,M9=*AQM
M-9]39VG'O=&$#&WC&9DA*_M<M!4#+<V,E=>^KCE(+S6;5?\!M89UEPR/%N
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M=0.W@"D2D)3 @'$!4201Q&%B6H'&7$C"9.A6Q_#<0%-C^?9Q<\^#]YZ]\#P
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MU?K5.>,W3V7]U) SFJ(L@YR:%F&9))!QQ&"6D#!4C$41MJ\P-YK84UN+&J5
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M(@IIEH6"!+2("FR5-_NVG:D%1=O$T-Y.RZ39/3@U-QHO!\GWEN$!/AYDRL_
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MFI$86XJZCNC%U,:<V^?'1UR]@FL!^G>MW?^%'PY%]C_;E-Q[GY=%<\=LZJ_
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M%SEG2X(T32$5))&T1E-89%D&PQB',F))@H0;T=IP<U-CL6^?KVX_WX*K[Y_
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MUGS0V7\^*?MRN V2'3S"/E(6A&OXS3(D+/$;3)TP?>9X.166WKY)MK!]AME
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M]!KMZR<BZX06HNXIO)5@#Q30H0)J6, ['>.S>PIK_4$?&J"P 0TXL_;/>_B
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M<6N.'W9"?"X) TDZZ@HR+-J'"\[ H[FM3]>K95VX^._%^N%Z4ZW5KK_\U-8
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M4J@ 10N81B)C:H%>B,2*_'>@^@TM\C6R@UIX8*0'6GRP2BCH Z2*#;$GBLM
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MPTD(B>%R1/_1>8K>J,]>4*U<IE!GH]R9YF%-6A4LOI0&FP7K%4LCE0(346%
M&TNIJ72>^* #T4EZ:F(P!AZH\*X%R"NZANFP-P#H=M-$ \ ZA<FD%(G %# ^
M0Z8.TOEXVO4 *L6'&]&-E$V6>L@D:HN1-TVN]!-4Q)BDO<3%$FT5@[<=></T
MZZL*LPIZ:0!M!^>E[OF_.]4<YZ/2/_GS.$R@Q#3+Q2A"0!]",&)$I!C.X-H)
M"KE)5#'!-#H0K(H']S19PW3\JXJN'O6P,ZJ^PCS,*@66HP0QAB(<*T)I@AI+
M0R'KB&9,:VTR]_I% LIA.@16CP!VEO7N-FBV])->L')\ <6&3C^OP^P/,]RT
MI>:><QM(+EE@:23ZA08YHMYRFZ5D'!ZX.KD_7!Z@95B7J4;J85^!-X"9H^E7
M6"S7CE[AH;N>@3\9,8P9G Z&&&90.#XF8G$]D!2L2!929%!EQWJ,H&$]H1KH
MZ47T#;@^EW1?>FZ:28:Q)B/.E,L;H-%JHB]'5!8&T6]#8 \T ^L#.;?H&-:Y
MJ0.8W07]?)RX-4ZF\+E4+/6S02V_P/SC;#J[;3<O^>%6.R&B(4(BVJ7R*!M7
M.E9XX-9Q$;)ZH*RUA[WJ2;*&=72J;%O]J:$)\W.Y]UX>,(VG*V1JLSG/IHLW
MD&=S6+_OS'^#Q6_CZ6Q^>1<1%Q3Z?+<_Y=U_K?#7O\'RRRQ=F^G%*!@4KE6&
M!&M0-+X,'S J$6 "O/,RLH<ZM/=UDOHB/ [3[;FNV6P3($UX?QN6-VO_#4PA
MCY<C19G@+ELB,/)!<2M&?'?=7P;I*,6=1CW0<Z<OG-^C9YB>TO4QN9_@&["]
M'V%Y(_3A(7+GHB=<E?DLD!/QH50N9B-2X!&9JY)*O47%,.VD:V)E=R$W8&'>
M^?D4;>WB!.;=#8HKB4C%0$/0Q,;2@BAZM)0V"6),$(J:;(VL I;'"!JHQW1-
MX/0B^P:LS%T^WOC%.(Z4<CDQ<$1J*$WX<:OU7DIB98PI1AV#K1)F/DC-L/40
M_2CZ!^AYOM2;2*#?9>/M>++">':4,N7,LD0<E/,E#)C+90N.&Z_-S.C(Q$/7
M%?J'SX:>88L87@1 NTB^"0C] 67B+J0#_%#_>=-5]3C?NQ%X7<W-F4N>&:*#
M5+A'0\ ]VCK"K0J^7#37HDKN]+F$#M0UO^:>5U57#>R%V_*WMM;&*"E=BB31
M$HYJ \0&7'E4)8G+3&;]T S*EP-B WMG7<#LB,[G:Z]=:&[,_OW[T]Q&#0EC
M768]D-(+CI2N3T0#;@Q>:F%3E9K\9](Y[,[< CQ[T> KNV=T>/S;R:=W?W_W
M\?3H/]X=?<1OW]WF9+\+1P]]?,V;1S]DIZ<K2%>;>:F]*;O[P325EBMS^ +3
MQ?CK)LEZA5;E @.?*1%=E9<I4SFS!*(C4*\S>H.TRM6D9]+9;YXL@(E&\EPJ
M4\JRB?@JQ$ <1<]8I: ?'*<U1)ZLVJY;$R=/Y\^>(_P&-M7NK.X!R11>UL<6
M9_[;2:EY0\4ME_-Q6"U]F,#9[*13Q+53S0Q7O+L$FM&S%BP2#.0225Q:HZ6V
M[J'N43T=KO; P+#;\$OB=1"5-PSU]\CQ^/-TW2DV?N_&.Y<&LLC]-'7?3=8X
M2/]WM3Z'VT9*(REB5"P%8H ;(B6JR(:<B<DLT2"I-@\-%:BW(.JP.:R9'P;*
M6ZZG!G#5\*I["_/QUZXB?_&_5\7+_-[=T/T[I,]P0W==)PK\BSGX!?[-^M]K
MM8FL=:"*&%;FCNG8!2.*6,F9I%E(R5YTC?7!U+ ;4=,KZL4QT_#Z*0HY](LO
M[R>SOSH!_.K'TVLM?8(X\8O%U;C@8G+\MU%F4FGJ.0G:!-0* /H-&&"#"$:"
M8I:Y*O%0KURTN>>\/#B?X=?51<IK7"9WV;[2$%JNJ 2X0*).99Q=$!C+,8M>
M-B\5TL(XJ%(YT!\+;6XAKV^!](.1U[@Z#C(^_%'V-YZHC^6NMPQ$I:2(Q)B4
MN!PX$32P  $-ATE-+)1MN!GV]M _SIKI'3D-%)D])823\H-NU^S>54:KSV$Y
MGL,ZH.O*+D\F&.Q]A.7O4[^^/@KI2ESS\0)5^G8UQZ]K/5Y;&26I#%%D$KLF
MXKF,*?%6$+" OY!2^5SOPL++\]OF$FPB\FD):8WO9ULE4:CT8$2R).4RJ4$+
M08+/0+CWGHJLN Q5NG[L2_BP2^0U9:F?I>+&]YBR0H-V% S%*"S2C%NF+779
M&K\PSIU-UCO^XLY6L[%X'9 \ Z'/U=B^UR?/7L2TXL9RG'\D4=S[F,J69"IM
M&:8%&!G)3(30/*4HC'KYZ'D+NH>]_MV*8>U;P0W8U0<XO>1R%)DPV2/M7'>K
MGW+B,# A*%GE0P;%0Q7_^@F:AKU5_I(X[$LQO6&L7N'7FX,/!Q\/WYW^_=V[
ML[W[2M_^L+Z+NIX@M?\2KO?CJ9_&L9]@+#/N,'X)+,]8!NX4X=&4-CL>B(V>
M$1\UH)D!EW65:I)MB-N[E5?7*NJ*52>8%S$$PC/R*UVY[")*565,R7&J(9HJ
M%T5ND]%,N58_F+C7MFMWF3<0[JZIWXPROKX[XVG0"G3I,,;*[&M!G-&4R #)
M*!F-,E4N43](S;#XV4>]#R)E'UDW )B2F2U;-_Y3.@E\]9/2/>!@>>CG\Y)!
M_@\_6<&(@4G4)X7^&RU,"85BBIQ$&\ 8&E!250"T%74M &HO%-QU=WI720,X
M.XAQMD(V/D$$9 G#!'3A+D>N9R_*93OTVG29.1*R+DWSBKU6TJ=,HY%5O.NG
MB!KV9+1_5/6F@ ; 5/J<3/$MWY&%D4[14,L9 <=,N1AJ20B^%+U%!9;)X.OT
M";])Q+#)UO[!LK. &P#'6AKEKM#B8K;PDU_GL]4%1HWK3N7XT[CNNP/IJNW.
MY3((-O&L,9BDB:'?B!86.95=\\[HM*#"Z(H.]BXD#YN,JF"E7D9Y#<#T9 X7
M?GS9X?7RJ.Z61$?4)BD#Y\1)*)555A$O72B=IR5XAU;;5+F>LP5MPV:?^@=>
MW^IH &&WB4^XQ2>= ]'1E461#+%26>(<S<S&%(!6M&W/04VU#H:US-4N(FX@
MWWTR+VT7E]]+)4#I*U>"C6[00MGT W-&9E:""AF+-67$<IF(EA@O&[!@=94K
MT4\1U8)+WDOFH#?)-V!EKCI/?RB59)_*M>WC_/MBW>9^)(T(D*,EFO-$9%9
M I39"4+C!BU2U+'.6?135+7@K?>"H_YDWP"0[DY(P+5P-5^HS,+Z:SR9C$P0
M&']@9)H!OTBC(O%! K'6^^""-,%7"O9^3%P+OG@OL.I=$PV@ZXKNJ+5BAD4"
MH<PW3\&0X+3';Z60U%OK1!6+]"R45':<>T')3A)M  EO-X^]:GQZ!?*1Y-'%
MY"21LA0L).Z(]9"(=2QPZXUDN<HEP<=):L%A[@4M/4F] ?S<" P_SJ9QX_LS
M4:K#-">EI)=(CU\\AH4D>L:=]YKA]ENMF.DN-<-VSN[3P=E;U@T 9C/P"6Q
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MTW(OIUNMPL2,_P$!K=$O+-W8T1.DQ"JGN''6R3JC09ZD:IAY#"^:'N]/*PU
M[ X/FP4II4-CKU >W%@BE?'H;R(2<"4Z36G U5.E@\B#U R;#.Q1VW?OH.PM
M^@;P\ZF4VTTAO?/S:>D,L3&T2D8MF<B$R81A#Y2["!$7&= 82K-_SJ&*;7J8
MG&$1U(.>[]T3V5OH#4#GWHWG-]_?P#1^02/^9[>XM+16BK*X7-1$VH ;=124
M* TYRFQLRG4&#_V L&'&P+SH'M>K;IK$VB4WF^7(/-,T"T68E:53"#J%+J(U
M3]&DY)U&J%2IR_D18<.:KGYA\$.,[:&3!C!6*H86FRM\'^$RY) R,9^E)S$!
MQC:*(1,A*9(D^@C6&,%UE8L?#U+3&IKV4?A=KWQOZ0]]Z-YU(#^(Z"TLQM>5
MEQ%<8!Z= U:&ARAN24CH8 9%!4TJ4!/O>.*/G+8_].G##)]ZD8VL'XFV!HG-
M.DDQ)@:EX%%;1'4V@@1F-<G)*LN!\L#83J 8<L_I26-/Z7\'\0V-@$\02@?Z
MLR\P]Q>P6H[CXG VOYBMC>AEC8B)3H&0:.5* 2Q3&(6*K(G-(5MM&<^P74G.
M-D]K"!V[Z'-64[@->"%ET@5^VOE;",LS_)MN!2E/#:?9$6>M(5*K4JA<!A;$
MP!UXIW*LXMT^1,PPL^A>-'K:6P<-XFBSUAPX!EUNGGFTQ8Y*=*B,(5E"4,SY
MS%V5;B$/DS.L/[N_FG^ FQUDW@!RT,W_"O-E&:I3&+DL88@Q9D438:P<O5B#
MF[@'M-E,,BDTC5S6:B1XGYJV<+.+FN_'TGO*O '@%,J/IJ7/<,FW=ZLI"!F4
ME)8@&^62/@3<?+E /4=M0!B9ZK2?O$_*,&,L7_8VZ'[R;PY!-TNS(<O2[Q?E
M8*&,FQ#$)I9(=EPEK5B@L<Z]ST<(&KC ?4]%/XF;':4^=*!U]M?L[,MLM? 8
M#_R%;'Q_/_X*IS =S^8WC.O'V1*N;O^E ,B'(EXF2:2/G 30@@"US@9PUND[
M]]P>B;J>_>B6T+.KNF<O)OL&[-*Z2_G1-,$W2&>SH\5BA9^]/AA<?^T6(0V:
MFL@3,4;DTO@H$TM#)EH9E"/$[%65JV+;D3?0K-T7W0(K**IQ^-UP0#T+TB89
M$"&R'$GC'N"<\<2 X:"BE\I4Z3^Z'7G#&KT:P'@&]G;44@/8._23R9JS2],M
M<9_PV9.@/0;('G<)IS#@$8[;$A][FZIT>[E+2+MXVE79=V/"?23? '+NW 7^
M,+O1D(1YH)YJ25269CTOTSKI"-,R)RTLJ%2EW=83- TT'7S(S@ [JZ1==&W6
MG0$J66:,N&P]D52J<FZ,Z\6*4J@<<:54F?;S)%5-7<W?7??;86H'132 JC)3
M"U=AJ46X-+HQ&BMT)*[,N)2EG,'9%$N)@]=HRBG:Y#IYSSN4-(F>7;3\P!BS
MW47> &9.88*_^OPK3&'N)UV;B_/Q=+Q8KAM:;L8(7C*7&,;5EBO"/4;:,CC<
MSIEFA!FD/CN3.:O2M?E95 [;4[8>UNJIJ@$</CG%\I*E(("6H?>V%&?)H!3Q
MP"-10<>8A+:!5<E0;$';,.T?ZF.N;[4T@+3K>UF+][/Y$_.'.N<B<O1+T9T@
MP3*!S!E.@BHU'BX)YW.BN8[%>Q:5V^VNK[LO6#VU-8#)$G1?WQS<K"MT:KV+
M.A =&2<2#)0A5P:1PF,VN&A5G:&?#Q$S<,OC>KJ?]:R(!L!T+1S<$:;)S]/B
M]XN$>P.G3%.^80KC(IDC")++U'&I@T$!T=)($NTY>@L<_Z]BV+:A;EBX[0^"
MN[:K=XT,?6"YG=7_,)["$?HDBY%,G$69/>%*(D<,B@\2$P'KN8]&,:GN].3:
MJTW[U8.W ]+K[,M571$-V#(T[U_'9=X4VOVWLU58YM5DPUZY_T.C+:)B+N*"
MX1Q=7*4"B9H+XY2T\F[E<6]C31XEJOF^[3M"X?Z(DW[TT@#&;G5<?+KAXM7L
M(#;BP$3*94Z0U[;,ZN,8]93#-DL9=1)9O-N)LD)GU6VI;;YO<#^HK*_)H??=
MZ^%5_F*\])/Q?T.Z3/R,K(DR:(SLC8CE_%<K8GEI9V)%Z:2CA=%NJTWVJ:<T
MW^AR/RCU*^779=T>G5LURCS;8, 3Z;-$BRX32A*=WR@U"XI92*'^D)0=B6^^
MO=J+V[Y^]-P"M@&?',<=4Z.LE;,N!A)D*G<?/"[) ($8S9-U'*2/50J(;A+1
M? .BGK"VJ]P;P,S1^84?SPO:CW.Y"_%A_!52=[=O<39[ ]=3.$84XZYL72 4
M2O-K4)ZXW$WV<#I%[I6M4Q"Y-87-MP+I!VUU--8"%*?X6;!8ED/DQ0U7XSK=
M.6(&-(HM$<VX*UW=!?%2!)(%R.0SE 'T=4I!?D1:\]?W>P)?OSIJ '4?5R7;
M>)P_P<5LOBS9IU/XW&7/1]X8IAU%VTU+0S$E,G)B)?')6QM"QM"HROW*QTEJ
M_KYN/RCK22?-H0L%]?MTC%S8')3F$DCTEB(7);=MG$(;;0U3B9E0IZ3M87*:
MOTY7 U4[Z6+H?,?A%S\?=POB$,.8^3BLNKDG(TC2@V>L=#:W1 K'T>GTLO0.
M1E:2S#G>*6Q[)-7QR /:OV[20YJC#^$V8'+>S^: DEJ/<X_?S^9^NO"QL/*K
M'T\_S!:+3[#>M$?9T&0,"BB%,LT@1DN" D>,1S-K*/)<QYW:GL3V"[G[L4V5
ME/9\.+HU'*?PV2\AG?78/GD6__PRFZ2KFQ6XE8N8@K D0DJXFH(FK@QP%,%I
M2ZE.)E;9!.^3TG[!4#\HVU,)#1BW=9P["L8+G54BN9P*2RM*;8#5Q'H=6 1G
M0YW1P>O'MW^*W@]<=A!V Q#Y,/9A/!DO40PCKK17P VQ,K"U;^=TX!@R9(Q+
M4TC.5RE7O$'#=F!Y_0GW7<4^M$N]:5/Y'B77N7VXZ_XQ7GXY7"V6LW.8G\QG
M:167B],OXXL+2.57'V<'$WSXM"LS_WT!!]/T:?SYR_(XG_CO)4K%S?P$YGDV
M/R\#,W_STU7&3UW-B\R[J0BCZ 6CTBB2M4=!.PW$6Y2[0-%(G=3]5BJ/-HE[
M>>JW0_3K3>N_#E@T8&D_06D\L6&A1$^?H21HJ#)"IU+Y7H;7L-)#*?G26CTR
M)B!K7:40Y"%BMD/JZS\2V%L1K8&IW+.8?X6/LVGL(J+ER'*1;6F@+\ML8!G0
M$[$BAC+K07F+$9$-58*%I\G:#F"O/^W?HW*&WN_?0B[C&M[ %%\LRYG_VT+%
MQD:CT3[SWSH-OO$+./43%#%:Y](KVW^&TOY6:FLBR0!E*A<5Q((I8P"SI\'Y
M[.[.37UDX]Z+C.U@]WK/ 5Y84:\'DK/I:H'?'R^_P+P,,8'I8EW"<LUX]AZT
MD(+04([?3$:W6W!)DO6(0)54T+IGA/Z8JNT ^WJ/&(95X]#XO3=+8'W2,LN7
MWO+B^"O,KP8,C+@%+9TW!%U:7)'>6.(-+E6I#9>,*^[L=GWTG_G@[<I^7_LI
M1D5E-. FWF/O>LVP$3...5>J]%SI1*<BQU?"$&,U=SH9&F.5$J6GB-H.=*__
M!*,WQ30 LDUIZ/3S!T#?XC*S]7T$$2*G01*=92CR8<19;3 ^SPFDS")!E;K?
M1^C9#EJO_]BB#W4TAZI-;J@DBDJ:?<22XQ@N433!DN.7D$BP6I2&Y3*"%\KG
M*F,!GJ1J.X2]_I.._E33 ,XN:_1._#B-#*4R2XV.HP)#I(V2.",EB=E9)@)G
M+%6YUWR3B.U0]/J/0'86?&.@N5'7.6+<A2Q-N;<H2W/?S(C77)!,$V[@^'T.
M=:J^'Z9G.RB]WK.'/M71!*I*)QZ,>V'1+0H7/0LF2V(M$BTY!UP4UI(HF59)
M!Q==E4WN#AW;H>CUGPOL(_ZADPKWYDM=]UOZ;3S!I3&;PB:U4JX]=/SI#!R$
MMD24X +W9B#69$>L$BXR[1D-=S:[;6>Q_?CAVV'J]1X%O(A2&C!9#[?X.BJW
M!",L%B.7(S59>Y)S3@0W>"@6.!+.R@0R'3&XK76^^11=V\'O]1X)U%!/ VC;
M[.W=;>HT7JY0;T?K8[7T9K7\.%O^)ZS=218D=TR6X]N,,4B.FOC(+3$)\9(8
M:./KC&S:DL#M\/=Z,_Q5%=8 $&\/$GGO(QR<%P&.0*K,R^00&J+%!94"QKV:
M$HW1+U4^*B%M#> ]1M!V#1=>;Q*_5X7L#*RO, ^S*M"ZC&P^^>6Z16>Z>>K%
MK:&:.<)<&;MF1'>-FJ'U!LVDI2[(*@V:MR=Q._B]_G1^):4U9^ENS#1:ORQ=
MG#X5A;)1]EQFHP-)C)?K/L(27WI 2(C28+R@?'@!-#Y!X79@?/T' '54]CJP
M>#(?1V CPX+U26ABLBW]%K,BEJ$[P4U@0G(F,Z^2A]N:PNVP^/J/"NJH;-"-
MNI/A)FPO'65OS,.Y,PUG%+EAU"A<6A'9D5SPTLL.N8N!&XR\8N+;51=M];CM
M,/5Z#PXJ";X)KZ\+R"$M2@5]8:74O!_G/_Q\[LL]_JQSHA09,$R5?OS>D0#.
M$*4C95[Z;%FJ8<^>)FL[P+W^XX4>E=,$V)Z:X'6ZG(__A(U-UL)QCY$20=N+
MP9/#X,D&1(D73ADIO-5W[5=?I^S;$;@= %__R405A34!Q<.)7RRNUM+QO"LF
M>/<-PZ7Q8LW4]4+;_';!1C'%[(*G1/B42SMM1VPTZ"OH[%B6 0/\*EGEG:C=
M#J2O]ZCCY539(V+_Y9=[VD I_-G]JOM-^;M/D'\J__[^Z>CJ"6.,[3_/_62<
MX6]Q=K[^_-/??_OMX--_'K\_/?KUX]'[H\.#CV<'AX?'OW\\._KXZ\GQAZ/#
MHW>GI_$+I-4$9OFR12C*_B,LW\+2CR>+VUPNQN<7$_B1<]C/@W^Y9ONN0#;/
MOX7(EQ(!?%L"FKST<U\3#2[Q?A 6W17%D4TT6$$=X<YBU.N9+-T'#88@+MG@
M@Q"V2ICX.$G[EQ!LFL^^+\.=4-B_SF8)U[7 W<$&2S2SN"]XZTEPRA((+@J@
M,>0ZY7(/DS/P/)!^\'"_>F!OR3>Q(U_Q\<=L_N?U2:'E@,%Y1"6;<C]29$V<
M4!D5SI@4BD>AJV3W'B9GV"EMM1&TN^3;0M G_]=O?@GSL9\L1H ADM:E?"9F
M1B0%27RD$M>%"CY)[Y*J:X)N4C/LQ+7:^-E9[FW!!_V"D>-4:Q/*\9VC2+US
M&,N (,I1!8I*JD5=L_-QR[+NWM-J+P66YTIY]W. V=)/FG'!;[4Q]S?:F+_Q
MDY+?6>#/#F?(W.)B-BW-T$OCX,4+NNK[$3B$2]^C2.N[_BG3K%WB)$>)NZKU
MBEAG2OVY$QCV DMWKZ:W[OI?*N+XMB)NMNA?CXMRH*T*N!G85!R*G($XS0*^
M8A3P-T'J*C4JVQ+8;'CP',S<:R970SL-G,D^RLV;[V427C=34;B8N55EJ&LH
M)0].D0!"$DJ]4(P;+^L,5]B"MF&Q5@<4]T\O>M50RZ K#&T&%]LH0A0L$R7*
MP1\'78:JHXLCRHAU*]#3>5G07=,V+.AZQ\.V>-M1.0W@[0-Z+ILYFTPG8U79
M [S-2#FEQ"4I"7"CI),Q:E>ER_TU"8VB9U?MWFV,N)NH&P#)FQ4*#MT&%,KE
MRZ/SB_GLZWJZ\(8IDU661I1^H$$0*5%*(7).0M;)"9H%5U7\SJVH&S:M5AM:
M_2NH =1U5[!+D^('6.$H*0LBEON.)7,8/0G>4Z)RU(QZ!LE429X\0=.PB;?J
MQJLG932 J]\\RG(*\^\WQ;1A)>CLF?&!@"R-_570Q/-,B4B!HUU.WK,JC?"?
MH&G8'%UM7/6EC*%OJ9ZNYI_'T4^N*T+_?7R]0)C+4F-D@P0C(U8ZXH.6)"2=
M$E,LYRT'D#[UE&%F[-7&2;_"'1HE1].NZV]1RNGW1:E+09_P[WZ>_D(A;_B)
MCF<=M2#H!.(NG50B-HA,T&/,1AB $+=KBK;%PX:9E/<BF.E;U UL7.]7\VEW
MTQ!E]7[\K;MSN.$DZ2BD-P)-I<5%P)(A 254[M]0Y="O@U@E=GN<I&'FX+W4
MMM63*AH U>%LNF[IVY5AHMP^(RN7O%A;KNQC=.K+92Y9IIE:E3-ABK(8/5.V
MSL6GIX@:9O3=2P&K-W4,"*U%:9OOIY_7";<(0M# 2E_)C-&!\AAU:L%(8#G&
MD*Q5;IO&4_BA-_"SV.QX-[!SZZG#AOM5D]^[2[<%2%SNO,$P95(B,9=&X:5W
MGW?&$ PCN740J W;'-1M#XHA$XQ[:.RNSG<0W\!:_VT\'9^OSC>$4Z1<,^>)
M%[[,(LB!."8YRD*$4J=A*6SCIVRE]UM/'ECSN^AMUH<0A]:^_W:3<$1\HN@:
M25;.7JCTR+D,1&&<EH1QUNAM9C=LI_V;3QYF.^A-^SL+L0'_\M$=\,/5U0R6
M'4\J*Q*X-V6N)B76*$U,P/@K!HN_KU*K_F/2ALWI#GN&OIM^6D;<K_/98H'6
MTZI2.$J<*U-<F07<?Y4@,4JO7=),Y"J-4)\FJ]&CSQU!L"W&GJ^1!O!U$./J
M?#4IS4_> A(1QW[= N]B IW"ING@O R6_N_U+(?'F!\Q[53*RA+#>3DWD8I8
M*I!Y)HPR++&0JEQ][HN!1L]4^\'L(%K>=TQO7?M9ZJG1[]2TN)U&4%RK@%ZH
M4U$2:GVT GA6N<K U:>(:O3DM;+M?*XV>JMNKX"LWQ>05Y,/XPPCE(OWC"=B
M))1;LP&]&H[1LH@TE;&A28=:_2!^1%NC)[&5<;:C;GK;J/N]3'%P>OKN[/3@
MX]L/1P=OCCX<G1V]._W[NP]OWQ]_.CWX\&Z7ZP\_^L@^+BP\B^R>KAB\'2_B
MK)2+KR!MYB+,IF5<%?[B8K;P$_3>5A?7->349<JT28B^LM'E<O#!HB,B>),%
M,,V\K+%RGTGGWJVZ;GWJT31.5J7>ZF$JRD\GL\5J#F>HE3?X.7^.I .6@XV$
MR3)HJ=3]>1H5KE>A/,N<RU"E@^N^A \;HM1$X[W67B^IXF9;/_S YG2IAYWN
MBVWWP2]@-A]B82#C::(&6V)@)J@L6ZLG'J(AX#5/EG-K;)6^+R]L/*]36L]:
M8^OY!5W#T1NW[DZ_ !17Y2"EK@G]_\_>FS6WE23I@G]E;-[]=NR+V;RDE%*W
MS)12CJ3JLGFBQ>(A88H"U "9F;J__GJ ($52)'4.< (GH*RJ,A47">'+%Q[N
M$;Z$\V][<?-M,_J"3CLEZR2[?"7:6&A;^NRRC]$FIYM<^,S ZVF9Z#&8?[SH
MK$\@G:;[^Z8V,:ICZP^H!AZ[Q!'L_--LS67Q76(B< -9)B3/ "U4S ,S:(0O
M)DC;)-7XR!9_CQWW[.NH/7WU!F)=MHJ5!,H[7INL*O#2DG1S3+7VWV719"[\
MD?@[,<L^ ML/SRKJ"S =O#JT%\LV.T75MT2?' C,I#DN3$TVXZ!=R<)[K;QM
M-.;M&.S-NXNZ1/;1=]]HF'6P^48Q^"9\OLX$S48ZYX.#X&/5A"=G,3 )I62&
MN:I"SW_5\XW>GWU[C(?>(1=#>^)@[AJ5]Y\7%Y_>X)=/^.<_WO_Z>D'?XG7=
M<AWC8:318 UZ4"PQ""H54)D5YASWPND?Q0<_6F1V3Z>]AE<-Q-V;E=SVS-WV
MY=VJKNZ\S ,JXQ,(3SPIIP3XQ!(P[6TRKA2-;<:H/$W7O&D,I^ 43*G8OG&Z
MV\T^.V.8L8 N$T/:9(I?<JJ)EJSP$F7&]N?V0Y1U9!P/Q<%PC.VAE-Y0=O4-
M[<KR[.O[<(YO5A</;];K(K*4I$;F %F(H%+R$,D[@1#H-#',TY'2I)?&(41W
MB\U]\/,4.ELJLP/@OK^,&_R?2Y+YBS]VA6W;W<TY&A5J.TZLA8T2R1LQ',&2
MCV,9&HRJR1/5(_3,F_5U"L?V%(KL$X^['2V-*,E%0PXQ^=M*ATP;2V<H/!NC
M8A%9-ZEZ?I2BF7ON3:'O'V-H#^'WAZ+KEDB8M3;:0[&*]I@*"6(T'))GJ&,*
MW)<FV88/4M,=>O;1]-/XV4/L,U>P/:\M4W%-,KSX6N/][8[2/*,0*8!SDL02
M8J0=91WM+2MY=$6608]-@PK9'B)@WDS4GL^^250V=Z$T?KE<IT]A@[]\7"->
MC9>\R])N9Y;B/#,R0@YU*%:-M3R29YEED-QJ(Y0>XI(-*Z,>2M5\I;:'*W[5
M6@MSW^[6_A*U:N7R\ZJ\7*7+&L:L+SZMOF!>;"XVKU\_WYEH;Q2%\NRJ.A44
M8P%B#>V=J5D[R:GL[D6@CUSU#EUQQ@KM-II>M19[!UY5^Z/@]4UU T7M0D3+
MP(CJAJB X)228*/D13 4)C7)+S\BC_/V<.OY7.\=<!WLQ3M</LUD-4>+O/OF
MC(7@$I.UE42N3C[3-5LGDPF*F0R:<%$W"8+V)?AG?Z;>$X%/75FV@L/\X\I'
ML+D;L/T.MU6]'U;$]C9=[0.N/R^65\SSXA1Z;J$8"DH5DPQ"<20&KXT)#GE(
M>9#;,RU=/_L;Y6&0GQL(IYGL_<MF@Q>U*^;K18B+<](A;OX+S_/+U;J^:K1+
M 1^X\!$2P_<1P5SIXL8&&4-M*YEH7PCC(&9G ;T*P=9.MZK5(?TSIHN7+&/A
M1I!=,1*4=!$<R[4UOF2">XSDE9YF,'&*Z>(CL#U7NO@8P'00#!PIF=*6Z)04
M!',M22I,1XAT<()15IF8I6/EW^GBW7I=>R![GG3Q,3#K8//MFT3*38G&\41L
MUBQ/P\@.:E9 2.N0_$YFVQQ*_TX7GPAZ$Z6+C\'!W \*3^4O"X7)9CK7)2=F
ME,1ZT:>WS0E-EMJ(Q,.@8/JG2Q<?I>&AZ>)CQ-V;E7P@F]2H@HF$!$5Q3C*2
M%CQR!Z;^L#AIN&W2:NS?Z>('.@53*K9OG.YV<R!A1#H0P$56&3(%*&Z)M/NB
M+B7'$EFK4NY33A<?A8/1Z>)CE-(;RL9F&+N4<Q:80-C$KRY-8]0:9%&^MJ@(
M/OT[7;PE?J9,%Q^CS Z >\S' :F"3C:%FGIH0<5:98<DGXR8DU <HV^"\]Y2
M $X^K;WO.X?] -?!7ASS!K;&+V&126)O+S[A^NHEY/GENJ*D9B$Y1Q8.BBV,
MU%-[<Y/9JR/VBBK.ZAR:7.M-1/_/?C&Q)S[W3Q"8#"QSWU:,X'GWQ?+C=O3M
MEN6[_)]QZR66HL%KKD!E4:X*RG1,J: /V;%AUQM34O6SAZ>'87]>$)S6"?'K
MCL(/X:\=KU$*+WFN$E<(RBH-444%T2DKE%&UG=_,Q\)W1/_L_M31SX+#8'%:
M6^ 5067Y<4$>ZXY5;9(.Z V$6-M\6&[!1^]!([FSQ6H=;/L7FG$T_^RU0D??
M  >!XK3P__A4$V6L]"Y'$"H)4+6SMF,Q0Q#*EL!U2$'.'B$<,K?FA+/L9P@/
MIH#):6V-_URM\I^+\W-.QY^/P7/B<=L6F)Q[,@0U;340Z[$D%</<7M$-L?,.
M?/\)H;\?#$X+ZJ^6M71[M?[*SQAS0@MKP#!A@.+^0DQJ"YIYD9U7R'R3C@M[
M43OO"/J?$.Q[ J$#M%]Y:O>:Q3_-[)G#%#CJ!&B9KQM:@0_DY96</8HL79%-
ML+X'K8.0[O[N2&\-@@XFK(VYVJJ76+?J'LXH6F$E:4FX1$FL>@?>!8KE&4,7
M6:$]W;X]XSB:!^'>_]UQ?RQ0G.SE_C7#7Z^?-(3G16?,8.K#N\K10'2H(''-
M>&(AB&#N;H6I;_;ODS3L28O]7:$^H_Y/"/6_I+2F[Y^O/G_!Y>;J@).*/#C+
M)$BM.$7H,H 3J,'8.B>-"R-P<J@_0,<P?/]MWVR/K>D.7/;]GB1NGUTV4A02
M+ .;/ G:EP@A9P4E&<62L4S[N1V:ARD?MAG^MH^X\R#DA.S\(Z?;F]4R[0XX
M98LMV2I0)M>AY%* 4Y&!%O2GD!3:EW(D!^<;5<-@_[=]JYT7!1V<"+=V[K@@
M/K$LI)(9E&8&%/(,7L1(/IUTT6<;3)NTT7T)'K81_O9OMD?!PV27.M/V]GCW
MXK]?O/G'B_<OW[W][?G;-Q_>_?+\P_M_OOKP7\__\?[#V]]>O'M_EX%AC3L&
M?.H473G&$C]1RXUW^ <2$%X2X*\[OOQS<?'I^>7F@O"^OFE'8) K2\XP<-2Y
M]N"SX'7V4-#9*'*1.32Y^!U(WZ%F] ?+W)IWZK(J-DIRAT0$582 P((E9TG'
M8KV0KLPAATZFW;9 TWT+UT15G78K^K%1V'_B^.#//HYU:SAW?"@JE=;.Y6C)
MX:NSEV-,M<F; NX3UO%2*;5)6CB2C7OPLW?9NS>>\%8-W_:0K-Z'2(JV)V.@
M<C#@:XE*<84K&6KAE6LADCUH/0W+-P9C]RU?:P5V$,Z0;QH^?ESCQZMHK>S$
M>H\I(1PWRDI@D2(S92,QE8. 5%PP*6*)6;1 Y2#JYBTV. 8.IU?2R1Z_4PR'
MWV.5XQS)1QD1/Q2PL7:FY]9#X%A'E#H)7JD 03A-F,W<L2;)M8T/Y^T%UCN\
MN%PO?U^=+]+75YO-);XMSVD'+"[>7-;J9PKDP]=-I>#]IUT.J67$>T$.&EF]
M(N"I=C2Q]05#<YFD=_='4C]R5SEZZ=,X9L>@Y<Y=8EM5='#"/B2V[]YZM2TY
M>F<@V2QK>U>$J!QY#10UL50R_:2))SR$N-,X7_<!8#,5S=J1>A!7MR[@*Q=1
M< 6:\>T%/ ,7:R%5$)QIU,6WJ;,>2-^\M7.SPV]/1<W]4+B3V^_K5;XDSJIC
ML[SX^CNN%ZM\%GG (J,#844!I17YPEYFL(FC=5P+Q]+ P_3Q5>8M.3O"N3F1
M@$\_%-B)XAW6ECF+Y4<20EFM/]?WHK?Q?/%Q]_A^C'AA%"E'#BKV%].1(P^6
MI!0V*V"J& IDA84HL  ZDY014071I+[UN$\?3^OA3(>4.?<*N!2AOHT+B,X8
ML"ID*61"8J*A$)ZF[C1BDC$X>N318T(E=1"*#&+JQ5]?,-6)%(O/]%?>EO?T
MTTTA>=+OKOHFQ2ASK(WR9&9T9H62(&B; 9/F3&HG2YL<_6G(/XUPICEVIU7S
MSP#N]Q=T\O\:+JXF-J+$%+ F7@OM0954G6UTD T&E;7A+#1YB)F6C2X,]5&!
M./5>V!\5/\.>>'V3(Y6TC%P&4H(0E?/ ZN.^!I:2CH(A=Z%)(^3I6.C"\)_T
M7M@/#3_#/KB*J_D9DD=G?!'@:VF]$D9"R$J"$5P';DLLN65H<C #)WX>[ G
MJ??!/FCX>UVSG-W;_;->M)SQGJ]:[HOJYK+E/YJI]'WZA/GR'%?E^:>P_(B;
MQ?(Z&'EH&%W3J[,]:3F.0J<0U)$OS]!A*BK7K,N40$7R$H*MT\&+$D%I(8TQ
M#4^HIL_V5TIXM7PT+^O=ZOS\Y6K]9UCG^EJ26=0< B]T0G"NP7'T(- IH[-5
MF?,?P7?TJEV<KY-BY.X$^58*Z,!'?)2G-UBSMWQ0'@V87"M$T!9P'L7V3L9+
MI8N21WLCO29J'JPUQL'0#,RQ2MD;8%^VOM[V%J MS-YAVDV J-. Z3M<_+$-
M^3@ZS0Q3(%Q-JY<J@B]& 3,A6&-3#*')2\!H2N<)L#L!Y"3J&X]2?X729<T-
MI86G>;Q_:M?5[--'."V%21XH_J'MF$%9&2'R9(!')4BVSI<R\,3=:_UY$D6.
M []CJ:7W<Y@8L=:G",F[4MO\>W!..&"!.2EUL0*/EB<WZAR>/-&D$[,W5BD'
MGL,OEGD"\_:$U&[RKFY+CKN24+, Y!S7)!U>P$N'D&76R 4QS]C!H<1#*W=Q
M93U/.'&P(CHU93=\G5G'D&%D8+0CN\R#@Z!- !MRX5X[VI--7E2>I*K3H.)P
M-(S)N1REFJXCBV]RN[Z13*N/R\7_QGRFO>)9I0"F"-JUE5%/)P&D4)2UDD4Q
M0]KO=V1V&E,<%X^'*>_0H*)-//$MP?G*>;W'X2_+3&+%Q<?E5?Y]^OIA'9:;
M\ZN\JY"*#RD(4,%KDG0F]NND86=4TI@]1IGWCC0.H:S3&&0RN,ZOSKD3VY]D
M_M4RK6N?H^HR/<%O=B*E.AX[,22'.<LZ>-!I$"(4)D*6ZOZDU'W@.XR83J.7
M(R*V@=*Z]ST+([\\> Y8!*\U=!%\/:Z1>6^5E<&Y3GW/R4>B=';6CU+-I-'T
ML1,+OCVN[HZ+S:TZ=\SQZV_A_U^MWZ\NUZEMM?<^A!S[_7E/$1V[9KR8XIA'
MT#'[ZI8*B)RL9:;MP)6+D=M3;NCR5!^&,XD1$T\"Y%4SPZ0AU->HP,A1EQ8=
MT[X%[T\1=1K/T6-0,Z8UQBB5='!D?VMV>+E9+'&S>8\?Z[>;;>IQ*CEID1E8
M'TA*2$YR< K!&F65KXW"2VZ!KR>IFA=@TRE_U4H3/<#JBO9?5S49[8R7Y*US
MF;:8JCT3C ?GF09O;$KD>E@=8A,8W:9B7MA,J-W[N-E;U/.'M?ES6+[_@FD1
MSB^^OK]<?URD</X;UB8<9TX%RZ.U$#(GF9"G"RX'#MJRD)BP6LJA+[M/+#,S
M*O;7W:J)(.>&Q-OUQ:?5%\R+5-,</RQJ<Y8/F#XM5^>KCPO<7+-$<L+$4KV*
MK-,5-8.(.4%)TMEB$@EP&#:&K3?OD]A$(&D@VAG1LB&.=GT(WJ[?X_J/1;JJ
MEI(B)A49244H RK7*ST9(\7,12G/'6-B2*$H??ZM<V:S \^M,^8Q N;%RN3>
MR21R[@,GFU^6><?!9K>9?):QI"C !<Y $< A9F9(URJE0$:2OIL8+-]3,<\1
M-(UBOT?)@5*>^P!Z@Y?KVMG](ZZ_[BQBYH5GPQ"0U1Z'L>:PF%H%1&=G<$%P
M(X>-C/C^LV=7_:':6DTGNKDU_VJYN5A?;GWR'?5>)]H'QH!$E4@204&4RH&Q
M/A87$K=*#U+\=Q\]SR'12.^'"6YNM;_#C[C$JQ*J]_]:+$DP_UQ=+O..%250
M<4L,<!/)W1(ID[L5#12>'!J22;S?&_G1ME%/K3//&VXC0$PHTKG1\>*OBS5^
M7EQ\O>4][]BP2C&O"N&[3HE4LF@"N910F/7"E*RDL8.0\?@:\[R3-D+%1**<
M&Q&_KQ=_A(NK#]J17W*4)5)$;9E .N4*0A4#!=A:%S3D9P^T$=]_]CS/DXT0
M<*#H.KC6?"2\>GU3(HYTM*$FOSEZY8%@G4A*%*PG5HV;QQS8/9>AZ8/,ZU%]
M*)HUM&QV9SZI/CK UP]>KU[\M9ON5-/@Z7]UJM]9\%(F3R=I(,,)"HF[@*J
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ML?G/]6JS.8O,&2:< ,.1[';)";S/$;05UN:LR$MI@K1'*>HIV6TJ@S:%\#M
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M#1/JH0M</=4!XOW%>O$OW$7OO!3FZF!V%3/]D8R#:*(&HU"Z0JZL;%.>/I3
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MU-\",M\(Z@DXXQ7])&[VE/K\SO-RL5K?FQMP->#$%_28, )7Y!<J<L[ !>G
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MWCG& &VM=D=5("K'B 'IK50Z6]^D47N_W6,.N;'<6[0=P>)FX+5,/N1(A.=
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MJK-_M#Z]>5.PZ!7QY%W=>)<5KP4H$E#EXH+EGNQU!,3V=X?0%#O;X71O17:
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MS]+\'&_G9X2S,$OX]3OBBF*/DYS7W87A[+:RAM*Y>P):OKPR[C+CBUS)K*,
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ME6Q2G]..I7&;P,<VF_%1THN][%$0NQY)<E,-^^ \7O_A[Z3,V_<J'X5DG$?
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M"Q$<1@T9K=,J%<NQKR&[@[+_ZE^:7T&(T S.K]H)W'\Q_+7@6#8IJL1 JF1
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MFUZ6%ZDZGD1]&_P\=)'#*::#P_HQ,^_)79#FUO8^\<J)7(*H5[6<PM]LP//
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MVQ+KSZ^[OT[.Z[J\2<Z<Q!D<)!GJO4 T$)5C$+1FA6?42A^H?&!SHGOKCCJ
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M [31<_9Z4+6+.K8'E[\$UPQ7!VJA1Z989H&1?.K0"88.8A8>;,Y:IEP<_7-
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M8(8J$-PQL)I8(%QRYTJ14ZR2)KV-H*,']#YZ[@T*\!?\@W\-C'9&2ZE!1RI
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MEDI$;Y7QRL4ZX\1V(Z_G2KZ:D.M**6U!;9NGNV;,"2D,(0R"*BD;+AOT<%&
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M_Z<+G36*O?62#%&@.<6%2$/I\B5Y:7!,.-!$K?9$*"JKY#IN)ZGG3:T3E>^
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M_0?"J,]3L*X4^R).#I!R ['F]?=EX^GQETU8LQDQS8@-UF8D'B-Q$80&PZ@
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M%ZP5P5)A% 5!%CR91+6AI+=%G@7J>1XH.8Z;1#Z=*'(VKHPU*ZOK2#M(KZ[
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MO,3JMT-Z(T<?#P 6R4*;N9,:@%E+"FP!1^V/AP5IR%NYENW>[=:,H)N.@ *
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MS& $4F NRW3(:GMKJ78KN! I7R)I*^A7U7!:4 MQ&>RJ(JWKM&(:3%85D<U
MABTA09+?UPI':6W<_F[;H_=^_#FR)H\O7<"7?G"&QI.:A8NHT/BOOC-<@7+3
MC*&)I#; (?+AQH*7\I2C(2AO"J#"U?BJQ=KW;*NU[W>7547! D1YT.S]$V%
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MT=<[AJIIP$9';XFD9-$ B,*TEE%)4I N.SS4?':2@B)+Y8!E+0V0*Y)$EN&
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M"UQP>1;B?V*6T.'":G0I2\AQ>?O$.7E;E3.PFL>[W\D@V+9QJ><FIMXC33J
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M/@;UK6SB\J:)$R O W\T!KB12>1@QF=GL6]WX_[:L<T%RSPUZ:CW ![L/\K
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MN_412>Y*46^&.39<T]))4M<35+4OE6JJDE))C#2"/QH.LE)FAE5U4FNOD9Q
M![-6=<R*#!8)Y"SZ13MB5L[,"MK<.=M%<HV <4SP84KGI\ W9"0LG,-PWNW6
M\-1XJK&M /Q\OHL/UK("L8&TE8K&J!5T&HO(Z$53GHUY!NKHS@5E8F+JE7(0
M#GG"1\+L43Y+2\R0"R<BCH!]]/!<<0I%+>$+F)?#2OIG+H9HL2=U:@R+$NE'
M@IT0PW9#V1B]YV9LZ=D,;9E )%]4(%3N0C!E((M',: RK$V,- &+3*F##;^N
MM6WW4R YY8Y.WL*SR)WQ?^#JXA)XS]TJ9Z[,6U''GW,C>^?RQ,GNX3))R;JQ
M9^J"5S'C/EC/8ELG/ECOP1;3F!A:,\.KT*J*_TDW*LK[XQ54+E.!RT3R5.19
M(ZO8HI+'(E7=>+'W/):=NMPE7HZ\.[1%S#;[FO*5::VN%\3B?TJ+G35"UF2+
M>#//GNRM"<!6=6L-=38Y2HD)J$#8Z=Z( V1:G),H -*$J65LM&395E6*,A4S
M+XQ\L[IM8[XB(5O%9MQ8PB[FO<!N4!S(3,FVJ]"]I[3]13AO;3%;23(U@RHE
M="N9J[4@NMYL&;'40^<BCD56%X"7,&KA?%:0(*,W5M5WFG8AI>OR;B*&P%%_
MWZY6Z&PV3F-[71"7E,4"DT2F,\H.4;BE\<FJ"[1<I3#U%G2<%6(<7-.*B8K1
MLY.O,+99Q<M1(MD, 8G"75LZ=V&I+A[9G;NLTYZ4:.<&$+A)Q;/11%\YIHF^
M!R#\1_^Z'XQ4:6A0EM(II^0Z;4V4/;H7H%OA>DN7W0K#*_<U602C1FA'C3CJ
MY6P"*D@-)RJ.Z4TS_5E9JRVI_9@SJJ"?AYD8RA ,G2]^='Q8E4W!6B LT#X*
MN"Q3#E6(J1XB?GBJ*X%CU&E>U221;WDNQ'CB&#&>6<Y#E@DJ5(,DATP5MJ&,
M99M<) "9$M>4CMQDGXL.QNU6Z=MS<YEVXNUZUPU6F;@P3&P&_J,[B- %G3/>
M,S([2< Z*$>6Y>)DDYTK;R*5A=(&6I7228&7'?4-;#L,8@?0WTDY4+/(LVJ3
M'9(%6T97T3QR4U%(=47IK+)LNTA4X^<"D]98Q=)E;9(054C@I#CD?Z79MY[U
MURV*A](A;WV2W;+,RG#*,%LSXY&*>F!M@V,1Z+0BEQD@2HS\D*@^7!2A<JY3
MENS)*;[?N'/"ID,I!I_+WB<\V'&2FCZ<G[M /<MT7M-#I&W)S\\=751[L#0#
M%Y:X%]S3?467A[2SDJR30L]/TTA6&-715C4CDVRD$E0-5.LAHZM.GXT%THB3
MC-'R'L0L&9=L3$B0EN-)$*5A*85TLD0!HDS39*[EZRKQ42A;BWE#CO53F-11
M53\]4854MPQNQA(>VT.<HJ:B"HNA;6[G<-<JGZ#G-Q(9"/,[@[RP?[54SI2,
M9Q7*4.0 LR*H<H[+$>P<)-&:KT!U.B59OR?K++:<)SA#A0A!AP'F>K1K2@XV
M:57- CNCPQ .L_H0=K <9*VH1#AA(H/A6THU""<I:C5F>,5M"K/9E<E8>]7/
MUN)9K6Q&!4:5[0R.=[&F/D WRV3>% GE=9(EXVD-%FJ+M_R#LL 6BE4R0\P4
MT%(W-TICW.I^\=QJS:[*9\G*//8\K7G!%!)IS&2JA8DY'6U-!)8LN_5Y2X.U
MZW>I8;?D"VM>!G"Y!C^KRXM+Z*.F7^O>]6VL7R0W*,@B<!"7AMLP(&]GH+:&
M"$B1?T]:@?0_=9K<7SBM>&[VI5AZQ!YJ9/9AT@%.ZL*J02TYM>H\Z? (-+[S
M:GD;KN*1#4"Y@>3(JJNVS@:158Y$H$4<5[!&S5>'M6*A%$=&?;5D>!4Z'')I
M!+=K/,DHR)UZ15?FIK#\GG2C,UP*%WBPH@5K5-\99*,XA:  - SI(P2E# LK
MC56[+^SO*3YIE=ZBF%Y*35;-6,F=LS([7W.Z975L:Z*XB2^T*S:CQJL8.<>)
M8G"A)2W,%<5-*.F)8UTS.3CI*+%>[Z[!WCZ8[[DK0F 5IV)OAXK3-V'4N+.]
M9AEBV L[(D+Q%>],MXR=I]Z9_G#.]";/4JC3/%=HM=?18"K 8T>0:&>)I%0O
M.0*Q+2SL"LA55L"JMVZ0U2 _W+.*G=63'!;2&NHC-!+N>I_[PK%:(F\1?#9\
M _)UD>3E:"1"H;2Y,JGJ25+9?@RBL8(/'F3%3*U_Y$L82SAC\\HCJ%V&9EDN
M\S!+;X,S6:*Q+\LJU!Z1286(;POC,]M/IB;)&E%ZP0G1BQI93J 5@DK:,A+;
MFZDGK:0Q2SIOS)\:D*J[=&&?,PHSD%P:>+DDE=W.E;SI#P9;3UGKDFU[JXO5
M'AY$D3=BDXK3N@DGYC?%<RV'CLJ%]N)GM@W)G.25V5[*=J&2XDG-J-]A!)7/
MMSJ:Z$H6V0?^^5P\IZ>.>4Z_3C*RP!&CD07VC7UFCNEM!_L'Q[V%Y-'%]"@T
M\UL944A%F#%@\)G\KOI?/2P%1G&>E!K4&@RNPTBD]804"&D5.3N'9ZNFR"H@
MRU3JU35XT2Y"(=-HOKS*,+H;5) R5V;$S"H/H0. (W[#XW0F8]AAL<L1@\<S
MU72CZG@N_EV+DY,#@D\@:Z&@[EJIH?6.'FI%RHY0;^E="WYEH=&_U);(T+92
M5GNV0PHIT1'D^K&R.^CR$@8C9&0R)IL1HR1.1_O!K:A^*VH16V $_P=64UJ+
MOYI?=) ?#;/M!M0E8:ZY;L>=-^8'GRVG_/X1VYJ.^[PAV#I;,(&0ZY.A;ODK
MRPIGE%A8'4 5(@]G0.:#TX[K %A6)RP?\NY,X>OVX6R]"3@6&,&CW(G"-[(3
M0.I"I D&EF4B)"$/Z%J&V,H0,\GZ=(SRJ,F5I:3&ONE>I9*=Y,VF6T _/)%!
M5.J,KV:JNBZB+O]-C-%D)1<L&0M4GOATF$9"^?E&R!\B@J6,4X T]5ZM#((K
M/[EK9S+7ZSR519Z6Z)S'(55,G+=S:]+@R N8<*M]PVX5I:-?J!='\D6;3U5M
M -HZD#VDY'KXZ@DDUW;+)WLBP;7MZW7!=7",BW!U=16\3S/,CD<Q\)FH!Z\=
M4P^6NM]415-=Y@,VXV/*R/D^4IOBL!5?TTUP1K-PP8C?J$^KNBTV%"],=34>
M=1#6C YTH=JD$7".JE/1;*RFW>EL:HQ;:UKT,(5V^:?K@]>>?.E8#[F8%<9^
MV)I$I>YM;(ME5]#D53<58N;1G%SUJD)'U46/V%$5KMU\<U3RRFRWRF8AR1V8
MA[X@H[^(,9W+G/?K(@V_:1;X*4WV+E7;S>#SC+[_N[$56LD.#4NC[-)!00/P
MA<8;\MUV&R.JK:K@*$8_@TPP+&OYDJOG9BK?D"WFW@=6FF>DJG&^V[W:7/L[
M?,N-H5,=@B([W.J,&3I%VC*1P(1@K[$K&YMC!R?=^Y (-,66JLT&E?436E64
M?]P36<,K4SAGR5>PM1V;-P]KVX?7/K"ZL^VR0]A"]&B6 I $\7(UB=?/Z+)'
MFV?7*\/=J-P\26_YC3.5FYO\844CXF[ [*$#>O/0!S;4E0T?V/!P+7U&(\S'
MEH7@HE*7RFD_RBURMU7)HC.>XN!TJX?:L6)?'^JE4[=:Y@O4]BL0U68%5;?1
MNIF6_'19(MU&V%1[1>J=@5AI?&^R(X:M6JAG[Q'7UA'5>AMX)73WP6;1%QWH
M4]>+0"PM9Q&%TBL]VMQP'4[@=,(IW)&QB GGD:Y.I:I:\6@72RO(C%$JK["&
M?&I%C)!@N6KFS\0@.'3'('C4/SPDFV":%WMZRR\LLMUJG.8S"5TXV'?,-JF2
MOJM-5@8@\E^NI2Q62K&QMU6.D#;8JP+1ABRF+)SV$,![ O.44M_4G:W41M3C
MK=9L[3IZMHA]LG26B5?K*1>PM\M\AS+V/::,G2T9<XRU]?'H<],X5GB)?D$+
M9>[J2,V&?+&VH6>UQ;3-SK.6&;.00]',G!Y<>+EI_K4H>TAJT5:M3::PS*S<
M8E)^V.EM\F$2+%<*B,]>]%NDV4V$O_:DZ,?R%V]37!@X+B[(4,=\LH&\4,_!
M;-E)IUEKKGFK[V5JC><\30!8=-3*]0309:O:PNZC&\:_DXH&_5>>;JKQ?,6B
M7[H@@F:ABDMZ^FFE'Y#IAULN .06#5W>A1.6C#D5DE9RBJ>==MK9;C:28X13
M,W2=12CZ354! GWU#RI/7V\]X4"\DVSKZ2R5^?8E-CPYU[[$87S:KH/;,<I9
M$ISK::9.,T>>9I;P-&><-X[SJQ-/01:_TN9F94G;,MW(G)P"WFKB!6OV)RQX
M;I?P7^QBT L:!9FL<)(\-79'RV]D(D_0YX.WUYNSRIH\C?(&C<(%6?!;.88_
M83I3;0$36#GFX\?SMAA(4U^[9A6_QIR=S(1#9L%7=L?S9^+Z#MUQ?1_W7YV2
M=7,VRYC(61Q\P5N[M])+(";XE!9H6LT+IFMHS:M.PS=6 \K:X:DJL149R^;D
M6\UX/7R?S1!9E+]CPF/5W$S9Z3&0&'.R939L$/$ITC>Z\)A9:GT$U,M;#,(U
MK^;!JP/M1+CX[?PCEB.>UUXPY#),9\2I7S)E1KN900/\&5TT9"3?NLE4Y= $
M@(LB5LGRB+H(L)5GK*H&.>,9E4NME1V(J?UIFR>MVF]J?9&K++^56]LL VGM
M,J465CWQ0K(_JYX!J6RXK5ODD$L7OVEWPR&?1==\#][UT W7 X@FDCH7*;.5
M&&5USYJ-B3"3ZA%:[:]E9 XZ]UM/Q@*<+%3$U( 9:;GJDDH>XQAP#5113Q_>
M;<=K^?#N!UO,10+5I7" <21H: 7RQDSQ2DS1Y7%8"=,!*I-=C?!<(6;'L:K2
MJ<*+,-Z+ @CN0$50U74LWM6X:\)42U?%D>J'2G?KY7<AGUE<I*%OK&)@NSYM
M:4E8F%M+$KB3MD2%V'5[WE$+I.\X6D_8'BGJ G(.#@BT,N,ZRMAMWB-=9"1+
MYFXNPEK:2ZTK&_'32IU!%,,F7JC*<$!=JMIQST/P==E&0*%'C'6X]#_J3%K'
M%<K\<%V >D$ J/:@FK\RG\AIU":]\8A[K2NT2*XD!AG$!=QNHV@5A&9:<MN8
MW4A'A\W+@AL6E[QQXXHQK*5IZ&%*4^4FTAN3RH0)4JWDM1;]0K(D$T5<*_A"
MN^\5$*^ _*C1E,J;YV4FF_N8D$NKW[S1CJGYXVKK"]E?J<-J5\ASL._IT^'X
MF#X5J]861!7KK4JLS"CASJJT@K=(CF6UO%39G_H5B_;$>^R4]W,$Z2;0G%.^
MM0K5EAQ4_K\VI.HA9W8/:Q5Q726AZ/&8!,$6!D_Z-(^T"M(/@DNI@YCC*)_6
M)0-UXXRJ@M:.L2C@OV05461G96(5_,*WD<$67@7C9',>[?9J@S2%2H,I^\95
M2YAY6X<6JA^#0=^QK'HY4J5'Y:5><^FZ9UAO%WHC=UP8.GMOK7R YQ(=?^!8
M=/P'S"=34BO7%>.Q7JOIH$=<F &7G6)OZ(RJU6*/:'GB\< /Y\NJ6%59=7;5
M05(;U\\$F6*Q)_@^-11,8VIGC[4#J0:UD5T57IB:@/A3+C)R>"JP30&$4)1H
MZ0,K:P;*^:URSEH%$YV6*W(O6'1"L' X2,D'WCZ/P%N'2<Q'W?JH6Q]!^2#@
MY%X I:O4<^SSV>SQZ&X-,E#/4TP+Q?AR5]9X7"IWY7*,]G[?"]#6>,Y 7(ZV
MKF[MME:@Z&GK+(O2657RH=Z!!OL:S I=6Z4>^M16_E\[/;''0,Q-F35^!]^V
MRTI\Y-+J(!LC)#EV/&=6I_((7Q>9X \T:HQEN_#W6)\"OAC="&P92W':+%?U
M8.HE65J+P3A<J'TMPY +GOKG8I8\=,PL^743ZR!:];&=F*JABS' V!%>5F3B
M-YLUT=1Q!66B<R4PYB+-IF1_E-W#<S$4,65'6+V\*8(7QZ':K<A(!!4^V(H[
M,M8<_JZ*/C&8SU\IWD,63PPCY+DI\]16VX<J1E6QSP8W6%E,X$7_5O'D)N(L
MY]A3!2[H/LZUV<.M(PPDH!?>, Q9FU=!:7DY!+(M2D2?K*U<3PVOAGR#92>'
M&'K5RFR6FN[3S<08&4:B>DWGEJ_*A(TJ!]0S.99'CAW+=\0G1?8HG%+MYKS.
M&9N,L>9] +[MIOCGW?M=LL*K "K9]XG<\ZJ[AFJ[J#SI2\0H1;[*!=V.],O$
M.>J=)_/]\+39E=0 $?DX)3<:.LQ^_NGX].U26/M/C',?+*S&,XASK[&>P?Z@
M_^ID:^Q']#<MUS>DIMFIH%ZF>*@0_:7$H)I)A7&94PCBV+#TK)1M9&)VBQV'
M&2Q/EO Y+,(>MG##8]?2-5@V:E/E---;66$/^$HOF$AA#,6U!!L>4>CHXF^J
MESL*1R@/V4V*:_%C3?9F5\BL7UUOI2Z3,4Q>9=[:L@V,'Q8%.&5,#<M3DH>H
M4Z+,L;5$4<HO"$WW/!RV4BQ5"H+BI<;SKC\$2\"T)@Y_6P%V\"]55#3OJ7@@
MZ4GNJ3BAO!XHE"]P8@K*(71CJ)+J_D:+KO8G6D_2Z,W$X5((DBUV"Y0RHKY'
M!2RMKW&HD <IYJ@(947UI@OJ \J?KT_[AT?;PX#-08 8&YU+I8,4U*!QYVQ7
MBD.24GE/$RE*C-^2]#;FT9AKFI1:!^@B%#&NSNHR.X9J4DZG7?-JJ4XL9]DF
MDESFRU-D'!8<U<I%O>=P.XEN-8RE9SIF(B3D&FX+50A8JI]5H+:R##W"6&MC
MVGFG=GE,*$]M,630N481@F-5E6 Z+1-E2,YE$*%!X%;5S^J%W1Z'M*-SGQ:;
M%S9>:3VM(I),7P09$UD;7<7?9/E_4O;KH9T+]5YUBZAXOMO#'FER70J,2Z3'
M1QE&52UMS7H[X;1*0VQT.H9A,;G\,D!1DB :(<:F*KA%TA3L#SLGZS&K,$><
M@0YR(B8A\EF)TV>9D%U?2^*V-#H5T-G<BD?&ZWLWV(#V<-X\H3K04_=[K:(T
M5+,&I&1LC $KWM,<U:*2=%2?G.KPT)6N+$;7'.R,?;7%YQ&[8\Y%@[9U,1CD
M ##8?%175,.8B2EU9$48LMUULJQ%>U>Q#E#W5CVQJJG"A19C",>,NI*3X0NW
MA9'T,!()2IP@S%<,CRE7#34P)< ?FPHZJK8)X"9"7]7:>C%V%>GAKS(::X+8
MS,A*4G%(7BF13^QW&(.#SP'VK0LWRP'^+A4A2:UNZEH/OT_8-]GM(,_R.WQU
M'L]U+HZ4$D2BU>D?$TKD><<S8SLE %OQ=3TIA5#/T=I$\LV.) UV;BFGK/I\
MKCH7X)PG8BB,I?P"I''@7/^7O2]M;AO)MOPKC)XW$V($K-!BV=:\B(Z0E^KG
M>=55#KOJ]6>0!"640("-1;+ZU\]=,V]B(2E;+D%L?>@NBP2!1"YW/?=<;&ZO
MW0T>W.L\.SPZ?D2O,ST,VK" X8VE?[6409=HQX%Y*-$D^.- P[<:NDUP0^2^
M(@L,[,7D%C9K5>"AF6K[71OJD-#)7%PF9^JKTMQ]6>-*.V7(;E"[&[RY>9G.
MDH4K+G@":A>,RF?,W%.")TQ9=N7(%5C6=U;JDGU(38WP8+#9&%_&> S4**1<
MK'-%T3F%8^!M1N("S%)*\%'=KBN5"\X2A0/E*/T Z?28<?&;0PG <GS42PS6
M.W82[J,+G*CSDHWN.$N96X8FFT+A V$M\192HD%  Q)A02"*TJ71E7#S95JN
M)$"/)Q\;X."J8G4F]9"2Y>Q5O[*O^A-<6W?8/20H/B=)29;O_JN_E46S#GC6
M8*,J-T1[3T?/O%%!:>(^YM,>:3)5)+#IX!(GO/G8KKB7/=&'F^@/Q:F-^#UV
MKYC82XF"PI"S^':R+..&2J__ <<+,W5O2R^,^@ =W:'E$LPH[^>X/KCZ.'\T
MW7%SV"50>38#G\W 'QT_Q PYYK0HIT'(1=+^>#&Y*NTXX649Y[4G@;B/]G60
M2(*L8-Z/O&1\PCJA \B(0G3#I%DI?EV6R4U!/2(EE=6LT=L3#B*'A8PLEI%:
M<B:"'HOK*TH)%*MU4J/K%TUF<7Y=-NMZ3G&T+/UGDRYB&REM)6W\K<%R4+/+
M6[AL4FG2F,-D!V^GUD<%F3E/Z"7R'@)CF6]*L( %EFKJJ6<HB&LE<VJ@6GTX
M4T**Q<IC'B@%+]]->Z?. ^]B)/)$%"L);&EEWQJ:B.[;JT*2DHB8*GT(NHVT
M<#!6"<F$"1;L%RJECX(%VR]OX28]_#/LY7X#]\^Q0\9F+T0^G9\LDQPC=\PY
M)P2U\4V<9@KO[MG@\"F=*)0V>7))M'4EIDOC);I.$D.W51R[S1Y[THCS*8H%
M$L/!6?XS+3L2M+<Q9JT?_(R=/"9*Y>8;8"IA2%%TU=<IQQ;)U394)IUNLM'D
MX,Y>2QJ"*G,P*CL#B9H(-B!5*J/+)&]@Y))&^A?^VC$;@<QM5HDH [E1@5 E
M\-XQ^8.Z20#]+EQ.-0^=>+EOM=P1V]H-@F)"3BD\X"9X<_Z80>.;5';!LW7]
M;%W_*=9UQU1T8H,Q;I3JQ7@<_"<#/9*UJF:J* C4H<ZJN()H"/.J!&[4*P)M
MW*J'I B56L_A'\:EKY)8<V8(J&&KT(QLLQ,@1JTS^Z.)0I<",G?0I@@]K3')
MA<BCH#(J0ZY7>&E,CZB#$#9M-O"F?:GN.1M9=<]%';)W!1DXME"%SS^AU=/"
MA5R1#[8Z]3YF941MB_[C.#HY.XK@K1^/H@[$X&.*E"=>D0M_P@/'49D[,JS&
M.FL>E5S#=^AJULL2!Y!X!V&9#-6(#Y QW@<N+WO"^5YHGY+_@?8V=BN[!S!Y
M!U!RU44E4SD%PFWO(N3YK)*:R#_7,4<WYE>@-5 78\^TB'NE190WDB+?R%\"
MHK%*&-V%_UG$JY@^9\1=A"[P,DG1!R \F"0(%:U%U1>,W"-Z<(3O.30O#BGY
MNF9WU? ,\JC@76>@35TMPT)ZNE&%90._L3BSZCJE/A,P TM0X3"(.-/D9">8
M5"7)-;>?FA<4!2)$<IHCO*2LIO<%^,# &^IB]?UQ*Q>]W.W)S\D\6]#_G,Q[
ML,GL3Y+Y$[J%3_2Y8OG)^Z+CK%AF>HLX:UP%B(0[ QQX+PR\MP[_J5N?'T1[
MCL'\) N#;"YLD:*>JVVU(0Z2T/?<<?+L7I85P5R(/P1N5&'-'5+.HT<VR8O\
MA4N[S)*8*T'%2ZN2=5RB7<2:GDHYRW7!'^$]3*="<OK,W9>2T\&0)%=K.9M%
M$A!:VZ5W=.!9UZ4$[WL#>A1C ; "3-5N'Q+$YVE\8%"D&$[1%!*SNL V]QF^
M>TT=['L<!>.&-3N7YC>)U(94#;P?!Q&I+K988=6L GP9R3]/3+Y0$<T!08QD
M'6/Y0U,T:$3BV,$ZS>?I.AXJ4]QB4!>"C:*4':PY7--D-"DX99<E/B5/+D&!
M,@ZVG8CYE@E#PPUG"Y]';/SP(U?(P/DE"87#V8IA&\3K>"YL-GTZ\GYOC-.-
M$7&8Y]_BKQA,0PHL3-&6G/A-6D$CC\J&E_WBF]B$AXY]A1ML$72O$DEN,XL/
MTXU[KVRYOA6=0A+70?F1$1KZ3F'W9GAUW#W<-RA\HBSM+,Z4AN7^PZ)&"V$[
MQJ<32#]8/)? /:E8>D1]Y'+NV)S!212GL^7HWV\K2]M0SXZEX4O;[^I[GQ+1
M+?6(FGMB-3I,3(ZY.XYQ6.'4ZC/P-,[5,V'W4%WIF'B7X\ID@2/7LD?A! Y@
MH#GM"^5B(?<&="D'_CLW0OM%RVL"/;NC2OJD'81\;YU 6W^#EKJ/QF9#3<!.
M. S);Z@KU9Z.2;->D,\^A ' &GU$E>1)LG!MO9E1)5E,*;1' 3PZXXS"*[_Y
M33%<J?J?4H.;9GM?,F2O1I8A>R>M<#;N=/8%*/JG71AA,YEP>[P_'G=/9&P,
MWO=]'0RD5I)V;HNT%"?E7L9\CW]#>0KT(N=)=1^8U_VBWKTX+^ZFMG&7MM@S
M4LM8TH4IP )FW/ MNY,B6XH*,Q!!NL6)E3/*_1QZ?&/8HZ 0+Y"%K+Y-DGR[
M_KS?MHB^H78JE]#.*EG-:(/ J\+6*BG[A(>"X"P%-@FC#\G[C>5CPV2 L>[B
M+DDJNB/J>KZCJKV6\WU@]U8TWAUT#PC\&+:7!R=U*^ FBR+GKH=(JBIE\X+=
M44'5CS_UWWX/"K7:-<!YA?Q?$G,*8+,>"=7W.N+FX:=A "/1P)U)F_957=KB
M<1*E!K#[H\#.]P',W"MTQ\?,O:9+!2!\AQ(&"ZD%I8C/55RNLJ22^I D75':
MV86KM\@H@:UW,=7;8O8^;ZR%_+/8K?7V6.8W0\6#%A+/F6/DG'[.'#_89':)
MU0;BX)8SNW3--S42S!']11,RSO\YLKH?-'+_ ^XB>L0_?_\@FR'WGRS3$DLS
MF#KO&T(& >T;\SUSL^953*S[0JL('R+='KS[(O)1^KZ81:>B"2]L535Y?,XW
M!O5U FD*$"MK!B)\=E=IN5!K39CN=KFOY;[=&EN0V:UZNQ$\4T<]4T?=CSHJ
M+S;NMHX9>R^OW-F\?##A9*/U5CE>CE9 [G>!1GYJROE5#(?T4TE9WGE--)X,
MVL/*FVW>M=AGVXZ=8[V]+\C.MSF?8;.??S:IN."4C"<[%#3/-6?J;W.1;Q9#
MS_86"S_'5.=3U:DK8RCG>'51*O=T;#B51#%I<3$7 D2JJ/ W97H#)ORE_-5.
M)G:,XFWTGS"O/W$ >E64WQ#\[9FQ6OO$2T%?DY/UN_N=,2$]0Q?>D9 ),3D!
M*2JYQ\2#<&AR*'+LX*R:D1**5RS3JQKMQBW1J9IRU[O;M::"5""M#JE!;.L>
MWQH61SI#_%Z%H? BLD$<^;"LHYR%G2O/N_7)I505",@)U#0FZ^]GYN\2B= (
MB\;[Y3=F:;KNW$-&VD]?_0F1]O[@1O(G!=K[GAX&VH_/#E^]P7EHF[2/J:OV
M)9_R>F3YE%]ST1*<%[2'[SW1B;=2=/>1]>1$^_0+[R:?>G&NE\V+3I+EDD.1
M!-M;]HR(9:6S2J@E%NBTE P$B4)P[XBXKF/,%+I^ V-%SWP0=LF?'C>[/]K(
M[Y@DD<D>?,S%<R.3K+N?798IJ./3_#>&+X.2/FVE-@@7")U<L YNP89BDVW)
M.A5T?++ BANL:'<8S@ :IQA4K :=(0-QT@:9]00SD)N.CAVJXY;-'HXJK3B*
MN62^!E<RH\9,<-BW/G?\6Y)G<Q0;<D]4Y)N1J<C?_,;\J;'T1 %(>I8XYU15
MYI,$F#UNS^3QMI,>#PO^V%!X8^I'/JZ9V1>)?#XRB?Q+,<&8E)1>U$D^>=M4
M6 ]<@8MP!W;_LI:\"T;6LC"X$Y9F/9GV&Y-GF3,L<WXXU\#&P11;]UKL>]X\
MF0TW#HO@NP(0ZFG]/^P,./E'B=B4'+PV0P_>XVMYAKYVXSD)!>MM.<8J3:H$
M&TS4[-4ZF3L0!,L99Q;NB4XX/1J93OC=4;-?>/XU6;G/"?9V3[X_HJ4K_P=M
MJ%O94 '?_'@]UN%3, ;O];M.(JUCG:Q?O,=<VS.8R-AN9\]@H@>;3)4C'F5B
M82L"D22T1YB^-M$##N1]1GID,A!L8$$9XD![8"[8?G4@R.XYWI33A-/) 8D[
ML(!'*6Z,& [G;132ADBQ\\"/6**<#QV)99%EQ:U*GVV*I75-:[<LFAU!1DQ!
M6B83URMWJ:WM\;^(=_U2%_-KW2^_%/F+#X+XGORZIFWU7]J8UY:H.^*C/E.E
M=8=JZ@=KB[*63-ND+(?;WV86(W95=?/VJ@C5OWW8)B%N??M#5JX5U7[(A1Q:
MG9ZY\24@&U%>K<4;^FE[41UVAW+[..9WPA*!P[)KJ]"#W@N+7"$X V^&K)JN
MU/]I>#E'!\FC%JQ'FKHLD\L&B1MT)19$"B)G/8<7XL[>\'59X'_A<<6"]UHQ
MAPU(*$7<L'7?N=":(>HSW\-8'+O<TN#R/R,,!V(DN 8$**+CC*J::NIKUZ;0
M=(9E:/ 3.!K/8:>1AKI1_3^!_?/8 20UR<ER%GDW;)[CI/8;YTZ9([Q3FI+L
M:EH8^;JSE<$/3"NK28W\<$E(2K;/8C 'N2^<P"OI7@LFV0RRDJ)(0JONH$-B
MO]&RF8+XJM-, F#^%61L.$L4#,V0)AL<Y1LI;^).V53VA'\25S==X*#\=$>E
M\AQOY*_7-&96</4$/>#YSW,(!4ABF%!VLE/3/AC+DV$:>OVHL,0=*36&S_DN
M*_2D.3:&CH3=S?=BU@AXQ)[&'OVW="XVNY #GD>TX3>\M?]M?/6=W?$MSOB^
M9)R.1Y9Q^FVLB9[-)ND(PJ^FZ0DWGB";0\^(GM<M)A.)+C(A63]Q.8G+LX/]
MHC:H9YN+F!"V[W&]%IAYDIKCQV\F*WC/JW:(,<2HPV,&GM-CS'WC4S@8FM[T
M/V>4.]/GZ$:7$NA;A)/MB[ OPO5D9,(U0,S/$.2>D)6*2A&99SVG,?M!!2G>
M?DAZT%/4N--X'VP<!U\XIF:BSXE+M%<KSXB)GPPW5 B>-KPA_AVSSZ^>?O8Y
MV)Q8(+CM&+]XQ"I"!0O^6<=Y>S7AR<DA=7ZU;BI:MWC0_A&7V.282I6ETHOS
MG$^MI+-_]__F7\CSN0D+.[]YU7+0_YZ4E^!!@7_K6KIVR@APFMZGU1R4$#:Z
M].TPGTK*;7)\],A1&^)599U>41NDI[;?^@]_/)I#?WR&D_ >G.^/^;R=.83=
M7:6+-"[AW/,G'^KY<VWQ]]MPIR.SX:S\2[%?@=D*$Y!9=]0R0+I4@!=T ].Z
M@$^3KVG%30Z8^HBHWUP7=T^JI"TK&?U'/:*7D_=@3MURLI5;%1#K1(*<(]CW
MTG3%0,X,)K'COK[UG;2=7C0@19$48J;1+1&[PB7NBB'#:ZH)T3;DR/LS2W"H
M<J]DL2\[[.6X=]@_&Y@V#$M3KJ;P:T/=,D"#)MBPV>Q"SD.E56>713W;C$@Q
M<)LA70>F]"EFRNVFA8?%/5#X32H.S,FXYO),PU](["]QFN$].'M3%>8UF*[,
M\Q_ZX?D 8B;,)AQ/O;PLJ5VZ</O<%DW&47MN=.]FZ^^(GL(XQ,7B!APG<&*H
M[OYP$H2N3PZ/#V93/6,]5@=1Q"#-"9]N9+V2UGBK=9;4R!E4U:Z7[A]-F5:+
M5-PG-X=F!8OR,LYA2W"^<&@]]^4XC:W]K#U.BR*IS,9!MCG5V[3A,(C#+7O8
M<PXZ)E(NC"/L:-P+B1%%)*G'(O?R<J2H1.29WV!2B8&)1$HC]YUJ1YM/L$^+
M?$_H7F;CL=5>'IZ>*K4Z2RF29X'E1L?Q[1V*PN^;_T<Z:D*!I)L;[0+/MQ"P
M<JWB1:NRVP,G4,2WB+EAXZZ[_NODW55<UF)>Z&<SFC[+^HT:!3MR+[BG:,TT
M)>2=((J,)+)F[B@RB1<42Z5 $6%)"X259\6\D>:D)26=*)4'YTO:9,G]/*V*
MN>6>G*KY>$Z5DBB]B]<4'O^7*'_CZSRU$W01[IP.$Y> G=B:1AT^YW=O'P[J
MLL6M<Q_:^WY,;3ZV5AF86#O!9N[X/PR ERRGOB3H>4\N8#V\SOWDV@A0;0&R
MS(N4>7-^3#<@H5)5C=AF15-[:U2X8<JDJ\=/CU]&9\>OS?/[:ADD,;=AN&]W
M'.YQ='Y\%AV_/-=;?..X82@GK_%>NXP<AGYZ-#SV=SN._>0T.CT_C5Z='W_K
MJ-]$)V>OHS>G;[:.VB4/CS<,_/V. W\5O3QY$YV]/-L^Z9OG_.35>71\_FK+
MZ$6;*]OEFL:%M.3TAR.\9/YT!&,)Y*\EAUKOPQ#MBGT\UT2LI='WQ?48&P_=
MJ[.>7=B_<]VN>QF]>74<'9\>;]]UL&-0',)#7I]$9Z?;Q!'=J62V:LXY/F?U
M3%;O]=//ZHW&KL+]2KA;0R7_SP:#D>" (2(%O.]/&3S ZHGHS<FV<R(4MBXE
M9$6P7J](,__HDZ.CD\'G@TI\_3(Z>;U-/'_KHX^/!Q^-Q_GLY>OH]/4V??S-
M#W\U^' R36#UHO,WQ]N>+@SVAGN/JH0I2'B)*;\=UIE5,]M#;\Y?12=OMLHK
M"M(0![+(OS:SGN>17G:F@6+@Y#*B8^I57]XH5:^=Q"TC\;G*>%;<[ T^9HRD
M=$.(;;0082?X $</P'_4&6)?.700/S)NFMJE2Y![4I=-(N%M#G6G.1&R4X0L
M1/D2J*A.5I7^.%EP?"<-$P#CJF];)!/L>[)*'Y42!*8R1K!Y/ <?9%\$R-@X
MU#[X/0B6,9\XZ^^(<F#MY[]FGZW"#6];"VQQK%2AZ7V*2KVW$-O22CZ='BPV
M)9\B)'%P0Y,:V[S@8*[/(A?Z)NH+)IA(PW$A'3Y\KF"<:#*'8^O:*-B$AGEM
MXW4FJS7I;?UH7KRHXLS_+?>!-Z!^.=BJL:DP'B8!YTD%1PW+,?A"*NET_-B$
M#?+09IG;:&*(NODC5T'PW]K,(IJ(6J;5H#607A[P8_U7N&1NN2E1CTV\[B2)
M22$'J1[R<VRR.ZT[=7U] FF;&30I($E02KJ4 XAJ$4<3FDQ\7\-PS'1JBU2"
MWCW6B 0='4>&; <VMC:,VRV*OZ0=H8AZ<U?2JT[AP;287)0QJ^9E.G,7KA72
M_F"CCI -H^\(S$ (QK*DJ(%@<)+$<*F.J#T#,.2#8[E;F>A@\=PL8$N&:9)X
M3BO&F;[M;W-PHJ,L)BOM]['2''0*LZRP_1R/'0T+52NM^"0KL%! H\G4]=+5
MUYE!3?5P:"=9?,AE$^/A3I+) :R='.=VQPLS7?UH>G/!!!,P/A_)PNU=[R)8
MJYD%X1JDQCR55, :=A*H+OX.!4JQ3&LZ>U*GQ.\7"HG>X<F\[XFN?#DV;CFC
M*^^ANY+-NBO8*K.">M4LDAG,/5P'_\X+1)HX2? ^F=7M PM>7T?HW!1U(@GU
MBDN[RZA'CO6DX2,K9G:X]93 \WR.:P+?YUU]9;5/187*>)?#R43FM(UN_:Y9
MA%O3H,N&NNVD8(+<%%)W7Q9?4SN?[PKNG5NY1GUZ5H<5;_1]FI>6;)/VM<H7
MT\T5[ LLC^T[\O*N9J5%.6Z1QOLB(\96#7B1N3SGEFA)H!M]X(8 D29YBGI%
M$9$<U(E<I 8S^](,C5D?\KBJ$.%(A;0$?&S%@_!#BC_!O[F.9;7.4A\/("B"
MKQLTDN#G^!8[2#T'P$T _,T^!L!'<[3'5HO6T4F7&R&1H,\J5FA11W(3##*4
M^J[<T(J-%DBG [4@W 2EM!B$NG+<-E[!$&PT?!;#[2F>C=?6!0HB'^;=$MIU
M-?(FO+[I(?(4%WI>4R'OFEM*ELG@<\3S($'$T?(-3[GAAZ #0?)65P%M-6H"
MM6DFR':_T6&N4\6FRYSW_&Y/@%*+\0"E%'[XDVN"25A^"H$\5X5\OS0=<U7(
M=^ PL>U2E60^>(D?QN#>HX4SBS,R;:JK!(4Q2]/WR9Q[3YX>1YCP.Y\<,%^/
MX^D:9<W\6WF7+_@N8V%PF)+H;,_H&QLMMNM1N1--V410 1J;"K^IC+.H_$82
M J,B[N#B>5Q=3998P^<8;.Z2&+S,),<D9G>Y>X<\.4 M*A'J*6RK+./^@]G=
MB#?%A4RL'J2Q"4_=)M'CJ9F__/51FX)X^Z?)>\52.P;0W>#^G(@$^Y*L:]F]
M1[A[3XY&W&[@=_?:@00;P:[DJ7X"HM]-X:-F8\<U)R-5AP>QC_]@H>%E0:1X
M3BR')[M][O&_'.^MM55MR:49< ,B5;-Z:>+2J]S3=K3[=^S::5],_#&7Y?:M
M_>3@Z]2$*-=ELHX'<$I_N[CX1$=D&:<EQCRY^(HN10HQ32%*C(4/@S]V6(&=
M6JI =^IJ%UVI%)A#1;5S G\K6R;<MLDZVKAU+[4^F2W1WPY'Q.6K R_FD$!Q
M)1RN9@@N"UK4(AHDVM(G5 Z#\C:$(&I5;G57U0GE4:FB$G/FT@%8< UU6618
MI[Q<IO.4JGB&YC:RN=4RB:LBYX!S534EOIG0*%*Z/A;,/2.I\=UQ6BM3BH\W
M0UZV6C: (X;LE9H#4[@O1WALI<!]Z;G"I><F)X<O#^9;,W.!GY\7E':?P=ZF
M$GF7B?.Y=3I)LZ(LBUO8+*LB3^X(RTB7";D"N(Q7,)H7&-R+)ED!P^9_4LJ"
MHP@8&: _]F5WC*VTK!W#P3IQHGTEIF_\$R.]R[)8D6GSM^(&) ^>8SC3;XO%
M'8H,S$=S K.^(G*WG!/.<=W79/S3IT^3GXL8\UGT-/@92DSA(TY@U5*'MBY@
M:6\2W60LDNPM7&D[)<'N) 'FDU^8\9+B(0*Y]$A8?&E.H26+W@0:W*,3_.?F
M-S(*6P<,,A4D(8RDJ=,L_1=^=*#T)5K5R_A1N4)%)3N8\/-YDBQ\J-M/5E=H
M=L=Y.)S;>U(Q[60\,6TM_KV855B61ID.V.^((7Y'F(LG6T7_)<7WP5W7=<3P
M(!?-Y=7&$N&#.(!*J?0@=FF0V/P='K'D1J*]%=<BPKTHIPP'@;X28P-O<!4O
MME.;2,)HUOMXLD,#3-HB7E''J47B>@9XE36/JR;.ZCO0/U47D17<!R4=O08?
M<D1VW!(3K>_0X(/>#7XB7,\.=Z(*$*YDH<71\AER;XCA)>\&&GFWEQ/PI1!K
MK.#^Q8+P(]XR?*YY:_7 WL>4_R--IMEF:\1@H;'0WO7>,Q(M3#L>_!6Q V4/
MDV. CH <@<7FX]W:^'H>DDSLVK"(X[?X*R+Q!HZ->0LY0;V_Q@8)&0D_16CY
M^U%K8$2&$7I' ;#=>RQ!Z>.9%/CSBC,<R)ZV2KQ4<O=%8MO/2=V4>64!8B*:
M8!<DN0*Q;V/J$R%65I:".\;&A5#_&U/!-J#9..A-XU+*/\3U#:R18T1IH>T<
MJ8JXVR&OBMQV:6]+MP2_ ^U13[^E;7M#+#26"I;>9+UT)BN\$7K&#-OW5'%@
M1R67(BB] %<-)7.5%_D+@[0*][C88P@]#]#%P37M.KXO?C=9,,CY?ZKB7$P0
MGM)UONH)B4_:-C(Z*GNXE*V)VV0%JT]_(8=8Z9B<9$@*\P2-2*CV!7.3@8FC
MK8_CJ3,!<"&X -"8# ,I@7L8#U>#NR;LNDX 5]/E3CP2O&7KNL!B<*!019=T
MI(EN*2Q-$!T._X%[YY79\8NT4A77.?1L$-C&G/C&6NK05$*^A"9.4=YI&*C
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MD]L8*1-<F34['RR>#)=!&"-GD--T@G7SM8-(M$3IZTU%-N/%/?[,<?W@J(X
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M23+8@8LP6!M(Q6C2Y 91,2_6=Q(;PT<$WSD7I-*&?["]9@GX@:$?T",7#5+
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MV2#<8W >T522;KEK,NOR)/.VF,>Y"+5]+\6S/*5Q;Q%Q$XM+ZBC>F7DG@V#
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M;W&)D]*6+)#<AP#(?K-3W/>2SAJ_$26>'3B9/T#X6W(59TL]O=OK)9K<',M
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MG/S5G^D-/XER";SEYYBKB;F^>HZY/MADX@[_12UVWH"?U=PG2/D JC#HX$*
MJW[Z_78!;]=T^>82YRCL&/6-2>=^/=+BPS.T<QT7J>41,7JP=G3SV,W>E_P9
M^Y<[^@D+M\;JG(O$OHQ*/2_MV*V3B6G%)87J3YVMP*^R9I3QL:12RD*(V;<U
MHM(:U];C98_,81]ZA5C5M>O,L#B3I0/C* 2Z&57 [45*M+MO!!=+&5(T) :A
MI9'!M"HVAK$;E["NE]109EOA_G[2[A\?C8<;@PW$ "Z]VID>->1!53O?6?<4
MQ^P'<1W<7A4,O*=20NS337[0M"7'[,8/O$WY/7I.W>B(,DY3E:*]!9?#&G:[
M_N$Y 9C'*^Z,Y'[#L6$7\LD;[!DQC29_%+,)8=TB9X]=I64BH>$5#DNA)P(9
MJ;B?$I].) WDR .=%!1R<&9*N5,@;QB4@LX^]C4(OZ,&*#%X>XN8NZ-@7=(Y
M*H.M CXO=IB8ME^:5H'/X/#1SEG(ESQA<4;>*)9.T(#K5 41?E2A"!6\C['5
M*<^ L"E)DVAY\R3AXN8B#Q?4O=;VA87=1HZ[[)8KQGV@/;IH:N&W8-J?*E40
MTT22(?>=):9H<:>#L=NT807JV.X59*!FRMZ$ZHS9AUQ((!@UU?:W0$_F:Z/_
MR)1P^8C0B6".\KV1LN-A>>BZX;C*&_K)VK:M;L/!D$"7BAD$_S<KBNM*N89M
M\U8?N5252K5U<FQZ%[W#*Q?"Y38YHP[N9L&W>[.)QL,UT-U$?1-/%C^"E^$S
M3# PAUE8GWAP+/T??$I)L@9S_#5*LA2VFE,W(GW"AN&\ W*4W0O*SORZRE-P
M1R9O&U H]4"=[/'YFS/.P*Z8C&2<P+AWO[[]/)+Z6(D3T_&F_(:/ H>+)I6D
M<'# 'E#V8K.4T>3@I+/N-I&DJ_H3O1"M_-^9?QC\ %3!;@W/3[< 'N!9IUN?
M]5\?/UU<P)4O=QK5#V(,V*6P6[A;SG8:YSL\9^#.<U+,3]F;'@*JSN$E2R</
MN@JB:5<1+L:F7[;&UBNIG@+?T"-K.)DSEX?92!=M^(B7Q-54D KYGBVW-UI@
M/!P<@G#^)FZ7-" [*IJ:BD]PT_[1E&D%1]V&EG[/B4GP2TVUCX6PP(3]$$RJ
MODT4WC$3-E3JH#<'YG;*=#844M;1]0UF3WKDK,?3(^?EX>DI0?ORF[0L-)O<
M:HCS' 7_RU]?OGZ.@C]<MZ-0(Z;LN6B9-^7\E^@I2PK-(3K3W/+SAK9M"RH5
M;FCJ?CB9O!\&:'5+BCC(J;QT^5W+)R>PT0K'K:UZBE+3^(R22',*-7" 9I@X
M&*.E<W'!K@0.$):E" D!O+W%XD3,6D!!4RVXCJ34I?7NGBREE0TV>%K&E@;9
MPMV8/..YAG0"",0PK:>O+>P,]'"W@)6Q?AC=4=SFTB(]-YU",RSH](UEN&%Z
M"XX1L@]V5ED6KN<MVF _OV%Y&6.$9"3R!Q-T#HRZM*MBBB%EL24"VC-7[4-T
M#V1AY($ Q6#]9Z33:;P_FE.#I),0_FWL>I=V3][$XV^:B@H^<U-)![>BPEMT
M#.)_Q>6B:-A*J/$UM/259I ?CDEP>+'P.9\P_%4;KO96XZ!BYM%4=OTW;,:^
M7!P!HEPN#M%^9%TYP)"@"QSZQP:AZZN"T-QAO,5.1O\,1(:+:. U(O7^EPW,
M#(B=.3LY'/GI/?Z;9"E!J B[64MH,-QK*AXQ3\;42,M(V3M8CO,WU*(G,HO,
M1ZQWF0N&QBI4A"X$&9/YX^PG&0\.]Q51+']K57=DCZ8=@MUSP-NU;)Z]RJ,]
M =_9X,3$^M"N#IX8"-((M'.#0!<D&XJ8DAFW]TV:W!JP31YG=Q6O*_%P%!4<
M%?+-J%=EYHH,<)XZHFA#.GF'%+''F]#\79:4#$"[?P9R4_ZLZH(9K^+\F@2R
MY'Y[=X,43-]G T3\-LDJ10$EVRW<%WOB/_QS?/[#1^7\_+X9'H<]J@7EGLA4
M25WNUH)&T)2VP)'[.*B$">GP^/6FM.H!?C'*4*A;TLDG2M.-HTI8EJH[N(T:
M<*(M=D@^-*#8D$0(/PSYBLC*Z+FW5\!$VT399Z&*IV;%PZ-2NBA+^$=)E:^U
M\D9H76.<HSEHD>UHA,0^K:K(QCYEQ%N+%1M'3;G3 3+5<^\!L/4%$=<#*+?*
MTX8'Z]ZW:I%Z>3L"G^2\"*_'PP<X'=*WB)5GYG)3YOP_<J[@:*%=!4(X91T@
M:!TG[.FY:,9++(I+XH*AM_T@I-5.EC%B4CQ%?]_P\D4[C=8/P-SL28IO02X"
MSM0NS]X5^CG\9'DJX@KPSIE"H S##6?J8><DMW'&=AO:L1(<= O2AUQMC?C.
M&9UNFQB?\7L'(%:EVWARK#V+3VN$#CL:[H7], ?*\9@#9X>OWN \=.!C7+GQ
M*Y5K/8<535CQS7-8\2'-N&]#Q[>WJZ,)EB(=-@A[>M=$)K2QP4/RWJ&%TQ+1
M"$/$>LN,I-@TGK([RPC1I!K(K9 Y*NQ8ZATU71=(?R%O=DLQ"8.[[(3&?'=F
MN'NSPH$+@E^!3P[GB7:%Q2EG\2V?>P3^S>0UYE>H]G(JN:. K\5ZD64D(*\E
M2G7DG93"UBR^HW^MXFL*/$G)4^!\4S76,BFUQH0UHE"RAG,E56N^71;5;-68
MX/(1!;MU6D:/%-[B1L# Q1]-SDVW@M);+D?=UH9ZUZ7S3#&[(OL,JYX0>0XP
M7X4D-*:P>+?WPT74)F05*]GA1U-(E4HR)(#HD\<:['15:EK0QKZ]5&JT0VCM
M.=!@!JT8O-FH&2X1>_OF,3TK[#\MM*Z8/^F6D2+%A%1@[XG%5(W'8GIU>/H2
MY^&BJ:\*K,!EB?DV9<WTBVNXTNG&_M14<]MEI4T'ODE5(?@93LBZ(-SSNK@E
MMQ%<)9T38LG/N4R"Q!,S,3.6EV/R!B*C7E2H]ZDNWHLX\HK6#N/X6;UNAZ9
M>I*K(L-;_4^!-0O,"\9TRHG5*QI<OY\NN9\SQWPC!Q@6G:R2A*3?HB&R4<IJ
M438GR1;$HH8V@S"4FA96FEN446/2%3NN4O2#TJ]83F+B$3.L1R:%2AG- >QG
MY><)R9%G2NG$2_<O&1H(EK*XX58,GL4Z\A36%(H)L=DMALV6+NS<56FM";$U
MEV%@1^25  Y)RRZ*M8>Z;+J_67]V^YGET4]D^./$A%>6K,^(0-"E0@?O#=_]
MPW5.)LY-55L]G4AIR97.:&)(P/LR0A2K@/W*>V60/1Q^I\$B O[1[OC2S**
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ML\/CQ^TE846;3#_NCPN1Z--H-X=$MF 7&C1L7/P[QM?/]S&^/A8#L!F/ :A
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M"NF)+]Y7H5JTX/-Q>U#?FQ%)5%ZUF+$:E+;=O?#^C/63YZ=8/QF/<3@?F7%
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MD^X8.A"U=6]MP&^.CO]0K!2[KL_G+-OTELHP3,,F@T8OBWB+MM&Q,=#O/SA
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M;,+FD=P,ZT]Z%1%P]3]-FWO:W-]L<^,*#&MS$TK(00F].$64T($&,RFVQ*%
M,%"I_PZR%@WSY@MAN.&,5\CUL*$]$0[<;#R@*N7 M<WH7S?$!UJ1!QQ0.+(.
M:?H_.3F&F>6RE?R<H%:S98M:4UAO<?+S'SS1W7FLR5VD5+V"2\5.WZG](_E0
M_&=T#FW7 /(\<8-T8O0,A;\F;YI69 /2Z!)-@_,9;H6S?)K]/0R(:&<O;B-J
MW47FZ2YLV@6<Z##\R580-E:5*$R:UXZK&UN'TF:P\(&S_KNMM?4VO.'>]R.S
MJ1^UV;D[><![.DWV-JZ.O.1$N#D1;MZ/<+.K\KU.'$4<D[:E)<E;AVM"X=Z1
M+:/:/=S[0=6X/)2!761%#J^/:C7P992?)4[JI?"[B.)][JA)+FZ#LK/NN[HM
MN&4LB;A_-X$PF$TBYH:S+TH<@YN[1G(IKVB>\M%(Y3"69\6:(S*)C'$GF59,
M1^#LD$LH7$"F'XX%8[4QSK=1CO@CG2C+:I/+%&HT[JZA$W$+5^-Q"U^</3ZG
M'*446Z)/R9>L.4[7,.JX,)Y_(XW&VCP,.R=PEWI='ZX4*82 N?0:(E? ]-BS
MQ_]%BQ7^ZH_@F5]2(CU!^E3R!=RQ;5N7#0M4<;;-_[)]WKT<NOW>SCAP6"LS
MPL>6'ZE/\]23U8VB?U1;_!,6X=2EX19&T\F'&;'ZUI2J@E;9_=[&Z8 MJT [
MEJ5_,U$XSNQ#NN.*$Q/,QFG8C<OQV WM8/7R9:^Y!3MZBW7LHS4B;RS[Y_LZ
M>Z0 B/?4@!WW^$C!28<"\*O;T!DWV?,5K%'D+N\*V.NN<V3&HYR[6KNRZ"$.
MB'<8MTUD0C5%G3'7$IA8=E<7[>5^=(7);--(.RQA1_"5V#",HLNG9J3AUZ(A
MP&P.O5GLQCY.5Z]8#;?:;1FV!]7AO(+XJ-/LT?,IOVZ?Y[6=^/=$4":SC%/[
M:^\2P-TBD_ZQ71PV[8Z5)7?!NXB/AUCU 3#PZ)?^BVGI_Z&E[ZR#@R[XF+)C
MT@9%%,ZPL.%P?*6I)4'0\M]4!97A6.[2MG!85?' XA >.C8'1]SO?E]9(N16
M&-1GR&R(T"Y7A8;R8!) ^BJ>84*NYOR")"KD*'999$2OT'EHI\W&7.I$7,BK
M\;B0VN;]_OW[Z.<J*5'_"U/&*%A\K+[CJ4"HQB;Q\FN7""\6[ALN2JA]/:(C
M<O(.3\8[Q&<9]V*;_+$]%MN$HW%P-"\G',TW7((C=OVEK&2\_FBFY7MJ&JL:
M/YS%?!%WMN4UEMVP=0)3M$'L$"D[N^(5%E10= @6LB"8J%DNJ'8;1N2N\V'>
M^)UZL"G$ GC%@!,;^=2,"*80&V-&'&5 /8)CXZJ^X@]AIKDJ;Q)BO^-VQ:#)
M3[IHHJQ9UM6-(4>FY-W''-8*O.F_X-&RV^C'I/P\8CH9\^YO^55>\:N,H;].
M.SUU=$VY9BF<>;[VHYD,*S7B=1:Y+9S(A]V=)A/^TF<ZES/Z5L(V"H'!1ZLK
M9/#3+J-?5.#0$E.<38 Z"TE?4;_KKO^TY1(0+$$*C[M]KIHSSOV>/N+EQ0B<
MTL:1T(&?1S^V#?8\-^!G^SWF5@AA!3Y&0_N<M)$L^;O_V)@Q *>\XJ9H)Z4L
M7;T)%])4T!D/XWQCL"SA=O/W5E]7M+/!Y7E\$0?OJC(=1K\AS>B8YB2W]TE_
MR1_1)OVII4K=&#;IV<D$QR,57E+!>VF0,&J'?FHYWJF7V)%*]+:!:0NA-,T8
M03&6^A5V^T%#GCPP86AE&+>?E68(T50C9FI+4(4T\70 ?58/)90FL<TR8R.%
MU7 I@//Y0;KS3NJVQJ P-6>,84@(:;51NFJSS=8+L)U/'L?1Q>.+<^,[8370
MZI"P=U9FV+B#M?Y=2P6?#TX'(\$P9%"5HYO>O?LD9]%O@D#;U-GO;8K@,#'1
M.Z1"+=V);@P#0N):+15L[*7V0R=([MBCV.9SZ]H300F$(V@(^AP^^=P_SSZ>
M11_7>(:9T_=52C+7V]I0W8<8C3X^#3/&*YM.5;S<5K7EI63-@B/[OSR,%!."
MA [& +>'P&4R[<4V-.-VZ&;>EN5/\#U8YJ;F[C4J52N?N@?^FXOO8W6<17P5
MX7RMT@E": *K AR\,(T4S-.@8[[W/)U(H2 ?3Z'@Q=GS%X112_(B8/486Q9@
MZEVXLW=!Z*6L%>+3@RIQTF\7.^2L(1T]YR(0(:R$%K5GHQJ'>2BVBJ_759ZJ
M EM:M0N?M,$8+,M?M*BKSUD])QXL.=U\5HUAE>G8G#,NX([/B1#&$ZH4AA8^
ML+-P8;#3F:$-OQ>I4UTA/U"71FF0[>A$3-GO8S)E#+=]8W73D/8=@^$CK7E.
M-LTD']!,W*D]S]M+IMPI5U:N>NSYXQW:L4U75U/% <%%MN!<8?_:6KHG_IXF
M;/P,*)/J@JDJB?NQ-8Q !F(H:$<*.YJJN&;RXP3,!YBLVK5MR7()/KQ"-124
MC9$#,W0[XC)3S<6MN?QP_#47S]ZAT;_K8'ATP)/!E.)'<T)<7)R1KSM4HKQ/
M+?Q83NUA^]H/#?;?%D<ELW QI36ILYW5I9DM+UF)W1CS,=B]UB-$'),(D<-P
M8K/6MB[UU[\\>_FW8QO^_JV1C&9+B!P$EB@2)B5ULQ)**/-;4M=8P3G>YB5<
M\!_AJ&4,<?B.IJ:UK:7<LZQJ#)+BR"G/XAD^KHPL1$&8'5GG!^5- :\CX05$
M2%);;W>554U*K4G6F:,(@:G'RRMF<Y7\6?<*L^P+.CUJ-80N693<BEOA@I76
M1C D=9&C+B\!V7)-\A*TG%)@=<\2OS%+W)$/KSH+0NY"EW'O,Y<U=L>E@]3P
M\0#JF-7HXNS9!'6RS_-JT6B+CW9GO:8FZ /3&,U6>0WAD4&#5V5Q.Q\V<B'O
M,C,2G]%Z%K*O$UW5T<6TG.WS[#[Y1X6B&E[+,PBP'5X0^)2(%ZLX+CB?U!.A
M+TD1OV3ZL">HSJGB%6O&3_Z4,QI:/Z&1N]%[KPP'_"_ZD5<ITCTK:DH_2'NG
MJE,^1^!)4%4R7R-SB[-SME:NE$X^9A"T+5(R&9200(04)B1OL,:#]1SB[,.C
MV,@U8SHCLKD*[6EN^4I<%PH_FI<.J4MP;WXJ'4_XJ6@;;<"ZPU@PZ8->L"<%
M8^[:O6W/IX6Y B<;KTRC&LRFCGR^S=9-O[&;_UG=%K/ ;D@2G&*O)"]PA/7S
M=]Q6H(@]]Y1R>K6-'0'=@DB<95X-,#!6468]0P8VT8DDS1?CB?],HU!64V.T
M^C/5=58F1]QHWLT@TPK;\&M*6A?5D5$$FK8Y[;E>&Q^[?.A+'1E'6WKT?LY$
M1NIV**BO;F9R3*[-^-M=IAC0C0&%.QG,16<]O><>V@.OIZT#__*\$]\ML0@A
M:^&$%4RM)M?N@^+6P.7G/90V 8*LBS"^RT0?K0'F],G3LXO9<G[0W3,T72?B
M6"W'XU@I)^S';;7\S,B_Z-4&P2M)<;Q.E4< X&Q:QOBW6)].J\W6HET^*+&@
M[G1W//Y5/:SNT23Q[KKTKU 2J(9A@DT.01]:[Z-VYV^2G+%61!8E/+VD3PX'
M6,-2 QK-6Q2KI4_KJ#3<@R36T%9DT?]\_!"]6GJK'T+Z7*B\:2-8],B)K.X1
M<FW_HP+;@KC@?%>4^B<$NKQX?/Q ES&9'EAH:!@J(E^L9<FQ'%N*1-0;),'!
M[5Y3:@MQ_TG)B-/?V]+TVPH3#GX'OX+,<>H3[U"0L?C5\+ EAF#FZZ66B;;>
M,JGO>I.10_][6^=-FB]-7T*=(1C5RE"JU@NQ_(:7!Q>;*.G .5RZ+3,=[4SA
MM/N<-?N]1UX4V652G(AA'"';+*S7OZ-L:8G3 V'ISV"_&.=SG(?_GQ8$BTY/
MG?F*D)N,0VF)X/;;^K=1D=PTK<,#%OV,>S!Z7U?++*,++O$N67FI-DGV+>WN
M63+G -9T\[*>P%+LC[_>?JQ2QKS.%O(UHOK^C-W4C&]%C0-"MZH4-*FNHH"N
M*3ITKTA/0AW:8CU/,'P=&P>ML?*BTE0MV_4QL\]VCU+37.BC#A/_Q5-]<:O#
M%LA?#\D&/S1H\:"]V3^,K#=;53IJ:?A0*"N1%=@F)R^Y'\O$$+6W^:-/;$+-
MUR<R:2\>CVS2:"Y04)@@&>11JJ1+]B5;MMM.I]1)3<?YR*8C8:UJ,R%&L7&=
M9=S@HE4 -H<P79^P&Z6%:.=#=MD6LNT^:E/Q^=G+'UX\NIA=S6?G7,TZ/SM_
M^O39(\Q]SY[,8PHD4B5$>?(86_.;7E@X0S ,!L7O*'^'(3:673Z@-]!BEW6-
MRB9<QEUB:S[5*PR"XSZOP7Z+\RH7U*QXF9'S1)=4XY.TVZNJSO^=J$JF0]:B
MC"F&P5C.A@2U."Q_L3_XNU\/T2:+#(Z=50B[L]IQ!E6O8MR$(6$A[^*62RJ9
MMC;]&3;=Q<@V':X2FIB\;+9UJQVGGVS3&:KV+> ?V ,/<3JLJ=MJM0*W'3F/
M?$M)%W(2GLL:/'HX^4YJ!I^,; 83D^/%/5O0M.Q@NDJVVP0!:^ARC+10J7BZ
M=^_>'33HY4Y(YK\!^W0J"_CIZ!9P W%TDC97<,Z/F'3+*(0(!:"NTS&P;L5<
M\93S6Y.QRK30 XNGC"\!?"DN)-<+/U(FR*8(DT12;W0JKY&/0W^CW7%2-B5\
M'E_T=;+!H>2J*GU3__*KX'/W)G,D'PLAPR:8BD,=E*&GD'O%@J:^N6(_B=R>
M\'FP>?"MD$[87R*F5+[E-%)OKVJ"V?:Q26R2VQKB=>4EC 4Q3,/9$L,1YI*N
MX';-\(#-K!9436!6+B"&N&/]\OLZ6V4U5OKHZW,P5H4]@V5<S#7V&WB'4N.>
M#\^8[WQ@C,%%J)=Y@R[!' ?G&B=WF11+\75#L+(D_%XC'U"JG!K"#6@TL+ K
M%)\J^N=F5>/.Z_V6X4KLQ53#P\"SP&R7D:$G2K:^UNJO-V56-U?Y!F^)U;3D
MDC7!:*!]/B5=/,[E\M(L6B+RV%3-UF@-3;5"IU9X/M4*'VPP4Z2IRA<MF\Z[
ME_$N13G<)&#-AI8\%@^WA?+440KS'ALT]L'WAEX7Y;;:[LW !I>I)>XL,S1+
M\.D;#'"7^1H,TJ9(EEEC-K[26>#C8S+N3C-L3:"_=;_>\*F%[GDQ&N,\-$4[
M;8<_Q8GM>> &V&W69V&%"M4TVCC7\ Z[ZNYEP<F0:W/2?02?HN Z[!N(%P<L
M[HE41T8HK_(6!FC-3$,RWA]5R/I$:R0[WMA249X6Q=4(V?IT[)U$^K&N-VK4
MN<JS5?26DEIXE/VJ$50M?_HI+Y,2&77MGX+@RBY72;KR@:6L)DZ2U620#;&)
M:BMW]>0:0QF1+*KK;/0X\X83U\_/S@^:PQE;C\:]Z4T.,6K@K(QS;3T_F]KD
MG>>YJU/R(&MGQ&UC8(P>3^O'R6CN;G$^[#+*&T=51OIAM0WV1-RY$3*6[KDD
MCLVU^W@'=CCF1(&#<+3XXS\+%<#G\:Q&#6I_$V0#YHR4$O!CNR&&$HL(/-9%
M.4OF0^0 /9%#' 6CT7BU=V'TITR1JDV\>/9?7NJJ6J^1?[93H F*"1Z_;"7\
M&+:JSV(30@YR77'O@ )22( " T(L_Q=)TT2S4,*@<SNY!@&$M?27$(8?A@!>
M3UE3%DF3-W,%]-(E.T/2OT(X'Z!#9&A$M-!Q9V=@;R0GL*'M#?QP^VA5M74T
MNW@ZA]NT%NO'4Z1]#W*9VY[F!2%)K_"I6I55&\)RGHC%*<9C<32=@8VEL+C?
MDX"TK*ICM2]OG4R"V2!]5-0F5+_8P4?=Z<NI%M+R;CG^3W_)CHTO-9#:F2J*
M3D7QHC,:1U%1W%:;_W<O?-!K&.Q%G4<_XT,,C=F3?:W&N,CVR=R@HV12_X,2
M2]H:8624&.^&QHG1<,OL+O9Z'QG3CU+8U!!+Y!N( FPU;>N*7BE+/]R@;L4\
MMB45UG+<#AGI@,66S9\=)^'QAXNWY!NY4H]>)3 .;C< ;8#?WV3X& W=Q=QZ
MEI.TU=P=B^P+7IN]&[+A\@R+#+R;K"O*SFY61\!KQ."M0&-R#)@MX\CV.9=&
MS_*N%=O5N_0U(4F1CH0_ZSTX 'S;TV.T3E 5X,5HCO3]50$&>,*.Q;?:1PH@
MK*OU\O]CDG!O^G_G:G=K $S<_]_=E_US</_?S6#=KW]Q1%S63Z8BBWV>N[FL
M=ZJ['&((_SRLUA/;\K=D6U8J93.IB<R8C*?FEJU:L55K]95_A(F16!<=<497
M.,APBI](IFEB9O[FQ_' 0?M0',U;TA(]1I+0B5C7 VW]"8EU>PWQ,,/N:9C<
MB;/U&T<_$V?KQ-DZ<;9.G*V'MZO[<;:.?%D?F@]TH.UA%RGH5*!V"M1/.J-Q
M% 7J46Z'\;+-NKMDHIR=*&?O[[M,U*L3]>KARG(GU.'YRI+DH;]M&SCOS 1Z
M& W#<_?GZN5\,?5R'F$OYXC[\5Y,[9SC;^?\$_3AC9#.0TCFFCAZNUT>ZW';
M)?! %&R,#N@R:1N#-^7?>HBK4V(K?_%L9(R+F Y55B9E,Q1^-0,F2#-*J*C<
M(=>ZY*.7XJV'W,8W6$BBM.@*L7G$*"OY44-J) &Q=ZV'-",'G>CG(YQH'Z7N
MDS@UPF'H^2_76':!1[@6/BEP=%M9+! :)I?"L)-E][OFKI6UWQ6^;L7M=8^3
M68G?"]1\GY78)6PBJ)5+,&U7"?5+P-3Y,QR062;725Y0G68%;F6C(9A3O[$,
MH911R)U[G<Q<OSR>N?YD:V;1VR^;K&RRAY_S+;5P;JB%<X"!?Q=W&!J]04M"
MJ\BYP<DLHK$IJO BHDZ6/5P3_>0#>";NI>XUNT?9_/*];,?^S2]X'*Q+ R@^
MC0AS;*T6P2#;%.BQAIH?_2X@KF_0UFY4BXGJ=^-,A)G=.*7#[/,,&(+#9,&4
M=]R<#H8XB/J1*5#JJMXX904*0=KZ.K^F6DI5;RJ' CFOHU>K55Z@C]-P?=JI
M'<!?7= [ERW@8T99+(XRX;''+U\:)A3>!K47XC31C'5:1MJHRT-F)C\3,HY1
M=.P:%\1EO<X#6YI<)NA@4.#\)EG#=" ;=$Y>9M52)%[54@&E7G-80+O377]&
M;,S34\3&C,;=?SDV+3[4'\$-@Q/&=@]_\EN0(NKFI:*:]%"%Z)HR!.G,V )N
MKQ)N-?IH*J]!Q6Z.%\=K.%U0!&OK=D)YC\$)[&[;%?>%!=UBG2XS__&J)G.:
MQ"YA9RN[0^*4C F.Y+4M#U':67)Z_)2,K!-%,<XT2]TF,?\^<R-^))HLG1D:
M'% <I5$[6US3OC@[?SHY7?9Y/B5?D.80EL:!RXX[MN.TYJ8U]TW6W)_!F)](
MOO+EZ-1K[=$8>"5BNK3ECBR;<5#V<V.^08.?>\/!OKZ36C%CDUY5EQ?,7Q9J
M@R/*IC(=2$*::K1_T&"^YS:F35LW;<+T0$=P]+T\^V$Z^>SS(*066Q/&<@+&
MIN*/3U3DS,R ; ]6%XN/(BJY75=YJFBUM&H7U%G1_2Z\&*E,N0UU%I505B6L
MG!3+,98'(M/:X(H%OQ0U(AQG<Y-0H>P;I5.*1)B(?38T>59X9CJ#1</2^\B^
M[]9S'13EJMVV#_.$@>2U;Z<1Q\_OS)@Z.O@S5\?W'I*(,SCQ5_ ]5/IU_(">
M*E@@*7Y^+A-.L9T\AJ+JDVW,9,X"U9<'@I\P@22/2)8*1H[.#YSVC>DEX*4@
MT\RP??2ADL_8&U:B46.U3+VO6QE^P\M!/'IOKIP_&2)#6K,;IF:@W@+X2"9F
M-<V:)2P^.\P;(E2C9H<",6BD?,HT8@V<E/#RQ:V>F8I/6[+F&X/&I7GB)H?O
MIGF#AOHF2_=?^<&"&7[OG>_<5.%3V6<YJ5-[='+;9E4W1BP/Y]'A7W^3-\HN
M3@J(#=H"515D!T^X.(-U)DJSV(5,90'8-"@CB(;DRU(LSHUQ\?2.3+?CZZ,9
M,ASX?>I_G'N(8!?N>N*36D*C$[S&:*!(\G7,,%BRI$NN!=7X33[0UEEZ&VL>
M)&S50N/<$#L^>N_$CX@*OMB(M=RV\%'6N\PNL971%VX,/,WPY&3/4Q.=4NA0
M4<[.>;<,Y'9SLD7.<LZQ3ZPLI<!I !N.V>ML#WXSN0DVUM?VG;C.18]#0T7X
MG^J&GC59<J3#$M?\SB>UD,>&(Z8*%XI]AL%+N0_LRU69L!QJ@23U*/RF(PBL
MR)L[;(WTA#;:V'#<[#0DTG 61UE=5Z1)6:WAY!:Z<W?=&S0C1RVO4AQB%^<O
M?C5V"U<EX06$_<0UQC90:Y2./(/7I#VA?.1;$5CN;E3K)HNKC^3M53WMVR/:
MMW]&Y,&SSFA,R(,'M*UCZTP8ANG$79P.A_EBK'(PL6Z&(134>7EV/KN:[Y+4
M&:]> M58P>46'-86(I *W/*#IB<5AG4B7:<C)'CMAP5O<]0[X>R WT0UH84/
MZ$!,:.&QHH7W @5S[5[!H]H5NV.S61CQ/IV,$ZPX['=Q<V#CA!<',D\XU/B\
M.%?KZ"JIUP4F@05?''L XZ9=K8B>IK?;M?N^/7FYN./^^+Y/1+';,A<UFE/J
MT'\YMA9*'VBYG61#OOUYUF7X>UA$L,@]G!"4#-_F5 S V-I??3B9*D [^UH2
M>+TM1?M!SNY[T0XL[43BL!&ROK\A#PQL0I*OHS H^R5;@EW(EP>-Q4^E[_V'
ML37"_&HMOY]GQ^*KB%.#EP[KX#67D'&C=]V[)LL^XP8.F],L,( -OO :PK5O
M1$H=/D^8(*O%/BY//MP.;^AY1^&_R[F['YL-0GGPTSVN>>/(;PS:8VJ1D,_M
MO%9R9S P5\FIB@1J$&8DI*V)I#<W2J8<!X6>SV5U@UJVT655I3"\O&1%LA0^
M)3P;>B)IN&(49BG#>K<.[6W_Z\4$7=-';0R%AQ%%[1V07<V;O#=&[2>;Y/*4
M_AFV"AU"@X,D@HZD(>GEQ,-Y]UJZ.PM^F"6&T1R%:*:(A3&F9X2_;(K$K[,O
MDB:7DO^*PEP" ;M6GYP _-M&F/JD;&^!V^Y-.1X<US0JL<\AIR<>UY!$5]5-
M!N[>08?$GLXFLU*C'YJ8PFKWU(:3VGBJ92<B8A<0"SCKS98)YO?WPXP7Q7AW
M0R,6.YS[J*,"X_8@5T4Z,]2/ZY.NC'J%0Q_N7:S,A:H6PFC!%7YOTWSI$)S)
MQ)Q,D#>V9L%_;JK2M="( \\: 6OU!',T>:NV+O/F/H29P\N!0DM&E5%3(&VC
MH5Y"]S-YX_KK98:P=)07RDL1$$*9]NND:(D1WWT;;Z^>1=&[^Y"'#K\)W!A#
MCXA#CXKJNHTVS1'*VNNQ["V$##\GS4CY@#NP&V^#?8&]=SSQ]H05<[!BST\1
M*_;M!O.>2^]-WFQ@&43_H"TRIA1/UXR@1053\N1QE,+\62)S[LF!,_T^-,2[
MW8=A#XC*M&2S.P\H*HB=+WI#+$;*JQDZQU2:;<$QD#8Z+ 5ODD)"">V;3.5Z
M6H'X6@/\< <%^C3-78ZD/QI>-8U4&DT018/\Y/$CF&Q1E'2.BMR YOC]O?$<
M?E=;@UM6B,%NX#$[&.?>,93!:$0_B<*VM@9[FDU8IN-/0(R@)7R77[K(;!95
M(/Y^HH#0KXI3V2;2N^.;*7\CS*HZUL5.[=-B3L17@K_8^K5>>2;E>FU0VQHU
MU]KFH45FHC^)09>@7W2OT==R,,?:O61*ON$#5S)6J"U;<U'_1BW-O5]D ;L0
MET?W;;AA/:?R$[Y"C"W1+DH2I40-T=)D5":C\L>-RLDD%L;&*?- OI*X2,W=
M/I+C]73/AWL!5N\,G9$?9;W9!A$_BTE6Q75FT5F<!2!#52=Y<T\-D-W)AOYC
MRQL3Z[-^NR$A. ^# GQ*#G\ 9'J2:)VMP5"6:4O>*&,ZR2/%AUDS]<R@VSGH
MNC_L!"^(G6.38,67W&'8\GQW, =7I+>0*XS9?&.12P<Q8>WT^:-V([@Z^5;$
M;8HG8WC&1HOQ#HE\%!MIUN,2[,<"TYL)=CQ%*2P2:2OU0B<G6MX=WF@L3=!'
M!D+N99[,:K@KB+.>4U&5B(J37\-Z7<.'X%W6+5(1H X)[D#R9#&3AVQIL;I/
M 7ICK\V!ET?03I1AMG4I"%2N%5BF@WZX0@CPM!V\H_;/I /V\=FSR4^SS_/*
M"MG\G-QP8?5_'2GG T>#(2AMG_/P-'"BZ7APHMJOU\4#3FC1;WKLCHU*Z)U3
M=J/3(SP@C+H1IF7Z3HM.TU%'J2 OK\&])A]+\IE4KZ>TAV9VB8#(78PJ@M#O
M-\Y&VB76W4]C*#KL+@OOJ"@>RR"/L,!S?!C>@'!RO-0"2BE0'12&9";\2*'/
MAKAS0C]/,<.$?I[0SQ/ZV4$_3R E!Z3T8@(I/=A@W@=6/X'B)U#\-P;%8PZ<
M[9\$?3X^;5O5 RAVYP-_#)#>N4,OMIRL\5(RYG\"H/G8&'K_1$#SP;2"CWP,
M%NR3Q]&/;9.3GL,;!&[: E"&--11V:X73)I-N$YXO0Z:;_#.3MG(,+TOD):A
MK;>.5((OO4"U+=0/N"2D%-=FYT(DY13 =M]YO.&_/"#KUXPB P K":WG:BC2
MI@6:(_-T U,H&-)5-@B+T]PG+:/N%)V,L1L;2_*[4,$D/*AHEA$,L!/"C7_T
M%ND?7@#]A W#IR?^!8(*)@[2^$(D 2R1G&,#2BERT^/!$6YR5>8W-Z5JZ<22
M63+41<88P1\+]0*65Q49KI+R0T2^7Q6QOJZA'BNS2[@U&*B8X"1%%NBB9$G!
MIG]@#TRN\>0:W]\U[NXT/%TW)CM!0%N# G,.6%J*PRM=-HMLE#&O3?3-<)<=
M=D+&-3:C7*-^Y!4HQB=-TZ[)9**!S<LV4TNKCAW96PLC[_'S\A4I5PUX@93/
MXI,*4>9UWE#EH2/%0CTZ=8XT_ 47)"Y;^&95WWI27B00MD@:)KDFX'EZG;,X
M&LIXP-($?QD5:G23#?5)8;T$'F(%4[MUA-?XFM<0#296!"[-B=-2^,O@N,?G
M3@H=G&8..S9O8.,NLNU-=B<*U9F9GI$8.*ADDE!RA-1HZ'=^308OR!I,J*90
MHR0#8U%Y1#9U?IVC$ ]>JH&A+A*([*OEMH9EU('3]+^"= J(Y;*4KO@'XFT8
M6@=P<W J8<$3.@"BFR\HEP;O_WM;\LOO+M3C]8D>**NS@8]0=5)JF#W3C7'/
M5F+/(L]6$@GIG&\3HJDR"DA:+JVS50T/9KA'Y7.B&&3IZ\*V-L<'JS/> ,NJ
MVJ"$1 ;&4W,2/H;8J!+M7B+.QK0>D#PS>T$*VNO?L_BLN_(H64&]RV@PK(<Y
MM"YA!()Z__"6&SX[ZXST)W77B@V3@S#(/&VQQT6KI?QY@\)U0O5DB1DC5_'.
M_;[ =,G6!88N.+3Y&-:#+U979)>IA0>1+%;F*Z..OU=%2U'?6AC\O@[@(4_5
MD17&C@5L]ZWE9(YI"<'>WX"9PRIA58)QJN#(7>7UFI7EV(BM6"JO8R%S=IG4
M\5!."53'LW[.S55%AK3,#'2#;6J6#N4=P5QS7A0A=M)+C2Z$6'-4U,MLXV0/
M>(YML.==MJ5C@?':5UD!-A,]%WIXZB.4@D*6SC5JCUV7A4H!*\42:E ?^#1]
M'A+VEVCE"W5>R1?"!V/W#K\(#VB>!48/7($LZ1PP@<_&UT$G%XL062H5MD)5
M>?TCP/0(V.;K_HK&;IC5KE(W#:'S+&^;95W=B"Q5?/>%!SPD<JY%95?23_E:
MR\R<#C9KHJ;'<-PWFM0E]0+9L4=MT3I?2CVIW6(Y"3VGZYQ=.L>AO9^_&8NW
M:9\VP4Y2K]5@*KG_QW^_>#F5W!]L,"GX4YT[V@[7>568NOO/R0VN5^]W%$%P
MTXQXXV*Q!M%TNU;\]9PW)'*U7U84KCB6I1J*._VF)B5C9S9U)UJH QL\NYX/
M65I1%;F-_EZ!)USB]\&8_EBEOHHK*5^?3)5A;'IA[\*3AX^HOMCMCU0'(-2F
M'K(%D0=@@7^P+8XD?PM#,B!KEXL4=(B;!_&2\YPST(HBY:+,(G723KU/9TA4
M4,C=+2PWVVS3.&5:.P@I[*1+EE4?BF6U\(+LTU1DM;5.>OL@T.6$P! D@@)8
M$I'MC12OL();T8LH&\10'=S49+@"LVA9UQ)_8PV D\_3@HN,XACSR#EZBSBD
MY LUV^JP)=@=J7W;\TF#WP-6)K^];SEYGG&28B,[;I.$%@57O896_5#)=B#)
M9.\D#G/_\P@7^QK\\%M8X0Q4=". ?I_?2[CP!^YV^D_&[H]-DL?1C#N.3-)L
M=5!AV2';VI..YU7M+&:;LO7@/B6I9W+(C!_@XEV:_1^!@.X\O&RU87$KB47.
M*>.A13<@O24\*)V.\R*[QBSB0E%"-0Y^Z@JAI=6R71MQ-".9%LT< IW$Z^IM
M/'^-4ZZ8.;KD4]R!0=$5&8.7-!9%1&EMN-&M+>.\_O5?[]X\.O\A^@7&$<:I
MF4\'T#T.(,>765:-SJ71JA^*E.T\B@XVKV6TU]M\B_ - ::?C%T>FU+20/EG
MR,JTC3?7BPP\<7 7JUI88Z^KG)BD,4$B"1;9Y5:_EY*'Y8J4\% DU]VP,YSZ
MO*'Z#N]-;^<KGQKLWP0?A1?+>MV6XM8TR.D%Z\E17C35&;4XC07Q,/4)@R!N
MAT1B)#%)S;I-10)D5407J(4VQWG(!)9A#8[*HV612X!Z4]6?'\F8V'KF@R[I
M _;U9^/IZU?])VX6A95UK *[K^@\MQCA'L5"Z;A45DNO)YW.==P9N'J;H$CN
M&=J&1HJ= I70HPU&W$7H%@QPO] #$UH=GN.JZ0JUDA)?''E*?%GTT>C@?>AY
MO3N>.3;JJVX*WV! B-=(WJ>%WW&%E.)W/GY^@7T'1V:IP$09:)5YDV?0432G
MEE(@V1''QT$NJYU#6&=KK W#_[!N'A$K#9^*'%TKT:-0Y!B(DI)D#3T69<K!
MZ% ZW;YGRD!NQ&(U>\X.O/\_JBV.=+--E ;J%G,)QJ^B6C,F)/B58Q]K3;>S
MZ1/+6+LB!, @U\ZH X")]G!'.^-ANQ4Q^40M,LQ=Y4(41KVD-*8\K$+KR%;6
M^$4:YV1YCV)E?6O<RU&MK/$A3?H]YP/GE[H@/M6HLM%,HYZT0](>>J:QXY;&
MP]X4.0N))* TM:,YX]!98#=BIF&H26*3R9>63?K,//#">OG5^&KL*]$OL/)#
MO6CVK[DE=19"5$6@\,TI+29K2J LX.%EZ>V1(>4F]V:T[HU?>''++=0 >HV4
M.)<&,CL!1AS R \38.3!!C/[DE#L3W:8H4Z"?\-UB+1-199>0N!:-0TV^5)]
M/%E*:AT;@)?)ADX/L)F<K>[]Z#PV?>S*>K=E)CRTSDA&G-6E)NB6>;ULUQBG
M4L.>L#-7!M=22T@:%@:2Y;*MDR4A5. ,HT1C:<-5_R@S)]FM/<<H@VG*U7 D
M_*0"#9CJU&NE5;O@O$L91-2$(:OJC) OL1Q^WJ'::8D>^Q&B3N=WXIWM=YY&
M5IB9F9PCK(:^W-9OQD>:'Q32:P\9[2/HZZ'Y\->_/'GYM]_ ;X;%RGLNS+DE
ME*@*5C*3$9C/X.4]-9VM 9*>2/9[-9[L]XNSQ^>4_=86Z+=?E,[] WFJ7-#\
MV>J03)RV7_T:%X\?CZR@]Q.C'--NTI=/GS#4PE3_T1U!4Q0S\BC&J>![M R9
ML4D2/4N190#?CW47/$ L^V?85NA1+L<"K3=]CU2'6%*E68\V5>OHKGA30)/
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MF<\*_$K9KC$SQ"SW;#CS1O^R8#0R9?9ES()KVR<?C"O3K*PH4M_K'O1.P?C
MI#V;=\Z>3U:6P%EDN*^<S80/P?N%O29!,;CU51R\_OW6[-9=#\Y*GHW^AT)G
M@EB@-I2&@[MH^]"62:4TK8OWZK_&G(R-89>R5H<YCK?)YTP;@4*O04:U_R5Q
M2SSOCF[/_H5ES\LW(4ZHGKJ);I$G<T.T/O(TW]D/L\5!*WWS R_8'?,\O]^R
MW7FE;[=V7\S[$S5JQ]=P<61G$,A?5LC4\^T^('RBQ0-72MO1Q>/S\T<7/\3\
MC_.7T;NS#V<_GD4OGCZ/J? "#\@8@X:@%_0ZA/.;O7C\7_.H258PQ4F]X+
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M30BM1NN 5($(>/Q[6^=-FG-PY^12\Z9IL:XB+6[H(955^2C9;+*DH'56U>C
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M7/9YWK-5T8;<UVJ]#J_'3%1/RZ04Y[ZJ3?L.YX;;6IAIP*@]><QZ/1:EI.0
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M3LKHTI9'^&5^N+<484*3BHC3<*P#VN[W^:1==0?6<Y >3%0QJDS!2$J.85K
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MS-$B(6I+.!\+EO!J;FG:DJ;HH$E_$HVF_;IG7[BSKXL%;(?-%?X.+?C*G>]
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M\F+#BF'(HA(928*?L5Q'XO/B^#GL23R % 0!$Z55+JTW1 LAJG*<R?\$_VT
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M\ZEVW"*W<0NKI?8XIA7:ZK\UIE4#87N@V7<_I!^=';\.B&I/)>4!86 M*<=
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M)AY6X^I!S5N[M#,DH:RM%\OC Y=M6;,<-O(.W;QH00@L;1=G?'20'UR"0SC
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MR-C>K)H"G\Q<]<34F@(+ER1*+\H"_C8FY?S;HJYLLH)ND!@:K1L3C5=Q831
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MS[AVCB+_-JFA+@+=UJYN9WJL2S&*="5/@LDQ(ZP=)N>%9'OCI7+.U1#LUG1
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M"T%UFZ/E>4S4:;-@;ZY__26<]7G,JN*P__K %7]#TQ1WQAY&3?%IX"XFH+2
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MUT5SHI4VXQ==_W=*+:V4YU+-QZ]N90Z6_0(S]E'GO'C5M!B&E@4CTR!HY6^
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MT@FO[/Y=*%W&P)8CA02L*X,*D,.FTGIF1"DHO!ZJS5><NL[+!A3WX*LS\ I
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M/ADQ?D\X.V[Q.#E,^H,P#"F-N[[?BX'%<3<Y'$!WT \'R1\!.NGA]$:GU+6
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MSDX [;!TE7N:JHEKB5&",[*&Y5L"^C&"^\CP<QH3;G&W; =$_^-?DFWX U?
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M09H)%.38:1 6%1\9G=+#5-GP[P3*NX&. <+NC9Z)J3"0'0J(:)%)8 A]3@)
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MS<U)V 2^>-;=[QST.KN+;<KKD_,66]D6+NZAJ:]'0V._C0"'B(@R+7/  RE
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M_A_MT3\?//H_4$L! A0#%     @ THI74FF+=AF@'04 B)TW !$
M     ( !     &EA<G0M,C R,#$R,S$N:'1M4$L! A0#%     @ THI74N_Q
M'BO;(P  48L! !$              ( !SQT% &EA<G0M,C R,#$R,S$N>'-D
M4$L! A0#%     @ THI74GRC+A7//0  3:4" !4              ( !V4$%
M &EA<G0M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( -**5U)K;J25VM0
M .-<"0 5              "  =M_!0!I87)T+3(P,C Q,C,Q7V1E9BYX;6Q0
M2P$"% ,4    " #2BE=2^?3L0%DE   Z*P  %               @ 'H5 8
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M2P$"% ,4    " #2BE=208SV5XL#  #H#@  %P              @ &!?@P
M:6%R="TR,#(P,3(S,7AE>'@R,RYH=&U02P$"% ,4    " #2BE=2EE$9AQH(
M  "D*   &               @ %!@@P :6%R="TR,#(P,3(S,7AE>'@S,3$N
M:'1M4$L! A0#%     @ THI74I+%GND@"   5"@  !@              ( !
MD8H, &EA<G0M,C R,#$R,S%X97AX,S$R+FAT;5!+ 0(4 Q0    ( -**5U*E
M!C@XA@0  /<1   8              "  >>2# !I87)T+3(P,C Q,C,Q>&5X
M>#,R,2YH=&U02P$"% ,4    " #2BE=2&R8P6Y0$   R$@  &
M    @ &CEPP :6%R="TR,#(P,3(S,7AE>'@S,C(N:'1M4$L! A0#%     @
MTHI74KWF#3G "P  F3@  !@              ( !;9P, &EA<G0M,C R,#$R
C,S%X97AX-#$S+FAT;5!+!08     $  0 #P$  !CJ P    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
